Citrus Sinensis ID: 018304

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------36
Protein Sequence
MRFQLILSNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR
Secondary Structure (PSIPRED)
cccHHHccccccccccccccccccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccccccccccccccccccccccccccEEEEEcccccHHHHcccccccccccccHHHEEEEEEEcccccccccccccccHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccEEEcccccccccccccccccccccEEEEEEccc
Secondary Structure Prediction (SSPRO)
cccEEEEEccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEcccHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEcccccccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHEEEEcccccccccccccEEEEEccccccccccccccccEccEEEEEEEccc
Coil and Loop (DISEMBL)
MRFQLILSNIsektendqiqnidlelpLFELATIVSATNNFsinkklgqggfgpvykgtlvdgQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTnksldsfifdQERCKILDWSKRFHIICGTargvmylhqdSRLRIIHRDLKASnvlldqdmnpkisdfglarafggdetegntkrvigtygymapeyasdgqfsvksdVFSFGILLLEIISgkknrgfyhsdnnlNLIGHAWKLwnegmpsqlidpciqgsfnLAEVIRCIHIGLlcvqqhpkdrpsmpsVILMLgsetvlpqpkqpgyladrnstrldssssrpessstntitiselegr
Flexible Loop (DISEMBL)
MRFQLILSnisektendqiQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLArafggdetegntkRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLADrnstrldssssrpessstntitiselegr
Low Complexity Region (SEG)
MRFQLILSNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLADrnstrldssssrpessstntitisELEGR
Disordered region (IsUnstruct)
*****************QIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQ***********IL************************************************
Disordered Region (DISOPRED)
*************************LPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYL**********************ITISELEGR
Disordered Region (DISEMBL)
MRFQLILSNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLADR****************************
Disordered Region (DISPRO)
*RFQLILSNI***********IDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLADRN************SSSTNTITISELEG*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRFQLILSNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	358	2.2.26 [Sep-21-2011]
O81833	815	G-type lectin S-receptor-	yes	no	0.941	0.413	0.630	1e-123
Q9S972	847	Receptor-like serine/thre	no	no	0.935	0.395	0.605	1e-118
O81905	850	Receptor-like serine/thre	no	no	0.938	0.395	0.626	1e-117
Q39086	843	Receptor-like serine/thre	no	no	0.905	0.384	0.619	1e-117
O81832	783	G-type lectin S-receptor-	no	no	0.969	0.443	0.602	1e-116
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.932	0.396	0.573	1e-115
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.966	0.406	0.589	1e-115
Q9SXB4	820	G-type lectin S-receptor-	no	no	0.913	0.398	0.597	1e-115
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.960	0.412	0.572	1e-113
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.927	0.392	0.601	1e-112

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  441 bits (1134), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 215/341 (63%), Positives = 265/341 (77%), Gaps = 4/341 (1%)

Query: 19  IQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQG 78
           I+  DL+LP+F+  TI  AT++FS    LG+GGFGPVYKG L DGQEIAVKRLS  S QG
Sbjct: 478 IEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQG 537

Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWS 138
           ++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+M NKSLD FIFD+ R   LDW 
Sbjct: 538 VEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWK 597

Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
           KR +II G ARG++YLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGLA++FGGD++E 
Sbjct: 598 KRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSES 657

Query: 199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA 258
           +T RV+GTYGYM PEYA DG FSVKSDVFSFG+L+LEII+GK NRGF H+D++LNL+GH 
Sbjct: 658 STNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHV 717

Query: 259 WKLWNEGMP-SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV 317
           WK+W E        +  ++ +  + EV+RCIH+ LLCVQQ P+DRP+M SV+LM GS++ 
Sbjct: 718 WKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSS 777

Query: 318 LPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           LP P QPG+  +RN   + SS S     S N ++I+ L+GR
Sbjct: 778 LPHPTQPGFFTNRNVPDISSSLSL---RSQNEVSITMLQGR 815

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  424 bits (1090), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 207/342 (60%), Positives = 258/342 (75%), Gaps = 7/342 (2%)

Query: 24  LELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK 83
           LELPL E   +  ATNNFS + KLGQGGFG VYKG L+DG+EIAVKRLSK+S QG  E  
Sbjct: 506 LELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFM 565

Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
           NEV L +KLQH NLV+LLGCC+   EK+LIYE++ N SLDS +FDQ R   L+W KRF I
Sbjct: 566 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 625

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
           I G ARG++YLHQDSR RIIHRDLKASNVLLD++M PKISDFG+AR FG +ETE NT+RV
Sbjct: 626 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 685

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN 263
           +GTYGYM+PEYA DG FS+KSDVFSFG+LLLEIISGK+N+GFY+S+ +LNL+G  W+ W 
Sbjct: 686 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 745

Query: 264 EGMPSQLIDP----CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE-TVL 318
           EG   +++DP     +   F   E++RCI IGLLCVQ+  +DRP M SV++MLGSE T +
Sbjct: 746 EGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAI 805

Query: 319 PQPKQPGYLADR--NSTRLDSSSSRPESSSTNTITISELEGR 358
           PQPK+PG+   R        SS+ R +  + N +T+S ++ R
Sbjct: 806 PQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  423 bits (1088), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 215/343 (62%), Positives = 259/343 (75%), Gaps = 7/343 (2%)

Query: 23  DLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 82
           DLELPL E   +  ATNNFS   KLGQGGFG VYKG L+DGQE+AVKRLSK S QG  E 
Sbjct: 508 DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEF 567

Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
           KNEV L ++LQH NLV+LL CC+   EK+LIYE++ N SLDS +FD+ R   L+W  RF 
Sbjct: 568 KNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFD 627

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           II G ARG++YLHQDSR RIIHRDLKASN+LLD+ M PKISDFG+AR FG DETE NT++
Sbjct: 628 IINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRK 687

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
           V+GTYGYM+PEYA DG FS+KSDVFSFG+LLLEIIS K+N+GFY+SD +LNL+G  W+ W
Sbjct: 688 VVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNW 747

Query: 263 NEGMPSQLIDPCIQGS---FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE-TVL 318
            EG   ++IDP I  S   F   E++RCI IGLLCVQ+  +DRP+M  VILMLGSE T +
Sbjct: 748 KEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTI 807

Query: 319 PQPKQPGYLADRNSTRLDSSSSR---PESSSTNTITISELEGR 358
           PQPK PGY  +R+    DSSSS+    ES + N IT+S L+ R
Sbjct: 808 PQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  421 bits (1081), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 205/331 (61%), Positives = 255/331 (77%), Gaps = 7/331 (2%)

Query: 35  VSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 94
            +ATNNFS + KLGQGGFG VYKG L+DG+EIAVKRLSK+S QG  E  NEV L +KLQH
Sbjct: 513 ATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQH 572

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            NLV+LLGCC+   EK+LIYE++ N SLDS +FDQ R   L+W KRF II G ARG++YL
Sbjct: 573 INLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYL 632

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           HQDSR RIIHRDLKASNVLLD++M PKISDFG+AR FG +ETE NT+RV+GTYGYM+PEY
Sbjct: 633 HQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEY 692

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP- 273
           A DG FS+KSDVFSFG+LLLEIISGK+N+GFY+S+ +LNL+G  W+ W EG   +++DP 
Sbjct: 693 AMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPI 752

Query: 274 ---CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE-TVLPQPKQPGYLAD 329
               +   F   E++RCI IGLLCVQ+  +DRP M SV++MLGSE T +PQPK+PG+   
Sbjct: 753 NIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIG 812

Query: 330 RNSTRLDSSSS--RPESSSTNTITISELEGR 358
           R+    DSSSS  R +  + N IT+S ++ R
Sbjct: 813 RSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  417 bits (1073), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 212/352 (60%), Positives = 267/352 (75%), Gaps = 5/352 (1%)

Query: 8   SNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIA 67
           S +S + + ++    DLELP  +L T+  AT+ FS   KLGQGGFGPVYKGTL  GQE+A
Sbjct: 436 SRVSSRKQEEE----DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVA 491

Query: 68  VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF 127
           VKRLS+ S QG++E KNE+ L +KLQHRNLVK+LG C+  EE++LIYE+  NKSLDSFIF
Sbjct: 492 VKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIF 551

Query: 128 DQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 187
           D+ER + LDW KR  II G ARG++YLH+DSRLRIIHRDLKASNVLLD DMN KISDFGL
Sbjct: 552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611

Query: 188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYH 247
           AR  GGDETE NT RV+GTYGYM+PEY  DG FS+KSDVFSFG+L+LEI+SG++NRGF +
Sbjct: 612 ARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRN 671

Query: 248 SDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF-NLAEVIRCIHIGLLCVQQHPKDRPSMP 306
            ++ LNL+GHAW+ + E    ++ID  +  S  +++EV+R IHIGLLCVQQ PKDRP+M 
Sbjct: 672 EEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMS 731

Query: 307 SVILMLGSETVLPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
            V+LML SE +L  P+QPG+  +RN    D+ S   E  S N  T+S ++ R
Sbjct: 732 VVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  416 bits (1069), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 192/335 (57%), Positives = 258/335 (77%), Gaps = 1/335 (0%)

Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 84
           ELPLFE   + ++T++FS+  KLGQGGFGPVYKG L +GQEIAVKRLS+ S QGL+EL N
Sbjct: 508 ELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMN 567

Query: 85  EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
           EV++ SKLQHRNLVKLLGCCI+GEE++L+YE+M  KSLD+++FD  + KILDW  RF+I+
Sbjct: 568 EVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIM 627

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
            G  RG++YLH+DSRL+IIHRDLKASN+LLD+++NPKISDFGLAR F  +E E NT+RV+
Sbjct: 628 EGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVV 687

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
           GTYGYM+PEYA +G FS KSDVFS G++ LEIISG++N   +  +NNLNL+ +AWKLWN+
Sbjct: 688 GTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWND 747

Query: 265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV-LPQPKQ 323
           G  + L DP +       E+ +C+HIGLLCVQ+   DRP++ +VI ML +E + L  PKQ
Sbjct: 748 GEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPKQ 807

Query: 324 PGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           P ++  R ++  +SS    +  S N ++++ + GR
Sbjct: 808 PAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  415 bits (1067), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 207/351 (58%), Positives = 264/351 (75%), Gaps = 5/351 (1%)

Query: 11  SEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKR 70
           S + + D  Q ID+  P FEL TI+ AT+NFS   KLGQGGFGPVYKG     QEIAVKR
Sbjct: 504 SGRFKQDDSQGIDV--PSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKR 561

Query: 71  LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE 130
           LS+ S QGL+E KNEV+L +KLQHRNLV+LLG C+ GEEKLL+YE+M +KSLD FIFD++
Sbjct: 562 LSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRK 621

Query: 131 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
            C+ LDW  R +II G ARG++YLHQDSRLRIIHRDLK SN+LLD++MNPKISDFGLAR 
Sbjct: 622 LCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARI 681

Query: 191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
           FGG ET  NT RV+GTYGYM+PEYA +G FS KSDVFSFG++++E ISGK+N GF+  + 
Sbjct: 682 FGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEK 741

Query: 251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
           +L+L+GHAW LW      +L+D  +Q S      ++C+++GLLCVQ+ P DRP+M +V+ 
Sbjct: 742 SLSLLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVF 801

Query: 311 MLGSE--TVLPQPKQPGYLADR-NSTRLDSSSSRPESSSTNTITISELEGR 358
           MLGS     LP PKQP ++  R  S+   SSS++PE+ S N +TI+  +GR
Sbjct: 802 MLGSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1

 Score =  415 bits (1067), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 200/335 (59%), Positives = 251/335 (74%), Gaps = 8/335 (2%)

Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 84
           ELPLFE   + +ATNNFS+  KLGQGGFGPVYKG L +GQEIAVKRLS+ S QGL+EL N
Sbjct: 493 ELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVN 552

Query: 85  EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
           EV++ SKLQHRNLVKLLGCCI GEE++L+YEFM  KSLD ++FD  R K+LDW  RF+II
Sbjct: 553 EVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNII 612

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
            G  RG++YLH+DSRLRIIHRDLKASN+LLD+++ PKISDFGLAR F G+E E NT+RV+
Sbjct: 613 NGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVV 672

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
           GTYGYMAPEYA  G FS KSDVFS G++LLEIISG++N       +N  L+ + W +WNE
Sbjct: 673 GTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIISGRRN-------SNSTLLAYVWSIWNE 725

Query: 265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV-LPQPKQ 323
           G  + L+DP I       E+ +CIHIGLLCVQ+   DRPS+ +V  ML SE   +P+PKQ
Sbjct: 726 GEINSLVDPEIFDLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIADIPEPKQ 785

Query: 324 PGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           P +++  N    +SS +     S N +TI+++ GR
Sbjct: 786 PAFISRNNVPEAESSENSDLKDSINNVTITDVTGR 820

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  407 bits (1046), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 201/351 (57%), Positives = 264/351 (75%), Gaps = 7/351 (1%)

Query: 11  SEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKR 70
           S + E D+ +N   ELPLF+L TIV+ATNNFS   KLG GGFGPVYKG L +  EIAVKR
Sbjct: 487 SFRFEQDKARN--RELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKR 544

Query: 71  LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE 130
           LS+ S QG++E KNEV L SKLQHRNLV++LGCC++ EEK+L+YE++ NKSLD FIF +E
Sbjct: 545 LSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEE 604

Query: 131 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
           +   LDW KR  I+ G ARG++YLHQDSRLRIIHRDLKASN+LLD +M PKISDFG+AR 
Sbjct: 605 QRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARI 664

Query: 191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
           FGG++ EG T RV+GT+GYMAPEYA +GQFS+KSDV+SFG+L+LEII+GKKN  F+   +
Sbjct: 665 FGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHEESS 724

Query: 251 NLNLIGHAWKLWNEGMPSQLIDPCI-QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
             NL+GH W LW  G  +++ID  + Q +++  EV++CI IGLLCVQ++  DR  M SV+
Sbjct: 725 --NLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVV 782

Query: 310 LMLG-SETVLPQPKQPGYLADRNSTRLDSSSSRPESS-STNTITISELEGR 358
           +MLG + T LP PK P + + R     + +  + ++  S N +T S+++GR
Sbjct: 783 IMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  406 bits (1044), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 205/341 (60%), Positives = 263/341 (77%), Gaps = 9/341 (2%)

Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 84
           ELPLFEL+TI +ATNNF+   KLG GGFGPVYKG L +G EIAVKRLSK S QG++E KN
Sbjct: 507 ELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKN 566

Query: 85  EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
           EV L SKLQHRNLV++LGCC++ EEK+L+YE++ NKSLD FIF +E+   LDW KR  II
Sbjct: 567 EVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGII 626

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
            G  RG++YLHQDSRLRIIHRDLKASNVLLD +M PKI+DFGLAR FGG++ EG+T RV+
Sbjct: 627 RGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVV 686

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
           GTYGYM+PEYA DGQFS+KSDV+SFG+L+LEII+GK+N  FY  + +LNL+ H W  W  
Sbjct: 687 GTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFY--EESLNLVKHIWDRWEN 744

Query: 265 GMPSQLIDPCI-QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV-LPQPK 322
           G   ++ID  + + +++  EV++C+HIGLLCVQ++  DRP M SV+ MLG   + LP PK
Sbjct: 745 GEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGHNAIDLPSPK 804

Query: 323 QPGYLAD--RNSTRLDSSSSRP--ESSST-NTITISELEGR 358
            P + A   RN+    SS + P  E+SST N +T+++++GR
Sbjct: 805 HPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	358
224113157	786	predicted protein [Populus trichocarpa]	0.986	0.449	0.722	1e-144
224113153	785	predicted protein [Populus trichocarpa]	0.960	0.438	0.734	1e-144
449458261	814	PREDICTED: receptor-like serine/threonin	0.946	0.416	0.719	1e-143
449476944	1267	PREDICTED: receptor-like serine/threonin	0.946	0.267	0.716	1e-142
224124250	820	predicted protein [Populus trichocarpa]	0.966	0.421	0.714	1e-141
224149094	310	predicted protein [Populus trichocarpa]	0.860	0.993	0.759	1e-140
224113149	820	predicted protein [Populus trichocarpa]	0.905	0.395	0.722	1e-137
356546914	788	PREDICTED: G-type lectin S-receptor-like	0.966	0.439	0.662	1e-136
224126243	836	predicted protein [Populus trichocarpa]	0.974	0.417	0.692	1e-136
224149798	361	predicted protein [Populus trichocarpa]	0.888	0.880	0.730	1e-136

>gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa]

 Score =  518 bits (1333), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 260/360 (72%), Positives = 300/360 (83%), Gaps = 7/360 (1%)

Query: 6   ILSNISEKTE----NDQI---QNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKG 58
           I  N SE  E    NDQI   +N DLELP FE A IV+ATNNFSI  KLGQGGFGPVYKG
Sbjct: 427 IRMNPSESAEMDQQNDQITDGENEDLELPQFEFAKIVNATNNFSIKNKLGQGGFGPVYKG 486

Query: 59  TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT 118
           TL DGQEIAVKRLS  S QG KE KNEVIL +KLQHRNLVKLLGC IQ EE+LL+YE+M 
Sbjct: 487 TLEDGQEIAVKRLSMSSRQGSKEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMP 546

Query: 119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM 178
           NKSLDSF+FDQ + K+LDWSKRF+IICG ARG++YLHQDSRLRIIHRDLK+SNVLLD+DM
Sbjct: 547 NKSLDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDM 606

Query: 179 NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           NPKISDFGLAR FGGD+TEGNT RV+GTYGYMAPEYA+DG FSVKSDVFSFGI+LLEI++
Sbjct: 607 NPKISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVT 666

Query: 239 GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQH 298
           GKK+RGFYH DN+L+LIG+AW+LW EG P +L+D   + S+NL+EV++CIHI LLCVQQ+
Sbjct: 667 GKKSRGFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAEESWNLSEVMKCIHISLLCVQQY 726

Query: 299 PKDRPSMPSVILMLGSETVLPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           P+DRPSM SV+LMLG E  LP+PK+PG+  DR      SSSS+ ESSSTN I+ S LE R
Sbjct: 727 PEDRPSMASVVLMLGGERTLPKPKEPGFFKDRGPVEAYSSSSKVESSSTNEISTSVLEPR 786

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa]

 Score =  516 bits (1329), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 255/347 (73%), Positives = 296/347 (85%), Gaps = 3/347 (0%)

Query: 15  ENDQI---QNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRL 71
           +NDQI   +N DLELP FE A IV+ATNNFSI  KLGQGGFGPVYKGTL DGQEIAVKRL
Sbjct: 439 QNDQITDGENEDLELPQFEFAKIVNATNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRL 498

Query: 72  SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQER 131
           S  S QG KE KNEVIL +KLQHRNLVKLLGC IQ EE+LL+YE+M NKSLDSF+FDQ +
Sbjct: 499 SMSSGQGSKEFKNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTK 558

Query: 132 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 191
            K+LDWSKRF+IICG ARG++YLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGLAR F
Sbjct: 559 SKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTF 618

Query: 192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           GGD+TEGNT RV+GTYGYMAPEYA+DG FSVKSDVFSFGI+LLEI++GKK+RGFYH DN+
Sbjct: 619 GGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNS 678

Query: 252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM 311
           L+LIG+AW+LW EG P +L+D   + S+NL+EV++CIHI LLCVQQ+P+DRPSM SV+LM
Sbjct: 679 LSLIGYAWRLWKEGKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLM 738

Query: 312 LGSETVLPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           LG E  LP+PK+PG+  DR      SSSS+ ESSSTN I+ S LE R
Sbjct: 739 LGGERTLPKPKEPGFFKDRGPVEAYSSSSKVESSSTNEISTSVLEPR 785

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus]

 Score =  512 bits (1319), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 244/339 (71%), Positives = 285/339 (84%)

Query: 20  QNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 79
           Q  DLELPLF LATI +AT+NFS   KLG+GGFG V++G L DG+EIAVKRLS  S QG 
Sbjct: 476 QEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGT 535

Query: 80  KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSK 139
            E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+M NKSLDSFIFD  R K+LDWSK
Sbjct: 536 DEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSK 595

Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
           RF+IICG ARG++YLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+AR FGGD+TEGN
Sbjct: 596 RFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGN 655

Query: 200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW 259
           T+RV+GTYGYMAPEYA DGQFS+KSDVFSFGIL+LEIISG+KNRGF+  ++ LNLIGHAW
Sbjct: 656 TRRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEKNRGFFRPNHALNLIGHAW 715

Query: 260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP 319
           KLWNEG P +LID  I  S+ L+EV+RCIH+ LLC+QQ P+DRP+M +V+LML SE  L 
Sbjct: 716 KLWNEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQLPEDRPTMSNVVLMLSSEGSLA 775

Query: 320 QPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           QPKQPG+  +R+S  + S S + ESS TN +TI+ LE R
Sbjct: 776 QPKQPGFYMERDSLEVFSVSGKNESSITNELTITLLEAR 814

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus]

 Score =  512 bits (1319), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 243/339 (71%), Positives = 286/339 (84%)

Query: 20  QNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 79
           Q  DLELPLF LATI +AT+NFS   KLG+GGFG V++G L DG+EIAVKRLS  S QG 
Sbjct: 476 QEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGT 535

Query: 80  KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSK 139
            E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+M NKSLDSFIFD  R K+LDWSK
Sbjct: 536 DEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSK 595

Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
           RF+IICG ARG++YLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+AR FGGD+TEGN
Sbjct: 596 RFNIICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGN 655

Query: 200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW 259
           T+RV+GTYGYMAPEYA DGQFS+KSDVFSFGIL+LEIISG+KNRGF+  ++ LNLIGHAW
Sbjct: 656 TRRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEKNRGFFRPNHALNLIGHAW 715

Query: 260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP 319
           KLWNEG P +LID  I  S+ L+EV+RCIH+ LLC+QQ P+DRP+M +V+LML SE  L 
Sbjct: 716 KLWNEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQLPEDRPTMSNVVLMLSSEGSLA 775

Query: 320 QPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           QPKQPG+  +R+S  + S S + ESS+TN +TI+ LE +
Sbjct: 776 QPKQPGFYMERDSLEVFSVSGKNESSTTNELTITLLEAK 814

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa]

 Score =  506 bits (1303), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 250/350 (71%), Positives = 281/350 (80%), Gaps = 4/350 (1%)

Query: 13  KTENDQIQN---IDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVK 69
           + ENDQI +    DLELPLF+  TI  ATN FS N KLG+GGFGPVYKGTL DGQEIA K
Sbjct: 471 REENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAK 530

Query: 70  RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ 129
            LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+M NKSLDSFIFDQ
Sbjct: 531 TLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQ 590

Query: 130 ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 189
            R K+LDWSKRF IICG ARG++YLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGLAR
Sbjct: 591 TRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLAR 650

Query: 190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD 249
            FGGD+TEGNT RV+GTYGYMAPEYA+DG FSVKSDVFSFGIL+LEIISGKK+RGF H D
Sbjct: 651 MFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFCHPD 710

Query: 250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVI-RCIHIGLLCVQQHPKDRPSMPSV 308
           ++L+LIGHAW+LW +G P  LI+     S NL+EVI RCI+I LLCVQQHP DRPSM +V
Sbjct: 711 HSLSLIGHAWRLWKDGKPLGLIEAFPGESCNLSEVIMRCINISLLCVQQHPDDRPSMATV 770

Query: 309 ILMLGSETVLPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           + MLG E  LPQPK+PG+       R  SSS   E  S N IT S L  R
Sbjct: 771 VWMLGGENTLPQPKEPGFFKGSGPFRPSSSSKNTELFSNNEITSSLLYPR 820

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224149094|ref|XP_002336757.1| predicted protein [Populus trichocarpa] gi|222836664|gb|EEE75057.1| predicted protein [Populus trichocarpa]

 Score =  504 bits (1299), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 234/308 (75%), Positives = 271/308 (87%)

Query: 23  DLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 82
           DLELP FE A IV+ATNNFSI  KLG GGFGPVYKGTL DGQEIAVKRLS  S QG KE 
Sbjct: 2   DLELPQFEFAKIVNATNNFSIKNKLGHGGFGPVYKGTLEDGQEIAVKRLSMSSRQGSKEF 61

Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
           KNEVIL +KLQHRNLVKLLGC IQ EE+LL+YE+M NKSLDSF+FDQ + K+LDWSKRF+
Sbjct: 62  KNEVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFN 121

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           IICG ARG++YLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGLAR FGGD+TEGNT R
Sbjct: 122 IICGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSR 181

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
           V+GTYGYMAPEYA+DG FSVKSDVFSFGI+LLEI++GKK+RGFYH DN+L+LIG+AW+LW
Sbjct: 182 VVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRLW 241

Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
            EG P +L+D   + S+NL+EV++CIHI LLCVQQ+P+DRPSM SV+LMLG E  LP+PK
Sbjct: 242 KEGKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERTLPKPK 301

Query: 323 QPGYLADR 330
           +PG+  DR
Sbjct: 302 EPGFFKDR 309

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa]

 Score =  496 bits (1276), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 237/328 (72%), Positives = 273/328 (83%), Gaps = 4/328 (1%)

Query: 4   QLILSNISEKTENDQIQN---IDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTL 60
           ++ L+  S + ENDQI +    DLELPLF+  TI  ATN FS N KLG+GGFGPVYKGTL
Sbjct: 462 KVTLTAFSNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTL 521

Query: 61  VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK 120
            DGQEIA K  S+ S QG+ E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+M NK
Sbjct: 522 EDGQEIAAKTHSRSSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNK 581

Query: 121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 180
           SLDSFIFDQ R ++LDWSKRF IICG ARG++YLHQDSRLRI+HRDLKASNVLLD+DMNP
Sbjct: 582 SLDSFIFDQTRGELLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNP 641

Query: 181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           KISDFGLAR FGGD+TEGNT RV+GTYGYMAPEYA+DG FSVKSDVFSFGIL+LEIISGK
Sbjct: 642 KISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGK 701

Query: 241 KNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVI-RCIHIGLLCVQQHP 299
           K+RGFYH D++L+LIGHAW+LW +G P  LI+     S NL+EVI RCI+I LLCVQQHP
Sbjct: 702 KSRGFYHPDHSLSLIGHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQQHP 761

Query: 300 KDRPSMPSVILMLGSETVLPQPKQPGYL 327
            DRPSM +V+ MLG E  LPQP +PG+ 
Sbjct: 762 DDRPSMATVVWMLGCENTLPQPNEPGFF 789

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356546914|ref|XP_003541865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max]

 Score =  492 bits (1266), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 230/347 (66%), Positives = 290/347 (83%), Gaps = 1/347 (0%)

Query: 12  EKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRL 71
           +  +N  +Q  D++LP+F+L+TI  AT+NF++  K+G+GGFGPVY+G+L DGQEIAVKRL
Sbjct: 443 KSNQNSGMQVDDMDLPVFDLSTIAKATSNFTVKNKIGEGGFGPVYRGSLTDGQEIAVKRL 502

Query: 72  SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQER 131
           S  S QGL E KNEV L +KLQHRNLVKLLGCC++GEEK+L+YE+M N SLDSFIFD++R
Sbjct: 503 SASSGQGLTEFKNEVKLIAKLQHRNLVKLLGCCLEGEEKMLVYEYMLNGSLDSFIFDEQR 562

Query: 132 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 191
              LDWSKRF+IICG A+G++YLHQDSRLRIIHRDLKASNVLLD ++NPKISDFG+AR F
Sbjct: 563 SGSLDWSKRFNIICGIAKGLLYLHQDSRLRIIHRDLKASNVLLDSELNPKISDFGMARIF 622

Query: 192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           G D+ EGNTKR++GTYGYMAPEYA+DG FSVKSDVFSFG+LLLEIISGK++RG+Y+ +++
Sbjct: 623 GVDQQEGNTKRIVGTYGYMAPEYATDGLFSVKSDVFSFGVLLLEIISGKRSRGYYNQNHS 682

Query: 252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM 311
            NLIGHAWKLW EG P +LID  I+ S +L++++ CIH+ LLCVQQ+P+DRP M SV+LM
Sbjct: 683 QNLIGHAWKLWKEGRPLELIDKSIEDSSSLSQMLHCIHVSLLCVQQNPEDRPGMSSVLLM 742

Query: 312 LGSETVLPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           L SE  LP+PKQPG+   + S   DSS+S+ + SSTN ITI+ LE R
Sbjct: 743 LVSELELPEPKQPGFFG-KYSGEADSSTSKQQLSSTNEITITLLEAR 788

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa]

 Score =  491 bits (1265), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 248/358 (69%), Positives = 281/358 (78%), Gaps = 9/358 (2%)

Query: 10  ISEKT-----ENDQIQN---IDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV 61
           +SEKT     ENDQI +    D+ELPLF+  TI  ATN FS+N K+G+GGFGPVYKGTL 
Sbjct: 479 LSEKTGGNREENDQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLE 538

Query: 62  DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKS 121
           DGQEIAVK LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+M N+S
Sbjct: 539 DGQEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRS 598

Query: 122 LDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 181
           LDSFIFDQ R K+LDWSKRF IICG ARG++YLHQDSRLRI+HRDLKASNVLLD+DMNPK
Sbjct: 599 LDSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPK 658

Query: 182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKK 241
           ISDFGLAR  GGD+TEGNT RVIGTYGYMAPEYA+DG FSVKSDVFSFGIL+LEIISGKK
Sbjct: 659 ISDFGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKK 718

Query: 242 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVI-RCIHIGLLCVQQHPK 300
           +RGFYH D +L+L  HAW+LW +G P  LI+     S NL+EVI RCI+I LLCVQ HP 
Sbjct: 719 SRGFYHPDRSLSLTAHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQHHPD 778

Query: 301 DRPSMPSVILMLGSETVLPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITISELEGR 358
           DRPSM +V+ MLG E  LPQP +PG+          SSSS  E  S N  T S L  R
Sbjct: 779 DRPSMATVVWMLGGENTLPQPNEPGFFKGSGPFGPSSSSSNIELYSNNEFTASLLYPR 836

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224149798|ref|XP_002336866.1| predicted protein [Populus trichocarpa] gi|222837033|gb|EEE75412.1| predicted protein [Populus trichocarpa]

 Score =  491 bits (1264), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 239/327 (73%), Positives = 271/327 (82%), Gaps = 9/327 (2%)

Query: 10  ISEKT-----ENDQIQN---IDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV 61
           I EKT     ENDQI +    DLELPLF+  TI  ATN FS N KLG+GGFGPVYKGTL 
Sbjct: 4   IPEKTGGNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLE 63

Query: 62  DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKS 121
           DGQEIA K  S+ S QG+ E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+M NKS
Sbjct: 64  DGQEIAAKTHSRSSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKS 123

Query: 122 LDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 181
           LDSFIFDQ R ++LDWSKRF IICG ARG++YLHQDSRLRI+HRDLKASNVLLD+DMNPK
Sbjct: 124 LDSFIFDQTRGELLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPK 183

Query: 182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKK 241
           ISDFGLAR FGGD+TEGNT RV+GTYGYMAPEYA+DG FSVKSDVFSFGIL+LEIISGKK
Sbjct: 184 ISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKK 243

Query: 242 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVI-RCIHIGLLCVQQHPK 300
           +RGFYH D++L+LIGHAW+LW +G P  LI+     S NL+EVI RCI+I LLCVQQHP 
Sbjct: 244 SRGFYHPDHSLSLIGHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQQHPD 303

Query: 301 DRPSMPSVILMLGSETVLPQPKQPGYL 327
           DRPSM +V+ MLG E  LPQP +PG+ 
Sbjct: 304 DRPSMATVVWMLGCENTLPQPNEPGFF 330

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	358
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.868	0.381	0.653	1e-109
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.879	0.402	0.631	1.3e-107
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.846	0.359	0.649	3.1e-106
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.846	0.357	0.646	8.3e-106
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.849	0.357	0.652	4.6e-105
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.837	0.353	0.611	1.4e-103
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.857	0.458	0.609	4.9e-101
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.846	0.365	0.615	3.4e-100
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.832	0.359	0.593	4.1e-100
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.893	0.474	0.574	4.4e-100

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1084 (386.6 bits), Expect = 1.0e-109, P = 1.0e-109
 Identities = 204/312 (65%), Positives = 251/312 (80%)

Query:    19 IQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQG 78
             I+  DL+LP+F+  TI  AT++FS    LG+GGFGPVYKG L DGQEIAVKRLS  S QG
Sbjct:   478 IEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQG 537

Query:    79 LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWS 138
             ++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+M NKSLD FIFD+ R   LDW 
Sbjct:   538 VEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWK 597

Query:   139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
             KR +II G ARG++YLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGLA++FGGD++E 
Sbjct:   598 KRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSES 657

Query:   199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA 258
             +T RV+GTYGYM PEYA DG FSVKSDVFSFG+L+LEII+GK NRGF H+D++LNL+GH 
Sbjct:   658 STNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHV 717

Query:   259 WKLWNEGMPSQLIDP-CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV 317
             WK+W E    ++ +   ++ +  + EV+RCIH+ LLCVQQ P+DRP+M SV+LM GS++ 
Sbjct:   718 WKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSS 777

Query:   318 LPQPKQPGYLAD 329
             LP P QPG+  +
Sbjct:   778 LPHPTQPGFFTN 789

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
 Identities = 202/320 (63%), Positives = 252/320 (78%)

Query:     8 SNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIA 67
             S +S + + ++    DLELP  +L T+  AT+ FS   KLGQGGFGPVYKGTL  GQE+A
Sbjct:   436 SRVSSRKQEEE----DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVA 491

Query:    68 VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF 127
             VKRLS+ S QG++E KNE+ L +KLQHRNLVK+LG C+  EE++LIYE+  NKSLDSFIF
Sbjct:   492 VKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIF 551

Query:   128 DQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 187
             D+ER + LDW KR  II G ARG++YLH+DSRLRIIHRDLKASNVLLD DMN KISDFGL
Sbjct:   552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611

Query:   188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYH 247
             AR  GGDETE NT RV+GTYGYM+PEY  DG FS+KSDVFSFG+L+LEI+SG++NRGF +
Sbjct:   612 ARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRN 671

Query:   248 SDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF-NLAEVIRCIHIGLLCVQQHPKDRPSMP 306
              ++ LNL+GHAW+ + E    ++ID  +  S  +++EV+R IHIGLLCVQQ PKDRP+M 
Sbjct:   672 EEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMS 731

Query:   307 SVILMLGSETVLPQPKQPGY 326
              V+LML SE +L  P+QPG+
Sbjct:   732 VVVLMLSSEMLLLDPRQPGF 751

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1051 (375.0 bits), Expect = 3.1e-106, P = 3.1e-106
 Identities = 200/308 (64%), Positives = 245/308 (79%)

Query:    24 LELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK 83
             LELPL EL  + +ATNNFS + KLGQGGFG VYKG L+DG+EIAVKRLSK+S QG  E  
Sbjct:   502 LELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFM 561

Query:    84 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
             NEV L +KLQH NLV+LLGCC+   EK+LIYE++ N SLDS +FDQ R   L+W KRF I
Sbjct:   562 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 621

Query:   144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
             I G ARG++YLHQDSR RIIHRDLKASNVLLD++M PKISDFG+AR FG +ETE NT+RV
Sbjct:   622 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 681

Query:   204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN 263
             +GTYGYM+PEYA DG FS+KSDVFSFG+LLLEIISGK+N+GFY+S+ +LNL+G  W+ W 
Sbjct:   682 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 741

Query:   264 EGMPSQLIDPC----IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV-L 318
             EG   +++DP     +   F   E++RCI IGLLCVQ+  +DRP M SV++MLGSET  +
Sbjct:   742 EGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAI 801

Query:   319 PQPKQPGY 326
             PQPK+PG+
Sbjct:   802 PQPKRPGF 809

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1047 (373.6 bits), Expect = 8.3e-106, P = 8.3e-106
 Identities = 199/308 (64%), Positives = 243/308 (78%)

Query:    24 LELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK 83
             LELPL E   +  ATNNFS + KLGQGGFG VYKG L+DG+EIAVKRLSK+S QG  E  
Sbjct:   506 LELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFM 565

Query:    84 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
             NEV L +KLQH NLV+LLGCC+   EK+LIYE++ N SLDS +FDQ R   L+W KRF I
Sbjct:   566 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 625

Query:   144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
             I G ARG++YLHQDSR RIIHRDLKASNVLLD++M PKISDFG+AR FG +ETE NT+RV
Sbjct:   626 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 685

Query:   204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN 263
             +GTYGYM+PEYA DG FS+KSDVFSFG+LLLEIISGK+N+GFY+S+ +LNL+G  W+ W 
Sbjct:   686 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 745

Query:   264 EGMPSQLIDP----CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV-L 318
             EG   +++DP     +   F   E++RCI IGLLCVQ+  +DRP M SV++MLGSET  +
Sbjct:   746 EGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAI 805

Query:   319 PQPKQPGY 326
             PQPK+PG+
Sbjct:   806 PQPKRPGF 813

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1040 (371.2 bits), Expect = 4.6e-105, P = 4.6e-105
 Identities = 201/308 (65%), Positives = 239/308 (77%)

Query:    23 DLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 82
             DLELPL E   +  ATNNFS   KLGQGGFG VYKG L+DGQE+AVKRLSK S QG  E 
Sbjct:   508 DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEF 567

Query:    83 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             KNEV L ++LQH NLV+LL CC+   EK+LIYE++ N SLDS +FD+ R   L+W  RF 
Sbjct:   568 KNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFD 627

Query:   143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
             II G ARG++YLHQDSR RIIHRDLKASN+LLD+ M PKISDFG+AR FG DETE NT++
Sbjct:   628 IINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRK 687

Query:   203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
             V+GTYGYM+PEYA DG FS+KSDVFSFG+LLLEIIS K+N+GFY+SD +LNL+G  W+ W
Sbjct:   688 VVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNW 747

Query:   263 NEGMPSQLIDPCIQGS---FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE-TVL 318
              EG   ++IDP I  S   F   E++RCI IGLLCVQ+  +DRP+M  VILMLGSE T +
Sbjct:   748 KEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTI 807

Query:   319 PQPKQPGY 326
             PQPK PGY
Sbjct:   808 PQPKAPGY 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 1009 (360.2 bits), Expect = 1.4e-103, Sum P(2) = 1.4e-103
 Identities = 184/301 (61%), Positives = 244/301 (81%)

Query:    25 ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 84
             EL ++ L  I +AT+NFS + KLG+GGFGPVY GTL  G+E+AVKRL + S QGL+E KN
Sbjct:   514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573

Query:    85 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             EVIL +KLQHRNLV+LLGCCI  EEK+L+YE+M NKSLD+F+F+ E+ ++LDW KRF II
Sbjct:   574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633

Query:   145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
              G ARG++YLH+DSRLR++HRDLKASN+LLD DM PKISDFG+AR FGGD+ + NT RV+
Sbjct:   634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693

Query:   205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
             GT+GYM+PEYA +G FSVKSDV+ FG+L+LEII+GK+   F+  +++LN+ G+AW+ WNE
Sbjct:   694 GTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNE 753

Query:   265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV-LPQPKQ 323
                ++LIDP I+ S ++ +V+RCIHI LLCVQ H  +RP +P+VILML +++  LP P+ 
Sbjct:   754 DNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRP 813

Query:   324 P 324
             P
Sbjct:   814 P 814

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
 Identities = 189/310 (60%), Positives = 242/310 (78%)

Query:    17 DQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE 76
             D I   D  L L +  TI +AT++F  + K+GQGGFG VYKGTL DG E+AVKRLSK S 
Sbjct:   326 DDITTAD-SLQL-DYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSG 383

Query:    77 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD 136
             QG  E KNEV+L +KLQHRNLV+LLG C+ GEE++L+YE++ NKSLD F+FD  +   LD
Sbjct:   384 QGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLD 443

Query:   137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
             W++R+ II G ARG++YLHQDSRL IIHRDLKASN+LLD DMNPKI+DFG+AR FG D+T
Sbjct:   444 WTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQT 503

Query:   197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG 256
             E NT R++GTYGYM+PEYA  GQ+S+KSDV+SFG+L+LEIISGKKN  FY +D   +L+ 
Sbjct:   504 EENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVS 563

Query:   257 HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET 316
             +AW LW+ G P +L+DP I  +    EV+RC+HIGLLCVQ+ P +RP++ +++LML S T
Sbjct:   564 YAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNT 623

Query:   317 V-LPQPKQPG 325
             V LP P+QPG
Sbjct:   624 VTLPVPRQPG 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 994 (355.0 bits), Expect = 3.4e-100, P = 3.4e-100
 Identities = 187/304 (61%), Positives = 233/304 (76%)

Query:    25 ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 84
             ELPLFE   +  ATNNFSI  KLGQGGFG VYKG L +G +IAVKRLS+ S QG++E  N
Sbjct:   496 ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVN 555

Query:    85 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             EV++ SKLQHRNLV+LLG CI+GEE++L+YEFM    LD+++FD  + ++LDW  RF+II
Sbjct:   556 EVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNII 615

Query:   145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
              G  RG+MYLH+DSRL+IIHRDLKASN+LLD+++NPKISDFGLAR F G+E E +T RV+
Sbjct:   616 DGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVV 675

Query:   205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
             GTYGYMAPEYA  G FS KSDVFS G++LLEI+SG++N  FY+   N NL  +AWKLWN 
Sbjct:   676 GTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNT 735

Query:   265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV-LPQPKQ 323
             G    L+DP I       E+ RC+H+GLLCVQ H  DRPS+ +VI ML SE   LP+PKQ
Sbjct:   736 GEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQ 795

Query:   324 PGYL 327
             P ++
Sbjct:   796 PAFI 799

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 959 (342.6 bits), Expect = 4.1e-100, Sum P(2) = 4.1e-100
 Identities = 178/300 (59%), Positives = 229/300 (76%)

Query:    29 FELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVIL 88
             F+   IV+ATNNF    KLGQGGFG VYKGT   G ++AVKRLSK S QG +E +NEV++
Sbjct:   496 FDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENEVVV 555

Query:    89 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA 148
              +KLQHRNLV+LLG C++GEEK+L+YEF+ NKSLD F+FD    + LDW++R+ II G A
Sbjct:   556 VAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIA 615

Query:   149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             RG++YLHQDSRL IIHRDLKA N+LLD DMNPK++DFG+AR FG D+TE NT+RV+GTYG
Sbjct:   616 RGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGTYG 675

Query:   209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL-NLIGHAWKLWNEGMP 267
             YMAPEYA  GQFS+KSDV+SFG+L+ EIISG KN   Y  D+++ NL+ + W+LW+ G  
Sbjct:   676 YMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTYTWRLWSNGSQ 735

Query:   268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG-SETVLPQPKQPGY 326
               L+DP    ++   ++ RCIHI LLCVQ+   DRP+M +++ ML  S  VL  PKQPG+
Sbjct:   736 LDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSAIVQMLTTSSIVLAVPKQPGF 795

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 993 (354.6 bits), Expect = 4.4e-100, P = 4.4e-100
 Identities = 185/322 (57%), Positives = 246/322 (76%)

Query:     8 SNISEKTEN-DQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEI 66
             + +S +TE+ D+      E   F+ + I +ATN FS + KLG GGFG VYKG L+ G+ +
Sbjct:   313 NKLSAETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETV 372

Query:    67 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI 126
             A+KRLS+ S QG +E KNEV + +KLQHRNL KLLG C+ GEEK+L+YEF+ NKSLD F+
Sbjct:   373 AIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFL 432

Query:   127 FDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 186
             FD E+ ++LDW +R+ II G ARG++YLH+DSRL IIHRDLKASN+LLD DM+PKISDFG
Sbjct:   433 FDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFG 492

Query:   187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFY 246
             +AR FG D+T+ NTKR++GTYGYM+PEYA  G++SVKSDV+SFG+L+LE+I+GKKN  FY
Sbjct:   493 MARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFY 552

Query:   247 HSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP 306
               D   +L+ + WKLW E  P +L+D  ++G+F   EVIRCIHI LLCVQ+   +RPSM 
Sbjct:   553 EEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMD 612

Query:   307 SVILMLGSETV-LPQPKQPGYL 327
              +++M+ S TV LP PK+ G+L
Sbjct:   613 DILVMMNSFTVTLPIPKRSGFL 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	358
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-57
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-57
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-54
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-49
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-47
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-40
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-39
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-36
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-35
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-30
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-30
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-29
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-29
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-28
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-27
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-27
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-26
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-26
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-26
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-26
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-25
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-25
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-25
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-24
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-24
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-23
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-23
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-23
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-22
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-21
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-20
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-20
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-20
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-20
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-20
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-19
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-15
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-13
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-10
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	7e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	8e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  186 bits (475), Expect = 3e-57
 Identities = 95/274 (34%), Positives = 138/274 (50%), Gaps = 34/274 (12%)

Query: 42  SINKKLGQGGFGPVYKGTLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 95
           ++ KKLG+G FG VYKGTL         E+AVK L +  SEQ ++E   E  +  KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N+VKLLG C + E  +++ E+M    L  ++    R K L  S         ARG+ YL 
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE 120

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT---YGYMAP 212
                  IHRDL A N L+ +++  KISDFGL+R    D  + +  +V G      +MAP
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAP 173

Query: 213 EYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E   +G+F+ KSDV+SFG+LL EI + G++    Y   +N  ++ +  K     +P    
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEE---PYPGMSNAEVLEYLKK--GYRLPK--P 226

Query: 272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
             C    + L          L C  + P+DRP+ 
Sbjct: 227 PNCPPELYKLM---------LQCWAEDPEDRPTF 251

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  186 bits (475), Expect = 3e-57
 Identities = 95/281 (33%), Positives = 141/281 (50%), Gaps = 35/281 (12%)

Query: 42  SINKKLGQGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 95
           ++ KKLG+G FG VYKG L         E+AVK L +  SEQ ++E   E  +  KL H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N+VKLLG C + E   ++ E+M    L S++  ++    L  S         ARG+ YL 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT---YGYMAP 212
                  IHRDL A N L+ +++  KISDFGL+R    D  + +  R  G      +MAP
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAP 172

Query: 213 EYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E   +G+F+ KSDV+SFG+LL EI + G++    Y   +N  ++ +   L N     Q  
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ---PYPGMSNEEVLEY---LKNGYRLPQ-P 225

Query: 272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
             C    ++L          L C  + P+DRP+   ++ +L
Sbjct: 226 PNCPPELYDLM---------LQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  178 bits (453), Expect = 6e-54
 Identities = 91/291 (31%), Positives = 128/291 (43%), Gaps = 53/291 (18%)

Query: 45  KKLGQGGFGPVYKGTLVDGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 99
           KKLG+G FG VYKG L        E+AVK L +  SE+  K+   E  +  KL H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKRFHIICGTARGVMY 153
           LLG C + E   L+ E+M    L  ++      F       L            A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT--YGYMA 211
           L      + +HRDL A N L+ +D+  KISDFGL+R     + +   K+  G     +MA
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRD--VYDDDYYRKKTGGKLPIRWMA 175

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIIS-------GKKN---RGFYHSDNNLNLIGHAWKL 261
           PE   DG F+ KSDV+SFG+LL EI +       G  N     +      L         
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP-------- 227

Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                P    + C      L E++        C Q  P+DRP+   ++  L
Sbjct: 228 ----KP----EYC---PDELYELMLS------CWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  176 bits (448), Expect = 2e-53
 Identities = 79/208 (37%), Positives = 109/208 (52%), Gaps = 17/208 (8%)

Query: 41  FSINKKLGQGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH 94
             + KKLG+G FG VYKGTL         ++AVK L +  SE+  +E   E  +  KL H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            N+V+LLG C QGE   ++ E+M    L  F+        L       +    A+G+ YL
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEYL 118

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTKRVIGTYGYMA 211
                   +HRDL A N L+ +++  KISDFGL+R    D+     G  K  I    +MA
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMA 172

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE   DG+F+ KSDV+SFG+LL EI + 
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (421), Expect = 8e-50
 Identities = 70/194 (36%), Positives = 99/194 (51%), Gaps = 11/194 (5%)

Query: 47  LGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 104
           LG+GGFG VY       G+++A+K + K     L E L  E+ +  KL H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                  L+ E+    SL   +  +E    L   +   I+     G+ YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 165 RDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YASDGQFSV 222
           RDLK  N+LLD D    K++DFGL++    D++   T    GT  YMAPE     G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSE 173

Query: 223 KSDVFSFGILLLEI 236
           KSD++S G++L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  165 bits (421), Expect = 2e-49
 Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 24/266 (9%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 98
           + I +KLG+G FG VY       G+ +A+K + K   +  +E +  E+ +  KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L       ++  L+ E+     L   +  ++R ++ +   RF  +      + YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
              I+HRDLK  N+LLD+D + K++DFGLAR     E        +GT  YMAPE     
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171

Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS 278
            +    D++S G++L E+++GK     +  D+ L  +           P    D     S
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKP---PFPGDDQLLELFKKIGKPKPPFPPPEWDI----S 224

Query: 279 FNLAEVIRCIHIGLLCVQQHPKDRPS 304
               ++IR        + + P+ R +
Sbjct: 225 PEAKDLIRK------LLVKDPEKRLT 244

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  161 bits (410), Expect = 1e-47
 Identities = 82/274 (29%), Positives = 140/274 (51%), Gaps = 33/274 (12%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
            ++  + LG+G FG VY     D G+ +AVK   LS  SE+ L+ L+ E+ + S LQH N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 97  LVKLLGCCIQGEEK-LLIY-EFMTNKSLDSFIFDQERCKILDWS--KRF--HIICGTARG 150
           +V+  G     E+  L I+ E+++  SL S +   ++   L     +++   I+ G    
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEG---- 113

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      I+HRD+K +N+L+D D   K++DFG A+  G  ET   T  V GT  +M
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           APE     ++   +D++S G  ++E+ +GK    +    N +  +   +K+ + G P ++
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK--PPWSELGNPMAAL---YKIGSSGEPPEI 225

Query: 271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
             P      +L+E          C+++ PK RP+
Sbjct: 226 --PE-----HLSEE--AKDFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (407), Expect = 4e-47
 Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 12/204 (5%)

Query: 41  FSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 97
           + + +KLG G FG VYK      G+ +AVK L K     +  +  + E+ +  +L H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+L+      +   L+ E+     L  ++        L   +   I     RG+ YLH  
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLH-- 115

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YAS 216
               IIHRDLK  N+LLD++   KI+DFGLA+      +   T   +GT  YMAPE    
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLG 172

Query: 217 DGQFSVKSDVFSFGILLLEIISGK 240
              +  K DV+S G++L E+++GK
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  142 bits (360), Expect = 2e-40
 Identities = 65/201 (32%), Positives = 110/201 (54%), Gaps = 9/201 (4%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           F I +K+G+GGFG VYK      G+E+A+K +   S++  +++ NE+ +  K +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
             G  ++ +E  ++ EF +  SL   +  +   + L  S+  ++     +G+ YLH    
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ 219
             IIHRD+KA+N+LL  D   K+ DFGL+              ++GT  +MAPE  +   
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173

Query: 220 FSVKSDVFSFGILLLEIISGK 240
           +  K+D++S GI  +E+  GK
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  139 bits (351), Expect = 5e-39
 Identities = 85/268 (31%), Positives = 131/268 (48%), Gaps = 29/268 (10%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           F++ +KLG G FG V++G   +   +A+K L        ++ + EV    +L+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
              C  GE   +I E M   SL +F+   E  ++L  +    + C  A G+ YL +    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF 220
             IHRDL A N+L+ +D+  K++DFGLAR    D    + K++   Y + APE AS G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 221 SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFN 280
           S KSDV+SFGILL E+ +     G               ++   GM +  +   I   + 
Sbjct: 182 STKSDVWSFGILLYEMFT----YG---------------QVPYPGMNNHEVYDQITAGYR 222

Query: 281 LAEVIRCIH----IGLLCVQQHPKDRPS 304
           +    +C      I L C    P+DRPS
Sbjct: 223 MPCPAKCPQEIYKIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  133 bits (336), Expect = 8e-37
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 10/202 (4%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  + +KLG G FG V+ GT     ++AVK L K      +    E  +  KL+H  LV
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L   C + E   ++ E+M+  SL  F+   E  K L   +   +    A G+ YL    
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLE--- 120

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYAS 216
               IHRDL A N+L+ +++  KI+DFGLAR    DE       K  I    + APE A+
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI---KWTAPEAAN 177

Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
            G+F++KSDV+SFGILL EI++
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 2e-36
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 29/213 (13%)

Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRN 96
           N+ +   +G+G FG VYKG  L  G  +A+K++S  KI E+ LK +  E+ L   L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH------IICGTA-- 148
           +VK +G     +   +I E+  N SL   I            K+F       +       
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQV 108

Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
            +G+ YLH+     +IHRD+KA+N+L  +D   K++DFG+A        +  +  V+GT 
Sbjct: 109 LQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTP 163

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            +MAPE       S  SD++S G  ++E+++G 
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  130 bits (328), Expect = 3e-35
 Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 27/205 (13%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 103
           +K+G+G  G VYK T    G+E+A+K++ ++ +Q  + + NE+++    +H N+V     
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDS 83

Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF----HI--ICG-TARGVMYLHQ 156
            + G+E  ++ E+M   SL           I+  +        I  +C    +G+ YLH 
Sbjct: 84  YLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEY 214
                +IHRD+K+ N+LL +D + K++DFG    F    T+  +KR  V+GT  +MAPE 
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPYWMAPEV 187

Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                +  K D++S GI+ +E+  G
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  121 bits (306), Expect = 3e-32
 Identities = 72/215 (33%), Positives = 111/215 (51%), Gaps = 25/215 (11%)

Query: 45  KKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNL 97
           ++LG+G FG VYKG L           +A+K L + +E  ++ E + E  L S LQH N+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIF-------------DQERCKILDWSKRFHII 144
           V LLG C + +   +++E++ +  L  F+              D+     LD S   HI 
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTKRV 203
              A G+ YL   S    +HRDL A N L+ + +  KISDFGL+R  +  D     +K +
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           +    +M PE    G+F+ +SD++SFG++L EI S
Sbjct: 188 LPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  120 bits (304), Expect = 4e-32
 Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 21/212 (9%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 96
            + I K++G+G FG VY      DG+   +K   LS +SE+  ++  NEV +  KL H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC-------KILDWSKRFHIICGTAR 149
           ++K      +  +  ++ E+     L   I  Q++        +ILDW   F  +C    
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
            + YLH  SR +I+HRD+K  N+ L  +   K+ DFG+++          T  V+GT  Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKK 241
           ++PE   +  ++ KSD++S G +L E+ + K 
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (303), Expect = 5e-32
 Identities = 72/198 (36%), Positives = 104/198 (52%), Gaps = 23/198 (11%)

Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLLGC 103
           +G+G FG V  G    GQ++AVK L   S  ++  L E      + + L+H NLV+LLG 
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEAS----VMTTLRHPNLVQLLGV 68

Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-LDWSKRFHIICGTARGVMYLHQDSRLRI 162
            +QG    ++ E+M   SL  ++  + R  I L     F +      G+ YL +      
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGMEYLEEK---NF 123

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQF 220
           +HRDL A NVL+ +D+  K+SDFGLA+       E +  +  G     + APE   + +F
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKF 176

Query: 221 SVKSDVFSFGILLLEIIS 238
           S KSDV+SFGILL EI S
Sbjct: 177 STKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 5e-32
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 22/214 (10%)

Query: 47  LGQGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVK 99
           LG+G FG V    LV     G+  A+K L K   I  + ++    E  + S++ H  +VK
Sbjct: 1   LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 100 LLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           L     Q EEKL L+ E+     L S +  +E     + ++ +         + YLH   
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFY--AAEIVLALEYLH--- 110

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
            L II+RDLK  N+LLD D + K++DFGLA+    + +  NT    GT  Y+APE     
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168

Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
            +    D +S G+LL E+++GK    FY  D   
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK--PPFYAEDRKE 200

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  117 bits (296), Expect = 4e-31
 Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 10/201 (4%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           F I +KLG+G +G VYK      GQ +A+K +    E+ L+E+  E+ +  +     +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
             G   +  +  ++ E+    S+   +  +   K L   +   I+  T +G+ YLH    
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ 219
            + IHRD+KA N+LL+++   K++DFG++       T      VIGT  +MAPE   +  
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 220 FSVKSDVFSFGILLLEIISGK 240
           ++ K+D++S GI  +E+  GK
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (302), Expect = 5e-31
 Identities = 85/329 (25%), Positives = 134/329 (40%), Gaps = 25/329 (7%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-R 95
           ++ I +KLG+G FG VY     D + +A+K L+K      + ++    E+ + + L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N+VKL           L+ E++   SL+  +    R   L  S+   I+      + YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 156 QDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGGDETEGN----TKRVIGTYGYM 210
                 IIHRD+K  N+LLD+D    K+ DFGLA+      +  +        +GT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 211 APEYA---SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           APE     S    S  SD++S GI L E+++G        + +  +       +     P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233

Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYL 327
           S            +++    +   LL     PK+R S  S +    S  +L   K     
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAK--DPKNRLSSSSDL----SHDLLAHLKLKESD 287

Query: 328 ADRNSTRLDSSSSRPESSSTNTITISELE 356
                   DS+  R     +    IS L 
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLN 316

Length = 384

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 6e-31
 Identities = 70/204 (34%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 45  KKLGQGGFGPVYKGTLV--DGQEI--AVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 99
           K+LG G FG V KG  +   G+E+  AVK L +      K E   E  + ++L H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
           L+G C +GE  +L+ E      L  ++  +    + D  +  H +   A G+ YL     
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV---AMGMAYLESK-- 114

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPEY 214
              +HRDL A NVLL      KISDFG++RA G             T G     + APE 
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPEC 169

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
            + G+FS KSDV+S+G+ L E  S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 8e-31
 Identities = 69/196 (35%), Positives = 99/196 (50%), Gaps = 10/196 (5%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           +KLG G FG V++G   +   +AVK L K      K+   E  +  KL+H  L++L   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
              E   ++ E M   SL  ++      + L   +   +    A G+ YL   +    IH
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQN---YIH 126

Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--TKRVIGTYGYMAPEYASDGQFSV 222
           RDL A NVL+ ++   K++DFGLAR    D  E     K  I    + APE A   +FS+
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK---WTAPEAALYNRFSI 183

Query: 223 KSDVFSFGILLLEIIS 238
           KSDV+SFGILL EI++
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (294), Expect = 1e-30
 Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 35/275 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 95
           ++    K LGQG  G VYK      G+  A+K++     E+  K+L  E+  L S  +  
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-----RG 150
            +VK  G   +  E  ++ E+M   SL   +   ++       +    +         +G
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGK--IPEP---VLAYIARQILKG 111

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      IIHRD+K SN+L++     KI+DFG+++    + T       +GT  YM
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYM 167

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF-YHSDNNLNLIGHAWKLWNEGMPSQ 269
           +PE      +S  +D++S G+ LLE   GK    F +      +       + +   PS 
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGK----FPFLPPGQPSFFELMQAICDGPPPSL 223

Query: 270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
              P  + S    + I        C+Q+ PK RPS
Sbjct: 224 ---PAEEFSPEFRDFISA------CLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 1e-30
 Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 8/197 (4%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           +K+G+G FG VYKG L    E+AVK  R +   +   K L+   IL  +  H N+VKL+G
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIG 59

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
            C+Q +   ++ E +   SL +F+  +++   L   K   +    A G+ YL   +    
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSV 222
           IHRDL A N L+ ++   KISDFG++R   G     +         + APE  + G+++ 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 223 KSDVFSFGILLLEIISG 239
           +SDV+S+GILL E  S 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  116 bits (293), Expect = 2e-30
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 45  KKLGQGGFGPVYKGT---LVDGQ--EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 98
           K+LG+G FG V       L D    ++AVK L+    EQ   + + E+ +   L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 99  KLLGCC--IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           K  G C    G    LI E++ + SL  ++  Q     ++  +         +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTKRVIGTYGYMAPEY 214
               R IHRDL A N+L++ +   KISDFGLA+      D            + Y APE 
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
               +FS  SDV+SFG+ L E+ +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  116 bits (292), Expect = 3e-30
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 51/236 (21%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-Q 93
           ++F   K +G+G F  V         +E A+K L K   I E+ +K +K E  + ++L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFI-----FDQERCK-----ILDWSKRFH 142
           H  ++KL     Q EE L  + E+  N  L  +I      D++  +     IL       
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL------ 113

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
                   + YLH      IIHRDLK  N+LLD+DM+ KI+DFG A+    + +  + K 
Sbjct: 114 -------ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163

Query: 203 VI------------------GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
                               GT  Y++PE  ++      SD+++ G ++ ++++GK
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  115 bits (290), Expect = 4e-30
 Identities = 92/279 (32%), Positives = 130/279 (46%), Gaps = 43/279 (15%)

Query: 47  LGQGGFGPVYKGTLVD-------GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 96
           LG G FG VY+GT  D          +AVK L K     E+  KE   E  L S   H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK----ILDWSKRFHIICGTARGVM 152
           +VKLLG C+  E + +I E M    L S++ D    +    +L   +   I    A+G +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 153 YLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFGLAR-AFGGDETEGNTKRVIGT 206
           YL Q   +  IHRDL A N L+     D D   KI DFGLAR  +  D      + ++  
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEG 265
             +MAPE   DG+F+ +SDV+SFG+L+ EI++ G++    Y + NN  ++ H       G
Sbjct: 178 R-WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP---YPALNNQEVLQHV----TAG 229

Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
              Q  + C    + L            C  Q P +RP+
Sbjct: 230 GRLQKPENCPDKIYQLM---------TNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  115 bits (290), Expect = 5e-30
 Identities = 75/301 (24%), Positives = 121/301 (40%), Gaps = 78/301 (25%)

Query: 47  LGQGGFGPVYKGT---LVDGQE---IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 99
           LG+G FG V+ G    L    +   +AVK L + +    ++  + E  L +  QH N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF---------IFDQER--CKILDWSKRFHIICGTA 148
             G C +G+  ++++E+M +  L+ F                    L  S+   I    A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT-- 206
            G++YL   +    +HRDL   N L+  D+  KI DFG++R    D    +  RV G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 207 --YGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
               +M PE     +F+ +SDV+SFG++L EI +  K   +  S+               
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------------- 231

Query: 265 GMPSQLIDPCIQGSFNLAEVIRCI-----------------HIGLLCVQQHPKDRPSMPS 307
                             EVI CI                  I L C ++ P+ R ++  
Sbjct: 232 ------------------EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKD 273

Query: 308 V 308
           +
Sbjct: 274 I 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 1e-29
 Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 10/205 (4%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 93
           +  +I K +G G FG V +G L     +EI  A+K L +  S++   +   E  +  +  
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N+++L G   +    ++I E+M N SLD F+  +E        +   ++ G A G+ Y
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           L   S +  +HRDL A N+L++ ++  K+SDFGL+R     E    TK       + APE
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178

Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +F+  SDV+SFGI++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  113 bits (284), Expect = 3e-29
 Identities = 89/269 (33%), Positives = 131/269 (48%), Gaps = 28/269 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
               + KKLG G FG V+ G      ++A+K L K      +    E  L  +LQH  LV
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L     Q E   +I E+M N SL  F+   E  K L  +K   +    A G+ ++    
Sbjct: 65  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIE--- 119

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTKRVIGTYGYMAPEYA 215
           R   IHRDL+A+N+L+ + +  KI+DFGLAR    +E    EG  K  I    + APE  
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG-AKFPI---KWTAPEAI 175

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           + G F++KSDV+SFGILL EI++    R  Y    N  +I +  + +   MP    D C 
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVT--YGRIPYPGMTNPEVIQNLERGYR--MPRP--DNCP 229

Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
           +  + L           LC ++ P++RP+
Sbjct: 230 EELYELM---------RLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 4e-29
 Identities = 66/209 (31%), Positives = 110/209 (52%), Gaps = 23/209 (11%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQ----EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLV 98
           K LG G FG VYKG  + +G+     +A+K L  + S +  KE+ +E  + + + H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-----LDWSKRFHIICGTARGVMY 153
           +LLG C+   +  LI + M    L  ++    +  I     L+W  +       A+G+ Y
Sbjct: 73  RLLGICL-SSQVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQI------AKGMSY 124

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           L +    R++HRDL A NVL+    + KI+DFGLA+    DE E + +       +MA E
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 214 YASDGQFSVKSDVFSFGILLLEIIS-GKK 241
                 ++ KSDV+S+G+ + E+++ G K
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 2e-28
 Identities = 81/302 (26%), Positives = 136/302 (45%), Gaps = 60/302 (19%)

Query: 39  NNFSINKKLGQGGFGPVYKG---TLVDGQ---EIAVKRLSK---ISEQGLKELKNEVILF 89
              ++ ++LGQG FG VY+G    +V G+    +A+K +++   + E+   E  NE  + 
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63

Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILD--WSKRFHI 143
            +    ++V+LLG    G+  L++ E M    L S++     + E    L     ++F  
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 144 ICG-TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL      + +HRDL A N ++ +D+  KI DFG+ R    D  E +  R
Sbjct: 124 MAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYR 176

Query: 203 VIGT----YGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-------GKKNRGFYHSDNN 251
             G       +MAPE   DG F+ KSDV+SFG++L E+ +       G  N      +  
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEV 230

Query: 252 LNLIGHAWKL-WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
           L  +     L   E  P +L++                 +  +C Q +PK RP+   ++ 
Sbjct: 231 LKFVIDGGHLDLPENCPDKLLE-----------------LMRMCWQYNPKMRPTFLEIVS 273

Query: 311 ML 312
            L
Sbjct: 274 SL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  110 bits (277), Expect = 3e-28
 Identities = 74/196 (37%), Positives = 103/196 (52%), Gaps = 10/196 (5%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           KKLG G FG V+ G   +  ++AVK L K     ++    E  L   LQH  LV+L    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            + E   +I E+M   SL  F+   E  K+L   K        A G+ Y+    R   IH
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 126

Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+NVL+ + +  KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTI 183

Query: 223 KSDVFSFGILLLEIIS 238
           KSDV+SFGILL EI++
Sbjct: 184 KSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  109 bits (273), Expect = 1e-27
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 24/225 (10%)

Query: 40  NFSINKKLGQGGFGPVYKGTLV----DGQE--IAVKRLSKI-SEQGLKELKNEVILFSKL 92
           + ++ + LG G FG VY+G       D  E  +AVK L +  SEQ   +   E ++ SK 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD----QERCKILDWSKRFHIICGTA 148
            H+N+V+L+G   +   + ++ E M    L SF+ +     ER   L            A
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARAFGGDETEGNTKRVIG 205
           +G  YL ++     IHRD+ A N LL         KI+DFG+AR            R + 
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-------GKKNR 243
              +M PE   DG F+ K+DV+SFG+LL EI S       G+ N+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  107 bits (268), Expect = 5e-27
 Identities = 85/263 (32%), Positives = 132/263 (50%), Gaps = 28/263 (10%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           KKLG G FG V+ GT     ++AVK L K      +    E  +  KL+H  LV+L    
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV- 69

Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
           +  E   ++ E+M+  SL  F+ D E  + L       +    A G+ Y+    R+  IH
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+++N+L+   +  KI+DFGLAR    +E    T R    +   + APE A  G+F++
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTI 182

Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS-FNL 281
           KSDV+SFGILL E+++  K R  Y   NN  ++    + +          PC Q    +L
Sbjct: 183 KSDVWSFGILLTELVT--KGRVPYPGMNNREVLEQVERGYRM--------PCPQDCPISL 232

Query: 282 AEVIRCIHIGLLCVQQHPKDRPS 304
            E++      L C ++ P++RP+
Sbjct: 233 HELM------LQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  106 bits (266), Expect = 2e-26
 Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 26/219 (11%)

Query: 42  SINKKLGQGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSKL-Q 93
           ++ K LG+G FG V K   V          +AVK L    +E+ L +L +E+ +   + +
Sbjct: 15  TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG------- 146
           H+N++ LLG C Q     ++ E+  + +L  F+  + R      S               
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKD 133

Query: 147 -------TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
                   ARG+ +L      + IHRDL A NVL+ +D   KI+DFGLAR     +    
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  105 bits (264), Expect = 2e-26
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 10/208 (4%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-IAVKR--LSKISEQGLKELKNEVILFSKLQHR 95
           +++ + + +G G    VY    +   E +A+KR  L K     + EL+ EV   S+  H 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N+VK     + G+E  L+  +++  SL   +        LD +    ++    +G+ YLH
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTKRVIGTYGYMAPE 213
            + +   IHRD+KA N+LL +D + KI+DFG++ +   GGD T    K  +GT  +MAPE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 214 YASDGQ-FSVKSDVFSFGILLLEIISGK 240
                  +  K+D++SFGI  +E+ +G 
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  106 bits (265), Expect = 3e-26
 Identities = 75/211 (35%), Positives = 104/211 (49%), Gaps = 18/211 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSKISEQGLKE-LKNEVILFSK 91
           NN S  K LG G FG V + T   L       ++AVK L   +    +E L +E+ + S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           L  H N+V LLG C  G   L+I E+     L +F+  ++R   L            A+G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTKRVIGTY 207
           + +L   +    IHRDL A NVLL      KI DFGLAR    D     +GN +  +   
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            +MAPE   +  ++ +SDV+S+GILL EI S
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 4e-26
 Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           K+LG G FG V+ G      ++A+K + +  +SE    E   E  +  KL H NLV+L G
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYG 66

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
            C +     ++ E+M N  L +++  +ER   L       +       + YL  +     
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---F 121

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYASDGQF 220
           IHRDL A N L+ +D   K+SDFGLAR    D+  +   TK  +    +  PE     +F
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK---WAPPEVFDYSRF 178

Query: 221 SVKSDVFSFGILLLEIISGKK 241
           S KSDV+SFG+L+ E+ S  K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  104 bits (261), Expect = 4e-26
 Identities = 75/279 (26%), Positives = 129/279 (46%), Gaps = 49/279 (17%)

Query: 40  NFSINKKLGQGGFGPVYKGTL-VDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 96
           +F I  K+G+G FG V+K     D +  A+K+  LSK++ +  +E  +E  + +KL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD---WSKRFHIICGTARGVMY 153
           +++     +   +  ++ E+  N  L   +  Q    + +   W  RF I      G+ +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           LH     +I+HRD+K+ N+ LD   N KI D G+A+    +    NT  ++GT  Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
              D  ++ KSDV++ G++L E  +GK                H +   N+G    LI  
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK----------------HPFDANNQG---ALILK 212

Query: 274 CIQGSF---------NLAEVIRCIHIGLLCVQQHPKDRP 303
            I+G F          LA++I        C+ +  + RP
Sbjct: 213 IIRGVFPPVSQMYSQQLAQLID------QCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  105 bits (263), Expect = 4e-26
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 50/299 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGT---LVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSK 91
           NN    + +GQG FG V++     L+  +    +AVK L +  S     + + E  L ++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--------------------FDQER 131
             H N+VKLLG C  G+   L++E+M    L+ F+                         
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 132 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-A 190
              L  +++  I    A G+ YL   S  + +HRDL   N L+ ++M  KI+DFGL+R  
Sbjct: 125 LP-LSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180

Query: 191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD 249
           +  D  + +    I    +M PE     +++ +SDV+++G++L EI S G +    Y+  
Sbjct: 181 YSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP---YYGM 236

Query: 250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
            +  +I +      +G      D C    +NL           LC  + P DRPS  S+
Sbjct: 237 AHEEVIYYV----RDGNVLSCPDNCPLELYNLMR---------LCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  103 bits (258), Expect = 9e-26
 Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 19/201 (9%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLVK 99
            ++ + +G+G FG V +G    GQ++AVK +   ++ Q   E   E  + +KL H+NLV+
Sbjct: 8   LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVR 63

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
           LLG  I      ++ E M+  +L +F+  + R  ++   +        A G+ YL     
Sbjct: 64  LLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK-- 119

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARA--FGGDETEGNTKRVIGTYGYMAPEYASD 217
            +++HRDL A N+L+ +D   K+SDFGLAR    G D ++   K       + APE    
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKH 171

Query: 218 GQFSVKSDVFSFGILLLEIIS 238
            +FS KSDV+S+G+LL E+ S
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  103 bits (258), Expect = 1e-25
 Identities = 84/273 (30%), Positives = 131/273 (47%), Gaps = 38/273 (13%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           +  + KKLG G FG V+  T     ++AVK + K     ++    E  +   LQH  LVK
Sbjct: 7   SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE-----RCKILDWSKRFHIICGTARGVMYL 154
           L    +  E   +I EFM   SL  F+   E       K++D+S +       A G+ ++
Sbjct: 66  L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFI 118

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTKRVIGTYGYMA 211
            Q +    IHRDL+A+N+L+   +  KI+DFGLAR    +E    EG    +     + A
Sbjct: 119 EQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI----KWTA 171

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           PE  + G F++KSDV+SFGILL+EI++    R  Y   +N  +I    +    G      
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVI----RALERGYRMPRP 225

Query: 272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
           + C +  +N         I + C +  P++RP+
Sbjct: 226 ENCPEELYN---------IMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (257), Expect = 1e-25
 Identities = 75/252 (29%), Positives = 119/252 (47%), Gaps = 42/252 (16%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           +++G G FG V+ G  ++ +++A+K  R   +SE+   E   E  +  KL H  LV+L G
Sbjct: 10  QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLYG 66

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR--FHIICGTARGVMYLHQDSRL 160
            C +     L++EFM +  L  ++    R +   +S+     +      G+ YL   +  
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT---YGYMAPEYASD 217
            +IHRDL A N L+ ++   K+SDFG+ R    D+   +T    GT     + +PE  S 
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSF 175

Query: 218 GQFSVKSDVFSFGILLLEIISGKK---------------NRGF------YHSDNNLNLIG 256
            ++S KSDV+SFG+L+ E+ S  K               N GF        S +   L+ 
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235

Query: 257 HAWKLWNEGMPS 268
           H WK   E  PS
Sbjct: 236 HCWKERPEDRPS 247

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  103 bits (259), Expect = 1e-25
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 22/215 (10%)

Query: 46  KLGQGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           +LG+G FG V+      L+  Q+   +AVK L + SE   ++ + E  L + LQH+++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF---------IFDQER---CKILDWSKRFHIICGT 147
             G C +G   L+++E+M +  L+ F         I           L   +   I    
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A G++YL   + L  +HRDL   N L+ Q +  KI DFG++R     +      R +   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKK 241
            +M PE     +F+ +SD++SFG++L EI + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  103 bits (257), Expect = 3e-25
 Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 46/293 (15%)

Query: 40  NFSINKKLGQGGFGPVYKGT------LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKL 92
           N  + K LG+G FG V K T            +AVK L + +    L++L +E  L  ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI---------------------FDQER 131
            H +++KL G C Q    LLI E+    SL SF+                      D   
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 132 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 191
            + L            +RG+ YL   + ++++HRDL A NVL+ +    KISDFGL+R  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
             +++     +      +MA E   D  ++ +SDV+SFG+LL EI++   N     +   
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237

Query: 252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
           L      + L   G   +  + C +  +NL          L C +Q P  RP+
Sbjct: 238 L------FNLLKTGYRMERPENCSEEMYNLM---------LTCWKQEPDKRPT 275

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  102 bits (255), Expect = 3e-25
 Identities = 65/198 (32%), Positives = 105/198 (53%), Gaps = 11/198 (5%)

Query: 42  SINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           ++  KLG G +G VY+G        +AVK L K     ++E   E  +  +++H NLV+L
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
           LG C +     +I EFMT  +L  ++ +  R + ++     ++    +  + YL + +  
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN-- 124

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD--ETEGNTKRVIGTYGYMAPEYASDG 218
             IHRDL A N L+ ++   K++DFGL+R   GD        K  I    + APE  +  
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYN 180

Query: 219 QFSVKSDVFSFGILLLEI 236
           +FS+KSDV++FG+LL EI
Sbjct: 181 KFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 5e-25
 Identities = 68/212 (32%), Positives = 111/212 (52%), Gaps = 19/212 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKR-----LSKISEQGLKELKNEVILFSKL 92
            N+   K LGQG FG VY    VD G+E+AVK+      S  +++ +  L+ E+ L   L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 93  QHRNLVKLLGCCIQGEEKLLIY-EFMTNKSLDSFIFDQERCKILDWSKRF--HIICGTAR 149
           QH  +V+  G C++ +E L I+ E+M   S+   +           ++++   I+     
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQIL----E 115

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TKRVIGTYG 208
           GV YLH +    I+HRD+K +N+L D   N K+ DFG ++      + G   K V GT  
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           +M+PE  S   +  K+DV+S G  ++E+++ K
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 5e-25
 Identities = 72/268 (26%), Positives = 127/268 (47%), Gaps = 30/268 (11%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 98
           F++ + +G+G FG VYK       Q +A+K +  + +E  +++++ E+   S+ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           K  G  ++G +  +I E+    S      D  +   LD +    I+     G+ YLH++ 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEYAS 216
               IHRD+KA+N+LL ++ + K++DFG++    G  T   +KR   +GT  +MAPE   
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
              +  K+D++S GI  +E+  G+      H    L LI       N   P  L      
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-----NN--PPSLEGNKF- 223

Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
            S    + +        C+ + PK+RPS
Sbjct: 224 -SKPFKDFVSL------CLNKDPKERPS 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  101 bits (254), Expect = 5e-25
 Identities = 68/200 (34%), Positives = 109/200 (54%), Gaps = 13/200 (6%)

Query: 47  LGQGGFGPVYKGTLVD--GQEI--AVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLL 101
           +G+G FG VY GTL+D  GQ+I  AVK L++I++ + +++   E I+     H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 102 GCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
           G C+  E   L++  +M +  L +FI  +     +     F +    A+G+ YL      
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYASDG 218
           + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E     
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 219 QFSVKSDVFSFGILLLEIIS 238
           +F+ KSDV+SFG+LL E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 6e-25
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 28/218 (12%)

Query: 41  FSINKKLGQGGFGPVYKGTLV--DG--QEIAVK--RLSKISEQGLKELKNEVILFSKLQH 94
             + K LG+G FG V +G L   DG   ++AVK  +L   +   ++E  +E        H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 95  RNLVKLLGCCIQGEEK------LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI----- 143
            N++KL+G C +          ++I  FM +  L SF+      ++    ++  +     
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLK 117

Query: 144 -ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD-ETEGNT 200
            +   A G+ YL   S    IHRDL A N +L +DM   ++DFGL++  + GD   +G  
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174

Query: 201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            ++     ++A E  +D  ++ KSDV++FG+ + EI +
Sbjct: 175 AKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  101 bits (252), Expect = 7e-25
 Identities = 86/265 (32%), Positives = 133/265 (50%), Gaps = 34/265 (12%)

Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           KLGQG FG V+ GT     ++A+K L K      +    E  +  KL+H  LV L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70

Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
             E   ++ EFM   SL  F+ + +  K L   +   +    A G+ Y+    R+  IHR
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSVK 223
           DL+A+N+L+  ++  KI+DFGLAR    +E    T R    +   + APE A  G+F++K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 224 SDVFSFGILLLEIISGKKNRGFYHSDNN---LNLIGHAWKLWNEGMPSQLIDPCIQG-SF 279
           SDV+SFGILL E+++  K R  Y    N   L  +   +++           PC QG   
Sbjct: 184 SDVWSFGILLTELVT--KGRVPYPGMVNREVLEQVERGYRM-----------PCPQGCPE 230

Query: 280 NLAEVIRCIHIGLLCVQQHPKDRPS 304
           +L E+++      LC ++ P +RP+
Sbjct: 231 SLHELMK------LCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (252), Expect = 8e-25
 Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 61/280 (21%)

Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLS-----KISEQGLKELKNEVILFSKLQHRNLVKL 100
           LG G FG VY+G  L DG   AVK +S     +  ++ +K+L+ E+ L SKLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 101 LGCCIQGEEKLLIY-EFMTNKSLDSFI-----FDQERCK-----ILDWSKRFHIICGTAR 149
           LG   + E+ L I+ E +   SL   +     F +   +     IL              
Sbjct: 68  LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ YLH       +HRD+K +N+L+D +   K++DFG+A+           K   G+  +
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYW 167

Query: 210 MAPEY-ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG--- 265
           MAPE  A  G + + +D++S G  +LE+ +GK              +   +K+       
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELP 221

Query: 266 -MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
            +P  L       S    + I        C+Q+ P  RP+
Sbjct: 222 PIPDHL-------SDEAKDFIL------KCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  100 bits (252), Expect = 1e-24
 Identities = 65/207 (31%), Positives = 86/207 (41%), Gaps = 25/207 (12%)

Query: 45  KKLGQGGFGPVYKGTLVDGQ----EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 99
           KKLG G FG V +G           +AVK L        + +   E  +   L H NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG----TARGVMYLH 155
           L G  +     + + E     SL     D+ R   L        +C      A G+ YL 
Sbjct: 61  LYGVVLTHPLMM-VTELAPLGSL----LDRLRKDALG-HFLISTLCDYAVQIANGMRYLE 114

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTKRVIGTYGYMA 211
                R IHRDL A N+LL  D   KI DFGL RA   +E     E + K       + A
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF---AWCA 168

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIIS 238
           PE      FS  SDV+ FG+ L E+ +
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  100 bits (251), Expect = 1e-24
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 17/205 (8%)

Query: 47  LGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 99
           LG+G FG V+    KG   +G E  + VK L K  ++    E + E+ +F KL H+N+V+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKRFHIICGTARGVMY 153
           LLG C + E   +I E+     L  F+       ++ +   L   ++  +    A G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           L   S  R +HRDL A N L+      K+S   L++     E     +  +    ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPE 188

Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
              +  FS KSDV+SFG+L+ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  100 bits (250), Expect = 2e-24
 Identities = 68/195 (34%), Positives = 105/195 (53%), Gaps = 11/195 (5%)

Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV+L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70

Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
             E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    R+  +HR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSVK 223
           DL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A  G+F++K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 224 SDVFSFGILLLEIIS 238
           SDV+SFGILL E+ +
Sbjct: 184 SDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-24
 Identities = 66/243 (27%), Positives = 115/243 (47%), Gaps = 31/243 (12%)

Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKRLSK------ISEQGLKELKNEVILFSKLQHRNL 97
            K+G+G +G VYK    + G+ +A+K++        I +  L+E+K    L  +L H N+
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNI 60

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           +KLL       +  L++EFM +  L   I  ++R + L  S     +    +G+ + H  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTKRVIGTYGYMAPE- 213
               I+HRDLK  N+L++ +   K++DFGLAR+FG      T       + T  Y APE 
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH-----YVVTRWYRAPEL 169

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
              D  +S   D++S G +  E++S    R  +   + ++ +   ++    G P   + P
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR---RPLFPGKSEIDQLFKIFRTL--GTPDPEVWP 224

Query: 274 CIQ 276
              
Sbjct: 225 KFT 227

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  100 bits (250), Expect = 2e-24
 Identities = 86/288 (29%), Positives = 137/288 (47%), Gaps = 53/288 (18%)

Query: 45  KKLGQGGFGPVYK---GTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   + + L++ + E+ +   LQH N+VK
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSL-DSFIFDQERC---KILDWSKRFHIICGTARGVMY 153
             G C   G   L L+ E++   SL D     +ER    K+L ++ +   IC   +G+ Y
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ---IC---KGMEY 123

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG---TYGYM 210
           L      R +HRDL   N+L++ +   KI DFGL +    D+ E    R  G    + Y 
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY- 178

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           APE  ++ +FSV SDV+SFG++L E+        F +SD + +      ++       Q+
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQM 230

Query: 271 IDPCIQGSFNLAEVIR----------C---IH-IGLLCVQQHPKDRPS 304
           I       ++L E+++          C   I+ I   C    P  RPS
Sbjct: 231 I------VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-24
 Identities = 74/216 (34%), Positives = 116/216 (53%), Gaps = 36/216 (16%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKE--LKNEVILFSKLQHR 95
           +   +KLG+G +G VYK      G+ +A+K  RL    E+G+    L+ E+ L  +L+H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR-EISLLKELKHP 58

Query: 96  NLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI-LDWSKR--FHIICGTARGV 151
           N+VKLL   I  E KL L++E+  +  L  ++ D+    +  +  K   + ++ G A   
Sbjct: 59  NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLA--- 112

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
            Y H     RI+HRDLK  N+L+++D   K++DFGLARAFG       T  V+ T  Y A
Sbjct: 113 -YCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRA 166

Query: 212 PE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
           PE       Y++    +V  D++S G +  E+I+GK
Sbjct: 167 PEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =   99 bits (250), Expect = 3e-24
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 37/218 (16%)

Query: 41  FSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ 93
           +    ++G+G +G VYK      G+ +A+K++   +E        ++E+K    L  KL+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56

Query: 94  HRNLVKLLGCCIQGEEK--LLIYEFMTNKSLDSFI------FDQERCKILDWSKRFHIIC 145
           H N+V+L        +    +++E+M +  L   +      F + + K          + 
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK--------CYMK 107

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
               G+ YLH +    I+HRD+K SN+L++ D   K++DFGLAR +    +   T RVI 
Sbjct: 108 QLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163

Query: 206 TYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           T  Y  PE    A+  ++  + D++S G +L E+  GK
Sbjct: 164 TLWYRPPELLLGAT--RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 98.9 bits (247), Expect = 4e-24
 Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 28/229 (12%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHR 95
           +F + + +G+G FG V      D +++ A+K ++K   + +  ++ + NE  +  +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 96  NLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTAR 149
            LV L     Q EE + L+ + +    L   +     F +E+ K          IC    
Sbjct: 61  FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIVL 111

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
            + YLH      IIHRD+K  N+LLD+  +  I+DF +A     D     T    GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF-YHSDNNLNLIGH 257
           MAPE      +SV  D +S G+   E + GK  R +  HS    + I  
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGK--RPYRGHSRTIRDQIRA 212

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 98.9 bits (247), Expect = 5e-24
 Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 32/209 (15%)

Query: 45  KKLGQGGFGPVYKGTLV-DGQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLV 98
            +LG G  G V K      G+ +AVK +       I +Q L+EL    IL  K     +V
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD-WSKRF------HIICGTARGV 151
              G      +  +  E+M   SLD         KIL     R        I     +G+
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLD---------KILKEVQGRIPERILGKIAVAVLKGL 113

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
            YLH   + +IIHRD+K SN+L++     K+ DFG++    G       K  +GT  YMA
Sbjct: 114 TYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMA 167

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE      +SVKSD++S G+ L+E+ +G+
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 98.7 bits (246), Expect = 7e-24
 Identities = 71/278 (25%), Positives = 134/278 (48%), Gaps = 43/278 (15%)

Query: 47  LGQGGFGP--VYK----GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           LG+G FG   +Y+     +LV  +E+ + RLS   E+  ++  NE+++ S LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
               +     L+  E+    +L   I  Q+  ++ +       +      V Y+H+    
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAG-- 121

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF 220
            I+HRD+K  N+ L +    K+ DFG+++  G + +   T  V+GT  YM+PE     ++
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178

Query: 221 SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFN 280
           + KSD+++ G +L E+++ K+    + + N LNL+    K+             +QG++ 
Sbjct: 179 NFKSDIWALGCVLYELLTLKRT---FDATNPLNLV---VKI-------------VQGNYT 219

Query: 281 L------AEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                  +E+I  +H     +QQ P+ RP+   V+   
Sbjct: 220 PVVSVYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 98.8 bits (246), Expect = 1e-23
 Identities = 68/222 (30%), Positives = 123/222 (55%), Gaps = 23/222 (10%)

Query: 28  LFELATIVSATN---NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELK 83
           L +L TIVS  +    ++  +K+GQG  G VY    V  GQE+A+K+++ + +Q  KEL 
Sbjct: 5   LEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELI 63

Query: 84  -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
            NE+++  + +H N+V  L   + G+E  ++ E++   SL   +   E C  +D      
Sbjct: 64  INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEG---- 115

Query: 143 IICGTARGVM----YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
            I    R  +    +LH +   ++IHRD+K+ N+LL  D + K++DFG       ++++ 
Sbjct: 116 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172

Query: 199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           +T  ++GT  +MAPE  +   +  K D++S GI+ +E++ G+
Sbjct: 173 ST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 98.6 bits (245), Expect = 1e-23
 Identities = 69/217 (31%), Positives = 113/217 (52%), Gaps = 29/217 (13%)

Query: 45  KKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           ++LG+  FG VYKG L         Q +A+K L   +E  L+E  K+E ++ S+LQH N+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIF-------------DQERCKILDWSKRFHII 144
           V LLG   + +   +I+ + ++  L  F+              D+     L+ +   HI+
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD--ETEGNTK 201
              A G+ +L   S   ++H+DL   NVL+   +N KISD GL R  +  D  +  GN+ 
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187

Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             I    +M+PE    G+FS+ SD++S+G++L E+ S
Sbjct: 188 LPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 20/224 (8%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRL-------SKISEQGLKELKNEVILF 89
             NF I KK+G+G F  VYK   L+DG+ +A+K++       +K  +  LKE+     L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56

Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-FDQERCKILDWSKRFHIICGTA 148
            +L H N++K L   I+  E  ++ E      L   I   +++ +++     +       
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + ++H     RI+HRD+K +NV +      K+ D GL R F    T  ++   +GT  
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPY 171

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
           YM+PE   +  ++ KSD++S G LL E+ + +    FY    NL
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 98.2 bits (244), Expect = 2e-23
 Identities = 68/234 (29%), Positives = 116/234 (49%), Gaps = 27/234 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKL 92
           +N  + ++LG+G FG V+      L   Q+   +AVK L   S+   K+   E  L + L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI----------LDWSKRFH 142
           QH ++VK  G C++G+  ++++E+M +  L+ F+       +          L  S+  H
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           I    A G++YL   +    +HRDL   N L+ +++  KI DFG++R    D    +  R
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYR 177

Query: 203 VIG----TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
           V G       +M PE     +F+ +SDV+S G++L EI +  K   +  S+N +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 35/272 (12%)

Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
            K+G G FG VY    L  G+ +AVK  R+     + +KE+ +E+ +   L+H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWS--KRFHIICGTARGVMYLHQDSR 159
           G  +  E+  +  E+ +  +L+  +   E  +ILD    + + +      G+ YLH    
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTL--QLLEGLAYLHSH-- 118

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET----EGNTKRVIGTYGYMAPEYA 215
             I+HRD+K +N+ LD +   K+ DFG A     + T    E  +    GT  YMAPE  
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPEVI 175

Query: 216 SDGQFSVK---SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 272
           + G+       +D++S G ++LE+ +GK  R +   DN   ++ H       G    + D
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGK--RPWSELDNEFQIMFHV----GAGHKPPIPD 229

Query: 273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
             +Q S    E    +     C++  PK RP+
Sbjct: 230 S-LQLS---PEGKDFLD---RCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 95.8 bits (238), Expect = 5e-23
 Identities = 75/263 (28%), Positives = 123/263 (46%), Gaps = 32/263 (12%)

Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCCI 105
           LG+G FG V+KGTL D   +AVK   +   Q LK +  +E  +  +  H N+VKL+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
           Q +   ++ E +      SF+  +++   L   +        A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 166 DLKASNVLLDQDMNPKISDFGLARAF-GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKS 224
           DL A N L+ ++   KISDFG++R    G  +    K++     + APE  + G++S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175

Query: 225 DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEV 284
           DV+S+GILL E  S             L +  +       GM +Q     ++  + ++  
Sbjct: 176 DVWSYGILLWETFS-------------LGVCPYP------GMTNQQAREQVEKGYRMSCP 216

Query: 285 IRC----IHIGLLCVQQHPKDRP 303
            +C      +   C    P++RP
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRP 239

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 96.2 bits (239), Expect = 7e-23
 Identities = 77/288 (26%), Positives = 142/288 (49%), Gaps = 42/288 (14%)

Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQ 93
           ++ +  K +G G FG V++G L + G++   +A+K L    +E+  ++  +E  +  +  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWS--KRFHIICGTARGV 151
           H N+++L G   + +  ++I E+M N +LD ++ D +     ++S  +   ++ G A G+
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGM 120

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--Y 209
            YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D+ EG      G     +
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRW 176

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE  +  +F+  SDV+SFGI++ E++S G++                    W+  M +
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER------------------PYWD--MSN 216

Query: 269 QLIDPCIQGSFNLAEVIRC----IHIGLLCVQQHPKDRPSMPSVILML 312
             +   I   F L   + C      + L C QQ    RP    ++ +L
Sbjct: 217 HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 96.3 bits (240), Expect = 7e-23
 Identities = 74/236 (31%), Positives = 122/236 (51%), Gaps = 21/236 (8%)

Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLL 101
           +K+G+G +G VYKG     GQ +A+K++   SE +G+      E+ L  +LQH N+V L 
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 102 GCCIQGEEKLLIYEFMT---NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
              +Q     LI+EF++    K LDS    Q     L  S  + I+    +G+++ H   
Sbjct: 66  DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH--- 118

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             R++HRDLK  N+L+D     K++DFGLARAF G      T  V+ T  Y APE     
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGS 176

Query: 219 Q-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
             +S   D++S G +  E+ +    +  +H D+ ++ +   +++   G P++ + P
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT---KKPLFHGDSEIDQLFRIFRIL--GTPTEDVWP 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 7e-23
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 30/223 (13%)

Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QH 94
            T  F + + +G+G +G VYK      GQ +A+K +  I ++  +E+K E  +  K   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62

Query: 95  RNLVKLLGCCIQ-----GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRF------H 142
            N+    G  I+      +++L L+ E     S    + D  +  +    KR       +
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIAY 117

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           I+  T RG+ YLH++   ++IHRD+K  N+LL ++   K+ DFG++     D T G    
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT 172

Query: 203 VIGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIISGK 240
            IGT  +MAPE        D  +  +SDV+S GI  +E+  GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 96.3 bits (239), Expect = 8e-23
 Identities = 65/216 (30%), Positives = 125/216 (57%), Gaps = 15/216 (6%)

Query: 30  ELATIVSATN---NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKEL-KN 84
           +L TIVS  +    ++  +K+GQG  G V+    V  GQE+A+K+++ + +Q  KEL  N
Sbjct: 7   KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIIN 65

Query: 85  EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
           E+++  +L++ N+V  L   + G+E  ++ E++   SL   +   E C  +D ++   + 
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETC--MDEAQIAAVC 121

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               + + +LH +   ++IHRD+K+ NVLL  D + K++DFG       ++++ +T  ++
Sbjct: 122 RECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           GT  +MAPE  +   +  K D++S GI+ +E++ G+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.4 bits (238), Expect = 9e-23
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 22/210 (10%)

Query: 45  KKLGQGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLV 98
           + +G+G FG V K   V    DG+ +  K +    ++E+  ++L +EV +  +L+H N+V
Sbjct: 6   ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 99  KLLGCCIQGEEKLL--IYEFMTNKSLDSFIFDQERCK----ILDWSKRFHIICGTARGVM 152
           +     I    + L  + E+     L   I   ++CK     ++    + I+      + 
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 153 YLH--QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
             H   D    ++HRDLK +N+ LD + N K+ DFGLA+  G D +   T   +GT  YM
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYM 177

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGK 240
           +PE  +   +  KSD++S G L+ E+ +  
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.4 bits (237), Expect = 1e-22
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 34/213 (15%)

Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLS------KISEQGLKELKNEVILFSKLQHRNLVKL 100
           LG+G +G VY G    GQ IAVK++         +E+  ++L+ EV L   L+H N+V+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH-----IICGTAR----GV 151
           LG C+      +  EF+   S+ S +             RF      + C   +    GV
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQILDGV 115

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF---GGDETEGNT-KRVIGTY 207
            YLH +    ++HRD+K +NV+L  +   K+ DFG AR     G   T  N  K + GT 
Sbjct: 116 AYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            +MAPE  ++  +  KSD++S G  + E+ +GK
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 39/218 (17%)

Query: 47  LGQGGFGPVYKGTLVD-GQEIAVKRL---SKISEQG-------LKELKNEVILFSKLQHR 95
           +G+G +G VY    V  G+ +AVK++   + I+ +        +K L++E+     L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 96  NLVKLLGCCIQGEEKLLIY-EFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTAR 149
           N+V+ LG     EE L I+ E++   S+ S +     F+++  +                
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR--------FFTEQVLE 119

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR----AFGGDETEGNTKRVIG 205
           G+ YLH      I+HRDLKA N+L+D D   KISDFG+++     +  D+    + +  G
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN--MSMQ--G 172

Query: 206 TYGYMAPEY-ASDGQ-FSVKSDVFSFGILLLEIISGKK 241
           +  +MAPE   S  Q +S K D++S G ++LE+ +G++
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 95.5 bits (237), Expect = 1e-22
 Identities = 81/287 (28%), Positives = 135/287 (47%), Gaps = 32/287 (11%)

Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +       K   
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQVLRFV---- 234

Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
              M   L+D        L E++R      +C Q +PK RPS   +I
Sbjct: 235 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 20/204 (9%)

Query: 45  KKLGQGGFGPVYKGTLVDGQE-----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 98
           K LG G FG VYKG  V   E     +A+K L++ +  +   E  +E ++ + + H +LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYL 154
           +LLG C+    +L + + M +  L  ++ + +       +L+W  +       A+G+MYL
Sbjct: 73  RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
            +    R++HRDL A NVL+    + KI+DFGLAR   GDE E N         +MA E 
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
               +F+ +SDV+S+G+ + E+++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 94.4 bits (235), Expect = 3e-22
 Identities = 57/204 (27%), Positives = 108/204 (52%), Gaps = 25/204 (12%)

Query: 47  LGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-LKELKNEVILFSKLQH---RNLVKLL 101
           +G+G +G VY+G  V  G+ +A+K ++  +    + +++ EV L S+L+     N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQ---ERCKILDWSKRFHIICGTARGVMYLHQDS 158
           G  ++G    +I E+    S+ + +      E+   +       II      + Y+H+  
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKVG 121

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV--IGTYGYMAPEYAS 216
              +IHRD+KA+N+L+    N K+ DFG+A        + ++KR   +GT  +MAPE  +
Sbjct: 122 ---VIHRDIKAANILVTNTGNVKLCDFGVAALL----NQNSSKRSTFVGTPYWMAPEVIT 174

Query: 217 DGQ-FSVKSDVFSFGILLLEIISG 239
           +G+ +  K+D++S GI + E+ +G
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 93.9 bits (233), Expect = 4e-22
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 13/200 (6%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
              + + +G+G FG V  G    G ++AVK +   ++   +    E  + ++L+H NLV+
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 63

Query: 100 LLGCCIQGEEKLLIY-EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           LLG  ++ +  L I  E+M   SL  ++  + R  +L               + YL  ++
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN 122

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
               +HRDL A NVL+ +D   K+SDFGL +      T+   K  +    + APE   + 
Sbjct: 123 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVK---WTAPEALREK 174

Query: 219 QFSVKSDVFSFGILLLEIIS 238
           +FS KSDV+SFGILL EI S
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 94.0 bits (234), Expect = 4e-22
 Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 19/211 (9%)

Query: 35  VSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 93
           V+  + + I  +LG G FG VYK      G   A K +   SE+ L++   E+ + S+ +
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK 60

Query: 94  HRNLVKLLGCCIQGEEKLLIY-EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           H N+V L       E KL I  EF    +LDS + + ER   L   +  ++       + 
Sbjct: 61  HPNIVGLYEAYFY-ENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALN 117

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYM 210
           +LH     ++IHRDLKA N+LL  D + K++DFG++ A      +   KR   IGT  +M
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQ---KRDTFIGTPYWM 170

Query: 211 APEYA-----SDGQFSVKSDVFSFGILLLEI 236
           APE        D  +  K+D++S GI L+E+
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 94.3 bits (234), Expect = 4e-22
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 45  KKLGQGGFGPVYKGTLV-----DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLV 98
           ++LG+  FG +YKG L        Q +A+K L  I+  Q   E + E  L ++L H N+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIF--------------DQERCKILDWSKRFHII 144
            LLG   Q +   +++E++    L  F+               D      LD     HI 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
              A G+ YL   S    +H+DL A N+L+ + ++ KISD GL+R     +      + +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +M PE    G+FS  SD++SFG++L EI S
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 93.6 bits (232), Expect = 6e-22
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 18/206 (8%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 95
           NF I KK+G+G F  VY+ T L+D + +A+K++     +  +  ++   E+ L  +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--FDQERCKILD---WSKRFHIICGTARG 150
           N++K L   I+  E  ++ E      L   I  F +++  I +   W K F  +C     
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
               H  SR R++HRD+K +NV +      K+ D GL R F    T  ++  ++GT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 211 APEYASDGQFSVKSDVFSFGILLLEI 236
           +PE   +  ++ KSD++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.4 bits (232), Expect = 6e-22
 Identities = 64/210 (30%), Positives = 111/210 (52%), Gaps = 25/210 (11%)

Query: 43  INKKLGQGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 97
           I + +G G FG V +G L + G+    +A+K L S  +E+  ++  +E  +  +  H N+
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC------GTARGV 151
           + L G   +    ++I EFM N +LDSF+   +         +F +I       G A G+
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQND--------GQFTVIQLVGMLRGIAAGM 119

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG---TYG 208
            YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D ++      +G      
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           + APE  +  +F+  SDV+S+GI++ E++S
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 93.4 bits (232), Expect = 7e-22
 Identities = 72/222 (32%), Positives = 99/222 (44%), Gaps = 54/222 (24%)

Query: 45  KKLGQGGFG--------PVYKGTLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 95
           + LG+G FG        P   GT   G+ +AVK L +   Q      K E+ +   L H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 96  NLVKLLGCCIQGEEK--LLIYEFMTNKSLDSF------------IFDQERCKILDWSKRF 141
           N+VK  GCC +   K   LI E++   SL  +            +F Q+ C+        
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICE-------- 118

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
                   G+ YLH       IHRDL A NVLLD D   KI DFGLA+A      EG+  
Sbjct: 119 --------GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEY 163

Query: 202 RVIGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             +   G     + A E   + +FS  SDV+SFG+ L E+++
Sbjct: 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 92.9 bits (231), Expect = 7e-22
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 19/209 (9%)

Query: 40  NFSINKKLGQGGFGPVYK-GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 96
           +F + KKLG+G +G VYK   L D Q  A+K   L  +S++  ++  NE+ + + + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKIL-----DWSKRFHIICGTARGV 151
           ++      + G +  ++ E+     L   I  +++ + L      W     I     RG+
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
             LH+    +I+HRDLK++N+LL  +   KI D G+++       +   K  IGT  YMA
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMA 169

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE      +S KSD++S G LL E+ +  
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.3 bits (232), Expect = 8e-22
 Identities = 67/202 (33%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 47  LGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGFG V    +   G+  A K+L K      +G +   NE  +  K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 103 CCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFH---IICGTARGVMYLHQDS 158
              + ++ L L+   M    L   I++       +    F+   IICG    + +LHQ  
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             RI++RDLK  NVLLD   N +ISD GLA    G +     K   GT GYMAPE     
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGE 169

Query: 219 QFSVKSDVFSFGILLLEIISGK 240
            +    D F+ G  L E+I+G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.0 bits (231), Expect = 8e-22
 Identities = 75/279 (26%), Positives = 134/279 (48%), Gaps = 48/279 (17%)

Query: 45  KKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRN 96
           ++LG G F   Y+      GTL+  +++   R +  SEQ   ++ L+ E+ L ++L H +
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPH 64

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD----QERCKILDWSKRFHIICGTARGVM 152
           ++++LG   +     L  E+M   S+   +      +E   I         +    RG+ 
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII----NYTEQLL---RGLS 117

Query: 153 YLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLA-----RAFGGDETEGNTKRVI 204
           YLH++   +IIHRD+K +N+L+D   Q +  +I+DFG A     +  G  E +G   +++
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLL 169

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
           GT  +MAPE     Q+    DV+S G +++E+ + K         N+L LI   +K+ + 
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASA 226

Query: 265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP 303
                   P I    +    +R   + L C++  P+DRP
Sbjct: 227 TTA-----PSIPEHLSPG--LR--DVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.0 bits (231), Expect = 9e-22
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 23/205 (11%)

Query: 47  LGQGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           LG+G +G VY    +  Q  IA+K + +   + ++ L  E+ L S L+HRN+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 106 QGEEKLLIYEFMTNKSLDSFI-------FDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +     +  E +   SL + +        D E+  I+ ++K+         G+ YLH   
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQI------LEGLKYLHD-- 126

Query: 159 RLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
             +I+HRD+K  NVL++      KISDFG ++   G      T+   GT  YMAPE    
Sbjct: 127 -NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDK 183

Query: 218 GQ--FSVKSDVFSFGILLLEIISGK 240
           G   +   +D++S G  ++E+ +GK
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 23/207 (11%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLV 98
           KKLG+G +  VYK      G+ +A+K++     +  K+  N     E+ L  +L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC---GTARGVMYLH 155
            LL          L++EFM    L+  I D    K +  +    I      T RG+ YLH
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVIKD----KSIVLTPA-DIKSYMLMTLRGLEYLH 119

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-- 213
                 I+HRDLK +N+L+  D   K++DFGLAR+FG    +  T +V+ T  Y APE  
Sbjct: 120 ---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVV-TRWYRAPELL 174

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGK 240
           + +   + V  D++S G +  E++   
Sbjct: 175 FGAR-HYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 23/210 (10%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS------KISEQGLKELKNEVILFSKL 92
            + I  ++G+G  G V+K      G+ +A+K+++       I  Q L+E+K         
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF-HIICGTARGV 151
           QH  +VKLL     G   +L+ E+M +  L   + D+ER       K +  ++    +GV
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGV 112

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
            Y+H      I+HRDLK +N+L+  D   KI+DFGLAR F  +E    + +V  T  Y A
Sbjct: 113 AYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRA 168

Query: 212 PE--YASDGQFSVKSDVFSFGILLLEIISG 239
           PE  Y +  ++    D+++ G +  E+++G
Sbjct: 169 PELLYGAR-KYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 30/226 (13%)

Query: 43  INKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
           + ++LG+G FG V+           D   +AVK L   +    K+ + E  L + LQH +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSF----------IFDQERCKI---LDWSKRFHI 143
           +VK  G C  G+  ++++E+M +  L+ F          + D +  +    L  S+  HI
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
               A G++YL   +    +HRDL   N L+  ++  KI DFG++R    D    +  RV
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 181

Query: 204 IG----TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF 245
            G       +M PE     +F+ +SDV+SFG++L EI +  K   F
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 91.7 bits (227), Expect = 4e-21
 Identities = 63/218 (28%), Positives = 124/218 (56%), Gaps = 15/218 (6%)

Query: 28  LFELATIVSATN---NFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK 83
           L +L +IVS  +    ++  +K+GQG  G VY    +  GQE+A+K+++ + +Q  KEL 
Sbjct: 5   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELI 63

Query: 84  -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
            NE+++  + ++ N+V  L   + G+E  ++ E++   SL   +   E C  +D  +   
Sbjct: 64  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAA 119

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +     + + +LH +   ++IHRD+K+ N+LL  D + K++DFG       ++++ +T  
Sbjct: 120 VCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-- 174

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           ++GT  +MAPE  +   +  K D++S GI+ +E++ G+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 23/205 (11%)

Query: 46  KLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           K+G+G +G VYK    + G+ +A+K  RL    E        E+ L  +L H N+V+LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 103 CCIQGEEKLLIYEFMT---NKSLDS---FIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
                 +  L++EF+     K +DS      D    K        + +    +G+ Y H 
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK-----SYLYQLL---QGIAYCHS 117

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
               R++HRDLK  N+L+D++   K++DFGLARAF G      T  V+ T  Y APE   
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 172

Query: 217 DG-QFSVKSDVFSFGILLLEIISGK 240
              Q+S   D++S G +  E+++ +
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.7 bits (225), Expect = 6e-21
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 33/217 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQ 93
           +   I K +G G FG V  G L + G+    +A+K L +  +E+  ++  +E  +  +  
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC------GT 147
           H N++ L G   + +  +++ E+M N SLD+F+   +         +F +I       G 
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD--------GQFTVIQLVGMLRGI 115

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D     T R     
Sbjct: 116 ASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----- 167

Query: 208 G------YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           G      + APE  +  +F+  SDV+S+GI++ E++S
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 90.3 bits (224), Expect = 8e-21
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 30/213 (14%)

Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKR--LSKISEQG-------LKELKNEVILFSKLQHRN 96
           +G G FG VY G     G+ +AVK+  L  +S          L  L  E+ L  +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTARGV 151
           +V+ LG  +  +   +  E++   S+ + +     F++   +        + +    +G+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKR--VIGTY 207
            YLH      IIHRD+K +N+L+D     KISDFG+++    +      N  R  + G+ 
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            +MAPE      ++ K+D++S G L++E+++GK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.5 bits (224), Expect = 8e-21
 Identities = 68/222 (30%), Positives = 110/222 (49%), Gaps = 20/222 (9%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 95
           NF I KK+G+G F  VY+ T L+DG  +A+K++     +  +   +   E+ L  +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--FDQERCKILD---WSKRFHIICGTARG 150
           N++K     I+  E  ++ E      L   I  F +++  I +   W K F  +C     
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
               H  SR R++HRD+K +NV +      K+ D GL R F    T  ++  ++GT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
           +PE   +  ++ KSD++S G LL E+ + +    FY    NL
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 90.2 bits (223), Expect = 2e-20
 Identities = 66/220 (30%), Positives = 123/220 (55%), Gaps = 19/220 (8%)

Query: 28  LFELATIVSATN---NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK 83
           L +L +IVS  +    ++  +K+GQG  G VY    +  GQE+A+++++ + +Q  KEL 
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELI 64

Query: 84  -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
            NE+++  + ++ N+V  L   + G+E  ++ E++   SL   +   E C  +D  +   
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAA 120

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +     + + +LH +   ++IHRD+K+ N+LL  D + K++DFG    F    T   +KR
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 173

Query: 203 --VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
             ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 60/291 (20%)

Query: 49  QGGFGPVYKGTLVDG-----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           +G FG ++ G L+D      +E+ VK +    SE  +  L  E  L   L H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 103 CCIQGEEK-LLIYEFMTNKSLDSFIFDQERCKILDWSKR--------FHIICGTARGVMY 153
            CI+  E   ++Y +M   +L  F+   ++C++ + +           H+    A G+ Y
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD-ETEG-NTKRVIGTYGYM 210
           LH   +  +IH+D+ A N ++D+++  KI+D  L+R  F  D    G N  R +    +M
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WM 186

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           A E   + ++S  SDV+SFG+LL E+++                +G          P   
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT----------------LG--------QTPYVE 222

Query: 271 IDP-----CIQGSFNLAEVIRC----IHIGLLCVQQHPKDRPSMPSVILML 312
           IDP      ++  + LA+ I C      +   C    P++RPS   ++  L
Sbjct: 223 IDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 77/281 (27%), Positives = 136/281 (48%), Gaps = 40/281 (14%)

Query: 42  SINKKLGQGGFGPVYKGTLVDGQEI---AVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           ++ K LG+G FG V +G L     I   AVK  +++  +   +++  +E +   +  H N
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 97  LVKLLGCCIQGEEK------LLIYEFMTNKSLDSFIFDQ---ERCKILDWSKRFHIICGT 147
           +++L+G C+Q  E       ++I  FM +  L SF+      +  + L        +   
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD-ETEGNTKRVIG 205
           A G+ YL   S    IHRDL A N +L+++MN  ++DFGL++  + GD   +G   ++  
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM-- 176

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
              ++A E  +D  ++ KSDV+SFG+ + EI +  + +  Y    N  +    +    +G
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT--RGQTPYPGVENSEI----YDYLRQG 230

Query: 266 MPSQLIDP--CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
             ++L  P  C+ G ++L            C   +PKDRPS
Sbjct: 231 --NRLKQPPDCLDGLYSLMSS---------CWLLNPKDRPS 260

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 59/217 (27%), Positives = 109/217 (50%), Gaps = 19/217 (8%)

Query: 31  LATIVSATN---NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEV 86
           L  +V   +         K+G+G  G V   T    G+++AVK++    +Q  + L NEV
Sbjct: 8   LQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67

Query: 87  ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC- 145
           ++    QH N+V++    + G+E  ++ EF+   +L   I    R       ++   +C 
Sbjct: 68  VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIATVCL 122

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--V 203
              + + +LH      +IHRD+K+ ++LL  D   K+SDFG    F    ++   +R  +
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSL 175

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           +GT  +MAPE  S   +  + D++S GI+++E++ G+
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 88.5 bits (219), Expect = 3e-20
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 35/214 (16%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK-NEVI-------LFSKL 92
           + + ++LG+G FG VY   + D + +A +RL  + E  + EL  NE +       L SKL
Sbjct: 2   YILQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK----------ILDWSKRFH 142
            H  +VK     ++ +   +I E+   + LD      E  K          + +W     
Sbjct: 60  DHPAIVKFHASFLERDAFCIITEYCEGRDLD---CKLEELKHTGKTLSENQVCEW----- 111

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
                  GV Y+HQ    RI+HRDLKA N+ L  ++  KI DFG++R   G      T  
Sbjct: 112 -FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-- 164

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEI 236
             GT  YM+PE      +  KSD++S G +L E+
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.4 bits (219), Expect = 3e-20
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           K+LG G FG V+ G      ++A+K +++  +SE+   E   E  +  KL H  LV+L G
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYG 66

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
            C Q +   ++ EFM N  L +++  ++R   L       +      G+ YL ++S    
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---F 121

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYASDGQF 220
           IHRDL A N L+      K+SDFG+ R    DE  +    K  +    +  PE  +  ++
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV---KWSPPEVFNFSKY 178

Query: 221 SVKSDVFSFGILLLEIISGKK 241
           S KSDV+SFG+L+ E+ +  K
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 28/225 (12%)

Query: 39  NNFSINKKLGQGGFGPVY-------------KGTLVDGQE--IAVKRL-SKISEQGLKEL 82
               + +KLG+G FG V+                  DGQ   +AVK L + +++    + 
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE-RCKI------- 134
             E+ + S+L++ N+++LLG C+  +   +I E+M N  L+ F+  +E            
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 135 -LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
            +  +   ++    A G+ YL   + L  +HRDL   N L+      KI+DFG++R    
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            +      R +    +MA E    G+F+  SDV++FG+ L E+ +
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.4 bits (219), Expect = 4e-20
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 18/202 (8%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           K+LG G FG V  G      ++A+K + +  +SE    E   E  +  KL H  LV+L G
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYG 66

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
            C +     ++ E+M+N  L +++  +E  K    S+   +      G+ YL      + 
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT---YGYMAPEYASDGQ 219
           IHRDL A N L+D     K+SDFGL+R    DE   +    +G+     +  PE     +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSK 177

Query: 220 FSVKSDVFSFGILLLEIIS-GK 240
           FS KSDV++FG+L+ E+ S GK
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 88.7 bits (220), Expect = 4e-20
 Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 19/209 (9%)

Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++    +G+ 
Sbjct: 61  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL----QGLA 114

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAF G      T  V+ T  Y AP
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAP 169

Query: 213 EYASDGQF-SVKSDVFSFGILLLEIISGK 240
           E     ++ S   D++S G +  E+++ +
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 73/223 (32%), Positives = 110/223 (49%), Gaps = 26/223 (11%)

Query: 39  NNFSINKKLGQGGFGPVYK----GTLVDGQE----IAVKRLS-KISEQGLKELKNEVILF 89
           +   + K LG+G FG V +    G      +    +AVK L    +++ L +L +E+ L 
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+    +L  F+           FD  +      
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 138 SKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           S +  + C    ARG+ YL  +SR R IHRDL A NVL+ +D   KI+DFGLAR     +
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFGIL+ EI +
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 87.7 bits (217), Expect = 6e-20
 Identities = 70/208 (33%), Positives = 107/208 (51%), Gaps = 22/208 (10%)

Query: 45  KKLGQGGFGPVYKG---TLVDGQEIAVKRLSKIS-EQGLK-ELKNEVILFSKLQHRNLVK 99
            +LG G FG V KG        + +AVK L   + +  LK EL  E  +  +L +  +V+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
           ++G C + E  +L+ E      L+ F+   +     + ++  H +   + G+ YL + + 
Sbjct: 61  MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN- 115

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPEY 214
              +HRDL A NVLL      KISDFGL++A G DE     K    T+G     + APE 
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPEC 169

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS-GKK 241
            +  +FS KSDV+SFG+L+ E  S G+K
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 88.2 bits (219), Expect = 6e-20
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 50/296 (16%)

Query: 42  SINKKLGQGGFGPVYKGTLVDGQEI-----------------AVKRLSK-ISEQGLKELK 83
           +  +KLG+G FG V+       Q+                  AVK L    S+   ++  
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--------FDQERCKIL 135
            EV + S+L   N+ +LLG C       +I E+M N  L+ F+              K L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 136 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD 194
            +S   ++    A G+ YL     L  +HRDL   N L+ ++   KI+DFG++R  +  D
Sbjct: 128 SFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 195 --ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN- 251
               +G     I    +MA E    G+F+ KSDV++FG+ L EI++  + + + H  +  
Sbjct: 185 YYRVQGRAPLPI---RWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241

Query: 252 -LNLIGHAWKLWNEGMPSQLIDP--CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
            +   GH ++  ++G    L  P  C +  + L          L C ++  +DRP+
Sbjct: 242 VIENAGHFFR--DDGRQIYLPRPPNCPKDIYELM---------LECWRRDEEDRPT 286

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 7e-20
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 22/205 (10%)

Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRL------SKISEQGLKELKNEVILFSKLQHRNLVK 99
           +LG+G  G V K  L +   I   +         + +Q L+EL+    +    +   +VK
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSCKSPYIVK 63

Query: 100 LLGCCIQGEEKLL--IYEFMTNKSLDSFIFDQERCKILDWSKRF--HIICGTARGVMYLH 155
             G  +      +    E+    SLDS I+ + + +     ++    I     +G+ YLH
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
                +IIHRD+K SN+LL +    K+ DFG++    G+          GT  YMAPE  
Sbjct: 123 SR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPERI 175

Query: 216 SDGQFSVKSDVFSFGILLLEIISGK 240
               +S+ SDV+S G+ LLE+   +
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 87.7 bits (217), Expect = 9e-20
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)

Query: 45  KKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           ++LGQG FG VY+G    ++ G+    +AVK +++  S +   E  NE  +       ++
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD-----------WSKRFHIICG 146
           V+LLG   +G+  L++ E M +  L S++    R    +             +   +   
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
            A G+ YL+     + +HRDL A N ++  D   KI DFG+ R    D  E +  R  G 
Sbjct: 128 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGK 180

Query: 207 ----YGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
                 +MAPE   DG F+  SD++SFG++L EI S  +    Y   +N  ++    K  
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVL----KFV 234

Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
            +G      D C +   +L           +C Q +PK RP+   ++ +L
Sbjct: 235 MDGGYLDQPDNCPERVTDLMR---------MCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 87.5 bits (217), Expect = 9e-20
 Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 11/205 (5%)

Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NEVILFSKLQHRNL 97
           NF   +KLG+G +  VYKG     G+ +A+K +   +E+G       E+ L  +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 98  VKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           V+L    I  E KL L++E+M +K L  ++        LD +          +G+ + H+
Sbjct: 61  VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
           +   R++HRDLK  N+L+++    K++DFGLARAFG      + + V  T  Y AP+   
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLL 173

Query: 217 DGQ-FSVKSDVFSFGILLLEIISGK 240
             + +S   D++S G ++ E+I+G+
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)

Query: 30  ELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF 89
           +L+ +      F + + +G G +G VYKG  V   ++A  ++  ++E   +E+K E+ + 
Sbjct: 7   DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66

Query: 90  SKL-QHRNLVKLLGCCI------QGEEKLLIYEFMTNKSLDSFIFDQE-RCKILDWSKRF 141
            K   HRN+    G  I        ++  L+ EF    S+   + + +      DW    
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-- 124

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
           +I     RG+ +LH     ++IHRD+K  NVLL ++   K+ DFG++     D T G   
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179

Query: 202 RVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISG 239
             IGT  +MAPE  +     D  +  +SD++S GI  +E+  G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 86.6 bits (214), Expect = 1e-19
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 11/198 (5%)

Query: 45  KKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 102
           +++G+G FG V+ G L  D   +AVK   +     LK +   E  +  +  H N+V+L+G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
            C Q +   ++ E +      +F+  +     L   +   ++   A G+ YL        
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTKRVIGTYGYMAPEYASDGQF 220
           IHRDL A N L+ +    KISDFG++R    G   + G  K++     + APE  + G++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRY 173

Query: 221 SVKSDVFSFGILLLEIIS 238
           S +SDV+SFGILL E  S
Sbjct: 174 SSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 86.7 bits (214), Expect = 2e-19
 Identities = 75/295 (25%), Positives = 140/295 (47%), Gaps = 38/295 (12%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 98
           F+  +K+G+G FG V+KG     Q++   ++  +  +E  +++++ E+ + S+     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           K  G  ++  +  +I E++   S      D      LD ++   I+    +G+ YLH + 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEYAS 216
           +   IHRD+KA+NVLL +    K++DFG+A    G  T+   KR   +GT  +MAPE   
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVIK 174

Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
              +  K+D++S GI  +E+  G+      H    L LI        +  P     P ++
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-------PKNNP-----PTLE 222

Query: 277 GSFN--LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLAD 329
           G+++  L E +        C+ + P  RP+      +L  + ++   K+  YL +
Sbjct: 223 GNYSKPLKEFVEA------CLNKEPSFRPTAKE---LLKHKFIVRFAKKTSYLTE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 34/212 (16%)

Query: 47  LGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVK 99
           + +G +G V+    K T   G   A+K + K   I +  + ++  E  + S+ Q   +VK
Sbjct: 1   ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 100 LLGCCIQGEEKL-LIYEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTARGVMY 153
           L     QG++ L L+ E++    L S +      D++  +I         I      + Y
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEY 108

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA------RAFGGDETEGNTKRVIGTY 207
           LH      IIHRDLK  N+L+D + + K++DFGL+      R    ++ E   KR++GT 
Sbjct: 109 LHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y+APE       S   D +S G +L E + G
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 15/203 (7%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAV-KRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           + I  +LG G FG VYK    +   +A  K +   SE+ L++   E+ + +   H N+VK
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG-TARGVMYLHQDS 158
           LL          ++ EF    ++D+ + + ER        +  ++C  T   + YLH++ 
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN- 122

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY---- 214
             +IIHRDLKA N+L   D + K++DFG++       T       IGT  +MAPE     
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 215 -ASDGQFSVKSDVFSFGILLLEI 236
            + D  +  K+DV+S GI L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 26/221 (11%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQE--------IAVKRLSK-ISEQGLKELKNEVILFSK 91
            ++ K LG+G FG V     +   +        +AVK L    +++ L +L +E+ +   
Sbjct: 14  LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73

Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI---------FDQERCKILDWSKRF 141
           + +H+N++ LLG C Q     ++ E+ +  +L  ++         +  + CK+ +    F
Sbjct: 74  IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133

Query: 142 H--IICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 197
              + C    ARG+ YL   +  + IHRDL A NVL+ +D   KI+DFGLAR     +  
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190

Query: 198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 85.9 bits (212), Expect = 4e-19
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 18/211 (8%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK 99
           F + + +G G +G VYKG  V   ++A  ++  ++    +E+K E+ +  K   HRN+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 100 LLGCCIQ------GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
             G  I+       ++  L+ EF    S+   I    +   L      +I     RG+ +
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSH 126

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           LHQ    ++IHRD+K  NVLL ++   K+ DFG++     D T G     IGT  +MAPE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 181

Query: 214 YAS-----DGQFSVKSDVFSFGILLLEIISG 239
             +     D  +  KSD++S GI  +E+  G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 12/197 (6%)

Query: 46  KLGQGGFGPV-YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V        G+++AVK +    +Q  + L NEV++    QH+N+V++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-RGVMYLHQDSRLRII 163
           + GEE  ++ EF+   +L   I  Q R       ++   +C +  + + YLH      +I
Sbjct: 88  LVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALCYLHSQG---VI 139

Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           HRD+K+ ++LL  D   K+SDFG       D  +   K ++GT  +MAPE  S   +  +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTE 197

Query: 224 SDVFSFGILLLEIISGK 240
            D++S GI+++E++ G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 13/200 (6%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVK 99
           + + +++G G +G VYK   +   E+   ++ K+      + ++ E+ +  + +H N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 100 LLGCCIQGEEKLLI-YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
             G      +KL I  E+    SL      Q     L   +  ++   T +G+ YLH+  
Sbjct: 65  YFGS-YLRRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHE-- 119

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA--- 215
               IHRD+K +N+LL +D + K++DFG++       T    K  IGT  +MAPE A   
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMAPEVAAVE 176

Query: 216 SDGQFSVKSDVFSFGILLLE 235
             G +  K D+++ GI  +E
Sbjct: 177 RKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 85.5 bits (211), Expect = 5e-19
 Identities = 76/295 (25%), Positives = 138/295 (46%), Gaps = 38/295 (12%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 98
           F+  +++G+G FG V+KG     Q++ A+K +  + +E  +++++ E+ + S+     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           K  G  ++G +  +I E++   S      D  R    D  +   ++    +G+ YLH + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEYAS 216
           +   IHRD+KA+NVLL +  + K++DFG+A    G  T+   KR   +GT  +MAPE   
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVIQ 174

Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
              +  K+D++S GI  +E+  G+      H    L LI             +   P + 
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------------PKNNPPTLT 222

Query: 277 GSF--NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLAD 329
           G F     E I        C+ + P  RP+      +L  + ++   K+  YL +
Sbjct: 223 GEFSKPFKEFIDA------CLNKDPSFRPTAKE---LLKHKFIVKNAKKTSYLTE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 85.5 bits (211), Expect = 5e-19
 Identities = 60/217 (27%), Positives = 112/217 (51%), Gaps = 11/217 (5%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 98
           F+  +++G+G FG VYKG     +E+   ++  +  +E  +++++ E+ + S+     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +  G  ++G +  +I E++   S      D  +   L+ +    I+    +G+ YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             R IHRD+KA+NVLL +  + K++DFG+A      + + NT   +GT  +MAPE     
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176

Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI 255
            +  K+D++S GI  +E+  G+      H    L LI
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 84.9 bits (210), Expect = 7e-19
 Identities = 69/206 (33%), Positives = 100/206 (48%), Gaps = 24/206 (11%)

Query: 47  LGQGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           LG+GGFG V        G L   +++  KRL K   +G +    E  + +K+  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 101 LGCCIQGEEKL-LIYEFMTNKSLDSFIF--DQERCKILDWSKRFH---IICGTARGVMYL 154
                Q +  L L+   M    L   I+  D+E     +    F+   II G    + +L
Sbjct: 59  -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHL 113

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           HQ    RII+RDLK  NVLLD D N +ISD GLA      +++  TK   GT G+MAPE 
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPEL 168

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
               ++    D F+ G+ L E+I+ +
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 85.5 bits (211), Expect = 7e-19
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 15/198 (7%)

Query: 46  KLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           +LG G FG VYK    + G   A K +   SE+ L++   E+ + +   H  +VKLLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-RGVMYLHQDSRLRII 163
               +  ++ EF    ++D+ + + +R        +  +IC      + YLH    ++II
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKII 132

Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA-----SDG 218
           HRDLKA NVLL  D + K++DFG++      +T       IGT  +MAPE        D 
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 219 QFSVKSDVFSFGILLLEI 236
            +  K+D++S GI L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 85.4 bits (211), Expect = 8e-19
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 26/219 (11%)

Query: 43  INKKLGQGGFGPVYKGTLV--DGQE------IAVKRL-SKISEQGLKELKNEVILFSKL- 92
           + K LG+G FG V     +  D ++      +AVK L S  +E+ L +L +E+ +   + 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDWSKRF 141
           +H+N++ LLG C Q     +I E+ +  +L  ++           ++  +      S + 
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 142 HIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
            + C    ARG+ YL   +  + IHRDL A NVL+ +D   KI+DFGLAR     +    
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 85.1 bits (210), Expect = 9e-19
 Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRLS-KISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     +        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 138 SKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 85.4 bits (211), Expect = 9e-19
 Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 18/207 (8%)

Query: 41  FSINKKLGQGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQH 94
           F   K LG G FG VYKG  + +G+++    A+K L +  S +  KE+ +E  + + + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC---KILDWSKRFHIICGTARGV 151
            ++ +LLG C+    +L+         LD     ++      +L+W  +       A+G+
Sbjct: 69  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 122

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
            YL +    R++HRDL A NVL+    + KI+DFGLA+  G DE E + +       +MA
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIIS 238
            E      ++ +SDV+S+G+ + E+++
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 12/197 (6%)

Query: 46  KLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V   T    G+++AVK++    +Q  + L NEV++     H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC-GTARGVMYLHQDSRLRII 163
           + G+E  ++ EF+   +L   I    R       ++   +C    R + YLH      +I
Sbjct: 89  LVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIATVCLSVLRALSYLHNQG---VI 140

Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           HRD+K+ ++LL  D   K+SDFG       +  +   K ++GT  +MAPE  S   +  +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTE 198

Query: 224 SDVFSFGILLLEIISGK 240
            D++S GI+++E+I G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 68/216 (31%), Positives = 110/216 (50%), Gaps = 49/216 (22%)

Query: 47  LGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQG--LKELKNEVILFSKLQ---HRNLVK 99
           +G+G +G VYK   L  G+ +A+K++   +SE+G  L  L+ E+ L  +L+   H N+V+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVR 65

Query: 100 LLGCC--IQGEEKL---LIYEFMTNKSLDSFIFDQERC--------KILDWSKRFHIICG 146
           LL  C   + + +L   L++E + ++ L +++    +C         I D  ++      
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHV-DQDLATYL---SKCPKPGLPPETIKDLMRQL----- 116

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
             RGV +LH     RI+HRDLK  N+L+  D   KI+DFGLAR +        T  V+ T
Sbjct: 117 -LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVV-T 169

Query: 207 YGYMAPE------YASDGQFSVKSDVFSFGILLLEI 236
             Y APE      YA+     V  D++S G +  E+
Sbjct: 170 LWYRAPEVLLQSSYAT----PV--DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 45/236 (19%)

Query: 35  VSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVI 87
            S   ++ I  KLG+G FG VYK   +  G+ +A+K++   +E+       L+E+K    
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK---- 59

Query: 88  LFSKLQHRNLVKLLGCCI-----QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
           +  KL+H N+V L+   +        ++  +Y  M      +   D +   +L+ +    
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY--MV-----TPYMDHDLSGLLE-NPSVK 111

Query: 143 IICGTARGVM--------YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           +     +  M        YLH++    I+HRD+KA+N+L+D     KI+DFGLAR + G 
Sbjct: 112 LTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 195 ETEGNTKRVIG---------TYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIISGK 240
                     G         T  Y  PE    + +++   D++  G +  E+ + +
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 28/210 (13%)

Query: 46  KLGQGGFGPVYKGT--LVDGQ-EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLL 101
           +LG G FG V KG   +   Q ++A+K L   +E+ ++ E+  E  +  +L +  +V+++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS--- 158
           G C + E  +L+ E  +   L+ F+            K+  I    +  V  +HQ S   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLS----------GKKDEIT--VSNVVELMHQVSMGM 108

Query: 159 ----RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAP 212
                   +HRDL A NVLL      KISDFGL++A G D++     R  G +   + AP
Sbjct: 109 KYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAP 167

Query: 213 EYASDGQFSVKSDVFSFGILLLEIIS-GKK 241
           E  +  +FS +SDV+S+GI + E  S G+K
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 26/208 (12%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           +K+G+G +G VYK    V  + IA+K  RL +  E        E+ L  ++QH N+V+L 
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 102 GCCIQGEEKL-LIYEFMT---NKSLDS---FIFDQERCKILDWSKRFHIICGTARGVMYL 154
              +  E++L L++E++     K +DS   F  +    K   +           RG+ Y 
Sbjct: 68  DV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ--------ILRGIAYC 118

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           H     R++HRDLK  N+L+D+  N  K++DFGLARAF G      T  V+ T  Y APE
Sbjct: 119 HSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPE 173

Query: 214 -YASDGQFSVKSDVFSFGILLLEIISGK 240
                  +S   D++S G +  E+++ K
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.2 bits (205), Expect = 3e-18
 Identities = 69/215 (32%), Positives = 111/215 (51%), Gaps = 25/215 (11%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 93
           N+ + K LG+G FG VY     D G+E+AVK++     S+ + + +  L+ E+ L   L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 94  HRNLVKLLGCCIQGEEKLL--IYEFMTNKSLDSFIFDQERCK---ILDWSKRF--HIICG 146
           H  +V+  GC    EEK L    E+M   S    I DQ +       + ++R+   I+  
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQIL-- 116

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TKRVIG 205
             +GV YLH +    I+HRD+K +N+L D   N K+ DFG ++        G   K V G
Sbjct: 117 --QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           T  +M+PE  S   +  K+DV+S    ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 23/203 (11%)

Query: 47  LGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 102
           LG GGFG V    +    +  A+K + K  I E G +E + +E  +  +  H  +VKL  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 103 CCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM----YLHQD 157
              + ++ + ++ E+     L + +  ++R    +++ RF+I C     V+    YLH  
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIAC-----VVLAFEYLH-- 110

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
               II+RDLK  N+LLD +   K+ DFG A+     +    T    GT  Y+APE   +
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN 166

Query: 218 GQFSVKSDVFSFGILLLEIISGK 240
             +    D +S GILL E+++G+
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 12/197 (6%)

Query: 46  KLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V   T+   G+ +AVK++    +Q  + L NEV++    QH N+V++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC-GTARGVMYLHQDSRLRII 163
           + G+E  ++ EF+   +L   I    R       ++   +C    + +  LH      +I
Sbjct: 87  LVGDELWVVMEFLEGGALTD-IVTHTRMN----EEQIAAVCLAVLKALSVLHAQG---VI 138

Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           HRD+K+ ++LL  D   K+SDFG       +      K ++GT  +MAPE  S   +  +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPE 196

Query: 224 SDVFSFGILLLEIISGK 240
            D++S GI+++E++ G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 45  KKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
             LG G  G V K      GT++  + + +   S + +Q L+EL+    +  + +   +V
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIV 66

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFI--FDQERCKILDWSKRFHIICGTARGVMYLHQ 156
              G  +      +  EFM   SLD           +IL       I      G+ YL+ 
Sbjct: 67  SFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY- 120

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
            +  RI+HRD+K SN+L++     K+ DFG++    G+         +GT  YM+PE   
Sbjct: 121 -NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQ 175

Query: 217 DGQFSVKSDVFSFGILLLEIISGK 240
            G+++VKSDV+S GI ++E+  GK
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 34/267 (12%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKL 100
           +++G G FG VY    V   E+ A+K++S   K S +  +++  EV    +L+H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
            GC ++     L+ E+    + D  I +  + K L   +   I  G  +G+ YLH   R 
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHSHER- 136

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE--YASD- 217
             IHRD+KA N+LL +    K++DFG A       +  N+   +GT  +MAPE   A D 
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLV----SPANS--FVGTPYWMAPEVILAMDE 188

Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
           GQ+  K DV+S GI  +E+   K       + N ++ + H          +Q   P +  
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHI---------AQNDSPTLSS 236

Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPS 304
           +         +     C+Q+ P+DRPS
Sbjct: 237 NDWSDYFRNFVD---SCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 18/203 (8%)

Query: 45  KKLGQGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 98
           K LG G FG VYKG  + DG+ +    A+K L +  S +  KE+ +E  + + +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC---KILDWSKRFHIICGTARGVMYLH 155
           +LLG C+    +L+         LD    +++R     +L+W  +       A+G+ YL 
Sbjct: 73  RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
           +   +R++HRDL A NVL+    + KI+DFGLAR    DETE +         +MA E  
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ +SDV+S+G+ + E+++
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.2 bits (205), Expect = 5e-18
 Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 34/271 (12%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 96
           FS  +++G G FG VY    V   E+ A+K++S   K S +  +++  EV    KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
            ++  GC ++     L+ E+    + D     ++  + ++ +   H   G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH---GALQGLAYLHS 133

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY-- 214
            +   +IHRD+KA N+LL +    K+ DFG A               +GT  +MAPE   
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVIL 184

Query: 215 -ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
              +GQ+  K DV+S GI  +E+   ++    +    N+N +   + +      +Q   P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLF----NMNAMSALYHI------AQNESP 232

Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
            +Q S + +E  R  +    C+Q+ P+DRP+
Sbjct: 233 ALQ-SGHWSEYFR--NFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 43/231 (18%)

Query: 45  KKLGQGGFGPVYKGTLVDGQE-----------------IAVKRL-SKISEQGLKELKNEV 86
           +KLG+G FG V+   +V+ Q+                 +AVK L    ++    +   EV
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70

Query: 87  ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI---------------FDQER 131
            + S+L+  N+++LLG C+  +   +I E+M N  L+ F+                    
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130

Query: 132 C-KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR- 189
           C   + +S   H+    A G+ YL   S L  +HRDL   N L+ +++  KI+DFG++R 
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187

Query: 190 AFGGD--ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            + GD    +G   R +    +MA E    G+F+  SDV++FG+ L EI+ 
Sbjct: 188 LYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 82/303 (27%), Positives = 137/303 (45%), Gaps = 59/303 (19%)

Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDG--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-Q 93
           N+      +G+G FG V K  +  DG   + A+KR+ +  S+   ++   E+ +  KL  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA----- 148
           H N++ LLG C       L  E+  + +L  F+    + ++L+    F I   TA     
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSS 123

Query: 149 -----------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 197
                      RG+ YL Q    + IHRDL A N+L+ ++   KI+DFGL+R       E
Sbjct: 124 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-----QE 175

Query: 198 GNTKRVIGTYG--YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI 255
              K+ +G     +MA E  +   ++  SDV+S+G+LL EI+S               L 
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------------LG 220

Query: 256 GHAWKLWNEGMP-SQLIDPCIQGSFNLAEVIRC----IHIGLLCVQQHPKDRPSMPSVIL 310
           G  +     GM  ++L +   QG + L + + C      +   C ++ P +RPS   +++
Sbjct: 221 GTPYC----GMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 275

Query: 311 MLG 313
            L 
Sbjct: 276 SLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.0 bits (202), Expect = 8e-18
 Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 17/211 (8%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 93
           N+   K LGQG FG VY    VD G+E+A K++     S  + + +  L+ E+ L   LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 94  HRNLVKLLGCCI-QGEEKLLIY-EFMTNKSLDSFIFDQERC-KILDWSKRFHIICGTARG 150
           H  +V+  GC   + E+ L I+ E+M   S+     DQ +    L  S           G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR-VIGTYGY 209
           + YLH +    I+HRD+K +N+L D   N K+ DFG ++        G   R V GT  +
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           M+PE  S   +  K+DV+S G  ++E+++ K
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.5 bits (209), Expect = 9e-18
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 24/289 (8%)

Query: 29  FELATIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVI 87
             +  I+S+    ++   + +G  G  YKG ++ +G +  VK ++ ++        +E+ 
Sbjct: 683 ITINDILSSLKEENV---ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIA 735

Query: 88  LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGT 147
              KLQH N+VKL+G C   +   LI+E++  K+L       E  + L W +R  I  G 
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL------SEVLRNLSWERRRKIAIGI 789

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A+ + +LH      ++  +L    +++D    P +    L      D           + 
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKC------FISS 842

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
            Y+APE       + KSD++ FG++L+E+++G K+        + +++  A   +++   
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTG-KSPADAEFGVHGSIVEWARYCYSDCHL 901

Query: 268 SQLIDPCIQG--SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS 314
              IDP I+G  S N  E++  +++ L C    P  RP    V+  L S
Sbjct: 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950

Length = 968

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKE---LKNEVILFSKLQH 94
            +F I  ++GQGG+G V+     D  EI A+KR+ K     L E   +  E  + +  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
             LVKLL    Q +E L L  E++      + + +       +   RF++        M+
Sbjct: 61  EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS--EDHARFYMA------EMF 111

Query: 154 LHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
              D+   L  IHRDLK  N L+D   + K++DFGL++      T  N+  V+G+  YMA
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMA 166

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      +    D +S G +L E + G
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 22/215 (10%)

Query: 41  FSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 94
           F++ + LG+G FG V +  L       Q++AVK L     S   ++E   E     +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 95  RNLVKLLGCCIQGEEK------LLIYEFMTNKSLDSFIFDQ---ERCKILDWSKRFHIIC 145
            N++KL+G  ++   K      ++I  FM +  L +F+      E    L        + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD-ETEGNTKRV 203
             A G+ YL   S    IHRDL A N +L+++M   ++DFGL++  + GD   +G   ++
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                ++A E  +D  ++  SDV++FG+ + EI++
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 25/215 (11%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 93
           N+ + K LGQG FG VY     D G+E+AVK++     S  + + +  L+ E+ L   L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 94  HRNLVKLLGCCIQGEEKLL--IYEFMTNKSLDSFIFDQERCK---ILDWSKRF--HIICG 146
           H  +V+  GC     E+ L    E M   S    I DQ +       + ++++   I+  
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQIL-- 116

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TKRVIG 205
              GV YLH +    I+HRD+K +N+L D   N K+ DFG ++        G   K V G
Sbjct: 117 --EGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           T  +M+PE  S   +  K+D++S G  ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 19/222 (8%)

Query: 31  LATIVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-IL 88
           L ++   T+ + I + +G+G +G VYK T   DG   AVK L  IS+   +E++ E  IL
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72

Query: 89  FSKLQHRNLVKLLGCCIQ-----GEEKLLIYEFMTNKSLDSFIFDQERC-KILDWSKRFH 142
            S   H N+VK  G   +     G +  L+ E     S+   +     C + LD +   +
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           I+ G   G+ +LH +   RIIHRD+K +N+LL  +   K+ DFG++          NT  
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188

Query: 203 VIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISG 239
            +GT  +MAPE  +     D  +  + DV+S GI  +E+  G
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 75/224 (33%), Positives = 110/224 (49%), Gaps = 46/224 (20%)

Query: 41  FSINKKLGQGGFGPVYKGTLVD---GQEIAVKRLSKI-----SEQGLKELKNEVILFSKL 92
           + I +KLG+G +G V+K   +D    + +A+K   KI     +    +    E++   +L
Sbjct: 9   YEILQKLGKGAYGIVWKA--IDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63

Query: 93  -QHRNLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKIL-DWSKRFHIICGT 147
             H N+VKLL   I+ E    IY   E+M    L + I    R  IL D  KR+ I+   
Sbjct: 64  GDHPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQL 116

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG-GDETEGN---TKRV 203
            + + Y+H  S   +IHRDLK SN+LL+ D   K++DFGLAR+    +E   N   T  V
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 204 IGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
             T  Y APE       Y       V  D++S G +L E++ GK
Sbjct: 174 -ATRWYRAPEILLGSTRYT----KGV--DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.1 bits (202), Expect = 1e-17
 Identities = 73/271 (26%), Positives = 132/271 (48%), Gaps = 34/271 (12%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 96
           F+  +++G G FG VY    V   E+ A+K++S   K S +  +++  EV    +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
            ++  GC ++     L+ E+    + D     ++  + ++ +   H   G  +G+ YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH---GALQGLAYLHS 143

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY-- 214
            +   +IHRD+KA N+LL +    K++DFG A               +GT  +MAPE   
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194

Query: 215 -ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
              +GQ+  K DV+S GI  +E ++ +K   F     N+N +   + +      +Q   P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIE-LAERKPPLF-----NMNAMSALYHI------AQNESP 242

Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
            +Q S   ++  R  +    C+Q+ P+DRP+
Sbjct: 243 TLQ-SNEWSDYFR--NFVDSCLQKIPQDRPT 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 41/222 (18%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRN 96
           + + K +G G +G V        G+++A+K++S +    L + K    E+ L   L+H N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKILDWSKRF------- 141
           ++ LL             + +   S + F        + + +  K++  S +        
Sbjct: 61  IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQ 106

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-- 199
           + +    RG+ YLH      +IHRDLK SN+L++ + + KI DFGLAR    DE E    
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 200 TKRVIGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIISGK 240
           T+ V+ T  Y APE   S  +++   D++S G +  E+++ K
Sbjct: 164 TEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 68/292 (23%), Positives = 134/292 (45%), Gaps = 42/292 (14%)

Query: 40  NFSINKKLGQGGFGPVYK-------GTLVDGQEIAVKRLS-----KISEQGLKELKNEV- 86
            +++ + LG G FG VYK         L+  +EI V   +     +  ++ + ++ +EV 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 87  ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL-DSFIFDQERCKILDWSKRFHIIC 145
           I+  +L+H N+V+     ++ +   ++ + +    L + F   +E+ +     + ++I  
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
                + YLH++ R  I+HRDL  +N++L +D    I+DFGLA+       E     V+G
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESKLTSVVG 175

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL----IGHAWKL 261
           T  Y  PE   +  +  K+DV++FG +L ++ + +     ++S N L+L    +   ++ 
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNMLSLATKIVEAVYEP 232

Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG 313
             EGM S+ +   I                  C+    + RP +  V  M+ 
Sbjct: 233 LPEGMYSEDVTDVITS----------------CLTPDAEARPDIIQVSAMIS 268

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 25/207 (12%)

Query: 45  KKLGQGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRN 96
           K LG+G FG V     KGT    +  AVK L K   + +  ++    E  + +   +H  
Sbjct: 1   KVLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSK-RFHIICGTARGVMYL 154
           L +L   C Q +++L  + E++    L   +F  +R    D  + RF+       G+ +L
Sbjct: 58  LTQLH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFL 112

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTKRVIGTYGYMAPE 213
           H+     II+RDLK  NVLLD + + KI+DFG+ +    G  T   T    GT  Y+APE
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPE 166

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGK 240
             S   +    D ++ G+LL E+++G+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 50/286 (17%)

Query: 40  NFSINKKLGQGGFGPVY--KGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHR 95
            + I KK+G+G FG +Y  K    D +   +K   L+K+  +  +  K EVIL +K++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 96  NLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTAR 149
           N+V       Q   +L I  E+     L   I  Q        +IL W          + 
Sbjct: 60  NIVTFFAS-FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISL 112

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
           G+ ++H     +I+HRD+K+ N+ L ++ M  K+ DFG+AR    D  E      +GT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSME-LAYTCVGTPY 167

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
           Y++PE   +  ++ K+D++S G +L E+ + K         NNL+               
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGNNLH--------------- 208

Query: 269 QLIDPCIQGSF-----NLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
           QL+    QG F     N +  +R +   L  V   P+DRPS+ S++
Sbjct: 209 QLVLKICQGYFAPISPNFSRDLRSLISQLFKVS--PRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 63/287 (21%)

Query: 45  KKLGQGGFGPVYKGTLV----DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLV 98
           KK+G+G FG   K  LV    DG++  +K +  SK+S +  +E + EV + S ++H N+V
Sbjct: 6   KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62

Query: 99  KL------LGC-------CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           +        G        C  G+    +Y+ +  +    F  DQ    ILDW   F  IC
Sbjct: 63  QYQESFEENGNLYIVMDYCEGGD----LYKKINAQRGVLFPEDQ----ILDW---FVQIC 111

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
                + ++H     +I+HRD+K+ N+ L +D   K+ DFG+AR    + T    +  IG
Sbjct: 112 ---LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIG 163

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           T  Y++PE   +  ++ KSD+++ G +L E+ + K                HA++    G
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK----------------HAFE---AG 204

Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQ---QHPKDRPSMPSVI 309
               L+   I+GS+          +  L  Q   ++P+DRPS+ S++
Sbjct: 205 NMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.5 bits (198), Expect = 4e-17
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 19/202 (9%)

Query: 46  KLGQGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++G G FG VY  T     E+ AVK++S   K + +  +++  EV    +L+H N ++  
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           GC ++     L+ E+    + D     ++  + ++ +   H   G  +G+ YLH  +   
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH---GALQGLAYLHSHN--- 141

Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY---ASDG 218
           +IHRD+KA N+LL +    K++DFG A       +  N+   +GT  +MAPE      +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVILAMDEG 195

Query: 219 QFSVKSDVFSFGILLLEIISGK 240
           Q+  K DV+S GI  +E+   K
Sbjct: 196 QYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.8 bits (197), Expect = 4e-17
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 20/224 (8%)

Query: 42  SINKKLGQGGFGPVYKGTLVDGQ----EIAVKRLSKISEQGLKEL-KNEVILFSKLQHRN 96
           ++ + +G+G FG VY+G  +  +     +AVK     +   ++E    E  +  +  H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL+G   +     ++ E      L S++  Q     LD +         +  + YL  
Sbjct: 69  IVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEY 214
               R +HRD+ A NVL+      K+ DFGL+R    +        K  I    +MAPE 
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI---KWMAPES 179

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGH 257
            +  +F+  SDV+ FG+ + EI+  G K   F    NN ++IG 
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKP--FQGVKNN-DVIGR 220

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 79.6 bits (196), Expect = 5e-17
 Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)

Query: 42  SINKKLGQGGFGPVYKG--TLVDGQE--IAVKRL-SKISEQGLKELKNEVILFSKLQHRN 96
            I + LG G FG + +G   L   +E  +A+  L +  S++  +    E +   +  H N
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +V+L G   +G   +++ E+M+N +LDSF+   E    L   +   ++ G A G+ YL  
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYL-- 123

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEY 214
            S +  +H+ L A  VL++ D+  KIS F   +    D++E    T        + APE 
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEA 179

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
                FS  SDV+SFGI++ E++S G++                    W+  M  Q +  
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGER------------------PYWD--MSGQDVIK 219

Query: 274 CIQGSFNLAEVIRC---IHIGLL-CVQQHPKDRPSMPSV 308
            ++  F L     C   +H  +L C Q+   +RP    +
Sbjct: 220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.5 bits (196), Expect = 6e-17
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 58/277 (20%)

Query: 47  LGQGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           LG G  G VYK   +  + I AVK +   I+ +  K++ +E+ +  K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA----RGVMYLHQDSRL 160
                  +  EFM   SLD +                H++   A    +G+ YL     L
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF 220
           +I+HRD+K SN+L++     K+ DFG++            K  +GT  YMAPE  S  Q+
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQY 170

Query: 221 SVKSDVFSFGILLLEIISGK-------KNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI-- 271
            + SDV+S GI  +E+  G+       KN+G                     MP QL+  
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------------------MPLQLLQC 211

Query: 272 ----DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
               DP +      +E    +H    C+++ PK+RP+
Sbjct: 212 IVDEDPPVLPVGQFSEKF--VHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 26/208 (12%)

Query: 47  LGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLVKL 100
           +G+G FG V K      G  +AVKR+    ++  KE K      +V++ S      +VK 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSS-DCPYIVKF 68

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSF---IFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            G   +  +  +  E M   SLD F   +++  +  ++       I   T + + YL ++
Sbjct: 69  YGALFREGDCWICMELMDI-SLDKFYKYVYEVLK-SVIPEEILGKIAVATVKALNYLKEE 126

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK-RVIGTYGYMAPE--- 213
             L+IIHRD+K SN+LLD++ N K+ DFG++    G   +   K R  G   YMAPE   
Sbjct: 127 --LKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERID 180

Query: 214 -YASDGQFSVKSDVFSFGILLLEIISGK 240
             A DG + V+SDV+S GI L E+ +GK
Sbjct: 181 PSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.7 bits (194), Expect = 9e-17
 Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 45  KKLGQGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           + +G+G FG V+         LV  ++I V++++K      +   NE  +   L H N++
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK-ILDWSKRFHIICGTARGVMYLHQD 157
           +     ++ +  +++ E+    +L  +I  Q+RC  +LD     H        + ++H  
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 158 SRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
               I+HRDLK  N+LLD+  M  KI DFG+++      ++     V+GT  Y++PE   
Sbjct: 121 L---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCE 174

Query: 217 DGQFSVKSDVFSFGILLLEIISGKK 241
              ++ KSD+++ G +L E+ S K+
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.7 bits (195), Expect = 1e-16
 Identities = 71/217 (32%), Positives = 102/217 (47%), Gaps = 39/217 (17%)

Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSK 91
           ++F   K LG G FG V    +KG+   G+  A+K LSK  I +    E + NE  +   
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57

Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR- 149
           ++H  LV L G   Q +  L L+ E++    L S          L  S RF      AR 
Sbjct: 58  IRHPFLVNLYGS-FQDDSNLYLVMEYVPGGELFSH---------LRKSGRFPE--PVARF 105

Query: 150 -------GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
                   + YLH    L I++RDLK  N+LLD D   KI+DFG A+       +G T  
Sbjct: 106 YAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYT 157

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           + GT  Y+APE      +    D ++ GIL+ E+++G
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 34/215 (15%)

Query: 47  LGQGGFGPVYKGTLV-DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLL 101
           +G+G FG V +  +  DG ++  A+K L +  SE   ++   E+ +  KL  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR------------ 149
           G C       +  E+    +L  F+    + ++L+    F    GTA             
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 150 ----GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
               G+ YL   S  + IHRDL A NVL+ +++  KI+DFGL+R   G+E     K+ +G
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--VKKTMG 178

Query: 206 TYG--YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                +MA E  +   ++ KSDV+SFG+LL EI+S
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 20/206 (9%)

Query: 45  KKLGQGGFGPVY------KGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNL 97
           + LG+G FG V       +G    G+++AVK L   S    + +LK E+ +   L H N+
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 98  VKLLGCCIQGEEK--LLIYEFMTNKSLDSFIFDQERCKI-LDWSKRFHI-ICGTARGVMY 153
           VK  G C +       LI EF+ + SL  ++  + + KI L    ++ + IC   +G+ Y
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQIC---KGMDY 124

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT-YGYMAP 212
           L   SR + +HRDL A NVL++ +   KI DFGL +A   D+     K  + +   + AP
Sbjct: 125 L--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 213 EYASDGQFSVKSDVFSFGILLLEIIS 238
           E     +F + SDV+SFG+ L E+++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 47  LGQGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGFG V    +   G+  A K+L K      +G     NE  +  K+  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH---IICGTARGVMYLHQDSR 159
                +   L+   M    L   I+        +    F+   I CG    +  LHQ+  
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ 219
            RI++RDLK  N+LLD   + +ISD GLA      +T    K  +GT GYMAPE   + +
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNER 177

Query: 220 FSVKSDVFSFGILLLEIISGK 240
           ++   D ++ G LL E+I+G+
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 4e-16
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 27/205 (13%)

Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVK 99
           K + +G FG VY       G   A+K L K       ++ N      I+  + +   + K
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKIL-----DWSKRFHIICGTARGVMYL 154
           L       +   L+ E++      S I      K L     DW+K++  I     GV  L
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQY--IAEVVLGVEDL 113

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           HQ     IIHRD+K  N+L+DQ  + K++DFGL+R   G E     K+ +GT  Y+APE 
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPET 164

Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                    SD +S G ++ E + G
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 82/250 (32%), Positives = 120/250 (48%), Gaps = 41/250 (16%)

Query: 45  KKLGQGGFGPVY---KGTLVD-GQEIAVKRLSKISEQGLK-----ELKNEVILFSKLQHR 95
           K LGQG FG V+   K T  D GQ  A+K L K +   LK       K E  + +++ H 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58

Query: 96  NLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICGTAR 149
            +VKL     Q E KL LI +F+    L        +F +E  K          +   A 
Sbjct: 59  FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELAL 109

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
            + +LH    L II+RDLK  N+LLD++ + K++DFGL++     + E       GT  Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEY 164

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN--LNLIGHAWKLWNEGMP 267
           MAPE  +    +  +D +SFG+L+ E+++G  +  F   D    + +I  A KL   GMP
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMILKA-KL---GMP 218

Query: 268 SQLIDPCIQG 277
            Q + P  Q 
Sbjct: 219 -QFLSPEAQS 227

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.9 bits (189), Expect = 6e-16
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)

Query: 45  KKLGQGGFGPVYKGTLV-DGQEI----AVKRL-SKISEQGLKELKNEVILFSKLQHRNLV 98
           K LG G FG V+KG  + +G  I    A+K +  +   Q  +E+ + ++    L H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-----LDWSKRFHIICGTARGVMY 153
           +LLG C  G    L+ +     SL   +  Q R  +     L+W  +       A+G+ Y
Sbjct: 73  RLLGIC-PGASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQI------AKGMYY 124

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           L +    R++HR+L A N+LL  D   +I+DFG+A     D+ +           +MA E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
               G+++ +SDV+S+G+ + E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.6 bits (188), Expect = 6e-16
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 28/212 (13%)

Query: 47  LGQGGFGPVYKGTLV-DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 101
           +G+G FG V K  +  DG  +  A+KR+ +  S+   ++   E+ +  KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDWSKR--FHIICGTA 148
           G C       L  E+  + +L  F+           F          S +   H     A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
           RG+ YL   S+ + IHRDL A N+L+ ++   KI+DFGL+R   G E     K+ +G   
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRLP 174

Query: 209 --YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             +MA E  +   ++  SDV+S+G+LL EI+S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 76.2 bits (187), Expect = 7e-16
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLV 98
           +F + +++G G +G VYK   V+  E+A  ++ K+   +    ++ E+I+    +H N+V
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
              G  ++ ++  +  EF    SL            L  S+  ++   T +G+ YLH   
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS-- 216
           +   +HRD+K +N+LL  + + K++DFG++       T    K  IGT  +MAPE A+  
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVE 181

Query: 217 -DGQFSVKSDVFSFGILLLEI 236
             G ++   D+++ GI  +E+
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 76.5 bits (188), Expect = 8e-16
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 35/227 (15%)

Query: 41  FSINKKLGQGGFGPVY------------KGTLVDGQE-----IAVKRL-SKISEQGLKEL 82
            +  +KLG+G FG V+            K   +D        +AVK L    ++    + 
Sbjct: 7   LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66

Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--------FDQERCKI 134
             E+ + S+L+  N+++LL  CI  +   +I E+M N  L+ F+         ++     
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGG 193
           + +S    +    A G+ YL   S L  +HRDL   N L+ ++   KI+DFG++R  + G
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183

Query: 194 D--ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           D    +G   R +    +M+ E    G+F+  SDV++FG+ L EI++
Sbjct: 184 DYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 76.3 bits (188), Expect = 8e-16
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 47  LGQGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHRNLVKLLGC 103
           LG+G +G V K   V  G  +AVKR+ + ++ Q  K L  ++ I    +     V   G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTARGVMYLHQD 157
             +  +  +  E M + SLD F       K+ D            I     + + YLH  
Sbjct: 69  LFREGDVWICMEVM-DTSLDKFYK-----KVYDKGLTIPEDILGKIAVSIVKALEYLH-- 120

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEY-- 214
           S+L +IHRD+K SNVL++++   K+ DFG++    G   +   K +  G   YMAPE   
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPERIN 176

Query: 215 --ASDGQFSVKSDVFSFGILLLEIISGK 240
              +   + VKSDV+S GI ++E+ +G+
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 16/200 (8%)

Query: 46  KLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKL 100
            +G+G +G V K    + GQ +A+K+  +  +   K +K     E+ +  +L+H NLV L
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
           +    + +   L++EF+ +  LD     ++    LD S+    +    RG+ + H  +  
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY-ASDGQ 219
            IIHRD+K  N+L+ Q    K+ DFG AR       E  T  V  T  Y APE    D +
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYV-ATRWYRAPELLVGDTK 177

Query: 220 FSVKSDVFSFGILLLEIISG 239
           +    D+++ G L+ E+++G
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 15/199 (7%)

Query: 47  LGQGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 101
           LG+G FG V    L   G+  AVK L K   + +  ++  +  + IL     H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 102 GCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
            CC Q  ++L  + EF+    L   +F  ++ +  D ++           +M+LH     
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF 220
            II+RDLK  NVLLD + + K++DFG+ +   G      T    GT  Y+APE   +  +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKE--GIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 221 SVKSDVFSFGILLLEIISG 239
               D ++ G+LL E++ G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 32/222 (14%)

Query: 31  LATIVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELK 83
             T+   TN +   + +G G FG V      + GQ +A+K++ K      ++++  +ELK
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMT---NKSLDSFIFDQERCKILDWSK 139
               L   L+H N++ L    I   E +  + E +    ++ L S   +++  +      
Sbjct: 62  ----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYF---- 113

Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
            + I+    RG+ Y+H      ++HRDLK SN+L++++ + KI DFGLAR       +  
Sbjct: 114 LYQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQ 161

Query: 200 TKRVIGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGK 240
               + T  Y APE     Q + V+ D++S G +  E++ GK
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 53/206 (25%), Positives = 102/206 (49%), Gaps = 20/206 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRN 96
           +++ + +++G G +G VYK   +   E+A  ++ K+ E G     ++ E+ +  + +H N
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECKHCN 67

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF---DQERCKILDWSKRFHIICGTARGVMY 153
           +V   G  +  E+  +  E+    SL             +I       ++   T +G+ Y
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIA------YVCRETLQGLAY 121

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           LH   ++   HRD+K +N+LL  + + K++DFG+A       T    K  IGT  +MAPE
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPE 176

Query: 214 YAS---DGQFSVKSDVFSFGILLLEI 236
            A+   +G ++   D+++ GI  +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 73.9 bits (181), Expect = 4e-15
 Identities = 74/273 (27%), Positives = 131/273 (47%), Gaps = 34/273 (12%)

Query: 45  KKLGQGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLV 98
           + +G+G +G V   +LV    DG++  +K+L+    S +  K  + E  L S+L+H N+V
Sbjct: 6   RVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 99  KLLGCCIQGEEKLL--IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
                  +GE+ LL  +  F     L   +  +++ K+L  ++        A  + YLH+
Sbjct: 63  AYRESW-EGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+HRDLK  NV L +    K+ D G+AR         +T  +IGT  YM+PE  S
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFS 175

Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
           +  ++ KSDV++ G  + E+ + K      H+ N  ++    +++    +P    D   +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLK------HAFNAKDMNSLVYRIIEGKLPPMPKDYSPE 229

Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
               L E+I      +L   + P+ RPS+ S++
Sbjct: 230 ----LGELIA----TMLS--KRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 68/303 (22%), Positives = 125/303 (41%), Gaps = 44/303 (14%)

Query: 11  SEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKR 70
           SE  ++D     D  +P  + A  V A+  +++ K L  G  G V+  T   GQ   V  
Sbjct: 42  SESDDDDD----DGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV-- 94

Query: 71  LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE 130
           + KI ++G   +  E +L   + H +++++    + G    ++   + + S D + +  +
Sbjct: 95  VLKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTK 149

Query: 131 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
           R + L   +   I      G+ YLH     RIIHRD+K  N+ ++      I D G A+ 
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206

Query: 191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
                       + GT    APE  +  +++ K+D++S GI+L E+++            
Sbjct: 207 ---PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST-------- 255

Query: 251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
                        E  PS   +       +L ++I  + +       HP++ P  P   L
Sbjct: 256 -----------IFEDPPSTPEEYVKSCHSHLLKIISTLKV-------HPEEFPRDPGSRL 297

Query: 311 MLG 313
           + G
Sbjct: 298 VRG 300

Length = 357

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 34/209 (16%)

Query: 47  LGQGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILF---SKLQHRN 96
           LG+G FG V    YK T   G+  A+K L K   I+   ++ L  E  +F   +  +H  
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFI----FDQERCKILDWSKRFHIICGTARGV 151
           LV L   C Q E+ +  + E+     L   I    F + R         F+  C    G+
Sbjct: 64  LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV-------FYAAC-VVLGL 114

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTKRVIGTYGYM 210
            YLH++   +I++RDLK  N+LLD +   KI+DFGL +   G  +    T    GT  ++
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFL 168

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE  ++  ++   D +  G+L+ E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 49/219 (22%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF-----SKLQHRNLVK 99
           K LG+G FG V    L    E             +K LK +V+L        +  R ++ 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFF----------AIKALKKDVVLEDDDVECTMVERRVLA 50

Query: 100 L---------LGCCIQGEEKLL-IYEFMTNKSL-----DSFIFDQERCKILDWSKRFH-- 142
           L         L C  Q +E L  + E++    L      S  FD+ R        RF+  
Sbjct: 51  LAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-------RFYAA 103

Query: 143 -IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
            IICG    + +LH+     II+RDLK  NVLLD+D + KI+DFG+ +     E + +T 
Sbjct: 104 EIICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST- 155

Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
              GT  Y+APE     +++   D +SFG+LL E++ G+
Sbjct: 156 -FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.1 bits (183), Expect = 5e-15
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEI-AVKR----LSKISE-QGLKELKNEVILFSKLQ-HRNL 97
           K+LG G FG VY     +  E+ A+K+         E   L+E+K+      KL  H N+
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNI 60

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           VKL     + +E   ++E+M   +L   + D++  K    S    II    +G+ ++H  
Sbjct: 61  VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIH-- 116

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN---TKRVIGTYGYMAPE- 213
            +    HRDLK  N+L+      KI+DFGLAR     E       T  V  T  Y APE 
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYV-STRWYRAPEI 169

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGK 240
                 +S   D+++ G ++ E+ + +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 40/214 (18%)

Query: 46  KLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHRNLVKLL 101
           ++G+G +G VY+      G+ +A+K++   +E+    +  L+ E+ L   L+H N+V+L 
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF------DQERCKILDWSKR-FH------IICGTA 148
                        E +  K LDS IF      +Q+   +LD     F       ++    
Sbjct: 73  -------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
           RG+ YLH++    IIHRDLK SN+LL      KI+DFGLAR + G   +  T +V+ T  
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLW 173

Query: 209 YMAPE--YASDGQFSVKSDVFSFGILLLEIISGK 240
           Y APE         +   D+++ G +L E+++ K
Sbjct: 174 YRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.4 bits (180), Expect = 7e-15
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 47  LGQGGFGPV------YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           LG+GGFG V        G +   +++  KRL K S + +  L+ E++   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
                      L+   M    L   I++    + L+  +  H       G+++LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS---M 114

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF 220
            I++RD+K  NVLLD   N ++SD GLA      +T   T+R  GT GYMAPE   +  +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA-GTNGYMAPEILKEEPY 171

Query: 221 SVKSDVFSFGILLLEIISGK 240
           S   D F+ G  + E+++G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 38/240 (15%)

Query: 40  NFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKI------SEQGLKELKNEVILF 89
            + + K+LGQG +G V       T  + + +A+K+++ +      +++ L+ELK   +L 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56

Query: 90  SKLQHRNLVKLLGCCI---QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI--- 143
               H+N+  L    I       +L +YE +    L   I   +           H    
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT------DAHFQSF 110

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTK 201
           I     G+ Y+H  +   ++HRDLK  N+L++ D   KI DFGLAR F     E  G   
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 202 RVIGTYGYMAPEYASDGQFSVKS-DVFSFGILLLEIISGK---KNRGFYHSDNNLNLIGH 257
             + T  Y APE     Q   K+ DV+S G +L E++  K   K + +      LN I  
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQ 224

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 45  KKLGQGGFGPVYK----GTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 99
            ++G G  G VYK     T   G+  A+K +    E  ++ ++  E+ +   + H N+VK
Sbjct: 80  NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
                    E  ++ EFM   SL+      E+  + D +++  I+ G A    YLH   R
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-FLADVARQ--ILSGIA----YLH---R 186

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA---- 215
             I+HRD+K SN+L++   N KI+DFG++R     +T       +GT  YM+PE      
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPERINTDL 244

Query: 216 SDGQFS-VKSDVFSFGILLLEIISGK 240
           + G +     D++S G+ +LE   G+
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)

Query: 41  FSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRN 96
           F   + LG+GGFG V    +   G+  A KRL K      +G     NE  +  K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTARGV 151
           +V L       +   L+   M    L   I++      E  + L ++    I+CG    +
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE--ILCG----L 115

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA-RAFGGDETEGNTKRVIGTYGYM 210
             LH+++    ++RDLK  N+LLD   + +ISD GLA +   G+   G     +GT GYM
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYM 168

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGK 240
           APE  ++ ++++  D +  G L+ E+I G+
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 68/214 (31%), Positives = 97/214 (45%), Gaps = 31/214 (14%)

Query: 41  FSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELK------NEVILFSKLQ 93
           F   + LG+GGFG V    +   G+  A K+L K   + +K+ K      NE  +  K+ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVN 58

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-------FDQERCKILDWSKRFHIICG 146
            R +V L       +   L+   M    L   I       FD+ER           I CG
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY----AAEITCG 114

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
               +  LH   R RI++RDLK  N+LLD   + +ISD GLA      ET    +  +GT
Sbjct: 115 ----LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGT 164

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            GYMAPE   + +++   D +  G L+ E+I GK
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 15/207 (7%)

Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQ 93
           N + +   +G+G +G V K      G+ +A+K+  K SE   +++K     EV +  +L+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N+V L     +     L++E++    L+     +     L        I    + + Y
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
            H      IIHRD+K  N+L+ +    K+ DFG ARA         T  V  T  Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171

Query: 214 -YASDGQFSVKSDVFSFGILLLEIISG 239
               D  +    DV++ G ++ E++ G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)

Query: 40  NFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSK 91
           NF + + LG G +G V+     G    G+  A+K L K +     +  +  + E  +   
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           ++    +  L    Q + KL LI +++    L + ++ +E     +   R +I    A  
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVYI----AEI 114

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           V+ L    +L II+RD+K  N+LLD + +  ++DFGL++ F  +E E       GT  YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173

Query: 211 APEY--ASDGQFSVKSDVFSFGILLLEIISG 239
           APE      G      D +S G+L  E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 71.2 bits (174), Expect = 3e-14
 Identities = 72/282 (25%), Positives = 134/282 (47%), Gaps = 44/282 (15%)

Query: 40  NFSINKKLGQGGFGPVYKGTLV----DGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
            +++ + +G+G FG   +  LV      Q+ A+K  RL K S   +++ + E +L +K++
Sbjct: 1   QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMK 56

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQE-----RCKILDWSKRFHIICGT 147
           H N+V       + +  L ++ E+     L   I  Q         IL W   F  +C  
Sbjct: 57  HPNIVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC-- 110

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             GV ++H+    R++HRD+K+ N+ L Q+   K+ DFG AR          T   +GT 
Sbjct: 111 -LGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTP 164

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
            Y+ PE   +  ++ KSD++S G +L E+ + K     + +++  NLI    +   + +P
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP---FQANSWKNLILKVCQGSYKPLP 221

Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
           S         S+ L  +I+ +       +++P+ RPS  +++
Sbjct: 222 SHY-------SYELRSLIKQM------FKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 27/206 (13%)

Query: 47  LGQGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGFG V    +   G+  A K+L K      +G     NE  +  K+  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFI-------FDQERCKILDWSKRFHIICGTARGVMYLH 155
                +   L+   M    L   I       FD++R           + CG       L 
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY----AAELCCG-------LE 116

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR-VIGTYGYMAPEY 214
              R RI++RDLK  N+LLD   + +ISD GLA        EG T R  +GT GYMAPE 
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI----PEGETVRGRVGTVGYMAPEV 172

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
            ++ +++   D +  G L+ E+I G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 71.1 bits (174), Expect = 4e-14
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 22/208 (10%)

Query: 45  KKLGQGGFGPVYKG---TLVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLV 98
            ++G G FG V  G     +    + VK L   +   EQ L     EV  + +L H N++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF--HIICGTARGVMYLHQ 156
           + LG CI+    LL+ EF     L +++            K     + C  A G+++LHQ
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTKRVIGTYGYMAPEYA 215
                 IH DL   N  L  D++ KI D+GLA   +  D         +    ++APE  
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELV 174

Query: 216 SDGQFSV-------KSDVFSFGILLLEI 236
                 +       KS+++S G+ + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 24/215 (11%)

Query: 45  KKLGQGGFGPVYKGTLV-DGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVK 99
           K LG+G FG V    L   G+  AVK L K    I +     +  + +L    ++  L  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 100 LLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFH---IICGTARGVMYLH 155
           L  C  Q +E L  + EF+    L   I D+ R  +  +   F+   I+CG    + +LH
Sbjct: 61  LY-CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLH 113

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
                 II+RDLK  NV+LD+D + KI+DFG+ +     +   +T    GT  Y+APE  
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEIL 168

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
              +++   D +SFG+LL E++ G+     +H D+
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSP---FHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 29/209 (13%)

Query: 45  KKLGQGGFGPVY----KGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRN 96
           K LG+G FG V+    KGT    Q  A+K L K    + +     +  + +L    +H  
Sbjct: 1   KMLGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 57

Query: 97  LVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSK-RFH---IICGTARGV 151
           L  L  C  Q +E L  + E++    L   +F  + C   D  +  F+   IICG    +
Sbjct: 58  LTHLY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG----L 109

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
            +LH      I++RDLK  N+LLD D + KI+DFG+ +     + +  T    GT  Y+A
Sbjct: 110 QFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT--FCGTPDYIA 164

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE     +++   D +SFG+LL E++ G+
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 53/205 (25%)

Query: 41  FSINKKLGQGGFGPVYKG---TLVDGQEIAVKRL--SKISEQGLKELK-NEVILFSKLQH 94
           + I   +G+G +G VYK       DG+E A+K+    K    G+ +    E+ L  +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD---QERCKILDW---SKRFHIICGTA 148
            N+V L+   ++  +K +             +FD    +  +I+ +   +KR  I     
Sbjct: 62  ENVVSLVEVFLEHADKSV-----------YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 149 R--------GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAF----- 191
           +        GV YLH +    ++HRDLK +N+L+  +       KI D GLAR F     
Sbjct: 111 KSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 192 ---GGDETEGNTKRVIGTYGYMAPE 213
                D        V+ T  Y APE
Sbjct: 168 PLADLD-------PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 50/156 (32%), Positives = 86/156 (55%), Gaps = 21/156 (13%)

Query: 46  KLGQGGFGPVYKGTLVDGQEI-AVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 102
           K+G+G +G V+K    +  EI A+KR+    + +G+      E+ L  +L+H+N+V+L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 103 CCIQGEEKL-LIYEFMTN---KSLDSF--IFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
             +  ++KL L++E+      K  DS     D E  K    S  F ++    +G+ + H 
Sbjct: 67  V-LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK----SFMFQLL----KGLAFCHS 117

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 192
                ++HRDLK  N+L++++   K++DFGLARAFG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 91
           NF + K LG G +G V+    V G +     A+K L K +     +  +  + E  +   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           ++    +  L    Q + KL LI +++    L + +  +ER K     +   I  G    
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEI-- 114

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           V+ L    +L II+RD+K  N+LLD + +  ++DFGL++ F  DE E       GT  YM
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173

Query: 211 APEY--ASDGQFSVKSDVFSFGILLLEIISG 239
           AP+     DG      D +S G+L+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 51/242 (21%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ-----GLKELKNEVILFSKLQ 93
            +     +G+G +G V   T    G ++A+K++S    Q      L+E+K    +  + +
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61

Query: 94  HRNLVKLLGCCIQG-----EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF---HI-- 143
           H N++ +L            +  ++ E M          + +  K++  ++     HI  
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELM----------ETDLYKLIK-TQHLSNDHIQY 110

Query: 144 -ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
            +    RG+ Y+H  +   ++HRDLK SN+LL+ + + KI DFGLAR    D    +T  
Sbjct: 111 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGF 165

Query: 203 V---IGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGK-----KNRGFYHSDNNLN 253
           +   + T  Y APE   +   ++   D++S G +L E++S +     K+   Y   + LN
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YL--HQLN 220

Query: 254 LI 255
           LI
Sbjct: 221 LI 222

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 17/203 (8%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVK 99
           K LG+G FG V    L    E+ A+K L K   + +  +   +  + IL    +H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 100 LLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSK-RFHIICGTARGVMYLHQD 157
           L  CC Q +++L  + E++    L   +F  +R +  D  + RF+    T   +M+LH+ 
Sbjct: 61  LH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRH 115

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
               +I+RDLK  N+LLD + + K++DFG+ +   G      T    GT  Y+APE   +
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCKE--GILNGVTTTTFCGTPDYIAPEILQE 170

Query: 218 GQFSVKSDVFSFGILLLEIISGK 240
            ++    D ++ G+L+ E+++G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 67/200 (33%), Positives = 90/200 (45%), Gaps = 13/200 (6%)

Query: 45  KKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVK 99
           K +G+G FG V       DG   AVK L K +    KE  + +    +L   L+H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
           L     Q  EKL       N     F   +ERC  L+   RF+     A  + YLH    
Sbjct: 61  L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERC-FLEPRARFYA-AEVASAIGYLHS--- 114

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ 219
           L II+RDLK  N+LLD   +  ++DFGL +   G E E  T    GT  Y+APE      
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 220 FSVKSDVFSFGILLLEIISG 239
           +    D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 32/195 (16%)

Query: 60  LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 117
            V GQ +A+K+LS+   +    K    E++L   + H+N++ LL              F 
Sbjct: 38  TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FT 85

Query: 118 TNKSLDSF--------IFDQERCKI----LDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
             KSL+ F        + D   C++    LD  +  +++     G+ +LH      IIHR
Sbjct: 86  PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHR 142

Query: 166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSD 225
           DLK SN+++  D   KI DFGLAR  G       T  V+  Y Y APE      +    D
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVD 199

Query: 226 VFSFGILLLEIISGK 240
           ++S G ++ E+I G 
Sbjct: 200 IWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)

Query: 46  KLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           +LG+G +G VYK      G  +  +EI   RL  + E    ++  E+ +  K     +V 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKAVSPYIVD 63

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
             G         +  E+M   SLD         + +       I     +G+ +L ++  
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-- 121

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG- 218
             IIHRD+K +NVL++ +   K+ DFG++    G+      K  IG   YMAPE    G 
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGG 177

Query: 219 -----QFSVKSDVFSFGILLLEIISGK 240
                 ++V+SDV+S G+ +LE+  G+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 61/239 (25%)

Query: 43  INKKLGQGGFGPVYKG-TLVDGQEIAVKRL-------------SKISEQG-----LKELK 83
               LG+G +G V K    + G+ +A+K++               +   G     L+ELK
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF-- 141
               + ++++H N++ L+   ++G+   L+ + M            +  K++D   R   
Sbjct: 73  ----IMNEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTE 118

Query: 142 -HIIC---GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD--- 194
             + C       G+  LH+      +HRDL  +N+ ++     KI+DFGLAR +G     
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 195 ----------ETEGNTKRVIGTYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
                       E  T +V+ T  Y APE    A    F+V  D++S G +  E+++GK
Sbjct: 176 DTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 45/194 (23%)

Query: 46  KLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLV 98
           K+GQG FG V+K       Q +A+K++   +E+       L+E+K   IL   L+H N+V
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENVV 74

Query: 99  KLLGCC---IQGEEK-----LLIYEF--------MTNKSLDSFIFDQERCKILDWSKRFH 142
            L+  C        +      L++EF        ++NK++    F     K         
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIK--------K 123

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--- 199
           ++     G+ Y+H   R +I+HRD+KA+N+L+ +D   K++DFGLARAF   +       
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 200 TKRVIGTYGYMAPE 213
           T RV+ T  Y  PE
Sbjct: 181 TNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 67/210 (31%), Positives = 95/210 (45%), Gaps = 36/210 (17%)

Query: 47  LGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 102
           +G+GGFG VY     D G+  A+K L K     +QG     NE I+ S      LV    
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55

Query: 103 C----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL---- 154
           C    C+        Y F T   L SFI D      L +    H +   A    Y     
Sbjct: 56  CPFIVCMS-------YAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107

Query: 155 ----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
               H  +R  +++RDLK +N+LLD+  + +ISD GLA  F   +   +    +GT+GYM
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162

Query: 211 APEYASDG-QFSVKSDVFSFGILLLEIISG 239
           APE    G  +   +D FS G +L +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 41/222 (18%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 92
           N+     ++G G  G VYK      G  +AVK++ +   +  +E K      +V+L S  
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS-- 70

Query: 93  QHR--NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF-------HI 143
            H    +VK  G  I   +  +  E M      S   D    K+L   +          +
Sbjct: 71  -HDCPYIVKCYGYFITDSDVFICMELM------STCLD----KLLKRIQGPIPEDILGKM 119

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK-R 202
                + + YL +     +IHRD+K SN+LLD   N K+ DFG++    G   +   K R
Sbjct: 120 TVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTR 173

Query: 203 VIGTYGYMAPEY----ASDGQFSVKSDVFSFGILLLEIISGK 240
             G   YMAPE       + ++ +++DV+S GI L+E+ +G+
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 25/206 (12%)

Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 102
           +KLG+G +  VYKG + ++GQ +A+K +S  +E+G+      E  L   L+H N+V LL 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLH 69

Query: 103 CCIQGEEKL-LIYEFMTNKSLDSFIFDQ----ERCKILDWSKRFHIICGTARGVMYLHQD 157
             I  +E L  ++E+M +  L  ++           +  +   F ++    RG+ Y+H  
Sbjct: 70  DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLF--MFQLL----RGLAYIH-- 120

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY--- 214
               I+HRDLK  N+L+      K++DFGLARA     ++  +  V+ T  Y  P+    
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLG 177

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
           A+D  +S   D++  G + +E++ G+
Sbjct: 178 ATD--YSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 42/103 (40%), Positives = 60/103 (58%), Gaps = 12/103 (11%)

Query: 142 HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET-- 196
            +I  +   ARG+ +L   SR + IHRDL A N+LL ++   KI DFGLAR    D    
Sbjct: 174 DLISYSFQVARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230

Query: 197 -EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            +G+ +  +    +MAPE   D  ++ +SDV+SFG+LL EI S
Sbjct: 231 RKGDARLPLK---WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 47  LGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 103
           +G G +G V        G+++A+K+LS+   S    K    E+ L   + H N++ LL  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 104 CIQGEEK------LLIYEFMTNKSLDSFIFDQERCKIL-DWSKRFHIICGTARGVMYLHQ 156
                         L+   M    L++ +    +C+ L D   +F ++    RG+ Y+H 
Sbjct: 83  FTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHIQF-LVYQILRGLKYIHS 136

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                IIHRDLK SN+ +++D   KI DFGLAR      T+      + T  Y APE   
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIML 188

Query: 217 D-GQFSVKSDVFSFGILLLEIISGK 240
           +   ++   D++S G ++ E+++GK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 29/211 (13%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNL 97
           + +G G FG V+  T   DG+ +A+K++  +       ++  +ELK    +    +H N+
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKHDNV 61

Query: 98  VKLLGCCIQG-----EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF--HIICGTARG 150
           +  L           EE  ++ E M    L   I   +     D  K F   I+    RG
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSS-DHVKVFLYQIL----RG 115

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      I+HRD+K  N+L++ +   KI DFGLAR    DE++  T+ V+  Y Y 
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171

Query: 211 APEYASDGQ-FSVKSDVFSFGILLLEIISGK 240
           APE     + ++   D++S G +  E++  +
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 37/222 (16%)

Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQ------GLKELKNEVILFSKLQ 93
           F I  ++G+G +G VYK    D G+ +A+K++   +E+       ++E+K    +  +L 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQLN 64

Query: 94  HRNLVKLLGCCIQGEEKL----------LIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
           HRN+V L       ++ L          L++E+M     D  +       ++ +S+    
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDH-- 117

Query: 144 ICGTAR----GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
           I    +    G+ Y H+ + L   HRD+K SN+LL+     K++DFGLAR +  +E+   
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174

Query: 200 TKRVIGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIISGK 240
           T +VI T  Y  PE    + ++    DV+S G +L E+ + K
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 59/171 (34%), Positives = 85/171 (49%), Gaps = 27/171 (15%)

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET---EGNTKRVI 204
           ARG+ +L   SR + IHRDL A N+LL ++   KI DFGLAR    D     +G+ +  +
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
               +MAPE   D  ++ +SDV+SFG+LL EI S             L    +     NE
Sbjct: 241 ---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-------------LGASPYPGVQINE 284

Query: 265 GMPSQLIDPCIQGSFNLA--EVIRCIHIGLLCVQQHPKDRPSMPSVILMLG 313
               +L D     +   A  E+ R   I L C Q  PK+RP+  +++ +LG
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYR---IMLACWQGDPKERPTFSALVEILG 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHR 95
           +F+    LG+G FG V         E+ A+K L K   I +  ++    E  + +     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 96  NLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +  L  C Q  ++L  + E++    L   I  Q+  K  +    F+     A G+ +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYA-AEIAIGLFFL 117

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA--FGGDETEGNTKRVIGTYGYMAP 212
           H      II+RDLK  NV+LD + + KI+DFG+ +   FGG      T+   GT  Y+AP
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCGTPDYIAP 170

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E  +   +    D ++FG+LL E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 67/247 (27%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 94
           ++F + K +G+G FG V+   LV     GQ  A+K L K     +K  +N++        
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRK--SDMIK--RNQIAHV--RAE 51

Query: 95  RN---------LVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSK 139
           R+         +VKL     Q EE L L+ E+M    L        +F +E       + 
Sbjct: 52  RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-------TA 103

Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDET- 196
           RF+I    A  V+ L    +L  IHRD+K  N+L+D D + K++DFGL +      D   
Sbjct: 104 RFYI----AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159

Query: 197 -----------EGNTKR-------------VIGTYGYMAPEYASDGQFSVKSDVFSFGIL 232
                      +    R              +GT  Y+APE      + ++ D +S G++
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219

Query: 233 LLEIISG 239
           L E++ G
Sbjct: 220 LYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 50/210 (23%), Positives = 100/210 (47%), Gaps = 25/210 (11%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 95
           +    K +G G FG V+     +     A+K ++    I  +  + + NE  +  ++ H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 96  NLVKLLGCCIQGEEKLL--IYEFMTNKSLDSFIFDQERCKILDWSKRFH---IICGTARG 150
            +++L     + +++ L  + E++    L S++  +   +  + +  F+   I+C     
Sbjct: 62  FIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCA---- 113

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      I++RDLK  N+LLD++ + K++DFG A+     +    T  + GT  Y+
Sbjct: 114 LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYL 165

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGK 240
           APE       +   D ++ GIL+ E++ G 
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 29/211 (13%)

Query: 40  NFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL 92
           +F + + LG G FG V    +KGT   G+  A+K L K   +  + ++ +  E  +  +L
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
            H  +V ++ C  Q E ++  + EF+    L + +    R    D +K +H     A  V
Sbjct: 76  SHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-DVAKFYH-----AELV 128

Query: 152 M---YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
           +   YLH      II+RDLK  N+LLD   + K++DFG A+     +    T  + GT  
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y+APE           D ++ G+LL E I+G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 42/95 (44%), Positives = 52/95 (54%), Gaps = 14/95 (14%)

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDET---EGNTKRVIGTYGYMAPEYASDGQ 219
           IHRD+ A NVLL      KI DFGLAR    D     +GN +  +    +MAPE   D  
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFDCV 290

Query: 220 FSVKSDVFSFGILLLEIIS-GKK-------NRGFY 246
           ++V+SDV+S+GILL EI S GK        N  FY
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 59/244 (24%), Positives = 111/244 (45%), Gaps = 41/244 (16%)

Query: 46  KLGQGGFGPVYKGTLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL--FSKLQHRNLV 98
           ++G+G +G V+K   +   G+ +A+KR+  +  E+G  L  ++   +L      +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 99  KLLGCCIQG----EEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           +L   C       E KL L++E +          DQ+    LD      +   T + +M+
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117

Query: 154 --------LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
                   LH     R++HRDLK  N+L+      K++DFGLAR +     +     V+ 
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 171

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           T  Y APE      ++   D++S G +  E+    + +  +   ++++ +G    +   G
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKILDVI--G 226

Query: 266 MPSQ 269
           +P +
Sbjct: 227 LPGE 230

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 11/199 (5%)

Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 102
           +KLG+G +  V+KG + +    +A+K +    E+G       EV L   L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   L++E++ +K L  ++ D      +   K F  +    RG+ Y H   R ++
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YASDGQFS 221
           +HRDLK  N+L+++    K++DFGLARA     T+  +  V+ T  Y  P+      ++S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183

Query: 222 VKSDVFSFGILLLEIISGK 240
            + D++  G +  E+ SG+
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 17/210 (8%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 91
           NF + K LG G +G V+    V G +     A+K L K +     + ++  + E  +   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           ++    +  L    Q E KL LI ++++   + + ++ ++     +   RF+    +   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS--EDEVRFY----SGEI 114

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           ++ L    +L I++RD+K  N+LLD + +  ++DFGL++ F  +E E  T    GT  YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYM 173

Query: 211 APEYA-SDGQFSVKSDVFSFGILLLEIISG 239
           APE     G      D +S GIL+ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 12/198 (6%)

Query: 46  KLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLG 102
           K+G+G +G V+K    + GQ +A+K+  +  +  +  K    E+ +  +L+H NLV L+ 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
              +  +  L++E+  +  L+     ++  + +       II  T + V + H+      
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNC 121

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY-ASDGQFS 221
           IHRD+K  N+L+ +    K+ DFG AR   G     +    + T  Y APE    D Q+ 
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYVATRWYRAPELLVGDTQYG 179

Query: 222 VKSDVFSFGILLLEIISG 239
              DV++ G +  E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 33/210 (15%)

Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 101
           K +G G  G V      V G  +AVK+LS+   ++   K    E++L   + H+N++ LL
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGTAR 149
                         F   KSL+ F        + D   C++    LD  +  +++     
Sbjct: 87  NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 134

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ +LH      IIHRDLK SN+++  D   KI DFGLAR    +     T  V+  Y Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-Y 188

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            APE      +    D++S G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 37/213 (17%)

Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 189

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E+I G 
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 31/92 (33%), Positives = 55/92 (59%), Gaps = 6/92 (6%)

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
           RG+ YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 163

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           YM+PE      ++V+SD++S G+ L+E+  G+
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 17/213 (7%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVK 99
           K +G+G FG V       DG+  AVK L K +    KE K+ +    +L   ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 100 LLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           L     Q  +KL  + +++    L  F   +ER    +   RF+     A  + YLH   
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGEL-FFHLQRERS-FPEPRARFYA-AEIASALGYLHS-- 114

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
            L II+RDLK  N+LLD   +  ++DFGL +   G E    T    GT  Y+APE     
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            +    D +  G +L E++ G     FY  D  
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP--FYSRDTA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 20/153 (13%)

Query: 46  KLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 103
           KLG+G +  VYKG + + GQ +A+K +    E+G       E  L   L+H N+V  L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70

Query: 104 CIQGEEKL-LIYEFMTNKSLDSFIFDQERC-KILDWSK----RFHIICGTARGVMYLHQD 157
            I  ++ L L++E++ +  L  ++   + C   L         F ++    RG+ Y HQ 
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYM---DDCGGGLSMHNVRLFLFQLL----RGLAYCHQR 122

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
              R++HRDLK  N+L+ +    K++DFGLARA
Sbjct: 123 ---RVLHRDLKPQNLLISERGELKLADFGLARA 152

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 44/218 (20%)

Query: 45  KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNL 97
           K +G+G +G V      +  +++A+K+++   +      + L+E+K    L   L H N+
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENV 66

Query: 98  VKLLGCCI-----QGEEKLLIYEFM---------TNKSLDSFIFDQERCKILDWSKRFHI 143
           + +             +  ++YE M         ++++L       + C+       + +
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSD-----DHCQYF----LYQL 117

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
           +    RG+ Y+H  +   ++HRDLK SN+LL+ + + KI DFGLAR     E        
Sbjct: 118 L----RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEY 168

Query: 204 IGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIISGK 240
           + T  Y APE   +  +++   DV+S G +  E++  K
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 65/210 (30%), Positives = 93/210 (44%), Gaps = 36/210 (17%)

Query: 47  LGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 102
           +G+GGFG VY     D G+  A+K L K     +QG     NE I+ S      LV    
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55

Query: 103 C----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL---- 154
           C    C       + Y F T   L  FI D      L +    H +        Y     
Sbjct: 56  CPFIVC-------MTYAFHTPDKL-CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107

Query: 155 ----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
               H  +R  +++RDLK +N+LLD+  + +ISD GLA  F   +   +    +GT+GYM
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162

Query: 211 APEYASDGQ-FSVKSDVFSFGILLLEIISG 239
           APE    G  +   +D FS G +L +++ G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 49/133 (36%), Positives = 74/133 (55%), Gaps = 18/133 (13%)

Query: 116 FMTNKSLDSFIFDQERCKILDWSKRF----HIICGT---ARGVMYLHQDSRLRIIHRDLK 168
           F+  KSL     ++E  +  D  K+      +IC +   A+G+ +L   SR + IHRDL 
Sbjct: 152 FVEEKSLSDV--EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SR-KCIHRDLA 206

Query: 169 ASNVLLDQDMNPKISDFGLARAFGGDET---EGNTKRVIGTYGYMAPEYASDGQFSVKSD 225
           A N+LL ++   KI DFGLAR    D     +G+ +  +    +MAPE   D  ++++SD
Sbjct: 207 ARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL---KWMAPETIFDRVYTIQSD 263

Query: 226 VFSFGILLLEIIS 238
           V+SFG+LL EI S
Sbjct: 264 VWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ--EIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           +F+  + LG G FG V   T  +     +A+KR  K   I ++ +  + +E  + + + H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG---TARGV 151
              V L G         L+ EF+      +F         L  +KRF    G    A+ V
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTF---------LRRNKRFPNDVGCFYAAQIV 141

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L I++RDLK  N+LLD+D   K++DFG A+       +  T  + GT  Y+A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIA 196

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE   +      +D ++ GI + EI+ G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 13/199 (6%)

Query: 46  KLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 103
           KLG+G +  VYKG + +    +A+K +    E+G       EV L   L+H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 104 CIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
            I  E+ L L++E++ +K L  ++ D      +   K F  +    RG+ Y H   R ++
Sbjct: 73  -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRKV 125

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YASDGQFS 221
           +HRDLK  N+L+++    K++DFGLARA     T+  +  V+ T  Y  P+       +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRPPDILLGSTDYS 183

Query: 222 VKSDVFSFGILLLEIISGK 240
            + D++  G +  E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 37/213 (17%)

Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 81  LLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   +   T  V+  Y
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 183

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 184 -YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 58/231 (25%), Positives = 102/231 (44%), Gaps = 41/231 (17%)

Query: 41  FSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK-ISEQGL--KELKNEVILFSKLQHRN 96
           + I + +G+GG G VY     V  + +A+K++ + +SE  L  K    E  + + L H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR-------------FHI 143
           +V +   C  G+       ++   +L S +    + + L  SK              FH 
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHK 121

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE------ 197
           IC T   + Y+H  S+  ++HRDLK  N+LL       I D+G A     +E +      
Sbjct: 122 ICAT---IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 198 --------GNTK--RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                     T   +++GT  YMAPE       S  +D+++ G++L ++++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 9/150 (6%)

Query: 45  KKLGQGGFGPVYKGTLVDG---QEIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 100
           K++G G FG V  G +  G    ++ VK L    S Q   +   E   +  LQH NL++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKIL--DWSKRFHIICGTARGVMYLHQDS 158
           LG C +    LL+ EF     L  ++    + +++  D +    + C  A G+++LH+++
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLA 188
               IH DL   N LL  D+  KI D+GL+
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 52/225 (23%)

Query: 43  INKKLGQGGFGPVYK----GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 96
           I K         + K     TLV     AVK+  L   S++ LK L+ E+I   +LQH N
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLV-----AVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH--------IICGTA 148
           ++  +   I   E  ++   M   S          C+ L    + H         I    
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGS----------CEDL---LKTHFPEGLPELAIAFIL 107

Query: 149 RGVM----YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
           + V+    Y+H       IHR +KAS++LL  D    +S    + +       G  +RV+
Sbjct: 108 KDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVV 161

Query: 205 GTYG--------YMAPE--YASDGQFSVKSDVFSFGILLLEIISG 239
             +         +++PE    +   ++ KSD++S GI   E+ +G
Sbjct: 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 19/215 (8%)

Query: 38  TNNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR 95
           ++ + I + +G+G +G V+K     +G + AVK L  I +   +E++ E  +   L  H 
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75

Query: 96  NLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTAR 149
           N+VK  G         G++  L+ E     S+   +    +R + ++     +I+     
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ +LH +   + IHRD+K +N+LL  +   K+ DFG++          NT   +GT  +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190

Query: 210 MAPEYAS-----DGQFSVKSDVFSFGILLLEIISG 239
           MAPE  +     D  +  + DV+S GI  +E+  G
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 35/214 (16%)

Query: 46  KLGQGGFGPVYKGTLVD-GQEIAVKRLS-KISEQGLK-ELKNEVILFSKLQ---HRNLVK 99
           ++G G +G VYK      G  +A+K +  + +E GL      EV L  +L+   H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 100 LLGCCIQG----EEKL-LIYEFMTNKSLDSFIFDQERC--------KILDWSKRFHIICG 146
           L+  C       E K+ L++E + ++ L +++   ++          I D  ++F     
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQF----- 117

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
             RG+ +LH +    I+HRDLK  N+L+      K++DFGLAR +     +     V+ T
Sbjct: 118 -LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVT 170

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
             Y APE      ++   D++S G +  E+   K
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 38/223 (17%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV--KLLG 102
           K LG+G FG V    LV  +E A  +   +     K LK EVI+        L   ++L 
Sbjct: 1   KLLGKGTFGKV---ILV--REKATGKYYAM-----KILKKEVIIAKDEVAHTLTESRVLQ 50

Query: 103 CCIQGEEKLLIYEFMTNKSL---------DSFIFDQERCKILDWSK-RFH---IICGTAR 149
                    L Y F T+  L             F   R ++    + RF+   I+  +A 
Sbjct: 51  NTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV--SAL 108

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYG 208
           G  YLH      +++RDLK  N++LD+D + KI+DFGL +      ++G T K   GT  
Sbjct: 109 G--YLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPE 160

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           Y+APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLL-- 101
           +G G +G V        G  +AVK+LS+  +  +  K    E+ L   ++H N++ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 102 ---GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
                 ++    + +   +    L++ +    +C+ L       +I    RG+ Y+H   
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
              IIHRDLK SN+ +++D   KI DFGLAR    DE  G     + T  Y APE   + 
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNW 192

Query: 219 -QFSVKSDVFSFGILLLEIISGK 240
             ++   D++S G ++ E+++G+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 95
           ++F    +LG G  G V K        I  ++L  +  +    ++N++I   ++ H    
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62

Query: 96  -NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC--KILDWSKRFHIICGTARGVM 152
             +V   G      E  +  E M   SLD  + + +R   +IL       +     RG+ 
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLA 117

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+P
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E      +SV+SD++S G+ L+E+  G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)

Query: 47  LGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLL-- 101
           +G G +G V         Q++AVK+LS+  +  +  +    E+ L   ++H N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 102 ---GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
                 I+   ++ +   +    L++ +    +C+ L       +I    RG+ Y+H   
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHSAG 138

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
              IIHRDLK SNV +++D   +I DFGLAR    DE  G     + T  Y APE   + 
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIMLNW 190

Query: 219 -QFSVKSDVFSFGILLLEIISGK 240
             ++   D++S G ++ E++ GK
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 28/210 (13%)

Query: 47  LGQGGFGPVYKGT---LVDGQ-----EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           LGQG F  ++KG    + D       E+ +K L K      +       + S+L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
              G C+ G+E +++ E++   SLD+++   +    + W  +  +    A  + +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 159 RLRIIHRDLKASNVLL-----DQDMNP---KISDFGLARAFGGDETEGNTKRVIGTYGYM 210
              + H ++ A NVLL      +  NP   K+SD G++      E     +R+     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171

Query: 211 APEYASDGQ-FSVKSDVFSFGILLLEIISG 239
            PE   + Q  S+ +D +SFG  L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 39/91 (42%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           ARG+ +L   +    +HRDL A NVLL Q    KI DFGLAR    D    +        
Sbjct: 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            +MAPE   D  ++  SDV+S+GILL EI S
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.2 bits (153), Expect = 3e-11
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 13/199 (6%)

Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 102
           +KLG+G +  VYKG + V+G+ +A+K +    E+G       E  L   L+H N+V LL 
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLH 69

Query: 103 CCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
             I  +E L L++E++ +  L  ++         +  K F  +    RG+ Y+HQ     
Sbjct: 70  DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIHQRY--- 123

Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YASDGQF 220
           I+HRDLK  N+L+      K++DFGLARA        + + V  T  Y  P+      ++
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEY 181

Query: 221 SVKSDVFSFGILLLEIISG 239
           S   D++  G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 26/243 (10%)

Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKR-LSKISEQGLKELK-NEVILFSKLQHRN-LVKL 100
           +K+G+G +G VYK      G+ +A+K+   ++ E+G+      E+ L   L     +V+L
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 101 LGCCIQGEEKL------LIYEFMTNKSLDSFIFDQER--CKILDWSKRFHIICGTARGVM 152
           L      EEK       L++E++ +  L  F+    R   + L        +    +GV 
Sbjct: 67  L-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           + H   +  ++HRDLK  N+L+D+     KI+D GL RAF     +  T  ++ T  Y A
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYRA 179

Query: 212 PEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           PE       +S   D++S G +  E+   +     +  D+ L  + H +KL   G P++ 
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP---LFPGDSELQQLLHIFKLL--GTPTEQ 234

Query: 271 IDP 273
           + P
Sbjct: 235 VWP 237

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 35/79 (44%), Positives = 46/79 (58%), Gaps = 6/79 (7%)

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDET---EGNTKRVIGTYGYMAPEYASDGQ 219
           IHRDL A N+LL      KI DFGLAR    D     +GN +  +    +MAPE   +  
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCV 292

Query: 220 FSVKSDVFSFGILLLEIIS 238
           ++ +SDV+S+GILL EI S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 36/218 (16%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKISEQG----LKELKNEVILFSKLQH 94
            +    ++ +G +G VY+       EI A+K+L K+ ++     +  L+ E+ +  KLQH
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQH 63

Query: 95  RNLVKL----LGCCIQGEEKLLIYEFMTN--KSL-----DSFIFDQERCKILDWSKRFHI 143
            N+V +    +G  +  ++  ++ E++ +  KSL       F+  + +C +L        
Sbjct: 64  PNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQ------- 114

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
                 GV +LH +    I+HRDLK SN+LL+     KI DFGLAR + G   +  T+ V
Sbjct: 115 ---LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLV 167

Query: 204 IGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIISGK 240
           + T  Y APE      ++S   D++S G +  E+++ K
Sbjct: 168 V-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 18/203 (8%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 101
           K++G G +G V        G+++A+K+LS+   SE   K    E+ L   +QH N++ LL
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 102 G---CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
                 + G+E    Y  M     D     +     L   K  +++     G+ Y+H   
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG 137

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
              IIHRDLK  N+ +++D   KI DFGLAR    + T       + T  Y APE   + 
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVILNW 189

Query: 219 -QFSVKSDVFSFGILLLEIISGK 240
             ++   D++S G ++ E+++GK
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 23/204 (11%)

Query: 46  KLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 103
           KLG+G +  V+KG + +    +A+K +    E+G       EV L   L+H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 104 CIQGEEKL-LIYEFMTN---KSLDSF--IFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            I  E  L L++E++ +   + LD+   +      KI      F ++    RG+ Y H  
Sbjct: 72  -IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIF----MFQLL----RGLSYCH-- 120

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YAS 216
            + +I+HRDLK  N+L+++    K++DFGLARA     T+  +  V+ T  Y  P+    
Sbjct: 121 -KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLG 177

Query: 217 DGQFSVKSDVFSFGILLLEIISGK 240
             ++S   D++  G +L E+ +G+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLG 102
           +G+G +  V    L    +I   ++ K      ++ +  ++ E  +F +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 103 CCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHI--ICGTARGVMYLHQDSR 159
            C Q   +L L+ E++    L  F   ++R K+ +   RF+   IC     + +LH+   
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL-MFHMQRQR-KLPEEHARFYAAEIC---IALNFLHERG- 116

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ 219
             II+RDLK  NVLLD D + K++D+G+ +   G      T    GT  Y+APE     +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEE 172

Query: 220 FSVKSDVFSFGILLLEIISGK 240
           +    D ++ G+L+ E+++G+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 22/202 (10%)

Query: 46  KLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN--EVILFSKLQ-HRNLVKLL 101
           K+G+G F  V K  +   G+  A+K + K   + L+++ N  E+    +L  H N+++L+
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 102 GCCIQGEEK--LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
                 +     L++E M + +L   I  ++R   L   +    +    + + ++H++  
Sbjct: 65  EVLFDRKTGRLALVFELM-DMNLYELIKGRKRP--LPEKRVKSYMYQLLKSLDHMHRNG- 120

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPE-YAS 216
             I HRD+K  N+L+  D   K++DFG  R        TE      I T  Y APE   +
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE-----YISTRWYRAPECLLT 172

Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           DG +  K D+++ G +  EI+S
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 62/245 (25%), Positives = 108/245 (44%), Gaps = 48/245 (19%)

Query: 45  KKLGQGGFGPV-YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 101
           K++G G +G V        G ++A+K+L +   SE   K    E+ L   ++H N++ LL
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSF----------------IFDQERCKILDWSKRFHIIC 145
                         F  + SLD F                +   E+   L   +   ++ 
Sbjct: 81  DV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVY 125

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
              +G+ Y+H      IIHRDLK  N+ +++D   KI DFGLAR     +T+      + 
Sbjct: 126 QMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVV 177

Query: 206 TYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
           T  Y APE   +   ++   D++S G ++ E+++GK     +   ++L+ +    K+   
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP---LFKGHDHLDQLMEIMKV--T 232

Query: 265 GMPSQ 269
           G PS+
Sbjct: 233 GTPSK 237

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 95
           ++F    +LG G  G V+K +      I  ++L  +  +    ++N++I   ++ H    
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62

Query: 96  -NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC--KILDWSKRFHIICGTARGVM 152
             +V   G      E  +  E M   SLD  +    R   +IL       +     +G+ 
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLT 117

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+P
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E      +SV+SD++S G+ L+E+  G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 31/235 (13%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEIA---VKRLSKISEQGLKELKNEVIL----FSKLQHRNL 97
           +++G G FG V    +     +A   VK L   +    KE +NE +     +  LQH N+
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELK--ANASSKE-QNEFLQQGDPYRILQHPNI 57

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMY 153
           ++ LG C++    LL++E+     L S++  ++      ++L   +   + C  A GV +
Sbjct: 58  LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTH 114

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTKRVIGTYGYMAP 212
           +H   +   +H DL   N  L  D+  K+ D+G+  + +  D  E    + +    ++AP
Sbjct: 115 MH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAP 170

Query: 213 EYAS---DGQFSVK----SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK 260
           E       G  + +    S+V++ G+ L E+         Y   ++  ++ H  K
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP--YSHLSDREVLNHVIK 223

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 22/214 (10%)

Query: 45  KKLGQGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNL 97
           K LG+G FG V    LV     G+  A+K L K   I++  +     E  +    +H  L
Sbjct: 1   KLLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 98  VKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
             L     Q +++L  + E++    L    F   R ++    +           + YLH 
Sbjct: 58  TSL-KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHS 113

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
               +I++RDLK  N++LD+D + KI+DFGL +   G       K   GT  Y+APE   
Sbjct: 114 G---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLE 168

Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
           D  +    D +  G+++ E++ G+    FY+ D+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 16/201 (7%)

Query: 47  LGQGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL-----KNEVILFSKLQHRNLVKL 100
           +G+G FG VY+    D + I A+K LSK      KE+     +  +++ + L     +  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 101 LGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
           L    Q +  L L+ ++M+   L  F   Q+  +  +   +F+I    A  V+ L    +
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYI----AELVLALEHLHK 114

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ 219
             I++RDLK  N+LLD   +  + DFGL++A   D    NT    GT  Y+APE   D +
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEK 172

Query: 220 -FSVKSDVFSFGILLLEIISG 239
            ++   D +S G+L+ E+  G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 7/98 (7%)

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH      +++RD+K  N++LD+D + KI+DFGL +   G       K   GT  Y+AP
Sbjct: 110 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAP 164

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
           E   D  +    D +  G+++ E++ G+    FY+ D+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 6/98 (6%)

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH +    +++RDLK  N++LD+D + KI+DFGL +   G +     K   GT  Y+AP
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAP 165

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
           E   D  +    D +  G+++ E++ G+    FY+ D+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A G+ +LH      II+RDLK  NV+LD + + KI+DFG+ +    D     TK   GT 
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTP 165

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y+APE  +   +    D ++FG+LL E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 15/207 (7%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHR 95
           +F+    LG+G FG V         E+ A+K L K   I +  ++    E  + +     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 96  NLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +  L  C Q  ++L  + E++    L   I  Q+  K  +    F+     + G+ +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYA-AEISVGLFFL 117

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPE 213
           H+     II+RDLK  NV+LD + + KI+DFG+ +       +G T R   GT  Y+APE
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGTPDYIAPE 171

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGK 240
             +   +    D +++G+LL E+++G+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 30/87 (34%), Positives = 53/87 (60%), Gaps = 1/87 (1%)

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H  S+  +IHRD+K++N+LL  +   K+ DFG ++ +    ++   +   GT  Y+APE 
Sbjct: 158 HVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKK 241
                +S K+D+FS G+LL E+++ K+
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 53/226 (23%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISE------QGLKELKNEVILFSKL 92
            +   + +G G +G V        G+++A+K++    +      + L+ELK    +    
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHF 61

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDS---FIFDQERCKILDWSKRFHIICGTA- 148
           +H N++ +                    +       + D      L  S   HII     
Sbjct: 62  KHDNIIAIRDI------------LRPPGADFKDVYVVMD------LMESDLHHIIHSDQP 103

Query: 149 --------------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
                         RG+ Y+H  +   +IHRDLK SN+L+++D   +I DFG+AR     
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160

Query: 195 ETEGNT--KRVIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEII 237
            TE        + T  Y APE   S  +++   D++S G +  E++
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 53.9 bits (130), Expect = 7e-10
 Identities = 22/48 (45%), Positives = 30/48 (62%), Gaps = 3/48 (6%)

Query: 314 SET-VLPQPKQPGYLADRNSTRLDSSSSRP--ESSSTNTITISELEGR 358
           SET  +PQPKQPG+   R+    DSSSS    ES + N +T+S ++ R
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 60.1 bits (145), Expect = 8e-10
 Identities = 70/252 (27%), Positives = 110/252 (43%), Gaps = 45/252 (17%)

Query: 36  SATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE-----LKNEVILFS 90
           S  N + + KK+G G FG V+       QE    +   IS +GLKE     L  EV +  
Sbjct: 10  SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMR 67

Query: 91  KLQHRNLVKLLGCCI-QGEEKLLI-YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA 148
           +L+H+N+V+ +   + +  +KL I  EF     L   I   ++C  +      H I    
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEHAIVDIT 124

Query: 149 RGVM----YLHQ----DSRLRIIHRDLKASNVLLD-------------QDMN----PKIS 183
           R ++    Y H      +  R++HRDLK  N+ L               ++N     KI 
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYA--SDGQFSVKSDVFSFGILLLEIISGKK 241
           DFGL++  G    E      +GT  Y +PE        +  KSD+++ G ++ E+ SGK 
Sbjct: 185 DFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241

Query: 242 NRGFYHSDNNLN 253
               +H  NN +
Sbjct: 242 P---FHKANNFS 250

Length = 1021

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 15/201 (7%)

Query: 45  KKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVK 99
           K +G+G FG V      +DG+  AVK L K      KE K+ +    +L   ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 100 LLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           L     Q  EKL  + +F+    L  F   Q      +   RF+     A  + YLH   
Sbjct: 61  L-HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS-- 114

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
            + I++RDLK  N+LLD   +  ++DFGL +   G      T    GT  Y+APE     
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 219 QFSVKSDVFSFGILLLEIISG 239
            +    D +  G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 15/201 (7%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVK 99
           K +G+G FG V       + +  AVK L K +    KE K+ +    +L   ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 100 LLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           L     Q  +KL  + +++    L  +   +ERC  L+   RF+     A  + YLH   
Sbjct: 61  L-HFSFQTADKLYFVLDYINGGEL-FYHLQRERC-FLEPRARFYA-AEIASALGYLHS-- 114

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
            L I++RDLK  N+LLD   +  ++DFGL +     E  G T    GT  Y+APE     
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 219 QFSVKSDVFSFGILLLEIISG 239
            +    D +  G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKI-----SEQGLKELKNEVILFSKLQ 93
           ++ + K +G+G FG V        Q++ A+K LSK      S+      + +++ F+   
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA--- 100

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +   V  L C  Q ++ L ++ E+M    L + + + +  +   W+K +     TA  V+
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFY-----TAEVVL 153

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTKRVIGTYGYMA 211
            L     + +IHRD+K  N+LLD+  + K++DFG       DET        +GT  Y++
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYIS 211

Query: 212 PEY----ASDGQFSVKSDVFSFGILLLEIISG 239
           PE       DG +  + D +S G+ L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 46/177 (25%), Positives = 86/177 (48%), Gaps = 9/177 (5%)

Query: 76  EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKI 134
           ++ +  ++ E  +F +  +   +  L  C Q E +L  + E++    L  F   ++R K+
Sbjct: 36  DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQR-KL 93

Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
            +   RF+     +  + YLH+     II+RDLK  NVLLD + + K++D+G+ +   G 
Sbjct: 94  PEEHARFYS-AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GL 147

Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
                T    GT  Y+APE      +    D ++ G+L+ E+++G+       S +N
Sbjct: 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 26/214 (12%)

Query: 45  KKLGQGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           + LG G  G V+    VD    + +AVK++     Q +K    E+ +  +L H N+VK+ 
Sbjct: 11  RPLGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY 68

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQER-----CKIL-------DWSKRFHIICGTAR 149
                    L   +  +   L+S    QE        +L       + ++ F  +    R
Sbjct: 69  EVLGPSGSDL-TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF--MYQLLR 125

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGD-ETEGNTKRVIGTY 207
           G+ Y+H  +   ++HRDLK +NV ++  D+  KI DFGLAR        +G     + T 
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 208 GYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGK 240
            Y +P    S   ++   D+++ G +  E+++GK
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 24/207 (11%)

Query: 45  KKLGQGGFGPVYKGTLVDGQE----IAVKRLSKI----SEQGLKELKNEVILFSKLQHRN 96
           K LG+GG+G V++   V G +     A+K L K     +++     K E  +   ++H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ-ERCKI-LDWSKRFHIICGTARGVMYL 154
           +V L+     G +  LI E+++   L    F   ER  I ++ +  F++    +   + L
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYL----SEISLAL 113

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--TKRVIGTYGYMAP 212
               +  II+RDLK  N+LLD   + K++DFGL +    +       T    GT  YMAP
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAP 169

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISG 239
           E           D +S G L+ ++++G
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)

Query: 39  NNFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
            +F +   +G+G FG V     K T   G   A+K + K   ++++ +   + E  + S 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWS-KRFHIICGTARG 150
                + +L       +   L+ E+     L S +   E     D    +F++    A  
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYL----AEL 111

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           V+ +H   ++  +HRD+K  NVL+D+  + K++DFG A     ++   N+K  +GT  Y+
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYI 170

Query: 211 APEY------ASDGQFSVKSDVFSFGILLLEIISGK 240
           APE          G + V+ D +S G++  E+I G+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 29/171 (16%)

Query: 81  ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE---FMTNKSLD----SFIFDQERCK 133
           +L+NE++   +L H N++K+        E++L  E   +M  +  D    SF++D+    
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEA--- 257

Query: 134 ILDWSKR------FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 187
             DW  R        I+      V Y+H     ++IHRD+K  N+ L+ D    + DFG 
Sbjct: 258 -FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT 313

Query: 188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           A  F   E E      +GT    +PE  +   +   +D++S G++LL+++S
Sbjct: 314 AMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 14/198 (7%)

Query: 47  LGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           +G+G FG V +    D Q I A+K + K   +S   +     E  + +++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 103 CCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
              Q  EKL L+  F+    L  F   Q   +      RF+    TA  +  L    +  
Sbjct: 60  FSFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLSRARFY----TAELLCALENLHKFN 113

Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           +I+RDLK  N+LLD   +  + DFGL +    D+ + NT    GT  Y+APE      ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYT 171

Query: 222 VKSDVFSFGILLLEIISG 239
              D ++ G+LL E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 32/76 (42%), Positives = 42/76 (55%)

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSV 222
           +HRDL A NVL+ +    KI DFGLAR    D    +         +MAPE   +  ++ 
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 223 KSDVFSFGILLLEIIS 238
            SDV+SFGILL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 50/209 (23%), Positives = 98/209 (46%), Gaps = 18/209 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL------SKISEQGLKELKNEVILFSK 91
           N F +   +G+G +G V K    + +EI A+K+        ++ E  L+ELK    +   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           L+  N+V+L     +  +  L++E++    L+  + ++    +     R +I     + +
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY-QLIKAI 113

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
            + H++    I+HRD+K  N+L+  +   K+ DFG AR    + +  N    + T  Y +
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRS 169

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE      +    D++S G +L E+  G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 45/190 (23%), Positives = 83/190 (43%), Gaps = 18/190 (9%)

Query: 63  GQEIAVKRLSKISEQGLKE---LKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMT 118
           G E+A+K L   + +   +    + E  L ++L H N+V LL         L  ++E++ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---D 175
            ++L   +        L   +   ++      +   H      I+HRDLK  N+++    
Sbjct: 63  GRTLREVLAAD---GALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116

Query: 176 QDMNPKISDFGLARAFGGDE-----TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFG 230
              + K+ DFG+     G       T   T  V+GT  Y APE       +  SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 231 ILLLEIISGK 240
           ++ LE ++G+
Sbjct: 177 LIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.2 bits (133), Expect = 9e-09
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 33/215 (15%)

Query: 47  LGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNE----------VILFSKLQHR 95
           LGQG F  +YKG L V      V    ++S   LK L ++            L S+L H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVV-LKVLGSDHRDSLAFFETASLMSQLSHK 61

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           +LVKL G C++ +E +++ E++    LD F+  ++    L W  +  +    A  + YL 
Sbjct: 62  HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNP-------KISDFGLARAFGGDETEGNTKRVIGTYG 208
                +++H ++   N+L+ +           K+SD G+       E     +RV     
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-----ERVERI-P 169

Query: 209 YMAPEYASDGQFSVKS--DVFSFGILLLEIISGKK 241
           ++APE   +GQ S+    D +SFG  LLEI S  +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 82/308 (26%)

Query: 58  GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 117
           GTLV    + +  L   +E+ LK L+NEV+L    +H N++        G    +I  FM
Sbjct: 25  GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81

Query: 118 TNKSLDSFI---FDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 174
              S +S +   F +   + L  +    I+ G  RG+ YLHQ+     IHR++KAS++L+
Sbjct: 82  AYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASHILI 134

Query: 175 DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ--------------F 220
             D    +S  GL+  +      G   +V+    Y  P++++                 +
Sbjct: 135 SGDGLVSLS--GLSHLYSLVR-NGQKAKVV----YDFPQFSTSVLPWLSPELLRQDLYGY 187

Query: 221 SVKSDVFSFGILLLEIISG--------------KKNRGFYHSDNNLNLIGHA---WKLWN 263
           +VKSD++S GI   E+ +G              +K +G  +S  ++          K   
Sbjct: 188 NVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQ 247

Query: 264 EGMPSQLIDPCIQGS----------------------FNLAEVIRCIHIGLLCVQQHPKD 301
            G+ S + +  +                          NL E         LC+QQ P+ 
Sbjct: 248 SGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE---------LCLQQDPEK 298

Query: 302 RPSMPSVI 309
           RPS  S++
Sbjct: 299 RPSASSLL 306

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTKRVIGTY 207
           R + Y+H  +   + HRDLK  N+L + D   KI DFGLAR AF    T       + T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 208 GYMAPEYASD--GQFSVKSDVFSFGILLLEIISGK 240
            Y APE       +++   D++S G +  E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 46/143 (32%), Positives = 75/143 (52%), Gaps = 13/143 (9%)

Query: 101 LGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
           L  C Q E +L  + EF++   L  F   ++R K+ +   RF+    +A   + L+    
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDL-MFHMQRQR-KLPEEHARFY----SAEISLALNFLHE 114

Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY--ASD 217
             II+RDLK  NVLLD + + K++D+G+ +   G      T    GT  Y+APE     D
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 218 GQFSVKSDVFSFGILLLEIISGK 240
             FSV  D ++ G+L+ E+++G+
Sbjct: 173 YGFSV--DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 50/209 (23%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G +G VYK    DG++     L +I   G+      E+ L  +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 105 IQGEEK--LLIYEFMTNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTARGVMYLHQD 157
           +   ++   L++++  +       F +     ++   L  S    ++     G+ YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 158 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAP 212
               ++HRDLK +N+L+     +    KI+D G AR F    +   +   V+ T+ Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +   K+ D+++ G +  E+++ +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 24/212 (11%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKELKNEVILFSK----LQH 94
           +F + K +G+G FG V        +++ A+K LSK   + +K  +++   F +    + H
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF--EMIK--RSDSAFFWEERDIMAH 99

Query: 95  RN--LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
            N   +  L    Q ++ L ++ E+M    L + + + +  +   W+ RF+    TA  V
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KWA-RFY----TAEVV 152

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           + L     +  IHRD+K  N+LLD+  + K++DFG       +         +GT  Y++
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYIS 211

Query: 212 PEY----ASDGQFSVKSDVFSFGILLLEIISG 239
           PE       DG +  + D +S G+ L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 27/217 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
           ++F I K +G+G FG V    +   + I A+K L+K   + LK  + E   F   + RN+
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLK--RAETACFR--EERNV 54

Query: 98  --------VKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA 148
                   +  L    Q E  L L+ ++     L + +   E  ++ +   RF+I    A
Sbjct: 55  LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYI----A 109

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             V+ +H   +L  +HRD+K  NVLLD + + +++DFG       D T   +   +GT  
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPD 168

Query: 209 YMAPEYASD-----GQFSVKSDVFSFGILLLEIISGK 240
           Y++PE         G++  + D +S G+ + E++ G+
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 49/209 (23%), Positives = 97/209 (46%), Gaps = 17/209 (8%)

Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G +G VYK    DG++     L +I   G+      E+ L  +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 105 IQGEEK--LLIYEFMTNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTARGVMYLHQD 157
           +   ++   L++++  +       F +     ++   L       ++     G+ YLH +
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 158 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAP 212
               ++HRDLK +N+L+     +    KI+D G AR F    +   +   V+ T+ Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +   K+ D+++ G +  E+++ +
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 10/157 (6%)

Query: 85  EVILFSKLQHRNLVKLLGCCIQGEEKLLIY-EFMTNKSLDSFIFDQERCKILDWSKRFHI 143
           E  +   + H ++++L G     +   LI   + T+  L  ++  +    I D      I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDI---LAI 187

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
                R + YLH++   RIIHRD+KA N+ ++   +  + DFG A  F  D         
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            GT    APE  +   +    D++S GI+L E+ +  
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 26/88 (29%), Positives = 50/88 (56%)

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           V+ L +    +++HRDLK++N+ L      K+ DFG ++ +    +        GT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIIS 238
           APE     ++S K+D++S G++L E+++
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 34/169 (20%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKE----LKNEVILFS 90
           ++F   K +G+G FG V    LV     G   A+K+L K SE   KE    ++ E  + +
Sbjct: 1   DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILA 56

Query: 91  KLQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-------DSFIFDQERCKILDWSKRFH 142
           +  +  +VKL     Q E  L LI E++    +       D+F  ++          RF+
Sbjct: 57  EADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE---------TRFY 106

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 191
           I    A  ++ +    +L  IHRD+K  N+LLD   + K+SDFGL    
Sbjct: 107 I----AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 9e-07
 Identities = 64/235 (27%), Positives = 97/235 (41%), Gaps = 53/235 (22%)

Query: 45  KKLGQGGFGPVY----KGTLVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRNL 97
           K LG+G  G V+    KGT   G+  A+K L K       ++K    E  + + L H  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63

Query: 98  VKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFH---IICGTARGVMY 153
             L     Q E  L L+ ++     L   +  Q    + +   RF+   ++      + Y
Sbjct: 64  PTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEY 118

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-------------ARAFGG------- 193
           LH    L I++RDLK  N+LL +  +  +SDF L             A   G        
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 194 -------DETEGNTKRVIGTYGYMAPEYAS-DGQ-FSVKSDVFSFGILLLEIISG 239
                  +E    +   +GT  Y+APE  S DG   +V  D ++ GILL E++ G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 50/230 (21%), Positives = 85/230 (36%), Gaps = 36/230 (15%)

Query: 35  VSATN-NFSINKKLGQGGFGPVYKGTL---VDGQEIAVKRLSKISEQGLKELKNEVILFS 90
            S     ++I   L  G  G V+  T       +++ VK ++     G K    E+ +  
Sbjct: 87  ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILK 141

Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR---------F 141
            + HR ++ L            I+ +   KS    +  + +C +  +  R          
Sbjct: 142 TISHRAIINL------------IHAY-RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI 188

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
            I       + YLH      IIHRD+K  N+ LD+  N  + DFG A             
Sbjct: 189 TIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245

Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
              GT    +PE  +   +  K+D++S G++L E+    KN   +     
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV--KNVTLFGKQVK 293

Length = 392

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 32/211 (15%)

Query: 47  LGQGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELK----NEVILFSKLQ 93
           LG+G    +Y G L             E  +K + K+ +   +++         +  ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H+++V L G C++  E +++ EF+    LD F+  +       W  +F +    A  + Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 154 LHQDSRLRIIHRDLKASNVLL-----DQDMNP--KISDFGLARAFGGDETEGNTKRVIGT 206
           L +D  L  +H ++   N+LL     D +  P  K+SD G+        T  + +  +  
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI------TVLSRQECVER 171

Query: 207 YGYMAPEYASDGQ-FSVKSDVFSFGILLLEI 236
             ++APE   D +  S+ +D +SFG  L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 28/214 (13%)

Query: 40  NFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKI-----SEQGLKELKNEVILFS 90
           ++ + K +G+G FG V    +K T    +  A+K LSK      S+      + +++ F+
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100

Query: 91  KLQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
              +   V  L    Q +  L ++ E+M    L + + + +  +   W+ RF+    TA 
Sbjct: 101 ---NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KWA-RFY----TAE 150

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
            V+ L     +  IHRD+K  N+LLD+  + K++DFG       +         +GT  Y
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDY 209

Query: 210 MAPEY----ASDGQFSVKSDVFSFGILLLEIISG 239
           ++PE       DG +  + D +S G+ L E++ G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 8/96 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 91
           +N    K LG G FG V + T    G+E     +AVK L   +    +E L +E+ + S 
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI 126
           L QH+N+V LLG C  G   L+I E+     L +F+
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 55/246 (22%), Positives = 108/246 (43%), Gaps = 36/246 (14%)

Query: 8   SNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-I 66
           +N  E  + +++ + D+           S   ++ +   +G G FG VY+   +D  E +
Sbjct: 44  NNAGEDEDEEKMIDNDINR---------SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKV 94

Query: 67  AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC----CIQGEEKLL----IYEFM- 117
           A+K++ +  +   +EL    ++   L H N++ L       C +  EK +    + EF+ 
Sbjct: 95  AIKKVLQDPQYKNREL----LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP 150

Query: 118 --TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD 175
              +K +  +  +     +       + +C   R + Y+H      I HRDLK  N+L+D
Sbjct: 151 QTVHKYMKHYARNNHALPLFLVKLYSYQLC---RALAYIHSKF---ICHRDLKPQNLLID 204

Query: 176 QDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA-SDGQFSVKSDVFSFGILL 233
            + +  K+ DFG A+     +    +   I +  Y APE       ++   D++S G ++
Sbjct: 205 PNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCII 261

Query: 234 LEIISG 239
            E+I G
Sbjct: 262 AEMILG 267

Length = 440

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 10/106 (9%)

Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
           RF++    A  V+ +    +L  +HRD+K  NVLLD++ + +++DFG       D T  +
Sbjct: 105 RFYL----AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160

Query: 200 TKRVIGTYGYMAPEY-----ASDGQFSVKSDVFSFGILLLEIISGK 240
              V GT  Y++PE         G++  + D +S G+ + E++ G+
Sbjct: 161 NVAV-GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 21/158 (13%)

Query: 88  LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-LDWSKRFHIICG 146
           L S++ H +L  + G C++G E +++ EF+ +  LD  +  +E+ ++ + W  +  +   
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAW--KITVAQQ 125

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVL-----LDQDMNP--KISDFGLARAFGGDETEGN 199
            A  + YL   +   ++H ++ A N+L     L +  +P  K+SD G+  +F     E  
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV--SFTALSREER 180

Query: 200 TKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEI 236
            +R+     ++APE    G   S  +D +SFG  LLEI
Sbjct: 181 VERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 60/282 (21%), Positives = 121/282 (42%), Gaps = 53/282 (18%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           +F I K +G+G FG           E+AV +L    +    ++ N+  +  + +     +
Sbjct: 2   DFEILKVIGRGAFG-----------EVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE 50

Query: 100 LLGCCIQGEEK---LLIYEFMTNKSL----DSFI-------FDQERCKILDWSKRFHIIC 145
                + G+ +    L Y F    +L    D ++         +   ++ +   RF++  
Sbjct: 51  ERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-- 108

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
             A  V+ +    +L  +HRD+K  N+L+D + + +++DFG       D T   +   +G
Sbjct: 109 --AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVG 165

Query: 206 TYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK 260
           T  Y++PE         G++  + D +S G+ + E++ G+    FY      +L+    K
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP--FYAE----SLVETYGK 219

Query: 261 LWNEG----MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQH 298
           + N       P+Q+ D     S +  ++IR     L+C ++H
Sbjct: 220 IMNHKERFQFPAQVTDV----SEDAKDLIR----RLICSREH 253

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 44/170 (25%)

Query: 41  FSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNE----------- 85
           F I K + +G FG VY G    + +  AVK + K   I++  + +++ E           
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 86  -VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----FDQERCKILDWSK 139
            V L+  LQ  N V             L+ E++    + S +     FD+E         
Sbjct: 66  IVHLYYSLQSANNV------------YLVMEYLIGGDVKSLLHIYGYFDEE-------MA 106

Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 189
             +I    A  + YLH+     IIHRDLK  N+L+  + + K++DFGL++
Sbjct: 107 VKYI-SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 56/237 (23%), Positives = 98/237 (41%), Gaps = 43/237 (18%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHR 95
           +F   K +G+G FG V      D G   A+K L K   + ++ +  ++ E  +  +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
            +VK+           LI EF+    + + +  ++   + +   +F+I    A  V+ + 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYI----AETVLAID 115

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-GGDETE----------------- 197
              +L  IHRD+K  N+LLD   + K+SDFGL         TE                 
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 198 GNTKR---------------VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            N+KR                +GT  Y+APE      ++   D +S G+++ E++ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 30/167 (17%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
            +F   K +G+G FG V    LV     G+  A+K L K     +  L  +K E  + ++
Sbjct: 1   EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL-------DSFIFDQERCKILDWSKRFHII 144
                +V L       +   LI EF+    L       D+F  D           RF++ 
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED---------VTRFYM- 107

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 191
              A  V+ +    +L  IHRD+K  N+L+D+  + K+SDFGL+  F
Sbjct: 108 ---AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 50/245 (20%), Positives = 106/245 (43%), Gaps = 43/245 (17%)

Query: 10  ISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVK 69
           I+    ND I+ I+ +      + ++   +  SI            YKG   + +E+ ++
Sbjct: 4   ITRSYIND-IKCIESDDIDKYTSVLIKENDQNSI------------YKGIF-NNKEVIIR 49

Query: 70  RLSK-------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL----LIYEFMT 118
              K       + +    E+KN      ++   N++K+ G  I   + L    LI E+ T
Sbjct: 50  TFKKFHKGHKVLIDITENEIKN----LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105

Query: 119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQD 177
              L   + D+E  K L +  +  +     +G+  L++  ++    +++L + + L+ ++
Sbjct: 106 RGYLREVL-DKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTEN 159

Query: 178 MNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLE 235
              KI   GL +      +    K V     Y + +  +D   ++++K D++S G++L E
Sbjct: 160 YKLKIICHGLEKIL----SSPPFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214

Query: 236 IISGK 240
           I +GK
Sbjct: 215 IFTGK 219

Length = 283

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 16/106 (15%)

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA---------FGG---- 193
           T   + YLH      I+HRDLK  N+L+    + K++DFGL++          + G    
Sbjct: 110 TVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           D  E   K+V GT  Y+APE      +    D ++ GI+L E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 63/251 (25%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRN 96
           F   K +G G FG V     VD   + A+K L K   +       +K E  + ++  +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSF-----IFDQERCKILDWSKRFHIICGTARG 150
           +VKL     Q ++ L  + +++    + S      IF+++         RF+I       
Sbjct: 63  VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYI-AELTCA 113

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-----------GG------ 193
           +  +H   ++  IHRD+K  N+L+D+D + K++DFGL   F           G       
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 194 ----DETEGNTKR--------------------VIGTYGYMAPEYASDGQFSVKSDVFSF 229
               +E     +                     ++GT  Y+APE      ++   D +S 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 230 GILLLEIISGK 240
           G++L E++ G+
Sbjct: 231 GVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 43/238 (18%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           ++F   K +G+G FG V      D G   A+K L K   + ++ +  ++ E  +  +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +VK+           LI EF+    + + +  ++   + + + +F+I   T   +  +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYI-AETVLAIDAI 117

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-GGDETE---------------- 197
           HQ   L  IHRD+K  N+LLD   + K+SDFGL         TE                
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 198 -GNTKR---------------VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
             N+KR                +GT  Y+APE      ++   D +S G+++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 54/245 (22%), Positives = 97/245 (39%), Gaps = 55/245 (22%)

Query: 45  KKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKL 100
           K LG G FG V     VD   + A+K L K   ++   +  +K E  + ++  +  +VKL
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
                  +    + +++    + S +   E     +   RF+I    A   + +    ++
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYI----AELTLAIESVHKM 120

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFG---------------------------- 192
             IHRD+K  N+L+D D + K++DFGL   F                             
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 193 -----GDETEGNTKR------------VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLE 235
                GD  +   +R            ++GT  Y+APE      ++   D +S G++L E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240

Query: 236 IISGK 240
           ++ G+
Sbjct: 241 MLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 45/127 (35%)

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF----------GGDETEGNT-------- 200
           ++  IHRD+K  N+L+D+D + K++DFGL   F           GD    ++        
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 201 ---------------------------KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILL 233
                                        ++GT  Y+APE      ++   D +S G++L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 234 LEIISGK 240
            E++ G+
Sbjct: 239 YEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 32/96 (33%), Positives = 44/96 (45%), Gaps = 8/96 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSK 91
           N  S  K LG G FG V + T            +AVK L   +    +E L +E+ + S 
Sbjct: 35  NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94

Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI 126
           L  H N+V LLG C  G   L+I E+     L +F+
Sbjct: 95  LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 3/83 (3%)

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y+H +    IIHRD+K  NVL++   +  + DFG A    G  +      + GT    AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 213 EYASDGQFSVKSDVFSFGILLLE 235
           E  +   ++   D++S G+++ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 14/25 (56%), Positives = 19/25 (76%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ 64
           +F + KKLG+G FG VYK +LV+ Q
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQ 157

Length = 566

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	358
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
smart00090	237	RIO RIO-like kinase.	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.59
KOG1243	690	consensus Protein kinase [General function predict	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.38
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.33
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.3
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.11
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.05
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.85
PRK09902	216	hypothetical protein; Provisional	98.81
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.81
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.72
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.64
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.57
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.4
PF01636	239	APH: Phosphotransferase enzyme family This family	98.39
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.38
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.28
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.17
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.14
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.09
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.07
PLN02876	822	acyl-CoA dehydrogenase	98.02
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.99
PRK10593	297	hypothetical protein; Provisional	97.98
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.96
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.95
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.93
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.66
KOG2270	520	consensus Serine/threonine protein kinase involved	97.65
PRK05231	319	homoserine kinase; Provisional	97.59
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.55
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.54
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.51
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.31
PLN02236	344	choline kinase	97.29
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.14
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.07
PLN02756	418	S-methyl-5-thioribose kinase	96.99
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.9
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.8
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.66
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.58
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.54
PRK12396	409	5-methylribose kinase; Reviewed	96.49
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.31
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.29
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.26
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.14
PRK11768	325	serine/threonine protein kinase; Provisional	95.99
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.78
PTZ00384	383	choline kinase; Provisional	95.59
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.46
PRK06148	1013	hypothetical protein; Provisional	95.05
COG2334	331	Putative homoserine kinase type II (protein kinase	95.05

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=341.73  Aligned_cols=257  Identities=26%  Similarity=0.348  Sum_probs=215.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-eeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-~~~lv~e  115 (358)
                      ++.+.++.||+|..|+||++.++. ++-+|+|.+.. .+....+++.+|+++++..+||+||.+|+.|.+.. ..+++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            467888999999999999999865 88899999943 45667788999999999999999999999999998 4999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||++|+|++++...   +.+++..+.+++.++++||.|||. ++   |+||||||.|+||+..|.+||||||.+..+-  
T Consensus       159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lv--  230 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILV--  230 (364)
T ss_pred             hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence            99999999998554   449999999999999999999996 77   9999999999999999999999999998763  


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCC--CCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFY--HSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                        ........||..|||||.+.+..|+.++||||||++++|+++|+.||...  .......++..+.    .+.++.+..
T Consensus       231 --nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv----~~ppP~lP~  304 (364)
T KOG0581|consen  231 --NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV----DEPPPRLPE  304 (364)
T ss_pred             --hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh----cCCCCCCCc
Confidence              22455778999999999999999999999999999999999999998764  1223333333333    233333333


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .        ....++.+||..||+.||.+|||+.+|+++-+-...
T Consensus       305 ~--------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  305 G--------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             c--------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            2        122467789999999999999999999998765543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-48  Score=359.09  Aligned_cols=251  Identities=26%  Similarity=0.384  Sum_probs=215.3

Q ss_pred             CCCCcceeecccCCccEEEEEE-cCCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .+|+..+.||+|+|+.||.+.+ ..|+.||+|++.+   ......+.+.+|+++.++|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6899999999999999999998 6699999999976   34556688899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |+|..++|..++.   .++.+++.+++.+++||+.||.|||+++   |+|||||..|+|++.+.++||+|||+|..+.  
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le--  169 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE--  169 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec--
Confidence            9999999999984   4456999999999999999999999999   9999999999999999999999999999874  


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .......+.+|||.|.|||++.....+..+||||+||++|.|+.|++||+.....+....+.     ..+...+..+   
T Consensus       170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-----~~~Y~~P~~l---  241 (592)
T KOG0575|consen  170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-----LNEYSMPSHL---  241 (592)
T ss_pred             CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-----hcCccccccc---
Confidence            23356678899999999999998899999999999999999999999998754433222221     1122222221   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                               .....+||.++|+.+|.+|||+.+|+.+-..
T Consensus       242 ---------s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  242 ---------SAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             ---------CHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence                     1234579999999999999999999987655

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-48  Score=344.10  Aligned_cols=261  Identities=25%  Similarity=0.325  Sum_probs=209.7

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChh-------hHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-------GLKELKNEVILFSKLQHRNLVKLLGCCIQG  107 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~-------~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  107 (358)
                      ...+.|.+.+.||+|+||.|-+|+.+ +|+.||||++++....       ....+.+|+++|++|+|||||++.++|+..
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            36678999999999999999999864 4999999999752111       123356999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC---CCeEEec
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISD  184 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~---~~i~L~D  184 (358)
                      +..|+||||++||.|.+++..+..   +.+..-..+++||+.|+.|||++|   |+||||||+|||+..+   -.+||+|
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999999966554   667777889999999999999999   9999999999999866   5699999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCcccccCCCC---CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF---SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      ||+++...   .....++.+||+.|.|||++.+...   ..+.|+||+||+||-+++|.+||.....+..  +.+.+.+.
T Consensus       323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~eQI~~G  397 (475)
T KOG0615|consen  323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKEQILKG  397 (475)
T ss_pred             cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHHHHhcC
Confidence            99999863   4456678899999999999977632   3488999999999999999999876554431  21111111


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                          ...      ...........+.++||.+||..||++|||+.|+|++.|..-.
T Consensus       398 ----~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  398 ----RYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             ----ccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence                000      0001122334567789999999999999999999999887633

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-46  Score=340.21  Aligned_cols=290  Identities=44%  Similarity=0.763  Sum_probs=250.7

Q ss_pred             CCcceeHHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEE
Q 018304           25 ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC  104 (358)
Q Consensus        25 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  104 (358)
                      ....++.+++..+.++|.-...||+|+||.||+|...++..|+||++..........+.+|++++..++|||++++++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            57778999999999999999999999999999999988899999988763332135599999999999999999999999


Q ss_pred             EeCC-eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEe
Q 018304          105 IQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS  183 (358)
Q Consensus       105 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~  183 (358)
                      .+.+ +.++|+||+.+|+|.+++...... .++|..+.+||.++|.||+|||....++|+|||||+.|||+|.+.+.||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 599999999999999999775543 69999999999999999999999987789999999999999999999999


Q ss_pred             ccccceecCCCCCCCccccc-cccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          184 DFGLARAFGGDETEGNTKRV-IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      |||++......  ....... .|+.+|++||....+..+.|+||||||+++.||++|+.+.+............+.+..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999653220  1111122 78999999999998999999999999999999999998877655455555778888888


Q ss_pred             hcCCCCccccCCcC-CCCCH-HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          263 NEGMPSQLIDPCIQ-GSFNL-AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       263 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ......+++|+.+. ..+.. .....+..+..+|++.+|.+||+|.+|++.|+.+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            88889999999876 55554 678889999999999999999999999999955443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=328.79  Aligned_cols=201  Identities=31%  Similarity=0.540  Sum_probs=183.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..+|.+.+.||+|.||+||+|+++. +..|+||.+.+.  .....+.+..|+.+|+.++|||||++++++.+++.+++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            4789999999999999999999754 899999999775  5667788889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC------CCeEEeccccc
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD------MNPKISDFGLA  188 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~------~~i~L~Df~~~  188 (358)
                      |||.||+|.+++.+.+.   +++.+++.++.|++.|+++||+++   |+||||||.|||++..      -.+||+|||++
T Consensus        89 EyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999976654   999999999999999999999999   9999999999999864      45899999999


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYH  247 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~  247 (358)
                      +.+.   ......+.+|++-|||||+++...|+.|+|+||+|+++|++++|..||....
T Consensus       163 R~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  163 RFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9874   3444557889999999999999999999999999999999999999987544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-47  Score=317.52  Aligned_cols=257  Identities=24%  Similarity=0.393  Sum_probs=207.1

Q ss_pred             CCCCcceeecccCCccEEEEEE-cCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceee-EEEeCCe-eEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG-CCIQGEE-KLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~-~~~~~~~-~~lv  113 (358)
                      .+|+|.+.||.|.||.||++.. .+|..+|.|.+.-  .+.........|+.+|++|+|||||++++ .|..++. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3579999999999999999985 4699999998863  45666777889999999999999999998 5655555 8999


Q ss_pred             EEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCC-CCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          114 YEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDS-RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~-~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ||+|.+|+|..++... +..+.+++..+|+++.|++.||+.+|+.- .+.|.||||||.|||++.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999999664 34456999999999999999999999932 135999999999999999999999999999987


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ...  ........|||.|++||++.+.+|+.|+||||+||++|||+.-..||...+       .....+.+.....+.++
T Consensus       179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLSLCKKIEQGDYPPLP  249 (375)
T ss_pred             cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------HHHHHHHHHcCCCCCCc
Confidence            432  223345689999999999999999999999999999999999999986541       11222233333333333


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      +        -....++..+|..|+.+||+.||+...++..+
T Consensus       250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            2        23345677899999999999999965555444

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-46  Score=317.43  Aligned_cols=266  Identities=21%  Similarity=0.296  Sum_probs=209.3

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|+.+.++|+|.||+||++++++ |+-||||.+....  ....+-.++|+++|++++|+|+|.++.+|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            579999999999999999999876 9999999996533  3445567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      ||+..-|.+ +.....+  ++.+.+.++++|++.|+.|+|+++   ++||||||+||+++.+|.+||||||+|+.+..  
T Consensus        82 ~~dhTvL~e-Le~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   82 YCDHTVLHE-LERYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             ecchHHHHH-HHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            998855555 4433332  999999999999999999999999   99999999999999999999999999998743  


Q ss_pred             CCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc---------C
Q 018304          196 TEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE---------G  265 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~  265 (358)
                      .....+....|-+|.|||++.+ ..|....|||++||++.||++|.+.|......+.+..+......+..         +
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            3344556677889999998887 68999999999999999999999988776655554444443221111         0


Q ss_pred             CCCccccCCcCC-----CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          266 MPSQLIDPCIQG-----SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       266 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      ....+.-+....     ..-+.....+++++..||+.||.+|++-++++++-
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~  285 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP  285 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence            000011111111     11112233578999999999999999999998753

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=328.35  Aligned_cols=259  Identities=32%  Similarity=0.495  Sum_probs=208.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCccceeeEEEeCC-eeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ--GLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-~~~lv~e  115 (358)
                      .+..+.+.||+|+||+||+|.+.+...|++|.+......  ..+.+.+|+.+|..++||||+++++++.... .+++|||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            344566679999999999999944445999999763322  2568999999999999999999999998887 7999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df~~~~~~~~~  194 (358)
                      |+++|+|.+++... ....++...++.|+.+|+.|+.|||+.+.  |+||||||+|||++.++ ++||+|||++......
T Consensus       121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999999774 23449999999999999999999999983  89999999999999997 9999999999875322


Q ss_pred             CCCCccccccccCCCCCccccc--CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYAS--DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .  .......||..|+|||++.  ...|+.|+||||||+++|||++|..||.....   ..+...   .......+.+..
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~---v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASA---VVVGGLRPPIPK  269 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHH---HHhcCCCCCCCc
Confidence            1  2233367899999999999  56999999999999999999999999876544   122222   222222222222


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .         ....+..++.+||..||+.||++.+++..|+.+..
T Consensus       270 ~---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  270 E---------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             c---------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            2         22356678999999999999999999999987644

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=332.72  Aligned_cols=256  Identities=26%  Similarity=0.361  Sum_probs=209.9

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  109 (358)
                      ....++|.+.+.||.|.|++|++|..+. ++.||||++.+   ..+.-.+.+..|-+.|.+| .||.|++++..|.|...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3445899999999999999999999755 99999999865   2333345566788999999 79999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      +|+|+||+++|.|.++|.+...   +++.-.+.++.+|+.||+|||++|   |+||||||+|||++.+++++|+|||.++
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999976644   999999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCC-----------CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH
Q 018304          190 AFGGDETE-----------GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA  258 (358)
Q Consensus       190 ~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  258 (358)
                      .+......           .......||..|.+||++.+...+..+|||+|||++|+|+.|.+||...+.-.....+...
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence            87432211           1113467999999999999999999999999999999999999998764433222222111


Q ss_pred             HHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          259 WKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ...+..+.+                 ....+||.+.|..||.+|+|+.+|-+|.-
T Consensus       303 ~y~fp~~fp-----------------~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF  340 (604)
T KOG0592|consen  303 DYEFPEGFP-----------------EDARDLIKKLLVRDPSDRLTSQQIKAHPF  340 (604)
T ss_pred             cccCCCCCC-----------------HHHHHHHHHHHccCccccccHHHHhhCcc
Confidence            111111111                 34567999999999999999999998763

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=319.56  Aligned_cols=251  Identities=26%  Similarity=0.377  Sum_probs=205.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..++|++++.||+|+||+||.++.++ ++-||+|++++   ....+.+....|..+|..++||.|+.++..|++.+++|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            34889999999999999999999765 88999999976   334567888999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      |+||+.||.|.-.+++...   +++..++-++..|+.||.|||++|   |+|||+||+|||++.+|+++|+|||++....
T Consensus       103 Vld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999999965544   999999999999999999999999   9999999999999999999999999998532


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                        .......+.+||+.|+|||++.+..|+.++|.||||+++|+|++|.+||...+....   ...+... +....+..+ 
T Consensus       177 --~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~---~~~I~~~-k~~~~p~~l-  249 (357)
T KOG0598|consen  177 --KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM---YDKILKG-KLPLPPGYL-  249 (357)
T ss_pred             --cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH---HHHHhcC-cCCCCCccC-
Confidence              222344457999999999999999999999999999999999999999865443211   1111110 001111111 


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC----ChHHHHHH
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP----SMPSVILM  311 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp----t~~ell~~  311 (358)
                                 ..+..+++.+.|+.+|+.|.    .+.+|-.+
T Consensus       250 -----------s~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  250 -----------SEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             -----------CHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                       23456799999999999995    45555443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=328.76  Aligned_cols=257  Identities=30%  Similarity=0.483  Sum_probs=212.0

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      ..+.+++.||+|.||.||.|.+++...|++|.++.. ......+.+|+++|++|+|++||++++++..+..++|||||+.
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            445778899999999999999977889999999763 3344677799999999999999999999999889999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      .|+|.+++... ....++...++.++.|||+|++||++++   +|||||...||||+++..+|++|||+++...+..+. 
T Consensus       285 ~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-  359 (468)
T KOG0197|consen  285 KGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-  359 (468)
T ss_pred             cCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee-
Confidence            99999999773 3344999999999999999999999999   999999999999999999999999999954333221 


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......-...|.|||.+....++.|+||||||++||||+| |+.|++...   ..+++..+.++.+-..+....+     
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms---n~ev~~~le~GyRlp~P~~CP~-----  431 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS---NEEVLELLERGYRLPRPEGCPD-----  431 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC---HHHHHHHHhccCcCCCCCCCCH-----
Confidence            1222234567999999999999999999999999999999 777754433   3455555555544444443332     


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                              .+.++|..||+.+|++|||+..+...++....
T Consensus       432 --------~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  432 --------EVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             --------HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence                    56679999999999999999999999887643

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-45  Score=325.53  Aligned_cols=274  Identities=22%  Similarity=0.283  Sum_probs=217.4

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhH-HHHHHHHHHHHhcC-CCCccceeeEEEeCC-ee
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL-KELKNEVILFSKLQ-HRNLVKLLGCCIQGE-EK  110 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~-~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~-~~  110 (358)
                      ....+||.++++||.|.||.||+|+.+. |..||||.+++.-.... ..-.+|+..|++++ ||||+++.+++.+.+ .+
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            4567899999999999999999999654 88999999976332221 22347999999998 999999999999988 99


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++|||||+. +|.+++..+  ...+++..++.|++||++||+++|.+|   +.|||+||+|||+.....+||+|||+|+.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            999999976 999999765  456999999999999999999999999   99999999999999899999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcccc-cCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +.   +..-.+....|-.|+|||++ +.+.|+.+.|+|++|||++|+++-++.|....   ..+.+..++..+.......
T Consensus       160 v~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s---E~Dqi~KIc~VLGtP~~~~  233 (538)
T KOG0661|consen  160 VR---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS---EIDQIYKICEVLGTPDKDS  233 (538)
T ss_pred             cc---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc---HHHHHHHHHHHhCCCcccc
Confidence            63   33344566788999999965 67789999999999999999999998876544   3444555555444433333


Q ss_pred             cccC---------CcC--CCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCC
Q 018304          270 LIDP---------CIQ--GSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQ  320 (358)
Q Consensus       270 ~~~~---------~~~--~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~  320 (358)
                      +...         .+.  ....     .....++.++|.+|+.+||.+|||+.+++++.-.....+.
T Consensus       234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            2221         000  0001     1234577899999999999999999999998766644433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=315.24  Aligned_cols=269  Identities=23%  Similarity=0.350  Sum_probs=216.7

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .....+.|++...||.|..+.||+|+... +..|+||++.-. .....+.+.+|+..|..++||||+.++..|..+..++
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            33456899999999999999999999644 899999999642 2334788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||+||.+|++.+++...-..+ +++..+..++.++++||.|||++|   .+|||||+.|||++.+|.|+|+|||.+..+
T Consensus       101 vVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             EeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence            9999999999999997765444 999999999999999999999999   999999999999999999999999998776


Q ss_pred             CCCCCCCcc--ccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          192 GGDETEGNT--KRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       192 ~~~~~~~~~--~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      .........  +...|+++|+|||++..  ..|+.|+||||||++..||.+|..||.-+.+-.   ++...   +. +.+
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk---vLl~t---Lq-n~p  249 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK---VLLLT---LQ-NDP  249 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH---HHHHH---hc-CCC
Confidence            443322211  45579999999999654  379999999999999999999999987665432   22111   11 222


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      +.......+.+........+.++|..||+.||.+|||+.+++.+-.
T Consensus       250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F  295 (516)
T KOG0582|consen  250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF  295 (516)
T ss_pred             CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence            2222222222333334457889999999999999999999997543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.3e-44  Score=297.77  Aligned_cols=277  Identities=25%  Similarity=0.366  Sum_probs=215.5

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .+|...++||+|.||.||+|++. +|+.||+|.++..+  +.......+|++.|+.++|+||+.++++|-+.+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            58999999999999999999964 59999999997532  2234567799999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |++. +|...+.+..  ..+....+..++.++++|++|||++.   |+||||||+|++++.+|.+||+|||+++.+....
T Consensus        82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9975 9999886544  34899999999999999999999999   9999999999999999999999999999875433


Q ss_pred             CCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ....  ....|-.|.|||++.|. .|+...|+||.||++.||+.|.+-|.....-   +.+..+.+.+..+.+....+-.
T Consensus       156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi---dQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI---DQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH---HHHHHHHHHcCCCCcccCcccc
Confidence            3222  22678889999987764 8999999999999999999998776554443   3333333333222222221111


Q ss_pred             c--------------CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCCCCCcc
Q 018304          275 I--------------QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYL  327 (358)
Q Consensus       275 ~--------------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~~~~~~  327 (358)
                      -              ....-.....+.++|+.+||.+||.+|+|+.+++++-.... .|.|..+..+
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~pt~~~~l  296 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS-LPLPTPPSKL  296 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc-CCCCCChhhC
Confidence            1              11122233456789999999999999999999999866554 4444444443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-44  Score=315.40  Aligned_cols=263  Identities=27%  Similarity=0.384  Sum_probs=209.7

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--eeEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLIY  114 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~lv~  114 (358)
                      ..+|...+.||+|.||.||++.+.+ |...+||.+...+....+.+.+|+.+|.+++|||||++++......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            4678999999999999999999755 8999999987654334677899999999999999999999754444  689999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEeccccceecCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGG  193 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~~~~~~~~  193 (358)
                      ||+.+|+|.+++.+...  .+++..+..++.||++||.|||++|   ++|+||||+|||++. ++.+||+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999977654  4999999999999999999999999   999999999999999 79999999999887542


Q ss_pred             -CCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          194 -DETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       194 -~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                       ...........|++.|+|||++.++ ....++|||||||++.+|+||..||...     ................+.+.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip  245 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIP  245 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCC
Confidence             1122233356799999999999853 3345999999999999999999998764     11222222222233233333


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                      +..         ..+..+++.+|+..+|++|||+.++|++.......+
T Consensus       246 ~~l---------s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  246 DSL---------SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ccc---------CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            221         124557999999999999999999999877665444

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=323.83  Aligned_cols=257  Identities=24%  Similarity=0.351  Sum_probs=211.0

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc----Ch-hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCC
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI----SE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE  108 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~----~~-~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~  108 (358)
                      ...++|++.+.||+|.||+|++|.+. ++..||+|++.+.    .. .....+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            45589999999999999999999864 5899999977652    11 34566778999999998 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-CCeEEecccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL  187 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-~~i~L~Df~~  187 (358)
                      ..++||||+.||.|.+++.+.   +.+.+...+.++.|++.|++|||++|   |+||||||+||+++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            999999999999999999763   33889999999999999999999999   9999999999999999 9999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCC-CC-CcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ-FS-VKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      +....  .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||...+..   .....+..  ..-
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~ki~~--~~~  240 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYRKIRK--GEF  240 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHHHHhc--CCc
Confidence            98753  2334555778999999999999877 86 7899999999999999999998762221   11111110  001


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ..+..+.           ..++.+|+++||..+|.+|+|+.+++.+-|...
T Consensus       241 ~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  241 KIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             cCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            1111110           345678999999999999999999998888876

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-43  Score=316.35  Aligned_cols=269  Identities=23%  Similarity=0.308  Sum_probs=211.4

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv  113 (358)
                      +.|+.+++||+|.||.||+|++. +|+-||+|.+....  +.......+|+.+|++|+||||+++.+...+.  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            56888999999999999999974 49999999987544  45566778999999999999999999998876  589999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      +|||+. +|..++....-  .+++..+..++.|++.||+|||++|   |+|||||..||||+++|.+||+|||++..+..
T Consensus       197 FeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             Eecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999986 88888765432  2999999999999999999999999   99999999999999999999999999997643


Q ss_pred             CCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH-----hhcCCC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL-----WNEGMP  267 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~  267 (358)
                      ... ...+....|..|.|||++.|. .|+.+.|+||.||||.||+.|++.|......+.+..+...+.-     |.....
T Consensus       271 ~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  271 SGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            322 224456689999999988875 8999999999999999999999998776665555555444322     221111


Q ss_pred             CccccCCcCCCC--CHHHH-----HHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          268 SQLIDPCIQGSF--NLAEV-----IRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       268 ~~~~~~~~~~~~--~~~~~-----~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      +..........+  .+.+.     ...++|+..+|..||.+|.|+.+.|+.=..
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            110001111111  11221     245789999999999999999999987554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=328.50  Aligned_cols=252  Identities=25%  Similarity=0.309  Sum_probs=211.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      +-|++.+.||.|..|.|-+|++. +|+..|||++.+.   .......+.+|+-+|+.+.|||++++|+++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            67999999999999999999974 5999999999763   3445677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++|-|.+++...+.   +++.+.++++.||+.|+.|+|..+   |+|||+||+|++++..+++||+|||+|..-   
T Consensus        92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe---  162 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE---  162 (786)
T ss_pred             EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---
Confidence            99999999999965544   999999999999999999999999   999999999999999999999999999762   


Q ss_pred             CCCCccccccccCCCCCcccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .......+.||.++|++||++.|.+|+ .++||||+|+|||.|++|+.||+.   ++...++..+.++.  -.++..+. 
T Consensus       163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~--f~MPs~Is-  236 (786)
T KOG0588|consen  163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGV--FEMPSNIS-  236 (786)
T ss_pred             cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCc--ccCCCcCC-
Confidence            334445677999999999999999995 789999999999999999999872   22223333333221  11222222 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                                 .+.-+|+++||.+||++|.|+.+|++|.+-..
T Consensus       237 -----------~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  237 -----------SEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             -----------HHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence                       13457999999999999999999999877653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=324.26  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=211.1

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      ..|.-..+||+|+.|.||.+... .++.|++|.+..........+.+|+.+|+..+|+|||.+++.|..++.+++||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            57888899999999999999864 48899999998766666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      +||+|.|.+....    +++..+..++.++++||+|||.++   |+|||||.+||+++.+|.+||+|||+|..+....  
T Consensus       353 ~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--  423 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--  423 (550)
T ss_pred             CCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc--
Confidence            9999999985443    999999999999999999999999   9999999999999999999999999998874332  


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .......||+.|+|||+.....|..+.||||||++++||+.|++||-..++   +..+..    ......+.+-..    
T Consensus       424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrAlyL----Ia~ng~P~lk~~----  492 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYL----IATNGTPKLKNP----  492 (550)
T ss_pred             CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHHHHH----HhhcCCCCcCCc----
Confidence            245577899999999999999999999999999999999999999654222   222111    111112222111    


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                         ......+.+|+.+||+.||++|+++.|||++-..
T Consensus       493 ---~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  493 ---EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             ---cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence               1122356789999999999999999999987443

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=310.57  Aligned_cols=260  Identities=22%  Similarity=0.380  Sum_probs=216.3

Q ss_pred             HhcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ...++|++.+.||+|.||+|-+++. +.|+.|+||.+.+   .+..+.-.+.+|+++|..|+||||++++.+|++.+..+
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            3568999999999999999999986 5699999999976   44566778899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||..+|.|.|++.....   +++.+.++++.||..|+.|+|.++   ++|||+|.+||+++.++++||+|||++..+
T Consensus       130 ivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence            99999999999999955444   999999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .   ......+.+|.+-|.+||++.|.+|. +..|-||||++||.|..|.-||+..+...   ++..+.    .   ..+
T Consensus       204 ~---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQIs----~---GaY  270 (668)
T KOG0611|consen  204 A---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQIS----R---GAY  270 (668)
T ss_pred             c---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHHhh----c---ccc
Confidence            3   23344578899999999999999984 67999999999999999999987654321   111111    1   111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK  322 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~  322 (358)
                      ..+...        .+..-||+|||..+|++|.|+.++..+-|-.+--..|.
T Consensus       271 rEP~~P--------SdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V  314 (668)
T KOG0611|consen  271 REPETP--------SDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPV  314 (668)
T ss_pred             cCCCCC--------chHHHHHHHHHhcCcccchhHHHHhhhheeeccccccc
Confidence            111111        12234899999999999999999999988765544443

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=330.77  Aligned_cols=261  Identities=26%  Similarity=0.312  Sum_probs=213.2

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcCC-CEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeE-EEeC----
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC-CIQG----  107 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~-~~~~----  107 (358)
                      ....++++|.+.|.+|||+.||+|.+..+ ..||+|++-..++..++.+.+|+++|+.|+ |+|||.+++. ....    
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            44568999999999999999999998665 999999998888999999999999999996 9999999993 2211    


Q ss_pred             --CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecc
Q 018304          108 --EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF  185 (358)
Q Consensus       108 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df  185 (358)
                        -.+.|.||||.||.|-|++.++.... +++.++++|++++++|+.+||... .+|+|||||-+|||+..+|..|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence              25679999999999999998765555 999999999999999999999996 78999999999999999999999999


Q ss_pred             ccceecCCCCC-CCccc------cccccCCCCCcccc---cCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhH
Q 018304          186 GLARAFGGDET-EGNTK------RVIGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI  255 (358)
Q Consensus       186 ~~~~~~~~~~~-~~~~~------~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~  255 (358)
                      |.+........ .....      ...-|+.|+|||.+   .+.+.+.|+|||+|||+||-||....||+....       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            99875422221 10000      12468899999965   567899999999999999999999999875422       


Q ss_pred             HHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          256 GHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                                  ..+++..+...-.......+.+||+.||+.+|.+||++-++++.+..+.
T Consensus       264 ------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  264 ------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             ------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                        1222222222222456678889999999999999999999999887663

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.5e-42  Score=315.47  Aligned_cols=261  Identities=30%  Similarity=0.447  Sum_probs=201.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~  108 (358)
                      ..++|++.+.||+|+||.||+|.+.      .+..|++|.+.... ......+.+|+.++..+ +||||+++++++...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4578999999999999999999741      24679999986532 33456788999999999 8999999999887644


Q ss_pred             -eeEEEEEecCCCCHHHHHhcccc--------------------------------------------------------
Q 018304          109 -EKLLIYEFMTNKSLDSFIFDQER--------------------------------------------------------  131 (358)
Q Consensus       109 -~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  131 (358)
                       ..+++|||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             67899999999999999865321                                                        


Q ss_pred             ---ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCC
Q 018304          132 ---CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG  208 (358)
Q Consensus       132 ---~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~  208 (358)
                         ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++................++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134778889999999999999999999   99999999999999999999999999876432221112222345578


Q ss_pred             CCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHH
Q 018304          209 YMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRC  287 (358)
Q Consensus       209 y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (358)
                      |+|||.+.+..++.++||||||+++|+|++ |..||.......  ...    .............         .....+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~~~~~~~~---------~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDGTRMRAPE---------NATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcCCCCCCCC---------CCCHHH
Confidence            999999988899999999999999999997 999986533221  111    1111111111111         112356


Q ss_pred             HHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          288 IHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       288 ~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .+++.+||+.+|++|||+.+|++.|+..
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            7899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.4e-41  Score=307.49  Aligned_cols=265  Identities=26%  Similarity=0.413  Sum_probs=200.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-----------------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccc
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK   99 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-----------------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~   99 (358)
                      .++|++.+.||+|+||.||+|.+.+                 +..|++|.+... .......+.+|++++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4789999999999999999997532                 336999988753 2334567889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCCHHHHHhcccc----------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 018304          100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQER----------------CKILDWSKRFHIICGTARGVMYLHQDSRLRII  163 (358)
Q Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~  163 (358)
                      +++++.+.+..+++|||+.+++|.+++.....                ...+++..++.++.||+.||.|||+.+   ++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            99999999999999999999999999854321                123677889999999999999999999   99


Q ss_pred             cCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhC--CC
Q 018304          164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG--KK  241 (358)
Q Consensus       164 H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g--~~  241 (358)
                      |+||+|+||+++.++.++|+|||++..+.............++..|+|||.+.+..++.++||||||+++|+|+++  ..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999998765332221122233456789999999888899999999999999999974  45


Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          242 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       242 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ||.....   ..........+.......... .     .......+.+++.+||..+|++|||+.+|.+.|++
T Consensus       241 p~~~~~~---~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTD---EQVIENAGEFFRDQGRQVYLF-R-----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCH---HHHHHHHHHHhhhcccccccc-C-----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            5543322   122222221111111100000 0     00112356789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=312.49  Aligned_cols=250  Identities=20%  Similarity=0.236  Sum_probs=203.2

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||+|.+. +++.|++|.+....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999975 48899999986422   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++....   .+++..++.++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||++..... 
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence            9999999999985543   3899999999999999999999999   99999999999999999999999999876422 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                          ......|++.|+|||.+.+..++.++|||||||++|+|++|..||......   .......    ... ..+    
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~i~----~~~-~~~----  217 (291)
T cd05612         154 ----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKIL----AGK-LEF----  217 (291)
T ss_pred             ----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCC-cCC----
Confidence                122346889999999999888999999999999999999999998643221   1111111    110 001    


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccCC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSET  316 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~~  316 (358)
                       ....    ...+.++|.+||+.||.+||+     +.+++++.|...
T Consensus       218 -~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         218 -PRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             -CccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence             0111    235668999999999999995     999999877653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.9e-42  Score=317.65  Aligned_cols=265  Identities=20%  Similarity=0.268  Sum_probs=207.4

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcC-C-----CCccceeeEEEeCCeeEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H-----RNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~iv~~~~~~~~~~~~~l  112 (358)
                      +|+|++.||+|.||.|.+|.+.. ++.||||++++ ...-..+...|+.+|..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            99999999999999999999754 99999999976 4556677888999999996 4     389999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC--CCeEEecccccee
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARA  190 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~--~~i~L~Df~~~~~  190 (358)
                      |+|.+. .+|.+++..+.-.+ ++...++.++.||++||.+||..+   |+|+||||+|||+.+-  ..||++|||++..
T Consensus       266 VfELL~-~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            999995 59999997766544 999999999999999999999999   9999999999999754  3699999999987


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH----------
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK----------  260 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  260 (358)
                      ....     ......+..|.|||++.|.+|+.+.||||||||++||++|.+.|...+..+.+..+..+..          
T Consensus       341 ~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  341 ESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            4221     2255567789999999999999999999999999999999888766554433333222210          


Q ss_pred             -----Hhhc-CCCCc-----------------------cccCCcC-C------CCCHHHHHHHHHHHhhhcCCCCCCCCC
Q 018304          261 -----LWNE-GMPSQ-----------------------LIDPCIQ-G------SFNLAEVIRCIHIGLLCVQQHPKDRPS  304 (358)
Q Consensus       261 -----~~~~-~~~~~-----------------------~~~~~~~-~------~~~~~~~~~l~~li~~cl~~~P~~Rpt  304 (358)
                           .+.. .....                       ..+...+ .      .........+++++.+||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                 0000 00000                       0000000 0      001133456799999999999999999


Q ss_pred             hHHHHHHhccC
Q 018304          305 MPSVILMLGSE  315 (358)
Q Consensus       305 ~~ell~~l~~~  315 (358)
                      ..+.+.+-+--
T Consensus       496 p~qal~Hpfl~  506 (586)
T KOG0667|consen  496 PAQALNHPFLT  506 (586)
T ss_pred             HHHHhcCcccc
Confidence            99999987665

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=312.64  Aligned_cols=256  Identities=23%  Similarity=0.341  Sum_probs=205.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|++|.||+|.+.. ++.|++|++....   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            479999999999999999999864 8899999987532   234456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999985433   3889999999999999999999999   99999999999999999999999999876422 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC-CccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP-SQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  273 (358)
                          ......|++.|+|||.+.+..++.++|||||||++|+|++|..||........   .... ..+..... +...+.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i-~~~~~~~~~~~~~~~  225 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---WENL-KYWKETLQRPVYDDP  225 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---HHHH-HhccccccCCCCCcc
Confidence                22345688999999999988999999999999999999999999865432211   1111 11111100 000000


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            .......+.+++.+||..+|.+|||+.+++.+.+..
T Consensus       226 ------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         226 ------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             ------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence                  011234567899999999999999999999987655

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.5e-41  Score=310.06  Aligned_cols=266  Identities=22%  Similarity=0.285  Sum_probs=205.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .++|++++.||+|++|.||++.+.. +..+++|.+... .......+.+|+++++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            5799999999999999999999764 788999988653 33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.+  +++|+||+|+||+++.++.++|+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999985543   3899999999999999999999853  2999999999999999999999999998764321 


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh-h--cCCCCc---
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW-N--EGMPSQ---  269 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~--~~~~~~---  269 (358)
                         ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...   ......... .  ......   
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCc
Confidence               2223458899999999998899999999999999999999999986433211   100000000 0  000000   


Q ss_pred             ----------------------------cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 ----------------------------LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ----------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                                  +...............++.+||.+||+.||++|||+.+|+++.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~  305 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK  305 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence                                        0000000000011234678899999999999999999999987654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=287.96  Aligned_cols=270  Identities=21%  Similarity=0.256  Sum_probs=213.6

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC---
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---  108 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~---  108 (358)
                      ++....+||+|.+.||+|||+.||+++. .++..|++|++......+.+..++|++..+.++|||+++++++...+.   
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            4556779999999999999999999984 458899999998888888899999999999999999999998875544   


Q ss_pred             --eeEEEEEecCCCCHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecc
Q 018304          109 --EKLLIYEFMTNKSLDSFIFDQERC-KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF  185 (358)
Q Consensus       109 --~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df  185 (358)
                        ..|++++|...|+|.+.+...... ..+++..+++|+.++++||++||+.. .++.|+||||.||++.+.+.++|+||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence              489999999999999999776543 36999999999999999999999986 57999999999999999999999999


Q ss_pred             ccceecCCCCCCC----ccc---cccccCCCCCcccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhH
Q 018304          186 GLARAFGGDETEG----NTK---RVIGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI  255 (358)
Q Consensus       186 ~~~~~~~~~~~~~----~~~---~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~  255 (358)
                      |.+....-.....    ..+   .-..+..|.|||++.-   ...+.++|||||||++|.|+.|..||+.-......-. 
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-  252 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-  252 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-
Confidence            9987642111110    011   1246889999998853   4568999999999999999999999875333111100 


Q ss_pred             HHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          256 GHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                                  -.+......-.........++++|.+||+.||.+||++.+|+.++..+.
T Consensus       253 ------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 ------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                        0011111111111224567889999999999999999999999988764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-41  Score=312.77  Aligned_cols=249  Identities=23%  Similarity=0.282  Sum_probs=202.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||+|.+.. ++.|++|.+...   .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            789999999999999999999754 889999998652   2233456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++....   .+++..+..++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999986543   3889999999999999999999999   999999999999999999999999998865321


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                           .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.....   ........    .... .+.   
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~----~~~~-~~p---  235 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEKIL----AGRL-KFP---  235 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHHHh----cCCc-CCC---
Confidence                 2234688999999999988899999999999999999999999854221   11111111    1110 010   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~  315 (358)
                        ...    ...+.++|.+||+.||.+||+     +.+++.+.+..
T Consensus       236 --~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~  275 (329)
T PTZ00263        236 --NWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH  275 (329)
T ss_pred             --CCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence              011    134668999999999999997     79999886654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-41  Score=309.13  Aligned_cols=259  Identities=21%  Similarity=0.276  Sum_probs=206.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .-++|++++.||+|+||.||+|+.++ |.-+|+|++++.   .......++.|-.+|...++++||+++..|.+.+.+|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            55899999999999999999999765 999999999873   34556778889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||++||++-.++.+..   .+++..++.++.+++.|++.+|+.|   ++||||||+|+||+..|++||+|||++..+.
T Consensus       219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999995544   4999999999999999999999999   9999999999999999999999999986442


Q ss_pred             CC-------------------CC--CC-----ccc-------------------cccccCCCCCcccccCCCCCCcccch
Q 018304          193 GD-------------------ET--EG-----NTK-------------------RVIGTYGYMAPEYASDGQFSVKSDVF  227 (358)
Q Consensus       193 ~~-------------------~~--~~-----~~~-------------------~~~~~~~y~aPE~~~~~~~~~~~Diw  227 (358)
                      ..                   ..  ..     ...                   ...|||.|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                   00  00     000                   02599999999999999999999999


Q ss_pred             hHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC---
Q 018304          228 SFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS---  304 (358)
Q Consensus       228 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---  304 (358)
                      |||||+|||+.|-+||...++...-..+..-...|..+....+             ..+..+||.+||+ ||++|.-   
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~-------------s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDL-------------SDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcc-------------cHHHHHHHHHHhc-CHHHhcCccc
Confidence            9999999999999998765544322222111111111111111             1345679999999 9999964   


Q ss_pred             hHHHHHHhccC
Q 018304          305 MPSVILMLGSE  315 (358)
Q Consensus       305 ~~ell~~l~~~  315 (358)
                      +.||-.+.+..
T Consensus       439 ~~EIK~HPfF~  449 (550)
T KOG0605|consen  439 AEEIKKHPFFK  449 (550)
T ss_pred             HHHHhcCCccc
Confidence            77777776554

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5e-41  Score=302.64  Aligned_cols=255  Identities=25%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .|++.+.||+|+||.||++.+. +++.|++|.+....   ......+.+|+.++..++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3788999999999999999864 58999999886422   2223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++..... ..+++..++.++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999999888754332 23889999999999999999999999   9999999999999999999999999987653221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                         ......|+..|+|||.+.+..++.++|||||||++|+|++|..||............   ....... ...+     
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~-~~~~-----  224 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKED-QEEY-----  224 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhcc-cccC-----
Confidence               122345889999999999999999999999999999999999998754432211111   1111110 0011     


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhcc
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGS  314 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~  314 (358)
                          .......+.+|+.+||+.||++||+     +.+++++.+.
T Consensus       225 ----~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~  264 (285)
T cd05631         225 ----SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF  264 (285)
T ss_pred             ----CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence                1111235668999999999999997     8999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.8e-41  Score=306.04  Aligned_cols=267  Identities=22%  Similarity=0.297  Sum_probs=199.8

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++.+.||.|+||.||+|.+. +++.|++|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            67999999999999999999875 48899999986432 22334667899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+ +|.+++....  ..+++..+..++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||++....... 
T Consensus        85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            975 8888875433  23788999999999999999999999   9999999999999999999999999987642211 


Q ss_pred             CCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH-----HHhhcCCCC-c
Q 018304          197 EGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW-----KLWNEGMPS-Q  269 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~  269 (358)
                       .......+++.|+|||.+.+ ..++.++||||+||++|+|++|..||...........+....     ..|...... .
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence             12223457889999998865 568999999999999999999999986544322211111110     001110000 0


Q ss_pred             ---cccCCcCCCC----CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          270 ---LIDPCIQGSF----NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       270 ---~~~~~~~~~~----~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                         ...+......    ......++.+|+.+||+.||.+|||+.+++++-+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence               0000000000    0011235678999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.5e-41  Score=310.05  Aligned_cols=246  Identities=21%  Similarity=0.247  Sum_probs=197.0

Q ss_pred             eeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           45 KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      +.||+|+||.||++.++ +|+.|++|++...   .......+..|+.+++.++||||+++++++...+..++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 4889999998752   2334456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcc
Q 018304          121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT  200 (358)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~  200 (358)
                      +|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++.....  .....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~  152 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATM  152 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcc
Confidence            9999885433   4899999999999999999999999   99999999999999999999999999865311  11222


Q ss_pred             ccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCC
Q 018304          201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFN  280 (358)
Q Consensus       201 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..   .......    ... ..+.     .   
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~~~----~~~-~~~p-----~---  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELIL----MEE-IRFP-----R---  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHHHH----cCC-CCCC-----C---
Confidence            3456899999999999899999999999999999999999998543221   1111111    110 1111     1   


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          281 LAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       281 ~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                       .....+.++|.+||+.||++||     ++.+++++-+..
T Consensus       217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~  255 (323)
T cd05571         217 -TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA  255 (323)
T ss_pred             -CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcC
Confidence             1123567899999999999999     899999876553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=316.78  Aligned_cols=271  Identities=27%  Similarity=0.428  Sum_probs=214.1

Q ss_pred             cceeHHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEE
Q 018304           27 PLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCC  104 (358)
Q Consensus        27 ~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  104 (358)
                      .....++++...++..+...||+|.||+||+|.|.+  .||||++..  ..++..+.|++|+..+++-+|.||+-+++++
T Consensus       380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             CCccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence            344457777888899999999999999999999844  567777753  5566889999999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                      ..... .||..+|+|.+|..+++-.+  ..+.....+.|+.||++|+.|||.++   |+|+|||..|||+.++++|||+|
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEec
Confidence            88877 89999999999999997655  33899999999999999999999999   99999999999999999999999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCcccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      ||++..-..-..........+...|+|||+++.+   +|+..+||||||+++|||++|..||.....+......   -+ 
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV---Gr-  607 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV---GR-  607 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe---cc-
Confidence            9998764322222233344577889999998743   7899999999999999999999998733222221111   11 


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                        +...++...   .   ......++.+|+..||.+++++||++.+|+..|+.+..
T Consensus       608 --G~l~pd~s~---~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  608 --GYLMPDLSK---I---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --cccCccchh---h---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              111111111   1   11223367778889999999999999999998888755

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-41  Score=306.87  Aligned_cols=268  Identities=20%  Similarity=0.265  Sum_probs=201.5

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++.+.||+|++|.||++.++. ++.|++|++....  ......+.+|+++++.++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            479999999999999999999864 7889999886532  2334667789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.++++..+...   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            9998777655432   234899999999999999999999999   9999999999999999999999999987653221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH--------HHh-hcCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW--------KLW-NEGM  266 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~-~~~~  266 (358)
                       ........++..|+|||.+.+..++.++||||+||++|+|++|..||...........+....        ..+ ....
T Consensus       155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence             112223457889999999988889999999999999999999999986543221111111100        000 0000


Q ss_pred             CCccccCCcCCCCC------HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          267 PSQLIDPCIQGSFN------LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       267 ~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ......+.......      ......+.+||.+||+.||++|||+.+++++-+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~  286 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA  286 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            00000000000000      012235788999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.1e-42  Score=311.80  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=208.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|.+.+.||+|.||.||+|+.+. .+.|++|.+.+  ..+.+.+.+.+|+++++.++||||+.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            689999999999999999998654 78999999976  345567889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.| +|..++.....   ++++.+..++.+++.||.|||+.+   |.|+|+||.||++...|.+|+||||+++....+ 
T Consensus        82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9987 99999965544   999999999999999999999999   999999999999999999999999999976432 


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                       ........||+.|+|||+..+.+|+..+|.||+||++||+++|++||-..      .+.+.+.....++...       
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v~~-------  219 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPVKP-------  219 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCCCC-------
Confidence             22344567999999999999999999999999999999999999997321      1222222222221111       


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                          +......+.+++...|..||..|.|..+++.+-
T Consensus       220 ----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  220 ----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             ----cccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence                113344677889999999999999999999764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=286.61  Aligned_cols=236  Identities=25%  Similarity=0.322  Sum_probs=198.0

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||.|.||.|.+++.+. |..+|+|++.+..   -...+...+|..+|+.+.||.++++++.|.+.+.+++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            578999999999999999999765 8899999997632   344566779999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||++||-|..++.+..   .+++..++.++.+|+.||+|||+.+   |++||+||+|||++.+|.+|++|||++..+.  
T Consensus       124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS--  195 (355)
T ss_pred             eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence            9999999999995544   3999999999999999999999999   9999999999999999999999999999753  


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                         ...-+.+||+.|+|||++....+..++|.|+||+++|||+.|..||-....   ......+...  .-..+....  
T Consensus       196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~--~v~fP~~fs--  265 (355)
T KOG0616|consen  196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEG--KVKFPSYFS--  265 (355)
T ss_pred             ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhC--cccCCcccC--
Confidence               334578999999999999999999999999999999999999999865444   2232222211  111222222  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDR  302 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~R  302 (358)
                                .++.+|+...|+.|-.+|
T Consensus       266 ----------~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  266 ----------SDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----------HHHHHHHHHHHhhhhHhh
Confidence                      245578888899998888

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=302.07  Aligned_cols=273  Identities=25%  Similarity=0.355  Sum_probs=208.0

Q ss_pred             ceeHHHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--------------cChhhHHHHHHHHHHHHhc
Q 018304           28 LFELATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--------------ISEQGLKELKNEVILFSKL   92 (358)
Q Consensus        28 ~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--------------~~~~~~~~~~~e~~~l~~l   92 (358)
                      +++..+-...-++|++.+.||+|.||+|-+|++. +++.||||++.+              ......+...+|+.+|+++
T Consensus        86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl  165 (576)
T KOG0585|consen   86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL  165 (576)
T ss_pred             eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence            3333444445589999999999999999999974 489999999964              1122345788999999999


Q ss_pred             CCCCccceeeEEEeC--CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 018304           93 QHRNLVKLLGCCIQG--EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKAS  170 (358)
Q Consensus        93 ~~~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~  170 (358)
                      +|+|||+++.+..+.  +.+|+|+|||..|.+...-   .....+.+.+.++++.+++.||+|||.+|   |+||||||.
T Consensus       166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs  239 (576)
T KOG0585|consen  166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS  239 (576)
T ss_pred             CCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence            999999999999775  5899999999988765432   22222899999999999999999999999   999999999


Q ss_pred             cEEEcCCCCeEEeccccceecCCCC---CCCccccccccCCCCCcccccCCC----CCCcccchhHhHHHHHHHhCCCCC
Q 018304          171 NVLLDQDMNPKISDFGLARAFGGDE---TEGNTKRVIGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIISGKKNR  243 (358)
Q Consensus       171 Nilv~~~~~i~L~Df~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~p~  243 (358)
                      |+|++.+|++||+|||.+.......   .........||+.|+|||...++.    -+.+.||||+|++||+|+.|+.||
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            9999999999999999998663221   112223357999999999887632    256899999999999999999997


Q ss_pred             CCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCC
Q 018304          244 GFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQP  321 (358)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~  321 (358)
                      -...   .......+.   ..  +-.+.       .....-..+.+||.+||+.||+.|.++.+|..+.|-......|
T Consensus       320 ~~~~---~~~l~~KIv---n~--pL~fP-------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  320 FDDF---ELELFDKIV---ND--PLEFP-------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             ccch---HHHHHHHHh---cC--cccCC-------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            4322   112211111   11  11111       1112234566899999999999999999999999988766555

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-41  Score=308.10  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=211.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-eEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~lv  113 (358)
                      .++|.+++++|.|+||.+++++++. ++.|++|.+.-  ..........+|+.++.++.|||||.+.+.|+.++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            4789999999999999999998654 78999998854  334445577899999999999999999999999988 9999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |+||+||++.+.+.+.+ ...++++.++.|+.||+.|+.|||+++   |+|||||+.|||++.++.|+|+|||+++.+..
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999998766 344999999999999999999999988   99999999999999999999999999998743


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..  .......||+.|+.||++.+.+|..|+|||||||++|+|++-+++|...+..   .++..+.....          
T Consensus       159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~~~----------  223 (426)
T KOG0589|consen  159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRGLY----------  223 (426)
T ss_pred             ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhccC----------
Confidence            32  2344678999999999999999999999999999999999999998665443   22222222111          


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                         ...+.....++..+|..||+.+|..||++.+||.+..
T Consensus       224 ---~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~  260 (426)
T KOG0589|consen  224 ---SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPH  260 (426)
T ss_pred             ---CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence               1112233446777999999999999999999998643

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.1e-40  Score=302.49  Aligned_cols=256  Identities=22%  Similarity=0.284  Sum_probs=199.8

Q ss_pred             CCCcceeecccCCccEEEEEEc----CCCEEEEEEeccc----ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~----~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~  110 (358)
                      +|++.+.||+|+||.||+++..    .++.|++|++.+.    .......+..|+++++.+ +|++|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999753    4789999998642    223345677899999999 589999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++||||+.+++|.+++....   .+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999985533   3899999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ...... .......|+..|+|||.+.+. .++.++|||||||++|+|++|..||...........+...   .... ...
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~---~~~~-~~~  229 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR---ILKC-DPP  229 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH---HhcC-CCC
Confidence            422211 122234689999999998765 4788999999999999999999998654333222221111   1111 011


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                      +.     ..    ....+.+++.+||+.||++||     ++.+++++.+..
T Consensus       230 ~~-----~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  271 (332)
T cd05614         230 FP-----SF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK  271 (332)
T ss_pred             CC-----CC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence            10     11    123456799999999999999     788999886643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.9e-40  Score=303.46  Aligned_cols=246  Identities=22%  Similarity=0.266  Sum_probs=196.5

Q ss_pred             eeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           45 KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      +.||+|+||.||++.+. +++.|++|++.+.   .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 4889999998652   2334566778999999999999999999999999999999999999


Q ss_pred             CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcc
Q 018304          121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT  200 (358)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~  200 (358)
                      +|.+++....   .+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++......  ....
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            9998885433   3899999999999999999999999   999999999999999999999999998653211  1122


Q ss_pred             ccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCC
Q 018304          201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFN  280 (358)
Q Consensus       201 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|..||......   ......   ....  ..+.     ..  
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~---~~~~--~~~p-----~~--  217 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI---LMED--IKFP-----RT--  217 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHh---ccCC--ccCC-----CC--
Confidence            3346889999999999889999999999999999999999998643221   111111   1010  0111     11  


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          281 LAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       281 ~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                        ....+.++|.+||+.||++||     ++.+++++.+..
T Consensus       218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  255 (328)
T cd05593         218 --LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT  255 (328)
T ss_pred             --CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence              123566899999999999997     899999886543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.7e-40  Score=300.47  Aligned_cols=272  Identities=23%  Similarity=0.292  Sum_probs=202.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++.+.||+|++|.||+|.+. +++.|++|.+..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            3578999999999999999999976 488999999865332 22345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+. ++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          83 EYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             ECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            9996 57777775432  33889999999999999999999999   999999999999999999999999998754211


Q ss_pred             CCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC-----
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS-----  268 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  268 (358)
                        ........+++.|+|||++.+ ..++.++||||+||++|+|++|..||.....  ....+.............     
T Consensus       157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccch
Confidence              112223457889999998765 4678899999999999999999999865322  111111111111100000     


Q ss_pred             ----ccccCCcC--CCCCHH-------HHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          269 ----QLIDPCIQ--GSFNLA-------EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       269 ----~~~~~~~~--~~~~~~-------~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                          .+......  ......       ....+.+++.+||+.||++|||+.+++++-+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                00000000  000000       113466899999999999999999999987765443

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-40  Score=299.97  Aligned_cols=245  Identities=18%  Similarity=0.320  Sum_probs=195.6

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccChhh---HHHHHHHHHHHHhcCCCCccceeeEEEe----CCeeEEEEEec
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFM  117 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~~~lv~e~~  117 (358)
                      ..||+|+++.||+|.+ +|+.|++|.+.......   ...+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999988 78999999997643222   5667799999999999999999999877    34678999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      .+|+|.+++....   .+++...+.++.+++.|+.+||+. +   ++||||+|+||++++++.++|+|||++..+.... 
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            9999999996543   488999999999999999999985 7   8999999999999999999999999987543211 


Q ss_pred             CCccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          197 EGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                          ....++..|+|||.+.+  ..++.++||||||+++|+|++|..||......   ........   ......+    
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~i~~---~~~~~~~----  243 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDLIIN---KNNSLKL----  243 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHh---cCCCCCC----
Confidence                12356788999999876  68899999999999999999999998654321   11111111   1111111    


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                           +......+.+++.+||+.||++|||+.++++.|+...
T Consensus       244 -----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        244 -----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                 0112335678999999999999999999999998653

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-40  Score=305.38  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=195.5

Q ss_pred             CCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHH---HhcCCCCccceeeEEEeCCeeEEE
Q 018304           41 FSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l---~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      |++++.||+|++|.||+|.+. +++.|++|.+.+..   ......+..|..++   ..++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            788999999999999999875 48999999997521   23345566666555   456799999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+.+++|..++..    ..+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999888743    23899999999999999999999999   99999999999999999999999998864321


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                        .........|++.|+|||.+.+..++.++|||||||++|+|++|..||......   .......    .... ..   
T Consensus       154 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~i~----~~~~-~~---  220 (324)
T cd05589         154 --FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDSIV----NDEV-RY---  220 (324)
T ss_pred             --CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCCC-CC---
Confidence              112223456889999999999889999999999999999999999998643321   1111111    1100 01   


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                        ...    ....+.++|.+||+.||.+||     ++.+++++.+..
T Consensus       221 --p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~  261 (324)
T cd05589         221 --PRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR  261 (324)
T ss_pred             --CCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcC
Confidence              011    123566899999999999999     688888876543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.9e-40  Score=302.60  Aligned_cols=268  Identities=21%  Similarity=0.272  Sum_probs=203.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .++|++.+.||.|+||.||++.+.. +..+++|.+... .......+.+|+++++.++|+||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            5799999999999999999999764 788899987653 33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |+.+++|.+++....   .+++..+..++.+++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999985433   388999999999999999999974 6   999999999999999999999999998654221


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC-C----CCc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG-M----PSQ  269 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~----~~~  269 (358)
                          ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...................... .    ...
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence                1223457889999999998889999999999999999999999986543211100000000000000 0    000


Q ss_pred             --------------------ccc----CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 --------------------LID----PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 --------------------~~~----~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                          +.+    .............++.+|+.+||+.||++|||+.+++.+-+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~  303 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK  303 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence                                000    0000000000123567899999999999999999999876553

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.4e-41  Score=307.47  Aligned_cols=257  Identities=21%  Similarity=0.254  Sum_probs=201.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||++.+. +++.|++|.+....   ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999875 48899999997522   234566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++....  ..+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999986542  23899999999999999999999999   999999999999999999999999999875322


Q ss_pred             CCCCccccccccCCCCCccccc------CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYAS------DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ... ......+++.|+|||++.      +..++.++|||||||++|+|++|..||......   .......   ......
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~---~~~~~~  228 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---KTYNNIM---NFQRFL  228 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---HHHHHHH---cCCCcc
Confidence            211 222346889999999886      456789999999999999999999998643321   1111111   111111


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .+..       .......+.+++.+||+ +|.+|||+.+++.+-+..
T Consensus       229 ~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~  267 (330)
T cd05601         229 KFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS  267 (330)
T ss_pred             CCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence            1111       01112356678899998 999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.5e-40  Score=294.01  Aligned_cols=255  Identities=32%  Similarity=0.504  Sum_probs=207.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      ..+|++.+.||.|++|.||+|.+.++..+++|.+..........+..|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            46799999999999999999998889999999998766656678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++++|.+++..... ..+++..++.++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+.........
T Consensus        85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          85 EKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            99999999976443 34899999999999999999999999   999999999999999999999999998765322111


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                        .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .........    ......      
T Consensus       161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~----~~~~~~------  225 (261)
T cd05148         161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITA----GYRMPC------  225 (261)
T ss_pred             --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHh----CCcCCC------
Confidence              112334567999999988889999999999999999998 8888754332   112221111    111100      


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                         .......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         226 ---PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence               11112356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-40  Score=307.73  Aligned_cols=264  Identities=18%  Similarity=0.190  Sum_probs=199.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..+|++++.||+|+||.||++.+.. ++.|++|....      ..+.+|+++++.++||||++++++|......++++|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            4689999999999999999999754 88999996532      3467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +. ++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++...... .
T Consensus       165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~  236 (391)
T PHA03212        165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N  236 (391)
T ss_pred             CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence            95 58888875433   3889999999999999999999999   999999999999999999999999998653211 1


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCC-C---CchhHHHHHHHhhcCCCCccc-
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD-N---NLNLIGHAWKLWNEGMPSQLI-  271 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~-  271 (358)
                      ........|++.|+|||++.+..++.++|||||||++|+|++|..||-..... .   ....+....... ...+..+. 
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~-g~~p~~~~~  315 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS-GTHPNEFPI  315 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh-cCChhhcCc
Confidence            11223456899999999999889999999999999999999999875332211 0   011111111110 00000000 


Q ss_pred             -----------------cCCcCCCC----CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          272 -----------------DPCIQGSF----NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       272 -----------------~~~~~~~~----~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                                       ........    ......++.+||.+||+.||++|||+.+++++-+...
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence                             00000000    0112346778999999999999999999999877654

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-40  Score=304.56  Aligned_cols=246  Identities=22%  Similarity=0.265  Sum_probs=196.0

Q ss_pred             eeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           45 KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      +.||+|+||.||++.+. +|+.|++|.+...   .......+.+|+.+++.++||||+++++.|...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999875 4899999998652   2334556778999999999999999999999999999999999999


Q ss_pred             CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcc
Q 018304          121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT  200 (358)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~  200 (358)
                      +|..++....   .+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++......  ....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~  152 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcc
Confidence            9998885433   3899999999999999999999999   999999999999999999999999998653111  1122


Q ss_pred             ccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCC
Q 018304          201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFN  280 (358)
Q Consensus       201 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..   .......   ...  ..+     ...  
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~---~~~--~~~-----p~~--  217 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELIL---MEE--IRF-----PRT--  217 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHh---cCC--CCC-----CCC--
Confidence            2346889999999999889999999999999999999999998543321   1111111   111  001     111  


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          281 LAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       281 ~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                        ....+.++|.+||+.||++||     ++.+++++-+..
T Consensus       218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~  255 (323)
T cd05595         218 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  255 (323)
T ss_pred             --CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence              123566899999999999998     899999876554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.8e-40  Score=308.89  Aligned_cols=258  Identities=21%  Similarity=0.271  Sum_probs=197.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..|++++.||+|+||.||+|.+.. ++.|++|++.+.   .......+..|+++++.++|+||+++++++.+.+..++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            368999999999999999998754 889999999652   2344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          81 DYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999986543   3889999999999999999999999   999999999999999999999999987533110


Q ss_pred             CC---------------------------------------------CCccccccccCCCCCcccccCCCCCCcccchhH
Q 018304          195 ET---------------------------------------------EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSF  229 (358)
Q Consensus       195 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  229 (358)
                      ..                                             ........|++.|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                             000112468899999999988889999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhh--cCCCCCCCCChHH
Q 018304          230 GILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLC--VQQHPKDRPSMPS  307 (358)
Q Consensus       230 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~~P~~Rpt~~e  307 (358)
                      ||++|+|++|..||.......   ...... .+...  ..+..   .    ......+.++|.+|  +..+|..||++.+
T Consensus       235 G~il~elltG~~Pf~~~~~~~---~~~~i~-~~~~~--~~~~~---~----~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTE---TQLKVI-NWENT--LHIPP---Q----VKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHH---HHHHHH-ccccc--cCCCC---C----CCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            999999999999986543211   111111 01110  00000   0    01123455677774  4555666999999


Q ss_pred             HHHHhccC
Q 018304          308 VILMLGSE  315 (358)
Q Consensus       308 ll~~l~~~  315 (358)
                      ++.+.+..
T Consensus       302 ~l~hp~f~  309 (381)
T cd05626         302 IKAHPFFS  309 (381)
T ss_pred             HhcCcccC
Confidence            99987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=304.38  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=208.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .....|...+.||+|.||.||+|.+.. ++.|++|++.- ....+...+.+|+.+|.+++++||.++|+.+..+..++++
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            345678888999999999999999754 88999999965 3344567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||||.||++.+.+.   ....+++..+.-++++++.|+.|||.++   .+|+|||+.||++..+|.++|+|||.+..+..
T Consensus        90 Mey~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHHhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999999983   3333588888899999999999999999   99999999999999999999999999987643


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..  ....+..||+.|||||++.+..|+.|+||||||+++++|++|.+|+....+..-+..       +....++.    
T Consensus       164 ~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------Ipk~~PP~----  230 (467)
T KOG0201|consen  164 TV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------IPKSAPPR----  230 (467)
T ss_pred             hh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------ccCCCCCc----
Confidence            32  233678899999999999988999999999999999999999999765444211111       11111221    


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                           .+......+.+||..||..+|+.|||+.+|+.+
T Consensus       231 -----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  231 -----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                 112333457789999999999999999999974

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.3e-40  Score=306.22  Aligned_cols=256  Identities=25%  Similarity=0.343  Sum_probs=198.7

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++++.||+|+||.||+|.+. +++.|++|.+.... ......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            56788999999999999999975 48999999986532 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+..       ...+..+..++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||++..+.... 
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            9999986532       2567788899999999999999999   9999999999999999999999999987653221 


Q ss_pred             CCccccccccCCCCCcccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          197 EGNTKRVIGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                       .......|+..|+|||.+..     ...+.++|||||||++|+|++|+.||................    ....... 
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~-  296 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----MSQPPEA-  296 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----ccCCCCC-
Confidence             11223468899999998743     233568999999999999999999987433221111111111    0111111 


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                              .......+.+||.+||+.+|++|||+.+++++-+....+.
T Consensus       297 --------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        297 --------PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             --------CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence                    0112235778999999999999999999999877666543

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=308.88  Aligned_cols=257  Identities=21%  Similarity=0.276  Sum_probs=198.7

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||++.+. +++.|++|.+.+.   .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999875 4889999998652   2334566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++...   +.+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999998653   34889999999999999999999999   999999999999999999999999998632110


Q ss_pred             CC------------CC---------------------------------ccccccccCCCCCcccccCCCCCCcccchhH
Q 018304          195 ET------------EG---------------------------------NTKRVIGTYGYMAPEYASDGQFSVKSDVFSF  229 (358)
Q Consensus       195 ~~------------~~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  229 (358)
                      ..            ..                                 ......|++.|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00            00                                 0012358899999999998899999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCC---CChH
Q 018304          230 GILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDR---PSMP  306 (358)
Q Consensus       230 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---pt~~  306 (358)
                      ||++|+|++|..||......   ....... .+..  ...+.+.       ......+.++|.+||+ +|.+|   +|+.
T Consensus       235 Gvil~elltG~~Pf~~~~~~---~~~~~i~-~~~~--~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSH---ETYRKII-NWRE--TLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHH---HHHHHHH-ccCC--ccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999999998643321   1111111 1111  0111110       0112346678999997 66665   6999


Q ss_pred             HHHHHhccC
Q 018304          307 SVILMLGSE  315 (358)
Q Consensus       307 ell~~l~~~  315 (358)
                      +++.+.+..
T Consensus       301 ~~l~hp~~~  309 (377)
T cd05629         301 EIKSHPFFR  309 (377)
T ss_pred             HHhcCCCcC
Confidence            999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=308.40  Aligned_cols=257  Identities=21%  Similarity=0.289  Sum_probs=201.1

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||+|.+.. ++.|++|++...   .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            479999999999999999999754 889999999652   2234456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++....   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999985533   3899999999999999999999999   999999999999999999999999998754221


Q ss_pred             CCCC------------------------------------ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh
Q 018304          195 ETEG------------------------------------NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS  238 (358)
Q Consensus       195 ~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~  238 (358)
                      ....                                    ......|++.|+|||++.+..++.++|||||||++|+|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0012358899999999998899999999999999999999


Q ss_pred             CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC---hHHHHHHhccC
Q 018304          239 GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS---MPSVILMLGSE  315 (358)
Q Consensus       239 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~ell~~l~~~  315 (358)
                      |..||......   ....... .+..  ...+...       ......+.++|.+|+. +|.+|++   +.+++.+.+..
T Consensus       235 G~~Pf~~~~~~---~~~~~i~-~~~~--~~~~~~~-------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~  300 (364)
T cd05599         235 GYPPFCSDNPQ---ETYRKII-NWKE--TLQFPDE-------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK  300 (364)
T ss_pred             CCCCCCCCCHH---HHHHHHH-cCCC--ccCCCCC-------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence            99998643321   1111111 0110  0011110       0112356678889996 9999998   99999876643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=307.50  Aligned_cols=257  Identities=22%  Similarity=0.329  Sum_probs=204.7

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|++|.||+|.+. +++.|++|++...   .......+..|++++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            57999999999999999999975 4899999998652   1234566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++...   ..+++..++.++.||+.||.|||+.|   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998654   34899999999999999999999999   999999999999999999999999998765322


Q ss_pred             C---------------------------CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCC
Q 018304          195 E---------------------------TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYH  247 (358)
Q Consensus       195 ~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~  247 (358)
                      .                           .........|++.|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0012223468899999999999999999999999999999999999986543


Q ss_pred             CCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-hHHHHHHhccC
Q 018304          248 SDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-MPSVILMLGSE  315 (358)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~ell~~l~~~  315 (358)
                      ..   ........ +.....  +...   ..    ....+.++|.+||. +|.+||+ +.+++++.+..
T Consensus       235 ~~---~~~~~i~~-~~~~~~--~p~~---~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~  289 (350)
T cd05573         235 LQ---ETYNKIIN-WKESLR--FPPD---PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK  289 (350)
T ss_pred             HH---HHHHHHhc-cCCccc--CCCC---CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence            21   11111111 101100  0000   00    22456679999997 9999999 99999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-40  Score=310.51  Aligned_cols=257  Identities=21%  Similarity=0.278  Sum_probs=198.5

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||++.+.. ++.|++|.+.+..   ......+.+|+++++.++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            479999999999999999999754 8899999986522   223456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999985533   3889999999999999999999999   999999999999999999999999997532100


Q ss_pred             C-----------------------------------------CCCccccccccCCCCCcccccCCCCCCcccchhHhHHH
Q 018304          195 E-----------------------------------------TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILL  233 (358)
Q Consensus       195 ~-----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il  233 (358)
                      .                                         .........|++.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00001123688999999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC---ChHHHHH
Q 018304          234 LEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP---SMPSVIL  310 (358)
Q Consensus       234 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp---t~~ell~  310 (358)
                      |+|++|..||.......   ..... ..+....  .+..   ..    .....+.++|.+|+ .+|.+|+   |+.+++.
T Consensus       235 yell~G~~Pf~~~~~~~---~~~~i-~~~~~~~--~~~~---~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         235 YEMLVGQPPFLADTPAE---TQLKV-INWETTL--HIPS---QA----KLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eehhhCCCCCCCCCHHH---HHHHH-hccCccc--cCCC---CC----CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999986543221   11111 1111100  0000   00    11224556777766 5999999   9999999


Q ss_pred             HhccC
Q 018304          311 MLGSE  315 (358)
Q Consensus       311 ~l~~~  315 (358)
                      +.+..
T Consensus       301 h~~~~  305 (376)
T cd05598         301 HPFFK  305 (376)
T ss_pred             CCCcC
Confidence            87654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-39  Score=292.79  Aligned_cols=257  Identities=30%  Similarity=0.486  Sum_probs=203.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-C-----CEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-G-----QEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~-----~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ++|++.+.||+|++|.||+|.+.. +     ..|++|.+.... ......+.+|+..+..++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478999999999999999998643 2     578999886432 334566889999999999999999999999988999


Q ss_pred             EEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC
Q 018304          112 LIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM  178 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~  178 (358)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999865321             134888999999999999999999999   99999999999999999


Q ss_pred             CeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHH
Q 018304          179 NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGH  257 (358)
Q Consensus       179 ~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~  257 (358)
                      .++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......   ...  
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~--  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI--  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence            999999999876532222222223345778999999988889999999999999999998 98887543321   111  


Q ss_pred             HHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                        ..+.........         ......+.+|+.+||+.+|.+|||+.+|+++|+.
T Consensus       237 --~~i~~~~~~~~~---------~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 --EMIRSRQLLPCP---------EDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHcCCcCCCc---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              112122211111         1122467789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.6e-40  Score=294.74  Aligned_cols=257  Identities=27%  Similarity=0.466  Sum_probs=203.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      ..+|.+.+.||+|++|.||+|.+.+      +..|++|.+...... ....+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3678999999999999999998633      478999998764443 457788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccc-----------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC
Q 018304          111 LLIYEFMTNKSLDSFIFDQE-----------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~  179 (358)
                      +++|||+++++|.+++....           ....+++..+..++.+++.|+.+||+++   ++|+||+|+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999996532           1234788899999999999999999999   999999999999999999


Q ss_pred             eEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHH
Q 018304          180 PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHA  258 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~  258 (358)
                      ++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH
Confidence            99999999876432221111222335678999999999999999999999999999998 99997543322   111111


Q ss_pred             HHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          259 WKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .    .........         .....+.+++.+||..+|++|||+.++++.|+
T Consensus       238 ~----~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 T----QGRLLQRPR---------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             H----cCCcCCCCC---------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1    111111111         11235678999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.2e-40  Score=307.04  Aligned_cols=259  Identities=30%  Similarity=0.416  Sum_probs=200.8

Q ss_pred             cCCCCcceeecccCCccEEEEEE------cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTL------VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  109 (358)
                      .++|++.+.||+|+||.||+|.+      ..+..|++|+++... ......+.+|+.++..+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            46899999999999999999963      225689999986432 33446678899999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcccc----------------------------------------------------------
Q 018304          110 KLLIYEFMTNKSLDSFIFDQER----------------------------------------------------------  131 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  131 (358)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999854321                                                          


Q ss_pred             --------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          132 --------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       132 --------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                                    ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          123778889999999999999999999   999999999999999999999999998765322211


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  .....    ...........    
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~~~~~~----  340 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYRMLSPE----  340 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCccCCCCC----
Confidence            11112234567999999998999999999999999999998 888875433221  11111    11111110000    


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                        .   ...++.+++.+||+.||++|||+.+|++.|+.
T Consensus       341 --~---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 --C---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             --C---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence              0   12357789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.4e-40  Score=314.60  Aligned_cols=255  Identities=17%  Similarity=0.222  Sum_probs=204.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC--CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ...|.+.+.||+|++|.||+|....  +..|++|.+..........+..|+.++..++||||+++++++..++..++|||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            3459999999999999999998643  57888887766555556677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |+++++|.+++... ....++++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..+...
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999999988543 23345889999999999999999999999   999999999999999999999999999876433


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ..........|++.|+|||++.+..++.++|||||||++|+|++|..||.....   ........   . .......   
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~~---~-~~~~~~~---  292 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQVL---Y-GKYDPFP---  292 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---h-CCCCCCC---
Confidence            222233445689999999999988999999999999999999999999854322   11111111   1 1111110   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                        .    .....+.++|.+||..+|++|||+.+++.+
T Consensus       293 --~----~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        293 --C----PVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             --c----cCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence              0    112357789999999999999999999754

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.8e-41  Score=307.78  Aligned_cols=249  Identities=23%  Similarity=0.292  Sum_probs=201.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC--CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD--GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~--~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|++.+.||+|+||.||+|.+.+  +..|++|.+...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            679999999999999999998644  368999988642   233455677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+.+++|.+++....   .+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus       110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999986543   3899999999999999999999999   99999999999999999999999999876522


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                           ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.....   ........    .... .+.  
T Consensus       184 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~i~----~~~~-~~p--  248 (340)
T PTZ00426        184 -----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKIL----EGII-YFP--  248 (340)
T ss_pred             -----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHHHHh----cCCC-CCC--
Confidence                 12345688999999999988899999999999999999999999864322   11111111    1110 010  


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                         ...    ...+.++|.+||+.+|++|+     |+.+++++.+..
T Consensus       249 ---~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~  288 (340)
T PTZ00426        249 ---KFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG  288 (340)
T ss_pred             ---CCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence               111    13456899999999999995     899999987654

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-40  Score=306.44  Aligned_cols=273  Identities=21%  Similarity=0.326  Sum_probs=198.6

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----eeE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL  111 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~~~  111 (358)
                      +|++.+.||+|++|.||+|.+. +++.|++|.+...  .......+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            6899999999999999999975 4899999988642  2233456788999999999999999999886432     479


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||+. ++|.+++....   .+++..+..++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 58888885433   3899999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCC-CCccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH--------HH
Q 018304          192 GGDET-EGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA--------WK  260 (358)
Q Consensus       192 ~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~  260 (358)
                      ..... ........++..|+|||++.+  ..++.++|||||||++|+|++|+.||...........+...        ..
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            22111 111223468899999998865  57899999999999999999999998654321111100000        00


Q ss_pred             HhhcCCCCccccCCcC-CCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          261 LWNEGMPSQLIDPCIQ-GSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                      .+.............. ....     ......+.+++.+||+.+|++|||+.+++++-+......
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            0000000000000000 0000     001234678999999999999999999999876654333

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.8e-39  Score=296.23  Aligned_cols=253  Identities=21%  Similarity=0.315  Sum_probs=196.9

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||++.+.. ++.|++|++++.   .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            479999999999998754 889999999752   233445677899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++...   +.+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~  152 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDT  152 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc--CCCc
Confidence            9999888543   33999999999999999999999999   99999999999999999999999999864211  1122


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC--chhHHHHHHHhhcCCCCccccCCcCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN--LNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||........  ............... ..+.     .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p-----~  226 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IRIP-----R  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-CCCC-----C
Confidence            2345689999999999998999999999999999999999999864332211  011111111111111 1111     1


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCC------hHHHHHHhccC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPS------MPSVILMLGSE  315 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt------~~ell~~l~~~  315 (358)
                      ..    ...+.+++.+||+.||.+|||      +.+++++-+..
T Consensus       227 ~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         227 SL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             CC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            11    234668999999999999997      78888876654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=293.97  Aligned_cols=257  Identities=25%  Similarity=0.321  Sum_probs=202.5

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .|++.+.||+|+||.||++.+. +++.|++|.+....   ......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4889999999999999999875 48899999986422   1223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999999988854332 34899999999999999999999999   9999999999999999999999999987653211


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                         ......++..|+|||.+.+..++.++||||+|+++|+|++|..||...........   ........ ...      
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~---~~~~~~~~-~~~------  223 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE---VERRVKED-QEE------  223 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH---HHHHhhhc-ccc------
Confidence               11234678899999999888899999999999999999999999865332211111   11111110 111      


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccCC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSET  316 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~~  316 (358)
                         +.......+.+++.+||..||++||     ++.+++++.+...
T Consensus       224 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         224 ---YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             ---cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence               1111233567899999999999999     8999988866553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.4e-40  Score=306.74  Aligned_cols=262  Identities=31%  Similarity=0.437  Sum_probs=202.5

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG  107 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~  107 (358)
                      ...++|++.+.||+|+||.||+|.+..      +..|++|.+... .......+.+|+++++.+ +|+||+++++.+...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            445689999999999999999987422      357999999753 233456788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcccc--------------------------------------------------------
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQER--------------------------------------------------------  131 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  131 (358)
                      ...++||||+.+|+|.+++.....                                                        
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            999999999999999999854211                                                        


Q ss_pred             -----------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcc
Q 018304          132 -----------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT  200 (358)
Q Consensus       132 -----------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~  200 (358)
                                 ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++............
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                       123788889999999999999999999   999999999999999999999999998765322211111


Q ss_pred             ccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       201 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ......    ..........     . 
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~----~~~~~~~~~~-----~-  339 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMV----KRGYQMSRPD-----F-  339 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHH----HcccCccCCC-----C-
Confidence            12234567999999988899999999999999999997 999976533221  111111    1111111100     0 


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         ...++.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       340 ---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         340 ---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               123567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-39  Score=293.23  Aligned_cols=261  Identities=28%  Similarity=0.470  Sum_probs=206.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      ..++|.+.+.||+|++|.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++...+..
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3578999999999999999999742      2456899998776666677889999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccc----------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCe
Q 018304          111 LLIYEFMTNKSLDSFIFDQE----------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP  180 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i  180 (358)
                      +++|||+++++|.+++....          ....+++..++.++.|++.||.|||+++   ++||||+|+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence            99999999999999986432          1124899999999999999999999999   9999999999999999999


Q ss_pred             EEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHH
Q 018304          181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      +|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ...... 
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~i-  235 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECI-  235 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-
Confidence            9999999875532221111222334678999999998889999999999999999998 88887543321   111111 


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                         .........     ...    ...+.+++.+||+.+|.+|||+.+++..|+.+.
T Consensus       236 ---~~~~~~~~~-----~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         236 ---TQGRVLQRP-----RTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             ---HcCCcCCCC-----CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence               111111111     111    235778999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.2e-39  Score=289.19  Aligned_cols=256  Identities=25%  Similarity=0.349  Sum_probs=202.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++++.||+|++|.||+|.+. +++.|++|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            47899999999999999999874 5889999988653 334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|..+.       .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999986542       2788899999999999999999999   999999999999999999999999998765321  


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.............................    
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  222 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV----  222 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC----
Confidence              22234678899999999988899999999999999999999999865433222111111111111111111111    


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ..    ...++.+++.+||+.+|++||++.+++++.+...
T Consensus       223 ~~----~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~  258 (279)
T cd06619         223 GQ----FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ  258 (279)
T ss_pred             Cc----CCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence            11    1235678999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-40  Score=285.27  Aligned_cols=269  Identities=21%  Similarity=0.245  Sum_probs=207.2

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQ--GLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv  113 (358)
                      ++|+.+..|++|.||.||+|+++. +.-||+|+++-..+.  -.=...+|+++|.+++||||+.+..+..-.  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            568999999999999999999755 889999999653221  122346899999999999999999887643  478999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||||+. +|..++.+..  +++....+.-++.|++.|+.|||.+.   |+|||+|++|++++..|.+|++|||+|+.++.
T Consensus       156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999987 9999997766  44999999999999999999999999   99999999999999999999999999998753


Q ss_pred             CCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .  ....+....|..|.|||++.+. .|+.+.|+||+|||+.+|+++++.|......+..+.+......-.+.+.+.+..
T Consensus       230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            3  2234456789999999988875 789999999999999999999998876555444444433322211222221111


Q ss_pred             CC-----cCCCCCHH----------HHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 PC-----IQGSFNLA----------EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ~~-----~~~~~~~~----------~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..     ........          ....-++|+..+|.+||.+|.|+.+.|++=+..
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~  365 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR  365 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence            11     00011110          112346788899999999999999999986655

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.6e-40  Score=299.63  Aligned_cols=244  Identities=25%  Similarity=0.325  Sum_probs=189.8

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||+|.+.+ ++.|++|.+....   .........|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999754 7889999986521   22334455666666654 899999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            99999885433   3899999999999999999999999   9999999999999999999999999987542211  22


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..   .......    ... ..+     ..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~i~----~~~-~~~-----~~--  217 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDSIL----NDR-PHF-----PR--  217 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----cCC-CCC-----CC--
Confidence            23456899999999999889999999999999999999999998653321   1111111    110 000     11  


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChH-HHHHHhc
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMP-SVILMLG  313 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~l~  313 (358)
                        .....+.+++.+||+.+|++||++. +++++.+
T Consensus       218 --~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~  250 (316)
T cd05592         218 --WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF  250 (316)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCChHHHHcCcc
Confidence              1123466799999999999999875 6666543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-39  Score=288.99  Aligned_cols=256  Identities=30%  Similarity=0.447  Sum_probs=204.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..++|+++++||+|++|.||+|...++..|++|.+.... .....+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            347899999999999999999998778899999886533 3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++..... ..+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999999865432 33888999999999999999999999   99999999999999999999999999987532211


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ........    .......    
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~----~~~~~~~----  226 (261)
T cd05072         159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQR----GYRMPRM----  226 (261)
T ss_pred             e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHc----CCCCCCC----
Confidence            1 1112234567999999988889999999999999999998 89887543221   11111111    1110000    


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                       .    .....+.+++.+||..+|++|||+.++++.|+.
T Consensus       227 -~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 -E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             0    112356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=287.53  Aligned_cols=257  Identities=30%  Similarity=0.431  Sum_probs=204.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..++|++.+.||+|++|.||+|.+.+++.|++|.+.... ...+.+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            346799999999999999999998778899999986533 3356788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++.... ...+++..+..++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999986544 234899999999999999999999999   99999999999999999999999999987642211


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      . ..........|+|||.+.+..++.++|+||||+++|+|++ |..||......   .......    ........    
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~~~~----  226 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQVD----QGYRMPCP----  226 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cCCCCCCC----
Confidence            1 1111122357999999988899999999999999999999 99887543211   1111111    11110000    


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                           ......+.+++.+||+.+|++||++.+|++.|+++
T Consensus       227 -----~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         227 -----PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -----CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                 11224677899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.6e-40  Score=296.39  Aligned_cols=264  Identities=22%  Similarity=0.316  Sum_probs=194.7

Q ss_pred             CCCCcceeecccCCccEEEEEEc--CCCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCccceeeEEEe-----
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ-----  106 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~--~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~-----  106 (358)
                      ++|++.+.||+|+||.||+|.+.  +++.|++|.+....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            48999999999999999999863  36789999886422  22233455677777665   69999999998852     


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      ....++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999996 589888865433 23889999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      ++......   .......+++.|+|||.+.+..++.++|||||||++|+|++|..||......   ..+...........
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~~  229 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPG  229 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCC
Confidence            98765322   2223445789999999998889999999999999999999999998654332   22222211111000


Q ss_pred             CCccc------cCCc--CCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          267 PSQLI------DPCI--QGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       267 ~~~~~------~~~~--~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .....      ....  ......     .....+.+++.+||+.+|++|||+.+++++-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~  289 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  289 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence            00000      0000  000001     11234568999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.1e-39  Score=303.74  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=196.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||++.+.. ++.|++|++.+..   ......+..|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            479999999999999999998754 8899999996522   233456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++...   +.+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999998653   34899999999999999999999999   999999999999999999999999998754211


Q ss_pred             CCC---------------------------------CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCC
Q 018304          195 ETE---------------------------------GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKK  241 (358)
Q Consensus       195 ~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  241 (358)
                      ...                                 .......|++.|+|||.+.+..++.++|||||||++|+|++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            000                                 00113468999999999998999999999999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcC--CCCCCCCChHHHHHHhccC
Q 018304          242 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQ--QHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       242 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~Rpt~~ell~~l~~~  315 (358)
                      ||......   .....+.. +...  ..+..     ..  .....+.++|.+|+.  .++..||++.+|+++-+..
T Consensus       235 Pf~~~~~~---~~~~~i~~-~~~~--~~~p~-----~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~  297 (363)
T cd05628         235 PFCSETPQ---ETYKKVMN-WKET--LIFPP-----EV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE  297 (363)
T ss_pred             CCCCCCHH---HHHHHHHc-CcCc--ccCCC-----cC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence            98643321   11111111 1010  00110     00  011234456666554  2344568999999986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-39  Score=299.02  Aligned_cols=246  Identities=24%  Similarity=0.302  Sum_probs=195.4

Q ss_pred             ceeecccCCccEEEEEEc----CCCEEEEEEeccc----ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           44 NKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++.||+|+||.||++...    .++.|++|++...    .......+..|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999852    4788999998652    12334556789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++....   .+.+..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  153 (323)
T cd05584          81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-  153 (323)
T ss_pred             CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence            999999999985433   3788899999999999999999999   999999999999999999999999998753211 


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                       ........|++.|+|||++.+..++.++||||||+++|+|++|..||......   .......   ...  ..+.    
T Consensus       154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~~---~~~--~~~~----  220 (323)
T cd05584         154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKIL---KGK--LNLP----  220 (323)
T ss_pred             -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHHH---cCC--CCCC----
Confidence             11223356889999999998888999999999999999999999998643321   1111111   111  0111    


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhcc
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGS  314 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~  314 (358)
                       ..    ....+.++|.+||+.+|++||     ++.+++++.+.
T Consensus       221 -~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~  259 (323)
T cd05584         221 -PY----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF  259 (323)
T ss_pred             -CC----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence             01    123567899999999999999     89999987654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.2e-40  Score=300.11  Aligned_cols=249  Identities=24%  Similarity=0.293  Sum_probs=197.0

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCC-CCccceeeEEEeCCeeEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv~  114 (358)
                      +|++++.||+|+||.||+|.+.+ ++.|++|++.+.   .......+..|..++..+.| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999765 789999998652   23345667788999999976 46888999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||++..... 
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC-
Confidence            9999999999885433   3889999999999999999999999   99999999999999999999999999864311 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                       .........|++.|+|||.+.+..++.++||||+||++|+|++|..||......   .......    ... ..+.   
T Consensus       154 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~----~~~-~~~~---  221 (324)
T cd05587         154 -GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIM----EHN-VSYP---  221 (324)
T ss_pred             -CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH----cCC-CCCC---
Confidence             112233456899999999999989999999999999999999999998643321   1111111    110 1111   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh-----HHHHHHhc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM-----PSVILMLG  313 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~l~  313 (358)
                        ..    ....+.+++.+||..+|.+|++.     .+++++.+
T Consensus       222 --~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~  259 (324)
T cd05587         222 --KS----LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAF  259 (324)
T ss_pred             --CC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCC
Confidence              11    12356689999999999999986     67777644

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.7e-39  Score=286.66  Aligned_cols=252  Identities=26%  Similarity=0.411  Sum_probs=200.1

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      ++|++.+.||+|+||.||++.++++..+++|.+.... .....+.+|+++++.++||||+++++++...+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            5689999999999999999998778899999886432 334677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++....  ..+++..++.++.+++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            999999986533  23889999999999999999999999   999999999999999999999999988754322111 


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....   ..........    ....  .+.   
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~----~~~~--~~~---  224 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRG----FRLY--RPK---  224 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCC----CCCC--CCC---
Confidence            1112234567999999988889999999999999999999 8888754322   1222222111    1100  000   


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                          .....+.+++.+||+.+|++|||+.++++.|.
T Consensus       225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                01235678999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.7e-39  Score=288.31  Aligned_cols=260  Identities=23%  Similarity=0.379  Sum_probs=205.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|++|.||+|.+. +++.|++|.+..   ........+.+|+++++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            58999999999999999999975 589999998754   23344456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          115 EFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||+++++|.+++.... ....+++..++.++.+++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999885432 2344889999999999999999999999   99999999999999999999999999876532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .......    ......+...  
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~----~~~~~~~~~~--  229 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQK----IEQCDYPPLP--  229 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHH----HhcCCCCCCC--
Confidence            21  1112335778899999998888899999999999999999999997432211 1111111    1111111111  


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                            .......+.+++.+||..+|++|||+.++++.++++.
T Consensus       230 ------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         230 ------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                  1112245778999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-39  Score=312.74  Aligned_cols=262  Identities=24%  Similarity=0.309  Sum_probs=207.0

Q ss_pred             HHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 018304           32 ATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE  108 (358)
Q Consensus        32 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  108 (358)
                      .+.....++|++.+.||+|+||.||++.+. +++.|++|.+...  .......+.+|+..+..++|+||+++...+...+
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            455566789999999999999999999864 5899999998642  3455667788999999999999999988775432


Q ss_pred             --------eeEEEEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC
Q 018304          109 --------EKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       109 --------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~  179 (358)
                              ..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence                    367999999999999998653 23345899999999999999999999999   999999999999999999


Q ss_pred             eEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH
Q 018304          180 PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      ++|+|||++..+.............|++.|+|||.+.+..++.++||||||+++|+|++|..||......   .......
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~~~~  258 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHKTL  258 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHh
Confidence            9999999987654332233334567899999999999999999999999999999999999998643211   1111111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                          ......+.     .    .....+.+++.+||+.+|.+|||+.+++.+.
T Consensus       259 ----~~~~~~~~-----~----~~~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        259 ----AGRYDPLP-----P----SISPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             ----cCCCCCCC-----C----CCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence                11111111     1    1123567899999999999999999998763

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=308.40  Aligned_cols=245  Identities=25%  Similarity=0.389  Sum_probs=202.5

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  109 (358)
                      ...-++|.++++||+|.||+|+++..++ ++.||||.+++   ..+++....+.|..++... +||.+++++..|.+.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            3344899999999999999999999765 88999999987   3456778888999999888 59999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      +|+||||+.||++..++    ..+.+++..++.++..++.||.|||++|   |+|||||.+|||+|.+|.+||+|||+++
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999954443    2233999999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ....  ......+.+||+.|+|||++.+..|+.+.|.|+|||++|+|+.|..||...+.++-.+.+   ..       .+
T Consensus       517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI---~~-------d~  584 (694)
T KOG0694|consen  517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI---VN-------DE  584 (694)
T ss_pred             ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---hc-------CC
Confidence            6432  233556789999999999999999999999999999999999999998765544322221   10       00


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM  305 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  305 (358)
                             ..|+.-...+..+++.++|..+|++|.-.
T Consensus       585 -------~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 -------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                   11122223456679999999999999765

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=300.60  Aligned_cols=244  Identities=22%  Similarity=0.273  Sum_probs=193.6

Q ss_pred             ecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           47 LGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        47 lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      ||+|+||.||++.+.. ++.|++|.+...   .......+..|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            6999999999999764 789999998642   234456677899999999999999999999999999999999999999


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcccc
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR  202 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~  202 (358)
                      .+++....   .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......  ......
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~  152 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNT  152 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCcccc
Confidence            99986533   3899999999999999999999999   999999999999999999999999998753211  122234


Q ss_pred             ccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHH
Q 018304          203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA  282 (358)
Q Consensus       203 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      ..|++.|+|||.+.+..++.++||||+||++|+|++|..||......   ....   .....  ...+..         .
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~---~~~~~--~~~~~~---------~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYR---KILQE--PLRFPD---------G  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHH---HHHcC--CCCCCC---------c
Confidence            56899999999999989999999999999999999999998643211   1111   11111  111111         1


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCC---hHHHHHHhccC
Q 018304          283 EVIRCIHIGLLCVQQHPKDRPS---MPSVILMLGSE  315 (358)
Q Consensus       283 ~~~~l~~li~~cl~~~P~~Rpt---~~ell~~l~~~  315 (358)
                      ....+.+++.+||+.||.+||+   +.+++.+.+..
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~  251 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS  251 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence            1235668999999999999975   67777765543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.8e-39  Score=288.35  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=199.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEc----CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|++.+.||+|+||.||+|.++    .+..|++|.+.... ......+.+|+..++.++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            467999999999999999999753    35689999987642 3344567899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+.+++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999986543  24899999999999999999999999   9999999999999999999999999865432


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      .... .......++..|+|||.+.+..++.++|||||||++|++++ |..||......   .......    ........
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~  230 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVE----DGFRLPAP  230 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHH----CCCCCCCC
Confidence            1111 11112234567999999988899999999999999999775 99997543321   1111111    11111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                           .    .....+.+++.+||+.+|.+|||+.+|++.|..
T Consensus       231 -----~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         231 -----R----NCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -----C----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence                 1    112356779999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.3e-40  Score=290.92  Aligned_cols=254  Identities=29%  Similarity=0.460  Sum_probs=201.6

Q ss_pred             CCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHH--HHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLK--ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~--~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      |++++.||+|++|+||++.+.. ++.|++|.+.........  ....|+..++.++|+||+++++++.+....+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            7889999999999999999866 668999999875544333  2345999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      .+++|.+++..   ...+++..++.++.||++||.+||+.+   ++|+||+|+||+++.++.++|+|||.+...  ....
T Consensus        81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN  152 (260)
T ss_dssp             TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred             ccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence            99999999962   233899999999999999999999999   999999999999999999999999998764  1222


Q ss_pred             CccccccccCCCCCccccc-CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH-HhhcCCCCccccCCc
Q 018304          198 GNTKRVIGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK-LWNEGMPSQLIDPCI  275 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  275 (358)
                      .......++..|.|||.+. +..++.++||||+|+++|+|++|..||................. ..........     
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  227 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR-----  227 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc-----
Confidence            3333456788999999988 78899999999999999999999999775521222222211111 0000000000     


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                            .....+.+++.+||+.+|++|||+.+++++-+
T Consensus       228 ------~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  228 ------EKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             ------TSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             ------hhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence                  00156788999999999999999999998754

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.6e-39  Score=291.43  Aligned_cols=259  Identities=27%  Similarity=0.451  Sum_probs=206.2

Q ss_pred             CCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .+|.+.+.||+|++|.||+|.+.      ++..+++|.+..........+.+|++.++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            56899999999999999999742      245688998877666666778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC
Q 018304          113 IYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~  179 (358)
                      ||||+.+++|.+++.....             ...+++..++.++.||+.|+.|||+++   ++|+||+|+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999965321             234789999999999999999999999   999999999999999999


Q ss_pred             eEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHH
Q 018304          180 PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHA  258 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~  258 (358)
                      ++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ....  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~--  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE--  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence            99999999875432221112223345678999999998899999999999999999998 99987543322   1111  


Q ss_pred             HHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          259 WKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                        ............         .....+.+++.+||+.+|++|||+.+|++.|..+.
T Consensus       237 --~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         237 --CITQGRVLERPR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             --HHhCCCCCCCCc---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence              111211111111         11235778999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-38  Score=282.59  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=203.4

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|.+.+.||+|++|.||++.++ +++.|++|.+..  ........+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            5889999999999999999975 488999998864  2345567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++..... ..+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-  155 (256)
T cd08529          81 AENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-  155 (256)
T ss_pred             CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence            999999999876432 34899999999999999999999999   9999999999999999999999999988653221 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       .......++..|+|||.+.+..++.++|+||||+++++|++|..||.....   .......    .......+..    
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~~~~~~~----  223 (256)
T cd08529         156 -NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKI----IRGVFPPVSQ----  223 (256)
T ss_pred             -chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HcCCCCCCcc----
Confidence             122334577889999999988899999999999999999999999864431   1111111    1111111111    


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                           .....+.+++.+||+.+|++||++.+++++-
T Consensus       224 -----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~  254 (256)
T cd08529         224 -----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP  254 (256)
T ss_pred             -----ccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence                 1224577899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.9e-40  Score=292.08  Aligned_cols=251  Identities=35%  Similarity=0.560  Sum_probs=192.0

Q ss_pred             CcceeecccCCccEEEEEEc-----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           42 SINKKLGQGGFGPVYKGTLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        42 ~i~~~lg~g~~g~v~~~~~~-----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .+.+.||.|.||.||+|.+.     .+..|+||.++.. .......+.+|++.++.++||||+++++++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35689999999999999976     2568999999653 34457889999999999999999999999998888999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++..... ..+++..++.++.||+.||.|||+++   ++|++|++.||+++.++.+||+|||++.......
T Consensus        82 ~~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             --TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999999976522 33899999999999999999999999   9999999999999999999999999998763222


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .............|+|||.+.+..++.++||||||+++|+|++ |..||....   .........    .......... 
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~----~~~~~~~~~~-  229 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLK----QGQRLPIPDN-  229 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHH----TTEETTSBTT-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc----ccccceeccc-
Confidence            2222233446678999999988889999999999999999999 678864432   122222221    1111111111 


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                              ....+.++|.+||..+|++|||+.+|++.|
T Consensus       230 --------~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  230 --------CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --------SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --------hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                    123566899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6e-39  Score=285.62  Aligned_cols=256  Identities=28%  Similarity=0.441  Sum_probs=202.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..+|.+.+.||+|++|.||+|.+.+ ++.+++|.+... ......+.+|++.++.++|+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            3568899999999999999999754 889999988753 33456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++..... ..+++..++.++.|+++||.+||+.+   ++|+||+|+||++++++.++|+|||.+........
T Consensus        84 ~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            999999999865432 33889999999999999999999999   99999999999999999999999999876532211


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      . .......+..|+|||.+.+..++.++||||||+++|+|++ |..||......   .....    ...........   
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~~~~~---  228 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKGYRMERPE---  228 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCCCCCCC---
Confidence            1 1111223567999999988899999999999999999998 88887543221   11111    11111111111   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            .....+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       229 ------~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         229 ------GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ------CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                  1123577899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=286.80  Aligned_cols=280  Identities=24%  Similarity=0.317  Sum_probs=212.8

Q ss_pred             HHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEe--
Q 018304           32 ATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--  106 (358)
Q Consensus        32 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--  106 (358)
                      .+......+|..++.||.|+||.|+.+.++. |..||+|.+..  ...-..+...+|+.+|+.++|+||+.+.+++..  
T Consensus        15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            3455566778888999999999999999754 89999999873  555667888899999999999999999999865  


Q ss_pred             ---CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEe
Q 018304          107 ---GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS  183 (358)
Q Consensus       107 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~  183 (358)
                         -+..|+|+|+++ .+|...+...   +.+++..+..+++|++.||.|+|+.+   ++|||+||.|++++.+-.+|++
T Consensus        95 ~~~f~DvYiV~elMe-tDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   95 RDKFNDVYLVFELME-TDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             ccccceeEEehhHHh-hHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEec
Confidence               346799999994 5999988443   34999999999999999999999999   9999999999999999999999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      |||+++.+.........+....|-.|.|||++.. ..|+.+.||||+|||+.||++|++.|.+.+.-.....+......-
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            9999998743322223345667889999997754 589999999999999999999999988766554444332221110


Q ss_pred             hcCC--------CCccccCCcC-CCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          263 NEGM--------PSQLIDPCIQ-GSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       263 ~~~~--------~~~~~~~~~~-~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      .+..        ...++..... ...+.     ......++|+.+||.+||.+|+|+++.|++.-.....
T Consensus       248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            0000        0000000000 00000     1112457899999999999999999999986555443

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-39  Score=298.97  Aligned_cols=244  Identities=23%  Similarity=0.265  Sum_probs=189.2

Q ss_pred             eeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHH-HHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||+|.+. +|+.|++|++....   ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999975 48999999986521   222234444444 56778999999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+++..++.++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~  152 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKT  152 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCc
Confidence            99999885533   4889999999999999999999999   99999999999999999999999999865321  1122


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..   .......    ... ..+.     .. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~----~~~-~~~~-----~~-  218 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNIL----NKP-LRLK-----PN-  218 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHHHHHH----cCC-CCCC-----CC-
Confidence            23456889999999999889999999999999999999999998643221   1111111    110 1111     01 


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCh----HHHHHHhc
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSM----PSVILMLG  313 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~----~ell~~l~  313 (358)
                         ....+.++|.+||+.+|.+||++    .+++++.+
T Consensus       219 ---~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~  253 (323)
T cd05575         219 ---ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF  253 (323)
T ss_pred             ---CCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence               12356789999999999999998    47776544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=283.56  Aligned_cols=254  Identities=28%  Similarity=0.396  Sum_probs=201.1

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ++|++.+.||+|++|.||++.+. +++.+++|.+....     ......+.+|+++++.++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999875 48999999886422     1234567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ++||+++++|.+++....   .+++..+..++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999985533   3889999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCCCC-ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEG-NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ...... ......++..|+|||.+.+..++.++||||+|+++|+|++|..||.....   ...   ............+.
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~---~~~~~~~~~~~~~~  229 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAA---IFKIATQPTNPQLP  229 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHH---HHHHhccCCCCCCC
Confidence            211111 11234567889999999988899999999999999999999999754221   111   11111111111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                               ......+.+++.+||..+|++|||+.+++.+.+
T Consensus       230 ---------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         230 ---------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             ---------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence                     112235668999999999999999999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-39  Score=292.25  Aligned_cols=265  Identities=23%  Similarity=0.388  Sum_probs=199.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC---------------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCcccee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD---------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLL  101 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~---------------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~  101 (358)
                      .++|++.+.||+|+||.||++.+.+               ...|++|.+... .......+.+|+++++.++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3689999999999999999987532               225889988653 334456788999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhcccc---------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcE
Q 018304          102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQER---------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV  172 (358)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Ni  172 (358)
                      +++...+..++||||+.+++|.+++.....         ...+++..++.++.+++.||.|||+.+   ++|+||+|+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            999999999999999999999999854321         123678899999999999999999999   99999999999


Q ss_pred             EEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh--CCCCCCCCCCCC
Q 018304          173 LLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS--GKKNRGFYHSDN  250 (358)
Q Consensus       173 lv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~p~~~~~~~~  250 (358)
                      +++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++  +..||.....  
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence            999999999999999876432221111122234568999999988889999999999999999998  4556543222  


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                       ...+......+..........  ...    .....+.+++.+||..+|++|||+.+|++.|.+
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 -EQVIENTGEFFRNQGRQIYLS--QTP----LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             -HHHHHHHHHhhhhccccccCC--CCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             122222222111111100000  000    112367789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-39  Score=306.16  Aligned_cols=256  Identities=21%  Similarity=0.282  Sum_probs=196.3

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .+|++++.||+|+||.||+|.+.. ++.|++|.+.+..   ......+.+|+.+++.++|+||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            368999999999999999999754 8899999986532   234566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++|+|.+++.+.   +.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          81 DYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999998553   34889999999999999999999999   999999999999999999999999997532100


Q ss_pred             CC---------------------------------------------CCccccccccCCCCCcccccCCCCCCcccchhH
Q 018304          195 ET---------------------------------------------EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSF  229 (358)
Q Consensus       195 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  229 (358)
                      ..                                             ........|++.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            00                                             000112358899999999998899999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC---hH
Q 018304          230 GILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS---MP  306 (358)
Q Consensus       230 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~  306 (358)
                      ||++|+|++|..||......   ....... .+  ........   ...    ......++|.+|+ .+|.+|++   +.
T Consensus       235 Gvil~elltG~~Pf~~~~~~---~~~~~i~-~~--~~~~~~p~---~~~----~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPL---ETQMKVI-NW--QTSLHIPP---QAK----LSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHH---HHHHHHH-cc--CCCcCCCC---ccc----CCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            99999999999998653321   1111111 01  00000000   001    1224456777765 59999997   88


Q ss_pred             HHHHHhcc
Q 018304          307 SVILMLGS  314 (358)
Q Consensus       307 ell~~l~~  314 (358)
                      +++++-+.
T Consensus       301 ei~~hp~f  308 (382)
T cd05625         301 EIKAHPFF  308 (382)
T ss_pred             HHhcCCCc
Confidence            88887554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-39  Score=304.57  Aligned_cols=257  Identities=18%  Similarity=0.210  Sum_probs=201.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .++|++.+.||+|+||.||++.+.. ++.|++|.+.+.   .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            4689999999999999999999754 889999998642   223345577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++...    .+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999988543    2888999999999999999999999   99999999999999999999999999876532


Q ss_pred             CCCCCccccccccCCCCCcccccCC----CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ... .......|++.|+|||.+.+.    .++.++|||||||++|+|++|..||......   .......   .......
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~---~~~~~~~  267 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIM---DHKNSLT  267 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHHHH---cCCCcCC
Confidence            211 122345689999999988653    4788999999999999999999998643321   1111111   1111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCC--CCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKD--RPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~l~~~  315 (358)
                      +..       .......+.++|.+||+.+|.+  |+|+.+++.+.+..
T Consensus       268 ~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~  308 (370)
T cd05596         268 FPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK  308 (370)
T ss_pred             CCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence            111       0011245668999999999988  99999999886543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.8e-40  Score=297.63  Aligned_cols=271  Identities=22%  Similarity=0.314  Sum_probs=201.7

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|.+.+.||+|+||.||+|.++ +++.|++|.+.... ......+.+|+++++.++|+||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            68999999999999999999875 47889999886432 22234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+ +|.+++....  ..++...+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++....... 
T Consensus        86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  158 (309)
T cd07872          86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-  158 (309)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence            975 8888775433  23788999999999999999999999   9999999999999999999999999987542211 


Q ss_pred             CCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH-----HhhcCCCC-c
Q 018304          197 EGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK-----LWNEGMPS-Q  269 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~-~  269 (358)
                       .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+.....     .|...... .
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence             11223356789999998765 4688999999999999999999999865543322222211110     00000000 0


Q ss_pred             cccCCcCC-------CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          270 LIDPCIQG-------SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       270 ~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ..+.....       .........+.++|.+||+.||.+|||+.+++++.+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            00000000       0000112356789999999999999999999998776543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-40  Score=295.67  Aligned_cols=261  Identities=23%  Similarity=0.317  Sum_probs=219.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +.+=|.+.+.||+|.|+.|-++++ ..|..|+||++.+..  ......+..|+..|+.++|||||++|.+......+|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            346789999999999999999975 579999999998743  44567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc-CCCCeEEeccccceecC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFG  192 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~-~~~~i~L~Df~~~~~~~  192 (358)
                      +|.-.+|+|.|||.++...  +++....+++.||+.|+.|+|+.+   ++|||+||+||.+. +-|-+||.|||++..+.
T Consensus        96 LELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            9999999999999887654  999999999999999999999999   99999999998775 66899999999998753


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                         ......+.+|...|.|||++.|..|+ ++.||||||+|||-|..|..||+..+..+.+..+               .
T Consensus       171 ---PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------m  232 (864)
T KOG4717|consen  171 ---PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------M  232 (864)
T ss_pred             ---CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------h
Confidence               33445577899999999999999996 5799999999999999999999876554443332               1


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK  322 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~  322 (358)
                      |.  ....+.....++.+||..||..||++|.|.++|...-|-....+.+-
T Consensus       233 DC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  233 DC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             cc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence            11  11223445668999999999999999999999999887665554443

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-39  Score=284.83  Aligned_cols=257  Identities=27%  Similarity=0.444  Sum_probs=202.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC----CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|++.+.||+|+||.||+|.+..    ...|++|.+.... ......+..|+..++.++|+||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3679999999999999999998743    3578999886533 3345567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      +|||+++++|.+++.....  .+++..++.++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||.+....
T Consensus        83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999865432  4899999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .........+....+    
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~----  230 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVEDGYRLPPP----  230 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCCCCCCC----
Confidence            2111111112234567999999988889999999999999999997 98887543211   111111111111100    


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                               ......+.+++.+||+.+|++||++.+|+++|..+
T Consensus       231 ---------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         231 ---------MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     01123567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.3e-39  Score=282.51  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=193.9

Q ss_pred             eeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           45 KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      +.||+|++|.||+|.+. +++.+++|.+... .......+.+|+++++.++|+||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999875 5889999987643 344456788999999999999999999999999999999999999999


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcccc
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR  202 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~  202 (358)
                      .+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|.||+++.++.++|+|||.+..............
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99985432  34889999999999999999999999   99999999999999999999999999875432211111111


Q ss_pred             ccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCH
Q 018304          203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNL  281 (358)
Q Consensus       203 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (358)
                      ...+..|+|||.+.+..++.++||||||+++|+|++ |..||......   ..    ..............         
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~----~~~~~~~~~~~~~~---------  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT----REAIEQGVRLPCPE---------  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH----HHHHHcCCCCCCcc---------
Confidence            123456999999988889999999999999999997 88887543221   11    11111111111111         


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          282 AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       282 ~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .....+.+++.+||+.+|++|||+.++++.|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            11235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-39  Score=289.99  Aligned_cols=256  Identities=23%  Similarity=0.382  Sum_probs=200.7

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .++|++.+.||+|++|.||+|.+. +++.|++|++..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            468999999999999999999974 4889999998765445556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++...   ..+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||++..+...  
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06646          88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT--  159 (267)
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc--
Confidence            9999999988543   34899999999999999999999999   999999999999999999999999998865321  


Q ss_pred             CCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          197 EGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ........++..|+|||.+.   ...++.++|+||+|+++|+|++|..||............      ......    ..
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~------~~~~~~----~~  229 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------SKSNFQ----PP  229 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee------ecCCCC----CC
Confidence            11122345778899999874   345788999999999999999999997433211110000      000000    00


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ....  .......+.+++.+||..+|++|||+.+++++++
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            0000  0111246778999999999999999999998763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-39  Score=297.54  Aligned_cols=245  Identities=22%  Similarity=0.305  Sum_probs=194.7

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||+|.+.. ++.|++|++.+.   .......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999755 789999998752   233445567788888876 799999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+++..++.++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~  152 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVT  152 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Ccc
Confidence            99998885443   3889999999999999999999999   999999999999999999999999998753211  112


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||......   .......   ....  ..     ... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~i~---~~~~--~~-----p~~-  218 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESIL---HDDV--LY-----PVW-  218 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHHHH---cCCC--CC-----CCC-
Confidence            23456889999999999889999999999999999999999998653321   1111111   1110  00     000 


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCC-------ChHHHHHHhcc
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRP-------SMPSVILMLGS  314 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rp-------t~~ell~~l~~  314 (358)
                         ....+.+++.+||+.+|++||       ++.+++++.+.
T Consensus       219 ---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         219 ---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             ---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence               123567899999999999999       88999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.6e-40  Score=302.63  Aligned_cols=246  Identities=22%  Similarity=0.271  Sum_probs=195.3

Q ss_pred             eeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           45 KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      +.||+|+||.||++.+. +++.|++|.+.+.   .......+..|+++++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 4889999998752   2234456678999999999999999999999999999999999999


Q ss_pred             CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      +|.+++....   .+++..++.++.||+.||.|||+ .+   ++||||||+||+++.++.++|+|||++......  ...
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~  152 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GAT  152 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccc
Confidence            9998885433   38999999999999999999997 78   999999999999999999999999998753211  112


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||......   .......   ...  ..+.     ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~---~~~--~~~p-----~~~  219 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELIL---MEE--IRFP-----RTL  219 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHh---cCC--CCCC-----CCC
Confidence            23446889999999999889999999999999999999999998543321   1111111   010  0111     111


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                          ...+.+++.+||+.||++|+     ++.+++++.+..
T Consensus       220 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  256 (325)
T cd05594         220 ----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA  256 (325)
T ss_pred             ----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence                23566899999999999996     999999886544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4e-39  Score=288.94  Aligned_cols=259  Identities=28%  Similarity=0.439  Sum_probs=200.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ..++|++.+.||+|++|.||+|.+.      .+..|++|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999998753      24679999886422 2344567889999999999999999999999899


Q ss_pred             eEEEEEecCCCCHHHHHhcccc-------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          110 KLLIYEFMTNKSLDSFIFDQER-------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                      .++||||+.+++|.+++.....       ...++...++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999865321       123577889999999999999999999   999999999999999999999


Q ss_pred             eccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHH
Q 018304          183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      +|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~---  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFV---  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence            99999875432222111112234678999999988889999999999999999998 68887543221   111111   


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                       ...........         ....+.+++.+||+.+|++|||+.++++.|+.
T Consensus       235 -~~~~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 -MEGGLLDKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -HcCCcCCCCCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             11111111111         12356789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-40  Score=274.11  Aligned_cols=254  Identities=24%  Similarity=0.323  Sum_probs=210.5

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      ...-++|++.+.||.|.||.||+|+.+. +--|++|++.+   .......++.+|+++-..|+||||+++|++|.+....
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            3445789999999999999999998644 67889999865   2234456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      |+++||...|.+...+..... +.+++...+.+..|+|.|+.|+|..+   ++||||||+|+|++..|.+|++|||.+..
T Consensus        98 yLilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             EEEEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence            999999999999999875433 33999999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .    ......+.+||..|.+||...+...+...|+|++|++.|+++.|..||+....++   ....+.+ .+-..+   
T Consensus       174 ~----p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~k-~~~~~p---  242 (281)
T KOG0580|consen  174 A----PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIRK-VDLKFP---  242 (281)
T ss_pred             c----CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHHH-ccccCC---
Confidence            3    3455667899999999999999999999999999999999999999987654222   2211111 111111   


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                                ........++|.+|+..+|.+|.+..+++.+.|
T Consensus       243 ----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  243 ----------STISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             ----------cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence                      111235668999999999999999999999865

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.7e-39  Score=295.38  Aligned_cols=244  Identities=23%  Similarity=0.297  Sum_probs=187.3

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHH-HHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~-~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||+|.+.. ++.|++|++.+..   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999754 8899999986522   12233344444 467788999999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|..++...   +.+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~  152 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEET  152 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCc
Confidence            9998887543   33889999999999999999999999   99999999999999999999999999864311  1122


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+..   ......   ...  ...+.        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~~~--~~~~~--------  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNI---LHK--PLQLP--------  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHH---hcC--CCCCC--------
Confidence            23456889999999999889999999999999999999999998543211   111111   111  11111        


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChH----HHHHHhc
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMP----SVILMLG  313 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~----ell~~l~  313 (358)
                       ......+.+++.+||+.+|.+||++.    +++++.+
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~  253 (321)
T cd05603         217 -GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF  253 (321)
T ss_pred             -CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence             11123567899999999999999864    5555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.9e-39  Score=290.14  Aligned_cols=264  Identities=30%  Similarity=0.431  Sum_probs=205.3

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEE
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC  104 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~  104 (358)
                      ++....++|++.+.||+|++|.||++.+..      ...+++|.+... .......+.+|+++++.+ +|+||+++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            444556789999999999999999998643      357899988753 334456688899999999 799999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhcc-------------ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 018304          105 IQGEEKLLIYEFMTNKSLDSFIFDQ-------------ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN  171 (358)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~N  171 (358)
                      ..+...+++|||+.+++|.+++...             .....+++..++.++.|++.||.|||+.+   ++|+||+|+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence            9999999999999999999998642             12345889999999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCC
Q 018304          172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN  250 (358)
Q Consensus       172 ilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~  250 (358)
                      |+++.++.++|+|||.+..+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||...... 
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-  241 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-  241 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-
Confidence            9999999999999999876533222111112234567999999988899999999999999999997 88887543221 


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                        ...    ............         ......+.+++.+||..+|++|||+.++++.|+.+
T Consensus       242 --~~~----~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         242 --ELF----KLLKEGYRMEKP---------QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             --HHH----HHHHcCCcCCCC---------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence              111    111111111110         11123577899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.9e-40  Score=315.80  Aligned_cols=259  Identities=31%  Similarity=0.501  Sum_probs=211.0

Q ss_pred             CCCCcceeecccCCccEEEEEE------cCCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTL------VDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .+.++.+.||+|+||+||+|..      .....|+||.++..... ....|.+|++++..++|||||++++++..++-.+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            4556779999999999999974      22457999999875555 7788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccc-------ccc----CCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCe
Q 018304          112 LIYEFMTNKSLDSFIFDQE-------RCK----ILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP  180 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-------~~~----~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i  180 (358)
                      +|+||+..|+|.+|+....       ...    +++....+.+|.|||.|++||-++.   ++||||...|.||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            9999999999999995532       122    3889999999999999999999999   9999999999999999999


Q ss_pred             EEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHH
Q 018304          181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      ||+|||+++.....++........-..+|||||-+..++|+.++||||+||+|||+++ |..||.....   .+++..+.
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EVIe~i~  719 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEVIECIR  719 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHHHHHHH
Confidence            9999999987644433332222334578999999999999999999999999999999 8888554433   23333332


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                          .+..-...+.+..         ++.+||..||+.+|++||+++||-..|+...
T Consensus       720 ----~g~lL~~Pe~CP~---------~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  720 ----AGQLLSCPENCPT---------EVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             ----cCCcccCCCCCCH---------HHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence                3333333333333         6778999999999999999999999987653

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.3e-39  Score=288.74  Aligned_cols=250  Identities=26%  Similarity=0.330  Sum_probs=195.1

Q ss_pred             ecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           47 LGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        47 lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      ||+|+||.||++.+. +++.|++|.+....   ......+..|+.+++.++|+||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999875 48899999986522   22334567899999999999999999999999999999999999999


Q ss_pred             HHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccc
Q 018304          123 DSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK  201 (358)
Q Consensus       123 ~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~  201 (358)
                      .+++... .....+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+..+....  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            9887542 23345899999999999999999999999   9999999999999999999999999987653221  1222


Q ss_pred             cccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCH
Q 018304          202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNL  281 (358)
Q Consensus       202 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (358)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||............  .......  ...         +..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~--~~~---------~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRILND--SVT---------YPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhhccc--CCC---------Ccc
Confidence            346888999999999999999999999999999999999998654322111110  0100000  000         011


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhcc
Q 018304          282 AEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGS  314 (358)
Q Consensus       282 ~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~  314 (358)
                      .....+.+++.+||+.+|++||     |+.+++++.+.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~  260 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF  260 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence            1223567899999999999999     77888887554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.8e-39  Score=296.34  Aligned_cols=261  Identities=29%  Similarity=0.434  Sum_probs=201.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC-
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~-  107 (358)
                      ..++|++.+.||.|+||.||+|.+.+      ++.|++|.+.... ......+..|++++..+ +|+||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            35689999999999999999996422      4689999886532 33456677899999999 799999999987654 


Q ss_pred             CeeEEEEEecCCCCHHHHHhcccc--------------------------------------------------------
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQER--------------------------------------------------------  131 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  131 (358)
                      ...+++|||+.+++|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            567899999999999999854321                                                        


Q ss_pred             --ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCC
Q 018304          132 --CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY  209 (358)
Q Consensus       132 --~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y  209 (358)
                        ...+++..+..++.||+.||.|||+++   |+||||+|.||+++.++.++|+|||++..+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              124788999999999999999999999   999999999999999999999999999765322222222233456789


Q ss_pred             CCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHH
Q 018304          210 MAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCI  288 (358)
Q Consensus       210 ~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  288 (358)
                      +|||.+.+..++.++|||||||++|+|++ |..||.......   ..   .............         ......+.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~---~~~~~~~~~~~~~---------~~~~~~~~  306 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EF---CRRLKEGTRMRAP---------EYATPEIY  306 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HH---HHHHhccCCCCCC---------ccCCHHHH
Confidence            99999999999999999999999999998 999975432221   11   1111111111110         11124577


Q ss_pred             HHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          289 HIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       289 ~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      +++.+||+.+|++||++.+|+++|..+
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.8e-40  Score=300.32  Aligned_cols=245  Identities=24%  Similarity=0.270  Sum_probs=192.4

Q ss_pred             ceeecccCCccEEEEEE----cCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           44 NKKLGQGGFGPVYKGTL----VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~----~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      ++.||+|+||.||++.+    ..|+.|++|++....  ......+..|++++++++||||+++++++.+.+..++||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36899999999999875    247899999997532  223345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++++|.+++.+..   .+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  .
T Consensus        81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~  152 (318)
T cd05582          81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--E  152 (318)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--C
Confidence            9999999885433   3899999999999999999999999   999999999999999999999999998754221  1


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .......|++.|+|||.+.+..++.++|||||||++|+|++|..||......   .......   ...  ..+.     .
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~i~---~~~--~~~p-----~  219 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTMIL---KAK--LGMP-----Q  219 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHHHH---cCC--CCCC-----C
Confidence            1223456889999999998888999999999999999999999998643221   1111111   110  0010     0


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhc
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLG  313 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~  313 (358)
                      .    ....+.+++.+||+.||++|||     +.+++.+.+
T Consensus       220 ~----~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~  256 (318)
T cd05582         220 F----LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF  256 (318)
T ss_pred             C----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence            1    1234668999999999999999     555665544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.2e-39  Score=287.33  Aligned_cols=253  Identities=26%  Similarity=0.424  Sum_probs=200.7

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .++|++.+.||+|++|.||++.+.++..+++|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            35789999999999999999988777789999887533 23456889999999999999999999999888999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      .+++|.+++.....  .+++..++.++.||+.||.|||+.+   ++|+||+|.||+++.++.++|+|||.+.........
T Consensus        82 ~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          82 SNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999865432  4899999999999999999999999   999999999999999999999999998765322111


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    .........    
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~----  224 (256)
T cd05113         157 -SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKVS----QGLRLYRPH----  224 (256)
T ss_pred             -ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHh----cCCCCCCCC----
Confidence             1111234567999999988889999999999999999998 88887643321   1111111    111110000    


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                           .....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       225 -----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 -----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 01246778999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.8e-39  Score=290.11  Aligned_cols=265  Identities=26%  Similarity=0.396  Sum_probs=203.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-----------------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccc
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-----------------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVK   99 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-----------------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~   99 (358)
                      .++|++.+.||+|+||.||++.+..                 +..|++|.+.... ......+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4689999999999999999987643                 2458899887533 345667889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCCHHHHHhcccc--------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 018304          100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQER--------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN  171 (358)
Q Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~N  171 (358)
                      +++++..++..+++||++.+++|.+++.....        ...+++..++.++.|++.||.|||+.+   ++|+||+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            99999999999999999999999999865431        124899999999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh--CCCCCCCCCCC
Q 018304          172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS--GKKNRGFYHSD  249 (358)
Q Consensus       172 ilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~p~~~~~~~  249 (358)
                      |+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++  +..||....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence            9999999999999999876533222222223345678999999888889999999999999999998  556654322  


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                       ....+......+...........      ......++.+++.+||+.+|++|||+.+|++.|++
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         239 -DQQVIENAGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -hHHHHHHHHhccccccccccCCC------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence             11222222221111111111110      01112467889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.1e-39  Score=300.35  Aligned_cols=266  Identities=28%  Similarity=0.379  Sum_probs=204.9

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCccceeeEE
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCC  104 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~  104 (358)
                      ......++|.+.+.||+|+||.||+|.+..      +..|++|.+.... ......+.+|++++..+. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            344446899999999999999999998532      3469999996532 334567889999999995 99999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhcccc-----------------------------------------------------
Q 018304          105 IQGEEKLLIYEFMTNKSLDSFIFDQER-----------------------------------------------------  131 (358)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------  131 (358)
                      ......++||||+++|+|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            999999999999999999998854311                                                     


Q ss_pred             ----------------------------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 018304          132 ----------------------------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN  171 (358)
Q Consensus       132 ----------------------------------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~N  171 (358)
                                                              ...+++..++.++.||+.||.|||+.+   ++|+||+|+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence                                                    123778888999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCC
Q 018304          172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN  250 (358)
Q Consensus       172 ilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~  250 (358)
                      |+++.++.++|+|||++..+.............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999876532222112222345678999999988889999999999999999997 888875432211


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                        ....    ...........         ......+.+++.+||+.+|++|||+.+|.+.|..+.
T Consensus       348 --~~~~----~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 --TFYN----KIKSGYRMAKP---------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --HHHH----HHhcCCCCCCC---------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence              1111    11111111110         111245778999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.8e-39  Score=299.78  Aligned_cols=262  Identities=16%  Similarity=0.197  Sum_probs=201.3

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE  108 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  108 (358)
                      +.....++|++.+.||+|+||.||++.+.. ++.+++|.+.+.   .......+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            344445799999999999999999999754 789999998642   2233455778999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..++||||+++++|.+++...    .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999999998543    2889999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCC----CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      ....... ........|++.|+|||++.+.    .++.++||||+||++|+|++|..||......   .......   ..
T Consensus       190 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~~~i~---~~  262 (370)
T cd05621         190 MKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTYSKIM---DH  262 (370)
T ss_pred             eecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHHHHHH---hC
Confidence            8653221 1122345689999999988654    3788999999999999999999998643321   1111111   11


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCC--CCChHHHHHHhccC
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKD--RPSMPSVILMLGSE  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~l~~~  315 (358)
                      .....+..       .......+.+++.+||..++.+  |+|+.+++++.+..
T Consensus       263 ~~~~~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         263 KNSLNFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             CcccCCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence            11111111       0111234557888899755543  89999999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-38  Score=283.32  Aligned_cols=256  Identities=30%  Similarity=0.449  Sum_probs=203.1

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ...++|+++++||+|++|.||+|...+++.|++|.+.... .....+.+|+.+++.++|+||+++++++. .+..+++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            3467899999999999999999998888999999987533 33467889999999999999999999874 457899999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++..... ..+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          81 YMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999999999865443 34889999999999999999999999   9999999999999999999999999987653211


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      . .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    .........  
T Consensus       157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~--  226 (260)
T cd05067         157 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLE----RGYRMPRPD--  226 (260)
T ss_pred             c-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHH----cCCCCCCCC--
Confidence            1 11112234568999999988889999999999999999998 99998643321   1111111    111111111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                             .....+.+++.+||..+|++|||+.++++.|+.
T Consensus       227 -------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         227 -------NCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -------CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                   112357789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.7e-38  Score=291.92  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=194.7

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||++.+.. ++.|++|++.+.   .......+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            479999999999999754 789999998752   233455677888888777 799999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~  152 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDT  152 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCc
Confidence            99998875433   3899999999999999999999999   99999999999999999999999999865321  1112


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC--chhHHHHHHHhhcCCCCccccCCcCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN--LNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .....|+..|+|||.+.+..++.++|||||||++|+|++|..||........  ............... ..+.     .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~p-----~  226 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIP-----R  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-CCCC-----C
Confidence            2345688999999999999999999999999999999999999864322211  111111111111111 1111     1


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCC------hHHHHHHhcc
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPS------MPSVILMLGS  314 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt------~~ell~~l~~  314 (358)
                      .    ....+.+++.+||+.||++|||      +.+++++-+.
T Consensus       227 ~----~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f  265 (329)
T cd05618         227 S----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  265 (329)
T ss_pred             C----CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence            1    1234668999999999999998      4688777544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-39  Score=283.91  Aligned_cols=257  Identities=30%  Similarity=0.475  Sum_probs=205.1

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ...++|++.+.||+|++|.||++.+++++.+++|.+.... ...+.+.+|++.++.++|+||+++++++......+++||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            3468999999999999999999998778899999887533 344678899999999999999999999998889999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++..... ..+++..++.++.+++.|+.|||+++   ++|+||+|+||+++.++.++|+|||.+..+....
T Consensus        82 ~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          82 YMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             ccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999966432 23899999999999999999999999   9999999999999999999999999987653211


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      . ........+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.....   ...............+    .  
T Consensus       158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~----~--  227 (261)
T cd05034         158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYRMPRP----P--  227 (261)
T ss_pred             h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCC----C--
Confidence            1 11112223467999999988889999999999999999998 9988754321   1122221111110000    0  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                             .....+.+++.+||+.+|++||++.++++.|+.
T Consensus       228 -------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         228 -------NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                   012357789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=298.05  Aligned_cols=258  Identities=22%  Similarity=0.288  Sum_probs=212.7

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh---hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCe
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE  109 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~  109 (358)
                      ......|++.+.||.|.||.||++..+. |+.+++|.+.+...   .....+.+|+.+|+++. ||||+.+++.|++.+.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            3455789999999999999999999866 99999999976333   23468899999999998 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC----CCeEEecc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDF  185 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~----~~i~L~Df  185 (358)
                      .++|||++.||.|.+.+...   . +++..+..++.|++.++.|||+.|   ++|+|+||+|+|+...    +.++++||
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            99999999999999999776   2 999999999999999999999999   9999999999999633    57999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      |++.....   .......+|++.|+|||++....|+..+||||+|+++|.|++|..||...........  .....+   
T Consensus       184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~--i~~~~~---  255 (382)
T KOG0032|consen  184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA--ILRGDF---  255 (382)
T ss_pred             CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH--HHcCCC---
Confidence            99998643   3455677899999999999999999999999999999999999999865443322221  111111   


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         .     ..............++|..||..||..|+|+.+++++.|-.
T Consensus       256 ---~-----f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  256 ---D-----FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             ---C-----CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence               1     11111122234566799999999999999999999987633

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.2e-39  Score=296.11  Aligned_cols=248  Identities=24%  Similarity=0.303  Sum_probs=195.7

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      +|++.+.||+|+||.||+|.+.. ++.|++|.+.+..   .........|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58999999999999999998764 7899999987522   22334566677888777 5889999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999885543   3889999999999999999999999   999999999999999999999999998753211


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                        ........|++.|+|||.+.+..++.++|||||||++|+|++|..||......   .......    ... ..+.   
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~----~~~-~~~p---  221 (323)
T cd05616         155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIM----EHN-VAYP---  221 (323)
T ss_pred             --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCC-CCCC---
Confidence              11223456889999999999999999999999999999999999998643321   1211111    111 0111   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh-----HHHHHHh
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM-----PSVILML  312 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~l  312 (358)
                        .    .....+.+++.+||+.+|++|++.     .+++++-
T Consensus       222 --~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~  258 (323)
T cd05616         222 --K----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  258 (323)
T ss_pred             --C----cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCC
Confidence              1    112356789999999999999985     6776653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-38  Score=288.97  Aligned_cols=265  Identities=24%  Similarity=0.397  Sum_probs=200.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-----------------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccc
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK   99 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-----------------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~   99 (358)
                      .++|++.+.||+|+||.||++.+.+                 +..+++|.+... .......+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3679999999999999999985421                 346889988753 3344567889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCCHHHHHhcccc--------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 018304          100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQER--------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN  171 (358)
Q Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~N  171 (358)
                      +++++...+..+++|||+.+++|.+++.....        ...+++..++.++.|++.|+.|||+.+   ++|+||+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999999865331        123777889999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh--CCCCCCCCCCC
Q 018304          172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS--GKKNRGFYHSD  249 (358)
Q Consensus       172 ilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~p~~~~~~~  249 (358)
                      |+++.++.++|+|||++..+..............+..|++||...+..++.++|+|||||++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999876532221111112233567999998888889999999999999999998  66776433221


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                         .........+.......... . .    ......+.+++.+||+.+|++|||+.+|++.|++
T Consensus       241 ---~~~~~~~~~~~~~~~~~~~~-~-~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 ---QVIENTGEFFRDQGRQVYLP-K-P----ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ---HHHHHHHHHHhhccccccCC-C-C----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               11211111111111111110 0 0    0112457789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-38  Score=291.36  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=199.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~----~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..+|++.+.||+|+||.||+|.+.. +.    .|++|.+... .......+.+|+.+++.++|+||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            3679999999999999999998643 33    4899988653 234456788899999999999999999998764 577


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ++++|+.+|+|.+++....  ..++...++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+
T Consensus        85 ~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999999986543  23888999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ..............+..|+|||.+.+..++.++||||||+++|+|++ |..||......    .+..   ..........
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----~~~~---~~~~~~~~~~  232 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISS---ILEKGERLPQ  232 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHH---HHhCCCCCCC
Confidence            43222111122234567999999998899999999999999999997 99887543211    1111   1111111000


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .     ..    ....+.+++.+||..+|.+|||+.+++..+....
T Consensus       233 ~-----~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         233 P-----PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             C-----CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0     01    1235678999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.4e-39  Score=298.92  Aligned_cols=267  Identities=22%  Similarity=0.319  Sum_probs=199.4

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----eeE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL  111 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~~~  111 (358)
                      +|++.+.||+|+||.||++.+. +++.|++|.+...  .......+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5889999999999999999974 5899999988652  2334567889999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +|+||+. ++|.+++...   ..+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 4787777443   34899999999999999999999999   999999999999999999999999998764


Q ss_pred             CCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH------------
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA------------  258 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------  258 (358)
                      .... ........++..|+|||.+.+. .++.++||||+||++|+|++|+.||...........+...            
T Consensus       154 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         154 EPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            3221 1112233567889999988764 5789999999999999999999998654432211111100            


Q ss_pred             ----HHHh-hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          259 ----WKLW-NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       259 ----~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                          ...+ .............  .........+.+||.+||+.||++|||+.+++++.+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence                0000 0000000000000  000111345678999999999999999999999876544

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-39  Score=282.81  Aligned_cols=269  Identities=23%  Similarity=0.286  Sum_probs=206.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCC-----
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRN-LVKLLGCCIQGE-----  108 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~-----  108 (358)
                      ...|..+++||+|+||+||+|..+ +|+.||+|.+.-..+  .......+|+.+++.++|+| |+.+++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            456788899999999999999965 489999999875433  24566789999999999999 999999999887     


Q ss_pred             -eeEEEEEecCCCCHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          109 -EKLLIYEFMTNKSLDSFIFDQERC-KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       109 -~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                       .+++||||+.. +|..++...... ..++...+..++.||+.||+|||+++   |+||||||.||+|+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             88999999965 999999665421 23777899999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      ++....-  .........+|..|.|||++.+. .|+...||||+|||+.||++++..|......   +.+..+......+
T Consensus       166 lAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP  240 (323)
T KOG0594|consen  166 LARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTP  240 (323)
T ss_pred             hHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCC
Confidence            9986531  12224455688899999998876 7899999999999999999999888765553   3333332222221


Q ss_pred             CCCccc--------cCCcCCCC---CHHH-----HHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLI--------DPCIQGSF---NLAE-----VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~--------~~~~~~~~---~~~~-----~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ......        ........   ....     ..+..+++.+||+.+|.+|.|+...+++-...
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~  306 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS  306 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence            111110        10111111   0000     02456799999999999999999999985443

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.8e-39  Score=287.74  Aligned_cols=256  Identities=25%  Similarity=0.333  Sum_probs=201.6

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .|++.+.||+|+||.||++.+.. ++.|++|.+....   ......+..|+.+++.++|++++.+++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47888999999999999998754 8899999886422   2223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999998855333 23899999999999999999999999   9999999999999999999999999987542211


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                         ......++..|+|||.+.+..++.++||||+|+++|+|++|..||.....................    ..     
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~-----  224 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE----EY-----  224 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh----hc-----
Confidence               112346788999999999889999999999999999999999998654322111111111111110    01     


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~  315 (358)
                      ..    .....+.+++.+||+.||++|||     +.+++++-+..
T Consensus       225 ~~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         225 SE----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             Cc----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence            01    11234668999999999999999     89999876653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-38  Score=285.31  Aligned_cols=257  Identities=28%  Similarity=0.443  Sum_probs=200.2

Q ss_pred             CCCCcceeecccCCccEEEEEE-----cCCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTL-----VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ++|++.+.||+|+||.||+|.+     ..+..+++|.+.. ........+.+|+++++.++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5689999999999999999974     2357899999874 333344678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcccc--------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC
Q 018304          113 IYEFMTNKSLDSFIFDQER--------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM  178 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~  178 (358)
                      +|||+.+++|.+++.....              ...+++..+..++.+++.||.|||+++   ++|+||+|+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999853221              124788899999999999999999999   99999999999999999


Q ss_pred             CeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHH
Q 018304          179 NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGH  257 (358)
Q Consensus       179 ~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~  257 (358)
                      .++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....   ......
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence            999999999876532222222223334567999999988889999999999999999998 8888754221   111111


Q ss_pred             HHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ..    .........     ..    ...+.+++.+||+.+|.+||++.+|+++|..
T Consensus       239 ~~----~~~~~~~~~-----~~----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VR----KRQLLPCSE-----DC----PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----cCCcCCCCC-----CC----CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11    111111111     11    2356779999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.7e-38  Score=280.77  Aligned_cols=259  Identities=24%  Similarity=0.387  Sum_probs=205.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|++|.||+|.+. +|+.|++|.++.   ........+.+|+++++.++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            58999999999999999999986 689999998863   22333567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          115 EFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||+++++|.+++.... ....+++..++.++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886532 2344899999999999999999999999   99999999999999999999999999876532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..  .......++..|.|||.+.+..++.++|+||||+++|+|++|..||......    ... ..............  
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~~~--  229 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCDYPPLP--  229 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCCCCCCC--
Confidence            21  1122345778899999998888999999999999999999999997543211    111 11111111111111  


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            .......+.++|.+||..+|++|||+.+|++.++.+
T Consensus       230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                  012233567899999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-38  Score=287.46  Aligned_cols=259  Identities=27%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..+.|++++.||.|++|.||+|.+.. ++.+++|.+..........+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            34789999999999999999999755 88999999987766677888899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|..++.+..  ..+++..++.++.|++.++.+||+.+   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus        90 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--  162 (292)
T cd06644          90 FCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--  162 (292)
T ss_pred             cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc--
Confidence            999999988875433  23899999999999999999999999   99999999999999999999999998865321  


Q ss_pred             CCCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          196 TEGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .........++..|+|||.+.     ...++.++|+|||||++|+|++|..||......   ..   ... .........
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~---~~~-~~~~~~~~~  235 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RV---LLK-IAKSEPPTL  235 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HH---HHH-HhcCCCccC
Confidence            122223445778899999874     345688999999999999999999997543321   11   111 111111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ..       .......+.+++.+||..+|++||++.+++++-+...
T Consensus       236 ~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         236 SQ-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             CC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            00       0111235678999999999999999999998766443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-39  Score=295.97  Aligned_cols=245  Identities=24%  Similarity=0.320  Sum_probs=193.8

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||+|.++. ++.|++|.+.+.   .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999754 789999998652   223445667788888876 699999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++.+..   .+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......  ...
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~  152 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT  152 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence            99999885543   3899999999999999999999999   999999999999999999999999998753211  112


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||......   .......    .... .+.     .  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~----~~~~-~~~-----~--  217 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAIL----NDEV-VYP-----T--  217 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHh----cCCC-CCC-----C--
Confidence            23346899999999999889999999999999999999999998653321   1111111    1110 000     0  


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCh------HHHHHHhcc
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSM------PSVILMLGS  314 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~------~ell~~l~~  314 (358)
                        .....+.+++.+||+.||.+||++      .+++.+-+.
T Consensus       218 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f  256 (320)
T cd05590         218 --WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF  256 (320)
T ss_pred             --CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence              012356789999999999999998      777776554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=281.24  Aligned_cols=250  Identities=33%  Similarity=0.486  Sum_probs=200.5

Q ss_pred             eeecccCCccEEEEEEcC----CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|++|.||+|.+..    +..|++|.+...... ....+..|++.++.++|+|++++++++.+....+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            478999999999998754    788999999764433 367888999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcccc------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          120 KSLDSFIFDQER------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       120 ~~L~~~l~~~~~------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ++|.+++.....      ...+++..++.++.|++.||.+||+++   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999976521      245999999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ........    ........ 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~-  229 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLR----KGYRLPKP-  229 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH----cCCCCCCC-
Confidence            322222333456788999999988889999999999999999999 5888765422   11111111    11111111 


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                              ......+.+++.+||+.+|++|||+.+++++|+
T Consensus       230 --------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         230 --------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --------ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                    111346778999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-38  Score=289.99  Aligned_cols=269  Identities=21%  Similarity=0.256  Sum_probs=203.2

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++.+.||+|++|.||++.+.. +..+++|.+... .......+.+|+++++.++||||+++++.+.+++..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            479999999999999999998754 788888888653 334456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      +++++|.+++...   +.+++..+..++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999998654   348999999999999999999998 57   999999999999999999999999988654221 


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC---c---
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS---Q---  269 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~---  269 (358)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.....................   .   
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence               1223457889999999888889999999999999999999999975433111100000000000000000   0   


Q ss_pred             ---------------cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          270 ---------------LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       270 ---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                                     .................+.+++.+||..+|++|||+.+|+.+.+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                           000000000000122357789999999999999999999999877543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-39  Score=301.13  Aligned_cols=266  Identities=17%  Similarity=0.217  Sum_probs=203.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC---CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ...+|++++.||.|++|.||++...+   +..|++|.+...     ....+|+++++.++|+||+++++++......+++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            34689999999999999999997532   578999988653     2345799999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||++. ++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++..+..
T Consensus       165 ~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99996 588888732   234899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ...........|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..+........ ..+...
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~-~~~~~~  316 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP-LEFPQN  316 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc-cccCCc
Confidence            3222223345689999999999988999999999999999999999999866554433333332222111100 000000


Q ss_pred             --------------CcCCCCCH-------HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 --------------CIQGSFNL-------AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 --------------~~~~~~~~-------~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                    .....+..       ....++.++|.+||..+|++|||+.+++.+-+..
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~  379 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT  379 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence                          00000000       1123566799999999999999999999987654

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-38  Score=288.86  Aligned_cols=263  Identities=23%  Similarity=0.382  Sum_probs=208.2

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ...++|++.+.||+|++|.||++.+. +++.|++|.+..........+.+|+.+++.++|+||+++++++..++..++||
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            34479999999999999999999974 58999999997655555567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++...    .+++..+..++.+++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            999999999998542    3788999999999999999999999   999999999999999999999999998764322


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .  .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........      ......+. ..   
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~~~~-~~---  236 (297)
T cd06656         169 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTPE-LQ---  236 (297)
T ss_pred             c--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCCCCC-CC---
Confidence            1  112234577889999999888899999999999999999999999854332211100      00000000 00   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQP  321 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~  321 (358)
                          ........+.+++.+||..+|++|||+.+++++-+.....+.+
T Consensus       237 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         237 ----NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence                0011123456799999999999999999999976655444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.8e-39  Score=287.60  Aligned_cols=249  Identities=24%  Similarity=0.320  Sum_probs=191.8

Q ss_pred             ecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           47 LGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        47 lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      ||+|+||.||++..+. |+.|++|.+....   ......+..|+++++.++||||+++++.+.++...++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999998754 8999999986421   11233455699999999999999999999999999999999999999


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcccc
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR  202 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~  202 (358)
                      .+++..... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            988855433 23889999999999999999999999   9999999999999999999999999987653221   2223


Q ss_pred             ccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHH
Q 018304          203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA  282 (358)
Q Consensus       203 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      ..++..|+|||.+.+..++.++||||+||++|+|++|..||........  ............ .. ...    .    .
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~-~~-~~~----~----~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE-VK-FEH----Q----N  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc-cc-ccc----c----c
Confidence            4578899999999888899999999999999999999999864332211  111111111111 00 000    0    1


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          283 EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       283 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ....+.+++.+||+.+|++||++.++++.+..
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence            12356789999999999999999766644433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.5e-39  Score=289.71  Aligned_cols=257  Identities=23%  Similarity=0.394  Sum_probs=204.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ...+|++.+.||+|++|.||+|.+. +++.|++|.+..........+.+|+.+++.++|+|++++++.+......++|||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            3479999999999999999999874 488999999876555556778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++...    .++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        98 ~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             ccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            99999999998432    3788999999999999999999999   9999999999999999999999999887542211


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......+++.|+|||.+.+..++.++|||||||++|+|++|..||.......   ..   ......... ....   
T Consensus       171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~---~~~~~~~~~-~~~~---  238 (296)
T cd06654         171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---AL---YLIATNGTP-ELQN---  238 (296)
T ss_pred             --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hH---HHHhcCCCC-CCCC---
Confidence              11223457789999999988888999999999999999999999985433211   11   011111110 0000   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                          .......+.+++.+||..+|++|||+.+++++-+...
T Consensus       239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         239 ----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             ----ccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence                0111235678999999999999999999998755443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.3e-39  Score=296.32  Aligned_cols=246  Identities=25%  Similarity=0.291  Sum_probs=195.5

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||++.+.. ++.|++|.+.+.   .......+..|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999998765 789999999753   233455667888888888 699999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++.+..   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~  152 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVT  152 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCc
Confidence            99998885543   3899999999999999999999999   99999999999999999999999999864211  1112


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|..||......   .......    .... .+     ..  
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~i~----~~~~-~~-----~~--  217 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQSIL----EDEV-RY-----PR--  217 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHHHH----cCCC-CC-----CC--
Confidence            22346889999999999999999999999999999999999998643311   1111111    1110 00     01  


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCCh-----HHHHHHhccC
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSM-----PSVILMLGSE  315 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~l~~~  315 (358)
                        .....+.++|.+||+.||++|||+     .+++++-+..
T Consensus       218 --~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~  256 (318)
T cd05570         218 --WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR  256 (318)
T ss_pred             --cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence              112356789999999999999999     9998876554

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4e-38  Score=289.19  Aligned_cols=252  Identities=22%  Similarity=0.325  Sum_probs=196.6

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||++.+.. ++.|++|++.+.   .......+..|+.++..+ +|++|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999998754 789999999752   233456677899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+++..++.++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~  152 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDT  152 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCc
Confidence            99998885433   3999999999999999999999999   99999999999999999999999999875311  1122


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....................... ..+..     . 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~p~-----~-  225 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-IRIPR-----F-  225 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-CCCCC-----C-
Confidence            2345689999999999999999999999999999999999999865433322222222222221111 11111     1 


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCC------hHHHHHHhcc
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPS------MPSVILMLGS  314 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt------~~ell~~l~~  314 (358)
                         ....+.+++.+||..||++|++      +.+++++-+.
T Consensus       226 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f  263 (327)
T cd05617         226 ---LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF  263 (327)
T ss_pred             ---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence               1134567999999999999998      4688877543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=282.75  Aligned_cols=251  Identities=27%  Similarity=0.433  Sum_probs=198.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      .+|++.+.||+|++|.||++.++.+..+++|.+.... .....+.+|+++++.++|+||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4689999999999999999998777789999886532 223467789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++.....  .+++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            9999999865432  4899999999999999999999999   999999999999999999999999998764321111 


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......   .......    ........      
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~------  223 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESVS----AGYRLYRP------  223 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHH----cCCcCCCC------
Confidence            1111123457999999988899999999999999999998 78887643322   1111111    11110000      


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                         ......+.+++.+||..+|++|||+.++++.|
T Consensus       224 ---~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         224 ---KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               01223577899999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=285.03  Aligned_cols=259  Identities=26%  Similarity=0.464  Sum_probs=203.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ..++|++.+.||+|++|.||+|.+..      +..|++|.+.... ......+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            34789999999999999999998643      3689999986532 3445567889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcccc-------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          110 KLLIYEFMTNKSLDSFIFDQER-------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                      .++||||+.+++|.+++.....       ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            9999999999999999865321       223788899999999999999999999   999999999999999999999


Q ss_pred             eccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHH
Q 018304          183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      +|||++..+.............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~--  235 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVI--  235 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHh--
Confidence            99999876533222112223345678999999988889999999999999999998 88887543221   1111111  


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                        ...........         ...+.+++.+||+.+|++|||+.++++.|+.
T Consensus       236 --~~~~~~~~~~~---------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 --DGGHLDLPENC---------PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             --cCCCCCCCCCC---------CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence              11111111111         3467789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=302.42  Aligned_cols=240  Identities=29%  Similarity=0.474  Sum_probs=194.7

Q ss_pred             ceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHH
Q 018304           44 NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLD  123 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  123 (358)
                      ++-||+|+.|.||+|+. .++.|+||.++...+       .+++.|++|+|+||+.+.++|.....+|||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            46799999999999988 789999998854332       5788899999999999999999999999999999999999


Q ss_pred             HHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccc
Q 018304          124 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV  203 (358)
Q Consensus       124 ~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~  203 (358)
                      ..+..   ..++....+..|..+||.|+.|||.+.   |+|||||.-||||+.+..|||+|||-+......   ...-..
T Consensus       201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF  271 (904)
T KOG4721|consen  201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF  271 (904)
T ss_pred             HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence            99844   344889999999999999999999999   999999999999999999999999998765322   233356


Q ss_pred             cccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHH
Q 018304          204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAE  283 (358)
Q Consensus       204 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (358)
                      .||..|+|||++++.+.+.|.|||||||+||+|+||..||..-+...      .+|..-.....-.+...+         
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwGVGsNsL~LpvPstc---------  336 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWGVGSNSLHLPVPSTC---------  336 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEeccCCcccccCcccC---------
Confidence            79999999999999999999999999999999999999965433211      111111111111111111         


Q ss_pred             HHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          284 VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       284 ~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...+.-||++||+..|.+||++.+++.+|.=.
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            12344588899999999999999999998654

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-39  Score=301.10  Aligned_cols=264  Identities=17%  Similarity=0.197  Sum_probs=202.7

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ  106 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  106 (358)
                      +.++....++|++.+.||+|+||.||++.++. ++.+++|.+.+.   .......+.+|+.+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            55666667999999999999999999999764 889999998642   22334556789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      ++..++||||+++++|.+++...    .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.++|+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999999999998543    2888999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCC----CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDG----QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      ++..+.... ........|++.|+|||++.+.    .++.++|||||||++|+|++|..||...+..   .....+   .
T Consensus       188 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i---~  260 (371)
T cd05622         188 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKI---M  260 (371)
T ss_pred             ceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HHHHHH---H
Confidence            998653221 1122345689999999988653    3788999999999999999999998643221   111111   1


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCC--CCChHHHHHHhccC
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKD--RPSMPSVILMLGSE  315 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~l~~~  315 (358)
                      .......+..       .......+.++|.+||...+.+  |+++.+++++.+..
T Consensus       261 ~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~  308 (371)
T cd05622         261 NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  308 (371)
T ss_pred             cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence            1111111111       0111234567889999844433  78999999987643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-40  Score=302.17  Aligned_cols=260  Identities=27%  Similarity=0.345  Sum_probs=206.1

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEec--ccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~--~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~  110 (358)
                      |...++.|+++++||+||.+.||++...+.+.|++|.+.  ..+...+..+.+|+..|.+| .|.+|+++++|=..++.+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            344568999999999999999999988777888888664  35667788899999999999 589999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      |+||||-+ .+|..++......  ++...+..++.||+.|+.++|++|   |||.||||.||++ ..|.+||+|||++..
T Consensus       436 YmvmE~Gd-~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             EEEeeccc-ccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            99999864 5999999665432  444588999999999999999999   9999999999999 778999999999998


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCC-----------CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDG-----------QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      +............+||+.|++||.+...           +.+.++||||||||||+|+.|+.||+.....     .....
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----~aKl~  583 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----IAKLH  583 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----HHHHH
Confidence            8766666677778999999999988532           2567999999999999999999998653311     11111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .....+...++.+  ..   ..   ..+.++++.||..||++|||+.+||++.-
T Consensus       584 aI~~P~~~Iefp~--~~---~~---~~li~~mK~CL~rdPkkR~si~eLLqhpF  629 (677)
T KOG0596|consen  584 AITDPNHEIEFPD--IP---EN---DELIDVMKCCLARDPKKRWSIPELLQHPF  629 (677)
T ss_pred             hhcCCCccccccC--CC---Cc---hHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence            1110111111111  11   01   12778999999999999999999999853

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.8e-39  Score=284.03  Aligned_cols=255  Identities=29%  Similarity=0.464  Sum_probs=200.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..++|++.+.||+|++|.||+|.+.++..+++|.+..... ....+.+|+.+++.++|+|++++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            3468999999999999999999987888899999875332 3456889999999999999999999875 4568899999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++..... ..+++..++.++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+........
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          82 MSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            999999999865432 23889999999999999999999999   99999999999999999999999999976532211


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      . ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......   .......    .......     
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~-----  224 (260)
T cd05070         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVE----RGYRMPC-----  224 (260)
T ss_pred             c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cCCCCCC-----
Confidence            1 1112234567999999888889999999999999999999 88887543221   1111111    1111111     


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                          .......+.+++.+||..+|++|||+.++.+.|++
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 ----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                11112357789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.3e-39  Score=308.24  Aligned_cols=265  Identities=19%  Similarity=0.269  Sum_probs=194.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--------
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--------  107 (358)
                      ...+|++.+.||+|+||.||+|.+. .++.|++|.+....    ....+|+.+++.++|+||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3468999999999999999999975 48899999886532    2345799999999999999998887432        


Q ss_pred             CeeEEEEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEecc
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDF  185 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df  185 (358)
                      ..+++||||+++ ++.+++... .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++ .++|+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999975 777766432 23345899999999999999999999999   99999999999998664 7999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      |++..+...   .......+++.|+|||++.+. .++.++|||||||++|+|++|..||......   ..+.........
T Consensus       216 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~  289 (440)
T PTZ00036        216 GSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV---DQLVRIIQVLGT  289 (440)
T ss_pred             ccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Confidence            999765321   122234578899999987654 6899999999999999999999998653322   122222111111


Q ss_pred             CCC-------CccccCCcCC--------CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          265 GMP-------SQLIDPCIQG--------SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       265 ~~~-------~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...       ..+.+-....        .+......++.+||.+||+.+|.+|||+.+++.+.+..
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~  355 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD  355 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence            000       0000000000        00001124677899999999999999999999887754

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-38  Score=291.04  Aligned_cols=267  Identities=27%  Similarity=0.398  Sum_probs=205.2

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC--------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceee
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLG  102 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~--------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~  102 (358)
                      +......+|++.+.||+|+||.||++.+..        +..|++|.+... .......+.+|+++++++ +|+||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            444555789999999999999999997522        236899988653 234567788999999999 7999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCC
Q 018304          103 CCIQGEEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKA  169 (358)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~  169 (358)
                      ++...+..++++||+.+++|.+++.....             ...++...+..++.|++.||.|||+++   ++|+||+|
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp  162 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA  162 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence            99999999999999999999999865321             123778889999999999999999999   99999999


Q ss_pred             CcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCC
Q 018304          170 SNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHS  248 (358)
Q Consensus       170 ~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~  248 (358)
                      +||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999876532221111112233457999999998899999999999999999998 7788654321


Q ss_pred             CCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          249 DNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      .   .....    ...........         .....+.+++.+||+.+|++|||+.++++.|+.....
T Consensus       243 ~---~~~~~----~~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         243 E---ELFKL----LKEGHRMDKPA---------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             H---HHHHH----HHcCCCCCCCC---------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            1   11111    11111111111         1123567899999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-38  Score=287.57  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=202.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++++.||+|++|.||++.+. .+..|++|.+... .......+.+|+++++.++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47899999999999999999975 5899999988653 344456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      +++++|..++........+++..+..++.+++.|+.|||+ .+   ++|+||+|+||+++.++.++|+|||.+..+... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999988654333458999999999999999999997 47   999999999999999999999999998764221 


Q ss_pred             CCCccccccccCCCCCcccccCC------CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                         ......++..|+|||.+.+.      .++.++|+|||||++|+|++|..||...........+   . .........
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~-~~~~~~~~~  229 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL---S-AIVDGDPPT  229 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH---H-HHhhcCCCC
Confidence               22234567789999988544      3478999999999999999999998543222111111   1 111111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      +.         .....++.++|.+||+.+|++||++.+++.+.+..
T Consensus       230 ~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~  266 (286)
T cd06622         230 LP---------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV  266 (286)
T ss_pred             CC---------cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhh
Confidence            11         11234567899999999999999999999876644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-38  Score=285.58  Aligned_cols=257  Identities=27%  Similarity=0.432  Sum_probs=202.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..+|.+.+.||+|+||.||++...      .+..+++|.+..........+.+|++.++.++|+||+++++++.+....+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            357889999999999999999642      25578899887766677788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhcccc------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC
Q 018304          112 LIYEFMTNKSLDSFIFDQER------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~  179 (358)
                      ++|||+.+++|.+++.....            ...+++..++.++.|++.|+.|||+.+   ++|+||+|+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999999865431            124788999999999999999999999   999999999999999999


Q ss_pred             eEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHH
Q 018304          180 PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHA  258 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~  258 (358)
                      ++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......   ......
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~  237 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIECI  237 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHHH
Confidence            99999999875432211111122234578999999988889999999999999999998 88887432221   111111


Q ss_pred             HHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          259 WKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ..    ........     ..    ...+.+++.+||+.+|.+||++.+|++.|+
T Consensus       238 ~~----~~~~~~~~-----~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 TQ----GRELERPR-----TC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             Hc----CccCCCCC-----CC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11    11111111     11    134668999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-38  Score=279.70  Aligned_cols=250  Identities=23%  Similarity=0.345  Sum_probs=200.3

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      +|++.+.||.|++|.||++.+. +++.+++|.+.. ......+.+.+|+.+++.++|+||+++++.+.+++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5899999999999999999975 488999998854 23345567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++++|.+++..... ..+++..++.++.|++.||.+||+++   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--  154 (255)
T cd08219          81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--  154 (255)
T ss_pred             CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence            99999998854332 34789999999999999999999999   9999999999999999999999999987653221  


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......   ......    .......+..     
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~~~~~-----  222 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLILKV----CQGSYKPLPS-----  222 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHHHH----hcCCCCCCCc-----
Confidence            1122345788899999998888999999999999999999999998643211   111111    1111111111     


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                          .....+.+++.+||..+|++|||+.+++..
T Consensus       223 ----~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 ----HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                112346689999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-39  Score=289.07  Aligned_cols=269  Identities=28%  Similarity=0.367  Sum_probs=197.7

Q ss_pred             CCC-CcceeecccCCccEEEEEE-----cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Ce
Q 018304           39 NNF-SINKKLGQGGFGPVYKGTL-----VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE  109 (358)
Q Consensus        39 ~~y-~i~~~lg~g~~g~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~  109 (358)
                      +|| ++.+.||+|+||+||++..     .++..|++|.+.... ......+.+|++.++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            456 9999999999999988652     247789999987533 23456678899999999999999999987654  36


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .+++|||+.+++|.+++...    .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence            78999999999999998543    2899999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCCCCc-cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          190 AFGGDETEGN-TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       190 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      .+........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLI  234 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhh
Confidence            6532211111 1122345679999999888899999999999999999999999754332100 0000000000000000


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...+..............+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            00000000000111124677899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-38  Score=280.26  Aligned_cols=250  Identities=30%  Similarity=0.483  Sum_probs=202.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .++|++.+.||.|++|.||+|.. .|+.|++|.+..... ....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            57899999999999999999987 588999999976543 5677889999999999999999999999889999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++++|.+++..... ..+++..++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999865442 24899999999999999999999999   99999999999999999999999999876522111 


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                          ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......   .......    .........    
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~----  222 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVE----KGYRMEAPE----  222 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----cCCCCCCcc----
Confidence                2234567999999988889999999999999999997 88887543221   1111111    111111111    


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                           .....+.+++.+||..+|++|||+.+++.+|+.
T Consensus       223 -----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         223 -----GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                 112456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2e-38  Score=295.06  Aligned_cols=269  Identities=23%  Similarity=0.280  Sum_probs=199.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----  108 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----  108 (358)
                      ...++|++.+.||+|+||.||++.+.. |..|++|.+...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            345899999999999999999998754 889999998642  3344566778999999999999999999986543    


Q ss_pred             --eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          109 --EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       109 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                        ..++||||+.+ +|.+.+..     .+++..+..++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence              46999999976 56665521     2788999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhH-----------
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI-----------  255 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~-----------  255 (358)
                      ++.....   ........++..|+|||.+.+..++.++|||||||++|+|++|..||...+........           
T Consensus       169 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             Ccccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            9875321   11223346788999999999999999999999999999999999998754321110000           


Q ss_pred             -HH---HHHHhhcCC--C-----CccccCCc-C--CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          256 -GH---AWKLWNEGM--P-----SQLIDPCI-Q--GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       256 -~~---~~~~~~~~~--~-----~~~~~~~~-~--~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                       ..   ....+....  .     ........ .  ..........+.+||.+||+.||++|||+.+++++.+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence             00   000000000  0     00000000 0  0000111235678999999999999999999999877654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.2e-39  Score=291.75  Aligned_cols=269  Identities=20%  Similarity=0.268  Sum_probs=201.4

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++.+.||.|++|.||+|.+. +++.|++|.+.... ......+.+|+..++.++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            68999999999999999999875 48899999986432 22334567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +. ++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  158 (301)
T cd07873          86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  158 (301)
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence            97 48888875533  23889999999999999999999999   9999999999999999999999999987542211 


Q ss_pred             CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC---CCcccc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM---PSQLID  272 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  272 (358)
                       .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+....   ............   ...+..
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhc
Confidence             111223467889999987654 578899999999999999999999865433211   111111110000   000000


Q ss_pred             ------CCcCC---C----CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          273 ------PCIQG---S----FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       273 ------~~~~~---~----~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                            .....   .    ........+.+||.+||+.||.+|||+.+++++-|.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                  00000   0    0001123467899999999999999999999988776443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-40  Score=287.69  Aligned_cols=259  Identities=25%  Similarity=0.317  Sum_probs=197.1

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----eeEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLLI  113 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~~~lv  113 (358)
                      .|+-.+.+|+|.||.||.|+... ++.||||.+.....    .-..|+++|+.++|||||++..+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            56778999999999999999654 79999998865332    2237999999999999999998886543     34589


Q ss_pred             EEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-CCeEEeccccceec
Q 018304          114 YEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAF  191 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-~~i~L~Df~~~~~~  191 (358)
                      |||++. +|.+.+... .....++...+.-+.+||+.||.|||+.|   |+||||||.|+|||.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 888888542 12234888889999999999999999999   9999999999999965 99999999999987


Q ss_pred             CCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ..+...   .....+-.|+|||++.|. .|+.+.||||.||++.||+-|++.|......+.+..+..+   +.-+...++
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~---lG~Pt~e~I  250 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV---LGTPTREDI  250 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH---hCCCCHHHH
Confidence            543332   344567789999988775 8999999999999999999999998775554444333322   211111111


Q ss_pred             cc----------CCcC-----CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          271 ID----------PCIQ-----GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       271 ~~----------~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      ..          +...     .........+.++|+.++|+++|.+|.++.+++.+-
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~  307 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP  307 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence            10          0000     011222334678899999999999999999999764

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-38  Score=286.43  Aligned_cols=262  Identities=25%  Similarity=0.413  Sum_probs=205.2

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe-CC
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GE  108 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~  108 (358)
                      ...++|++.+.||+|+||.||+|.+..     +..|++|.+... .......+.+|+..++.++|+||+++++++.. +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            356899999999999999999999765     678999988653 34456778899999999999999999998765 46


Q ss_pred             eeEEEEEecCCCCHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEe
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERC-----KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS  183 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~  183 (358)
                      ..+++++|+.+++|.+++......     ..+++..++.++.+++.||.|||+.+   ++|+||+|.||++++++.++|+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998664322     45899999999999999999999999   9999999999999999999999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHh
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      |||++..+.............++..|+|||.+.+..++.++||||||+++|++++ |..||.....   ......    .
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~  232 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY----L  232 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHH----H
Confidence            9999875432221111122335667999999988889999999999999999998 9999754322   111111    1


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .........         ......+.+++.+||..+|++|||+.++++.|+.+.
T Consensus       233 ~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         233 KDGYRLAQP---------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HcCCCCCCC---------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111110000         011235778999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-38  Score=281.42  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=198.7

Q ss_pred             CCcceeecccCCccEEEEEEcC----CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-----
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-----  109 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-----  109 (358)
                      |++.+.||+|+||.||+|....    +..|++|.+...  .......+..|++.++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6788999999999999998643    367999988742  23445678899999999999999999998766544     


Q ss_pred             -eEEEEEecCCCCHHHHHhccc---cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecc
Q 018304          110 -KLLIYEFMTNKSLDSFIFDQE---RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF  185 (358)
Q Consensus       110 -~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df  185 (358)
                       .++++||+++++|..++....   ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999885432   2234899999999999999999999999   999999999999999999999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      |++.................+..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ........    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~----~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLR----H  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----c
Confidence            99886533222212222234567999999888889999999999999999999 8888754322   12221111    1


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ........         .....+.+++.+||+.+|++|||+.++++.|.++
T Consensus       231 ~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNRLKQPE---------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCCCCc---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111111         1223677899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.7e-39  Score=309.09  Aligned_cols=277  Identities=19%  Similarity=0.245  Sum_probs=199.7

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCC------CCccceeeEEEe
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQ  106 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~------~~iv~~~~~~~~  106 (358)
                      +....++|++.+.||+|+||+||+|.+.. ++.|+||++.... ........|+++++.++|      .++++++++|..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            33456899999999999999999998754 7889999986532 223345567777777654      458888888876


Q ss_pred             C-CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCC------
Q 018304          107 G-EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDM------  178 (358)
Q Consensus       107 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~------  178 (358)
                      . .+.++||+++ +++|.+++.+.   ..+++..++.++.||+.||.|||+ .+   |+||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            5 4788999988 66888888543   348999999999999999999998 48   99999999999998765      


Q ss_pred             ----------CeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCC
Q 018304          179 ----------NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHS  248 (358)
Q Consensus       179 ----------~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~  248 (358)
                                .+||+|||.+...     ........++..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      4999999987532     1122345689999999999999999999999999999999999999875443


Q ss_pred             CCCchhHHHHHH----HhhcCC----CCccc------cCCcCC-----------CCCHHHHHHHHHHHhhhcCCCCCCCC
Q 018304          249 DNNLNLIGHAWK----LWNEGM----PSQLI------DPCIQG-----------SFNLAEVIRCIHIGLLCVQQHPKDRP  303 (358)
Q Consensus       249 ~~~~~~~~~~~~----~~~~~~----~~~~~------~~~~~~-----------~~~~~~~~~l~~li~~cl~~~P~~Rp  303 (358)
                      ......+.....    .|....    ...+.      ......           .........+.+||.+||++||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            222111111100    000000    00000      000000           00011123567899999999999999


Q ss_pred             ChHHHHHHhccCCCCCCCCC
Q 018304          304 SMPSVILMLGSETVLPQPKQ  323 (358)
Q Consensus       304 t~~ell~~l~~~~~~~~~~~  323 (358)
                      |+.+++++-+.....+..++
T Consensus       431 ta~e~L~Hp~~~~~~~~~~~  450 (467)
T PTZ00284        431 NARQMTTHPYVLKYYPECRQ  450 (467)
T ss_pred             CHHHHhcCccccccCCcccc
Confidence            99999999888765554444

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.1e-39  Score=289.29  Aligned_cols=263  Identities=23%  Similarity=0.313  Sum_probs=192.5

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCccceeeEEEeC-----C
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG-----E  108 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~-----~  108 (358)
                      +|++.+.||+|++|.||+|.+.. ++.|++|.+....  ......+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            68999999999999999999764 8899999886422  11223445666666655   699999999988642     4


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999975 88888755432 23899999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ......   .......++..|+|||.+.+..++.++||||+||++|+|++|..||.......   ...............
T Consensus       156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED  229 (288)
T ss_pred             ccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence            765321   11223457889999999988899999999999999999999999975433221   111111111000000


Q ss_pred             c----------cccCCcCC---CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          269 Q----------LIDPCIQG---SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       269 ~----------~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .          ........   .........+.+++.+||+.||++|||+.+++.+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~  287 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF  287 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            0          00000000   000112235678999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-38  Score=285.92  Aligned_cols=257  Identities=28%  Similarity=0.437  Sum_probs=199.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcC------CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .+|++.+.||.|++|.||+|.+.+      ++.|++|.+...... ....+..|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            457899999999999999998632      478999999754332 3456788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccc-------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC
Q 018304          112 LIYEFMTNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM  178 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~  178 (358)
                      +++||+.+++|.+++....             ....+++..++.++.|++.||.|||+.+   ++||||||.||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            9999999999999984321             1234788889999999999999999999   99999999999999999


Q ss_pred             CeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHH
Q 018304          179 NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGH  257 (358)
Q Consensus       179 ~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~  257 (358)
                      .++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~  238 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEM  238 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence            999999999876532222222223345678999999988889999999999999999998 77776543221   11111


Q ss_pred             HHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                          ..........+         .....+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       239 ----i~~~~~~~~~~---------~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 ----IRNRQVLPCPD---------DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----HHcCCcCCCCC---------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                11111111111         112346689999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.8e-39  Score=286.76  Aligned_cols=255  Identities=23%  Similarity=0.381  Sum_probs=201.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .++|++.+.||+|++|.||+|.+. +++.|++|.++.........+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            468999999999999999999875 4889999998765555556678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++....   .+++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            99999999985433   4899999999999999999999999   999999999999999999999999998765321  


Q ss_pred             CCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          197 EGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ........++..|+|||.+.   ...++.++|+|||||++|+|++|..||........   ....   ............
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~---~~~~~~~~~~~~  233 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLM---TKSNFQPPKLKD  233 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhh---hccCCCCCcccc
Confidence            12223446788999999874   45688899999999999999999999744322111   1000   001111110100


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                          ..  .....+.+++.+||..+|++|||+.+|+++-
T Consensus       234 ----~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~  266 (267)
T cd06645         234 ----KM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQHP  266 (267)
T ss_pred             ----cC--CCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence                00  1123467899999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.4e-38  Score=283.23  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=200.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..++|++.++||+|++|.||+|.+.++..|++|.+.... .....+..|+++++.++|+||+++++++.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            347899999999999999999998777789999987532 233567889999999999999999998744 567899999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++..... ..+++..++.++.+++.||.+||+.+   ++|+||+|.||+++.++.++|+|||.+..+.....
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          82 MSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            999999999965332 33789999999999999999999999   99999999999999999999999999876532221


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      . ......++..|+|||...+..++.++|+||||+++|+|++ |..||......   .......    ......      
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~~----~~~~~~------  223 (262)
T cd05071         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVE----RGYRMP------  223 (262)
T ss_pred             c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHHh----cCCCCC------
Confidence            1 1112335567999999888889999999999999999999 78787543221   1111111    111000      


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         ........+.+++.+||+.+|++|||+.++++.|+..
T Consensus       224 ---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               0112234677899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-38  Score=283.28  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=204.1

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||.|++|.||++.+. ++..+++|.+...   .......+.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57899999999999999999964 5889999987642   2334457788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          115 EFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||+++++|.+++.... ....+++..++.++.++++|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886432 2345899999999999999999999999   99999999999999999999999999876532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....    .............  
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~~~~~~~~~~--  229 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSL----CKKIEQCDYPPLP--  229 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHH----hhhhhcCCCCCCC--
Confidence            211  112345778999999998888999999999999999999999997532211 0011    1111111111110  


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            .......+.+++.+||..+|++|||+.+|++.+...
T Consensus       230 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         230 ------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                  011233577899999999999999999999988754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-38  Score=286.14  Aligned_cols=265  Identities=25%  Similarity=0.325  Sum_probs=198.2

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||+|++|.||+|.+. +++.|++|.+....  ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5899999999999999999975 48899999886432  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +. ++|.+++........+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 588888866544455899999999999999999999999   9999999999999999999999999987643211 


Q ss_pred             CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC--------CC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG--------MP  267 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~  267 (358)
                       .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.......   ........+...        ..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID---QLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCChhhhhcchh
Confidence             111223467889999987654 57889999999999999999999986433211   111110000000        00


Q ss_pred             -Cc---cccCCcCCC---CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          268 -SQ---LIDPCIQGS---FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       268 -~~---~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                       ..   .........   .......++.++|.+||..||.+|||+.+|+++-+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~  284 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY  284 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence             00   000000000   00011235678999999999999999999998743

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.9e-38  Score=283.44  Aligned_cols=257  Identities=29%  Similarity=0.445  Sum_probs=199.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .++|.+.+.||+|++|.||+|.+..      +..|++|.+.... ......+..|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4679999999999999999998753      4678899886433 33345678899999999999999999999988899


Q ss_pred             EEEEEecCCCCHHHHHhcccc----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC---CeEEe
Q 018304          111 LLIYEFMTNKSLDSFIFDQER----CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS  183 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~---~i~L~  183 (358)
                      +++|||+++++|.+++.....    ...+++..++.++.||+.|+.|||+.+   ++|+||+|+||+++.++   .++|+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865432    124889999999999999999999999   99999999999998654   59999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHh
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      |||++..+..............+..|+|||.+.+..++.++|||||||++|+|++ |..||......   .......   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~---  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVT---  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---
Confidence            9999876532221111112223467999999988899999999999999999997 98887643322   1111111   


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                       ........     ..    ....+.+++.+||+.+|++|||+.+|+++|.
T Consensus       236 -~~~~~~~~-----~~----~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 -GGGRLDPP-----KG----CPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -cCCcCCCC-----CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             11111110     11    1235678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.6e-39  Score=292.62  Aligned_cols=245  Identities=25%  Similarity=0.302  Sum_probs=191.2

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||+|.++. +..|++|.+....   .........|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999764 8899999986521   22345566777777765 899999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~  152 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNR  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCc
Confidence            99999885533   3889999999999999999999999   99999999999999999999999999864311  1112


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|+..|+|||.+.+..++.++||||+||++|+|++|..||...+..   .......    ... ..+.     .. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~----~~~-~~~~-----~~-  218 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIR----VDT-PHYP-----RW-  218 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCC-CCCC-----CC-
Confidence            23456899999999999889999999999999999999999998643221   1111111    111 1111     11 


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChH-HHHHHhcc
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMP-SVILMLGS  314 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~l~~  314 (358)
                         ...++.+++.+||+.||++||++. +++++.+.
T Consensus       219 ---~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f  251 (316)
T cd05620         219 ---ITKESKDILEKLFERDPTRRLGVVGNIRGHPFF  251 (316)
T ss_pred             ---CCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence               123566899999999999999985 67655443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-38  Score=289.03  Aligned_cols=266  Identities=28%  Similarity=0.413  Sum_probs=205.6

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGC  103 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~  103 (358)
                      +....++|.+.+.||+|+||.||++...        ++..+++|.+... .......+.+|+..++.+ +||||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3455688999999999999999999741        2347899988643 234456788999999999 89999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 018304          104 CIQGEEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKAS  170 (358)
Q Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~  170 (358)
                      +......+++|||+.+++|.+++.....             ...++...++.++.||+.||.|||+++   ++|+||+|+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence            9999999999999999999999965421             134788889999999999999999999   999999999


Q ss_pred             cEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCC
Q 018304          171 NVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD  249 (358)
Q Consensus       171 Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~  249 (358)
                      ||+++.++.++|+|||.+..+.............++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999886533222212222334567999999988889999999999999999998 77776433211


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                         ...    ............         ......+.+++.+||..+|++|||+.++++.|..+...
T Consensus       247 ---~~~----~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 ---ELF----KLLKEGHRMDKP---------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ---HHH----HHHHcCCcCCCC---------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence               111    111111111111         01124567899999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=293.32  Aligned_cols=259  Identities=20%  Similarity=0.245  Sum_probs=197.3

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||++.+.. ++.|++|.+.+   ........+.+|..++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            579999999999999999999754 88999999864   22334456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++.+..  ..+++..+..++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999986532  23899999999999999999999999   999999999999999999999999998765322


Q ss_pred             CCCCccccccccCCCCCcccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .. .......|++.|+|||++.+     ..++.++||||+||++|+|++|..||......   ......   ........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~~~~i---~~~~~~~~  228 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKI---MNHKEHFQ  228 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HHHHHH---HcCCCccc
Confidence            11 11223458999999998863     45788999999999999999999998543221   111111   11111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCC--CCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPK--DRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~--~Rpt~~ell~~l~~~  315 (358)
                      +....      ......+.+++.+||+.+++  .|+++.+++++-+..
T Consensus       229 ~~~~~------~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~  270 (331)
T cd05597         229 FPPDV------TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE  270 (331)
T ss_pred             CCCcc------CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence            11100      00123456788887765443  378999999987653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.4e-38  Score=285.85  Aligned_cols=257  Identities=30%  Similarity=0.450  Sum_probs=200.4

Q ss_pred             CCCcceeecccCCccEEEEEEcC------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      +|++.+.||+|+||.||+|.+..      ...+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58899999999999999998532      2468888876533 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccc---------------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 018304          113 IYEFMTNKSLDSFIFDQE---------------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN  171 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~N  171 (358)
                      ++||+.+++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++|+||+|+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999985421                     1134788999999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCC
Q 018304          172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN  250 (358)
Q Consensus       172 ilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~  250 (358)
                      |++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999876532222112222335668999999888889999999999999999998 99887543211 


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                        ...    ...........     ..    .....+.+++.+||+.+|++||++.++++.|+.+
T Consensus       237 --~~~----~~~~~~~~~~~-----~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         237 --RLF----NLLKTGYRMER-----PE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             --HHH----HHHhCCCCCCC-----CC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence              111    11111111110     01    1123577899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.8e-39  Score=288.92  Aligned_cols=264  Identities=25%  Similarity=0.406  Sum_probs=199.8

Q ss_pred             cCCCCcceeecccCCccEEEEEE-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Cee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~  110 (358)
                      .++|++++.||+|+||.||++..     ..+..|++|.+..........+.+|+++++.++||||+++++++...  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46899999999999999999974     24789999999876666677889999999999999999999987543  467


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++|+||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            89999999999999986432  23889999999999999999999999   99999999999999999999999999886


Q ss_pred             cCCCCCCC-ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCC--------C-chhHHHHHH
Q 018304          191 FGGDETEG-NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN--------N-LNLIGHAWK  260 (358)
Q Consensus       191 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~--------~-~~~~~~~~~  260 (358)
                      +....... ......++..|+|||.+.+..++.++||||||+++|+|++|..++.......        . .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            53221111 1111123445999999988889999999999999999999877643221100        0 000000000


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .........         ........+.+++.+||..+|++|||+.+|+..|+.+
T Consensus       238 ~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGRLP---------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000000000         0011123577899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.4e-39  Score=295.41  Aligned_cols=238  Identities=23%  Similarity=0.285  Sum_probs=184.5

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHH-HHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~-~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||++.+.. ++.|++|++.+..   ......+..|. .+++.++|+||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            479999999999999764 7789999986522   12223333343 456778999999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+.+..+..++.||++||.|||+.|   ++||||||+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~  152 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGT  152 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCC
Confidence            99999885533   3888899999999999999999999   99999999999999999999999999875321  1122


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||......   .......   ...  ..+.        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~---~~~--~~~~--------  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNIL---NKP--LQLK--------  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHHH---hCC--cCCC--------
Confidence            33456899999999999999999999999999999999999998643221   1111111   110  0110        


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChHH
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMPS  307 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~e  307 (358)
                       ......+.+++.+||+.+|.+||++.+
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         217 -PNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence             011235667999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-38  Score=289.31  Aligned_cols=259  Identities=29%  Similarity=0.419  Sum_probs=200.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC--------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG  107 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~--------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~  107 (358)
                      .++|.+.+.||+|+||.||++.+..        ...+++|.+... .......+..|+++++.+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4789999999999999999997532        246999988753 234456688899999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL  174 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv  174 (358)
                      +..++||||+.+++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||+|+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999965421             124888999999999999999999999   9999999999999


Q ss_pred             cCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCch
Q 018304          175 DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLN  253 (358)
Q Consensus       175 ~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~  253 (358)
                      +.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......   .
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---H
Confidence            9999999999999875432111111111223467999999988889999999999999999998 88887432211   1


Q ss_pred             hHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          254 LIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...    ............         .....+.+++.+||..+|++|||+.++++.|+.+
T Consensus       251 ~~~----~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         251 LFK----LLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHH----HHHcCCCCCCCC---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            111    111111111111         1123667899999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-38  Score=281.16  Aligned_cols=253  Identities=27%  Similarity=0.421  Sum_probs=203.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .++|++.+.||+|++|.||+|.+.. ++.+++|.+.....  ...+.+|+++++.++|+||+++++++.+....++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3689999999999999999999865 78999999875432  67889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++....  ..+++..++.++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||++....... 
T Consensus        80 ~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-  153 (256)
T cd06612          80 CGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-  153 (256)
T ss_pred             CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence            99999999985433  34899999999999999999999999   9999999999999999999999999988653221 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       .......++..|+|||.+.+..++.++||||||+++|+|++|..||...........       ........+      
T Consensus       154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~------  219 (256)
T cd06612         154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNKPPPTL------  219 (256)
T ss_pred             -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccCCCCCC------
Confidence             122234477889999999888999999999999999999999999865332211100       000000000      


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                       .........+.+++.+||+.+|++|||+.+++++-+
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~  255 (256)
T cd06612         220 -SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF  255 (256)
T ss_pred             -CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence             001112245778999999999999999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.8e-39  Score=293.90  Aligned_cols=244  Identities=25%  Similarity=0.317  Sum_probs=190.9

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||+|.+.. ++.|++|.+....   .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999765 7899999986531   22334556677777765 899999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAK  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCc
Confidence            9999998543   33889999999999999999999999   999999999999999999999999998753211  112


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|++.|+|||.+.+..++.++||||+||++|+|++|..||......   .......    ...+ .+     ... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~----~~~~-~~-----~~~-  218 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR----MDNP-CY-----PRW-  218 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCCC-CC-----Ccc-
Confidence            23456889999999999889999999999999999999999998643321   1111111    1110 00     011 


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChH-HHHHHhc
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMP-SVILMLG  313 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~l~  313 (358)
                         ....+.+++.+||+.+|++||++. +++++-+
T Consensus       219 ---~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~  250 (316)
T cd05619         219 ---LTREAKDILVKLFVREPERRLGVKGDIRQHPF  250 (316)
T ss_pred             ---CCHHHHHHHHHHhccCHhhcCCChHHHHcCcc
Confidence               123466899999999999999997 7766533

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=280.72  Aligned_cols=255  Identities=22%  Similarity=0.389  Sum_probs=204.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .++|++.+.||.|++|.||+|.+.. ++.+++|.+..........+.+|+++++.++||||+++++++.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            4689999999999999999998754 788999999876666678889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++....  ..+++..++.++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||.+......  
T Consensus        82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--  154 (262)
T cd06613          82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--  154 (262)
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh--
Confidence            99999999886542  33899999999999999999999999   999999999999999999999999998764321  


Q ss_pred             CCccccccccCCCCCcccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ........++..|+|||.+.+.   .++.++|+||||+++|+|++|..||......   ...   .............  
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~---~~~~~~~~~~~~~--  226 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RAL---FLISKSNFPPPKL--  226 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhccCCCccc--
Confidence            1112234577789999998766   7899999999999999999999997543221   111   1111110000000  


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                          .........+.+++.+||..+|.+|||+.+++.+
T Consensus       227 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 ----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                0112233467889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.3e-38  Score=281.99  Aligned_cols=261  Identities=26%  Similarity=0.393  Sum_probs=201.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~----~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..+|++++.||.|++|.||+|.+.. +.    .|++|.+... .......+.+|+.++..++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            4688999999999999999998643 44    4889988653 33445677889999999999999999998865 4578


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ++++|+++|+|.+++....  +.+++..++.++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++..+
T Consensus        85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            9999999999999985533  34899999999999999999999999   999999999999999999999999998876


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .............++..|+|||...+..++.++|||||||++|+|++ |..||......   ....    .+........
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~~~  232 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPD----LLEKGERLPQ  232 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCcCCC
Confidence            32221111112234567999999988889999999999999999998 88887543221   1111    1111111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQ  320 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~  320 (358)
                      .         ......+.+++.+||..||++||++.++++.|......+.
T Consensus       233 ~---------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         233 P---------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             C---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence            0         0112356789999999999999999999999887765553

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.2e-39  Score=299.65  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=198.1

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||++.+.. ++.|++|++...   .......+..|+.++..++|++|+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            479999999999999999998754 889999998642   2334566778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++.+..   .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999985533   3899999999999999999999999   999999999999999999999999998654211


Q ss_pred             CCC---------------------------------CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCC
Q 018304          195 ETE---------------------------------GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKK  241 (358)
Q Consensus       195 ~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  241 (358)
                      ...                                 .......|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            000                                 00112358899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC---hHHHHHHhccC
Q 018304          242 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS---MPSVILMLGSE  315 (358)
Q Consensus       242 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~ell~~l~~~  315 (358)
                      ||......   .....+.. +..  ...+...     .  .....+.++|.+|+ .+|.+|++   +.+++++-+..
T Consensus       235 Pf~~~~~~---~~~~~i~~-~~~--~~~~p~~-----~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~  297 (360)
T cd05627         235 PFCSETPQ---ETYRKVMN-WKE--TLVFPPE-----V--PISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE  297 (360)
T ss_pred             CCCCCCHH---HHHHHHHc-CCC--ceecCCC-----C--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCC
Confidence            98654322   11111110 000  0001100     0  01234556777766 49999985   78888876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-38  Score=298.80  Aligned_cols=265  Identities=20%  Similarity=0.212  Sum_probs=196.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +.+|.+.+.||+|+||.||++.+.. ++.|++|....      ....+|+++++.++|+||+++++++..+...+++||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5589999999999999999999755 78899996432      2356899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +. ++|.+++....  ..+++..++.++.|++.||.|||+++   |+|+||||+|||++.++.++|+|||++..+.....
T Consensus       242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 58888875432  24899999999999999999999999   99999999999999999999999999876533222


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCC-CCCCCCCCc---hhHHHHHHHhh--cCCCCcc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNR-GFYHSDNNL---NLIGHAWKLWN--EGMPSQL  270 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~-~~~~~~~~~---~~~~~~~~~~~--~~~~~~~  270 (358)
                      ........|+..|+|||++.+..++.++|||||||++|+|++|..++ .........   ..+........  .......
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            22222356899999999999999999999999999999999987653 221111100   11111111000  0000000


Q ss_pred             cc----------------CCcCCCCCH---HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          271 ID----------------PCIQGSFNL---AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       271 ~~----------------~~~~~~~~~---~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ..                .........   .....+.+||.+||+.||.+|||+.|+|++-+.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence            00                000000000   111256789999999999999999999998665

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.3e-38  Score=280.71  Aligned_cols=256  Identities=26%  Similarity=0.434  Sum_probs=195.2

Q ss_pred             CCcceeecccCCccEEEEEEcC-CC--EEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC------Ce
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQ--EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EE  109 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~--~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~------~~  109 (358)
                      |.+.+.||+|+||.||+|.+.. +.  .+++|.++..  .......+..|++.++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578899999999999998755 32  6899987642  345567788899999999999999999876432      24


Q ss_pred             eEEEEEecCCCCHHHHHhccc---cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQE---RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      .+++|||+.+++|.+++....   ....+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999874321   2234889999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      ++..+..............+..|++||...+..++.++||||||+++|+|++ |..||.....   ......    ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~----~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDY----LRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHcC
Confidence            9886532221111222335668999999988889999999999999999999 7888754222   111111    1111


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .......         .....+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       231 ~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRLKQPP---------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111111         1123467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-38  Score=281.96  Aligned_cols=255  Identities=24%  Similarity=0.281  Sum_probs=206.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      +.|++++.||.|.-|+||++...+ +..+|+|++.+   .......++..|-++|..++||.++.+|..|+.+...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            578999999999999999999765 68999999976   23445566778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |||.||+|..+.+++.. +.+++..++.++..++.||+|||-.|   |++|||||+||||.++|++.|+||.++..+...
T Consensus       157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999887655 34999999999999999999999999   999999999999999999999999986543110


Q ss_pred             C-----------------------------C-C------------------------CccccccccCCCCCcccccCCCC
Q 018304          195 E-----------------------------T-E------------------------GNTKRVIGTYGYMAPEYASDGQF  220 (358)
Q Consensus       195 ~-----------------------------~-~------------------------~~~~~~~~~~~y~aPE~~~~~~~  220 (358)
                      .                             . .                        .......||..|+|||++.|..-
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence            0                             0 0                        00112358889999999999999


Q ss_pred             CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCC
Q 018304          221 SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPK  300 (358)
Q Consensus       221 ~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  300 (358)
                      +.+.|+|+||+++|||+.|..||...+......-+  +.      .+..+...       ......+.|||++.|..||+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v~------~~l~Fp~~-------~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--VG------QPLKFPEE-------PEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--hc------CCCcCCCC-------CcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999876655332211  11      11111111       12234577899999999999


Q ss_pred             CCCC----hHHHHHHh
Q 018304          301 DRPS----MPSVILML  312 (358)
Q Consensus       301 ~Rpt----~~ell~~l  312 (358)
                      +|.-    +.||-++-
T Consensus       378 kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHP  393 (459)
T ss_pred             hhhccccchHHhhcCc
Confidence            9998    88988765

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.2e-39  Score=287.37  Aligned_cols=257  Identities=26%  Similarity=0.350  Sum_probs=202.6

Q ss_pred             CCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      |++.+.||.|++|.||++.+.. +..+++|.+..........+.+|+++++.++|+|++++++++..++..++|+||+.+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            7889999999999999999765 778899988776666677788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|..++.+..  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~  159 (282)
T cd06643          87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  159 (282)
T ss_pred             CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--ccc
Confidence            99998875422  34899999999999999999999999   999999999999999999999999998654211  112


Q ss_pred             cccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          200 TKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .....++..|+|||.+.     +..++.++|+||+||++|+|++|..||......   .......    .........  
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~--  230 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIA----KSEPPTLAQ--  230 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHHHh----hcCCCCCCC--
Confidence            22345788999999873     345788999999999999999999997543221   1111111    111111100  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                       .    ......+.++|.+||..+|.+|||+.+++.+.+....-
T Consensus       231 -~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         231 -P----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             -c----cccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence             0    01123567899999999999999999999887755443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.1e-38  Score=284.05  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=200.4

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE  108 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  108 (358)
                      ...++|++.+.||+|++|.||+|..++      +..|++|.+.... ......+.+|+..++.++|+||+++++++.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            345789999999999999999997532      4579999886432 223345678999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcccc-------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeE
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQER-------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK  181 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~  181 (358)
                      ..++||||+.+++|.+++.+...       ........++.++.|++.||.|||+++   ++|+||+|+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999965321       233567788999999999999999999   99999999999999999999


Q ss_pred             EeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHH
Q 018304          182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~  260 (358)
                      |+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||......   .....   
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~---  233 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKF---  233 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---
Confidence            999999875432221111122234567999999988889999999999999999998 67786532211   11111   


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ...........         .....+.+++.+||+.+|++|||+.++++.+...
T Consensus       234 -~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 -VMDGGYLDQPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -HHcCCCCCCCC---------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence             11111111110         0123677899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.1e-38  Score=288.04  Aligned_cols=258  Identities=19%  Similarity=0.219  Sum_probs=197.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||++.+.. ++.|++|.+.+.   .......+.+|..++..++|++|+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            579999999999999999999754 788999998642   2233455778899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++....  ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999996532  23889999999999999999999999   999999999999999999999999998765322


Q ss_pred             CCCCccccccccCCCCCcccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .. .......|++.|+|||.+.+     ..++.++||||+|+++|+|++|..||......   ......   ........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i---~~~~~~~~  228 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKI---MNHEERFQ  228 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HHHHHH---HcCCCccc
Confidence            11 11223468999999998865     46788999999999999999999998543221   111111   11111001


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCC--CCChHHHHHHhcc
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKD--RPSMPSVILMLGS  314 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~l~~  314 (358)
                      +....      ......+.+++.+||+..+.+  |+++.+++.+.+.
T Consensus       229 ~p~~~------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f  269 (331)
T cd05624         229 FPSHI------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF  269 (331)
T ss_pred             CCCcc------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence            11000      011235667888999876544  5689999887654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2e-38  Score=290.78  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=194.5

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      +|++.+.||+|+||.||+|.+.. ++.|++|++.+.   .......+..|..++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47889999999999999998754 889999998752   2233455677888888885 577888999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999885433   3899999999999999999999999   999999999999999999999999998753211


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                        ........|++.|+|||.+.+..++.++||||+||++|+|++|..||......   ........   ..  ..+.   
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~---~~--~~~p---  221 (323)
T cd05615         155 --GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIME---HN--VSYP---  221 (323)
T ss_pred             --CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---CC--CCCC---
Confidence              11223445889999999999889999999999999999999999998653321   11111111   11  0111   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh-----HHHHHHh
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM-----PSVILML  312 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~l  312 (358)
                        ..    ....+.+++.+||+.+|.+|++.     .++.++-
T Consensus       222 --~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~  258 (323)
T cd05615         222 --KS----LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA  258 (323)
T ss_pred             --cc----CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCc
Confidence              11    12356689999999999999984     5666553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.8e-38  Score=281.00  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=197.3

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CC----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~----~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ++|++.+.||.|++|.||+|.+.. +.    .+++|.+.... ......+..|+..+..++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            678999999999999999998743 43    47778775432 233456777888889999999999999875 456788


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ++||+.+++|.+++....  +.+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+....
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999986533  34899999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .    ...+.........
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~~~~  233 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGERLAQP  233 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcCCCC
Confidence            2222122223446678999999988899999999999999999998 988875432211   1    1111111111100


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .      .   ....+.+++.+||..+|++|||+.++++.|....-
T Consensus       234 ~------~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         234 Q------I---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             C------C---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            0      0   12346678999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.3e-38  Score=313.32  Aligned_cols=259  Identities=23%  Similarity=0.296  Sum_probs=198.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL  111 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~  111 (358)
                      ..++|++++.||.|+||.||++.+.. +..+++|.+..  ........+..|+.+++.++||||++++++|.+.  ..++
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            44799999999999999999999765 67888998864  2344556788999999999999999999988654  4689


Q ss_pred             EEEEecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCC----CCcccCCCCCCcEEEcC----------
Q 018304          112 LIYEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSR----LRIIHRDLKASNVLLDQ----------  176 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~----~~i~H~di~~~Nilv~~----------  176 (358)
                      +||||+.+++|.+++.... ....+++..++.++.||+.||.|||+.+.    .+|+|+||+|+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999986532 23459999999999999999999998431    23999999999999964          


Q ss_pred             -------CCCeEEeccccceecCCCCCCCccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCCC
Q 018304          177 -------DMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNRGFYH  247 (358)
Q Consensus       177 -------~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~  247 (358)
                             .+.++|+|||++..+...   .......+++.|+|||++.+  ..++.++|||||||++|+|++|..||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   234899999998765321   12234468999999998854  458899999999999999999999985432


Q ss_pred             CCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          248 SDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ..   .   .....+....  .+..    .    .....+.+||.+||..+|.+|||+.+++.+-+.
T Consensus       248 ~~---~---qli~~lk~~p--~lpi----~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        248 NF---S---QLISELKRGP--DLPI----K----GKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             cH---H---HHHHHHhcCC--CCCc----C----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            21   1   1111111111  0000    0    012356789999999999999999999975443

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-38  Score=280.20  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=204.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++.+.||.|++|.||+|.+.. ++.|++|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            479999999999999999999754 8899999986533 33456678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++...    .+++..++.++.|++.|+.+||+.+   ++|+||+|+||++++++.++|+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999998643    4899999999999999999999999   9999999999999999999999999998764221 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......   .......    ......+...   
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~----~~~~~~~~~~---  221 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLFLIP----KNNPPSLEGN---  221 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHHHhh----hcCCCCCccc---
Confidence             1222345778899999998888999999999999999999999998644321   1111111    1111111111   


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       .    ....+.+++.+||..+|++|||+.+++++-+..
T Consensus       222 -~----~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~  255 (274)
T cd06609         222 -K----FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIK  255 (274)
T ss_pred             -c----cCHHHHHHHHHHhhCChhhCcCHHHHhhChhhc
Confidence             0    223567899999999999999999999875554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-39  Score=297.04  Aligned_cols=268  Identities=22%  Similarity=0.289  Sum_probs=199.7

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--  107 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--  107 (358)
                      .+....++|++++.||.|+||.||+|.+. +++.|++|.+....  ......+.+|+.+++.++|+||+++++++...  
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878           9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            34455689999999999999999999875 47899999986532  22345567899999999999999999887543  


Q ss_pred             ----CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEe
Q 018304          108 ----EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS  183 (358)
Q Consensus       108 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~  183 (358)
                          ...+++++++ +++|.+++..    ..+++..+..++.||+.||.|||+++   ++|+||+|+||+++.++.++|+
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence                3468999988 6799888743    23999999999999999999999999   9999999999999999999999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      |||++.....     ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......   .+.......
T Consensus       161 Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~  232 (343)
T cd07878         161 DFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVV  232 (343)
T ss_pred             CCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHh
Confidence            9999876432     1223457889999998876 578899999999999999999999986533211   111111100


Q ss_pred             hcCCCCcccc------------CCcC-CCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          263 NEGMPSQLID------------PCIQ-GSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       263 ~~~~~~~~~~------------~~~~-~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                       .........            .... .....     .....+.+++.+||+.||.+|||+.+++++-+....
T Consensus       233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         233 -GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             -CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence             000000000            0000 00000     001235689999999999999999999998776543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.5e-38  Score=278.12  Aligned_cols=256  Identities=30%  Similarity=0.441  Sum_probs=202.7

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ...++|++.+.||+|++|.||++.+.++..+++|.+... ......+.+|+++++.++|+||+++++++.+ ...+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            356899999999999999999998877888999988653 3345678889999999999999999999877 77899999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++..... ..+++..+..++.+++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          81 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             eCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999999999966433 33788899999999999999999999   9999999999999999999999999987653221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      . .......++..|+|||.+.+..++.++|+||||+++|++++ |..||......   ......    .........   
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~~~~---  225 (260)
T cd05073         157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYRMPRP---  225 (260)
T ss_pred             c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCCCCCCCc---
Confidence            1 11112234567999999988889999999999999999998 88887543221   111111    111111111   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                            ......+.+++.+||+.+|++||++.++++.|+.
T Consensus       226 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         226 ------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  1122357789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.9e-38  Score=277.25  Aligned_cols=250  Identities=27%  Similarity=0.407  Sum_probs=197.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEE-eCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~~~~lv~e~  116 (358)
                      .++|++.+.||+|++|.||++.. .+..+++|.+....  ....+.+|+.+++.++|+|++++++++. .++..++++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            36899999999999999999976 58889999886533  3456889999999999999999998754 45678999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++..... ..+++..++.++.+++.||.+||+++   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          82 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999999865432 33889999999999999999999999   9999999999999999999999999987542211 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                          .....+..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ........    ........+   
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~~---  222 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE----KGYKMDAPD---  222 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh----cCCCCCCCC---
Confidence                12234567999999988889999999999999999997 8888753321   11111111    111111111   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            .....+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       223 ------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         223 ------GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  1123567899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3e-38  Score=286.09  Aligned_cols=257  Identities=23%  Similarity=0.383  Sum_probs=205.0

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      ++|++.+.||.|++|.||+|.+. +++.|++|.+..........+.+|+..++.++|+|++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            57999999999999999999864 58999999987655555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      .+++|.+++...    .+++..+..++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--  169 (296)
T cd06655          99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--  169 (296)
T ss_pred             CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc--
Confidence            999999988532    3889999999999999999999999   9999999999999999999999999987643221  


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......   .....   .... ...+..   ..
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~---~~~~~---~~~~-~~~~~~---~~  239 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLI---ATNG-TPELQN---PE  239 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhcC-CcccCC---cc
Confidence            11223457788999999988889999999999999999999999985533211   11111   1111 111000   00


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      .    ....+.++|.+||..+|++|||+.+++.+-+.....
T Consensus       240 ~----~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         240 K----LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             c----CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            1    112466799999999999999999999876665433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-39  Score=296.39  Aligned_cols=267  Identities=29%  Similarity=0.440  Sum_probs=210.3

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcC--C--CE-EEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVD--G--QE-IAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCI  105 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~--~--~~-v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  105 (358)
                      +....++..+.++||+|+||.||+|..+.  +  .. ||+|....   ........+.+|++++++++||||+++|++..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33444566888999999999999998533  2  23 89998874   44677888999999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecc
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF  185 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df  185 (358)
                      ...-+++|||+|.||+|.+++.+...  .++......++.+.+.||+|||+++   ++||||..+|+|++.++.+|++||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence            99999999999999999999977654  3999999999999999999999999   999999999999999999999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      |++....  ..........-...|+|||.+....|+.++||||||+++||+++ |..||......   .+...+   ...
T Consensus       307 GLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI---~~~  378 (474)
T KOG0194|consen  307 GLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI---VKN  378 (474)
T ss_pred             ccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---Hhc
Confidence            9987532  11111112234578999999999999999999999999999999 77776543322   222222   112


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCC
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK  322 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~  322 (358)
                      +.......         .....+..++.+||..+|++||||.++.+.++.+.....+.
T Consensus       379 ~~r~~~~~---------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  379 GYRMPIPS---------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             CccCCCCC---------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence            22221111         11224456788999999999999999999999887665553

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.7e-39  Score=293.13  Aligned_cols=243  Identities=23%  Similarity=0.275  Sum_probs=187.7

Q ss_pred             eeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHH-HHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||++.+. +|+.|++|++.+.   .......+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999875 4889999998652   1223334445544 46778999999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|..++...   ..+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~  152 (325)
T cd05604          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDT  152 (325)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCC
Confidence            9999888543   34899999999999999999999999   99999999999999999999999999864311  1122


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..   .......    .... .+     ..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~~~----~~~~-~~-----~~--  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNIL----HKPL-VL-----RP--  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHHHHH----cCCc-cC-----CC--
Confidence            23456889999999999999999999999999999999999998643221   1111111    1100 00     00  


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChH----HHHHHh
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMP----SVILML  312 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~----ell~~l  312 (358)
                        .....+.+++.+||+.+|.+||++.    +++++.
T Consensus       218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~  252 (325)
T cd05604         218 --GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHP  252 (325)
T ss_pred             --CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCC
Confidence              1123466799999999999999885    555543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-38  Score=295.58  Aligned_cols=265  Identities=23%  Similarity=0.281  Sum_probs=199.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----  107 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----  107 (358)
                      ...++|++.+.||+|+||.||++++.. ++.|++|.+...  .......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            345899999999999999999999754 889999998652  233456677899999999999999999887543     


Q ss_pred             -CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          108 -EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       108 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                       ...++||||+.+ +|.+++..     .++...++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence             357999999975 77776632     2788899999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhh---
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN---  263 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  263 (358)
                      ++......   .......++..|+|||++.+..++.++|||||||++|+|++|..||...+...   ..........   
T Consensus       172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~  245 (364)
T cd07875         172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPC  245 (364)
T ss_pred             CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence            99764221   12233467889999999999999999999999999999999999986543221   1111111000   


Q ss_pred             ---------------cCCC--C-----ccccCCc---CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          264 ---------------EGMP--S-----QLIDPCI---QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       264 ---------------~~~~--~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                     ...+  .     .+.....   ...........+.++|.+||+.||.+|||+.+++++.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~  322 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  322 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                           0000  0     0000000   0000111223567899999999999999999999987764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-38  Score=292.56  Aligned_cols=193  Identities=22%  Similarity=0.332  Sum_probs=163.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ....+|++++.||+|++|.||+|.+.. +..|++|.....      ....|+.+++.++|+||+++++++......++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            344689999999999999999999754 678999975432      2346899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |++. ++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.++|+|||.+..... 
T Consensus       137 e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-  209 (357)
T PHA03209        137 PHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-  209 (357)
T ss_pred             EccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc-
Confidence            9995 58888775432  34899999999999999999999999   99999999999999999999999999875321 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNR  243 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  243 (358)
                        ........|+..|+|||.+.+..++.++|||||||++|+|+++..++
T Consensus       210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 --APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              11222345889999999999889999999999999999999865553

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-38  Score=283.54  Aligned_cols=261  Identities=24%  Similarity=0.348  Sum_probs=205.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .++|++++.||+|++|.||++.+.. ++.|++|.+.... ......+.+|+++++.++||||+++++++......++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            3689999999999999999999754 8889999876532 3445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |+++++|.+++...   +.+++..+..++.+++.|+.|||+ .+   ++|+||+|+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            99999999988543   348999999999999999999997 57   999999999999999999999999987653211


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC-----chhHHHHHHHhhcCCCCc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN-----LNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  269 (358)
                          ......++..|+|||.+.+..++.++|+|||||++|+|++|..||........     ............ .....
T Consensus       158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  232 (284)
T cd06620         158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPR  232 (284)
T ss_pred             ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCC
Confidence                12234678899999998888899999999999999999999999875443211     111111111111 11111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      +..        ......+.+++.+||+.+|++|||+.+++.+.+.+..
T Consensus       233 ~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         233 LPS--------SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CCc--------hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            111        0122357789999999999999999999998766543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.8e-38  Score=282.69  Aligned_cols=255  Identities=24%  Similarity=0.303  Sum_probs=199.0

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .|+..+.||+|+||.||++.+. +++.+++|.+....   ......+.+|+++++.++|+||+.+.+.+.+++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4788899999999999999875 48899999886422   2233456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05632          81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-  155 (285)
T ss_pred             eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence            9999999988865432 24899999999999999999999999   999999999999999999999999998764221 


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........   ........... ..+.    
T Consensus       156 --~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~-~~~~----  225 (285)
T cd05632         156 --ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE-EVYS----  225 (285)
T ss_pred             --CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc-cccC----
Confidence              1122346789999999998889999999999999999999999998643221111   11111111110 0110    


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhcc
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGS  314 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~  314 (358)
                       .    .....+.+|+.+||+.+|++|||     +.+++.+-+.
T Consensus       226 -~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05632         226 -A----KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF  264 (285)
T ss_pred             -c----cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence             1    11224567999999999999999     7788876443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-38  Score=296.54  Aligned_cols=269  Identities=23%  Similarity=0.281  Sum_probs=199.8

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----  108 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----  108 (358)
                      ...++|++.+.||+|+||.||++.+. .++.|++|.+...  .......+.+|+.+++.++|+||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45589999999999999999999875 4889999998652  3334566778999999999999999999886543    


Q ss_pred             --eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          109 --EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       109 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                        ..+++|||+.+ ++.+.+..     .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence              56999999975 66666532     2788999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHH---------
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGH---------  257 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~---------  257 (358)
                      ++.....   ........++..|+|||.+.+..++.++|||||||++|+|++|..||...+..........         
T Consensus       165 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         165 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9876422   1122334678999999999988999999999999999999999999865432111000000         


Q ss_pred             ------HHHHhhcCCC-------Cc-cccCCcC--CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          258 ------AWKLWNEGMP-------SQ-LIDPCIQ--GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       258 ------~~~~~~~~~~-------~~-~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                            ....+....+       .. ..+....  ..........+.++|.+||+.||++|||+.+++++.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence                  0000000000       00 0000000  0001112245678999999999999999999999876653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-37  Score=275.39  Aligned_cols=251  Identities=25%  Similarity=0.343  Sum_probs=199.5

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-CeeEEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYE  115 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv~e  115 (358)
                      +|++.+.||.|++|.||++.+.. ++.|++|.+...  .......+.+|+++++.++|+|++++++.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            58999999999999999999754 788999998642  234456678899999999999999999887643 46789999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++..... ..+++..++.++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999999999865332 34899999999999999999999999   9999999999999999999999999987653221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..   .......    .......     
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~----~~~~~~~-----  222 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYRII----EGKLPPM-----  222 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH----hcCCCCC-----
Confidence              1223445788999999999889999999999999999999999997543211   1111111    1111111     


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                          .......+.+++.+||+.+|++|||+.+++.+-
T Consensus       223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~  255 (257)
T cd08223         223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILRQP  255 (257)
T ss_pred             ----ccccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence                111224677899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-38  Score=285.06  Aligned_cols=267  Identities=23%  Similarity=0.320  Sum_probs=200.2

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++.+.||+|++|.||+|.++. ++.|++|.+....  ......+.+|+++++.++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            579999999999999999999864 8899999886432  2233557789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|..++...   ..+++..++.++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99998888776432   23899999999999999999999999   9999999999999999999999999998753221


Q ss_pred             CCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH--------hhcCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL--------WNEGM  266 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~  266 (358)
                      .  ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..................        +....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1223346778999998765 46789999999999999999999998654432211111111000        00000


Q ss_pred             -CCccccCCcCCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          267 -PSQLIDPCIQGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       267 -~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                       ......+........     .....+.+++.+||+.+|++|||+.+++.+-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~  285 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY  285 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence             000000000000000     11245778999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=275.13  Aligned_cols=258  Identities=24%  Similarity=0.335  Sum_probs=204.8

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ...++|++-+.||+|.|+.|+++.+.. |+.+++|++..  ......+.+.+|+.+-+.|+||||+++.+.+......|+
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            345789999999999999999998654 89999998753  444567889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CCCeEEeccccce
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLAR  189 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~~i~L~Df~~~~  189 (358)
                      |+|++.|+.|..-|....   .+++..+-+.+.||++||.|+|.++   |+|||++|+|+++-+   ...+||+|||++.
T Consensus        88 vFe~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence            999999998866664443   3889999999999999999999999   999999999999963   3459999999999


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .+......   .-..|+|.|+|||+++..+|+..+|||+.|++||-|+.|..||-..+   ...+.+.+...- -..+..
T Consensus       162 ~l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I~~g~-yd~~~~  234 (355)
T KOG0033|consen  162 EVNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQIKAGA-YDYPSP  234 (355)
T ss_pred             EeCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhccc-cCCCCc
Confidence            87522222   23469999999999999999999999999999999999999974322   122222222110 011111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .++         .......+|+++||..||.+|.|+.|.|.+.|-.
T Consensus       235 ~w~---------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~  271 (355)
T KOG0033|consen  235 EWD---------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC  271 (355)
T ss_pred             ccC---------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence            122         1223456799999999999999999999887644

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.7e-38  Score=281.86  Aligned_cols=258  Identities=28%  Similarity=0.450  Sum_probs=200.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .++|++.+.||.|+||.||++.+.      ++..+++|.+.... ......+.+|+.+++.++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            468999999999999999999863      36789999887533 33456688899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcccc-------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 018304          111 LLIYEFMTNKSLDSFIFDQER-------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN  171 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~N  171 (358)
                      +++|||+.+++|.+++.....                   ...+++..++.++.|++.||.+||+.+   ++|+||+|.|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            999999999999999864321                   123778889999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCC
Q 018304          172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN  250 (358)
Q Consensus       172 ilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~  250 (358)
                      |+++.++.++|+|||.+..+..............+..|+|||.+.+..++.++||||||+++|+|++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876432221111122234567999999888889999999999999999997 77776432211 


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                        ...    .............         .....+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       240 --~~~----~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 --EVI----YYVRDGNVLSCPD---------NCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --HHH----HHHhcCCCCCCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              111    1111111111110         112457789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.6e-38  Score=285.14  Aligned_cols=262  Identities=31%  Similarity=0.445  Sum_probs=203.8

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCccceeeEEEe
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ  106 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~  106 (358)
                      ....++|++.+.||+|++|.||++.+.      .+..+++|.+.... ......+.+|+.+++.+ +|+||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            345578999999999999999999742      24579999887533 33456688999999999 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      .+..+++|||+.+++|.+++..... ..+++..+..++.+++.||.|||+++   ++|+||+|+||+++.++.++|+|||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999999865332 23899999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      ++................++..|+|||.+.+..++.++||||+|+++|+|++ |..||.......  ...    ......
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~----~~~~~~  260 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFY----KLIKEG  260 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHH----HHHHcC
Confidence            9876533221111222345678999999988889999999999999999998 888875433211  111    111111


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ......         ......+.+++.+||..+|++|||+.+|++.|...
T Consensus       261 ~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 YRMAQP---------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CcCCCC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111000         01123577899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-38  Score=277.70  Aligned_cols=248  Identities=29%  Similarity=0.424  Sum_probs=195.7

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHH
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLD  123 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  123 (358)
                      ++||.|++|.||++.+.+++.|++|.+...... ....+.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            478999999999999867999999988764333 4567889999999999999999999999999999999999999999


Q ss_pred             HHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccc
Q 018304          124 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV  203 (358)
Q Consensus       124 ~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~  203 (358)
                      +++....  ..++...++.++.+++.|+.+||+++   ++|+||+|+||+++.++.++|+|||.+...............
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9985532  23789999999999999999999999   999999999999999999999999998764322111111122


Q ss_pred             cccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHH
Q 018304          204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA  282 (358)
Q Consensus       204 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      ..+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......   ......    .......         ...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~----~~~~~~~---------~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIE----SGYRMPA---------PQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHh----cCCCCCC---------Ccc
Confidence            23567999999988889999999999999999998 788865433211   111111    1100000         011


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          283 EVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       283 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ....+.+++.+||+.+|++|||+.+|++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1236778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-38  Score=280.61  Aligned_cols=257  Identities=26%  Similarity=0.378  Sum_probs=204.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .++|++.+.||.|++|.||++.+. ++..+++|.+..........+..|+++++.++|+||+++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            367999999999999999999875 4889999999776666677888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++....  ..+++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+......  
T Consensus        84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--  156 (280)
T cd06611          84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--  156 (280)
T ss_pred             cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence            99999999986533  24899999999999999999999999   999999999999999999999999987654211  


Q ss_pred             CCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          197 EGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ........++..|+|||.+.     +..++.++|+||||+++|+|++|..||......   ...   .. +.......+.
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~---~~-~~~~~~~~~~  229 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVL---LK-ILKSEPPTLD  229 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHH---HH-HhcCCCCCcC
Confidence            11222345788899999874     345788999999999999999999997643221   111   11 1111111110


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .       .......+.+++.+||+.+|.+|||+.+++++-+..
T Consensus       230 ~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  266 (280)
T cd06611         230 Q-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS  266 (280)
T ss_pred             C-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence            0       001123567899999999999999999999876544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.2e-38  Score=283.05  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=198.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CC--EEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~--~v~vK~~~~-~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|++.+.||+|++|.||+|.+++ +.  .+++|.++. ........+.+|++++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            579999999999999999998754 33  468888764 2334456788899999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhccc-------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCe
Q 018304          114 YEFMTNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP  180 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i  180 (358)
                      +||+++++|.+++....             ....+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985532             1124888999999999999999999999   9999999999999999999


Q ss_pred             EEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHH
Q 018304          181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      +|+|||++.....   .........+..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ......
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~~~  232 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEKLP  232 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh
Confidence            9999999864211   111111223456999999988889999999999999999997 999975433221   111111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                          ........     .    .....+.+++.+||+.+|.+|||+.++++.|.....
T Consensus       233 ----~~~~~~~~-----~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         233 ----QGYRMEKP-----R----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             ----cCCCCCCC-----C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                11111110     0    112356789999999999999999999998876643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-37  Score=277.19  Aligned_cols=254  Identities=29%  Similarity=0.443  Sum_probs=199.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .++|++.+.||+|++|.||++.+..+..+++|.+.... .....+.+|+.+++.++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            46799999999999999999998777789999876432 23456788999999999999999998875 45678999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      .+++|.+++..... ..+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+........ 
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05069          83 GKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence            99999999865432 33789999999999999999999999   99999999999999999999999999876532211 


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .......++..|+|||...+..++.++||||||+++|+|++ |..||......   .......    ........     
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~~~~-----  225 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVE----RGYRMPCP-----  225 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCCCCCCC-----
Confidence            11112234567999999888889999999999999999999 88887543221   1111111    11111110     


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                          ......+.+++.+||..+|++||++.++++.|++
T Consensus       226 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         226 ----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                1112457789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.6e-37  Score=273.76  Aligned_cols=252  Identities=24%  Similarity=0.385  Sum_probs=203.1

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||.|++|.||.+... +++.+++|.+...  .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            6899999999999999999864 4889999987642  345556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++..... ..+++..+..++.|++.++.|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            999999999865432 34899999999999999999999999   99999999999999999999999999876533221


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                        ......+++.|.|||.+.+..++.++|+||+|+++|+|++|..||......   ....   . ..........     
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~---~-~~~~~~~~~~-----  222 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV---K-IVQGNYTPVV-----  222 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHH---H-HHcCCCCCCc-----
Confidence              223445788999999998888899999999999999999999997543221   1111   1 1111111111     


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                          ......+.+++.+||+.+|.+|||+.++++++.
T Consensus       223 ----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         223 ----SVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             ----cccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence                112235778999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9e-38  Score=280.80  Aligned_cols=264  Identities=27%  Similarity=0.417  Sum_probs=203.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-----CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEe--CCe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-----DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEE  109 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-----~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~  109 (358)
                      ...|++.+.||+|++|.||++.+.     .+..+++|.+...... ....+.+|++.++.++|+||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            357889999999999999999853     2678999999764443 46778899999999999999999999877  557


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .+++|||+++++|.+++.....  .+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            8999999999999999965442  3899999999999999999999999   9999999999999999999999999988


Q ss_pred             ecCCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCc--------hhHHHHHH
Q 018304          190 AFGGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL--------NLIGHAWK  260 (358)
Q Consensus       190 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~  260 (358)
                      ........ .......++..|++||.+.+..++.++||||||+++++|++|..|+.........        ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76422111 1111223455699999988888999999999999999999999886543221100        00111111


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..........         .......+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERLPR---------PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcCCC---------CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111000         011124577899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7e-38  Score=286.09  Aligned_cols=262  Identities=29%  Similarity=0.408  Sum_probs=202.1

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI  105 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~  105 (358)
                      ...++|.+.+.||+|++|.||++...        ....+++|.+... .......+..|+++++.+ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34478999999999999999999742        2446889988753 234456788899999999 6999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcE
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV  172 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Ni  172 (358)
                      +....+++|||+.+++|.+++.....             ...+++..+..++.|++.||.|||+++   ++|+||+|+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            98899999999999999999965321             234888999999999999999999999   99999999999


Q ss_pred             EEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCC
Q 018304          173 LLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNN  251 (358)
Q Consensus       173 lv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~  251 (358)
                      +++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||......  
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--  243 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--  243 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999976532221111112223457999999988889999999999999999999 88887543221  


Q ss_pred             chhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                       .......    .........         .....+.+++.+||..+|++|||+.++++.|+...
T Consensus       244 -~~~~~~~----~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         244 -ELFKLLR----EGHRMDKPS---------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             -HHHHHHH----cCCCCCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence             1111111    111111111         11235668999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.9e-37  Score=276.21  Aligned_cols=253  Identities=28%  Similarity=0.401  Sum_probs=199.8

Q ss_pred             CCCcceeecccCCccEEEEEEcCCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +|++.+.||.|+||.||+|...+++.+++|.+....      ......+.+|++.++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            589999999999999999988788999999886421      22345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      +||+++++|.+++.+..   .+++..+..++.|++.||.+||+.+   ++|+||+|.||+++.++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999985533   3889999999999999999999999   99999999999999999999999998875421


Q ss_pred             CC----CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          194 DE----TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       194 ~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ..    .........++..|+|||.+.+..++.++|+||||+++|+|++|..||.......   .......  .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~--~~~~~~~  229 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYIGA--HRGLMPR  229 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHHhhh--ccCCCCC
Confidence            11    1111123457888999999988889999999999999999999999986432211   1100000  0011111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      +.     .    .....+.++|.+||+.+|.+|||+.+++++-
T Consensus       230 ~~-----~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  263 (265)
T cd06631         230 LP-----D----SFSAAAIDFVTSCLTRDQHERPSALQLLRHD  263 (265)
T ss_pred             CC-----C----CCCHHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence            11     1    1224567899999999999999999998753

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-39  Score=273.71  Aligned_cols=257  Identities=23%  Similarity=0.309  Sum_probs=203.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--------cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--------ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ  106 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--------~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~  106 (358)
                      .-..|.-.+.||.|..+.|-++.++ +|+.+++|++..        ....-......|+.+|+++ .||+|+++.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3467888899999999999988764 488899998843        2233344566899999999 69999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      +.-.++|+|.++.|-|.|++...-.   +++...++++.|+++|++|||.++   |+|||+||+||+++++-+++|+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence            9999999999999999999965443   999999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccC------CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  260 (358)
                      ++..+.   .....+..+||++|+|||.+..      ..|+...|+|++|+++|.|+.|.+||=....   +-.+    +
T Consensus       169 Fa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---mlML----R  238 (411)
T KOG0599|consen  169 FACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---MLML----R  238 (411)
T ss_pred             eeeccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HHHH----H
Confidence            998763   3345567899999999998853      4678899999999999999999999632211   1111    1


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .+.++.- ++..     ....+......+||.+||+.||.+|.|++++|.+.+.+
T Consensus       239 ~ImeGky-qF~s-----peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  239 MIMEGKY-QFRS-----PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             HHHhccc-ccCC-----cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            1111111 0000     00112223456899999999999999999999987664

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2e-37  Score=274.52  Aligned_cols=252  Identities=27%  Similarity=0.472  Sum_probs=199.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      .+|++.+.||.|++|.||++.+.++..+++|.+.... .....+.+|+++++.++|||++++++++......+++|||+.
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            5789999999999999999998778899999886532 233567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++....  ..+++..++.++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+......... 
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            999999986533  23789999999999999999999999   999999999999999999999999998765322111 


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......    ......  ..+   .
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~--~~~---~  224 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETI----NAGFRL--YKP---R  224 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH----hCCCCC--CCC---C
Confidence            1112224567999999988889999999999999999998 88887543321   111111    111100  000   0


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .    ....+.+++.+||+.+|++|||+.++++.|.
T Consensus       225 ~----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 L----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             C----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            0    1245778999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-37  Score=277.05  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=198.7

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh---------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE---------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~---------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      +|.+.+.||.|++|.||+|.+. +++.+++|.+.....         .....+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5889999999999999999875 478999998864221         123567789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++++||+++++|.+++...   +.+++..+..++.|++.||.+||+.+   ++|+||+|+||++++++.++|+|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999999554   33889999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCCC----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          190 AFGGDETE----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       190 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      .+......    .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......   .......    ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~  227 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKIG----EN  227 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHHh----cc
Confidence            66422111    1112234778899999998888999999999999999999999998643221   1111111    11


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      ....+.         ......+.++|.+||+.+|.+||++.+++++-
T Consensus       228 ~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  265 (267)
T cd06628         228 ASPEIP---------SNISSEAIDFLEKTFEIDHNKRPTAAELLKHP  265 (267)
T ss_pred             CCCcCC---------cccCHHHHHHHHHHccCCchhCcCHHHHhhCC
Confidence            111111         11224567899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=8.2e-38  Score=284.20  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=197.2

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CC--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~--~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|++.+.||+|+||.||+|.+.. +.  .+++|.+... .......+.+|++++.++ +|+||+++++++.+++..+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            578999999999999999998743 44  4577766542 334456778899999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCe
Q 018304          114 YEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP  180 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i  180 (358)
                      |||+++++|.+++.....             ...+++..++.++.|++.|+.|||+.+   ++||||+|+||+++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            999999999999865321             234889999999999999999999999   9999999999999999999


Q ss_pred             EEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHH
Q 018304          181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      +|+|||++.....   .........+..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~  237 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP  237 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHHh
Confidence            9999999853211   111111223567999999888888999999999999999998 99987543321   1111111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          ........     .    .....+.+++.+||+.+|++||++.+++..|...
T Consensus       238 ----~~~~~~~~-----~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         238 ----QGYRLEKP-----L----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             ----cCCcCCCC-----C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                11000000     0    1123567899999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.1e-38  Score=282.45  Aligned_cols=266  Identities=23%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             ceeHHHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEE
Q 018304           28 LFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI  105 (358)
Q Consensus        28 ~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~  105 (358)
                      .+....+....++|++.+.||+|++|.||++.+.. ++.+++|.+.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            34455666678999999999999999999998754 7899999876532 2235677899999999 6999999999874


Q ss_pred             -----eCCeeEEEEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC
Q 018304          106 -----QGEEKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       106 -----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~  179 (358)
                           .++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence                 345789999999999999987542 22345889999999999999999999999   999999999999999999


Q ss_pred             eEEeccccceecCCCCCCCccccccccCCCCCcccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchh
Q 018304          180 PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL  254 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~  254 (358)
                      ++|+|||++..+...  ........++..|+|||.+..     ..++.++||||+||++|+|++|..||.......   .
T Consensus       163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~  237 (286)
T cd06638         163 VKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---A  237 (286)
T ss_pred             EEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---H
Confidence            999999998765322  112233458889999998753     457889999999999999999999975432211   1


Q ss_pred             HHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          255 IGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .   .. ...........+   .    .....+.+++.+||+.+|++|||+.+++++++
T Consensus       238 ~---~~-~~~~~~~~~~~~---~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         238 L---FK-IPRNPPPTLHQP---E----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             H---hh-ccccCCCcccCC---C----CcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            1   00 001111111110   0    01235778999999999999999999998864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=292.52  Aligned_cols=245  Identities=21%  Similarity=0.237  Sum_probs=187.2

Q ss_pred             ecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhc---CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           47 LGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        47 lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      ||+|+||.||+|.+.. ++.|++|++.+..   .........|..++...   .||||+++++.+.+.+..++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999754 8999999986421   22233444566666554   699999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.....  ....
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~  152 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKT  152 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCC
Confidence            99998885433   3899999999999999999999999   99999999999999999999999999865321  1122


Q ss_pred             cccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCC
Q 018304          200 TKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS  278 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .....|+..|+|||.+.+. .++.++|||||||++|+|++|..||......   ...    ....... ..+...    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~----~~i~~~~-~~~~~~----~  220 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMY----RNIAFGK-VRFPKN----V  220 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHH----HHHHcCC-CCCCCc----c
Confidence            3345689999999988754 5789999999999999999999997543211   111    1111111 011110    0


Q ss_pred             CCHHHHHHHHHHHhhhcCCCCCCCC----ChHHHHHHhccC
Q 018304          279 FNLAEVIRCIHIGLLCVQQHPKDRP----SMPSVILMLGSE  315 (358)
Q Consensus       279 ~~~~~~~~l~~li~~cl~~~P~~Rp----t~~ell~~l~~~  315 (358)
                          ....+.+++.+||+.+|.+||    ++.+++++.+..
T Consensus       221 ----~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~  257 (330)
T cd05586         221 ----LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA  257 (330)
T ss_pred             ----CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence                123456799999999999998    688888876543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-37  Score=287.93  Aligned_cols=261  Identities=29%  Similarity=0.438  Sum_probs=198.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEE------cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC-
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL------VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~-  107 (358)
                      ..++|++.+.||.|+||.||+|.+      .+++.|++|.+.... ......+.+|+.++..+ +|+||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            347899999999999999999974      236789999997532 33456788899999999 689999999987654 


Q ss_pred             CeeEEEEEecCCCCHHHHHhcccc--------------------------------------------------------
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQER--------------------------------------------------------  131 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  131 (358)
                      ...+++|||+++++|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            467899999999999999854211                                                        


Q ss_pred             --------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccc
Q 018304          132 --------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV  203 (358)
Q Consensus       132 --------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~  203 (358)
                              ...+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++..+............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    123677888999999999999999999   999999999999999999999999998764322111111122


Q ss_pred             cccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHH
Q 018304          204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA  282 (358)
Q Consensus       204 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ..    ..............     .    
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~~~~~~~-----~----  306 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF----CRRLKEGTRMRAPD-----Y----  306 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HH----HHHHhccCCCCCCC-----C----
Confidence            34567999999988899999999999999999997 888875432211  11    11111111111110     0    


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          283 EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       283 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ....+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            113567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.8e-37  Score=284.24  Aligned_cols=259  Identities=18%  Similarity=0.220  Sum_probs=196.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||++.++. ++.+++|.+.+.   .......+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            479999999999999999999755 778999998642   2233445778899999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+|+|.+++.+..  ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999996532  23899999999999999999999999   999999999999999999999999998754322


Q ss_pred             CCCCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .. .......|++.|+|||++.     ...++.++|||||||++|+|++|..||.....   ........   .......
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~---~~~~~~~  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIM---NHKERFQ  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH---HHHHHHHh---CCCcccc
Confidence            11 1122346899999999875     34678999999999999999999999854321   11111111   1111001


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCC--CCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKD--RPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~l~~~  315 (358)
                      +...      .......+.+++.+|++.++..  |+++.+++++-+..
T Consensus       229 ~p~~------~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~  270 (332)
T cd05623         229 FPAQ------VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT  270 (332)
T ss_pred             CCCc------cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence            1100      0011235667888888665444  68999999886543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1e-37  Score=276.59  Aligned_cols=249  Identities=29%  Similarity=0.411  Sum_probs=196.2

Q ss_pred             eeecccCCccEEEEEEcC--C--CEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD--G--QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~--~--~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|++|.||+|.+.+  +  ..|++|.+..... ...+.+.+|+..++.++|+||+++++++.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  2689999977554 566788899999999999999999999988 889999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC-C
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-G  198 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~-~  198 (358)
                      ++|.+++..... ..+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999866443 34899999999999999999999999   999999999999999999999999998876332111 1


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ........   ........     .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~---~~~~~~~~-----~  224 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDK---EGERLERP-----E  224 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh---cCCcCCCC-----c
Confidence            1112345678999999988899999999999999999998 99997532221   11111111   11000000     0


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                          .....+.+++.+||+.+|++|||+.++++.|.
T Consensus       225 ----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         225 ----ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                11235778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-37  Score=278.08  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=199.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-C---CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~---~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .+|++.+.||+|++|.||+|.+.. +   ..|++|.+... .......+..|+..++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            568999999999999999998643 3   36999998753 344567888999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+.+++|.+++....  +.+++..++.++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999986543  33889999999999999999999999   99999999999999999999999999876532


Q ss_pred             CCCCCcccccc---ccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          194 DETEGNTKRVI---GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       194 ~~~~~~~~~~~---~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ...........   .+..|+|||.+.+..++.++||||+|+++|+|++ |..||......   .........+....+  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~~~~~~--  233 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDYRLPPP--  233 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCcCCCc--
Confidence            22111111111   1346999999988899999999999999999886 99887543221   121111111100000  


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                             .    .....+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       234 -------~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         234 -------M----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -------c----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   0    1123466799999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3e-37  Score=272.44  Aligned_cols=247  Identities=28%  Similarity=0.390  Sum_probs=194.7

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHH
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLD  123 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  123 (358)
                      +.||+|++|.||+|...++..+++|.+.... ......+.+|+++++.++|+||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4689999999999998778899999886533 333456788999999999999999999999999999999999999999


Q ss_pred             HHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccc
Q 018304          124 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV  203 (358)
Q Consensus       124 ~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~  203 (358)
                      +++....  ..+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......... .....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            9885433  23789999999999999999999999   999999999999999999999999998754222111 11122


Q ss_pred             cccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHH
Q 018304          204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA  282 (358)
Q Consensus       204 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      .++..|+|||.+.+..++.++||||||+++|++++ |..||......   .......    .........         .
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~---------~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVE----KGYRMSCPQ---------K  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cCCCCCCCC---------C
Confidence            33567999999988889999999999999999998 88887543221   1111111    111111111         1


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          283 EVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       283 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ....+.+++.+||..+|++|||+.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1246778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-37  Score=278.74  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=198.7

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC------
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG------  107 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~------  107 (358)
                      ...+.|++.+.||.|++|.||+|.+.+ ++.+++|.+.... .....+..|+.+++.+ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            356789999999999999999998754 8889999986543 3345678899999998 699999999998753      


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                      ...+++|||+.+++|.+++..... ..+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            457899999999999999865432 34889999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      +......  ........++..|+|||.+.     +..++.++|+||+||++|+|++|..||......      .......
T Consensus       158 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~~~  229 (272)
T cd06637         158 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIP  229 (272)
T ss_pred             ceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHHHh
Confidence            8764221  12223456788999999875     345788999999999999999999997532211      1111111


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      . ........    .    .....+.+++.+||..+|.+|||+.+++++-+
T Consensus       230 ~-~~~~~~~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  271 (272)
T cd06637         230 R-NPAPRLKS----K----KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF  271 (272)
T ss_pred             c-CCCCCCCC----C----CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence            1 11111111    1    11235678999999999999999999998744

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-37  Score=273.82  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=200.1

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +|+..+.||+|++|.||+|... ++..|++|.+....     ......+.+|+..++.++|+||+++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5888999999999999999976 58999999886533     33556788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      +||+++++|.+++.+..   .+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999985433   3889999999999999999999999   99999999999999999999999999876532


Q ss_pred             CCCCCccccccccCCCCCcccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ..   ......++..|++||.+.... ++.++|+||||+++|+|++|..||.....   ....   ...........+..
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~---~~~~~~~~~~~~~~  225 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAV---FKIGRSKELPPIPD  225 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHH---HHHHhcccCCCcCC
Confidence            22   223455788899999887665 89999999999999999999999865431   1111   11111011111111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                               .....+.+++.+||+.+|++|||+.+++.+-
T Consensus       226 ---------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~  256 (258)
T cd06632         226 ---------HLSDEAKDFILKCLQRDPSLRPTAAELLEHP  256 (258)
T ss_pred             ---------CcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence                     1124566799999999999999999999764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.7e-37  Score=276.39  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=204.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++.+.||.|++|.||+|... ++..+++|.+.... ......+.+|++.++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            57999999999999999999865 47899999886432 23567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++........+++..++.++.|++.|+.+||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999966443345899999999999999999999999   99999999999999999999999999876543222


Q ss_pred             CC--ccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          197 EG--NTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       197 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..  ......++..|+|||.+... .++.++|+||||+++|+|++|..||.......   ......    ......+...
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~~~~~~  230 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTL----QNDPPSLETG  230 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHh----cCCCCCcCCc
Confidence            11  12234578899999988766 78999999999999999999999986443221   111111    1111111110


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      ..    .......+.+++.+||+.+|++|||+.+|+++-
T Consensus       231 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p  265 (267)
T cd06610         231 AD----YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK  265 (267)
T ss_pred             cc----cccccHHHHHHHHHHcCCChhhCcCHHHHhhCC
Confidence            00    012234567899999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-37  Score=278.63  Aligned_cols=263  Identities=25%  Similarity=0.375  Sum_probs=198.4

Q ss_pred             CCCCcceeecccCCccEEEEEE-----cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Cee
Q 018304           39 NNFSINKKLGQGGFGPVYKGTL-----VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK  110 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~  110 (358)
                      .-|++++.||+|++|.||++..     ..+..|++|.+.... ......+.+|+++++.++|+||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4579999999999999999973     247789999986532 34456788999999999999999999998775  567


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      +++|||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            89999999999999985432  23899999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCC--------CCchhHHHHHHH
Q 018304          191 FGGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD--------NNLNLIGHAWKL  261 (358)
Q Consensus       191 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~  261 (358)
                      +...... .......++..|+|||.+.+..++.++||||||+++|+|+++..|+......        ............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            5322211 1112334566799999988888999999999999999999987653221100        000000001111


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..........         ......+.+|+.+||+.+|++|||+.++++.++.+
T Consensus       239 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRLPRP---------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccCCCC---------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111111100         01224677899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=274.31  Aligned_cols=248  Identities=32%  Similarity=0.468  Sum_probs=193.4

Q ss_pred             eeecccCCccEEEEEEcC-C---CEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-G---QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~---~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|++|.||+|.+.. +   ..+++|.+..... .....+.+|+++++.+.|+||+++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997533 2   6899999875332 34567888999999999999999999875 4568999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+++..++.++.|++.|+.+||..+   ++|+||+|+||+++.++.++|+|||.+..+........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999996544   4899999999999999999999999   99999999999999999999999999876532221111


Q ss_pred             -cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          200 -TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       200 -~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .........    ........     
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~----~~~~~~~~-----  221 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES----GERLPRPE-----  221 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc----CCcCCCCC-----
Confidence             111123457999999988899999999999999999998 9999764332   122222211    11111111     


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          .....+.+++.+||..+|++|||+.+|++.|+..
T Consensus       222 ----~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         222 ----ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                1123567899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-37  Score=278.37  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=204.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ...|+.++.||.|++|.||+|.+.. +..|++|.+... .......+.+|+.+++.+.|+||+++++++.++...++|||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            4578899999999999999999754 889999988653 24456778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++..    ..+++..+..++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          83 YLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999998853    23888999999999999999999999   9999999999999999999999999987653221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......++..|+|||.+.+..++.++|+||||+++|+|++|..||........   ..    .......        
T Consensus       156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~----~~~~~~~--------  218 (277)
T cd06640         156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---LF----LIPKNNP--------  218 (277)
T ss_pred             --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---hh----hhhcCCC--------
Confidence              122234567789999999888899999999999999999999999764332111   00    0001111        


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ..........+.+++.+||+.+|++||++.+++.+.+..
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06640         219 -PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             -CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence             111223345677899999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.3e-38  Score=285.59  Aligned_cols=264  Identities=20%  Similarity=0.321  Sum_probs=188.3

Q ss_pred             ceeecccCCccEEEEEEc---CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEEEEEecC
Q 018304           44 NKKLGQGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMT  118 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~e~~~  118 (358)
                      .++||+|+||.||+|.++   .++.|++|.+....  ....+.+|+++++.++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   36789999986532  22456789999999999999999998864  346789999986


Q ss_pred             CCCHHHHHhccc------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE----cCCCCeEEeccccc
Q 018304          119 NKSLDSFIFDQE------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLA  188 (358)
Q Consensus       119 ~~~L~~~l~~~~------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv----~~~~~i~L~Df~~~  188 (358)
                      + +|.+++....      ....+++..++.++.||+.||.|||+++   ++|+||||+||++    +.++.++|+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 8887764321      1124889999999999999999999999   9999999999999    45678999999999


Q ss_pred             eecCCCCC-CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC------chhHHHHHH
Q 018304          189 RAFGGDET-EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN------LNLIGHAWK  260 (358)
Q Consensus       189 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~  260 (358)
                      ........ ........+++.|+|||.+.+. .++.++||||+||++|+|++|..||........      ...+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            76532211 1122345678899999988764 689999999999999999999999865433211      111111111


Q ss_pred             HhhcCCC---------C---ccccC----CcCC-C-C------CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          261 LWNEGMP---------S---QLIDP----CIQG-S-F------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       261 ~~~~~~~---------~---~~~~~----~~~~-~-~------~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .......         .   .....    .... . .      .......+.++|.+||+.||.+|||+.+++++-+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            1000000         0   00000    0000 0 0      0001124678999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-37  Score=274.96  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||+|++|.+|++... +++.|++|.+...  .......+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            6899999999999999999865 4889999988642  334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++..... ..+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-  155 (256)
T cd08218          81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-  155 (256)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence            999999998865332 23789999999999999999999999   9999999999999999999999999987653221 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       .......++..|+|||.+.+..++.++|+||||+++++|++|..||......   ...   .... .+......     
T Consensus       156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~---~~~~-~~~~~~~~-----  222 (256)
T cd08218         156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLV---LKII-RGSYPPVS-----  222 (256)
T ss_pred             -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHH---HHHh-cCCCCCCc-----
Confidence             1122345778899999998888999999999999999999999997543211   111   1111 11111111     


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                          ......+.++|.+||+.+|++||++.+|+++-+
T Consensus       223 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         223 ----SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             ----ccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence                111235778999999999999999999998743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-37  Score=274.55  Aligned_cols=255  Identities=27%  Similarity=0.352  Sum_probs=206.5

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++.+.||.|++|.||++.+.. ++.|++|.+..... .....+.+|+..+..++|+|++++++++......+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            478999999999999999999865 89999999876443 4567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      +++++|.+++...   ..+++..++.++.|+++|+.+||+ .+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999654   348999999999999999999999 99   9999999999999999999999999988753222


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||................    ......+.... 
T Consensus       155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~-  227 (264)
T cd06623         155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPPPSLPAEE-  227 (264)
T ss_pred             C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCCCCCCccc-
Confidence            1  1123457788999999988889999999999999999999999976554311111111111    11111111110 


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                             ....+.+++.+||..+|++|||+.+++++-+
T Consensus       228 -------~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~  258 (264)
T cd06623         228 -------FSPEFRDFISACLQKDPKKRPSAAELLQHPF  258 (264)
T ss_pred             -------CCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence                   2246778999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-37  Score=278.60  Aligned_cols=264  Identities=22%  Similarity=0.309  Sum_probs=201.4

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||.|++|.||+|.+. +|+.|++|.+....  ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            6899999999999999999975 48899999987533  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      + +++|.+++....  ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999986543  44899999999999999999999999   99999999999999999999999999876532221


Q ss_pred             CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC--------
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP--------  267 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  267 (358)
                       .......++..|+|||.+.+. .++.++||||+|+++++|++|..+|.....   ................        
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence             112234578889999987654 568999999999999999999777644322   1222111111111000        


Q ss_pred             CccccCC---cCCCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          268 SQLIDPC---IQGSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       268 ~~~~~~~---~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .......   ......     ......+.+++.+||..+|++|||+.+++.+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~  284 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY  284 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence            0000000   000000     012256788999999999999999999998865

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=297.93  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=210.3

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      -|.|+..||.|+||+||++..++ +-..+.|++.......+..+.-|+++|..++||+|+++++.|..++.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            47889999999999999998765 44556788887788889999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      ||-++.++.....  .+.+..+.-+++++++||.|||+++   |+|||||..|||++-+|.++|+|||.+...  .....
T Consensus       113 GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~q  185 (1187)
T KOG0579|consen  113 GGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTRQ  185 (1187)
T ss_pred             CchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc--hhHHh
Confidence            9999999866543  3999999999999999999999999   999999999999999999999999998753  22233


Q ss_pred             ccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          199 NTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ......||+.|+|||+..     +.+|+.++||||||++|.+|..+.+|-...      .......+ +....++.++.+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllK-iaKSePPTLlqP  258 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLK-IAKSEPPTLLQP  258 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHH-HhhcCCCcccCc
Confidence            445678999999999864     568999999999999999999999984322      22222222 223344444432


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..       -...+.+++.+||..||.+||++.+|+++.+..
T Consensus       259 S~-------Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  259 SH-------WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             ch-------hhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            22       134577899999999999999999999987655

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-37  Score=281.54  Aligned_cols=266  Identities=23%  Similarity=0.380  Sum_probs=209.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .++|++.+.||+|++|.||++.+. ++..|++|.+..........+.+|+.+++.++|||++++++++...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            479999999999999999999864 5789999998765555557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++.+.    .+++..+..++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-  169 (293)
T cd06647          98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  169 (293)
T ss_pred             CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence            9999999998543    2788899999999999999999999   9999999999999999999999999887543221 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       .......+++.|++||.+.+..++.++|+||||+++|++++|..||............      ..... ..+      
T Consensus       170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~-~~~------  235 (293)
T cd06647         170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT-PEL------  235 (293)
T ss_pred             -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC-CCC------
Confidence             1222345778899999988888899999999999999999999998653332111110      00000 000      


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCCCCCc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGY  326 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~~~~~  326 (358)
                       .........+.++|.+||..+|++||++.+++.+-+.....+.-..+..
T Consensus       236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~  284 (293)
T cd06647         236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPL  284 (293)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccch
Confidence             0011112356689999999999999999999998766655544433333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.7e-38  Score=287.43  Aligned_cols=264  Identities=20%  Similarity=0.272  Sum_probs=195.9

Q ss_pred             Ccceeeccc--CCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           42 SINKKLGQG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        42 ~i~~~lg~g--~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +++++||+|  ++++||++.++ +|+.|++|.+...  .......+.+|+++++.++||||+++++++..++..++||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            367889999  67899999874 4899999998653  234456777899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++..... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++++||+..........
T Consensus        81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999999865432 23889999999999999999999999   99999999999999999999999986543311110


Q ss_pred             -----CCccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          197 -----EGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       197 -----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                           ........++..|+|||.+.+  ..++.++|||||||++|+|++|..||........  ....    .. .....
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~----~~-~~~~~  229 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEK----LN-GTVPC  229 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHH----hc-CCccc
Confidence                 001112345667999999875  4688999999999999999999999864322110  0000    00 00000


Q ss_pred             ccc------------------------CC------------cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          270 LID------------------------PC------------IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       270 ~~~------------------------~~------------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ..+                        ..            ............+.+++.+||+.||++|||+.+|+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~  309 (327)
T cd08227         230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  309 (327)
T ss_pred             cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence            000                        00            000011112346778999999999999999999998766


Q ss_pred             cCC
Q 018304          314 SET  316 (358)
Q Consensus       314 ~~~  316 (358)
                      ...
T Consensus       310 f~~  312 (327)
T cd08227         310 FKQ  312 (327)
T ss_pred             hhh
Confidence            543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=284.56  Aligned_cols=256  Identities=22%  Similarity=0.255  Sum_probs=202.2

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|++|.||+|...+ ++.|++|.+....   ......+.+|++.++.++|+||+++++.+.+....+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            479999999999999999999765 8999999987532   234567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++..... ..+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999999865332 34899999999999999999999999   999999999999999999999999998754221


Q ss_pred             CCC---------------------------CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCC
Q 018304          195 ETE---------------------------GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYH  247 (358)
Q Consensus       195 ~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~  247 (358)
                      ...                           .......|+..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01112356788999999988889999999999999999999999986443


Q ss_pred             CCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC----hHHHHHHhc
Q 018304          248 SDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS----MPSVILMLG  313 (358)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt----~~ell~~l~  313 (358)
                      ...   ..   ........  ....       .......+.+++.+||..+|++|||    +.+++.+-+
T Consensus       237 ~~~---~~---~~~~~~~~--~~~~-------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~  291 (316)
T cd05574         237 RDE---TF---SNILKKEV--TFPG-------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF  291 (316)
T ss_pred             hHH---HH---HHHhcCCc--cCCC-------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence            221   11   11111110  0000       0012346778999999999999999    888888644

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.2e-37  Score=272.28  Aligned_cols=249  Identities=22%  Similarity=0.376  Sum_probs=199.8

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||.|++|.||++... +++.+++|.+...  .......+.+|+++++.++|+|++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            6899999999999999999875 4889999988653  334567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df~~~~~~~~~~  195 (358)
                      +++++|.+++..... ..+++..++.++.+++.++.+||+++   ++|+||+|+||+++.++ .++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            999999999965432 33899999999999999999999999   99999999999998654 57999999998753221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                         ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..   .......    ......+.+.  
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~----~~~~~~~~~~--  224 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKIM----SGTFAPISDR--  224 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHHH----hcCCCCCCCC--
Confidence               222345778999999998888899999999999999999999997654322   1111111    1111111111  


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                             ....+.+++.+||..+|++|||+.+++.+
T Consensus       225 -------~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         225 -------YSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -------cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                   12356789999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-37  Score=277.38  Aligned_cols=258  Identities=25%  Similarity=0.360  Sum_probs=205.1

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++.+.||.|++|.||++.++ +++.+++|.+.... ......+.+|++.++.++||||+++++.+..+...++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            47899999999999999999986 48899999887643 34556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      +.+++|.+++....  ..+++..+..++.|++.|+.+||+ .+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999986543  448999999999999999999999 88   9999999999999999999999999986542111


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                          .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... ...........+...  
T Consensus       156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~--  227 (265)
T cd06605         156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFEL-LQYIVNEPPPRLPSG--  227 (265)
T ss_pred             ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHH-HHHHhcCCCCCCChh--
Confidence                1125577889999999888999999999999999999999999765432111 11111 111111111111111  


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            .....+.++|.+||..+|++|||+.+++.+-+..
T Consensus       228 ------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         228 ------KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             ------hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence                  0233577899999999999999999999876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.4e-37  Score=289.27  Aligned_cols=264  Identities=27%  Similarity=0.396  Sum_probs=202.8

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCccceeeEEE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCI  105 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~  105 (358)
                      .....++|.+.+.||+|+||.||+|.+.      .+..|++|.+.... ......+.+|++++..+. ||||+++++.+.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4444567899999999999999999853      24689999997632 333456889999999997 999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhcccc------------------------------------------------------
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQER------------------------------------------------------  131 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  131 (358)
                      .....++||||+.+|+|.+++.....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999854321                                                      


Q ss_pred             -----------------------------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 018304          132 -----------------------------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKAS  170 (358)
Q Consensus       132 -----------------------------------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~  170 (358)
                                                               ...+++..++.++.||+.||.|||+.+   ++|+||+|.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                     123667788899999999999999999   999999999


Q ss_pred             cEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCC
Q 018304          171 NVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD  249 (358)
Q Consensus       171 Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~  249 (358)
                      ||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999876432211111122345678999999988889999999999999999998 88887543321


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .   ..   ......+......     .    .....+.+++.+||..+|.+||++.+|++.|+.+
T Consensus       349 ~---~~---~~~~~~~~~~~~p-----~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 E---QF---YNAIKRGYRMAKP-----A----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             H---HH---HHHHHcCCCCCCC-----C----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1   11   1111111111100     0    1124577899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-37  Score=309.38  Aligned_cols=260  Identities=20%  Similarity=0.262  Sum_probs=198.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|++|.||+|.+.. ++.|++|.+...   .......+.+|++++..++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            689999999999999999999754 899999998652   2233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcccc--------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          115 EFMTNKSLDSFIFDQER--------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      ||++|++|.+++.....        ....+...++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211        122556778899999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCC----------------CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCC
Q 018304          187 LARAFGGDET----------------EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN  250 (358)
Q Consensus       187 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~  250 (358)
                      ++........                ........|++.|+|||.+.+..++.++||||+||++|+|++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976521100                001112458999999999999999999999999999999999999986522211


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-ChHHHHHHhccC
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-SMPSVILMLGSE  315 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ell~~l~~~  315 (358)
                      .   .   .... ...+.....   .    ......+.+++.+||..||++|| ++.++++.|+..
T Consensus       239 i---~---~~~~-i~~P~~~~p---~----~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 I---S---YRDV-ILSPIEVAP---Y----REIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             h---h---hhhh-ccChhhccc---c----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0   0   0000 000000000   0    01123466799999999999995 556666665543

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-37  Score=276.85  Aligned_cols=256  Identities=25%  Similarity=0.434  Sum_probs=200.8

Q ss_pred             CCCcceeecccCCccEEEEEE-cCCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      +|+..+.||+|++|.||++.+ .+++.+++|.+....      ......+..|+..++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            588899999999999999986 458899999886422      2245678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEeccccceec
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAF  191 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df~~~~~~  191 (358)
                      |+||+++++|.+++.+.   +.+++..++.++.|++.||.+||+++   ++|+||+|.||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999998543   34889999999999999999999999   99999999999998776 5999999998765


Q ss_pred             CCCCC--CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          192 GGDET--EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       192 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .....  ........++..|+|||.+.+..++.++|+||+|+++++|++|..||...........   ........... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~-  230 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASATTAP-  230 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccCCCC-
Confidence            32211  1112234577899999999888899999999999999999999999864332211111   11110011111 


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                              .........+.+++.+||..+|.+|||+.+++.+-+
T Consensus       231 --------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~  266 (268)
T cd06630         231 --------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV  266 (268)
T ss_pred             --------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence                    111122345778999999999999999999997643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.4e-37  Score=273.45  Aligned_cols=246  Identities=29%  Similarity=0.409  Sum_probs=191.4

Q ss_pred             eecccCCccEEEEEEc---CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           46 KLGQGGFGPVYKGTLV---DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~---~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      .||+|+||.||+|.++   ++..+++|++....  ....+.+.+|+.+++.+.|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999642   47889999886432  334567888999999999999999999875 45678999999999


Q ss_pred             CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc-
Q 018304          121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-  199 (358)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~-  199 (358)
                      +|.+++....   .+++..++.++.|++.|+.+||+++   ++|+||+|.||+++.++.++|+|||.+..+........ 
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999985433   3899999999999999999999999   99999999999999999999999999876533221111 


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS  278 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......   .......    .........     .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~----~~~~~~~~~-----~  222 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIE----SGERMECPQ-----R  222 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----CCCCCCCCC-----C
Confidence            112233568999999888888999999999999999998 89997643221   1222211    111111111     1


Q ss_pred             CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          279 FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       279 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                          ....+.++|.+||+.+|++||++.+|.+.|..
T Consensus       223 ----~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         223 ----CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ----CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                12356689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.5e-37  Score=275.80  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=200.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC----CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|++.+.||+|+||.||+|.+..    +..+++|.+.... ......+.+|+.+++.++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            3688999999999999999998642    3378999886532 3345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      +|||+++++|.+++....  ..+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+..+.
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999999986543  23889999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCCCCc-cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          193 GDETEGN-TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       193 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ....... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.......   .......    ......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~----~~~~~~  230 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEE----GYRLPA  230 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhC----CCcCCC
Confidence            2211111 111122457999999988889999999999999999886 999975433221   1111111    110000


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                               .......+.+++.+||+.+|.+|||+.++++.|...
T Consensus       231 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         231 ---------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                     001123566899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.5e-37  Score=272.18  Aligned_cols=251  Identities=34%  Similarity=0.545  Sum_probs=198.5

Q ss_pred             CCcceeecccCCccEEEEEEcC-C----CEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-G----QEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~----~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      +++.+.||.|++|.||++.+.. +    ..+++|.+...... ....+..|+..++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4678999999999999998754 3    78999999764432 5678889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++....... +++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhhcc-CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999986543322 899999999999999999999999   999999999999999999999999999876433


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ...... ...++..|+|||.+.+..++.++|+||+|+++++|++ |..||.....   ........    ......... 
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~~-  227 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLK----KGYRLPKPE-  227 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh----cCCCCCCCC-
Confidence            211111 2235678999999888889999999999999999998 7777654221   11111111    111111111 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                              .....+.+++.+||..+|++|||+.++++.|
T Consensus       228 --------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      228 --------NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                    1234577899999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.2e-38  Score=282.15  Aligned_cols=264  Identities=20%  Similarity=0.269  Sum_probs=195.5

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||.|++|.||+|.+. +|+.+++|.+....  ......+.+|+.+++.++|+||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            6899999999999999999975 48899999886422  22234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+ +|.+++....  ..+++..++.++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            975 7877775432  34899999999999999999999999   9999999999999999999999999987643211 


Q ss_pred             CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC---------
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM---------  266 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  266 (358)
                       .......++..|+|||.+.+. .++.++||||||+++|+|++|..|+.....  ................         
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhhh
Confidence             112233467889999988764 478999999999999999999988532221  1111111111100000         


Q ss_pred             CCcc-ccCCcCCCC-----CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          267 PSQL-IDPCIQGSF-----NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       267 ~~~~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .... .........     .......+.++|.+||+.||.+|||+.+++.+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence            0000 000000000     0112245678999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.9e-37  Score=273.97  Aligned_cols=257  Identities=26%  Similarity=0.453  Sum_probs=200.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CC---EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQ---EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~---~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|+..+.||+|++|.||+|.... +.   .+++|.+... .......+..|+++++.++|+||+++.+++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3578889999999999999998743 33   6899988653 23445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++....  ..+++..+..++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999986533  33889999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCCCCcc-ccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          193 GDETEGNT-KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       193 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ........ .....+..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    .......
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~i~----~~~~~~~  231 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKAIN----DGFRLPA  231 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHh----cCCCCCC
Confidence            22111111 11122356999999988889999999999999999997 99997543221   1111111    1111000


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .         ......+.+++.+||+.+|++||++.+|++.|.++
T Consensus       232 ~---------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         232 P---------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0         01123567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=308.18  Aligned_cols=259  Identities=33%  Similarity=0.527  Sum_probs=208.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC--CC----EEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD--GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~--~~----~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      ....+..+.||+|+||.||.|...+  +.    .|++|.+.+ .+......+.+|+.+|..++||||+++++++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3556888999999999999998543  43    488998876 4466778899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccc----cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      ++++|||++|+|..|+.+..    ....+....++.++.+||+|+.||++++   ++||||...|+|++....+|++|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997652    1234889999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      +++.+.+..+........-...|+|||.+..+.++.|+||||||+++||+++ |..||....   +.+++......-+-.
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~---n~~v~~~~~~ggRL~  924 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS---NFEVLLDVLEGGRLD  924 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc---hHHHHHHHHhCCccC
Confidence            9996544444333333334468999999999999999999999999999999 777755433   333333222211112


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .+...             ...+.++|..||+.+|++||++..|++.+..+
T Consensus       925 ~P~~C-------------P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  925 PPSYC-------------PEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             CCCCC-------------ChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            22211             12566899999999999999999999977665

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.3e-38  Score=280.43  Aligned_cols=251  Identities=24%  Similarity=0.404  Sum_probs=200.8

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +.|+..+.||+|++|.||+|.+.. +..|++|.+.... ......+.+|+++++.++|+||+++++++..++..++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            457888999999999999998754 7889999886432 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++..    ..+++..++.++.+++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            999999998843    23889999999999999999999999   9999999999999999999999999987653211 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......   ...    .........       
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~~~~~-------  220 (277)
T cd06642         156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF----LIPKNSPPT-------  220 (277)
T ss_pred             -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh----hhhcCCCCC-------
Confidence             11223356788999999988889999999999999999999999975332211   110    011111111       


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                        ........+.+++.+||+.+|++|||+.+++.+.+.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06642         221 --LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI  256 (277)
T ss_pred             --CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence              111123457789999999999999999999987653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-37  Score=279.80  Aligned_cols=262  Identities=27%  Similarity=0.404  Sum_probs=201.8

Q ss_pred             eHHHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEe-
Q 018304           30 ELATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ-  106 (358)
Q Consensus        30 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~-  106 (358)
                      +..+.....++|++.+.||.|+||.||+|.+.. ++.+++|.+.... .....+..|+.+++.+ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            445555667899999999999999999999754 8899999886543 3445678899999998 79999999999853 


Q ss_pred             -----CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeE
Q 018304          107 -----GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK  181 (358)
Q Consensus       107 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~  181 (358)
                           .+..+++|||+.+++|.+++..... ..+++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 4578999999999999999865433 33888889999999999999999999   99999999999999999999


Q ss_pred             EeccccceecCCCCCCCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHH
Q 018304          182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG  256 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~  256 (358)
                      |+|||.+......  ........++..|+|||.+.     +..++.++|+||||+++|+|++|..||........   ..
T Consensus       162 l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~~  236 (282)
T cd06636         162 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---LF  236 (282)
T ss_pred             EeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---hh
Confidence            9999998754211  11223345788999999875     34678899999999999999999999754322111   10


Q ss_pred             HHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          257 HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .    ..........    .    ......+.++|.+||+.+|.+|||+.+|+++-+
T Consensus       237 ~----~~~~~~~~~~----~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         237 L----IPRNPPPKLK----S----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             h----HhhCCCCCCc----c----cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            0    0011111111    0    011235778999999999999999999987643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-37  Score=276.46  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=199.0

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC----------hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS----------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE  108 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~----------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  108 (358)
                      +|.+.+.||.|++|.||+|... +++.+++|.+....          ....+.+..|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            6889999999999999999865 48899999875311          112345778999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..++||||+.+++|.+++...   ..+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998554   34889999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCC--CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      ................++..|+|||.+.+..  ++.++|+||||+++|+|++|..||.....      ............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKRS  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhcccc
Confidence            7643222222223345778999999887654  78999999999999999999999743211      111111111111


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ...+..     .........+.+++.+||..+|++|||+.+++++.+
T Consensus       230 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (272)
T cd06629         230 APPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF  271 (272)
T ss_pred             CCcCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence            111111     111122346778999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.8e-37  Score=275.25  Aligned_cols=265  Identities=24%  Similarity=0.279  Sum_probs=203.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~  114 (358)
                      ++|++.+.||.|++|.||++.+.. ++.+++|.+.... ......+.+|+++++.++|+||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            478999999999999999999854 8899999887532 23456788999999999999999999988654  4789999


Q ss_pred             EecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          115 EFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||+++++|.+++.... ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999999875422 2344889999999999999999999999   99999999999999999999999999865422


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .    ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....... ..........+.+.
T Consensus       158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~  231 (287)
T cd06621         158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELL-SYIVNMPNPELKDE  231 (287)
T ss_pred             c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHH-HHHhcCCchhhccC
Confidence            1    1123446788999999988899999999999999999999999987553311 1111111 11111111111111


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ...  .......+.+++.+||+.+|++|||+.+++++-+..
T Consensus       232 -~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~  270 (287)
T cd06621         232 -PGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK  270 (287)
T ss_pred             -CCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence             110  011234577899999999999999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.4e-37  Score=277.63  Aligned_cols=248  Identities=25%  Similarity=0.312  Sum_probs=201.3

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|++|.||++.+.. ++.+++|.+....   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            479999999999999999999754 8899999886522   234566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++...   ..+++..+..++.|++.||.+||+.+   ++|+||+|.||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998554   34899999999999999999999999   999999999999999999999999998765322


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                           .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....   ........    ... ..+.   
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~~-~~~~---  218 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKIL----EGK-VRFP---  218 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh----cCC-ccCC---
Confidence                 2234578899999999888889999999999999999999999754331   11111111    111 0111   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhcc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGS  314 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~  314 (358)
                        ...    ...+.+++.+||..+|.+|+     ++.+++.+.+.
T Consensus       219 --~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~  257 (290)
T cd05580         219 --SFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF  257 (290)
T ss_pred             --ccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence              111    23566899999999999999     88899887553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.4e-37  Score=276.22  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=188.4

Q ss_pred             eeecccCCccEEEEEEcC---CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           45 KKLGQGGFGPVYKGTLVD---GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~---~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      +.||+|+||.||+|.+.+   +..+++|.+.... ......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998643   4578999886533 233456788999999999999999999999988999999999999


Q ss_pred             CHHHHHhcccc--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          121 SLDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       121 ~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +|.+++.....  ....+...+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999865332  223567788899999999999999999   9999999999999999999999999986532222111


Q ss_pred             ccccccccCCCCCcccccCC-------CCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          199 NTKRVIGTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ......++..|+|||.+.+.       .++.++||||||+++|+|++ |..||......   ......   ... ....+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~---~~~-~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYT---VRE-QQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH---hhc-ccCCC
Confidence            22233466789999987542       35789999999999999996 99998653322   111111   111 11111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ..+...    ......+.+++..|| .+|++|||+.+|+..|+
T Consensus       231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111    111224567888999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.2e-37  Score=271.80  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=200.2

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIY  114 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~  114 (358)
                      +|++.+.||.|++|.||++.+. ++..+++|.+..  ........+..|+++++.++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5899999999999999999864 478999998864  234455678889999999999999999998764  34678999


Q ss_pred             EecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          115 EFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLH-----QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH-----~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ||+++++|.+++.... ....+++..++.++.+|+.||.+||     +.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999999999986532 2345899999999999999999999     777   999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ........  ......++..|+|||.+.+..++.++|+||||+++++|++|..||.....   ....    .........
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~----~~~~~~~~~  228 (265)
T cd08217         158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA----SKIKEGKFR  228 (265)
T ss_pred             ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH----HHHhcCCCC
Confidence            87532221  12234578899999999888899999999999999999999999865431   1111    111112111


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                      .+.         ......+.+++.+||..+|++|||+.+|+++
T Consensus       229 ~~~---------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 RIP---------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCc---------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            111         1123467789999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.2e-37  Score=275.19  Aligned_cols=258  Identities=24%  Similarity=0.341  Sum_probs=198.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..+.......||+|++|.||+|.+.+ +..|++|.+..........+.+|+.+++.++|+||+++++++..++..++++|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            33455556789999999999998654 77899999877666666788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~~~~~~~~~  194 (358)
                      |+.+++|.+++.........++..+..++.|++.|+.|||+.+   ++|+||+|.||+++. ++.++|+|||.+......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            9999999999865422111378888999999999999999999   999999999999976 679999999998765321


Q ss_pred             CCCCccccccccCCCCCcccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .  .......++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||........  ..   ...........+  
T Consensus       163 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~---~~~~~~~~~~~~--  233 (268)
T cd06624         163 N--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AM---FKVGMFKIHPEI--  233 (268)
T ss_pred             C--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hH---hhhhhhccCCCC--
Confidence            1  112223477899999987654  378899999999999999999999754322110  00   000000000111  


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                             +......+.+++.+||..+|++|||+.+++++-+
T Consensus       234 -------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  267 (268)
T cd06624         234 -------PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF  267 (268)
T ss_pred             -------CcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence                   1112235678999999999999999999998754

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-36  Score=269.44  Aligned_cols=254  Identities=28%  Similarity=0.433  Sum_probs=205.9

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY  114 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~  114 (358)
                      +|++.+.||+|++|.||+|.+. +++.+++|.+....  ......+.+|++.++.++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5888999999999999999986 58899999886643  24567888999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++.+..   .+++..++.++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999986544   4999999999999999999999999   999999999999999999999999998876433


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ..........++..|.|||.+.+..++.++|+||||+++++|++|..||....     .................+..  
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~--  227 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPEIPE--  227 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcCCCc--
Confidence            32112334567889999999988889999999999999999999999986654     11111111111111111111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                             .....+.+++.+||..+|++||++.+++.+-+
T Consensus       228 -------~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~  259 (260)
T cd06606         228 -------HLSEEAKDFLRKCLRRDPKKRPTADELLQHPF  259 (260)
T ss_pred             -------ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence                   11346778999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=281.40  Aligned_cols=266  Identities=23%  Similarity=0.312  Sum_probs=197.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      -++|++.+.||+|++|.||+|.++ +++.|++|.+...... ....+.+|+++++.++|+||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            378999999999999999999975 4889999998653222 22446689999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+ +|.+++.....  .+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          84 YLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9975 89988865432  4889999999999999999999999   9999999999999999999999999986532111


Q ss_pred             CCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc----
Q 018304          196 TEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL----  270 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  270 (358)
                        .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.....  ....................    
T Consensus       158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhh
Confidence              11112235778999998765 4678999999999999999999999854331  11111111111111000000    


Q ss_pred             -----ccCCc----CCC-----CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          271 -----IDPCI----QGS-----FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       271 -----~~~~~----~~~-----~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                           .....    ...     ........+.+++.+||+.+|++|||+.+++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~  290 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY  290 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence                 00000    000     00111145678999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-37  Score=274.63  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=200.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CC----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~----~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..+|++.+.||+|+||.||+|.++. |.    .+++|.+.... ......+.+|+..++.++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            4688999999999999999998643 32    58888876543 3345678889999999999999999999887 7889


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ++|||+.+++|.+++.....  .+++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+..+
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999999865432  3899999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .............++..|+|||.+.+..++.++|+||||+++|+|++ |..||......   .......    .......
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~  232 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLE----KGERLPQ  232 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHh----CCCCCCC
Confidence            42222111112223567999999888889999999999999999998 99997543221   1111111    1111000


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .     .    .....+.+++.+||..+|++|||+.++++.|....
T Consensus       233 ~-----~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         233 P-----P----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             C-----C----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            0     0    01134667899999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=293.46  Aligned_cols=258  Identities=28%  Similarity=0.418  Sum_probs=209.0

Q ss_pred             eecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHH
Q 018304           46 KLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDS  124 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  124 (358)
                      +||+|.||+||.|++.+ ...++||.+...+.....-+.+|+...++++|.|||++.+.+..++..-++||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999866 55899999987777777889999999999999999999999999888899999999999999


Q ss_pred             HHhccccccCC--CHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc-CCCCeEEeccccceecCCCCCCCccc
Q 018304          125 FIFDQERCKIL--DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTK  201 (358)
Q Consensus       125 ~l~~~~~~~~~--~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~-~~~~i~L~Df~~~~~~~~~~~~~~~~  201 (358)
                      ++..  ..+++  ++.++-.+..||++||.|||.+.   |+|||||=+||+|+ -.|.+||+|||-++.+-  .......
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccc
Confidence            9854  33445  89999999999999999999999   99999999999997 56899999999988762  3344555


Q ss_pred             cccccCCCCCcccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          202 RVIGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       202 ~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      +..||.-|+|||++..+  .|..++|||||||++.||.||++||-........-.- ...-...             ...
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-VGmyKvH-------------P~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-VGMYKVH-------------PPI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-hcceecC-------------CCC
Confidence            77899999999999765  6888999999999999999999998665544322111 1110011             112


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChHHHHH--HhccCCCCCCCCCC
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL--MLGSETVLPQPKQP  324 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~--~l~~~~~~~~~~~~  324 (358)
                      +.....+...+|.+|+.++|.+||++.+||+  +|+.....++|+.+
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls  847 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS  847 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence            2233445667999999999999999999996  56655555666555

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.7e-38  Score=282.89  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=201.7

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      .|.....||.|++|.||++.+. ++..|++|.+..........+.+|+..++.++|+||+++++.+..++..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3454577999999999999875 488999999876555566778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++...    .+++..++.++.||+.|+.|||+++   ++|+||+|+||+++.++.++|+|||++.......  .
T Consensus       103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~  173 (292)
T cd06658         103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P  173 (292)
T ss_pred             CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence            99999987432    3889999999999999999999999   9999999999999999999999999987543221  1


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS  278 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ........    ......+..     .
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~~-----~  241 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIR----DNLPPRVKD-----S  241 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hcCCCcccc-----c
Confidence            22234578899999999888899999999999999999999999754222   11111111    111111111     0


Q ss_pred             CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          279 FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       279 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                        ......+.+++.+||..+|++|||+.+++++-+.....
T Consensus       242 --~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         242 --HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             --cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence              01123456789999999999999999999976555333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.7e-37  Score=273.31  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=185.9

Q ss_pred             eeecccCCccEEEEEEcC---CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           45 KKLGQGGFGPVYKGTLVD---GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~---~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997533   3578888775432 334456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcccc--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          121 SLDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       121 ~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +|.+++.....  ....++..+..++.||+.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999966432  223567788999999999999999999   9999999999999999999999999986432211111


Q ss_pred             ccccccccCCCCCccccc-------CCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          199 NTKRVIGTYGYMAPEYAS-------DGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ......++..|+|||.+.       ...++.++||||||+++|+|++ |..||.....   .........   . ....+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~---~-~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQVVR---E-QDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhh---c-cCccC
Confidence            112233456799999864       2356889999999999999999 7777654321   111111111   1 11111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ..+.....    ....+.+++..|| .+|++|||+.+|++.|.
T Consensus       231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111111    1234456777888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.2e-37  Score=274.77  Aligned_cols=256  Identities=23%  Similarity=0.362  Sum_probs=199.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC----CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..++|.+.+.||.|++|.||+|.+.+    ...+++|...... ....+.+.+|+.+++.++|+||+++++++.+ ...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            34679999999999999999998643    2468899886644 4455678899999999999999999998875 4578


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ++|||+++++|.+++....  ..+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          83 IVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999996533  23899999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ....... .....+...|+|||.+....++.++||||||+++|+|++ |..||......   .......    .......
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~----~~~~~~~  229 (270)
T cd05056         158 EDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIE----NGERLPM  229 (270)
T ss_pred             cccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH----cCCcCCC
Confidence            3321111 112223457999999888889999999999999999986 99997544322   1111111    1111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..     .    ....+.+++.+||..+|++|||+.++++.|..+
T Consensus       230 ~~-----~----~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         230 PP-----N----CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             CC-----C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11     1    123567799999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=280.34  Aligned_cols=268  Identities=22%  Similarity=0.316  Sum_probs=200.2

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++.+.||+|++|.||+|.+.+ ++.|++|.+...  .......+.+|+++++.++|+||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            479999999999999999999764 889999988642  23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |++++.+..+....   ..+++..++.++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99987776655332   23899999999999999999999999   9999999999999999999999999987653322


Q ss_pred             CCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC------CCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG------MPS  268 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~  268 (358)
                      . .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+...............      ...
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            1 122234567889999998887 88999999999999999999999986433221111111100000000      000


Q ss_pred             -----ccccCCcC----CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          269 -----QLIDPCIQ----GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       269 -----~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                           ........    ..+.......+.++|.+||..+|++|||+.+++.+-+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  287 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY  287 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence                 00000000    0001111356788999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.1e-37  Score=278.14  Aligned_cols=265  Identities=24%  Similarity=0.322  Sum_probs=199.7

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh-----hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~-----~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +|++.+.||.|++|.||+|.+. +++.|++|.+.....     .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            5889999999999999999975 488999999875332     2344567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+ +++|.+++....  ..+++..++.++.||++||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999986543  24899999999999999999999999   99999999999999999999999999876532


Q ss_pred             CCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC-----
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP-----  267 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  267 (358)
                      ..  .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..+|.....   ................     
T Consensus       155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD---IDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc---HHHHHHHHHHcCCCchhhhhh
Confidence            21  11222345678999998754 4678999999999999999999777653322   1222222111100000     


Q ss_pred             ----CccccCCcCCCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          268 ----SQLIDPCIQGSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       268 ----~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          .............     ......+.++|.+||+.+|++|||+.+++++-+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~  286 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS  286 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence                0000000000001     11234678899999999999999999999975444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8e-37  Score=273.64  Aligned_cols=257  Identities=27%  Similarity=0.424  Sum_probs=199.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .++|++++.||+|+||.||+|+.+.      .+.+++|.+...... ....+.+|+++++.++|+||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            3689999999999999999998642      457889988654333 456788999999999999999999999998899


Q ss_pred             EEEEEecCCCCHHHHHhcccccc------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCK------ILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                      ++||||+++++|.+++.......      .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999996544221      4899999999999999999999999   99999999999999999999999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      ||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .....    ..
T Consensus       161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~----~~  232 (275)
T cd05046         161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNR----LQ  232 (275)
T ss_pred             cccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHH----HH
Confidence            99876432111 112222345667999999888888999999999999999998 77786432211   11111    11


Q ss_pred             cCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          264 EGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ........    ..    .....+.+++.+||+.+|++|||+.+++..|+
T Consensus       233 ~~~~~~~~----~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 AGKLELPV----PE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCCcCCCC----CC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11110000    01    11235778999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.9e-37  Score=273.91  Aligned_cols=240  Identities=20%  Similarity=0.356  Sum_probs=186.1

Q ss_pred             eeecccCCccEEEEEEcC-------------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           45 KKLGQGGFGPVYKGTLVD-------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-------------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      +.||+|++|.||+|+...             ...+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997422             2358889887655555667888999999999999999999999988999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC-------eEEec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-------PKISD  184 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~-------i~L~D  184 (358)
                      ++|||+++++|..++....  ..+++..++.++.||++|+.|||+.+   ++|+||+|+||+++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999998875432  34899999999999999999999999   999999999999986664       89999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCccccc-CCCCCCcccchhHhHHHHHHH-hCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEII-SGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      ||.+.....      .....++..|+|||.+. +..++.++||||||+++|+|+ .|..||......    ..   ....
T Consensus       156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~---~~~~  222 (262)
T cd05077         156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA----EK---ERFY  222 (262)
T ss_pred             CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh----HH---HHHH
Confidence            998865321      11234677899999876 467899999999999999998 577775432211    00   1111


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ... . ....         .....+.++|.+||+.||++||++.+|++.++
T Consensus       223 ~~~-~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQ-C-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcC-c-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            111 0 0000         11235678999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.2e-38  Score=282.34  Aligned_cols=264  Identities=23%  Similarity=0.336  Sum_probs=198.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++.+.||+|++|.||+|.+.+ ++.|++|.+.....  .....+.+|+++++.++|+||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            479999999999999999999864 88999998864222  234567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.++.....   .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999988888764332   3899999999999999999999999   9999999999999999999999999987653222


Q ss_pred             CCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc----------
Q 018304          196 TEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE----------  264 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  264 (358)
                        .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.....   .............          
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHHhc
Confidence              12223456788999998765 4578899999999999999999988754322   1111111110000          


Q ss_pred             -CC-CCccccCCcCCCC-----CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          265 -GM-PSQLIDPCIQGSF-----NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       265 -~~-~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                       .. ......+......     .......+.+++.+||..+|++||++.+++++-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence             00 0000000000000     0011345778999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.8e-37  Score=275.19  Aligned_cols=249  Identities=24%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      +|++.+.||.|++|.||++.+. +++.|++|.+.+..   ....+.+.+|++.+++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999976 48899999986522   2456788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++...   ..+++..+..++.|+++||.|||+.+   ++|+||+|.||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998654   34899999999999999999999999   9999999999999999999999999987653221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                         ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........    ...... ......    
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~-~~~~~~----  222 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET-ADVLYP----  222 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc-ccccCc----
Confidence               22334577889999999888899999999999999999999999875543211111    111110 011111    


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCCh--HHHHHH
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSM--PSVILM  311 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~--~ell~~  311 (358)
                           ......+.++|.+||+.+|.+||++  .+++.+
T Consensus       223 -----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         223 -----ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             -----ccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence                 0112567789999999999999999  777654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-36  Score=271.50  Aligned_cols=253  Identities=27%  Similarity=0.381  Sum_probs=194.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Cee
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK  110 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~  110 (358)
                      .+|++.+.||+|++|.||++.+.. +..|++|.+....     ......+.+|+.+++.++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            479999999999999999998754 8899999885421     23345678899999999999999999988763  577


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++++||+++++|.+++.+..   .+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999985433   3889999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCC-CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          191 FGGDET-EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       191 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||......      ..............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~  229 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPTNPQ  229 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCCCCC
Confidence            432111 11122344778899999998888999999999999999999999998643211      11111111111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      +         .......+.+++ +||..+|++||++.+|+++-+
T Consensus       230 ~---------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~  263 (266)
T cd06651         230 L---------PSHISEHARDFL-GCIFVEARHRPSAEELLRHPF  263 (266)
T ss_pred             C---------chhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence            1         111122344566 688899999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.2e-37  Score=272.92  Aligned_cols=253  Identities=26%  Similarity=0.355  Sum_probs=196.8

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Cee
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK  110 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~  110 (358)
                      ++|++.+.||+|++|.||++.+.+ +..|++|.+...     .......+.+|+.+++.++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            589999999999999999999754 889999987531     123456788899999999999999999988764  467


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      +++|||+++++|.+++.+..   .+++..++.++.+++.||.+||+.+   ++|+||+|.||+++.++.++|+|||.+..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999985433   3788999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCC-CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          191 FGGDET-EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       191 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ...... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||......      ............  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~--  227 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN--  227 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCCCC--
Confidence            432111 11122345778899999998888999999999999999999999997543211      111111111100  


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                             ..........+.+++.+||. +|++||++.+|+++.+
T Consensus       228 -------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~  263 (265)
T cd06652         228 -------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF  263 (265)
T ss_pred             -------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence                   11112233456678889984 9999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=276.74  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=199.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC------
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE------  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~------  108 (358)
                      ..++|++.+.||.|++|.||+|.+. +++.+++|.+..... ....+.+|+.+++.+ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4589999999999999999999975 478999998876443 346788999999999 7999999999997654      


Q ss_pred             eeEEEEEecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                      ..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999999986533 2245899999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      +......  ........++..|+|||.+..     ..++.++||||||+++|+|++|..||......   ....   . .
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---~-~  230 (275)
T cd06608         160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALF---K-I  230 (275)
T ss_pred             ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHH---H-h
Confidence            8764321  122233457888999998753     35678999999999999999999998532211   1111   1 1


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .......+..       .......+.+++.+||..||++|||+.+|+++-+
T Consensus       231 ~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         231 PRNPPPTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             hccCCCCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence            1111111110       1112345778999999999999999999998643

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.2e-37  Score=271.22  Aligned_cols=247  Identities=28%  Similarity=0.447  Sum_probs=195.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      ++|++.+.||+|++|.||++.. .++.+++|.+....  ....+.+|+.+++.++|+|++++++++... ..+++|||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5689999999999999999875 78889999886532  335778899999999999999999998654 5799999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++..... ..+++..++.++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||.+......    
T Consensus        82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            9999999865433 23889999999999999999999999   999999999999999999999999998754211    


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                       ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......   .......    ........     .
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~-----~  220 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECVE----KGYRMEPP-----E  220 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHh----CCCCCCCC-----C
Confidence             112233567999999988889999999999999999997 88887543321   1111111    11111100     1


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                          .....+.+++.+||+.+|++||++.+|++.|+.
T Consensus       221 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 ----GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                112456689999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=282.34  Aligned_cols=270  Identities=20%  Similarity=0.294  Sum_probs=199.2

Q ss_pred             CCCcceeecccCCccEEEEEEcC---CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD---GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL  111 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~---~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~  111 (358)
                      +|++.+.||+|++|.||+|.+..   +..|++|.+....   ......+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999754   7899999997632   34446677899999999999999999999988  7899


Q ss_pred             EEEEecCCCCHHHHHhcccc--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC----CCCeEEecc
Q 018304          112 LIYEFMTNKSLDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF  185 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~----~~~i~L~Df  185 (358)
                      +||||+++ ++.+++.....  ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.    ++.++|+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 67776643321  225899999999999999999999999   999999999999999    899999999


Q ss_pred             ccceecCCCCC-CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCc------hhHHH
Q 018304          186 GLARAFGGDET-EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL------NLIGH  257 (358)
Q Consensus       186 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~------~~~~~  257 (358)
                      |++........ ........++..|+|||.+.+. .++.++||||||+++++|++|..||.........      ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99876533221 1122234567889999987664 5789999999999999999999998765443210      01111


Q ss_pred             HHHHhhcCCC---------Ccccc---CCcCCCC---CH--------HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          258 AWKLWNEGMP---------SQLID---PCIQGSF---NL--------AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       258 ~~~~~~~~~~---------~~~~~---~~~~~~~---~~--------~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ....+.....         .....   ......+   ..        .....+.+++.+||+.+|++|||+.+++++-+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            1111100000         00000   0000000   00        12235788999999999999999999998744

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.5e-37  Score=274.28  Aligned_cols=251  Identities=34%  Similarity=0.501  Sum_probs=194.5

Q ss_pred             eeecccCCccEEEEEEcC-------CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           45 KKLGQGGFGPVYKGTLVD-------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +.||+|++|.||+|.+++       +..+++|.+.... ......+.+|++.++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998643       2578889876532 23456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccc----cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-----CeEEecccc
Q 018304          117 MTNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-----NPKISDFGL  187 (358)
Q Consensus       117 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-----~i~L~Df~~  187 (358)
                      +++++|.+++.+..    ....+++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996532    1233788999999999999999999999   99999999999999877     899999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      +..+.............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ........    ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT----AGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh----cCC
Confidence            876533222222223345678999999998899999999999999999998 9988754322   11111111    111


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      .....         ......+.+++.+||..+|++||++.++++.|++
T Consensus       231 ~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 RLQKP---------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ccCCc---------ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            00000         1112456789999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.7e-37  Score=281.25  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=201.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      ..|+....||+|+||.||++.+. +++.|++|.+..........+.+|+..++.++|||++++++++..++..++++||+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            34555668999999999999875 58899999986544445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++++|.+++..    ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus       101 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--  171 (297)
T cd06659         101 QGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--  171 (297)
T ss_pred             CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--
Confidence            99999987743    23889999999999999999999999   9999999999999999999999999986542211  


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......   .......    .........   . 
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~---~-  240 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLR----DSPPPKLKN---A-  240 (297)
T ss_pred             ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh----ccCCCCccc---c-
Confidence            1223345788999999998888999999999999999999999997643221   1111111    111110000   0 


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                         ......+.+++.+||+.+|++||++.+++++.+....
T Consensus       241 ---~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         241 ---HKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             ---CCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence               0112346689999999999999999999997655533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-36  Score=271.10  Aligned_cols=254  Identities=27%  Similarity=0.466  Sum_probs=200.9

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|.+.+.||+|++|.||+|.+. +++.|++|.+.....  .....+.+|+++++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            6899999999999999999865 588999999876443  3677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++...   ..+++..+..++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999998553   23788999999999999999999999   99999999999999999999999999877543222


Q ss_pred             CCc--cccccccCCCCCcccccCCC---CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          197 EGN--TKRVIGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       197 ~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ...  .....++..|+|||.+.+..   ++.++||||||+++|+|++|..||......  ........    ......+.
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~----~~~~~~~~  228 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVG----AGHKPPIP  228 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHh----cCCCCCCC
Confidence            111  12345678999999987765   889999999999999999999998643311  11110111    11111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      ..       ......+.+++.+||+.+|++|||+.+++.+-
T Consensus       229 ~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~  262 (264)
T cd06626         229 DS-------LQLSPEGKDFLDRCLESDPKKRPTASELLQHP  262 (264)
T ss_pred             cc-------cccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence            10       01123456799999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=271.40  Aligned_cols=249  Identities=28%  Similarity=0.443  Sum_probs=191.9

Q ss_pred             eeecccCCccEEEEEEcC-CC--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~--~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|++|.||+|.+++ +.  .+++|.+... .......+.+|++++..+ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998754 43  5688887643 344556788999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          120 KSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       120 ~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      ++|.+++.....             ...+++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999865321             124789999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      ++....   ..........+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..   ......    ...
T Consensus       158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~  227 (270)
T cd05047         158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL----PQG  227 (270)
T ss_pred             Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHH----hCC
Confidence            875321   1111111223457999999988889999999999999999997 99997543221   111111    111


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ......         ......+.+++.+||..+|.+|||+.+++..|..+
T Consensus       228 ~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 YRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CCCCCC---------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            111111         01123567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-36  Score=269.81  Aligned_cols=248  Identities=27%  Similarity=0.396  Sum_probs=190.5

Q ss_pred             eecccCCccEEEEEEc---CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCC
Q 018304           46 KLGQGGFGPVYKGTLV---DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKS  121 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~  121 (358)
                      .||+|+||.||+|.+.   .+..|++|.+.... ......+.+|+.+++.++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999763   25579999886543 333456889999999999999999999875 457899999999999


Q ss_pred             HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc-c
Q 018304          122 LDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-T  200 (358)
Q Consensus       122 L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~-~  200 (358)
                      |.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........... .
T Consensus        81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999985432  34899999999999999999999999   99999999999999999999999999875432221111 1


Q ss_pred             ccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       201 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    ........        
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~--------  220 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIE----QGKRLDCP--------  220 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHH----CCCCCCCC--------
Confidence            11123467999999888889999999999999999996 99897543221   1111111    11111111        


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ......+.+++.+||..+|++||++.+|.+.|+..
T Consensus       221 -~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 -AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             11124566899999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-36  Score=270.74  Aligned_cols=250  Identities=27%  Similarity=0.417  Sum_probs=188.4

Q ss_pred             eeecccCCccEEEEEEcC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEE-eCCeeEEEEEecC
Q 018304           45 KKLGQGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLLIYEFMT  118 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~~~~lv~e~~~  118 (358)
                      +.||+|+||.||+|.+.+    +..+++|.+... .......+..|+.+++.++||||+++++++. .+...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998532    357999988542 3345667888999999999999999999765 4556789999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC-
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-  197 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~-  197 (358)
                      +++|.+++.....  ..+...+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...... 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999865432  2677788899999999999999999   999999999999999999999999998754321111 


Q ss_pred             -CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhC-CCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          198 -GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG-KKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       198 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                       .......++..|+|||.+.+..++.++||||||+++|+|++| ..||....   .........   ... .....    
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~---~~~-~~~~~----  224 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYLL---QGR-RLLQP----  224 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHh---cCC-CCCCC----
Confidence             111123346689999998888899999999999999999995 45543221   111111111   111 11000    


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ..    ....+.+++.+||..+|++||++.+|+..|+..
T Consensus       225 -~~----~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         225 -EY----CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -Cc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             00    113577899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.1e-37  Score=277.92  Aligned_cols=255  Identities=21%  Similarity=0.235  Sum_probs=195.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|++|.||++.+.. ++.|++|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            479999999999999999999755 7899999886533   234456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++...   +.+++..+..++.+++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||++......
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999998543   34899999999999999999999999   999999999999999999999999987632100


Q ss_pred             CC-------------CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH
Q 018304          195 ET-------------EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       195 ~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      ..             ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~--  229 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVI--  229 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH--
Confidence            00             0011123467789999999888899999999999999999999999753221   11111111  


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh---HHHHHHhc
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM---PSVILMLG  313 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~---~ell~~l~  313 (358)
                       ........    ..    ......+.++|.+||+.+|++||+.   .+++++.+
T Consensus       230 -~~~~~~~~----~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~  275 (305)
T cd05609         230 -SDDIEWPE----GD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF  275 (305)
T ss_pred             -hcccCCCC----cc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence             11100000    00    0112346789999999999999995   55555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=276.58  Aligned_cols=248  Identities=27%  Similarity=0.435  Sum_probs=206.4

Q ss_pred             CCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      |.++++||+|.||.||++.++. |+-+++|.+..  +.++..+..|+.++++++.+++|++|+.+-....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            6789999999999999998765 99999998875  55678899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      |++.|++..  +++++.+.++..++...++||+|||...   -+|||||..||+++.+|..||+|||.+-.+.  +.--.
T Consensus       113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAK  185 (502)
T KOG0574|consen  113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAK  185 (502)
T ss_pred             CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhHHh
Confidence            999999854  3456999999999999999999999999   9999999999999999999999999987653  22334


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .++..||+.|+|||++..-.|+.++||||||++..+|..|++||..-.+-.....+       ....++.+.        
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT~PPPTF~--------  250 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PTKPPPTFK--------  250 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cCCCCCCCC--------
Confidence            45678999999999999999999999999999999999999996543222111110       111111111        


Q ss_pred             CHHH-HHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          280 NLAE-VIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       280 ~~~~-~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      .+.+ ..++-++++.||-.+|++|.|+..|+++.
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            1112 34677899999999999999999999874

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-36  Score=274.55  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=203.1

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      +|.-.+.||.|++|.||++.+. +++.+++|.+..........+.+|+.+++.++|+|++++++++...+..++++||+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            4666789999999999999864 588999998876555555678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++..    ..++...++.++.|++.|+.+||+++   ++|+||+|+||+++.++.++|+|||.+.......  .
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--P  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--c
Confidence            9999999855    23889999999999999999999999   9999999999999999999999999876543211  1


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS  278 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                      ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....   ........    ..........     
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~----~~~~~~~~~~-----  238 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIR----DNLPPKLKNL-----  238 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHH----hcCCCCCccc-----
Confidence            12234578899999999888899999999999999999999999754221   11111111    1111111100     


Q ss_pred             CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          279 FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       279 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                        ......+.+++.+||..+|++|||+.+++++-+.....
T Consensus       239 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         239 --HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             --ccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence              01123577899999999999999999999876555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.5e-37  Score=272.58  Aligned_cols=254  Identities=22%  Similarity=0.405  Sum_probs=198.9

Q ss_pred             CCCcceeecccCCccEEEEEEcC--CCEEEEEEecc----------cChhhHHHHHHHHHHHHh-cCCCCccceeeEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD--GQEIAVKRLSK----------ISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ  106 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~--~~~v~vK~~~~----------~~~~~~~~~~~e~~~l~~-l~~~~iv~~~~~~~~  106 (358)
                      .|++.+.||+|++|.||++.+..  ++.+++|.+..          ........+..|+.++.. ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999755  67899998753          223344556778887765 699999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.++.+||+ .+   ++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999988542 223348999999999999999999996 66   99999999999999999999999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      ||.+.......   ......++..|++||.+.+..++.++|+||||+++|+|++|..||......   .......    .
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~----~  227 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKIV----E  227 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHHh----h
Confidence            99988653222   223455788899999998888999999999999999999999997543211   1111111    1


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ........    .    .....+.+++.+||+.||++||++.++..++.+
T Consensus       228 ~~~~~~~~----~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         228 AVYEPLPE----G----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             ccCCcCCc----c----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            11111110    0    112356789999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.7e-36  Score=277.19  Aligned_cols=263  Identities=20%  Similarity=0.314  Sum_probs=187.3

Q ss_pred             eeecccCCccEEEEEEcC---CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~e~~~~  119 (358)
                      .+||+|+||.||+|...+   +..|++|.+....  ....+.+|+++++.++||||+++++++..  +...+++|||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            589999999999998643   5789999886533  22456789999999999999999998854  4577899999865


Q ss_pred             CCHHHHHhccc------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE----cCCCCeEEeccccce
Q 018304          120 KSLDSFIFDQE------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLAR  189 (358)
Q Consensus       120 ~~L~~~l~~~~------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv----~~~~~i~L~Df~~~~  189 (358)
                       +|.+++....      ....+++..++.++.||+.||.|||+.+   ++|+||||+||++    +.++.++|+|||++.
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             7777764221      1224888999999999999999999999   9999999999999    456789999999998


Q ss_pred             ecCCCCCC-CccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC------chhHHHHHHH
Q 018304          190 AFGGDETE-GNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN------LNLIGHAWKL  261 (358)
Q Consensus       190 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~  261 (358)
                      ........ .......++..|+|||.+.+. .++.++|||||||++|+|++|..||........      ..........
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            65332211 122334678899999988764 578999999999999999999999865432211      0111111110


Q ss_pred             hhcCCC---------C---ccccCCcCCCC------------CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          262 WNEGMP---------S---QLIDPCIQGSF------------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       262 ~~~~~~---------~---~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ......         .   ..........+            .......+.+++.+||+.||.+|||+.+++++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            000000         0   00000000000            0011234778999999999999999999998754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.6e-36  Score=275.79  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=196.7

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CC----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~----~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .++|++.+.||+|++|.||+|.+.. +.    .+++|.+.... ......+.+|+.+++.++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            3678999999999999999998643 43    57888876533 22334677899999999999999999988654 467


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +++||+++|+|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++..+
T Consensus        85 ~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            8999999999999986543  23889999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ....    ..........
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~~~  232 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPD----LLEKGERLPQ  232 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCCCCCC
Confidence            32222111222334668999999988889999999999999999997 88887543211   1111    1111110000


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                           ...    ....+.+++.+||..+|++||++.++++.++.+.
T Consensus       233 -----~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         233 -----PPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             -----CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 001    1235678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.9e-37  Score=275.69  Aligned_cols=264  Identities=27%  Similarity=0.373  Sum_probs=201.9

Q ss_pred             eHHHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC
Q 018304           30 ELATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG  107 (358)
Q Consensus        30 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~  107 (358)
                      ...++....++|++.+.||+|++|.||++..+ +++.+++|.+.... .....+..|+.+++.+ +|+|++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34555566789999999999999999999975 48899999886532 2335667889999998 799999999998754


Q ss_pred             -----CeeEEEEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeE
Q 018304          108 -----EEKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK  181 (358)
Q Consensus       108 -----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~  181 (358)
                           ...++||||+++++|.+++... .....+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence                 3579999999999999988542 22345899999999999999999999999   99999999999999999999


Q ss_pred             EeccccceecCCCCCCCccccccccCCCCCcccccCC-----CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHH
Q 018304          182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG  256 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~  256 (358)
                      |+|||++.......  .......++..|+|||.+...     .++.++||||||+++|+|++|..||......   ..  
T Consensus       169 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~--  241 (291)
T cd06639         169 LVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KT--  241 (291)
T ss_pred             Eeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HH--
Confidence            99999987643211  112234577889999987543     3688999999999999999999997543221   11  


Q ss_pred             HHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          257 HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                       ... +.......+...       ......+.++|.+||+.+|++||++.+++++-+
T Consensus       242 -~~~-~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~  289 (291)
T cd06639         242 -LFK-IPRNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF  289 (291)
T ss_pred             -HHH-HhcCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence             111 111111111111       111235778999999999999999999998744

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.7e-37  Score=283.71  Aligned_cols=269  Identities=25%  Similarity=0.305  Sum_probs=201.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----  107 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----  107 (358)
                      ...++|++.+.||+|++|.||+|.+. +++.|++|.+.+.  .......+.+|+.+++.++|+||++++++|...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            45689999999999999999999975 4899999998642  333445677899999999999999999988644     


Q ss_pred             -CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          108 -EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       108 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                       ...++||||+.+ +|.+.+...     ++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence             356999999965 888776321     788899999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH-----
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL-----  261 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  261 (358)
                      ++.......   ......++..|+|||.+.+..++.++|||||||++|+|++|..||...+...   ........     
T Consensus       164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~  237 (353)
T cd07850         164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID---QWNKIIEQLGTPS  237 (353)
T ss_pred             cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence            998653221   1223456788999999998999999999999999999999999986543211   11111000     


Q ss_pred             -------------hhcCCC-------CccccCCc----CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          262 -------------WNEGMP-------SQLIDPCI----QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       262 -------------~~~~~~-------~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                                   +.....       ........    ...........+.++|.+||+.||++|||+.+++.+-+...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                         000000       00000000    000011123456789999999999999999999998766544


Q ss_pred             CC
Q 018304          318 LP  319 (358)
Q Consensus       318 ~~  319 (358)
                      ..
T Consensus       318 ~~  319 (353)
T cd07850         318 YD  319 (353)
T ss_pred             cC
Confidence            43

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.7e-37  Score=275.88  Aligned_cols=263  Identities=22%  Similarity=0.294  Sum_probs=196.0

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++++.||.|++|.||+|.+. +++.|++|.+....  ......+.+|+++++.++||||+++++++.+++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5899999999999999999875 48899999886432  22335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +. ++|.+++..... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  154 (284)
T ss_pred             cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence            96 588888865433 34899999999999999999999999   9999999999999999999999999987543211 


Q ss_pred             CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC---------
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM---------  266 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  266 (358)
                       .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.......   .............         
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCChhhhhhhhH
Confidence             111223457789999987664 45889999999999999999999986433211   1111111000000         


Q ss_pred             -------CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          267 -------PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       267 -------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                             ........... ........+.++|.+||+.||.+|||+.+++.+-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  283 (284)
T cd07860         231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF  283 (284)
T ss_pred             HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence                   00000000000 00011234668999999999999999999998744

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.6e-36  Score=265.00  Aligned_cols=251  Identities=29%  Similarity=0.469  Sum_probs=203.8

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      +|++.+.||+|++|.||++.+. +++.+++|.+..........+.+|++.++.++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            5889999999999999999985 588999999977555566788899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++....  ..+++..++.++.+++.|+.+||+.+   ++|+||+|.||+++.++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999986543  34899999999999999999999999   99999999999999999999999999876532221  


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS  278 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                       .....++..|+|||.+.+..++.++|+||||+++++|++|..||......   .......    ...........    
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~~~----  221 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIA----TNGPPGLRNPE----  221 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHH----hcCCCCcCccc----
Confidence             23455788999999998888899999999999999999999997543211   1111111    11111111110    


Q ss_pred             CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          279 FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       279 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                         .....+.+++.+||+.+|++|||+.+++++-
T Consensus       222 ---~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~  252 (253)
T cd05122         222 ---KWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP  252 (253)
T ss_pred             ---ccCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence               0123577899999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.8e-37  Score=278.49  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=198.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~l  112 (358)
                      .++|++.+.||.|++|.||+|.+.. |+.|++|.+....  ........+|+.+++.++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4789999999999999999999754 8999999886422  22223456799999999999999999998765  46899


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+.+ +|.+++....  ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999965 8888875533  34899999999999999999999999   9999999999999999999999999988653


Q ss_pred             CCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc--
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ--  269 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  269 (358)
                      ...  .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+..   .................  
T Consensus       160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhch
Confidence            221  11122334678999998865 46789999999999999999999998643322   22221111111000000  


Q ss_pred             -c-----ccC-CcC-CCC-CH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 -L-----IDP-CIQ-GSF-NL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 -~-----~~~-~~~-~~~-~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       +     ... ... ... ..     .....+.++|.+||+.||++|||+.+++.+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence             0     000 000 000 00     0134567899999999999999999999987665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.6e-37  Score=270.44  Aligned_cols=238  Identities=25%  Similarity=0.436  Sum_probs=186.3

Q ss_pred             eeecccCCccEEEEEEcCCC-----------EEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           45 KKLGQGGFGPVYKGTLVDGQ-----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~-----------~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +.||+|+||.||+|.+....           .+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999975432           5777877553332 5778899999999999999999999888 778999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-------CeEEeccc
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-------NPKISDFG  186 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-------~i~L~Df~  186 (358)
                      |||+.+++|.+++.....  .+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++       .++|+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999865442  4889999999999999999999999   99999999999999887       79999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCC--CCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      ++.....      .....+...|+|||.+.+.  .++.++||||||+++|+|++ |..||.......   ..    ..+.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~----~~~~  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KE----RFYQ  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HH----HHHh
Confidence            9876432      1223456779999998776  78999999999999999999 466654432111   10    0111


Q ss_pred             cCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          264 EGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ....  ....         ....+.+++.+||..+|.+|||+.++++.|.
T Consensus       221 ~~~~--~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQHR--LPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCCC--CCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1100  0000         0156778999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.7e-36  Score=269.81  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=195.5

Q ss_pred             CCcceeecccCCccEEEEEEc----CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC------
Q 018304           41 FSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------  108 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~------  108 (358)
                      |++.+.||+|++|.||+|.+.    .++.+++|.+...  .....+.+.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999853    3678999988653  3345667888999999999999999999886542      


Q ss_pred             eeEEEEEecCCCCHHHHHhccc---cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQE---RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF  185 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df  185 (358)
                      ..+++++|+.+++|.+++....   ....++...++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2368899999999998874322   1123788999999999999999999999   999999999999999999999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      |++................++..|++||.+.+..++.++||||||+++|+|++ |..||...+.   ........    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----K  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----c
Confidence            99876532221111222334567999999988888999999999999999999 7888654322   11111111    1


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .......         ......+.+++.+||..+|++|||+.++++.|+.+
T Consensus       231 ~~~~~~~---------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRLKQP---------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110000         11224677899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-36  Score=272.33  Aligned_cols=248  Identities=27%  Similarity=0.321  Sum_probs=193.4

Q ss_pred             ecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           47 LGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        47 lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      ||+|+||.||++.+. +|+.|++|.+....   ......+..|+++++.++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 48899999886422   22344566899999999999999999999999999999999999999


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcccc
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR  202 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~  202 (358)
                      .+++..... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.....   ......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCcccc
Confidence            999865443 24899999999999999999999999   99999999999999999999999998876432   111223


Q ss_pred             ccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHH
Q 018304          203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA  282 (358)
Q Consensus       203 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+....    .......         ...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT----LEMAVEY---------PDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc----ccccccC---------Ccc
Confidence            346778999999888889999999999999999999999986544322211111100    0000011         011


Q ss_pred             HHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhcc
Q 018304          283 EVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGS  314 (358)
Q Consensus       283 ~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~  314 (358)
                      ....+.++|.+||+.+|.+||     ++.+++.+.+.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~  257 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF  257 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence            133567899999999999999     77778876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.8e-36  Score=269.68  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=200.2

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +-|++.+.||+|++|.||+|.+. ++..+++|.+.... ......+.+|+..+..++|+||+++++++..++..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34788999999999999999874 47899999876432 33456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+++|.+++...    .+++..+..++.+++.++.+||+.+   ++|+||+|.||++++++.++|+|||++..+.... 
T Consensus        84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            9999999988532    3889999999999999999999999   9999999999999999999999999987653221 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                       .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......   ....    .........+     .
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~~-----~  222 (277)
T cd06641         156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLF----LIPKNNPPTL-----E  222 (277)
T ss_pred             -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHH----HHhcCCCCCC-----C
Confidence             1122345678899999998888899999999999999999999997543211   1111    1111111111     1


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          ......+.+++.+||+.+|.+||++.+++.+-+..
T Consensus       223 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~  257 (277)
T cd06641         223 ----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             ----cccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence                11224567899999999999999999999975443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-36  Score=272.46  Aligned_cols=239  Identities=22%  Similarity=0.321  Sum_probs=183.8

Q ss_pred             eecccCCccEEEEEEcC-------------------------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccce
Q 018304           46 KLGQGGFGPVYKGTLVD-------------------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL  100 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~~-------------------------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~  100 (358)
                      .||+|+||.||+|....                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            68999999999997421                         13588888865444445667788999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC--
Q 018304          101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM--  178 (358)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~--  178 (358)
                      ++++......++||||+++++|..++....  +.+++..+..++.||+.||.|||+++   ++|+||+|.||+++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999885432  33889999999999999999999999   99999999999997543  


Q ss_pred             -----CeEEeccccceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHH-hCCCCCCCCCCCCC
Q 018304          179 -----NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEII-SGKKNRGFYHSDNN  251 (358)
Q Consensus       179 -----~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~-~g~~p~~~~~~~~~  251 (358)
                           .++++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++|+|+ +|..||....... 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                 3899999987543111      12245678999998865 56899999999999999995 6888875432221 


Q ss_pred             chhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                        ......    ..  .....     .    ....+.++|.+||+.+|++|||+.+|++.|.
T Consensus       230 --~~~~~~----~~--~~~~~-----~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 --KERFYE----KK--HRLPE-----P----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHHHHH----hc--cCCCC-----C----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              111111    00  00000     0    1125678999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.6e-37  Score=274.84  Aligned_cols=258  Identities=26%  Similarity=0.363  Sum_probs=195.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHH-HHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~-l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++.+.||+|+||.||++.++. |+.|++|.+.... ......+..|+.. ++.++||||+++++++..+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            479999999999999999999764 8999999987532 2223444555554 566689999999999999999999999


Q ss_pred             ecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          116 FMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       116 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |++ ++|.+++... .....+++..++.++.|++.||.|||++ +   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 5888877542 2334589999999999999999999997 8   99999999999999999999999999876532


Q ss_pred             CCCCCccccccccCCCCCcccccC----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .   .......++..|+|||.+.+    ..++.++|+||+|+++|+|++|..||.....  .........    ......
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~----~~~~~~  227 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVV----EEPSPQ  227 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHH----hcCCCC
Confidence            1   11122457788999998764    4568899999999999999999999753221  111111111    111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      +....        ....+.++|.+||..+|++|||+.+++++-+....
T Consensus       228 ~~~~~--------~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         228 LPAEK--------FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             CCccc--------cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            11111        12357789999999999999999999987655543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-38  Score=291.82  Aligned_cols=246  Identities=26%  Similarity=0.410  Sum_probs=198.5

Q ss_pred             CcceeecccCCccEEEEEEcC-CCEEEEEEec--c--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe--eEEEE
Q 018304           42 SINKKLGQGGFGPVYKGTLVD-GQEIAVKRLS--K--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--KLLIY  114 (358)
Q Consensus        42 ~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~--~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~--~~lv~  114 (358)
                      ++..+||+|+|.+||+|.+.. |..|+=-.++  .  ........+..|+.+|+.|+|+||+++|+++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            556799999999999999744 6666522221  1  345566889999999999999999999999988765  77999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEeccccceecCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGG  193 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~~~~~~~~  193 (358)
                      |.+.+|+|..|..+.+.   .+...+.+|+.||++||.|||++. ++|+|||||.+||||+. .|.|||+|+|+|.... 
T Consensus       123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r-  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR-  197 (632)
T ss_pred             ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh-
Confidence            99999999999966555   889999999999999999999986 79999999999999984 5999999999998753 


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                         ....+...|||.|||||... ..|+...||||||+++.||.|+.+||  ..-..+..+...+..+........+.++
T Consensus       198 ---~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY--sEC~n~AQIYKKV~SGiKP~sl~kV~dP  271 (632)
T KOG0584|consen  198 ---KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY--SECTNPAQIYKKVTSGIKPAALSKVKDP  271 (632)
T ss_pred             ---ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh--hhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence               22333468999999999765 89999999999999999999999994  3444445555455444333333333332


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                                  .+.+||.+||.. .++|||+.|||..
T Consensus       272 ------------evr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  272 ------------EVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence                        345799999999 9999999999974

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.4e-36  Score=267.60  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=199.6

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||.|++|.||++.++. |..+++|.+...  .......+.+|+++++.++|+||+++++.+.+....++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            58899999999999999999754 889999998653  123445678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC-eEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~-i~L~Df~~~~~~~~~~  195 (358)
                      +.+++|.+++..... ..+++..+..++.+++.|+.|||+.+   ++|+||+|.||++++++. ++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999999865433 23789999999999999999999999   999999999999998864 6999999887653221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......++..|+|||.+.+..++.++|+||||+++++|++|..||.....      ........ ........    
T Consensus       157 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~----  223 (257)
T cd08225         157 --ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC-QGYFAPIS----  223 (257)
T ss_pred             --ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-cccCCCCC----
Confidence              112233577889999998888899999999999999999999999753221      11111111 11111111    


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                           ......+.+++.+||..+|++|||+.+++.+.+
T Consensus       224 -----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~  256 (257)
T cd08225         224 -----PNFSRDLRSLISQLFKVSPRDRPSITSILKRPF  256 (257)
T ss_pred             -----CCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence                 111235778999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-37  Score=274.19  Aligned_cols=240  Identities=25%  Similarity=0.426  Sum_probs=186.5

Q ss_pred             eeecccCCccEEEEEEcC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           45 KKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +.||+|+||.||+|.+..        ...+++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999998643        234888887665555566788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC--------eEEeccccc
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--------PKISDFGLA  188 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~--------i~L~Df~~~  188 (358)
                      +.+++|.+++.....  .+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.        ++++|||.+
T Consensus        81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999865432  3889999999999999999999999   999999999999987765        699999987


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCC-CCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK-KNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      .....      .....++..|+|||.+.+. .++.++||||||+++|+|++|. .||......   ...    .....  
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~---~~~----~~~~~--  220 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---KKL----QFYED--  220 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---HHH----HHHHc--
Confidence            64321      1223467789999988764 5789999999999999999985 454322211   111    00111  


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ...+..         .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       221 ~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 RHQLPA---------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cccCCC---------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            001111         11235678999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.3e-37  Score=278.48  Aligned_cols=270  Identities=21%  Similarity=0.296  Sum_probs=195.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC------
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------  108 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~------  108 (358)
                      .++|++.+.||+|++|.||+|.+.. ++.|++|.+....  ......+.+|+++++.++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            4689999999999999999999754 8899999886422  222345567999999999999999999887654      


Q ss_pred             --eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          109 --EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       109 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                        ..++||||+.+ +|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              34999999965 7877775432  23899999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCC--CccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          187 LARAFGGDETE--GNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       187 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      ++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            98765322211  111223467789999987654 478899999999999999999999765433222222221111100


Q ss_pred             cCCCCcc-----ccC-CcCCCC---------CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          264 EGMPSQL-----IDP-CIQGSF---------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       264 ~~~~~~~-----~~~-~~~~~~---------~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ....+..     .+. ......         .......+.++|.+||..+|.+|||+.+++++-|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~  309 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF  309 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence            0000000     000 000000         0001235678999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=269.82  Aligned_cols=251  Identities=25%  Similarity=0.420  Sum_probs=199.2

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .|++.+.||.|++|.||+|.+. +++.|++|.+... .......+.+|+.+++.++   |+|++++++++..+...+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5889999999999999999974 5889999988653 3344567788999999986   999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++...    .+++..++.++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999988542    4899999999999999999999999   999999999999999999999999998876432


Q ss_pred             CCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .  .......++..|+|||.+.++ .++.++|+||||+++|+|++|..||........      .. .........+...
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~-~~~~~~~~~~~~~  225 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MM-LIPKSKPPRLEDN  225 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hh-ccccCCCCCCCcc
Confidence            2  112234577889999987654 578999999999999999999999864332111      00 0001111111110


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                          .    ....+.+++.+||+.+|++||++.+++.+-+.
T Consensus       226 ----~----~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         226 ----G----YSKLLREFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             ----c----CCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence                0    22457789999999999999999999986554

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4e-36  Score=267.17  Aligned_cols=247  Identities=23%  Similarity=0.304  Sum_probs=197.4

Q ss_pred             ecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           47 LGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        47 lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      ||.|++|.||++.+.. ++.+++|.+....   ......+.+|+++++.++|+||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999854 8899999986522   23456788999999999999999999999999999999999999999


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcccc
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR  202 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~  202 (358)
                      .+++.+..   .++...+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            99995543   3889999999999999999999999   9999999999999999999999999988653221   2223


Q ss_pred             ccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHH
Q 018304          203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA  282 (358)
Q Consensus       203 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      ..++..|++||.+.+..++.++|+||+|+++|+|++|..||.....+ .........   .........         ..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~---~~~~~~~~~---------~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYNDIL---KGNGKLEFP---------NY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHHHh---ccCCCCCCC---------cc
Confidence            45788899999988888999999999999999999999998655431 111111111   001111111         11


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC
Q 018304          283 EVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE  315 (358)
Q Consensus       283 ~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~  315 (358)
                      ....+.++|.+||+.+|++||+     +.+++++-+..
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence            1346778999999999999999     89999876643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-38  Score=285.76  Aligned_cols=266  Identities=26%  Similarity=0.419  Sum_probs=213.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..+...+.++||+|-||.|.++....+..||+|.++.... ...+.+.+|+++|.+++||||++++++|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            3467789999999999999999987789999999986443 445889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++|+|.+|+.++..-. .....-..++.||+.|++||.+.+   ++||||.+.|+|++.++++|++|||+++.+....
T Consensus       616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999997764322 455666779999999999999999   9999999999999999999999999999765554


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh--CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS--GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      +........-..+|+|||.+..++++.++|+|+||+++||+++  ...||+....+   ..+......++.+....++..
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceeccC
Confidence            4444444556689999999999999999999999999999876  55675543332   223333333333332222221


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            +......++++|.+||..+-++|||+++|..+|.+.
T Consensus       769 ------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  769 ------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                  112233567899999999999999999999988764

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.8e-37  Score=275.99  Aligned_cols=264  Identities=23%  Similarity=0.292  Sum_probs=197.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv  113 (358)
                      ++|++.+.||.|++|.||+|.+.. ++.+++|.++...  ......+.+|+++++.++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            579999999999999999999864 8899999986532  22233566899999999999999999998877  789999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      +||+.+ +|.+++.....  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+..+..
T Consensus        85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 89888865432  4899999999999999999999999   99999999999999999999999999886543


Q ss_pred             CCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC-------
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG-------  265 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  265 (358)
                      ..  .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.......   ........+...       
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID---QLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchHHHHH
Confidence            21  112234467889999988654 46889999999999999999999986543221   111111111000       


Q ss_pred             ----------CCCccccCCcCCCCCHH-HHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          266 ----------MPSQLIDPCIQGSFNLA-EVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       266 ----------~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                                .............+... ....+.++|.+||+.+|++|||+.+++++-+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~  292 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY  292 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence                      00000000000111111 1345678999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.6e-36  Score=274.06  Aligned_cols=265  Identities=24%  Similarity=0.358  Sum_probs=195.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .++|.+.+.||+|++|.||+|.+. ++..|++|.+.... ......+.+|+..++.++|+||+++++++.++...++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            478999999999999999999875 48899999986533 2223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+. +++.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          84 YMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             ccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            996 57777664432  23778888999999999999999999   9999999999999999999999999987542211


Q ss_pred             CCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC--------
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM--------  266 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  266 (358)
                        .......++..|+|||.+.+. .++.++||||||+++|+|++|..||......  ...+...+..+....        
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         158 --QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             --CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhh
Confidence              112233467889999988654 5788999999999999999999998643321  111111111110000        


Q ss_pred             -----CCccccCCcCCCC-----CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          267 -----PSQLIDPCIQGSF-----NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       267 -----~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                           .............     .......+.+++.+||..||++|||+.+++.+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~  289 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP  289 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence                 0000000000000     001124566899999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.4e-36  Score=266.97  Aligned_cols=254  Identities=20%  Similarity=0.373  Sum_probs=185.5

Q ss_pred             eeecccCCccEEEEEEcCC---CEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           45 KKLGQGGFGPVYKGTLVDG---QEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~---~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      +.||+|+||.||++...++   ..+++|.+.... ......+.+|+..++.++||||+++++.+.+....++||||+.++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3689999999999975443   345667665432 344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcccc-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          121 SLDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       121 ~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      +|.+++..... ....+...++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999865432 234677788899999999999999999   99999999999999999999999998754211111111


Q ss_pred             cccccccCCCCCcccccC-------CCCCCcccchhHhHHHHHHHhC-CCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          200 TKRVIGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIISG-KKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      .....++..|+|||.+..       ..++.++||||||+++|+|+++ ..||.....   ........   .. ....+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~---~~-~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVI---KD-QQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH---hh-cccccC
Confidence            223456788999998743       2457899999999999999974 556543221   11221111   11 111222


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ++.....    ....+.+++..|| .+|++|||+.+|++.|.
T Consensus       231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222111    1234566888899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-37  Score=284.80  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=213.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..|.+++.||+|.|+.|.++++. ++..|++|.+.+.  +......+.+|+++|+.++||||++++.+.+....+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            68999999999999999999974 4999999999873  23334557899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+|.+.+++.++..   ..+..+...+.|+..|++|||+++   |+|||||.+|++++.+-++||+|||++..+.   
T Consensus       136 ya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---  206 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD---  206 (596)
T ss_pred             eccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec---
Confidence            9999999999977665   667899999999999999999999   9999999999999999999999999999873   


Q ss_pred             CCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .......++|++.|.|||++.+.+| .+.+|+||+|+++|.|+.|..||+...-                   ..+-+..
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------------k~Lr~rv  267 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------------KELRPRV  267 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------ccccchh
Confidence            4445667899999999999999887 5789999999999999999999874332                   2222222


Q ss_pred             cCCCCCHHH--HHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCC
Q 018304          275 IQGSFNLAE--VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQ  320 (358)
Q Consensus       275 ~~~~~~~~~--~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~  320 (358)
                      +.+.+..+.  ..++-++|+++|..+|.+|+++.++...-|.......
T Consensus       268 l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  268 LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            222222221  2356679999999999999999999998887654433

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.3e-36  Score=263.77  Aligned_cols=252  Identities=24%  Similarity=0.366  Sum_probs=204.1

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||.|++|.||++.+. +++.+++|.+....  ......+.+|++.++.++|+|++++.+.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            6899999999999999999975 48899999987543  25566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      +++++|.+++.... ....+++..++.++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986542 1245999999999999999999999999   9999999999999999999999999987653322


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......+++.|+|||...+..++.++|+||+|+++++|++|..||......   .....    ........+..   
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~----~~~~~~~~~~~---  225 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALK----ILKGQYPPIPS---  225 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHH----HhcCCCCCCCC---
Confidence              1223345788899999988888999999999999999999999997544311   11111    11111111111   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                            .....+.+++.+||..+|++|||+.+++++-
T Consensus       226 ------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~  256 (258)
T cd08215         226 ------QYSSELRNLVSSLLQKDPEERPSIAQILQSP  256 (258)
T ss_pred             ------CCCHHHHHHHHHHcCCChhhCcCHHHHhcCC
Confidence                  1123567899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-36  Score=273.68  Aligned_cols=258  Identities=24%  Similarity=0.374  Sum_probs=205.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..+.|++.+.||+|++|.||++.+. ++..+++|.+..... ....+.+|++.++.++|+|++++++.+......++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4467999999999999999999986 488999999976443 45678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++....  ..+++..++.++.+++.||.+||+.|   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999996644  24999999999999999999999999   9999999999999999999999999886543221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......++..|++||.+.+..++.++|+||||+++|+|++|..||......   .......    ..........  
T Consensus       171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~~--  239 (286)
T cd06614         171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLIT----TKGIPPLKNP--  239 (286)
T ss_pred             --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hcCCCCCcch--
Confidence              1122334678899999998888999999999999999999999997543221   1111111    1111111110  


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                           ......+.++|.+||+.+|.+|||+.+++++.+...
T Consensus       240 -----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         240 -----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             -----hhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence                 001235678999999999999999999998665443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-36  Score=273.18  Aligned_cols=264  Identities=23%  Similarity=0.343  Sum_probs=198.9

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      +|++.+.||.|++|.||+|.+. ++..|++|.+..... .....+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5899999999999999999985 488999999875432 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      .+ +|.+++........+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            75 88888866544445899999999999999999999999   9999999999999999999999999987542211  


Q ss_pred             CccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC---------CC
Q 018304          198 GNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG---------MP  267 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  267 (358)
                      .......++..|++||.+.+. .++.++|+||||+++|+|++|..||.......   ............         ..
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcC
Confidence            111223457789999987654 57889999999999999999999986543221   111111111000         00


Q ss_pred             CccccCCcCC------CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          268 SQLIDPCIQG------SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       268 ~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      ..+.......      .........+.+++.+||+.+|.+||++.+++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~  282 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP  282 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence            0000000000      00011124567899999999999999999999764

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=272.77  Aligned_cols=263  Identities=23%  Similarity=0.306  Sum_probs=196.1

Q ss_pred             CCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           41 FSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      |++.+.||.|++|.||+|.++ +|..|++|++....  ......+.+|++.++.++|+|++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            788999999999999999875 58999999886532  223356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      + ++|.+++..... ..+++..++.++.|+++||.|||+.+   ++|+||+|.||+++.++.++|+|||.+........ 
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 589998865442 24899999999999999999999999   99999999999999999999999999875422111 


Q ss_pred             CccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC---------C
Q 018304          198 GNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM---------P  267 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~  267 (358)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......   .............         .
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID---QLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHHhhhhhhc
Confidence             11122457789999987654 57889999999999999999999986543211   1111111000000         0


Q ss_pred             CccccCCcC------CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          268 SQLIDPCIQ------GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       268 ~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .........      ..........+.++|.+||+.+|.+|||+.+++++-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  282 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY  282 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence            000000000      0000111245778999999999999999999997644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-37  Score=281.60  Aligned_cols=272  Identities=20%  Similarity=0.291  Sum_probs=199.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----Ce
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~  109 (358)
                      .+++|++.+.||+|++|.||+|.+. +|+.|++|.+... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            4579999999999999999999875 4899999998642 223445677899999999999999999887544     35


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++++||+.+ +|.+++..    ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          83 VYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            7999999965 78777633    23899999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCCC-CccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          190 AFGGDETE-GNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       190 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ........ .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+...   ..............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence            65322111 11123457888999998654 568899999999999999999999985432111   11111110000000


Q ss_pred             -----------CccccCCc-CCCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          268 -----------SQLIDPCI-QGSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       268 -----------~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                                 ........ .....     ......+.+++.+||+.+|++|||+.+++++-+......
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                       00000000 00000     011345778999999999999999999999866654443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-37  Score=295.37  Aligned_cols=272  Identities=19%  Similarity=0.244  Sum_probs=189.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC--CCEEEEE------------------EecccChhhHHHHHHHHHHHHhcCCCC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD--GQEIAVK------------------RLSKISEQGLKELKNEVILFSKLQHRN   96 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~--~~~v~vK------------------~~~~~~~~~~~~~~~e~~~l~~l~~~~   96 (358)
                      ..++|++++.||+|+||.||++..+.  +...+.|                  .+. ........+.+|+.+++.++|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999986532  2111111                  111 12234456789999999999999


Q ss_pred             ccceeeEEEeCCeeEEEEEecCCCCHHHHHhcccc--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE
Q 018304           97 LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL  174 (358)
Q Consensus        97 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv  174 (358)
                      |+++++++.+.+..+++++++. ++|.+++.....  ........++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999985 477777643221  122446677889999999999999999   9999999999999


Q ss_pred             cCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchh
Q 018304          175 DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL  254 (358)
Q Consensus       175 ~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~  254 (358)
                      +.++.++|+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|+|++|..++-..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999986532211 112235689999999999999999999999999999999998754322222221122


Q ss_pred             HHHHHHHhhcCCCCccccC-------C----cC-CCCCH-------HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          255 IGHAWKLWNEGMPSQLIDP-------C----IQ-GSFNL-------AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~-------~----~~-~~~~~-------~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      +......+.. ....+.+.       .    .. .....       ....++.++|.+||++||++|||+.|++++.+..
T Consensus       380 ~~~~~~~~~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        380 LLKIIDSLSV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHhccc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            1111111100 00000000       0    00 00000       0112456789999999999999999999976643

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=274.61  Aligned_cols=268  Identities=19%  Similarity=0.237  Sum_probs=207.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcC--CC----CccceeeEEEeCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ--HR----NLVKLLGCCIQGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--~~----~iv~~~~~~~~~~~  109 (358)
                      ..++|.+++.+|+|.||.|..+.+.. +..|++|+++... ......+-|+++|+++.  .|    -++++.++|+..++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            37899999999999999999998755 7899999987633 33455667899999993  23    37888899999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-------------
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-------------  176 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-------------  176 (358)
                      .|+|+|.+ |.++.+++.++.. .+++...++.+++|+++++.+||+.+   ++|.|+||+||++.+             
T Consensus       166 iCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999998 6699999966544 34999999999999999999999999   999999999999921             


Q ss_pred             -------CCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCC
Q 018304          177 -------DMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD  249 (358)
Q Consensus       177 -------~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~  249 (358)
                             +..|+++|||.+..-     .........|-.|.|||++.+-.++.++||||+||||+||++|...|.+-+..
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~-----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFD-----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCccee-----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   234899999999863     23335667889999999999999999999999999999999999998887754


Q ss_pred             CCchhHHHHHHHhhcCCCCcc-------------------------ccCCcC----CCCCHHHHHHHHHHHhhhcCCCCC
Q 018304          250 NNLNLIGHAWKLWNEGMPSQL-------------------------IDPCIQ----GSFNLAEVIRCIHIGLLCVQQHPK  300 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~  300 (358)
                      +.+.+.+.+.+..+......-                         .+.+..    ......+...|++|+++||.+||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            444344433322211111110                         000000    001123456789999999999999


Q ss_pred             CCCChHHHHHHhccC
Q 018304          301 DRPSMPSVILMLGSE  315 (358)
Q Consensus       301 ~Rpt~~ell~~l~~~  315 (358)
                      +|+|+.|++.+....
T Consensus       396 ~RiTl~EAL~HpFF~  410 (415)
T KOG0671|consen  396 RRITLREALSHPFFA  410 (415)
T ss_pred             ccccHHHHhcCHHhh
Confidence            999999999876543

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=272.63  Aligned_cols=263  Identities=23%  Similarity=0.324  Sum_probs=198.5

Q ss_pred             CCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEEEE
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYE  115 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~e  115 (358)
                      |++.+.||.|++|.||+|.+.+ ++.+++|.+....  ......+.+|+++++.++|+|++++++++.+.  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            7889999999999999999765 8899999997642  33445677899999999999999999999888  78999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++ +|.+++....  ..+++..++.++.|+++||.+||+.+   ++|+||+|.||++++++.++|+|||.+.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 8888875542  34899999999999999999999999   9999999999999999999999999988764332


Q ss_pred             CCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc---
Q 018304          196 TEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI---  271 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  271 (358)
                      . .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........   .................   
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccc
Confidence            1 11222345678999997765 4678999999999999999999999865443211   11111111110000000   


Q ss_pred             c--------------CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          272 D--------------PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       272 ~--------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      +              ..............+.+++.+||+.+|++|||+.+++++-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~  286 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY  286 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence            0              00000000001346788999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-36  Score=274.25  Aligned_cols=266  Identities=23%  Similarity=0.265  Sum_probs=195.0

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCe-----
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE-----  109 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~-----  109 (358)
                      ++|++.+.||+|++|.||+|.+. +++.|++|.+....  ......+.+|+.+++.+. |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999975 48899999876532  223356778999999995 6999999999987665     


Q ss_pred             eEEEEEecCCCCHHHHHhcccc--ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEeccc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQER--CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFG  186 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~  186 (358)
                      .+++|||+++ +|.+++.....  ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 88888755332  245899999999999999999999999   999999999999998 8899999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      .+..+....  .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......   .............
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKLLGTP  231 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence            987642211  11122345778999998765 46789999999999999999999998643221   1111111111000


Q ss_pred             CCCcc------ccCC-cC--CCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          266 MPSQL------IDPC-IQ--GSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       266 ~~~~~------~~~~-~~--~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .....      .... ..  ....     ......+.++|.+||..+|.+|||+.+++.+-+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~  293 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY  293 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence            00000      0000 00  0000     112245778999999999999999999998744

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.1e-36  Score=265.22  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=201.9

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||.|++|.||++.+. +++.+++|.+...  .......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5899999999999999999865 4789999998652  234456677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      +++++|.+++.... ....+++..++.++.+++.|+.+||+.+   ++|+||+|.||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999986532 2244899999999999999999999999   999999999999999999999999998765332 


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                         ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..   ..    ...........+     
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~----~~~~~~~~~~~~-----  221 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DL----RYKVQRGKYPPI-----  221 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHhcCCCCCC-----
Confidence               222345778999999998888999999999999999999999998644321   11    111111111111     


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                          ......++.+++.+||..+|++|||+.+++++
T Consensus       222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                11233467889999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=262.45  Aligned_cols=248  Identities=27%  Similarity=0.447  Sum_probs=200.8

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +|++.+.||+|++|.||++.+. +++.|++|.+.....  .....+.+|++++..++|+|++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5899999999999999999875 478999999876443  4567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++...   ..+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998654   34899999999999999999999999   99999999999999999999999999987643221


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                        ......++..|+|||...+..++.++|+|++|+++|+|++|..||.....   ....   .... ......+..    
T Consensus       155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~---~~~~-~~~~~~~~~----  221 (254)
T cd06627         155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAAL---FRIV-QDDHPPLPE----  221 (254)
T ss_pred             --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHH---HHHh-ccCCCCCCC----
Confidence              12234577889999998877889999999999999999999999754321   1111   1110 111111111    


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                           .....+.+++.+||..+|++|||+.+++.+
T Consensus       222 -----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         222 -----GISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -----CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                 112356689999999999999999999865

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.4e-36  Score=272.27  Aligned_cols=252  Identities=27%  Similarity=0.391  Sum_probs=197.5

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|.+.+.||+|++|.||+|.+. +++.|++|.+...   .......+.+|+++++.++||||+++.+++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            67999999999999999999875 4889999988642   2334456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+ ++.+++....  +.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~g-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCLG-SASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhCC-CHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            99974 7777664332  34899999999999999999999999   999999999999999999999999998654211


Q ss_pred             CCCCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                            ....++..|+|||.+.   ...++.++||||||+++|+|++|..||......   ..   .... .......+.
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~---~~~~-~~~~~~~~~  235 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SA---LYHI-AQNDSPTLS  235 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HH---HHHH-hcCCCCCCC
Confidence                  2335677899999874   356889999999999999999999997533211   11   1110 011111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                              .......+.+++.+||..+|++||++.+|+.+.+....
T Consensus       236 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         236 --------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             --------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                    01122357789999999999999999999998766543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.7e-36  Score=272.72  Aligned_cols=255  Identities=23%  Similarity=0.340  Sum_probs=200.8

Q ss_pred             CcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           42 SINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        42 ~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      .....||+|++|.||++..+ ++..|++|.+..........+.+|+.+++.++|+|++++++.+..++..+++|||++++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            33468999999999999875 58899999886555555677889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcc
Q 018304          121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT  200 (358)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~  200 (358)
                      +|.+++...    .+++..++.++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||.+.......  ...
T Consensus       103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~  173 (292)
T cd06657         103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR  173 (292)
T ss_pred             cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccc
Confidence            999987432    3889999999999999999999999   9999999999999999999999999887543211  122


Q ss_pred             ccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCC
Q 018304          201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFN  280 (358)
Q Consensus       201 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (358)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......   ........    .....+.. .      
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~----~~~~~~~~-~------  239 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD----NLPPKLKN-L------  239 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----hCCcccCC-c------
Confidence            3345778899999988888899999999999999999999997542221   11111111    11111100 0      


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          281 LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       281 ~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                      ......+.+++.+||+.+|.+||++.+++++-+.....+
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            011224667899999999999999999999766655554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.5e-37  Score=281.00  Aligned_cols=272  Identities=19%  Similarity=0.291  Sum_probs=200.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~~  110 (358)
                      +.+|++.+.||.|++|.||+|.++ ++..|++|.+....  ......+.+|+.+++.++|+||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            479999999999999999999875 48999999987532  2345667789999999999999999988763    3467


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++||||+. ++|.+++...   +.+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 5888888543   33899999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCCC--CccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH-------
Q 018304          191 FGGDETE--GNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK-------  260 (358)
Q Consensus       191 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  260 (358)
                      .......  .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.....       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5322211  11123467888999998765 4688999999999999999999999865432211111000000       


Q ss_pred             -HhhcCCCCccccC-CcCCCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          261 -LWNEGMPSQLIDP-CIQGSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       261 -~~~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                       ............. .......     ......+.++|.+||+.+|++|||+.+++.+.+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence             0000000000000 0000011     112356788999999999999999999999877653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-36  Score=272.47  Aligned_cols=252  Identities=24%  Similarity=0.329  Sum_probs=201.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|.+.+.||+|++|.||++.+. +++.|++|++.+.   .......+..|+++++.+. |+||+++++++.+++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            57999999999999999999975 5899999998652   2334466788999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||++.+++|.+++.+..   .+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999986543   4999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCC------------------CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhH
Q 018304          194 DETE------------------GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI  255 (358)
Q Consensus       194 ~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~  255 (358)
                      ....                  .......++..|+|||...+..++.++|+||||++++++++|..||.....   ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence            2211                  122233467889999998888889999999999999999999999765431   1111


Q ss_pred             HHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh----HHHHHHhc
Q 018304          256 GHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM----PSVILMLG  313 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~----~ell~~l~  313 (358)
                      ....   ..  ...+..         .....+.+++.+||+.+|++|||+    .+++.+.+
T Consensus       232 ~~~~---~~--~~~~~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         232 QKIL---KL--EYSFPP---------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             HHHH---hc--CCCCCC---------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence            1111   00  000000         113356789999999999999999    88887643

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.9e-36  Score=270.86  Aligned_cols=260  Identities=20%  Similarity=0.247  Sum_probs=191.7

Q ss_pred             CCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCccceeeEEEeC--CeeEEEEE
Q 018304           41 FSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIYE  115 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~--~~~~lv~e  115 (358)
                      |++++.||+|++|.||+|.+. +++.|++|.+.... .........|+..+..+. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            788999999999999999875 48899999886532 222233456888888884 99999999999987  88999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+ ++.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||.+.......
T Consensus        81 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9975 7777775432  34899999999999999999999999   999999999999999 999999999987653221


Q ss_pred             CCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh-----------h
Q 018304          196 TEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW-----------N  263 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~  263 (358)
                      .   .....++..|+|||.+.+ ..++.++||||+||++|+|++|..||...+..+   .........           .
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence            1   122346788999997644 567889999999999999999999986543221   111111100           0


Q ss_pred             cCCCCccccC-CcCC---CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          264 EGMPSQLIDP-CIQG---SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       264 ~~~~~~~~~~-~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .........+ ....   .........+.++|.+||..+|++|||+.+++++-+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            0000000000 0000   000112356788999999999999999999998743

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=271.39  Aligned_cols=262  Identities=24%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             CCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           41 FSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      |++.+.||.|++|.||++.+. +++.+++|.+.....  .....+..|+++++.++|+||+++++++.+++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            778899999999999999875 588999998865332  24567778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      .+ ++.+++....  ..+++..++.++.+++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 8888775533  34899999999999999999999999   9999999999999999999999999987764322  


Q ss_pred             CccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC---Ccccc-
Q 018304          198 GNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP---SQLID-  272 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-  272 (358)
                      .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..   +..............   ..... 
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhcccchhh
Confidence            112223467789999988776 7899999999999999999999987543321   121111111111000   00000 


Q ss_pred             ----------CCcC--CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          273 ----------PCIQ--GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       273 ----------~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                                ....  ..........+.++|.+||+.+|.+||++.+++.+-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~  282 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY  282 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence                      0000  0001122356789999999999999999999998643

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.6e-35  Score=269.50  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=201.0

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      +.|...+.||+|++|.||++.+. ++..+++|.+...   .......+.+|++.++.++|+|++++++++.+++..++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            44888999999999999999975 4889999988642   2334457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+ ++.+++....  ..+++..+..++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++..... 
T Consensus       105 e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99975 7777764432  34899999999999999999999999   99999999999999999999999998765321 


Q ss_pred             CCCCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                           .....++..|+|||.+.   +..++.++|+||||+++|+|++|..||......   .......   ..... ...
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~---~~~~~-~~~  245 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIA---QNESP-TLQ  245 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHH---hccCC-CCC
Confidence                 12335778899999873   456889999999999999999999997543211   1111111   11111 000


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQ  323 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~~  323 (358)
                      .        ......+.+++.+||+.+|.+||++.+++++++.....+.+..
T Consensus       246 ~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~  289 (317)
T cd06635         246 S--------NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVL  289 (317)
T ss_pred             C--------ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccch
Confidence            0        0112346789999999999999999999999888776665543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-36  Score=280.65  Aligned_cols=267  Identities=21%  Similarity=0.294  Sum_probs=198.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----C
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~  108 (358)
                      ...+|++.+.||.|++|.||++.+. +++.|++|.+...  .......+..|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3578999999999999999999875 4899999988642  233345667899999999999999999987654     2


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..++++||+. ++|.+++...   ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence            4799999996 5888887543   34899999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      .......  .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+...   ..............
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  230 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSE  230 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCh
Confidence            7653221  11223456788999998764 468899999999999999999999986543211   11111100000000


Q ss_pred             -----------CccccC---CcCC---CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          268 -----------SQLIDP---CIQG---SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       268 -----------~~~~~~---~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                 ......   ....   .........+.++|.+||+.+|++|||+.+++++.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~  295 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA  295 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence                       000000   0000   00011234577899999999999999999999986654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.9e-36  Score=272.71  Aligned_cols=266  Identities=21%  Similarity=0.281  Sum_probs=196.1

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++.+.||.|++|.||+|.++ +++.|++|.+....  ......+.+|+++++.++|+||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999975 48899999886532  2334567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~~~~~~~~~  194 (358)
                      |+. ++|.+++...... .+++..++.++.||+.||.|||+++   ++|+||+|+||+++. ++.++|+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDF-AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCC-CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 4787777543332 2678888999999999999999999   999999999999985 567999999998754221


Q ss_pred             CCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc-
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID-  272 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  272 (358)
                        ........++..|+|||.+.+. .++.++||||+|+++|+|++|..||......   .........+... ....+. 
T Consensus       157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~-~~~~~~~  230 (294)
T PLN00009        157 --VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTP-NEETWPG  230 (294)
T ss_pred             --ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC-Chhhccc
Confidence              1111223457889999987654 5789999999999999999999998653321   1111111111110 000000 


Q ss_pred             ------C--CcC--CCC-----CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 ------P--CIQ--GSF-----NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ------~--~~~--~~~-----~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            .  ...  ...     .......+.+++.+||+.+|++||++.+++++-+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence                  0  000  000     011123467899999999999999999999875443

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=262.13  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=196.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Cee
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK  110 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~  110 (358)
                      .+|++.+.||+|++|.||++.+.. +..|++|.+...     .......+.+|+++++.++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            579999999999999999999754 889999987431     233456788899999999999999999998764  467


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++++||+++++|.+++....   .+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999985433   3889999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCC-CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          191 FGGDET-EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       191 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ...............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~  229 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTKPM  229 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCCCCC
Confidence            532111 1111234578889999999888889999999999999999999999854321      111111111111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      +.         ......+.+++.+||. +|..|||+.+++.+.
T Consensus       230 ~p---------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         230 LP---------DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             CC---------cccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence            11         1122356679999999 579999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8e-36  Score=274.16  Aligned_cols=265  Identities=23%  Similarity=0.308  Sum_probs=193.5

Q ss_pred             eeeccc--CCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQG--GFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g--~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      ..||.|  ++|.||++.+. .|+.|++|.+..  ......+.+.+|+.+++.++||||++++++|..++..++++||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  88999999975 589999999864  2344557788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC-
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-  198 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~-  198 (358)
                      +++.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999998866433 23889999999999999999999999   9999999999999999999999997654321111100 


Q ss_pred             ----ccccccccCCCCCcccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH------------
Q 018304          199 ----NTKRVIGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK------------  260 (358)
Q Consensus       199 ----~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  260 (358)
                          ......++..|+|||.+.+.  .++.++||||+||++|+|++|..||........  .......            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence                01112245669999998763  578999999999999999999999865432110  0000000            


Q ss_pred             ----H-------hhcCCC---------CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 ----L-------WNEGMP---------SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ----~-------~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          .       +.....         ...................+.+|+++||+.||++|||+.+++++.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~  312 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK  312 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence                0       000000         000000111111223445688999999999999999999999887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-36  Score=280.58  Aligned_cols=269  Identities=21%  Similarity=0.285  Sum_probs=197.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--------
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--------  107 (358)
                      .+.+|++.+.||.|++|.||+|.+.. ++.|++|.+..........+.+|+++++.++||||+++++++...        
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            35899999999999999999999754 889999998766556667788999999999999999999776543        


Q ss_pred             ------CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCe
Q 018304          108 ------EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNP  180 (358)
Q Consensus       108 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i  180 (358)
                            ...+++|||+. ++|.+++..    ..+++..++.++.||++||.|||+.+   ++|+||+|+||+++. ++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~  154 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence                  35789999997 488887743    23889999999999999999999999   999999999999974 5678


Q ss_pred             EEeccccceecCCCCCC-CccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH
Q 018304          181 KISDFGLARAFGGDETE-GNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA  258 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  258 (358)
                      +|+|||.+..+...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......   .....
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~~  231 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE---QMQLI  231 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence            99999998765322111 11122346778999997654 467889999999999999999999985433211   11111


Q ss_pred             HHHhhcC-----------CCCccccCCcCCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          259 WKLWNEG-----------MPSQLIDPCIQGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       259 ~~~~~~~-----------~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .......           ................     .....+.+++.+||+.+|++|||+.+++.+-+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            1000000           0000000000000000     11245778999999999999999999998877653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-36  Score=265.42  Aligned_cols=243  Identities=24%  Similarity=0.255  Sum_probs=184.2

Q ss_pred             eeecccCCccEEEEEEcC-CCEEEEEEecccCh---hhHHHHHHHHHHH-HhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILF-SKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~---~~~~~~~~e~~~l-~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||.|++|.||+|.+.. ++.|++|.+.+...   .....+..|...+ ...+|+|++++++++..++..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            679999999999998754 88999999865322   1222333444443 345899999999999999999999999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      ++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.....      
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            99999985433   4899999999999999999999999   99999999999999999999999998875422      


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                      .....++..|+|||.+.+..++.++||||+|+++|+|++|..||......   ......    ...... . ...    .
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~-~-~~~----~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDNI----LSRRIN-W-PEE----V  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----HhcccC-C-CCc----c
Confidence            22334678899999988888899999999999999999999998543221   111111    111000 0 000    0


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChH---HHHHHh
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMP---SVILML  312 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~---ell~~l  312 (358)
                      .......+.+++.+||..+|++||++.   +++.+.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~  252 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP  252 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence            001224577899999999999999765   555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-36  Score=278.57  Aligned_cols=271  Identities=23%  Similarity=0.314  Sum_probs=204.1

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----eeE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL  111 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~~~  111 (358)
                      +|++.+.||.|++|.||+|.+.. ++.|++|.+....  ......+.+|+.+++.++|+||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            68999999999999999999754 8999999887633  344567889999999999999999999988775     789


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ++|||+.+ +|.+++.+..   .+++..++.++.+++.||.+||+.+   ++|+||+|.||+++.++.++|+|||.+...
T Consensus        81 lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999974 8888885433   4999999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCC-CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC--
Q 018304          192 GGDET-EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP--  267 (358)
Q Consensus       192 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  267 (358)
                      ..... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.......   ..............  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~  230 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEED  230 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChhH
Confidence            43221 0112234567889999999877 78999999999999999999999986544211   11111111100000  


Q ss_pred             ---------CccccC-CcCCCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCC
Q 018304          268 ---------SQLIDP-CIQGSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQ  320 (358)
Q Consensus       268 ---------~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~  320 (358)
                               ...... .......     ......+.++|.+||+.+|++|||+.+++.+.+.......
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                     000000 0000000     0122456789999999999999999999998766544433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.4e-36  Score=271.39  Aligned_cols=259  Identities=27%  Similarity=0.365  Sum_probs=195.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|+..+.||+|++|.||++.+.. ++.+++|.+.... ......+.+|+..+.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            456778899999999999998754 8999999986532 334566788999999995 9999999999999889999999


Q ss_pred             ecCCCCHHHHHhc--cccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          116 FMTNKSLDSFIFD--QERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       116 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      |+.. ++.++...  ......+++..+..++.+++.||+|||+. +   ++|+||+|+||+++.++.++|+|||++..+.
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9864 66554321  11224489999999999999999999975 7   9999999999999999999999999987543


Q ss_pred             CCCCCCccccccccCCCCCcccccCC---CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ...   ......++..|+|||.+.+.   .++.++||||+|+++|+|++|..||....     .......... ......
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~-~~~~~~  230 (288)
T cd06616         160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVV-KGDPPI  230 (288)
T ss_pred             cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhc-CCCCCc
Confidence            211   11233577889999988765   68899999999999999999999986543     1111111111 111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      +..     .........+.+|+.+||+.+|++|||+.+|+.+-+..
T Consensus       231 ~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~  271 (288)
T cd06616         231 LSN-----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK  271 (288)
T ss_pred             CCC-----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence            111     11112234577899999999999999999999876543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-35  Score=266.42  Aligned_cols=247  Identities=24%  Similarity=0.290  Sum_probs=187.5

Q ss_pred             eecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHH---hcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           46 KLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFS---KLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~---~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      .||+|+||.||++.+.. ++.+++|.+.+..   ........++..+++   ...|+||+.+++.+...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999754 8899999886421   111222334443333   3469999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......    
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----  150 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence            999999885433   3899999999999999999999999   999999999999999999999999998754221    


Q ss_pred             ccccccccCCCCCccccc-CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......++..|+|||.+. +..++.++||||+||++|+|++|..||......... ......    ......+       
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~----~~~~~~~-------  218 (279)
T cd05633         151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT----LTVNVEL-------  218 (279)
T ss_pred             CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh----hcCCcCC-------
Confidence            122345889999999876 456889999999999999999999998654332211 111110    0011111       


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccCC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSET  316 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~~  316 (358)
                        .......+.++|.+||+.||.+||     |+.+++++.+...
T Consensus       219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence              111223567899999999999999     6999999876653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.8e-37  Score=261.65  Aligned_cols=277  Identities=21%  Similarity=0.277  Sum_probs=207.4

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-----CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEe-C
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-----GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-G  107 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-----~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~  107 (358)
                      +.-..|++++.||+|.||.||+|..++     ++.+++|.++...  ........+|+..++.++|+|++.+..+|.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            334789999999999999999996322     3378999887532  2233556789999999999999999999987 6


Q ss_pred             CeeEEEEEecCCCCHHHHHhcc--ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC----CCeE
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQ--ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD----MNPK  181 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~----~~i~  181 (358)
                      ..+++++||.+. +|..+|.-+  ...+.++...+..+++||+.|+.|||++-   |+|||+||.||+|..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            789999999987 888888432  33345999999999999999999999999   9999999999999987    8999


Q ss_pred             EeccccceecCCCCCCC-ccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCC------Cch
Q 018304          182 ISDFGLARAFGGDETEG-NTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDN------NLN  253 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~------~~~  253 (358)
                      |+|+|+++.+....... .......|..|.|||++.|. .|+.+.|+|++|||+.||++-++.|.......      ..+
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            99999999875433222 33345678899999988875 79999999999999999999998887654322      223


Q ss_pred             hHHHHHHHhhcCCCCccccCCcCCCC------------C---HHH--------HHHHHHHHhhhcCCCCCCCCChHHHHH
Q 018304          254 LIGHAWKLWNEGMPSQLIDPCIQGSF------------N---LAE--------VIRCIHIGLLCVQQHPKDRPSMPSVIL  310 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------~---~~~--------~~~l~~li~~cl~~~P~~Rpt~~ell~  310 (358)
                      .+..+...+.-+......+-..-..+            +   +..        ...-++|+.+||.+||.+|.|+++.++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            33444433332222222111100001            0   000        012478999999999999999999999


Q ss_pred             HhccCC
Q 018304          311 MLGSET  316 (358)
Q Consensus       311 ~l~~~~  316 (358)
                      +.-...
T Consensus       337 h~yF~~  342 (438)
T KOG0666|consen  337 HPYFTE  342 (438)
T ss_pred             cccccc
Confidence            865553

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2e-35  Score=267.30  Aligned_cols=261  Identities=18%  Similarity=0.193  Sum_probs=182.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcCC----CEEEEEEecccChhhH-----------HHHHHHHHHHHhcCCCCccce
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVDG----QEIAVKRLSKISEQGL-----------KELKNEVILFSKLQHRNLVKL  100 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~----~~v~vK~~~~~~~~~~-----------~~~~~e~~~l~~l~~~~iv~~  100 (358)
                      ...++|++.+.||+|+||.||+|.+.++    ..+++|..........           .....++..+..+.|++++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4558999999999999999999987543    4556664432211110           011223344556789999999


Q ss_pred             eeEEEeCC----eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC
Q 018304          101 LGCCIQGE----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ  176 (358)
Q Consensus       101 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~  176 (358)
                      ++......    ..+++++++.. ++.+.+...   ...++..++.++.|++.||.|||+.+   ++||||||+||+++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            98765543    33677787643 666665332   22678889999999999999999999   999999999999999


Q ss_pred             CCCeEEeccccceecCCCCC-----CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC
Q 018304          177 DMNPKISDFGLARAFGGDET-----EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN  251 (358)
Q Consensus       177 ~~~i~L~Df~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~  251 (358)
                      ++.++|+|||++..+.....     ........|++.|+|||...+..++.++|||||||++|+|++|..||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            99999999999976532111     1111234589999999999999999999999999999999999999876533221


Q ss_pred             chhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      .  .......+.......    .......   ...+.+++..||+.+|++||++.+|++.+
T Consensus       242 ~--~~~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 L--IHAAKCDFIKRLHEG----KIKIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             H--HHHhHHHHHHHhhhh----hhccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1  111110000000000    0000001   24567899999999999999999999876

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-35  Score=273.17  Aligned_cols=280  Identities=23%  Similarity=0.317  Sum_probs=205.5

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEe-CC
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GE  108 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~  108 (358)
                      ++..+.++|++.+.||.|++|.||++.+. +++.|++|.+.+  ........+..|+++++.++||||+++.++|.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            34557889999999999999999999875 588999998754  222334667789999999999999999999876 45


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..++++||+ +++|.+++..    ..++...+..++.|+++||.+||+.+   ++|+||+|.||+++.++.++|+|||.+
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence            789999998 5588888743    23788888999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH--------H
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA--------W  259 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~  259 (358)
                      .....     ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...        .
T Consensus       156 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         156 RIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             cccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            75321     1122346778999998765 56899999999999999999999998654321111110000        0


Q ss_pred             HHhhcCCCCccccCCcC-CCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCCCCC
Q 018304          260 KLWNEGMPSQLIDPCIQ-GSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPG  325 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~~~~  325 (358)
                      ..+.......+...... .....     .....+.++|.+||+.+|++|||+.+++.+-+......++..+-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~  302 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV  302 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC
Confidence            00000000000000000 00011     11246778999999999999999999999877766665555543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.2e-36  Score=274.89  Aligned_cols=272  Identities=21%  Similarity=0.275  Sum_probs=200.6

Q ss_pred             HhcCCCCc-ceeecccCCccEEEEEEc-CCCEEEEEEecccChhh--------------HHHHHHHHHHHHhcCCCCccc
Q 018304           36 SATNNFSI-NKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQG--------------LKELKNEVILFSKLQHRNLVK   99 (358)
Q Consensus        36 ~~~~~y~i-~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--------------~~~~~~e~~~l~~l~~~~iv~   99 (358)
                      +..++|.. .+.||.|++|.||+|.+. .++.|++|.+.......              ...+.+|+++++.++|+||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            45678875 467999999999999975 48999999886532211              124678999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC
Q 018304          100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~  179 (358)
                      +++++..++..+++|||+. ++|.+++...   ..+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI  157 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence            9999999999999999997 5888888543   33899999999999999999999999   999999999999999999


Q ss_pred             eEEeccccceecCCCCC------------CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCC
Q 018304          180 PKISDFGLARAFGGDET------------EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFY  246 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~  246 (358)
                      ++|+|||.+........            ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999876531110            0111122357789999988764 4689999999999999999999998654


Q ss_pred             CCCCCchhHHHHHHHhhcCCCCcccc--------C---CcCCC---CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          247 HSDNNLNLIGHAWKLWNEGMPSQLID--------P---CIQGS---FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~---~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      +..   .................+..        .   .....   ........+.++|.+||+.+|++|||+.+++.+.
T Consensus       238 ~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        238 NEI---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             CHH---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            432   12222221111111100000        0   00000   0011134577899999999999999999999987


Q ss_pred             ccCCC
Q 018304          313 GSETV  317 (358)
Q Consensus       313 ~~~~~  317 (358)
                      +....
T Consensus       315 ~~~~~  319 (335)
T PTZ00024        315 YFKSD  319 (335)
T ss_pred             ccCCC
Confidence            77633

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-36  Score=278.16  Aligned_cols=275  Identities=22%  Similarity=0.290  Sum_probs=203.8

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG  107 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  107 (358)
                      .+++....++|.+.+.||+|++|.||++.+. +++.|++|.+....  ......+.+|+++++.++|+||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            4566677899999999999999999999864 58899999987532  22345677899999999999999999988643


Q ss_pred             ------CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeE
Q 018304          108 ------EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK  181 (358)
Q Consensus       108 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~  181 (358)
                            ...+++++++ +++|.+++...    .+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3467888877 67998887432    3899999999999999999999999   99999999999999999999


Q ss_pred             EeccccceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH
Q 018304          182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  260 (358)
                      |+|||++.....     ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.......   .......
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~  232 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILR  232 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence            999999875421     1223456788999998766 468899999999999999999999985433211   1111111


Q ss_pred             HhhcCCCCcccc---------------CCcCCCC---CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCC
Q 018304          261 LWNEGMPSQLID---------------PCIQGSF---NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK  322 (358)
Q Consensus       261 ~~~~~~~~~~~~---------------~~~~~~~---~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~  322 (358)
                      ... ........               .......   .......+.++|.+||+.+|.+|||+.+++++-+.....++..
T Consensus       233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~  311 (345)
T cd07877         233 LVG-TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  311 (345)
T ss_pred             HhC-CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence            000 00000000               0000000   0011235678999999999999999999999987766554443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=281.50  Aligned_cols=247  Identities=27%  Similarity=0.417  Sum_probs=199.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      +.|.=++.||.|.||.||.+++.. .+.|+||.++.   ....-...+..|+..|+++.|||++.+-++|..+.+.++||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            357778899999999999999754 77899999864   33445677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |||-| +-.|++.-++  +++.+..+..|+.+.+.||.|||+++   .+|||||..||++++.|.|||+|||.+...   
T Consensus       106 EYClG-SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~---  176 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM---  176 (948)
T ss_pred             HHHhc-cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc---
Confidence            99965 8888874433  45999999999999999999999999   999999999999999999999999998764   


Q ss_pred             CCCCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                         ...+...|||.|+|||++.   .+.|+-++||||||++..+|...++|.-.++.   +..   ... +..+..+.+-
T Consensus       177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---MSA---LYH-IAQNesPtLq  246 (948)
T KOG0577|consen  177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSA---LYH-IAQNESPTLQ  246 (948)
T ss_pred             ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---HHH---HHH-HHhcCCCCCC
Confidence               2234667999999999875   46899999999999999999999999433222   111   111 1122222221


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                              ...-...+.+|+..||+.-|.+|||..+++.+.
T Consensus       247 --------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  247 --------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             --------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence                    222344677899999999999999999888754

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.2e-35  Score=263.42  Aligned_cols=253  Identities=22%  Similarity=0.253  Sum_probs=193.8

Q ss_pred             HHHHHHhcCCCCcceee--cccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEe
Q 018304           31 LATIVSATNNFSINKKL--GQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ  106 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~l--g~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~  106 (358)
                      +.+.....++|++.+.+  |+|+||.||++..+ ++..+++|.+.......     .|+.....+ +|+||+++++.+..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            44555556788888887  99999999999875 47889999886532111     123333323 69999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEecc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDF  185 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df  185 (358)
                      .+..++||||+++++|.+++....   .+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++ .++|+||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence            999999999999999999985543   4999999999999999999999999   99999999999999888 9999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      |.+......      ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... .... ......  .
T Consensus       155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~-~~~~~~--~  224 (267)
T PHA03390        155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLE-SLLKRQ--Q  224 (267)
T ss_pred             ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHH-HHHHhh--c
Confidence            998764321      12347789999999988889999999999999999999999987432221 1111 111111  1


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-hHHHHHHhc
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-MPSVILMLG  313 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~ell~~l~  313 (358)
                      .......         .....+.++|.+||+.+|.+||+ +++++++-|
T Consensus       225 ~~~~~~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~  264 (267)
T PHA03390        225 KKLPFIK---------NVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF  264 (267)
T ss_pred             ccCCccc---------ccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence            1111111         12235678999999999999996 699997654

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-35  Score=270.28  Aligned_cols=267  Identities=20%  Similarity=0.221  Sum_probs=192.5

Q ss_pred             cceeecccCCccEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCC
Q 018304           43 INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      +.+.+|.|+++.++++.. +++.|++|.+...  .......+.+|++.++.++|+||+++++++.+.+..+++|||+.++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344444444444444433 5899999998653  4556678899999999999999999999999999999999999999


Q ss_pred             CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC----
Q 018304          121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET----  196 (358)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~----  196 (358)
                      +|.+++...... .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+||+.+..+.....    
T Consensus        85 ~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999998764332 3889999999999999999999999   99999999999999999999999998875532111    


Q ss_pred             -CCccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh----hcCCCCc
Q 018304          197 -EGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW----NEGMPSQ  269 (358)
Q Consensus       197 -~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~  269 (358)
                       ........++..|+|||.+.+  ..++.++|+||+|+++|+|++|..||.......  ..........    .......
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence             111122345678999998865  358899999999999999999999986432211  1111110000    0000000


Q ss_pred             -----------ccc----CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          270 -----------LID----PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       270 -----------~~~----~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                                 ...    .............++.+++.+||+.+|++|||+.+++++.+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~  300 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ  300 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence                       000    00011111223346778999999999999999999999877543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1e-35  Score=270.13  Aligned_cols=267  Identities=22%  Similarity=0.279  Sum_probs=195.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----  108 (358)
                      ..++|++.+.||.|++|.||+|.++. ++.|++|.+....  ......+.+|+++++.++|||++++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            45789999999999999999999864 8899999986532  223356678999999999999999999887654     


Q ss_pred             -----eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEe
Q 018304          109 -----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS  183 (358)
Q Consensus       109 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~  183 (358)
                           ..++++||+++ ++.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||+|.||++++++.++|+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence                 78999999976 676766543  234899999999999999999999999   9999999999999999999999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      |||.+........ .......++..|+|||.+.+. .++.++||||||+++|+|++|..||......   ..........
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~  234 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC  234 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence            9999876532221 111122346789999987653 5788999999999999999999997643322   2222222211


Q ss_pred             hcCCCCccc---cCC------cCCC-------CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          263 NEGMPSQLI---DPC------IQGS-------FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       263 ~~~~~~~~~---~~~------~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .........   ...      ....       ........+.+++.+||+.+|.+|||+.+++++-+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  301 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW  301 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            111110000   000      0000       00001235778999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.5e-35  Score=264.85  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=195.7

Q ss_pred             CCCcceeecccCCccEEEEEEc----CCCEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~  110 (358)
                      +|++.+.||.|++|.||++.+.    ++..|++|.+.+..    ......+.+|+.++..+ +|+||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5889999999999999999753    46789999886422    22345677899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++||||+.+++|.+++...   ..+++..++.++.|++.+|.+||+.+   ++|+||+|.||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999998543   33889999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCC--CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ...... .......++..|++||.+.+..  .+.++|+||||+++|+|++|..||............  ........  .
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~--~  229 (288)
T cd05583         155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSK--P  229 (288)
T ss_pred             cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH--HHHHHccC--C
Confidence            532211 1112235788999999887654  688999999999999999999998643222111111  11111110  0


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..     ...    ....+.+++.+||+.+|++|||+.++.+.|...
T Consensus       230 ~~-----~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         230 PF-----PKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             CC-----Ccc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            00     011    123566899999999999999987776666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=266.28  Aligned_cols=262  Identities=23%  Similarity=0.291  Sum_probs=195.2

Q ss_pred             CCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh-hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEEec
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      |++.+.||.|++|.||+|...+ ++.|++|.+..... .......+|+..++.++ |+|++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7889999999999999999854 78899998865322 22234457899999998 999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                       +++|.+++..... ..+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence             6789888865442 34899999999999999999999999   9999999999999999999999999987653221  


Q ss_pred             CccccccccCCCCCccccc-CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC-----------
Q 018304          198 GNTKRVIGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG-----------  265 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  265 (358)
                       ......++..|+|||.+. +..++.++|+||||+++++|++|..||........   ...........           
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhHhhh
Confidence             122345677899999775 44678999999999999999999999755432211   11111100000           


Q ss_pred             --CCCccccCCcCC---CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          266 --MPSQLIDPCIQG---SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       266 --~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                        ............   .........+.+++.+||+.+|++|||+.+++.+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~  282 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY  282 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence              000000000000   000011346788999999999999999999998643

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.7e-35  Score=268.32  Aligned_cols=254  Identities=28%  Similarity=0.395  Sum_probs=198.0

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..|...+.||.|++|.||+|++.. +..+++|.+..   ........+.+|+++++.++|+|++++.+++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            458888999999999999999754 78899998853   22334456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+. +++.+++....  ..+++..++.++.+++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||++..... 
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-  167 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence            9996 57777764332  33889999999999999999999999   99999999999999999999999999876421 


Q ss_pred             CCCCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                           .....++..|+|||.+.   ...++.++||||||+++|+|++|..||.......   ....    +.........
T Consensus       168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~----~~~~~~~~~~  235 (308)
T cd06634         168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH----IAQNESPALQ  235 (308)
T ss_pred             -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHH----HhhcCCCCcC
Confidence                 12334678899999874   3467889999999999999999999975432211   1110    1111111110


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                              .......+.++|.+||..+|++||++.+++.+.+.....+
T Consensus       236 --------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             --------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence                    1112235678999999999999999999999988776544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-35  Score=272.21  Aligned_cols=270  Identities=22%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-  108 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-  108 (358)
                      ++....++|++++.||+|++|.||++.+. ++..|++|.+...  .......+.+|+.+++.++|+||+++++++..+. 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            45557889999999999999999999864 4889999988542  2333456778999999999999999999987654 


Q ss_pred             -----eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEe
Q 018304          109 -----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS  183 (358)
Q Consensus       109 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~  183 (358)
                           ..++||||+ +++|.+++..    ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence                 358999998 6799888743    23899999999999999999999999   9999999999999999999999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      |||++.....     ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......   ..........
T Consensus       161 dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~  232 (343)
T cd07880         161 DFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVT  232 (343)
T ss_pred             eccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhc
Confidence            9999875422     1123346788999998765 45789999999999999999999998643321   1111111000


Q ss_pred             h-----------cCCCCccccCCcCC------CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          263 N-----------EGMPSQLIDPCIQG------SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       263 ~-----------~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      .           ..............      .........+.++|.+||+.||++|||+.+++.+-+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            0           00000000000000      00001123467899999999999999999999876665443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.4e-36  Score=264.94  Aligned_cols=246  Identities=24%  Similarity=0.325  Sum_probs=191.7

Q ss_pred             ecccCCccEEEEEEcC-CCEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           47 LGQGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        47 lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      ||.|++|.||++.+.. ++.+++|.+.....   .....+.+|++.++.++|+||+++++.+..+...++++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999865 89999999865332   4556788899999999999999999999999999999999999999


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC------
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET------  196 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~------  196 (358)
                      .+++.+..   .+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99986543   4899999999999999999999999   99999999999999999999999999875422211      


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      ........++..|++||...+..++.++|+||||+++|+|++|..||......   .......    .... .....   
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~----~~~~-~~~~~---  223 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNIL----NGKI-EWPED---  223 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh----cCCc-CCCcc---
Confidence            01222345678899999988888899999999999999999999997543321   1111111    1000 00000   


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                          ......+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       224 ----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         224 ----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                001345678999999999999999944444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-35  Score=263.45  Aligned_cols=261  Identities=23%  Similarity=0.330  Sum_probs=193.6

Q ss_pred             CCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCccceeeEEEeCCe-----
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEE-----  109 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~~~-----  109 (358)
                      |++.+.||.|++|.||+|.++. ++.|++|.+....  ......+.+|+.+++.+   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7889999999999999999865 8999999996422  22233455677777666   59999999999988776     


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .+++|||+.+ +|.+++..... ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 88888755433 23899999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC--
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP--  267 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  267 (358)
                      .+....   ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......   ...............  
T Consensus       156 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         156 IYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHh
Confidence            753221   112234677899999999888999999999999999999999887643322   111111111100000  


Q ss_pred             --------CccccCCcCC---CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          268 --------SQLIDPCIQG---SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       268 --------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                              ..........   .........+.++|.+||+.+|++||++.+++.+-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~  285 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP  285 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence                    0000000000   00112234567899999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.6e-35  Score=262.59  Aligned_cols=256  Identities=23%  Similarity=0.294  Sum_probs=196.4

Q ss_pred             CCCcceeecccCCccEEEEEEc----CCCEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~  110 (358)
                      +|++.+.||.|++|.||++.+.    +|..|++|.+....    ......+.+|+.++..+ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999863    57899999986522    22345677899999999 589999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++|+||+++++|.+++....   .+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999986533   3889999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ...... .......++..|+|||.+.+.  .++.++||||||+++|+|++|..||...........  .........  .
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~--~  229 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKSE--P  229 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH--HHHHhhccC--C
Confidence            532211 112234578889999988653  467899999999999999999999864322211111  111111111  0


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                      .+     ..    .....+.+++.+||..+|++||     ++.+++.+-+..
T Consensus       230 ~~-----~~----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  272 (290)
T cd05613         230 PY-----PQ----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ  272 (290)
T ss_pred             CC-----Cc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccc
Confidence            01     00    1123566899999999999997     788888875543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.7e-35  Score=268.27  Aligned_cols=267  Identities=22%  Similarity=0.322  Sum_probs=193.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCC------
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------  108 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~------  108 (358)
                      .++|++.+.||.|++|.||+|.+.. ++.+++|.+.....  .....+.+|++.++.++|+||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4799999999999999999999754 88999998854222  12235678999999999999999998875443      


Q ss_pred             --eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          109 --EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       109 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                        ..++++||+.+ ++...+....  ..+++..++.++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46899999965 6776664432  34999999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCc---------cccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHH
Q 018304          187 LARAFGGDETEGN---------TKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG  256 (358)
Q Consensus       187 ~~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~  256 (358)
                      ++...........         .....++..|+|||.+.+. .++.++||||||+++|+|++|..||.......   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~  237 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLH  237 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence            9876532221111         1122457789999987654 57899999999999999999999976433321   111


Q ss_pred             HHHHHhhcCCCC---------cccc--CCcCCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          257 HAWKLWNEGMPS---------QLID--PCIQGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       257 ~~~~~~~~~~~~---------~~~~--~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .....+......         ....  .........     .....+.+++.+||..+|++|||+.+++.+-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~  310 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY  310 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence            111111110000         0000  000000000     11145778999999999999999999998654

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1e-35  Score=274.50  Aligned_cols=267  Identities=24%  Similarity=0.348  Sum_probs=196.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC--Cee
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG--EEK  110 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~--~~~  110 (358)
                      ..++|++.+.||+|++|.||+|.+. +++.+++|.+..  ........+..|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578999999999999999999975 488999998854  2233345567899999999 999999999988654  368


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++||||+.+ +|.+++...    .+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        85 ~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            999999974 898887543    4888899999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCCC---CccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh----
Q 018304          191 FGGDETE---GNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW----  262 (358)
Q Consensus       191 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----  262 (358)
                      .......   .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......   .........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~  233 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPS  233 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence            5322211   12223457888999997754 467889999999999999999999986433221   111111000    


Q ss_pred             -------hcCCCCccccCCcCCC------CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          263 -------NEGMPSQLIDPCIQGS------FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       263 -------~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                             .......+.+......      ........+.++|.+||+.+|++|||+.+++++-+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~  298 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV  298 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence                   0000000000000000      000123467789999999999999999999987433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-36  Score=278.96  Aligned_cols=271  Identities=22%  Similarity=0.311  Sum_probs=203.7

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-  109 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-  109 (358)
                      +....++|++.+.||+|++|.||+|.+.. ++.|++|.+...  .......+.+|+.+++.++|+|++++.+++...+. 
T Consensus        10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            33467899999999999999999999854 789999988642  23344567789999999999999999988866554 


Q ss_pred             -----eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          110 -----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       110 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                           .++|+||+ +++|.+++..    ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcc
Confidence                 89999998 5699998854    33899999999999999999999999   99999999999999999999999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      ||++......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||......   .......... 
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~-  232 (343)
T cd07851         162 FGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLV-  232 (343)
T ss_pred             cccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhc-
Confidence            9998764321     223356778999998765 36789999999999999999999998643321   1111111111 


Q ss_pred             cCCCCccccCC------------cC-CCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCC
Q 018304          264 EGMPSQLIDPC------------IQ-GSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQP  321 (358)
Q Consensus       264 ~~~~~~~~~~~------------~~-~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~  321 (358)
                      ......+....            .. .....     .....+.++|.+||..+|++|||+.+|+++-+........
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence            00000000000            00 00000     1134678999999999999999999999987776555443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.2e-35  Score=302.72  Aligned_cols=261  Identities=25%  Similarity=0.498  Sum_probs=201.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ...|...+.||+|+||.||+|.+. ++..|++|.+......    ...|++.+++++||||+++++++.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            356788899999999999999974 5899999988653321    23568899999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++..      +++..+.+++.+++.|++|||....++++||||||+||+++.++..++. ++......    
T Consensus       765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----  833 (968)
T PLN00113        765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----  833 (968)
T ss_pred             CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence            999999999832      7899999999999999999995433349999999999999988887765 55433211    


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                        ......++..|+|||.+.+..++.++|||||||++|||++|+.||..... .......+..............++...
T Consensus       834 --~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        834 --TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             --cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence              11123567899999999989999999999999999999999999853322 222333333332322223333343332


Q ss_pred             C--CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          277 G--SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       277 ~--~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .  .....+..++.+++.+||+.+|++|||+.++++.|+...
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            2  234456667889999999999999999999999998653

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=273.84  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=204.2

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcC---C--CEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVD---G--QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG  107 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~---~--~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  107 (358)
                      +....+.....+.||.|.||.||.|.+.+   |  -.|+||.-+. ...+....+..|+-+|++++||||+++++++.+.
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~  463 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ  463 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence            33344455566789999999999998522   3  3688887765 3445578899999999999999999999999664


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                       ..++|||.++-|-|..+++..+..  ++...+..+++||+.||.|||+.+   .+||||...||+|.+..-+||+|||+
T Consensus       464 -P~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  464 -PMWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             -ceeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence             668999999999999999776654  999999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      ++.+.+....... ...-..-|+|||-+.-..++.++|||.||+++||++. |..||..-...+-...+       ..+.
T Consensus       538 SR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------EnGe  609 (974)
T KOG4257|consen  538 SRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------ENGE  609 (974)
T ss_pred             hhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------cCCC
Confidence            9988655443332 2234557999998888889999999999999999876 99998765544322221       1222


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      .....+.+..         .+..|+.+||.++|.+||++.++...|+.
T Consensus       610 RlP~P~nCPp---------~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  610 RLPCPPNCPP---------ALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             CCCCCCCCCh---------HHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence            2222232322         56679999999999999999998877643

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.7e-35  Score=265.14  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=194.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ..++|++.+.||+|++|.||+|.+.. ++.|++|.+.... ......+..|+..+... .|+||+++++++.+....+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            44788999999999999999999865 8899999987532 23344556677766666 599999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      |||+.+ ++.+++....  ..+++..+..++.+++.|+.|||+ .+   ++|+||+|+||++++++.++|+|||.+..+.
T Consensus        93 ~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            999854 7777765433  248999999999999999999997 57   9999999999999999999999999987543


Q ss_pred             CCCCCCccccccccCCCCCcccccCCC----CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ...   ......++..|+|||.+.+..    ++.++||||||+++|+|++|..||......  ...+..   .... ...
T Consensus       167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~---~~~~-~~~  237 (296)
T cd06618         167 DSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTK---ILQE-EPP  237 (296)
T ss_pred             CCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHH---HhcC-CCC
Confidence            211   112234677899999886543    788999999999999999999997542211  111111   1111 111


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ......       .....+.+++.+||..+|++||++.+++++.+..
T Consensus       238 ~~~~~~-------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  277 (296)
T cd06618         238 SLPPNE-------GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR  277 (296)
T ss_pred             CCCCCC-------CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            111100       1123577899999999999999999999887644

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=264.56  Aligned_cols=262  Identities=26%  Similarity=0.332  Sum_probs=198.7

Q ss_pred             CCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      |++.+.||+|++|.||+|.... ++.+++|.+....  ......+..|+.+++.++|+|++++++++.+....++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            6788999999999999999765 8999999987642  333456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      . ++|.+++....  ..+++..++.++.+++.||.+||+.+   ++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            7 48999986543  23899999999999999999999999   99999999999999999999999999876532211 


Q ss_pred             CccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC--------C
Q 018304          198 GNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP--------S  268 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~  268 (358)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......   ...............        .
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhccc
Confidence             12223456789999988766 7899999999999999999999887554321   111111111100000        0


Q ss_pred             ccccCCcCC-------CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          269 QLIDPCIQG-------SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       269 ~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ...+.....       .........+.+++.+||..+|++||++.+++.+-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~  281 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY  281 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence            000000000       000011346788999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-34  Score=259.50  Aligned_cols=247  Identities=25%  Similarity=0.299  Sum_probs=187.6

Q ss_pred             eecccCCccEEEEEEcC-CCEEEEEEecccCh---hhHHHHHHHH---HHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           46 KLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEV---ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~---~~~~~~~~e~---~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      .||+|++|.||++.+.. ++.|++|.+.+...   ........|.   ..+....|++|+.+.+.+...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999998754 88999998865221   1111233333   34444579999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++...   +.+++..++.++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++......    
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----  150 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence            99999988543   34899999999999999999999999   999999999999999999999999998754221    


Q ss_pred             ccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......++..|+|||.+.+. .++.++||||+|+++|+|++|..||............ ....    .....+..     
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~----~~~~~~~~-----  220 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL----TMAVELPD-----  220 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhh----ccCCCCCC-----
Confidence            12234688899999998754 6899999999999999999999998654332211111 0000    00111111     


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccCC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSET  316 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~~  316 (358)
                      .    ....+.+++.+||..+|.+||     ++.+++++.+...
T Consensus       221 ~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         221 S----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             c----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence            1    124577899999999999999     9999998766653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.8e-35  Score=258.99  Aligned_cols=252  Identities=26%  Similarity=0.349  Sum_probs=193.6

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecc-----cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK-----ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~-----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +|.+.+.||+|++|.||++.+.. +..+.+|.++.     ........+..|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            68999999999999999998754 44455555542     1122334566788999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          114 YEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      +||+.+++|.+++... .....+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++. +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642 22345899999999999999999999999   999999999999964 679999999987653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....      ....... .........  
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~-~~~~~~~~~--  225 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLR-IVEGPTPSL--  225 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHH-HHcCCCCCC--
Confidence            221  12223456788999999888888999999999999999999999975322      1111111 111111111  


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                             .......+.++|.+||+.+|++||++.+++++-+
T Consensus       226 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         226 -------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             -------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence                   1122346778999999999999999999998743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=283.87  Aligned_cols=261  Identities=27%  Similarity=0.440  Sum_probs=216.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcC----CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ...+|.++||.|.||.|++|..+-    ...|+||.++. ..+.....|+.|+.+|-+++||||+++.++.....-..||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            456788999999999999998643    34799999975 4455667789999999999999999999999999899999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      .|||++|+|+.|+..+.+.  +....+.-+++.|+.|+.||-+.+   ++||||...||||+.+..+|++|||+++.+.+
T Consensus       709 TEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            9999999999999776643  888899999999999999999999   99999999999999999999999999997744


Q ss_pred             CCCCCccccc--cccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          194 DETEGNTKRV--IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       194 ~~~~~~~~~~--~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .. .......  .-..+|.|||.+.-.+++.++||||+|+++||.++ |+.||-.+   .+.+++..+...++-+.+.+.
T Consensus       784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm---SNQdVIkaIe~gyRLPpPmDC  859 (996)
T KOG0196|consen  784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVIKAIEQGYRLPPPMDC  859 (996)
T ss_pred             CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc---chHHHHHHHHhccCCCCCCCC
Confidence            33 2222222  23468999999999999999999999999999877 89994322   345566666666555555443


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQP  321 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~  321 (358)
                      .             ..|.+|+..||+.|-..||.+.+|+..|..+.-.|..
T Consensus       860 P-------------~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  860 P-------------AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             c-------------HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            3             3677899999999999999999999999888655543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=261.12  Aligned_cols=251  Identities=23%  Similarity=0.289  Sum_probs=202.8

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .-.++|.+++.||+|.||+|-+++.+. ++.|++|++++   ...++.+....|-.+|+..+||.+..+-..|...+.+|
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            345789999999999999999998654 89999999976   44666777888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||.+||.|.-.+.+.+   .+++...+.+-..|+.||.|||+++   |++||+|.+|++++++|++|++|||+|+.-
T Consensus       245 FVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence            9999999999988775533   3899999999999999999999999   999999999999999999999999999752


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                        -.........+||+.|+|||++.+..|..+.|.|.+|+++|+|+.|+.||-..+...-..++....        ..+.
T Consensus       319 --I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed--------~kFP  388 (516)
T KOG0690|consen  319 --IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED--------LKFP  388 (516)
T ss_pred             --ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh--------ccCC
Confidence              233445567899999999999999999999999999999999999999975444332222211100        0111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHH
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILM  311 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~  311 (358)
                      ...         ..+...|+...|..||.+|.-     +.||.++
T Consensus       389 r~l---------s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  389 RTL---------SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ccC---------CHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            111         112335777889999999953     5666654

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=281.91  Aligned_cols=255  Identities=27%  Similarity=0.376  Sum_probs=202.8

Q ss_pred             CCCcceeecccCCccEEEEEEcC--CC--EEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD--GQ--EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~--~~--~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      +.+..+.||+|.||.|++|.|..  |+  .|+||.+...... ....|..|+.+|..|+|+|++++|++..+ ...-+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            44778999999999999999744  43  6899999764444 67889999999999999999999999887 6778999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |.++.|+|.+.+.+ .....+....++.++.||+.|+.||.+++   ++|||+...|+++-....|||+|||+.+.+..+
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999987 34455899999999999999999999999   999999999999999999999999999988544


Q ss_pred             CCCCcc-ccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          195 ETEGNT-KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       195 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...... ........|+|||.++..+++.++|+|++|+++|||++ |+.||..-...   .+++.+...      ..+. 
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL~~iD~~------erLp-  335 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QILKNIDAG------ERLP-  335 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHHHhcccc------ccCC-
Confidence            333222 22334567999999999999999999999999999999 66776443222   222211110      0010 


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         .   .....+++++++.+||..+|.+|||+..|.+.+-..
T Consensus       336 ---R---Pk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  336 ---R---PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             ---C---CCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence               1   122345788899999999999999999998654333

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=272.35  Aligned_cols=260  Identities=28%  Similarity=0.437  Sum_probs=208.2

Q ss_pred             HHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           32 ATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        32 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .+++-...+..+-.+||.|.||.||.|+|+. .-.|+||.++. +......|..|+.+|+.++|||+|+++++|..+.-+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4555556667778899999999999999976 77899999865 456778999999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      |||.|||..|+|.+++...... .++...++.++.||..|++||..++   ++||||...|.||..+..+|++|||+++.
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999999665443 3888888999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      +... ....+.-..-..-|.|||-+.-..++.|+|||+||++||++.| |..||..-+   ..    .+...+..+...+
T Consensus       415 MtgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---lS----qVY~LLEkgyRM~  486 (1157)
T KOG4278|consen  415 MTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---LS----QVYGLLEKGYRMD  486 (1157)
T ss_pred             hcCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---HH----HHHHHHhcccccc
Confidence            6422 2222222334567999999888899999999999999999998 667754322   11    2222222222222


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      -...+.         ..+.+||+.||+++|.+||++.|+-+.++
T Consensus       487 ~PeGCP---------pkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  487 GPEGCP---------PKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             CCCCCC---------HHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            222222         25678999999999999999999987664

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=252.24  Aligned_cols=266  Identities=21%  Similarity=0.237  Sum_probs=201.9

Q ss_pred             cCCCCcce-eecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC----Cee
Q 018304           38 TNNFSINK-KLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EEK  110 (358)
Q Consensus        38 ~~~y~i~~-~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~----~~~  110 (358)
                      .++|.+.. +||-|-.|+|..+.++. ++++++|++...     ...++|++..-.. .|+|||.++++|++.    ..+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            35666554 79999999999998754 899999988532     3566888877666 599999999998653    466


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC---CCeEEecccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGL  187 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~---~~i~L~Df~~  187 (358)
                      .+|||.++||.|...++.+.. +.+++.++..++.||+.|+.|||+.+   |.||||||+|+|.+..   ..+||+|||+
T Consensus       135 LiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence            899999999999999977654 44999999999999999999999999   9999999999999744   4699999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ++...   ......+.+.|+.|.|||++...+|+..+|+||+|+++|-|+.|-+||=. ..+..  ........++.+. 
T Consensus       211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS-~hg~a--ispgMk~rI~~gq-  283 (400)
T KOG0604|consen  211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLA--ISPGMKRRIRTGQ-  283 (400)
T ss_pred             ccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc-cCCcc--CChhHHhHhhccC-
Confidence            98742   34455567789999999999999999999999999999999999999632 22211  1001111111100 


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCCCC
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQP  324 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~~~  324 (358)
                      -.+.     ........+...++|+.+|+.+|.+|.|+.+++.+-|-......|..+
T Consensus       284 y~FP-----~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tp  335 (400)
T KOG0604|consen  284 YEFP-----EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTP  335 (400)
T ss_pred             ccCC-----ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCC
Confidence            0011     111112234566799999999999999999999998876555544443

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.7e-34  Score=261.37  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=193.0

Q ss_pred             CCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           41 FSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      |...+.||+|++|.||+|++. ++..|++|.+...   .......+.+|++.++.++|+|++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            777888999999999999874 4889999988642   223445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+ ++.+++....  ..+++..++.++.||+.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....    
T Consensus       103 ~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            964 7777764432  34889999999999999999999999   9999999999999999999999999876421    


Q ss_pred             CCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          197 EGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                        ......++..|+|||.+.   +..++.++||||||+++|+|++|..||.....   ........   ... ...... 
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~~---~~~-~~~~~~-  242 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIA---QND-SPTLQS-  242 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHH---hcC-CCCCCc-
Confidence              122345778899999874   45688899999999999999999999644322   11111111   111 111111 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         ..    ....+.+++.+||+.+|.+||++.+++.+-+..
T Consensus       243 ---~~----~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         243 ---NE----WTDSFRGFVDYCLQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             ---cc----cCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence               01    112466799999999999999999999875544

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-35  Score=271.94  Aligned_cols=264  Identities=23%  Similarity=0.317  Sum_probs=194.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----  108 (358)
                      ..++|.+.+.||+|++|.||+|.+. +|+.|++|.+.+.  .......+.+|+.+++.++|+||+++++++....     
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3589999999999999999999975 4899999998652  2223455778999999999999999999987543     


Q ss_pred             -eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          109 -EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       109 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                       ..++++||+.. +|..+.   .  ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~---~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM---G--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHH---c--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence             45899999964 676654   1  23889999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC-
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG-  265 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  265 (358)
                      +.....     ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......   ..+.......... 
T Consensus       164 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~  235 (342)
T cd07879         164 ARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPG  235 (342)
T ss_pred             CcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCC
Confidence            875321     1123346778999998876 46889999999999999999999998653321   1111111100000 


Q ss_pred             ----------CCCcccc---CCcCCCC---CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          266 ----------MPSQLID---PCIQGSF---NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       266 ----------~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                                .......   .......   .......+.++|.+||+.||++||++.+++.+-+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                      0000000   0000000   00112356789999999999999999999987555443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-34  Score=252.82  Aligned_cols=241  Identities=26%  Similarity=0.330  Sum_probs=192.4

Q ss_pred             ecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           47 LGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        47 lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      ||.|++|.||++.+.. ++.+++|.+....   ......+..|+++++.++|+||+++++.+..+...+++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999754 8899999886532   22455788899999999999999999999999999999999999999


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcccc
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR  202 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~  202 (358)
                      .+++....   .+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            99986543   3899999999999999999999999   9999999999999999999999999987653221  12234


Q ss_pred             ccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHH
Q 018304          203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA  282 (358)
Q Consensus       203 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      ..++..|++||...+..++.++|+||||+++|+|++|..||...+.   ........    .. ...+..         .
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~----~~-~~~~~~---------~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL----KD-PLRFPE---------F  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh----cC-CCCCCC---------C
Confidence            4577889999999888889999999999999999999999854332   11111111    10 000110         0


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCh---HHHHHHh
Q 018304          283 EVIRCIHIGLLCVQQHPKDRPSM---PSVILML  312 (358)
Q Consensus       283 ~~~~l~~li~~cl~~~P~~Rpt~---~ell~~l  312 (358)
                      ....+.+++.+||..+|++|||+   .+++.+.
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~  248 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHP  248 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCC
Confidence            13456789999999999999999   6776654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=248.35  Aligned_cols=253  Identities=22%  Similarity=0.350  Sum_probs=198.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++.+++..||+|..|.||++.... |.-.+||.+.+ .+.++.+++...+.++... ++|+||+++++|..+....+.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            344778899999999999998755 88999999976 4456677888888888777 49999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      .+ +..++.++.+..  +++++..+-++...+++||.||-.++  +|+|||+||.|||++..|++||||||++-.+-+. 
T Consensus       172 lM-s~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-  245 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-  245 (391)
T ss_pred             HH-HHHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc-
Confidence            88 446666664433  44999999999999999999998876  5999999999999999999999999998776332 


Q ss_pred             CCCccccccccCCCCCcccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                        ..+....|-+.|+|||.+..   ..|+.++||||||++++||.||..||..-+.  ..+.+-.+.    ...++.+..
T Consensus       246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvl----n~ePP~L~~  317 (391)
T KOG0983|consen  246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVL----NEEPPLLPG  317 (391)
T ss_pred             --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHH----hcCCCCCCc
Confidence              23334567889999998854   4789999999999999999999999765332  233332222    222222221


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      .. .      ....+.+++..||+.|+.+||...+|+++-
T Consensus       318 ~~-g------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  318 HM-G------FSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             cc-C------cCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            11 1      233567889999999999999999999874

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.5e-35  Score=267.77  Aligned_cols=268  Identities=23%  Similarity=0.296  Sum_probs=193.5

Q ss_pred             CCCcceeecccCCccEEEEEEcC---CCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC----Ce
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE  109 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~---~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~----~~  109 (358)
                      +|++.+.||+|++|.||++.+..   +..|++|.+...  .......+..|+.+++.+ +|+||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            58899999999999999999743   678999988642  222345677899999999 599999999875432    45


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .+++++++. ++|.+++...   ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688899886 5888888543   34899999999999999999999999   9999999999999999999999999997


Q ss_pred             ecCCCCCC--CccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          190 AFGGDETE--GNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       190 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      .+......  .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+...   .............
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~  230 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD  230 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence            65322111  11123457889999998765 468999999999999999999999986543211   1111110000000


Q ss_pred             -----------CCcc---ccCCcCC---CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          267 -----------PSQL---IDPCIQG---SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       267 -----------~~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                                 ....   .......   .........+.+++.+||+.+|++|||+.+++.+-+-...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                       0000   0000000   0000012457789999999999999999999988665444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=251.71  Aligned_cols=256  Identities=22%  Similarity=0.321  Sum_probs=201.8

Q ss_pred             eeecccCCccEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           45 KKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      +.||+|+++.|.-+.. .+|..|+||++.+........+.+|++++.+. .|+||++++++|++++..|+|||.+.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            4799999999998874 57999999999998888889999999999999 599999999999999999999999999999


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC---eEEeccccceecCCC--CC-
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGGD--ET-  196 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~---i~L~Df~~~~~~~~~--~~-  196 (358)
                      ...|+++..   +++.++..+...|+.||.+||.+|   |.|||+||+||+......   +|||||.+..-...+  .+ 
T Consensus       164 LshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQKRKH---FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            999976655   999999999999999999999999   999999999999976544   899999886543221  11 


Q ss_pred             --CCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC--
Q 018304          197 --EGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP--  267 (358)
Q Consensus       197 --~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  267 (358)
                        .....+.+|+..|||||+..     ...|+.++|.||||+|+|-|+.|-.||......+-.         |..+..  
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---------WdrGe~Cr  308 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---------WDRGEVCR  308 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---------ccCCCccH
Confidence              12223456888999999752     236889999999999999999999999876553211         111111  


Q ss_pred             ---CccccCCcCCCCCH------HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          268 ---SQLIDPCIQGSFNL------AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       268 ---~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         ..+...+..+.+..      .......++|+..|..++.+|.++..++.+.|..
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~  365 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ  365 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence               01111222222222      1223446789999999999999999999876654

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=298.94  Aligned_cols=254  Identities=26%  Similarity=0.379  Sum_probs=203.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .-+|.-...||.|.||.||-|.+.+ |.-.++|.+...  .......+.+|..++..++|||+++++++=.+.+..+|+|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3588888899999999999999754 888899988642  2344566789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |||.+|+|.+.+....   ..++.....+..|++.|+.|||++|   ||||||||.||+++.+|-+|++|||.+..+..+
T Consensus      1314 EyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            9999999999984433   2677777788899999999999999   999999999999999999999999999987544


Q ss_pred             C--CCCccccccccCCCCCcccccCCC---CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          195 E--TEGNTKRVIGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       195 ~--~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .  .....+...||+-|+|||++.+.+   -..++|||||||++.||+||+.||...+..-  .    +......+..+.
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--a----IMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--A----IMYHVAAGHKPQ 1461 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--H----HHhHHhccCCCC
Confidence            2  122334567999999999987643   3568999999999999999999987765431  1    112222333333


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      +...         ...+=.+++.+||..||+.|-++.+|+++-
T Consensus      1462 ~P~~---------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 IPER---------LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             Cchh---------hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            3332         122334789999999999999999999873

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=263.66  Aligned_cols=256  Identities=25%  Similarity=0.334  Sum_probs=206.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..+.|+.-++||+|+||.||-++... |+.|++|.+.+   ..........+|-.+|..++.+.||.+-..|++.+.+++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            34788999999999999999998654 99999997754   223445567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      |+..|+||+|.-.|.+... ..+++..++.++.+|+.||++||+.+   |++||+||+|||+|+.|+++|+|+|++..+.
T Consensus       263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999999988765 33999999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ....   .+...||.+|+|||++.+..|+...|.|+|||++|+|+.|+.||...........+......    ...+   
T Consensus       339 ~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----~~~e---  408 (591)
T KOG0986|consen  339 EGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----DPEE---  408 (591)
T ss_pred             CCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc----chhh---
Confidence            4432   22337999999999999999999999999999999999999998776654433222222111    1111   


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHh
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILML  312 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l  312 (358)
                            +.-....+..++++..|+.||++|.-     +.++-++.
T Consensus       409 ------y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp  447 (591)
T KOG0986|consen  409 ------YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP  447 (591)
T ss_pred             ------cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence                  11122235567888899999999854     55666543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.3e-34  Score=284.49  Aligned_cols=254  Identities=28%  Similarity=0.435  Sum_probs=189.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe---------
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ---------  106 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~---------  106 (358)
                      -.+|+.++.||+||||.||+++.+ +|+.||||.+.-. .......+.+|+..|.+|+|||+|+++..+..         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            467889999999999999999964 6999999999653 45567788999999999999999999852200         


Q ss_pred             ---------------------------------------------------------------------C----------
Q 018304          107 ---------------------------------------------------------------------G----------  107 (358)
Q Consensus       107 ---------------------------------------------------------------------~----------  107 (358)
                                                                                           +          
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                 0          


Q ss_pred             -------------------------------CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc
Q 018304          108 -------------------------------EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ  156 (358)
Q Consensus       108 -------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~  156 (358)
                                                     ..+||-||||+..++.+++.++...  -.....|+++.+|++||.|+|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHh
Confidence                                           1126789999987777777544321  1477889999999999999999


Q ss_pred             CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC----------------CCCCCCccccccccCCCCCcccccCC--
Q 018304          157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG----------------GDETEGNTKRVIGTYGYMAPEYASDG--  218 (358)
Q Consensus       157 ~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~--  218 (358)
                      .|   ++||||||.|||++.++.|||+|||++....                ........+...||.-|+|||++.+.  
T Consensus       716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            99   9999999999999999999999999998721                01111233446799999999998765  


Q ss_pred             -CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCC
Q 018304          219 -QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQ  297 (358)
Q Consensus       219 -~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  297 (358)
                       +|+.|+|+||||++++||+.   ||++     .++.+.... .++.+..+.-      ..+.......=..+|++|++.
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa~iL~-~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~h  857 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERASILT-NLRKGSIPEP------ADFFDPEHPEEASLIRWLLSH  857 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCc-----hHHHHHHHH-hcccCCCCCC------cccccccchHHHHHHHHHhcC
Confidence             49999999999999999987   4433     122222221 1222222211      111112222334689999999


Q ss_pred             CCCCCCChHHHHHH
Q 018304          298 HPKDRPSMPSVILM  311 (358)
Q Consensus       298 ~P~~Rpt~~ell~~  311 (358)
                      ||.+|||+.+||..
T Consensus       858 dP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  858 DPSKRPTATELLNS  871 (1351)
T ss_pred             CCccCCCHHHHhhc
Confidence            99999999999964

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=285.49  Aligned_cols=280  Identities=19%  Similarity=0.209  Sum_probs=216.7

Q ss_pred             eeHHHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEE
Q 018304           29 FELATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCC  104 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  104 (358)
                      ..+++..-..++|+|++.||+|+||.|.+++.+. ++-||+|++++   ......+.|..|-.+|-..+.+.|++++..|
T Consensus        65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF  144 (1317)
T KOG0612|consen   65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF  144 (1317)
T ss_pred             HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence            3466667777999999999999999999999755 88999999987   5566778899999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                      .++.++|+||||++||+|-.++.+..   .+++..++.++..|+.||.-||+.|   +|||||||+|||++..|+++|+|
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence            99999999999999999999996655   4999999999999999999999999   99999999999999999999999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCccccc----C-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYAS----D-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      ||.|..+.... ........|||.|.+||++.    + +.|...+|.||+|+++|+|+.|..||-...   -..-...+.
T Consensus       219 FGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads---lveTY~KIm  294 (1317)
T KOG0612|consen  219 FGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS---LVETYGKIM  294 (1317)
T ss_pred             chhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH---HHHHHHHHh
Confidence            99998775332 23344567999999999885    2 578999999999999999999999973211   111111111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC---hHHHHHHhccC-------CCCCCCCCCCcccC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS---MPSVILMLGSE-------TVLPQPKQPGYLAD  329 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~ell~~l~~~-------~~~~~~~~~~~~~~  329 (358)
                      ..   ...-.+++       .........+||++.+ -+|+.|..   +.++-.|..+.       ....+|-.|...+.
T Consensus       295 ~h---k~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd  363 (1317)
T KOG0612|consen  295 NH---KESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSD  363 (1317)
T ss_pred             ch---hhhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCC
Confidence            11   11111111       0112234445666555 47888888   99998876543       33355555554433

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-33  Score=279.72  Aligned_cols=146  Identities=27%  Similarity=0.419  Sum_probs=131.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .++|.+++.||+|+||.||+|.+. .++.|++|++...   .......+..|+.++..++|+||+++++.+...+..++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            378999999999999999999986 4889999998642   233456788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      |||+.+++|.+++....   .+++..++.++.||+.||.|||..+   |+|+||||+|||++.++.++|+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999985433   3889999999999999999999999   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=269.64  Aligned_cols=206  Identities=28%  Similarity=0.449  Sum_probs=178.2

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC------ee
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EK  110 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~------~~  110 (358)
                      .-|...+.||+|+||.||+|+++ .|+.||||.+.+.. ....+....|+++|++++|+|||+++++=++..      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            56778889999999999999964 59999999997622 334567789999999999999999998755443      45


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc--CCCC--eEEeccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD--QDMN--PKISDFG  186 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~--~~~~--i~L~Df~  186 (358)
                      .+|||||.||+|...+...++...+++..++.++.+++.||.|||.+|   |+||||||.||++-  .+|+  .||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            799999999999999999888877999999999999999999999999   99999999999985  3354  7999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCccccc-CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN  250 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~  250 (358)
                      .++.+.++   .......||..|++||... .+.|+..+|.|||||++|+.+||..||.....+.
T Consensus       170 ~Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk  231 (732)
T KOG4250|consen  170 AARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK  231 (732)
T ss_pred             ccccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence            99987433   2556778999999999887 5889999999999999999999999988766653

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-33  Score=247.38  Aligned_cols=225  Identities=20%  Similarity=0.145  Sum_probs=175.1

Q ss_pred             cCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhc
Q 018304           50 GGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD  128 (358)
Q Consensus        50 g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  128 (358)
                      |.+|.||++.+.. ++.|++|.+.....     ...|...+....||||+++++++...+..+++|||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            8899999999754 88999999976432     22344455556799999999999999999999999999999999855


Q ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCC
Q 018304          129 QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG  208 (358)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~  208 (358)
                      ..   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||.+......     .....++..
T Consensus        79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence            43   3899999999999999999999999   999999999999999999999999987654221     112234567


Q ss_pred             CCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHH
Q 018304          209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCI  288 (358)
Q Consensus       209 y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  288 (358)
                      |+|||...+..++.++|+||+|+++|+|++|..|+........            ......     ....    ....+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~~~~-----~~~~----~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THTTLN-----IPEW----VSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cccccC-----Cccc----CCHHHH
Confidence            9999998888889999999999999999999987543211100            000000     0111    123566


Q ss_pred             HHHhhhcCCCCCCCCCh-----HHHHHH
Q 018304          289 HIGLLCVQQHPKDRPSM-----PSVILM  311 (358)
Q Consensus       289 ~li~~cl~~~P~~Rpt~-----~ell~~  311 (358)
                      ++|.+||+.||++|||+     .+++.+
T Consensus       207 ~li~~~l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         207 SLLQQLLQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             HHHHHHccCCHHHhcCCCccchHHHHcC
Confidence            89999999999999996     666654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=251.98  Aligned_cols=269  Identities=26%  Similarity=0.393  Sum_probs=203.6

Q ss_pred             CCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc--CCCCccceeeEEEeCC----eeEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL--QHRNLVKLLGCCIQGE----EKLLI  113 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l--~~~~iv~~~~~~~~~~----~~~lv  113 (358)
                      ..++.+.||+|+||.||+|.. .++.||||++..   ...+.+.+|-++....  +|+||+++++.-+..+    .+.+|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            337889999999999999988 679999999954   4556777888887765  7999999998766555    78999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC------CCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS------RLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~------~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                      ++|.+.|+|.+++..+.    +++....+++..|+.||+|||+.-      ++.|+|||||+.||||.+|++..|+|||+
T Consensus       287 t~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999996544    999999999999999999999764      45799999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCC-CCC-----CcccchhHhHHHHHHHhCCCCCCCCCCCC-Cch-------
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFS-----VKSDVFSFGILLLEIISGKKNRGFYHSDN-NLN-------  253 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~-----~~~DiwslG~il~~l~~g~~p~~~~~~~~-~~~-------  253 (358)
                      +..+.........-...||.+|+|||++.+. ++.     .+.||||+|.++|||++...-+.....+. .+-       
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            9988655555555557899999999998764 333     36899999999999999765442111110 000       


Q ss_pred             --hHHHHH-HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCC
Q 018304          254 --LIGHAW-KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQ  320 (358)
Q Consensus       254 --~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~  320 (358)
                        .+..+. ...+....+.+.+....    -....-+.+.+..||..||+.|.|+.=+-+.++++.....
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence              000111 11112222222222222    1334456789999999999999999999998888765543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=267.31  Aligned_cols=244  Identities=23%  Similarity=0.257  Sum_probs=195.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..+.|.+...+|.|.|+.|-.+.+.. ++..++|++.+..    ....+|+.++... +|+||+++.+.+.++.+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            36789999999999999998888654 8899999997642    2233677666666 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE-cCCCCeEEeccccceecCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv-~~~~~i~L~Df~~~~~~~~  193 (358)
                      |.+.|+-+.+.+....    .....+..|+.+|+.|+.|||++|   ++|||+||+|||+ ++.|+++|+|||.+..+..
T Consensus       396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999988877774433    333777889999999999999999   9999999999999 5899999999999987532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .     ....+-|..|.|||++....|+.++||||||++||+|++|..||.....+  ......    ...+...     
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~----i~~~~~s-----  532 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTR----IQMPKFS-----  532 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHh----hcCCccc-----
Confidence            2     22345678899999999999999999999999999999999998765554  111111    1111111     


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                             ........+|+.+||++||.+||++.++..+-|.
T Consensus       533 -------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 -------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                   1112345579999999999999999999998887

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=256.50  Aligned_cols=266  Identities=23%  Similarity=0.321  Sum_probs=198.7

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc-------cChhhHHHHHHHHHHHHhcCCCCccceee
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK-------ISEQGLKELKNEVILFSKLQHRNLVKLLG  102 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~-------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~  102 (358)
                      +++.....++|-++..||+|+|+.||++.+.. .+.|++|+-..       ......+...+|..+.+.|+||.||++|+
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            55666677899999999999999999999755 77888886532       11223345678999999999999999999


Q ss_pred             EEEeC-CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CC
Q 018304          103 CCIQG-EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DM  178 (358)
Q Consensus       103 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~  178 (358)
                      +|.-+ +.+|-|+|||+|.+|+-++..++   .+++.+++.|+.||+.||.||.... .+|+|-||||.|||+.+   -|
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccc
Confidence            99654 57899999999999999985544   4999999999999999999999875 78999999999999953   47


Q ss_pred             CeEEeccccceecCCCCCCCcc-----ccccccCCCCCcccccC----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCC
Q 018304          179 NPKISDFGLARAFGGDETEGNT-----KRVIGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSD  249 (358)
Q Consensus       179 ~i~L~Df~~~~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~  249 (358)
                      .+||+|||++..+.........     ....||.+|++||.+.-    .+.+.|.||||+|+|+|+.+.|+.||+.....
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            8999999999987544332111     23468999999997642    35688999999999999999999998764332


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                        .++++... .+.. ....+..       .+....+..++|++||.+.-++|....+|...
T Consensus       691 --QdILqeNT-IlkA-tEVqFP~-------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  691 --QDILQENT-ILKA-TEVQFPP-------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             --HHHHhhhc-hhcc-eeccCCC-------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence              11111110 0000 0011111       11112234469999999999999887777654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-33  Score=247.45  Aligned_cols=268  Identities=22%  Similarity=0.335  Sum_probs=202.7

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc--CCCCccceeeEEEeCC----
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL--QHRNLVKLLGCCIQGE----  108 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l--~~~~iv~~~~~~~~~~----  108 (358)
                      .....+..+.+.||+|.||.||+|.+ .|..||||++...++   ....+|.++.+..  +|+||+.+++.-..++    
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            34567889999999999999999999 899999999975333   4566788888774  9999999998765543    


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCcccCCCCCCcEEEcCCCCeEEe
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKIS  183 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-----~~~~i~H~di~~~Nilv~~~~~i~L~  183 (358)
                      .+++|.+|.+.|+|.|++.+..    ++....++++..+|.||++||-.     |++.|.|||||+.||+|.++|...|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            6799999999999999996633    99999999999999999999964     67789999999999999999999999


Q ss_pred             ccccceecCCCC--CCCccccccccCCCCCcccccCC----CC-C-CcccchhHhHHHHHHHhCC----------CCCCC
Q 018304          184 DFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYASDG----QF-S-VKSDVFSFGILLLEIISGK----------KNRGF  245 (358)
Q Consensus       184 Df~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~----~~-~-~~~DiwslG~il~~l~~g~----------~p~~~  245 (358)
                      |+|++.......  .....+...||-+|+|||++...    .+ + ..+||||||.++||++...          .||-.
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            999998764332  22334456799999999998643    11 2 3589999999999998643          34322


Q ss_pred             CCC-CCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          246 YHS-DNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       246 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .-+ +...+..   .+..   -...+.....+.....+.+..+.++|+.||..+|..|-|+--+-..|.++.
T Consensus       439 ~Vp~DPs~eeM---rkVV---Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  439 VVPSDPSFEEM---RKVV---CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCCCCHHHH---hcce---eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            111 1111111   1100   112222233344455677888999999999999999999988877766553

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.4e-34  Score=261.92  Aligned_cols=268  Identities=19%  Similarity=0.172  Sum_probs=209.0

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCC------CCccceeeEEEeCC
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQGE  108 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~------~~iv~~~~~~~~~~  108 (358)
                      ..+.+|.+....|.|-|++|..|.+.. |+.||||+|.+. +--.+.=..|+++|+.|+.      -|+++++..|.+.+
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            467899999999999999999999755 889999999763 3333445679999999963      38999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-CCeEEecccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL  187 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-~~i~L~Df~~  187 (358)
                      ++|+|||.+ ..+|.+.+.+....-.+....++.++.|++-||..|-..|   |+|.||||+||||+.. ..+||||||.
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence            999999998 5699999988766666999999999999999999999999   9999999999999855 5689999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      +.....    ...+.....-.|.|||++.|.+|+...|+||+||+||+|+||+..|........+.+...+...++....
T Consensus       584 A~~~~e----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  584 ASFASE----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             cccccc----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            987532    2233344556799999999999999999999999999999999998887665544443322211111000


Q ss_pred             --CccccCCcC-----------------------------------------CCCCHHHHHHHHHHHhhhcCCCCCCCCC
Q 018304          268 --SQLIDPCIQ-----------------------------------------GSFNLAEVIRCIHIGLLCVQQHPKDRPS  304 (358)
Q Consensus       268 --~~~~~~~~~-----------------------------------------~~~~~~~~~~l~~li~~cl~~~P~~Rpt  304 (358)
                        ..+.+.-+.                                         ..-.......|.+|+.+||..||++|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence              000000000                                         0011233456788999999999999999


Q ss_pred             hHHHHHHh
Q 018304          305 MPSVILML  312 (358)
Q Consensus       305 ~~ell~~l  312 (358)
                      ..+.|.+.
T Consensus       740 ~nqAL~Hp  747 (752)
T KOG0670|consen  740 VNQALKHP  747 (752)
T ss_pred             HHHHhcCC
Confidence            99999764

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=260.72  Aligned_cols=257  Identities=25%  Similarity=0.345  Sum_probs=202.7

Q ss_pred             HhcCCCCc--ceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           36 SATNNFSI--NKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        36 ~~~~~y~i--~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .+..-|+|  .+.||+|.||+||-|++. +|+.|+||++.+  .......++++|+.+|+++.||.|+.+...|++.+..
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv  638 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV  638 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence            33334444  468999999999999874 599999999976  3344458899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC---CCeEEecccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGL  187 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~---~~i~L~Df~~  187 (358)
                      ++|||.+.| +..++|...+. +.+++..-..++.||+.||.|||.++   |+|+|+||+||++.+.   .++||||||+
T Consensus       639 FVVMEKl~G-DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGf  713 (888)
T KOG4236|consen  639 FVVMEKLHG-DMLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGF  713 (888)
T ss_pred             EEEehhhcc-hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccc
Confidence            999999966 66666654333 33999998999999999999999999   9999999999999744   5799999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ++.+..   ....+...||+.|+|||+++.+.|...-|+||+|+|+|--++|..||......  .+.++...--+.... 
T Consensus       714 ARiIgE---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~P-  787 (888)
T KOG4236|consen  714 ARIIGE---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPNP-  787 (888)
T ss_pred             eeecch---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccCCCc-
Confidence            998743   33455678999999999999999999999999999999999999997654332  222211111111111 


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                  ........++||...|+..-.+|-|...-+.+.|..
T Consensus       788 ------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  788 ------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             ------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence                        111122456788899999999999999988887754

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=258.89  Aligned_cols=274  Identities=23%  Similarity=0.286  Sum_probs=216.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCC-EEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQ-EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~-~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .+.+++..||-|+||.|=++..+... .+++|.+++   .+......+..|-++|...+.|.|+++|..|.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45678889999999999998874433 478887765   34455577888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |-|-||.|...+.+...   +++.+...++..+++|++|||++|   |++||+||+|.+++.+|-+||.|||+++.+.  
T Consensus       500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--  571 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--  571 (732)
T ss_pred             HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc--
Confidence            99999999999955443   889999999999999999999999   9999999999999999999999999999863  


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                       .....-+.+||+.|.|||++.+..-+.++|.|+||+++|||++|.+||...++-.....   +.+.+..-..+..+.  
T Consensus       572 -~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~---ILkGid~i~~Pr~I~--  645 (732)
T KOG0614|consen  572 -SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL---ILKGIDKIEFPRRIT--  645 (732)
T ss_pred             -cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH---HHhhhhhhhcccccc--
Confidence             33444567899999999999999999999999999999999999999876655433333   222222222222111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC---------CCCCCCCCCCcccCCCCCCCC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE---------TVLPQPKQPGYLADRNSTRLD  336 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~---------~~~~~~~~~~~~~~~~~~~~~  336 (358)
                                ....++|++..+.+|.+|.-     +.++-.|.|..         ..+++|-.|..........-+
T Consensus       646 ----------k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd  711 (732)
T KOG0614|consen  646 ----------KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFD  711 (732)
T ss_pred             ----------hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhcc
Confidence                      23446888999999999976     88888888766         334555555555444443333

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=263.09  Aligned_cols=256  Identities=28%  Similarity=0.428  Sum_probs=206.0

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEe-----CC
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ-----GE  108 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~-----~~  108 (358)
                      .-.+-|+|++.||.|.+|.||+++.. +++..++|+... +.+.-..+..|+++|+.+ .|||++.++++|..     ++
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            34578999999999999999999864 588889998765 344446778899999998 69999999999864     46


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      .+++|||||.+|+..|++.+.. ...+.+..+..+++.++.|+.+||.+.   ++||||+=.||+++.++.|||+|||.+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence            8899999999999999997766 445999999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      ..+  ........+..|++.|+|||++..     ..|+..+|+||||++..+|.-|.+|+..+-+-..+.       ...
T Consensus       171 aQl--dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF-------~Ip  241 (953)
T KOG0587|consen  171 AQL--DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LIP  241 (953)
T ss_pred             eee--ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-------cCC
Confidence            876  234455567789999999999853     357789999999999999999999954332221111       111


Q ss_pred             cCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          264 EGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      ...++.+..       +..-...+.++|..||..|-++||++.+++++.
T Consensus       242 RNPPPkLkr-------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  242 RNPPPKLKR-------PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             CCCCccccc-------hhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence            222222221       122245678899999999999999999999863

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-33  Score=219.18  Aligned_cols=267  Identities=23%  Similarity=0.301  Sum_probs=200.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .+|.-.++||+|.||+||+++..+ ++-|++|++.-  .++.......+|+-+++.++|.||++++++...+..+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            356677899999999999999654 88899998864  334456778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      ||.. .|..+.....  +.++.+.++.++.|++.|+.++|+++   +.|||+||.|.+++.+|.+||+|||+++.++-. 
T Consensus        82 ~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip-  154 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP-  154 (292)
T ss_pred             HhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence            9965 8888875544  34899999999999999999999999   999999999999999999999999999875321 


Q ss_pred             CCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCC---CCcc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGM---PSQL  270 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  270 (358)
                       ......-..|..|.+|+++.+. -|+...|+||.||++.|+.. |.+.|...+.++....+.+......+..   +..+
T Consensus       155 -vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             -eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence             2223334568899999988775 67899999999999999998 5555655554444333333222211111   1122


Q ss_pred             ccCCcCCCCCHH----H-HH----HHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          271 IDPCIQGSFNLA----E-VI----RCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       271 ~~~~~~~~~~~~----~-~~----~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .+...-..+...    . ..    .=.+++.+.|.-+|..|.++++.+++.-
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpy  285 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPY  285 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcc
Confidence            222222222111    1 01    1246777888899999999999988643

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-35  Score=241.93  Aligned_cols=271  Identities=23%  Similarity=0.347  Sum_probs=199.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEe--------
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------  106 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--------  106 (358)
                      .+.|+-..+||+|.||.||+|..++ |+.|++|.+--  ....-.-...+|+++|..+.|+|++.++..+..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            3567778899999999999998755 78888876532  122223446689999999999999988877643        


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      ...+|+||.+|+. +|..++.+...+  ++...+.+++.++..||.|+|+..   |+|||+|+.|++++.+|.++|+|||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr--~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVR--FSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCcccc--ccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence            2357999999976 888888655332  999999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCC--CCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH--
Q 018304          187 LARAFGGDE--TEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL--  261 (358)
Q Consensus       187 ~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  261 (358)
                      +++.+....  ..........|..|.+||.+.|. .|+.+.|||+.||++.+|+++.+-+...........+...+..  
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            997664332  22233445678999999988765 7899999999999999999999887665544444444333322  


Q ss_pred             ---hhcCCCCccccCC-----cCCCCC--HHH------HHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          262 ---WNEGMPSQLIDPC-----IQGSFN--LAE------VIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       262 ---~~~~~~~~~~~~~-----~~~~~~--~~~------~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                         |++-..-.+....     ....+.  ...      ....++|+.++|..||.+|+++.+++.+-+.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F  318 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF  318 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence               2211111111111     111110  001      1245789999999999999999999987554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-31  Score=234.77  Aligned_cols=239  Identities=26%  Similarity=0.372  Sum_probs=190.7

Q ss_pred             CCccEEEEEEcC-CCEEEEEEecccChhh-HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhc
Q 018304           51 GFGPVYKGTLVD-GQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD  128 (358)
Q Consensus        51 ~~g~v~~~~~~~-~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  128 (358)
                      ++|.||+|.+.+ ++.+++|++....... ...+.+|++.++.++|+|++++++++......++++|++.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            578999999865 8999999997654443 67888999999999999999999999999999999999999999999855


Q ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCC
Q 018304          129 QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG  208 (358)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~  208 (358)
                      ...   ++...++.++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            433   889999999999999999999999   9999999999999999999999999998753321   2334457788


Q ss_pred             CCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHH
Q 018304          209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCI  288 (358)
Q Consensus       209 y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  288 (358)
                      |++||...+..++.++|||++|+++++|++|..||......  ...    ...............       ......+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~----~~~~~~~~~~~~~~~-------~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LEL----FKKIGKPKPPFPPPE-------WKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH----HHHHhccCCCCcccc-------ccCCHHHH
Confidence            99999998888899999999999999999999997543111  111    111111111100000       00224677


Q ss_pred             HHHhhhcCCCCCCCCChHHHHHH
Q 018304          289 HIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       289 ~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                      +++.+||..+|++||++.+++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhhC
Confidence            89999999999999999999984

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-32  Score=264.59  Aligned_cols=265  Identities=30%  Similarity=0.421  Sum_probs=204.8

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC--------CCEEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCCccceee
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLG  102 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~--------~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~  102 (358)
                      ..+...++..+.+.||+|+||.|++|..+.        ...|+||.++. ....+...+..|+++|+.+ .|+||+.+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            444445566777899999999999997321        34789999875 3335677889999999999 6999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhccc-----c------c--cCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCC
Q 018304          103 CCIQGEEKLLIYEFMTNKSLDSFIFDQE-----R------C--KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKA  169 (358)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~------~--~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~  169 (358)
                      .+......++|+||+..|+|.+++...+     .      .  ..++...++.++.||+.|++||++.+   ++|||+..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999889999999999999999996655     0      0  13888999999999999999999999   99999999


Q ss_pred             CcEEEcCCCCeEEeccccceecCCCCCCCccccc-cccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCC
Q 018304          170 SNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYH  247 (358)
Q Consensus       170 ~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~  247 (358)
                      .||+++.+..+|++|||+++.............. .-...|+|||.+....|+.++||||+|+++||+++ |..||....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999864333222111111 12345999999999999999999999999999999 777764411


Q ss_pred             CCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          248 SDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .  ..++.    ...+.+...+....         ...++.++++.||+.+|++||++.++.+.+...
T Consensus       527 ~--~~~l~----~~l~~G~r~~~P~~---------c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 P--TEELL----EFLKEGNRMEQPEH---------CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             c--HHHHH----HHHhcCCCCCCCCC---------CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            1  11122    22222222222221         234677899999999999999999999999883

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=237.44  Aligned_cols=292  Identities=21%  Similarity=0.324  Sum_probs=218.3

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|.++++||+|.|++|.++.++. .+-|++|++++   ..++.......|-.+..+. +||.++-+...|.++..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            689999999999999999998654 88999999876   4566677788888888887 699999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      .||++||+|--.++++..   ++++.++.+...|+.||.|||++|   |++||+|.+||+++..|.+||+|||+++.-  
T Consensus       330 ieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~--  401 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--  401 (593)
T ss_pred             EEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC--
Confidence            999999998766654443   999999999999999999999999   999999999999999999999999999752  


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchh-HHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL-IGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  272 (358)
                      ........+.+||+.|.|||++++..|....|.|+||+++++|+.|+.||+.-..++...- -....+.+-+... .+  
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-ri--  478 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-RI--  478 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-cc--
Confidence            2233445578899999999999999999999999999999999999999987554332221 1122222111111 00  


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC------hHHHHH----------HhccCCCCCCCCCCCcccC--CCCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS------MPSVIL----------MLGSETVLPQPKQPGYLAD--RNSTR  334 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt------~~ell~----------~l~~~~~~~~~~~~~~~~~--~~~~~  334 (358)
                         +++...    ....+++.-|..||.+|.-      +.++-+          .|++-.. .+|-+|.....  -...-
T Consensus       479 ---prslsv----kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v-~ppf~p~i~~d~~l~~fd  550 (593)
T KOG0695|consen  479 ---PRSLSV----KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQV-LPPFQPQITDDYGLDNFD  550 (593)
T ss_pred             ---cceeeh----hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhccc-CCCCCCccccccCccccc
Confidence               111111    2234666778899998843      334332          2222222 33344443332  25556


Q ss_pred             CCCCCCCCCCCCCcc
Q 018304          335 LDSSSSRPESSSTNT  349 (358)
Q Consensus       335 ~~~~~~~~~~~~~~~  349 (358)
                      .+.++.+...+|+++
T Consensus       551 ~qft~e~~qltpdd~  565 (593)
T KOG0695|consen  551 TQFTSEPVQLTPDDE  565 (593)
T ss_pred             cccccCCcccCCCCH
Confidence            677777887777765

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-32  Score=253.67  Aligned_cols=207  Identities=23%  Similarity=0.352  Sum_probs=176.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +.-|..++.||-|+||.|.++...+ ...|++|.+.+.   .......++.|-++|...+++.+|++|..|.+++.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            3457778899999999999998655 667899988762   244556678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |+|++||++-.++.+...   +.+..++.++..+..|+++.|.-|   ++||||||+|||||.+|.+||+|||+|.-+..
T Consensus       708 MdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence            999999999999877665   889999999999999999999999   99999999999999999999999999865421


Q ss_pred             C---------CCC----------------C---------------ccccccccCCCCCcccccCCCCCCcccchhHhHHH
Q 018304          194 D---------ETE----------------G---------------NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILL  233 (358)
Q Consensus       194 ~---------~~~----------------~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il  233 (358)
                      .         ...                +               ..-...||+.|+|||++....|+..+|.||.|+||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence            0         000                0               00013589999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCC
Q 018304          234 LEIISGKKNRGFYHSDN  250 (358)
Q Consensus       234 ~~l~~g~~p~~~~~~~~  250 (358)
                      |+|+.|..||......+
T Consensus       862 ~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHhhCCCCccCCCCCc
Confidence            99999999997766554

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=239.40  Aligned_cols=256  Identities=27%  Similarity=0.341  Sum_probs=195.9

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEe
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      +.+=+..||.|+||+|++-.++. |+..|||++...+. .+..++..|.+..... ++||||++|+..-.+...++.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            33445789999999999988755 99999999976443 6677788888766665 799999999998888899999999


Q ss_pred             cCCCCHHHHHhcc--ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          117 MTNKSLDSFIFDQ--ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       117 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      +. .+|+.+....  .....+++..+-++....+.||.||-..-  .|+|||+||+|||++..|.+||||||++-.+.+ 
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-  220 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-  220 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence            95 5877765321  11233999999999999999999997754  499999999999999999999999999876522 


Q ss_pred             CCCCccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                        ......-.|-..|+|||.+..  ..|+.++|+||||++|||+.||..|+..++.     ++....... .+.++.+..
T Consensus       221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l~~  292 (361)
T KOG1006|consen  221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPILLF  292 (361)
T ss_pred             --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCeecC
Confidence              222223346677999998864  3599999999999999999999999654433     333333332 233333332


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                          ...+......+..+|..||..|-+.||...+|..+
T Consensus       293 ----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 ----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                22234455677889999999999999999999875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4.1e-33  Score=263.99  Aligned_cols=252  Identities=27%  Similarity=0.411  Sum_probs=200.7

Q ss_pred             CCcceeecccCCccEEEEEEcC-----CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-----~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .+-.++||+|+||+||+|.+-.     +-+|++|++.. ...+....+.+|+-.|..++|||++++++++.... .-+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            4557899999999999998632     34688888754 33445677889999999999999999999997765 77899


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      +|++.|+|.|++..++.  .+..+.++.|..||++|+.|||.+.   ++||||...||||.+-..+|+.|||++..+...
T Consensus       777 q~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999976543  4899999999999999999999999   999999999999999999999999999886433


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..........-.+-|+|-|.+....|+.++|||||||++||++| |..|+......+..+.+                ..
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------------e~  915 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------------EK  915 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------------hc
Confidence            33222222334567889998899999999999999999999998 88886654443332222                11


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      -.+-+.++....++.-++.+||..|+..||+++++...+..
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            11122334445677789999999999999999999876543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.3e-33  Score=246.12  Aligned_cols=245  Identities=25%  Similarity=0.335  Sum_probs=194.1

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  109 (358)
                      ..-..+|.++.+||+|.||+|.++..++ .+.|+||++++   ..+++.+.-+.|-.+|... +-|.++++...|.+-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            3344688999999999999999997655 67899999876   2234445556677777666 46788999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      +|+||||+.||+|--.++....   +.+..+..++..|+-||-+||++|   |++||||.+|||++.+|.+||+|||++.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence            9999999999999887765544   778888999999999999999999   9999999999999999999999999997


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .-  -......++.+||+.|+|||++...+|..+.|.||+|++||||+.|..||+..+.+   .+.+.+...        
T Consensus       499 En--i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~aI~eh--------  565 (683)
T KOG0696|consen  499 EN--IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQAIMEH--------  565 (683)
T ss_pred             cc--ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHc--------
Confidence            52  12234556789999999999999999999999999999999999999998765443   222222211        


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS  304 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  304 (358)
                            +-.++.....+..+++...|..+|.+|.-
T Consensus       566 ------nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  566 ------NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence                  11122222334556788889999999853

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=1.9e-31  Score=259.58  Aligned_cols=266  Identities=18%  Similarity=0.213  Sum_probs=170.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-----CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeE------EE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC------CI  105 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~------~~  105 (358)
                      ..++|++.+.||+|+||.||+|.+.+     +..|++|.+......  .....  +.++...+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~--e~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMN--ERVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHH--HHHHhhchhhHHHHHHhhhcccccc
Confidence            45799999999999999999999744     689999988643221  11111  11222222222222211      23


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhccccc-----------------cCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQERC-----------------KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK  168 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~  168 (358)
                      .+...++|+||+.+++|.+++......                 .......+..++.||+.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            456789999999999999988543210                 01123456789999999999999999   9999999


Q ss_pred             CCcEEEcC-CCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCC----------------------CCCCccc
Q 018304          169 ASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG----------------------QFSVKSD  225 (358)
Q Consensus       169 ~~Nilv~~-~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D  225 (358)
                      |+|||++. ++.+||+|||++..+.... ........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 5899999999997643221 1122345678999999965322                      2345679


Q ss_pred             chhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH-------HHhhcCCCCccccCCcCCCCC--HHHHHHHHHHHhhhcC
Q 018304          226 VFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW-------KLWNEGMPSQLIDPCIQGSFN--LAEVIRCIHIGLLCVQ  296 (358)
Q Consensus       226 iwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~  296 (358)
                      |||+||++|+|+++..+++.     .........       ..|.......... .....+.  ........+||.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASP-DLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccch-hhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999986655221     111110000       0111111110000 0000000  0011234579999999


Q ss_pred             CCCCCCCChHHHHHHhccCC
Q 018304          297 QHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       297 ~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .||++|||+.+++++-+...
T Consensus       436 ~dP~kR~ta~e~L~Hpff~~  455 (566)
T PLN03225        436 FKGRQRISAKAALAHPYFDR  455 (566)
T ss_pred             CCcccCCCHHHHhCCcCcCC
Confidence            99999999999999877654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.8e-31  Score=238.18  Aligned_cols=131  Identities=26%  Similarity=0.399  Sum_probs=112.8

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----C---CCccceeeEEEe---
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----H---RNLVKLLGCCIQ---  106 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----~---~~iv~~~~~~~~---  106 (358)
                      .||.+.++||.|.|++||++.+. +.+.||+|+++. ..........|+++|++++     +   .+||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            79999999999999999999974 477889998854 4556677889999999984     2   369999999975   


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE
Q 018304          107 -GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL  174 (358)
Q Consensus       107 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv  174 (358)
                       +.++|+|+|++ |.+|..+|.....++ ++...+..|+.||+.||.|||...  +|+|.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             45899999999 568888887655544 999999999999999999999986  59999999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=8.2e-32  Score=221.14  Aligned_cols=262  Identities=19%  Similarity=0.288  Sum_probs=194.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCC--eeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~--~~~l  112 (358)
                      ..++|++++++|+|.++.||-|.. .+++++++|+++..   ..+.+.+|+.+|+.|. +|||++++++..+..  ...+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            348999999999999999999985 46889999999643   3478899999999996 999999999998764  5679


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-CCeEEeccccceec
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAF  191 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-~~i~L~Df~~~~~~  191 (358)
                      |+||+++.+...+..      .++...++.++.++++||.|+|+.|   |.|||+||.|++++.. ..++|.|+|++...
T Consensus       113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            999999988877652      2778889999999999999999999   9999999999999854 57999999999875


Q ss_pred             CCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc------
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE------  264 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  264 (358)
                      ....   ..+....+..|-.||++.+. -|+..-|+|||||++..|+..+.||-.-  .++.+.+..+.+.+..      
T Consensus       184 Hp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG--~dN~DQLVkIakVLGt~el~~Y  258 (338)
T KOG0668|consen  184 HPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVKIAKVLGTDELYAY  258 (338)
T ss_pred             CCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC--CCCHHHHHHHHHHhChHHHHHH
Confidence            3221   22222344557799988764 6789999999999999999999996432  2222222222111111      


Q ss_pred             -----------------CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          265 -----------------GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       265 -----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                       ......+.........--...+.++++.+.|.+|-.+|+|+.|...+....
T Consensus       259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence                             111111111111111111123456788899999999999999999876554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.4e-30  Score=245.21  Aligned_cols=272  Identities=19%  Similarity=0.214  Sum_probs=180.3

Q ss_pred             HhcCCCCcceeecccCCccEEEEEE-----------------cCCCEEEEEEecccChhhHHHH--------------HH
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTL-----------------VDGQEIAVKRLSKISEQGLKEL--------------KN   84 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~-----------------~~~~~v~vK~~~~~~~~~~~~~--------------~~   84 (358)
                      ...++|++.++||+|+||.||+|.+                 ..++.|+||.+..........+              ..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3467999999999999999999964                 2356799999865433222222              23


Q ss_pred             HHHHHHhcCCCC-----ccceeeEEEe--------CCeeEEEEEecCCCCHHHHHhcccc--------------------
Q 018304           85 EVILFSKLQHRN-----LVKLLGCCIQ--------GEEKLLIYEFMTNKSLDSFIFDQER--------------------  131 (358)
Q Consensus        85 e~~~l~~l~~~~-----iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------  131 (358)
                      |+.++.+++|.+     +++++++|..        ....++||||+.+++|.+++.....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            555666665544     3566666643        3467999999999999998854211                    


Q ss_pred             -ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCC
Q 018304          132 -CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM  210 (358)
Q Consensus       132 -~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~  210 (358)
                       ...+++..++.++.|++.+|.|||+.+   ++|+||||.||+++.++.++|+|||++........ .......+++.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCccee
Confidence             112456788899999999999999999   99999999999999999999999999865422111 1111223478999


Q ss_pred             CcccccCCC--------------------C--CCcccchhHhHHHHHHHhCCC-CCCCCCCCC-CchhHHHHHHHhhcCC
Q 018304          211 APEYASDGQ--------------------F--SVKSDVFSFGILLLEIISGKK-NRGFYHSDN-NLNLIGHAWKLWNEGM  266 (358)
Q Consensus       211 aPE~~~~~~--------------------~--~~~~DiwslG~il~~l~~g~~-p~~~~~~~~-~~~~~~~~~~~~~~~~  266 (358)
                      |||.+....                    +  ..+.||||+||++++|++|.. ||....... ...........|+...
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            999875321                    1  234799999999999999875 543211110 0000001111111111


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCC---CCCCChHHHHHHhccCC
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHP---KDRPSMPSVILMLGSET  316 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~Rpt~~ell~~l~~~~  316 (358)
                      .... +    ............+|+.+||..+|   .+|+|+.++++|.+...
T Consensus       458 ~~~~-~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        458 GQKY-D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccCC-C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            0000 0    00111122356678999999766   68999999999988754

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=232.16  Aligned_cols=267  Identities=22%  Similarity=0.337  Sum_probs=212.5

Q ss_pred             eHHHHHHhcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceee
Q 018304           30 ELATIVSATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLG  102 (358)
Q Consensus        30 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~  102 (358)
                      .++++.....|++....+-+|.||.||.|.+.+      .+.|.+|.++. .++-....+..|.-.+..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            367888889999999999999999999996533      34677777754 33345667788888999999999999999


Q ss_pred             EEEe-CCeeEEEEEecCCCCHHHHHh-----ccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC
Q 018304          103 CCIQ-GEEKLLIYEFMTNKSLDSFIF-----DQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ  176 (358)
Q Consensus       103 ~~~~-~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~  176 (358)
                      +... .+..++++++..-|+|..|+.     +....+.++...+..++.|++.|+++||+++   ++|.||...|.++++
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            8765 457789999999899999997     4445556888889999999999999999999   999999999999999


Q ss_pred             CCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhH
Q 018304          177 DMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLI  255 (358)
Q Consensus       177 ~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~  255 (358)
                      ..++||+|=.+++.+-..++.+....--....|++||.+.+..|+.++|+||||+++|||++ |+.|+..-++   .++.
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---fEm~  508 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---FEME  508 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---HHHH
Confidence            99999999998887654444444444445678999999999999999999999999999999 8888654333   3333


Q ss_pred             HHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          256 GHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .....+.+-..+..             ...++..++.-||...|++||++.++..-|.+.
T Consensus       509 ~ylkdGyRlaQP~N-------------CPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  509 HYLKDGYRLAQPFN-------------CPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHHhccceecCCCC-------------CcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            33333332222222             223567788899999999999999999877653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=254.42  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=187.7

Q ss_pred             CCcceeecccCCcc-EEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEecC
Q 018304           41 FSINKKLGQGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        41 y~i~~~lg~g~~g~-v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      |.-.+++|.|..|+ ||+|.. +|+.||||++-.   .-...+.+|+..|+.. +||||+++++.=.+....|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            33345788999874 599987 899999998853   3445677999999999 69999999998888889999999997


Q ss_pred             CCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---C--CCeEEeccccceecC
Q 018304          119 NKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---D--MNPKISDFGLARAFG  192 (358)
Q Consensus       119 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~--~~i~L~Df~~~~~~~  192 (358)
                      . +|.+++... ...........+..+.|+++||++||+.+   |+||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6 999999663 11111222456788999999999999999   999999999999975   3  469999999999886


Q ss_pred             CCCCCC-ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhC-CCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          193 GDETEG-NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG-KKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       193 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ...... ......|+.+|.|||++.....+.+.||||+||++|+.++| .+||+..-..+.. +       ......-..
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-I-------l~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-I-------LTGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-h-------hcCccceee
Confidence            544332 23345689999999999988888899999999999998885 8998753322110 0       001111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      +.+       ..+. ...+||.+|+.++|..||++.+|+.+.
T Consensus       735 L~~-------~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~HP  768 (903)
T KOG1027|consen  735 LEP-------LPDC-EAKDLISRMLNPDPQLRPSATDVLNHP  768 (903)
T ss_pred             ecc-------CchH-HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence            111       1101 445799999999999999999999764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=244.96  Aligned_cols=196  Identities=27%  Similarity=0.410  Sum_probs=169.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--------hhhHHHHHHHHHHHHhcC---CCCccceeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---HRNLVKLLGCCI  105 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~  105 (358)
                      ..+|..++.+|.|+||.|++|.++. ...|++|.+.+..        +..+..+-.|+.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3579999999999999999999865 6689999987622        222333446999999997   999999999999


Q ss_pred             eCCeeEEEEEecC-CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          106 QGEEKLLIYEFMT-NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       106 ~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                      +++.+|++||... +.+|.++|....+   +++.+...++.|++.|+++||+++   |+|||||-+||.++.+|-+||.|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence            9999999999863 5689999955444   999999999999999999999999   99999999999999999999999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCcccccCCCCC-CcccchhHhHHHHHHHhCCCCC
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIISGKKNR  243 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p~  243 (358)
                      ||.+....    ........||..|.|||++.|.+|- ..-|||++|++||.+...+.||
T Consensus       714 fgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99998753    3334467899999999999998884 5689999999999999998885

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.3e-29  Score=213.92  Aligned_cols=211  Identities=35%  Similarity=0.576  Sum_probs=181.7

Q ss_pred             ecccCCccEEEEEEcC-CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHH
Q 018304           47 LGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDS  124 (358)
Q Consensus        47 lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  124 (358)
                      ||+|.+|.||++...+ ++.+++|.+...... ....+.+|++.++.+.|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999854 899999999764332 34678899999999999999999999999899999999999899999


Q ss_pred             HHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEeccccceecCCCCCCCccccc
Q 018304          125 FIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTKRV  203 (358)
Q Consensus       125 ~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~~~~~~~~~~~~~~~~~~  203 (358)
                      ++....  ..++...++.++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+||+.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            986542  23889999999999999999999999   999999999999999 89999999999986532211  12334


Q ss_pred             cccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHH
Q 018304          204 IGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA  282 (358)
Q Consensus       204 ~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (358)
                      .+...|.+||..... .++.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            567789999988876 788999999999999999                                              


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          283 EVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       283 ~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                        ..+.+++.+|+..+|++||++.++++++
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              3566799999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-30  Score=209.02  Aligned_cols=216  Identities=25%  Similarity=0.355  Sum_probs=172.3

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~  110 (358)
                      .....++..-+..||+|++|.|-+.++ .+|.-.++|.+.. .+....++..+|+++.... .+|.++++|+........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            444456667778999999999988775 4699999999864 3445567777888876665 799999999988888899


Q ss_pred             EEEEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          111 LLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      ++.||.+. .+|+.+.... ...+.+++..+-+++..++.||.|||++-  .++|||+||.|||++.+|++|+||||.+-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999995 5888876442 44456999999999999999999999975  59999999999999999999999999998


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccC----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHH
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASD----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGH  257 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~  257 (358)
                      .+.+.   .......|--.|+|||.+..    ..|+.++||||||+++.||.+++.||+...  .+...+..
T Consensus       198 ~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkq  264 (282)
T KOG0984|consen  198 YLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQ  264 (282)
T ss_pred             eehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHH
Confidence            76322   12222446677999998853    378999999999999999999999965443  34444433

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=217.04  Aligned_cols=280  Identities=20%  Similarity=0.282  Sum_probs=204.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeE-EEeCCeeEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGC-CIQGEEKLL  112 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~-~~~~~~~~l  112 (358)
                      ...+.|.|.+.||+|.||.+-++.++. ++.+++|.+... ....+.+.+|...--.| .|.||+.-|++ |+..+.+++
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            344679999999999999999999865 778999999763 44556777888877777 48899987654 677788899


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc--CCCCeEEecccccee
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARA  190 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~--~~~~i~L~Df~~~~~  190 (358)
                      ++||++-|+|.+-+....    +.+..-.+++.|++.|+.|+|+++   ++|||||.+||||-  +..++||||||....
T Consensus       100 ~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             eeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence            999999999999885533    778888899999999999999999   99999999999995  445899999999876


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCC-----CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      .+.     ..........|.+||.....     ...+.+|+|.||+++|..++|..||.-...   .+.--+.+..|...
T Consensus       173 ~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~~Y~~~~~w~~r  244 (378)
T KOG1345|consen  173 VGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDKPYWEWEQWLKR  244 (378)
T ss_pred             cCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCchHHHHHHHhcc
Confidence            421     12222345679999976432     346789999999999999999999873222   22233444555555


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCC---CChHHHHHHhccCCCCCCCCCCCcccCCCCCCCCC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDR---PSMPSVILMLGSETVLPQPKQPGYLADRNSTRLDS  337 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---pt~~ell~~l~~~~~~~~~~~~~~~~~~~~~~~~~  337 (358)
                      ....+.+....      ....+..+.++-|..+|++|   -++......+|-.......+.+......+....+.
T Consensus       245 k~~~~P~~F~~------fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~d~~S~  313 (378)
T KOG1345|consen  245 KNPALPKKFNP------FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNIDTASK  313 (378)
T ss_pred             cCccCchhhcc------cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhccccccCCcch
Confidence            55544432222      12244557778899999999   44454455555556666666666665555554444

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=242.30  Aligned_cols=285  Identities=22%  Similarity=0.308  Sum_probs=219.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      -.++|+.+..+|+|.+|-||+++++. ++..++|+++-...+..+-+.+|+-+++..+|+||+.+++.+...+.+++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            35789999999999999999999754 88999999987777778888899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      ||.+|+|.+..   ....++++..+..+++..++++.|||+.+   -+|||||=.||++++.|.++|.|||.+..+.  .
T Consensus        93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit--a  164 (829)
T KOG0576|consen   93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT--A  164 (829)
T ss_pred             ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh--h
Confidence            99999999986   34455999999999999999999999999   9999999999999999999999999987652  3


Q ss_pred             CCCccccccccCCCCCcccc---cCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          196 TEGNTKRVIGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .....+...|++.|+|||+.   +.+.|..++|||++|++..++-...+|.   ..-.++..+....+  ....++.+.+
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl---fdlhpmr~l~LmTk--S~~qpp~lkD  239 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL---FDLHPMRALFLMTK--SGFQPPTLKD  239 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc---cccchHHHHHHhhc--cCCCCCcccC
Confidence            34455667899999999976   4568899999999999999998877771   11111111111111  1112222222


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc------------C-CCCCCCCCCCcccCCCCCCCCCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS------------E-TVLPQPKQPGYLADRNSTRLDSSS  339 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~------------~-~~~~~~~~~~~~~~~~~~~~~~~~  339 (358)
                      .-       .-...+.+|++.||..+|++|||++.+|.+---            + +..+++++-.++.+..-+......
T Consensus       240 k~-------kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  240 KT-------KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             Cc-------cchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            21       113356789999999999999999988874211            0 344555566666555544444443


Q ss_pred             CC
Q 018304          340 SR  341 (358)
Q Consensus       340 ~~  341 (358)
                      .+
T Consensus       313 ~~  314 (829)
T KOG0576|consen  313 MR  314 (829)
T ss_pred             hh
Confidence            33

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-31  Score=221.14  Aligned_cols=270  Identities=23%  Similarity=0.310  Sum_probs=193.4

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----CeeE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EEKL  111 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~~  111 (358)
                      +.+-.+.||.|+||.||.+.+. +|+.|++|.+..  .+-...+.+.+|+.+|.-.+|.|++...+...-.     ...|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3456789999999999999874 599999998865  2333456788999999999999998888765433     2457


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ++.|.+.. +|..++.....   ++...+.-+++||+.||.|||+.+   |.||||||.|.+|+++-.+|+||||+++.-
T Consensus       134 V~TELmQS-DLHKIIVSPQ~---Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQA---LTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHh-hhhheeccCCC---CCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            78888854 88888755443   788888889999999999999999   999999999999999999999999999863


Q ss_pred             CCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH------------
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA------------  258 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------  258 (358)
                      .... ......-..|..|.|||++.|. .|+.+.||||+||++.||+..+..|....+...++++-..            
T Consensus       207 e~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  207 DQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             chhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            2211 1222233567889999998875 7999999999999999999999888765554433332211            


Q ss_pred             HHHhhcCCCCcc-ccCCcCCCC----CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          259 WKLWNEGMPSQL-IDPCIQGSF----NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       259 ~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      +.+.+....+.- ..+.....+    .......-+++..++|.+||.+|.+..+.+.++..-..
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            111111100000 000000000    11112233457778999999999999999887655433

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=216.10  Aligned_cols=267  Identities=25%  Similarity=0.276  Sum_probs=195.3

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC---
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---  108 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~---  108 (358)
                      .....||.-++.+|.|+. .|..+.+. .++.|++|.+..  .+........+|...+..++|+||++++.+|.-..   
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            334578888999999998 66666653 489999998754  23344566778999999999999999999985443   


Q ss_pred             ---eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecc
Q 018304          109 ---EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF  185 (358)
Q Consensus       109 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df  185 (358)
                         ..|+|||++. .+|...+. .+    ++-.++..+++|++.|+.+||+.+   |+||||||+||++..+..+|+.||
T Consensus        92 ~~~e~y~v~e~m~-~nl~~vi~-~e----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   92 EFQEVYLVMELMD-ANLCQVIL-ME----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             HHHhHHHHHHhhh-hHHHHHHH-Hh----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccc
Confidence               5689999995 48888875 12    788899999999999999999999   999999999999999999999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH-------
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA-------  258 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------  258 (358)
                      |++..-.   ..-.......+-.|.|||++.+..|...+||||+||++.+|++|+..|...+..+....+...       
T Consensus       163 g~ar~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  163 GLARTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             hhhcccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            9997532   112333456777899999999888999999999999999999999887754322211111100       


Q ss_pred             --------HHHhhc--------CCCCccccCCcCCCC--CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          259 --------WKLWNE--------GMPSQLIDPCIQGSF--NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       259 --------~~~~~~--------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                              ...+-.        ....-+.|.......  +........+++.+||..+|++|.|+.++|.+.--
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~  313 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI  313 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence                    000000        000111111111110  11122235678999999999999999999998644

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.3e-27  Score=206.78  Aligned_cols=198  Identities=33%  Similarity=0.482  Sum_probs=171.3

Q ss_pred             CCcceeecccCCccEEEEEEcC-CCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecC
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      |.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6788999999999999999865 889999999875544 56788899999999999999999999998899999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      +++|.+++......  +++..++.++.+++.++.+||+.+   ++|+||++.||+++.++.++|+|||.+........ .
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            99999998654321  788999999999999999999999   99999999999999999999999999887643320 1


Q ss_pred             ccccccccCCCCCcccc-cCCCCCCcccchhHhHHHHHHHhCCCCCC
Q 018304          199 NTKRVIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGKKNRG  244 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~p~~  244 (358)
                      ......+...|++||.. ....++.++|+|+||+++++|++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22334567789999988 56677889999999999999999999974

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=4.4e-28  Score=215.42  Aligned_cols=271  Identities=21%  Similarity=0.341  Sum_probs=197.9

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEc----CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE  108 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~  108 (358)
                      +....+.|..+++||.|.|++||++.+.    .+..|++|.+....  ....+.+|+++|..+ -+.||+.+.+.+..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344578999999999999999999853    36789999886533  336788999999999 5899999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEecccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGL  187 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~~  187 (358)
                      +..+|+||++.....++..   .   ++...+..+++.++.||.++|.+|   |+||||||.||+.+. .++-.|+|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~---~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR---S---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHh---c---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            9999999999999999873   2   778999999999999999999999   999999999999984 57899999999


Q ss_pred             ceecCCC--------------C-----------------CC-----------CccccccccCCCCCcccccC-CCCCCcc
Q 018304          188 ARAFGGD--------------E-----------------TE-----------GNTKRVIGTYGYMAPEYASD-GQFSVKS  224 (358)
Q Consensus       188 ~~~~~~~--------------~-----------------~~-----------~~~~~~~~~~~y~aPE~~~~-~~~~~~~  224 (358)
                      +......              .                 ..           .......||++|.|||++.. +..+.+.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            8721000              0                 00           00011358999999998765 4678899


Q ss_pred             cchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH----------------HhhcCCCCc----------c-ccCCcCC
Q 018304          225 DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK----------------LWNEGMPSQ----------L-IDPCIQG  277 (358)
Q Consensus       225 DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~----------~-~~~~~~~  277 (358)
                      ||||.|+++..++++..||-....+...-.......                .|.......          + ...+...
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            999999999999999999755443322111111100                010000000          0 0001110


Q ss_pred             CCC-------HH-HHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          278 SFN-------LA-EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       278 ~~~-------~~-~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...       .+ ....+++++.+||..||.+|.|+++.|.+.-.-
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence            010       00 012578899999999999999999999875443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=6.4e-27  Score=238.26  Aligned_cols=202  Identities=19%  Similarity=0.230  Sum_probs=138.2

Q ss_pred             HhcCC-CCccceeeEE-------EeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 018304           90 SKLQH-RNLVKLLGCC-------IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR  161 (358)
Q Consensus        90 ~~l~~-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~  161 (358)
                      +.++| .||++++++|       ......++++|++ +++|.+++....  ..+++..++.++.||+.||.|||++|   
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---  100 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---  100 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            34445 4777777776       2334567788987 569999996432  34899999999999999999999999   


Q ss_pred             cccCCCCCCcEEEcCCCCe-------------------EEeccccceecCCCCC--------------CCccccccccCC
Q 018304          162 IIHRDLKASNVLLDQDMNP-------------------KISDFGLARAFGGDET--------------EGNTKRVIGTYG  208 (358)
Q Consensus       162 i~H~di~~~Nilv~~~~~i-------------------~L~Df~~~~~~~~~~~--------------~~~~~~~~~~~~  208 (358)
                      |+||||||+||||+..+.+                   +++|||++........              ........+++.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999665544                   5555555432110000              000011346788


Q ss_pred             CCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHH
Q 018304          209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCI  288 (358)
Q Consensus       209 y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  288 (358)
                      |+|||++.+..++.++|||||||++|||++|..|+....     .........   ..+...          ........
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~---~~~~~~----------~~~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR---VLPPQI----------LLNWPKEA  242 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh---hcChhh----------hhcCHHHH
Confidence            999999999999999999999999999999887743211     111111100   000000          11122345


Q ss_pred             HHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          289 HIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       289 ~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      +++.+||+.+|.+|||+.+++++.+..
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhchhhh
Confidence            788899999999999999999876543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1.1e-25  Score=188.04  Aligned_cols=169  Identities=16%  Similarity=0.129  Sum_probs=123.8

Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      |+|.+++....  ..+++..++.++.|++.||.|||+++         ||+||+++.++.+++  ||++......     
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-----   62 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-----   62 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence            58889886432  34999999999999999999999975         999999999999999  9998765321     


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSF  279 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (358)
                        ...+++.|+|||++.+..++.++|||||||++|+|++|..||......  ...............    .... ....
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~----~~~~-~~~~  133 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADD----PRDR-SNLE  133 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCC----cccc-ccHH
Confidence              125789999999999999999999999999999999999997543221  111111111111110    0000 0000


Q ss_pred             CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          280 NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       280 ~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .......+.+++.+||..+|.+|||+.+++++++..
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            011112578899999999999999999999988654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-23  Score=191.82  Aligned_cols=259  Identities=22%  Similarity=0.253  Sum_probs=190.9

Q ss_pred             CCCcceeecccCCccEEEEEEcCC--CEEEEEEecccChhhHHHHHHHHHHHHhcC----CCCccceeeEE-EeCCeeEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVDG--QEIAVKRLSKISEQGLKELKNEVILFSKLQ----HRNLVKLLGCC-IQGEEKLL  112 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~~--~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~----~~~iv~~~~~~-~~~~~~~l  112 (358)
                      +|++.+.||+|+||.||++.+...  ..+++|............+..|..++..+.    ..++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999997553  478888876543332226778888888886    26899999998 47778899


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-----CCeEEecccc
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGL  187 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-----~~i~L~Df~~  187 (358)
                      ||+.+ |.+|.++..... .+.++..+++.++.|++.+|++||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 779999875555 345999999999999999999999999   9999999999999854     3599999999


Q ss_pred             ce--ecCCCCC----CCc--cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH
Q 018304          188 AR--AFGGDET----EGN--TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       188 ~~--~~~~~~~----~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      ++  .......    ...  .....||..|+++....+...+.+.|+||++.++.++..|..||................
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            98  3211111    011  123459999999999999999999999999999999999999986554432222211111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .......         .......+.   .++...+-..+...+|....+...++..
T Consensus       254 ~~~~~~~---------~~~~~~~~~---~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  254 RKLLTDR---------FGDLKPEEF---AKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             hhhcccc---------ccCCChHHH---HHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            1110000         111122233   3334344457899999999998887655

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=7.4e-24  Score=183.22  Aligned_cols=214  Identities=20%  Similarity=0.319  Sum_probs=180.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      -+-.|++.++||+|.||..+.|.. -+++.||||.-...  ...-++..|+...+.| ..++|.+++.+...+-+..+|+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            356799999999999999999984 46999999977653  3446888999999999 5799999999888888999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-----CCeEEeccccce
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGLAR  189 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-----~~i~L~Df~~~~  189 (358)
                      |.+ |.+|.|+..-..+.  ++..+++-+|.||+.-++++|++.   +++|||||+|+||..-     ..+.++|||+++
T Consensus       104 dLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            998 67998887544433  999999999999999999999999   9999999999999633     349999999999


Q ss_pred             ecCCCCC-----CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH
Q 018304          190 AFGGDET-----EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA  258 (358)
Q Consensus       190 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  258 (358)
                      .+.+...     ....+...||.+|++-....+...+...|+-+||-++++.+.|..||.....+..-...+.+
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            8755433     23445567999999999999999999999999999999999999999987776554444333

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-23  Score=174.67  Aligned_cols=213  Identities=21%  Similarity=0.304  Sum_probs=176.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ...++|+++++||+|.||-+|+|.. .+|..||+|.-+.....  -++..|..+.+.|+ ...|+.+..++.+.....+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            4568999999999999999999985 56999999988653333  46778999999996 47888889889888999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC---CCeEEecccccee
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARA  190 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~---~~i~L~Df~~~~~  190 (358)
                      |+.+ |.+|.++.+-....  ++..+++-++-||+.-++|+|.++   ++||||||+|++..-+   .++.|+|||+++.
T Consensus        90 MdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence            9998 77999988655543  889999999999999999999999   9999999999999643   5699999999987


Q ss_pred             cCCCCC-----CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHH
Q 018304          191 FGGDET-----EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG  256 (358)
Q Consensus       191 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~  256 (358)
                      +.+...     ....+.+.||..|.+-....+...+...|+-|+|.++.++-.|..||............+
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE  234 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE  234 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence            643222     223345679999999888888888999999999999999999999998766554443333

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=3.7e-23  Score=189.31  Aligned_cols=167  Identities=20%  Similarity=0.223  Sum_probs=129.6

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEc--CCCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCccc-eeeEEE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLV--DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVK-LLGCCI  105 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~--~~~~v~vK~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~-~~~~~~  105 (358)
                      +....++|.+.+.||+|+||+||+|++.  +++.+++|.+...     .......+.+|+++|+.++|+|++. +++   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            4567789999999999999999999874  4677899986432     2234566889999999999999885 443   


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCC-CCCcEEEcCCCCeEEec
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISD  184 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di-~~~Nilv~~~~~i~L~D  184 (358)
                       ....++||||++|++|...    ..   ..   ...++.+++++|.|||+.|   |+|||| ||+||+++.++.++|+|
T Consensus        90 -~~~~~LVmE~~~G~~L~~~----~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHLA----RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             -cCCcEEEEEccCCCCHHHh----Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence             2467999999999998632    11   11   1467889999999999999   999999 99999999999999999


Q ss_pred             cccceecCCCCCCCc------cccccccCCCCCcccccC
Q 018304          185 FGLARAFGGDETEGN------TKRVIGTYGYMAPEYASD  217 (358)
Q Consensus       185 f~~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~  217 (358)
                      ||++..+........      .....+++.|.+||.+..
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999987643321111      123457788999998753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=2.6e-21  Score=176.12  Aligned_cols=262  Identities=29%  Similarity=0.380  Sum_probs=195.9

Q ss_pred             CCcceeecccCCccEEEEEEcCCCEEEEEEecccChh---hHHHHHHHHHHHHhcCCC-CccceeeEEEeCCeeEEEEEe
Q 018304           41 FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~~-~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      |.+.+.||.|.||.||++.+.  ..+++|.+......   ....+.+|+..+..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            788999999999999999885  88888988653322   366788999999999887 799999999777778999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df~~~~~~~~~~  195 (358)
                      +.++++.+++........+.......++.+++.++.++|+.+   ++|||++|+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977644321124899999999999999999999999   99999999999999888 79999999988654332


Q ss_pred             CCC----ccccccccCCCCCcccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          196 TEG----NTKRVIGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       196 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ...    ......++..|.+||.+.+   ..+....|+|++|++++++++|..||...........   ...........
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ---TLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH---HHHHHHhcCCc
Confidence            221    2356678999999999887   5788899999999999999999999655443200111   11111111111


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                      ........ .........+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCc-cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000 0002222356678889999999999999987764

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-24  Score=211.94  Aligned_cols=262  Identities=17%  Similarity=0.189  Sum_probs=187.4

Q ss_pred             eeHHHHHHhcC-CCCcceeecccCCccEEEEEEcCCCEEEEEEecccC-hhhHHHHHHHHHH--HHhcCCCCccceeeEE
Q 018304           29 FELATIVSATN-NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVIL--FSKLQHRNLVKLLGCC  104 (358)
Q Consensus        29 ~~~~~~~~~~~-~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~--l~~l~~~~iv~~~~~~  104 (358)
                      ...+.+.+... +|...+.||++.|=+|.+|++.+|. |++|++-+.. .-.+..+.+.++.  ...+++||.+.+..+.
T Consensus        12 ~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~   90 (1431)
T KOG1240|consen   12 SPVEVYFSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL   90 (1431)
T ss_pred             chHHHHhhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH
Confidence            34555555544 8999999999999999999987787 8889886533 3334444443333  4445899999998887


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                      +.+...|+|-+|... +|.|.+..   +..+...+...++.|++.|+..+|..|   |+|||||.+||||+.-.-+.|+|
T Consensus        91 ~t~kAAylvRqyvkh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtD  163 (1431)
T KOG1240|consen   91 VTDKAAYLVRQYVKH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTD  163 (1431)
T ss_pred             HhhHHHHHHHHHHhh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhc
Confidence            778888999999976 89888844   444888899999999999999999999   99999999999999999999999


Q ss_pred             cccceecCCCC-CCCccc----cccccCCCCCcccccCC----------C-CCCcccchhHhHHHHHHHh-CCCCCCCCC
Q 018304          185 FGLARAFGGDE-TEGNTK----RVIGTYGYMAPEYASDG----------Q-FSVKSDVFSFGILLLEIIS-GKKNRGFYH  247 (358)
Q Consensus       185 f~~~~~~~~~~-~~~~~~----~~~~~~~y~aPE~~~~~----------~-~~~~~DiwslG~il~~l~~-g~~p~~~~~  247 (358)
                      |...+...-.. ......    +...-.+|.|||.+...          . .+++.||||+||++.||++ |+++|....
T Consensus       164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ  243 (1431)
T KOG1240|consen  164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ  243 (1431)
T ss_pred             ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH
Confidence            99876543221 111121    22344589999987531          2 5788999999999999998 566664311


Q ss_pred             CCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          248 SDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      -      +.+....  ...+..+++.+.        ...+.++|..|++.||++|.++++.|+.-..
T Consensus       244 L------~aYr~~~--~~~~e~~Le~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  244 L------LAYRSGN--ADDPEQLLEKIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             H------HhHhccC--ccCHHHHHHhCc--------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            0      0000000  000111111111        1135679999999999999999999998443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.5e-22  Score=172.81  Aligned_cols=172  Identities=14%  Similarity=0.180  Sum_probs=133.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChh---hHHH------HHHHHHHHHhcCCCCccceeeEEEeC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ---GLKE------LKNEVILFSKLQHRNLVKLLGCCIQG  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~---~~~~------~~~e~~~l~~l~~~~iv~~~~~~~~~  107 (358)
                      ..++|++++.||.|+||.||++.. ++..+++|.+......   ....      +.+|+..+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            469999999999999999999766 6778999999642211   1122      57889999999999999999887644


Q ss_pred             --------CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC
Q 018304          108 --------EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       108 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~  179 (358)
                              ...+++|||++|.+|.++..       +++    ..+.+++.++..+|+.|   ++|||++|.||+++.+| 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999988731       332    24568999999999999   99999999999999988 


Q ss_pred             eEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh
Q 018304          180 PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS  238 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~  238 (358)
                      ++|+|||...........              ........+..++|+|+||+++..+..
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999999987653211100              003334456679999999999877654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2.6e-23  Score=202.26  Aligned_cols=259  Identities=22%  Similarity=0.249  Sum_probs=182.7

Q ss_pred             CcceeecccCCccEEEEEEcC-CCEEEEEEec-----ccChhhHHH-HHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           42 SINKKLGQGGFGPVYKGTLVD-GQEIAVKRLS-----KISEQGLKE-LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        42 ~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~-----~~~~~~~~~-~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .....+|.|++|.++...... ...+..|.+.     ......... +..|+-+-..+.|+|++.....+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            566789999999777776432 3333333221     111111111 445666667788999988777766665555559


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |||+. +|..++...   ..+....+.-++.|++.|+.|+|+.|   +.|+|+|++|++++.+|.+|++|||.+......
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99998 999988554   23888899999999999999999999   999999999999999999999999999876443


Q ss_pred             CCC--CccccccccCCCCCcccccCCCCCC-cccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETE--GNTKRVIGTYGYMAPEYASDGQFSV-KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ...  .......|...|+|||.+.+..|++ ..||||.|++++.|.+|+.||......+.....      ..........
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~~~~~  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQRNIF  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hccccccccc
Confidence            333  3344567888999999999999875 699999999999999999998776554432100      0000000000


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..  .....-........+|.+||+.+|.+|.|+.+|++--|..
T Consensus       548 ~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~  589 (601)
T KOG0590|consen  548 EG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR  589 (601)
T ss_pred             cC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence            00  0000011112456699999999999999999999865543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=6.6e-21  Score=160.52  Aligned_cols=140  Identities=19%  Similarity=0.172  Sum_probs=108.5

Q ss_pred             cceeecccCCccEEEEEEcCCCEEEEEEecccChh--h------------------------HHHHHHHHHHHHhcCCCC
Q 018304           43 INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ--G------------------------LKELKNEVILFSKLQHRN   96 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~~~~   96 (358)
                      +.+.||+|++|.||+|.+.+|+.|++|+++.....  .                        ......|++.+..+.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            35789999999999999878999999998653211  0                        112345899999998777


Q ss_pred             ccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH-hcCCCCCcccCCCCCCcEEEc
Q 018304           97 LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL-HQDSRLRIIHRDLKASNVLLD  175 (358)
Q Consensus        97 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~L-H~~~~~~i~H~di~~~Nilv~  175 (358)
                      +.....+. . ...++||||++++++.......   ..++...++.++.|++.+|.++ |+.|   ++||||||+||+++
T Consensus        81 v~~p~~~~-~-~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~  152 (190)
T cd05147          81 IPCPEPIL-L-KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH  152 (190)
T ss_pred             CCCCcEEE-e-cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence            64433322 2 2338999999987765543222   2388999999999999999999 7989   99999999999998


Q ss_pred             CCCCeEEeccccceec
Q 018304          176 QDMNPKISDFGLARAF  191 (358)
Q Consensus       176 ~~~~i~L~Df~~~~~~  191 (358)
                       ++.++|+|||++...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             578999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.1e-21  Score=162.95  Aligned_cols=249  Identities=20%  Similarity=0.326  Sum_probs=181.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++..++.+|.....|..|+|++ .|..+++|++..  ........+.+|.-.|+...||||+.+++.+....++.++..|
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            3445667899999999999999 455566676643  1222234567788889999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEE--eccccceecCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLARAFGGD  194 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L--~Df~~~~~~~~~  194 (358)
                      ++-|+|...+...... ..+.....+++.+|+.|++|||+.. +-|.--.+++..++++++.+.+|  +|-.++..    
T Consensus       269 mp~gslynvlhe~t~v-vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq----  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----  342 (448)
T ss_pred             ccchHHHHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee----
Confidence            9999999999765443 3777888999999999999999986 23344468899999998876544  44333221    


Q ss_pred             CCCCccccccccCCCCCcccccCCCC---CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQF---SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                           .......+.|++||.+...+-   -.++|+|||++++|||.|.+.||....+-+..  .......++..+++   
T Consensus       343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--mkialeglrv~ipp---  412 (448)
T KOG0195|consen  343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--MKIALEGLRVHIPP---  412 (448)
T ss_pred             -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--hhhhhccccccCCC---
Confidence                 112234678999998876543   45899999999999999999998765543211  11112222222222   


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                                .....+.+|+.-|+..||.+||.+..++-.|+.
T Consensus       413 ----------gis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  413 ----------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             ----------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence                      223356678889999999999999998877764

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=7.4e-20  Score=154.57  Aligned_cols=140  Identities=21%  Similarity=0.227  Sum_probs=109.8

Q ss_pred             cceeecccCCccEEEEEEcCCCEEEEEEecccChh--------------------------hHHHHHHHHHHHHhcCCCC
Q 018304           43 INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ--------------------------GLKELKNEVILFSKLQHRN   96 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~~~~   96 (358)
                      +.+.||+|++|.||+|.+.+|+.|++|++......                          .......|...+..+.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            46789999999999999878999999998753211                          0122357889999998888


Q ss_pred             ccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEc
Q 018304           97 LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLD  175 (358)
Q Consensus        97 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~  175 (358)
                      +.....+...  ..++||||++++++.......   ..++...+..++.+++.++.++|+ .|   ++|+||+|+||+++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~  152 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH  152 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence            7544443322  348999999887554332221   237788999999999999999999 99   99999999999998


Q ss_pred             CCCCeEEeccccceec
Q 018304          176 QDMNPKISDFGLARAF  191 (358)
Q Consensus       176 ~~~~i~L~Df~~~~~~  191 (358)
                       ++.++|+|||++..+
T Consensus       153 -~~~~~liDFG~a~~~  167 (190)
T cd05145         153 -DGKPYIIDVSQAVEL  167 (190)
T ss_pred             -CCCEEEEEcccceec
Confidence             899999999999865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=1.7e-20  Score=164.93  Aligned_cols=232  Identities=23%  Similarity=0.332  Sum_probs=144.2

Q ss_pred             CCcceeecccCCccEEEEEEcC-CCEEEEEEecc---cChhhHHHHHHHHHHHHhcC----------CCCccceeeEEE-
Q 018304           41 FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ----------HRNLVKLLGCCI-  105 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~----------~~~iv~~~~~~~-  105 (358)
                      +...+.||.|+++.||.+.+.. |+++++|++..   ......+.+++|.-....+.          |-.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4556799999999999999865 89999998753   22334555665554443322          112333333222 


Q ss_pred             --------eCC--------eeEEEEEecCCCCHHHHHhcc---cc-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccC
Q 018304          106 --------QGE--------EKLLIYEFMTNKSLDSFIFDQ---ER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR  165 (358)
Q Consensus       106 --------~~~--------~~~lv~e~~~~~~L~~~l~~~---~~-~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~  165 (358)
                              ...        ..+++|+-+. ++|.+++...   .. ...+.......+..|+++.+++||++|   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                    111        2367788774 5888876331   11 112334455667799999999999999   9999


Q ss_pred             CCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccC--------CCCCCcccchhHhHHHHHHH
Q 018304          166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD--------GQFSVKSDVFSFGILLLEII  237 (358)
Q Consensus       166 di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~  237 (358)
                      ||+|+|++++.+|.+.|+||+.....+...     .....+..|.|||....        ..++.+.|.|+||+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999877542111     11234567999997633        25688999999999999999


Q ss_pred             hCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCC
Q 018304          238 SGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDR  302 (358)
Q Consensus       238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  302 (358)
                      ++..||+..........               .+..+.      +....+..||..+|+.+|.+|
T Consensus       245 C~~lPf~~~~~~~~~~~---------------~f~~C~------~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW---------------DFSRCR------DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG---------------GGTTSS---------HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc---------------cchhcC------CcCHHHHHHHHHHccCCcccC
Confidence            99999876544322111               111111      233455679999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=3.4e-20  Score=184.48  Aligned_cols=203  Identities=21%  Similarity=0.266  Sum_probs=163.5

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCccceeeEEEeC
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQG  107 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~  107 (358)
                      ..+....+..|.|-+.||.|+||.||+|...+|+.||+|+-+..+.-+ -.+.  .+++.+|+   -+.|.++...+...
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-fYI~--~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-FYIC--LQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-eeeh--HHHHHhhchhhhcchHHHHHHHccC
Confidence            456667778999999999999999999998789999999876533221 1111  12233333   34566666666667


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-------CCCe
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-------DMNP  180 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-------~~~i  180 (358)
                      +..++|++|.+.|+|.++++   ..+.+++..+..+..||+..++.||..+   ||||||||+|+++..       ..-+
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence            88899999999999999997   3444999999999999999999999999   999999999999942       2359


Q ss_pred             EEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 018304          181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKN  242 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  242 (358)
                      +|+|||.+.-+............+.+-.+--+|...|.+|+...|.|+|+.+++.|+.|+.-
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99999998776544444455566788889999999999999999999999999999999865

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=8e-20  Score=161.91  Aligned_cols=196  Identities=21%  Similarity=0.279  Sum_probs=138.3

Q ss_pred             CCCCccceeeEEEeC---------------------------CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHH
Q 018304           93 QHRNLVKLLGCCIQG---------------------------EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC  145 (358)
Q Consensus        93 ~~~~iv~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~  145 (358)
                      .||||+++...|.+.                           .++|+||.-.+. +|.+++..+.    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            599999999877432                           245888887765 8999885544    66777888999


Q ss_pred             HHHHHHHHHhcCCCCCcccCCCCCCcEEEc--CCC--CeEEeccccceecCCC----CCCCccccccccCCCCCcccccC
Q 018304          146 GTARGVMYLHQDSRLRIIHRDLKASNVLLD--QDM--NPKISDFGLARAFGGD----ETEGNTKRVIGTYGYMAPEYASD  217 (358)
Q Consensus       146 ~i~~al~~LH~~~~~~i~H~di~~~Nilv~--~~~--~i~L~Df~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~  217 (358)
                      |+++|+.|||.+|   +.|||+|++||++.  +|+  .++++|||++-.-...    ......-...|+...+|||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   99999999999995  333  4899999997643211    11112223346778899998754


Q ss_pred             CC------CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHH
Q 018304          218 GQ------FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIG  291 (358)
Q Consensus       218 ~~------~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  291 (358)
                      .+      .-.|+|.|+.|.+.||+++...||=  ..++..-..    ..+.+...+.+.+....         .+.+++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY--~rGem~L~~----r~Yqe~qLPalp~~vpp---------~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY--KRGEMLLDT----RTYQESQLPALPSRVPP---------VARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCccc--ccchheech----hhhhhhhCCCCcccCCh---------HHHHHH
Confidence            22      2358999999999999999999962  222211111    11334445555544433         456788


Q ss_pred             hhhcCCCCCCCCChHHHHHH
Q 018304          292 LLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       292 ~~cl~~~P~~Rpt~~ell~~  311 (358)
                      ...|+.||++|++..=....
T Consensus       491 ~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHHhcCCccccCCccHHHhH
Confidence            89999999999996544433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.4e-19  Score=168.92  Aligned_cols=217  Identities=24%  Similarity=0.358  Sum_probs=162.5

Q ss_pred             HHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-ccCCC
Q 018304           89 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI-IHRDL  167 (358)
Q Consensus        89 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i-~H~di  167 (358)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.+...  .+++.....+++.|++|+.|||...   | +|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence            4678899999999999999999999999999999999977332  2889999999999999999999998   6 99999


Q ss_pred             CCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCC-------CCCCcccchhHhHHHHHHHhCC
Q 018304          168 KASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIISGK  240 (358)
Q Consensus       168 ~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~~l~~g~  240 (358)
                      ++.|.+++..+.+||.|||+.................-...|.|||.+++.       ..+.++||||+|++++++++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998765321111111122244579999998763       1467899999999999999999


Q ss_pred             CCCCCCCCCCCc-hhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          241 KNRGFYHSDNNL-NLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       241 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .||+........ ..+..+.........+.+...    .   .....++.++.+||..+|.+||++..+-..+.....
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~----~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELL----N---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcchhhh----h---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            998875444332 233232221111111111111    0   111257789999999999999999999988766543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=2.4e-18  Score=144.03  Aligned_cols=185  Identities=16%  Similarity=0.151  Sum_probs=137.4

Q ss_pred             CCcceeecccCCccEEEEEEcCCCEEEEEEecccChh----hHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEE
Q 018304           41 FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~----~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .-+...|++|+||+|+.+.. ++.+++.+.+.....-    ....+.+|+++|+++. ++++++++++    +..+++||
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            34678999999999997765 7889998877653321    1124778999999995 5889999886    34689999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCC-CCCcEEEcCCCCeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di-~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |+.|.+|.....         .. ...++.+++.++.++|++|   |+|+|| +|.||+++.++.++|+|||++......
T Consensus        79 yI~G~~L~~~~~---------~~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         79 YLAGAAMYQRPP---------RG-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             eecCccHHhhhh---------hh-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999988865431         11 1357789999999999999   999999 799999999999999999999864322


Q ss_pred             CCCC---c--------cccccccCCCCCcccccCC-CCC-CcccchhHhHHHHHHHhCCCCC
Q 018304          195 ETEG---N--------TKRVIGTYGYMAPEYASDG-QFS-VKSDVFSFGILLLEIISGKKNR  243 (358)
Q Consensus       195 ~~~~---~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~DiwslG~il~~l~~g~~p~  243 (358)
                      ....   .        .-....++.++.|+...-. ..+ ...+.++-|+-+|.++|+..+.
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            2100   0        0012356778888754322 223 5678889999999999998773

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=5.1e-20  Score=172.17  Aligned_cols=232  Identities=26%  Similarity=0.283  Sum_probs=174.6

Q ss_pred             eecccCCccEEEEEE----cCCCEEEEEEecccChh--hHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEEecC
Q 018304           46 KLGQGGFGPVYKGTL----VDGQEIAVKRLSKISEQ--GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~----~~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      .+|.|.+|.|+++..    ..+.-+++|...+....  .......|..++...+ ||.++++...|..+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999998753    23677888877652211  1114557888888886 9999999999999999999999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCC
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG  198 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~  198 (358)
                      ++.+...+....   .+.+.....+...++-+++.+|+.+   ++|+|+|++||+++.+|.+++.|||.++..-.     
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~-----  149 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-----  149 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh-----
Confidence            988877764433   3778888888999999999999999   99999999999999999999999999876421     


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS  278 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (358)
                       .+..+|+..|+|||+++  ....++|.||+|+++++|++|..||..       +....+.+.  .-..+          
T Consensus       150 -~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~--~~~~p----------  207 (612)
T KOG0603|consen  150 -EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKA--ELEMP----------  207 (612)
T ss_pred             -hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhh--ccCCc----------
Confidence             11228899999999988  557789999999999999999999875       222111110  01111          


Q ss_pred             CCHHHHHHHHHHHhhhcCCCCCCCCCh--HHHHHHh
Q 018304          279 FNLAEVIRCIHIGLLCVQQHPKDRPSM--PSVILML  312 (358)
Q Consensus       279 ~~~~~~~~l~~li~~cl~~~P~~Rpt~--~ell~~l  312 (358)
                        ........+++..++..+|.+|.-.  ..+.+..
T Consensus       208 --~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  208 --RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             --hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence              1112233457888999999999665  3444433

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=2e-18  Score=146.90  Aligned_cols=136  Identities=19%  Similarity=0.315  Sum_probs=105.1

Q ss_pred             CcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-----CCCCccceeeEEEeCC---eeE-E
Q 018304           42 SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLLGCCIQGE---EKL-L  112 (358)
Q Consensus        42 ~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~~~~~---~~~-l  112 (358)
                      .-.+.||+|++|.||.  +......+||++..........+.+|+.+++.+     +||||++++++++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3357899999999996  433333368888654444557789999999999     5799999999999874   333 7


Q ss_pred             EEEe--cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHH-HHHhcCCCCCcccCCCCCCcEEEcC----CCCeEEec-
Q 018304          113 IYEF--MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV-MYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISD-  184 (358)
Q Consensus       113 v~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al-~~LH~~~~~~i~H~di~~~Nilv~~----~~~i~L~D-  184 (358)
                      |+||  +.+++|.+++.+..    +++.  ..++.+++.++ .|||+++   |+|+||||+||+++.    +++++|+| 
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  55789999995421    5555  35677888777 9999999   999999999999973    34799999 


Q ss_pred             cccc
Q 018304          185 FGLA  188 (358)
Q Consensus       185 f~~~  188 (358)
                      ||..
T Consensus       154 ~G~~  157 (210)
T PRK10345        154 IGES  157 (210)
T ss_pred             CCCc
Confidence            5543

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=3.6e-18  Score=148.76  Aligned_cols=164  Identities=18%  Similarity=0.133  Sum_probs=121.2

Q ss_pred             cccccCCCCccee-HHHHHHhc--CCCCcceeecccCCccEEEEE--EcCCCEEEEEEecccChh---------------
Q 018304           18 QIQNIDLELPLFE-LATIVSAT--NNFSINKKLGQGGFGPVYKGT--LVDGQEIAVKRLSKISEQ---------------   77 (358)
Q Consensus        18 ~~~~~~~~~~~~~-~~~~~~~~--~~y~i~~~lg~g~~g~v~~~~--~~~~~~v~vK~~~~~~~~---------------   77 (358)
                      .+.|..++++-++ ++...-..  --|.+.+.||.|++|.||+|.  ..+|+.|++|.+......               
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~   83 (237)
T smart00090        4 DRATYEEVLDGRTRLALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFK   83 (237)
T ss_pred             cceehhhccChHHHHHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhc
Confidence            3456666666665 33333333  459999999999999999998  456999999998643210               


Q ss_pred             ---------hHHHHHHHHHHHHhcCCC--CccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHH
Q 018304           78 ---------GLKELKNEVILFSKLQHR--NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG  146 (358)
Q Consensus        78 ---------~~~~~~~e~~~l~~l~~~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~  146 (358)
                               ....+..|+..+..+.+.  .+++++..   . ..++||||+++.+|..+....   .......+..++.|
T Consensus        84 ~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~q  156 (237)
T smart00090       84 YRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDD  156 (237)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc---CCcchHHHHHHHHH
Confidence                     112356799999999653  34444432   2 358999999998887654222   22566677899999


Q ss_pred             HHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       147 i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ++.++.+||+.|  .++|+||+|+||+++ ++.++|+|||.+...
T Consensus       157 i~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      157 ILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             HHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999986  499999999999998 889999999998753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=5.3e-19  Score=162.36  Aligned_cols=174  Identities=25%  Similarity=0.385  Sum_probs=130.9

Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      .+++.|++|...+|.+|+.........+....+.++.|++.|+.|   ++   .+|+|++|.||++..+..++|+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999876666668899999999999999999   77   999999999999999999999999998


Q ss_pred             eecCCCC----CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          189 RAFGGDE----TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       189 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      .......    ....+....|+..|++||++.+..|+.++|||+||++|++|+. -..+|+         .... ...++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t-~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIAT-LTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHh-hhhhh
Confidence            7654322    1224455679999999999999999999999999999999998 222211         1111 11111


Q ss_pred             cCCCC-ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHH
Q 018304          264 EGMPS-QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV  308 (358)
Q Consensus       264 ~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  308 (358)
                      .+..+ .++...     +     .-..|+.+++...|.+||++.+.
T Consensus       474 ~g~ip~~~~~d~-----p-----~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  474 DGIIPPEFLQDY-----P-----EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             cCCCChHHhhcC-----c-----HHHHHHHHhcCCCcccCchHHHH
Confidence            22221 222111     1     12357889999999999955444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=3.2e-17  Score=140.94  Aligned_cols=135  Identities=21%  Similarity=0.285  Sum_probs=112.5

Q ss_pred             ceeecccCCccEEEEEEcCCCEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           44 NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE--------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++.||+|++|.||+|.+ .|..+++|.......        .....+.+|+..+..+.|+++.....++.+.+..+++||
T Consensus         1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            36799999999999987 778899997643211        112356789999999999998877777777788899999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      |++|++|.+++....      . ....++.+++.++.++|+.+   ++|+|++|.||+++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999884321      2 77899999999999999999   99999999999998 78999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=1.1e-16  Score=136.30  Aligned_cols=145  Identities=19%  Similarity=0.197  Sum_probs=113.4

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChh----------------------hHHHHHHHHHH
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ----------------------GLKELKNEVIL   88 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~----------------------~~~~~~~e~~~   88 (358)
                      ..++...+.-|.+.+.||+|++|.||++...+|+.|++|++......                      .......|+..
T Consensus         7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            45666666679999999999999999998878999999987542200                      11225578888


Q ss_pred             HHhcCCC--CccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCC
Q 018304           89 FSKLQHR--NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRD  166 (358)
Q Consensus        89 l~~l~~~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~d  166 (358)
                      +..+.++  .++..++    ....+++|||+++++|.++..         ......++.+++.++.++|+.+   ++|+|
T Consensus        87 l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~D  150 (198)
T cd05144          87 LKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGD  150 (198)
T ss_pred             HHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence            8888776  3444443    245589999999999876532         1234678899999999999999   99999


Q ss_pred             CCCCcEEEcCCCCeEEeccccceec
Q 018304          167 LKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       167 i~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      |+|.||+++.++.++|+|||.+...
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.72  E-value=4.5e-18  Score=166.94  Aligned_cols=212  Identities=23%  Similarity=0.276  Sum_probs=144.0

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .....+|..++.|..|++|.||+++++. .+.+++| +.+++-     +.+-  ++....+|.+               |
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfv---------------v  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFV---------------V  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCcce---------------e
Confidence            3455799999999999999999998865 7788884 433221     1110  2222223332               2


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                            |+=...+   +..+.++..        ++.+++|||+.+   |+|+|++|+|.+|+.-|++|++|||+++....
T Consensus       136 ------gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 ------GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             ------chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                  1222222   222224432        278999999999   99999999999999999999999999765311


Q ss_pred             CCC-------------CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH
Q 018304          194 DET-------------EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       194 ~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  260 (358)
                      ...             ....+..++|+.|.|||++.-+.|....|+|++|+|+|+.+.|+.||....+.+-+..+..-..
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            100             1112235799999999999888999999999999999999999999877655544444333333


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP  303 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  303 (358)
                      .|.+.....           .   .+..++|.+.|+.+|..|-
T Consensus       276 ~wpE~dea~-----------p---~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  276 EWPEEDEAL-----------P---PEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cccccCcCC-----------C---HHHHHHHHHHHHhChHhhc
Confidence            343331111           1   1344678889999999994

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=8.2e-17  Score=137.07  Aligned_cols=130  Identities=23%  Similarity=0.340  Sum_probs=105.7

Q ss_pred             eecccCCccEEEEEEcCCCEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           46 KLGQGGFGPVYKGTLVDGQEIAVKRLSKISE--------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .||+|++|.||+|.+ .+..+++|.......        .....+.+|++++..+.++++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            479999999999986 678899998643211        11355678999999998887665555566677789999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      +|++|.+++....    .      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.+++.|||.+..
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998874321    1      78999999999999999   99999999999998 89999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=1.9e-16  Score=154.58  Aligned_cols=144  Identities=20%  Similarity=0.277  Sum_probs=114.2

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEe-ccc-C------hhhHHHHHHHHHHHHhcCCCCccceee
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRL-SKI-S------EQGLKELKNEVILFSKLQHRNLVKLLG  102 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~-~~~-~------~~~~~~~~~e~~~l~~l~~~~iv~~~~  102 (358)
                      +.........|...+.||+|++|.||++.+... .+++|.. .+. .      ......+.+|+++++.++|++++....
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            333344445667789999999999999987443 3444432 211 1      112355778999999999999988877


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                      +..+....++||||+++++|.+++.           ....++.+++.++.+||+.+   ++||||+|.||++ .++.++|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence            7777778899999999999999873           34678999999999999999   9999999999999 6789999


Q ss_pred             ecccccee
Q 018304          183 SDFGLARA  190 (358)
Q Consensus       183 ~Df~~~~~  190 (358)
                      +|||++..
T Consensus       469 iDFGla~~  476 (535)
T PRK09605        469 IDFGLGKY  476 (535)
T ss_pred             EeCccccc
Confidence            99999865

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=4.6e-15  Score=119.93  Aligned_cols=135  Identities=22%  Similarity=0.193  Sum_probs=112.3

Q ss_pred             cceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC--CCccceeeEEEeCCeeEEEEEecCCC
Q 018304           43 INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      +++.||.|.++.||++.. ++..+++|.......  ...+..|+..++.+++  .++++++.++...+..+++|||+.+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGT-KDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEe-cCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            568899999999999987 447899998865433  4567889999999975  58999998888778899999999887


Q ss_pred             CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      .+..+          +......++.++++++..+|.....+++|+|++|.||++++.+.+++.||+.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76543          4456677889999999999996433499999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=3.8e-15  Score=125.49  Aligned_cols=136  Identities=21%  Similarity=0.238  Sum_probs=97.4

Q ss_pred             cceeecccCCccEEEEEEcCCCEEEEEEecccChh--hHHH----------------------HHHHHHHHHhcCCC--C
Q 018304           43 INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ--GLKE----------------------LKNEVILFSKLQHR--N   96 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~~~--~   96 (358)
                      +.+.||+|++|.||+|.+.+++.|++|++......  ....                      ...|...+..+.+.  .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            35789999999999999877999999988642211  0011                      13455556565433  3


Q ss_pred             ccceeeEEEeCCeeEEEEEecCCCCHHHH-HhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEE
Q 018304           97 LVKLLGCCIQGEEKLLIYEFMTNKSLDSF-IFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLL  174 (358)
Q Consensus        97 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv  174 (358)
                      +.+++..    ...+++|||++++.+... +....    . ......++.+++.++.++|. .+   ++|+||+|+||++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili  148 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV  148 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh----h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence            4444443    246899999998543211 11101    1 15678899999999999999 88   9999999999999


Q ss_pred             cCCCCeEEeccccceec
Q 018304          175 DQDMNPKISDFGLARAF  191 (358)
Q Consensus       175 ~~~~~i~L~Df~~~~~~  191 (358)
                      + ++.++|+|||.+...
T Consensus       149 ~-~~~~~liDfg~a~~~  164 (187)
T cd05119         149 D-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             E-CCcEEEEECcccccc
Confidence            9 899999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=5.1e-17  Score=158.48  Aligned_cols=264  Identities=23%  Similarity=0.290  Sum_probs=193.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC--CCEEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD--GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~--~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~  111 (358)
                      ....|.+.+.||+|.++.|-......  ...+++|.+....  ......+..|..+-+.+. |.|++++++...+.+..+
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            35788999999999999998887533  4456666665433  333444555777767776 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHh-cCCCCCcccCCCCCCcEEEcCCC-CeEEeccccce
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH-QDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLAR  189 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH-~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df~~~~  189 (358)
                      ++.+|..++++.+.+.. ......+....-.++.|+..++.|+| ..+   +.|+||+|+|.+++..+ .+++.|||++.
T Consensus        98 ~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999999888732 12112666777789999999999999 888   99999999999999999 99999999999


Q ss_pred             ecCC-CCCCCccccccc-cCCCCCcccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          190 AFGG-DETEGNTKRVIG-TYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       190 ~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      .+.. ..........+| ++.|.|||...+.. .....|+||.|+++..+++|..|+...........      .|....
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~------~~~~~~  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS------SWKSNK  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce------eecccc
Confidence            8765 444444455667 99999999988754 46789999999999999999999776554431111      011111


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ...  ......    .......+++.+++..+|..|.+.+++-..-+...
T Consensus       248 ~~~--~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  248 GRF--TQLPWN----SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccc--ccCccc----cCChhhhhcccccccCCchhccccccccccccccc
Confidence            000  000000    01113446778899999999999998876544443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=1.2e-14  Score=126.78  Aligned_cols=134  Identities=17%  Similarity=0.217  Sum_probs=103.0

Q ss_pred             eeec-ccCCccEEEEEEcCCCEEEEEEecccC-------------hhhHHHHHHHHHHHHhcCCCCc--cceeeEEEeCC
Q 018304           45 KKLG-QGGFGPVYKGTLVDGQEIAVKRLSKIS-------------EQGLKELKNEVILFSKLQHRNL--VKLLGCCIQGE  108 (358)
Q Consensus        45 ~~lg-~g~~g~v~~~~~~~~~~v~vK~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i--v~~~~~~~~~~  108 (358)
                      ..|| .|+.|+||.+.. ++..+++|.+....             ......+.+|++++..+.|++|  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4676 888999999877 57888988774311             1223456789999999988774  66776644332


Q ss_pred             ----eeEEEEEecCC-CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEe
Q 018304          109 ----EKLLIYEFMTN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS  183 (358)
Q Consensus       109 ----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~  183 (358)
                          ..++|||++++ .+|.+++...    .++..    .+.+++.++.+||+.|   |+|+||+|.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 6898887432    24443    3568999999999999   9999999999999998999999


Q ss_pred             cccccee
Q 018304          184 DFGLARA  190 (358)
Q Consensus       184 Df~~~~~  190 (358)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998875

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=2.9e-15  Score=130.27  Aligned_cols=207  Identities=19%  Similarity=0.221  Sum_probs=143.0

Q ss_pred             HHHHHhcCCCCccceeeEEEeCC-----eeEEEEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 018304           86 VILFSKLQHRNLVKLLGCCIQGE-----EKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSR  159 (358)
Q Consensus        86 ~~~l~~l~~~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~  159 (358)
                      ..-+.++.|.||+++..|+.+..     ...++.||+..|++..++.+. +..+.+......+|+.||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            34555667999999988875543     468999999999999999764 34456888999999999999999999985 


Q ss_pred             CCcccCCCCCCcEEEcCCCCeEEeccccceecC--CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHH
Q 018304          160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFG--GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII  237 (358)
Q Consensus       160 ~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~--~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~  237 (358)
                      +.++|+++..+.|++..+|-+|++--.-...-.  ............+.++|.+||.-...+.+-++|||++|+...+|.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            789999999999999988888886422111100  000001111234678999999766667788999999999999999


Q ss_pred             hCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHh
Q 018304          238 SGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML  312 (358)
Q Consensus       238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l  312 (358)
                      -+..--.......  .....+.     .....+-+....            .++.+|++..|..||++.+++.+.
T Consensus       277 ilEiq~tnseS~~--~~ee~ia-----~~i~~len~lqr------------~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESKV--EVEENIA-----NVIIGLENGLQR------------GSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCccee--ehhhhhh-----hheeeccCcccc------------CcCcccccCCCCCCcchhhhhcCc
Confidence            8875422222111  1100000     001111111111            467789999999999999998765

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.54  E-value=1.5e-13  Score=130.19  Aligned_cols=167  Identities=17%  Similarity=0.245  Sum_probs=130.1

Q ss_pred             EcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHH
Q 018304           60 LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSK  139 (358)
Q Consensus        60 ~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  139 (358)
                      ..++.+|.|+..+..+......+.+-++.|+.++||||+++++.++.+.+.|+|+|-+.  .|..++.+      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34588899988877666556778889999999999999999999999999999999884  67777743      44777


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCC
Q 018304          140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ  219 (358)
Q Consensus       140 ~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  219 (358)
                      +..-++||+.||.+||+.+  .++|++|+...|+|+..|..+|++|..+........  ..........|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            8888999999999998554  399999999999999999999999998865422111  111222233566776543222


Q ss_pred             CCCcccchhHhHHHHHHHhCC
Q 018304          220 FSVKSDVFSFGILLLEIISGK  240 (358)
Q Consensus       220 ~~~~~DiwslG~il~~l~~g~  240 (358)
                        -..|.|.|||++++++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3569999999999999994

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.40  E-value=2.8e-12  Score=121.49  Aligned_cols=139  Identities=27%  Similarity=0.326  Sum_probs=94.7

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccChhhHH----------------------------------------HHHH
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK----------------------------------------ELKN   84 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~----------------------------------------~~~~   84 (358)
                      +.||+|+.|.||+|+.++|+.|+||+..........                                        .+..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            579999999999999989999999998542211100                                        0223


Q ss_pred             HHHHHHhc----CCCCccceeeEE-EeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHH-HHHHHhcCC
Q 018304           85 EVILFSKL----QHRNLVKLLGCC-IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR-GVMYLHQDS  158 (358)
Q Consensus        85 e~~~l~~l----~~~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~-al~~LH~~~  158 (358)
                      |+..+..+    ++.+-+.+-.++ ...+..++||||++|.+|.++...... . .+   ...++..++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~-~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-G-LD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-C-CC---HHHHHHHHHHHHHHHHHhCC
Confidence            33333333    122222222222 223457899999999999887643211 1 22   2345555555 477889999


Q ss_pred             CCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       159 ~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                         ++|+|++|.||+++.+++++++|||++..+
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence               999999999999999999999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=4.2e-13  Score=125.94  Aligned_cols=252  Identities=22%  Similarity=0.286  Sum_probs=181.2

Q ss_pred             HhcCCCCcceeecc--cCCccEEEEEE--c-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC
Q 018304           36 SATNNFSINKKLGQ--GGFGPVYKGTL--V-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG  107 (358)
Q Consensus        36 ~~~~~y~i~~~lg~--g~~g~v~~~~~--~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~  107 (358)
                      .....+-+.+.+|.  |.+|.+|.+..  . ++..+++|.-+.  ........-.+++...+.+ .|++.++.+..++..
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence            34467888899999  99999999975  2 377888887332  2222223334566666677 489999988999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHH----HHHHHhcCCCCCcccCCCCCCcEEEcCC-CCeEE
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR----GVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKI  182 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~----al~~LH~~~~~~i~H~di~~~Nilv~~~-~~i~L  182 (358)
                      +..++-.|++. .+|..+......  .++...++..+.+...    |+.++|+.+   ++|.|++|.||+...+ ...++
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence            99999999995 688877754333  3888899999999999    999999999   9999999999999999 88999


Q ss_pred             eccccceecCCCCCCC---ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH
Q 018304          183 SDFGLARAFGGDETEG---NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      +||++...+.......   ......+...|++||... +.++.++|+|++|.+..+-..+..+........        |
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W  335 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------W  335 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------c
Confidence            9999998876544222   122335778899999765 567889999999999999888876643321110        0


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHH
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL  310 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  310 (358)
                      ...+.   ..     ....+...-..++...+..|++.+|-.|++...+..
T Consensus       336 ~~~r~---~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 SQLRQ---GY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccc---cc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            00000   00     111111111223444777899999999999887764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.38  E-value=3.8e-12  Score=105.28  Aligned_cols=131  Identities=23%  Similarity=0.149  Sum_probs=96.8

Q ss_pred             ceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           44 NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      ++.|+.|.++.||++.. .+..|++|....... .......|+..++.+.+.+ +++++.+.  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            46789999999999987 578899998755322 2234568899999886544 34555443  3346899999999887


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC--CCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      .+.    .    ..   ....+.++++++..||..+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        79 ~~~----~----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            543    0    11   1245678999999999987  11249999999999998 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.33  E-value=3.4e-11  Score=100.82  Aligned_cols=137  Identities=16%  Similarity=0.126  Sum_probs=99.5

Q ss_pred             cceeecccCCccEEEEEEcC-------CCEEEEEEecc-------------cC---------hhhHHH----HHHHHHHH
Q 018304           43 INKKLGQGGFGPVYKGTLVD-------GQEIAVKRLSK-------------IS---------EQGLKE----LKNEVILF   89 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~-------~~~v~vK~~~~-------------~~---------~~~~~~----~~~e~~~l   89 (358)
                      +...||.|-.+.||.|...+       +..+|+|+.+.             .+         ......    ..+|+..|
T Consensus         1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L   80 (197)
T cd05146           1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL   80 (197)
T ss_pred             CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence            35679999999999997543       47899997641             00         111222    33899999


Q ss_pred             HhcCC--CCccceeeEEEeCCeeEEEEEecCCCCHHH-HHhccccccCCCHHHHHHHHHHHHHHHHHH-hcCCCCCcccC
Q 018304           90 SKLQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDS-FIFDQERCKILDWSKRFHIICGTARGVMYL-HQDSRLRIIHR  165 (358)
Q Consensus        90 ~~l~~--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~i~~al~~L-H~~~~~~i~H~  165 (358)
                      +++..  -++++++++    ...++||||+.+..+.. .+.+ .   .++......++.+++.++..| |..+   ++||
T Consensus        81 ~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~---~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          81 KRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-A---KLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-c---ccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            99853  466677754    46789999997643321 1211 1   145556677889999999998 8999   9999


Q ss_pred             CCCCCcEEEcCCCCeEEeccccceec
Q 018304          166 DLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       166 di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      |+++.||++. ++.+.|+||+.+...
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeC
Confidence            9999999996 578999999998765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.30  E-value=4.5e-12  Score=121.72  Aligned_cols=142  Identities=21%  Similarity=0.267  Sum_probs=90.8

Q ss_pred             CCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChh----------------------------------hHHHHHH
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQ----------------------------------GLKELKN   84 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~----------------------------------~~~~~~~   84 (358)
                      .|+. +.||+|..|.||+|+.++ |+.||||+.......                                  ....+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 789999999999999877 999999998642111                                  1111223


Q ss_pred             HHHHHHh------c----CCCCccceeeEEE-eCCeeEEEEEecCCCCHHHHHh--ccc-cccCCCHHHHHHHHHHHHHH
Q 018304           85 EVILFSK------L----QHRNLVKLLGCCI-QGEEKLLIYEFMTNKSLDSFIF--DQE-RCKILDWSKRFHIICGTARG  150 (358)
Q Consensus        85 e~~~l~~------l----~~~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~--~~~-~~~~~~~~~~~~~~~~i~~a  150 (358)
                      |++..+.      +    .+.+.+.+-.++. .....++||||++|+.+.++-.  ... ..+.+.+..+..++.|+   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence            3332222      2    1222222222222 1345679999999999987531  111 11113333344444444   


Q ss_pred             HHHHhcCCCCCcccCCCCCCcEEEcCCC----CeEEeccccceecC
Q 018304          151 VMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGLARAFG  192 (358)
Q Consensus       151 l~~LH~~~~~~i~H~di~~~Nilv~~~~----~i~L~Df~~~~~~~  192 (358)
                          ...|   ++|+|++|.||+++.+|    ++++.|||+...+.
T Consensus       277 ----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                3577   99999999999999888    99999999987763

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=9.9e-11  Score=94.64  Aligned_cols=143  Identities=24%  Similarity=0.300  Sum_probs=110.8

Q ss_pred             cceeecccCCccEEEEEEcCCCEEEEEE-ecc-------cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           43 INKKLGQGGFGPVYKGTLVDGQEIAVKR-LSK-------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~~~~v~vK~-~~~-------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .+..|.+|+.+.|+++.+ .|+.++||. +.+       ...-......+|+..|.++.--.|.-..-+|.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            678999999999999988 788877774 322       11223345668999999887667766666788888889999


Q ss_pred             EecCC-CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC---CeEEecccccee
Q 018304          115 EFMTN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARA  190 (358)
Q Consensus       115 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~---~i~L~Df~~~~~  190 (358)
                      ||++| .++.+++...-... ........++..|=+.+.-||..+   ++|||+..+||++..++   .+.+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 47888886644332 344444788999999999999999   99999999999997654   358999999865

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.26  E-value=1.3e-10  Score=107.40  Aligned_cols=170  Identities=22%  Similarity=0.309  Sum_probs=132.3

Q ss_pred             CCccEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCeeEEEEEecCC-CCHHH
Q 018304           51 GFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFMTN-KSLDS  124 (358)
Q Consensus        51 ~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~  124 (358)
                      ...+.|++.. .+|..|++|+++.......+....-++.++++.|+|+|++.++|..    +..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3467899985 4699999999976555555566677899999999999999998873    3478999999875 57776


Q ss_pred             HHhccc------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          125 FIFDQE------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       125 ~l~~~~------------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      +.-...            .....++..+|.++.|+..||.++|+.|   +.-+-+.+.+|+++.+-++++...|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            653321            1223788999999999999999999999   9999999999999999999999988877653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKN  242 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  242 (358)
                      ...              .  |.+.   -..+.|.=-||.++..|.+|...
T Consensus       445 ~d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC--------------C--cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            222              0  1111   12367888999999999999644

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1.5e-10  Score=94.04  Aligned_cols=131  Identities=21%  Similarity=0.298  Sum_probs=99.8

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEe-cc-------cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRL-SK-------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~-~~-------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..+++|+.+.++.+.+ -|.++++|.= ++       ...-......+|+.++..+.-..+.-.+-++.+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4678999999999976 3444666643 22       0011223455799999998766666666666778888999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++|..|.+.+...          ...++..+=..+.-||..+   |+|||+.++||++.++ ++.+.|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCC-cEEEEECCcccc
Confidence            9999999988544          1456677778889999999   9999999999999665 499999999874

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=3.3e-09  Score=96.11  Aligned_cols=196  Identities=13%  Similarity=0.148  Sum_probs=135.5

Q ss_pred             CCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccc----eee--EEEeCCe-eEE
Q 018304           41 FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK----LLG--CCIQGEE-KLL  112 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~----~~~--~~~~~~~-~~l  112 (358)
                      ....+.||+|+.+.+|-.-  .-...+.|+..........+   .+..|... .||-+-.    ...  +.-+... ..+
T Consensus        13 i~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            3556789999999998643  22344668887655443222   23333333 5553222    100  1112222 568


Q ss_pred             EEEecCCC-CHHHHHhc---cccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          113 IYEFMTNK-SLDSFIFD---QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       113 v~e~~~~~-~L~~~l~~---~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      +|+.+.+. .+.+++..   .......++..+++++..++.+.+.||..|   .+-||++++|+||.+++.+.|.|-...
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence            88888764 34444422   234455888999999999999999999999   999999999999999999999997766


Q ss_pred             eecCCCCCCCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhC-CCCCCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISG-KKNRGFYH  247 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g-~~p~~~~~  247 (358)
                      ...   ..........+...|.+||.-.     +..-+...|.|.||+++++|+.| ++||..-.
T Consensus       165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            553   2333444556889999999754     23456789999999999999886 89987643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=4.9e-10  Score=96.76  Aligned_cols=142  Identities=19%  Similarity=0.238  Sum_probs=105.9

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCC--CCccceeeEEEeCC---eeEEEEEecC
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE---EKLLIYEFMT  118 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~~~~---~~~lv~e~~~  118 (358)
                      +.|+.|..+.+|++...+|..+++|....... .....+..|+++++.+.+  .++++++.+.....   ..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999876668999998765322 134577899999999965  34677777665532   5689999999


Q ss_pred             CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 018304          119 NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS----------------------------------------  158 (358)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~----------------------------------------  158 (358)
                      |.++.+.+..    ..++......++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888765421    12566666777777777777777531                                        


Q ss_pred             -------------CCCcccCCCCCCcEEEcC--CCCeEEecccccee
Q 018304          159 -------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLARA  190 (358)
Q Consensus       159 -------------~~~i~H~di~~~Nilv~~--~~~i~L~Df~~~~~  190 (358)
                                   ...++|+|+++.||+++.  ++.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         124799999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.11  E-value=1.5e-10  Score=109.02  Aligned_cols=247  Identities=21%  Similarity=0.185  Sum_probs=169.6

Q ss_pred             CCCCcceeecccCCccEEEEEE--cCCCEEEEEEecccChhhHHH--HHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTL--VDGQEIAVKRLSKISEQGLKE--LKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~--~~~~~v~vK~~~~~~~~~~~~--~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .+|..+..||.|.++.|+....  .++..|++|.+.+........  -..|+-+...+ .|.+.+.++..+......++-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            5888999999999999998764  347889999886633322222  23566666666 588888888877777788899


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-CCeEEeccccceecC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFG  192 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-~~i~L~Df~~~~~~~  192 (358)
                      -|||+++++........   .+++..++.+..|++.++.++|+..   ++|+|++|.||++.++ +..+++||+....+.
T Consensus       345 ~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             hhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccc
Confidence            99999988877663222   3888889999999999999999999   9999999999999886 788999999875421


Q ss_pred             CCCCCCccccccccCCC-CCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEGNTKRVIGTYGY-MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..    .......+..| .++.......+-.+.|+++||..+.+.+++...-   ........       ...+...   
T Consensus       419 ~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls---~~~~~~~~-------i~~~~~p---  481 (524)
T KOG0601|consen  419 FS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS---ESGVQSLT-------IRSGDTP---  481 (524)
T ss_pred             ee----cccccccccccccchhhccccccccccccccccccccccccCcccC---ccccccee-------eeccccc---
Confidence            11    01111122223 3455555667788999999999999999987441   11100000       0001000   


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          ....   ....+..+...+...++..||++.++..+....
T Consensus       482 ----~~~~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  482 ----NLPG---LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ----CCCc---hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                0000   112333456678899999999999988765543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.07  E-value=1.6e-09  Score=93.24  Aligned_cols=149  Identities=20%  Similarity=0.207  Sum_probs=110.8

Q ss_pred             ceeHHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecc----------cC------------hhhHHHHHHH
Q 018304           28 LFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK----------IS------------EQGLKELKNE   85 (358)
Q Consensus        28 ~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~----------~~------------~~~~~~~~~e   85 (358)
                      .+++.....-+.=+.+..+||-|-.+.||.|.+.+|.++++|.-..          ..            .-......+|
T Consensus        80 ~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rE  159 (304)
T COG0478          80 ALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAERE  159 (304)
T ss_pred             HHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHH
Confidence            3456666666666788899999999999999998899999995421          00            1122335679


Q ss_pred             HHHHHhcCCC--CccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 018304           86 VILFSKLQHR--NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII  163 (358)
Q Consensus        86 ~~~l~~l~~~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~  163 (358)
                      .+.|..|...  .+++.+++    +...+|||+++|..|...-        ++....-.++..|++-+..+...|   ++
T Consensus       160 f~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iV  224 (304)
T COG0478         160 FEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IV  224 (304)
T ss_pred             HHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---cc
Confidence            9999999644  77777764    4567999999986665432        223344455556666666666788   99


Q ss_pred             cCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          164 HRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       164 H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      |||+++-||+|+++|.+.+.||..+...
T Consensus       225 HGDlSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         225 HGDLSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             ccCCchheEEEecCCCEEEEeCcccccC
Confidence            9999999999999999999999988654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.05  E-value=7.4e-09  Score=91.55  Aligned_cols=139  Identities=19%  Similarity=0.130  Sum_probs=99.1

Q ss_pred             ecccCCccEEEEEEcCCCEEEEEEecccChh-hHH----------HHHHHHHHHHhcCCCC--ccceeeEEEeC-----C
Q 018304           47 LGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLK----------ELKNEVILFSKLQHRN--LVKLLGCCIQG-----E  108 (358)
Q Consensus        47 lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~-~~~----------~~~~e~~~l~~l~~~~--iv~~~~~~~~~-----~  108 (358)
                      +.......|+++.. +|+.|++|......-. ..+          .+.+|+..+..+...+  .+.++.+++..     .
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333344666655 7889999977542211 111          3678898888885433  34455565442     3


Q ss_pred             eeEEEEEecCCC-CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-------CCCe
Q 018304          109 EKLLIYEFMTNK-SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-------DMNP  180 (358)
Q Consensus       109 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-------~~~i  180 (358)
                      ..++|+|++++. +|.+++..... ...+......++.+++..+..||..|   ++|+|+++.|||++.       ++.+
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence            468999999875 79998753222 23566777899999999999999999   999999999999975       4679


Q ss_pred             EEecccccee
Q 018304          181 KISDFGLARA  190 (358)
Q Consensus       181 ~L~Df~~~~~  190 (358)
                      .|+||+.+..
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=1.2e-08  Score=85.28  Aligned_cols=124  Identities=23%  Similarity=0.259  Sum_probs=82.2

Q ss_pred             EEEEEEcCCCEEEEEEeccc--------------------------ChhhHHHHHHHHHHHHhcCCC--CccceeeEEEe
Q 018304           55 VYKGTLVDGQEIAVKRLSKI--------------------------SEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQ  106 (358)
Q Consensus        55 v~~~~~~~~~~v~vK~~~~~--------------------------~~~~~~~~~~e~~~l~~l~~~--~iv~~~~~~~~  106 (358)
                      ||.|...+|..+++|+....                          ..-......+|++.|..+...  ++++++++.  
T Consensus         2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~--   79 (188)
T PF01163_consen    2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN--   79 (188)
T ss_dssp             EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred             EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence            88998888999999986420                          011223456899999999755  567776553  


Q ss_pred             CCeeEEEEEecC--CCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHH-HhcCCCCCcccCCCCCCcEEEcCCCCeEEe
Q 018304          107 GEEKLLIYEFMT--NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY-LHQDSRLRIIHRDLKASNVLLDQDMNPKIS  183 (358)
Q Consensus       107 ~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~-LH~~~~~~i~H~di~~~Nilv~~~~~i~L~  183 (358)
                        ..++||||++  |..+..+....     ++......++.+++..+.. +|..|   ++|||+++.||+++.+ .+.+.
T Consensus        80 --~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 --RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             --TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred             --CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence              4579999998  65555443211     1134455677777775555 57999   9999999999999877 99999


Q ss_pred             ccccceec
Q 018304          184 DFGLARAF  191 (358)
Q Consensus       184 Df~~~~~~  191 (358)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.85  E-value=1.2e-09  Score=108.67  Aligned_cols=253  Identities=19%  Similarity=0.234  Sum_probs=163.3

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEe---cccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~---~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ..+..+.+.+++-+.+|.++.++.+.-.. |.-...+..   ..........+..+-.++-...+|.++.....+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            56677888999999999999999876322 322222222   11111111222222222222334555555544555667


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .+++++|..+++|...+++..   ..+..-.+.....+..++++||...   +.|+|++|.|.+...+|...+.||+...
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence            899999999999988875544   3666666777888999999999998   9999999999999999999999997332


Q ss_pred             ecCC------C--C----------------CC-----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCC
Q 018304          190 AFGG------D--E----------------TE-----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK  240 (358)
Q Consensus       190 ~~~~------~--~----------------~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  240 (358)
                      ....      .  .                ..     .......+++.|.+||...+..-...+|+|+.|+++++.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            2110      0  0                00     0111245789999999999988889999999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChH
Q 018304          241 KNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP  306 (358)
Q Consensus       241 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  306 (358)
                      .||..........-+      .+...+  ........      ....-+++...+..+|.+|..+.
T Consensus      1033 pp~na~tpq~~f~ni------~~~~~~--~p~g~~~~------s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENI------LNRDIP--WPEGPEEG------SYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhhhhcc------ccCCCC--CCCCcccc------ChhhhhhhhhhhccCchhccCcc
Confidence            997654432211110      000000  00000011      11223466677889999998877

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=1.2e-07  Score=79.77  Aligned_cols=137  Identities=16%  Similarity=0.146  Sum_probs=101.5

Q ss_pred             cccCCccEEEEEEcCCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCC--CCccceeeEEE-eC----CeeEEEE
Q 018304           48 GQGGFGPVYKGTLVDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQH--RNLVKLLGCCI-QG----EEKLLIY  114 (358)
Q Consensus        48 g~g~~g~v~~~~~~~~~~v~vK~~~~~~------~~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~-~~----~~~~lv~  114 (358)
                      |+|+.+.|+.... +|+.+.+|.-.+-.      +-....+.+|+..++.+..  -.++++. ++. ..    ...+||+
T Consensus        27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            4588888988765 55578888765200      2245678899999999853  2345554 332 11    1457999


Q ss_pred             EecCC-CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC--eEEecccccee
Q 018304          115 EFMTN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLARA  190 (358)
Q Consensus       115 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~--i~L~Df~~~~~  190 (358)
                      |-+.+ .+|.+++.+... ...+......++.+++.++.-||+.|   +.|+|+.+.||+++.+|.  +.++||.-+..
T Consensus       105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98764 588888754322 23678888899999999999999999   999999999999986677  99999987764

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.81  E-value=1.3e-07  Score=79.82  Aligned_cols=138  Identities=16%  Similarity=0.160  Sum_probs=91.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHH---------HHHHHHHHhc---CCCCccceeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL---------KNEVILFSKL---QHRNLVKLLGCC  104 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~---------~~e~~~l~~l---~~~~iv~~~~~~  104 (358)
                      ..++|.+.+.+.......|.+... +|..+++|.......-....+         .+.+..+..+   .......++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            458999999999988888877755 789999998754221111111         1222323333   223333333332


Q ss_pred             E-----eCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC
Q 018304          105 I-----QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       105 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~  179 (358)
                      +     .....+++|||++|..|.++..       +++    .++..+.+++..+|..|   ++|||.+|.|++++++ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence            2     2234568999999988876531       222    24455778899999999   9999999999999855 5


Q ss_pred             eEEecccccee
Q 018304          180 PKISDFGLARA  190 (358)
Q Consensus       180 i~L~Df~~~~~  190 (358)
                      +++.||+....
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999976543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=4.3e-09  Score=100.82  Aligned_cols=151  Identities=17%  Similarity=0.244  Sum_probs=98.5

Q ss_pred             HHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCcc-------ccccccCCCCCcccccCC
Q 018304          146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-------KRVIGTYGYMAPEYASDG  218 (358)
Q Consensus       146 ~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~  218 (358)
                      +++.|+.++|...  .++|++|.|++|+++..+..||++|+++............       ........|.|||.+.+.
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            3448999999987  4999999999999999999999999998765331111111       112355689999999988


Q ss_pred             CCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCC
Q 018304          219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQ  297 (358)
Q Consensus       219 ~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  297 (358)
                      ..+.++|+||+|+++|.++. |+.-+...........             ....+......+......++.+=+.+++..
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHhcC
Confidence            88999999999999999995 4444333222111110             000000000011111112344455678999


Q ss_pred             CCCCCCChHHHHHH
Q 018304          298 HPKDRPSMPSVILM  311 (358)
Q Consensus       298 ~P~~Rpt~~ell~~  311 (358)
                      ++..||++..+...
T Consensus       252 ~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  252 DSAVRPTLDLLLSI  265 (700)
T ss_pred             CcccCcchhhhhcc
Confidence            99999988777654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=2.2e-07  Score=79.33  Aligned_cols=105  Identities=26%  Similarity=0.288  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHhcCC--CCccceeeEEEeCC----eeEEEEEecCC-CCHHHHHhccccccCCCHHHHHHHHHHHHHHHH
Q 018304           80 KELKNEVILFSKLQH--RNLVKLLGCCIQGE----EKLLIYEFMTN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVM  152 (358)
Q Consensus        80 ~~~~~e~~~l~~l~~--~~iv~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~  152 (358)
                      ....+|+..+..+..  -..++.+.+.+...    ..++|+|++++ .+|.+++.....   .+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            456678888877753  33556666665532    45899999987 479998855333   566777899999999999


Q ss_pred             HHhcCCCCCcccCCCCCCcEEEcCCC---CeEEecccccee
Q 018304          153 YLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARA  190 (358)
Q Consensus       153 ~LH~~~~~~i~H~di~~~Nilv~~~~---~i~L~Df~~~~~  190 (358)
                      -||..|   ++|+|+++.|||++.++   .+.|+||+-+..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999   99999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.64  E-value=7.7e-07  Score=76.14  Aligned_cols=153  Identities=20%  Similarity=0.222  Sum_probs=107.5

Q ss_pred             CcceeHHHHHHhcCCCCcceeec---ccCCccEEEEEEcCCCEEEEEEecccC------------------------hhh
Q 018304           26 LPLFELATIVSATNNFSINKKLG---QGGFGPVYKGTLVDGQEIAVKRLSKIS------------------------EQG   78 (358)
Q Consensus        26 ~~~~~~~~~~~~~~~y~i~~~lg---~g~~g~v~~~~~~~~~~v~vK~~~~~~------------------------~~~   78 (358)
                      .=..+.+.+.....+..+....|   .|-.+.||+|...++..+++|++....                        .-.
T Consensus        32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            34455777777788887777555   566778888887779999999885311                        112


Q ss_pred             HHHHHHHHHHHHhcC--CCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccC--CCHHHHHHHHHHHHHHHHHH
Q 018304           79 LKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI--LDWSKRFHIICGTARGVMYL  154 (358)
Q Consensus        79 ~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~al~~L  154 (358)
                      ..+..+|+..|+++.  +-.+++.+.+.    ...+|||++.....     .....+.  +.......+..++++.+.-|
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~-----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l  182 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL-----PAPRLKDVPLELEEAEGLYEDVVEYMRRL  182 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC-----CCCCcccCCcCchhHHHHHHHHHHHHHHH
Confidence            233557888888885  34566666655    55799999864310     0111111  22335677788889999988


Q ss_pred             hc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          155 HQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       155 H~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      .. .+   ++|+||+.-|||+. ++.+.++|++.+...
T Consensus       183 ~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         183 YKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHhcC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence            88 77   99999999999998 889999999998764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.57  E-value=1.9e-06  Score=74.63  Aligned_cols=140  Identities=16%  Similarity=0.141  Sum_probs=85.9

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--CccceeeEEEeCCeeEEEEEecCCCC-
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQGEEKLLIYEFMTNKS-  121 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~~~~~~~~~~~lv~e~~~~~~-  121 (358)
                      ..||+|..+.||+.   .+..+++|......  ....+.+|++.++.+..-  .+++++.+..+.+...++||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            67899999999984   35578888876532  335578899999998643  35778888878888889999999863 


Q ss_pred             HHHHH--------------hc----cccc--cCCCHHHHH-HHHHH----------HHH-HHHHHhcC-CCCCcccCCCC
Q 018304          122 LDSFI--------------FD----QERC--KILDWSKRF-HIICG----------TAR-GVMYLHQD-SRLRIIHRDLK  168 (358)
Q Consensus       122 L~~~l--------------~~----~~~~--~~~~~~~~~-~~~~~----------i~~-al~~LH~~-~~~~i~H~di~  168 (358)
                      +...+              ..    -...  ......... .+..+          +.. ...+|... ....++|+|++
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            22111              00    0000  001111100 00000          000 11122111 12347899999


Q ss_pred             CCcEEEcCCCCeEEecccccee
Q 018304          169 ASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       169 ~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      |.||++++++ +.+.||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.57  E-value=6.1e-07  Score=86.06  Aligned_cols=138  Identities=17%  Similarity=0.262  Sum_probs=89.2

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccChhhH----------------------------------HH------HHH
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL----------------------------------KE------LKN   84 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~----------------------------------~~------~~~   84 (358)
                      ..|+.+.-|.||+|..++|+.||||+....-....                                  +.      +..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68899999999999998999999998753111111                                  01      112


Q ss_pred             HHHHHHhcC-----CCC--ccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC
Q 018304           85 EVILFSKLQ-----HRN--LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD  157 (358)
Q Consensus        85 e~~~l~~l~-----~~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~  157 (358)
                      |+..+.++.     .++  |++++  .+..+..+++|||++|..+.++.......  .+...+.....++  -+..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~--f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRA--FLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHH--HHHHHHhc
Confidence            333333321     222  22222  22345678999999999998885332211  5544444333332  22333345


Q ss_pred             CCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       158 ~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      |   +.|.|.+|.||+|..+|++.+.|||+...+
T Consensus       285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             C---ccccCCCccceEEecCCcEEEEcCcceecC
Confidence            6   999999999999999999999999998765

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.40  E-value=6e-06  Score=72.49  Aligned_cols=76  Identities=12%  Similarity=0.100  Sum_probs=54.6

Q ss_pred             eecccCC-ccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEEecCCCCHH
Q 018304           46 KLGQGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMTNKSLD  123 (358)
Q Consensus        46 ~lg~g~~-g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  123 (358)
                      .|..|.+ +.||+... ++..+++|+.....   ...+..|+++++.+. +-.+++++.+....+..++||++++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3445555 78898865 45788889876532   345678999888883 445667888777666789999999987776


Q ss_pred             HH
Q 018304          124 SF  125 (358)
Q Consensus       124 ~~  125 (358)
                      ..
T Consensus        81 ~~   82 (244)
T cd05150          81 AL   82 (244)
T ss_pred             Hh
Confidence            43

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.39  E-value=1e-05  Score=70.17  Aligned_cols=78  Identities=19%  Similarity=0.269  Sum_probs=56.8

Q ss_pred             ceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--CccceeeEEEe---CCeeEEEEEecC
Q 018304           44 NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQ---GEEKLLIYEFMT  118 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~~~~~~---~~~~~lv~e~~~  118 (358)
                      ++.|+.|..+.||++...+ ..+++|.....  .....+..|..+++.+...  .+++++.....   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4688999999999998855 69999987653  4556777888888888432  35667764433   235689999999


Q ss_pred             CCCHHH
Q 018304          119 NKSLDS  124 (358)
Q Consensus       119 ~~~L~~  124 (358)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            887777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.38  E-value=9.5e-06  Score=68.38  Aligned_cols=132  Identities=17%  Similarity=0.274  Sum_probs=95.4

Q ss_pred             ceeecccCCccEEEEEEcCCCEEEEEEecccC----------------hhhHHHHHHHHHHHHhcC------CCCcccee
Q 018304           44 NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS----------------EQGLKELKNEVILFSKLQ------HRNLVKLL  101 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~----------------~~~~~~~~~e~~~l~~l~------~~~iv~~~  101 (358)
                      ...||+|+.-.||.  +.++...+||+.....                ........+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45789999999987  5567788899886544                223456667777666665      78899999


Q ss_pred             eEEEeCCeeEEEEEecCC------CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc
Q 018304          102 GCCIQGEEKLLIYEFMTN------KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD  175 (358)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~  175 (358)
                      ++.+++....+|+|.+.+      .+|.+++....    ++. .+.   ..+-+-..+|-+++   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELR---QALDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHH---HHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998753      46888873322    554 333   33445567778888   99999999999996


Q ss_pred             CC--C--CeEEec-cccc
Q 018304          176 QD--M--NPKISD-FGLA  188 (358)
Q Consensus       176 ~~--~--~i~L~D-f~~~  188 (358)
                      ..  +  .+.|+| ||..
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            33  2  477777 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.28  E-value=9.6e-06  Score=65.81  Aligned_cols=129  Identities=20%  Similarity=0.271  Sum_probs=94.6

Q ss_pred             CcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCcc-ceeeEEEeCCeeEEEEEecCCC
Q 018304           42 SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        42 ~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv-~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      .+.+.|++|..|.||++.+ .|..+++|+-..  ++....+..|+++|..+.-.++. +++.+..    .++.|||+.|.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            5568899999999999998 666888887654  34446788999999999765544 4555432    23559999998


Q ss_pred             CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC-CCcEEEcCCCCeEEecccccee
Q 018304          121 SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK-ASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~-~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      .|.++-...      +    .+.+..+++.-.-|...|   |-|+.|+ |...++.+++.+.|.||..+..
T Consensus        98 ~L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887764211      1    234455777777888888   9999987 5555555666999999999874

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.17  E-value=1e-05  Score=67.77  Aligned_cols=104  Identities=21%  Similarity=0.217  Sum_probs=82.1

Q ss_pred             HHHHHHHhcCC-CCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 018304           84 NEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI  162 (358)
Q Consensus        84 ~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i  162 (358)
                      +|.-+++.+++ ++++++++++    ..+++.||...+++..........-..++..+.++|.++++.+++|+....+.+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57888888865 6999999998    446799999866554321010111227899999999999999999999766669


Q ss_pred             ccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          163 IHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       163 ~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      .-.|++++|+-++++|++++.|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            99999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.14  E-value=3e-05  Score=74.46  Aligned_cols=138  Identities=15%  Similarity=0.210  Sum_probs=87.1

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccCh-------------------------------hhHHHHHHHHHHHHh--
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE-------------------------------QGLKELKNEVILFSK--   91 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~-------------------------------~~~~~~~~e~~~l~~--   91 (358)
                      +.|+.-..|.|++|+.++|+.|+||+-+..-+                               +-...+..|++.++.  
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            57899999999999999999999998643111                               111111122222222  


Q ss_pred             --------cCCCC------ccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC
Q 018304           92 --------LQHRN------LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD  157 (358)
Q Consensus        92 --------l~~~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~  157 (358)
                              +.|-+      |++++-.+  .....++|||++|..+.|.-.- ...+ ++...+..-+.+...  +-+=..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i-~~~g-i~~~~i~~~l~~~~~--~qIf~~  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI-DKRG-ISPHDILNKLVEAYL--EQIFKT  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH-HHcC-CCHHHHHHHHHHHHH--HHHHhc
Confidence                    22333      44443222  3467899999999877765321 2222 666655554444322  223334


Q ss_pred             CCCCcccCCCCCCcEEEcC----CCCeEEeccccceec
Q 018304          158 SRLRIIHRDLKASNVLLDQ----DMNPKISDFGLARAF  191 (358)
Q Consensus       158 ~~~~i~H~di~~~Nilv~~----~~~i~L~Df~~~~~~  191 (358)
                      |   ++|+|=+|.||++..    ++.+.+.|||+...+
T Consensus       321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             C---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            5   999999999999983    678999999998765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.09  E-value=5.9e-07  Score=85.73  Aligned_cols=187  Identities=17%  Similarity=0.147  Sum_probs=134.0

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .-|..-+-+++++++++++.+....+....+.+...     -...-++++|.+++||| .+..++.++-++...+.++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            445566778899999999887544555556666543     33456889999999999 666666666667788999998


Q ss_pred             CCC-CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          118 TNK-SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       118 ~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      .++ +..........  .+..-.....+..-+++++++|+..   -+|+|    ||+. .++..++++|+....+.... 
T Consensus       317 s~~rs~~~~~~~se~--~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  317 STGRSSALEMTVSEI--ALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILG-SEEEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             cCCccccccCChhhH--hhhhhhhhhhhhhhccccccccccc---ccCcc----cccc-cccccccccccCCcccCccc-
Confidence            776 22221111111  0334444556666778999999975   58888    6665 44788999999987764332 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNR  243 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  243 (358)
                        ..+...+++.++|||......+....|.|++|.-..++.-|..|-
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence              345667899999999999999999999999999888888888773

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.07  E-value=5e-05  Score=77.57  Aligned_cols=201  Identities=19%  Similarity=0.183  Sum_probs=134.3

Q ss_pred             HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE----EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH
Q 018304           79 LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL----LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL  154 (358)
Q Consensus        79 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~L  154 (358)
                      ......|.+.+....|+|+..++.+........    +..++|...++...++.   ....+....+.+..++.+|+.++
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHH
Confidence            344456777888889999999998875544332    34567777777777643   33488999999999999999999


Q ss_pred             hcCCCCCcccCCCCCC---cEEEcCCCCeEEe--ccccceecCCCCCCCccccccccCCCCCcccccCCCCC--Ccccch
Q 018304          155 HQDSRLRIIHRDLKAS---NVLLDQDMNPKIS--DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS--VKSDVF  227 (358)
Q Consensus       155 H~~~~~~i~H~di~~~---Nilv~~~~~i~L~--Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~Diw  227 (358)
                      |+..   +.|.-+...   +.-++.++.+..+  ||+.+..+.....   .........+.++|......++  ...|+|
T Consensus       303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHH
Confidence            9997   666665555   5555666666666  8888776532221   1122234557777766555443  457999


Q ss_pred             hHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHH
Q 018304          228 SFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPS  307 (358)
Q Consensus       228 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  307 (358)
                      ++|..+..+..|..+-.....                  +..+.+....        ....+...+|+..++++|+++.+
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~------------------~~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAV------------------PVSLLDVLST--------SELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccc------------------hhhhhccccc--------hhhhhhhhhhcchhhhhccchhh
Confidence            999999999998866221111                  1111111100        02445677899999999999999


Q ss_pred             HHHHhcc
Q 018304          308 VILMLGS  314 (358)
Q Consensus       308 ll~~l~~  314 (358)
                      ++.+...
T Consensus       431 ll~~~f~  437 (1351)
T KOG1035|consen  431 LLTHPFL  437 (1351)
T ss_pred             hhhchhc
Confidence            9986543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.02  E-value=0.00011  Score=75.83  Aligned_cols=78  Identities=15%  Similarity=0.328  Sum_probs=56.6

Q ss_pred             ceeecccCCccEEEEEEcCC---CEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCc--cceeeEEEeC---CeeEEE
Q 018304           44 NKKLGQGGFGPVYKGTLVDG---QEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNL--VKLLGCCIQG---EEKLLI  113 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~---~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i--v~~~~~~~~~---~~~~lv  113 (358)
                      ++.++.|.+..+|+....++   ..+++|+..... ......+.+|+.+++.+. |.++  ++++.++.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            67889999999999876443   467888764321 123356789999999995 6654  7777777654   367899


Q ss_pred             EEecCCCC
Q 018304          114 YEFMTNKS  121 (358)
Q Consensus       114 ~e~~~~~~  121 (358)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.99  E-value=9.3e-06  Score=72.11  Aligned_cols=150  Identities=15%  Similarity=0.177  Sum_probs=108.2

Q ss_pred             cceeHHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecc---------cCh---------h----hHHHHHH
Q 018304           27 PLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK---------ISE---------Q----GLKELKN   84 (358)
Q Consensus        27 ~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~---------~~~---------~----~~~~~~~   84 (358)
                      -.+++++...-+.-+.+..+||-|-.+-+|++.+.+|+..++|.-.-         .+.         .    ..-...+
T Consensus        80 DyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~k  159 (465)
T KOG2268|consen   80 DYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATK  159 (465)
T ss_pred             hHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHH
Confidence            34567777777778999999999999999999998899999985321         000         0    0011346


Q ss_pred             HHHHHHhcCC--CCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 018304           85 EVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI  162 (358)
Q Consensus        85 e~~~l~~l~~--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i  162 (358)
                      |+..|+.|..  --+++.+++    +..++|||++.+..|...-      ...+...   +...+..-+.-|-.+|   +
T Consensus       160 EfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---l  223 (465)
T KOG2268|consen  160 EFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---L  223 (465)
T ss_pred             HHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---c
Confidence            8888888843  345666654    3568999999998876542      1133333   4444556677788888   9


Q ss_pred             ccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          163 IHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       163 ~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      +|||.+--||+|+.++.++++||..+...+
T Consensus       224 IHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  224 IHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             eecccchheeEEecCCCEEEeechHhhccC
Confidence            999999999999999999999998766543

>PRK10593 hypothetical protein; Provisional

Probab=97.98  E-value=0.00015  Score=65.58  Aligned_cols=79  Identities=11%  Similarity=0.093  Sum_probs=57.7

Q ss_pred             CCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC---CCccceeeEEEeC---CeeEEEE
Q 018304           41 FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG---EEKLLIY  114 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~---~~iv~~~~~~~~~---~~~~lv~  114 (358)
                      -.-.+.||+|..+.||.....++ .+++|..+..  .....+..|+..|+.+..   -.++++++++.++   +..++||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34456899999999999876445 5777775431  123578899999999843   3688888877553   5689999


Q ss_pred             EecCCCCH
Q 018304          115 EFMTNKSL  122 (358)
Q Consensus       115 e~~~~~~L  122 (358)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.96  E-value=0.00012  Score=63.83  Aligned_cols=74  Identities=20%  Similarity=0.266  Sum_probs=48.8

Q ss_pred             ceeecccCCccEEEEEEcC--CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEEEEecCCC
Q 018304           44 NKKLGQGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      ++.|..|-...+|++...+  +..|++|+....... .-....|+.+++.+...+ .++++..+.    ..++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            4678888899999997653  678999977543221 122346888888885333 345544332    24899999886


Q ss_pred             CH
Q 018304          121 SL  122 (358)
Q Consensus       121 ~L  122 (358)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.95  E-value=0.00011  Score=64.21  Aligned_cols=74  Identities=16%  Similarity=0.277  Sum_probs=46.6

Q ss_pred             ceeecccCCc-cEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC---CccceeeEEEeCC---eeEEEEEe
Q 018304           44 NKKLGQGGFG-PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQGE---EKLLIYEF  116 (358)
Q Consensus        44 ~~~lg~g~~g-~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~---~iv~~~~~~~~~~---~~~lv~e~  116 (358)
                      ++.|+.|+.. .||+.    +..+++|.....  .....+..|++.+..+...   .+.+++......+   ..+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567766665 58875    346778865542  2345788899999888532   3455554433322   34789999


Q ss_pred             cCCCCHH
Q 018304          117 MTNKSLD  123 (358)
Q Consensus       117 ~~~~~L~  123 (358)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9986653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.93  E-value=0.00011  Score=65.10  Aligned_cols=139  Identities=17%  Similarity=0.133  Sum_probs=78.6

Q ss_pred             eecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEEecCCCCHHH
Q 018304           46 KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMTNKSLDS  124 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~  124 (358)
                      .+..|....+|+... ++..+++|..........-....|..+++.+....+ ++++...  .  .++|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence            456788889998874 677899987654222210134678889988854333 4444433  2  368999999866532


Q ss_pred             H--------------Hhc---ccc-ccCCCHH-HHHHHHHHH---------HHHHHHHhcC-----CCCCcccCCCCCCc
Q 018304          125 F--------------IFD---QER-CKILDWS-KRFHIICGT---------ARGVMYLHQD-----SRLRIIHRDLKASN  171 (358)
Q Consensus       125 ~--------------l~~---~~~-~~~~~~~-~~~~~~~~i---------~~al~~LH~~-----~~~~i~H~di~~~N  171 (358)
                      .              +.+   ... ...++.. .+..+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1              111   100 0111111 111221111         1112222111     01248999999999


Q ss_pred             EEEcCCCCeEEecccccee
Q 018304          172 VLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       172 ilv~~~~~i~L~Df~~~~~  190 (358)
                      |++++++ +.|.||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9998876 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.75  E-value=0.00047  Score=64.44  Aligned_cols=75  Identities=15%  Similarity=0.223  Sum_probs=54.0

Q ss_pred             ceeecccCCccEEEEEEcCC-CEEEEEEeccc----C---hhhHHHHHHHHHHHHhcC-C--CCccceeeEEEeCCeeEE
Q 018304           44 NKKLGQGGFGPVYKGTLVDG-QEIAVKRLSKI----S---EQGLKELKNEVILFSKLQ-H--RNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~-~~v~vK~~~~~----~---~~~~~~~~~e~~~l~~l~-~--~~iv~~~~~~~~~~~~~l  112 (358)
                      .+.||.|....||++...+| +.++||.-...    .   .........|.+.|+.+. +  .++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46889999999999998666 58999975311    1   124456677888888863 2  356777766  4566889


Q ss_pred             EEEecCCC
Q 018304          113 IYEFMTNK  120 (358)
Q Consensus       113 v~e~~~~~  120 (358)
                      |||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999763

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.66  E-value=0.0016  Score=58.75  Aligned_cols=143  Identities=20%  Similarity=0.174  Sum_probs=83.2

Q ss_pred             ceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--Cccceee------EEEeCCeeEEEEE
Q 018304           44 NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLG------CCIQGEEKLLIYE  115 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~~------~~~~~~~~~lv~e  115 (358)
                      ++.|..|....+|+... ++..+++|+...   .....+..|+.++..+...  .+++++.      +....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            56778888889999865 455788898764   2234566788888777432  2444443      1233456689999


Q ss_pred             ecCCCCHHH-----------HH---hccc-ccc-------CCCHHHHH----------HHHHHHHHHHHHHhcC----CC
Q 018304          116 FMTNKSLDS-----------FI---FDQE-RCK-------ILDWSKRF----------HIICGTARGVMYLHQD----SR  159 (358)
Q Consensus       116 ~~~~~~L~~-----------~l---~~~~-~~~-------~~~~~~~~----------~~~~~i~~al~~LH~~----~~  159 (358)
                      +++|..+..           .+   +... ...       ...+....          .....+..++.++...    -.
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998865422           01   1000 000       00000000          0111123344444431    11


Q ss_pred             CCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          160 LRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       160 ~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ..++|+|++|.||++++++.+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            2499999999999999877778999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.65  E-value=0.00052  Score=62.30  Aligned_cols=144  Identities=22%  Similarity=0.193  Sum_probs=99.5

Q ss_pred             CCCcceeecccCCccEEEEEEcCCCEEEEEEecc--------------------------cChhhHHHHHHHHHHHHhcC
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--------------------------ISEQGLKELKNEVILFSKLQ   93 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~--------------------------~~~~~~~~~~~e~~~l~~l~   93 (358)
                      =-.+...|+.|-.+-||.+...+|..+|||+.+.                          ......-+...|+..|+++.
T Consensus       145 i~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~  224 (520)
T KOG2270|consen  145 IVEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN  224 (520)
T ss_pred             eeecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence            3455677889999999999988899999998741                          12223344567888888887


Q ss_pred             CCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEE
Q 018304           94 HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL  173 (358)
Q Consensus        94 ~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nil  173 (358)
                      ...|+-.--...  ...++||+++.......=.   -..-.++...+..+-.+++.-+.-|.+..  .++|.||+--|++
T Consensus       225 ~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L  297 (520)
T KOG2270|consen  225 NAGIPCPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL  297 (520)
T ss_pred             hcCCCCCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence            666543322221  2347999998532211100   01112666778888888888888887765  4999999999999


Q ss_pred             EcCCCCeEEeccccceec
Q 018304          174 LDQDMNPKISDFGLARAF  191 (358)
Q Consensus       174 v~~~~~i~L~Df~~~~~~  191 (358)
                      + .+|.+.++|-+.+...
T Consensus       298 y-hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  298 Y-HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             E-ECCEEEEEEccccccC
Confidence            9 6678999998876543

>PRK05231 homoserine kinase; Provisional

Probab=97.59  E-value=0.0041  Score=56.86  Aligned_cols=156  Identities=17%  Similarity=0.192  Sum_probs=81.6

Q ss_pred             HHHHHHhcCCCCc-----ceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--Cccceee-
Q 018304           31 LATIVSATNNFSI-----NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLG-  102 (358)
Q Consensus        31 ~~~~~~~~~~y~i-----~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~~-  102 (358)
                      .+++...-..|.+     ++.|+.|....+|+....+| .+++|++....   ...+..++..++.|...  .+++++. 
T Consensus         9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~   84 (319)
T PRK05231          9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVAR   84 (319)
T ss_pred             HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence            3344333345544     35667788789999876444 78889875322   23344455666555321  2344442 


Q ss_pred             -----EEEeCCeeEEEEEecCCCCHH-----------HHHhc---c-cccc-----CCC---HHHHH------------H
Q 018304          103 -----CCIQGEEKLLIYEFMTNKSLD-----------SFIFD---Q-ERCK-----ILD---WSKRF------------H  142 (358)
Q Consensus       103 -----~~~~~~~~~lv~e~~~~~~L~-----------~~l~~---~-~~~~-----~~~---~~~~~------------~  142 (358)
                           +....+..+++++|++|..+.           ..+.+   . ....     ...   +....            .
T Consensus        85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (319)
T PRK05231         85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA  164 (319)
T ss_pred             CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence                 123355678999999886431           11111   0 0000     001   00100            0


Q ss_pred             HHHH-HHHHHHHHhcC----CCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          143 IICG-TARGVMYLHQD----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       143 ~~~~-i~~al~~LH~~----~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      .+.+ +...+..+...    -..+++|+|+++.||+++++...-+.||+.+..
T Consensus       165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            1111 11122233211    122499999999999998665568999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.55  E-value=0.0022  Score=58.37  Aligned_cols=144  Identities=22%  Similarity=0.195  Sum_probs=80.5

Q ss_pred             ceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--CccceeeE------EEeCCeeEEEEE
Q 018304           44 NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGC------CIQGEEKLLIYE  115 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~~~------~~~~~~~~lv~e  115 (358)
                      ++.++.|....+|+... ++..+++|+.....  ....+..|.+++..|...  .+++++..      ....+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t-~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEe-CCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            56777888889999875 44468888775421  123455667777777422  24444432      122356789999


Q ss_pred             ecCCCCHH-----------HHH---hccc-ccc-C----CCHHH---HH------------HHHHHHHHHHHHHhc----
Q 018304          116 FMTNKSLD-----------SFI---FDQE-RCK-I----LDWSK---RF------------HIICGTARGVMYLHQ----  156 (358)
Q Consensus       116 ~~~~~~L~-----------~~l---~~~~-~~~-~----~~~~~---~~------------~~~~~i~~al~~LH~----  156 (358)
                      |++|..+.           ..+   +... ... .    .....   ..            .....+...+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99874431           111   1100 000 0    00000   00            001112334444532    


Q ss_pred             CCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       157 ~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      .-...++|+|+++.||+++.++.+.+.||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            1123499999999999999887678999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.54  E-value=0.0018  Score=54.36  Aligned_cols=125  Identities=26%  Similarity=0.362  Sum_probs=84.5

Q ss_pred             CCCCcceeecccCC-ccEEEEEEcCCCEEEEEEecc---c---------Ch---------hhHHHHHHHHHHHHhc---C
Q 018304           39 NNFSINKKLGQGGF-GPVYKGTLVDGQEIAVKRLSK---I---------SE---------QGLKELKNEVILFSKL---Q   93 (358)
Q Consensus        39 ~~y~i~~~lg~g~~-g~v~~~~~~~~~~v~vK~~~~---~---------~~---------~~~~~~~~e~~~l~~l---~   93 (358)
                      .+++.++.||.|.. |.||++.. +|+.|++|++..   .         ..         ....-+..|-...-+|   .
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78899999999999 99999988 788999999421   0         00         1112244555554444   4


Q ss_pred             CCCc--cceeeEEEeCC------------------eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHH
Q 018304           94 HRNL--VKLLGCCIQGE------------------EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY  153 (358)
Q Consensus        94 ~~~i--v~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~  153 (358)
                      +.++  ++++++..-..                  ...||.||+....            .+..    .-+.+|..-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            4556  88888873221                  1246777665433            0222    234567777889


Q ss_pred             HhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       154 LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      +|..|   |+-+|+++.|..     .=+|+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99999   999999999987     2378888864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.51  E-value=0.00088  Score=60.74  Aligned_cols=75  Identities=27%  Similarity=0.376  Sum_probs=49.6

Q ss_pred             ceeecccCCccEEEEEEcC-------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEEEE
Q 018304           44 NKKLGQGGFGPVYKGTLVD-------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++.|..|-...+|+....+       ++.+++|+..... ........|+.++..+...+ .++++.++.    -..|++
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e   77 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE   77 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence            4567778888999987644       4789999875532 22345567888888885333 345555553    236899


Q ss_pred             ecCCCCHH
Q 018304          116 FMTNKSLD  123 (358)
Q Consensus       116 ~~~~~~L~  123 (358)
                      |++|..+.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            98886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.31  E-value=0.0037  Score=56.07  Aligned_cols=76  Identities=20%  Similarity=0.260  Sum_probs=49.1

Q ss_pred             CCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEEEEEec
Q 018304           41 FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .+-.+.++.|.-..+|+.. .+++.+.+|.-.   ......+..|++-|+.|.   .-.+++++.+....+..++++||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3445678888889999876 478899999775   233356778888888884   346788999988888889999998


Q ss_pred             CCC
Q 018304          118 TNK  120 (358)
Q Consensus       118 ~~~  120 (358)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.29  E-value=0.0037  Score=57.79  Aligned_cols=142  Identities=19%  Similarity=0.287  Sum_probs=81.9

Q ss_pred             ceeecccCCccEEEEEEcC-----CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEEec
Q 018304           44 NKKLGQGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~lv~e~~  117 (358)
                      +..|..|-.-.+|++...+     ++.|++|+.........+. ..|..+++.+...++ +++++.+..+    .|.+|+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            4466668888999987432     3689999876544333333 578888888854443 3556665332    578998


Q ss_pred             CCCCHHHH--------------H---hccc--ccc-CCCHHHHHHHHHHH-----------------HHHHHHH----hc
Q 018304          118 TNKSLDSF--------------I---FDQE--RCK-ILDWSKRFHIICGT-----------------ARGVMYL----HQ  156 (358)
Q Consensus       118 ~~~~L~~~--------------l---~~~~--~~~-~~~~~~~~~~~~~i-----------------~~al~~L----H~  156 (358)
                      ++.++...              +   ++..  ... ......+.+++.++                 ...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            77665321              0   1100  000 11122333333221                 1111112    11


Q ss_pred             -CCCCCcccCCCCCCcEEEcC-CCCeEEecccccee
Q 018304          157 -DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA  190 (358)
Q Consensus       157 -~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~~~~~  190 (358)
                       .....++|+|+++.||++++ ++.+.+.||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11224899999999999986 47899999988754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.14  E-value=0.0066  Score=54.24  Aligned_cols=30  Identities=27%  Similarity=0.539  Sum_probs=25.4

Q ss_pred             CcccCCCCCCcEEEcCCCCe-EEecccccee
Q 018304          161 RIIHRDLKASNVLLDQDMNP-KISDFGLARA  190 (358)
Q Consensus       161 ~i~H~di~~~Nilv~~~~~i-~L~Df~~~~~  190 (358)
                      .++|+|+++.||++++++++ -|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            48999999999999875664 5999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.07  E-value=0.01  Score=53.66  Aligned_cols=142  Identities=16%  Similarity=0.216  Sum_probs=88.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEec--ccChhhHHHHHHHHHHHHhcCC--CCccceeeEEEeCC--eeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE--EKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~--~~~~~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~~~~--~~~l  112 (358)
                      ....+++.+..|..-.+|.... ++++++++ ..  ............|+..++.+.-  ......+.++.++.  ..+.
T Consensus        25 ~~~~~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          25 AGLLIVEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CCCceeeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            4455666666666666676655 38889988 43  1333445666778888888743  34555666666665  6699


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHH-HHHHHHHHHhcC----------------------------------
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC-GTARGVMYLHQD----------------------------------  157 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~-~i~~al~~LH~~----------------------------------  157 (358)
                      ||+|++|..+.+......    ..    ..++. .++..|..||+-                                  
T Consensus       103 v~~~veGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~  174 (321)
T COG3173         103 VMEWVEGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELG  174 (321)
T ss_pred             EEEEecceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhcc
Confidence            999998843322210000    00    11111 333333433332                                  


Q ss_pred             ----------------C-----CCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          158 ----------------S-----RLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       158 ----------------~-----~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                                      -     ...++|||+++.|++++.++.+=+.||+.+..
T Consensus       175 ~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         175 GRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                            1     23499999999999999998899999999875

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.99  E-value=0.0047  Score=57.77  Aligned_cols=81  Identities=14%  Similarity=0.098  Sum_probs=54.6

Q ss_pred             cceeecccCCccEEEEEEcCCCEEEEEEecc----cCh---hhHHHHHHHHHHHHhcC--C-CCccceeeEEEeCCeeEE
Q 018304           43 INKKLGQGGFGPVYKGTLVDGQEIAVKRLSK----ISE---QGLKELKNEVILFSKLQ--H-RNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~----~~~---~~~~~~~~e~~~l~~l~--~-~~iv~~~~~~~~~~~~~l  112 (358)
                      -.+.||.|....||+... ++..++||.-..    ...   ........|+..|+.+.  . .++++++.+..  +..++
T Consensus        36 ~~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            467889999999999887 456799997651    111   23444555677777664  2 47778887764  56788


Q ss_pred             EEEecCC--CCHHHHH
Q 018304          113 IYEFMTN--KSLDSFI  126 (358)
Q Consensus       113 v~e~~~~--~~L~~~l  126 (358)
                      +||++++  ..+.+-+
T Consensus       113 vME~L~~~~~ilr~~L  128 (418)
T PLN02756        113 GMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEeecCCcceehhhhh
Confidence            9999976  2444443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.90  E-value=0.011  Score=54.42  Aligned_cols=72  Identities=14%  Similarity=0.163  Sum_probs=49.0

Q ss_pred             eecccCCccEEEEEEcCC-CEEEEEEecc-------cChhhHHHHHHHHHHHHhcC--CC-CccceeeEEEeCCeeEEEE
Q 018304           46 KLGQGGFGPVYKGTLVDG-QEIAVKRLSK-------ISEQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~~~-~~v~vK~~~~-------~~~~~~~~~~~e~~~l~~l~--~~-~iv~~~~~~~~~~~~~lv~  114 (358)
                      .||.|....||++...+| +.++||.-..       .-.-...+..-|.+.|+...  .| .+++++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999987554 6899996531       12334556667888887763  34 4555553  3456677999


Q ss_pred             EecCC
Q 018304          115 EFMTN  119 (358)
Q Consensus       115 e~~~~  119 (358)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.80  E-value=0.013  Score=53.92  Aligned_cols=142  Identities=15%  Similarity=0.192  Sum_probs=79.2

Q ss_pred             ceeecccCCccEEEEEEcC----CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEEecC
Q 018304           44 NKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~lv~e~~~  118 (358)
                      ++.|..|-.-.+|+....+    +..|++|+........ -.-.+|..+++.+...++ +++++++..    .+|.+|++
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~----G~i~~fi~   93 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGN----GMIQSFIN   93 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCC----cEeehhhc
Confidence            4556668888899886533    2388999876533322 223478888888865444 355655522    25888887


Q ss_pred             CCCHHHH-------H-------hcccccc------CCCHHHHHHHHHHH-------------------------HHHHHH
Q 018304          119 NKSLDSF-------I-------FDQERCK------ILDWSKRFHIICGT-------------------------ARGVMY  153 (358)
Q Consensus       119 ~~~L~~~-------l-------~~~~~~~------~~~~~~~~~~~~~i-------------------------~~al~~  153 (358)
                      +.++..-       +       .+.....      ......+.+++.++                         +..+..
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            7654210       1       1100000      01122222222221                         111111


Q ss_pred             Hh-cCC-CCCcccCCCCCCcEEEcC-CCCeEEecccccee
Q 018304          154 LH-QDS-RLRIIHRDLKASNVLLDQ-DMNPKISDFGLARA  190 (358)
Q Consensus       154 LH-~~~-~~~i~H~di~~~Nilv~~-~~~i~L~Df~~~~~  190 (358)
                      +. ..+ ...++|+|+.+.||++++ ++.++++||+.+..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            21 111 124899999999999974 57899999998754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.66  E-value=0.045  Score=49.80  Aligned_cols=30  Identities=23%  Similarity=0.297  Sum_probs=27.4

Q ss_pred             CcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          161 RIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       161 ~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      +++|+|+.++||+++.++.+.+.||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            599999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.58  E-value=0.0031  Score=59.77  Aligned_cols=71  Identities=17%  Similarity=0.208  Sum_probs=47.3

Q ss_pred             EEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-CeeEEEEEecCCCCHHHHHhcc
Q 018304           55 VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFMTNKSLDSFIFDQ  129 (358)
Q Consensus        55 v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~  129 (358)
                      ++.|..+.|..+ ..=+.-..  ...++....++++.+.|+|...++++.... ....+|+|++ +.+|.++....
T Consensus         5 ~~~a~~~~~~~c-~nglplt~--~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPLTP--NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             EEehhcCCCccc-cCCCcCCC--cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            455555455544 22222222  225667788999999999999998877543 3567899998 56999987443

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.54  E-value=0.015  Score=49.45  Aligned_cols=117  Identities=15%  Similarity=0.163  Sum_probs=69.7

Q ss_pred             cCCccEEEEEEcCCCEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhc
Q 018304           50 GGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD  128 (358)
Q Consensus        50 g~~g~v~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  128 (358)
                      |+.++...++.+-|. ..+|.+...+-. ....+.+++.++.++.  .|+++..-  +...+.++.|.|.....      
T Consensus        73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            333444444332233 344444432222 3345567777776654  36666532  34467799999865221      


Q ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          129 QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                            ...    .++..=+.+|...|+.+ ...+|||..|+|||-++.|-+||.|-+..
T Consensus       142 ------~~~----N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 ------NFS----NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ------chh----HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence                  111    11111246788889543 35999999999999999999999997654

The function of this family is unknown.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.49  E-value=0.018  Score=53.59  Aligned_cols=74  Identities=12%  Similarity=0.113  Sum_probs=52.0

Q ss_pred             ceeecccCCccEEEEEEcC-CCEEEEEEecc------cChhhHHHHHHHHHHHHhcC--CC-CccceeeEEEeCCeeEEE
Q 018304           44 NKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK------ISEQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~------~~~~~~~~~~~e~~~l~~l~--~~-~iv~~~~~~~~~~~~~lv  113 (358)
                      .+.||.|....||++.+.+ ++.++||.-..      .-.-...+..-|.+.|+...  .| ++++++.  .+.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            5688999999999998743 67899986421      22345566777888888773  45 4556654  345677889


Q ss_pred             EEecCC
Q 018304          114 YEFMTN  119 (358)
Q Consensus       114 ~e~~~~  119 (358)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999854

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.31  E-value=0.18  Score=45.78  Aligned_cols=28  Identities=25%  Similarity=0.392  Sum_probs=24.8

Q ss_pred             CcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          161 RIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       161 ~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      +++|||+++.||+++. +.+.+.||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            4899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.29  E-value=0.017  Score=49.30  Aligned_cols=30  Identities=33%  Similarity=0.516  Sum_probs=21.6

Q ss_pred             CcccCCCCCCcEEE-cCCCCeEEecccccee
Q 018304          161 RIIHRDLKASNVLL-DQDMNPKISDFGLARA  190 (358)
Q Consensus       161 ~i~H~di~~~Nilv-~~~~~i~L~Df~~~~~  190 (358)
                      .++|+|+.+.||++ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8889999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.26  E-value=0.00046  Score=72.71  Aligned_cols=157  Identities=14%  Similarity=0.028  Sum_probs=110.3

Q ss_pred             HHHHHHHhcCCCCccceeeEEEeC--CeeEEEEEecCCCCHHHHHhcccc-ccCCCHHHHHHHHHHH-HHHHHHHhcCC-
Q 018304           84 NEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYEFMTNKSLDSFIFDQER-CKILDWSKRFHIICGT-ARGVMYLHQDS-  158 (358)
Q Consensus        84 ~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~i-~~al~~LH~~~-  158 (358)
                      .|.+.++...|+++...+.-....  ...+..++|+.+|.+.+.+.+... ..+++.. .....+++ +.+..-+|+.. 
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~-~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRS-PVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhc-hHHHHHHHHHhccchhhhccc
Confidence            344455566788877766555432  355788999999999999866433 3333333 33444444 55555555543 


Q ss_pred             -CCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHH
Q 018304          159 -RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII  237 (358)
Q Consensus       159 -~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~  237 (358)
                       .+..+|.++++.|.++..+-+++++++|+.+..  ...........+++.|+.|++...-+++.++|+|..|+.+|.+.
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             346899999999999999999999999998832  11122233445667788888888778888899999999999999


Q ss_pred             hCCCCC
Q 018304          238 SGKKNR  243 (358)
Q Consensus       238 ~g~~p~  243 (358)
                      .|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            888764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.14  E-value=0.077  Score=45.44  Aligned_cols=78  Identities=14%  Similarity=0.191  Sum_probs=55.5

Q ss_pred             CcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEEEEEecC
Q 018304           42 SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        42 ~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      +-.+.+..|.--..|...+ +..++.+|.-.   ......+..|+.-|..+.   .-.+.+++.+....++.|+|+||++
T Consensus        19 ~er~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          19 KEREEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             hcccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            3335666666666676655 67788888543   344466777887777774   3568888988888999999999998


Q ss_pred             CCCHH
Q 018304          119 NKSLD  123 (358)
Q Consensus       119 ~~~L~  123 (358)
                      -+.++
T Consensus        95 ~~~~d   99 (286)
T COG3001          95 TGPLD   99 (286)
T ss_pred             CCCCC
Confidence            76554

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.99  E-value=0.19  Score=46.07  Aligned_cols=94  Identities=14%  Similarity=0.127  Sum_probs=54.7

Q ss_pred             CcceeHHHHHHhcCCCCcc-----eeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--Ccc
Q 018304           26 LPLFELATIVSATNNFSIN-----KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLV   98 (358)
Q Consensus        26 ~~~~~~~~~~~~~~~y~i~-----~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv   98 (358)
                      .+.+++..+...-..+-+.     ..| .+....||+....++..+++|+... .......+..|.+.+..|...  .++
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l-~s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~   85 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLAL-NSYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVV   85 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEee-ccccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCC
Confidence            4445555555555444332     223 3455678998876788899998753 223446677788887777321  122


Q ss_pred             cee---e--EEEeCCeeEEEEEecCCCC
Q 018304           99 KLL---G--CCIQGEEKLLIYEFMTNKS  121 (358)
Q Consensus        99 ~~~---~--~~~~~~~~~lv~e~~~~~~  121 (358)
                      ...   +  +...++..+.++++++|..
T Consensus        86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         86 APLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            211   1  2233456788999988753

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.78  E-value=0.084  Score=48.34  Aligned_cols=104  Identities=15%  Similarity=0.177  Sum_probs=70.2

Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..|++|++. |+++...       +....+++..++++.+..+.-+..+-  +.-||++...||+++ +|++.|+||.++
T Consensus       300 y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         300 YLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             EEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence            456777775 4555322       22667888899999888888888776  589999999999999 999999999999


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhH
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGI  231 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  231 (358)
                      +.-....       .......-.|-++.|.. +..-+||-+.-
T Consensus       369 Rl~~~q~-------~isy~rldhp~lF~G~d-d~QFeIYrlMr  403 (488)
T COG5072         369 RLSYSQG-------IISYNRLDHPDLFNGVD-DYQFEIYRLMR  403 (488)
T ss_pred             ecccCCc-------eeeccccCchhhhcCcc-ceeeeHHHHHH
Confidence            8421111       11112234455555333 66667776433

>PTZ00384 choline kinase; Provisional

Probab=95.59  E-value=0.13  Score=48.20  Aligned_cols=77  Identities=23%  Similarity=0.290  Sum_probs=46.0

Q ss_pred             CcceeecccCCccEEEEEEcCC--CE-----EEEEEecccChhhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEE
Q 018304           42 SINKKLGQGGFGPVYKGTLVDG--QE-----IAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        42 ~i~~~lg~g~~g~v~~~~~~~~--~~-----v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~lv  113 (358)
                      ..++.|..|-...+|++...++  ..     |+++.... .....-.-..|+++++.+...+ =.++++.+.    .+++
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l  127 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI  127 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence            3455676788999999975332  22     44443222 1111112246888999986544 445666663    3699


Q ss_pred             EEecCCCCHH
Q 018304          114 YEFMTNKSLD  123 (358)
Q Consensus       114 ~e~~~~~~L~  123 (358)
                      .||++|.++.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999886653

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.46  E-value=0.091  Score=46.69  Aligned_cols=48  Identities=23%  Similarity=0.247  Sum_probs=35.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       142 ~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      +.+..+-.++.-.+..- ..++|+|+.|+|++.++.+.++|+||..+..
T Consensus       136 ~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         136 KKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            34444444555444440 2499999999999999999999999988754

>PRK06148 hypothetical protein; Provisional

Probab=95.05  E-value=1.1  Score=47.61  Aligned_cols=164  Identities=18%  Similarity=0.220  Sum_probs=87.3

Q ss_pred             CCCCcceeHHHHHHhc-CCCCcc---eeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC--CCC
Q 018304           23 DLELPLFELATIVSAT-NNFSIN---KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--HRN   96 (358)
Q Consensus        23 ~~~~~~~~~~~~~~~~-~~y~i~---~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--~~~   96 (358)
                      ....|..+.+++...- ..|-+.   +.|+ |..-.+|+....+|..+++|+.....  .......|...|..|.  .+.
T Consensus         5 ~~~~p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~g   81 (1013)
T PRK06148          5 SHPAPEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPD   81 (1013)
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCC
Confidence            3345555655554333 455543   4564 45678899887678899999987532  2234444555665552  122


Q ss_pred             --ccceee--------EEEe-CC--eeEEEEEecCCCCHHHHH-----------------hcc-ccc------cCCCH--
Q 018304           97 --LVKLLG--------CCIQ-GE--EKLLIYEFMTNKSLDSFI-----------------FDQ-ERC------KILDW--  137 (358)
Q Consensus        97 --iv~~~~--------~~~~-~~--~~~lv~e~~~~~~L~~~l-----------------~~~-~~~------~~~~~--  137 (358)
                        +.+++.        .... +.  ..+.+++|++|..+.+..                 +.. ...      ..+.+  
T Consensus        82 lpvP~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl  161 (1013)
T PRK06148         82 LPVPRLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDL  161 (1013)
T ss_pred             CCcCeeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCccccccccc
Confidence              223221        1111 11  456789999987765511                 000 000      00111  


Q ss_pred             ---------------HHHHHHHHHHHHHHH-----HHhcCCCCCcccCCCCCCcEEEcCCC--CeE-Eecccccee
Q 018304          138 ---------------SKRFHIICGTARGVM-----YLHQDSRLRIIHRDLKASNVLLDQDM--NPK-ISDFGLARA  190 (358)
Q Consensus       138 ---------------~~~~~~~~~i~~al~-----~LH~~~~~~i~H~di~~~Nilv~~~~--~i~-L~Df~~~~~  190 (358)
                                     ...+.++..+++.+.     .+... ...++|+|+++.||+++.++  ++. |.|||.+..
T Consensus       162 ~~~~~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        162 RHAGRARDRLHFIDDPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ccchhhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                           111222223333222     12111 12499999999999999775  565 999998754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.05  E-value=0.31  Score=44.66  Aligned_cols=141  Identities=21%  Similarity=0.230  Sum_probs=78.1

Q ss_pred             eecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--ccce----eeE--EEeCC--eeEEEEE
Q 018304           46 KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKL----LGC--CIQGE--EKLLIYE  115 (358)
Q Consensus        46 ~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~----~~~--~~~~~--~~~lv~e  115 (358)
                      .|.+ ....+|+....+|+. ++|+....  .....+..|...++.|....  +...    -+-  ..-..  ..+.+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 566789888755555 88888653  34467777888888873211  1111    111  11123  6678899


Q ss_pred             ecCCCCHHH-H-----------H---hcc-cccc--------CCCHHH----H---------HHHHHHHHHHHHHHhcCC
Q 018304          116 FMTNKSLDS-F-----------I---FDQ-ERCK--------ILDWSK----R---------FHIICGTARGVMYLHQDS  158 (358)
Q Consensus       116 ~~~~~~L~~-~-----------l---~~~-~~~~--------~~~~~~----~---------~~~~~~i~~al~~LH~~~  158 (358)
                      |++|..+.. .           +   +.. +...        ...+..    .         .....++...+..+...=
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999877662 1           1   000 0000        111110    0         011122223333333221


Q ss_pred             -----CCC--cccCCCCCCcEEEcCCCC-eEEecccccee
Q 018304          159 -----RLR--IIHRDLKASNVLLDQDMN-PKISDFGLARA  190 (358)
Q Consensus       159 -----~~~--i~H~di~~~Nilv~~~~~-i~L~Df~~~~~  190 (358)
                           ..+  ++|+|+.|.||+++.+.. +-+.||+.+..
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence                 112  899999999999998875 89999998753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	358
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-53
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-41
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-34
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-24
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-23
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-23
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-23
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-22
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-22
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-22
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-22
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-22
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-22
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-22
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-22
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-22
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-22
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-22
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-22
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-22
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-21
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-21
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-21
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-21
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-21
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-21
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-21
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-21
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-21
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-21
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-21
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-21
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-21
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-21
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-21
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-21
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-21
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-21
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-21
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-21
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-21
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-21
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-19
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-19
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-19
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-19
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-19
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-19
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-18
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-18
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-18
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-18
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-18
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-18
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-18
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-18
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-18
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-18
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-17
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-17
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-17
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-17
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-17
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-17
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-17
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-16
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-16
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-16
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-16
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-15
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-12
3soa_A	444	Full-Length Human Camkii Length = 444		5e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-11
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-07

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 118/293 (40%), Positives = 177/293 (60%), Gaps = 7/293 (2%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELK 83
           +L  F L  +  A++NFS    LG+GGFG VYKG L DG  +AVKRL +   QG + + +
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFH 142
            EV + S   HRNL++L G C+   E+LL+Y +M N S+ S + ++ E    LDW KR  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           I  G+ARG+ YLH     +IIHRD+KA+N+LLD++    + DFGLA+    D  + +   
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDXHVXX 201
Query: 203 VI-GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKK--NRGFYHSDNNLNLIGHAW 259
            + GT G++APEY S G+ S K+DVF +G++LLE+I+G++  +     +D+++ L+    
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
            L  E     L+D  +QG++   EV + I + LLC Q  P +RP M  V+ ML
Sbjct: 262 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  205 bits (522), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 116/293 (39%), Positives = 175/293 (59%), Gaps = 7/293 (2%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELK 83
           +L  F L  +  A++NF     LG+GGFG VYKG L DG  +AVKRL +   QG + + +
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFH 142
            EV + S   HRNL++L G C+   E+LL+Y +M N S+ S + ++ E    LDW KR  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           I  G+ARG+ YLH     +IIHRD+KA+N+LLD++    + DFGLA+    D  + +   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDXHVXX 193
Query: 203 VI-GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKK--NRGFYHSDNNLNLIGHAW 259
            + G  G++APEY S G+ S K+DVF +G++LLE+I+G++  +     +D+++ L+    
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
            L  E     L+D  +QG++   EV + I + LLC Q  P +RP M  V+ ML
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 102/289 (35%), Positives = 162/289 (56%), Gaps = 9/289 (3%)
Query: 26  LPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 85
           +PL +L     ATNNF     +G G FG VYKG L DG ++A+KR +  S QG++E + E
Sbjct: 29  VPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-LDWSKRFHII 144
           +   S  +H +LV L+G C +  E +LIY++M N +L   ++  +   + + W +R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
            G ARG+ YLH  +   IIHRD+K+ N+LLD++  PKI+DFG+++  G +  + +   V+
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXXVV 201
Query: 205 -GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN 263
            GT GY+ PEY   G+ + KSDV+SFG++L E++  +           +NL   A +  N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 264 EGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
            G   Q++DP +        + +     + C+    +DRPSM  V+  L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 102/289 (35%), Positives = 162/289 (56%), Gaps = 9/289 (3%)
Query: 26  LPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 85
           +PL +L     ATNNF     +G G FG VYKG L DG ++A+KR +  S QG++E + E
Sbjct: 29  VPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-LDWSKRFHII 144
           +   S  +H +LV L+G C +  E +LIY++M N +L   ++  +   + + W +R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
            G ARG+ YLH  +   IIHRD+K+ N+LLD++  PKI+DFG+++  G +  + +   V+
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVV 201
Query: 205 -GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN 263
            GT GY+ PEY   G+ + KSDV+SFG++L E++  +           +NL   A +  N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 264 EGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
            G   Q++DP +        + +     + C+    +DRPSM  V+  L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 93/235 (39%), Positives = 134/235 (57%), Gaps = 15/235 (6%)
Query: 15  ENDQIQNIDLELPLFELATIVSATNNFSIN------KKLGQGGFGPVYKGTLVDGQEIAV 68
           EN  ++  D     F    + + TNNF          K+G+GGFG VYKG  V+   +AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAV 59
Query: 69  KRLSKISEQGLKELKN----EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDS 124
           K+L+ + +   +ELK     E+ + +K QH NLV+LLG    G++  L+Y +M N SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 125 FIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 184
            +   +    L W  R  I  G A G+ +LH++     IHRD+K++N+LLD+    KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           FGLARA           R++GT  YMAPE A  G+ + KSD++SFG++LLEII+G
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 93/235 (39%), Positives = 134/235 (57%), Gaps = 15/235 (6%)
Query: 15  ENDQIQNIDLELPLFELATIVSATNNFSIN------KKLGQGGFGPVYKGTLVDGQEIAV 68
           EN  ++  D     F    + + TNNF          K+G+GGFG VYKG  V+   +AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAV 59
Query: 69  KRLSKISEQGLKELKN----EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDS 124
           K+L+ + +   +ELK     E+ + +K QH NLV+LLG    G++  L+Y +M N SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 125 FIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 184
            +   +    L W  R  I  G A G+ +LH++     IHRD+K++N+LLD+    KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           FGLARA           R++GT  YMAPE A  G+ + KSD++SFG++LLEII+G
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 91/227 (40%), Positives = 130/227 (57%), Gaps = 15/227 (6%)
Query: 23  DLELPLFELATIVSATNNFSIN------KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE 76
           D     F    + + TNNF          K+G+GGFG VYKG  V+   +AVK+L+ + +
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVD 61
Query: 77  QGLKELKN----EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC 132
              +ELK     E+ + +K QH NLV+LLG    G++  L+Y +M N SL   +   +  
Sbjct: 62  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 121
Query: 133 KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 192
             L W  R  I  G A G+ +LH++     IHRD+K++N+LLD+    KISDFGLARA  
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
                    R++GT  YMAPE A  G+ + KSD++SFG++LLEII+G
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/221 (39%), Positives = 126/221 (57%), Gaps = 15/221 (6%)
Query: 29  FELATIVSATNNFSIN------KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 82
           F    + + TNNF          K G+GGFG VYKG  V+   +AVK+L+ + +   +EL
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 83  KN----EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWS 138
           K     E+ + +K QH NLV+LLG    G++  L+Y +  N SL   +   +    L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
            R  I  G A G+ +LH++     IHRD+K++N+LLD+    KISDFGLARA        
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
              R++GT  Y APE A  G+ + KSD++SFG++LLEII+G
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 117/216 (54%), Gaps = 29/216 (13%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE----QGLKELKNEVILFSKLQHRN 96
            ++ + +G GGFG VY+   + G E+AVK      +    Q ++ ++ E  LF+ L+H N
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK---ILDWSKRFHIICGTARGVMY 153
           ++ L G C++     L+ EF     L+  +   +R     +++W+ +       ARG+ Y
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQI------ARGMNY 120
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNP--------KISDFGLARAFGGDETEGNTK-RVI 204
           LH ++ + IIHRDLK+SN+L+ Q +          KI+DFGLAR     E    TK    
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAA 175
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           G Y +MAPE      FS  SDV+S+G+LL E+++G+
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 143/294 (48%), Gaps = 35/294 (11%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 97
           + +I +K+G G FG V++     G ++AVK L +     + + E   EV +  +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V  +G   Q     ++ E+++  SL   +      + LD  +R  +    A+G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
               I+HR+LK+ N+L+D+    K+ DFGL+R      T  ++K   GT  +MAPE   D
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRD 213
Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC--- 274
              + KSDV+SFG++L E+ + ++  G      NLN             P+Q++      
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWG------NLN-------------PAQVVAAVGFK 254
Query: 275 ---IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS--ETVLPQPKQ 323
              ++   NL   +  I  G  C    P  RPS  +++ +L    ++ +P P +
Sbjct: 255 CKRLEIPRNLNPQVAAIIEG--CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 141/294 (47%), Gaps = 35/294 (11%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 97
           + +I +K+G G FG V++     G ++AVK L +     + + E   EV +  +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V  +G   Q     ++ E+++  SL   +      + LD  +R  +    A+G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
               I+HRDLK+ N+L+D+    K+ DFGL+R          +K   GT  +MAPE   D
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLX--SKXAAGTPEWMAPEVLRD 213
Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC--- 274
              + KSDV+SFG++L E+ + ++  G      NLN             P+Q++      
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWG------NLN-------------PAQVVAAVGFK 254
Query: 275 ---IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS--ETVLPQPKQ 323
              ++   NL   +  I  G  C    P  RPS  +++ +L    ++ +P P +
Sbjct: 255 CKRLEIPRNLNPQVAAIIEG--CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/196 (37%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           KKLG G FG V+ G   +  ++AVK L K     ++    E  L   LQH  LV+L    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            + E   +I EFM   SL  F+   E  K+L   K        A G+ Y+    R   IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+NVL+ + +  KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGCFTI 189
Query: 223 KSDVFSFGILLLEIIS 238
           KS+V+SFGILL EI++
Sbjct: 190 KSNVWSFGILLYEIVT 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+LG G FG V+ G   +  ++AVK L K     ++    E  L   LQH  LV+L    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            + E   +I E+M   SL  F+   E  K+L   K        A G+ Y+    R   IH
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+NVL+ + +  KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGCFTI 190
Query: 223 KSDVFSFGILLLEIIS 238
           KSDV+SFGILL EI++
Sbjct: 191 KSDVWSFGILLYEIVT 206

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 140/285 (49%), Gaps = 29/285 (10%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+LG G FG V+ GT     ++A+K L K      +    E  +  KL+H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAV- 72
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
           +  E   ++ E+M   SL  F+ D E  + L       +    A G+ Y+    R+  IH
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+++N+L+   +  KI+DFGLAR    +E    T R    +   + APE A  G+F++
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEX---TARQGAKFPIKWTAPEAALYGRFTI 185
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG-SFNL 281
           KSDV+SFGILL E+++  K R  Y   NN  ++        E +      PC Q    +L
Sbjct: 186 KSDVWSFGILLTELVT--KGRVPYPGMNNREVL--------EQVERGYRMPCPQDCPISL 235
Query: 282 AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
            E++  IH    C ++ P++RP+   +   L       +P+ QPG
Sbjct: 236 HELM--IH----CWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 109/218 (50%), Gaps = 24/218 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 91
           NN    K LG G FG V + T    G+E     +AVK L   +    KE L +E+ + S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-------FDQERCKILDWSKRFHI 143
           L QH N+V LLG C  G   L+I E+     L +F+        D+E  + L+     H 
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNT 200
               A+G+ +L   +    IHRD+ A NVLL      KI DFGLAR    D     +GN 
Sbjct: 158 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           +  +    +MAPE   D  ++V+SDV+S+GILL EI S
Sbjct: 215 RLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/221 (36%), Positives = 110/221 (49%), Gaps = 26/221 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 91
           NN    K LG G FG V + T    G+E     +AVK L   +    KE L +E+ + S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           L QH N+V LLG C  G   L+I E+     L +F+  + + ++L+    F I   TA  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTAST 163
Query: 151 VMYLHQDSRL----------RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TE 197
              LH  S++            IHRD+ A NVLL      KI DFGLAR    D     +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           GN +  +    +MAPE   D  ++V+SDV+S+GILL EI S
Sbjct: 224 GNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 109/218 (50%), Gaps = 24/218 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 91
           NN    K LG G FG V + T    G+E     +AVK L   +    KE L +E+ + S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-------FDQERCKILDWSKRFHI 143
           L QH N+V LLG C  G   L+I E+     L +F+        D+E  + L+     H 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNT 200
               A+G+ +L   +    IHRD+ A NVLL      KI DFGLAR    D     +GN 
Sbjct: 166 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           +  +    +MAPE   D  ++V+SDV+S+GILL EI S
Sbjct: 223 RLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 185 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 238
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 239 ---MEGGLLDKPDNCPDMLLELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 283
Query: 323 QPGY 326
           +PG+
Sbjct: 284 EPGF 287

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 86  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 140
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTI 197
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 198 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 251
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 252 R---------LCWKERPEDRPT 264

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 190 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 243
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 244 R---------LCWKERPEDRPT 256

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 84  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTI 195
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 196 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 249
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 250 R---------LCWKERPEDRPT 262

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 247
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 248 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 292
Query: 323 QPGY 326
           +PG+
Sbjct: 293 EPGF 296

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 79  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 133
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTI 190
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 191 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 244
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 245 R---------LCWKERPEDRPT 257

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 80  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 134
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTI 191
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 192 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 245
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 246 R---------LCWKERPEDRPT 258

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 87  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 141
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTI 198
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 199 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 252
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 253 R---------LCWKERPEDRPT 265

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 129/263 (49%), Gaps = 26/263 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 190 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 243
Query: 283 EVIRCIHIGLLCVQQHPKDRPSM 305
                     LC ++ P+DRP+ 
Sbjct: 244 R---------LCWKERPEDRPTF 257

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 84  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 195
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 196 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 249
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 250 R---------LCWKERPEDRPT 262

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 83  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 137
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 194
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 195 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 248
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 249 R---------LCWKERPEDRPT 261

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 73  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 127
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 184
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 185 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 238
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 239 R---------LCWKERPEDRPT 251

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 190 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 243
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 244 R---------LCWKERPEDRPT 256

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 138/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 67  QLYAV-VSEEPIXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE--- 121
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--YMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 122 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTAPEAAL 178
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 179 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 232
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 233 SLHDLM---------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 273

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 88  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 142
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           RDL+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 199
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 200 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 253
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 254 R---------LCWKERPEDRPT 266

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 27/283 (9%)
Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
             E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    R+  +HR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSVK 223
           DL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A  G+F++K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 224 SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAE 283
           SDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +   +L  
Sbjct: 362 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPESLHDLM- 414
Query: 284 VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
                     C ++ P++RP+   +   L       +P+ QPG
Sbjct: 415 --------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 138/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 70  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE--- 124
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 125 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 181
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 182 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 235
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 236 SLHDLM---------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 276

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 27/283 (9%)
Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
             E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    R+  +HR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSVK 223
           DL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A  G+F++K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 224 SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAE 283
           SDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +   +L  
Sbjct: 362 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPESLHDLM- 414
Query: 284 VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
                     C ++ P++RP+   +   L       +P+ QPG
Sbjct: 415 --------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 246
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 247 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 291
Query: 323 QPGY 326
           +PG+
Sbjct: 292 EPGF 295

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/221 (36%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 91
           NN    K LG G FG V + T    G+E     +AVK L   +    KE L +E+ + S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           L QH N+V LLG C  G   L+I E+     L +F+  + + ++L+    F I   T   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTLST 163
Query: 151 VMYLHQDSRL----------RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TE 197
              LH  S++            IHRD+ A NVLL      KI DFGLAR    D     +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           GN +  +    +MAPE   D  ++V+SDV+S+GILL EI S
Sbjct: 224 GNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 246
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 247 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 291
Query: 323 QPGY 326
           +PG+
Sbjct: 292 EPGF 295

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 253
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 254 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 298
Query: 323 QPGY 326
           +PG+
Sbjct: 299 EPGF 302

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 247
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 248 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 292
Query: 323 QPGY 326
           +PG+
Sbjct: 293 EPGF 296

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 134 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 191 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 244
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 245 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 289
Query: 323 QPGY 326
           +PG+
Sbjct: 290 EPGF 293

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 240
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 241 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 285
Query: 323 QPGY 326
           +PG+
Sbjct: 286 EPGF 289

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 131/272 (48%), Gaps = 36/272 (13%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           +  + KKLG G FG V+  T     ++AVK + K     ++    E  +   LQH  LVK
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 74
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK-----ILDWSKRFHIICGTARGVMYL 154
           L    +  E   +I EFM   SL  F+   E  K     ++D+S +       A G+ ++
Sbjct: 75  L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFI 127
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAP 212
            Q +    IHRDL+A+N+L+   +  KI+DFGLAR    +E    T R    +   + AP
Sbjct: 128 EQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAP 181
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 272
           E  + G F++KSDV+SFGILL+EI++    R  Y   +N  +I    + +    P     
Sbjct: 182 EAINFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVIRALERGYRMPRPEN--- 236
Query: 273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
            C +  +N         I + C +  P++RP+
Sbjct: 237 -CPEELYN---------IMMRCWKNRPEERPT 258

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 138/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 77  QLYAV-VSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX---TARQGAKFPIKWTAPEAAL 188
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 189 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 242
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 243 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 165 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 221
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 222 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 275
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 276 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 320
Query: 323 QPGY 326
           +PG+
Sbjct: 321 EPGF 324

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 138/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 66  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 120
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--YMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 121 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 177
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 178 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 231
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 232 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 272

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 138/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 68  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 122
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 123 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 179
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 180 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 233
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 234 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 274

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           ++LG G FG V+ G      ++AVK L + S         E  L  +LQH+ LV+L    
Sbjct: 15  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +    IH
Sbjct: 74  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 128
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSV 222
           R+L+A+N+L+   ++ KI+DFGLAR    +E    T R    +   + APE  + G F++
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 185
Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLA 282
           KSDV+SFGILL EI++    R  Y    N  +I +  + +    P    D C +  + L 
Sbjct: 186 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLM 239
Query: 283 EVIRCIHIGLLCVQQHPKDRPS 304
                     LC ++ P+DRP+
Sbjct: 240 R---------LCWKERPEDRPT 252

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 138/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 77  QLYAV-VSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 189 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 242
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 243 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 138/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 189 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 242
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 243 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 27/283 (9%)
Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
             E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    R+  +HR
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSVK 223
           DL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A  G+F++K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 224 SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAE 283
           SDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +   +L  
Sbjct: 362 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPESLHDLM- 414
Query: 284 VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
                     C ++ P++RP+   +   L       +P+ QPG
Sbjct: 415 --------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 449

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 137/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M   SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 74  QLYAV-VSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVE--- 128
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 129 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 185
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 186 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 239
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 240 SLHDLM---------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 27/283 (9%)
Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV+L    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AVV 331
Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
             E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    R+  +HR
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSVK 223
           DL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A  G+F++K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 224 SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAE 283
           SDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +   +L  
Sbjct: 445 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPESLHDLM- 497
Query: 284 VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
                     C ++ P++RP+   +   L       +P+ QPG
Sbjct: 498 --------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQPG 532

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 137/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M   SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 74  QLYAV-VSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVE--- 128
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 129 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEW---TARQGAKFPIKWTAPEAAL 185
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 186 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 239
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 240 SLHDLM---------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 280

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 19/230 (8%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           +N  + ++LG+G FG V+           D   +AVK L   S+   K+   E  L + L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI----------LDWSKRFH 142
           QH ++VK  G C++G+  ++++E+M +  L+ F+       +          L  S+  H
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           I    A G++YL   +    +HRDL   N L+ +++  KI DFG++R     +       
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 189
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
            +    +M PE     +F+ +SDV+S G++L EI +  K   +  S+N +
Sbjct: 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 138/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 77  QLYAV-VSEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 189 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 242
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 243 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKIL---DWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++     + E   +L     SK   
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N  + +D   KI DFG+ R     +      +
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 240
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 241 ---MEGGLLDKPDNCPDMLLELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 285
Query: 323 QPGY 326
           +PG+
Sbjct: 286 EPGF 289

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 131/273 (47%), Gaps = 36/273 (13%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           +  + KKLG G FG V+  T     ++AVK + K     ++    E  +   LQH  LVK
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK-----ILDWSKRFHIICGTARGVMYL 154
           L    +  E   +I EFM   SL  F+   E  K     ++D+S +       A G+ ++
Sbjct: 248 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFI 300
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAP 212
            Q +    IHRDL+A+N+L+   +  KI+DFGLAR    +E    T R    +   + AP
Sbjct: 301 EQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAP 354
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 272
           E  + G F++KSDV+SFGILL+EI++    R  Y   +N  +I    + +    P     
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVIRALERGYRMPRPEN--- 409
Query: 273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
            C +  +N         I + C +  P++RP+ 
Sbjct: 410 -CPEELYN---------IMMRCWKNRPEERPTF 432

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 138/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  K++H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 189 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 242
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 243 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 137/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 132 RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 189 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 242
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 243 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 112/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL--- 148
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E     N         +MA E  
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/231 (34%), Positives = 109/231 (47%), Gaps = 37/231 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 91
           NN    K LG G FG V + T    G+E     +AVK L   +    KE L +E+ + S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--------------------FDQE 130
           L QH N+V LLG C  G   L+I E+     L +F+                     D+E
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 131 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
             + L+     H     A+G+ +L   +    IHRD+ A NVLL      KI DFGLAR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 191 FGGDE---TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              D     +GN +  +    +MAPE   D  ++V+SDV+S+GILL EI S
Sbjct: 208 IMNDSNYIVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL   
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL--- 167
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E  
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELMT 250

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL   
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL--- 168
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E  
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL   
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL--- 148
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E  
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL--- 149
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+   L  F+   E  K L   +   +    A G+ Y+    
Sbjct: 77  QLYAV-VSEEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 189 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 242
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 243 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 135/283 (47%), Gaps = 27/283 (9%)
Query: 46  KLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV+L    +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 249
Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
             E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+    R+  +HR
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDGQFSVK 223
           DL+A+N+L+ +++  K++DFGL R    +E    T R    +   + APE A  G+F++K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 224 SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAE 283
           SDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +   +L  
Sbjct: 363 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPESLHDLM- 415
Query: 284 VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
                     C ++ P++RP+   +   L       +P+ QPG
Sbjct: 416 --------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPG 450

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL--- 149
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL--- 146
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 113/204 (55%), Gaps = 13/204 (6%)
Query: 43  INKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNL 97
            N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N+
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 98  VKLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           + LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL  
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL-- 147
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEY 214
            +  + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
               +F+ KSDV+SFG+LL E+++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL   
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL--- 141
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E  
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 27/290 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L    +  E   ++ E+M+   L  F+   E  K L   +   +    A G+ Y+    
Sbjct: 77  QLYAV-VSEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYAS 216
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E    T R    +   + APE A 
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAAL 188
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
            G+F++KSDV+SFGILL E+ +  K R  Y    N  ++    + +    P +    C +
Sbjct: 189 YGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPE----CPE 242
Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
              +L            C ++ P++RP+   +   L       +P+ QPG
Sbjct: 243 SLHDLM---------CQCWRKDPEERPTFEYLQAFLEDYFTSTEPQYQPG 283

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 113/204 (55%), Gaps = 13/204 (6%)
Query: 43  INKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNL 97
            N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N+
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 98  VKLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           + LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ YL  
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL-- 144
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEY 214
            +  + +HRDL A N +LD+    K++DFGLAR     E  +  N         +MA E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
               +F+ KSDV+SFG+LL E+++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 140/304 (46%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-------FDQERCKILDWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++        +         SK   
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 253
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 254 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 298
Query: 323 QPGY 326
           +PG+
Sbjct: 299 EPGF 302

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 140/304 (46%), Gaps = 38/304 (12%)
Query: 37  ATNNFSINKKLGQGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 89
           A    +++++LGQG FG VY    KG + D  E  +A+K +++ +    + E  NE  + 
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-------FDQERCKILDWSKRFH 142
            +    ++V+LLG   QG+  L+I E MT   L S++        +         SK   
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +    A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      +
Sbjct: 133 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
            +    +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  ++       
Sbjct: 190 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV---- 243
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
              M   L+D        L E++R      +C Q +PK RPS   +I  +  E       
Sbjct: 244 ---MEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEM------ 288
Query: 323 QPGY 326
           +PG+
Sbjct: 289 EPGF 292

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ +L   
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL--- 154
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E +   N         +MA E  
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELMT 237

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/280 (31%), Positives = 133/280 (47%), Gaps = 27/280 (9%)
Query: 27  PLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEV 86
           P +E A  V       + ++LG G  G V+ G      ++AVK L + S         E 
Sbjct: 2   PWWEDAWEVP-RETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEA 59
Query: 87  ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG 146
            L  +LQH+ LV+L     Q E   +I E+M N SL  F+      K L  +K   +   
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQ 117
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
            A G+ ++ + +    IHRDL+A+N+L+   ++ KI+DFGLAR     E    T R    
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX---TAREGAK 171
Query: 207 Y--GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
           +   + APE  + G F++KSDV+SFGILL EI++    R  Y    N  +I +  + +  
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYRM 229
Query: 265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
             P    D C +  + L           LC ++ P+DRP+
Sbjct: 230 VRP----DNCPEELYQLMR---------LCWKERPEDRPT 256

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 142/300 (47%), Gaps = 40/300 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQG----- 78
           E P   L T+  A N     K++G+GGFG V+KG LV D   +A+K L     +G     
Sbjct: 7   EFPKSRLPTL--ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 79  --LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD 136
              +E + EV + S L H N+VKL G  +      ++ EF+    L   + D  +   + 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIK 120
Query: 137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMN----PKISDFGLARAF 191
           WS +  ++   A G+ Y+ Q+    I+HRDL++ N+ L   D N     K++DFGL++  
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 192 GGDETEGNTKRVIGTYGYMAPEY--ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD 249
              ++  +   ++G + +MAPE   A +  ++ K+D +SF ++L  I++G+     Y S 
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SY 233
Query: 250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
             +  I     +  EG+   + + C     N+ E         LC    PK RP    ++
Sbjct: 234 GKIKFIN---MIREEGLRPTIPEDCPPRLRNVIE---------LCWSGDPKKRPHFSYIV 281

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL--- 208
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E +   N         +MA E  
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 20/204 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQE-----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 98
           K LG G FG VYKG  V   E     +A+K L++ +  +   E  +E ++ + + H +LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYL 154
           +LLG C+    +L + + M +  L  ++ + +       +L+W  +       A+G+MYL
Sbjct: 104 RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 156
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
            +    R++HRDL A NVL+    + KI+DFGLAR   GDE E N         +MA E 
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
               +F+ +SDV+S+G+ + E+++
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ +L   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL--- 147
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E +   N         +MA E  
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ +L   
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL--- 150
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E +   N         +MA E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ +L   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL--- 149
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E +   N         +MA E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ +L   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL--- 149
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E +   N         +MA E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 136/278 (48%), Gaps = 34/278 (12%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 15  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           G   +  +  ++ ++    SL   +   E     +  K   I   TARG+ YLH  S   
Sbjct: 75  GYSTK-PQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS--- 128
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---YASDG 218
           IIHRDLK++N+ L +D   KI DFGLA            +++ G+  +MAPE        
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS 278
            +S +SDV++FGI+L E+++G+     Y + NN +               Q+I+   +GS
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRD---------------QIIEMVGRGS 230
Query: 279 F--NLAEV-----IRCIHIGLLCVQQHPKDRPSMPSVI 309
              +L++V      R   +   C+++   +RPS P ++
Sbjct: 231 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 268

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVD--GQEI--AVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 98
           N+ +G+G FG VY GTL+D  G++I  AVK L++I++ G + +   E I+     H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 99  KLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            LLG C++ E   L++  +M +  L +FI ++     +     F +    A+G+ +L   
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL--- 150
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYA 215
           +  + +HRDL A N +LD+    K++DFGLAR     E +   N         +MA E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 20/204 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQE-----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 98
           K LG G FG VYKG  V   E     +A+K L++ +  +   E  +E ++ + + H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGTARGVMYL 154
           +LLG C+    +L + + M +  L  ++ + +       +L+W  +       A+G+MYL
Sbjct: 81  RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 133
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
            +    R++HRDL A NVL+    + KI+DFGLAR   GDE E N         +MA E 
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
               +F+ +SDV+S+G+ + E+++
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 135/278 (48%), Gaps = 34/278 (12%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           G      +  ++ ++    SL   +   E     +  K   I   TARG+ YLH  S   
Sbjct: 87  GYST-APQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---YASDG 218
           IIHRDLK++N+ L +D   KI DFGLA            +++ G+  +MAPE        
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS 278
            +S +SDV++FGI+L E+++G+     Y + NN +               Q+I+   +GS
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRD---------------QIIEMVGRGS 242
Query: 279 F--NLAEV-----IRCIHIGLLCVQQHPKDRPSMPSVI 309
              +L++V      R   +   C+++   +RPS P ++
Sbjct: 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 136/279 (48%), Gaps = 34/279 (12%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
            ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  
Sbjct: 26  ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
           +G   +  +  ++ ++    SL   +   E     +  K   I   TARG+ YLH  S  
Sbjct: 86  MGYSTK-PQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS-- 140
Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---YASD 217
            IIHRDLK++N+ L +D   KI DFGLA            +++ G+  +MAPE       
Sbjct: 141 -IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
             +S +SDV++FGI+L E+++G+     Y + NN +               Q+I+   +G
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRD---------------QIIEMVGRG 241
Query: 278 SF--NLAEV-----IRCIHIGLLCVQQHPKDRPSMPSVI 309
           S   +L++V      R   +   C+++   +RPS P ++
Sbjct: 242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/225 (35%), Positives = 110/225 (48%), Gaps = 32/225 (14%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 91
           NN    K LG G FG V + T    G+E     +AVK L   +    KE L +E+ + S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR---------- 140
           L QH N+V LLG C  G   L+I E+     L +F+  ++R   L++S            
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-RRKRPPGLEYSYNPSHNPEEQLS 164
Query: 141 ----FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE- 195
                H     A+G+ +L   +    IHRD+ A NVLL      KI DFGLAR    D  
Sbjct: 165 SRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221
Query: 196 --TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              +GN +  +    +MAPE   D  ++V+SDV+S+GILL EI S
Sbjct: 222 YIVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G FG VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 69
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKK 128
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAY 184
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY---- 240
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 241 -------ELMRA------CWQWNPSDRPSFAEI 260

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 113/217 (52%), Gaps = 29/217 (13%)
Query: 45  KKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           ++LG+  FG VYKG L         Q +A+K L   +E  L+E  ++E +L ++LQH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIF-----------DQERC--KILDWSKRFHII 144
           V LLG   + +   +I+ + ++  L  F+            D +R     L+     H++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETE--GNTK 201
              A G+ YL   S   ++H+DL   NVL+   +N KISD GL R  +  D  +  GN+ 
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             I    +MAPE    G+FS+ SD++S+G++L E+ S
Sbjct: 209 LPIR---WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 40/300 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQG----- 78
           E P   L T+  A N     K++G+GGFG V+KG LV D   +A+K L     +G     
Sbjct: 7   EFPKSRLPTL--ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 79  --LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD 136
              +E + EV + S L H N+VKL G  +      ++ EF+    L   + D  +   + 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIK 120
Query: 137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMN----PKISDFGLARAF 191
           WS +  ++   A G+ Y+ Q+    I+HRDL++ N+ L   D N     K++DFG ++  
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-- 177
Query: 192 GGDETEGNTKRVIGTYGYMAPEY--ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD 249
              ++  +   ++G + +MAPE   A +  ++ K+D +SF ++L  I++G+     Y S 
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SY 233
Query: 250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
             +  I     +  EG+   + + C     N+ E         LC    PK RP    ++
Sbjct: 234 GKIKFIN---MIREEGLRPTIPEDCPPRLRNVIE---------LCWSGDPKKRPHFSYIV 281

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 113/217 (52%), Gaps = 29/217 (13%)
Query: 45  KKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           ++LG+  FG VYKG L         Q +A+K L   +E  L+E  ++E +L ++LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIF-----------DQERC--KILDWSKRFHII 144
           V LLG   + +   +I+ + ++  L  F+            D +R     L+     H++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGDETE--GNTK 201
              A G+ YL   S   ++H+DL   NVL+   +N KISD GL R  +  D  +  GN+ 
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             I    +MAPE    G+FS+ SD++S+G++L E+ S
Sbjct: 192 LPIR---WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 117/219 (53%), Gaps = 16/219 (7%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--FDQERCKILDWSKR 140
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   D +   I    + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QL 149
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             ++ G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGLAR    D     T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT 206
Query: 201 KRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI EF+   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 69
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKK 128
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAY 184
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY---- 240
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 241 -------ELMRA------CWQWNPSDRPSFAEI 260

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 40/300 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQG----- 78
           E P   L T+  A N     K++G+GGFG V+KG LV D   +A+K L     +G     
Sbjct: 7   EFPKSRLPTL--ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 79  --LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD 136
              +E + EV + S L H N+VKL G  +      ++ EF+    L   + D  +   + 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIK 120
Query: 137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMN----PKISDFGLARAF 191
           WS +  ++   A G+ Y+ Q+    I+HRDL++ N+ L   D N     K++DF L++  
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-- 177
Query: 192 GGDETEGNTKRVIGTYGYMAPEY--ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD 249
              ++  +   ++G + +MAPE   A +  ++ K+D +SF ++L  I++G+     Y S 
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SY 233
Query: 250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
             +  I     +  EG+   + + C     N+ E         LC    PK RP    ++
Sbjct: 234 GKIKFIN---MIREEGLRPTIPEDCPPRLRNVIE---------LCWSGDPKKRPHFSYIV 281

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 128/271 (47%), Gaps = 42/271 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           +  + KKLG G FG V+  T     ++AVK + K     ++    E  +   LQH  LVK
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 241
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK-----ILDWSKRFHIICGTARGVMYL 154
           L    +  E   +I EFM   SL  F+   E  K     ++D+S +       A G+ ++
Sbjct: 242 L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFI 294
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
            Q +    IHRDL+A+N+L+   +  KI+DFGLAR           K  I    + APE 
Sbjct: 295 EQRN---YIHRDLRAANILVSASLVCKIADFGLARV--------GAKFPIK---WTAPEA 340
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC 274
            + G F++KSDV+SFGILL+EI++    R  Y   +N  +I    + +    P      C
Sbjct: 341 INFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVIRALERGYRMPRPEN----C 394
Query: 275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
            +  +N         I + C +  P++RP+ 
Sbjct: 395 PEELYN---------IMMRCWKNRPEERPTF 416

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 116/218 (53%), Gaps = 14/218 (6%)
Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           F + +KLG+G +G VYK    + GQ +A+K++    E  L+E+  E+ +  +    ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVK 88
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
             G   +  +  ++ E+    S+   I  + R K L   +   I+  T +G+ YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEYASD 217
           +R IHRD+KA N+LL+ + + K++DFG+A    G  T+   KR  VIGT  +MAPE   +
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDXMAKRNXVIGTPFWMAPEVIQE 199
Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI 255
             ++  +D++S GI  +E+  GK      H    + +I
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 135
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAY 191
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 247
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 248 -------ELMRA------CWQWNPSDRPSFAEI 267

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G   +  +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 71  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 123
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 135
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 191
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 247
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 248 -------ELMRA------CWQWNPSDRPSFAEI 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 69
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKK 128
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 129 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAY 184
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY---- 240
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 241 -------ELMRA------CWQWNPSDRPSFAEI 260

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 13  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G   +  +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 73  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 125
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 126 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 186
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 242
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 243 -------ELMRA------CWQWNPSDRPSFAEI 262

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 72
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 73  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 131
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 132 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAY 187
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 243
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 244 -------ELMRA------CWQWNPSDRPSFAEI 263

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G      +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 71  GYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 123
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 186
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 242
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 243 -------ELMRA------CWQWNPSDRPSFAEI 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 134
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 135 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 190
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 246
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 247 -------ELMRA------CWQWNPSDRPSFAEI 266

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 117/219 (53%), Gaps = 16/219 (7%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--FDQERCKILDWSKR 140
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   D +   I    + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QL 149
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             ++ G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D     T
Sbjct: 150 VGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 201 KRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 135
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 191
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 247
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 248 -------ELMRA------CWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 84
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 85  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 143
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 144 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 199
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 200 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 255
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 256 -------ELMRA------CWQWNPSDRPSFAEI 275

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q   + +D  K         +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL--- 133
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 73
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 132
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 188
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 244
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 245 -------ELMRA------CWQWNPSDRPSFAEI 264

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 116/223 (52%), Gaps = 24/223 (10%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 33  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 91
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   +         +F 
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFT 143
Query: 143 IIC------GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
           +I       G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D  
Sbjct: 144 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 200
Query: 197 EGNTKRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              T R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 201 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 116/223 (52%), Gaps = 24/223 (10%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   +         +F 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFT 145
Query: 143 IIC------GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
           +I       G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D  
Sbjct: 146 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 197 EGNTKRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              T R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G   +  +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 76  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 128
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 129 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 116/223 (52%), Gaps = 24/223 (10%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   +         +F 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFT 145
Query: 143 IIC------GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
           +I       G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D  
Sbjct: 146 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 197 EGNTKRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              T R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 116/223 (52%), Gaps = 24/223 (10%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   +         +F 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFT 145
Query: 143 IIC------GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
           +I       G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D  
Sbjct: 146 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 197 EGNTKRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              T R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 117/219 (53%), Gaps = 16/219 (7%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--FDQERCKILDWSKR 140
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   D +   I    + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QL 149
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             ++ G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D     T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 201 KRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 124/218 (56%), Gaps = 15/218 (6%)
Query: 28  LFELATIVSATN---NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK 83
           L +L +IVS  +    ++  +K+GQG  G VY    +  GQE+A+++++ + +Q  KEL 
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELI 64
Query: 84  -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
            NE+++  + ++ N+V  L   + G+E  ++ E++   SL   +   E C  +D  +   
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAA 120
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +     + + +LH +   ++IHRD+K+ N+LL  D + K++DFG       ++++ +T  
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-- 175
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 135
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 191
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 247
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 248 -------ELMRA------CWQWNPSDRPSFAEI 267

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G   +  +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 76  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 128
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 129 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKL 92
            +  +  +LG+G FG V+      L+  Q+   +AVK L + SE   ++ + E  L + L
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 77
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ-ERCKI-----------LDWSKR 140
           QH+++V+  G C +G   L+++E+M +  L+ F+       K+           L   + 
Sbjct: 78  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             +    A G++YL   + L  +HRDL   N L+ Q +  KI DFG++R     +     
Sbjct: 138 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            R +    +M PE     +F+ +SDV+SFG++L EI +  K   +  S+  
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 117/225 (52%), Gaps = 28/225 (12%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 23  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 81
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   +         +F 
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFT 133
Query: 143 IIC------GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
           +I       G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D  
Sbjct: 134 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 190
Query: 197 EGNTKRVIG---TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              T R  G      + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 191 AAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 73
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 132
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 188
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 244
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 245 -------ELMRA------CWQWNPSDRPSFAEI 264

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 117/225 (52%), Gaps = 28/225 (12%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   +         +F 
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFT 116
Query: 143 IIC------GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
           +I       G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D  
Sbjct: 117 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 197 EGNTKRVIG---TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              T R  G      + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 174 AAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 38  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G   +  +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 98  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 150
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 151 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G   +  +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 71  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 123
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 129
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKL 92
            +  +  +LG+G FG V+      L+  Q+   +AVK L + SE   ++ + E  L + L
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 71
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ-ERCKI-----------LDWSKR 140
           QH+++V+  G C +G   L+++E+M +  L+ F+       K+           L   + 
Sbjct: 72  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             +    A G++YL   + L  +HRDL   N L+ Q +  KI DFG++R     +     
Sbjct: 132 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            R +    +M PE     +F+ +SDV+SFG++L EI +  K   +  S+  
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 239

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 76
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKK 135
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 136 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 191
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 247
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 248 -------ELMRA------CWQWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 186
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 242
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 243 -------ELMRA------CWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 186
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 242
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 243 -------ELMRA------CWQWNPSDRPSFAEI 262

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G   +  +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 99  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 151
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 152 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 22/271 (8%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 186
Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
            +FS+KSDV++FG+LL EI +      +  S      +   ++L  +    +  + C + 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
            + L            C Q +P DRPS   +
Sbjct: 241 VYELMRA---------CWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 22/271 (8%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 131 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 186
Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
            +FS+KSDV++FG+LL EI +      +  S      +   ++L  +    +  + C + 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
            + L            C Q +P DRPS   +
Sbjct: 241 VYELMRA---------CWQWNPSDRPSFAEI 262

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 116/219 (52%), Gaps = 16/219 (7%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--FDQERCKILDWSKR 140
             E  +  +  H N+++L G   + +  +++ E+M N SLDSF+   D +   I    + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QL 149
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             ++ G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL R    D     T
Sbjct: 150 VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 201 KRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 136
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 31  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G   +  +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 91  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 143
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 144 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 135
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 72
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 73  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 131
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD T            + APE  + 
Sbjct: 132 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAY 187
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 243
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 244 -------ELMRA------CWQWNPSDRPSFAEI 263

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 73
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 132
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD T            + APE  + 
Sbjct: 133 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAY 188
Query: 218 GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN-EGMPSQLIDPCI 275
            +FS+KSDV++FG+LL EI + G              L+   +++   EG P ++     
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY---- 244
Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                  E++R       C Q +P DRPS   +
Sbjct: 245 -------ELMRA------CWQWNPSDRPSFAEI 264

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 137
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++  +
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF----DQERCKILDWSKRFHIICGTARGVMYLHQD 157
           G   +  +  ++ ++    SL   +       E  K++D +++      TA+G+ YLH  
Sbjct: 99  GYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ------TAQGMDYLHAK 151
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE---Y 214
           S   IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE    
Sbjct: 152 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +S +SDV++FGI+L E+++G+
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKL 92
            +  +  +LG+G FG V+      L+  Q+   +AVK L + SE   ++ + E  L + L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ-ERCKI-----------LDWSKR 140
           QH+++V+  G C +G   L+++E+M +  L+ F+       K+           L   + 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             +    A G++YL   + L  +HRDL   N L+ Q +  KI DFG++R     +     
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            R +    +M PE     +F+ +SDV+SFG++L EI +  K   +  S+  
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAV-KRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           LG+G FG   K T  +  E+ V K L +  E+  +    EV +   L+H N++K +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR 165
           + +    I E++   +L   I   +      WS+R       A G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR------------VIGTYGYMAPE 213
           DL + N L+ ++ N  ++DFGLAR    ++T+    R            V+G   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 214 YASDGQFSVKSDVFSFGILLLEII 237
             +   +  K DVFSFGI+L EII
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 134/281 (47%), Gaps = 32/281 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           +  +  +++G G FG V+ G  ++  ++A+K  R   +SE+   E + EV++  KL H  
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMM--KLSHPK 63
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           LV+L G C++     L++EFM +  L  ++  Q    +        +      G+ YL +
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE 121
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
            S   +IHRDL A N L+ ++   K+SDFG+ R    D+   +T        + +PE  S
Sbjct: 122 AS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFS 177
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL---IGHAWKLWNEGMPSQLIDP 273
             ++S KSDV+SFG+L+ E+ S  K    Y + +N  +   I   ++L+   + S  +  
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVEDISTGFRLYKPRLASTHV-- 233
Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS 314
                           I   C ++ P+DRP+   ++  L +
Sbjct: 234 --------------YQIMNHCWKERPEDRPAFSRLLRQLAA 260

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 123/220 (55%), Gaps = 19/220 (8%)
Query: 28  LFELATIVSATN---NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK 83
           L +L +IVS  +    ++  +K+GQG  G VY    +  GQE+A+++++ + +Q  KEL 
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELI 64
Query: 84  -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
            NE+++  + ++ N+V  L   + G+E  ++ E++   SL   +   E C  +D  +   
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAA 120
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +     + + +LH +   ++IHRD+K+ N+LL  D + K++DFG    F    T   +KR
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 173
Query: 203 --VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
             ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 174 SEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 123/220 (55%), Gaps = 19/220 (8%)
Query: 28  LFELATIVSATN---NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK 83
           L +L +IVS  +    ++  +K+GQG  G VY    +  GQE+A+++++ + +Q  KEL 
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELI 64
Query: 84  -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
            NE+++  + ++ N+V  L   + G+E  ++ E++   SL   +   E C  +D  +   
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAA 120
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +     + + +LH +   ++IHRD+K+ N+LL  D + K++DFG    F    T   +KR
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 173
Query: 203 --VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
             ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 174 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 115/223 (51%), Gaps = 24/223 (10%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E  +  +  H N+++L G   + +  +++ E M N SLDSF+   +         +F 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--------AQFT 145
Query: 143 IIC------GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
           +I       G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D  
Sbjct: 146 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 197 EGNTKRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              T R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 123/220 (55%), Gaps = 19/220 (8%)
Query: 28  LFELATIVSATN---NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK 83
           L +L +IVS  +    ++  +K+GQG  G VY    +  GQE+A+++++ + +Q  KEL 
Sbjct: 7   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELI 65
Query: 84  -NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
            NE+++  + ++ N+V  L   + G+E  ++ E++   SL   +   E C  +D  +   
Sbjct: 66  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAA 121
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +     + + +LH +   ++IHRD+K+ N+LL  D + K++DFG    F    T   +KR
Sbjct: 122 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 174
Query: 203 --VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
             ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 175 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 115/223 (51%), Gaps = 24/223 (10%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E  +  +  H N+++L G   + +  +++ E M N SLDSF+   +         +F 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--------AQFT 145
Query: 143 IIC------GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
           +I       G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D  
Sbjct: 146 VIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 197 EGNTKRVIG-TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              T R       + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 141/284 (49%), Gaps = 29/284 (10%)
Query: 31  LATIV-SATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK--ISEQGL-KELKNE 85
           LAT +     +F +   LG+G F  VY+  ++  G E+A+K + K  + + G+ + ++NE
Sbjct: 2   LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           V +  +L+H ++++L           L+ E   N  ++ ++  + R K    ++  H + 
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH 119
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
               G++YLH      I+HRDL  SN+LL ++MN KI+DFGLA        +  T  + G
Sbjct: 120 QIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCG 174
Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           T  Y++PE A+     ++SDV+S G +   ++ G+         N LN +     L +  
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----VLADYE 230
Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
           MPS L    I+    + +++R          ++P DR S+ SV+
Sbjct: 231 MPSFL---SIEAKDLIHQLLR----------RNPADRLSLSSVL 261

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 116/225 (51%), Gaps = 28/225 (12%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKG--TLVDGQEI--AVKRLS-KISEQGLKEL 82
           + E A  + ATN  SI+K +G G FG V  G   L   +EI  A+K L    +E+  ++ 
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E  +  +  H N+++L G   + +  +++ E M N SLDSF+   +         +F 
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--------AQFT 116
Query: 143 IIC------GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
           +I       G A G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D  
Sbjct: 117 VIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 197 EGNTKRVIG---TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              T R  G      + +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 174 AAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHRDL   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 23/213 (10%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKL 92
            +   I K +G G  G V  G L V GQ    +A+K L +  +E+  ++  +E  +  + 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGV 151
            H N+++L G   +G   +++ E+M N SLD+F+   + +  I+   +   ++ G   G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM---QLVGMLRGVGAGM 164
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--- 208
            YL   S L  +HRDL A NVL+D ++  K+SDFGL+R    D     T     T G   
Sbjct: 165 RYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT-----TTGGKI 216
Query: 209 ---YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              + APE  +   FS  SDV+SFG+++ E+++
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+A+K + K  ++   L++L  EV +   L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL       +   LI E+ +   +  ++    R K  +   +F  I      V Y HQ
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS---AVQYCHQ 129
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
               RI+HRDLKA N+LLD DMN KI+DFG +  F      G      G+  Y APE   
Sbjct: 130 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDTFCGSPPYAAPELFQ 183
Query: 217 DGQFS-VKSDVFSFGILLLEIISG 239
             ++   + DV+S G++L  ++SG
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 110/218 (50%), Gaps = 21/218 (9%)
Query: 33  TIVSATN------NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELK 83
           +I SAT+      N+ + K +G+G F  V     ++ G+E+AVK + K  ++   L++L 
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
            EV +   L H N+VKL       +   L+ E+ +   +  ++    R K  +   +F  
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KR 202
           I      V Y HQ     I+HRDLKA N+LLD DMN KI+DFG +  F    T GN    
Sbjct: 123 IVS---AVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF----TVGNKLDT 172
Query: 203 VIGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIISG 239
             G+  Y APE     ++   + DV+S G++L  ++SG
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 114/198 (57%), Gaps = 12/198 (6%)
Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK-NEVILFSKLQHRNLVKLLG 102
           +K+GQG  G VY    +  GQE+A+++++ + +Q  KEL  NE+++  + ++ N+V  L 
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
             + G+E  ++ E++   SL   +   E C  +D  +   +     + + +LH +   ++
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVV--TETC--MDEGQIAAVCRECLQALEFLHSN---QV 138
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSV 222
           IHR++K+ N+LL  D + K++DFG       ++++ +T  ++GT  +MAPE  +   +  
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 196
Query: 223 KSDVFSFGILLLEIISGK 240
           K D++S GI+ +E+I G+
Sbjct: 197 KVDIWSLGIMAIEMIEGE 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 23/213 (10%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKL 92
            +   I K +G G  G V  G L V GQ    +A+K L +  +E+  ++  +E  +  + 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGV 151
            H N+++L G   +G   +++ E+M N SLD+F+   + +  I+   +   ++ G   G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM---QLVGMLRGVGAGM 164
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--- 208
            YL   S L  +HRDL A NVL+D ++  K+SDFGL+R    D     T     T G   
Sbjct: 165 RYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKI 216
Query: 209 ---YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              + APE  +   FS  SDV+SFG+++ E+++
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 29/292 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQ-----EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLV 98
           K +G G FG VYKG L          +A+K L +  +E+   +   E  +  +  H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G   + +  ++I E+M N +LD F+  +E+       +   ++ G A G+ YL   +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL---A 164
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASD 217
            +  +HRDL A N+L++ ++  K+SDFGL+R    D E    T        + APE  S 
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
            +F+  SDV+SFGI++ E+++    R ++   N+        K  N+G        C   
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT-YGERPYWELSNH-----EVMKAINDGFRLPTPMDCPSA 278
Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLAD 329
            + L          + C QQ    RP    ++ +L  + ++  P     LAD
Sbjct: 279 IYQLM---------MQCWQQERARRPKFADIVSIL--DKLIRAPDSLKTLAD 319

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+A+K + K  ++   L++L  EV +   L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           +VKL    I+ E+ L LI E+ +   +  ++    R K  +   +F  I      V Y H
Sbjct: 76  IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS---AVQYCH 131
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
           Q    RI+HRDLKA N+LLD DMN KI+DFG +  F      G      G   Y APE  
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDAFCGAPPYAAPELF 185
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
              ++   + DV+S G++L  ++SG
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 110/200 (55%), Gaps = 13/200 (6%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 102
           +K+G+G +G VYK     G+ +A+KR+   +E +G+      E+ L  +L H N+V L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 103 CCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
             I  E  L L++EFM  K L   + D+ +  + D   + ++     RGV + HQ    R
Sbjct: 87  V-IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLY-QLLRGVAHCHQH---R 139
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY-ASDGQF 220
           I+HRDLK  N+L++ D   K++DFGLARAF G      T  V+ T  Y AP+      ++
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGSKKY 197
Query: 221 SVKSDVFSFGILLLEIISGK 240
           S   D++S G +  E+I+GK
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 110/200 (55%), Gaps = 13/200 (6%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 102
           +K+G+G +G VYK     G+ +A+KR+   +E +G+      E+ L  +L H N+V L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 103 CCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
             I  E  L L++EFM  K L   + D+ +  + D   + ++     RGV + HQ    R
Sbjct: 87  V-IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLY-QLLRGVAHCHQH---R 139
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY-ASDGQF 220
           I+HRDLK  N+L++ D   K++DFGLARAF G      T  V+ T  Y AP+      ++
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGSKKY 197
Query: 221 SVKSDVFSFGILLLEIISGK 240
           S   D++S G +  E+I+GK
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 36/278 (12%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           ++ ++G G FG VYKG       + + ++   + +  +  +NEV +  K +H N++  +G
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQER----CKILDWSKRFHIICGTARGVMYLHQDS 158
              + +   ++ ++    SL   +  QE      +++D +++      TA+G+ YLH  +
Sbjct: 100 YMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQ------TAQGMDYLHAKN 152
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLA----RAFGGDETEGNTKRVIGTYGYMAPE- 213
              IIHRD+K++N+ L + +  KI DFGLA    R  G  + E  T  V+    +MAPE 
Sbjct: 153 ---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPEV 205
Query: 214 --YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
                +  FS +SDV+S+GI+L E+++G+    + H +N   +I    + +     S+L 
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGE--LPYSHINNRDQIIFMVGRGYASPDLSKLY 263
Query: 272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
             C +    L            CV++  ++RP  P ++
Sbjct: 264 KNCPKAMKRLVAD---------CVKKVKEERPLFPQIL 292

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 22/233 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
            +  + ++LG+G FG V+           D   +AVK L   +    K+ + E  L + L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-------------LDWSK 139
           QH ++VK  G C  G+  ++++E+M +  L+ F+       +             L  S+
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
             HI    A G++YL   +    +HRDL   N L+  ++  KI DFG++R     +    
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
               +    +M PE     +F+ +SDV+SFG++L EI +  K   F  S+  +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 132/280 (47%), Gaps = 32/280 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           +  +  +++G G FG V+ G  ++  ++A+K  R   +SE+   E + EV++  KL H  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMM--KLSHPK 61
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           LV+L G C++     L++EFM +  L  ++  Q    +        +      G+ YL +
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE 119
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                +IHRDL A N L+ ++   K+SDFG+ R    D+   +T        + +PE  S
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFS 175
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL---IGHAWKLWNEGMPSQLIDP 273
             ++S KSDV+SFG+L+ E+ S  K    Y + +N  +   I   ++L+   + S  +  
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVEDISTGFRLYKPRLASTHV-- 231
Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG 313
                           I   C ++ P+DRP+   ++  L 
Sbjct: 232 --------------YQIMNHCWKERPEDRPAFSRLLRQLA 257

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA-VVLLYMATQISSAMEYLEKK 337
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHR+L A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 338 N---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 393
Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
            +FS+KSDV++FG+LL EI +      +  S      +   ++L  +    +  + C + 
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 447
Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
            +   E++R       C Q +P DRPS   +
Sbjct: 448 VY---ELMRA------CWQWNPSDRPSFAEI 469

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 7/201 (3%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 259 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 317
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R ++ +     ++    +  + YL + 
Sbjct: 318 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKK 376
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHR+L A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 377 N---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 432
Query: 218 GQFSVKSDVFSFGILLLEIIS 238
            +FS+KSDV++FG+LL EI +
Sbjct: 433 NKFSIKSDVWAFGVLLWEIAT 453

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 45  KKLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++LG+G FG V       L D  G+ +AVK+L   +E+ L++ + E+ +   LQH N+VK
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 100 LLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
             G C   G   L LI E++   SL  ++  Q+  + +D  K         +G+ YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 131
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYAS 216
              R IHR+L   N+L++ +   KI DFGL +    D+     K        + APE  +
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           + +FSV SDV+SFG++L E+ +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 132/280 (47%), Gaps = 32/280 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           +  +  +++G G FG V+ G  ++  ++A+K  R   +SE+   E + EV++  KL H  
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMM--KLSHPK 63
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           LV+L G C++     L++EFM +  L  ++  Q    +        +      G+ YL +
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE 121
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                +IHRDL A N L+ ++   K+SDFG+ R    D+   +T        + +PE  S
Sbjct: 122 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFS 177
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL---IGHAWKLWNEGMPSQLIDP 273
             ++S KSDV+SFG+L+ E+ S  K    Y + +N  +   I   ++L+   + S  +  
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVEDISTGFRLYKPRLASTHV-- 233
Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG 313
                           I   C ++ P+DRP+   ++  L 
Sbjct: 234 --------------YQIMNHCWKERPEDRPAFSRLLRQLA 259

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 132/280 (47%), Gaps = 32/280 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           +  +  +++G G FG V+ G  ++  ++A+K  R   +SE+   E + EV++  KL H  
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMM--KLSHPK 66
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           LV+L G C++     L++EFM +  L  ++  Q    +        +      G+ YL +
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE 124
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                +IHRDL A N L+ ++   K+SDFG+ R    D+   +T        + +PE  S
Sbjct: 125 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFS 180
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL---IGHAWKLWNEGMPSQLIDP 273
             ++S KSDV+SFG+L+ E+ S  K    Y + +N  +   I   ++L+   + S  +  
Sbjct: 181 FSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVEDISTGFRLYKPRLASTHV-- 236
Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG 313
                           I   C ++ P+DRP+   ++  L 
Sbjct: 237 --------------YQIMNHCWRERPEDRPAFSRLLRQLA 262

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 32  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
           L H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 46  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
           L H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 137/287 (47%), Gaps = 48/287 (16%)
Query: 43  INKKLGQGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 97
           I K +G G FG V  G L V G+    +A+K L +  +++  ++  +E  +  +  H N+
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 92
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC------GTARGV 151
           + L G   + +  ++I E+M N SLD+F+   +         RF +I       G   G+
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKND--------GRFTVIQLVGMLRGIGSGM 144
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG-TYGYM 210
            YL   S +  +HRDL A N+L++ ++  K+SDFG++R    D     T R       + 
Sbjct: 145 KYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 201
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           APE  +  +F+  SDV+S+GI++ E++S G++                    W+  M +Q
Sbjct: 202 APEAIAYRKFTSASDVWSYGIVMWEVMSYGER------------------PYWD--MSNQ 241
Query: 270 LIDPCIQGSFNLAEVIRC---IHIGLL-CVQQHPKDRPSMPSVILML 312
            +   I+  + L   + C   +H  +L C Q+   DRP    ++ ML
Sbjct: 242 DVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 122/229 (53%), Gaps = 16/229 (6%)
Query: 43  INKKLGQGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 97
           I + +G G FG V  G L + G+    +A+K L S  +E+  ++  +E  +  +  H N+
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQ 156
           + L G   +    ++I EFM N SLDSF+   + +  ++   +   ++ G A G+ YL  
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL-- 151
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG---TYGYMAPE 213
            + +  +HRDL A N+L++ ++  K+SDFGL+R    D ++      +G      + APE
Sbjct: 152 -ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKL 261
                +F+  SDV+S+GI++ E++S G++      + + +N I   ++L
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 259

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 137/287 (47%), Gaps = 48/287 (16%)
Query: 43  INKKLGQGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 97
           I K +G G FG V  G L V G+    +A+K L +  +++  ++  +E  +  +  H N+
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC------GTARGV 151
           + L G   + +  ++I E+M N SLD+F+   +         RF +I       G   G+
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKND--------GRFTVIQLVGMLRGIGSGM 129
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG-TYGYM 210
            YL   S +  +HRDL A N+L++ ++  K+SDFG++R    D     T R       + 
Sbjct: 130 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 186
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           APE  +  +F+  SDV+S+GI++ E++S G++                    W+  M +Q
Sbjct: 187 APEAIAYRKFTSASDVWSYGIVMWEVMSYGER------------------PYWD--MSNQ 226
Query: 270 LIDPCIQGSFNLAEVIRC---IHIGLL-CVQQHPKDRPSMPSVILML 312
            +   I+  + L   + C   +H  +L C Q+   DRP    ++ ML
Sbjct: 227 DVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 46/286 (16%)
Query: 43  INKKLGQGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 97
           I K +G G FG V  G L V G+    +A+K L +  +++  ++  +E  +  +  H N+
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC------GTARGV 151
           + L G   + +  ++I E+M N SLD+F+   +         RF +I       G   G+
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKND--------GRFTVIQLVGMLRGIGSGM 123
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG-TYGYM 210
            YL   S +  +HRDL A N+L++ ++  K+SDFG++R    D     T R       + 
Sbjct: 124 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 180
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           APE  +  +F+  SDV+S+GI++ E++S  +                    W+  M +Q 
Sbjct: 181 APEAIAYRKFTSASDVWSYGIVMWEVMSYGER-----------------PYWD--MSNQD 221
Query: 271 IDPCIQGSFNLAEVIRC---IHIGLL-CVQQHPKDRPSMPSVILML 312
           +   I+  + L   + C   +H  +L C Q+   DRP    ++ ML
Sbjct: 222 VIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+AVK + K  ++   L++L  EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL       +   L+ E+ +   +  ++    R K  +   +F  I      V Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCHQ 131
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEYA 215
                I+HRDLKA N+LLD DMN KI+DFG +  F    T GN      G+  Y APE  
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPELF 184
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
              ++   + DV+S G++L  ++SG
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 132/280 (47%), Gaps = 32/280 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           +  +  +++G G FG V+ G  ++  ++A+K + +  +SE    E + EV++  KL H  
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE-EAEVMM--KLSHPK 83
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           LV+L G C++     L++EFM +  L  ++  Q    +        +      G+ YL +
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE 141
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                +IHRDL A N L+ ++   K+SDFG+ R    D+   +T        + +PE  S
Sbjct: 142 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFS 197
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL---IGHAWKLWNEGMPSQLIDP 273
             ++S KSDV+SFG+L+ E+ S  K    Y + +N  +   I   ++L+   + S  +  
Sbjct: 198 FSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVEDISTGFRLYKPRLASTHV-- 253
Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG 313
                           I   C ++ P+DRP+   ++  L 
Sbjct: 254 --------------YQIMNHCWKERPEDRPAFSRLLRQLA 279

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+AVK + K  ++   L++L  EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL       +   L+ E+ +   +  ++    R K  +   +F  I      V Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCHQ 131
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEYA 215
                I+HRDLKA N+LLD DMN KI+DFG +  F    T GN      G+  Y APE  
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPELF 184
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
              ++   + DV+S G++L  ++SG
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 117/214 (54%), Gaps = 16/214 (7%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NEVILFSKL 92
           +S+++ F   +KLG G +  VYKG     G  +A+K +   SE+G       E+ L  +L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTN---KSLDS-FIFDQERCKILDWSKRFHIICGT 147
           +H N+V+L    I  E KL L++EFM N   K +DS  + +  R   L+  K F      
Sbjct: 61  KHENIVRLYDV-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ--WQL 117
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
            +G+ + H++   +I+HRDLK  N+L+++    K+ DFGLARAFG      +++ V  T 
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TL 172
Query: 208 GYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGK 240
            Y AP+     + +S   D++S G +L E+I+GK
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 128/290 (44%), Gaps = 43/290 (14%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 72  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAF--GGDETEGNTKR 202
           A G  YL ++     IHRD+ A N LL         KI DFG+AR     G   +G    
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF--YHSDNNLNLIGHAWK 260
           +     +M PE   +G F+ K+D +SFG+LL EI S     G+  Y S +N  ++     
Sbjct: 248 L--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFVTS 301
Query: 261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
                 P     P  +             I   C Q  P+DRP+  ++IL
Sbjct: 302 GGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNF-AIIL 337

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 29/277 (10%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHR 95
           NF I KK+G+G F  VY+   L+DG  +A+K++     +  +   +   E+ L  +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--FDQERCKILDWS--KRFHIICGTARGV 151
           N++K     I+  E  ++ E      L   I  F +++  I + +  K F  +C      
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE-- 150
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
              H  SR R++HRD+K +NV +      K+ D GL R F    T  ++  ++GT  YM+
Sbjct: 151 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 204
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           PE   +  ++ KSD++S G LL E+ + +    FY   + +NL     K+     P    
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQS--PFY--GDKMNLYSLCKKIEQCDYPPL-- 258
Query: 272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
            P    S  L +++       +C+   P+ RP +  V
Sbjct: 259 -PSDHYSEELRQLVN------MCINPDPEKRPDVTYV 288

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 31  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 23  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 31  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 38  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF--YHSDNNLNLIGHAWKLW 262
               +M PE   +G F+ K+D +SFG+LL EI S     G+  Y S +N  ++       
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFVTSGG 269
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
               P     P  +             I   C Q  P+DRP+  ++IL
Sbjct: 270 RMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNF-AIIL 303

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 58  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF--YHSDNNLNLIGHAWKLW 262
               +M PE   +G F+ K+D +SFG+LL EI S     G+  Y S +N  ++       
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFVTSGG 289
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
               P     P  +             I   C Q  P+DRP+  ++IL
Sbjct: 290 RMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNF-AIIL 323

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 32  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF--YHSDNNLNLIGHAWKLW 262
               +M PE   +G F+ K+D +SFG+LL EI S     G+  Y S +N  ++       
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFVTSGG 263
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
               P     P  +             I   C Q  P+DRP+  ++IL
Sbjct: 264 RMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNF-AIIL 297

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 48  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF--YHSDNNLNLIGHAWKLW 262
               +M PE   +G F+ K+D +SFG+LL EI S     G+  Y S +N  ++       
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFVTSGG 279
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
               P     P  +             I   C Q  P+DRP+  ++IL
Sbjct: 280 RMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNF-AIIL 313

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 46  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 32/280 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           +  +  +++G G FG V+ G  ++  ++A+K  R   +SE+   E + EV++  KL H  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE-EAEVMM--KLSHPK 64
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           LV+L G C++     L+ EFM +  L  ++  Q    +        +      G+ YL +
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE 122
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                +IHRDL A N L+ ++   K+SDFG+ R    D+   +T        + +PE  S
Sbjct: 123 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFS 178
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL---IGHAWKLWNEGMPSQLIDP 273
             ++S KSDV+SFG+L+ E+ S  K    Y + +N  +   I   ++L+   + S  +  
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVEDISTGFRLYKPRLASTHV-- 234
Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG 313
                           I   C ++ P+DRP+   ++  L 
Sbjct: 235 --------------YQIMNHCWRERPEDRPAFSRLLRQLA 260

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 128/290 (44%), Gaps = 43/290 (14%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 49  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAF--GGDETEGNTKR 202
           A G  YL ++     IHRD+ A N LL         KI DFG+AR     G   +G    
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF--YHSDNNLNLIGHAWK 260
           +     +M PE   +G F+ K+D +SFG+LL EI S     G+  Y S +N  ++     
Sbjct: 225 L--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFVTS 278
Query: 261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
                 P     P  +             I   C Q  P+DRP+  ++IL
Sbjct: 279 GGRMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNF-AIIL 314

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+AVK + K  ++   L++L  EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL       +   L+ E+ +   +  ++    R K  +   +F  I      V Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCHQ 131
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEYA 215
                I+HRDLKA N+LLD DMN KI+DFG +  F    T GN      G   Y APE  
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDAFCGAPPYAAPELF 184
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
              ++   + DV+S G++L  ++SG
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 46  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+AR              +
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF--YHSDNNLNLIGHAWKLW 262
               +M PE   +G F+ K+D +SFG+LL EI S     G+  Y S +N  ++       
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFVTSGG 277
Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
               P     P  +             I   C Q  P+DRP+  ++IL
Sbjct: 278 RMDPPKNCPGPVYR-------------IMTQCWQHQPEDRPNF-AIIL 311

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+AV+ + K  ++   L++L  EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL       +   L+ E+ +   +  ++    R K  +   +F  I      V Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCHQ 131
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEYA 215
                I+HRDLKA N+LLD DMN KI+DFG +  F    T GN      G+  Y APE  
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDEFCGSPPYAAPELF 184
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
              ++   + DV+S G++L  ++SG
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 24/208 (11%)
Query: 48  GQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 107
            +G FG V+K  L++ + +AVK +  I ++   + + EV     ++H N+++ +G   +G
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVK-IFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 108 E----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD------ 157
                +  LI  F    SL  F+    +  ++ W++  HI    ARG+ YLH+D      
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 158 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
             +  I HRD+K+ NVLL  ++   I+DFGLA  F   ++ G+T   +GT  YMAPE   
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VL 205
Query: 217 DGQFSVKSDVF------SFGILLLEIIS 238
           +G  + + D F      + G++L E+ S
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 121/243 (49%), Gaps = 24/243 (9%)
Query: 46  KLGQGGFGPV-YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V        G+++AVK +    +Q  + L NEV++    QH N+V++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC-GTARGVMYLHQDSRLRII 163
           + GEE  ++ EF+   +L   I  Q R       ++   +C    + + YLH      +I
Sbjct: 112 LVGEELWVLMEFLQGGALTD-IVSQVRLN----EEQIATVCEAVLQALAYLHAQG---VI 163
Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           HRD+K+ ++LL  D   K+SDFG       D  +   K ++GT  +MAPE  S   ++ +
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATE 221
Query: 224 SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAE 283
            D++S GI+++E++ G+     Y SD+ +     A K   +  P     P ++ S  ++ 
Sbjct: 222 VDIWSLGIMVIEMVDGEPP---YFSDSPV----QAMKRLRDSPP-----PKLKNSHKVSP 269
Query: 284 VIR 286
           V+R
Sbjct: 270 VLR 272

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              NT        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 139/280 (49%), Gaps = 32/280 (11%)
Query: 43  INKKLGQGGFGPVYKGTL-VDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           I + +G G FG V +G L   G++   +A+K L    +E+  +E  +E  +  + +H N+
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFI-FDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           ++L G        +++ EFM N +LDSF+  +  +  ++   +   ++ G A G+ YL +
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAE 136
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG---TYGYMAPE 213
              +  +HRDL A N+L++ ++  K+SDFGL+R    + ++      +G      + APE
Sbjct: 137 ---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 272
             +  +F+  SD +S+GI++ E++S G++      + + +N I   ++L           
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL----------P 243
Query: 273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
           P      +L +++      L C Q+    RP  P V+  L
Sbjct: 244 PPPDCPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 277

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+AV+ + K  ++   L++L  EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL       +   L+ E+ +   +  ++    R K  +   +F  I      V Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---AVQYCHQ 131
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEYA 215
                I+HRDLKA N+LLD DMN KI+DFG +  F    T GN      G+  Y APE  
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPELF 184
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
              ++   + DV+S G++L  ++SG
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 139/280 (49%), Gaps = 32/280 (11%)
Query: 43  INKKLGQGGFGPVYKGTL-VDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           I + +G G FG V +G L   G++   +A+K L    +E+  +E  +E  +  + +H N+
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFI-FDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           ++L G        +++ EFM N +LDSF+  +  +  ++   +   ++ G A G+ YL +
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAE 134
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG---TYGYMAPE 213
              +  +HRDL A N+L++ ++  K+SDFGL+R    + ++      +G      + APE
Sbjct: 135 ---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 272
             +  +F+  SD +S+GI++ E++S G++      + + +N I   ++L           
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL----------P 241
Query: 273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
           P      +L +++      L C Q+    RP  P V+  L
Sbjct: 242 PPPDCPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 275

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 131/271 (48%), Gaps = 34/271 (12%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 96
           FS  +++G G FG VY    V   E+ A+K++S   K S +  +++  EV    KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
            ++  GC ++     L+ E+    + D     ++  + ++ +   H   G  +G+ YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH---GALQGLAYLHS 172
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY-- 214
            +   +IHRD+KA N+LL +    K+ DFG A               +GT  +MAPE   
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 215 -ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
              +GQ+  K DV+S GI  +E ++ +K   F     N+N +   + +      +Q   P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIE-LAERKPPLF-----NMNAMSALYHI------AQNESP 271
Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
            +Q S + +E  R       C+Q+ P+DRP+
Sbjct: 272 ALQ-SGHWSEYFRNFVDS--CLQKIPQDRPT 299

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 131/271 (48%), Gaps = 34/271 (12%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 96
           FS  +++G G FG VY    V   E+ A+K++S   K S +  +++  EV    KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
            ++  GC ++     L+ E+    + D     ++  + ++ +   H   G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH---GALQGLAYLHS 133
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY-- 214
            +   +IHRD+KA N+LL +    K+ DFG A               +GT  +MAPE   
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVIL 184
Query: 215 -ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
              +GQ+  K DV+S GI  +E ++ +K   F     N+N +   + +      +Q   P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIE-LAERKPPLF-----NMNAMSALYHI------AQNESP 232
Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
            +Q S + +E  R       C+Q+ P+DRP+
Sbjct: 233 ALQ-SGHWSEYFRNFVDS--CLQKIPQDRPT 260

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 43  INKKLGQGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 97
           I + +G G FG V  G L + G+    +A+K L S  +E+  ++  +E  +  +  H N+
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC------GTARGV 151
           + L G   +    ++I EFM N SLDSF+   +         +F +I       G A G+
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--------GQFTVIQLVGMLRGIAAGM 122
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG---TYG 208
            YL   + +  +HR L A N+L++ ++  K+SDFGL+R    D ++      +G      
Sbjct: 123 KYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 179
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           + APE     +F+  SDV+S+GI++ E++S
Sbjct: 180 WTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 138 SKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQ-------EIAVKRLSKI-SEQGLKELKNEVILFSK 91
           N ++ + LG G FG VY+G  V G        ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 32  NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+ +      +   L      H+    
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL ++     IHRD+ A N LL         KI DFG+A+              +
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHRN 96
           + I  +LG G FG VYK      +E +V   +K+    SE+ L++   E+ + +   H N
Sbjct: 39  WEIIGELGDGAFGKVYKAQ---NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG-TARGVMYLH 155
           +VKLL          ++ EF    ++D+ + + ER        +  ++C  T   + YLH
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLH 152
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY- 214
            +   +IIHRDLKA N+L   D + K++DFG++       T       IGT  +MAPE  
Sbjct: 153 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVV 207
Query: 215 ----ASDGQFSVKSDVFSFGILLLEI 236
               + D  +  K+DV+S GI L+E+
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY G        +AVK L + + + ++E   E  +  +++H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 90
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C       ++ E+M   +L  ++ +  R ++       ++    +  + YL + 
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTA-VVLLYMATQISSAMEYLEKK 149
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
           +    IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 150 N---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAY 205
Query: 218 GQFSVKSDVFSFGILLLEIIS 238
             FS+KSDV++FG+LL EI +
Sbjct: 206 NTFSIKSDVWAFGVLLWEIAT 226

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           + + +G+G FG V K      +++A+K++   SE+  K    E+   S++ H N+VKL G
Sbjct: 13  VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 69
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
            C+      L+ E+    SL + +   E       +         ++GV YLH      +
Sbjct: 70  ACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 163 IHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           IHRDLK  N+LL       KI DFG A       T  N K   G+  +MAPE      +S
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT--NNK---GSAAWMAPEVFEGSNYS 182
Query: 222 VKSDVFSFGILLLEIISGKK 241
            K DVFS+GI+L E+I+ +K
Sbjct: 183 EKCDVFSWGIILWEVITRRK 202

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 132/288 (45%), Gaps = 46/288 (15%)
Query: 41  FSINKKLGQGGFGPVYKGTL-VDGQE---IAVKRLS-KISEQGLKELKNEVILFSKLQHR 95
            +I + +G G FG V  G L + G+    +A+K L    +E+  ++   E  +  +  H 
Sbjct: 24  ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC------GTAR 149
           N++ L G   + +  +++ E+M N SLD+F+   +         +F +I       G + 
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKND--------GQFTVIQLVGMLRGISA 135
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG-TYG 208
           G+ YL   S +  +HRDL A N+L++ ++  K+SDFGL+R    D     T R       
Sbjct: 136 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 192
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
           + APE  +  +F+  SDV+S+GI++ E++S    R ++                   M +
Sbjct: 193 WTAPEAIAFRKFTSASDVWSYGIVMWEVVS-YGERPYWE------------------MTN 233
Query: 269 QLIDPCIQGSFNLAEVIRC----IHIGLLCVQQHPKDRPSMPSVILML 312
           Q +   ++  + L   + C      + L C Q+    RP    ++ ML
Sbjct: 234 QDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           + + +G+G FG V K      +++A+K++   SE+  K    E+   S++ H N+VKL G
Sbjct: 12  VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 68
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
            C+      L+ E+    SL + +   E       +         ++GV YLH      +
Sbjct: 69  ACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 163 IHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           IHRDLK  N+LL       KI DFG A       T  N K   G+  +MAPE      +S
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT--NNK---GSAAWMAPEVFEGSNYS 181
Query: 222 VKSDVFSFGILLLEIISGKK 241
            K DVFS+GI+L E+I+ +K
Sbjct: 182 EKCDVFSWGIILWEVITRRK 201

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRN 96
            +  + +++G+G FG V+ G L  D   +AVK   +     LK +   E  +  +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE---RCKILDWSKRFHIICGTARGVMY 153
           +V+L+G C Q +   ++ E +      +F+  +    R K L       ++   A G+ Y
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAAGMEY 228
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTKRVIGTYGYMA 211
           L        IHRDL A N L+ +    KISDFG++R  A G     G  ++V     + A
Sbjct: 229 LESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV--PVKWTA 283
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIIS 238
           PE  + G++S +SDV+SFGILL E  S
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 33/212 (15%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHRN 96
           + I  +LG G FG VYK      +E +V   +K+    SE+ L++   E+ + +   H N
Sbjct: 39  WEIIGELGDGAFGKVYKAQ---NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG-TARGVMYLH 155
           +VKLL          ++ EF    ++D+ + + ER        +  ++C  T   + YLH
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLH 152
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV------IGTYGY 209
            +   +IIHRDLKA N+L   D + K++DFG++          NT+ +      IGT  +
Sbjct: 153 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--------NTRXIQRRDXFIGTPYW 201
Query: 210 MAPEY-----ASDGQFSVKSDVFSFGILLLEI 236
           MAPE      + D  +  K+DV+S GI L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 33/212 (15%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHRN 96
           + I  +LG G FG VYK      +E +V   +K+    SE+ L++   E+ + +   H N
Sbjct: 39  WEIIGELGDGAFGKVYKAQ---NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG-TARGVMYLH 155
           +VKLL          ++ EF    ++D+ + + ER        +  ++C  T   + YLH
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLH 152
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV------IGTYGY 209
            +   +IIHRDLKA N+L   D + K++DFG++          NT+ +      IGT  +
Sbjct: 153 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK--------NTRXIQRRDSFIGTPYW 201
Query: 210 MAPEY-----ASDGQFSVKSDVFSFGILLLEI 236
           MAPE      + D  +  K+DV+S GI L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 113/237 (47%), Gaps = 31/237 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKIS 75
           E P +EL       +   + K LG+G FG V     +           ++AVK L S  +
Sbjct: 19  EDPRWELPR-----DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 76  EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-------- 126
           E+ L +L +E+ +   + +H+N++ LLG C Q     +I E+ +  +L  ++        
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 127 ---FDQERCKILDWSKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 181
              F+         S +  + C    ARG+ YL   +  + IHRDL A NVL+ +D   K
Sbjct: 134 EFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMK 190
Query: 182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           I+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 191 IADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 18/223 (8%)
Query: 29  FELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVIL 88
            +L+ +      F + + +G G +G VYKG  V   ++A  ++  ++    +E+K E+ +
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 89  FSKL-QHRNLVKLLGCCIQ------GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF 141
             K   HRN+    G  I+       ++  L+ EF    S+   I +  +   L      
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIA 132
Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
           +I     RG+ +LHQ    ++IHRD+K  NVLL ++   K+ DFG++     D T G   
Sbjct: 133 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 187
Query: 202 RVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISG 239
             IGT  +MAPE  +     D  +  KSD++S GI  +E+  G
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+AVK + K  ++   L++L  EV +   L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL       +   L+ E+ +   +  ++      K  +   +F  I      V Y HQ
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS---AVQYCHQ 124
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEYA 215
                I+HRDLKA N+LLD DMN KI+DFG +  F    T GN      G+  Y APE  
Sbjct: 125 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEF----TFGNKLDTFCGSPPYAAPELF 177
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
              ++   + DV+S G++L  ++SG
Sbjct: 178 QGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRN 96
            +  + +++G+G FG V+ G L  D   +AVK   +     LK +   E  +  +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE---RCKILDWSKRFHIICGTARGVMY 153
           +V+L+G C Q +   ++ E +      +F+  +    R K L       ++   A G+ Y
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAAGMEY 228
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTKRVIGTYGYMA 211
           L        IHRDL A N L+ +    KISDFG++R  A G     G  ++V     + A
Sbjct: 229 LESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTA 283
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIIS 238
           PE  + G++S +SDV+SFGILL E  S
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 34/283 (12%)
Query: 45  KKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           ++LGQG FG VY+G    ++ G+    +AVK +++  S +   E  NE  +       ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR--------FHIICGTAR 149
           V+LLG   +G+  L++ E M +  L S++    R +  +   R          +    A 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      + +    +
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           MAPE   DG F+  SD++SFG++L EI S  +    Y   +N  ++    K   +G    
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVL----KFVMDGGYLD 252
Query: 270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
             D C +         R   +  +C Q +PK RP+   ++ +L
Sbjct: 253 QPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           ++ K+LG G FG V  G      ++AVK + + S     E   E     KL H  LVK  
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           G C +     ++ E+++N  L +++  +   K L+ S+   +      G+ +L      +
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---Q 124
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT---YGYMAPEYASDG 218
            IHRDL A N L+D+D+  K+SDFG+ R    D+   +    +GT     + APE     
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYF 180
Query: 219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
           ++S KSDV++FGIL+ E+ S GK     Y +   +  +    +L+   + S  I      
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI------ 234
Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
                       I   C  + P+ RP+   ++
Sbjct: 235 ----------YQIMYSCWHELPEKRPTFQQLL 256

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 34/283 (12%)
Query: 45  KKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           ++LGQG FG VY+G    ++ G+    +AVK +++  S +   E  NE  +       ++
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR--------FHIICGTAR 149
           V+LLG   +G+  L++ E M +  L S++    R +  +   R          +    A 
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 138
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      + +    +
Sbjct: 139 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           MAPE   DG F+  SD++SFG++L EI S  +    Y   +N  ++    K   +G    
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVL----KFVMDGGYLD 249
Query: 270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
             D C +         R   +  +C Q +PK RP+   ++ +L
Sbjct: 250 QPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 117/245 (47%), Gaps = 40/245 (16%)
Query: 24  LELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQE----IAVKRLSK-ISE 76
           LE P +E         N  + K LG+G FG V K T   + G+     +AVK L +  S 
Sbjct: 13  LEDPKWEFPR-----KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP 67
Query: 77  QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC---- 132
             L++L +E  +  ++ H +++KL G C Q    LLI E+    SL  F+ +  +     
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 133 ---------KILDWSKRFHIICG--------TARGVMYLHQDSRLRIIHRDLKASNVLLD 175
                      LD      +  G         ++G+ YL   + ++++HRDL A N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 176 QDMNPKISDFGLARAFGGDETEGNTKRVIG--TYGYMAPEYASDGQFSVKSDVFSFGILL 233
           +    KISDFGL+R     E +   KR  G     +MA E   D  ++ +SDV+SFG+LL
Sbjct: 185 EGRKMKISDFGLSRDVY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 234 LEIIS 238
            EI++
Sbjct: 243 WEIVT 247

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 137/291 (47%), Gaps = 56/291 (19%)
Query: 43  INKKLGQGGFGPVYKGTL-VDGQE---IAVKRLS-KISEQGLKELKNEVILFSKLQHRNL 97
           I + +G G FG V  G L + G+    +A+K L    +E+  ++   E  +  +  H N+
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNV 106
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC------GTARGV 151
           V L G   +G+  +++ EFM N +LD+F+   +         +F +I       G A G+
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDAFLRKHD--------GQFTVIQLVGMLRGIAAGM 158
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--- 208
            YL   + +  +HRDL A N+L++ ++  K+SDFGL+R       E + + V  T G   
Sbjct: 159 RYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-----EDDPEAVYTTTGGKI 210
Query: 209 ---YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
              + APE     +F+  SDV+S+GI++ E++S  +                    W+  
Sbjct: 211 PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----------------PYWD-- 251
Query: 266 MPSQLIDPCIQGSFNLAEVIRC---IHIGLL-CVQQHPKDRPSMPSVILML 312
           M +Q +   I+  + L   + C   +H  +L C Q+   +RP    ++ +L
Sbjct: 252 MSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 117/245 (47%), Gaps = 40/245 (16%)
Query: 24  LELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQE----IAVKRLSK-ISE 76
           LE P +E         N  + K LG+G FG V K T   + G+     +AVK L +  S 
Sbjct: 13  LEDPKWEFPR-----KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP 67
Query: 77  QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC---- 132
             L++L +E  +  ++ H +++KL G C Q    LLI E+    SL  F+ +  +     
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 133 ---------KILDWSKRFHIICG--------TARGVMYLHQDSRLRIIHRDLKASNVLLD 175
                      LD      +  G         ++G+ YL   + ++++HRDL A N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 176 QDMNPKISDFGLARAFGGDETEGNTKRVIG--TYGYMAPEYASDGQFSVKSDVFSFGILL 233
           +    KISDFGL+R     E +   KR  G     +MA E   D  ++ +SDV+SFG+LL
Sbjct: 185 EGRKMKISDFGLSRDVY--EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 234 LEIIS 238
            EI++
Sbjct: 243 WEIVT 247

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  KKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           ++LGQG FG VY+G    ++ G+    +AVK +++  S +   E  NE  +       ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR--------FHIICGTAR 149
           V+LLG   +G+  L++ E M +  L S++    R +  +   R          +    A 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      + +    +
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           MAPE   DG F+  SD++SFG++L EI S
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   +I+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+AVK + K  ++   L++L  EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL       +   L+ E+ +   +  ++    R K  +   +F  I      V Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS---AVQYCHQ 131
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEYA 215
                I+HRDLKA N+LLD D N KI+DFG +  F    T GN      G   Y APE  
Sbjct: 132 KF---IVHRDLKAENLLLDADXNIKIADFGFSNEF----TFGNKLDAFCGAPPYAAPELF 184
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
              ++   + DV+S G++L  ++SG
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 46  KLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V   T    G+++AVK++    +Q  + L NEV++     H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC-GTARGVMYLHQDSRLRII 163
           + G+E  ++ EF+   +L   +      +     ++   +C    R + YLH      +I
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLSVLRALSYLHNQG---VI 163
Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           HRD+K+ ++LL  D   K+SDFG       +  +   K ++GT  +MAPE  S   +  +
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTE 221
Query: 224 SDVFSFGILLLEIISGK 240
            D++S GI+++E+I G+
Sbjct: 222 VDIWSLGIMVIEMIDGE 238

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 41  FSINKKLGQGGFGPVY--KGTLVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHR 95
           + I  KLG GG   VY  + T+++ + +A+K +    +  E+ LK  + EV   S+L H+
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N+V ++    + +   L+ E++   +L  +I   E    L      +       G+ + H
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
               +RI+HRD+K  N+L+D +   KI DFG+A+A   + +   T  V+GT  Y +PE A
Sbjct: 129 D---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQA 184
Query: 216 SDGQFSVKSDVFSFGILLLEIISGK 240
                   +D++S GI+L E++ G+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I E+ +  +L  ++           +D  R      
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 33/238 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKIS 75
           E P +EL       +   + K LG+G FG V     +           ++AVK L S  +
Sbjct: 4   EDPRWELPR-----DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 76  EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI 134
           E+ L +L +E+ +   + +H+N++ LLG C Q     +I E+ +  +L  ++    R   
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPG 117
Query: 135 LDW------------SKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 180
           L++            S +  + C    ARG+ YL   +  + IHRDL A NVL+ +D   
Sbjct: 118 LEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 174
Query: 181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 33/238 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKIS 75
           E P +EL       +   + K LG+G FG V     +           ++AVK L S  +
Sbjct: 12  EDPRWELPR-----DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 66
Query: 76  EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI 134
           E+ L +L +E+ +   + +H+N++ LLG C Q     +I E+ +  +L  ++    R   
Sbjct: 67  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPG 125
Query: 135 LDWS------------KRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 180
           L++S             +  + C    ARG+ YL   +  + IHRDL A NVL+ +D   
Sbjct: 126 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 182
Query: 181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 183 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 33/238 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKIS 75
           E P +EL       +   + K LG+G FG V     +           ++AVK L S  +
Sbjct: 8   EDPRWELPR-----DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 62
Query: 76  EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI 134
           E+ L +L +E+ +   + +H+N++ LLG C Q     +I E+ +  +L  ++    R   
Sbjct: 63  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPG 121
Query: 135 LDWS------------KRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 180
           L++S             +  + C    ARG+ YL   +  + IHRDL A NVL+ +D   
Sbjct: 122 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 178
Query: 181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 179 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 33/238 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKIS 75
           E P +EL       +   + K LG+G FG V     +           ++AVK L S  +
Sbjct: 19  EDPRWELPR-----DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 76  EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI 134
           E+ L +L +E+ +   + +H+N++ LLG C Q     +I E+ +  +L  ++    R   
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPG 132
Query: 135 LDWS------------KRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 180
           L++S             +  + C    ARG+ YL   +  + IHRDL A NVL+ +D   
Sbjct: 133 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 189
Query: 181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 33/238 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKIS 75
           E P +EL       +   + K LG+G FG V     +           ++AVK L S  +
Sbjct: 19  EDPRWELPR-----DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 76  EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI 134
           E+ L +L +E+ +   + +H+N++ LLG C Q     +I E+ +  +L  ++    R   
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPG 132
Query: 135 LDW------------SKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 180
           L++            S +  + C    ARG+ YL   +  + IHRDL A NVL+ +D   
Sbjct: 133 LEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 189
Query: 181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ + + L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 119
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 33/238 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKIS 75
           E P +EL       +   + K LG+G FG V     +           ++AVK L S  +
Sbjct: 11  EDPRWELPR-----DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 65
Query: 76  EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI 134
           E+ L +L +E+ +   + +H+N++ LLG C Q     +I E+ +  +L  ++    R   
Sbjct: 66  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPG 124
Query: 135 LDWS------------KRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP 180
           L++S             +  + C    ARG+ YL   +  + IHRDL A NVL+ +D   
Sbjct: 125 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 181
Query: 181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 182 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 117/238 (49%), Gaps = 22/238 (9%)
Query: 46  KLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V   T+   G+ +AVK++    +Q  + L NEV++    QH N+V++    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
           + G+E  ++ EF+   +L   +        ++  +   +     + +  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKS 224
           RD+K+ ++LL  D   K+SDFG       +      K ++GT  +MAPE  S   +  + 
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 225 DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL-----IDPCIQG 277
           D++S GI+++E++ G+     Y ++  L     A K+  + +P +L     + P ++G
Sbjct: 207 DIWSLGIMVIEMVDGEPP---YFNEPPLK----AMKMIRDNLPPRLKNLHKVSPSLKG 257

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 117/238 (49%), Gaps = 22/238 (9%)
Query: 46  KLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V   T+   G+ +AVK++    +Q  + L NEV++    QH N+V++    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
           + G+E  ++ EF+   +L   +        ++  +   +     + +  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKS 224
           RD+K+ ++LL  D   K+SDFG       +      K ++GT  +MAPE  S   +  + 
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 225 DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL-----IDPCIQG 277
           D++S GI+++E++ G+     Y ++  L     A K+  + +P +L     + P ++G
Sbjct: 209 DIWSLGIMVIEMVDGEPP---YFNEPPLK----AMKMIRDNLPPRLKNLHKVSPSLKG 259

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 116/245 (47%), Gaps = 40/245 (16%)
Query: 24  LELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQE----IAVKRLSK-ISE 76
           LE P +E         N  + K LG+G FG V K T   + G+     +AVK L +  S 
Sbjct: 13  LEDPKWEFPR-----KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP 67
Query: 77  QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC---- 132
             L++L +E  +  ++ H +++KL G C Q    LLI E+    SL  F+ +  +     
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 133 ---------KILDWSKRFHIICG--------TARGVMYLHQDSRLRIIHRDLKASNVLLD 175
                      LD      +  G         ++G+ YL   + + ++HRDL A N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVA 184
Query: 176 QDMNPKISDFGLARAFGGDETEGNTKRVIG--TYGYMAPEYASDGQFSVKSDVFSFGILL 233
           +    KISDFGL+R     E +   KR  G     +MA E   D  ++ +SDV+SFG+LL
Sbjct: 185 EGRKMKISDFGLSRDVY--EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 234 LEIIS 238
            EI++
Sbjct: 243 WEIVT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 125/262 (47%), Gaps = 41/262 (15%)
Query: 1   MRFQLILSNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTL 60
           + FQ +L+ +SE    +  ++   ELP           +   + K LG+G FG V     
Sbjct: 44  LYFQGMLAGVSEY---ELPEDPRWELP----------RDRLVLGKPLGEGAFGQVVLAEA 90
Query: 61  VD--------GQEIAVKRL-SKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 110
           +           ++AVK L S  +E+ L +L +E+ +   + +H+N++ LLG C Q    
Sbjct: 91  IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150
Query: 111 LLIYEFMTNKSLDSFIFDQERCKILDWS------------KRFHIICG--TARGVMYLHQ 156
            +I E+ +  +L  ++    R   L++S             +  + C    ARG+ YL  
Sbjct: 151 YVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-- 207
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
            +  + IHRDL A NVL+ +D   KI+DFGLAR     +    T        +MAPE   
Sbjct: 208 -ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 266
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           D  ++ +SDV+SFG+LL EI +
Sbjct: 267 DRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 119
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 117/238 (49%), Gaps = 22/238 (9%)
Query: 46  KLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V   T+   G+ +AVK++    +Q  + L NEV++    QH N+V++    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
           + G+E  ++ EF+   +L   +        ++  +   +     + +  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKS 224
           RD+K+ ++LL  D   K+SDFG       +      K ++GT  +MAPE  S   +  + 
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 225 DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL-----IDPCIQG 277
           D++S GI+++E++ G+     Y ++  L     A K+  + +P +L     + P ++G
Sbjct: 202 DIWSLGIMVIEMVDGEPP---YFNEPPLK----AMKMIRDNLPPRLKNLHKVSPSLKG 252

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 117/238 (49%), Gaps = 22/238 (9%)
Query: 46  KLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V   T+   G+ +AVK++    +Q  + L NEV++    QH N+V++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
           + G+E  ++ EF+   +L   +        ++  +   +     + +  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKS 224
           RD+K+ ++LL  D   K+SDFG       +      K ++GT  +MAPE  S   +  + 
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 225 DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL-----IDPCIQG 277
           D++S GI+++E++ G+     Y ++  L     A K+  + +P +L     + P ++G
Sbjct: 252 DIWSLGIMVIEMVDGEPP---YFNEPPLK----AMKMIRDNLPPRLKNLHKVSPSLKG 302

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 31/237 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKIS 75
           E P +EL       +   + K LG+G FG V     +           ++AVK L S  +
Sbjct: 19  EDPRWELPR-----DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 76  EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI 134
           E+ L +L +E+ +   + +H+N++ LLG C Q     +I E+ +  +L  ++  +E   +
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGL 133
Query: 135 L-----------DWSKRFHIICG--TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 181
                         S +  + C    ARG+ YL   +  + IHRDL A NVL+ +D   K
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMK 190
Query: 182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           I+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 117/238 (49%), Gaps = 22/238 (9%)
Query: 46  KLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V   T+   G+ +AVK++    +Q  + L NEV++    QH N+V++    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
           + G+E  ++ EF+   +L   +        ++  +   +     + +  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKS 224
           RD+K+ ++LL  D   K+SDFG       +      K ++GT  +MAPE  S   +  + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 225 DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL-----IDPCIQG 277
           D++S GI+++E++ G+     Y ++  L     A K+  + +P +L     + P ++G
Sbjct: 198 DIWSLGIMVIEMVDGEPP---YFNEPPLK----AMKMIRDNLPPRLKNLHKVSPSLKG 248

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 34/283 (12%)
Query: 45  KKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           ++LGQG FG VY+G    ++ G+    +AVK +++  S +   E  NE  +       ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR--------FHIICGTAR 149
           V+LLG   +G+  L++ E M +  L S++    R +  +   R          +    A 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      + +    +
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           MAPE   DG F+  SD++SFG++L EI S  +    Y   +N  ++    K   +G    
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVL----KFVMDGGYLD 252
Query: 270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
             D C +         R   +  +C Q +PK RP+   ++ +L
Sbjct: 253 QPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQE----IAVKRLSKISE-QGLKELKNEVILFSKLQHRNLV 98
           ++ +G+G FG VY G  +D  +     A+K LS+I+E Q ++    E +L   L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 99  KLLGCCIQGEE-KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
            L+G  +  E    ++  +M +  L  FI   +R   +     F +    ARG+ YL + 
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYLAEQ 143
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYA 215
              + +HRDL A N +LD+    K++DFGLAR     E  +    +       + A E  
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ KSDV+SFG+LL E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 130/309 (42%), Gaps = 55/309 (17%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKISEQGLKE-LKNEVILFSKL 92
           N    K LG G FG V   T           ++AVK L + ++   +E L +E+ + ++L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 93  -QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF--------------------DQER 131
             H N+V LLG C       LI+E+     L +++                     ++E 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 132 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 191
             +L +          A+G+ +L   S    +HRDL A NVL+      KI DFGLAR  
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 192 GGDE---TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKN--RGFY 246
             D      GN +  +    +MAPE   +G +++KSDV+S+GILL EI S   N   G  
Sbjct: 223 MSDSNYVVRGNARLPVK---WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 247 HSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP 306
              N   LI + +K+      ++ I   +Q                 C     + RPS P
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQS----------------CWAFDSRKRPSFP 323
Query: 307 SVILMLGSE 315
           ++   LG +
Sbjct: 324 NLTSFLGCQ 332

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 117/238 (49%), Gaps = 22/238 (9%)
Query: 46  KLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           K+G+G  G V   T+   G+ +AVK++    +Q  + L NEV++    QH N+V++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
           + G+E  ++ EF+   +L   +        ++  +   +     + +  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKS 224
           RD+K+ ++LL  D   K+SDFG       +      K ++GT  +MAPE  S   +  + 
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 225 DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL-----IDPCIQG 277
           D++S GI+++E++ G+     Y ++  L     A K+  + +P +L     + P ++G
Sbjct: 329 DIWSLGIMVIEMVDGEPP---YFNEPPLK----AMKMIRDNLPPRLKNLHKVSPSLKG 379

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 119
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 34/283 (12%)
Query: 45  KKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           ++LGQG FG VY+G    ++ G+    +AVK +++  S +   E  NE  +       ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR--------FHIICGTAR 149
           V+LLG   +G+  L++ E M +  L S++    R +  +   R          +    A 
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ YL+     + +HRDL A N ++  D   KI DFG+ R     +      + +    +
Sbjct: 141 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           MAPE   DG F+  SD++SFG++L EI S  +    Y   +N  ++    K   +G    
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVL----KFVMDGGYLD 251
Query: 270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
             D C +         R   +  +C Q +PK RP+   ++ +L
Sbjct: 252 QPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I  + +  +L  ++           +D  R      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 119
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL   C Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 147
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 148 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 119
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 119
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 119
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 108/200 (54%), Gaps = 15/200 (7%)
Query: 46  KLGQGGFGPVYKGTLVDGQ---EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLL 101
           +LG G FG V +G     +   ++A+K L + +E+   +E+  E  +  +L +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF-DQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
           G C Q E  +L+ E      L  F+   +E   + + ++  H +   + G+ YL + +  
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV---SMGMKYLEEKN-- 130
Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEYASDG 218
             +HRDL A NVLL      KISDFGL++A G D++   T R  G +   + APE  +  
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFR 188
Query: 219 QFSVKSDVFSFGILLLEIIS 238
           +FS +SDV+S+G+ + E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 112/229 (48%), Gaps = 33/229 (14%)
Query: 39  NNFSINKKLGQGGFGPVYKGT---LVDGQE---IAVKRLSKISEQGLK-ELKNEVILFSK 91
           NN    + +G+G FG V++     L+  +    +AVK L + +   ++ + + E  L ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE--------------RCKI--- 134
             + N+VKLLG C  G+   L++E+M    L+ F+                  R ++   
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 135 ----LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR- 189
               L  +++  I    A G+ YL   S  + +HRDL   N L+ ++M  KI+DFGL+R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            +  D  + +    I    +M PE     +++ +SDV+++G++L EI S
Sbjct: 224 IYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 48  GQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 107
            +G FG V+K  L++   +AVK      +Q  +  + E+     ++H NL++ +    +G
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 108 E----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD------ 157
                E  LI  F    SL  ++    +  I+ W++  H+    +RG+ YLH+D      
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 158 --SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
              +  I HRD K+ NVLL  D+   ++DFGLA  F   +  G+T   +GT  YMAPE  
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 216 SDGQFSVKSDVF------SFGILLLEIIS 238
            +G  + + D F      + G++L E++S
Sbjct: 198 -EGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 119
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 141/283 (49%), Gaps = 23/283 (8%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-IAVKRLS-KISEQGLKELKNEVILFSKLQHRN 96
           +++ + + +G G    V        +E +A+KR++ +  +  + EL  E+   S+  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD-----QERCKILDWSKRFHIICGTARGV 151
           +V      +  +E  L+ + ++  S+   I       + +  +LD S    I+     G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTKRV-IGTYG 208
            YLH++ +   IHRD+KA N+LL +D + +I+DFG++   A GGD T    ++  +GT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 209 YMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           +MAPE     + +  K+D++SFGI  +E+ +G      YH    + ++     L N+  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA---APYHKYPPMKVL--MLTLQNDP-P 245
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGL-LCVQQHPKDRPSMPSVI 309
           S  ++  +Q    L +  +     + LC+Q+ P+ RP+   ++
Sbjct: 246 S--LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 141/283 (49%), Gaps = 23/283 (8%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-IAVKRLS-KISEQGLKELKNEVILFSKLQHRN 96
           +++ + + +G G    V        +E +A+KR++ +  +  + EL  E+   S+  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD-----QERCKILDWSKRFHIICGTARGV 151
           +V      +  +E  L+ + ++  S+   I       + +  +LD S    I+     G+
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTKRV-IGTYG 208
            YLH++ +   IHRD+KA N+LL +D + +I+DFG++   A GGD T    ++  +GT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 209 YMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           +MAPE     + +  K+D++SFGI  +E+ +G      YH    + ++     L N+  P
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP---YHKYPPMKVL--MLTLQNDP-P 240
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGL-LCVQQHPKDRPSMPSVI 309
           S  ++  +Q    L +  +     + LC+Q+ P+ RP+   ++
Sbjct: 241 S--LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 129/283 (45%), Gaps = 34/283 (12%)
Query: 45  KKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           ++LGQG FG VY+G    ++ G+    +AVK +++  S +   E  NE  +       ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR--------FHIICGTAR 149
           V+LLG   +G+  L++ E M +  L S++    R +  +   R          +    A 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ YL+     + +HRDL A N ++  D   KI DFG+ R            + +    +
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           MAPE   DG F+  SD++SFG++L EI S  +    Y   +N  ++    K   +G    
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVL----KFVMDGGYLD 252
Query: 270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
             D C +         R   +  +C Q +PK RP+   ++ +L
Sbjct: 253 QPDNCPE---------RVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSK-ISEQGLKELKNEV-ILFS 90
           +  ++ K LG+G FG V +            + +AVK L +  +    + L +E+ IL  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 91  KLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQ--ERCKILDWSKRF----HI 143
              H N+V LLG C + G   ++I EF    +L +++  +  E     D  K F    H+
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 144 ICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
           IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D      
Sbjct: 147 ICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                   +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 120 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           + +G+G FG V  G    G ++AVK +   ++   +    E  + ++L+H NLV+LLG  
Sbjct: 18  QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 105 IQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 163
           ++ +  L ++ E+M   SL  ++  + R  +L               + YL  ++    +
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FV 130
Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           HRDL A NVL+ +D   K+SDFGL +     +  G          + APE   +  FS K
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREAAFSTK 185
Query: 224 SDVFSFGILLLEIIS 238
           SDV+SFGILL EI S
Sbjct: 186 SDVWSFGILLWEIYS 200

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 5   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 123 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 9/204 (4%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNL 97
           ++ + + LG+G +G V      V  + +AVK +  K +    + +K E+ +   L H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+YLH  
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG- 121
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
             + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+APE    
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 218 GQFSVKS-DVFSFGILLLEIISGK 240
            +F  +  DV+S GI+L  +++G+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 45  KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLV 98
           K LG G FG VYKG  + DG+ + +    K+     S +  KE+ +E  + + +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC---KILDWSKRFHIICGTARGVMYLH 155
           +LLG C+    +L+         LD    ++ R     +L+W  +       A+G+ YL 
Sbjct: 83  RLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYLE 136
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
               +R++HRDL A NVL+    + KI+DFGLAR    DETE +         +MA E  
Sbjct: 137 D---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 193
Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
              +F+ +SDV+S+G+ + E+++
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 38  TNNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQ 93
           ++ +   + LG+G FG V      + GQE AVK +SK  + ++  KE L  EV L  +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++KL           L+ E  T   L   I  ++R   +D ++   II     G+ Y
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITY 141
Query: 154 LHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           +H++   +I+HRDLK  N+LL+   +D N +I DFGL+  F   E     K  IGT  Y+
Sbjct: 142 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 195
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE    G +  K DV+S G++L  ++SG
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 8   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 66
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 67  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 125
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 126 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 176
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 177 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 12  EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 70
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 71  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 129
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 130 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 180
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 181 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 38  TNNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQ 93
           ++ +   + LG+G FG V      + GQE AVK +SK  + ++  KE L  EV L  +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++KL           L+ E  T   L   I  ++R   +D ++   II     G+ Y
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITY 147
Query: 154 LHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           +H++   +I+HRDLK  N+LL+   +D N +I DFGL+  F   E     K  IGT  Y+
Sbjct: 148 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 201
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE    G +  K DV+S G++L  ++SG
Sbjct: 202 APE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 3   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL 120
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 121 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 172 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 3   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYL 120
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 121 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 172 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 5   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 123 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 6   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 64
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 65  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL 123
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 124 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 174
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 175 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 120 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 122 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 9   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 127 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 178 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           + +G+G FG V  G    G ++AVK +   ++   +    E  + ++L+H NLV+LLG  
Sbjct: 12  QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 105 IQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 163
           ++ +  L ++ E+M   SL  ++  + R  +L               + YL  ++    +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FV 124
Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           HRDL A NVL+ +D   K+SDFGL +     +  G          + APE   + +FS K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTK 179
Query: 224 SDVFSFGILLLEIIS 238
           SDV+SFGILL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 120 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 122 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V        +   +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----------FDQERCKILDW 137
             + +H+N++ LLG C Q     +I  + +  +L  ++           +D  R      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 SKRFHIICGT--ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           + +  + C    ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 5   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 123 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYL 119
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 120 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 38  TNNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQ 93
           ++ +   + LG+G FG V      + GQE AVK +SK  + ++  KE L  EV L  +L 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++KL           L+ E  T   L   I  ++R   +D ++   II     G+ Y
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITY 164
Query: 154 LHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           +H++   +I+HRDLK  N+LL+   +D N +I DFGL+  F   E     K  IGT  Y+
Sbjct: 165 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 218
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE    G +  K DV+S G++L  ++SG
Sbjct: 219 APEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 5   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 123 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 38  TNNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQ 93
           ++ +   + LG+G FG V      + GQE AVK +SK  + ++  KE L  EV L  +L 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++KL           L+ E  T   L   I  ++R   +D ++   II     G+ Y
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITY 165
Query: 154 LHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           +H++   +I+HRDLK  N+LL+   +D N +I DFGL+  F   E     K  IGT  Y+
Sbjct: 166 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 219
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE    G +  K DV+S G++L  ++SG
Sbjct: 220 APEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 31/225 (13%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSKISEQG-----LKELKNEVI 87
           +   + K LG+G FG V +            + +AVK L + +        + ELK   I
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 88  LFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKR 140
           L     H N+V LLG C + G   ++I EF    +L +++      F   +    D  K 
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 141 F----HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
           F    H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 92
             F   K LG G FG VYKG  +   E     +A+K L +  S +  KE+ +E  + + +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGTA 148
            + ++ +LLG C+    +L I + M    L  ++ + +       +L+W  +       A
Sbjct: 69  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------A 121
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
           +G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +E E + +       
Sbjct: 122 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 27  EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 85
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 86  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 144
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 145 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 195
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 196 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           + +G+G FG V  G    G ++AVK +   ++   +    E  + ++L+H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 105 IQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 163
           ++ +  L ++ E+M   SL  ++  + R  +L               + YL  ++    +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           HRDL A NVL+ +D   K+SDFGL +     +  G          + APE   + +FS K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTK 366
Query: 224 SDVFSFGILLLEIIS 238
           SDV+SFGILL EI S
Sbjct: 367 SDVWSFGILLWEIYS 381

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 104
           + +G+G FG V  G    G ++AVK +   ++   +    E  + ++L+H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 105 IQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 163
           ++ +  L ++ E+M   SL  ++  + R  +L               + YL  ++    +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           HRDL A NVL+ +D   K+SDFGL +     +  G          + APE   + +FS K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTK 194
Query: 224 SDVFSFGILLLEIIS 238
           SDV+SFGILL EI S
Sbjct: 195 SDVWSFGILLWEIYS 209

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSK-ISEQGLKELKNEV-ILFS 90
           +   + K LG+G FG V +            + +AVK L +  +    + L +E+ IL  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 91  KLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKRF-- 141
              H N+V LLG C + G   ++I EF    +L +++      F   +    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 142 --HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
             H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D  
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                       +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 31/225 (13%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSKISEQG-----LKELKNEVI 87
           +   + K LG+G FG V +            + +AVK L + +        + ELK   I
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 74
Query: 88  LFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKR 140
           L     H N+V LLG C + G   ++I EF    +L +++      F   +    D  K 
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 141 F----HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
           F    H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    
Sbjct: 135 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 191
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSK-ISEQGLKELKNEV-ILFS 90
           +   + K LG+G FG V +            + +AVK L +  +    + L +E+ IL  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 91  KLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKRF-- 141
              H N+V LLG C + G   ++I EF    +L +++      F   +    D  K F  
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 142 --HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
             H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D  
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                       +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 117
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 172
Query: 213 E-YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E       +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 227
Query: 272 DPCI 275
            P +
Sbjct: 228 WPGV 231

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 135/293 (46%), Gaps = 34/293 (11%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL--KNEVILFSKLQHRNLV 98
           F+  +K+G+G FG V+KG     Q++   ++  + E   +    + E+ + S+     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           K  G  ++  +  +I E++   S      D      LD ++   I+    +G+ YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
           +   IHRD+KA+NVLL +    K++DFG+A      + + NT   +GT  +MAPE     
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 179
Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS 278
            +  K+D++S GI  +E+  G+      H    L LI        +  P     P ++G+
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-------PKNNP-----PTLEGN 227
Query: 279 FN--LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLAD 329
           ++  L E +        C+ + P  RP+      +L  + +L   K+  YL +
Sbjct: 228 YSKPLKEFVEA------CLNKEPSFRPTAKE---LLKHKFILRNAKKTSYLTE 271

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 71  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 124
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 179
Query: 213 E-YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E       +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 234
Query: 272 DPCI 275
            P +
Sbjct: 235 WPGV 238

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/326 (25%), Positives = 147/326 (45%), Gaps = 47/326 (14%)
Query: 8   SNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIA 67
           S +   TEN   Q++D E    EL         F+  +K+G+G FG V+KG     Q++ 
Sbjct: 9   SGVDLGTENLYFQSMDPE----EL---------FTKLEKIGKGSFGEVFKGIDNRTQKVV 55
Query: 68  VKRLSKISEQGLKEL--KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF 125
             ++  + E   +    + E+ + S+     + K  G  ++  +  +I E++   S    
Sbjct: 56  AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS---- 111
Query: 126 IFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 185
             D      LD ++   I+    +G+ YLH + +   IHRD+KA+NVLL +    K++DF
Sbjct: 112 ALDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADF 168
Query: 186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF 245
           G+A      + + NT   +GT  +MAPE      +  K+D++S GI  +E+  G+     
Sbjct: 169 GVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 226
Query: 246 YHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFN--LAEVIRCIHIGLLCVQQHPKDRP 303
            H    L LI        +  P     P ++G+++  L E +        C+ + P  RP
Sbjct: 227 LHPMKVLFLI-------PKNNP-----PTLEGNYSKPLKEFVEA------CLNKEPSFRP 268
Query: 304 SMPSVILMLGSETVLPQPKQPGYLAD 329
           +      +L  + +L   K+  YL +
Sbjct: 269 TAKE---LLKHKFILRNAKKTSYLTE 291

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 92
             F   K LG G FG VYKG  +   E     +A+K L +  S +  KE+ +E  + + +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGTA 148
            + ++ +LLG C+    +L I + M    L  ++ + +       +L+W  +       A
Sbjct: 72  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------A 124
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
            G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +E E + +       
Sbjct: 125 EGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 31/225 (13%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSKISEQG-----LKELKNEVI 87
           +   + K LG+G FG V +            + +AVK L + +        + ELK   I
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 88  LFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKR 140
           L     H N+V LLG C + G   ++I EF    +L +++      F   +    D  K 
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 141 F----HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
           F    H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 126/247 (51%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++    +
Sbjct: 62  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----Q 115
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWY 170
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 225
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 226 EVVWPGV 232

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 9/209 (4%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 92
           V    ++ + + LG+G  G V      V  + +AVK +  K +    + +K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+VK  G   +G  + L  E+ +   L   I         D  + FH +     GV+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVV 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 213 EYASDGQFSVKS-DVFSFGILLLEIISGK 240
           E     +F  +  DV+S GI+L  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD-ETCT------RFYT-AEIV 142
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++   S  SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 108/200 (54%), Gaps = 15/200 (7%)
Query: 46  KLGQGGFGPVYKGTLVDGQ---EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLL 101
           +LG G FG V +G     +   ++A+K L + +E+   +E+  E  +  +L +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIF-DQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
           G C Q E  +L+ E      L  F+   +E   + + ++  H +   + G+ YL + +  
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV---SMGMKYLEEKN-- 456
Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--YMAPEYASDG 218
             +HR+L A NVLL      KISDFGL++A G D++   T R  G +   + APE  +  
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFR 514
Query: 219 QFSVKSDVFSFGILLLEIIS 238
           +FS +SDV+S+G+ + E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 124/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 117
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 172
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 227
Query: 272 DPCI 275
            P +
Sbjct: 228 WPGV 231

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 124/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 171
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 226
Query: 272 DPCI 275
            P +
Sbjct: 227 WPGV 230

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 124/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 117
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 172
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 227
Query: 272 DPCI 275
            P +
Sbjct: 228 WPGV 231

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 125/244 (51%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++    +G+ 
Sbjct: 71  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLA 124
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 179
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 234
Query: 272 DPCI 275
            P +
Sbjct: 235 WPGV 238

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 124/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 171
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 226
Query: 272 DPCI 275
            P +
Sbjct: 227 WPGV 230

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  KKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           ++LGQG FG VY+G    ++ G+    +AVK +++  S +   E  NE  +       ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR--------FHIICGTAR 149
           V+LLG   +G+  L++ E M +  L S++    R +  +   R          +    A 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ YL+     + +HR+L A N ++  D   KI DFG+ R     +      + +    +
Sbjct: 142 GMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           MAPE   DG F+  SD++SFG++L EI S
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 45  KKLGQGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNL 97
           ++LGQG FG VY+G    ++ G+    +AVK +++  S +   E  NE  +       ++
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR--------FHIICGTAR 149
           V+LLG   +G+  L++ E M +  L S++    R +  +   R          +    A 
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ YL+     + +HR+L A N ++  D   KI DFG+ R     +      + +    +
Sbjct: 143 GMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           MAPE   DG F+  SD++SFG++L EI S
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 31/225 (13%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSKISEQG-----LKELKNEVI 87
           +   + K LG+G FG V +            + +AVK L + +        + ELK   I
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 120
Query: 88  LFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKR 140
           L     H N+V LLG C + G   ++I EF    +L +++      F   +    D  K 
Sbjct: 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 180
Query: 141 F----HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
           F    H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    
Sbjct: 181 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 237
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 238 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 124/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 68  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 121
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 176
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 231
Query: 272 DPCI 275
            P +
Sbjct: 232 WPGV 235

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 103/226 (45%), Gaps = 32/226 (14%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSK 91
           N  S  K LG G FG V + T            +AVK L   +    +E L +E+ + S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSL--------DSFIFDQERCKILDWSKRFH 142
           L  H N+V LLG C  G   L+I E+     L        DSFI  +    I++  +   
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 143 IICG-------TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
            +          A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 196 ---TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +GN +  +    +MAPE   +  ++ +SDV+S+GI L E+ S
Sbjct: 223 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 103/226 (45%), Gaps = 32/226 (14%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSK 91
           N  S  K LG G FG V + T            +AVK L   +    +E L +E+ + S 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSL--------DSFIFDQERCKILDWSKRFH 142
           L  H N+V LLG C  G   L+I E+     L        DSFI  +    I++  +   
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 143 IICG-------TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
            +          A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D 
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 196 ---TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +GN +  +    +MAPE   +  ++ +SDV+S+GI L E+ S
Sbjct: 216 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSK-ISEQGLKELKNEV-ILFS 90
           +   + K LG+G FG V +            + +AVK L +  +    + L +E+ IL  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 91  KLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKRF-- 141
              H N+V LLG C + G   ++I EF    +L +++      F   +    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 142 --HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
             H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D  
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                       +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 107/224 (47%), Gaps = 30/224 (13%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSKISEQG-----LKELKNEVI 87
           +  ++ K LG+G FG V +            + +AVK L + +        + ELK   I
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 84
Query: 88  LFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKIL-----DWSKRF 141
           L     H N+V LLG C + G   ++I EF    +L +++  +    +      D  K F
Sbjct: 85  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF 144
Query: 142 ----HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
               H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D
Sbjct: 145 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                         +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 125/244 (51%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++    +G+ 
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLS 117
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 172
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 227
Query: 272 DPCI 275
            P +
Sbjct: 228 WPGV 231

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSK-ISEQGLKELKNEV-ILFS 90
           +   + K LG+G FG V +            + +AVK L +  +    + L +E+ IL  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 91  KLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKRF-- 141
              H N+V LLG C + G   ++I EF    +L +++      F   +    D  K F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 142 --HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
             H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D  
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                       +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 103/226 (45%), Gaps = 32/226 (14%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSK 91
           N  S  K LG G FG V + T            +AVK L   +    +E L +E+ + S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSL--------DSFIFDQERCKILDWSKRFH 142
           L  H N+V LLG C  G   L+I E+     L        DSFI  +    I++  +   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 143 IICG-------TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
            +          A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 196 ---TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +GN +  +    +MAPE   +  ++ +SDV+S+GI L E+ S
Sbjct: 200 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL--KNEVILFSKLQHRNLV 98
           F+  +++G+G FG V+KG     Q++   ++  + E   +    + E+ + S+     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           K  G  ++G +  +I E++   S      D  R    D  +   ++    +G+ YLH + 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
           +   IHRD+KA+NVLL +  + K++DFG+A      + + NT   +GT  +MAPE     
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 195
Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYH---------SDNNLNLIGHAWKLWNEGMPSQ 269
            +  K+D++S GI  +E+  G+      H          +N   L+G   K + E     
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKE----- 250
Query: 270 LIDPCI 275
            ID C+
Sbjct: 251 FIDACL 256

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 103/226 (45%), Gaps = 32/226 (14%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSK 91
           N  S  K LG G FG V + T            +AVK L   +    +E L +E+ + S 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSL--------DSFIFDQERCKILDWSKRFH 142
           L  H N+V LLG C  G   L+I E+     L        DSFI  +    I++  +   
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 143 IICG-------TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
            +          A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D 
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 196 ---TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +GN +  +    +MAPE   +  ++ +SDV+S+GI L E+ S
Sbjct: 218 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 103/226 (45%), Gaps = 32/226 (14%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSK 91
           N  S  K LG G FG V + T            +AVK L   +    +E L +E+ + S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSL--------DSFIFDQERCKILDWSKRFH 142
           L  H N+V LLG C  G   L+I E+     L        DSFI  +    I++  +   
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 143 IICG-------TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
            +          A+G+ +L   +    IHRDL A N+LL      KI DFGLAR    D 
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 196 ---TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
               +GN +  +    +MAPE   +  ++ +SDV+S+GI L E+ S
Sbjct: 223 NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 47  LGQGGFGPVYK-GTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLVKLLGC 103
           LG+G FG V K    +  QE AVK ++K S +      +  EV L  KL H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 163
                   ++ E  T   L   I  ++R    D ++   II     G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 164 HRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF 220
           HRDLK  N+LL   ++D + KI DFGL+  F   +     K  IGT  Y+APE    G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLR-GTY 199
Query: 221 SVKSDVFSFGILLLEIISG 239
             K DV+S G++L  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 136/295 (46%), Gaps = 38/295 (12%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL--KNEVILFSKLQHRNLV 98
           F+  +K+G+G FG V+KG     Q++   ++  + E   +    + E+ + S+     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           K  G  ++  +  +I E++   S      D      LD ++   I+    +G+ YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEYAS 216
           +   IHRD+KA+NVLL +    K++DFG+A    G  T+   KR   +GT  +MAPE   
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEVIK 177
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
              +  K+D++S GI  +E+  G+      H    L LI        +  P     P ++
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-------PKNNP-----PTLE 225
Query: 277 GSFN--LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLAD 329
           G+++  L E +        C+ + P  RP+      +L  + +L   K+  YL +
Sbjct: 226 GNYSKPLKEFVEA------CLNKEPSFRPTAKE---LLKHKFILRNAKKTSYLTE 271

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 126/247 (51%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L +F+       I   L  S  F ++    +
Sbjct: 64  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLL----Q 117
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 227
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 228 EVVWPGV 234

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 17/209 (8%)
Query: 38  TNNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQ 93
           ++ +   + LG+G FG V      + GQE AVK +SK  + ++  KE L  EV L  +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N+ KL           L+ E  T   L   I  ++R   +D ++   II     G+ Y
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITY 141
Query: 154 LHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
            H++   +I+HRDLK  N+LL+   +D N +I DFGL+  F   E     K  IGT  Y+
Sbjct: 142 XHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYI 195
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE    G +  K DV+S G++L  ++SG
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 47  LGQGGFGPVYK-GTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLVKLLGC 103
           LG+G FG V K    +  QE AVK ++K S +      +  EV L  KL H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 163
                   ++ E  T   L   I  ++R    D ++   II     G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 164 HRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF 220
           HRDLK  N+LL   ++D + KI DFGL+  F   +     K  IGT  Y+APE    G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLR-GTY 199
Query: 221 SVKSDVFSFGILLLEIISG 239
             K DV+S G++L  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/199 (34%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 47  LGQGGFGPVYK-GTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLVKLLGC 103
           LG+G FG V K    +  QE AVK ++K S +      +  EV L  KL H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRII 163
                   ++ E  T   L   I  ++R    D ++   II     G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 164 HRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF 220
           HRDLK  N+LL   ++D + KI DFGL+  F   +     K  IGT  Y+APE    G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLR-GTY 199
Query: 221 SVKSDVFSFGILLLEIISG 239
             K DV+S G++L  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 136/295 (46%), Gaps = 38/295 (12%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL--KNEVILFSKLQHRNLV 98
           F+  +K+G+G FG V+KG     Q++   ++  + E   +    + E+ + S+     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           K  G  ++  +  +I E++   S      D      LD ++   I+    +G+ YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEYAS 216
           +   IHRD+KA+NVLL +    K++DFG+A    G  T+   KR   +GT  +MAPE   
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEVIK 192
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
              +  K+D++S GI  +E+  G+      H    L LI        +  P     P ++
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-------PKNNP-----PTLE 240
Query: 277 GSFN--LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLAD 329
           G+++  L E +        C+ + P  RP+      +L  + +L   K+  YL +
Sbjct: 241 GNYSKPLKEFVEA------CLNKEPSFRPTAKE---LLKHKFILRNAKKTSYLTE 286

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K L  G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 9   EAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 127 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 178 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+  L +  S + 
Sbjct: 36  EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKA 94
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 95  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 153
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 154 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 204
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 205 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 122 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 120
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 121 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           + I  +LG G FG VYK    + G   A K +   SE+ L++   E+ + +   H  +VK
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-RGVMYLHQDS 158
           LLG      +  ++ EF    ++D+ + + +R        +  ++C      + +LH   
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK- 128
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA--- 215
             RIIHRDLKA NVL+  + + +++DFG++      +T       IGT  +MAPE     
Sbjct: 129 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEVVMCE 184
Query: 216 --SDGQFSVKSDVFSFGILLLEI 236
              D  +  K+D++S GI L+E+
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEM 207

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 92
             F   K LG G FG VYKG  +   E     +A+K L +  S +  KE+ +E  + + +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKILDWSKRFHIICGTA 148
            + ++ +LLG C+    +L I + M    L  ++ + +       +L+W  +       A
Sbjct: 79  DNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------A 131
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
           +G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +E E + +       
Sbjct: 132 KGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K L  G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 9   EAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 127 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 178 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 122 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 120 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 170
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K L  G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFGLA+  G +
Sbjct: 120 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 31/225 (13%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSKISEQG-----LKELKNEVI 87
           +   + K LG+G FG V +            + +AVK L + +        + ELK   I
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 85
Query: 88  LFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFI------FDQERCKILDWSKR 140
           L     H N+V LLG C + G   ++I EF    +L +++      F   +    D  K 
Sbjct: 86  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD 145
Query: 141 F----HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
           F    H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    
Sbjct: 146 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 202
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 203 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 9   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 127 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 177
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 178 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMT---NKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF++    K +D+         ++  S  F ++ G A 
Sbjct: 62  HPNIVKLLDV-IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK-SYLFQLLQGLA- 118
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 119 ---FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 225
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 226 EVVWPGV 232

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 125/249 (50%), Gaps = 24/249 (9%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSK 91
           + +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMT---NKSLDSFIFDQERCKILDWSKRFHIICGT 147
           L H N+VKLL   I  E KL L++EF++    K +D+         ++  S  F ++ G 
Sbjct: 62  LNHPNIVKLLDV-IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK-SYLFQLLQGL 119
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A    + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T 
Sbjct: 120 A----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 170
Query: 208 GYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM 266
            Y APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGT 225
Query: 267 PSQLIDPCI 275
           P +++ P +
Sbjct: 226 PDEVVWPGV 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQG 78
           E P   L  I+  T  F   K LG G FG VYKG  +   E     +A+K L +  S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQE----RCKI 134
            KE+ +E  + + + + ++ +LLG C+    +L I + M    L  ++ + +       +
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
           L+W  +       A+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 122 LNWCVQI------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           E E + +       +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 25/204 (12%)
Query: 40  NFSINKKLGQGGFGPV---YKGTLVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 91
           N+ I K LG+G FG V   Y  T   GQ++A+K      L+K   QG   ++ E+     
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQG--RIEREISYLRL 64
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           L+H +++KL       +E +++ E+  N+  D +I  +++    +  + F  I      V
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIIS---AV 120
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TKRVIGTYGYM 210
            Y H   R +I+HRDLK  N+LLD+ +N KI+DFGL+       T+GN  K   G+  Y 
Sbjct: 121 EYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYA 173
Query: 211 APEYASDGQFS-VKSDVFSFGILL 233
           APE  S   ++  + DV+S G++L
Sbjct: 174 APEVISGKLYAGPEVDVWSCGVIL 197

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           + I  +LG G FG VYK    + G   A K +   SE+ L++   E+ + +   H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-RGVMYLHQDS 158
           LLG      +  ++ EF    ++D+ + + +R        +  ++C      + +LH   
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK- 136
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA--- 215
             RIIHRDLKA NVL+  + + +++DFG++      +T       IGT  +MAPE     
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 216 --SDGQFSVKSDVFSFGILLLEI 236
              D  +  K+D++S GI L+E+
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEM 215

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 119
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 120 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 25/204 (12%)
Query: 40  NFSINKKLGQGGFGPV---YKGTLVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 91
           N+ I K LG+G FG V   Y  T   GQ++A+K      L+K   QG   ++ E+     
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQG--RIEREISYLRL 60
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           L+H +++KL       +E +++ E+  N+  D +I  +++    +  + F  I      V
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIIS---AV 116
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TKRVIGTYGYM 210
            Y H   R +I+HRDLK  N+LLD+ +N KI+DFGL+       T+GN  K   G+  Y 
Sbjct: 117 EYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYA 169
Query: 211 APEYASDGQFS-VKSDVFSFGILL 233
           APE  S   ++  + DV+S G++L
Sbjct: 170 APEVISGKLYAGPEVDVWSCGVIL 193

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 25/204 (12%)
Query: 40  NFSINKKLGQGGFGPV---YKGTLVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 91
           N+ I K LG+G FG V   Y  T   GQ++A+K      L+K   QG   ++ E+     
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQG--RIEREISYLRL 69
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           L+H +++KL       +E +++ E+  N+  D +I  +++    +  + F  I      V
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIIS---AV 125
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TKRVIGTYGYM 210
            Y H   R +I+HRDLK  N+LLD+ +N KI+DFGL+       T+GN  K   G+  Y 
Sbjct: 126 EYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYA 178
Query: 211 APEYASDGQFS-VKSDVFSFGILL 233
           APE  S   ++  + DV+S G++L
Sbjct: 179 APEVISGKLYAGPEVDVWSCGVIL 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 125/249 (50%), Gaps = 24/249 (9%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSK 91
           + +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGT 147
           L H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G 
Sbjct: 63  LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A    + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T 
Sbjct: 121 A----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 171
Query: 208 GYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM 266
            Y APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G 
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGT 226
Query: 267 PSQLIDPCI 275
           P +++ P +
Sbjct: 227 PDEVVWPGV 235

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 25/204 (12%)
Query: 40  NFSINKKLGQGGFGPV---YKGTLVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 91
           N+ I K LG+G FG V   Y  T   GQ++A+K      L+K   QG   ++ E+     
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQG--RIEREISYLRL 70
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           L+H +++KL       +E +++ E+  N+  D +I  +++    +  + F  I      V
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIIS---AV 126
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TKRVIGTYGYM 210
            Y H   R +I+HRDLK  N+LLD+ +N KI+DFGL+       T+GN  K   G+  Y 
Sbjct: 127 EYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYA 179
Query: 211 APEYASDGQFS-VKSDVFSFGILL 233
           APE  S   ++  + DV+S G++L
Sbjct: 180 APEVISGKLYAGPEVDVWSCGVIL 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 47  LGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC-- 103
           +G GGFG V+K    +DG+   +KR+   +E+  +E+K      +KL H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK----ALAKLDHVNIVHYNGCWD 74
Query: 104 ------------CIQGEEKLLI--YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
                         + + K L    EF    +L+ +I ++ R + LD      +     +
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITK 133
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           GV Y+H     ++I+RDLK SN+ L      KI DFGL  +   D   G   R  GT  Y
Sbjct: 134 GVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRSKGTLRY 187
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEII 237
           M+PE  S   +  + D+++ G++L E++
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 117
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 118 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 143
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 140
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 143
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 142
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 140
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 63  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 119
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 120 ---FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 226
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 227 EVVWPGV 233

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 224
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 225 EVVWPGV 231

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 139
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 63  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 119
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 120 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 226
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 227 EVVWPGV 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 140
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 118
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 142
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 124
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 224
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 225 EVVWPGV 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 142
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y AP
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 171
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 226
Query: 272 DPCI 275
            P +
Sbjct: 227 WPGV 230

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 62  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 118
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 119 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 225
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 226 EVVWPGV 232

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 125/249 (50%), Gaps = 24/249 (9%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSK 91
           + +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGT 147
           L H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G 
Sbjct: 62  LNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A    + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T 
Sbjct: 120 A----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 170
Query: 208 GYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM 266
            Y APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGT 225
Query: 267 PSQLIDPCI 275
           P +++ P +
Sbjct: 226 PDEVVWPGV 234

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 139
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 63  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 119
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 120 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 226
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 227 EVVWPGV 233

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 64  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 120
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 121 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 227
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 228 EVVWPGV 234

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGP-VYKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F   V    L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 140
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 62  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 118
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 119 ---FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 225
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 226 EVVWPGV 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 142
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 224
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 225 EVVWPGV 231

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 224
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 225 EVVWPGV 231

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 146/323 (45%), Gaps = 49/323 (15%)
Query: 30  ELATIVSATNNFSINKKLGQGGFGPVYKGTLV--DGQ--EIAVKRLSK--ISEQGLKELK 83
           +L  ++     F++ + LG+G FG V +  L   DG   ++AVK L    I+   ++E  
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEK------LLIYEFMTNKSLDSFIFDQ---ERCKI 134
            E     +  H ++ KL+G  ++   K      ++I  FM +  L +F+      E    
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGG 193
           L        +   A G+ YL   S    IHRDL A N +L +DM   ++DFGL+R  + G
Sbjct: 134 LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 194 D-ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKN--RGFYHSDN 250
           D   +G   ++     ++A E  +D  ++V SDV++FG+ + EI++  +    G  +++ 
Sbjct: 191 DYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248
Query: 251 NLNLIGHAWKLWNEGMPSQLIDP--CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
              LIG           ++L  P  C++  ++L            C    PK RPS   +
Sbjct: 249 YNYLIGG----------NRLKQPPECMEEVYDLM---------YQCWSADPKQRPSFTCL 289
Query: 309 IL----MLGSETVLPQPKQPGYL 327
            +    +LG  +VL   + P Y+
Sbjct: 290 RMELENILGHLSVLSTSQDPLYI 312

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 133/279 (47%), Gaps = 47/279 (16%)
Query: 45  KKLGQGGFGPVYKGTLV----DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLV 98
           +K+G+G FG   K  LV    DG++  +K +  S++S +  +E + EV + + ++H N+V
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ-----ERCKILDWSKRFHIICGTARGVMY 153
           +      +     ++ ++     L   I  Q     +  +ILDW   F  IC   +    
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW---FVQICLALK---- 139
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
            H   R +I+HRD+K+ N+ L +D   ++ DFG+AR    + T    +  IGT  Y++PE
Sbjct: 140 -HVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPE 195
Query: 214 YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
              +  ++ KSD+++ G +L E+ + K                HA++    G    L+  
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLK----------------HAFE---AGSMKNLVLK 236
Query: 274 CIQGSFNLAEVIRCIHIGLLCVQ---QHPKDRPSMPSVI 309
            I GSF    +     +  L  Q   ++P+DRPS+ S++
Sbjct: 237 IISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 142
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 34/212 (16%)
Query: 45  KKLGQGGFG--------PVYKGTLVDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHR 95
           + LG+G FG        P   GT   G+ +AVK L +    Q     K E+ +   L H 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 96  NLVKLLGCC-IQGEEKL-LIYEFMTNKSLDSFIFDQE--RCKILDWSKRFHIICGTARGV 151
           +++K  GCC  QGE+ L L+ E++   SL  ++        ++L ++++   IC    G+
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ---IC---EGM 130
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--- 208
            YLH       IHR+L A NVLLD D   KI DFGLA+A      EG+    +   G   
Sbjct: 131 AYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSP 183
Query: 209 --YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             + APE   + +F   SDV+SFG+ L E+++
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTAR 149
           H N+VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
              + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y
Sbjct: 118 ---FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 210 MAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P 
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPD 224
Query: 269 QLIDPCI 275
           +++ P +
Sbjct: 225 EVVWPGV 231

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y AP
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 171
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 226
Query: 272 DPCI 275
            P +
Sbjct: 227 WPGV 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 95  RNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTA 148
              VKL     Q +EKL     +  N  L  +I     FD E C       RF+      
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYT-AEIV 145
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  
Sbjct: 146 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y++PE  ++      SD+++ G ++ ++++G
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+   RL   +E        E+ L  +L H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 64  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 117
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 172
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 227
Query: 272 DPCI 275
            P +
Sbjct: 228 WPGV 231

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+   RL   +E        E+ L  +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 63  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 116
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y AP
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 171
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 226
Query: 272 DPCI 275
            P +
Sbjct: 227 WPGV 230

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 34/212 (16%)
Query: 45  KKLGQGGFG--------PVYKGTLVDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHR 95
           + LG+G FG        P   GT   G+ +AVK L +    Q     K E+ +   L H 
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 96  NLVKLLGCC-IQGEEKL-LIYEFMTNKSLDSFIFDQE--RCKILDWSKRFHIICGTARGV 151
           +++K  GCC  QGE+ L L+ E++   SL  ++        ++L ++++   IC    G+
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ---IC---EGM 130
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--- 208
            YLH       IHR+L A NVLLD D   KI DFGLA+A      EG+    +   G   
Sbjct: 131 AYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSP 183
Query: 209 --YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             + APE   + +F   SDV+SFG+ L E+++
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 120/243 (49%), Gaps = 22/243 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVMY 153
           +VKLL   I  E KL +     ++ L +F+       I   L  S  F ++ G A    +
Sbjct: 63  IVKLLDV-IHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA----F 117
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
            H     R++HRDLK  N+L++ +   K++DFGLARAFG       T  V+ T  Y APE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 172
Query: 214 YASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 272
                + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++ 
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVVW 227
Query: 273 PCI 275
           P +
Sbjct: 228 PGV 230

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DG--QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 93
           N+      +G+G FG V K  +  DG   + A+KR+ +  S+   ++   E+ +  KL  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSL-------------DSFIFDQERCKILDWSKR 140
           H N++ LLG C       L  E+  + +L              +F         L   + 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
            H     ARG+ YL Q    + IHRDL A N+L+ ++   KI+DFGL+R       E   
Sbjct: 135 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYV 186
Query: 201 KRVIG--TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           K+ +G     +MA E  +   ++  SDV+S+G+LL EI+S
Sbjct: 187 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 123/244 (50%), Gaps = 24/244 (9%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGTARGVM 152
           +VKLL   I  E KL L++EF+ ++ L  F+       I   L  S  F ++ G A    
Sbjct: 65  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA---- 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T  Y AP
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 213 EYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           E     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G P +++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGTPDEVV 228
Query: 272 DPCI 275
            P +
Sbjct: 229 WPGV 232

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DG--QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 93
           N+      +G+G FG V K  +  DG   + A+KR+ +  S+   ++   E+ +  KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSL-------------DSFIFDQERCKILDWSKR 140
           H N++ LLG C       L  E+  + +L              +F         L   + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
            H     ARG+ YL Q    + IHRDL A N+L+ ++   KI+DFGL+R       E   
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYV 196
Query: 201 KRVIG--TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           K+ +G     +MA E  +   ++  SDV+S+G+LL EI+S
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEI----AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   Y+ T +D +E+     V +   +     +++  E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K +   +  + +  T +GV YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L+ DM+ KI DFGLA      E +G  K+ + GT  Y+APE       S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKTLCGTPNYIAPEVLCKKGHS 220
Query: 222 VKSDVFSFGILLLEIISGK 240
            + D++S G +L  ++ GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 24/249 (9%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSK 91
           + +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGT 147
           L H N+VKLL   I  E KL L++EF++   L  F+       I   L  S  F ++ G 
Sbjct: 61  LNHPNIVKLLDV-IHTENKLYLVFEFLS-MDLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A    + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T 
Sbjct: 119 A----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 169
Query: 208 GYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM 266
            Y APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G 
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGT 224
Query: 267 PSQLIDPCI 275
           P +++ P +
Sbjct: 225 PDEVVWPGV 233

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 24/249 (9%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSK 91
           + +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI---LDWSKRFHIICGT 147
           L H N+VKLL   I  E KL L++EF++   L  F+       I   L  S  F ++ G 
Sbjct: 62  LNHPNIVKLLDV-IHTENKLYLVFEFLS-MDLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A    + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V  T 
Sbjct: 120 A----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 170
Query: 208 GYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM 266
            Y APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++    G 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--TLGT 225
Query: 267 PSQLIDPCI 275
           P +++ P +
Sbjct: 226 PDEVVWPGV 234

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 139/306 (45%), Gaps = 50/306 (16%)
Query: 30  ELATIVSATNNFSINKKLGQGGFGPVYKGTLV--DGQ--EIAVK--RLSKISEQGLKELK 83
           +L  +V   N   + K LG+G FG V +G L   DG   ++AVK  +L   S++ ++E  
Sbjct: 25  KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL 84
Query: 84  NEVILFSKLQHRNLVKLLGCCI----QGEEK-LLIYEFMTNKSLDSFIFD---QERCKIL 135
           +E        H N+++LLG CI    QG  K ++I  FM    L +++     +   K +
Sbjct: 85  SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 136 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGD 194
                   +   A G+ YL   S    +HRDL A N +L  DM   ++DFGL++  + GD
Sbjct: 145 PLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
Query: 195 -ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-------GKKNRGFY 246
              +G   ++     ++A E  +D  ++ KSDV++FG+ + EI +       G +N   Y
Sbjct: 202 YYRQGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 247 HSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP 306
               +  L GH  K      P   +D        L E++        C +  P DRP+  
Sbjct: 260 ----DYLLHGHRLK-----QPEDCLD-------ELYEIMYS------CWRTDPLDRPTFS 297
Query: 307 SVILML 312
            + L L
Sbjct: 298 VLRLQL 303

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 27/221 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSKISEQG-----LKELKNEVI 87
           +  ++ K LG+G FG V +            + +AVK L + +        + ELK   I
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 88  LFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQ--ERCKILDWSKRF--- 141
           L     H N+V LLG C + G   ++I EF    +L +++  +  E     D  K F   
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTL 143
Query: 142 -HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 197
            H+I  +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D   
Sbjct: 144 EHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                      +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 201 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEI----AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   Y+ T +D +E+     V +   +     +++  E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K +   +  + +  T +GV YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L+ DM+ KI DFGLA      E +G  K+ + GT  Y+APE       S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKXLCGTPNYIAPEVLCKKGHS 220
Query: 222 VKSDVFSFGILLLEIISGK 240
            + D++S G +L  ++ GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           +K+G+G +G VYK     G+  A+K  RL K  E        E+ +  +L+H N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD---------WSKRFHIICGTARGVMY 153
                +  +L++E +          DQ+  K+LD          +K F  +     G+ Y
Sbjct: 68  VIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSF--LLQLLNGIAY 115
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
            H     R++HRDLK  N+L++++   KI+DFGLARAF G      T  V+ T  Y AP+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPD 170
Query: 214 Y-ASDGQFSVKSDVFSFGILLLEIISG 239
                 ++S   D++S G +  E+++G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           +K+G+G +G VYK     G+  A+K  RL K  E        E+ +  +L+H N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD---------WSKRFHIICGTARGVMY 153
                +  +L++E +          DQ+  K+LD          +K F  +     G+ Y
Sbjct: 68  VIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSF--LLQLLNGIAY 115
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
            H     R++HRDLK  N+L++++   KI+DFGLARAF G      T  V+ T  Y AP+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPD 170
Query: 214 Y-ASDGQFSVKSDVFSFGILLLEIISG 239
                 ++S   D++S G +  E+++G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEI----AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   Y+ T +D +E+     V +   +     +++  E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K +   +  + +  T +GV YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 147
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR-VIGTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L+ DM+ KI DFGLA      E +G  K+ + GT  Y+APE       S
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKDLCGTPNYIAPEVLCKKGHS 204
Query: 222 VKSDVFSFGILLLEIISGK 240
            + D++S G +L  ++ GK
Sbjct: 205 FEVDIWSLGCILYTLLVGK 223

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEI----AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   Y+ T +D +E+     V +   +     +++  E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K +   +  + +  T +GV YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR-VIGTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L+ DM+ KI DFGLA      E +G  K+ + GT  Y+APE       S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKI---EFDGERKKDLCGTPNYIAPEVLCKKGHS 220
Query: 222 VKSDVFSFGILLLEIISGK 240
            + D++S G +L  ++ GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 39  NNFSINKKLGQGGFGPVYKG------TLVDGQEIAVKRLSKISEQG-----LKELKNEVI 87
           +   + K LG+G FG V +            + +AVK L + +        + ELK   I
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---I 85
Query: 88  LFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQER----CKILDWSKRF- 141
           L     H N+V LLG C + G   ++I EF    +L +++  +       K  D  K F 
Sbjct: 86  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFL 145
Query: 142 ---HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
              H+I  +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D 
Sbjct: 146 TLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                        +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 20/206 (9%)
Query: 45  KKLGQGGFGPVY------KGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNL 97
           + LG+G FG V       +G    G+++AVK L   S    + +LK E+ +   L H N+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 98  VKLLGCCIQ--GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI-ICGTARGVMYL 154
           VK  G C +  G    LI EF+ + SL  ++   +    L    ++ + IC   +G+ YL
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC---KGMDYL 142
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK--RVIGTYGYMAP 212
              SR + +HRDL A NVL++ +   KI DFGL +A   D+     K  R    + Y AP
Sbjct: 143 --GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-AP 198
Query: 213 EYASDGQFSVKSDVFSFGILLLEIIS 238
           E     +F + SDV+SFG+ L E+++
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 45  KKLGQGGFGPVY------KGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNL 97
           + LG+G FG V       +G    G+++AVK L   S    + +LK E+ +   L H N+
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 98  VKLLGCCIQ--GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           VK  G C +  G    LI EF+ + SL  ++  + + KI +  ++        +G+ YL 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI-NLKQQLKYAVQICKGMDYL- 130
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK--RVIGTYGYMAPE 213
             SR + +HRDL A NVL++ +   KI DFGL +A   D+     K  R    + Y APE
Sbjct: 131 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APE 187
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
                +F + SDV+SFG+ L E+++
Sbjct: 188 CLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           +K+G+G +G VYK     G+  A+K  RL K  E        E+ +  +L+H N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILD---------WSKRFHIICGTARGVMY 153
                +  +L++E +          DQ+  K+LD          +K F  +     G+ Y
Sbjct: 68  VIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSF--LLQLLNGIAY 115
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
            H     R++HRDLK  N+L++++   KI+DFGLARAF G      T  ++ T  Y AP+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPD 170
Query: 214 Y-ASDGQFSVKSDVFSFGILLLEIISG 239
                 ++S   D++S G +  E+++G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   ++ +  D +E+   ++      +     +++  E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K L   +  + +     G  YLH++   R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L++D+  KI DFGLA      E +G  K+V+ GT  Y+APE  S    S
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 222 VKSDVFSFGILLLEIISGK 240
            + DV+S G ++  ++ GK
Sbjct: 218 FEVDVWSIGCIMYTLLVGK 236

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   ++ +  D +E+   ++   S        +++  E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K L   +  + +     G  YLH++   R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L++D+  KI DFGLA      E +G  K+V+ GT  Y+APE  S    S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 222 VKSDVFSFGILLLEIISGK 240
            + DV+S G ++  ++ GK
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 114/234 (48%), Gaps = 39/234 (16%)
Query: 45  KKLGQGGFG--------PVYKGTLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 95
           + LG+G FG        P   GT   G+ +AVK L +     L+   + E+ +   L H 
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 70
Query: 96  NLVKLLGCC-IQGEEKL-LIYEFMTNKSLDSFIFDQERC----KILDWSKRFHIICGTAR 149
           ++VK  GCC  QGE+ + L+ E++   SL  ++     C    ++L ++++   IC    
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQ---IC---E 122
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG- 208
           G+ YLH       IHR L A NVLLD D   KI DFGLA+A      EG+    +   G 
Sbjct: 123 GMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGD 175
Query: 209 ----YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA 258
               + APE   + +F   SDV+SFG+ L E+++   +    H+     LIGH 
Sbjct: 176 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFT-ELIGHT 228

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 114/234 (48%), Gaps = 39/234 (16%)
Query: 45  KKLGQGGFG--------PVYKGTLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 95
           + LG+G FG        P   GT   G+ +AVK L +     L+   + E+ +   L H 
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 71
Query: 96  NLVKLLGCC-IQGEEKL-LIYEFMTNKSLDSFIFDQERC----KILDWSKRFHIICGTAR 149
           ++VK  GCC  QGE+ + L+ E++   SL  ++     C    ++L ++++   IC    
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQ---IC---E 123
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG- 208
           G+ YLH       IHR L A NVLLD D   KI DFGLA+A      EG+    +   G 
Sbjct: 124 GMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGD 176
Query: 209 ----YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA 258
               + APE   + +F   SDV+SFG+ L E+++   +    H+     LIGH 
Sbjct: 177 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFT-ELIGHT 229

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 15/244 (6%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL--KNEVILFSKLQHRNLV 98
           F+   ++G+G FG VYKG     +E+   ++  + E   +    + E+ + S+     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +  G  ++  +  +I E++   S      D  +   L+ +    I+    +G+ YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 135
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEYAS 216
             R IHRD+KA+NVLL +  + K++DFG+A    G  T+   KR   +GT  +MAPE   
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEVIK 189
Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
              +  K+D++S GI  +E+  G+      H    L LI        EG  S+     ++
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVE 249
Query: 277 GSFN 280
              N
Sbjct: 250 ACLN 253

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 98
           + + ++LG GGFG V +    D G+++A+K+  + +S +  +    E+ +  KL H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 99  KL------LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
                   L      +  LL  E+     L  ++   E C  L       ++   +  + 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 153 YLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           YLH++   RIIHRDLK  N++L    Q +  KI D G A+    D+ E  T+  +GT  Y
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGTLQY 190
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE     +++V  D +SFG L  E I+G
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 98
           + + ++LG GGFG V +    D G+++A+K+  + +S +  +    E+ +  KL H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 99  KL------LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
                   L      +  LL  E+     L  ++   E C  L       ++   +  + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 153 YLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           YLH++   RIIHRDLK  N++L    Q +  KI D G A+    D+ E  T+  +GT  Y
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGTLQY 189
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE     +++V  D +SFG L  E I+G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DG--QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 93
           N+      +G+G FG V K  +  DG   + A+KR+ +  S+   ++   E+ +  KL  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSL-------------DSFIFDQERCKILDWSKR 140
           H N++ LLG C       L  E+  + +L              +F         L   + 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
            H     ARG+ YL Q    + IHR+L A N+L+ ++   KI+DFGL+R       E   
Sbjct: 142 LHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRG-----QEVYV 193
Query: 201 KRVIG--TYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           K+ +G     +MA E  +   ++  SDV+S+G+LL EI+S
Sbjct: 194 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   ++ +  D +E+   ++      +     +++  E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K L   +  + +     G  YLH++   R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L++D+  KI DFGLA      E +G  K+V+ GT  Y+APE  S    S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 222 VKSDVFSFGILLLEIISGK 240
            + DV+S G ++  ++ GK
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 47  LGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC-- 103
           +G GGFG V+K    +DG+   ++R+   +E+  +E+K      +KL H N+V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVK----ALAKLDHVNIVHYNGCWD 75
Query: 104 -------------------------CIQGEEKLLI--YEFMTNKSLDSFIFDQERCKILD 136
                                      + + K L    EF    +L+ +I ++ R + LD
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLD 134
Query: 137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
                 +     +GV Y+H     ++IHRDLK SN+ L      KI DFGL  +   D  
Sbjct: 135 KVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-- 189
Query: 197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII 237
            G   R  GT  YM+PE  S   +  + D+++ G++L E++
Sbjct: 190 -GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 122/252 (48%), Gaps = 34/252 (13%)
Query: 37  ATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQ 93
           +  NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHI--------I 144
           H N+VKLL   I  E KL L++E +          DQ+  K +D S    I        +
Sbjct: 64  HPNIVKLLDV-IHTENKLYLVFEHV----------DQDLKKFMDASALTGIPLPLIKSYL 112
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               +G+ + H     R++HRDLK  N+L++ +   K++DFGLARAFG        + V 
Sbjct: 113 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 205 GTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN 263
            T  Y APE     + +S   D++S G +  E+++    R  +  D+ ++ +   ++   
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR--T 222
Query: 264 EGMPSQLIDPCI 275
            G P +++ P +
Sbjct: 223 LGTPDEVVWPGV 234

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 34/212 (16%)
Query: 45  KKLGQGGFG--------PVYKGTLVDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHR 95
           + LG+G FG        P   GT   G+ +AVK L +    Q     K E+ +   L H 
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 96  NLVKLLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQE--RCKILDWSKRFHIICGTARGV 151
           +++K  GCC   G   L L+ E++   SL  ++        ++L ++++   IC    G+
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ---IC---EGM 147
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--- 208
            YLH       IHRDL A NVLLD D   KI DFGLA+A      EG+    +   G   
Sbjct: 148 AYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEXYRVREDGDSP 200
Query: 209 --YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             + APE   + +F   SDV+SFG+ L E+++
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRN 96
            +F   + LG+GGFG V++    VD    A+KR+   + +  +E +  EV   +KL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 97  LVKLLGCCIQ---------GEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKR--FH 142
           +V+     ++            K+ +Y   +    ++L  ++    RC I +  +    H
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLH 122
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE----- 197
           I    A  V +LH      ++HRDLK SN+    D   K+ DFGL  A   DE E     
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 198 -----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII 237
                      +GT  YM+PE      +S K D+FS G++L E++
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE------LKNEVILFSKLQH 94
           + I + LG+G FG V   T    Q+     L  IS Q LK+      ++ E+     L+H
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVA--LKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF--HIICGTARGVM 152
            +++KL        + +++ E+   +  D +I +++R    D  +RF   IIC     + 
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAGGELFD-YIVEKKRMT-EDEGRRFFQQIICA----IE 122
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TKRVIGTYGYMA 211
           Y H   R +I+HRDLK  N+LLD ++N KI+DFGL+       T+GN  K   G+  Y A
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAA 175
Query: 212 PEYASDGQFS-VKSDVFSFGILLLEIISGK 240
           PE  +   ++  + DV+S GI+L  ++ G+
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   ++ +  D +E+   ++      +     +++  E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K L   +  + +     G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L++D+  KI DFGLA      E +G  K+ + GT  Y+APE  S    S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 222 VKSDVFSFGILLLEIISGK 240
            + DV+S G ++  ++ GK
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   ++ +  D +E+   ++      +     +++  E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K L   +  + +     G  YLH++   R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L++D+  KI DFGLA      E +G  K+ + GT  Y+APE  S    S
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 199
Query: 222 VKSDVFSFGILLLEIISGK 240
            + DV+S G ++  ++ GK
Sbjct: 200 FEVDVWSIGCIMYTLLVGK 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGF   ++ +  D +E+   ++      +     +++  E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
                +   ++ E    +SL       +R K L   +  + +     G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPEYASDGQFS 221
           IHRDLK  N+ L++D+  KI DFGLA      E +G  K+ + GT  Y+APE  S    S
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKTLCGTPNYIAPEVLSKKGHS 195
Query: 222 VKSDVFSFGILLLEIISGK 240
            + DV+S G ++  ++ GK
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 38/227 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           +N  + + +G+G +G VYKG+L D + +AVK  S  + Q     KN +     ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 99  KLLGCCIQGEEK---------LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +     I G+E+         LL+ E+  N SL  ++         DW     +     R
Sbjct: 71  RF----IVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTR 122
Query: 150 GVMYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD------ETE 197
           G+ YLH +       +  I HRDL + NVL+  D    ISDFGL+    G+      E +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 198 GNTKRVIGTYGYMAPEYAS------DGQFSVKS-DVFSFGILLLEII 237
                 +GT  YMAPE         D + ++K  D+++ G++  EI 
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 110/239 (46%), Gaps = 44/239 (18%)
Query: 18  QIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS- 75
           Q +N++L + L          N+FS+++ +G+GGFG VY     D G+  A+K L K   
Sbjct: 176 QWKNVELNIHL--------TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 76  --EQGLKELKNEVILFSKLQHRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQ 129
             +QG     NE I+ S      LV    C    C+        Y F T   L SFI D 
Sbjct: 228 KMKQGETLALNERIMLS------LVSTGDCPFIVCMS-------YAFHTPDKL-SFILDL 273
Query: 130 ERCKILDWSKRFHIICGTARGVMYL--------HQDSRLRIIHRDLKASNVLLDQDMNPK 181
                L +    H +   A    Y         H  +R  +++RDLK +N+LLD+  + +
Sbjct: 274 MNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVR 332
Query: 182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISG 239
           ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 333 ISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 110/239 (46%), Gaps = 44/239 (18%)
Query: 18  QIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS- 75
           Q +N++L + L          N+FS+++ +G+GGFG VY     D G+  A+K L K   
Sbjct: 175 QWKNVELNIHL--------TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 226
Query: 76  --EQGLKELKNEVILFSKLQHRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQ 129
             +QG     NE I+ S      LV    C    C+        Y F T   L SFI D 
Sbjct: 227 KMKQGETLALNERIMLS------LVSTGDCPFIVCMS-------YAFHTPDKL-SFILDL 272
Query: 130 ERCKILDWSKRFHIICGTARGVMYL--------HQDSRLRIIHRDLKASNVLLDQDMNPK 181
                L +    H +   A    Y         H  +R  +++RDLK +N+LLD+  + +
Sbjct: 273 MNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVR 331
Query: 182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISG 239
           ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 332 ISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 110/239 (46%), Gaps = 44/239 (18%)
Query: 18  QIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS- 75
           Q +N++L + L          N+FS+++ +G+GGFG VY     D G+  A+K L K   
Sbjct: 176 QWKNVELNIHL--------TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 76  --EQGLKELKNEVILFSKLQHRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQ 129
             +QG     NE I+ S      LV    C    C+        Y F T   L SFI D 
Sbjct: 228 KMKQGETLALNERIMLS------LVSTGDCPFIVCMS-------YAFHTPDKL-SFILDL 273
Query: 130 ERCKILDWSKRFHIICGTARGVMYL--------HQDSRLRIIHRDLKASNVLLDQDMNPK 181
                L +    H +   A    Y         H  +R  +++RDLK +N+LLD+  + +
Sbjct: 274 MNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVR 332
Query: 182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISG 239
           ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 333 ISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 110/239 (46%), Gaps = 44/239 (18%)
Query: 18  QIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS- 75
           Q +N++L + L          N+FS+++ +G+GGFG VY     D G+  A+K L K   
Sbjct: 176 QWKNVELNIHL--------TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 76  --EQGLKELKNEVILFSKLQHRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQ 129
             +QG     NE I+ S      LV    C    C+        Y F T   L SFI D 
Sbjct: 228 KMKQGETLALNERIMLS------LVSTGDCPFIVCMS-------YAFHTPDKL-SFILDL 273
Query: 130 ERCKILDWSKRFHIICGTARGVMYL--------HQDSRLRIIHRDLKASNVLLDQDMNPK 181
                L +    H +   A    Y         H  +R  +++RDLK +N+LLD+  + +
Sbjct: 274 MNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVR 332
Query: 182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISG 239
           ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 333 ISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 8/234 (3%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + +  K+LG G FG V  G      ++A+K + + S     E   E  +   L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C +     +I E+M N  L +++  +E        +   +       + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             + +HRDL A N L++     K+SDFGL+R    DE   +         +  PE     
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 176
Query: 219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           +FS KSD+++FG+L+ EI S GK     + +      I    +L+   + S+ +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 230

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 8/234 (3%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + +  K+LG G FG V  G      ++A+K + + S     E   E  +   L H  LV
Sbjct: 8   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 66
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C +     +I E+M N  L +++  +E        +   +       + YL    
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 123
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             + +HRDL A N L++     K+SDFGL+R    DE   +         +  PE     
Sbjct: 124 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 180
Query: 219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           +FS KSD+++FG+L+ EI S GK     + +      I    +L+   + S+ +
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 234

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 8/234 (3%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + +  K+LG G FG V  G      ++A+K + + S     E   E  +   L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 82
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C +     +I E+M N  L +++  +E        +   +       + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 139
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             + +HRDL A N L++     K+SDFGL+R    DE   +         +  PE     
Sbjct: 140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 196
Query: 219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           +FS KSD+++FG+L+ EI S GK     + +      I    +L+   + S+ +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 8/234 (3%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + +  K+LG G FG V  G      ++A+K + + S     E   E  +   L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 82
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C +     +I E+M N  L +++  +E        +   +       + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 139
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             + +HRDL A N L++     K+SDFGL+R    DE   +         +  PE     
Sbjct: 140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPV-RWSPPEVLMYS 196
Query: 219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           +FS KSD+++FG+L+ EI S GK     + +      I    +L+   + S+ +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 8/234 (3%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + +  K+LG G FG V  G      ++A+K + + S     E   E  +   L H  LV
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 67
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C +     +I E+M N  L +++  +E        +   +       + YL    
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 124
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             + +HRDL A N L++     K+SDFGL+R    DE   +         +  PE     
Sbjct: 125 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 181
Query: 219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           +FS KSD+++FG+L+ EI S GK     + +      I    +L+   + S+ +
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 235

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 8/234 (3%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + +  K+LG G FG V  G      ++A+K + + S     E   E  +   L H  LV
Sbjct: 15  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 73
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C +     +I E+M N  L +++  +E        +   +       + YL    
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 130
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             + +HRDL A N L++     K+SDFGL+R    DE   +         +  PE     
Sbjct: 131 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 187
Query: 219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           +FS KSD+++FG+L+ EI S GK     + +      I    +L+   + S+ +
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 241

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 40  NFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQHR 95
           +F I + LG G FG V+   +  +G+  A+K L K     LK+++   +E ++ S + H 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
            ++++ G     ++  +I +++    L S +   +R    +   +F+        + YLH
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYA-AEVCLALEYLH 123
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
                 II+RDLK  N+LLD++ + KI+DFG A+          T  + GT  Y+APE  
Sbjct: 124 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVV 175
Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
           S   ++   D +SFGIL+ E+++G     FY S+ 
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYT--PFYDSNT 208

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 8/234 (3%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + +  K+LG G FG V  G      ++A+K + + S     E   E  +   L H  LV
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 67
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C +     +I E+M N  L +++  +E        +   +       + YL    
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK- 124
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             + +HRDL A N L++     K+SDFGL+R    DE   +         +  PE     
Sbjct: 125 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYS 181
Query: 219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           +FS KSD+++FG+L+ EI S GK     + +      I    +L+   + S+ +
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 235

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++  Q+   + D      ++   + G+ YL + +
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 132 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ----THGKWPVKWYAPE 184
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++  Q+   + D      ++   + G+ YL + +
Sbjct: 90  RMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN 145
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 146 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPE 198
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++  Q+   + D      ++   + G+ YL + +
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN 127
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPE 180
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++  Q+   + D      ++   + G+ YL + +
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN 147
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPE 200
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++  Q+   + D      ++   + G+ YL + +
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN 147
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPE 200
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++  Q+   + D      ++   + G+ YL + +
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN 137
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPE 190
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++  Q+   + D      ++   + G+ YL + +
Sbjct: 70  RMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN 125
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 126 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPE 178
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++  Q+   + D      ++   + G+ YL + +
Sbjct: 76  RMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN 131
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 132 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPE 184
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH----------- 94
           LGQG FG V K    +D +  A+K++ + +E+ L  + +EV+L + L H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 95  --RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
             RN VK +    +     +  E+  N++L   I  +   +  D  + + +       + 
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD--EYWRLFRQILEALS 130
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD------------ETEGNT 200
           Y+H      IIHRDLK  N+ +D+  N KI DFGLA+                  +  N 
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 201 KRVIGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEII 237
              IGT  Y+A E     G ++ K D++S GI+  E+I
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++      K  +  +  H +   + G+ YL + +
Sbjct: 434 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV---SMGMKYLEESN 489
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 490 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPE 542
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 44  NKKLGQGGFGPVYKGTLVDGQEIAVKRL----SKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG     + +    +    ++ ++  LK EL  E  +  +L +  +V
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++      K  +  +  H +   + G+ YL + +
Sbjct: 435 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV---SMGMKYLEESN 490
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG-----YMAPE 213
               +HRDL A NVLL      KISDFGL++A   DE     +    T+G     + APE
Sbjct: 491 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPE 543
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +FS KSDV+SFG+L+ E  S
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 45  KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLV 98
           K LG G FG V+KG  + +G+ I +    K+ E     Q  + + + ++    L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-----LDWSKRFHIICGTARGVMY 153
           +LLG C  G    L+ +++   SL   +  Q R  +     L+W  +       A+G+ Y
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQI------AKGMYY 130
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           L +     ++HR+L A NVLL      +++DFG+A     D+ +           +MA E
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
               G+++ +SDV+S+G+ + E+++
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 21/238 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK----ISEQGLKELKNEVILFSKLQH 94
           +F ++K LG+G FG V+        Q  A+K L K    + +     +  + +L    +H
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 78
Query: 95  RNLVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
             L  +  C  Q +E L  + E++    L   ++  + C   D S+          G+ +
Sbjct: 79  PFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 134
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTKRVIGTYGYMAP 212
           LH      I++RDLK  N+LLD+D + KI+DFG+ +    GD     T    GT  Y+AP
Sbjct: 135 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKTNEFCGTPDYIAP 188
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           E     +++   D +SFG+LL E++ G+     +H  +   L  H+ ++ N   P  L
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELF-HSIRMDNPFYPRWL 242

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 45  KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLV 98
           K LG G FG V+KG  + +G+ I +    K+ E     Q  + + + ++    L H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-----LDWSKRFHIICGTARGVMY 153
           +LLG C  G    L+ +++   SL   +  Q R  +     L+W  +       A+G+ Y
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQI------AKGMYY 148
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           L +     ++HR+L A NVLL      +++DFG+A     D+ +           +MA E
Sbjct: 149 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
               G+++ +SDV+S+G+ + E+++
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA-RAFGGDETEGNTKRVIGTYGYMA 211
           Y H     R+IHRD+K  N+LL      KI+DFG +  A     TE     + GT  Y+ 
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTE-----LCGTLDYLP 174
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE         K D++S G+L  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 12/212 (5%)
Query: 36  SATNNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKL 92
           S   ++ +   +G G +G   K     DG+ +  K L    ++E   + L +EV L  +L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 93  QHRNLVKLLGCCIQGEEKLL--IYEFMTNKSLDSFIFD--QERCKILDWSKRFHIICGTA 148
           +H N+V+     I      L  + E+     L S I    +ER + LD      ++    
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLT 121
Query: 149 RGVMYLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
             +   H+  D    ++HRDLK +NV LD   N K+ DFGLAR    D  E   K  +GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--EDFAKEFVGT 179
Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             YM+PE  +   ++ KSD++S G LL E+ +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 39  NNFSINKKLGQGGFGPVY---KGTLVD-GQEIAVKRLSKISEQGLKELKN--EVILFSKL 92
           ++F + K LGQG FG V+   K T  D G   A+K L K + +    ++   E  + + +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICG 146
            H  +VKL     Q E KL LI +F+    L        +F +E  K          +  
Sbjct: 88  NHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF--------YLAE 138
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
            A G+ +LH    L II+RDLK  N+LLD++ + K++DFGL++     + E       GT
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--AIDHEKKAYSFCGT 193
Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
             YMAPE  +    S  +D +S+G+L+ E+++G
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 26  LPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 85
           LPL    TI        + K++G+G +G V+ G    G+++AVK      E      + E
Sbjct: 27  LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFR-ETE 81
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           +     ++H N++  +   I+G         +T+   +  ++D  +   LD      +  
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAY 141
Query: 146 GTARGVMYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE--- 197
            +  G+ +LH +      +  I HRDLK+ N+L+ ++    I+D GLA  F  D  E   
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 198 -GNTKRVIGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEI 236
             NT+  +GT  YM PE   +       Q  + +D++SFG++L E+
Sbjct: 202 PPNTR--VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLK---ELKNEVILFSKLQHR 95
           ++ +   LG G FG V  G   + G ++AVK L++   + L    ++K E+      +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           +++KL        +  ++ E+++   L  +I    R + ++  + F  I      V Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDYCH 128
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
              R  ++HRDLK  NVLLD  MN KI+DFGL+      E     +   G+  Y APE  
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVI 182
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
           S   ++  + D++S G++L  ++ G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLK---ELKNEVILFSKLQHR 95
           ++ +   LG G FG V  G   + G ++AVK L++   + L    ++K E+      +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           +++KL        +  ++ E+++   L  +I    R + ++  + F  I      V Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDYCH 128
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
              R  ++HRDLK  NVLLD  MN KI+DFGL+      E   ++    G+  Y APE  
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVI 182
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
           S   ++  + D++S G++L  ++ G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 21/238 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK----ISEQGLKELKNEVILFSKLQH 94
           +F ++K LG+G FG V+        Q  A+K L K    + +     +  + +L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 95  RNLVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
             L  +  C  Q +E L  + E++    L   ++  + C   D S+          G+ +
Sbjct: 78  PFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTKRVIGTYGYMAP 212
           LH      I++RDLK  N+LLD+D + KI+DFG+ +    GD     T    GT  Y+AP
Sbjct: 134 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKTNXFCGTPDYIAP 187
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           E     +++   D +SFG+LL E++ G+     +H  +   L  H+ ++ N   P  L
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELF-HSIRMDNPFYPRWL 241

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 46  KLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           +LG+G FG V       L D  G  +AVK+L        ++ + E+ +   L    +VK 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 101 LGCCI-QGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            G     G  +L L+ E++ +  L  F+  Q     LD S+         +G+ YL   S
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 129
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--YMAPEYAS 216
           R R +HRDL A N+L++ + + KI+DFGLA+    D+ +    R  G     + APE  S
Sbjct: 130 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DXXVVREPGQSPIFWYAPESLS 187
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           D  FS +SDV+SFG++L E+ +
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 12/212 (5%)
Query: 36  SATNNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKL 92
           S   ++ +   +G G +G   K     DG+ +  K L    ++E   + L +EV L  +L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 93  QHRNLVKLLGCCIQGEEKLL--IYEFMTNKSLDSFIFD--QERCKILDWSKRFHIICGTA 148
           +H N+V+     I      L  + E+     L S I    +ER + LD      ++    
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLT 121
Query: 149 RGVMYLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
             +   H+  D    ++HRDLK +NV LD   N K+ DFGLAR    D +   T   +GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             YM+PE  +   ++ KSD++S G LL E+ +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           +NF   + LG+G FG V    + + G   AVK L K   + +  ++    E  + S  ++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 95  RNLVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
              +  L CC Q  ++L  + EF+    L   +F  ++ +  D ++           +M+
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           LH      II+RDLK  NVLLD + + K++DFG+ +   G      T    GT  Y+APE
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDYIAPE 194
Query: 214 YASDGQFSVKSDVFSFGILLLEIISG 239
              +  +    D ++ G+LL E++ G
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 46  KLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           +LG+G FG V       L D  G  +AVK+L        ++ + E+ +   L    +VK 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 101 LGCCI-QGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            G     G + L L+ E++ +  L  F+  Q     LD S+         +G+ YL   S
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 132
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--YMAPEYAS 216
           R R +HRDL A N+L++ + + KI+DFGLA+    D+ +    R  G     + APE  S
Sbjct: 133 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWYAPESLS 190
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           D  FS +SDV+SFG++L E+ +
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA-RAFGGDETEGNTKRVIGTYGYMA 211
           Y H     R+IHRD+K  N+LL      KI+DFG +  A     T+     + GT  Y+ 
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLP 174
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE         K D++S G+L  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 46  KLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           +LG+G FG V       L D  G  +AVK+L        ++ + E+ +   L    +VK 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 101 LGCCI-QGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            G     G + L L+ E++ +  L  F+  Q     LD S+         +G+ YL   S
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 133
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--YMAPEYAS 216
           R R +HRDL A N+L++ + + KI+DFGLA+    D+ +    R  G     + APE  S
Sbjct: 134 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWYAPESLS 191
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           D  FS +SDV+SFG++L E+ +
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFT 213

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH----------- 94
           LGQG FG V K    +D +  A+K++ + +E+ L  + +EV+L + L H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 95  --RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
             RN VK +    +     +  E+  N +L   I  +   +  D  + + +       + 
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD--EYWRLFRQILEALS 130
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD------------ETEGNT 200
           Y+H      IIHRDLK  N+ +D+  N KI DFGLA+                  +  N 
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 201 KRVIGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEII 237
              IGT  Y+A E     G ++ K D++S GI+  E+I
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA-RAFGGDETEGNTKRVIGTYGYMA 211
           Y H     R+IHRD+K  N+LL      KI+DFG +  A     T+     + GT  Y+ 
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLP 175
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE         K D++S G+L  E + GK
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 46  KLGQGGFGPV---YKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           +LG+G FG V       L D  G  +AVK+L        ++ + E+ +   L    +VK 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 101 LGCCI-QGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            G     G + L L+ E++ +  L  F+  Q     LD S+         +G+ YL   S
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GS 145
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG--YMAPEYAS 216
           R R +HRDL A N+L++ + + KI+DFGLA+    D+ +    R  G     + APE  S
Sbjct: 146 R-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWYAPESLS 203
Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
           D  FS +SDV+SFG++L E+ +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA-RAFGGDETEGNTKRVIGTYGYMA 211
           Y H     R+IHRD+K  N+LL      KI+DFG +  A     T+     + GT  Y+ 
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLP 179
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE         K D++S G+L  E + GK
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG   +     +  +T  + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDT--LCGTLDYLPP 176
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
              I + +G+G FG VY G       I +  + + +E  LK  K EV+ + + +H N+V 
Sbjct: 34  QLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
            +G C+      +I      ++L S + D +   +LD +K   I     +G+ YLH    
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG- 150
Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFG---GDETEGNTKRVIGTYGYMAPE--- 213
             I+H+DLK+ NV  D +    I+DFGL    G       E   +   G   ++APE   
Sbjct: 151 --ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 214 -YASDGQ-----FSVKSDVFSFGILLLEI 236
             + D +     FS  SDVF+ G +  E+
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA-RAFGGDETEGNTKRVIGTYGYMA 211
           Y H     R+IHRD+K  N+LL      KI+DFG +  A     T+     + GT  Y+ 
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLP 174
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE         K D++S G+L  E + GK
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 134/290 (46%), Gaps = 26/290 (8%)
Query: 47  LGQGGFGPVYKGTLVD-GQEIAVKR-LSKISEQGLKELK-NEVILFSKLQHRNLVKLLGC 103
           +G+G +G V K    D G+ +A+K+ L    ++ +K++   E+ L  +L+H NLV LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 104 CIQGEEKLLIYEFMTNKSLDSF-IFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI 162
           C + +   L++EF+ +  LD   +F       LD+      +     G+ + H  +   I
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHSHN---I 145
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YASDGQFS 221
           IHRD+K  N+L+ Q    K+ DFG AR         + +  + T  Y APE    D ++ 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPELLVGDVKYG 203
Query: 222 VKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNL 281
              DV++ G L+ E+  G+     +  D++++ + H        +P        Q  FN 
Sbjct: 204 KAVDVWAIGCLVTEMFMGEP---LFPGDSDIDQLYHIMMCLGNLIPRH------QELFNK 254
Query: 282 AEVIRCIHIGLLCVQQHPKDR--PSMPSVILMLGSETVLPQPKQPGYLAD 329
             V   + +  +  ++ P +R  P +  V++ L  + +   P +  + A+
Sbjct: 255 NPVFAGVRLPEI-KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 40  NFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLK---ELKNEVILFSKLQHR 95
           ++ +   LG G FG V  G   + G ++AVK L++   + L    +++ E+      +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           +++KL        +  ++ E+++   L  +I    R   LD  +   +      GV Y H
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH 133
Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
              R  ++HRDLK  NVLLD  MN KI+DFGL+      E     +   G+  Y APE  
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRXSCGSPNYAAPEVI 187
Query: 216 SDGQFS-VKSDVFSFGILLLEIISG 239
           S   ++  + D++S G++L  ++ G
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 201
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 36  SATNNFSINKK-------LGQGGFGPVYKGTLVDGQE----IAVKRLSKISEQGLKE-LK 83
           S+T ++ I ++       +G+G FG V++G  +  +     +A+K     +   ++E   
Sbjct: 28  SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 87
Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
            E +   +  H ++VKL+G  I      +I E  T   L SF+  Q R   LD +     
Sbjct: 88  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILY 144
Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
               +  + YL      R +HRD+ A NVL+  +   K+ DFGL+R +  D T     + 
Sbjct: 145 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKG 200
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII 237
                +MAPE  +  +F+  SDV+ FG+ + EI+
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHR 95
           F   +KLG G FG V+   LV+ +   ++R+ K      S+  +++++ E+ +   L H 
Sbjct: 24  FIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           N++K+           ++ E     + L+  +  Q R K L       ++      + Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           H      ++H+DLK  N+L  QD +P    KI DFGLA  F  DE   N     GT  YM
Sbjct: 141 HSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYM 193
Query: 211 APE-YASDGQFSVKSDVFSFGILLLEIISG 239
           APE +  D  F  K D++S G+++  +++G
Sbjct: 194 APEVFKRDVTF--KCDIWSAGVVMYFLLTG 221

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 36  SATNNFSINKK-------LGQGGFGPVYKGTLVDGQE----IAVKRLSKISEQGLKE-LK 83
           S+T ++ I ++       +G+G FG V++G  +  +     +A+K     +   ++E   
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
            E +   +  H ++VKL+G  I      +I E  T   L SF+  Q R   LD +     
Sbjct: 65  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILY 121
Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
               +  + YL      R +HRD+ A NVL+  +   K+ DFGL+R +  D T     + 
Sbjct: 122 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKG 177
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII 237
                +MAPE  +  +F+  SDV+ FG+ + EI+
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 12/212 (5%)
Query: 36  SATNNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKL 92
           S   ++ +   +G G +G   K     DG+ +  K L    ++E   + L +EV L  +L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 93  QHRNLVKLLGCCIQGEEKLL--IYEFMTNKSLDSFIFD--QERCKILDWSKRFHIICGTA 148
           +H N+V+     I      L  + E+     L S I    +ER + LD      ++    
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLT 121
Query: 149 RGVMYLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
             +   H+  D    ++HRDLK +NV LD   N K+ DFGLAR    D +    K  +GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGT 179
Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             YM+PE  +   ++ KSD++S G LL E+ +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQH 94
           ++N+ + ++LG+G F  V +      G E A K ++  K+S +  ++L+ E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            N+V+L     +     L+++ +T   L   I  +E     D S   H I      + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 120
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           H +    I+HR+LK  N+LL         K++DFGLA      E         GT GY++
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 174
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      +S   D+++ G++L  ++ G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 23/202 (11%)
Query: 47  LGQGGFGPVYKGTLVDGQEI-AVKRLS---------KISEQGLKELKNEVILFSKLQHRN 96
           LG+G F  VYK    +  +I A+K++           I+   L+E+K    L  +L H N
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK----LLQELSHPN 73
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           ++ LL          L+++FM    L+  I D          K + ++  T +G+ YLHQ
Sbjct: 74  IIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQ 130
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+HRDLK +N+LLD++   K++DFGLA++FG        + V  T  Y APE   
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLF 185
Query: 217 DGQ-FSVKSDVFSFGILLLEII 237
             + + V  D+++ G +L E++
Sbjct: 186 GARMYGVGVDMWAVGCILAELL 207

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQH 94
           ++N+ + ++LG+G F  V +      G E A K ++  K+S +  ++L+ E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            N+V+L     +     L+++ +T   L   I  +E     D S   H I      + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 121
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           H +    I+HR+LK  N+LL         K++DFGLA      E         GT GY++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      +S   D+++ G++L  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQH 94
           ++N+ + ++LG+G F  V +      G E A K ++  K+S +  ++L+ E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            N+V+L     +     L+++ +T   L   I  +E     D S   H I      + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 121
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           H +    I+HR+LK  N+LL         K++DFGLA      E         GT GY++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      +S   D+++ G++L  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 47  LGQGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           LG+G +G VY G  +  Q  IA+K + +   +  + L  E+ L   L+H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR----GVMYLHQDSRLR 161
           +     +  E +   SL + +    R K          I    +    G+ YLH +   +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 128
Query: 162 IIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ- 219
           I+HRD+K  NVL++      KISDFG ++   G      T+   GT  YMAPE    G  
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPR 186
Query: 220 -FSVKSDVFSFGILLLEIISGK 240
            +   +D++S G  ++E+ +GK
Sbjct: 187 GYGKAADIWSLGCTIIEMATGK 208

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 47  LGQGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 105
           LG+G +G VY G  +  Q  IA+K + +   +  + L  E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR----GVMYLHQDSRLR 161
           +     +  E +   SL + +    R K          I    +    G+ YLH +   +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 162 IIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ- 219
           I+HRD+K  NVL++      KISDFG ++   G      T+   GT  YMAPE    G  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPR 200
Query: 220 -FSVKSDVFSFGILLLEIISGK 240
            +   +D++S G  ++E+ +GK
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK 222

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 14/222 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQ----EIAVKRLSKISEQGLKE-LKNEVILFSK 91
           A  +  +N+ LG+G FG VY+G   + +     +AVK   K      KE   +E ++   
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-FDQERCKILDWSKRFHIICGTARG 150
           L H ++VKL+G  I+ E   +I E      L  ++  ++   K+L        IC   + 
Sbjct: 82  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC---KA 137
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YL     +  +HRD+   N+L+      K+ DFGL+R +  DE             +M
Sbjct: 138 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWM 193
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
           +PE  +  +F+  SDV+ F + + EI+S  K   F+  + ++
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 235

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V     V  G +IAVK+LS+  +  +  K    E+ L 
Sbjct: 45  TIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL 104
Query: 90  SKLQHRNLVKLL-----GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 105 KHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 160
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 161 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 212
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   +++  D++S G ++ E+++G+
Sbjct: 213 ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQH 94
           ++N+ + ++LG+G F  V +      G E A K ++  K+S +  ++L+ E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            N+V+L     +     L+++ +T   L   I  +E     D S   H I      + Y 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 144
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           H +    I+HR+LK  N+LL         K++DFGLA      E         GT GY++
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 198
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      +S   D+++ G++L  ++ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 14/222 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQ----EIAVKRLSKISEQGLKE-LKNEVILFSK 91
           A  +  +N+ LG+G FG VY+G   + +     +AVK   K      KE   +E ++   
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-FDQERCKILDWSKRFHIICGTARG 150
           L H ++VKL+G  I+ E   +I E      L  ++  ++   K+L        IC   + 
Sbjct: 66  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC---KA 121
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YL     +  +HRD+   N+L+      K+ DFGL+R +  DE             +M
Sbjct: 122 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWM 177
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
           +PE  +  +F+  SDV+ F + + EI+S  K   F+  + ++
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 219

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY     + + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     ++IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 43  INKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           + + +G+G FG V++G  +        +A+K     +   ++E    E +   +  H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           VKL+G  I      +I E  T   L SF+  Q R   LD +         +  + YL   
Sbjct: 74  VKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
              R +HRD+ A NVL+  +   K+ DFGL+R +  D T     +      +MAPE  + 
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 218 GQFSVKSDVFSFGILLLEII 237
            +F+  SDV+ FG+ + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 14/222 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQ----EIAVKRLSKISEQGLKE-LKNEVILFSK 91
           A  +  +N+ LG+G FG VY+G   + +     +AVK   K      KE   +E ++   
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-FDQERCKILDWSKRFHIICGTARG 150
           L H ++VKL+G  I+ E   +I E      L  ++  ++   K+L        IC   + 
Sbjct: 70  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC---KA 125
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YL     +  +HRD+   N+L+      K+ DFGL+R +  DE             +M
Sbjct: 126 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWM 181
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
           +PE  +  +F+  SDV+ F + + EI+S  K   F+  + ++
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 36  SATNNFSINKK-------LGQGGFGPVYKGTLVDGQE----IAVKRLSKISEQGLKE-LK 83
           ++T ++ I ++       +G+G FG V++G  +  +     +A+K     +   ++E   
Sbjct: 2   ASTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 61
Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
            E +   +  H ++VKL+G  I      +I E  T   L SF+  Q R   LD +     
Sbjct: 62  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILY 118
Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
               +  + YL      R +HRD+ A NVL+  +   K+ DFGL+R +  D T     + 
Sbjct: 119 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKG 174
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII 237
                +MAPE  +  +F+  SDV+ FG+ + EI+
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQE----IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           + + +G+G FG V++G  +  +     +A+K     +   ++E    E +   +  H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           VKL+G  I      +I E  T   L SF+  Q R   LD +         +  + YL   
Sbjct: 74  VKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
              R +HRD+ A NVL+  +   K+ DFGL+R +  D T     +      +MAPE  + 
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 218 GQFSVKSDVFSFGILLLEII 237
            +F+  SDV+ FG+ + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG----QEIAVKRLSKISEQGLKELKN--EVILFSKL 92
           + F + K LGQG FG V+    + G    Q  A+K L K + +    ++   E  +  ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICG 146
            H  +VKL     Q E KL LI +F+    L        +F +E  K          +  
Sbjct: 84  NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF--------YLAE 134
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
            A  + +LH    L II+RDLK  N+LLD++ + K++DFGL++     + E       GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGT 189
Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
             YMAPE  +    +  +D +SFG+L+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 43  INKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           + + +G+G FG V++G  +        +A+K     +   ++E    E +   +  H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           VKL+G  I      +I E  T   L SF+  Q R   LD +         +  + YL   
Sbjct: 74  VKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
              R +HRD+ A NVL+  +   K+ DFGL+R +  D T     +      +MAPE  + 
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 218 GQFSVKSDVFSFGILLLEII 237
            +F+  SDV+ FG+ + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG----QEIAVKRLSKISEQGLKELKN--EVILFSKL 92
           + F + K LGQG FG V+    + G    Q  A+K L K + +    ++   E  +  ++
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICG 146
            H  +VKL     Q E KL LI +F+    L        +F +E  K          +  
Sbjct: 85  NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF--------YLAE 135
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
            A  + +LH    L II+RDLK  N+LLD++ + K++DFGL++     + E       GT
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGT 190
Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
             YMAPE  +    +  +D +SFG+L+ E+++G
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTN----KSLDSFI-FDQERCKILDWSKRFHIICGT 147
           +H N+++L G         LI E+       K L     FD++R            I   
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT--------YITEL 122
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A  + Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT 
Sbjct: 123 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTL 175
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y+ PE         K D++S G+L  E + GK
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTN----KSLDSFI-FDQERCKILDWSKRFHIICGT 147
           +H N+++L G         LI E+       K L     FD++R            I   
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT--------YITEL 122
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A  + Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT 
Sbjct: 123 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTL 175
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y+ PE         K D++S G+L  E + GK
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI++FG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG----QEIAVKRLSKISEQGLKELKN--EVILFSKL 92
           + F + K LGQG FG V+    + G    Q  A+K L K + +    ++   E  +  ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICG 146
            H  +VKL     Q E KL LI +F+    L        +F +E  K          +  
Sbjct: 84  NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAE 134
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
            A  + +LH    L II+RDLK  N+LLD++ + K++DFGL++     + E       GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGT 189
Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
             YMAPE  +    +  +D +SFG+L+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQE----IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           + + +G+G FG V++G  +  +     +A+K     +   ++E    E +   +  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           VKL+G  I      +I E  T   L SF+  Q R   LD +         +  + YL   
Sbjct: 71  VKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK 127
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
              R +HRD+ A NVL+  +   K+ DFGL+R +  D T     +      +MAPE  + 
Sbjct: 128 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 218 GQFSVKSDVFSFGILLLEII 237
            +F+  SDV+ FG+ + EI+
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 45  KKLGQGGFGPVY----KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           KKLG G +G V     K T V+ + I + R + +S     +L  EV +   L H N++KL
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVE-RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
                      L+ E      L   I  + +   +D +    II     GV YLH+ +  
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVLSGVTYLHKHN-- 156
Query: 161 RIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
            I+HRDLK  N+LL   ++D   KI DFGL+  F   E +   K  +GT  Y+APE    
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPEVLR- 211
Query: 218 GQFSVKSDVFSFGILLLEIISG 239
            ++  K DV+S G++L  +++G
Sbjct: 212 KKYDEKCDVWSIGVILFILLAG 233

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQE----IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           + + +G+G FG V++G  +  +     +A+K     +   ++E    E +   +  H ++
Sbjct: 17  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 76
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           VKL+G  I      +I E  T   L SF+  Q R   LD +         +  + YL   
Sbjct: 77  VKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK 133
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
              R +HRD+ A NVL+  +   K+ DFGL+R +  D T     +      +MAPE  + 
Sbjct: 134 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 218 GQFSVKSDVFSFGILLLEII 237
            +F+  SDV+ FG+ + EI+
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKL 92
           A  +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+++L G         LI E+     L +   + ++    D  +    I   A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y H     R+IHRD+K  N+LL      KI++FG    +           + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 37  ATNNFSINKK---LGQGGFGPVYK-GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           A N+F    K   LG G FG V+K      G ++A K +     +  +E+KNE+ + ++L
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSL-DSFIFDQERCKILDWSKRFHIICGTARGV 151
            H NL++L        + +L+ E++    L D  I +      LD       IC    G+
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC---EGI 200
Query: 152 MYLHQDSRLRIIHRDLKASNVL-LDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGY 209
            ++HQ   + I+H DLK  N+L +++D    KI DFGLAR +   E     K   GT  +
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEF 254
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +    S  +D++S G++   ++SG
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKLQH 94
            +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            N+++L G         LI E+     L +   + ++    D  +    I   A  + Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H     R+IHRD+K  N+LL  +   KI+DFG    +           + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                   K D++S G+L  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 112/228 (49%), Gaps = 38/228 (16%)
Query: 41  FSINKKLGQGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKN--EVILFSKLQ-H 94
           + + KKLG+G +G V+K   +D   G+ +AVK++    +      +   E+++ ++L  H
Sbjct: 11  YELVKKLGKGAYGIVWKS--IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 95  RNLVKLLGCCIQGEEK--LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            N+V LL       ++   L++++M    L + I    R  IL+   + +++    + + 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVVYQLIKVIK 123
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG------------------- 193
           YLH      ++HRD+K SN+LL+ + + K++DFGL+R+F                     
Sbjct: 124 YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 194 DETEGNTKRVIGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIISGK 240
           D+ +      + T  Y APE      +++   D++S G +L EI+ GK
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 38  TNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK---ELKNEVILFSKLQ 93
           ++ + + + LG GG   V+    L D +++AVK L     +        + E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 94  HRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           H  +V +          G    ++ E++   +L   +  +     +   +   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 127
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYG 208
            + + HQ+    IIHRD+K +N+L+      K+ DFG+ARA      +   T  VIGT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           Y++PE A       +SDV+S G +L E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELKNEVILFSKLQH 94
            +F I + LG+G FG VY       + I A+K L  +++ + G++ +L+ EV + S L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            N+++L G         LI E+     L +   + ++    D  +    I   A  + Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H     R+IHRD+K  N+LL  +   KI+DFG    +           + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                   K D++S G+L  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 14/210 (6%)
Query: 36  SATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS--KISEQGLKELKNEVILFSKL 92
           S T+ + + + +G+G F  V +   L  G E A K ++  K+S +  ++L+ E  +   L
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+V+L     +     L+++ +T   L   I  +E     D S   H I      V+
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVL 117
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           + HQ   + ++HRDLK  N+LL         K++DFGLA    GD+         GT GY
Sbjct: 118 HCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGY 172
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           ++PE      +    D+++ G++L  ++ G
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQH 94
           N F   + LG+GGFG V    +   G+  A K+L K   +   G     NE  +  K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH---IICGTARGV 151
           R +V L       +   L+   M    L   I+   +    +    F+   I CG     
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----- 298
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYM 210
             L    R RI++RDLK  N+LLD   + +ISD GLA        EG T K  +GT GYM
Sbjct: 299 --LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV----PEGQTIKGRVGTVGYM 352
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGK 240
           APE   + +++   D ++ G LL E+I+G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQH 94
           N F   + LG+GGFG V    +   G+  A K+L K   +   G     NE  +  K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH---IICGTARGV 151
           R +V L       +   L+   M    L   I+   +    +    F+   I CG     
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----- 298
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYM 210
             L    R RI++RDLK  N+LLD   + +ISD GLA        EG T K  +GT GYM
Sbjct: 299 --LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV----PEGQTIKGRVGTVGYM 352
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGK 240
           APE   + +++   D ++ G LL E+I+G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
           +++ I+++LG G FG V++ T    G   A K +    E   + ++ E+   S L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF-HIICGTARGVMYLHQ 156
           V L        E ++IYEFM+   L   + D+      D +  +   +C   +G+ ++H+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC---KGLCHMHE 273
Query: 157 DSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           ++    +H DLK  N++     +   K+ DFGL       + + + K   GT  + APE 
Sbjct: 274 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEV 327
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL-NLIGHAWKL 261
           A        +D++S G+L   ++SG    G  + D  L N+    W +
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM 375

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVK 99
           + +G G +G V   Y   L   Q++AVK+LS+  +  +  +    E+ L   L+H N++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 100 LL-----GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           LL        I+   ++ +   +    L++ +    +C+ L       ++    RG+ Y+
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYI 139
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H      IIHRDLK SNV +++D   +I DFGLAR    +E  G     + T  Y APE 
Sbjct: 140 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADEEMTG----YVATRWYRAPEI 191
Query: 215 ASDG-QFSVKSDVFSFGILLLEIISGK 240
             +   ++   D++S G ++ E++ GK
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 111/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   +C+ L      + +    RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 212 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 259

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 38  TNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK---ELKNEVILFSKLQ 93
           ++ + + + LG GG   V+    L D +++AVK L     +        + E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 94  HRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           H  +V +          G    ++ E++   +L   +  +     +   +   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 127
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYG 208
            + + HQ+    IIHRD+K +N+++      K+ DFG+ARA      +   T  VIGT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           Y++PE A       +SDV+S G +L E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH----------- 94
           LGQG FG V K    +D +  A+K++ + +E+ L  + +EV L + L H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 95  --RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
             RN VK      +     +  E+  N++L   I  +   +  D  + + +       + 
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD--EYWRLFRQILEALS 130
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD------------ETEGNT 200
           Y+H      IIHR+LK  N+ +D+  N KI DFGLA+                  +  N 
Sbjct: 131 YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 201 KRVIGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEII 237
              IGT  Y+A E     G ++ K D +S GI+  E I
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 43  INKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           + + +G+G FG V++G  +        +A+K     +   ++E    E +   +  H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           VKL+G  I      +I E  T   L SF+  Q R   LD +         +  + YL   
Sbjct: 74  VKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
              R +HRD+ A NVL+      K+ DFGL+R +  D T     +      +MAPE  + 
Sbjct: 131 ---RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 218 GQFSVKSDVFSFGILLLEII 237
            +F+  SDV+ FG+ + EI+
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 38  TNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK---ELKNEVILFSKLQ 93
           ++ + + + LG GG   V+    L D +++AVK L     +        + E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 94  HRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           H  +V +          G    ++ E++   +L   +  +     +   +   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 127
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYG 208
            + + HQ+    IIHRD+K +N+++      K+ DFG+ARA      +   T  VIGT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           Y++PE A       +SDV+S G +L E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI----AVKRLSKIS----EQGLKELKNEVILFS 90
            NF + K LG G +G V+    + G +     A+K L K +     +  +  + E  +  
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 91  KLQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
            ++    +  L    Q E KL LI +++    L + +  +ER           I  G   
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT----EHEVQIYVGEI- 168
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
            V+ L    +L II+RD+K  N+LLD + +  ++DFGL++ F  DETE       GT  Y
Sbjct: 169 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 226
Query: 210 MAPEY--ASDGQFSVKSDVFSFGILLLEIISG 239
           MAP+     D       D +S G+L+ E+++G
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
           +++ I+++LG G FG V++ T    G   A K +    E   + ++ E+   S L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF-HIICGTARGVMYLHQ 156
           V L        E ++IYEFM+   L   + D+      D +  +   +C   +G+ ++H+
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC---KGLCHMHE 167
Query: 157 DSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           ++    +H DLK  N++     +   K+ DFGL       + + + K   GT  + APE 
Sbjct: 168 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEV 221
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL-NLIGHAWKL 261
           A        +D++S G+L   ++SG    G  + D  L N+    W +
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM 269

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVK 99
           + +G G +G V   Y   L   Q++AVK+LS+  +  +  +    E+ L   L+H N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 100 LL-----GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           LL        I+   ++ +   +    L++ +    +C+ L       ++    RG+ Y+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYI 147
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H      IIHRDLK SNV +++D   +I DFGLAR    +E  G     + T  Y APE 
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQ-ADEEMTG----YVATRWYRAPEI 199
Query: 215 ASDG-QFSVKSDVFSFGILLLEIISGK 240
             +   ++   D++S G ++ E++ GK
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 33  TIVSATNNFSINK-----KLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELK-N 84
           ++ +A +  SI++     KLG+G +G VYK    V  + +A+KR+  +  E+G+      
Sbjct: 23  SVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR 82
Query: 85  EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
           EV L  +LQHRN+++L           LI+E+  N  L  ++ D+     +   K F  +
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSF--L 138
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNP--KISDFGLARAFGGDETEGN 199
                GV + H  SR R +HRDLK  N+LL   D    P  KI DFGLARAF G      
Sbjct: 139 YQLINGVNFCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 200 TKRVIGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEII 237
           T  +I T  Y  PE       +S   D++S   +  E++
Sbjct: 195 THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 35  VSATNNFSINKK-------LGQGGFGPVYKGTLVDGQE----IAVKRLSKISEQGLKE-L 82
           + +T ++ I ++       +G+G FG V++G  +  +     +A+K     +   ++E  
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF 438
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E +   +  H ++VKL+G  I      +I E  T   L SF+  Q R   LD +    
Sbjct: 439 LQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLIL 495
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
                +  + YL      R +HRD+ A NVL+  +   K+ DFGL+R +  D T     +
Sbjct: 496 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASK 551
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII 237
                 +MAPE  +  +F+  SDV+ FG+ + EI+
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 46  KLGQGGFGPVYKGT-LVDGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHRNLVKLLG 102
           ++G+G +G V K      GQ +AVKR+ S + E+  K+L  ++ ++        +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 103 CCIQGEEKLLIYEFMTNKSLDSF------IFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
              +  +  +  E M+  S D F      + D     ++       I   T + + +L +
Sbjct: 89  ALFREGDCWICMELMST-SFDKFYKYVYSVLDD----VIPEEILGKITLATVKALNHLKE 143
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK-RVIGTYGYMAPEY- 214
           +  L+IIHRD+K SN+LLD+  N K+ DFG++    G   +   K R  G   YMAPE  
Sbjct: 144 N--LKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERI 197
Query: 215 ---ASDGQFSVKSDVFSFGILLLEIISGK 240
              AS   + V+SDV+S GI L E+ +G+
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 40/254 (15%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ--GLKELKNEVILFS 90
           + + +++F +   LG+G +G V   T    G+ +A+K++    +    L+ L+ E+ +  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 91  KLQHRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG 146
             +H N++ +         +   ++ I + +    L   I  Q    +L      + I  
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ----MLSDDHIQYFIYQ 120
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF---GGDETEGNTKR- 202
           T R V  LH  +   +IHRDLK SN+L++ + + K+ DFGLAR       D +E   ++ 
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 203 ----VIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLE------IISGKKNR-------- 243
                + T  Y APE   +  ++S   DV+S G +L E      I  G+  R        
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 244 --GFYHSDNNLNLI 255
             G  HSDN+L  I
Sbjct: 238 IIGTPHSDNDLRCI 251

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 40/254 (15%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ--GLKELKNEVILFS 90
           + + +++F +   LG+G +G V   T    G+ +A+K++    +    L+ L+ E+ +  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 91  KLQHRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG 146
             +H N++ +         +   ++ I + +    L   I  Q    +L      + I  
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ----MLSDDHIQYFIYQ 120
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF---GGDETEGNTKR- 202
           T R V  LH  +   +IHRDLK SN+L++ + + K+ DFGLAR       D +E   ++ 
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 203 ----VIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLE------IISGKKNR-------- 243
                + T  Y APE   +  ++S   DV+S G +L E      I  G+  R        
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 244 --GFYHSDNNLNLI 255
             G  HSDN+L  I
Sbjct: 238 IIGTPHSDNDLRCI 251

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 40/254 (15%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ--GLKELKNEVILFS 90
           + + +++F +   LG+G +G V   T    G+ +A+K++    +    L+ L+ E+ +  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 91  KLQHRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG 146
             +H N++ +         +   ++ I + +    L   I  Q    +L      + I  
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ----MLSDDHIQYFIYQ 120
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF---GGDETEGNTKR- 202
           T R V  LH  +   +IHRDLK SN+L++ + + K+ DFGLAR       D +E   ++ 
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 203 ----VIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLE------IISGKKNR-------- 243
                + T  Y APE   +  ++S   DV+S G +L E      I  G+  R        
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 244 --GFYHSDNNLNLI 255
             G  HSDN+L  I
Sbjct: 238 IIGTPHSDNDLRCI 251

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNL 97
           + + ++LG+G F  V +   ++ GQE A K ++  K+S +  ++L+ E  +   L+H N+
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+L     +     LI++ +T   L   I  +E     D S   H I      V++ HQ 
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVLHCHQ- 139
Query: 158 SRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGGDETEGNTKR---VIGTYGYMA 211
             + ++HRDLK  N+LL   +     K++DFGLA      E EG  +      GT GY++
Sbjct: 140 --MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-----IEVEGEQQAWFGFAGTPGYLS 192
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      +    D+++ G++L  ++ G
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 101
           K +G G  G V      V G  +AVK+LS+   ++   K    E++L   + H+N++ LL
Sbjct: 30  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGTAR 149
                         F   K+L+ F        + D   C++    LD  +  +++     
Sbjct: 90  NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 137
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ +LH      IIHRDLK SN+++  D   KI DFGLAR    +     T  V+  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRY-Y 191
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            APE      ++   D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 35  VSATNNFSINKK-------LGQGGFGPVYKGTLVDGQE----IAVKRLSKISEQGLKE-L 82
           + +T ++ I ++       +G+G FG V++G  +  +     +A+K     +   ++E  
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF 438
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             E +   +  H ++VKL+G  I      +I E  T   L SF+  Q R   LD +    
Sbjct: 439 LQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLIL 495
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
                +  + YL      R +HRD+ A NVL+      K+ DFGL+R +  D T     +
Sbjct: 496 YAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASK 551
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII 237
                 +MAPE  +  +F+  SDV+ FG+ + EI+
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 120/291 (41%), Gaps = 35/291 (12%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQ--EIAVKRLSK---ISEQ 77
           E PL  L  ++    +  + +KLG G FG V +G      G+   +AVK L        +
Sbjct: 5   EGPLQSLTCLI-GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 78  GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDW 137
            + +   EV     L HRNL++L G  +    K+ + E     SL   +   +   +L  
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 138 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDE 195
             R+ +    A G+ YL      R IHRDL A N+LL      KI DFGL RA     D 
Sbjct: 123 LSRYAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI 255
                 R +  + + APE      FS  SD + FG+ L E+ +       Y  +  + L 
Sbjct: 178 XVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLN 229
Query: 256 GHA--WKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
           G     K+  EG      + C Q  +N         + + C    P+DRP+
Sbjct: 230 GSQILHKIDKEGERLPRPEDCPQDIYN---------VMVQCWAHKPEDRPT 271

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   +   T  V+  Y
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPEVVTRY 190
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y APE      +    D++S G ++ E+I G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 47  LGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGFG V+   +   G+  A K+L+K   +   G +    E  + +K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFD-QERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
                 +  L+   M    +   I++  E        +          G+ +LHQ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           II+RDLK  NVLLD D N +ISD GLA      +T+  TK   GT G+MAPE     ++ 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 222 VKSDVFSFGILLLEIISGK 240
              D F+ G+ L E+I+ +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 47  LGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGFG V+   +   G+  A K+L+K   +   G +    E  + +K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFD-QERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
                 +  L+   M    +   I++  E        +          G+ +LHQ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           II+RDLK  NVLLD D N +ISD GLA      +T+  TK   GT G+MAPE     ++ 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 222 VKSDVFSFGILLLEIISGK 240
              D F+ G+ L E+I+ +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 47  LGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGFG V+   +   G+  A K+L+K   +   G +    E  + +K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFD-QERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
                 +  L+   M    +   I++  E        +          G+ +LHQ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           II+RDLK  NVLLD D N +ISD GLA      +T+  TK   GT G+MAPE     ++ 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 222 VKSDVFSFGILLLEIISGK 240
              D F+ G+ L E+I+ +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 47  LGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHRNLVKLLG 102
           LG+GGFG V+   +   G+  A K+L+K   +   G +    E  + +K+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFD-QERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
                 +  L+   M    +   I++  E        +          G+ +LHQ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           II+RDLK  NVLLD D N +ISD GLA      +T+  TK   GT G+MAPE     ++ 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 222 VKSDVFSFGILLLEIISGK 240
              D F+ G+ L E+I+ +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 120/291 (41%), Gaps = 35/291 (12%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQ--EIAVKRLSK---ISEQ 77
           E PL  L  ++    +  + +KLG G FG V +G      G+   +AVK L        +
Sbjct: 5   EGPLQSLTCLI-GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 78  GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDW 137
            + +   EV     L HRNL++L G  +    K+ + E     SL   +   +   +L  
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 138 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDE 195
             R+ +    A G+ YL      R IHRDL A N+LL      KI DFGL RA     D 
Sbjct: 123 LSRYAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI 255
                 R +  + + APE      FS  SD + FG+ L E+ +       Y  +  + L 
Sbjct: 178 YVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLN 229
Query: 256 GHA--WKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
           G     K+  EG      + C Q  +N         + + C    P+DRP+
Sbjct: 230 GSQILHKIDKEGERLPRPEDCPQDIYN---------VMVQCWAHKPEDRPT 271

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 30  ELA-TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNE 85
           ELA TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E
Sbjct: 8   ELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 86  VILFSKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERC-KILDWSK 139
           + L   ++H N++ LL              + +   +    L++ +    +C K+ D   
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCAKLTDDHV 123
Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
           +F +I    RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G 
Sbjct: 124 QF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG- 177
Query: 200 TKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
               + T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 178 ---YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 14/215 (6%)
Query: 31  LATIVSATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLS--KISEQGLKELKNEVI 87
           +AT    T+++ + ++LG+G F  V +       QE A K ++  K+S +  ++L+ E  
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREAR 82
Query: 88  LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGT 147
           +   L+H N+V+L     +     L+++ +T   L   I  +E     D S   H I   
Sbjct: 83  ICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIHQI 139
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGGDETEGNTKRVI 204
              V ++HQ     I+HRDLK  N+LL         K++DFGLA    G++         
Sbjct: 140 LESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FA 194
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           GT GY++PE      +    D+++ G++L  ++ G
Sbjct: 195 GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG----FV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG----FV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 45  KKLGQGGFGPVYKGTLVDGQ-EIAVKRLSKIS-------------EQGLKELKNEVILFS 90
           +KLG G +G V      +G  E A+K + K               E+  +E+ NE+ L  
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L H N++KL       +   L+ EF     L   I ++ +    D     +I+     G
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSG 158
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           + YLH+ +   I+HRD+K  N+LL+     +N KI DFGL+  F  D      +  +GT 
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTA 212
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y+APE     +++ K DV+S G+++  ++ G
Sbjct: 213 YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 86/174 (49%), Gaps = 28/174 (16%)
Query: 79  LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF--------MTNKSLDSFIFDQE 130
           ++++  E+ +  KL H N+VKL+       E  L   F        M   +L     DQ 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 131 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
           R    D  K          G+ YLH     +IIHRD+K SN+L+ +D + KI+DFG++  
Sbjct: 140 RFYFQDLIK----------GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 191 F-GGDETEGNTKRVIGTYGYMAPEYASDGQ--FSVKS-DVFSFGILLLEIISGK 240
           F G D    NT   +GT  +MAPE  S+ +  FS K+ DV++ G+ L   + G+
Sbjct: 187 FKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 137
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 189
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 22/220 (10%)
Query: 31  LATIVSA--TNNFSINKKLGQGGFGPVYKGT-LVDGQEIA--VKRLSKISEQGLKELKNE 85
           +ATI     T  + + ++LG+G F  V +   ++ GQE A  +    K+S +  ++L+ E
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
             +   L+H N+V+L     +     LI++ +T   L   I  +E     D S   H I 
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQ 117
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAFGGDETEGNTKR 202
                V++ HQ   + ++HR+LK  N+LL   +     K++DFGLA      E EG  + 
Sbjct: 118 QILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-----IEVEGEQQA 169
Query: 203 ---VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
                GT GY++PE      +    D+++ G++L  ++ G
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 26  TIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 86  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 141
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 142 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 193
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 194 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 127
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 179
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 116/283 (40%), Gaps = 34/283 (12%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQ--EIAVKRLSK---ISEQGLKELKNE 85
           T +    +  + +KLG G FG V +G      G+   +AVK L        + + +   E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           V     L HRNL++L G  +    K+ + E     SL   +   +   +L    R+ +  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 118
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTKRV 203
             A G+ YL      R IHRDL A N+LL      KI DFGL RA     D       R 
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA--WKL 261
           +  + + APE      FS  SD + FG+ L E+ +       Y  +  + L G     K+
Sbjct: 176 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKI 227
Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
             EG      + C Q  +N         + + C    P+DRP+
Sbjct: 228 DKEGERLPRPEDCPQDIYN---------VMVQCWAHKPEDRPT 261

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 151
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 152 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 203
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 150
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 151 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 202
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 47  LGQGGFGPVYKGTLVDGQE-IAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 104
           LG G F  V        Q+ +A+K ++K + +G +  ++NE+ +  K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
             G    LI + ++   L   I ++      D S+   +I      V YLH    L I+H
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVH 139
Query: 165 RDLKASNVL---LDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEYASDGQF 220
           RDLK  N+L   LD+D    ISDFGL++     E  G+      GT GY+APE  +   +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 221 SVKSDVFSFGILLLEIISG 239
           S   D +S G++   ++ G
Sbjct: 196 SKAVDCWSIGVIAYILLCG 214

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 151
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 152 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMXG----XV 203
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 127
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMAG----FV 179
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y APE      +    D++S G ++ E+I G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 208 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 255

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQE-IAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +     LG G F  V        Q+ +A+K ++K + +G +  ++NE+ +  K++H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            L      G    LI + ++   L   I ++      D S+   +I      V YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 159 RLRIIHRDLKASNVL---LDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEY 214
            L I+HRDLK  N+L   LD+D    ISDFGL++     E  G+      GT GY+APE 
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEV 189
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
            +   +S   D +S G++   ++ G
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 112/247 (45%), Gaps = 26/247 (10%)
Query: 8   SNISEKTENDQIQ-NIDLELPLF---EL-ATIVSATNNFSINKKLGQGGFGPVYKG-TLV 61
           S +   TEN   Q N   E P F   EL  TI      +     +G G +G V       
Sbjct: 9   SGVDLGTENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK 68
Query: 62  DGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGC-----CIQGEEKLLIY 114
            G  +AVK+LS+  +  +  K    E+ L   ++H N++ LL        ++    + + 
Sbjct: 69  TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 128
Query: 115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 174
             +    L++ +    +C+ L       +I    RG+ Y+H      IIHRDLK SN+ +
Sbjct: 129 THLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAV 181
Query: 175 DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILL 233
           ++D   KI DFGLAR    DE  G     + T  Y APE   +   ++   D++S G ++
Sbjct: 182 NEDCELKILDFGLAR-HTDDEMXG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 236
Query: 234 LEIISGK 240
            E+++G+
Sbjct: 237 AELLTGR 243

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 228 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 275

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 208 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 255

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 89  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 190
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y APE      +    D++S G ++ E+I G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 38  TNNFSINKKLGQGGFGPVY--KGTLVDGQEIAVKRLSKISEQGLKE---LKNEVILFSKL 92
           ++ +   KKLG G +G V   K  L  G E A+K + K S         L +EV +  +L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSL-DSFIFDQERCKILDWSKRFHIICGTARGV 151
            H N++KL           L+ E      L D  I  Q+  ++        ++ GT    
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT--- 135
Query: 152 MYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
            YLH+ +   I+HRDLK  N+LL+   +D   KI DFGL+  F   E  G  K  +GT  
Sbjct: 136 -YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAY 188
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y+APE     ++  K DV+S G++L  ++ G
Sbjct: 189 YIAPEVLRK-KYDEKCDVWSCGVILYILLCG 218

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 108/227 (47%), Gaps = 12/227 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ
Sbjct: 208 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQ 249

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 210 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 257

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 155
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 216 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 263

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 208 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 255

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D   C++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 116/283 (40%), Gaps = 34/283 (12%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQ--EIAVKRLSK---ISEQGLKELKNE 85
           T +    +  + +KLG G FG V +G      G+   +AVK L        + + +   E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           V     L HRNL++L G  +    K+ + E     SL   +   +   +L    R+ +  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 118
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTKRV 203
             A G+ YL      R IHRDL A N+LL      KI DFGL RA     D       R 
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA--WKL 261
           +  + + APE      FS  SD + FG+ L E+ +       Y  +  + L G     K+
Sbjct: 176 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKI 227
Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
             EG      + C Q  +N         + + C    P+DRP+
Sbjct: 228 DKEGERLPRPEDCPQDIYN---------VMVQCWAHKPEDRPT 261

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 138
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG----YV 190
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 116/283 (40%), Gaps = 34/283 (12%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQ--EIAVKRLSK---ISEQGLKELKNE 85
           T +    +  + +KLG G FG V +G      G+   +AVK L        + + +   E
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           V     L HRNL++L G  +    K+ + E     SL   +   +   +L    R+ +  
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 122
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTKRV 203
             A G+ YL      R IHRDL A N+LL      KI DFGL RA     D       R 
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA--WKL 261
           +  + + APE      FS  SD + FG+ L E+ +       Y  +  + L G     K+
Sbjct: 180 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKI 231
Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
             EG      + C Q  +N         + + C    P+DRP+
Sbjct: 232 DKEGERLPRPEDCPQDIYN---------VMVQCWAHKPEDRPT 265

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 45  KKLGQGGFGPVYKG-TLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 101
           K +G G  G V      V G  +AVK+LS+   ++   K    E++L   + H+N++ LL
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGTAR 149
                         F   K+L+ F        + D   C++    LD  +  +++     
Sbjct: 88  NV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 135
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           G+ +LH      IIHRDLK SN+++  D   KI DFGLAR    +     T  V+  Y Y
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFM--MTPYVVTRY-Y 189
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            APE      +    D++S G ++ E++ G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y APE      +    D++S G ++ E+I G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 116/283 (40%), Gaps = 34/283 (12%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQ--EIAVKRLSK---ISEQGLKELKNE 85
           T +    +  + +KLG G FG V +G      G+   +AVK L        + + +   E
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           V     L HRNL++L G  +    K+ + E     SL   +   +   +L    R+ +  
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 122
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTKRV 203
             A G+ YL      R IHRDL A N+LL      KI DFGL RA     D       R 
Sbjct: 123 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA--WKL 261
           +  + + APE      FS  SD + FG+ L E+ +       Y  +  + L G     K+
Sbjct: 180 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKI 231
Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
             EG      + C Q  +N         + + C    P+DRP+
Sbjct: 232 DKEGERLPRPEDCPQDIYN---------VMVQCWAHKPEDRPT 265

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL---KELKNEVILFSKLQHRNLVKLLGC 103
           +G+G +G V++G+   G+ +AVK  S   E+      EL N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH-----QDS 158
            +           +T+      ++D  +   LD      I+   A G+ +LH        
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE---GNTKRVIGTYGYMAPEYA 215
           +  I HRDLK+ N+L+ ++    I+D GLA        +   GN  RV GT  YMAPE  
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPE-V 188
Query: 216 SDGQFSV-------KSDVFSFGILLLEI 236
            D    V       + D+++FG++L E+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LSK  +  +  K    E+ L 
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 143
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 144 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 195
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 108/227 (47%), Gaps = 12/227 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 147
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ
Sbjct: 208 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQ 249

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 116/283 (40%), Gaps = 34/283 (12%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGTL--VDGQ--EIAVKRLSK---ISEQGLKELKNE 85
           T +    +  + +KLG G FG V +G      G+   +AVK L        + + +   E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           V     L HRNL++L G  +    K+ + E     SL   +   +   +L    R+ +  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV-- 118
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTKRV 203
             A G+ YL      R IHRDL A N+LL      KI DFGL RA     D       R 
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA--WKL 261
           +  + + APE      FS  SD + FG+ L E+ +       Y  +  + L G     K+
Sbjct: 176 V-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNGSQILHKI 227
Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
             EG      + C Q  +N         + + C    P+DRP+
Sbjct: 228 DKEGERLPRPEDCPQDIYN---------VMVQCWAHKPEDRPT 261

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 43/230 (18%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGL 79
           ELP     T VS T+       +G G +G V   + +D   G+++A+K+LS+   SE   
Sbjct: 21  ELP----KTYVSPTH-------VGSGAYGSV--CSAIDKRSGEKVAIKKLSRPFQSEIFA 67
Query: 80  KELKNEVILFSKLQHRNLVKLLGCCIQGE------EKLLIYEFMTN--KSLDSFIFDQER 131
           K    E++L   +QH N++ LL             +  L+  FM    + +    F +E+
Sbjct: 68  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK 127
Query: 132 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 191
            +        +++    +G+ Y+H      ++HRDLK  N+ +++D   KI DFGLAR  
Sbjct: 128 IQ--------YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-- 174
Query: 192 GGDETEGNTKRVIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGK 240
                +      + T  Y APE   S   ++   D++S G ++ E+++GK
Sbjct: 175 ---HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 47  LGQGGFGPVYKGTLVDGQE-IAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 104
           LG G F  V        Q+ +A+K ++K + +G +  ++NE+ +  K++H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
             G    LI + ++   L   I ++      D S+   +I      V YLH    L I+H
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LGIVH 139
Query: 165 RDLKASNVL---LDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEYASDGQF 220
           RDLK  N+L   LD+D    ISDFGL++     E  G+      GT GY+APE  +   +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 221 SVKSDVFSFGILLLEIISG 239
           S   D +S G++   ++ G
Sbjct: 196 SKAVDCWSIGVIAYILLCG 214

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 138
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG----YV 190
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 138
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG----YV 190
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVK 99
           + +G G +G V   Y   L   Q++AVK+LS+  +  +  +    E+ L   L+H N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 100 LL-----GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           LL        I+   ++ +   +    L++ +  Q    + D   +F ++    RG+ Y+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ---ALSDEHVQF-LVYQLLRGLKYI 147
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H      IIHRDLK SNV +++D   +I DFGLAR    +E  G     + T  Y APE 
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQ-ADEEMTG----YVATRWYRAPEI 199
Query: 215 ASDG-QFSVKSDVFSFGILLLEIISGK 240
             +   ++   D++S G ++ E++ GK
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 21  TIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 136
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----YV 188
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQE-IAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLV 98
           +     LG G F  V        Q+ +A+K ++K + +G +  ++NE+ +  K++H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            L      G    LI + ++   L   I ++      D S+   +I      V YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD-- 134
Query: 159 RLRIIHRDLKASNVL---LDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMAPEY 214
            L I+HRDLK  N+L   LD+D    ISDFGL++     E  G+      GT GY+APE 
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEV 189
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
            +   +S   D +S G++   ++ G
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL---KELKNEVILFSKLQHRNLVKLLGC 103
           +G+G +G V++G+   G+ +AVK  S   E+      EL N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH-----QDS 158
            +           +T+      ++D  +   LD      I+   A G+ +LH        
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE---GNTKRVIGTYGYMAPEYA 215
           +  I HRDLK+ N+L+ ++    I+D GLA        +   GN  RV GT  YMAPE  
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVL 189
Query: 216 SDGQFSV-------KSDVFSFGILLLEI 236
            D    V       + D+++FG++L E+
Sbjct: 190 -DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL---KELKNEVILFSKLQHRNLVKLLGC 103
           +G+G +G V++G+   G+ +AVK  S   E+      EL N V+L    +H N++  +  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH-----QDS 158
            +           +T+      ++D  +   LD      I+   A G+ +LH        
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE---GNTKRVIGTYGYMAPEYA 215
           +  I HRDLK+ N+L+ ++    I+D GLA        +   GN  RV GT  YMAPE  
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVL 218
Query: 216 SDGQFSV-------KSDVFSFGILLLEI 236
            D    V       + D+++FG++L E+
Sbjct: 219 -DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 36  SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLS--KISEQGLKELKNEVILFSKL 92
           S T+ + + ++LG+G F  V +   +  GQE A K ++  K+S +  ++L+ E  +   L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+V+L     +     L+++ +T   L   I  +E     D S   H I      V 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVN 117
Query: 153 YLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           + H +    I+HRDLK  N+LL    +    K++DFGLA    GD+         GT GY
Sbjct: 118 HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGY 172
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           ++PE      +    D+++ G++L  ++ G
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 9   NISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPV---YKGTLVDGQE 65
           N+S+   ++Q  ++++    F   T++    N    K +G G  G V   Y   L   + 
Sbjct: 38  NMSKSKVDNQFYSVEVGDSTF---TVLKRYQNL---KPIGSGAQGIVCAAYDAVL--DRN 89
Query: 66  IAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLD 123
           +A+K+LS+   ++   K    E++L   + H+N++ LL              F   K+L+
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLE 137
Query: 124 SF--------IFDQERCKI----LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN 171
            F        + D   C++    LD  +  +++     G+ +LH      IIHRDLK SN
Sbjct: 138 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 194
Query: 172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGI 231
           +++  D   KI DFGLAR  G   T       + T  Y APE      +    D++S G 
Sbjct: 195 IVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 232 LLLEIISGK 240
           ++ E++  K
Sbjct: 252 IMGEMVRHK 260

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 31/224 (13%)
Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGL 79
           ELP     T VS T+       +G G +G V   + +D   G+++A+K+LS+   SE   
Sbjct: 39  ELP----KTYVSPTH-------VGSGAYGSV--CSAIDKRSGEKVAIKKLSRPFQSEIFA 85
Query: 80  KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWS- 138
           K    E++L   +QH N++ LL            Y+F     +     D ++   +++S 
Sbjct: 86  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMGMEFSE 143
Query: 139 -KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 197
            K  +++    +G+ Y+H      ++HRDLK  N+ +++D   KI DFGLAR       +
Sbjct: 144 EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HAD 195
Query: 198 GNTKRVIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGK 240
                 + T  Y APE   S   ++   D++S G ++ E+++GK
Sbjct: 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 38  TNNFSINKKLGQGGFGPVY--KGTLVDGQEIAVKRLSKISEQGLKE---LKNEVILFSKL 92
           ++ +   KKLG G +G V   K  L  G E A+K + K S         L +EV +  +L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSL-DSFIFDQERCKILDWSKRFHIICGTARGV 151
            H N++KL           L+ E      L D  I  Q+  ++        ++ GT    
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT--- 118
Query: 152 MYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
            YLH+ +   I+HRDLK  N+LL+   +D   KI DFGL+  F   E  G  K  +GT  
Sbjct: 119 -YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAY 171
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           Y+APE     ++  K DV+S G++L  ++ G
Sbjct: 172 YIAPEVLRK-KYDEKCDVWSCGVILYILLCG 201

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           ++F I + +G+G FG V      D +++ A+K ++K   +    ++ +  E+ +   L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----FDQERCKILDWSKRFHIICGTAR 149
             LV L       E+  ++ + +    L   +     F +E  K+         IC    
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELVM 126
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
            + YL      RIIHRD+K  N+LLD+  +  I+DF +A A    ET+  T  + GT  Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA-AMLPRETQITT--MAGTKPY 180
Query: 210 MAPEYASDGQ---FSVKSDVFSFGILLLEIISGKK 241
           MAPE  S  +   +S   D +S G+   E++ G++
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D   C++    LD  +  +++   
Sbjct: 81  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 182
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 43/249 (17%)
Query: 9   NISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPV---YKGTLVDGQE 65
           N+S+   ++Q  ++++    F   T++    N    K +G G  G V   Y   L   + 
Sbjct: 38  NMSKSKVDNQFYSVEVGDSTF---TVLKRYQNL---KPIGSGAQGIVCAAYDAVL--DRN 89
Query: 66  IAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLD 123
           +A+K+LS+   ++   K    E++L   + H+N++ LL              F   K+L+
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLE 137
Query: 124 SF--------IFDQERCKI----LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN 171
            F        + D   C++    LD  +  +++     G+ +LH      IIHRDLK SN
Sbjct: 138 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 194
Query: 172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGI 231
           +++  D   KI DFGLAR  G   T       + T  Y APE      +    D++S G 
Sbjct: 195 IVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 232 LLLEIISGK 240
           ++ E++  K
Sbjct: 252 IMGEMVRHK 260

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +  Q   K+ D   +F +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ---KLTDDHVQF-LI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 32  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 89
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 90  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 137
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 138 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPFVVTR 191
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y APE      +    D++S G ++ E+I G
Sbjct: 192 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 136
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----YV 188
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 81
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D   C++    LD  +  +++   
Sbjct: 82  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 183
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 86/172 (50%), Gaps = 27/172 (15%)
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTKRV 203
            ARG+ +L   S  + IHRDL A N+LL ++   KI DFGLAR    +     +G+T+  
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS--GKKNRGFYHSDNNLNLIGHAWKL 261
           +    +MAPE   D  +S KSDV+S+G+LL EI S  G    G    ++  + +      
Sbjct: 265 L---KWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRL------ 315
Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG 313
             EGM  ++  P     ++  E+     I L C  + PK+RP    ++  LG
Sbjct: 316 -REGM--RMRAP----EYSTPEI---YQIMLDCWHRDPKERPRFAELVEKLG 357

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 142
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 143 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----YV 194
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 81
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D   C++    LD  +  +++   
Sbjct: 82  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 183
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 137
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 189
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----XV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    + + ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 228 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 275

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 46  KLGQGGFGPVYKGTLVD-GQEIAVKR-LSKISEQGLKELK-NEVILFSKLQHRNLVKLLG 102
           K+G+G +G V+K    D GQ +A+K+ L    +  +K++   E+ +  +L+H NLV LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 103 CCIQGEEKLLIYEFMTN---KSLDSFI--FDQERCKILDWSKRFHIICGTARGVMYLHQD 157
              +     L++E+  +     LD +     +   K + W         T + V + H+ 
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCHKH 121
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YAS 216
           +    IHRD+K  N+L+ +    K+ DFG AR   G     + +  + T  Y +PE    
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELLVG 176
Query: 217 DGQFSVKSDVFSFGILLLEIISG 239
           D Q+    DV++ G +  E++SG
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 38  TNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK---ELKNEVILFSKLQ 93
           ++ + + + LG GG   V+    L   +++AVK L     +        + E    + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 94  HRNLVKLLGC----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           H  +V +          G    ++ E++   +L   +  +     +   +   +I    +
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 127
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYG 208
            + + HQ+    IIHRD+K +N+++      K+ DFG+ARA      +   T  VIGT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           Y++PE A       +SDV+S G +L E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 154
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 155 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 206
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 133
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 185
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D   C++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 137
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 189
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D   C++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 137
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 138 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG----YV 189
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 136
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 188
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 138
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 190
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D    ++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y APE      +    D++S G+++ E+I G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 136
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 137 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 188
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 212 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 259

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 15  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 75  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 130
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 131 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 182
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 183 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 36  SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLS--KISEQGLKELKNEVILFSKL 92
           S T+ + + ++LG+G F  V +   +  GQE A K ++  K+S +  ++L+ E  +   L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H N+V+L     +     L+++ +T   L   I  +E     D S   H I      V 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVN 117
Query: 153 YLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           + H +    I+HRDLK  N+LL    +    K++DFGLA    GD+         GT GY
Sbjct: 118 HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGY 172
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           ++PE      +    D+++ G++L  ++ G
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 29  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 86
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D   C++    LD  +  +++   
Sbjct: 87  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 134
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 135 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 188
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 189 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 151
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 152 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 203
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 128
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 129 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 180
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D    ++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y APE      +    D++S G+++ E+I G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 143
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 144 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 195
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 143
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 144 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 195
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 88
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D   C++    LD  +  +++   
Sbjct: 89  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 190
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 88
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D   C++    LD  +  +++   
Sbjct: 89  LLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 190
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 133
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 185
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 128
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 129 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 180
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 133
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG----YV 185
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 127
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 128 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 179
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +  Q   K+ D   +F +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ---KLTDDHVQF-LI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 133
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 134 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 185
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 49/290 (16%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN-- 96
           +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +++L    I  +    IY  M   ++D   + +++  I  W ++ +        V  +HQ
Sbjct: 90  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQ 145
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+H DLK +N L+   M  K+ DFG+A     D T       +GT  YM PE   
Sbjct: 146 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 217 DGQFSVKS-----------DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           D   S ++           DV+S G +L  +  GK    F    N ++ + HA       
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL-HA------- 251
Query: 266 MPSQLIDPCIQGSF------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
               +IDP  +  F      +L +V++C      C+++ PK R S+P ++
Sbjct: 252 ----IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELL 291

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 142
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 143 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 194
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 14  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 74  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 129
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 130 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 181
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 150
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    DE  G     +
Sbjct: 151 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 202
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 212 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 259

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +    +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 210 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 257

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 49/290 (16%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN-- 96
           +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +++L    I  +    IY  M   ++D   + +++  I  W ++ +        V  +HQ
Sbjct: 74  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQ 129
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+H DLK +N L+   M  K+ DFG+A     D T       +GT  YM PE   
Sbjct: 130 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185
Query: 217 DGQFSVKS-----------DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           D   S ++           DV+S G +L  +  GK    F    N ++ + HA       
Sbjct: 186 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL-HA------- 235
Query: 266 MPSQLIDPCIQGSF------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
               +IDP  +  F      +L +V++C      C+++ PK R S+P ++
Sbjct: 236 ----IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELL 275

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 4/103 (3%)
Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD-ETE 197
           +   +I    + + + HQ+    IIHRD+K +N+++      K+ DFG+ARA      + 
Sbjct: 117 RAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
             T  VIGT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 213 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 260

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 153
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 214 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 261

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 144
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 205 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 252

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 212 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 259

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 43  INKKLGQGGFGPVYKGTLVD----GQ----EIAVKRLSKISEQGLKELKNEVILFSKLQH 94
            N+ LGQG F  ++KG   +    GQ    E+ +K L K      +       + SKL H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           ++LV   G C+ G+E +L+ EF+   SLD+++   + C  + W  +  +    A  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 155 HQDSRLRIIHRDLKASNVLL--DQDM---NP---KISDFGLARAFGGDETEGNTKRVIGT 206
            +++   +IH ++ A N+LL  ++D    NP   K+SD G++      +       +   
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI------LQER 180
Query: 207 YGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
             ++ PE   + +  ++ +D +SFG  L EI SG         D  L+ +    KL    
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSG--------GDKPLSALDSQRKLQFYE 232
Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS 314
              QL  P    +  LA +I        C+   P  RPS  ++I  L S
Sbjct: 233 DRHQLPAP---KAAELANLINN------CMDYEPDHRPSFRAIIRDLNS 272

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 49/290 (16%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN-- 96
           +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +++L    I  +    IY  M   ++D   + +++  I  W ++ +        V  +HQ
Sbjct: 70  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQ 125
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+H DLK +N L+   M  K+ DFG+A     D T       +GT  YM PE   
Sbjct: 126 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181
Query: 217 DGQFSVKS-----------DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           D   S ++           DV+S G +L  +  GK    F    N ++ + HA       
Sbjct: 182 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL-HA------- 231
Query: 266 MPSQLIDPCIQGSF------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
               +IDP  +  F      +L +V++C      C+++ PK R S+P ++
Sbjct: 232 ----IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELL 271

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 39  NNFSINKKLGQGGFGPVYK----GTLVDGQEIAVK-----RLSKISEQGL--KELKNEVI 87
           +++ + ++LG G F  V K    GT   G+E A K     RLS  S +G+  +E++ EV 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSS-SRRGVSREEIEREVN 60
Query: 88  LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGT 147
           +  +++H N++ L        + +LI E ++   L  F+ ++E    L   +    +   
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQI 117
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNV-LLDQDM-NPKIS--DFGLARAFGGDETEGNTKRV 203
             GV YLH     RI H DLK  N+ LLD+++ NP+I   DFG+A      E     K +
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNI 171
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            GT  ++APE  +     +++D++S G++   ++SG
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 206 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 253

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 39  NNFSINKKLGQGGFGPVYK----GTLVDGQEIAVK-----RLSKISEQGL--KELKNEVI 87
           +++ + ++LG G F  V K    GT   G+E A K     RLS  S +G+  +E++ EV 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSS-SRRGVSREEIEREVN 67
Query: 88  LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGT 147
           +  +++H N++ L        + +LI E ++   L  F+ ++E    L   +    +   
Sbjct: 68  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQI 124
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNV-LLDQDM-NPKIS--DFGLARAFGGDETEGNTKRV 203
             GV YLH     RI H DLK  N+ LLD+++ NP+I   DFG+A      E     K +
Sbjct: 125 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNI 178
Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            GT  ++APE  +     +++D++S G++   ++SG
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 212 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 259

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 213 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 260

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL---KELKNEVILFSKLQHRNLVKLLGC 103
           +G+G +G V++G L  G+ +AVK  S   EQ      E+ N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILGFIAS 70
Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-----S 158
            +           +T+      ++D  + + L+      +    A G+ +LH +      
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLA--RAFGGDETE-GNTKRVIGTYGYMAPEY- 214
           +  I HRD K+ NVL+  ++   I+D GLA   + G D  + GN  RV GT  YMAPE  
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAPEVL 189
Query: 215 ----ASDGQFSVK-SDVFSFGILLLEI 236
                +D   S K +D+++FG++L EI
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 109/233 (46%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V    +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 165 RDLKASNVLLDQDMNPKISDFGLAR-AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+L++   + KI DFGLAR A    +  G     + T  Y APE   + +   K
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTK 227
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 228 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 275

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 107/227 (47%), Gaps = 12/227 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      V+   +A+K++S    Q   +    E+ +    +H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 149
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ
Sbjct: 210 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQ 251

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T    +  + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 49/290 (16%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN-- 96
           +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +++L    I  +    IY  M   ++D   + +++  I  W ++ +        V  +HQ
Sbjct: 71  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQ 126
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+H DLK +N L+   M  K+ DFG+A     D T       +GT  YM PE   
Sbjct: 127 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 217 DGQFSVKS-----------DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           D   S ++           DV+S G +L  +  GK    F    N ++ + HA       
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL-HA------- 232
Query: 266 MPSQLIDPCIQGSF------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
               +IDP  +  F      +L +V++C      C+++ PK R S+P ++
Sbjct: 233 ----IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELL 272

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 4/103 (3%)
Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD-ETE 197
           +   +I    + + + HQ+    IIHRD+K +N+++      K+ DFG+ARA      + 
Sbjct: 134 RAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 190
Query: 198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
             T  VIGT  Y++PE A       +SDV+S G +L E+++G+
Sbjct: 191 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 39  NNFSINKKLGQGGFGPVYK----GTLVDGQEIAVKRLSK----ISEQGL--KELKNEVIL 88
           +++ + ++LG G F  V K    GT   G+E A K + K     S +G+  +E++ EV +
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 89  FSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA 148
             +++H N++ L        + +LI E ++   L  F+ ++E    L   +    +    
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQIL 139
Query: 149 RGVMYLHQDSRLRIIHRDLKASNV-LLDQDM-NPKIS--DFGLARAFGGDETEGNTKRVI 204
            GV YLH     RI H DLK  N+ LLD+++ NP+I   DFG+A      E     K + 
Sbjct: 140 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNIF 193
Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           GT  ++APE  +     +++D++S G++   ++SG
Sbjct: 194 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 39  NNFSINKKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           ++F    +LG G  G V K      G ++  + I ++    I  Q ++EL+    +  + 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 71
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +V   G      E  +  E M   SLD  + + +R       K   +     RG+ 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VSIAVLRGLA 128
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YMAP
Sbjct: 129 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAP 182
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E      +SV+SD++S G+ L+E+  G+
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 46  KLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 103
           KLG+G +  VYKG + +    +A+K +    E+G       EV L   L+H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 104 CIQGEEKLLIYEFMTNKSLDSFIFDQERC-KILDWSKRFHIICGTARGVMYLHQDSRLRI 162
               +   L++E++ +K L  ++ D   C  I++       +    RG+ Y H   R ++
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YASDGQFS 221
           +HRDLK  N+L+++    K++DFGLARA     T+     V+ T  Y  P+       +S
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVV-TLWYRPPDILLGSTDYS 179
Query: 222 VKSDVFSFGILLLEIISGK 240
            + D++  G +  E+ +G+
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 100 LLGCCI------QGEEKLLIYEFMTNKSLDSFI---FDQERCKILDWSKRFHIICGTARG 150
           LL          + ++  L+ E M + +L   I    D ER   L     + ++CG    
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYL----LYQMLCG---- 138
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGK 240
           APE      +    D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI D+GLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 98
           F   + LG G F  V        G+  AVK + K + +G +  ++NE+ +  K++H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            L           L+ + ++   L   I ++      D S    +I      V YLH   
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST---LIRQVLDAVYYLH--- 137
Query: 159 RLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
           R+ I+HRDLK  N+L    D++    ISDFGL++  G  +         GT GY+APE  
Sbjct: 138 RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV---MSTACGTPGYVAPEVL 194
Query: 216 SDGQFSVKSDVFSFGILLLEIISG 239
           +   +S   D +S G++   ++ G
Sbjct: 195 AQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKIS-EQGLK-ELKNEVILFSKLQ 93
           AT+ +    ++G G +G VYK      G  +A+K +   + E+GL      EV L  +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 94  ---HRNLVKLLGCCIQGEEK-----LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
              H N+V+L+  C            L++E + ++ L +++ D+     L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
              RG+ +LH +    I+HRDLK  N+L+      K++DFGLAR +     +     V+ 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAPVVV 173
Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           T  Y APE      ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 49/290 (16%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN-- 96
           +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +++L    I  +    IY  M   ++D   + +++  I  W ++ +        V  +HQ
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQ 173
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+H DLK +N L+   M  K+ DFG+A     D T       +GT  YM PE   
Sbjct: 174 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 217 DGQFSVKS-----------DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           D   S ++           DV+S G +L  +  GK    F    N ++ + HA       
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL-HA------- 279
Query: 266 MPSQLIDPCIQGSF------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
               +IDP  +  F      +L +V++C      C+++ PK R S+P ++
Sbjct: 280 ----IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELL 319

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKIS-EQGLK-ELKNEVILFSKLQ 93
           AT+ +    ++G G +G VYK      G  +A+K +   + E+GL      EV L  +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 94  ---HRNLVKLLGCCIQGEEK-----LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
              H N+V+L+  C            L++E + ++ L +++ D+     L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
              RG+ +LH +    I+HRDLK  N+L+      K++DFGLAR +     +     V+ 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVV 173
Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           T  Y APE      ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 81
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 82  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 183
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 184 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRL---SKISEQGLK-ELKNEVILFSKLQH 94
           ++F I + LG+G FG VY         I   ++   S+I ++G++ +L+ E+ + + L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICGTAR 149
            N+++L           LI E+     L      S  FD++R           I+   A 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTAT--------IMEELAD 134
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
            +MY H     ++IHRD+K  N+LL      KI+DFG    +         K + GT  Y
Sbjct: 135 ALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDY 187
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           + PE       + K D++  G+L  E++ G  N  F  + +N
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVG--NPPFESASHN 227

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGTLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL 88
           +  A   +    ++G+G +G V+K   +   G+ +A+KR+  +  E+G  L  ++   +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 89  --FSKLQHRNLVKLLGCCIQG----EEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRF 141
                 +H N+V+L   C       E KL L++E +          DQ+    LD     
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEP 115
Query: 142 HIICGTA--------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
            +   T         RG+ +LH     R++HRDLK  N+L+      K++DFGLAR +  
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS- 171
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
              +     V+ T  Y APE      ++   D++S G +  E+   K
Sbjct: 172 --FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 110/233 (47%), Gaps = 12/233 (5%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A++++S    Q   +    E+ +  + +H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           S D++S G +L E++S   NR  +   + L+ + H   +   G PSQ    CI
Sbjct: 212 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHILGIL--GSPSQEDLNCI 259

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 106/268 (39%), Gaps = 72/268 (26%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRN 96
            +F   + +G+GGFG V++    VD    A+KR+   + +  +E +  EV   +KL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 97  LVKLLGCCIQGE--------EKLLIYEFMTNKSLDS------------------------ 124
           +V+     ++          +++ + +  T+  L S                        
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 125 ---------FIFDQ-ERCK---ILDWSKR------------FHIICGTARGVMYLHQDSR 159
                    +++ Q + C+   + DW  R             HI    A  V +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG----------Y 209
             ++HRDLK SN+    D   K+ DFGL  A   DE E      +  Y           Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLY 242
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEII 237
           M+PE      +S K D+FS G++L E++
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 35  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 92
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 93  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 140
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 141 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTR 194
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 195 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D   C++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T    +  + T 
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/100 (40%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 142 HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
           H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D    
Sbjct: 194 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250
Query: 199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                     +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/100 (40%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 142 HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
           H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D    
Sbjct: 192 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 248
Query: 199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                     +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 249 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/100 (40%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 142 HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
           H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D    
Sbjct: 199 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 255
Query: 199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                     +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 256 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +  Q   K+ D   +F +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ---KLTDDHVQF-LI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGL R    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/100 (40%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 142 HIICGT---ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
           H+IC +   A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D    
Sbjct: 201 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 257
Query: 199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                     +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 258 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 49/290 (16%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN-- 96
           +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +++L    I  +    IY  M   ++D   + +++  I  W ++ +        V  +HQ
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQ 173
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+H DLK +N L+   M  K+ DFG+A     D T       +GT  YM PE   
Sbjct: 174 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 217 DGQFSVKS-----------DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           D   S ++           DV+S G +L  +  GK    F    N ++ + HA       
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL-HA------- 279
Query: 266 MPSQLIDPCIQGSF------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
               +IDP  +  F      +L +V++C      C+++ PK R S+P ++
Sbjct: 280 ----IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELL 319

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 39/243 (16%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGTLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL 88
           +  A   +    ++G+G +G V+K   +   G+ +A+KR+  +  E+G  L  ++   +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 89  --FSKLQHRNLVKLLGCCIQG----EEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRF 141
                 +H N+V+L   C       E KL L++E +          DQ+    LD     
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEP 115
Query: 142 HIICGTA--------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
            +   T         RG+ +LH     R++HRDLK  N+L+      K++DFGLAR +  
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS- 171
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLN 253
              +     V+ T  Y APE      ++   D++S G +  E+    + +  +   ++++
Sbjct: 172 --FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVD 226
Query: 254 LIG 256
            +G
Sbjct: 227 QLG 229

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 43  INKKLGQGGFGPVYKGTLVD----GQ----EIAVKRLSKISEQGLKELKNEVILFSKLQH 94
            N+ LGQG F  ++KG   +    GQ    E+ +K L K      +       + SKL H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           ++LV   G C  G+E +L+ EF+   SLD+++   + C  + W  +  +    A  + +L
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFL 129
Query: 155 HQDSRLRIIHRDLKASNVLL--DQDM---NP---KISDFGLARAFGGDETEGNTKRVIGT 206
            +++   +IH ++ A N+LL  ++D    NP   K+SD G++      +       +   
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI------LQER 180
Query: 207 YGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
             ++ PE   + +  ++ +D +SFG  L EI SG         D  L+ +    KL    
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSG--------GDKPLSALDSQRKLQFYE 232
Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS 314
              QL  P    +  LA +I        C+   P  RPS  ++I  L S
Sbjct: 233 DRHQLPAP---KAAELANLINN------CMDYEPDHRPSFRAIIRDLNS 272

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DF LAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 39/243 (16%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGTLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL 88
           +  A   +    ++G+G +G V+K   +   G+ +A+KR+  +  E+G  L  ++   +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 89  --FSKLQHRNLVKLLGCCIQG----EEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRF 141
                 +H N+V+L   C       E KL L++E +          DQ+    LD     
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEP 115
Query: 142 HIICGTA--------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
            +   T         RG+ +LH     R++HRDLK  N+L+      K++DFGLAR +  
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS- 171
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLN 253
              +     V+ T  Y APE      ++   D++S G +  E+    + +  +   ++++
Sbjct: 172 --FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVD 226
Query: 254 LIG 256
            +G
Sbjct: 227 QLG 229

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   KSL+ F        + D    ++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y APE      +    D++S G ++ E+I G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHR 95
           +  F++ KK  +   G  Y    +       KR +K S +G+  ++++ EV +  ++QH 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIK------KRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N++ L        + +LI E +    L  F+ ++E     + ++    I     GV YLH
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLH 131
Query: 156 QDSRLRIIHRDLKASNV-LLDQDM-NPKIS--DFGLARA--FGGDETEGNTKRVIGTYGY 209
               L+I H DLK  N+ LLD+++  P+I   DFGLA    FG +      K + GT  +
Sbjct: 132 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPAF 183
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG 87
Query: 100 LLGCCI------QGEEKLLIYEFMTNKSLDSFI---FDQERCKILDWSKRFHIICGTARG 150
           LL          + ++  ++ E M + +L   I    D ER   L     + ++CG    
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL----LYQMLCG---- 138
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE      +    D++S G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 103/215 (47%), Gaps = 10/215 (4%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQHRNLVKLLGCC 104
           +G+G +G V      ++   +A+K++S    Q   +    E+ +  + +H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
                + +   ++    +++ ++   + + L      + +    RG+ Y+H  +   ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 165 RDLKASNVLLDQDMNPKISDFGLARAFGGD-ETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           RDLK SN+LL+   + KI DFGLAR    D +  G     + T  Y APE   + +   K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 224 S-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGH 257
           S D++S G +L E++S   NR  +   + L+ + H
Sbjct: 206 SIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 237

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIIS 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D    ++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQE-IAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
           ++ F +  +LG+G    VY+      Q+  A+K L K  ++  K ++ E+ +  +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           ++KL        E  L+ E +T   L   I ++      D +     I      V YLH+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL---EAVAYLHE 166
Query: 157 DSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           +    I+HRDLK  N+L      D   KI+DFGL++     E +   K V GT GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPE 220
Query: 214 YASDGQFSVKSDVFSFGILLLEIISG 239
                 +  + D++S GI+   ++ G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 37  ATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKIS-EQGLK-ELKNEVILFSKLQ 93
           AT+ +    ++G G +G VYK      G  +A+K +   + E+GL      EV L  +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 94  ---HRNLVKLLGCCIQGEEK-----LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
              H N+V+L+  C            L++E + ++ L +++ D+     L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
              RG+ +LH +    I+HRDLK  N+L+      K++DFGLAR +     +     V+ 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFPVVV 173
Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           T  Y APE      ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 100 LLGCCI------QGEEKLLIYEFMTNKSLDSFI---FDQERCKILDWSKRFHIICGTARG 150
           LL          + ++  ++ E M + +L   I    D ER   L     + ++CG    
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL----LYQMLCG---- 138
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE      +    D++S G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 41  FSINKKLGQGGFGPVYK-----GTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQ 93
           +   ++LG G F  V K       L    +   KR +K S +G+  ++++ EV +  ++Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E +    L  F+ ++E    L   +    +     GV Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTY 207
           LH    L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTP 181
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            ++APE  +     +++D++S G++   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 40  NFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            F   + LG G F  V+     + G+  A+K + K        L+NE+ +  K++H N+V
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            L           L+ + ++   L   I ++      D S    +I      V YLH++ 
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQQVLSAVKYLHENG 126
Query: 159 RLRIIHRDLKASNVL-LDQDMNPKI--SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
              I+HRDLK  N+L L  + N KI  +DFGL++     E  G      GT GY+APE  
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVL 179
Query: 216 SDGQFSVKSDVFSFGILLLEIISG 239
           +   +S   D +S G++   ++ G
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 39  NNFSINKKLGQGGFGPV--------------YKGTLVDGQEIAVKRLS-KIS-EQGLKEL 82
           N++ I + L QG F  +              Y+ +L++ +    K  + KIS +    + 
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL---DSFIF--DQERCKILDW 137
           KNE+ + + +++   +   G     +E  +IYE+M N S+   D + F  D+     +  
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 138 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 197
                II        Y+H +    I HRD+K SN+L+D++   K+SDFG +      + +
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 198 GNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILL 233
           G+     GTY +M PE+ S+       K D++S GI L
Sbjct: 209 GSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHR 95
           +  F++ KK  +   G  Y    +       KR +K S +G+  ++++ EV +  ++QH 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIK------KRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N++ L        + +LI E +    L  F+ ++E     + ++    I     GV YLH
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLH 131
Query: 156 QDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTYGY 209
               L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT  +
Sbjct: 132 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEF 183
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 100 LLGCCI------QGEEKLLIYEFMTNKSLDSFI---FDQERCKILDWSKRFHIICGTARG 150
           LL          + ++  ++ E M + +L   I    D ER   L     + ++CG    
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL----LYQMLCG---- 138
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE      +    D++S G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHR 95
           +  F++ KK  +   G  Y    +       KR +K S +G+  ++++ EV +  ++QH 
Sbjct: 20  SGQFAVVKKCREKSTGLQYAAKFIK------KRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N++ L        + +LI E +    L  F+ ++E     + ++    I     GV YLH
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLH 130
Query: 156 QDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTYGY 209
               L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT  +
Sbjct: 131 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEF 182
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 126/290 (43%), Gaps = 49/290 (16%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN-- 96
           +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +++L    I  +    IY  M   ++D   + +++  I  W ++ +        V  +HQ
Sbjct: 90  IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQ 145
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+H DLK +N L+   M  K+ DFG+A     D         +GT  YM PE   
Sbjct: 146 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIK 201
Query: 217 DGQFSVKS-----------DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           D   S ++           DV+S G +L  +  GK    F    N ++ + HA       
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL-HA------- 251
Query: 266 MPSQLIDPCIQGSF------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
               +IDP  +  F      +L +V++C      C+++ PK R S+P ++
Sbjct: 252 ----IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELL 291

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 41  FSINKKLGQGGFGPVYK-----GTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQ 93
           +   ++LG G F  V K       L    +   KR +K S +G+  ++++ EV +  ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E +    L  F+ ++E     + ++    I     GV Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYY 128
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTY 207
           LH    L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT 
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTP 180
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            ++APE  +     +++D++S G++   ++SG
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 41  FSINKKLGQGGFGPVYK-----GTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQ 93
           +   ++LG G F  V K       L    +   KR +K S +G+  ++++ EV +  ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E +    L  F+ ++E     + ++    I     GV Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYY 129
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTY 207
           LH    L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTP 181
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            ++APE  +     +++D++S G++   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLV 98
           F++ KK  +   G  Y    +       KR +K S +G+  ++++ EV +  ++QH N++
Sbjct: 24  FAVVKKCREKSTGLQYAAKFIK------KRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            L        + +LI E +    L  F+ ++E     + ++    I     GV YLH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLHS-- 132
Query: 159 RLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTYGYMAP 212
            L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT  ++AP
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEFVAP 186
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISG 239
           E  +     +++D++S G++   ++SG
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 41  FSINKKLGQGGFGPVYK-----GTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQ 93
           +   ++LG G F  V K       L    +   KR +K S +G+  ++++ EV +  ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E +    L  F+ ++E    L   +    +     GV Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTY 207
           LH    L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTP 181
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            ++APE  +     +++D++S G++   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 41  FSINKKLGQGGFGPVYK-----GTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQ 93
           +   ++LG G F  V K       L    +   KR +K S +G+  ++++ EV +  ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E +    L  F+ ++E     + ++    I     GV Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYY 129
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTY 207
           LH    L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTP 181
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            ++APE  +     +++D++S G++   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           N F   K LG+G FG V          I VK  +      +K LK EVI+        L 
Sbjct: 148 NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197
Query: 99  --KLLGCCIQGEEKLLIYEFMTNKSL---------DSFIFDQERCKILDWSKRFHIICGT 147
             ++L          L Y F T+  L             F   R ++    +        
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
              + YLH  S   +++RDLK  N++LD+D + KI+DFGL +   G +     K   GT 
Sbjct: 258 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTP 313
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            Y+APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 355

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 41  FSINKKLGQGGFGPVYK-----GTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQ 93
           +   ++LG G F  V K       L    +   KR +K S +G+  ++++ EV +  ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E +    L  F+ ++E    L   +    +     GV Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYY 129
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTY 207
           LH    L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTP 181
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            ++APE  +     +++D++S G++   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHR 95
           +  F++ KK  +   G  Y    +       KR +K S +G+  ++++ EV +  ++QH 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIK------KRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N++ L        + +LI E +    L  F+ ++E     + ++    I     GV YLH
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLH 131
Query: 156 QDSRLRIIHRDLKASNV-LLDQDM-NPKIS--DFGLARA--FGGDETEGNTKRVIGTYGY 209
               L+I H DLK  N+ LLD+++  P+I   DFGLA    FG +      K + GT  +
Sbjct: 132 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEF 183
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQE----IAVKRLSKI----SEQGLKELKNEVILFSKL 92
           F + + LG+GG+G V++   V G       A+K L K     + +     K E  +  ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H  +V L+     G +  LI E+++   L       ER  I         +   +  + 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           +LHQ     II+RDLK  N++L+   + K++DFGL +    D T  +T    GT  YMAP
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAP 190
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISG 239
           E       +   D +S G L+ ++++G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 41  FSINKKLGQGGFGPVYK-----GTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQ 93
           +   ++LG G F  V K       L    +   KR +K S +G+  ++++ EV +  ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E +    L  F+ ++E     + ++    I     GV Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYY 129
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTY 207
           LH    L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT 
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTP 181
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            ++APE  +     +++D++S G++   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 39  NNFSINKKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           ++F    +LG G  G V+K      G ++  + I ++    I  Q ++EL+    +  + 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 64
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +V   G      E  +  E M   SLD  +    R       K   +     +G+ 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLT 121
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+P
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSP 175
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGKKNR 243
           E      +SV+SD++S G+ L+E+  G+  R
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPR 206

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 87
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D    ++    LD  +  +++   
Sbjct: 88  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTR 189
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 37/213 (17%)
Query: 45  KKLGQGGFGPV---YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVK 99
           K +G G  G V   Y   L   + +A+K+LS+   ++   K    E++L   + H+N++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSF--------IFDQERCKI----LDWSKRFHIICGT 147
           LL              F   K+L+ F        + D    ++    LD  +  +++   
Sbjct: 81  LLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 128
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      IIHRDLK SN+++  D   KI DFGLAR  G   T       + T 
Sbjct: 129 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTR 182
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y APE      +    D++S G ++ E++  K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           N F   K LG+G FG V          I VK  +      +K LK EVI+        L 
Sbjct: 151 NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 200
Query: 99  --KLLGCCIQGEEKLLIYEFMTNKSL---------DSFIFDQERCKILDWSKRFHIICGT 147
             ++L          L Y F T+  L             F   R ++    +        
Sbjct: 201 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 260
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
              + YLH  S   +++RDLK  N++LD+D + KI+DFGL +   G +     K   GT 
Sbjct: 261 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTP 316
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            Y+APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 358

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           N F   K LG+G FG V          I VK  +      +K LK EVI+        L 
Sbjct: 9   NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 58
Query: 99  --KLLGCCIQGEEKLLIYEFMTNKSL---------DSFIFDQERCKILDWSKRFHIICGT 147
             ++L          L Y F T+  L             F   R ++    +        
Sbjct: 59  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 118
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
              + YLH  S   +++RDLK  N++LD+D + KI+DFGL +   G +     K   GT 
Sbjct: 119 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKXFCGTP 174
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            Y+APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHR 95
           +  F++ KK  +   G  Y    +       KR +K S +G+  ++++ EV +  ++QH 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIK------KRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N++ L        + +LI E +    L  F+ ++E     + ++    I     GV YLH
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLH 131
Query: 156 QDSRLRIIHRDLKASNV-LLDQDM-NPKIS--DFGLARA--FGGDETEGNTKRVIGTYGY 209
               L+I H DLK  N+ LLD+++  P+I   DFGLA    FG +      K + GT  +
Sbjct: 132 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEF 183
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           N F   K LG+G FG V          I VK  +      +K LK EVI+        L 
Sbjct: 10  NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 59
Query: 99  --KLLGCCIQGEEKLLIYEFMTNKSL---------DSFIFDQERCKILDWSKRFHIICGT 147
             ++L          L Y F T+  L             F   R ++    +        
Sbjct: 60  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 119
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
              + YLH  S   +++RDLK  N++LD+D + KI+DFGL +   G +     K   GT 
Sbjct: 120 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKXFCGTP 175
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            Y+APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 217

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           N F   K LG+G FG V          I VK  +      +K LK EVI+        L 
Sbjct: 8   NEFEYLKLLGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 57
Query: 99  --KLLGCCIQGEEKLLIYEFMTNKSL---------DSFIFDQERCKILDWSKRFHIICGT 147
             ++L          L Y F T+  L             F   R ++    +        
Sbjct: 58  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 117
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
              + YLH  S   +++RDLK  N++LD+D + KI+DFGL +   G +     K   GT 
Sbjct: 118 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKXFCGTP 173
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            Y+APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 215

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGTLVDGQE---IAVKRLSKISEQGLKELKNEVILFS 90
           I+  ++ + + K +G G FG      + D Q    +AVK + +  E+  + +K E+I   
Sbjct: 14  IMHDSDRYELVKDIGAGNFG--VARLMRDKQANELVAVKYIER-GEKIDENVKREIINHR 70
Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L+H N+V+     +      ++ E+ +   L   I +  R    +   RF        G
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISG 127
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYG 208
           V Y H    +++ HRDLK  N LLD    P  KI+DFG ++A          K  +GT  
Sbjct: 128 VSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA---SVLHSQPKSAVGTPA 181
Query: 209 YMAPEYASDGQFSVK-SDVFSFGILLLEIISG 239
           Y+APE     ++  K +DV+S G+ L  ++ G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGC-----CIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL        ++    + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI  FGLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI D GLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 39  NNFSINKKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           ++F    +LG G  G V+K      G ++  + I ++    I  Q ++EL+    +  + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +V   G      E  +  E M   SLD  +    R       K   +     +G+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLT 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E      +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI D GLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGL--KELKNEVILFSKLQHR 95
           +  F++ KK  +   G  Y    +       KR +K S +G+  ++++ EV +  ++QH 
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIK------KRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N++ L        + +LI E +    L  F+ ++E     + ++    I     GV YLH
Sbjct: 75  NVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYLH 131
Query: 156 QDSRLRIIHRDLKASNV-LLDQDMNP---KISDFGLARA--FGGDETEGNTKRVIGTYGY 209
               L+I H DLK  N+ LLD+++     KI DFGLA    FG +      K + GT  +
Sbjct: 132 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEF 183
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQE----IAVKRLSKI----SEQGLKELKNEVILFSKL 92
           F + + LG+GG+G V++   V G       A+K L K     + +     K E  +  ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +H  +V L+     G +  LI E+++   L       ER  I         +   +  + 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           +LHQ     II+RDLK  N++L+   + K++DFGL +    D T   T    GT  YMAP
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAP 190
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISG 239
           E       +   D +S G L+ ++++G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 126/290 (43%), Gaps = 49/290 (16%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN-- 96
           +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +++L    I  +    IY  M   ++D   + +++  I  W ++ +        V  +HQ
Sbjct: 118 IIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYW-KNMLEAVHTIHQ 173
Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+H DLK +N L+   M  K+ DFG+A     D T       +G   YM PE   
Sbjct: 174 HG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 217 DGQFSVKS-----------DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG 265
           D   S ++           DV+S G +L  +  GK    F    N ++ + HA       
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL-HA------- 279
Query: 266 MPSQLIDPCIQGSF------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
               +IDP  +  F      +L +V++C      C+++ PK R S+P ++
Sbjct: 280 ----IIDPNHEIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELL 319

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 39  NNFSINKKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           ++F    +LG G  G V+K      G ++  + I ++    I  Q ++EL+    +  + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +V   G      E  +  E M   SLD  +    R       K   +     +G+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLT 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E      +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 13/217 (5%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHR 95
           +F + + +G+G +  V    L     I   R+ K      ++ +  ++ E  +F +  + 
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 96  NLVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +  L  C Q E +L  + E++    L   +F  +R + L            +  + YL
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H+     II+RDLK  NVLLD + + K++D+G+ +   G      T    GT  Y+APE 
Sbjct: 170 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEI 224
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
                +    D ++ G+L+ E+++G+       S +N
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 39  NNFSINKKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           ++F    +LG G  G V+K      G ++  + I ++    I  Q ++EL+    +  + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +V   G      E  +  E M   SLD  +    R       K   +     +G+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLT 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E      +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEI-AVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           +K+G+G +G V+K    +  EI A+KR  L    E        E+ L  +L+H+N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 102 GCCIQGEEKLLIYEFMT---NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
                 ++  L++EF      K  DS   D      LD       +    +G+ + H  +
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
              ++HRDLK  N+L++++   K++DFGLARAFG       +  V+ T  Y  P+     
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGA 176
Query: 219 Q-FSVKSDVFSFGILLLEIISGKK 241
           + +S   D++S G +  E+ +  +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAAR 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 95
           ++F    +LG G  G V+K +      +  ++L  I  +    ++N++I   ++ H    
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKL--IHLEIKPAIRNQIIRELQVLHECNS 125
Query: 96  -NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +V   G      E  +  E M   SLD  +    R       K   +     +G+ YL
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 182
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
            +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+PE 
Sbjct: 183 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 236
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +SV+SD++S G+ L+E+  G+
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 39  NNFSINKKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           ++F    +LG G  G V+K      G ++  + I ++    I  Q ++EL+    +  + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +V   G      E  +  E M   SLD  +    R       K   +     +G+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLT 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E      +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 39  NNFSINKKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           ++F    +LG G  G V+K      G ++  + I ++    I  Q ++EL+    +  + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +V   G      E  +  E M   SLD  +    R       K   +     +G+ 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLT 118
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E      +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 38  TNNFSINKKLGQGGFGP----VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 93
           ++ + + + +G G +      V+K T     E AVK + K      +E++   IL    Q
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIE---ILLRYGQ 79
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L      G+   L+ E M    L   I  Q+     + S   H I    + V Y
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTI---GKTVEY 136
Query: 154 LHQDSRLRIIHRDLKASNVL-LDQDMNP---KISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH      ++HRDLK SN+L +D+  NP   +I DFG A+    +   G       T  +
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN--GLLMTPCYTANF 191
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE      +    D++S GILL  +++G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 33  TIVSATNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+  +  +  K    E+ L 
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 90  SKLQHRNLVKLLGCCIQGEE-----KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
             ++H N++ LL              + +   +    L++ +    +C+ L       +I
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLI 131
Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI D GLAR    DE  G     +
Sbjct: 132 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-HTDDEMTG----YV 183
Query: 205 GTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F+    LG+G FG V        +E+ A+K L K   I +  ++    E  + + L  
Sbjct: 19  TDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
              +  L  C Q  ++L  + E++    L   I  Q+  K  +    F+     + G+ +
Sbjct: 79  PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYA-AEISIGLFF 135
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           LH+     II+RDLK  NV+LD + + KI+DFG+ +    D     T+   GT  Y+APE
Sbjct: 136 LHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGTPDYIAPE 190
Query: 214 YASDGQFSVKSDVFSFGILLLEIISGK 240
             +   +    D +++G+LL E+++G+
Sbjct: 191 IIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 38  TNNFSINKKLGQGGFGP----VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 93
           T+ + + + +G G +      ++K T     E AVK + K      +E++   IL    Q
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIIDKSKRDPTEEIE---ILLRYGQ 74
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L      G+   ++ E M    L   I  Q   K     +   ++    + V Y
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEY 131
Query: 154 LHQDSRLRIIHRDLKASNVL-LDQDMNP---KISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH      ++HRDLK SN+L +D+  NP   +I DFG A+    +   G       T  +
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANF 186
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE      +    D++S G+LL  +++G
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 37  ATNNFSINKKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFS 90
           AT+ +    ++G G +G VYK      G  V  + + V                EV L  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 91  KLQ---HRNLVKLLGCCIQGEEK-----LLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
           +L+   H N+V+L+  C            L++E + ++ L +++ D+     L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           ++    RG+ +LH +    I+HRDLK  N+L+      K++DFGLAR +     +     
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALTP 178
Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           V+ T  Y APE      ++   D++S G +  E+   K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 38  TNNFSINKKLGQGGFGP----VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 93
           ++ + + + +G G +      V+K T     E AVK + K      +E++   IL    Q
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIE---ILLRYGQ 79
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L      G+   L+ E M    L   I  Q+     + S   H I    + V Y
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTI---GKTVEY 136
Query: 154 LHQDSRLRIIHRDLKASNVL-LDQDMNP---KISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH      ++HRDLK SN+L +D+  NP   +I DFG A+    +   G       T  +
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN--GLLMTPCYTANF 191
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE      +    D++S GILL  +++G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 39  NNFSINKKLGQGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 92
           ++F    +LG G  G V+K      G ++  + I ++    I  Q ++EL+    +  + 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 88
Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +V   G      E  +  E M   SLD  +    R       K   +     +G+ 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLT 145
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YL +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+P
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 199
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E      +SV+SD++S G+ L+E+  G+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 95
           ++F    +LG G  G V+K +      +  ++L  +  +    ++N++I   ++ H    
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNS 82
Query: 96  -NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +V   G      E  +  E M   SLD  +    R       K   +     +G+ YL
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 139
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
            +  + +I+HRD+K SN+L++     K+ DFG++    G   +      +GT  YM+PE 
Sbjct: 140 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 193
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +SV+SD++S G+ L+E+  G+
Sbjct: 194 LQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 39  NNFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
           N+F   K LG+G FG V     K T   G+  A+K L K   I++  +     E  +   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            +H  L  L     Q  ++L  + E+     L    F   R ++    +           
Sbjct: 62  TRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      +++RD+K  N++LD+D + KI+DFGL +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKXFCGTPEYL 172
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 211

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 39  NNFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
           N+F   K LG+G FG V     K T   G+  A+K L K   I++  +     E  +   
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            +H  L  L     Q  ++L  + E+     L    F   R ++    +           
Sbjct: 67  TRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 122
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      +++RD+K  N++LD+D + KI+DFGL +   G       K   GT  Y+
Sbjct: 123 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKXFCGTPEYL 177
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 39  NNFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
           N+F   K LG+G FG V     K T   G+  A+K L K   I++  +     E  +   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            +H  L  L     Q  ++L  + E+     L    F   R ++    +           
Sbjct: 62  TRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      +++RD+K  N++LD+D + KI+DFGL +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKXFCGTPEYL 172
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 211

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 39  NNFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
           N+F   K LG+G FG V     K T   G+  A+K L K   I++  +     E  +   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            +H  L  L     Q  ++L  + E+     L    F   R ++    +           
Sbjct: 62  TRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      +++RD+K  N++LD+D + KI+DFGL +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKXFCGTPEYL 172
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 211

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 13/217 (5%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHR 95
           +F + + +G+G +  V    L     I   ++ K      ++ +  ++ E  +F +  + 
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 96  NLVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +  L  C Q E +L  + E++    L   +F  +R + L            +  + YL
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H+     II+RDLK  NVLLD + + K++D+G+ +   G      T    GT  Y+APE 
Sbjct: 127 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGTPNYIAPEI 181
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
                +    D ++ G+L+ E+++G+       S +N
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 39  NNFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
           N+F   K LG+G FG V     K T   G+  A+K L K   I++  +     E  +   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            +H  L  L     Q  ++L  + E+     L    F   R ++    +           
Sbjct: 62  TRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      +++RD+K  N++LD+D + KI+DFGL +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 172
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 211

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 33/209 (15%)
Query: 47  LGQGGFGPVYKGTLVDGQ---EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLL 101
           +G G +G V   + VDG+   ++A+K+L +   SE   K    E+ L   ++H N++ LL
Sbjct: 33  VGSGAYGAV--CSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 102 GCCIQGE------EKLLIYEFMTN---KSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
                 E      +  L+  FM     K +      ++R + L        +    +G+ 
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL--------VYQMLKGLR 142
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           Y+H      IIHRDLK  N+ +++D   KI DFGLAR     + +      + T  Y AP
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAP 194
Query: 213 EYASDG-QFSVKSDVFSFGILLLEIISGK 240
           E   +  +++   D++S G ++ E+I+GK
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 39  NNFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
           N+F   K LG+G FG V     K T   G+  A+K L K   I++  +     E  +   
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            +H  L  L     Q  ++L  + E+     L    F   R ++    +           
Sbjct: 65  TRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 120
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      +++RD+K  N++LD+D + KI+DFGL +   G       K   GT  Y+
Sbjct: 121 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 175
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 214

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGTLVDGQE---IAVKRLSKISEQGLKELKNEVILFS 90
           I+  ++ + + K +G G FG      + D Q    +AVK + +  E+    +K E+I   
Sbjct: 14  IMHDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER-GEKIAANVKREIINHR 70
Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L+H N+V+     +      ++ E+ +   L   I +  R    +   RF        G
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISG 127
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYG 208
           V Y H    +++ HRDLK  N LLD    P  KI DFG +++          K  +GT  
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA 181
Query: 209 YMAPEYASDGQFSVK-SDVFSFGILLLEIISG 239
           Y+APE     ++  K +DV+S G+ L  ++ G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 39  NNFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
           N+F   K LG+G FG V     K T   G+  A+K L K   I++  +     E  +   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            +H  L  L     Q  ++L  + E+     L    F   R ++    +           
Sbjct: 62  TRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + YLH      +++RD+K  N++LD+D + KI+DFGL +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 172
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           APE   D  +    D +  G+++ E++ G+    FY+ D+ 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 211

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 13/217 (5%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHR 95
           +F + + +G+G +  V    L     I   ++ K      ++ +  ++ E  +F +  + 
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 96  NLVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +  L  C Q E +L  + E++    L   +F  +R + L            +  + YL
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H+     II+RDLK  NVLLD + + K++D+G+ +   G      T    GT  Y+APE 
Sbjct: 123 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGTPNYIAPEI 177
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
                +    D ++ G+L+ E+++G+       S +N
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELK 83
           L E+       ++F I + LG+G FG VY       + I A+K L  S++ ++G++ +L+
Sbjct: 4   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 63
Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----FDQERCKILDWS 138
            E+ + S L+H N++++       +   L+ EF     L   +     FD++R       
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--- 120
Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
                +   A  + Y H+    ++IHRD+K  N+L+      KI+DFG    +       
Sbjct: 121 -----MEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSL 168
Query: 199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
             + + GT  Y+ PE         K D++  G+L  E + G
Sbjct: 169 RRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 19/240 (7%)
Query: 26  LPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 85
           LPL    TI        + + +G+G FG V++G    G+E+AVK  S   E+     + E
Sbjct: 32  LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAE 86
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           +     L+H N++  +    +          +++      +FD      +       +  
Sbjct: 87  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL 146
Query: 146 GTARGVMYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLA--RAFGGDETEG 198
            TA G+ +LH +      +  I HRDLK+ N+L+ ++    I+D GLA       D  + 
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 199 NTKRVIGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
                +GT  YMAPE   D       +   ++D+++ G++  E I+ + + G  H D  L
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 265

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 19/240 (7%)
Query: 26  LPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 85
           LPL    TI        + + +G+G FG V++G    G+E+AVK  S   E+     + E
Sbjct: 19  LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAE 73
Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           +     L+H N++  +    +          +++      +FD      +       +  
Sbjct: 74  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL 133
Query: 146 GTARGVMYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLA--RAFGGDETEG 198
            TA G+ +LH +      +  I HRDLK+ N+L+ ++    I+D GLA       D  + 
Sbjct: 134 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 193
Query: 199 NTKRVIGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
                +GT  YMAPE   D       +   ++D+++ G++  E I+ + + G  H D  L
Sbjct: 194 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 252

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 13/217 (5%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHR 95
           +F + + +G+G +  V    L     I   ++ K      ++ +  ++ E  +F +  + 
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 96  NLVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +  L  C Q E +L  + E++    L   +F  +R + L            +  + YL
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H+     II+RDLK  NVLLD + + K++D+G+ +   G      T    GT  Y+APE 
Sbjct: 138 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGTPNYIAPEI 192
Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
                +    D ++ G+L+ E+++G+       S +N
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 229

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 41  FSINKKLGQGGFGPVYK-GTLVDGQEIAVK----RLSKISEQGL--KELKNEVILFSKLQ 93
           + I ++LG G F  V K      G E A K    R S+ S +G+  +E++ EV +  ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E ++   L  F+  +E    L   +    I     GV Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDM---NPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH     +I H DLK  N+ LLD+++   + K+ DFGLA      E     K + GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEF 184
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 36  SATNNFSINKKLGQGGFGPVYKGTLVDGQEI--AVKRLSKISEQGLKELKNEV----ILF 89
           +  ++F   K +G+G FG V        +E+  AVK L K +    KE K+ +    +L 
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
             ++H  LV L       ++   + +++    L  +   +ERC  L+   RF+     A 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL-FYHLQRERC-FLEPRARFYA-AEIAS 150
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
            + YLH    L I++RDLK  N+LLD   +  ++DFGL +     E    T    GT  Y
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEY 205
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE      +    D +  G +L E++ G
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 41  FSINKKLGQGGFGPVYK-GTLVDGQEIAVK----RLSKISEQGL--KELKNEVILFSKLQ 93
           + I ++LG G F  V K      G E A K    R S+ S +G+  +E++ EV +  ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E ++   L  F+  +E    L   +    I     GV Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDM---NPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH     +I H DLK  N+ LLD+++   + K+ DFGLA      E     K + GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEF 184
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 41  FSINKKLGQGGFGPVYK-GTLVDGQEIAVK----RLSKISEQGL--KELKNEVILFSKLQ 93
           + I ++LG G F  V K      G E A K    R S+ S +G+  +E++ EV +  ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E ++   L  F+  +E    L   +    I     GV Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDM---NPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH     +I H DLK  N+ LLD+++   + K+ DFGLA      E     K + GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEF 184
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 111/250 (44%), Gaps = 27/250 (10%)
Query: 14  TENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS 72
           TEN   Q++  E  L + A        +     +G+G    V +      G E AVK + 
Sbjct: 69  TENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME 128
Query: 73  ----KISEQGLKELKNEV-----ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLD 123
               ++S + L+E++        IL     H +++ L+          L+++ M    L 
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL- 187
Query: 124 SFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 183
            F +  E+  + +   R  I+      V +LH ++   I+HRDLK  N+LLD +M  ++S
Sbjct: 188 -FDYLTEKVALSEKETR-SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242
Query: 184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEY------ASDGQFSVKSDVFSFGILLLEII 237
           DFG +      E     + + GT GY+APE        +   +  + D+++ G++L  ++
Sbjct: 243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 238 SGKKNRGFYH 247
           +G     F+H
Sbjct: 300 AGSP--PFWH 307

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 30/212 (14%)
Query: 46  KLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLV 98
           K+GQG FG V+K      GQ++A+K++   +E+       L+E+K    +   L+H N+V
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 79
Query: 99  KLLGCCIQGEEKL--------LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L+  C               L+++F  +  L   + +      L   KR  ++     G
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNG 136
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG---GDETEGNTKRVIGTY 207
           + Y+H++   +I+HRD+KA+NVL+ +D   K++DFGLARAF      +      RV+ T 
Sbjct: 137 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 192
Query: 208 GYMAPE-YASDGQFSVKSDVFSFGILLLEIIS 238
            Y  PE    +  +    D++  G ++ E+ +
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 30/210 (14%)
Query: 46  KLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLV 98
           K+GQG FG V+K      GQ++A+K++   +E+       L+E+K    +   L+H N+V
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 80
Query: 99  KLLGCCIQGEEKL--------LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L+  C               L+++F  +  L   + +      L   KR  ++     G
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNG 137
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG---GDETEGNTKRVIGTY 207
           + Y+H++   +I+HRD+KA+NVL+ +D   K++DFGLARAF      +      RV+ T 
Sbjct: 138 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 208 GYMAPE-YASDGQFSVKSDVFSFGILLLEI 236
            Y  PE    +  +    D++  G ++ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGTLVDGQE---IAVKRLSKISEQGLKELKNEVILFS 90
           I+  ++ + + K +G G FG      + D Q    +AVK + +  E+  + +K E+I   
Sbjct: 13  IMHDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHR 69
Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L+H N+V+     +      ++ E+ +   L   I +  R    +   RF        G
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISG 126
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYG 208
           V Y H    +++ HRDLK  N LLD    P  KI DFG +++          K  +GT  
Sbjct: 127 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA 180
Query: 209 YMAPEYASDGQFSVK-SDVFSFGILLLEIISG 239
           Y+APE     ++  K +DV+S G+ L  ++ G
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 30/212 (14%)
Query: 46  KLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLV 98
           K+GQG FG V+K      GQ++A+K++   +E+       L+E+K    +   L+H N+V
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 80
Query: 99  KLLGCCIQGEEKL--------LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L+  C               L+++F  +  L   + +      L   KR  ++     G
Sbjct: 81  NLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNG 137
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG---GDETEGNTKRVIGTY 207
           + Y+H++   +I+HRD+KA+NVL+ +D   K++DFGLARAF      +      RV+ T 
Sbjct: 138 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 208 GYMAPE-YASDGQFSVKSDVFSFGILLLEIIS 238
            Y  PE    +  +    D++  G ++ E+ +
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 41  FSINKKLGQGGFGPVYK-GTLVDGQEIAVK----RLSKISEQGL--KELKNEVILFSKLQ 93
           + I ++LG G F  V K      G E A K    R S+ S +G+  +E++ EV +  ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E ++   L  F+  +E    L   +    I     GV Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDM---NPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH     +I H DLK  N+ LLD+++   + K+ DFGLA      E     K + GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEF 184
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 26/229 (11%)
Query: 45  KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL--- 100
           K LG GG G V+     D  + +A+K++     Q +K    E+ +  +L H N+VK+   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 101 -----------LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
                      +G   +     ++ E+M     +      E+  +L+   R   +    R
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARL-FMYQLLR 131
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDET-EGNTKRVIGTY 207
           G+ Y+H  +   ++HRDLK +N+ ++ +D+  KI DFGLAR      + +G+    + T 
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 208 GYMAPE-YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI 255
            Y +P    S   ++   D+++ G +  E+++GK      H    + LI
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 30/212 (14%)
Query: 46  KLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLV 98
           K+GQG FG V+K      GQ++A+K++   +E+       L+E+K    +   L+H N+V
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 80
Query: 99  KLLGCCIQGEEKL--------LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L+  C               L+++F  +  L   + +      L   KR  ++     G
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNG 137
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG---GDETEGNTKRVIGTY 207
           + Y+H++   +I+HRD+KA+NVL+ +D   K++DFGLARAF      +      RV+ T 
Sbjct: 138 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TL 193
Query: 208 GYMAPE-YASDGQFSVKSDVFSFGILLLEIIS 238
            Y  PE    +  +    D++  G ++ E+ +
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 41  FSINKKLGQGGFGPVYK-GTLVDGQEIAVK----RLSKISEQGL--KELKNEVILFSKLQ 93
           + I ++LG G F  V K      G E A K    R S+ S +G+  +E++ EV +  ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E ++   L  F+  +E    L   +    I     GV Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDM---NPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH     +I H DLK  N+ LLD+++   + K+ DFGLA      E     K + GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEF 184
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 46  KLGQGGFGPVYKG----TLVDGQ--EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           ++G+G F  VYKG    T V+    E+  ++L+K   Q  KE   E      LQH N+V+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQHPNIVR 89
Query: 100 LLGC---CIQGEEKL-LIYEFMTNKSLDSFI--FDQERCKIL-DWSKRFHIICGTARGVM 152
                   ++G++ + L+ E  T+ +L +++  F   + K+L  W ++        +G+ 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQ 143
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +LH  +   IIHRDLK  N+ +       KI D GLA      +     K VIGT  + A
Sbjct: 144 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXA 198
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE   + ++    DV++FG   LE  + +
Sbjct: 199 PEXYEE-KYDESVDVYAFGXCXLEXATSE 226

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 28  LFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRL--SKISEQGLK-ELK 83
           L E+       ++F I + LG+G FG VY       + I A+K L  S++ ++G++ +L+
Sbjct: 3   LAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-----FDQERCKILDWS 138
            E+ + S L+H N++++       +   L+ EF     L   +     FD++R       
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--- 119
Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
                +   A  + Y H+    ++IHRD+K  N+L+      KI+DFG    +       
Sbjct: 120 -----MEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSL 167
Query: 199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
             + + GT  Y+ PE         K D++  G+L  E + G
Sbjct: 168 RRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 107/244 (43%), Gaps = 39/244 (15%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQ--GLKELKNEVILFSKLQHR 95
           + + I   +G G +G V +    ++ + +A+K++ ++ E     K +  E+ + ++L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI---ICGTARGVM 152
           ++VK+L   I  + +     ++  +  DS      R  +  +    HI   +     GV 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVK 170
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG------- 205
           Y+H      I+HRDLK +N L++QD + K+ DFGLAR     E  GN++  I        
Sbjct: 171 YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN-GNSQLPISPREDDMN 226
Query: 206 -------------------TYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGKKNRGF 245
                              T  Y APE       ++   DV+S G +  E+++  K    
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 246 YHSD 249
           YH+D
Sbjct: 287 YHAD 290

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 90/218 (41%), Gaps = 33/218 (15%)
Query: 43  INKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKL 100
           + + L +GGF  VY+   V  G+E A+KRL    E+  + +  EV    KL  H N+V+ 
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 101 LGCCIQGEEK-------LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
                 G+E+        L+   +    L  F+   E    L       I   T R V +
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA---------------RAFGGDETEG 198
           +H+  +  IIHRDLK  N+LL      K+ DFG A               RA   +E   
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 199 NTKRVIGTYGYMAPE---YASDGQFSVKSDVFSFGILL 233
           NT     T  Y  PE     S+     K D+++ G +L
Sbjct: 211 NT-----TPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEI-AVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
           +K+G+G +G V+K    +  EI A+KR  L    E        E+ L  +L+H+N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 102 GCCIQGEEKLLIYEFMT---NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
                 ++  L++EF      K  DS   D      LD       +    +G+ + H  +
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
              ++HRDLK  N+L++++   K+++FGLARAFG       +  V+ T  Y  P+     
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGA 176
Query: 219 Q-FSVKSDVFSFGILLLEIISG 239
           + +S   D++S G +  E+ + 
Sbjct: 177 KLYSTSIDMWSAGCIFAELANA 198

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 41  FSINKKLGQGGFGPVYK-GTLVDGQEIAVK----RLSKISEQGL--KELKNEVILFSKLQ 93
           + I ++LG G F  V K      G E A K    R S+ S +G+  +E++ EV +  ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L        + +LI E ++   L  F+  +E    L   +    I     GV Y
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 154 LHQDSRLRIIHRDLKASNV-LLDQDM---NPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH     +I H DLK  N+ LLD+++   + K+ DFGLA      E     K + GT  +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEF 184
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE  +     +++D++S G++   ++SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 63  GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL 122
           G   + + + ++ E  LKE+    IL     H N+++L           L+++ M    L
Sbjct: 55  GGSFSAEEVQELREATLKEVD---ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL 111
Query: 123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 182
             F +  E+  + +   R  I+      +  LH   +L I+HRDLK  N+LLD DMN K+
Sbjct: 112 --FDYLTEKVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL 165
Query: 183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEY----ASDGQ--FSVKSDVFSFGILLLEI 236
           +DFG +      E     + V GT  Y+APE      +D    +  + D++S G+++  +
Sbjct: 166 TDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222
Query: 237 ISGKKNRGFYHSDNNLNL 254
           ++G  +  F+H    L L
Sbjct: 223 LAG--SPPFWHRKQMLML 238

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 63  GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL 122
           G   + + + ++ E  LKE+    IL     H N+++L           L+++ M    L
Sbjct: 42  GGSFSAEEVQELREATLKEVD---ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL 98
Query: 123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 182
             F +  E+  + +   R  I+      +  LH   +L I+HRDLK  N+LLD DMN K+
Sbjct: 99  --FDYLTEKVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL 152
Query: 183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEY----ASDGQ--FSVKSDVFSFGILLLEI 236
           +DFG +      E     + V GT  Y+APE      +D    +  + D++S G+++  +
Sbjct: 153 TDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 209
Query: 237 ISGKKNRGFYHSDNNLNL 254
           ++G  +  F+H    L L
Sbjct: 210 LAG--SPPFWHRKQMLML 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 63  GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSL 122
           G   + + + ++ E  LKE+    IL     H N+++L           L+++ M    L
Sbjct: 55  GGSFSAEEVQELREATLKEVD---ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL 111
Query: 123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 182
             F +  E+  + +   R  I+      +  LH   +L I+HRDLK  N+LLD DMN K+
Sbjct: 112 --FDYLTEKVTLSEKETR-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL 165
Query: 183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEY----ASDGQ--FSVKSDVFSFGILLLEI 236
           +DFG +      E     + V GT  Y+APE      +D    +  + D++S G+++  +
Sbjct: 166 TDFGFSCQLDPGE---KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222
Query: 237 ISGKKNRGFYHSDNNLNL 254
           ++G  +  F+H    L L
Sbjct: 223 LAG--SPPFWHRKQMLML 238

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 46  KLGQGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHRNLVKLLG 102
           +LG+G +G V K   V  GQ +AVKR+ + ++ Q  K L  ++ I    +     V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 103 CCIQGEEKLLIYEFMTNKSLDSF---IFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
              +  +  +  E M + SLD F   + D+ +    D   +  I     + + +LH  S+
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH--SK 172
Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEYA--- 215
           L +IHRD+K SNVL++     K+ DFG++    G   +   K +  G   YMAPE     
Sbjct: 173 LSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDSVAKTIDAGCKPYMAPERINPE 228
Query: 216 -SDGQFSVKSDVFSFGILLLEI 236
            +   +SVKSD++S GI ++E+
Sbjct: 229 LNQKGYSVKSDIWSLGITMIEL 250

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 46  KLGQGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHRNLVKLLG 102
           +LG+G +G V K   V  GQ +AVKR+ + ++ Q  K L  ++ I    +     V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 103 CCIQGEEKLLIYEFMTNKSLDSF---IFDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
              +  +  +  E M + SLD F   + D+ +    D   +  I     + + +LH  S+
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH--SK 128
Query: 160 LRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA---- 215
           L +IHRD+K SNVL++     K+ DFG++     D  +       G   YMAPE      
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPEL 185
Query: 216 SDGQFSVKSDVFSFGILLLEI 236
           +   +SVKSD++S GI ++E+
Sbjct: 186 NQKGYSVKSDIWSLGITMIEL 206

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 36  SATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 94
           S  + + I ++LG G FG V++      G+    K ++         +KNE+ + ++L H
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI----FDQERCKILDWSKRFHIICGTARG 150
             L+ L        E +LI EF++   L   I    +     +++++ ++         G
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------ACEG 161
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
           + ++H+ S   I+H D+K  N++ +  +  + KI DFGLA     DE     K    T  
Sbjct: 162 LKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAE 215
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           + APE          +D+++ G+L   ++SG
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           + + +G+G FG V++G    G+E+AVK  S   E+     + E+     L+H N++  + 
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIA 64
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD----- 157
              +          +++      +FD      +       +   TA G+ +LH +     
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLA--RAFGGDETEGNTKRVIGTYGYMAPEYA 215
            +  I HRDLK+ N+L+ ++    I+D GLA       D  +      +GT  YMAPE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 216 SDG------QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
            D       +   ++D+++ G++  E I+ + + G  H D  L
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 226

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           + + +G+G FG V++G    G+E+AVK  S   E+     + E+     L+H N++  + 
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIA 67
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD----- 157
              +          +++      +FD      +       +   TA G+ +LH +     
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLA--RAFGGDETEGNTKRVIGTYGYMAPEYA 215
            +  I HRDLK+ N+L+ ++    I+D GLA       D  +      +GT  YMAPE  
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 216 SDG------QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
            D       +   ++D+++ G++  E I+ + + G  H D  L
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 229

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           + + +G+G FG V++G    G+E+AVK  S   E+     + E+     L+H N++  + 
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIA 65
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD----- 157
              +          +++      +FD      +       +   TA G+ +LH +     
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLA--RAFGGDETEGNTKRVIGTYGYMAPEYA 215
            +  I HRDLK+ N+L+ ++    I+D GLA       D  +      +GT  YMAPE  
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 216 SDG------QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
            D       +   ++D+++ G++  E I+ + + G  H D  L
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 227

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           + + +G+G FG V++G    G+E+AVK  S   E+     + E+     L+H N++  + 
Sbjct: 13  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIA 70
Query: 103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD----- 157
              +          +++      +FD      +       +   TA G+ +LH +     
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLA--RAFGGDETEGNTKRVIGTYGYMAPEYA 215
            +  I HRDLK+ N+L+ ++    I+D GLA       D  +      +GT  YMAPE  
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 216 SDG------QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
            D       +   ++D+++ G++  E I+ + + G  H D  L
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 232

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 38  TNNFSINKKLGQGGFGP----VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 93
           T+ + + + +G G +      ++K T     E AVK + K      +E++   IL    Q
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKAT---NXEFAVKIIDKSKRDPTEEIE---ILLRYGQ 74
Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N++ L      G+   ++ E      L   I  Q   K     +   ++    + V Y
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQ---KFFSEREASAVLFTITKTVEY 131
Query: 154 LHQDSRLRIIHRDLKASNVL-LDQDMNP---KISDFGLARAFGGDETEGNTKRVIGTYGY 209
           LH      ++HRDLK SN+L +D+  NP   +I DFG A+    +   G       T  +
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLXTPCYTANF 186
Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +APE      +    D++S G+LL   ++G
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKI-----SEQGLKELKNEVILFSK 91
             ++ + K +G+G FG V        Q++ A+K LSK      S+      + +++ F+ 
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA- 132
Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
             +   V  L C  Q ++ L ++ E+M    L + + + +  +   W+K +     TA  
Sbjct: 133 --NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFY-----TAEV 183
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTKRVIGTYGY 209
           V+ L     + +IHRD+K  N+LLD+  + K++DFG       DET   +    +GT  Y
Sbjct: 184 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVHCDTAVGTPDY 241
Query: 210 MAPEY----ASDGQFSVKSDVFSFGILLLEIISG 239
           ++PE       DG +  + D +S G+ L E++ G
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 101/246 (41%), Gaps = 34/246 (13%)
Query: 31  LATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQG-----------L 79
           +A + +  + +++ + +  G +G V  G   +G  +A+KR+      G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 80  KELKNEVILFSKLQHRNLVKLLGCCIQGEE----KLLIYEFMTNKSLDSFIFDQERCKIL 135
           K +  E+ L +   H N++ L    +  EE    KL +   +    L   I DQ      
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 136 DWSKRF--HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
              + F  HI+ G       LH      ++HRDL   N+LL  + +  I DF LAR    
Sbjct: 134 QHIQYFMYHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE--- 183
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGK---KNRGFYHSD 249
           D  + N    +    Y APE     + F+   D++S G ++ E+ + K   +   FY   
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--- 240
Query: 250 NNLNLI 255
           N LN I
Sbjct: 241 NQLNKI 246

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 101/246 (41%), Gaps = 34/246 (13%)
Query: 31  LATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQG-----------L 79
           +A + +  + +++ + +  G +G V  G   +G  +A+KR+      G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 80  KELKNEVILFSKLQHRNLVKLLGCCIQGEE----KLLIYEFMTNKSLDSFIFDQERCKIL 135
           K +  E+ L +   H N++ L    +  EE    KL +   +    L   I DQ      
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 136 DWSKRF--HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
              + F  HI+ G       LH      ++HRDL   N+LL  + +  I DF LAR    
Sbjct: 134 QHIQYFMYHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE--- 183
Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGK---KNRGFYHSD 249
           D  + N    +    Y APE     + F+   D++S G ++ E+ + K   +   FY   
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--- 240
Query: 250 NNLNLI 255
           N LN I
Sbjct: 241 NQLNKI 246

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 29  FELATIVSATNNFSINKKLGQGGFGPV-YKGTLVDGQEIAVKRLSKISEQGLKELKNEVI 87
           F+   ++    ++   +KLG+GGF  V     L DG   A+KR+    +Q  +E + E  
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 88  LFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFMTNKSLDSFIFDQERCK----ILDWSK 139
           +     H N+++L+  C++      E  L+  F    +L + I   ER K     L   +
Sbjct: 79  MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQ 135
Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN 199
              ++ G  RG+  +H        HRDLK +N+LL  +  P + D G +        EG+
Sbjct: 136 ILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG-SMNQACIHVEGS 191
Query: 200 TKRVI--------GTYGYMAPEYASDGQFSV---KSDVFSFGILLLEIISGK 240
            + +          T  Y APE  S     V   ++DV+S G +L  ++ G+
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGTLVDGQE---IAVKRLSKISEQGLKELKNEVILFS 90
           I+  ++ + + K +G G FG      + D Q    +AVK + +  E+  + +K E+I   
Sbjct: 14  IMHDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHR 70
Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L+H N+V+     +      ++ E+ +   L   I +  R    +   RF        G
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISG 127
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYG 208
           V Y H    +++ HRDLK  N LLD    P  KI  FG +++          K  +GT  
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS---SVLHSQPKSTVGTPA 181
Query: 209 YMAPEYASDGQFSVK-SDVFSFGILLLEIISG 239
           Y+APE     ++  K +DV+S G+ L  ++ G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LKE++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E+     + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+++DQ    K++DFGLA+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKI------SEQGLKELKNEVILFSK 91
           + + I + +G G +G V      + GQ++A+K++         +++ L+ELK    +   
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKH 110
Query: 92  LQHRNLVK----LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGT 147
            +H N++     L      GE K +       +S    I    +   L+  + F  +   
Sbjct: 111 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF--LYQL 168
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--TKRVIG 205
            RG+ Y+H     ++IHRDLK SN+L++++   KI DFG+AR       E        + 
Sbjct: 169 LRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 206 TYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGKK 241
           T  Y APE   S  +++   D++S G +  E+++ ++
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 34  IVSATNNFSINKKLGQGGFGPVYKGTLVDGQE---IAVKRLSKISEQGLKELKNEVILFS 90
           I+  ++ + + K +G G FG      + D Q    +AVK + +  E+  + +K E+I   
Sbjct: 14  IMHDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHR 70
Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L+H N+V+     +      ++ E+ +   L   I +  R    +   RF        G
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISG 127
Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYG 208
           V Y H    +++ HRDLK  N LLD    P  KI  FG +++          K  +GT  
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS---SVLHSQPKDTVGTPA 181
Query: 209 YMAPEYASDGQFSVK-SDVFSFGILLLEIISG 239
           Y+APE     ++  K +DV+S G+ L  ++ G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKI------SEQGLKELKNEVILFSK 91
           + + I + +G G +G V      + GQ++A+K++         +++ L+ELK    +   
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKH 109
Query: 92  LQHRNLVK----LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGT 147
            +H N++     L      GE K +       +S    I    +   L+  + F  +   
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF--LYQL 167
Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--TKRVIG 205
            RG+ Y+H     ++IHRDLK SN+L++++   KI DFG+AR       E        + 
Sbjct: 168 LRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 206 TYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGKK 241
           T  Y APE   S  +++   D++S G +  E+++ ++
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 24/232 (10%)
Query: 39  NNFSI--NKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQ 93
           NNF I  +K+LG+G F  V +  +   GQE A K L K    +    E+ +E+ +    +
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 94  H-RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               ++ L        E +LI E+     + S     E  +++  +    +I     GV 
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVY 145
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGGDETEGNTKRVIGTYG 208
           YLHQ++   I+H DLK  N+LL   + P    KI DFG++R  G        + ++GT  
Sbjct: 146 YLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIGH---ACELREIMGTPE 198
Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIIS------GKKNRGFYHSDNNLNL 254
           Y+APE  +    +  +D+++ GI+   +++      G+ N+  Y + + +N+
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K +G G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E+M    + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    K++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K +G G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E+M    + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    K++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEI--AVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           +++   +G+G +G V K  +  G  I  A K++ K   + +   K E+ +   L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L        +  L+ E  T   L   +  +   ++   S    I+      V Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH--- 123
Query: 159 RLRIIHRDLKASNVLL--DQDMNP-KISDFGLARAFGGDETEGNTKRV-IGTYGYMAPEY 214
           +L + HRDLK  N L   D   +P K+ DFGLA  F      G   R  +GT  Y++P+ 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF----KPGKMMRTKVGTPYYVSPQ- 178
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
             +G +  + D +S G+++  ++ G
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGL--KELKNEVILFSKLQH 94
           + + + +G+G F  V +    + GQ+ AVK +      S  GL  ++LK E  +   L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK-ILDWSKRFHIICGTARGVMY 153
            ++V+LL          +++EFM    L   I  +     +   +   H +      + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNP---KISDFGLARAFGGDETEGNTKRVIGTYGYM 210
            H ++   IIHRD+K  NVLL    N    K+ DFG+A   G        +  +GT  +M
Sbjct: 146 CHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFM 200
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE      +    DV+  G++L  ++SG
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 29  FELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEI--AVKRLSKISEQGLKELKNEV 86
           F+ +T       +++   +G+G +G V K  +  G  I  A K++ K   + +   K E+
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 87  ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICG 146
            +   L H N+++L        +  L+ E  T   L   +  +   ++   S    I+  
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKD 131
Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLL--DQDMNP-KISDFGLARAFGGDETEGNTKRV 203
               V Y H   +L + HRDLK  N L   D   +P K+ DFGLA  F      G   R 
Sbjct: 132 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF----KPGKMMRT 184
Query: 204 -IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            +GT  Y++P+   +G +  + D +S G+++  ++ G
Sbjct: 185 KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 47  LGQGGFGPVYKGTLVDGQEIAVKRLSKIS-------EQGLKELKNEVILFSKLQHRNLVK 99
           LG+G +G V +  ++D + +  + +  +          G   +K E+ L  +L+H+N+++
Sbjct: 13  LGEGSYGKVKE--VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 100 LLGCCIQGEEKLLIYEFM------TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           L+   +  EEK  +Y  M        + LDS    ++R  +      F   C    G+ Y
Sbjct: 71  LVDV-LYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYF---CQLIDGLEY 124
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           LH      I+H+D+K  N+LL      KIS  G+A A      +   +   G+  +  PE
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 214 YAS--DGQFSVKSDVFSFGILLLEIISG 239
            A+  D     K D++S G+ L  I +G
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 98  VKLLGCCI-QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K ++Y  +    +   ++   R     +S+    +            
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 131
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 186
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++     QG K  KN E+ +  KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNI 75
Query: 98  VKLLGCCI-QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    + + ++   R     +S+    +            
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVAR----HYSRAKQTLPVIYVKLYMYQL 131
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 186
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LKE++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E+     + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+++DQ    +++DFGLA+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 115/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E M     D F F  ER  + +   R         
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQ-DLFDFITERGALQEELAR-SFFWQVLE 125
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 126 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 178
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 213
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 214 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGTLVDG-QEIAVKRLSKISEQGL--KELKNEVILFSK 91
           V   +N+ I   +G+G +G VY     +  + +A+K+++++ E  +  K +  E+ + ++
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYE--FMTNKSLDSFIFDQERCKILDWSKRFH-IICGTA 148
           L+   +++L    I   E LL ++  ++  +  DS +    +  I    +    I+    
Sbjct: 84  LKSDYIIRLHDLII--PEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLL 141
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
            G  ++H+     IIHRDLK +N LL+QD + KI DFGLAR    D+
Sbjct: 142 LGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 121
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 122 AVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 174
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 209
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 210 FEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFY----AAQIV 144
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 199
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 48/79 (60%), Gaps = 2/79 (2%)
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           II+RDLK  NV+LD + + KI+DFG+ +    D     TK   GT  Y+APE  +   + 
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDYIAPEIIAYQPYG 520
Query: 222 VKSDVFSFGILLLEIISGK 240
              D ++FG+LL E+++G+
Sbjct: 521 KSVDWWAFGVLLYEMLAGQ 539

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++     QG K  KN E+ +  KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNI 75
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 131
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 186
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++     QG K  KN E+ +  KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNI 75
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 131
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 186
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 220

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 41  FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 100
           + I + LG+G FG V++      ++  + +  K+       +K E+ + +  +HRN++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR-----FHIICGTARGVMYLH 155
                  EE ++I+EF++   LD  IF++      + ++R      H +C     + +LH
Sbjct: 67  HESFESMEELVMIFEFISG--LD--IFERINTSAFELNEREIVSYVHQVC---EALQFLH 119
Query: 156 QDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARAFG-GDETEGNTKRVIGTYGYMAP 212
             +   I H D++  N++    +    KI +FG AR    GD    N + +     Y AP
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAP 172
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISG 239
           E       S  +D++S G L+  ++SG
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E+     + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFXEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+++DQ    K++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFY----AAQIVLTF 155
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 16/211 (7%)
Query: 34  IVSATNNFSINKKLGQGGFG--PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK 91
           I+  ++ +   K +G G FG   + +  L   + +AVK + + +    + ++ E+I    
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLT-KELVAVKYIERGAAID-ENVQREIINHRS 72
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           L+H N+V+     +      +I E+ +   L   I +  R    +    F  +     GV
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS---GV 129
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYGY 209
            Y H    ++I HRDLK  N LLD    P  KI DFG +++          K  +GT  Y
Sbjct: 130 SYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY 183
Query: 210 MAPEYASDGQFSVK-SDVFSFGILLLEIISG 239
           +APE     ++  K +DV+S G+ L  ++ G
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 48/79 (60%), Gaps = 2/79 (2%)
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           II+RDLK  NV+LD + + KI+DFG+ +    D     TK   GT  Y+APE  +   + 
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDYIAPEIIAYQPYG 199
Query: 222 VKSDVFSFGILLLEIISGK 240
              D ++FG+LL E+++G+
Sbjct: 200 KSVDWWAFGVLLYEMLAGQ 218

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K +G G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    K++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIV 144
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 199
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFY----AAQIV 172
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 227
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 140
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 195
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFAEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 36  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFY----AAQIV 146
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 201
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIV 172
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 227
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 49/84 (58%), Gaps = 8/84 (9%)
Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY-----AS 216
           +IHRD+K SN+LLD+    K+ DFG++     D+ +    R  G   YMAPE       +
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPT 202
Query: 217 DGQFSVKSDVFSFGILLLEIISGK 240
              + +++DV+S GI L+E+ +G+
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQ 226

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIV 152
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 207
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIV 152
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 207
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIV 152
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 207
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E+     + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+++DQ    K++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPV----YKGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    +K T   G   A+K L K     LK+++   NE  +   
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E+     + S +  +   +  +   RF+     A+ V
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFY----AAQIV 152
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+++DQ    K++DFG A+       +G T  + GT  Y+A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLA 207
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 155
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 150
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 151 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 205
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 206 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 40  NFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN------EVILFSKL 92
            + +   LG+GGFG V+ G  L D  ++A+K + +    G   L +      EV L  K+
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 93  Q----HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA 148
                H  +++LL      E  +L+ E     + D F +  E+  + +   R    C   
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSR----CFFG 146
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           + V  +       ++HRD+K  N+L+D +    K+ DFG + A   DE   +     GT 
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFD---GTR 202
Query: 208 GYMAPEYASDGQF-SVKSDVFSFGILLLEIISG 239
            Y  PE+ S  Q+ ++ + V+S GILL +++ G
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 131
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 186
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 220

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 143
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 198
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 199 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 232

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +  +   +  +   RF+     A+ V+  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 155
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 210
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 143
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 198
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 199 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 139
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 140 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 194
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 195 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 131
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 186
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 220

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 165
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 220
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 221 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 254

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 79
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 135
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 136 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 190
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 191 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 224

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 132
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 133 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSR 187
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 188 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 221

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 46  KLGQGGFGPVYKGTLVDGQ---EIAVKRLSKISEQGLKELK-NEVILFSKLQHRNLVKLL 101
           +LG+G FG V++  + D Q   + AVK++       L+  +  E++  + L    +V L 
Sbjct: 81  RLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           G   +G    +  E +   SL   + +Q     L   +  + +     G+ YLH  SR R
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQ---GCLPEDRALYYLGQALEGLEYLH--SR-R 186
Query: 162 IIHRDLKASNVLLDQD-MNPKISDFGLA-----RAFGGDETEGNTKRVIGTYGYMAPEYA 215
           I+H D+KA NVLL  D  +  + DFG A        G D   G+   + GT  +MAPE  
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY--IPGTETHMAPEVV 244
Query: 216 SDGQFSVKSDVFSFGILLLEIISG 239
                  K DV+S   ++L +++G
Sbjct: 245 LGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 124
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 125 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 177
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 212
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 213 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 255

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 136
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 137 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 191
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 192 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 225

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 121
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 174
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 209
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 210 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 131
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 186
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 220

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 165
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 220
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 221 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 254

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 144
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 145 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 199
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 200 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 42  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 152
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 207
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 125
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 126 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 178
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 213
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 214 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 159
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 160 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 214
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 215 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 248

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 167
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 168 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 222
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 223 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 256

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 169
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 170 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 224
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 225 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 258

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 172
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLA 227
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 126
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 127 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 179
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 214
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 215 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 126
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 127 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 179
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 214
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 215 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNL 97
           +++  K +G G FG VY+  L D G+ +A+K++ +      K  KN E+ +  KL H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 98  VKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA-------- 148
           V+L       GE+K  +Y  +    +   ++   R     +S+    +            
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR----HYSRAKQTLPVIYVKLYMYQL 210
Query: 149 -RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +   
Sbjct: 211 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 265
Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+D   S+  DV+S G +L E++ G+
Sbjct: 266 Y-YRAPELIFGATDYTSSI--DVWSAGCVLAELLLGQ 299

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 90
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 91  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 148
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 149 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 201
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 236
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 237 FEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 279

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             L KL           ++ E+     + S +  +   +  +   RF+     A+ V+  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFXEPHARFY----AAQIVLTF 155
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+++DQ    K++DFG A+       +G T  + GT  Y+APE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 126
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 127 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 179
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 214
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 215 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 153
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 154 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 206
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 241
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 242 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 140
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 141 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 193
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 228
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 229 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 154
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 155 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 207
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G  +  F H +    +IG           
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE---EIIGG---------- 252
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                   Q  F       C H+   C+   P DRP+   +
Sbjct: 253 --------QVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 140
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 141 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 193
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 228
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 229 FEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 154
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 155 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 207
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G  +  F H +    +IG           
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE---EIIGG---------- 252
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                   Q  F       C H+   C+   P DRP+   +
Sbjct: 253 --------QVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 153
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 154 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 206
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G  +  F H +    +IG           
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE---EIIGG---------- 251
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                   Q  F       C H+   C+   P DRP+   +
Sbjct: 252 --------QVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 168
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 169 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 221
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 256
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 257 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 141
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 142 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 194
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 229
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 230 FEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 272

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 168
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 169 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 221
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 256
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 257 FEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 141
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 142 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 194
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 229
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 230 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK--ISEQGLKE------LKNEVILF 89
           + + ++K LG G  G V         +++A+K +SK   +    +E      ++ E+ + 
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
            KL H  ++K+       E+  ++ E M    L   +   +R K       F+ +     
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---L 131
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVI-G 205
            V YLH++    IIHRDLK  NVLL   ++D   KI+DFG ++  G    E +  R + G
Sbjct: 132 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCG 184
Query: 206 TYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISG 239
           T  Y+APE         ++   D +S G++L   +SG
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 115
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 116 VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 173
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 174 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 226
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 227 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 261
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 262 FEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK--ISEQGLKE------LKNEVILF 89
           + + ++K LG G  G V         +++A+K +SK   +    +E      ++ E+ + 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
            KL H  ++K+       E+  ++ E M    L   +   +R K       F+ +     
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---L 125
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVI-G 205
            V YLH++    IIHRDLK  NVLL   ++D   KI+DFG ++  G    E +  R + G
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCG 178
Query: 206 TYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISG 239
           T  Y+APE         ++   D +S G++L   +SG
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK--ISEQGLKE------LKNEVILF 89
           + + ++K LG G  G V         +++A+K +SK   +    +E      ++ E+ + 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
            KL H  ++K+       E+  ++ E M    L   +   +R K       F+ +     
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---L 125
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVI-G 205
            V YLH++    IIHRDLK  NVLL   ++D   KI+DFG ++  G    E +  R + G
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCG 178
Query: 206 TYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISG 239
           T  Y+APE         ++   D +S G++L   +SG
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK--ISEQGLKE------LKNEVILF 89
           + + ++K LG G  G V         +++A+K +SK   +    +E      ++ E+ + 
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
            KL H  ++K+       E+  ++ E M    L   +   +R K       F+ +     
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---L 124
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVI-G 205
            V YLH++    IIHRDLK  NVLL   ++D   KI+DFG ++  G    E +  R + G
Sbjct: 125 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCG 177
Query: 206 TYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISG 239
           T  Y+APE         ++   D +S G++L   +SG
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 160
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 161 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 213
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 248
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 249 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 141
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 142 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 194
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G                          +P
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------------IP 229
Query: 268 SQLIDPCIQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSV 308
            +  +  I+G     + +   C H+   C+   P DRP+   +
Sbjct: 230 FEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPXDRPTFEEI 272

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 30  ELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF 89
           E + ++    +F     LG G  G +    + D +++AVKR   I  +       EV L 
Sbjct: 15  ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLL 71
Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA 148
            +  +H N+++   C  +  +   I   +   +L  ++  ++   +    +   ++  T 
Sbjct: 72  RESDEHPNVIRYF-CTEKDRQFQYIAIELCAATLQEYVEQKDFAHL--GLEPITLLQQTT 128
Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARAFG-GDETEGNTKR 202
            G+ +LH    L I+HRDLK  N+L+        +   ISDFGL +    G  +      
Sbjct: 129 SGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 203 VIGTYGYMAPEYASDG---QFSVKSDVFSFGILLLEIIS 238
           V GT G++APE  S+      +   D+FS G +   +IS
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 39  NNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSK--ISEQGLKE------LKNEVILF 89
           + + ++K LG G  G V         +++A+K +SK   +    +E      ++ E+ + 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 90  SKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
            KL H  ++K+       E+  ++ E M    L   +   +R K       F+ +     
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---L 125
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVI-G 205
            V YLH++    IIHRDLK  NVLL   ++D   KI+DFG ++  G    E +  R + G
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLCG 178
Query: 206 TYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISG 239
           T  Y+APE         ++   D +S G++L   +SG
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 121
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 174
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G  +  F H +    +IG           
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE---EIIGG---------- 219
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                   Q  F       C H+   C+   P DRP+   +
Sbjct: 220 --------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             L KL           ++ E+     + S +  +   +  +   RF+     A+ V+  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 155
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+++DQ    K++DFG A+       +G T  + GT  Y+APE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 39  NNFSINKKLGQGGFGPVYK-GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            +F    +LG G +G V+K  +  DG+  AVKR    S    +  K+     +++     
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR----SMSPFRGPKDRARKLAEVGSHEK 112
Query: 98  VKLLGCCIQGEEK------LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR-- 149
           V    CC++ E+       L +   +   SL      Q+ C+    S     + G  R  
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCGPSL------QQHCEAWGASLPEAQVWGYLRDT 166
Query: 150 --GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
              + +LH      ++H D+K +N+ L      K+ DFGL    G   T G  +   G  
Sbjct: 167 LLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDP 220
Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEI 236
            YMAPE    G +   +DVFS G+ +LE+
Sbjct: 221 RYMAPELL-QGSYGTAADVFSLGLTILEV 248

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E+     + S +  +   +  +   RF+     A+ V+  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 154
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+++DQ    +++DFG A+       +G T  + GT  Y+APE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCC 104
           LG+G    V     L+  QE AVK + K        +  EV +  + Q HRN+++L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            + +   L++E M   S+ S I  +     L+ S    ++   A  + +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG---IAH 134
Query: 165 RDLKASNVLLDQ--DMNP-KISDFGLARA--FGGDETEGNTKRVI---GTYGYMAPE--- 213
           RDLK  N+L +    ++P KI DFGL       GD +  +T  ++   G+  YMAPE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 214 -YASDGQ-FSVKSDVFSFGILLLEIISG 239
            ++ +   +  + D++S G++L  ++SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+++DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 154
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 155 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 207
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G  +  F H +    +IG           
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE---EIIGG---------- 252
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                   Q  F       C H+   C+   P DRP+   +
Sbjct: 253 --------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 153
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 154 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 206
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G  +  F H +    +IG           
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE---EIIGG---------- 251
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                   Q  F       C H+   C+   P DRP+   +
Sbjct: 252 --------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 153
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 154 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 206
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G  +  F H +    +IG           
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE---EIIGG---------- 251
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                   Q  F       C H+   C+   P DRP+   +
Sbjct: 252 --------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 39  NNFSINKKLGQGGFGPVY-KGTLVDGQEIAVKRLSKISEQGLKELK---NEVILFSKLQH 94
           + F   K LG G FG V     +  G   A+K L K     LK+++   NE  +   +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             L KL           ++ E+     + S +  +   +  +   RF+     A+ V+  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFY----AAQIVLTF 155
Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                L +I+RDLK  N+++DQ    K++DFG A+       +G T  + GT  Y+APE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                ++   D ++ G+L+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  V D   +A+K + K       EL N      EV+L  K
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 92  LQH--RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E       D F F  ER  + +   R         
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR-SFFWQVLE 154
Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG + A   D    +     GT  
Sbjct: 155 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRV 207
Query: 209 YMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++  +S  V+S GILL +++ G  +  F H +    +IG           
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE---EIIGG---------- 252
Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                   Q  F       C H+   C+   P DRP+   +
Sbjct: 253 --------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           YLH    L +I+RDLK  N+L+DQ    K++DFG A+       +G T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 213 EYASDGQFSVKSDVFSFGILLLEIISG 239
           E      ++   D ++ G+L+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 46  KLGQGGFGPVYKGTLVDGQ---EIAVKRLSKISEQGLKELK-NEVILFSKLQHRNLVKLL 101
           +LG+G FG V++  + D Q   + AVK++       L+  +  E++  + L    +V L 
Sbjct: 100 RLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           G   +G    +  E +   SL   + +Q     L   +  + +     G+ YLH  SR R
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQ---GCLPEDRALYYLGQALEGLEYLH--SR-R 205
Query: 162 IIHRDLKASNVLLDQD-MNPKISDFGLARAFGGD---ETEGNTKRVIGTYGYMAPEYASD 217
           I+H D+KA NVLL  D  +  + DFG A     D   ++      + GT  +MAPE    
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 218 GQFSVKSDVFSFGILLLEIISG 239
                K DV+S   ++L +++G
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 28  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 138
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+D+    +++DFG A+       +G T  + GT  Y+A
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 193
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 23/227 (10%)
Query: 26  LPLFELATIVSATNNFSINK-------KLGQGGFGPVYKGTLV-DGQEIAVKRL-SKISE 76
           +P  E      A  NF +         +LG+G +G V K   V  GQ  AVKR+ + ++ 
Sbjct: 14  IPTTENLYFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS 73
Query: 77  QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF---IFDQERCK 133
           Q  K L  ++ +  +             +  E  + I   + + SLD F   + D+ +  
Sbjct: 74  QEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTI 133
Query: 134 ILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG 193
             D   +  I     + + +LH  S+L +IHRD+K SNVL++     K  DFG++     
Sbjct: 134 PEDILGK--IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVD 189
Query: 194 DETEGNTKRVIGTYGYMAPEYA----SDGQFSVKSDVFSFGILLLEI 236
           D  +       G   Y APE      +   +SVKSD++S GI  +E+
Sbjct: 190 DVAKDIDA---GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ ++ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 110/237 (46%), Gaps = 44/237 (18%)
Query: 35  VSATNNFSINKKLGQGGFGPVYKGTLVDGQE-IAVKRLSKISEQGL--KELKNEVILFSK 91
           V   +N+ I   +G+G +G VY     + ++ +A+K+++++ E  +  K +  E+ + ++
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 92  LQHRNLVKLLGCCI-----QGEEKLLIYEFMTN---KSLDSFIF-DQERCKILDWSKRFH 142
           L+   +++L    I     + +E  ++ E   +   K   + IF  +E  K         
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT-------- 133
Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG---- 198
           I+     G  ++H+     IIHRDLK +N LL+QD + K+ DFGLAR    ++       
Sbjct: 134 ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 199 ------------NTKRVIGTY----GYMAPEYASDGQFSVKS-DVFSFGILLLEIIS 238
                       N K+ + ++     Y APE     +   KS D++S G +  E+++
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 38  TNNFSINKKLGQGGFGPVYKGTLVD---GQEIAVKRLSK--------ISEQGLKELKNEV 86
           +  +S    LG G FG V+  T VD    +E+ VK + K        I +  L ++  E+
Sbjct: 23  SQKYSTMSPLGSGAFGFVW--TAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 87  ILFSKLQHRNLVKLLGCCI-QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
            + S+++H N++K+L     QG  +L++ +  +   L +FI   +R   LD     +I  
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFR 137
Query: 146 GTARGVMYLHQDSRLR-IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
                V YL    RL+ IIHRD+K  N+++ +D   K+ DFG A      E         
Sbjct: 138 QLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFC 190
Query: 205 GTYGYMAPEYASDGQF-SVKSDVFSFGILLLEII 237
           GT  Y APE      +   + +++S G+ L  ++
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 82  LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF 141
           ++ E+ +  KL H  ++K+       E+  ++ E M    L   +   +R K       F
Sbjct: 187 VETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEG 198
           + +      V YLH++    IIHRDLK  NVLL   ++D   KI+DFG ++  G    E 
Sbjct: 246 YQM---LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ET 295
Query: 199 NTKRVI-GTYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISG 239
           +  R + GT  Y+APE         ++   D +S G++L   +SG
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 107/255 (41%), Gaps = 40/255 (15%)
Query: 12  EKTENDQIQNIDLELPLFELATIVSATNNFSINKK-LGQGGFGPVYKGTLVDGQEIAVKR 70
           +K    +I NI    P FE      +  N  +++K LG G  G V       G+ +AVKR
Sbjct: 14  KKGRKSRIANI----PNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR 64
Query: 71  -LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--- 126
            L    +  L E+K   +L     H N+++   C    +  L I   + N +L   +   
Sbjct: 65  MLIDFCDIALMEIK---LLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESK 120
Query: 127 -FDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL--------DQD 177
               E  K+        ++   A GV +LH    L+IIHRDLK  N+L+        DQ 
Sbjct: 121 NVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQ 177
Query: 178 MNPK-----ISDFGLARAF--GGDETEGNTKRVIGTYGYMAPEY---ASDGQFSVKSDVF 227
              +     ISDFGL +    G      N     GT G+ APE    ++  + +   D+F
Sbjct: 178 TGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIF 237
Query: 228 SFGILLLEIISGKKN 242
           S G +   I+S  K+
Sbjct: 238 SMGCVFYYILSKGKH 252

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT  Y+A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           P       ++   D ++ G+L+ E+ +G
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 82  LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF 141
           ++ E+ +  KL H  ++K+       E+  ++ E M    L   +   +R K       F
Sbjct: 201 VETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEG 198
           + +      V YLH++    IIHRDLK  NVLL   ++D   KI+DFG ++  G    E 
Sbjct: 260 YQM---LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ET 309
Query: 199 NTKRVI-GTYGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISG 239
           +  R + GT  Y+APE         ++   D +S G++L   +SG
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 107/255 (41%), Gaps = 40/255 (15%)
Query: 12  EKTENDQIQNIDLELPLFELATIVSATNNFSINKK-LGQGGFGPVYKGTLVDGQEIAVKR 70
           +K    +I NI    P FE      +  N  +++K LG G  G V       G+ +AVKR
Sbjct: 14  KKGRKSRIANI----PNFE-----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR 64
Query: 71  -LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI--- 126
            L    +  L E+K   +L     H N+++   C    +  L I   + N +L   +   
Sbjct: 65  MLIDFCDIALMEIK---LLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESK 120
Query: 127 -FDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL--------DQD 177
               E  K+        ++   A GV +LH    L+IIHRDLK  N+L+        DQ 
Sbjct: 121 NVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQ 177
Query: 178 MNPK-----ISDFGLARAF--GGDETEGNTKRVIGTYGYMAPEY---ASDGQFSVKSDVF 227
              +     ISDFGL +    G      N     GT G+ APE    ++  + +   D+F
Sbjct: 178 TGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIF 237
Query: 228 SFGILLLEIISGKKN 242
           S G +   I+S  K+
Sbjct: 238 SMGCVFYYILSKGKH 252

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKI-----SEQGLKELKNEVILFSKLQ 93
           +F I K +G+G FG V    + + + I A+K L+K      +E      + +V++    Q
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +  L    Q E  L L+ ++     L + +   E  K+ +   RF+I      G M
Sbjct: 135 ---WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFED-KLPEDMARFYI------GEM 184
Query: 153 YLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
            L  DS  +L  +HRD+K  NVLLD + + +++DFG       D T   +   +GT  Y+
Sbjct: 185 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVAVGTPDYI 243
Query: 211 APEYASD-----GQFSVKSDVFSFGILLLEIISGK 240
           +PE         G++  + D +S G+ + E++ G+
Sbjct: 244 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 34/225 (15%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKR-LSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 103
           K LG G  G V       G+ +AVKR L    +  L E+K   +L     H N+++   C
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY-C 76
Query: 104 CIQGEEKLLIYEFMTNKSLDSFI----FDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
               +  L I   + N +L   +       E  K+        ++   A GV +LH    
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 160 LRIIHRDLKASNVLLD-------------QDMNPKISDFGLARAF--GGDETEGNTKRVI 204
           L+IIHRDLK  N+L+              +++   ISDFGL +    G      N     
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 205 GTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIISGKKN 242
           GT G+ APE   +        + +   D+FS G +   I+S  K+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKI-----SEQGLKELKNEVILFSKLQ 93
           +F I K +G+G FG V    + + + I A+K L+K      +E      + +V++    Q
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
               +  L    Q E  L L+ ++     L + +   E  K+ +   RF+I      G M
Sbjct: 151 ---WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFED-KLPEDMARFYI------GEM 200
Query: 153 YLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
            L  DS  +L  +HRD+K  NVLLD + + +++DFG       D T   +   +GT  Y+
Sbjct: 201 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVAVGTPDYI 259
Query: 211 APEYASD-----GQFSVKSDVFSFGILLLEIISGK 240
           +PE         G++  + D +S G+ + E++ G+
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 46  KLGQGGFGPVYKGTLVDGQ---EIAVKRLSKISEQGLKELK-NEVILFSKLQHRNLVKLL 101
           +LG+G FG V++  + D Q   + AVK++       L+  +  E++  + L    +V L 
Sbjct: 79  RLGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLY 130
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           G   +G    +  E +   SL   I  Q  C  L   +  + +     G+ YLH     R
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLI-KQMGC--LPEDRALYYLGQALEGLEYLHTR---R 184
Query: 162 IIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTKRVI------GTYGYMAPEY 214
           I+H D+KA NVLL  D     + DFG A      + +G  K ++      GT  +MAPE 
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCL---QPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                   K D++S   ++L +++G
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELK---NEVILFSK 91
           + F   K LG G FG V    LV     G   A+K L K     LK+++   NE  +   
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +    LVKL           ++ E++    + S +  +   +  +   RF+     A+ V
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFY----AAQIV 151
Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           +       L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + GT   +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALA 206
Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISG 239
           PE      ++   D ++ G+L+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 34/225 (15%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKR-LSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 103
           K LG G  G V       G+ +AVKR L    +  L E+K   +L     H N+++   C
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY-C 76
Query: 104 CIQGEEKLLIYEFMTNKSLDSFI----FDQERCKILDWSKRFHIICGTARGVMYLHQDSR 159
               +  L I   + N +L   +       E  K+        ++   A GV +LH    
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 160 LRIIHRDLKASNVLLD-------------QDMNPKISDFGLARAF--GGDETEGNTKRVI 204
           L+IIHRDLK  N+L+              +++   ISDFGL +    G      N     
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS 193
Query: 205 GTYGYMAPEYASDG-------QFSVKSDVFSFGILLLEIISGKKN 242
           GT G+ APE   +        + +   D+FS G +   I+S  K+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 47  LGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCC 104
           LG+G    V     L+  QE AVK + K        +  EV +  + Q HRN+++L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH 164
            + +   L++E M   S+ S I  +     L+ S    ++   A  + +LH      I H
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG---IAH 134
Query: 165 RDLKASNVLLDQ--DMNP-KISDFGLARA--FGGDETEGNTKRVI---GTYGYMAPE--- 213
           RDLK  N+L +    ++P KI DF L       GD +  +T  ++   G+  YMAPE   
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 214 -YASDGQ-FSVKSDVFSFGILLLEIISG 239
            ++ +   +  + D++S G++L  ++SG
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGL--KELKNEVILFSKLQH 94
           + + + +G+G F  V +    + GQ+ AVK +      S  GL  ++LK E  +   L+H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK-ILDWSKRFHIICGTARGVMY 153
            ++V+LL          +++EFM    L   I  +     +   +   H +      + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNP---KISDFGLARAFGGDETEGNTKRVIGTYGYM 210
            H ++   IIHRD+K   VLL    N    K+  FG+A   G        +  +GT  +M
Sbjct: 148 CHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFM 202
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE      +    DV+  G++L  ++SG
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 46  KLGQGGFGPVYKGTLVDGQ---EIAVKRLSKISEQGLKELK-NEVILFSKLQHRNLVKLL 101
           ++G+G FG V++  + D Q   + AVK++       L+  +  E++  + L    +V L 
Sbjct: 81  RVGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLY 132
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           G   +G    +  E +   SL   I  Q  C  L   +  + +     G+ YLH     R
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLI-KQMGC--LPEDRALYYLGQALEGLEYLHTR---R 186
Query: 162 IIHRDLKASNVLLDQD-MNPKISDFGLARAFGGD---ETEGNTKRVIGTYGYMAPEYASD 217
           I+H D+KA NVLL  D     + DFG A     D   ++      + GT  +MAPE    
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 218 GQFSVKSDVFSFGILLLEIISG 239
                K D++S   ++L +++G
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 45  KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN-EVILFSKLQHRNLVKLLGC 103
           K +G G FG V++  LV+  E+A+K++ +      K  KN E+ +   ++H N+V L   
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 104 CIQ-GEEKLLIYEFMTNKSLDSFIFDQER--CKILDWSKRFHI---ICGTARGVMYLHQD 157
               G++K  ++  +  + +   ++   R   K+        I   +    R + Y+H  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS- 159
Query: 158 SRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA- 215
             + I HRD+K  N+LLD      K+ DFG A+     E   N   +   Y Y APE   
Sbjct: 160 --IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSXICSRY-YRAPELIF 214
Query: 216 SDGQFSVKSDVFSFGILLLEIISGK 240
               ++   D++S G ++ E++ G+
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGL--KELKNEVILFSKLQH 94
           + + + +G+G F  V +    + GQ+ AVK +      S  GL  ++LK E  +   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK-ILDWSKRFHIICGTARGVMY 153
            ++V+LL          +++EFM    L   I  +     +   +   H +      + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNP---KISDFGLARAFGGDETEGNTKRVIGTYGYM 210
            H ++   IIHRD+K   VLL    N    K+  FG+A   G        +  +GT  +M
Sbjct: 146 CHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFM 200
Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISG 239
           APE      +    DV+  G++L  ++SG
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 46  KLGQGGFGPVYKGTLVDGQ---EIAVKRLSKISEQGLKELK-NEVILFSKLQHRNLVKLL 101
           ++G+G FG V++  + D Q   + AVK++       L+  +  E++  + L    +V L 
Sbjct: 65  RVGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           G   +G    +  E +   SL   I  Q  C  L   +  + +     G+ YLH     R
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI-KQMGC--LPEDRALYYLGQALEGLEYLHTR---R 170
Query: 162 IIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTKRVI------GTYGYMAPEY 214
           I+H D+KA NVLL  D     + DFG A      + +G  K ++      GT  +MAPE 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCL---QPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 215 ASDGQFSVKSDVFSFGILLLEIISG 239
                   K D++S   ++L +++G
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNG 252
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	358
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-149
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-143
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-128
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-80
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-71
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-68
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-67
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-66
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-66
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-65
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-64
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-51
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-48
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-48
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-48
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-48
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-48
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-48
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-48
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-47
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-47
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-47
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-47
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-47
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-47
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-47
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-46
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-46
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-46
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-46
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-46
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-46
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-46
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-46
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-46
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-46
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-46
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-45
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-45
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-45
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-45
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-45
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-45
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-45
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-45
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-44
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-44
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-44
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-44
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-44
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-44
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-44
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-44
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-44
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-44
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-44
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-43
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-43
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-43
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-42
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-42
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-41
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-41
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-41
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-41
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-41
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-40
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-37
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-37
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-37
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-36
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-36
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-35
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-34
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-34
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-33
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-33
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-32
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-32
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-30
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-27
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-26
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-19
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  422 bits (1088), Expect = e-149
 Identities = 101/314 (32%), Positives = 157/314 (50%), Gaps = 19/314 (6%)

Query: 15  ENDQIQNIDLELPLFELATIVSATNNFS------INKKLGQGGFGPVYKGTLVDGQEIAV 68
           EN  ++  D     F    + + TNNF          K+G+GGFG VYKG + +   +AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59

Query: 69  KRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDS 124
           K+L+ +    +E+  ++   E+ + +K QH NLV+LLG    G++  L+Y +M N SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 125 FIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 184
            +   +    L W  R  I  G A G+ +LH++     IHRD+K++N+LLD+    KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176

Query: 185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRG 244
           FGLARA         T R++GT  YMAPE    G+ + KSD++SFG++LLEII+G     
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 245 FYHSDNNLNLIGHAWKLWNEGMP-SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP 303
            +       L+    ++ +E       ID  +    +   V     +   C+ +    RP
Sbjct: 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292

Query: 304 SMPSVILMLGSETV 317
            +  V  +L   T 
Sbjct: 293 DIKKVQQLLQEMTA 306

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  408 bits (1052), Expect = e-143
 Identities = 118/294 (40%), Positives = 176/294 (59%), Gaps = 5/294 (1%)

Query: 29  FELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVI 87
           F L  +  A++NFS    LG+GGFG VYKG L DG  +AVKRL +   QG + + + EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 88  LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-LDWSKRFHIICG 146
           + S   HRNL++L G C+   E+LL+Y +M N S+ S + ++   +  LDW KR  I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
           +ARG+ YLH     +IIHRD+KA+N+LLD++    + DFGLA+     +T   T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKN--RGFYHSDNNLNLIGHAWKLWNE 264
            G++APEY S G+ S K+DVF +G++LLE+I+G++        +D+++ L+     L  E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL 318
                L+D  +QG++   EV + I + LLC Q  P +RP M  V+ ML  + + 
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  370 bits (952), Expect = e-128
 Identities = 102/286 (35%), Positives = 159/286 (55%), Gaps = 6/286 (2%)

Query: 29  FELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVIL 88
             L  +  ATNNF     +G G FG VYKG L DG ++A+KR +  S QG++E + E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 89  FSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-LDWSKRFHIICGT 147
            S  +H +LV L+G C +  E +LIY++M N +L   ++  +   + + W +R  I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-GGDETEGNTKRVIGT 206
           ARG+ YLH  +   IIHRD+K+ N+LLD++  PKI+DFG+++     D+T  +T  V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM 266
            GY+ PEY   G+ + KSDV+SFG++L E++  +           +NL   A +  N G 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264

Query: 267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
             Q++DP +        + +     + C+    +DRPSM  V+  L
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  291 bits (746), Expect = 2e-97
 Identities = 69/306 (22%), Positives = 126/306 (41%), Gaps = 28/306 (9%)

Query: 29  FELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVIL 88
                +   +    + +   +G FG V+K   +  + +AVK      +Q   + + EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 89  FSKLQHRNLVKLLGCCIQGE----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
              ++H N+++ +G   +G     +  LI  F    SL  F+    +  ++ W++  HI 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 145 CGTARGVMYLHQD-------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE 197
              ARG+ YLH+D        +  I HRD+K+ NVLL  ++   I+DFGLA  F   ++ 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 198 GNTKRVIGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
           G+T   +GT  YMAPE             ++ D+++ G++L E+ S          +  L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 253 NLIGHAWKLWN-EGMPS----QLIDPCIQGSFNLAEVIRCI-HIGLLCVQQHPKDRPSMP 306
                  +  + E M      +   P ++  +     +  +      C     + R S  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 307 SVILML 312
            V   +
Sbjct: 308 CVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  247 bits (631), Expect = 5e-80
 Identities = 67/323 (20%), Positives = 117/323 (36%), Gaps = 42/323 (13%)

Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
             +N  + + +G+G +G VYKG+L D + +AVK  S  + Q     K  +     ++H N
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68

Query: 97  LVKLLGCCIQGE-----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           + + +    +       E LL+ E+  N SL  ++         DW     +     RG+
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124

Query: 152 MYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG------DETEGN 199
            YLH +       +  I HRDL + NVL+  D    ISDFGL+    G       E +  
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 200 TKRVIGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL 252
               +GT  YMAPE                + D+++ G++  EI     +     S    
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244

Query: 253 NLIGHAWKLWNEGMPSQLID--------PCIQGSFNLAEVIRCIHIGLL--CVQQHPKDR 302
            +     ++ N      +          P    ++    +        +  C  Q  + R
Sbjct: 245 QMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303

Query: 303 PSMPSVILMLGS-ETVLPQPKQP 324
            +       +     +  + K  
Sbjct: 304 LTAQXAEERMAELMMIWERNKSV 326

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  223 bits (571), Expect = 3e-71
 Identities = 77/287 (26%), Positives = 136/287 (47%), Gaps = 23/287 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 96
            + +I +K+G G FG V++     G ++AVK L       + + E   EV +  +L+H N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +V  +G   Q     ++ E+++  SL   +      + LD  +R  +    A+G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
                I+HR+LK+ N+L+D+    K+ DFGL+R      T  ++K   GT  +MAPE   
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLR 212

Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
           D   + KSDV+SFG++L E+ + ++    +    NLN       +  +    ++      
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQ---PWG---NLNPAQVVAAVGFKCKRLEIPRNLNP 266

Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS--ETVLPQP 321
               +A +I        C    P  RPS  +++ +L    ++ +P P
Sbjct: 267 Q---VAAIIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  214 bits (547), Expect = 9e-68
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 26/288 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
               + + +G+G FG V K      +++A+K++   SE   K    E+   S++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           KL G C+      L+ E+    SL + +   E       +         ++GV YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 159 RLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
              +IHRDLK  N+LL       KI DFG A      + + +     G+  +MAPE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
             +S K DVFS+GI+L E+I+ +K    +  +         W + N   P  LI    + 
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAFRIMWAVHNGTRPP-LIKNLPKP 232

Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS-ETVLPQPKQP 324
              +  ++        C  + P  RPSM  ++ ++       P   +P
Sbjct: 233 ---IESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  211 bits (539), Expect = 6e-67
 Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 36/282 (12%)

Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQHRNLV 98
           + + +G GGFG VY+     G E+AVK      ++     ++ ++ E  LF+ L+H N++
Sbjct: 11  LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            L G C++     L+ EF     L+  +      K +      +     ARG+ YLH ++
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125

Query: 159 RLRIIHRDLKASNVLLDQDMNP--------KISDFGLARAFGGDETEGNTKRVIGTYGYM 210
            + IIHRDLK+SN+L+ Q +          KI+DFGLAR +             G Y +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWM 181

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           APE      FS  SDV+S+G+LL E+++G+     +     ++ +  A+ +    +   +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV---PFR---GIDGLAVAYGVAMNKLALPI 235

Query: 271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
              C +     A+++        C    P  RPS  +++  L
Sbjct: 236 PSTCPEP---FAKLME------DCWNPDPHSRPSFTNILDQL 268

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  209 bits (534), Expect = 5e-66
 Identities = 76/289 (26%), Positives = 133/289 (46%), Gaps = 38/289 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-------LKELKNEVILFS 90
           N     K++G+GGFG V+KG LV D   +A+K L     +G        +E + EV + S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            L H N+VKL G         ++ EF+    L   + D+     + WS +  ++   A G
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALG 134

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARAFGGDETEGNTKRVIG 205
           + Y+       I+HRDL++ N+ L        +  K++DFGL++     ++  +   ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188

Query: 206 TYGYMAPE--YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN 263
            + +MAPE   A +  ++ K+D +SF ++L  I++G+     +  + +   I     +  
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-DEYSYGKIKFINMIRE 244

Query: 264 EGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
           EG+   + + C      L  VI       LC    PK RP    ++  L
Sbjct: 245 EGLRPTIPEDCPPR---LRNVIE------LCWSGDPKKRPHFSYIVKEL 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  209 bits (535), Expect = 8e-66
 Identities = 79/316 (25%), Positives = 125/316 (39%), Gaps = 37/316 (11%)

Query: 43  INKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
             + LG+G FG   K T    G+ + +K L +  E+  +    EV +   L+H N++K +
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
           G   + +    I E++   +L   I   +      WS+R       A G+ YLH    + 
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MN 128

Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR------------VIGTYGY 209
           IIHRDL + N L+ ++ N  ++DFGLAR    ++T+    R            V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
           MAPE  +   +  K DVFSFGI+L EII         +    ++   +     +   P  
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-DYLPRTMDFGLNVRGFLDRYCPPN 247

Query: 270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS-----ETVLPQPKQP 324
               C    F +          + C    P+ RPS   +   L +        LP   Q 
Sbjct: 248 ----CPPSFFPIT---------VRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL 294

Query: 325 GYLADRNSTRLDSSSS 340
             L            S
Sbjct: 295 EQLDRGFWETYRRGES 310

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  204 bits (520), Expect = 5e-64
 Identities = 56/281 (19%), Positives = 116/281 (41%), Gaps = 32/281 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 96
              +   KL +   G ++KG    G +I VK L     S +  ++   E        H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 97  LVKLLGCCIQGEEKLL--IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           ++ +LG C          I  +M   SL + + +     ++D S+        ARG+ +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFL 127

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE- 213
           H    L I    L + +V++D+DM  +IS   +  +F        +   +    ++APE 
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEA 179

Query: 214 --YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
                +      +D++SF +LL E+++ +     +    +L+ +    K+  EG+   + 
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREV---PFA---DLSNMEIGMKVALEGLRPTIP 233

Query: 272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                    ++++++      +C+ + P  RP    ++ +L
Sbjct: 234 PGISPH---VSKLMK------ICMNEDPAKRPKFDMIVPIL 265

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  204 bits (520), Expect = 8e-64
 Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 30/282 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 96
              ++ +++G G FG VYKG      ++AVK L  +  + Q L+  KNEV +  K +H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           ++  +G      +  ++ ++    SL   +   E     +  K   I   TARG+ YLH 
Sbjct: 82  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHA 138

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE--- 213
                IIHRDLK++N+ L +D   KI DFGLA            +++ G+  +MAPE   
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG-MPSQLID 272
                 +S +SDV++FGI+L E+++G+     Y + NN + I     +      P     
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQI--IEMVGRGSLSPDLSKV 250

Query: 273 P--CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
              C +    +  ++        C+++   +RPS P ++  +
Sbjct: 251 RSNCPKR---MKRLMA------ECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  194 bits (496), Expect = 7e-60
 Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 37/284 (13%)

Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVKL 100
           I + +G+G FG VY G      E+A++ +   + +E  LK  K EV+ + + +H N+V  
Sbjct: 37  IGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
           +G C+      +I      ++L S + D +   +LD +K   I     +G+ YLH     
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---K 149

Query: 161 RIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR---VIGTYGYMAPE---- 213
            I+H+DLK+ NV  D +    I+DFGL    G  +      +     G   ++APE    
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 214 -----YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
                      FS  SDVF+ G +  E+ + +     +            W++     P+
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---FK---TQPAEAIIWQMGTGMKPN 262

Query: 269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                  +    +++++        C     ++RP+   ++ ML
Sbjct: 263 LSQIGMGKE---ISDILL------FCWAFEQEERPTFTKLMDML 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  183 bits (466), Expect = 3e-55
 Identities = 69/318 (21%), Positives = 126/318 (39%), Gaps = 49/318 (15%)

Query: 26  LPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 85
           LPL    TI        + K++G+G +G V+ G    G+++AVK      E      + E
Sbjct: 27  LPLLVQRTIAK---QIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA-SWFRETE 81

Query: 86  VILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMTNKSLDSFIFDQERCKILDWSKRF 141
           +     ++H N++  +   I+G        LI ++  N SL  ++    +   LD     
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSML 137

Query: 142 HIICGTARGVMYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLARAF--GGD 194
            +   +  G+ +LH +         I HRDLK+ N+L+ ++    I+D GLA  F    +
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 195 ETEGNTKRVIGTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIISGKKNRGF--- 245
           E +      +GT  YM PE        +  Q  + +D++SFG++L E+     + G    
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257

Query: 246 ----YHSDNNLNLIGHAWKLW--NEGM-----PSQLIDPCIQGSFNLAEVIRCIHIGLLC 294
               YH     +      +     + +          D C++    + +++        C
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQ---MGKLMT------EC 308

Query: 295 VQQHPKDRPSMPSVILML 312
              +P  R +   V   L
Sbjct: 309 WAHNPASRLTALRVKKTL 326

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  181 bits (460), Expect = 9e-55
 Identities = 62/303 (20%), Positives = 119/303 (39%), Gaps = 50/303 (16%)

Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF--SKLQHRNLVKL 100
           + + +G+G +G V++G+   G+ +AVK     S +  K    E  L+    L+H N++  
Sbjct: 12  LLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGF 67

Query: 101 LGCCIQGEEK----LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +   +          LI  +    SL  ++    +   LD      I+   A G+ +LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 157 DSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLAR--AFGGDETEGNTKRVIGTYGY 209
           +         I HRDLK+ N+L+ ++    I+D GLA   +   ++ +      +GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 210 MAPE------YASDGQFSVKSDVFSFGILLLEIISGKKNRGF-------YHSDNNLNLIG 256
           MAPE               + D+++FG++L E+     + G        ++     +   
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 257 HAWKLW--NEGM-----PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
              +     +            DP +     LA++++       C  Q+P  R +   + 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTS---LAKLMK------ECWYQNPSARLTALRIK 294

Query: 310 LML 312
             L
Sbjct: 295 KTL 297

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (448), Expect = 1e-52
 Identities = 63/337 (18%), Positives = 125/337 (37%), Gaps = 51/337 (15%)

Query: 8   SNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIA 67
           + + +   +         LPL    TI        + + +G+G FG V++G    G+E+A
Sbjct: 14  TTLKDLIYDMTTSGSGSGLPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVA 69

Query: 68  VKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMTNKSL 122
           VK  S   E+   +E   E+     L+H N++  +    +         L+ ++  + SL
Sbjct: 70  VKIFSSREERSWFREA--EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 127

Query: 123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-----SRLRIIHRDLKASNVLLDQD 177
             ++        +       +   TA G+ +LH +      +  I HRDLK+ N+L+ ++
Sbjct: 128 FDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183

Query: 178 MNPKISDFGLARAF--GGDETEGNTKRVIGTYGYMAPE------YASDGQFSVKSDVFSF 229
               I+D GLA       D  +      +GT  YMAPE           +   ++D+++ 
Sbjct: 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243

Query: 230 GILLLEIISGKKNRGF-------YHSDNNLNLIGHAWKLW--NEGM-----PSQLIDPCI 275
           G++  EI       G        Y+     +      +     + +             +
Sbjct: 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL 303

Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
           +    +A+++R       C   +   R +   +   L
Sbjct: 304 RV---MAKIMR------ECWYANGAARLTALRIKKTL 331

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  172 bits (439), Expect = 7e-51
 Identities = 68/306 (22%), Positives = 116/306 (37%), Gaps = 64/306 (20%)

Query: 39  NNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHRN 96
            +  + +++G+G FG V+ G L  D   +AVK     +      +   E  +  +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +V+L+G C Q +   ++ E +      +F+  +     L       ++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEY 214
                 IHRDL A N L+ +    KISDFG++R          G  ++V     + APE 
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
            + G++S +SDV+SFGILL E  S G      Y                   +       
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASP---Y-----------------PNL------- 319

Query: 274 CIQGSFNLAEVIRCIHIG-----------------LLCVQQHPKDRPSMPSVILMLGSET 316
                 +  +    +  G                   C    P  RPS  ++   L  ++
Sbjct: 320 ------SNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL--QS 371

Query: 317 VLPQPK 322
           +  + +
Sbjct: 372 IRKRHR 377

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  165 bits (420), Expect = 1e-48
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 31/223 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE------IAVKRLSKISEQGLKELKNEVILFSKL 92
            +  +  +LG+G FG V+     +         +AVK L + SE   ++ + E  L + L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF------------IFDQERCKILDWSKR 140
           QH+++V+  G C +G   L+++E+M +  L+ F              +      L   + 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             +    A G++YL   + L  +HRDL   N L+ Q +  KI DFG++R    D    + 
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDY 213

Query: 201 KRVIGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            RV G        +M PE     +F+ +SDV+SFG++L EI +
Sbjct: 214 YRV-GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  164 bits (417), Expect = 2e-48
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 34/225 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG------QEIAVKRLSKISEQGLKELKNEVILFSKL 92
            +  + ++LG+G FG V+     +         +AVK L   +    K+ + E  L + L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF-------------IFDQERCKILDWSK 139
           QH ++VK  G C  G+  ++++E+M +  L+ F                ++    L  S+
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---T 196
             HI    A G++YL   +    +HRDL   N L+  ++  KI DFG++R     +    
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191

Query: 197 EGNTK---RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            G+T    R      +M PE     +F+ +SDV+SFG++L EI +
Sbjct: 192 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  162 bits (412), Expect = 6e-48
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 11/202 (5%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + +  K+LG G FG V  G      ++A+K + K       E   E  +   L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C +     +I E+M N  L +++  +E        +   +       + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYAS 216
             + +HRDL A N L++     K+SDFGL+R    DE  +   +K  +    +  PE   
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR---WSPPEVLM 194

Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
             +FS KSD+++FG+L+ EI S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  163 bits (415), Expect = 6e-48
 Identities = 70/302 (23%), Positives = 121/302 (40%), Gaps = 53/302 (17%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 93
            +    ++LG+G FG V            G+ +AVK+L   +E+ L++ + E+ +   LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 94  HRNLVKLLGCCIQGEEK--LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           H N+VK  G C     +   LI E++   SL  ++  Q+  + +D  K         +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTKRVIGTY 207
            YL      R IHRDL   N+L++ +   KI DFGL +    D+     +   +  I   
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI--- 212

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
            + APE  ++ +FSV SDV+SFG++L E+ +  +      ++    +           M 
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----GQMI 268

Query: 268 SQLIDPCIQGSFNLAEVIRCIHIG-----------------LLCVQQHPKDRPSMPSVIL 310
                           +I  +                      C   +   RPS   + L
Sbjct: 269 VF-------------HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315

Query: 311 ML 312
            +
Sbjct: 316 RV 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  162 bits (413), Expect = 6e-48
 Identities = 70/302 (23%), Positives = 121/302 (40%), Gaps = 53/302 (17%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 93
            +    ++LG+G FG V            G+ +AVK+L   +E+ L++ + E+ +   LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 94  HRNLVKLLGCCIQGEEK--LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           H N+VK  G C     +   LI E++   SL  ++  Q+  + +D  K         +G+
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTKRVIGTY 207
            YL      R IHRDL   N+L++ +   KI DFGL +    D+     +   +  I   
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI--- 181

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
            + APE  ++ +FSV SDV+SFG++L E+ +  +      ++    +           M 
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----GQMI 237

Query: 268 SQLIDPCIQGSFNLAEVIRCIHIG-----------------LLCVQQHPKDRPSMPSVIL 310
                           +I  +                      C   +   RPS   + L
Sbjct: 238 VF-------------HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284

Query: 311 ML 312
            +
Sbjct: 285 RV 286

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  161 bits (411), Expect = 7e-48
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 11/202 (5%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           +  +  +++G G FG V+ G  ++  ++A+K + +      ++   E  +  KL H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C++     L+ EFM +  L  ++  + +  +        +      G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYAS 216
              +IHRDL A N L+ ++   K+SDFG+ R    D+  +   TK  +    + +PE  S
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178

Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
             ++S KSDV+SFG+L+ E+ S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  161 bits (411), Expect = 7e-48
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
              ++ K+LG G FG V  G      ++AVK + K       E   E     KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           K  G C +     ++ E+++N  L +++  +   K L+ S+   +      G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYAS 216
             + IHRDL A N L+D+D+  K+SDFG+ R    D+  +   TK  +    + APE   
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK---WSAPEVFH 178

Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
             ++S KSDV++FGIL+ E+ S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  162 bits (413), Expect = 2e-47
 Identities = 74/344 (21%), Positives = 130/344 (37%), Gaps = 68/344 (19%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 93
            +     +LG+G FG V            G  +AVK+L        ++ + E+ +   L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 94  HRNLVKLLGCCIQGEEK--LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
              +VK  G       +   L+ E++ +  L  F+  Q     LD S+         +G+
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE----GNTKRVIGTY 207
            YL      R +HRDL A N+L++ + + KI+DFGLA+    D+         +  I   
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI--- 194

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGM 266
            + APE  SD  FS +SDV+SFG++L E+ +   K+                    +   
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPSA 235

Query: 267 PSQLIDPCIQGSFNLAEVIRCIHIG-----------------LLCVQQHPKDRPSMPSVI 309
               +  C +    L+ ++  +  G                  LC    P+DRPS  ++ 
Sbjct: 236 EFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALG 295

Query: 310 LMLGSETVLPQPKQPGYLADRNSTRLDSSSSRPESSSTNTITIS 353
             L               +        + ++ PE    ++++ S
Sbjct: 296 PQLDM-----------LWSGSRGCETHAFTAHPEGKH-HSLSFS 327

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  161 bits (410), Expect = 2e-47
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 21/209 (10%)

Query: 42  SINKKLGQGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 96
             N+ +G+G FG VY GTL+D        AVK L++I     + +   E I+     H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 97  LVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           ++ LLG C++ E   L +  +M +  L +FI  +                  A+G+ YL 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG------Y 209
             +  + +HRDL A N +LD+    K++DFGLAR    D  +     V    G      +
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKW 198

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           MA E     +F+ KSDV+SFG+LL E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  161 bits (410), Expect = 3e-47
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 27/219 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 91
              +++++LGQG FG VY+G      +      +A+K +++  S +   E  NE  +  +
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF-------IFDQERCKILDWSKRFHII 144
               ++V+LLG   QG+  L+I E MT   L S+       + +         SK   + 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
              A G+ YL   +  + +HRDL A N ++ +D   KI DFG+ R    D  E +  R  
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRK- 196

Query: 205 GTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           G  G      M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  160 bits (408), Expect = 5e-47
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 13/204 (6%)

Query: 43  INKKLGQGGFGPVYKGTLVDGQE----IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNL 97
            ++ +G+G FG VY G  +D  +     A+K LS+I   Q ++    E +L   L H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 98  VKLLGCCIQGEE-KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           + L+G  +  E    ++  +M +  L  FI  +   +              ARG+ YL  
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL-- 140

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPEY 214
            +  + +HRDL A N +LD+    K++DFGLAR     E     +         + A E 
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
               +F+ KSDV+SFG+LL E+++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  160 bits (407), Expect = 5e-47
 Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 11/203 (5%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L K     ++E   E  +  +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R + +      ++    +  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL--- 127

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYA 215
            +   IHRDL A N L+ ++   K++DFGL+R   GD        K  I    + APE  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184

Query: 216 SDGQFSVKSDVFSFGILLLEIIS 238
           +  +FS+KSDV++FG+LL EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  160 bits (406), Expect = 5e-47
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 25/207 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
               + + +G+G FG V  G    G ++AVK +   +    +    E  + ++L+H NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77

Query: 99  KLLGCCIQGEEKLLI-YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           +LLG  ++ +  L I  E+M   SL  ++  + R  +L               + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG------YMA 211
                +HRDL A NVL+ +D   K+SDFGL +    + +                  + A
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTA 182

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIIS 238
           PE   + +FS KSDV+SFGILL EI S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  159 bits (405), Expect = 8e-47
 Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
               + ++LG G FG V+ G      ++AVK L K           E  L  +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L     Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++    
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI---E 126

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYAS 216
               IHRDL+A+N+L+   ++ KI+DFGLAR    +E       K  I    + APE  +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK---WTAPEAIN 183

Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
            G F++KSDV+SFGILL EI++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  163 bits (415), Expect = 1e-46
 Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  + KKLG G FG V+  T     ++AVK + K     ++    E  +   LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           KL     + E   +I EFM   SL  F+   E        K        A G+ ++    
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI---E 301

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMAPEYAS 216
           +   IHRDL+A+N+L+   +  KI+DFGLAR    +E       K  I    + APE  +
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAIN 358

Query: 217 DGQFSVKSDVFSFGILLLEIIS 238
            G F++KSDV+SFGILL+EI++
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  159 bits (404), Expect = 2e-46
 Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 57/304 (18%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-----DGQEIAVKRL-SKISEQGLKELKNEVILFSKL 92
                 + LG+G FG V            G+++AVK L  +     + +LK E+ +   L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 93  QHRNLVKLLGCCIQGEEK--LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            H N+VK  G C +       LI EF+ + SL  ++   +    ++  ++        +G
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTKRVIGT 206
           + YL      + +HRDL A NVL++ +   KI DFGL +A   D+     + +    +  
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV-- 193

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEG 265
             + APE     +F + SDV+SFG+ L E+++    +       + + L        +  
Sbjct: 194 -FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS------SPMALFLKMIGPTHGQ 246

Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIG-----------------LLCVQQHPKDRPSMPSV 308
           M                 ++  +  G                   C +  P +R S  ++
Sbjct: 247 MTVT-------------RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293

Query: 309 ILML 312
           I   
Sbjct: 294 IEGF 297

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  163 bits (414), Expect = 2e-46
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 13/201 (6%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
               + + +G+G FG V  G    G ++AVK +   +    +    E  + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249

Query: 99  KLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           +LLG  ++ +  L ++ E+M   SL  ++  + R  +L               + YL   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 305

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
                +HRDL A NVL+ +D   K+SDFGL +    + +       +    + APE   +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALRE 360

Query: 218 GQFSVKSDVFSFGILLLEIIS 238
            +FS KSDV+SFGILL EI S
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  159 bits (404), Expect = 2e-46
 Identities = 71/304 (23%), Positives = 110/304 (36%), Gaps = 59/304 (19%)

Query: 39  NNFSINKKLGQGGFGPVYKGTL---VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKL 92
                 + LG+G FG V         DG     AVK L +    Q     K E+ +   L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 93  QHRNLVKLLGCCIQGEEK--LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
            H +++K  GCC         L+ E++   SL  ++        +  ++          G
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTKRVIGT 206
           + YLH       IHRDL A NVLLD D   KI DFGLA+A            +    +  
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-- 201

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEG 265
             + APE   + +F   SDV+SFG+ L E+++    ++        L            G
Sbjct: 202 -FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----------IG 249

Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIG-----------------LLCVQQHPKDRPSMPSV 308
           +         QG   +  +   +  G                   C +     RP+  ++
Sbjct: 250 IA--------QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL 301

Query: 309 ILML 312
           I +L
Sbjct: 302 IPIL 305

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  159 bits (404), Expect = 3e-46
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 19/213 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 92
             F   K LG G FG VYKG  +   E     +A+K L +  S +  KE+ +E  + + +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            + ++ +LLG C+      LI + M    L  ++  +E    +      +     A+G+ 
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTKRVIGTYGY 209
           YL      R++HRDL A NVL+    + KI+DFGLA+  G +E        K  I    +
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI---KW 185

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIIS-GKK 241
           MA E      ++ +SDV+S+G+ + E+++ G K
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  159 bits (404), Expect = 3e-46
 Identities = 82/332 (24%), Positives = 139/332 (41%), Gaps = 74/332 (22%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 92
           +  +  K +G G FG VYKG L          +A+K L    +E+   +   E  +  + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+++L G   + +  ++I E+M N +LD F+  +E+       +   ++ G A G+ 
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG---- 208
           YL   + +  +HRDL A N+L++ ++  K+SDFGL+R    D     T       G    
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213

Query: 209 --YMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEG 265
             + APE  S  +F+  SDV+SFGI++ E+++ G++    Y                   
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---Y-----------------WE 253

Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIG-----------------LLCVQQHPKDRPSMPSV 308
           + +              EV++ I+ G                 + C QQ    RP    +
Sbjct: 254 LSNH-------------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 300

Query: 309 ILMLGSETVLPQP-KQPGYLADRNSTRLDSSS 339
           + +L      P   K       R S RL S+S
Sbjct: 301 VSILDKLIRAPDSLKTLADFDPRVSIRLPSTS 332

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  159 bits (403), Expect = 4e-46
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 33/217 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 93
           +   I K +G G  G V  G L     +++  A+K L +  +E+  ++  +E  +  +  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N+++L G   +G   +++ E+M N SLD+F+  +         +   ++ G   G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY---- 209
           L   S L  +HRDL A NVL+D ++  K+SDFGL+R    D                   
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212

Query: 210 --------MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                    APE  +   FS  SDV+SFG+++ E+++
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  159 bits (405), Expect = 6e-46
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 13/205 (6%)

Query: 42  SINKKLGQGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 96
             N+ +G+G FG VY GTL+D        AVK L++I     + +   E I+     H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 97  LVKLLGCCIQGEEKLL-IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           ++ LLG C++ E   L +  +M +  L +FI  +                  A+G+ +L 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY--GYMAPE 213
             +  + +HRDL A N +LD+    K++DFGLAR     E +    +        +MA E
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
                +F+ KSDV+SFG+LL E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  157 bits (399), Expect = 6e-46
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 35/226 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 91
           +     ++LG+  FG VYKG L         Q +A+K L         +E ++E +L ++
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF-------------IFDQERCKILDWS 138
           LQH N+V LLG   + +   +I+ + ++  L  F               D+     L+  
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--- 195
              H++   A G+ YL   S   ++H+DL   NVL+   +N KISD GL R     +   
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 196 TEGNTK---RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             GN+    R      +MAPE    G+FS+ SD++S+G++L E+ S
Sbjct: 186 LLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  158 bits (401), Expect = 8e-46
 Identities = 68/219 (31%), Positives = 99/219 (45%), Gaps = 27/219 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 91
            N ++ + LG G FG VY+G +          ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI----FDQERCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+        +   L      H+    
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL        IHRD+ A N LL         KI DFG+AR    D    +  R  
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK- 201

Query: 205 GTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           G         M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  157 bits (400), Expect = 9e-46
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 29/220 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE----IAVKRLSK--ISEQGLKELKNEVILFSKL 92
           N   + K LG+G FG V +G L         +AVK +     S++ ++E  +E       
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 93  QHRNLVKLLGCCIQGE-----EKLLIYEFMTNKSLDSFI---FDQERCKILDWSKRFHII 144
            H N+++LLG CI+       + ++I  FM    L +++     +   K +        +
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA-FGGDETEGNTK-- 201
              A G+ YL   S    +HRDL A N +L  DM   ++DFGL++  + GD         
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 202 ---RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              +      ++A E  +D  ++ KSDV++FG+ + EI +
Sbjct: 211 MPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  157 bits (400), Expect = 1e-45
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 28/220 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG----QEIAVKRLSK--ISEQGLKELKNEVILFSKL 92
             F++ + LG+G FG V +  L        ++AVK L    I+   ++E   E     + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 93  QHRNLVKLLGCCIQGEEK------LLIYEFMTNKSLDSFIFD---QERCKILDWSKRFHI 143
            H ++ KL+G  ++   K      ++I  FM +  L +F+      E    L        
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
           +   A G+ YL   S    IHRDL A N +L +DM   ++DFGL+R        G+  R 
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQ 195

Query: 204 IGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            G        ++A E  +D  ++V SDV++FG+ + EI++
Sbjct: 196 -GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  161 bits (410), Expect = 1e-45
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 7/201 (3%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L K     ++E   E  +  +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R + +      ++    +  + YL   
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL--- 334

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
            +   IHR+L A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393

Query: 218 GQFSVKSDVFSFGILLLEIIS 238
            +FS+KSDV++FG+LL EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  158 bits (402), Expect = 1e-45
 Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 27/219 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 91
            N ++ + LG G FG VY+G +          ++AVK L ++ SEQ   +   E ++ SK
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI----FDQERCKILDWSKRFHIICGT 147
             H+N+V+ +G  +Q   + ++ E M    L SF+        +   L      H+    
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVI 204
           A G  YL        IHRD+ A N LL         KI DFG+AR    D       R  
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRK- 242

Query: 205 GTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           G         M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  157 bits (400), Expect = 2e-45
 Identities = 78/334 (23%), Positives = 130/334 (38%), Gaps = 87/334 (26%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V            +AVK L    +E+ L +L +E+ + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF-------------IFDQERCKIL 135
             + +H+N++ LLG C Q     +I E+ +  +L  +               ++   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 136 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
            +          ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR    D 
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207

Query: 196 TEGNTKRVIGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
              +  +   T G     +MAPE   D  ++ +SDV+SFG+L+ EI +     G      
Sbjct: 208 NNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LG------ 256

Query: 251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIG-----------------LL 293
                         G P             + E+ + +  G                   
Sbjct: 257 --------------GSPYP--------GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 294

Query: 294 CVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYL 327
           C    P  RP+   ++  L  + +L       YL
Sbjct: 295 CWHAVPSQRPTFKQLVEDL--DRILTLTTNEEYL 326

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  157 bits (398), Expect = 2e-45
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 17/220 (7%)

Query: 27  PLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLK 80
            +  LA I   T      K LG G FG V+KG  +   E     + +K +  K   Q  +
Sbjct: 2   AMKVLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60

Query: 81  ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR 140
            + + ++    L H ++V+LLG C       L+ +++   SL   +  ++    L     
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLL 117

Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
            +     A+G+ YL       ++HR+L A NVLL      +++DFG+A     D+ +   
Sbjct: 118 LNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ--L 172

Query: 201 KRVIGTY--GYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                     +MA E    G+++ +SDV+S+G+ + E+++
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  156 bits (397), Expect = 4e-45
 Identities = 79/345 (22%), Positives = 127/345 (36%), Gaps = 88/345 (25%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE---IAVKRL-SKISEQGLKELKNEVILFSKL-Q 93
           N+      +G+G FG V K  +         A+KR+    S+   ++   E+ +  KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF-------------IFDQERCKILDWSKR 140
           H N++ LLG C       L  E+  + +L  F                      L   + 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
            H     ARG+ YL   S+ + IHRDL A N+L+ ++   KI+DFGL+R  G +     T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199

Query: 201 K-----RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI 255
                 R      +MA E  +   ++  SDV+S+G+LL EI+S     G           
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS----LG----------- 238

Query: 256 GHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIG-----------------LLCVQQH 298
                    G P   +          AE+   +  G                   C ++ 
Sbjct: 239 ---------GTPYCGMTC--------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREK 281

Query: 299 PKDRPSMPSVILMLGSETVLPQPKQ---PGYLADRNSTRLDSSSS 340
           P +RPS   +++ L    +L + K               +D S+ 
Sbjct: 282 PYERPSFAQILVSL--NRMLEERKTYVNTTLYEKFTYAGIDCSAE 324

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  157 bits (398), Expect = 6e-45
 Identities = 66/209 (31%), Positives = 110/209 (52%), Gaps = 17/209 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 93
            N SI+K +G G FG V  G L     +EI  A+K L    +E+  ++   E  +  +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N+++L G   + +  +++ E+M N SLDSF+  ++        +   ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTKRVIGTYGY 209
           L   S +  +HRDL A N+L++ ++  K+SDFGL R    D     T    K  I    +
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI---RW 216

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            +PE  +  +F+  SDV+S+GI+L E++S
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  155 bits (394), Expect = 8e-45
 Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 43/234 (18%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 91
            N  + K LG+G FG V K T            +AVK L +  S   L++L +E  +  +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF-------------IFDQERCKILDWS 138
           + H +++KL G C Q    LLI E+    SL  F                      LD  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 139 KRFHIICGT--------ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR- 189
               +  G         ++G+ YL   + ++++HRDL A N+L+ +    KISDFGL+R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 190 AFGGDETEGNTK-----RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            +  D     ++     +      +MA E   D  ++ +SDV+SFG+LL EI++
Sbjct: 200 VYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  155 bits (394), Expect = 1e-44
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 41/233 (17%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 91
           NN    + +G+G FG V++              +AVK L +  S     + + E  L ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF---------------------IFDQE 130
             + N+VKLLG C  G+   L++E+M    L+ F                          
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 131 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
               L  +++  I    A G+ YL   S  + +HRDL   N L+ ++M  KI+DFGL+R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR- 222

Query: 191 FGGDETEGNTKRVIGTYGY-----MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
              +    +  +            M PE     +++ +SDV+++G++L EI S
Sbjct: 223 ---NIYSADYYKA-DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  153 bits (389), Expect = 1e-44
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 93
               + + +G+G FG V++G  +  +   +  A+K      S+   ++   E +   +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H ++VKL+G   +     +I E  T   L SF+  Q R   LD +         +  + Y
Sbjct: 75  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE--TEGNTKRVIGTYGYMA 211
           L      R +HRD+ A NVL+  +   K+ DFGL+R             K  I    +MA
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIIS 238
           PE  +  +F+  SDV+ FG+ + EI+ 
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  154 bits (391), Expect = 2e-44
 Identities = 66/224 (29%), Positives = 93/224 (41%), Gaps = 28/224 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 91
           N  S  K LG G FG V + T     +      +AVK L         + L +E+ + S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF---------------IFDQERCKIL 135
           L  H N+V LLG C  G   L+I E+     L +F                  ++    L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 136 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD 194
           D           A+G+ +L   +    IHRDL A N+LL      KI DFGLAR      
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                    +    +MAPE   +  ++ +SDV+S+GI L E+ S
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  152 bits (387), Expect = 3e-44
 Identities = 51/217 (23%), Positives = 98/217 (45%), Gaps = 28/217 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFS 90
            +   N+ LGQG F  ++KG   +          E+ +K L K      +       + S
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           KL H++LV   G C+ G+E +L+ EF+   SLD+++  ++    ++   +  +    A  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP--------KISDFGLARAFGGDETEGNTKR 202
           + +L       +IH ++ A N+LL ++ +         K+SD G++        +   +R
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQER 180

Query: 203 VIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIIS 238
           +     ++ PE   +    ++ +D +SFG  L EI S
Sbjct: 181 I----PWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  154 bits (390), Expect = 3e-44
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 92
             F   K LG G FG VYKG  +   E     +A+K L    S +  KE+ +E  + + +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            + ++ +LLG C+      LI + M    L  ++  +E    +      +     A+G+ 
Sbjct: 75  DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE---TEGNTKRVIGTYGY 209
           YL      R++HRDL A NVL+    + KI+DFGLA+  G +E        K  I    +
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI---KW 185

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           MA E      ++ +SDV+S+G+ + E+++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  154 bits (392), Expect = 4e-44
 Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 38/229 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD--------GQEIAVKRL-SKISEQGLKELKNEVILF 89
           +  ++ K LG+G FG V     V            +AVK L    +E+ L +L +E+ + 
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF-------------IFDQERCKIL 135
             + +H+N++ LLG C Q     +I E+ +  +L  +               ++   + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 136 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGGD 194
            +          ARG+ YL   +  + IHRDL A NVL+ ++   KI+DFGLAR     D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 195 ETEGNTK-----RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
             +  T      +      +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 258 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  153 bits (389), Expect = 5e-44
 Identities = 76/225 (33%), Positives = 104/225 (46%), Gaps = 34/225 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 91
           NN    K LG G FG V + T     +      +AVK L S       + L +E+ + S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR---------- 140
           L QH N+V LLG C  G   L+I E+     L +F+  + R    D +            
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 141 -FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET--- 196
             H     A+G+ +L   +    IHRD+ A NVLL      KI DFGLAR    D     
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 197 EGNTK---RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           +GN +   +      +MAPE   D  ++V+SDV+S+GILL EI S
Sbjct: 223 KGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  152 bits (386), Expect = 5e-44
 Identities = 64/270 (23%), Positives = 120/270 (44%), Gaps = 31/270 (11%)

Query: 43  INKKLGQGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVK 99
            + ++G+G F  VYKG       E+A    +  K+++   +  K E  +   LQH N+V+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 100 LLGCCI---QGEEKLLIY-EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
                    +G++ +++  E MT+ +L +++   +R K++             +G+ +LH
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 156 QDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
             +   IIHRDLK  N+ +     + KI D GLA      +     K VIGT  +MAPE 
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM 201

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC 274
             +  +    DV++FG+ +LE+ + +      +  +        ++    G+     D  
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASFDKV 254

Query: 275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
                 + E+I        C++Q+  +R S
Sbjct: 255 A--IPEVKEIIE------GCIRQNKDERYS 276

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  151 bits (384), Expect = 8e-44
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 22/210 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV--DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKLQ 93
            +  +N+ LG+G FG VY+G      G++I  AVK   K  +    ++  +E ++   L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H ++VKL+G   + E   +I E      L  ++  +     L             + + Y
Sbjct: 72  HPHIVKLIGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK-----RVIGTYG 208
           L     +  +HRD+   N+L+      K+ DFGL+R    ++    +      +      
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------ 179

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           +M+PE  +  +F+  SDV+ F + + EI+S
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  151 bits (384), Expect = 9e-44
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 49/288 (17%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            +F   + +G GGFG V+K    +DG+   +KR+   +E    + + EV   +KL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66

Query: 98  VKLLGC---------------CIQGEEKLLIY-EFMTNKSLDSFIFDQERCKILDWSKRF 141
           V   GC                    + L I  EF    +L+ +I ++ R + LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
            +     +GV Y+H     ++I+RDLK SN+ L      KI DFGL  +    + +G   
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179

Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL 261
           R  GT  YM+PE  S   +  + D+++ G++L E++        + +      +      
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDL------ 231

Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
                   +I            +++        + + P+DRP+   ++
Sbjct: 232 -----RDGIISDIF--DKKEKTLLQ------KLLSKKPEDRPNTSEIL 266

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  154 bits (391), Expect = 9e-44
 Identities = 68/230 (29%), Positives = 108/230 (46%), Gaps = 40/230 (17%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 89
           +   + K LG+G FG V     +           ++AVK L    +E+ L +L +E+ + 
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGT- 147
             + +H+N++ LLG C Q     +I E+ +  +L  ++    R   L++S          
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQ 187

Query: 148 -------------ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR-AFGG 193
                        ARG+ YL   +  + IHRDL A NVL+ +D   KI+DFGLAR     
Sbjct: 188 LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

Query: 194 DETEGNTK-----RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           D  +  T      +      +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 245 DYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  156 bits (395), Expect = 9e-44
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 7/200 (3%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L     + E   ++ E+M+  SL  F+  +   K L   +   +    A G+ Y+    
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 297

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E             + APE A  G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356

Query: 219 QFSVKSDVFSFGILLLEIIS 238
           +F++KSDV+SFGILL E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  151 bits (383), Expect = 1e-43
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 17/204 (8%)

Query: 43  INKKLGQGGFGPVYKGTLVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 98
            + +LG G FG V +G     ++   +A+K L +   +   +E+  E  +  +L +  +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L+G C Q E  +L+ E      L  F+    + + +  S    ++   + G+ YL    
Sbjct: 74  RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTKRVIGTYGYMAPEY 214
               +HRDL A NVLL      KISDFGL++A G D+         K  +    + APE 
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 184

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
            +  +FS +SDV+S+G+ + E +S
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS 208

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  152 bits (385), Expect = 1e-43
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 35/227 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 91
           +   + K LG+G FG V +            + +AVK L    +    + L +E+ +   
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 92  L-QHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGT-- 147
           +  H N+V LLG C +    L +I EF    +L +++  +    +        +      
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 148 -----------ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
                      A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D  
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIY 199

Query: 197 EGNTKRVIGTYG-----YMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
           +                +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 200 KDPDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  156 bits (396), Expect = 2e-43
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 7/200 (3%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L K      +    E  +  KL+H  LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L     + E   ++ E+M+  SL  F+  +   K L   +   +    A G+ Y+    
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 380

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
           R+  +HRDL+A+N+L+ +++  K++DFGLAR    +E             + APE A  G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439

Query: 219 QFSVKSDVFSFGILLLEIIS 238
           +F++KSDV+SFGILL E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  152 bits (385), Expect = 3e-43
 Identities = 67/234 (28%), Positives = 99/234 (42%), Gaps = 43/234 (18%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 91
            N    K LG G FG V   T     +      +AVK L  K      + L +E+ + ++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSF-----------IFDQERCKILDWSK 139
           L  H N+V LLG C       LI+E+     L ++             + E  K L+  +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 140 RFHIICGT---------ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR- 189
             +++            A+G+ +L        +HRDL A NVL+      KI DFGLAR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 190 AFGGDETEGNTK-----RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
                            +      +MAPE   +G +++KSDV+S+GILL EI S
Sbjct: 222 IMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  149 bits (378), Expect = 1e-42
 Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 19/214 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTL--VDGQEI--AVKRL---SKISEQGLKELKNEVILFSK 91
            +  + +KLG G FG V +G      G+ +  AVK L        + + +   EV     
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           L HRNL++L G  +      ++ E     SL   +  ++                 A G+
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGM 134

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT---YG 208
            YL      R IHRDL A N+LL      KI DFGL RA   ++     +        + 
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKK 241
           + APE      FS  SD + FG+ L E+ + G++
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  148 bits (377), Expect = 1e-42
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 44  NKKLGQGGFGPVYKGTL-VDGQEI--AVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG   +       AVK L           EL  E  +  +L +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++   ++ + +       ++   + G+ YL    
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE----GNTKRVIGTYGYMAPEY 214
               +HRDL A NVLL      KISDFGL++A   DE       + K  +    + APE 
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPEC 191

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
            +  +FS KSDV+SFG+L+ E  S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (379), Expect = 2e-42
 Identities = 69/334 (20%), Positives = 146/334 (43%), Gaps = 44/334 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 95
             +   +K+G+G FG         DG++  +K   +S++S +  +E + EV + + ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC-----KILDWSKRFHIICGTARG 150
           N+V+      +     ++ ++     L   I  Q+       +ILDW   F  IC     
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW---FVQIC---LA 137

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           + ++H     +I+HRD+K+ N+ L +D   ++ DFG+AR              IGT  Y+
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYL 192

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           +PE   +  ++ KSD+++ G +L E+ + K     + + +  NL+    K+ +   P   
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHA---FEAGSMKNLV---LKIISGSFPP-- 244

Query: 271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV---------ILMLGSETVLPQP 321
           +      S++L  ++          +++P+DRPS+ S+         I    S  ++ + 
Sbjct: 245 VSLHY--SYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEE 296

Query: 322 KQPGYLADRNSTRLDSSSSRPESSSTNTITISEL 355
                 +   S  + +       +S + +   ++
Sbjct: 297 FCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKI 330

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  146 bits (371), Expect = 2e-41
 Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 49/289 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 96
             +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 97  L--VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
              ++L    I  +   ++ E   N  L+S++   ++ K +D  +R          V  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE- 213
           HQ     I+H DLK +N L+  D   K+ DFG+A     D T       +GT  YM PE 
Sbjct: 144 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 214 ----------YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI------GH 257
                       S  + S KSDV+S G +L  +  GK    F    N ++ +       H
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIIDPNH 257

Query: 258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP 306
             +   +     L D           V++C      C+++ PK R S+P
Sbjct: 258 EIEFP-DIPEKDLQD-----------VLKC------CLKRDPKQRISIP 288

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  146 bits (370), Expect = 2e-41
 Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 45/295 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 96
            +F   + LG+GGFG V++    VD    A+KR+     E   +++  EV   +KL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 97  LVKLLGCCI---------QGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKRFHII 144
           +V+     +             K+ +Y   +    ++L  ++  +   +  + S   HI 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV- 203
              A  V +LH      ++HRDLK SN+    D   K+ DFGL  A   DE E       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 204 ---------IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL 254
                    +GT  YM+PE      +S K D+FS G++L E++       F      +  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVRT 236

Query: 255 IGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
           +     + N   P        +       +++        +   P +RP   ++I
Sbjct: 237 LT---DVRNLKFPP---LFTQK-YPCEYVMVQ------DMLSPSPMERPEAINII 278

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  152 bits (385), Expect = 2e-41
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 17/204 (8%)

Query: 43  INKKLGQGGFGPVYKGTL-VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQHRNLV 98
            + +LG G FG V +G   +  ++I  A+K L     +   +E+  E  +  +L +  +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L+G C Q E  +L+ E      L  F+    + + +  S    ++   + G+ YL    
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE----TEGNTKRVIGTYGYMAPEY 214
               +HR+L A NVLL      KISDFGL++A G D+         K  +    + APE 
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510

Query: 215 ASDGQFSVKSDVFSFGILLLEIIS 238
            +  +FS +SDV+S+G+ + E +S
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  144 bits (365), Expect = 5e-41
 Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 38/288 (13%)

Query: 36  SATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKL 92
           S   ++ +   +G G +G   K     DG+ +  K      ++E   + L +EV L  +L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62

Query: 93  QHRNLVKLLGCCIQGEEKLL--IYEFMTNKSLDSFIFDQERCK-------ILDWSKRFHI 143
           +H N+V+     I      L  + E+     L S I    + +       +L        
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV---MTQ 119

Query: 144 ICGTARGVMYLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
           +      +   H+  D    ++HRDLK +NV LD   N K+ DFGLAR    D +   T 
Sbjct: 120 LT---LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT- 175

Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL 261
             +GT  YM+PE  +   ++ KSD++S G LL E+ +      F  + +   L G   K+
Sbjct: 176 -FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFT-AFSQKELAG---KI 228

Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
                    I      S  L E+I         +      RPS+  ++
Sbjct: 229 REGKFRR--IPYRY--SDELNEIIT------RMLNLKDYHRPSVEEIL 266

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  145 bits (367), Expect = 6e-41
 Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 39/279 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQH 94
            NF I KK+G+G F  VY+   L+DG  +A+K++     +  +   +   E+ L  +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 95  RNLVKLLGCCIQGEEKLLIY-EFMTNKSLDSFIFDQERCK-------ILDWSKRFHIICG 146
            N++K     I+ + +L I  E      L   I   ++ K       +  +   F  +C 
Sbjct: 92  PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY---FVQLC- 146

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
               + ++H     R++HRD+K +NV +      K+ D GL R F    T  ++  ++GT
Sbjct: 147 --SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL-NLIGHAWKLWNEG 265
             YM+PE   +  ++ KSD++S G LL E+ + +    FY    NL +L     K   + 
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSLC----KKIEQC 253

Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
               L  P    S  L +++       +C+   P+ RP 
Sbjct: 254 DYPPL--PSDHYSEELRQLVN------MCINPDPEKRPD 284

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  146 bits (371), Expect = 7e-41
 Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 49/289 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 96
             +SI K++G GG   V++      Q  A+K   L +   Q L   +NE+   +KLQ  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 97  L--VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
              ++L       ++ + +     N  L+S++   ++ K +D  +R          V  +
Sbjct: 116 DKIIRLYDY-EITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE- 213
           HQ     I+H DLK +N L+  D   K+ DFG+A     D T       +G   YM PE 
Sbjct: 172 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 214 ----------YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI------GH 257
                       S  + S KSDV+S G +L  +  GK    F    N ++ +       H
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNH 285

Query: 258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP 306
             +   +     L D           V++C      C+++ PK R S+P
Sbjct: 286 EIEFP-DIPEKDLQD-----------VLKC------CLKRDPKQRISIP 316

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  151 bits (382), Expect = 7e-41
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 12/205 (5%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 93
               + + +G+G FG V++G  +  +   +  A+K   +  S+   ++   E +   +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H ++VKL+G   +     +I E  T   L SF+  Q R   LD +         +  + Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           L      R +HRD+ A NVL+  +   K+ DFGL+R          +K  +    +MAPE
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPE 562

Query: 214 YASDGQFSVKSDVFSFGILLLEIIS 238
             +  +F+  SDV+ FG+ + EI+ 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  145 bits (367), Expect = 1e-40
 Identities = 72/289 (24%), Positives = 119/289 (41%), Gaps = 49/289 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRN 96
             +SI K++G GG   V++      Q  A+K ++      Q L   +NE+   +KLQ  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 97  L--VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
              ++L       ++ + +     N  L+S++   ++ K +D  +R          V  +
Sbjct: 69  DKIIRLYDY-EITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE- 213
           HQ     I+H DLK +N L+  D   K+ DFG+A     D T       +GT  YM PE 
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 214 ----------YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI------GH 257
                       S  + S KSDV+S G +L  +  GK    F    N ++ +       H
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIIDPNH 238

Query: 258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP 306
             +   +     L D           V++C      C+++ PK R S+P
Sbjct: 239 EIEFP-DIPEKDLQD-----------VLKC------CLKRDPKQRISIP 269

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  142 bits (361), Expect = 3e-40
 Identities = 72/298 (24%), Positives = 116/298 (38%), Gaps = 56/298 (18%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
            ++F     LGQG FG V K    +D +  A+K++   +E+ L  + +EV+L + L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63

Query: 97  LVKLLGC----------CIQGEEKLLIY---EFMTNKSLDSFIFDQ----ERCKILDWSK 139
           +V+                  ++K  ++   E+  N +L   I  +    +R +      
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-- 121

Query: 140 RFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF-------- 191
            F  I      + Y+H      IIHRDLK  N+ +D+  N KI DFGLA+          
Sbjct: 122 -FRQIL---EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 192 ----GGDETEGNTKRVIGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIISGKKNRGFY 246
                   +  N    IGT  Y+A E     G ++ K D++S GI+  E+I       F 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFS 229

Query: 247 HSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
                +N+     K           D          ++IR      L +   P  RP 
Sbjct: 230 TGMERVNI----LKKLRSVSIEFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPG 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  142 bits (361), Expect = 5e-40
 Identities = 64/318 (20%), Positives = 116/318 (36%), Gaps = 54/318 (16%)

Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSK 91
            ++    ++   +KLG+GGF  V     L DG   A+KR+    +Q  +E + E  +   
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82

Query: 92  LQHRNLVKLLGCCIQ----GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------ 141
             H N+++L+  C++      E  L+  F    +L + I   +                 
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG-----NFLTEDQIL 137

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
            ++ G  RG+  +H        HRDLK +N+LL  +  P + D G               
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 202 RVI-------GTYGYMAPE------YASDGQFSVKSDVFSFGILLLEIISGKK--NRGFY 246
             +        T  Y APE      +    +   ++DV+S G +L  ++ G+   +  F 
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQ 251

Query: 247 HSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP 306
             D+    + +             I    + S  L +++         +   P  RP +P
Sbjct: 252 KGDSVALAVQNQLS----------IPQSPRHSSALWQLLNS------MMTVDPHQRPHIP 295

Query: 307 SVILMLGSETVLPQPKQP 324
            ++  L      P P Q 
Sbjct: 296 LLLSQL-EALQPPAPGQH 312

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  137 bits (347), Expect = 4e-38
 Identities = 63/270 (23%), Positives = 100/270 (37%), Gaps = 34/270 (12%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHR 95
           +F    +LG G +G V+K     DG+  AVKR        +       EV    K+ QH 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 96  NLVKLLGCCIQGEEKLLIY-EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             V+L     +    L +  E     SL      +     L  ++ +  +  T   + +L
Sbjct: 118 CCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H      ++H D+K +N+ L      K+ DFGL    G   T G  +   G   YMAPE 
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE- 226

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC 274
              G +   +DVFS G+ +LE+    +     H       +            + L    
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME---LPHGGEGWQQLRQ--GYLPPEFTAGL---- 277

Query: 275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
              S  L  V+       + ++  PK R +
Sbjct: 278 ---SSELRSVLV------MMLEPDPKLRAT 298

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  135 bits (342), Expect = 1e-37
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 19/205 (9%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 103
             LG+G +G VY G  L +   IA+K + +   +  + L  E+ L   L+H+N+V+ LG 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 104 CIQGEEKLLIY-EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR----GVMYLHQDS 158
                  + I+ E +   SL + +  + +   L  ++    I    +    G+ YLH + 
Sbjct: 88  F-SENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNE--QTIGFYTKQILEGLKYLHDN- 141

Query: 159 RLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE--YA 215
             +I+HRD+K  NVL++      KISDFG ++   G      T    GT  YMAPE    
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197

Query: 216 SDGQFSVKSDVFSFGILLLEIISGK 240
               +   +D++S G  ++E+ +GK
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  135 bits (342), Expect = 2e-37
 Identities = 67/217 (30%), Positives = 112/217 (51%), Gaps = 17/217 (7%)

Query: 30  ELATIVSATN---NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNE 85
           +L            F + +KLG+G +G VYK      GQ +A+K++    E  L+E+  E
Sbjct: 17  KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKE 74

Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           + +  +    ++VK  G   +  +  ++ E+    S+   I  + R K L   +   I+ 
Sbjct: 75  ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQ 132

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--V 203
            T +G+ YLH     R IHRD+KA N+LL+ + + K++DFG+A    G  T+   KR  V
Sbjct: 133 STLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTV 185

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           IGT  +MAPE   +  ++  +D++S GI  +E+  GK
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  134 bits (340), Expect = 3e-37
 Identities = 62/222 (27%), Positives = 119/222 (53%), Gaps = 23/222 (10%)

Query: 28  LFELATIVSATN---NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK 83
           L +L +IVS  +    ++  +K+GQG  G VY    +  GQE+A+++++   +   + + 
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
           NE+++  + ++ N+V  L   + G+E  ++ E++   SL   +        +D      I
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMD---EGQI 118

Query: 144 --IC-GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             +C    + + +LH +   ++IHRD+K+ N+LL  D + K++DFG    F    T   +
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQS 171

Query: 201 KR--VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           KR  ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  134 bits (339), Expect = 8e-37
 Identities = 65/241 (26%), Positives = 116/241 (48%), Gaps = 19/241 (7%)

Query: 8   SNISEKTENDQIQNIDL--ELPLFELATIVSATN---NFSINKKLGQGGFGPVYKGT-LV 61
           S +   TEN   Q+  +  E     L  +V   +         K+G+G  G V       
Sbjct: 9   SGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH 68

Query: 62  DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKS 121
            G+++AVK +    +Q  + L NEV++    QH N+V++    + GEE  ++ EF+   +
Sbjct: 69  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128

Query: 122 LDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK 181
           L   +        L+  +   +     + + YLH      +IHRD+K+ ++LL  D   K
Sbjct: 129 LTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVK 181

Query: 182 ISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           +SDFG    F    ++   KR  ++GT  +MAPE  S   ++ + D++S GI+++E++ G
Sbjct: 182 LSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

Query: 240 K 240
           +
Sbjct: 238 E 238

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  133 bits (336), Expect = 1e-36
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 20/222 (9%)

Query: 30  ELATIVSATN---NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNE 85
           E   +    +    + I  +LG G FG VYK      G   A K +   SE+ L++   E
Sbjct: 7   EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE 66

Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIIC 145
           + + +   H  +VKLLG      +  ++ EF    ++D+ +   E  + L   +   +  
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCR 124

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--V 203
                + +LH     RIIHRDLKA NVL+  + + +++DFG++        +   KR   
Sbjct: 125 QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSF 177

Query: 204 IGTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIISGK 240
           IGT  +MAPE        D  +  K+D++S GI L+E+   +
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  133 bits (337), Expect = 1e-36
 Identities = 49/222 (22%), Positives = 89/222 (40%), Gaps = 24/222 (10%)

Query: 36  SATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 93
           ++ + + ++  LGQG    V++G     G   A+K  + IS     +    E  +  KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 94  HRNLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           H+N+VKL     +           EF    SL + + +      L  S+   ++     G
Sbjct: 66  HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 151 VMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
           + +L +     I+HR++K  N++     D     K++DFG AR    DE       + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178

Query: 207 YGYMAPE--------YASDGQFSVKSDVFSFGILLLEIISGK 240
             Y+ P+             ++    D++S G+      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  132 bits (333), Expect = 8e-36
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 20/209 (9%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 95
            +   + LG+GGF   ++ +  D  +  A K + K  + +   +E +  E+ +   L H+
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 96  NLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHI--ICGTARGVM 152
           ++V   G   +  + + ++ E    +SL      + R  + +   R+++  I     G  
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GCQ 155

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMA 211
           YLH+    R+IHRDLK  N+ L++D+  KI DFGLA      E +G  K+V+ GT  Y+A
Sbjct: 156 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIA 209

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE  S    S + DV+S G ++  ++ GK
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  130 bits (330), Expect = 8e-36
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 95
            +   + LG+GGF   ++ +  D  +  A K + K  + +   +E +  E+ +   L H+
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 96  NLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           ++V   G   +  + + ++ E    +SL      ++     +       I     G  YL
Sbjct: 76  HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL---GCQYL 131

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAPE 213
           H   R R+IHRDLK  N+ L++D+  KI DFGLA      E +G  K+V+ GT  Y+APE
Sbjct: 132 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPE 185

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGK 240
             S    S + DV+S G ++  ++ GK
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (326), Expect = 2e-35
 Identities = 59/208 (28%), Positives = 110/208 (52%), Gaps = 15/208 (7%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 94
            +F +   LG+G F  VY+   +  G E+A+K + K  + + G+ + ++NEV +  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
            ++++L     +    + L+ E   N  ++ ++  + R K    ++  H +     G++Y
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLY 127

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAP 212
           LH      I+HRDL  SN+LL ++MN KI+DFGLA      +        + GT  Y++P
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL---KMPHEKHYTLCGTPNYISP 181

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E A+     ++SDV+S G +   ++ G+
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  129 bits (327), Expect = 3e-35
 Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 15/204 (7%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 98
           F+  +K+G+G FG V+KG      + +A+K +  + +E  +++++ E+ + S+     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           K  G  ++  +  +I E++   S      D      LD ++   I+    +G+ YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYMAPEYAS 216
             + IHRD+KA+NVLL +    K++DFG+A    G  T+   KR   +GT  +MAPE   
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVIK 192

Query: 217 DGQFSVKSDVFSFGILLLEIISGK 240
              +  K+D++S GI  +E+  G+
Sbjct: 193 QSAYDSKADIWSLGITAIELARGE 216

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  132 bits (333), Expect = 4e-35
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 21/211 (9%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 98
           +F     LG G  G +    + D +++AVKR+     +       EV L  +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81

Query: 99  KLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           +   C  +  +   +  E     +L  ++  +++       +   ++  T  G+ +LH  
Sbjct: 82  RYF-CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136

Query: 158 SRLRIIHRDLKASNVLL-----DQDMNPKISDFGLARAFGGDETE-GNTKRVIGTYGYMA 211
             L I+HRDLK  N+L+        +   ISDFGL +              V GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 212 PEY---ASDGQFSVKSDVFSFGILLLEIISG 239
           PE          +   D+FS G +   +IS 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (331), Expect = 4e-35
 Identities = 49/222 (22%), Positives = 89/222 (40%), Gaps = 24/222 (10%)

Query: 36  SATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 93
           ++ + + ++  LGQG    V++G     G   A+K  + IS     +    E  +  KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 94  HRNLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           H+N+VKL     +           EF    SL + + +      L  S+   ++     G
Sbjct: 66  HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 151 VMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
           + +L +     I+HR++K  N++     D     K++DFG AR    DE       + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGT 178

Query: 207 YGYMAPE--------YASDGQFSVKSDVFSFGILLLEIISGK 240
             Y+ P+             ++    D++S G+      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (326), Expect = 9e-35
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 22/204 (10%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 101
            ++G+G FG V++      G + AVK  RL     +       E++  + L    +V L 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116

Query: 102 GCCIQGEEKLLIY-EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRL 160
           G   +G   + I+ E +   SL   I   ++   L   +  + +     G+ YLH     
Sbjct: 117 GAVREGP-WVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR--- 169

Query: 161 RIIHRDLKASNVLLDQDMNP-KISDFGLAR---AFGGDETEGNTKRVIGTYGYMAPEYAS 216
           RI+H D+KA NVLL  D +   + DFG A      G  ++      + GT  +MAPE   
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 217 DGQFSVKSDVFSFGILLLEIISGK 240
                 K D++S   ++L +++G 
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC 253

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (326), Expect = 9e-35
 Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 24/238 (10%)

Query: 12  EKTENDQIQNIDLELPLFELATIVSATNN-FSINKKLGQGGFGPVYKGTLV-DGQEIAVK 69
           E+ E D+ Q   LE  L +   +    ++ F    +LG G  G V+K +    G  +A K
Sbjct: 5   EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64

Query: 70  RLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD 128
            +  +I      ++  E+ +  +     +V   G      E  +  E M   SLD     
Sbjct: 65  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD----- 119

Query: 129 QERCKILDWSKRF------HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 182
               ++L  + R        +     +G+ YL    + +I+HRD+K SN+L++     K+
Sbjct: 120 ----QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKL 173

Query: 183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            DFG++    G   +      +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 174 CDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 1e-34
 Identities = 73/336 (21%), Positives = 119/336 (35%), Gaps = 46/336 (13%)

Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSK 91
           T+        + + L +GGF  VY+   +  G+E A+KRL    E+  + +  EV    K
Sbjct: 22  TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKK 81

Query: 92  LQ-HRNLVKLLGCCIQGEEK-------LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
           L  H N+V+       G+E+        L+   +    L  F+   E    L       I
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR- 202
              T R V ++H+  +  IIHRDLK  N+LL      K+ DFG A           + + 
Sbjct: 142 FYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200

Query: 203 ---------VIGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
                       T  Y  PE     S+     K D+++ G +L  +   +    F   D 
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FE--DG 256

Query: 251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI- 309
               I +        +P                +IR        +Q +P++R S+  V+ 
Sbjct: 257 AKLRIVNG----KYSIPPHD-----TQYTVFHSLIRA------MLQVNPEERLSIAEVVH 301

Query: 310 ---LMLGSETVLPQPKQPGYLADRNSTRLDSSSSRP 342
               +  +  V P+      L         + S  P
Sbjct: 302 QLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (319), Expect = 3e-34
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 95
           ++     +LG+G +G V K   V  GQ +AVKR+ + ++ Q  K L  ++ I    +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTAR 149
             V   G   +  +  +  E M + SLD F       +++D  +         I     +
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
            + +LH  S+L +IHRD+K SNVL++     K+ DFG++     D+   +     G   Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDI--DAGCKPY 175

Query: 210 MAPE----YASDGQFSVKSDVFSFGILLLEIISGK 240
           MAPE      +   +SVKSD++S GI ++E+   +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  126 bits (318), Expect = 5e-34
 Identities = 58/293 (19%), Positives = 105/293 (35%), Gaps = 55/293 (18%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKL-Q 93
           T  F   +K+G G FG V+K    +DG   A+KR           +    EV   + L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 94  HRNLVKLLGCCIQGEEKLLIY-EFMTNKSLDSFIFDQER-CKILDWSKRFHIICGTARGV 151
           H ++V+      + +  +LI  E+    SL   I +  R       ++   ++    RG+
Sbjct: 70  HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNP-------------------KISDFGLARAFG 192
            Y+H      ++H D+K SN+ + +   P                   KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 193 GDETEGNTKRVIGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
             + E       G   ++A E    +     K+D+F+  + ++     +          N
Sbjct: 186 SPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE------PLPRN 233

Query: 252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
               G  W    +G   ++       S    E+++      + +   P+ RPS
Sbjct: 234 ----GDQWHEIRQGRLPRIPQ---VLSQEFTELLK------VMIHPDPERRPS 273

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  131 bits (331), Expect = 6e-34
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
            + + ++LG GGFG V +      G+++A+K+  +      +E    E+ +  KL H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 98  VKLLGCCIQGEEKL-------LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           V        G +KL       L  E+     L  ++   E C  L       ++   +  
Sbjct: 75  VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           + YLH+    RIIHRDLK  N++L    Q +  KI D G A+     E        +GT 
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTL 187

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y+APE     +++V  D +SFG L  E I+G 
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  125 bits (317), Expect = 2e-33
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 22/221 (9%)

Query: 30  ELATIVSATN---NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKEL 82
           ++A +    +    FS  +++G G FG VY    + + + +A+K++S   K S +  +++
Sbjct: 42  DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 101

Query: 83  KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFH 142
             EV    KL+H N ++  GC ++     L+ E+    + D     +   K L   +   
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAA 158

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           +  G  +G+ YLH      +IHRD+KA N+LL +    K+ DFG A          N+  
Sbjct: 159 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS-- 209

Query: 203 VIGTYGYMAPE---YASDGQFSVKSDVFSFGILLLEIISGK 240
            +GT  +MAPE      +GQ+  K DV+S GI  +E+   K
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  123 bits (311), Expect = 8e-33
 Identities = 71/285 (24%), Positives = 116/285 (40%), Gaps = 46/285 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 95
            +     ++G+G +G V K      GQ +AVKR+ S + E+  K+L  ++ ++       
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTAR 149
            +V+  G   +  +  +  E M + S D F     +                 I   T +
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYG 208
            + +L     L+IIHRD+K SN+LLD+  N K+ DFG++    G   +   K    G   
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRP 190

Query: 209 YMAPE----YASDGQFSVKSDVFSFGILLLEIISGKKNRGF-YHSDNN----LNLIGHAW 259
           YMAPE     AS   + V+SDV+S GI L E+ +G+    F Y   N+    L  +    
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR----FPYPKWNSVFDQLTQVV--- 243

Query: 260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
                  P        + S +    +        C+ +    RP 
Sbjct: 244 ---KGDPPQLSNSEEREFSPSFINFVNL------CLTKDESKRPK 279

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  122 bits (308), Expect = 1e-32
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 18/208 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 94
            +F I + LG+G FG VY          +A+K L K  + + G++  L+ EV + S L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
            N+++L G       ++ LI E+    ++   +   ++    D  +    I   A  + Y
Sbjct: 69  PNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSY 124

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYMAP 212
            H     R+IHRD+K  N+LL      KI+DFG +          + +  + GT  Y+ P
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRTDLCGTLDYLPP 176

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGK 240
           E         K D++S G+L  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  123 bits (310), Expect = 1e-32
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 24/215 (11%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 98
           F + + +G G +G VYKG  +  GQ  A+K +  ++    +E+K E+ +  K   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIA 84

Query: 99  KLLGCCIQG-----EEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
              G  I+      +++L L+ EF    S+   +    +   L      +I     RG+ 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIGTYGYM 210
           +LHQ    ++IHRD+K  NVLL ++   K+ DFG++            +R   IGT  +M
Sbjct: 144 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTPYWM 196

Query: 211 APE-----YASDGQFSVKSDVFSFGILLLEIISGK 240
           APE        D  +  KSD++S GI  +E+  G 
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  123 bits (309), Expect = 3e-32
 Identities = 42/291 (14%), Positives = 88/291 (30%), Gaps = 27/291 (9%)

Query: 4   QLILSNISEKTEN-DQIQNIDLELPLFELATIVSATNN-FSINKKLGQGGFGPVYKGTLV 61
             +LS +S+   +         +LP  +  T     +    ++  LG+G F  VY+ T  
Sbjct: 28  FKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQG 87

Query: 62  D------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 115
           D       Q+  +K     +          +           +K     +     +L+ E
Sbjct: 88  DLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147

Query: 116 FMTNKSLDSFI--FDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 173
             +  +L + I  +     K++               +  +H      IIH D+K  N +
Sbjct: 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFI 204

Query: 174 L-----------DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSV 222
           L           D      + D G +                 T G+   E  S+  ++ 
Sbjct: 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY 264

Query: 223 KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK-LWNEGMPSQLID 272
           + D F     +  ++ G        ++         ++ L +  M ++   
Sbjct: 265 QIDYFGVAATVYCMLFGTYM--KVKNEGGECKPEGLFRRLPHLDMWNEFFH 313

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  120 bits (304), Expect = 6e-32
 Identities = 75/304 (24%), Positives = 135/304 (44%), Gaps = 38/304 (12%)

Query: 43  INKKLGQGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLV 98
           I  KLG GG   VY     +   ++A+K +    +  E+ LK  + EV   S+L H+N+V
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 99  KLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
            ++      EE    Y   E++   +L  +I        L      +       G+ + H
Sbjct: 75  SMID---VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH 128

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
               +RI+HRD+K  N+L+D +   KI DFG+A+A   + +   T  V+GT  Y +PE A
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQA 184

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS--QLIDP 273
                   +D++S GI+L E++ G+     ++ +  +++   A K   + +P+    +  
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP---FNGETAVSI---AIKHIQDSVPNVTTDVRK 238

Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS-ETVL--PQPKQPGYLADR 330
            I    +L+ VI      L   ++   +R    ++  M     +VL   +  +  Y  D+
Sbjct: 239 DI--PQSLSNVI------LRATEKDKANRY--KTIQEMKDDLSSVLHENRANEDVYELDK 288

Query: 331 NSTR 334
             T 
Sbjct: 289 MKTI 292

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  122 bits (306), Expect = 8e-32
 Identities = 35/317 (11%), Positives = 72/317 (22%), Gaps = 51/317 (16%)

Query: 27  PLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKEL 82
                + +        + + L  G    V+    V+  ++ A+K  +     S   L+ L
Sbjct: 50  ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109

Query: 83  KNEVILFSKLQHRNLVKLLGCC----------IQGEEK----------------LLIYEF 116
                  ++L   +  +               +Q +                  LL+   
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169

Query: 117 MT---NKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 173
            +        +  F               +     R    L       ++H      N+ 
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLF 226

Query: 174 LDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY--ASDGQFSVKSDVFSFGI 231
           +  D    + D       G                Y   E+  AS   F+   + +  G+
Sbjct: 227 IMPDGRLMLGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 232 LLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIG 291
            +  +        F      +        L   G  S     C      +  +I      
Sbjct: 282 SIYRVWCLF--LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG----R 335

Query: 292 LLCVQQHPKDRPSMPSV 308
            L      + R      
Sbjct: 336 FLNF--DRRRRLLPLEA 350

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  122 bits (306), Expect = 2e-31
 Identities = 50/355 (14%), Positives = 95/355 (26%), Gaps = 80/355 (22%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH------ 94
             LGQ       + T    G+   V             +K++K EV+    L+       
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 95  ----------RNLVKLLGCCIQGEEK-----------LLIYEFM--TNKSLDSFIFDQER 131
                      +LVK          +             +Y  M    ++    +     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 132 -CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
             K L    R  +     R +  LH      ++H  L+  +++LDQ     ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 191 FGGDETEGNTKRVIGTYGYMAPEYAS----------DGQFSVKSDVFSFGILLLEIISGK 240
                 +G +       G+  PE  +              +   D ++ G+ +  I    
Sbjct: 261 ------DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

Query: 241 KNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPK 300
                                   G    +   C      +  ++     G L  +   +
Sbjct: 315 --LPNTDDA-------------ALGGSEWIFRSCKNIPQPVRALLE----GFL--RYPKE 353

Query: 301 DRPSMPSVILMLGSETVLPQ--PKQPGYLADRNSTRLD----SSSSRPESSSTNT 349
           DR      +     E +  +     P Y  D   TR      S +S+P+ +    
Sbjct: 354 DRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAE 408

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  121 bits (306), Expect = 2e-31
 Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 36/229 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNL 97
           N     K LG G  G V       G+ +AVKR+             E+ +L     H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71

Query: 98  VKLLGCCIQGEEKL-LIYEFMTNKSLDSFI----FDQERCKILDWSKRFHIICGTARGVM 152
           ++   C    +  L +  E   N +L   +       E  K+        ++   A GV 
Sbjct: 72  IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 153 YLHQDSRLRIIHRDLKASNVLLD-------------QDMNPKISDFGLARAFGGDET--E 197
           +LH    L+IIHRDLK  N+L+              +++   ISDFGL +     ++   
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 198 GNTKRVIGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISG 239
            N     GT G+ APE         +  + +   D+FS G +   I+S 
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  118 bits (299), Expect = 3e-31
 Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 14/213 (6%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 96
           +++ + + +G G    V         +++A+KR++ +  +  + EL  E+   S+  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICGTARGV 151
           +V      +  +E  L+ + ++  S+           + +  +LD S    I+     G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-ARAFGGDETEGNTKR--VIGTYG 208
            YLH++     IHRD+KA N+LL +D + +I+DFG+ A    G +   N  R   +GT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 209 YMAPE-YASDGQFSVKSDVFSFGILLLEIISGK 240
           +MAPE       +  K+D++SFGI  +E+ +G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (301), Expect = 3e-31
 Identities = 54/230 (23%), Positives = 99/230 (43%), Gaps = 39/230 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV--DGQEIAVKRLSK-----------------ISEQGL 79
           N++ I + L QG F  +    L   D +  A+K+  K                   +   
Sbjct: 31  NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 80  KELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWS 138
            + KNE+ + + +++   +   G  I   +++ +IYE+M N S+  F          +++
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLD-KNYT 145

Query: 139 KRF------HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 192
                     II        Y+H  +   I HRD+K SN+L+D++   K+SDFG +    
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM- 202

Query: 193 GDETEGNTKRVIGTYGYMAPE-YASDGQFS-VKSDVFSFGILLLEIISGK 240
               +   K   GTY +M PE ++++  ++  K D++S GI L  +    
Sbjct: 203 ---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  119 bits (299), Expect = 4e-31
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 18/211 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 95
           N+     ++G G  G V+K      G  IAVK++    +++  K +  ++ ++       
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
            +V+  G  I   +  +  E M     +     +     +       +     + + YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLK 141

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV-IGTYGYMAPE- 213
              +  +IHRD+K SN+LLD+    K+ DFG++    G   +   K    G   YMAPE 
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGIS----GRLVDDKAKDRSAGCAAYMAPER 195

Query: 214 ----YASDGQFSVKSDVFSFGILLLEIISGK 240
                 +   + +++DV+S GI L+E+ +G+
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  119 bits (299), Expect = 1e-30
 Identities = 44/218 (20%), Positives = 80/218 (36%), Gaps = 22/218 (10%)

Query: 38  TNNFSINKKLGQG--GFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKL 92
              + +   +G+G      V        G+ + V+R  L   S + +  L+ E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI--IC-GTAR 149
            H N+V      I   E  ++  FM   S    I        +D      I  I  G  +
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLK 139

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-----KRVI 204
            + Y+H       +HR +KAS++L+  D    +S      +               K  +
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 205 GTYGYMAPE--YASDGQFSVKSDVFSFGILLLEIISGK 240
               +++PE    +   +  KSD++S GI   E+ +G 
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  117 bits (294), Expect = 2e-30
 Identities = 63/332 (18%), Positives = 109/332 (32%), Gaps = 84/332 (25%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 96
            +F   + +G+GGFG V++    VD    A+KR+     E   +++  EV   +KL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 97  LVKLLGCCIQGE----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +V+     ++      ++ +   ++ ++S D  +             R      T   V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 153 YLHQDSR----------------------------------LRI---------------- 162
            L   S                                   L I                
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK----------RVIGTYGYMAP 212
           +HRDLK SN+    D   K+ DFGL  A   DE E                +GT  YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 272
           E      +S K D+FS G++L E++          +           ++  +    +   
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFS------TQMERV------RIITDVRNLKFPL 293

Query: 273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS 304
              Q       +++        +   P +RP 
Sbjct: 294 LFTQKYPQEHMMVQ------DMLSPSPTERPE 319

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  119 bits (300), Expect = 7e-30
 Identities = 38/209 (18%), Positives = 81/209 (38%), Gaps = 30/209 (14%)

Query: 43  INKKLGQGGFGPVYKG--TLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 99
           +   +  GG G +Y      V+G+ + +K L    +   +     E    +++ H ++V+
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 100 LLGCCIQGEE-----KLLIY---EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +       E        + Y   E++  +SL       ++   L  ++    +      +
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQK---LPVAEAIAYLLEILPAL 195

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
            YLH    + +++ DLK  N++L ++   K+ D G                + GT G+ A
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQA 245

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE       +V +D+++ G  L  +    
Sbjct: 246 PEIVR-TGPTVATDIYTVGRTLAALTLDL 273

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (286), Expect = 2e-29
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 20/209 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 94
           ++F I + LG+G FG VY          +A+K L K  + ++G++  L+ E+ + S L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVM 152
            N++++        +++ L+ EF     L    + + ++    D  +    +   A  + 
Sbjct: 74  PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALH 128

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN-TKRVIGTYGYMA 211
           Y H     ++IHRD+K  N+L+      KI+DFG +             + + GT  Y+ 
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSV-----HAPSLRRRTMCGTLDYLP 180

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGK 240
           PE         K D++  G+L  E + G 
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  116 bits (292), Expect = 4e-29
 Identities = 67/226 (29%), Positives = 99/226 (43%), Gaps = 30/226 (13%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 94
           +  +   KKLG G +G V      V   E A+K + K  +S     +L  EV +   L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTA 148
            N++KL           L+ E      L    FD    +I+    +F       II    
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGEL----FD----EIIH-RMKFNEVDAAVIIKQVL 146

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
            GV YLH+     I+HRDLK  N+LL   ++D   KI DFGL+  F   +     K  +G
Sbjct: 147 SGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLG 200

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
           T  Y+APE     ++  K DV+S G++L  +++G     F    + 
Sbjct: 201 TAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY--PPFGGQTDQ 243

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  116 bits (292), Expect = 4e-29
 Identities = 72/216 (33%), Positives = 106/216 (49%), Gaps = 31/216 (14%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 93
           ++ +   + LG+G FG V      + GQE AVK +SK     +   + L  EV L  +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICG 146
           H N++KL     + +    L+ E  T   L    FD    +I+   KRF       II  
Sbjct: 85  HPNIMKLYEFF-EDKGYFYLVGEVYTGGEL----FD----EIIS-RKRFSEVDAARIIRQ 134

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRV 203
              G+ Y+H+    +I+HRDLK  N+LL    +D N +I DFGL+  F   +     K  
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDK 188

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           IGT  Y+APE    G +  K DV+S G++L  ++SG
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  113 bits (284), Expect = 5e-29
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 17/205 (8%)

Query: 43  INKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLV 98
           + + +G+GG G VY+    V  + +A+K +S+   S+   +  ++ E     +LQ  ++V
Sbjct: 38  LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 99  KLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
            +      GE    +Y     +    L + +  Q     L   +   I+      +   H
Sbjct: 98  PIHD---FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH 151

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
                   HRD+K  N+L+  D    + DFG+A A   DE        +GT  YMAPE  
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERF 207

Query: 216 SDGQFSVKSDVFSFGILLLEIISGK 240
           S+   + ++D+++   +L E ++G 
Sbjct: 208 SESHATYRADIYALTCVLYECLTGS 232

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  115 bits (290), Expect = 6e-29
 Identities = 73/217 (33%), Positives = 103/217 (47%), Gaps = 34/217 (15%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 94
              ++I   LG+G FG V K    +  QE AVK ++K     +    +  EV L  KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 95  RNLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKRF------HIIC 145
            N++KL       E+    Y   E  T   L    FD    +I+   KRF       II 
Sbjct: 81  PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FD----EIIK-RKRFSEHDAARIIK 128

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKR 202
               G+ Y+H+     I+HRDLK  N+LL   ++D + KI DFGL+  F  +      K 
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKD 182

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            IGT  Y+APE    G +  K DV+S G++L  ++SG
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (285), Expect = 7e-29
 Identities = 32/241 (13%), Positives = 66/241 (27%), Gaps = 54/241 (22%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ------- 93
             LGQ       + T    G+   V             +K++K EV+    L+       
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 94  ------------------HRNLVKLLGCCIQGEEK--LLIYEFMTNKSLDSF--IFD-QE 130
                              + ++++              +Y  M +        +     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 131 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
             K L    R  +     R +  LH      ++H  L+  +++LDQ     ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 191 FGGDETEGNTKRVIGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIISG 239
            G             + G+  PE  +               +   D ++ G+++  I   
Sbjct: 256 DGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 240 K 240
            
Sbjct: 310 D 310

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  111 bits (281), Expect = 1e-28
 Identities = 72/319 (22%), Positives = 135/319 (42%), Gaps = 43/319 (13%)

Query: 43  INKKLGQGGFGPVYKGT-LVDGQEIAVK----RLSKISEQGLKELKNEVILFSKLQHRNL 97
           + + LG GG   V+    L D +++AVK     L++         + E    + L H  +
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAI 74

Query: 98  VKLLGCCIQGEEKL-------LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           V +      GE +        ++ E++   +L   +  +     +   +   +I    + 
Sbjct: 75  VAVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE-TEGNTKRVIGTYGY 209
           + + H   +  IIHRD+K +N+++      K+ DFG+ARA      +   T  VIGT  Y
Sbjct: 129 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS- 268
           ++PE A       +SDV+S G +L E+++G+     +  D+ +++   A++   E     
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSV---AYQHVREDPIPP 239

Query: 269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS-ETVL--PQPKQPG 325
                 +  S +L  V+      L  + ++P++R    +   M      V     P+ P 
Sbjct: 240 SARHEGL--SADLDAVV------LKALAKNPENRY--QTAAEMRADLVRVHNGEPPEAPK 289

Query: 326 YLADRNSTRLDSSSSRPES 344
            L D   T L SS++   S
Sbjct: 290 VLTDAERTSLLSSAAGNLS 308

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  114 bits (288), Expect = 2e-28
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 34/219 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           + F   + LG+GGFG V+   +    ++ A K+L+K      +G +    E  + +K+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFM---------TNKSLDSFIFDQERCKILDWSKRF--- 141
           R +V L     + +  L L+   M          N   D+  F + R         F   
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
            I+ G    + +LHQ     II+RDLK  NVLLD D N +ISD GLA      +T+  TK
Sbjct: 297 QIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TK 347

Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
              GT G+MAPE     ++    D F+ G+ L E+I+ +
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  114 bits (287), Expect = 2e-28
 Identities = 66/256 (25%), Positives = 113/256 (44%), Gaps = 41/256 (16%)

Query: 8   SNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEI 66
            + S   EN   Q I +   ++          ++   +KLG G +G V          E 
Sbjct: 5   HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64

Query: 67  AVKRLSK-------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 112
           A+K + K               E+  +E+ NE+ L   L H N++KL     + ++   L
Sbjct: 65  AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKYFYL 123

Query: 113 IYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTARGVMYLHQDSRLRIIHRD 166
           + EF     L    F+    +I++   +F      +I+     G+ YLH+     I+HRD
Sbjct: 124 VTEFYEGGEL----FE----QIIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRD 171

Query: 167 LKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVK 223
           +K  N+LL   +  +N KI DFGL+  F  D      +  +GT  Y+APE     +++ K
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEK 227

Query: 224 SDVFSFGILLLEIISG 239
            DV+S G+++  ++ G
Sbjct: 228 CDVWSCGVIMYILLCG 243

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  110 bits (277), Expect = 4e-28
 Identities = 73/215 (33%), Positives = 99/215 (46%), Gaps = 38/215 (17%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 94
              ++I   LG+G FG V K    +  QE AVK ++K     +    +  EV L  KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 95  RNLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKRF------HIIC 145
            N++KL       E+    Y   E  T   L    FD    +I+   KRF       II 
Sbjct: 81  PNIMKLFEIL---EDSSSFYIVGELYTGGEL----FD----EIIK-RKRFSEHDAARIIK 128

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKR 202
               G+ Y+H+     I+HRDLK  N+LL   ++D + KI DFGL+  F  +      K 
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKD 182

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 233
            IGT  Y+APE    G +  K DV+S G    ILL
Sbjct: 183 RIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILL 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  110 bits (278), Expect = 4e-28
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F   K LG+G F  V     +      A+K L K   I E  +  +  E  + S+L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFI-----FDQERCKILDWSKRFH---IIC 145
              VKL     Q +EKL     +  N  L  +I     FD+          RF+   I+ 
Sbjct: 90  PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAEIVS 141

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
                + YLH      IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +G
Sbjct: 142 A----LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           T  Y++PE  ++      SD+++ G ++ ++++G 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  113 bits (285), Expect = 5e-28
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 33/217 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           N F   + LG+GGFG V    +    ++ A K+L K      +G     NE  +  K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSL-------DSFIFDQERCKILDWSKRF---HI 143
           R +V L     + ++ L L+   M    L           F + R         F    I
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAEI 295

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
            CG    +  LH   R RI++RDLK  N+LLD   + +ISD GLA      +T    K  
Sbjct: 296 CCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           +GT GYMAPE   + +++   D ++ G LL E+I+G+
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  113 bits (284), Expect = 8e-28
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 33/210 (15%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
            +++ I+++LG G FG V++ T    G   A K +    E   + ++ E+   S L+H  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI-----------IC 145
           LV L        E ++IYEFM+   L    F+    K+ D  +   +           +C
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----FE----KVAD--EHNKMSEDEAVEYMRQVC 265

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRV 203
               G+ ++H+      +H DLK  N++     +   K+ DFGL       +   + K  
Sbjct: 266 K---GLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVT 316

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILL 233
            GT  + APE A        +D++S G+L 
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  109 bits (274), Expect = 1e-27
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 30/218 (13%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQH 94
            + +   LG+G +G V +          AVK L K        G   +K E+ L  +L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 95  RNLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFD---QERCKILDWSKRFH-IICGT 147
           +N+++L+   +  EEK  +Y   E+      +  + D   ++R  +      F  +I G 
Sbjct: 66  KNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDG- 121

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
              + YLH      I+H+D+K  N+LL      KIS  G+A A      +   +   G+ 
Sbjct: 122 ---LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 208 GYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGK 240
            +  PE A+      G    K D++S G+ L  I +G 
Sbjct: 176 AFQPPEIANGLDTFSGF---KVDIWSAGVTLYNITTGL 210

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  109 bits (275), Expect = 1e-27
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 17/207 (8%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 96
           N+ + K +G+G F  V     ++ G+E+A+K +  ++++   L++L  EV +   L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 97  LVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYL 154
           +VKL    I+ E+ L LI E+ +   +  ++    R K  +   +F  I+      V Y 
Sbjct: 76  IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA----VQYC 130

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H   + RI+HRDLKA N+LLD DMN KI+DFG +  F             G   Y APE 
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPEL 184

Query: 215 ASDGQFS-VKSDVFSFGILLLEIISGK 240
               ++   + DV+S G++L  ++SG 
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (272), Expect = 1e-27
 Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 20/203 (9%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
              +++   +G+G +G V            A K++ K   + +   K E+ +   L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 97  LVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           +++L       E+   IY   E  T   L   +  +   +  D ++    +      V Y
Sbjct: 68  IIRLYETF---EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS---AVAY 121

Query: 154 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYM 210
            H+   L + HRDLK  N L      D   K+ DFGLA  F   +     +  +GT  Y+
Sbjct: 122 CHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYV 175

Query: 211 APEYASDGQFSVKSDVFSFGILL 233
           +P+   +G +  + D +S G+++
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMM 197

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (276), Expect = 2e-27
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 23/205 (11%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
            + + I ++LG G FG V++      G+    K ++         +KNE+ + ++L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTARG 150
           L+ L        E +LI EF++   L    FD    +I     +       + +     G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGEL----FD----RIAAEDYKMSEAEVINYMRQACEG 161

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYG 208
           + ++H+     I+H D+K  N++ +       KI DFGLA     DE     K    T  
Sbjct: 162 LKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAE 215

Query: 209 YMAPEYASDGQFSVKSDVFSFGILL 233
           + APE          +D+++ G+L 
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLG 240

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  112 bits (281), Expect = 3e-27
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 40/221 (18%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKL-- 92
           N+FS+++ +G+GGFG VY     D  ++ A+K L K     +QG     NE I+ S +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 93  -QHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFI-----FDQERCKILDWSKRFH--- 142
                +V +        +KL  I + M    L   +     F +          RF+   
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAE 300

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           II G    + ++H      +++RDLK +N+LLD+  + +ISD GLA  F   +       
Sbjct: 301 IILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---S 350

Query: 203 VIGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIISGK 240
           V GT+GYMAPE    G     S   D FS G +L +++ G 
Sbjct: 351 V-GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  107 bits (270), Expect = 5e-27
 Identities = 58/215 (26%), Positives = 89/215 (41%), Gaps = 40/215 (18%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
              F   + LG G F  V+     + G+  A+K + K        L+NE+ +  K++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 97  LVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQ--------ERCKILDWSKRFHIIC 145
           +V L       E     Y   + ++   L    FD+        E+    D S     + 
Sbjct: 68  IVTLEDIY---ESTTHYYLVMQLVSGGEL----FDRILERGVYTEK----DASLVIQQVL 116

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKR 202
                V YLH+     I+HRDLK  N+L    +++    I+DFGL++        G    
Sbjct: 117 S---AVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMST 166

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 233
             GT GY+APE  +   +S   D +S G    ILL
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  106 bits (268), Expect = 5e-27
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 41/216 (18%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 95
            + F   +KLG G FG V+       G E  +K ++K   Q   E ++ E+ +   L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 96  NLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKR------------ 140
           N++K+       E+   +Y   E      L     +    +I+    R            
Sbjct: 81  NIIKIFEVF---EDYHNMYIVMETCEGGEL----LE----RIVSAQARGKALSEGYVAEL 129

Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETE 197
              +      + Y H      ++H+DLK  N+L          KI DFGLA  F  DE  
Sbjct: 130 MKQMMN---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH- 182

Query: 198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILL 233
             +    GT  YMAPE       + K D++S G+++
Sbjct: 183 --STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  106 bits (267), Expect = 7e-27
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           ++ + + LG+G +G V      V  + +AVK +         E +K E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 98  VKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYLH 155
           VK  G   +      L  E+ +   L   I         D  + FH ++ G    V+YLH
Sbjct: 68  VKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG----VVYLH 122

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
               + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+APE  
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 216 S----DGQFSVKSDVFSFGILLLEIISG 239
                  +     DV+S GI+L  +++G
Sbjct: 180 KRREFHAE---PVDVWSCGIVLTAMLAG 204

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  107 bits (269), Expect = 1e-26
 Identities = 55/256 (21%), Positives = 92/256 (35%), Gaps = 65/256 (25%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVILFS 90
            +S    LG G FG V+        +E+ VK + K        I +  L ++  E+ + S
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKS--------------LDSFIFDQERCKILD 136
           +++H N++K+              +   N+               L +FI    R     
Sbjct: 85  RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131

Query: 137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
            S  F  +      V YL       IIHRD+K  N+++ +D   K+ DFG A      E 
Sbjct: 132 ASYIFRQLVS---AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ER 182

Query: 197 EGNTKRVIGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIISG--------KKNRG 244
                   GT  Y APE        G    + +++S G+ L  ++          +    
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEA 239

Query: 245 FYH-----SDNNLNLI 255
             H     S   ++L+
Sbjct: 240 AIHPPYLVSKELMSLV 255

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (270), Expect = 1e-26
 Identities = 56/253 (22%), Positives = 96/253 (37%), Gaps = 47/253 (18%)

Query: 8   SNISEKTENDQIQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEI 66
               + TEN   Q++  E  L + A        +     +G+G    V +      G E 
Sbjct: 63  DAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEF 122

Query: 67  AVKRLSK--------ISEQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIY--- 114
           AVK +            E+  +  + E  IL     H +++ L+      E    ++   
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSFMFLVF 179

Query: 115 EFMTNKSLDSFIFD--------QERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRD 166
           + M    L    FD         E+    +       +      V +LH      I+HRD
Sbjct: 180 DLMRKGEL----FDYLTEKVALSEK----ETRSIMRSLLE---AVSFLHA---NNIVHRD 225

Query: 167 LKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE------YASDGQF 220
           LK  N+LLD +M  ++SDFG +      E     + + GT GY+APE        +   +
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGY 282

Query: 221 SVKSDVFSFGILL 233
             + D+++ G++L
Sbjct: 283 GKEVDLWACGVIL 295

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (269), Expect = 1e-26
 Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 21/206 (10%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSKLQH 94
           + + + +G+G F  V +      GQ+ AVK     + +       ++LK E  +   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKIL----DWSKRFHIICGTARG 150
            ++V+LL          +++EFM    L   I  +     +      S     I      
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---A 142

Query: 151 VMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           + Y H      IIHRD+K   VLL   +     K+  FG+A   G           +GT 
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILL 233
            +MAPE      +    DV+  G++L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  105 bits (265), Expect = 3e-26
 Identities = 69/222 (31%), Positives = 115/222 (51%), Gaps = 32/222 (14%)

Query: 35  VSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVIL 88
           +S+++ F   +KLG G +  VYKG     G  +A+K +   SE+G     ++E+     L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----L 56

Query: 89  FSKLQHRNLVKLLGCCIQGEEKL-LIYEFMTN--KSLDSFIFDQERCKILDWSKRFHIIC 145
             +L+H N+V+L    I  E KL L++EFM N  K            + L+ +   +   
Sbjct: 57  MKELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
              +G+ + H++   +I+HRDLK  N+L+++    K+ DFGLARAF G      +  V+ 
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV- 170

Query: 206 TYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
           T  Y AP+       Y++    S+  D++S G +L E+I+GK
Sbjct: 171 TLWYRAPDVLMGSRTYST----SI--DIWSCGCILAEMITGK 206

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (266), Expect = 3e-26
 Identities = 49/252 (19%), Positives = 86/252 (34%), Gaps = 52/252 (20%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 91
              + +   +GQG +G V            A+K     ++ +I+ + ++ +K EV L  K
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF---------- 141
           L H N+ +L       +   L+ E      L   +           +             
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 142 ---------------------------HIICGTARGVMYLHQDSRLRIIHRDLKASNVLL 174
                                      +I+      + YLH      I HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 175 --DQDMNPKISDFGLARAFGGDETEGNT--KRVIGTYGYMAPE--YASDGQFSVKSDVFS 228
             ++    K+ DFGL++ F               GT  ++APE    ++  +  K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 229 FGILLLEIISGK 240
            G+LL  ++ G 
Sbjct: 262 AGVLLHLLLMGA 273

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  106 bits (266), Expect = 4e-26
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
             S  + LG G FG V+K      G ++A K +     +  +E+KNE+ + ++L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTARGVM 152
           +L        + +L+ E++    L    FD    +I+D S           +     G+ 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL----FD----RIIDESYNLTELDTILFMKQICEGIR 201

Query: 153 YLHQDSRLRIIHRDLKASNVLL-DQDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYM 210
           ++HQ   + I+H DLK  N+L  ++D    KI DFGLAR +   E     K   GT  ++
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFL 255

Query: 211 APEYASDGQFSVKSDVFSFGILL 233
           APE  +    S  +D++S G++ 
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIA 278

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (262), Expect = 5e-26
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 41/217 (18%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 94
           ++N+ + ++LG+G F  V +      G E A K ++   +S +  ++L+ E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 95  RNLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQ--------ERCKILDWSKRFHI 143
            N+V+L       +E+   Y   + +T   L    F+         E     D S     
Sbjct: 65  PNIVRLHDSI---QEESFHYLVFDLVTGGEL----FEDIVAREFYSEA----DASHCIQQ 113

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNT 200
           I      + Y H      I+HR+LK  N+LL    +    K++DFGLA      E     
Sbjct: 114 ILE---SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---W 164

Query: 201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 233
               GT GY++PE      +S   D+++ G    ILL
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (263), Expect = 5e-26
 Identities = 72/224 (32%), Positives = 109/224 (48%), Gaps = 43/224 (19%)

Query: 36  SATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILF 89
                +   +K+G+G +G VYK     G+ +A+KR+   +E        ++E+     L 
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LL 73

Query: 90  SKLQHRNLVKLLGCCIQGEEKL-LIYEFMTN---KSLDSF--IFDQERCKILDWSKRFHI 143
            +L H N+V L+   I  E  L L++EFM     K LD         + KI       + 
Sbjct: 74  KELHHPNIVSLI-DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIY-----LYQ 127

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
           +    RGV + HQ    RI+HRDLK  N+L++ D   K++DFGLARAF G      T  V
Sbjct: 128 LL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEV 180

Query: 204 IGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
           + T  Y AP+       Y++    SV  D++S G +  E+I+GK
Sbjct: 181 V-TLWYRAPDVLMGSKKYST----SV--DIWSIGCIFAEMITGK 217

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  105 bits (263), Expect = 5e-26
 Identities = 42/205 (20%), Positives = 81/205 (39%), Gaps = 24/205 (11%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
              + I + LG+G FG V++       +    K +          +K E+ + +  +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTARG 150
           ++ L       EE ++I+EF++   +    F+    +I   +           +      
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDI----FE----RINTSAFELNEREIVSYVHQVCEA 114

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYG 208
           + +LH      I H D++  N++     +   KI +FG AR     +     + +     
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPE 168

Query: 209 YMAPEYASDGQFSVKSDVFSFGILL 233
           Y APE       S  +D++S G L+
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  105 bits (263), Expect = 6e-26
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
           ++ + + LG+G +G V      V  + +AVK +         E +K E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 98  VKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYLH 155
           VK  G   +      L  E+ +   L   I         D  + FH ++ G    V+YLH
Sbjct: 68  VKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG----VVYLH 122

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
               + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+APE  
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 216 S----DGQFSVKSDVFSFGILLLEIISG 239
                  +     DV+S GI+L  +++G
Sbjct: 180 KRREFHAE---PVDVWSCGIVLTAMLAG 204

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  104 bits (261), Expect = 7e-26
 Identities = 54/221 (24%), Positives = 86/221 (38%), Gaps = 42/221 (19%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE---------LKNEV- 86
             N+   + LG+G    V +       +E AVK +                      EV 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 87  ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ--------ERCKILDWS 138
           IL     H N+++L           L+++ M    L    FD         E+    +  
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK----ETR 127

Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
           K    +      +  LH+   L I+HRDLK  N+LLD DMN K++DFG +      E   
Sbjct: 128 KIMRALLE---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179

Query: 199 NTKRVIGTYGYMAPE------YASDGQFSVKSDVFSFGILL 233
             + V GT  Y+APE        +   +  + D++S G+++
Sbjct: 180 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (261), Expect = 9e-26
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 42/221 (19%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 92
             +    K+G+G +G V+K      GQ +A+K   K  E     +       E+ +  +L
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59

Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTN---KSLDSF--IFDQERCKILDWSKRFHIICG 146
           +H NLV LL    + + +L L++E+  +     LD +     +   K + W         
Sbjct: 60  KHPNLVNLL-EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ-------- 110

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
           T + V + H+      IHRD+K  N+L+ +    K+ DFG AR      ++     V  T
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-T 165

Query: 207 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
             Y +PE       Y       V  DV++ G +  E++SG 
Sbjct: 166 RWYRSPELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (265), Expect = 9e-26
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 25/211 (11%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 88
            + + ++K LG G  G V         +++A++ +SK                ++ E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 89  FSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA 148
             KL H  ++K+       E+  ++ E M    L   +   +R K       F+ +    
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 250

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
             V YLH+     IIHRDLK  NVLL   ++D   KI+DFG ++  G        + + G
Sbjct: 251 -AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303

Query: 206 TYGYMAPE---YASDGQFSVKSDVFSFGILL 233
           T  Y+APE         ++   D +S G++L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  103 bits (260), Expect = 1e-25
 Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 51/239 (21%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK------------------------ 73
           N +++  ++G+G +G V       D    A+K LSK                        
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 74  --ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFD 128
                  ++++  E+ +  KL H N+VKL+   +    +  +Y   E +    +     +
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----ME 127

Query: 129 QERCKIL--DWSKRFH--IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 184
               K L  D ++ +   +I G    + YLH     +IIHRD+K SN+L+ +D + KI+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSV---KSDVFSFGILLLEIISGK 240
           FG++  F G   +      +GT  +MAPE  S+ +        DV++ G+ L   + G+
Sbjct: 181 FGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  103 bits (260), Expect = 2e-25
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 41/219 (18%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 88
            + + ++K LG G  G V         +++A+K +SK                ++ E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 89  FSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFD--------QERCKILDWSKR 140
             KL H  ++K+       E+  ++ E M    L    FD        +E          
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEA----TCKLY 119

Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETE 197
           F+ +      V YLH      IIHRDLK  NVLL   ++D   KI+DFG ++  G     
Sbjct: 120 FYQMLL---AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172

Query: 198 GNTKRVIGTYGYMAPE---YASDGQFSVKSDVFSFGILL 233
              + + GT  Y+APE         ++   D +S G++L
Sbjct: 173 --MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  103 bits (259), Expect = 2e-25
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 43/221 (19%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSKL 92
             +    KLG+G +  VYKG   +    +A+K +    E+G     ++E+     L   L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57

Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTN---KSLDS--FIFDQERCKILDWSKRFHIICG 146
           +H N+V L    I  E+ L L++E++     + LD    I +    K+  +         
Sbjct: 58  KHANIVTLH-DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ-------- 108

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
             RG+ Y H+    +++HRDLK  N+L+++    K++DFGLARA     T+     V+ T
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-T 163

Query: 207 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
             Y  P+       Y      S + D++  G +  E+ +G+
Sbjct: 164 LWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  102 bits (256), Expect = 3e-25
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFS 90
            +++ + ++LG G F  V K      G+E A K + K            +E++ EV +  
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           +++H N++ L        + +LI E ++   L  F+ ++E     + ++    I     G
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---G 120

Query: 151 VMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
           V YLH     RI H DLK  N++L      +   K+ DFG+A            K + GT
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGT 174

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILL 233
             ++APE  +     +++D++S G++ 
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (260), Expect = 3e-25
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 37/215 (17%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 94
           ++N+ + ++LG+G F  V +      G E A K ++   +S +  ++L+ E  +  KLQH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQ--------ERCKILDWSKRFHIIC 145
            N+V+L    IQ E    L+++ +T   L    F+         E     D S     I 
Sbjct: 88  PNIVRLHD-SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEA----DASHCIQQIL 138

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKR 202
                + Y H      I+HR+LK  N+LL    +    K++DFGLA      E       
Sbjct: 139 E---SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHG 189

Query: 203 VIGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 233
             GT GY++PE      +S   D+++ G    ILL
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  102 bits (256), Expect = 3e-25
 Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 44/223 (19%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 91
             +   +K+G+G +G V+K       + +A+KR+    +        L+E+     L  +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57

Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTN---KSLDS--FIFDQERCKILDWSKRFHIIC 145
           L+H+N+V+L    +  ++KL L++EF      K  DS     D E  K          + 
Sbjct: 58  LKHKNIVRLH-DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLL 111

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
              +G+ + H      ++HRDLK  N+L++++   K+++FGLARAF G      +  V+ 
Sbjct: 112 ---KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV- 163

Query: 206 TYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGKK 241
           T  Y  P+       Y++    S+  D++S G +  E+ +  +
Sbjct: 164 TLWYRPPDVLFGAKLYST----SI--DMWSAGCIFAELANAGR 200

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 4e-25
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 20/207 (9%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFS 90
            + +   ++LG G F  V K      G + A K + K            ++++ EV +  
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           ++QH N++ L        + +LI E +    L  F+ ++E     + ++    I     G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126

Query: 151 VMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
           V YLH    L+I H DLK  N++L          KI DFGLA            K + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 180

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILL 233
             ++APE  +     +++D++S G++ 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVIT 207

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  103 bits (259), Expect = 5e-25
 Identities = 52/217 (23%), Positives = 99/217 (45%), Gaps = 30/217 (13%)

Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
              ++  K +G G FG V++  LV+  E+A+K++ +      +EL+    +   ++H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94

Query: 98  VKLLGCCIQGEEKL------LIYEFMTNKSLDSFIFDQERCKI---LDWSKRF-HIICGT 147
           V L        +K       L+ E++  +++        + K    +   K + + +   
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL-- 151

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIGT 206
            R + Y+H    + I HRD+K  N+LLD      K+ DFG A+       E N   +   
Sbjct: 152 -RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSR 205

Query: 207 YGYMAPEY---ASDGQFSVKSDVFSFGILLLEIISGK 240
           Y Y APE    A+   ++   D++S G ++ E++ G+
Sbjct: 206 Y-YRAPELIFGAT--NYTTNIDIWSTGCVMAELMQGQ 239

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  102 bits (256), Expect = 5e-25
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 20/207 (9%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFS 90
            + + I ++LG G F  V K      G E A K + K            +E++ EV +  
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           ++ H N++ L        + +LI E ++   L  F+  +E     + +     I     G
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---G 127

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGGDETEGNTKRVIGT 206
           V YLH     +I H DLK  N++L     P    K+ DFGLA            K + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILL 233
             ++APE  +     +++D++S G++ 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  102 bits (257), Expect = 5e-25
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 29/219 (13%)

Query: 36  SATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILF 89
           S    +     LG+G F  VYK       Q +A+K++        K+  N     E+ L 
Sbjct: 7   SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 66

Query: 90  SKLQHRNLVKLLGCCIQGEEKL-LIYEFMTN---KSLDS--FIFDQERCKILDWSKRFHI 143
            +L H N++ LL      +  + L+++FM       +     +      K          
Sbjct: 67  QELSHPNIIGLLDA-FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM----- 120

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
              T +G+ YLHQ     I+HRDLK +N+LLD++   K++DFGLA++F G      T +V
Sbjct: 121 ---TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQV 173

Query: 204 IGTYGYMAPE--YASDGQFSVKSDVFSFGILLLEIISGK 240
           + T  Y APE  + +   + V  D+++ G +L E++   
Sbjct: 174 V-TRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  102 bits (257), Expect = 7e-25
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 20/207 (9%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVILFS 90
            + + I ++LG G F  V K      G E A K + K            +E++ EV +  
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           ++ H N++ L        + +LI E ++   L  F+  +E     + +     I     G
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---G 127

Query: 151 VMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
           V YLH     +I H DLK  N++L        + K+ DFGLA            K + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILL 233
             ++APE  +     +++D++S G++ 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  101 bits (253), Expect = 7e-25
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 18/208 (8%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 95
           ++ +   LG G FG V  G   + G ++AVK L++  I    +   +K E+      +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 96  NLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMY 153
           +++KL    I       ++ E+++   L  +I    R + ++  + F  I+      V Y
Sbjct: 72  HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA----VDY 126

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
            H   R  ++HRDLK  NVLLD  MN KI+DFGL+      E     +   G+  Y APE
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPE 180

Query: 214 YASDGQFS-VKSDVFSFGILLLEIISGK 240
             S   ++  + D++S G++L  ++ G 
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGT 208

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  101 bits (253), Expect = 8e-25
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 43/221 (19%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 92
             +   +K+G+G +G VYK     G+  A+K++    E        ++E+     +  +L
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57

Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTN---KSLDS--FIFDQERCKILDWSKRFHIICG 146
           +H N+VKL    I  +++L L++E +     K LD      +    K             
Sbjct: 58  KHSNIVKLY-DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ-------- 108

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
              G+ Y H     R++HRDLK  N+L++++   KI+DFGLARAF G      T  ++ T
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-T 163

Query: 207 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
             Y AP+       Y++    ++  D++S G +  E+++G 
Sbjct: 164 LWYRAPDVLMGSKKYST----TI--DIWSVGCIFAEMVNGT 198

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  101 bits (254), Expect = 1e-24
 Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 28/207 (13%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
           T+ + + + +G G +    +        E AVK + K      +E++   IL    QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTARG 150
           ++ L      G+   ++ E M    L     D    KIL   K F       ++    + 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGEL----LD----KILR-QKFFSEREASAVLFTITKT 128

Query: 151 VMYLHQDSRLRIIHRDLKASNVLL-DQDMNP---KISDFGLARAFGGDETEGNTKRVIGT 206
           V YLH      ++HRDLK SN+L  D+  NP   +I DFG A+    +     T     T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILL 233
             ++APE      +    D++S G+LL
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  101 bits (253), Expect = 1e-24
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 42/221 (19%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 92
             +     +G+G +G V K      G+ +A+K   K  E    ++       E+ L  +L
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81

Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTN---KSLDSF--IFDQERCKILDWSKRFHIICG 146
           +H NLV LL    + +++  L++EF+ +     L+ F    D +  +   +         
Sbjct: 82  RHENLVNLL-EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-------- 132

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
              G+ + H      IIHRD+K  N+L+ Q    K+ DFG AR       E     V  T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-T 187

Query: 207 YGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
             Y APE       Y      +V  DV++ G L+ E+  G+
Sbjct: 188 RWYRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (252), Expect = 2e-24
 Identities = 50/229 (21%), Positives = 89/229 (38%), Gaps = 54/229 (23%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFSKL 92
            + +   LG GGFG VY G  + D   +A+K + K              +  EV+L  K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 93  QHR--NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK----ILDW--------- 137
                 +++L              ++      DSF+   ER +    + D+         
Sbjct: 104 SSGFSGVIRL-------------LDWFERP--DSFVLILERPEPVQDLFDFITERGALQE 148

Query: 138 --SKRF--HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFG 192
             ++ F   ++      V + H      ++HRD+K  N+L+D +    K+ DFG      
Sbjct: 149 ELARSFFWQVLEA----VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL- 200

Query: 193 GDETEGNTKRVIGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIISGK 240
               +       GT  Y  PE+    ++    + V+S GILL +++ G 
Sbjct: 201 ---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  102 bits (257), Expect = 2e-24
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 38/224 (16%)

Query: 31  LATIVSA--TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNE 85
           +ATI     T  + + ++LG+G F  V +   ++ GQE A   ++   +S +  ++L+ E
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60

Query: 86  VILFSKLQHRNLVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQERCKILDWSKRF- 141
             +   L+H N+V+L        E+   Y   + +T   L    F+     I+   + + 
Sbjct: 61  ARICRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGEL----FE----DIVA-REYYS 108

Query: 142 -----HIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGG 193
                H I      V++ HQ   + ++HR+LK  N+LL    +    K++DFGLA    G
Sbjct: 109 EADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165

Query: 194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFG----ILL 233
           ++         GT GY++PE      +    D+++ G    ILL
Sbjct: 166 EQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (252), Expect = 2e-24
 Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 33/211 (15%)

Query: 44  NKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLL 101
              LG+G    V     L+  QE AVK + K        +  EV +  + Q HRN+++L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTARGVMYLH 155
               + +   L++E M   S+           I    + F       ++   A  + +LH
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSI----LS----HIHK-RRHFNELEASVVVQDVASALDFLH 128

Query: 156 QDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF--GGDETEGNTKR---VIGTY 207
                 I HRDLK  N+L    +Q    KI DF L       GD +  +T       G+ 
Sbjct: 129 N---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 208 GYMAPE-----YASDGQFSVKSDVFSFGILL 233
            YMAPE           +  + D++S G++L
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 40/222 (18%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 91
           + +    KLG+G +G VYK    V  + +A+KR+    E+       ++E+     L  +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89

Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           LQHRN+++L    I    +L LI+E+     L  ++   ++   +        +     G
Sbjct: 90  LQHRNIIELK-SVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRVIKSFLYQLING 144

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNP-----KISDFGLARAFGGDETEGNTKRVIG 205
           V + H     R +HRDLK  N+LL           KI DFGLARAF G      T  +I 
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII- 199

Query: 206 TYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
           T  Y  PE       Y++    SV  D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHYST----SV--DIWSIACIWAEMLMKT 235

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (250), Expect = 5e-24
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 33/211 (15%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
           ++ F +  +LG+G    VY+       +  A+K L K  ++  K ++ E+ +  +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109

Query: 97  LVKLLGCCIQGEEKLLIY---EFMTNKSLDSFIFDQ----ERCKILDWSKRFHIICGTAR 149
           ++KL       E    I    E +T   L   I ++    ER    D +     I     
Sbjct: 110 IIKLKEIF---ETPTEISLVLELVTGGELFDRIVEKGYYSER----DAADAVKQILE--- 159

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
            V YLH+     I+HRDLK  N+L      D   KI+DFGL++           K V GT
Sbjct: 160 AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213

Query: 207 YGYMAPEYASDGQFSVKSDVFSFG----ILL 233
            GY APE      +  + D++S G    ILL
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILL 244

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 28/201 (13%)

Query: 44  NKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLL 101
           +K LG+G F    K       Q  AVK +SK   +     + E+      + H N+VKL 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTARGVMYLH 155
                     L+ E +    L    F+    +I    K F      +I+      V ++H
Sbjct: 73  EVFHDQLHTFLVMELLNGGEL----FE----RIKK-KKHFSETEASYIMRKLVSAVSHMH 123

Query: 156 QDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
               + ++HRDLK  N+L    + ++  KI DFG AR    D     T     T  Y AP
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178

Query: 213 EYASDGQFSVKSDVFSFGILL 233
           E  +   +    D++S G++L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 98.9 bits (247), Expect = 7e-24
 Identities = 61/327 (18%), Positives = 113/327 (34%), Gaps = 99/327 (30%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEV----IL 88
            + +   LG+GGFG V+ G  L D  ++A+K + +                 EV     +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 89  FSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCK----ILDW------- 137
            +   H  +++L              ++   +  + F+   ER      + D+       
Sbjct: 92  GAGGGHPGVIRL-------------LDWFETQ--EGFMLVLERPLPAQDLFDYITEKGPL 136

Query: 138 ----SKRF--HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARA 190
               S+ F   ++      + + H      ++HRD+K  N+L+D      K+ DFG    
Sbjct: 137 GEGPSRCFFGQVVAA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189

Query: 191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIISG--------KK 241
                 +       GT  Y  PE+ S  Q+  + + V+S GILL +++ G        + 
Sbjct: 190 L----HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI 245

Query: 242 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKD 301
                H                   P+ +   C         +IR       C+   P  
Sbjct: 246 LEAELH------------------FPAHVSPDCCA-------LIRR------CLAPKPSS 274

Query: 302 RPSMPSVI----LMLGSETVLPQPKQP 324
           RPS+  ++    +   +E V   P + 
Sbjct: 275 RPSLEEILLDPWMQTPAEDVPLNPSKG 301

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  100 bits (250), Expect = 9e-24
 Identities = 61/233 (26%), Positives = 107/233 (45%), Gaps = 35/233 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           ++F I + +G+G FG V      D +++ A+K ++K   +    ++ +  E+ +   L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICGTA 148
             LV L     Q EE + ++ + +    L      +  F +E  K+         IC   
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELV 125

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YL      RIIHRD+K  N+LLD+  +  I+DF +A     +        + GT  
Sbjct: 126 MALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKP 179

Query: 209 YMAPE-YASDGQ----FSVKSDVFSFGILLLEIISGKKNRGFY-HSDNNLNLI 255
           YMAPE ++S       F+V  D +S G+   E++ G+  R ++  S  +   I
Sbjct: 180 YMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR--RPYHIRSSTSSKEI 228

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 26/202 (12%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR-NLVKL 100
           K+LG+G F  V +      GQE A K L K    +    E+ +E+ +    +    ++ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 101 LGCCIQGEEKLLIYEFMTNKSLDSFIFD---QERCKIL---DWSKRFHIICGTARGVMYL 154
                   E +LI E+     +    F     E  +++   D  +    I     GV YL
Sbjct: 95  HEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILE---GVYYL 147

Query: 155 HQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           HQ     I+H DLK  N+LL       + KI DFG++R  G        + ++GT  Y+A
Sbjct: 148 HQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLA 201

Query: 212 PEYASDGQFSVKSDVFSFGILL 233
           PE  +    +  +D+++ GI+ 
Sbjct: 202 PEILNYDPITTATDMWNIGIIA 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 36/206 (17%)

Query: 44  NKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNLVKLL 101
            + LG G  G V +      GQ+ A+K L         + + EV   +      ++V +L
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88

Query: 102 GCC---IQGEEKL-LIYEFMTNKSLDSFIFDQERCKILD-WSKRF------HIICGTARG 150
                   G+  L +I E M    L    F     +I +   + F       I+      
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----FS----RIQERGDQAFTEREAAEIMRDIGTA 140

Query: 151 VMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           + +LH      I HRD+K  N+L    ++D   K++DFG A+      T+   +    T 
Sbjct: 141 IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTP 193

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILL 233
            Y+APE     ++    D++S G+++
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIM 219

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 99.0 bits (247), Expect = 3e-23
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 39/222 (17%)

Query: 38  TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
             +++  K +G G FG VY+  L D G+ +A+K++ +      +EL+    +  KL H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108

Query: 97  LVKLLGCCIQGEEKL------LIYEFMTNKSLDSFI--FDQERCKILDWSKRFHI--ICG 146
           +V+L        EK       L+ +++  +++      + + +  +     + ++  +  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 166

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNTKRVIG 205
             R + Y+H      I HRD+K  N+LLD D    K+ DFG A+       E N   +  
Sbjct: 167 --RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICS 219

Query: 206 TYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
            Y Y APE       Y      +   DV+S G +L E++ G+
Sbjct: 220 RY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 99.1 bits (247), Expect = 4e-23
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 24/211 (11%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 95
           ++ +   LG G FG V  G   + G ++AVK L++  I    +   ++ E+      +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 96  NLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMY 153
           +++KL    I     + ++ E+++   L  +I    R    +  + F  I+ G    V Y
Sbjct: 77  HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG----VDY 131

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
            H   R  ++HRDLK  NVLLD  MN KI+DFGL+      E     +   G+  Y APE
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPE 185

Query: 214 YAS----DGQFSVKSDVFSFGILLLEIISGK 240
             S     G    + D++S G++L  ++ G 
Sbjct: 186 VISGRLYAGP---EVDIWSSGVILYALLCGT 213

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 50/232 (21%)

Query: 36  SATNNFSINKKLGQGGFGPVYKG--TLVDGQEIAVKRLSKISEQG------------LKE 81
            A   +    ++G+G +G V+K       G+ +A+KR+   + +             L+ 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67

Query: 82  LKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILD 136
           L+         +H N+V+L           E KL L++E +          DQ+    LD
Sbjct: 68  LETF-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLD 110

Query: 137 WSKRFHIICGTA--------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA 188
                 +   T         RG+ +LH     R++HRDLK  N+L+      K++DFGLA
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167

Query: 189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           R +        T  V+ T  Y APE      ++   D++S G +  E+   K
Sbjct: 168 RIYSFQMAL--TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 47/222 (21%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHR 95
            + I + LG+G FG V   T     Q++A+K +S+  + +  +   ++ E+     L+H 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKS------------LDSFIFDQERCKILDWSKRFH- 142
           +++KL             Y+ +T  +            L  +I +++R    +  + F  
Sbjct: 70  HIIKL-------------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQ 116

Query: 143 IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR 202
           IIC     + Y H   R +I+HRDLK  N+LLD ++N KI+DFGL+            K 
Sbjct: 117 IICA----IEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKT 166

Query: 203 VIGTYGYMAPEYAS----DGQFSVKSDVFSFGILLLEIISGK 240
             G+  Y APE  +     G    + DV+S GI+L  ++ G+
Sbjct: 167 SCGSPNYAAPEVINGKLYAGP---EVDVWSCGIVLYVMLVGR 205

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.3 bits (245), Expect = 5e-23
 Identities = 44/207 (21%), Positives = 83/207 (40%), Gaps = 35/207 (16%)

Query: 43  INKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNLVKL 100
            ++ LG G  G V +       ++ A+K L         + + EV + +   Q  ++V++
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120

Query: 101 LGCC---IQGEEKL-LIYEFMTNKSLDSFIFDQERCKILD-WSKRF------HIICGTAR 149
           +        G + L ++ E +    L    F     +I D   + F       I+     
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----FS----RIQDRGDQAFTEREASEIMKSIGE 172

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
            + YLH    + I HRD+K  N+L      +   K++DFG A+      +         T
Sbjct: 173 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYT 226

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILL 233
             Y+APE     ++    D++S G+++
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 96.5 bits (241), Expect = 5e-23
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 52/234 (22%)

Query: 36  SATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG---------------L 79
            AT+ +    ++G G +G VYK      G  +A+K +   +  G               L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 80  KELKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKI 134
           + L+         +H N+V+L+          E K+ L++E +          DQ+    
Sbjct: 66  RRLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTY 108

Query: 135 LDWSKRFHIICGTA--------RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 186
           LD +    +   T         RG+ +LH +    I+HRDLK  N+L+      K++DFG
Sbjct: 109 LDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFG 165

Query: 187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           LAR +        T  V+ T  Y APE      ++   D++S G +  E+   K
Sbjct: 166 LARIYSYQMA--LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 97.9 bits (244), Expect = 6e-23
 Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 43  INKKLGQGGFGPVYKG---TLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 97
              K+G+G +G VYK       D ++ A+K++    IS    +E    + L  +L+H N+
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNV 80

Query: 98  VKLLGCCIQ-GEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRF------HIICGTAR 149
           + L    +   + K+ L++++     L   I      K      +        ++     
Sbjct: 81  ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGG-DETEGNTKRVI 204
           G+ YLH +    ++HRDLK +N+L+  +       KI+D G AR F    +   +   V+
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 205 GTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
            T+ Y APE       Y      ++  D+++ G +  E+++ +
Sbjct: 197 VTFWYRAPELLLGARHYTK----AI--DIWAIGCIFAELLTSE 233

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 62/232 (26%), Positives = 106/232 (45%), Gaps = 52/232 (22%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 91
           + +    K+GQG FG V+K      GQ++A+K++   +E+       L+E+K   IL   
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK---IL-QL 72

Query: 92  LQHRNLVKLLGCCIQGEEKL--------LIYEFMTN---KSLDS--FIFDQERCKILDWS 138
           L+H N+V L+  C               L+++F  +     L +    F     K +   
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--- 129

Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
               ++     G+ Y+H++   +I+HRD+KA+NVL+ +D   K++DFGLARAF   +   
Sbjct: 130 --MQMLL---NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

Query: 199 N---TKRVIGTYGYMAPE-------YASDGQFSVKSDVFSFGILLLEIISGK 240
               T RV+ T  Y  PE       Y          D++  G ++ E+ +  
Sbjct: 182 PNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 32/217 (14%)

Query: 39  NNFSINKKLGQGGFGPVY---KGTLVDGQEI-AVKRLSK--ISEQGLKELKNEVILFSKL 92
           + F + K LGQG FG V+   K +  D +++ A+K L K  +  +     K E  +  ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 93  QHRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFH---I 143
            H  +VKL     Q E KL LI +F+    L        +F +E         +F+   +
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-------KFYLAEL 135

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
                  + +LH    L II+RDLK  N+LLD++ + K++DFGL++     E +  +   
Sbjct: 136 ALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--F 186

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            GT  YMAPE  +    +  +D +SFG+L+ E+++G 
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 26/204 (12%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 97
            +   K +G G FG        +  + +AVK + +     + E ++ E+I    L+H N+
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNI 78

Query: 98  VKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFH-IICGTARGVMYLH 155
           V+     I     L +I E+ +   L   I +  R    +    F  ++ G    V Y H
Sbjct: 79  VRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG----VSYCH 133

Query: 156 QDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
               ++I HRDLK  N LLD       KI DFG +++          K  +GT  Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPE 187

Query: 214 YAS----DGQFSVKSDVFSFGILL 233
                  DG+    +DV+S G+ L
Sbjct: 188 VLLRQEYDGK---IADVWSCGVTL 208

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 49/221 (22%), Positives = 92/221 (41%), Gaps = 31/221 (14%)

Query: 38  TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFSKL 92
            + F + +  GQG FG V  G     G  +A+K   K+ +      +N     +   + L
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDLAVL 76

Query: 93  QHRNLVKLLGCCIQGEEK-------LLIYEFMTNKSLDSFI--FDQERCKILDWSKRFHI 143
            H N+V+L        E+        ++ E++   +L      + + +        +  +
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 144 --ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLARAFGGDETEGNT 200
             +    R +  LH  S + + HRD+K  NVL+++     K+ DFG A+     E   N 
Sbjct: 136 FQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NV 189

Query: 201 KRVIGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIISGK 240
             +   Y Y APE    +  ++   D++S G +  E++ G+
Sbjct: 190 AYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 92.5 bits (230), Expect = 7e-21
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           N F   K LG+G FG V            A+K L K   +++  +     E  +    +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICGTA 148
             L  L     Q  ++L  + E+     L        +F ++R        RF+      
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAE-IV 258

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH  S   +++RDLK  N++LD+D + KI+DFGL +    D     T    GT  
Sbjct: 259 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPE 314

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           Y+APE   D  +    D +  G+++ E++ G+
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 24/212 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           N+F   K LG+G FG V            A+K L K   I++  +     E  +    +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICGTA 148
             L  L     Q  ++L  + E+     L        +F +ER        RF+      
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAE-IV 115

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             + YLH      +++RD+K  N++LD+D + KI+DFGL +    D     T    GT  
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPE 170

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           Y+APE   D  +    D +  G+++ E++ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 37/229 (16%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR 95
            +++ + +KLG+G +  V++   + + +++ VK L  + +   K++K E+ +   L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91

Query: 96  NLVKLLGCCIQGEEK--LLIYEFMTNKSLDSFI--FDQERCK-----ILDWSKRFHIICG 146
           N++ L         +   L++E + N               +     IL           
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL----------- 140

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTKRVIG 205
             + + Y H  S   I+HRD+K  NV++D +    ++ D+GLA        +    RV  
Sbjct: 141 --KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVAS 193

Query: 206 TYGYMAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLN 253
            Y +  PE   D Q    S D++S G +L  +I  K    F+H  +N +
Sbjct: 194 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK--EPFFHGHDNYD 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 31/219 (14%)

Query: 39  NNFSINKKLGQGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
           ++F I K +G+G F  V     K T   GQ  A+K ++K   +    +   + E  +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117

Query: 92  LQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFH---IICGT 147
              R + +L     Q E  L L+ E+     L + +         + + RF+   I+   
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA- 174

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
              +  +H+   L  +HRD+K  N+LLD+  + +++DFG       D T   +   +GT 
Sbjct: 175 ---IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTP 227

Query: 208 GYMAPE-------YASDGQFSVKSDVFSFGILLLEIISG 239
            Y++PE           G +  + D ++ G+   E+  G
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 35/224 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 94
           + F   K LG G FG V      +     A+K L K     LK++    NE  +   +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFI-----FDQERCKILDWSKRF---HIIC 145
             LVKL     +    L ++ E++    + S +     F +          RF    I+ 
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-------RFYAAQIVL 152

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
                  YLH    L +I+RDLK  N+L+DQ    +++DFG A+       +G T  + G
Sbjct: 153 T----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCG 200

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD 249
           T   +APE      ++   D ++ G+L+ E+ +G     F+   
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQ 242

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.8 bits (220), Expect = 5e-20
 Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 3/91 (3%)

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A+G+ +L   +  + IHRDL A N+LL +    KI DFGLAR    D             
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 19/160 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 91
           +   + K LG+G FG V +            + +AVK L    +    + L +E+ +   
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 92  L-QHRNLVKLLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +  H N+V LLG C + G   ++I EF    +L +++           SKR   +    +
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 189
           G  +      +  I  DLK     +    +   S F   +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.4 bits (220), Expect = 5e-20
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 34/219 (15%)

Query: 39  NNFSINKKLGQGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNEVILFS 90
             F + + LG+GG+G V+   K T  +  +I A+K L K   +         K E  +  
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 91  KLQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRF--- 141
           +++H  +V L+    Q   KL LI E+++   L        IF ++          F   
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-------CFYLA 128

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
            I       + +LHQ     II+RDLK  N++L+   + K++DFGL +    D T  +T 
Sbjct: 129 EISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT- 180

Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
              GT  YMAPE       +   D +S G L+ ++++G 
Sbjct: 181 -FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 88.0 bits (219), Expect = 7e-20
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 33/214 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 94
            +F I + LG G FG V+           A+K L K     LK++    +E ++ S + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTNKSLDSFI-----FDQERCKILDWSKRFH---IIC 145
             ++++ G   Q  +++ +I +++    L S +     F            +F+   +  
Sbjct: 66  PFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAEVCL 117

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
                + YLH      II+RDLK  N+LLD++ + KI+DFG A+          T  + G
Sbjct: 118 A----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCG 165

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
           T  Y+APE  S   ++   D +SFGIL+ E+++G
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 50/220 (22%), Positives = 94/220 (42%), Gaps = 35/220 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 94
            +F I K +G+G FG V    L +  ++ A+K L+K       E    + E  +      
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 95  RNLVKLLGCCIQGEEKL-LIYEF------MTNKSLDSFIFDQERCKILDWSKRFH---II 144
           + +  L     Q +  L L+ ++      +T  S       +E         RF+   ++
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-------RFYLAEMV 185

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
                 +  +HQ   L  +HRD+K  N+L+D + + +++DFG       D T   +   +
Sbjct: 186 IA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAV 237

Query: 205 GTYGYMAPE-----YASDGQFSVKSDVFSFGILLLEIISG 239
           GT  Y++PE         G++  + D +S G+ + E++ G
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 31/216 (14%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 93
           ++F   K +G+G FG V        +   AVK L K   + ++  K + +E  +L   ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRF---HII 144
           H  LV L     Q  +KL  + +++    L         F + R        RF    I 
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIA 149

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
                 + YLH    L I++RDLK  N+LLD   +  ++DFGL +     E    T    
Sbjct: 150 SA----LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFC 200

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           GT  Y+APE      +    D +  G +L E++ G 
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 37/219 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 87
           +NF   + LG+G FG V    + +  ++ AVK L K  I +       ++V        I
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------DDDVECTMTEKRI 76

Query: 88  LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRF 141
           L     H  L +L  CC Q  ++L  + EF+    L      S  FD+ R        RF
Sbjct: 77  LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RF 128

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
           +        +M+LH      II+RDLK  NVLLD + + K++DFG+ +    +     T 
Sbjct: 129 YAAE-IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT- 183

Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
              GT  Y+APE   +  +    D ++ G+LL E++ G 
Sbjct: 184 -FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 25/213 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 93
            +F+    LG+G FG V         E+ AVK L K   I +  ++    E  +L    +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICGT 147
              L +L   C Q  ++L  + E++    L         F +           F+     
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-I 451

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
           A G+ +L       II+RDLK  NV+LD + + KI+DFG+ +    D     T    GT 
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTP 506

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            Y+APE  +   +    D ++FG+LL E+++G+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 93
            +F+    LG+G FG V         E+ AVK L K   I +  ++    E  +L    +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFH---II 144
              L +L   C Q  ++L  + E++    L         F +           F+   I 
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAEIA 131

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
            G    + +L       II+RDLK  NV+LD + + KI+DFG+ +    D     T    
Sbjct: 132 IG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FC 182

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           GT  Y+APE  +   +    D ++FG+LL E+++G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 85.7 bits (213), Expect = 6e-19
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 93
            +F + + +G+G +  V    L     I A+K + K     ++ +  ++ E  +      
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFH---II 144
           H  LV L   C Q E +L  + E++    L           +E         RF+   I 
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEIS 120

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
                 + YLH+     II+RDLK  NVLLD + + K++D+G+ +         +T    
Sbjct: 121 LA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FC 171

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           GT  Y+APE      +    D ++ G+L+ E+++G+
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 32/217 (14%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 90
              +     +G G +G V        G+++A+K+LS+  +         +EL     L  
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78

Query: 91  KLQHRNLVKLL------GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
            +QH N++ LL             +  L+  FM    L   +      K  +   ++ ++
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM----GLKFSEEKIQY-LV 132

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               +G+ Y+H      ++HRDLK  N+ +++D   KI DFGLAR    + T       +
Sbjct: 133 YQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YV 184

Query: 205 GTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   S   ++   D++S G ++ E+++GK
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 40/224 (17%)

Query: 39  NNFSINKKLGQGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNE-VILF 89
            NF + K LG G +G V+   K +  D  ++ A+K L K   + +    E  + E  +L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 90  SKLQHRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFH- 142
              Q   LV L     Q E KL LI +++    L         F +          + + 
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QIYV 165

Query: 143 --IICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
             I+      + +LH+   L II+RD+K  N+LLD + +  ++DFGL++ F  DETE   
Sbjct: 166 GEIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-A 217

Query: 201 KRVIGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIISGK 240
               GT  YMAP+    G      +V  D +S G+L+ E+++G 
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 93
            +F + + +G+G +  V    L     I A++ + K     ++ +  ++ E  +      
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFH---II 144
           H  LV L   C Q E +L  + E++    L           +E         RF+   I 
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAEIS 163

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
                 + YLH+     II+RDLK  NVLLD + + K++D+G+ +         +T    
Sbjct: 164 LA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FC 214

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           GT  Y+APE      +    D ++ G+L+ E+++G+
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 35/219 (15%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 90
              +   K +G G  G V      +  + +A+K+LS+  +         +EL     L  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79

Query: 91  KLQHRNLVKLL------GCCIQGEEKLLIYEFMTNKSLDSFI---FDQERCKILDWSKRF 141
            + H+N++ LL          + ++  ++ E M + +L   I    D ER          
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMS-------- 130

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
           +++     G+ +LH      IIHRDLK SN+++  D   KI DFGLAR      +   T 
Sbjct: 131 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 185

Query: 202 RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            V+ T  Y APE      +    D++S G ++ E+I G 
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 29/216 (13%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 90
              +   K +G G  G V      V  + +A+K+LS+  +         +EL     L  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116

Query: 91  KLQHRNLVKLL------GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
            + H+N++ LL          + ++  L+ E M + +L   I    + ++      + ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----QMELDHERMSY-LL 170

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
                G+ +LH      IIHRDLK SN+++  D   KI DFGLAR      +   T  V+
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 225

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            T  Y APE      +    D++S G ++ E++  K
Sbjct: 226 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 93
            +F ++K LG+G FG V+        +  A+K L K   + +  ++    E  +L    +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 94  HRNLVKLLGCCIQGEEKL-LIYEFMTNKSL-----DSFIFDQERCKILDWSKRFHIICGT 147
           H  L  +  C  Q +E L  + E++    L         FD  R         F+     
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAE-I 127

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
             G+ +LH      I++RDLK  N+LLD+D + KI+DFG+ +     + + NT    GT 
Sbjct: 128 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTP 182

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISG 239
            Y+APE     +++   D +SFG+LL E++ G
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 31/217 (14%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 90
              +   + +G G +G V        G ++A+K+L +  +         +EL+    L  
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79

Query: 91  KLQHRNLVKLL------GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
            ++H N++ LL             +  L+  FM    L   +    + + L   +   ++
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLV 134

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               +G+ Y+H      IIHRDLK  N+ +++D   KI DFGLAR    + T       +
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YV 186

Query: 205 GTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +  +++   D++S G ++ E+I+GK
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 32/217 (14%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            ++ + K +G+G FG V        +++ A+K LSK   I          E  + +    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 95  RNLVKLLGCCIQGEEKL-LIYEFMTN----KSLDSFIFDQERCKILDWSKRFH---IICG 146
             +V+L     Q +  L ++ E+M        + ++   ++         RF+   ++  
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYTAEVVLA 180

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
               +  +H    +  IHRD+K  N+LLD+  + K++DFG       +         +GT
Sbjct: 181 ----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232

Query: 207 YGYMAPE----YASDGQFSVKSDVFSFGILLLEIISG 239
             Y++PE       DG +  + D +S G+ L E++ G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 52/220 (23%), Positives = 98/220 (44%), Gaps = 33/220 (15%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 91
              ++    +G+G +G V      ++   +A+K++S    Q      L+E+K    +  +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81

Query: 92  LQHRNLVKLLGCCI-QGEEKL----LIYEFMT---NKSLDSFIFDQERCKILDWSKRFHI 143
            +H N++ +         E++    ++ + M     K L +     +           + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC--------YF 133

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN--TK 201
           +    RG+ Y+H  +   ++HRDLK SN+LL+   + KI DFGLAR    D       T+
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 202 RVIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGK 240
            V  T  Y APE   +   ++   D++S G +L E++S +
Sbjct: 191 YVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 51/247 (20%), Positives = 92/247 (37%), Gaps = 57/247 (23%)

Query: 38  TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 96
           +  +S+ K LG G FG V +   ++ G+  A+K++ +      +EL     +   L H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDHVN 61

Query: 97  LVKLLGC--------------------CIQGEEKLLIYEFMTNKSLDSFIF--------D 128
           ++KL+                             +  +      +     +         
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 129 QERCKILDWSKR-------FHI------ICGTARGVMYLHQDSRLRIIHRDLKASNVLLD 175
               K+L    R         I      +    R V ++H    L I HRD+K  N+L++
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQNLLVN 175

Query: 176 QDMNP-KISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YASDGQFSVKSDVFSFGILL 233
              N  K+ DFG A+      +E +   +   + Y APE      +++   D++S G + 
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 234 LEIISGK 240
            E+I GK
Sbjct: 233 GELILGK 239

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 43/198 (21%), Positives = 85/198 (42%), Gaps = 31/198 (15%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 90
            + + I   +G G +G V +    ++ + +A+K++ ++ E        L+E+     + +
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107

Query: 91  KLQHRNLVKLLGCCIQGEEKL-----LIYEFMT---NKSLDSFIF-DQERCKILDWSKRF 141
           +L H ++VK+L   I  + +      ++ E       K   + ++  +   K        
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-------- 159

Query: 142 HIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK 201
            ++     GV Y+H  S   I+HRDLK +N L++QD + K+ DFGLAR     E   +  
Sbjct: 160 TLLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

Query: 202 RVIGTYGYMAPEYASDGQ 219
            +      M        +
Sbjct: 217 PISPREDDMNLVTFPHTK 234

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 35/162 (21%), Positives = 64/162 (39%), Gaps = 32/162 (19%)

Query: 43  INKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNLVKL 100
            ++ LG G  G V +       ++ A+K L         + + EV + +   Q  ++V++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76

Query: 101 LGCC---IQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRF-------HIICGTAR 149
           +        G + L ++ E +    L    F     +I D   +         I+     
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGEL----FS----RIQDRGDQAFTEREASEIMKSIGE 128

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLA 188
            + YLH    + I HRD+K  N+L      +   K++DFG A
Sbjct: 129 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 31/217 (14%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 90
              +     +G G +G V        G  +AVK+LS+  +         +EL+    L  
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83

Query: 91  KLQHRNLVKLL------GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHII 144
            ++H N++ LL          +  +  L+   M    L++ +    +C+ L       +I
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQFLI 138

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
               RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + T       +
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----YV 190

Query: 205 GTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGK 240
            T  Y APE   +   ++   D++S G ++ E+++G+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 46/230 (20%)

Query: 38  TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQG---------------LKEL 82
            + +++ + +  G +G V  G   +G  +A+KR+      G               L+E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 83  KNEVILFSKLQHRNLVKLLGCCI-QGEEKL----LIYEFMTN------KSLDSFIFDQER 131
           +    L +   H N++ L    +   E  +    L+ E M              I  Q  
Sbjct: 81  R----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136

Query: 132 CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF 191
              +     +HI+     G+  LH+     ++HRDL   N+LL  + +  I DF LAR  
Sbjct: 137 QYFM-----YHIL----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 192 GGDETEGNTKRVIGTYGYMAPEY-ASDGQFSVKSDVFSFGILLLEIISGK 240
             D  +  T  V     Y APE       F+   D++S G ++ E+ + K
Sbjct: 185 TADANK--THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 40/228 (17%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQ 93
            + +   K LG GG G V+        + +A+K   KI     + +K+   E+ +  +L 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66

Query: 94  HRNLVKLL----------GCCIQGEEKL----LIYEFMT---NKSLDSFIFDQERCKILD 136
           H N+VK+              +    +L    ++ E+M       L+     +E  +   
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR--- 123

Query: 137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDE 195
                  +    RG+ Y+H  +   ++HRDLK +N+ ++ +D+  KI DFGLAR      
Sbjct: 124 -----LFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 196 TEGN--TKRVIGTYGYMAPE-YASDGQFSVKSDVFSFGILLLEIISGK 240
           +     ++ ++ T  Y +P    S   ++   D+++ G +  E+++GK
Sbjct: 176 SHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 42/228 (18%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 91
           +++F +   LG+G +G V   T    G+ +A+K++    +       L+E+K    +   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65

Query: 92  LQHRNLVKLLGCCI-QGEEKL----LIYEFMT---NKSLDSFIFDQERCKILDWSKRFHI 143
            +H N++ +         E      +I E M    ++ + + +   +  +        + 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ--------YF 117

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
           I  T R V  LH  +   +IHRDLK SN+L++ + + K+ DFGLAR    DE+  +    
Sbjct: 118 IYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEP 172

Query: 204 IGTYGYM----------APEY-ASDGQFSVKSDVFSFGILLLEIISGK 240
            G    M          APE   +  ++S   DV+S G +L E+   +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 43/207 (20%), Positives = 77/207 (37%), Gaps = 49/207 (23%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 90
            +N+ I   +G+G +G VY        + +A+K+++++ E        L+E+     + +
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80

Query: 91  KLQHRNLVKLLGCCI-QGEEKL----LIYEFM---------TNKSLDS----FIFDQERC 132
           +L+   +++L    I     K     ++ E           T   L       I      
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN--- 137

Query: 133 KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG 192
            +L              G  ++H      IIHRDLK +N LL+QD + K+ DFGLAR   
Sbjct: 138 -LL-------------LGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

Query: 193 GDETEGNTKRVIGTYGYMAPEYASDGQ 219
            ++       +               Q
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQ 207

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 46/235 (19%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 90
              + + KKLG+G +G V+K      G+ +AVK++    +         +E+    IL  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64

Query: 91  KLQHRNLVKLLGCCI--QGEEKLLIYEFMT---NKSLDSFIFDQERCKILDWSKRFHIIC 145
              H N+V LL         +  L++++M    +  + + I +    +        +++ 
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ--------YVVY 116

Query: 146 GTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIG 205
              + + YLH  S   ++HRD+K SN+LL+ + + K++DFGL+R+F       N   +  
Sbjct: 117 QLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 206 TYG-------------------YMAPEYA-SDGQFSVKSDVFSFGILLLEIISGK 240
                                 Y APE      +++   D++S G +L EI+ GK
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.3 bits (171), Expect = 1e-13
 Identities = 36/219 (16%), Positives = 65/219 (29%), Gaps = 57/219 (26%)

Query: 37  ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRL--------SKISEQGLKELKNEVIL 88
            T      +K+G+G FG V++    D   +A+K +        +   ++  +E+  E+I+
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 89  FSKLQ---------HRNLVKLLGCCI-QGEE-KLLIYEFMTNKSLDSFIFDQER------ 131
             +L              + L      QG    LL+  +    S      D+        
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 132 ------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL 173
                              K+   +    I+      +        LR  HRDL   NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 174 LDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           L +    K+      ++             I + G    
Sbjct: 195 LKKTSLKKLHYTLNGKSST-----------IPSCGLQVS 222

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 45/188 (23%), Positives = 80/188 (42%), Gaps = 30/188 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 96
           N + + +K+G G FG +Y GT +  G+E+A+K     ++     L  E  ++  +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI--ICGTA----RG 150
           +  +  C  +G+  +++ E +   SL+        C     S++F +  +   A      
Sbjct: 67  IPTIRWCGAEGDYNVMVME-LLGPSLEDLF---NFC-----SRKFSLKTVLLLADQMISR 117

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLARAFGGDETEG-----NTKR 202
           + Y+H  +    IHRD+K  N L+          I DFGLA+ +    T         K 
Sbjct: 118 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174

Query: 203 VIGTYGYM 210
           + GT  Y 
Sbjct: 175 LTGTARYA 182

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 42/225 (18%)

Query: 43  INKKLGQGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELK-------NEVILFSK 91
           + +KLG G F  V+    +V+   +A+K +      +E    E+K        +      
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82

Query: 92  LQHRNLVKLLGC-CIQGEEKL---LIYEFMTNKSLDSFIFDQERCKILDWSKRFHI--IC 145
           +   +++KLL     +G   +   +++E +  ++L + I   E        +   +  + 
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-------HRGIPLIYVK 134

Query: 146 GTAR----GVMYLHQDSRLRIIHRDLKASNVLLDQDMNP------KISDFGLARAFGGDE 195
             ++    G+ Y+H   R  IIH D+K  NVL++   +P      KI+D G A       
Sbjct: 135 QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----W 187

Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
            + +    I T  Y +PE      +   +D++S   L+ E+I+G 
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 36/291 (12%), Positives = 80/291 (27%), Gaps = 55/291 (18%)

Query: 46  KLGQGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLL 101
             G       ++       +++A+  +     + +  L+E  +  +  S++    + ++L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLR 161
                    L++ E++   SL                     +   A      H   R  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVA--DTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 162 IIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS 221
           +       S V +  D        G                V+     M          +
Sbjct: 150 VALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDA-------N 180

Query: 222 VKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM--PSQLIDPCIQGSF 279
            + D+   G  L  ++     R         + +  A +        P+ + D  I   F
Sbjct: 181 PQDDIRGIGASLYALLVN---RWPLPEAGVRSGLAPAERDTAGQPIEPADI-DRDI--PF 234

Query: 280 NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLADR 330
            ++ V          VQ     R +   + LM  +  V  + +  G + + 
Sbjct: 235 QISAVA------ARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEA 279

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 39/201 (19%), Positives = 74/201 (36%), Gaps = 32/201 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
           N + + KK+G GGFG +Y        ++ A   + K+  Q    L +E+  + ++  ++ 
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDC 95

Query: 98  V----KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC-----KILDWSKRFHI--ICG 146
           +    +       G            K         ER      KI   +  F    +  
Sbjct: 96  IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ 155

Query: 147 TA----RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLARAFGGDET---- 196
                   + Y+H++     +H D+KA+N+LL      ++  +D+GL+  +  +      
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212

Query: 197 -EGNTKRVIGTYGYMAPEYAS 216
            E   K   GT      E+ S
Sbjct: 213 QENPRKGHNGT-----IEFTS 228

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 32/189 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
           N F + +K+G G FG +Y GT +   +E+A+K  +  ++     L  E  ++  LQ    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64

Query: 98  V-KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQER-------CKILDWSKRFHIICGTAR 149
           +  +    ++G+  +L+ + +   SL+       R         + D      +I     
Sbjct: 65  IPNVRWFGVEGDYNVLVMD-LLGPSLEDLFNFCSRKLSLKTVLMLADQ-----MIN---- 114

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLARAFGGDETEG-----NTK 201
            V ++H  S    +HRD+K  N L+          I DFGLA+ +    T         K
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171

Query: 202 RVIGTYGYM 210
            + GT  Y 
Sbjct: 172 NLTGTARYA 180

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 38/190 (20%), Positives = 87/190 (45%), Gaps = 32/190 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 96
            ++ + +++G+G FG +++GT L++ Q++A+K   + S+     L++E   +  L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI--ICGTA----RG 150
           +  +     +G   +L+ + +   SL+  +   + C      ++F +  +   A      
Sbjct: 68  IPNVYYFGQEGLHNVLVID-LLGPSLEDLL---DLC-----GRKFSVKTVAMAAKQMLAR 118

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLARAFGGDETEG-----NT 200
           V  +H+ S   +++RD+K  N L+ +  +       + DFG+ + +    T+        
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

Query: 201 KRVIGTYGYM 210
           K + GT  YM
Sbjct: 176 KNLSGTARYM 185

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 42/231 (18%), Positives = 78/231 (33%), Gaps = 62/231 (26%)

Query: 25  ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKEL 82
           +  + E+ T ++A   + +   +GQGGFG +Y   +   + +        K+       L
Sbjct: 22  QFAVGEIITDMAA-AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL 80

Query: 83  KNEVILFSKLQHRNLV---------------KLLGCCIQGEEKLLIYEFMT----NKSLD 123
             E+  + +      +               K  G  +  +     Y FM        L 
Sbjct: 81  FTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQ 139

Query: 124 SFIFDQERCKILDWSKRFHIICGTARGVM-----------YLHQDSRLRIIHRDLKASNV 172
             I++         +KRF         V+           Y+H+      +H D+KASN+
Sbjct: 140 K-IYEA--N-----AKRFSRKT-----VLQLSLRILDILEYIHEHE---YVHGDIKASNL 183

Query: 173 LLDQDMNPKI--SDFGLARAFGGDET-----EGNTKRVIGTYGYMAPEYAS 216
           LL+     ++   D+GLA  +  +           +   GT      E+ S
Sbjct: 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT-----IEFTS 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.2 bits (141), Expect = 9e-10
 Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 32/190 (16%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 96
            NF + KK+G G FG +  G  L   + +A+K     S     +L  E   + +L     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI--ICGTA----RG 150
           + ++      G+   ++ E +   SL+  +FD   C      + F +  +   A      
Sbjct: 67  IPQVYYFGPCGKYNAMVLE-LLGPSLED-LFDL--C-----DRTFSLKTVLMIAIQLISR 117

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLARAFGGDETE-----GNT 200
           + Y+H  +   +I+RD+K  N L+ +  N       I DF LA+ +   ET+        
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

Query: 201 KRVIGTYGYM 210
           K + GT  YM
Sbjct: 175 KSLTGTARYM 184

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 32/209 (15%), Positives = 69/209 (33%), Gaps = 45/209 (21%)

Query: 39  NNFSINKKLGQGGFGPVYKGT---------LVDGQEIAVKRLSKISEQGLKELK------ 83
             + +     +   G +Y+               Q+ ++K L     +   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 84  --NEVILFSKLQHRNLV---KLLGCCIQGEEKLLIYEFMT----NKSLDSFIFDQERCKI 134
              +V  + KL    L+     +G  +  ++    Y F+      +SL S   D     +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHV 155

Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLARAFG 192
           L       + C     + +LH++     +H ++ A N+ +D +   ++  + +G A  + 
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212

Query: 193 GDET-----EGNTKRVIGTYGYMAPEYAS 216
                    EG+     G       E+ S
Sbjct: 213 PSGKHVAYVEGSRSPHEGD-----LEFIS 236

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 49/229 (21%), Positives = 85/229 (37%), Gaps = 52/229 (22%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQ 93
            + + I+  +G+G FG V K    V+ + +A+K          Q   E++   +L   + 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMN 108

Query: 94  HR------NLVKLLGC-------CIQGEEKLL---IYEFMTNKSLDSFIFDQERCKILDW 137
                    +V L          C+  E  +L   +Y+ + N +      +  R      
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLNLTR------ 160

Query: 138 SKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDE 195
                        +++L     L IIH DLK  N+LL        KI DFG +    G  
Sbjct: 161 ----KFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR 214

Query: 196 TEGNTKRVIGTY----GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
                   I  Y     Y +PE      + +  D++S G +L+E+ +G+
Sbjct: 215 --------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 54/226 (23%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHR- 95
           + + K +G+G FG V K       Q +A+K +    +   Q  +E++   IL   L+ + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154

Query: 96  -----NLVKLLGC-------CIQGEEKLL---IYEFMTNKSLDSFIFDQERCKILDWSKR 140
                N++ +L         C+  E  LL   +YE +       F     R         
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVR--------- 203

Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEG 198
                   + +  LH   + RIIH DLK  N+LL Q      K+ DFG +  +       
Sbjct: 204 -KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQR--- 255

Query: 199 NTKRVIGTY----GYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
                + TY     Y APE     ++ +  D++S G +L E+++G 
Sbjct: 256 -----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 52/266 (19%), Positives = 94/266 (35%), Gaps = 74/266 (27%)

Query: 38  TNNFSINKKLGQGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--- 93
              + + +KLG G F  V+    +   + +A+K + K +E   +   +E+ L   ++   
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94

Query: 94  -----HRNLVKLLGC-CIQGEE---KLLIYEFMTNKSLDSFIFDQERCKI-LDWSKRFHI 143
                   +V+LL    I G       +++E +    L  +I       + L   K+  I
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--I 151

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLL----------------------------- 174
           I    +G+ YLH  ++ RIIH D+K  N+LL                             
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 175 --------------------DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                                + +  KI+D G A       TE      I T  Y + E 
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEV 264

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                ++  +D++S   +  E+ +G 
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGD 290

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 57/242 (23%), Positives = 89/242 (36%), Gaps = 58/242 (23%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQ 93
            N F + +K+G G FG V     + + +  AVK    + K +     E     IL  K+Q
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQ 89

Query: 94  HR-----NLVKLLGC-------CIQGEEKLL---IYEFMTNKSLDSFIFDQERCKILDWS 138
           +      N+VK  G        C+  E   L   +YE +T  + + F  +  +       
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIK------- 140

Query: 139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG 198
                     + + YL    ++ + H DLK  N+LLD     K          G      
Sbjct: 141 ---LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194

Query: 199 NTKR--------------------VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS 238
            TK                     +I T  Y APE   +  + V SD++SFG +L E+ +
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

Query: 239 GK 240
           G 
Sbjct: 255 GS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 45/238 (18%), Positives = 79/238 (33%), Gaps = 54/238 (22%)

Query: 38  TNNFSINKKLGQGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKL 92
              + I   LG+G FG V +         ++A+K    + K  E    E+    +L  K+
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73

Query: 93  QHR------NLVKLLGC-------CIQGEEKLL---IYEFMTNKSLDSFIFDQERCKILD 136
           + +        V +          CI  E  LL    +EF+   +   +     R     
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVR----- 126

Query: 137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA------ 190
                H+       + +LH     ++ H DLK  N+L        + +   +        
Sbjct: 127 -----HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178

Query: 191 -------FGGDETEGNTK-RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
                  FG    +      ++ T  Y  PE   +  ++   DV+S G +L E   G 
Sbjct: 179 TSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 53/238 (22%), Positives = 84/238 (35%), Gaps = 54/238 (22%)

Query: 38  TNNFSINKKLGQGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKL 92
           +  + I   LG+G FG V +       G+ +AVK    + +  E    E++   +L   L
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHL 68

Query: 93  QHR------NLVKLLGC-------CIQGEEKLL---IYEFMTNKSLDSFIFDQERCKILD 136
                      V++L         CI  E  LL    Y+F+       F  D  R     
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIR----- 121

Query: 137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA------ 190
                 +     + V +LH     ++ H DLK  N+L  Q    +  +  + R       
Sbjct: 122 -----KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173

Query: 191 -------FGGDETEGNTK-RVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
                  FG    +      ++ T  Y APE      +S   DV+S G +L+E   G 
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 3e-05
 Identities = 34/287 (11%), Positives = 74/287 (25%), Gaps = 70/287 (24%)

Query: 48  GQGGFGPVYKGTLVDGQEIAVKRLSKISEQ--------GLKELKNEVILFSKLQHRNLVK 99
           G  G G   K  +     + V    K+  +         LK   +   +   LQ   L+ 
Sbjct: 157 GVLGSG---KTWVA----LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ--KLLY 207

Query: 100 LLGC-CIQGEEKLLIYEFMTN---KSLDSFIFDQERCK---ILD--WSKR----FHIICG 146
            +        +     +   +     L   +  +       +L    + +    F++ C 
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC- 266

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
                       ++ +  R  + ++ L          D   +     DE +    + +  
Sbjct: 267 ------------KILLTTRFKQVTDFLSAATTTHISLDH-HSMTLTPDEVKSLLLKYLDC 313

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM 266
                P                     L II+     G    DN        WK  N   
Sbjct: 314 RPQDLPREVLTT-----------NPRRLSIIAESIRDGLATWDN--------WKHVNCDK 354

Query: 267 PSQLIDPCIQGSFNLAEVIRCIH-IGLLCVQQHPKDRPSMPSVILML 312
            + +I+  +      AE  +    + +      P        ++ ++
Sbjct: 355 LTTIIESSLN-VLEPAEYRKMFDRLSVF-----PPSAHIPTILLSLI 395

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	358
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.11
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.84
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.46
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.44
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.37
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.16
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.08
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.85
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.85
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.7
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.46
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.46
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.45
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.37
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.33
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.27
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.26
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.21
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.89
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.87
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.75
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.67
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.27
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.72
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.96

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.1e-56  Score=405.88  Aligned_cols=254  Identities=21%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++++.||+|+||.||+|++.. |+.||||++.+  ........+.+|+++|+.++||||++++++|++++.+|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            699999999999999999999754 89999999965  344556788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      ||+||+|.+++..... ..+++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||++..+..  
T Consensus       104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--  177 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--  177 (350)
T ss_dssp             CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred             CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence            9999999999965433 33789999999999999999999999   99999999999999999999999999986521  


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.   ...+..+.   .... ..+..   
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~---~~~~-~~~~~---  247 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLKII---SGSF-PPVSL---  247 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH---HTCC-CCCCT---
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHH---cCCC-CCCCc---
Confidence            11123346799999999999999999999999999999999999999864322   22222222   1211 11111   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                        .    ...++.+||.+||+.||++|||+.+++++-|.
T Consensus       248 --~----~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~  280 (350)
T 4b9d_A          248 --H----YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI  280 (350)
T ss_dssp             --T----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             --c----CCHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence              1    12356789999999999999999999987543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.7e-55  Score=396.20  Aligned_cols=256  Identities=23%  Similarity=0.342  Sum_probs=212.5

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      +.|++.++||+|+||.||+|.++. |+.||||++........+.+.+|+++|+.++||||++++++|.+++.+|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            569999999999999999999864 8999999997655555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++|+|.+++.+.    .+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++..+...  .
T Consensus       154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~  224 (346)
T 4fih_A          154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V  224 (346)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--S
T ss_pred             CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--C
Confidence            999999998542    3999999999999999999999999   999999999999999999999999999876322  2


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+   ....+..+..    .....+..     
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~----~~~~~~~~-----  292 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRD----NLPPRLKN-----  292 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHH----SSCCCCSC-----
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHc----CCCCCCCc-----
Confidence            23345689999999999999999999999999999999999999986432   2222222221    11111110     


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                        ......++.+||.+||+.||++|||+.|++++-|....
T Consensus       293 --~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          293 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             --cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence              00112356789999999999999999999998876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.4e-54  Score=390.37  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=207.2

Q ss_pred             CCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ++|.+.++||+|+||.||+|.+.      +++.||||+++.......+.+.+|+++|.+++||||+++++++.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56788899999999999999864      367899999988777778889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcccc------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCe
Q 018304          113 IYEFMTNKSLDSFIFDQER------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP  180 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i  180 (358)
                      |||||++|+|.+++.+...            ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999965431            235899999999999999999999999   9999999999999999999


Q ss_pred             EEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHH
Q 018304          181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      ||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |+.||.....   ...+..+.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~  274 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCIT  274 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence            9999999987643333333345578999999999999999999999999999999998 8999865332   22332222


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ...    .......+         ...+.+||.+||+.||++|||+.+|+++|+.+..
T Consensus       275 ~g~----~~~~p~~~---------~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          275 QGR----ELERPRAC---------PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HTC----CCCCCTTC---------CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cCC----CCCCcccc---------cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            211    11111111         1356789999999999999999999999987643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.8e-54  Score=388.02  Aligned_cols=258  Identities=28%  Similarity=0.457  Sum_probs=211.4

Q ss_pred             CCCCcceeecccCCccEEEEEEc------CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ++|.+.+.||+|+||.||+|.+.      ++..||||.++.......+.+.+|+++|++++||||+++++++.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            67899999999999999999863      367899999988777778889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccc----------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          113 IYEFMTNKSLDSFIFDQE----------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                      |||||++|+|.+++....          ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996542          2235999999999999999999999999   999999999999999999999


Q ss_pred             eccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHH
Q 018304          183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      +|||+++...............||+.|+|||.+.+..|+.++|||||||++|||+| |+.||.....   ......+.. 
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~-  245 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQ-  245 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHH-
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc-
Confidence            99999986533222222333468999999999999999999999999999999998 8999865432   223322222 


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         +........         ....+.+||.+||+.||++|||+.+|++.|+.+
T Consensus       246 ---~~~~~~p~~---------~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          246 ---GRVLQRPRT---------CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             ---TCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCcc---------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               111111111         123577899999999999999999999998765

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.6e-55  Score=391.62  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=207.3

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||+||+|++.. |+.||+|++.+.   .......+.+|+++|+.++||||++++++|++++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            579999999999999999999754 899999999752   2344677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |||+||+|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++..+...
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999996543   3999999999999999999999999   999999999999999999999999999987544


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .........+||+.|+|||++.+..|+.++||||+||++|+|++|..||...+   .......+..   ..  ..+.+  
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~---~~--~~~p~--  255 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKIIK---LE--YDFPE--  255 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH---TC--CCCCT--
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHc---CC--CCCCc--
Confidence            33444556789999999999999999999999999999999999999986432   2222222221   11  11111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHH
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV  308 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~el  308 (358)
                         ..    ..++.+||.+||+.||++|||+.|+
T Consensus       256 ---~~----s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          256 ---KF----FPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             ---TC----CHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             ---cc----CHHHHHHHHHHccCCHhHCcChHHH
Confidence               11    1356789999999999999999985

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-54  Score=385.61  Aligned_cols=260  Identities=27%  Similarity=0.431  Sum_probs=201.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..+++++.+.||+|+||+||+|.++  ..|+||+++.  ......+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            4478899999999999999999864  3589998864  345566789999999999999999999998754 5789999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |||++|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus       111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            9999999999996543  33999999999999999999999999   999999999999999999999999999865433


Q ss_pred             CCCCccccccccCCCCCcccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..........||+.|+|||++.+   ..|+.++|||||||++|||++|+.||......  ....................
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~~~  263 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDLSKLY  263 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCSTTSC
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCccccc
Confidence            33333445679999999999864   46899999999999999999999998643321  11111111111111111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..         ....+.+||.+||+.||++|||+.+|++.|+.+
T Consensus       264 ~~---------~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          264 KN---------CPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             TT---------SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             cc---------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11         123567899999999999999999999998765

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-53  Score=397.76  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=212.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      +.|++++.||+|+||.||+|.++. |+.||||++........+.+.+|+.+|+.++||||++++++|.+++.+|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            579999999999999999999854 8999999997655555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      +||+|.+++...    .+++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||++..+...  .
T Consensus       231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~  301 (423)
T 4fie_A          231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--V  301 (423)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--C
T ss_pred             CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--C
Confidence            999999998542    3999999999999999999999999   999999999999999999999999999876322  2


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||....   ....+..+..    .....+...   .
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~----~~~~~~~~~---~  371 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRD----NLPPRLKNL---H  371 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHH----SCCCCCSCT---T
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHc----CCCCCCccc---c
Confidence            23445689999999999999999999999999999999999999985432   2222222221    111111110   0


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .    ....+.+||.+||+.||++|||+.|++++-|....
T Consensus       372 ~----~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          372 K----VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             S----SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             c----CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            1    12356789999999999999999999998776543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.3e-53  Score=373.25  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=193.5

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++.+.   .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999975 4899999999652   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+ +|+|.+++.+..   .+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++..... 
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-  164 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence            999 679999885543   4999999999999999999999999   99999999999999999999999999986532 


Q ss_pred             CCCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                        .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.   ......+..    ... .+.. 
T Consensus       165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~~----~~~-~~p~-  233 (275)
T 3hyh_A          165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNISN----GVY-TLPK-  233 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----TCC-CCCT-
T ss_pred             --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHc----CCC-CCCC-
Confidence              223345679999999999998876 5799999999999999999999864321   122222221    111 1111 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                          ..    ...+.+||.+||+.||++|||+.|++++-|...
T Consensus       234 ----~~----s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          234 ----FL----SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ----TS----CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ----CC----CHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                11    235678999999999999999999999877643

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.1e-53  Score=385.16  Aligned_cols=263  Identities=23%  Similarity=0.269  Sum_probs=208.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .+.|++.++||+|+||.||+|.++. |+.||||+++....     ..+|+.+++.++||||++++++|.+++.+|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            3678899999999999999999854 89999999975321     24799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEeccccceecCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFGGDE  195 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df~~~~~~~~~~  195 (358)
                      |+||+|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+|||++.+| .+||+|||++..+....
T Consensus       132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999996543   4999999999999999999999999   99999999999999987 69999999998764322


Q ss_pred             CC---CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC-Cccc
Q 018304          196 TE---GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP-SQLI  271 (358)
Q Consensus       196 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  271 (358)
                      ..   ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||........   ...+..   ...+ ..+.
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~---~~~~~~~~~  279 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIAS---EPPPIREIP  279 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHH---SCCGGGGSC
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHc---CCCCchhcC
Confidence            11   122335799999999999999999999999999999999999999875444322   222211   1111 1111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC----CCCCCCCCCCc
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE----TVLPQPKQPGY  326 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~----~~~~~~~~~~~  326 (358)
                      .         .....+.++|.+||+.||++|||+.||+++|...    ..+..|+....
T Consensus       280 ~---------~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          280 P---------SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             T---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             c---------cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            1         1123566899999999999999999999876543    44555555443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.2e-53  Score=381.96  Aligned_cols=258  Identities=27%  Similarity=0.437  Sum_probs=209.0

Q ss_pred             CCCCcceeecccCCccEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      +++++.+.||+|+||.||+|.+.      +++.||||.++.. .....+.+.+|+.++.+++||||+++++++.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45688999999999999999862      3678999999653 2334577899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccc-------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC
Q 018304          112 LIYEFMTNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM  178 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~  178 (358)
                      +|||||++|+|.+++....             ....+++..++.++.||+.||.|||+++   |+||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999996532             1235899999999999999999999999   99999999999999999


Q ss_pred             CeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHH
Q 018304          179 NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGH  257 (358)
Q Consensus       179 ~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~  257 (358)
                      .+||+|||+++.+.............||+.|+|||.+.+..|+.++|||||||++|||++ |..||.....   ..+...
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence            999999999986543333333345578999999999999999999999999999999998 8999865432   222222


Q ss_pred             HHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      +.    ........+.+         ...+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       260 i~----~~~~~~~p~~~---------~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 IR----NRQVLPCPDDC---------PAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HH----TTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HH----cCCCCCCcccc---------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22    22222222111         23567899999999999999999999999753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-52  Score=372.72  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=201.7

Q ss_pred             CCC-CcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCee
Q 018304           39 NNF-SINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK  110 (358)
Q Consensus        39 ~~y-~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~~  110 (358)
                      ++| ++.+.||+|+||.||+|.+.. +..||+|.+..  ........+.+|+++++.++||||++++++|.+    +..+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            455 778899999999999999854 88999999864  344556778999999999999999999999976    3467


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEeccccce
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLAR  189 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~~~~  189 (358)
                      ++|||||++|+|.+++.+.   +.+++..++.++.||+.||.|||+++ .+|+||||||+|||++. +|.+||+|||++.
T Consensus       105 ~lvmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            9999999999999999654   34999999999999999999999875 34999999999999984 7999999999997


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ...    .......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||......  ...    .........+.
T Consensus       181 ~~~----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~----~~~i~~~~~~~  249 (290)
T 3fpq_A          181 LKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQI----YRRVTSGVKPA  249 (290)
T ss_dssp             GCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHH----HHHHTTTCCCG
T ss_pred             eCC----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHH----HHHHHcCCCCC
Confidence            532    223345689999999998875 6999999999999999999999998543221  111    11111221111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..+..    .    ..++.+||.+||+.||++|||+.+++++-|..
T Consensus       250 ~~~~~----~----~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~  287 (290)
T 3fpq_A          250 SFDKV----A----IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  287 (290)
T ss_dssp             GGGGC----C----CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCCcc----C----CHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence            11111    1    12467899999999999999999999987643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.3e-52  Score=380.66  Aligned_cols=270  Identities=27%  Similarity=0.405  Sum_probs=215.9

Q ss_pred             ceeHHHHHHhcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCC-CCccc
Q 018304           28 LFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH-RNLVK   99 (358)
Q Consensus        28 ~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~-~~iv~   99 (358)
                      .++..+++...++|++.+.||+|+||.||+|.+..      ++.|++|.+... .......+.+|+++|.++.| |||++
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            34556666677899999999999999999998643      357999999753 34456778899999999965 89999


Q ss_pred             eeeEEEeC-CeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccC
Q 018304          100 LLGCCIQG-EEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR  165 (358)
Q Consensus       100 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~  165 (358)
                      ++++|.+. +.+++|||||++|+|.+++.+...             ...+++..++.++.||+.||.|||+++   |+||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence            99998664 578999999999999999965432             234889999999999999999999999   9999


Q ss_pred             CCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCC
Q 018304          166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRG  244 (358)
Q Consensus       166 di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~  244 (358)
                      ||||+|||++.++.+||+|||+++.+.............||+.|+|||++.+..|+.++|||||||++|||++ |..||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987644333333445678999999999999999999999999999999998 899986


Q ss_pred             CCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          245 FYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ......  .....+.    .+......+..         ..++.++|.+||+.||++|||+.+|+++|+.+
T Consensus       290 ~~~~~~--~~~~~i~----~g~~~~~p~~~---------~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          290 GVKIDE--EFCRRLK----EGTRMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             TCCCSH--HHHHHHH----HTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCHHH--HHHHHHH----cCCCCCCCccC---------CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            543321  1222222    22211221111         13567899999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.9e-53  Score=380.82  Aligned_cols=252  Identities=24%  Similarity=0.290  Sum_probs=199.3

Q ss_pred             CCCCcceeecccCCccEEEEEEc----CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ++|++++.||+|+||+||+|++.    .++.||+|++.+..  ......+.+|+++|+.++||||++++++|.+++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999863    36789999996522  2223457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      |||||+||+|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++....
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999996543   3999999999999999999999999   9999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ..  .......+||+.|+|||++.+..|+.++||||+||++|+|++|..||...+.   ......+..   ...  .+..
T Consensus       178 ~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~---~~~--~~p~  247 (304)
T 3ubd_A          178 DH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMILK---AKL--GMPQ  247 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---CCC--CCCT
T ss_pred             CC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHHHc---CCC--CCCC
Confidence            22  2233456799999999999999999999999999999999999999864322   222222221   111  1111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~  315 (358)
                           ..    ..++.+||.+||+.||++|||     ++|++++-|..
T Consensus       248 -----~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~  286 (304)
T 3ubd_A          248 -----FL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS  286 (304)
T ss_dssp             -----TS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred             -----cC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence                 11    235678999999999999998     47899877654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.1e-51  Score=367.29  Aligned_cols=256  Identities=25%  Similarity=0.365  Sum_probs=194.0

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--------
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--------  108 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--------  108 (358)
                      ++|++++.||+|+||.||+|.++ +|+.||+|.+.... ....+.+.+|+++|+.++||||++++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999975 48999999996533 344567889999999999999999999987654        


Q ss_pred             ----eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          109 ----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       109 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                          .+|+|||||++|+|.+++.........+...++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999977655555677788999999999999999999   99999999999999999999999


Q ss_pred             cccceecCCCCCC----------CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchh
Q 018304          185 FGLARAFGGDETE----------GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL  254 (358)
Q Consensus       185 f~~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~  254 (358)
                      ||++..+......          ......+||+.|+|||++.+..|+.++|||||||++|+|++   ||...     ...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence            9999876432211          11223579999999999999999999999999999999996   65321     111


Q ss_pred             HHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          255 IGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...... ......+...         ......+.+||.+||+.||++|||+.+++++-+..
T Consensus       234 ~~~~~~-~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~  284 (299)
T 4g31_A          234 VRTLTD-VRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE  284 (299)
T ss_dssp             HHHHHH-HHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHH-HhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence            111111 1111111111         11223456799999999999999999999976544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.3e-50  Score=364.38  Aligned_cols=268  Identities=21%  Similarity=0.293  Sum_probs=198.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----eeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----~~~lv  113 (358)
                      ..+|.+.+.||+|+||.||+|.+ +|+.||||++...... ......|+..+..++||||+++++++.+++    .+++|
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            45788999999999999999988 7899999999753322 222334555666789999999999998754    57999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-----~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      |||+++|+|.+++...    .+++..+++++.|++.||.|||++.     .++|+||||||+|||++.++.+||+|||++
T Consensus        80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999643    3899999999999999999999871     122999999999999999999999999999


Q ss_pred             eecCCCCCC--CccccccccCCCCCcccccCC------CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC--------c
Q 018304          189 RAFGGDETE--GNTKRVIGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN--------L  252 (358)
Q Consensus       189 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~--------~  252 (358)
                      .........  .......||+.|+|||++.+.      .++.++|||||||++|||++|..||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            876432221  122345799999999998764      367799999999999999999887654332110        0


Q ss_pred             hhHHHHHHHhhcC-CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          253 NLIGHAWKLWNEG-MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       253 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ............. ..+.+.+    ..........+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCG----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCc----cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            0111111111111 1111111    111234456778899999999999999999999999765

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-49  Score=368.31  Aligned_cols=269  Identities=19%  Similarity=0.286  Sum_probs=206.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC------C
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------E  108 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~------~  108 (358)
                      +++|++++.||+|+||.||+|.+. +|+.||||++.+.  .......+.+|+++|+.++||||+++++++...      +
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            468999999999999999999985 4999999999752  334456788999999999999999999987643      5


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      .+|+|||||+ |+|.+++.+.   +.+++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 5799988543   34999999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCC--CCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          189 RAFGGDE--TEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       189 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      ..+....  ........+||+.|+|||++.+. .++.++||||+||++|+|++|..||...+..   ..+..+.......
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p  282 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTP  282 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence            8653221  12233456899999999998875 5699999999999999999999998654332   2222222221111


Q ss_pred             CCCccccCC------------c-CCCCCHH-----HHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          266 MPSQLIDPC------------I-QGSFNLA-----EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       266 ~~~~~~~~~------------~-~~~~~~~-----~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                       ........            . .......     ....+.+||.+||+.||++|||+.|++++-|....
T Consensus       283 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          283 -SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             -CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             -ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence             11110000            0 0001111     12356789999999999999999999999887654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.5e-48  Score=357.85  Aligned_cols=266  Identities=20%  Similarity=0.268  Sum_probs=200.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc----CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..++|++.+.||+|+||.||+|+++    .++.||+|.+....  ....+.+|+++|+.+ +||||++++++|.+.++.+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4688999999999999999999863    36789999986643  335678899999998 6999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-CCeEEecccccee
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARA  190 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-~~i~L~Df~~~~~  190 (358)
                      +||||+++++|.+++.      .+++..++.++.||+.||.|||++|   |+||||||+|||++.+ +.+||+|||++..
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999982      2899999999999999999999999   9999999999999876 8999999999986


Q ss_pred             cCCCCCC--------------------------CccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCC
Q 018304          191 FGGDETE--------------------------GNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNR  243 (358)
Q Consensus       191 ~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~  243 (358)
                      .......                          ......+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            5322110                          111234699999999998775 5899999999999999999999997


Q ss_pred             CCCCCCCCchhHHHHHHHhh----------------------------------c--CCCCccccCCcCC----CCCHHH
Q 018304          244 GFYHSDNNLNLIGHAWKLWN----------------------------------E--GMPSQLIDPCIQG----SFNLAE  283 (358)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~----------------------------------~--~~~~~~~~~~~~~----~~~~~~  283 (358)
                      ....  +....+..+.....                                  .  ...+.........    ......
T Consensus       248 ~~~~--~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          248 YKAS--DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SCCS--SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCC--CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            4322  22222221111000                                  0  0000000000000    000011


Q ss_pred             HHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          284 VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       284 ~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..++.+||.+||+.||++|||+.|++++-|..
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~  357 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFK  357 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence            23567899999999999999999999987754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.4e-48  Score=379.38  Aligned_cols=257  Identities=22%  Similarity=0.305  Sum_probs=212.2

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      ++|++.+.||+|+||.||+|.++. |+.||+|.+..........+.+|+++|+.++||||++++++|.+.+.+++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            689999999999999999999854 8999999998777777788899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC--CCeEEeccccceecCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAFGGDE  195 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~--~~i~L~Df~~~~~~~~~~  195 (358)
                      .||+|.+++.+..  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||++..+..  
T Consensus       237 ~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--  309 (573)
T 3uto_A          237 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--  309 (573)
T ss_dssp             CCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred             CCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence            9999999985433  33899999999999999999999999   9999999999999854  8999999999988632  


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                       .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.....   ...+..+... ...........  
T Consensus       310 -~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~~i~~~-~~~~~~~~~~~--  382 (573)
T 3uto_A          310 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSC-DWNMDDSAFSG--  382 (573)
T ss_dssp             -TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTT-CCCCCSGGGTT--
T ss_pred             -CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHhC-CCCCCcccccC--
Confidence             2233456799999999999999999999999999999999999999864332   1222222111 00111111111  


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                             ....+.+||.+||+.||.+|||+.++++|-|...
T Consensus       383 -------~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~  416 (573)
T 3uto_A          383 -------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  416 (573)
T ss_dssp             -------SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             -------CCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence                   1235678999999999999999999999877553

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.4e-47  Score=349.79  Aligned_cols=282  Identities=35%  Similarity=0.607  Sum_probs=240.0

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      ..++....++|++.+.||+|+||.||+|.+.+++.|++|.+..........+.+|+.+++.++||||+++++++.+.+..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            34455567999999999999999999999878999999998876666678889999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcccc-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          111 LLIYEFMTNKSLDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      ++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999865432 234899999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ...............+++.|+|||.+.+..++.++||||||+++|+|++|..||.............+............
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            65433222233345688999999999888999999999999999999999999987666665555555544445555556


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..+..............+.+++.+||+.||++|||+.+++++|+.+
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            6666666667778888899999999999999999999999999865

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.3e-47  Score=369.68  Aligned_cols=253  Identities=25%  Similarity=0.312  Sum_probs=203.1

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHH---HHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELK---NEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~---~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ++|++++.||+|+||.||+|+++. |+.||+|++.+..   ......+.   .++.++..++||||++++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            689999999999999999999865 9999999996421   11222333   3456667778999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||++||+|.+++.+..   .+++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||++..+
T Consensus       269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999996543   3999999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ...    .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||................   ...  ..+
T Consensus       343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~~~--~~~  413 (689)
T 3v5w_A          343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TMA--VEL  413 (689)
T ss_dssp             SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---HCC--CCC
T ss_pred             CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---CCC--CCC
Confidence            332    2345689999999999864 589999999999999999999999986544333222222211   111  111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~  315 (358)
                      .+     ..    ..++.+||.+||+.||.+|++     +.+|++|-+..
T Consensus       414 p~-----~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~  454 (689)
T 3v5w_A          414 PD-----SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  454 (689)
T ss_dssp             CT-----TS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred             Cc-----cC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence            11     11    235678999999999999998     79999887754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.7e-47  Score=344.80  Aligned_cols=290  Identities=40%  Similarity=0.685  Sum_probs=241.3

Q ss_pred             CCcceeHHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCccceeeE
Q 018304           25 ELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGC  103 (358)
Q Consensus        25 ~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~  103 (358)
                      .+..+..+++....++|++.+.||+|+||.||+|.+.+++.|++|++..... .....+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            5677889999999999999999999999999999987899999999975332 222367899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcC---CCCCcccCCCCCCcEEEcCCCC
Q 018304          104 CIQGEEKLLIYEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQD---SRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~---~~~~i~H~di~~~Nilv~~~~~  179 (358)
                      +.+.+..++||||+.+++|.+++.... ....+++..++.++.|++.||.|||++   +   ++|+||+|+||+++.++.
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence            999999999999999999999997653 334589999999999999999999999   8   999999999999999999


Q ss_pred             eEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCC--CCCCchhHHH
Q 018304          180 PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYH--SDNNLNLIGH  257 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~--~~~~~~~~~~  257 (358)
                      ++|+|||++....... ........|++.|+|||.+.+..++.++||||||+++|+|++|..||....  ..........
T Consensus       173 ~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             EEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             EEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            9999999998753222 122233458999999999988889999999999999999999999986422  1222333344


Q ss_pred             HHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      ............+.+..............+.+++.+||+.||.+|||+.+|+++|+.....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  312 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA  312 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence            4444455556666666666777888888999999999999999999999999999876443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.2e-45  Score=329.88  Aligned_cols=260  Identities=23%  Similarity=0.381  Sum_probs=211.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|.+..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            3479999999999999999999974 589999999976555566778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++...    .+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999998553    3899999999999999999999999   9999999999999999999999999988753222


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......|++.|+|||++.+..++.++||||||+++|+|++|..||......   ........   ..... ...   
T Consensus       171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~---~~~~~-~~~---  238 (297)
T 3fxz_A          171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIAT---NGTPE-LQN---  238 (297)
T ss_dssp             --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH---HCSCC-CSC---
T ss_pred             --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---CCCCC-CCC---
Confidence              2233456899999999999999999999999999999999999998543221   11111111   11110 000   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                          .......+.++|.+||+.||++|||+.+++++.+.....+
T Consensus       239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ----ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence                0011235678999999999999999999999877665443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2e-45  Score=335.87  Aligned_cols=263  Identities=25%  Similarity=0.344  Sum_probs=207.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            3579999999999999999999986 58999999986432 223456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999998543   33999999999999999999999999   999999999999999999999999999865333


Q ss_pred             CCCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..........|++.|+|||++.+..+ +.++||||||+++|+|++|..||........  ...    .+......  ...
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~----~~~~~~~~--~~~  230 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYS----DWKEKKTY--LNP  230 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHH----HHHTTCTT--STT
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHH----HHhccccc--CCc
Confidence            22223335578999999999887765 7789999999999999999999865443211  111    11111100  000


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                            .......+.+||.+||+.||++|||+.+++++.|......
T Consensus       231 ------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ------cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                  0011235668999999999999999999999988775543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-44  Score=327.38  Aligned_cols=293  Identities=34%  Similarity=0.531  Sum_probs=228.5

Q ss_pred             ccccccCCCCcceeHHHHHHhcCCCCcc------eeecccCCccEEEEEEcCCCEEEEEEeccc----ChhhHHHHHHHH
Q 018304           17 DQIQNIDLELPLFELATIVSATNNFSIN------KKLGQGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEV   86 (358)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~~~~~~y~i~------~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~----~~~~~~~~~~e~   86 (358)
                      ++.+-.+.....+..+++....++|...      +.||+|++|.||+|.+ +++.|++|.+...    .......+.+|+
T Consensus         3 ~~~~~~~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~   81 (307)
T 2nru_A            3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEI   81 (307)
T ss_dssp             --------CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHH
T ss_pred             CCCCCCCCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHH
Confidence            3344444456778888999888888776      8999999999999987 7889999998642    234467788999


Q ss_pred             HHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCC
Q 018304           87 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRD  166 (358)
Q Consensus        87 ~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~d  166 (358)
                      .+++.++||||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+++   ++|+|
T Consensus        82 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~d  158 (307)
T 2nru_A           82 KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRD  158 (307)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred             HHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCC
Confidence            999999999999999999999999999999999999999976655566999999999999999999999999   99999


Q ss_pred             CCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCC
Q 018304          167 LKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFY  246 (358)
Q Consensus       167 i~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~  246 (358)
                      |+|+||+++.++.++|+|||++................+++.|+|||.+.+ .++.++||||||+++|+|++|..||...
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            999999999999999999999987543322222334568899999998765 5789999999999999999999998765


Q ss_pred             CCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          247 HSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ........+...... .........+... ..........+.+++.+||+.+|.+|||+.+++++|+.+.
T Consensus       238 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          238 REPQLLLDIKEEIED-EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             BSSSBTTHHHHHHHT-TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             cchHHHHHHHHHhhh-hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            544332222111110 0111111222211 2234556677889999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.3e-45  Score=331.63  Aligned_cols=272  Identities=26%  Similarity=0.418  Sum_probs=206.7

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE  108 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  108 (358)
                      ..++....++|++.+.||+|+||.||+|.+ .++.|++|++...  .......+.+|+++++.++||||+++++++.+..
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            344445568999999999999999999987 7889999998653  3445567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..++||||+.+++|.+++........+++..++.++.|++.||.|||+++ .+++||||||+||+++.++.++|+|||++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            99999999999999999976554445999999999999999999999985 34999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ......  ........|++.|+|||++.+..++.++||||||+++|+|++|..||......   ........   .....
T Consensus       187 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~~---~~~~~  258 (309)
T 3p86_A          187 RLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVGF---KCKRL  258 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHHH---SCCCC
T ss_pred             cccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---cCCCC
Confidence            754211  12233456899999999999999999999999999999999999998653321   11111111   11111


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCC
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQP  321 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~  321 (358)
                      .+..     ..    ...+.++|.+||+.+|.+|||+.++++.|+.+.....|
T Consensus       259 ~~~~-----~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          259 EIPR-----NL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             CCCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             CCCc-----cC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence            1111     11    13567899999999999999999999999887554333

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.9e-45  Score=335.28  Aligned_cols=254  Identities=26%  Similarity=0.375  Sum_probs=209.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ..++|++.+.||+|+||.||+|.+ .+|+.|++|++...  .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            457899999999999999999998 45999999998653  445567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999986543   3999999999999999999999999   99999999999999999999999999976532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                         ........|++.|+|||++.+..++ .++||||+||++|+|++|..||......   .......   .....  +. 
T Consensus       167 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~---~~~~~--~p-  234 (328)
T 3fe3_A          167 ---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRERVL---RGKYR--IP-  234 (328)
T ss_dssp             ---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HCCCC--CC-
T ss_pred             ---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH---hCCCC--CC-
Confidence               2233456789999999999888775 7899999999999999999998653321   1111111   11110  00 


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                          .    .....+.+++.+||..||.+|||+.+++++.|...
T Consensus       235 ----~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          235 ----F----YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             ----T----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             ----C----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence                0    01235668999999999999999999999877654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=327.24  Aligned_cols=260  Identities=28%  Similarity=0.435  Sum_probs=211.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .++|++.+.||+|+||.||+|.+.. ++.|++|.+..........+.+|+++++.++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            4789999999999999999999854 899999999877777888899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++........
T Consensus        89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999996533  33899999999999999999999999   99999999999999999999999999987633221


Q ss_pred             CC------------ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          197 EG------------NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       197 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      ..            ......|++.|+|||++.+..++.++||||||+++|+|++|..||.............. ......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~  242 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDR  242 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHHHH
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccccc
Confidence            11            01134688999999999999999999999999999999999999765443221111100 000111


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ..+..+.             ..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       243 ~~~~~~~-------------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          243 YCPPNCP-------------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             TCCTTCC-------------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCCC-------------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111111             14667999999999999999999999998774

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-44  Score=327.84  Aligned_cols=269  Identities=26%  Similarity=0.326  Sum_probs=207.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++++.||+|+||.||+|.+.+++.|++|.+....  ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            458999999999999999999999889999999986532  223467789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++ +|.+++....  ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99975 7877775533  33899999999999999999999999   999999999999999999999999999875322


Q ss_pred             CCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                        ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||..........   ..........+......
T Consensus       173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQV  247 (311)
T ss_dssp             --CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGG
T ss_pred             --cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhh
Confidence              122234467899999998876 568999999999999999999999987655443322   22222211111111000


Q ss_pred             ---------Cc--CCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          274 ---------CI--QGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       274 ---------~~--~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                               ..  ......     ....++.+||.+||+.||++|||+.+++++.+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence                     00  000001     11235678999999999999999999999877654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-44  Score=324.08  Aligned_cols=274  Identities=20%  Similarity=0.277  Sum_probs=216.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--eeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~l  112 (358)
                      ..++|++.+.||+|+||.||+|.+.. ++.|++|++.... ......+.+|+++++.++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            45789999999999999999999865 8999999997533 234567789999999999999999999998765  7799


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE----cCCCCeEEeccccc
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLA  188 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv----~~~~~i~L~Df~~~  188 (358)
                      ||||+++++|.+++........+++..++.++.||+.||.|||+++   ++|+||||+||++    +.++.++|+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999977655555999999999999999999999999   9999999999999    77788999999999


Q ss_pred             eecCCCCCCCccccccccCCCCCccccc--------CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC-chhHHHHH
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYAS--------DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN-LNLIGHAW  259 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~  259 (358)
                      .......   ......+++.|+|||++.        +..++.++|||||||++|+|++|..||........ ........
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            8763322   223456899999999875        56789999999999999999999999875544322 22222222


Q ss_pred             HHhhcCCCCccc-----------cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          260 KLWNEGMPSQLI-----------DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       260 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ..........+.           ...............+.+++.+||+.||++|||+.+++++..+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            221111111100           001112334556667888999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.3e-43  Score=323.48  Aligned_cols=280  Identities=22%  Similarity=0.321  Sum_probs=216.0

Q ss_pred             cccccccccCCCCcceeHHHHHHhcCC----------CCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHH
Q 018304           14 TENDQIQNIDLELPLFELATIVSATNN----------FSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKEL   82 (358)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~   82 (358)
                      .-..+..|.-...+.++.+++....+.          |...+.||+|+||.||+|.+. +|+.|++|++..........+
T Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~   89 (321)
T 2c30_A           10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL   89 (321)
T ss_dssp             ---------------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHH
T ss_pred             hhhhhccceeecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHH
Confidence            334555666677777888777766543          788889999999999999986 599999999976555666788


Q ss_pred             HHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 018304           83 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRI  162 (358)
Q Consensus        83 ~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i  162 (358)
                      .+|+.+++.++||||+++++++...+..++||||+++++|.+++...    .+++..++.++.|++.||.|||+.+   +
T Consensus        90 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---i  162 (321)
T 2c30_A           90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---V  162 (321)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence            89999999999999999999999999999999999999999998542    3999999999999999999999999   9


Q ss_pred             ccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 018304          163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKN  242 (358)
Q Consensus       163 ~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  242 (358)
                      +|+||+|+||+++.++.++|+|||++.......  .......|++.|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus       163 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  240 (321)
T 2c30_A          163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP  240 (321)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999988753221  223345689999999999988999999999999999999999999


Q ss_pred             CCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          243 RGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      |.....   ........    ......+..       .......+.+++.+||+.||++|||+.+++++.+...
T Consensus       241 f~~~~~---~~~~~~~~----~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          241 YFSDSP---VQAMKRLR----DSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             TTTSCH---HHHHHHHH----HSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             CCCCCH---HHHHHHHh----cCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence            864322   11111111    111111111       0011235678999999999999999999999877653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.6e-44  Score=330.21  Aligned_cols=257  Identities=21%  Similarity=0.295  Sum_probs=207.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChh------hHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ..++|++.+.||+|+||.||+|.++. |+.|++|.+.+....      ....+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            45789999999999999999999864 899999999753321      34678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC----CeEEecc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF  185 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~----~i~L~Df  185 (358)
                      .++||||+.+++|.+++...   ..+++..++.++.||+.||.|||++|   |+|+||+|+||+++.++    .++|+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999999543   34999999999999999999999999   99999999999998776    7999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      |++......   .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....   ......+... ...
T Consensus       164 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~-~~~  236 (361)
T 2yab_A          164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITAV-SYD  236 (361)
T ss_dssp             SSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTT-CCC
T ss_pred             CCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc-CCC
Confidence            999876432   223345689999999999988999999999999999999999999854322   1111111110 000


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .....+.         .....+.+||.+||..||.+|||+.+++++.|..
T Consensus       237 ~~~~~~~---------~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          237 FDEEFFS---------QTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             CCHHHHT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             CCchhcc---------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence            0000100         0123567899999999999999999999987754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.2e-44  Score=332.43  Aligned_cols=259  Identities=28%  Similarity=0.412  Sum_probs=209.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeC
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG  107 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~  107 (358)
                      .++|++.+.||+|+||.||+|.+.        ++..|++|.+... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            468999999999999999999863        2457999999753 344567788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL  174 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv  174 (358)
                      +..++||||+.+++|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999966431             134889999999999999999999999   9999999999999


Q ss_pred             cCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCch
Q 018304          175 DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLN  253 (358)
Q Consensus       175 ~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~  253 (358)
                      +.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......   .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence            9999999999999987644333333334456788999999999999999999999999999999 99998654322   2


Q ss_pred             hHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          254 LIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ......    .........         .....+.++|.+||+.+|.+|||+.++++.|+.+
T Consensus       314 ~~~~~~----~~~~~~~~~---------~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          314 LFKLLK----EGHRMDKPA---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             HHHHHH----TTCCCCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHh----cCCCCCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            221111    111111111         1123577899999999999999999999998765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.3e-45  Score=331.63  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=207.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----eeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----~~~l  112 (358)
                      ..++|++.+.||+|+||.||+|.+ .++.|++|++.... ........|+.+++.++||||+++++++.+..    ..++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            347899999999999999999987 58999999997643 33345566888899999999999999998754    4699


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC----------CCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD----------SRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----------~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                      ||||+++++|.+++...    .+++..++.++.|++.||.|||+.          +   ++|+||||+||+++.++.+||
T Consensus       100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence            99999999999999543    289999999999999999999999          8   999999999999999999999


Q ss_pred             eccccceecCCCCCCCccccccccCCCCCcccccCC-----CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHH-
Q 018304          183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-----QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG-  256 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~-  256 (358)
                      +|||++................+++.|+|||++.+.     .++.++|||||||++|+|++|..||............. 
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            999999876544433334445789999999998763     45568899999999999999999987654332221111 


Q ss_pred             --------HHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          257 --------HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       257 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                              ..................   .........+.++|.+||+.||++|||+.++++.|+.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    111111111111111111   11123445688899999999999999999999999865

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.4e-44  Score=328.46  Aligned_cols=253  Identities=21%  Similarity=0.253  Sum_probs=207.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .++|++++.||+|+||.||+|.++ +|+.|++|++.+.   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999976 4899999999652   233456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.++|+|||++.....
T Consensus        84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999986543   3899999999999999999999999   99999999999999999999999999875321


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                        .........|++.|+|||++.+..++.++||||||+++|+|++|..||...+.   ......+.   ...  ..+.  
T Consensus       158 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~---~~~--~~~p--  225 (337)
T 1o6l_A          158 --DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELIL---MEE--IRFP--  225 (337)
T ss_dssp             --TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH---HCC--CCCC--
T ss_pred             --CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHHHHH---cCC--CCCC--
Confidence              11223456789999999999999999999999999999999999999854321   11111111   111  0111  


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                         ..    ....+.++|.+||+.||++||     ++.+++++.+..
T Consensus       226 ---~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~  265 (337)
T 1o6l_A          226 ---RT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             ---TT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             ---CC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence               11    123567899999999999999     999999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=329.91  Aligned_cols=258  Identities=19%  Similarity=0.245  Sum_probs=208.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..++|++.+.||+|+||.||+|.+.. ++.|++|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            35799999999999999999999864 889999998754 3445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC--CCCeEEeccccceecCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGG  193 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~--~~~i~L~Df~~~~~~~~  193 (358)
                      |+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.  ++.++|+|||++..+..
T Consensus        82 ~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            999999999985432  24899999999999999999999999   999999999999987  78999999999987632


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .   .......+++.|+|||++.+..++.++||||||+++|+|++|..||......   .......... ......... 
T Consensus       157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~-~~~~~~~~~-  228 (321)
T 1tki_A          157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAE-YTFDEEAFK-  228 (321)
T ss_dssp             T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTC-CCCCHHHHT-
T ss_pred             C---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHcCC-CCCChhhhc-
Confidence            2   2234456899999999999888899999999999999999999998643321   1211111110 000000000 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                              .....+.++|.+||..||.+|||+.+++++.+...
T Consensus       229 --------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          229 --------EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             --------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             --------cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence                    01235678999999999999999999999877543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-43  Score=319.23  Aligned_cols=269  Identities=20%  Similarity=0.270  Sum_probs=205.1

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++.+.||+|+||.||+|.+.. ++.|++|++...  .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            689999999999999999999854 889999998642  33345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+ ++.+++....  ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++...... 
T Consensus        82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-  154 (292)
T ss_dssp             CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence            9976 5555554322  34999999999999999999999999   999999999999999999999999999875322 


Q ss_pred             CCCccccccccCCCCCcccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc--
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID--  272 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  272 (358)
                       ........+++.|+|||.+.+.. ++.++||||||+++|+|++|..||-.  .........................  
T Consensus       155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC--CCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence             22233456789999999987765 79999999999999999998888532  2222223333322221111111000  


Q ss_pred             -------------CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          273 -------------PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       273 -------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                                   ..............+.+||.+||+.||++|||+.+++++-+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                         000000111123456789999999999999999999998876543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.5e-44  Score=328.85  Aligned_cols=253  Identities=22%  Similarity=0.311  Sum_probs=204.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      -++|++.+.||+|+||.||+|.+. +++.|++|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            378999999999999999999974 58999999986421   12235688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+ +|+|.+++....   .+++..++.++.|++.||.|||+.|   ++||||+|+||+++.++.++|+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 678888885543   3999999999999999999999999   99999999999999999999999999976532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .   .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+           ....  
T Consensus       161 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----------~~~~--  224 (336)
T 3h4j_B          161 G---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-----------NSCV--  224 (336)
T ss_dssp             S---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-----------CSSC--
T ss_pred             C---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-----------HcCC--
Confidence            2   22334568999999999988776 68999999999999999999998654332211110           0000  


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ......    ....+.++|.+||+.||.+|||+.+++++.|....
T Consensus       225 ~~~p~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          225 YVMPDF----LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             CCCCTT----SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             CCCccc----CCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            000111    12356789999999999999999999998876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=339.84  Aligned_cols=258  Identities=23%  Similarity=0.295  Sum_probs=205.8

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ...++|++.+.||+|+||.||+|.+. +|+.+++|.+....  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34678999999999999999999875 48899999986532  3445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc---CCCCeEEeccccce
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLAR  189 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~---~~~~i~L~Df~~~~  189 (358)
                      ||||+.+++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++   .++.++|+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999986543   3999999999999999999999999   99999999999998   46789999999997


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ......  .......|++.|+|||++.+..++.++|||||||++|+|++|..||.....   ........... ...+..
T Consensus       162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~-~~~~~~  235 (444)
T 3soa_A          162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIKAGA-YDFPSP  235 (444)
T ss_dssp             CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTC-CCCCTT
T ss_pred             EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhCC-CCCCcc
Confidence            653221  122345689999999999988999999999999999999999999854321   12222221110 011111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      .+.         .....+.+||.+||+.||++|||+.+++++.+.
T Consensus       236 ~~~---------~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~  271 (444)
T 3soa_A          236 EWD---------TVTPEAKDLINKMLTINPSKRITAAEALKHPWI  271 (444)
T ss_dssp             TTT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred             ccc---------cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence            111         112356789999999999999999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=328.34  Aligned_cols=257  Identities=22%  Similarity=0.302  Sum_probs=207.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ..++|++.+.||+|+||.||+|.+.. ++.|++|.+.....      .....+.+|+.+++.++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34679999999999999999999864 89999999865322      135678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC----CeEEecc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF  185 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~----~i~L~Df  185 (358)
                      .++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++    .++|+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999999543   34999999999999999999999999   99999999999999887    7999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      |++......   .......+++.|+|||++.+..++.++||||||+++|+|++|..||......   ........ ....
T Consensus       163 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~-~~~~  235 (326)
T 2y0a_A          163 GLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSA-VNYE  235 (326)
T ss_dssp             TTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHH-TCCC
T ss_pred             CCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHh-cCCC
Confidence            999876322   1223456899999999999889999999999999999999999998543221   11111111 0001


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .......         .....+.++|.+||+.||++|||+.+++++.+..
T Consensus       236 ~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          236 FEDEYFS---------NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             CCHHHHT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             cCccccc---------cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence            1100000         0123567899999999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=331.15  Aligned_cols=270  Identities=29%  Similarity=0.405  Sum_probs=215.4

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC--------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEE
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC  104 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~--------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~  104 (358)
                      ....++|++.+.||+|+||.||+|.+..        +..|++|++... .......+.+|+++++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3445799999999999999999998632        357999999753 344567788999999999 899999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 018304          105 IQGEEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN  171 (358)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~N  171 (358)
                      .+.+..++||||+.+++|.+++.....             ...+++..++.++.||+.||.|||+.+   ++||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            999999999999999999999966432             234899999999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCC
Q 018304          172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN  250 (358)
Q Consensus       172 ilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~  250 (358)
                      |+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...... 
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999987644333333334456788999999999999999999999999999999 99997643321 


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCCCC
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQ  323 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~~~  323 (358)
                        ...    ..............         ....+.+++.+||+.+|++|||+.+|++.|+.+........
T Consensus       301 --~~~----~~~~~~~~~~~~~~---------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          301 --ELF----KLLKEGHRMDKPSN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             --HHH----HHHHTTCCCCCCSS---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             --HHH----HHHHcCCCCCCCcc---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence              111    11222211111111         12357789999999999999999999999988854443333

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-44  Score=331.95  Aligned_cols=257  Identities=21%  Similarity=0.284  Sum_probs=209.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .++|++.+.||+|+||.||+|.+. +++.|++|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            478999999999999999999985 4889999999876666667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC--CCCeEEeccccceecCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGD  194 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~--~~~i~L~Df~~~~~~~~~  194 (358)
                      +.+++|.+++....  ..+++..++.++.||+.||.|||+++   ++||||+|+||+++.  ++.++|+|||++......
T Consensus       130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999999986532  23899999999999999999999999   999999999999974  578999999999875322


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                         .......+++.|+|||++.+..++.++|||||||++|+|++|..||.....   .......... ..........  
T Consensus       205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~-~~~~~~~~~~--  275 (387)
T 1kob_A          205 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRC-DWEFDEDAFS--  275 (387)
T ss_dssp             ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHC-CCCCCSSTTT--
T ss_pred             ---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-CCCCCccccc--
Confidence               223345689999999999988999999999999999999999999865322   1222211111 0001111111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                             .....+.++|.+||+.||++|||+.+++++.+..
T Consensus       276 -------~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (387)
T 1kob_A          276 -------SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  309 (387)
T ss_dssp             -------TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             -------cCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence                   1123567899999999999999999999987654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.1e-44  Score=331.65  Aligned_cols=272  Identities=27%  Similarity=0.400  Sum_probs=215.4

Q ss_pred             CcceeHHHHHHhcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCc
Q 018304           26 LPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNL   97 (358)
Q Consensus        26 ~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i   97 (358)
                      ......+++....++|++.+.||+|+||.||+|.+.      +++.|++|++... .......+.+|++++..+ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            344556777778899999999999999999999742      2578999999763 344556788999999999 78999


Q ss_pred             cceeeEEEeCC-eeEEEEEecCCCCHHHHHhcccc---------------------------------------------
Q 018304           98 VKLLGCCIQGE-EKLLIYEFMTNKSLDSFIFDQER---------------------------------------------  131 (358)
Q Consensus        98 v~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------  131 (358)
                      +++++++.+.+ ..++||||+.+++|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            99999998765 48999999999999999966432                                             


Q ss_pred             ------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          132 ------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       132 ------------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                                        ...+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              122889999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......  .......    .........
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~----~~~~~~~~~  319 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLK----EGTRMRAPD  319 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHH----HTCCCCCCT
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHH----cCCCCCCCC
Confidence            333333344567889999999999999999999999999999998 999986543321  1111111    111111111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .         ....+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       320 ~---------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          320 Y---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             T---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            1         113577899999999999999999999999764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7e-44  Score=321.32  Aligned_cols=265  Identities=26%  Similarity=0.409  Sum_probs=205.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Ce
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~  109 (358)
                      ..++|++++.||+|+||.||+|.+     .+++.|++|.+..........+.+|+++++.++||||+++++++...  ..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            458999999999999999999983     24889999999887777778899999999999999999999998654  46


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+++++|.+++.....  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             eEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            8999999999999999966432  3899999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCC---------CCchhHHHHH
Q 018304          190 AFGGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD---------NNLNLIGHAW  259 (358)
Q Consensus       190 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~  259 (358)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++|..|+......         ..........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            75332211 1222334667799999999999999999999999999999999887543210         0000011111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .............         .....+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       243 ~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          243 ELLKNNGRLPRPD---------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHTTCCCCCCT---------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhccCcCCCCc---------CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111111111111         1123577899999999999999999999998765

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.9e-43  Score=326.29  Aligned_cols=261  Identities=23%  Similarity=0.288  Sum_probs=199.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..++|++++.||+|+||.||++.+. +++.|++|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            4589999999999999999999986 58999999997533 233567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC--eEEeccccceecCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLARAFGG  193 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~--i~L~Df~~~~~~~~  193 (358)
                      |+.+++|.+++....   .+++..++.++.|++.||.|||++|   |+||||||+||+++.++.  ++|+|||++.... 
T Consensus        97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~-  169 (361)
T 3uc3_A           97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-  169 (361)
T ss_dssp             CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc-
Confidence            999999999985543   3999999999999999999999999   999999999999987765  9999999987432 


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCc-ccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVK-SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                        .........|++.|+|||++.+..++.+ +|||||||++|+|++|..||............  .........  .+..
T Consensus       170 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~~--~~~~  243 (361)
T 3uc3_A          170 --LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVKY--SIPD  243 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTCC--CCCT
T ss_pred             --ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCCC--CCCC
Confidence              1222334568999999999988877655 89999999999999999998765443322221  111111110  0000


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      .       ......+.+||.+||+.||++|||+.+++++.+.....
T Consensus       244 ~-------~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          244 D-------IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             T-------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             c-------CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            0       00123567899999999999999999999988775443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-43  Score=331.26  Aligned_cols=276  Identities=19%  Similarity=0.238  Sum_probs=208.9

Q ss_pred             HHhcCCCCcceeeccc--CCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           35 VSATNNFSINKKLGQG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g--~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ....++|++.+.||+|  ++|.||+|.+. +++.|++|++...  .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            3456899999999999  99999999986 4899999999653  34556778889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.++|+|||.+.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence            9999999999999999866432 33999999999999999999999999   9999999999999999999999999876


Q ss_pred             ecCCCC-----CCCccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          190 AFGGDE-----TEGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       190 ~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      ......     .........+++.|+|||++.+  ..++.++|||||||++|+|++|..||............  .....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~  254 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTV  254 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--hcCCC
Confidence            542111     1112223467888999999887  57899999999999999999999998654433211110  00000


Q ss_pred             hc-----CCCCc--------------ccc------------CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          263 NE-----GMPSQ--------------LID------------PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       263 ~~-----~~~~~--------------~~~------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                      ..     .....              ..+            ..............+.+||.+||+.||++|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            00     00000              000            000000111122457889999999999999999999988


Q ss_pred             hccCC
Q 018304          312 LGSET  316 (358)
Q Consensus       312 l~~~~  316 (358)
                      .+...
T Consensus       335 p~f~~  339 (389)
T 3gni_B          335 SFFKQ  339 (389)
T ss_dssp             GGGGG
T ss_pred             HHHHH
Confidence            66553

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2e-43  Score=318.56  Aligned_cols=263  Identities=16%  Similarity=0.209  Sum_probs=211.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++.+.||+|++|.||+|.+ .+++.|++|.+....  ....+.+|+..++.+ +|+|++++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            467899999999999999999997 458999999986533  224577899999999 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC-----eEEeccccce
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLAR  189 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~-----i~L~Df~~~~  189 (358)
                      ||+ +++|.+++....  ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.     ++|+|||++.
T Consensus        86 e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 889999996543  23999999999999999999999999   999999999999987766     9999999998


Q ss_pred             ecCCCCCC-----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          190 AFGGDETE-----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       190 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      ........     .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            76433221     1223456899999999999999999999999999999999999998775544433333332222111


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .....+...         ....+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus       240 ~~~~~~~~~---------~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          240 TPLRELCAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             SCHHHHTTT---------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccHHHHHhh---------CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            111111111         1135678999999999999999999999998763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-43  Score=317.60  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=206.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..++|++.+.||+|+||.||+|.+. .++.|++|.+..   ........+.+|+..++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            3579999999999999999999975 488999998853   334556778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus        89 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999996543   4999999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ... ........|++.|+|||.+.+..++.++||||||+++|+|++|..||......      ...........+ ....
T Consensus       163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~-~~~~  234 (294)
T 4eqm_A          163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVP-NVTT  234 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCC-CHHH
T ss_pred             ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCC-Ccch
Confidence            221 12223456899999999999999999999999999999999999998643321      111111111111 1110


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-ChHHHHHHhccCCCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-SMPSVILMLGSETVLP  319 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ell~~l~~~~~~~  319 (358)
                      . ....    ....+.++|.+||..||.+|| ++.++.+.|.......
T Consensus       235 ~-~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          235 D-VRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             H-SCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             h-cccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            0 0011    123567899999999999998 8999999988765443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.1e-43  Score=323.44  Aligned_cols=261  Identities=18%  Similarity=0.218  Sum_probs=209.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .+++|++.+.||+|+||.||+|.+. +++.|++|.+.....  ...+..|+.+++.+ +|+||+++++++.+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            4589999999999999999999974 588999999865332  24577899999999 8999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC-----eEEeccccce
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLAR  189 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~-----i~L~Df~~~~  189 (358)
                      ||+ +++|.+++....  ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.     ++|+|||++.
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            999 889999986542  34999999999999999999999999   999999999999998887     9999999998


Q ss_pred             ecCCCCCCC-----ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          190 AFGGDETEG-----NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       190 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      .+.......     ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.....................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            764332211     123557899999999999999999999999999999999999999776544433333322221111


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .....+..     . .    ..+.+++.+||..+|.+||++.+|++.|+.+
T Consensus       239 ~~~~~~~~-----~-~----p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          239 TPIEVLCE-----N-F----PEMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             SCHHHHTT-----T-C----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CCHHHHhc-----c-C----hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            11100000     0 0    1577899999999999999999999988655

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-43  Score=314.96  Aligned_cols=259  Identities=27%  Similarity=0.393  Sum_probs=209.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..++|++.+.||+|+||.||+|.+.++..|++|.+.... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            357899999999999999999998888899999997633 2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           85 ISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             CTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            99999999996543  23999999999999999999999999   99999999999999999999999999986533221


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      . ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    .........   
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~---  228 (268)
T 3sxs_A          160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKVS----QGHRLYRPH---  228 (268)
T ss_dssp             E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH----TTCCCCCCT---
T ss_pred             h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHHH----cCCCCCCCC---
Confidence            1 1122345667999999988889999999999999999999 99997643322   1111111    111111000   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                        ..    ...+.+++.+||+.+|++|||+.+++++|+.+...
T Consensus       229 --~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          229 --LA----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             --TS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             --cC----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence              01    13567899999999999999999999999987543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.8e-44  Score=331.08  Aligned_cols=256  Identities=23%  Similarity=0.328  Sum_probs=206.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ..++|++.+.||+|+||.||+|.+.. ++.|++|++...  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            45789999999999999999999754 899999999652  344567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC---CCeEEecccccee
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARA  190 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~---~~i~L~Df~~~~~  190 (358)
                      |||+.+++|.+++...   ..+++..++.++.||+.||.|||+++   |+|+||||+||+++.+   +.++|+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999998543   34899999999999999999999999   9999999999999865   4599999999986


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ....   .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.   ........... ...+...
T Consensus       181 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~~~-~~~~~~~  253 (362)
T 2bdw_A          181 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGA-YDYPSPE  253 (362)
T ss_dssp             CTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-CCCCTTG
T ss_pred             ecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCC-CCCCccc
Confidence            5322   122345689999999999988999999999999999999999999754321   11211111110 0111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ++         .....+.+||.+||+.||++|||+.+++++.|.
T Consensus       254 ~~---------~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  288 (362)
T 2bdw_A          254 WD---------TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  288 (362)
T ss_dssp             GG---------GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred             cc---------CCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            11         112356789999999999999999999987654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.9e-44  Score=325.58  Aligned_cols=259  Identities=26%  Similarity=0.420  Sum_probs=206.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEc----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|++.+.||+|+||.||+|.+.    .+..|++|.+... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            468999999999999999999974    2446999999763 44556778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++....
T Consensus       128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999999985543  23999999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCCC-ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          193 GDETEG-NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       193 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    .......
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~----~~~~~~~  275 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSVE----EGYRLPA  275 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHH----TTCCCCC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCCCCCC
Confidence            322111 1122345668999999998899999999999999999999 99997543321   1221111    1111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ..         .....+.++|.+||..||++|||+.+|++.|+.+..
T Consensus       276 ~~---------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          276 PM---------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             CT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC---------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11         112357789999999999999999999999988743

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.5e-44  Score=316.87  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=207.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..++|++.+.||+|+||.||+|.+.+++.|++|.+.... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            347899999999999999999999888999999997643 2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        87 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  160 (269)
T 4hcu_A           87 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-  160 (269)
T ss_dssp             CTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred             CCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-
Confidence            99999999996543  34899999999999999999999999   9999999999999999999999999987643211 


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    ........    
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~----  229 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIS----TGFRLYKP----  229 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----TTCCCCCC----
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHh----cCccCCCC----
Confidence            111222345678999999998899999999999999999999 99997643321   1111111    11111100    


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ..    ....+.+++.+||+.+|++|||+.+++++|+.+
T Consensus       230 -~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          230 -RL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             -TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -Cc----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence             11    123567899999999999999999999999765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.9e-43  Score=326.37  Aligned_cols=259  Identities=22%  Similarity=0.258  Sum_probs=205.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++....     ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4568999999999999999999975 48999999986421     11356788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC---eEEeccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFG  186 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~---i~L~Df~  186 (358)
                      ++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.   ++|+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988886543 2334899999999999999999999999   999999999999986654   9999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      ++.......  .......+++.|+|||++.+..++.++|||||||++|+|++|..||....    .......... ....
T Consensus       179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~-~~~~  251 (351)
T 3c0i_A          179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKG-KYKM  251 (351)
T ss_dssp             TCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHT-CCCC
T ss_pred             ceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcC-CCCC
Confidence            998764321  12234568999999999998899999999999999999999999986421    1111111110 0000


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ....+.         .....+.+||.+||..||++|||+.+++++.+.
T Consensus       252 ~~~~~~---------~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~  290 (351)
T 3c0i_A          252 NPRQWS---------HISESAKDLVRRMLMLDPAERITVYEALNHPWL  290 (351)
T ss_dssp             CHHHHT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             Cccccc---------cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence            000000         012356789999999999999999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.4e-43  Score=328.63  Aligned_cols=260  Identities=21%  Similarity=0.315  Sum_probs=204.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|++++.||+|+||.||+|.++. ++.|++|++.+.   .......+..|..++.++ +||||++++++|.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4789999999999999999999865 788999999753   233345577899999887 89999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.++|+|||++....
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999986543   3999999999999999999999999   9999999999999999999999999997532


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCc--hhHHHHHHHhhcCCCCcc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL--NLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  270 (358)
                      .  ........+|++.|+|||++.+..++.++|||||||++|+|++|..||.........  .............. ..+
T Consensus       205 ~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~  281 (396)
T 4dc2_A          205 R--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRI  281 (396)
T ss_dssp             C--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-CCC
T ss_pred             c--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-cCC
Confidence            1  222334567999999999999999999999999999999999999998654322111  01111111111111 111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh------HHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM------PSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~------~ell~~l~~~  315 (358)
                      ..     .    ....+.+||.+||+.||.+||++      .+++++.+..
T Consensus       282 p~-----~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~  323 (396)
T 4dc2_A          282 PR-----S----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  323 (396)
T ss_dssp             CT-----T----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred             CC-----c----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence            11     1    12356789999999999999995      7888877654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=332.22  Aligned_cols=254  Identities=24%  Similarity=0.307  Sum_probs=202.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..++|++++.||+|+||.||+|.++. ++.|++|++.+.   .......+..|..++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            34899999999999999999999764 899999999752   234456678899999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||+.+++|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.++|+|||++...
T Consensus       101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999986543   3999999999999999999999999   999999999999999999999999998753


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..  ........+|++.|+|||++.+..++.++|||||||++|+|++|..||.....   ......+..   ...  .+.
T Consensus       175 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~---~~~--~~p  244 (353)
T 3txo_A          175 IC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILN---DEV--VYP  244 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---CCC--CCC
T ss_pred             cc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHHHHHc---CCC--CCC
Confidence            21  12233456799999999999988899999999999999999999999864332   122222211   111  000


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh------HHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM------PSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~------~ell~~l~~~  315 (358)
                           ..    ....+.++|.+||+.||.+||++      .+++++.+..
T Consensus       245 -----~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~  285 (353)
T 3txo_A          245 -----TW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK  285 (353)
T ss_dssp             -----TT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred             -----CC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence                 01    12356689999999999999999      8899877654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.4e-43  Score=315.90  Aligned_cols=265  Identities=23%  Similarity=0.331  Sum_probs=201.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++++.||+|+||.||+|.+..++.|++|.+.....  .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            68999999999999999999997799999999865332  2346778999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+ +|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  153 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--  153 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--
Confidence            976 8988886533  33899999999999999999999999   999999999999999999999999998765321  


Q ss_pred             CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc----
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI----  271 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  271 (358)
                      ........+++.|+|||++.+. .++.++||||||+++|+|++|..||......   ...................    
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence            1122334678999999988764 5899999999999999999999998653321   2222222211111100000    


Q ss_pred             ----cCCcC-------CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          272 ----DPCIQ-------GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       272 ----~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                          +....       ..........+.++|.+||+.||++|||+.+++++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence                00000       00001112456789999999999999999999988664

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-43  Score=322.64  Aligned_cols=263  Identities=29%  Similarity=0.409  Sum_probs=211.6

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ  106 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  106 (358)
                      .....++|++.+.||+|+||.||+|.+.      ++..|++|.+... .......+.+|+++++.++||||+++++++.+
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3344689999999999999999999862      3478999999753 34556778899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcccc---------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccC
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQER---------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR  165 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~  165 (358)
                      .+..++||||+.+++|.+++.....                     ...+++..++.++.||+.||.|||+++   ++|+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence            9999999999999999999976432                     123889999999999999999999999   9999


Q ss_pred             CCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCC
Q 018304          166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRG  244 (358)
Q Consensus       166 di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~  244 (358)
                      ||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987643333223334456778999999988889999999999999999999 999986


Q ss_pred             CCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          245 FYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .....   .......    .........         .....+.+++.+||+.||++|||+.++++.|+.+
T Consensus       255 ~~~~~---~~~~~~~----~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          255 GIPPE---RLFNLLK----TGHRMERPD---------NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             TCCGG---GHHHHHH----TTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCHH---HHHHHhh----cCCcCCCCc---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            54332   1211111    111111111         1123577899999999999999999999998765

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.2e-43  Score=321.21  Aligned_cols=259  Identities=22%  Similarity=0.316  Sum_probs=205.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|++++.||+|+||.||+|.++. ++.|++|++.+.   .......+..|..++..+ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            689999999999999999999864 889999999753   344566788999999988 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.++|+|||++.....
T Consensus        89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999986543   3999999999999999999999999   99999999999999999999999999875321


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCc--hhHHHHHHHhhcCCCCccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL--NLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  271 (358)
                        .........|++.|+|||++.+..++.++|||||||++|+|++|..||.........  ............... .+.
T Consensus       163 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~p  239 (345)
T 3a8x_A          163 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIP  239 (345)
T ss_dssp             --TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CCC
T ss_pred             --CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CCC
Confidence              112233557899999999999999999999999999999999999998653322111  011111111111111 111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh------HHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM------PSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~------~ell~~l~~~  315 (358)
                           ..    ....+.++|.+||+.||.+||++      .+++++-+..
T Consensus       240 -----~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~  280 (345)
T 3a8x_A          240 -----RS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  280 (345)
T ss_dssp             -----TT----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred             -----CC----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence                 11    12356789999999999999995      7888877654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=327.24  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=206.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||++.+.. ++.|++|.+.+.   .......+.+|+.+++.++||||++++++|.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            789999999999999999999765 889999998652   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++...   ..+++..++.++.||+.||.|||++|   |+||||||+||+++.+|.++|+|||++..+.. 
T Consensus        95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-  167 (384)
T ss_dssp             CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred             ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence            999999999998653   33999999999999999999999999   99999999999999999999999999987532 


Q ss_pred             CCCCccccccccCCCCCcccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                        ........|++.|+|||++.+   ..++.++|||||||++|+|++|..||.................    .. ..+.
T Consensus       168 --~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~-~~~p  240 (384)
T 4fr4_A          168 --ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TV-VTYP  240 (384)
T ss_dssp             --TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CC-CCCC
T ss_pred             --CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----cc-cCCC
Confidence              223345679999999999864   4689999999999999999999999875544332222222211    11 1111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-hHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-MPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~ell~~l~~~  315 (358)
                      .     .    ....+.+||.+||+.||.+||+ +.+|+++.+..
T Consensus       241 ~-----~----~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~  276 (384)
T 4fr4_A          241 S-----A----WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN  276 (384)
T ss_dssp             T-----T----SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred             C-----c----CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence            1     1    1235678999999999999998 88888765543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3e-43  Score=323.74  Aligned_cols=267  Identities=26%  Similarity=0.408  Sum_probs=212.3

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEE
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCI  105 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  105 (358)
                      +.....++|++.+.||+|+||.||+|.+.+      ++.|++|.+... .......+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            334456899999999999999999999743      478999999763 3445677889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhcccc---------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQER---------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIH  164 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H  164 (358)
                      +.+..++||||+++++|.+++.....                     ...+++..++.++.||+.||.|||+++   ++|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            99999999999999999999966421                     145899999999999999999999999   999


Q ss_pred             CCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCC
Q 018304          165 RDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNR  243 (358)
Q Consensus       165 ~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~  243 (358)
                      +||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999876532222222334457888999999988899999999999999999999 99997


Q ss_pred             CCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          244 GFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      ......   ....    ............     .    ....+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       278 ~~~~~~---~~~~----~~~~~~~~~~~~-----~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          278 YGMAHE---EVIY----YVRDGNILACPE-----N----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TTSCHH---HHHH----HHHTTCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCCChH---HHHH----HHhCCCcCCCCC-----C----CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            543221   1111    111222111111     1    123577899999999999999999999999987654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.7e-43  Score=321.33  Aligned_cols=256  Identities=24%  Similarity=0.353  Sum_probs=202.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-------
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-------  108 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-------  108 (358)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            367999999999999999999986 58999999986533 335677889999999999999999999986643       


Q ss_pred             --------------------------------------------------eeEEEEEecCCCCHHHHHhccccccCCCHH
Q 018304          109 --------------------------------------------------EKLLIYEFMTNKSLDSFIFDQERCKILDWS  138 (358)
Q Consensus       109 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  138 (358)
                                                                        ..++||||+++++|.+++..........+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              279999999999999999876665667778


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC----------CccccccccCC
Q 018304          139 KRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE----------GNTKRVIGTYG  208 (358)
Q Consensus       139 ~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~----------~~~~~~~~~~~  208 (358)
                      .++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.........          .......+++.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999999   999999999999999999999999999876433211          12233468999


Q ss_pred             CCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHH
Q 018304          209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCI  288 (358)
Q Consensus       209 y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  288 (358)
                      |+|||.+.+..++.++||||||+++|+|++|..|+.        ... ...........+..         .......+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~-~~~~~~~~~~~~~~---------~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERV-RIITDVRNLKFPLL---------FTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHH-HHHHHHHTTCCCHH---------HHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHH-HHHHHhhccCCCcc---------cccCChhHH
Confidence            999999999999999999999999999999876521        111 11111111111111         112234567


Q ss_pred             HHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          289 HIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       289 ~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ++|.+||+.||++|||+.+++++.+.
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~~~f  329 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIENAIF  329 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred             HHHHHHccCCCCcCCCHHHHhhchhh
Confidence            89999999999999999999997654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.3e-43  Score=323.64  Aligned_cols=249  Identities=21%  Similarity=0.236  Sum_probs=206.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||++.+. +|+.|++|++.+..   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999986 48999999986522   234567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.++|+|||++..... 
T Consensus       121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC-
Confidence            9999999999996543   3899999999999999999999999   99999999999999999999999999987532 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                          ......|++.|+|||++.+..++.++|||||||++|+|++|..||.....   ......+..    ... .+..  
T Consensus       194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~----~~~-~~p~--  259 (350)
T 1rdq_E          194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVS----GKV-RFPS--  259 (350)
T ss_dssp             ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----CCC-CCCT--
T ss_pred             ----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHHHHHc----CCC-CCCC--
Confidence                22345789999999999999999999999999999999999999864321   122222211    111 1111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~  315 (358)
                         ..    ...+.++|.+||+.||.+||+     +.+++++.+..
T Consensus       260 ---~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          260 ---HF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             ---TC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             ---CC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence               11    235678999999999999998     99999887654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-43  Score=323.23  Aligned_cols=272  Identities=24%  Similarity=0.310  Sum_probs=193.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++++.||+|+||.||+|.+. +++.|++|.+.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            4579999999999999999999875 48999999986533 223467789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhcccc---ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          115 EFMTNKSLDSFIFDQER---CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ||++ ++|.+++.....   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 599998865421   134899999999999999999999999   999999999999999999999999999875


Q ss_pred             CCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ...  ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||......   ............. ....
T Consensus       159 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~-~~~~  232 (317)
T 2pmi_A          159 GIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTP-NESL  232 (317)
T ss_dssp             TSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSC-CTTT
T ss_pred             CCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC-ChhH
Confidence            322  122234467899999999876 46899999999999999999999998654332   1222221111110 0000


Q ss_pred             cc-------------CCcCCCC--------CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          271 ID-------------PCIQGSF--------NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       271 ~~-------------~~~~~~~--------~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      +.             .......        .......+.+||.+||+.||++|||+.+++++-+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            00             0000000        001123577899999999999999999999987765433

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.1e-44  Score=325.38  Aligned_cols=266  Identities=24%  Similarity=0.393  Sum_probs=195.3

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC-C---CEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD-G---QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ  106 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~---~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  106 (358)
                      ++....++|++.+.||+|+||.||+|.+.. +   ..|++|.+...  .......+.+|+++++.++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            344455799999999999999999998654 3   27999998753  34456788899999999999999999999988


Q ss_pred             CCee------EEEEEecCCCCHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC
Q 018304          107 GEEK------LLIYEFMTNKSLDSFIFDQERC---KILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD  177 (358)
Q Consensus       107 ~~~~------~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~  177 (358)
                      ....      ++||||+.+++|.+++......   ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence            7655      8999999999999998654321   24899999999999999999999999   9999999999999999


Q ss_pred             CCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHH
Q 018304          178 MNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIG  256 (358)
Q Consensus       178 ~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~  256 (358)
                      +.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   ....
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~  250 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYN  250 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHH
Confidence            9999999999986543332222333446778999999999999999999999999999999 89997654332   2222


Q ss_pred             HHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          257 HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ....    ........         .....+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       251 ~~~~----~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          251 YLIG----GNRLKQPP---------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHHT----TCCCCCCT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhc----CCCCCCCC---------ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1111    11111111         112357789999999999999999999988887633

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-43  Score=324.98  Aligned_cols=270  Identities=21%  Similarity=0.295  Sum_probs=210.8

Q ss_pred             cceeHHHHHHhcCCCCcc-eeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhc-CCCCcccee
Q 018304           27 PLFELATIVSATNNFSIN-KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKL-QHRNLVKLL  101 (358)
Q Consensus        27 ~~~~~~~~~~~~~~y~i~-~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l-~~~~iv~~~  101 (358)
                      +-+..+......++|.+. +.||+|+||.||+|.+.. ++.|++|++....  ......+.+|+.+++.+ .||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            334445566778899998 899999999999999864 8999999987532  23356788999999999 579999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CC
Q 018304          102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DM  178 (358)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~  178 (358)
                      +++.+.+..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+++   ++||||+|+||+++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCC
Confidence            999999999999999999999999855322 34999999999999999999999999   999999999999987   78


Q ss_pred             CeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH
Q 018304          179 NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA  258 (358)
Q Consensus       179 ~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  258 (358)
                      .++|+|||++......   .......+++.|+|||++.+..++.++||||||+++|+|++|..||......   ......
T Consensus       172 ~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i  245 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNI  245 (327)
T ss_dssp             CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred             cEEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHH
Confidence            9999999999875322   1223456899999999999999999999999999999999999998553321   111111


Q ss_pred             HHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          259 WKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .. ...........         .....+.++|.+||+.||.+|||+.+++++.+...
T Consensus       246 ~~-~~~~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~  293 (327)
T 3lm5_A          246 SQ-VNVDYSEETFS---------SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ  293 (327)
T ss_dssp             HH-TCCCCCTTTTT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred             Hh-cccccCchhhc---------ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence            11 11111111111         11235678999999999999999999999877653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.1e-44  Score=332.06  Aligned_cols=259  Identities=25%  Similarity=0.376  Sum_probs=206.9

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ...++|++.+.||+|+||.||+|.+. +++.|++|.+... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34578999999999999999999986 5899999998753 233445678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||++.....
T Consensus       191 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999996543  23899999999999999999999999   99999999999999999999999999986432


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    .........
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~  338 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFVE----KGGRLPCPE  338 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHHH----TTCCCCCCT
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCCCCCCCC
Confidence            211111112234667999999988889999999999999999998 99997653321   1111111    111111111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .         ....+.++|.+||+.||++|||+.+|++.|+.+
T Consensus       339 ~---------~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          339 L---------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             T---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            1         113567899999999999999999999999765

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.4e-43  Score=324.08  Aligned_cols=269  Identities=25%  Similarity=0.352  Sum_probs=210.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEE--eCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~  109 (358)
                      ..++|++.+.||+|+||.||+|.+     ..++.|++|++..........+.+|+++++.++|+||+++++++.  +...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            347999999999999999999983     347899999998877777788999999999999999999999887  4457


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+++++|.+++.....  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence            8999999999999999965432  3999999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCC--------CCchhHHHHHH
Q 018304          190 AFGGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD--------NNLNLIGHAWK  260 (358)
Q Consensus       190 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~  260 (358)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++|..||......        ...........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76432221 1222345777899999999888999999999999999999999996542211        01111111111


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                      ...........         ......+.++|.+||+.||++|||+.+|+++|+.+....
T Consensus       256 ~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          256 LLEEGQRLPAP---------PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HhhcccCCCCC---------CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            11122111111         111235778999999999999999999999999885543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=322.59  Aligned_cols=249  Identities=24%  Similarity=0.323  Sum_probs=205.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||++.+. +|+.|++|++.+..   ......+.+|..+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            68999999999999999999985 48999999996522   234567788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+++   ++||||+|+||+++.+|.++|+|||++..... 
T Consensus        86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            9999999999996543   3899999999999999999999999   99999999999999999999999999987532 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                          ......|++.|+|||++.+..++.++|||||||++|+|++|..||.....   ......+.   ....  .+.   
T Consensus       159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~---~~~~--~~p---  223 (318)
T 1fot_A          159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKIL---NAEL--RFP---  223 (318)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH---HCCC--CCC---
T ss_pred             ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH---hCCC--CCC---
Confidence                22345789999999999999999999999999999999999999854321   11211111   1110  111   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                        ...    ...+.++|.+||+.||++||     ++.+++++-+..
T Consensus       224 --~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~  263 (318)
T 1fot_A          224 --PFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  263 (318)
T ss_dssp             --TTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             --CCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence              111    23567899999999999999     999999887654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=322.77  Aligned_cols=258  Identities=26%  Similarity=0.346  Sum_probs=200.0

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCC--CCccceeeEEEeCCeeE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~~~~~~~  111 (358)
                      ..+++|++.+.||+|+||.||++.+.+++.|++|.+..  ........+.+|+.+++.++|  +||+++++++.+.+..+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            35678999999999999999999988899999999864  334456778899999999976  99999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +|||+ .+++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++ ++.++|+|||++...
T Consensus        86 lv~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEEeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            99995 5779999996543   4899999999999999999999999   99999999999996 678999999999875


Q ss_pred             CCCCCCCccccccccCCCCCcccccC-----------CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  260 (358)
                      .............|++.|+|||++.+           ..++.++|||||||++|+|++|..||.....     .......
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~  232 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA  232 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHH
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHH
Confidence            43333223345578999999999864           6788999999999999999999999854221     1111111


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .........+....         ...+.+++.+||+.||.+|||+.+++++.+..
T Consensus       233 ~~~~~~~~~~~~~~---------~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          233 IIDPNHEIEFPDIP---------EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             HHCTTSCCCCCCCS---------CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HhcCCcccCCcccC---------CHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            11111111111111         13567899999999999999999999987765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-42  Score=326.28  Aligned_cols=258  Identities=19%  Similarity=0.214  Sum_probs=195.4

Q ss_pred             CCCCcc-eeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHh-cCCCCccceeeEEEe----CCeeE
Q 018304           39 NNFSIN-KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ----GEEKL  111 (358)
Q Consensus        39 ~~y~i~-~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~-l~~~~iv~~~~~~~~----~~~~~  111 (358)
                      ++|.+. +.||+|+||.||++.+.. ++.|++|++...     ..+.+|++++.+ .+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            567776 689999999999999864 889999998642     345678888754 489999999999876    56789


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CCCeEEeccccc
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLA  188 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~~i~L~Df~~~  188 (358)
                      +||||+.+++|.+++..... ..+++..++.++.||+.||.|||+++   |+||||||+||+++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999966432 34999999999999999999999999   999999999999997   788999999999


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCch-hHHHHHHHhhcCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLN-LIGHAWKLWNEGMP  267 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~  267 (358)
                      .....   ........+++.|+|||++.+..++.++|||||||++|+|++|..||.......... ........ ....+
T Consensus       212 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-~~~~~  287 (400)
T 1nxk_A          212 KETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-QYEFP  287 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-CCCCC
T ss_pred             cccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-cccCC
Confidence            86532   122335568999999999999999999999999999999999999987654332211 11111110 00001


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      ...+.         .....+.+||.+||+.||++|||+.+++++.+.....
T Consensus       288 ~~~~~---------~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          288 NPEWS---------EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TTTTT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             Ccccc---------cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            00000         1123567899999999999999999999987765443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-43  Score=321.35  Aligned_cols=261  Identities=23%  Similarity=0.236  Sum_probs=185.8

Q ss_pred             CCCCcc---eeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSIN---KKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~---~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|++.   +.||+|+||.||+|.+.. ++.|++|++...   ......+|+.+++.+. ||||+++++++.+....++|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            445554   789999999999999854 899999999653   3456778999999996 99999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC---CeEEecccccee
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLARA  190 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~---~i~L~Df~~~~~  190 (358)
                      |||+++++|.+++...   +.+++..++.++.||+.||.|||+++   ++||||+|+||+++.++   .++|+|||++..
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           85 MELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             ECCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            9999999999999654   34999999999999999999999999   99999999999998765   799999999986


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ....  ........+++.|+|||++.+..++.++||||||+++|+|++|..||.......................... 
T Consensus       159 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-  235 (325)
T 3kn6_A          159 KPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-  235 (325)
T ss_dssp             CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-
T ss_pred             cCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-
Confidence            5322  2222345678999999999999999999999999999999999999876544322222222222222211110 


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ..     .........+.+||.+||+.||.+|||+.+++++.|...
T Consensus       236 ~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          236 EG-----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             CS-----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             Cc-----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence            00     000011245778999999999999999999998877654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.2e-44  Score=324.74  Aligned_cols=259  Identities=21%  Similarity=0.319  Sum_probs=196.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe---
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~---  109 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++...   .......+.+|+.+++.++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            4589999999999999999999974 5889999999753   33445678899999999999999999999877654   


Q ss_pred             -eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          110 -KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       110 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                       .++||||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence             399999999999999996543   3999999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          189 RAFGGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       189 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ..+...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||......   .   ...........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~---~~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---S---VAYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---H---HHHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---H---HHHHHhcCCCC
Confidence            765332211 2223356899999999999999999999999999999999999998543321   1   11111111111


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ....   ...    .....+.++|.+||+.||++||+..+++.+-+.
T Consensus       238 ~~~~---~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          238 PPSA---RHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             CHHH---HST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             Cccc---ccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence            1100   000    012356789999999999999988777754443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.8e-43  Score=313.42  Aligned_cols=257  Identities=24%  Similarity=0.337  Sum_probs=206.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ..++|++.+.||+|++|.||+|.+.. ++.|++|++..  ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            46899999999999999999999754 88999999864  2344567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC---eEEecccccee
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARA  190 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~---i~L~Df~~~~~  190 (358)
                      |||+.+++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.   ++|+|||.+..
T Consensus        84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999998886543   3999999999999999999999999   999999999999986655   99999999977


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ....   .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......   .......... ...+...
T Consensus       158 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~-~~~~~~~  230 (284)
T 3kk8_A          158 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGA-YDYPSPE  230 (284)
T ss_dssp             CCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTC-CCCCTTT
T ss_pred             cccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHhcc-ccCCchh
Confidence            5322   2223456889999999999999999999999999999999999997543221   1111111110 0111100


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..     .    ....+.+++.+||+.||++|||+.+++++.+..
T Consensus       231 ~~-----~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (284)
T 3kk8_A          231 WD-----T----VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC  266 (284)
T ss_dssp             TT-----T----SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred             hc-----c----cCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence            00     1    123567899999999999999999999876543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.2e-43  Score=309.97  Aligned_cols=254  Identities=30%  Similarity=0.475  Sum_probs=194.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .++|++.+.||+|+||.||+|.+ .++.|++|++....    ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            47899999999999999999998 58899999986532    23356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC--------CCCeEEecc
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ--------DMNPKISDF  185 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~--------~~~i~L~Df  185 (358)
                      |||+++++|.+++..    ..+++..++.++.|++.||.|||+++..+++|+||+|+||+++.        ++.++|+||
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999843    24999999999999999999999987445779999999999985        678999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      |++......    ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......      ..........
T Consensus       161 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~  230 (271)
T 3dtc_A          161 GLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNK  230 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSC
T ss_pred             Ccccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCC
Confidence            999764322    222446889999999999889999999999999999999999998643221      1111111111


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .......         .....+.+++.+||+.+|++|||+.+++++|+.+
T Consensus       231 ~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 LALPIPS---------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCCCCCc---------ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1111111         1123577899999999999999999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.7e-43  Score=323.36  Aligned_cols=254  Identities=23%  Similarity=0.307  Sum_probs=207.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..++|.+.+.||+|+||.||++.+.. ++.|++|++...   .......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            34789999999999999999999865 789999998653   34456778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+.+++|.+++....   .+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus       119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999999885533   3899999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ..  ........++..|+|||++.+..++.++||||||+++|+|++|..||......   .......    .... .+. 
T Consensus       193 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~----~~~~-~~~-  261 (335)
T 2owb_A          193 YD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIK----KNEY-SIP-  261 (335)
T ss_dssp             ST--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH----HTCC-CCC-
T ss_pred             cC--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHh----cCCC-CCC-
Confidence            22  12233456889999999999888999999999999999999999998653321   1111111    1110 010 


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          ...    ...+.++|.+||+.||++|||+.+++++.+..
T Consensus       262 ----~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~  296 (335)
T 2owb_A          262 ----KHI----NPVAASLIQKMLQTDPTARPTINELLNDEFFT  296 (335)
T ss_dssp             ----TTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             ----ccC----CHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence                111    13466799999999999999999999876654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=313.21  Aligned_cols=254  Identities=28%  Similarity=0.453  Sum_probs=199.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .++|++.+.||+|+||.||++.+ .++.|++|.+...  .....+.+|+++++.++||||+++++++.  +..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            36899999999999999999988 5789999999653  34567889999999999999999999886  4589999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc---CCCCCcccCCCCCCcEEEcCCCC-eEEeccccceecCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ---DSRLRIIHRDLKASNVLLDQDMN-PKISDFGLARAFGG  193 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~~~~i~H~di~~~Nilv~~~~~-i~L~Df~~~~~~~~  193 (358)
                      ++++|.+++........++...++.++.|++.||.|||+   ++   ++|+||+|+||+++.++. ++|+|||++.....
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            999999999766555558899999999999999999999   66   999999999999998887 79999999875421


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                           ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......    ....... ...........
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~  228 (307)
T 2eva_A          159 -----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAV-HNGTRPPLIKN  228 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHH-HTTCCCCCBTT
T ss_pred             -----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHH-hcCCCCCcccc
Confidence                 1223458999999999999999999999999999999999999986433221    1111111 11111111111


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                           .    ...+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       229 -----~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          229 -----L----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             -----C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             -----c----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                 1    13567899999999999999999999999877433

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-43  Score=323.18  Aligned_cols=267  Identities=29%  Similarity=0.409  Sum_probs=208.9

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI  105 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~  105 (358)
                      .....++|++.+.||+|+||.||+|.+.      .+..|++|.+... .......+.+|+.+++.+ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3345589999999999999999999862      3568999999753 233456788999999999 8999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhccccc--------------------cCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccC
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQERC--------------------KILDWSKRFHIICGTARGVMYLHQDSRLRIIHR  165 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~  165 (358)
                      +.+..++||||+++++|.+++......                    ..+++..++.++.||+.||.|||+++   ++|+
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            999999999999999999999664321                    33789999999999999999999999   9999


Q ss_pred             CCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCC
Q 018304          166 DLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRG  244 (358)
Q Consensus       166 di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~  244 (358)
                      ||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986543322222334456788999999988899999999999999999998 999986


Q ss_pred             CCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          245 FYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      ......  .......    .........         .....+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus       277 ~~~~~~--~~~~~~~----~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          277 GIPVDA--NFYKLIQ----NGFKMDQPF---------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             TCCCSH--HHHHHHH----TTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cCCcHH--HHHHHHh----cCCCCCCCC---------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            543321  1111111    111111111         1123577899999999999999999999999876443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=327.52  Aligned_cols=260  Identities=29%  Similarity=0.436  Sum_probs=207.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .++|++.+.||+|+||.||+|.+.      .++.|++|.+... .......+.+|+.+++.++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            478999999999999999999843      3568999998653 344556788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhcccc----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC---CeEEe
Q 018304          111 LLIYEFMTNKSLDSFIFDQER----CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS  183 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~---~i~L~  183 (358)
                      ++||||+.+++|.+++.....    ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++   .++|+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999966432    234899999999999999999999999   99999999999999555   49999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHh
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      |||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.....   ........   
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i~---  300 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVT---  300 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH---
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH---
Confidence            9999975432222223334567889999999998999999999999999999998 9999764332   12221111   


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                       .........     .    ....+.+|+.+||+.+|++|||+.+|+++|+.+.
T Consensus       301 -~~~~~~~~~-----~----~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 -SGGRMDPPK-----N----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             -TTCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -cCCCCCCCc-----c----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence             111111111     1    1135678999999999999999999999998763

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.8e-44  Score=327.74  Aligned_cols=256  Identities=23%  Similarity=0.294  Sum_probs=205.8

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  109 (358)
                      ....++|++.+.||+|+||.||+|.++. |+.|++|++.+..   ......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            3456899999999999999999999864 8899999997532   23456677899999887 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+++++|.+++....   .+++..++.++.||+.||.|||++|   |+||||||+||+++.+|.++|+|||++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999986543   3999999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .....  .......+|++.|+|||++.+..++.++|||||||++|+|++|..||...+.   ......+..    .. ..
T Consensus       167 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~----~~-~~  236 (345)
T 1xjd_A          167 ENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRM----DN-PF  236 (345)
T ss_dssp             CCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----CC-CC
T ss_pred             hcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHh----CC-CC
Confidence            53211  1223456789999999999999999999999999999999999999864322   122222111    11 01


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChH-HHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP-SVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~l~~~  315 (358)
                      +.     ..    ....+.++|.+||+.||++||++. +++++.+..
T Consensus       237 ~p-----~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~  274 (345)
T 1xjd_A          237 YP-----RW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR  274 (345)
T ss_dssp             CC-----TT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred             CC-----cc----cCHHHHHHHHHHhcCCHhHcCCChHHHHcCcccc
Confidence            11     11    123567899999999999999998 888766544

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=313.72  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=195.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh--------------------------hhHHHHHHHHHHHH
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE--------------------------QGLKELKNEVILFS   90 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~--------------------------~~~~~~~~e~~~l~   90 (358)
                      .++|++.+.||+|+||.||+|.+.. ++.|++|++.....                          .....+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4799999999999999999999754 88999999865321                          12356789999999


Q ss_pred             hcCCCCccceeeEEEe--CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 018304           91 KLQHRNLVKLLGCCIQ--GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK  168 (358)
Q Consensus        91 ~l~~~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~  168 (358)
                      .++||||+++++++.+  ....++||||+++++|.+++.    ...+++..++.++.||+.||.|||+++   ++|+||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  568899999999999988652    234999999999999999999999999   9999999


Q ss_pred             CCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCC---CCCcccchhHhHHHHHHHhCCCCCCC
Q 018304          169 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIISGKKNRGF  245 (358)
Q Consensus       169 ~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~p~~~  245 (358)
                      |+||+++.++.++|+|||++.......  .......+++.|+|||.+.+..   ++.++||||||+++|+|++|..||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999998753221  1223456899999999987665   37789999999999999999999854


Q ss_pred             CCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          246 YHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ...   ........    ..... ...   ...    ....+.++|.+||+.||++|||+.+++++.+
T Consensus       243 ~~~---~~~~~~~~----~~~~~-~~~---~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~  295 (298)
T 2zv2_A          243 ERI---MCLHSKIK----SQALE-FPD---QPD----IAEDLKDLITRMLDKNPESRIVVPEIKLHPW  295 (298)
T ss_dssp             SSH---HHHHHHHH----HCCCC-CCS---SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred             ccH---HHHHHHHh----cccCC-CCC---ccc----cCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence            321   11111111    11110 000   001    1235678999999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-43  Score=315.68  Aligned_cols=257  Identities=20%  Similarity=0.286  Sum_probs=206.9

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ...++|++.+.||+|+||.||+|.+.. +..+++|.+..........+.+|+++++.++||||+++++++.+....++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            346789999999999999999999865 7799999997755566778899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE---cCCCCeEEeccccceec
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF  191 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv---~~~~~i~L~Df~~~~~~  191 (358)
                      ||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           86 ELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            9999999999886543   3899999999999999999999999   9999999999999   78899999999999875


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ...   .......+++.|+|||.+.+. ++.++||||||+++|+|++|..||......   .......    ...... .
T Consensus       160 ~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~~-~  227 (277)
T 3f3z_A          160 KPG---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVMLKIR----EGTFTF-P  227 (277)
T ss_dssp             CTT---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCCCCC-C
T ss_pred             cCc---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHHHHH----hCCCCC-C
Confidence            322   223345689999999988754 899999999999999999999998653321   1111111    111100 0


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ....     ......+.++|.+||+.||++|||+.+++++.+..
T Consensus       228 ~~~~-----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  266 (277)
T 3f3z_A          228 EKDW-----LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE  266 (277)
T ss_dssp             HHHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             chhh-----hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence            0000     00123567899999999999999999999876543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.1e-43  Score=315.08  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=204.5

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ...++|++.+.||+|+||.||++.+.++..|++|.+.... .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            4457899999999999999999999888899999997643 234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          100 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999996533  23999999999999999999999999   9999999999999999999999999987643211


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                       ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    ........   
T Consensus       175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~~~~~---  243 (283)
T 3gen_A          175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIA----QGLRLYRP---  243 (283)
T ss_dssp             -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH----TTCCCCCC---
T ss_pred             -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHh----cccCCCCC---
Confidence             111122345678999999998899999999999999999998 99998654322   1111111    11111100   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                        ...    ...+.+++.+||+.+|.+|||+.+++++|+.+
T Consensus       244 --~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          244 --HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             --TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence              001    13577899999999999999999999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.8e-43  Score=329.20  Aligned_cols=264  Identities=17%  Similarity=0.187  Sum_probs=208.3

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEe
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ  106 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  106 (358)
                      +.++....++|++++.||+|+||.||+|.++. ++.|++|++.+..   ......+.+|+.++..++||||++++++|.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            34444556899999999999999999999865 8899999986521   1223347789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      .+..++||||+++|+|.+++...    .+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence            99999999999999999998543    3899999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCC----CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQ----FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      ++....... .......+|++.|+|||++.+..    ++.++|||||||++|+|++|..||...+.   ......+....
T Consensus       214 ~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~  289 (410)
T 3v8s_A          214 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHK  289 (410)
T ss_dssp             TCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHH
T ss_pred             eeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHhcc
Confidence            998753221 11223567999999999987655    78999999999999999999999864332   22222222111


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCC--CCChHHHHHHhccC
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKD--RPSMPSVILMLGSE  315 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~l~~~  315 (358)
                      .....+..      ..    ....+.+||.+||+.+|.+  ||++.+|+++.+..
T Consensus       290 ~~~~~p~~------~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          290 NSLTFPDD------ND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             HHCCCCTT------CC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             ccccCCCc------cc----ccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence            01111100      00    1135668999999999988  99999999988765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.6e-43  Score=313.39  Aligned_cols=261  Identities=29%  Similarity=0.454  Sum_probs=195.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++.+.||+|+||.||+|.+.  ..+++|.+..  ........+.+|+.+++.++|+||++++++. .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            4689999999999999999999763  3599998864  3345567788999999999999999999964 556789999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999985433  34999999999999999999999999   999999999999999999999999998765332


Q ss_pred             CCCCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..........+++.|+|||.+.   +..++.++||||||+++|+|++|..||......  ..................+.
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  251 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLSPDLSKVR  251 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSCCCCTTSSC
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccccCcchhhcc
Confidence            2233334456899999999886   567888999999999999999999998654322  11111111111111111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .         .....+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       252 ~---------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          252 S---------NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             T---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             c---------cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            1         11245778999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.5e-43  Score=320.53  Aligned_cols=259  Identities=23%  Similarity=0.347  Sum_probs=202.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCE----EEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQE----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~----v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .++|++.+.||+|+||.||+|.+.. ++.    |++|.+.... ......+.+|+.+++.++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            4789999999999999999999754 443    7888775422 223345668999999999999999999886 45788


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||+.+++|.+++....  ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            9999999999999986542  34899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ............. ....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~~~-~~~~  241 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLLEKGERLA-QPQI  241 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHHHTTCBCC-CCTT
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHHHcCCCCC-CCCc
Confidence            44433333344567789999999998999999999999999999999 99998754332   2222221111111 1111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      ..            ..+.+++.+||..||.+|||+.+++++|+.+...
T Consensus       242 ~~------------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          242 CT------------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             BC------------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             Cc------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11            1345799999999999999999999999877543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.5e-44  Score=331.05  Aligned_cols=270  Identities=23%  Similarity=0.269  Sum_probs=209.2

Q ss_pred             eeHHHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----CCCccceee
Q 018304           29 FELATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HRNLVKLLG  102 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----~~~iv~~~~  102 (358)
                      +.+++-....++|++++.||+|+||.||+|.+. +++.|++|++.. ..........|+.+++.+.     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            344445556789999999999999999999985 488999999975 3344566778999999986     999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC------
Q 018304          103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ------  176 (358)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~------  176 (358)
                      ++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++   |+||||||+||+++.      
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence            999999999999999 8899999976443 23899999999999999999999999   999999999999975      


Q ss_pred             -------------------CCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHH
Q 018304          177 -------------------DMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEII  237 (358)
Q Consensus       177 -------------------~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~  237 (358)
                                         ++.++|+|||++.....     ......+++.|+|||++.+..++.++|||||||++|+|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                               78999999999986432     223456889999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc------------------cCCcCCCCCHH---------------HH
Q 018304          238 SGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI------------------DPCIQGSFNLA---------------EV  284 (358)
Q Consensus       238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~---------------~~  284 (358)
                      +|..||.......   ........ ....+....                  ...........               ..
T Consensus       254 ~g~~pf~~~~~~~---~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          254 TGSLLFRTHEHME---HLAMMESI-IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HSSCSCCCSSHHH---HHHHHHHH-TCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HCCCCCCCCcHHH---HHHHHHHh-cCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            9999986543221   11111111 011110000                  00000000000               01


Q ss_pred             HHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          285 IRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       285 ~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ..+.+||.+||+.||++|||+.+++++.+
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence            45678999999999999999999998765

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-43  Score=317.64  Aligned_cols=272  Identities=23%  Similarity=0.296  Sum_probs=202.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      -++|++++.||+|++|.||+|.+.. ++.|++|.+....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3789999999999999999999865 8999999886532  334566789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++...   ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999999887543   33899999999999999999999999   999999999999999999999999999875322


Q ss_pred             CCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH--------HhhcC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK--------LWNEG  265 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~  265 (358)
                        ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.....        .+...
T Consensus       156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 --SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             --ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence              112234467889999998876 5789999999999999999999999865443222111111100        00000


Q ss_pred             C-CCccccCCcCCCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          266 M-PSQLIDPCIQGSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       266 ~-~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      . ..............     ......+.+++.+||+.||++|||+.+++++.+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence            0 00000000000000     0112357789999999999999999999998776543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.9e-42  Score=310.65  Aligned_cols=256  Identities=29%  Similarity=0.514  Sum_probs=200.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhh-------HHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-------LKELKNEVILFSKLQHRNLVKLLGCCIQGE  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-------~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  108 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|.+.......       ...+.+|+.+++.++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            3489999999999999999999975 58999999986532211       157889999999999999999999986544


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC-----eEEe
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKIS  183 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~-----i~L~  183 (358)
                        ++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++ .+++|+||+|+||+++.++.     ++|+
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             --eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence              79999999999998885543  34999999999999999999999985 34999999999999988776     9999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCccccc--CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS--DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      |||++....     .......+++.|+|||.+.  ...++.++||||||+++|+|++|..||........    ......
T Consensus       172 Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~  242 (287)
T 4f0f_A          172 DFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMI  242 (287)
T ss_dssp             CCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHH
T ss_pred             CCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHH
Confidence            999987532     2233456899999999984  45678999999999999999999999865443321    111111


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ........+...         ....+.++|.+||+.||.+|||+.++++.|+.+
T Consensus       243 ~~~~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEGLRPTIPED---------CPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSCCCCCCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccCCCCCCCcc---------cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111222111111         123577899999999999999999999998763

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.1e-43  Score=321.87  Aligned_cols=253  Identities=23%  Similarity=0.279  Sum_probs=197.2

Q ss_pred             cCCCCcceeecccCCccEEEEEE----cCCCEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      .++|++.+.||+|+||.||++.+    .+++.|++|++.+..    ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            47899999999999999999987    368999999997532    2344567789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+.+++|.+++....   .+++..++.++.||+.||.|||+++   |+||||+|+||+++.++.++|+|||++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999986543   3899999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .....  ........|++.|+|||++.+..++.++||||||+++|+|++|..||.....   .........   ...  .
T Consensus       170 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~---~~~--~  239 (327)
T 3a62_A          170 ESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTIDKILK---CKL--N  239 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH---TCC--C
T ss_pred             ccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh---CCC--C
Confidence            53211  1122345689999999999988999999999999999999999999864332   112211111   110  0


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                      +.     ..    ....+.++|.+||+.||.+||     ++.+++++.+..
T Consensus       240 ~p-----~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~  281 (327)
T 3a62_A          240 LP-----PY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR  281 (327)
T ss_dssp             CC-----TT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred             CC-----CC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence            11     01    123567899999999999999     888999987764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-42  Score=316.34  Aligned_cols=267  Identities=21%  Similarity=0.246  Sum_probs=202.1

Q ss_pred             cCCCCcc-eeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 018304           38 TNNFSIN-KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        38 ~~~y~i~-~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .++|++. +.||+|+||.||+|.+. +++.|++|++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4789985 78999999999999965 5899999999776556677888999999985 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC---eEEeccccceec
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLARAF  191 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~---i~L~Df~~~~~~  191 (358)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.   ++|+|||++...
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999996543   3899999999999999999999999   999999999999998776   999999998765


Q ss_pred             CCCCC-----CCccccccccCCCCCcccccC-----CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchh-------
Q 018304          192 GGDET-----EGNTKRVIGTYGYMAPEYASD-----GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL-------  254 (358)
Q Consensus       192 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~-------  254 (358)
                      .....     ........+++.|+|||++.+     ..++.++|||||||++|+|++|..||...........       
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            32111     111223458899999998865     4578999999999999999999999876543221100       


Q ss_pred             -HHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          255 -IGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       255 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                       ............. .+..... .    .....+.+||.+||+.||++|||+.+++++.+...
T Consensus       245 ~~~~~~~~i~~~~~-~~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  301 (316)
T 2ac3_A          245 CQNMLFESIQEGKY-EFPDKDW-A----HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG  301 (316)
T ss_dssp             HHHHHHHHHHHCCC-CCCHHHH-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred             HHHHHHHHHhccCc-ccCchhc-c----cCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence             0011111111111 0000000 0    01235778999999999999999999999877653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-43  Score=322.02  Aligned_cols=266  Identities=28%  Similarity=0.431  Sum_probs=211.1

Q ss_pred             HHHHHhcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEE
Q 018304           32 ATIVSATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCC  104 (358)
Q Consensus        32 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  104 (358)
                      +++....++|++.+.||+|+||.||+|.+.      .++.|++|.+... .......+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            345556789999999999999999999864      2678999999753 234456688999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhcccc-------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC
Q 018304          105 IQGEEKLLIYEFMTNKSLDSFIFDQER-------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD  177 (358)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~  177 (358)
                      .+.+..++||||+.+++|.+++.....       ...+++..++.++.||+.||.|||+++   ++|+||+|+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence            999999999999999999999865432       134789999999999999999999999   9999999999999999


Q ss_pred             CCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHH
Q 018304          178 MNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIG  256 (358)
Q Consensus       178 ~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~  256 (358)
                      +.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   ....
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~  251 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR  251 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHH
Confidence            9999999999876532222222223346788999999998899999999999999999999 88887543221   1111


Q ss_pred             HHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          257 HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                          ............         .....+.++|.+||..+|.+|||+.+++++|+...
T Consensus       252 ----~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          252 ----FVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             ----HHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             ----HHHcCCcCCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence                111111111111         11235678999999999999999999999998763

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.7e-43  Score=325.23  Aligned_cols=259  Identities=27%  Similarity=0.438  Sum_probs=197.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEc----CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|++.+.||+|+||.||+|.+.    .+..|++|.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            358999999999999999999864    4678999999753 34456778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++....  ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus       124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999999996543  24899999999999999999999999   9999999999999999999999999998653


Q ss_pred             CCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          193 GDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       193 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .................  
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~~~~--  273 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLPPPM--  273 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECCCCT--
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCc--
Confidence            32211 11112234678999999998999999999999999999998 9999754322   12222222111111110  


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                                 .....+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus       274 -----------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          274 -----------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             -----------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                       112357789999999999999999999999987743

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-43  Score=325.46  Aligned_cols=267  Identities=19%  Similarity=0.208  Sum_probs=205.1

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ  106 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  106 (358)
                      ++....++|++.+.||+|+||.||+|.+.. +..|++|++...     .......+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            456778999999999999999999999754 889999998642     33456788899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhcccc-------------------------------------ccCCCHHHHHHHHHHHHH
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQER-------------------------------------CKILDWSKRFHIICGTAR  149 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------~~~~~~~~~~~~~~~i~~  149 (358)
                      .+..++||||+++++|.+++.....                                     ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999999853110                                     112467788999999999


Q ss_pred             HHHHHhcCCCCCcccCCCCCCcEEEcCCC--CeEEeccccceecCCCCCC--CccccccccCCCCCcccccC--CCCCCc
Q 018304          150 GVMYLHQDSRLRIIHRDLKASNVLLDQDM--NPKISDFGLARAFGGDETE--GNTKRVIGTYGYMAPEYASD--GQFSVK  223 (358)
Q Consensus       150 al~~LH~~~~~~i~H~di~~~Nilv~~~~--~i~L~Df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~  223 (358)
                      ||.|||+.+   ++|+||+|+||+++.++  .++|+|||++..+......  .......+++.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999999   99999999999998776  8999999999865322111  12334568999999998865  678999


Q ss_pred             ccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC
Q 018304          224 SDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP  303 (358)
Q Consensus       224 ~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  303 (358)
                      +||||||+++|+|++|..||......   ...   .............  ..     ......+.++|.+||+.+|.+||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~---~~~---~~~~~~~~~~~~~--~~-----~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDA---DTI---SQVLNKKLCFENP--NY-----NVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCCCTTSG--GG-----GGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChH---HHH---HHHHhcccccCCc--cc-----ccCCHHHHHHHHHHcCCChhHCC
Confidence            99999999999999999998643322   111   1111111111100  00     01123567899999999999999


Q ss_pred             ChHHHHHHhccC
Q 018304          304 SMPSVILMLGSE  315 (358)
Q Consensus       304 t~~ell~~l~~~  315 (358)
                      |+.+++++.+..
T Consensus       324 s~~~~l~hp~~~  335 (345)
T 3hko_A          324 DAMRALQHPWIS  335 (345)
T ss_dssp             CHHHHHHSHHHH
T ss_pred             CHHHHhcChhhc
Confidence            999999976543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=320.29  Aligned_cols=256  Identities=24%  Similarity=0.296  Sum_probs=191.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..++|++.+.||+|+||.||+|.+.. ++.|++|++....  ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            45789999999999999999999865 7899999997633  34567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CCCeEEeccccceecC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARAFG  192 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~~i~L~Df~~~~~~~  192 (358)
                      |+++++|.+++...   +.+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.   ++.++|+|||++....
T Consensus       129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999998543   34899999999999999999999999   999999999999975   8899999999987653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ..   .......|++.|+|||++.+..++.++|||||||++|+|++|..||......  ........    ..... ...
T Consensus       203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~----~~~~~-~~~  272 (349)
T 2w4o_A          203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRIL----NCEYY-FIS  272 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHH----TTCCC-CCT
T ss_pred             cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHH----hCCCc-cCC
Confidence            21   1223456899999999999989999999999999999999999997543321  11111111    11110 010


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..     .......+.+||.+||+.||++|||+.+++++.+..
T Consensus       273 ~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  310 (349)
T 2w4o_A          273 PW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT  310 (349)
T ss_dssp             TT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred             ch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence            00     001123567899999999999999999999986654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1e-42  Score=315.97  Aligned_cols=264  Identities=28%  Similarity=0.386  Sum_probs=210.7

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEE------cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCccceeeEEE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTL------VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCI  105 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~  105 (358)
                      .....++|++.+.||+|+||.||+|.+      .+++.|++|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            334457999999999999999999985      236789999997533 34557788999999999 8999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhcccc---------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQER---------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKAS  170 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~  170 (358)
                      +.+..++||||+++++|.+++.....               ...+++..++.++.||+.||.|||+++   ++|+||+|+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence            99999999999999999999966432               124899999999999999999999999   999999999


Q ss_pred             cEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCC
Q 018304          171 NVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD  249 (358)
Q Consensus       171 Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~  249 (358)
                      ||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999987643332222333456778999999988899999999999999999998 99998654432


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .  ..........    .....     ..    ....+.+++.+||..||.+|||+.++++.|+..
T Consensus       255 ~--~~~~~~~~~~----~~~~~-----~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          255 S--KFYKMIKEGF----RMLSP-----EH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             H--HHHHHHHHTC----CCCCC-----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             h--HHHHHhccCC----CCCCc-----cc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            1  1111111111    11000     01    123567899999999999999999999999765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-42  Score=311.44  Aligned_cols=251  Identities=25%  Similarity=0.418  Sum_probs=202.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-C-------CEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-G-------QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~-------~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      .++|++.+.||+|+||.||+|.+.. +       ..|++|.+..........+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4789999999999999999998644 3       4799999987666777889999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC--------eE
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--------PK  181 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~--------i~  181 (358)
                      .++||||+.+++|.+++....  ..+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.        ++
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999996543  23899999999999999999999999   999999999999998887        99


Q ss_pred             EeccccceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCC-CCCCCCCCCchhHHHHH
Q 018304          182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKN-RGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~  259 (358)
                      |+|||++....      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..| |.....   .... ...
T Consensus       162 l~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~-~~~  231 (289)
T 4fvq_A          162 LSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---QRKL-QFY  231 (289)
T ss_dssp             ECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH-HHH
T ss_pred             eccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---HHHH-HHh
Confidence            99999986431      2234457889999999887 6789999999999999999996554 322111   1111 111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .  .......   ..         ...+.+++.+||+.||++|||+.+++++|+.+..
T Consensus       232 ~--~~~~~~~---~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          232 E--DRHQLPA---PK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             H--TTCCCCC---CS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             h--ccCCCCC---CC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1  1111111   11         1135679999999999999999999999998754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=314.62  Aligned_cols=269  Identities=23%  Similarity=0.312  Sum_probs=200.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-----hhhHHHHHHHHHHHHhc---CCCCccceeeEEEeC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~~  107 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++....     ........+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4579999999999999999999974 58999999986422     11123455677766666   499999999999876


Q ss_pred             C-----eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          108 E-----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       108 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                      .     ..+++|||+. ++|.+++...... .+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.++|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     5799999997 5999998664432 3899999999999999999999999   999999999999999999999


Q ss_pred             eccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      +|||++.....   ........+++.|+|||++.+..++.++|||||||++|+|++|..||......   ..........
T Consensus       162 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~  235 (308)
T 3g33_A          162 ADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLI  235 (308)
T ss_dssp             CSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHH
T ss_pred             eeCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence            99999976532   22234567899999999999899999999999999999999999998653322   2222222222


Q ss_pred             hcCCCCccccC------Cc--CCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          263 NEGMPSQLIDP------CI--QGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       263 ~~~~~~~~~~~------~~--~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ...........      ..  ......     .....+.+||.+||+.||++|||+.+++++-+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~  302 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK  302 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence            11111111000      00  000011     11245778999999999999999999999876553

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.6e-43  Score=316.83  Aligned_cols=257  Identities=22%  Similarity=0.313  Sum_probs=204.8

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ...++|++.+.||+|++|.||++.+. +|+.|++|.+..........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            45678999999999999999999975 58999999997655445567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE---cCCCCeEEeccccceec
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF  191 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv---~~~~~i~L~Df~~~~~~  191 (358)
                      ||+++++|.+++....   .+++..++.++.|++.||.|||+.+   ++|+||+|+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           86 QLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999999985543   3899999999999999999999999   9999999999999   77889999999998753


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      .    ........+++.|+|||.+.+..++.++||||||+++|+|++|..||.....   ........... ........
T Consensus       160 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~-~~~~~~~~  231 (304)
T 2jam_A          160 Q----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIKEGY-YEFESPFW  231 (304)
T ss_dssp             C----CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHCC-CCCCTTTT
T ss_pred             C----CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCC-CCCCcccc
Confidence            2    1223345689999999999999999999999999999999999999854322   11111111110 00011111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .         .....+.++|.+||+.||++|||+.+++++.+..
T Consensus       232 ~---------~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (304)
T 2jam_A          232 D---------DISESAKDFICHLLEKDPNERYTCEKALSHPWID  266 (304)
T ss_dssp             T---------TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             c---------cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence            1         1123577899999999999999999999876544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5e-43  Score=312.42  Aligned_cols=261  Identities=25%  Similarity=0.344  Sum_probs=207.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++.+.||+|++|.||+|.+. +++.|++|.+... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4578999999999999999999986 5899999998643 2334577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++++|.+++...   ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999988543   34899999999999999999999999   999999999999999999999999999765322


Q ss_pred             CCCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..........+++.|+|||.+.+..+ +.++||||||+++|+|++|..||........  ...    .+......  ...
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~~~~~~~--~~~  230 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYS----DWKEKKTY--LNP  230 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHH----HHHTTCTT--STT
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHH----Hhhhcccc--cCc
Confidence            22222334568899999999887665 7789999999999999999999865443211  111    11111100  000


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                            .......+.++|.+||+.||++|||+.+++++.+....
T Consensus       231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence                  00112356689999999999999999999998776544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.6e-43  Score=325.67  Aligned_cols=255  Identities=23%  Similarity=0.278  Sum_probs=199.6

Q ss_pred             CCCCc--ceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSI--NKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i--~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      +.|.+  .+.||+|+||.||+|.+. +|+.|++|++..........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E  166 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME  166 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            34444  568999999999999975 489999999987666667788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE--cCCCCeEEeccccceecCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL--DQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv--~~~~~i~L~Df~~~~~~~~  193 (358)
                      |+++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+|+||+|+||++  +.++.++|+|||++.....
T Consensus       167 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          167 YVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             CCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             CCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            999999999886533  23899999999999999999999999   9999999999999  5678899999999987632


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..   ......+++.|+|||++.+..++.++|||||||++|+|++|..||......   .......... ......... 
T Consensus       242 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~-~~~~~~~~~-  313 (373)
T 2x4f_A          242 RE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLNNILACR-WDLEDEEFQ-  313 (373)
T ss_dssp             TC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTC-CCSCSGGGT-
T ss_pred             cc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcc-CCCChhhhc-
Confidence            22   223446899999999999889999999999999999999999998653321   1221111110 000111100 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                              .....+.+||.+||+.||.+|||+.+++++.+.
T Consensus       314 --------~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~  346 (373)
T 2x4f_A          314 --------DISEEAKEFISKLLIKEKSWRISASEALKHPWL  346 (373)
T ss_dssp             --------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             --------cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence                    112357789999999999999999999997654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-42  Score=335.50  Aligned_cols=260  Identities=25%  Similarity=0.325  Sum_probs=211.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.|++|++.+.   .......+.+|+++++.++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3478999999999999999999985 4899999999652   22344667899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.++|+|||++....
T Consensus       262 VmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999866443 33899999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...   ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.........    .+..
T Consensus       338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~----~~p~  410 (576)
T 2acx_A          338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----EYSE  410 (576)
T ss_dssp             TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC----CCCT
T ss_pred             cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc----cCCc
Confidence            221   223457899999999999889999999999999999999999998765443322222222211111    1111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSET  316 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~~  316 (358)
                           .    ....+.+||.+||+.||.+||     ++.+++++-+...
T Consensus       411 -----~----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          411 -----R----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             -----T----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             -----c----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence                 1    123567899999999999999     7899999877653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.4e-43  Score=320.74  Aligned_cols=257  Identities=21%  Similarity=0.298  Sum_probs=206.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ..++|++.+.||+|+||.||+|.+.. |+.|++|.+.....      .....+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            34679999999999999999999864 89999999865322      135678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC----CeEEecc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF  185 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~----~i~L~Df  185 (358)
                      .++||||+++++|.+++...   ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++    .++|+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999999653   34899999999999999999999999   99999999999999887    7999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      |++......   .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......   ......... ...
T Consensus       164 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~-~~~  236 (321)
T 2a2a_A          164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANITSV-SYD  236 (321)
T ss_dssp             TTCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTT-CCC
T ss_pred             ccceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhc-ccc
Confidence            999876432   1223456889999999999899999999999999999999999998543221   111111100 000


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .......         .....+.++|.+||+.||++|||+.+++++.+..
T Consensus       237 ~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~  277 (321)
T 2a2a_A          237 FDEEFFS---------HTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (321)
T ss_dssp             CCHHHHT---------TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred             cChhhhc---------ccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence            0000000         0113567899999999999999999999987654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-42  Score=330.90  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=206.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .++|.+.+.||+|+||.||+|.+. +|+.|++|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            378999999999999999999985 59999999996532   22356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++...   +.+++..++.++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            9999999999998543   34999999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .   ......+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.....   ......+.    .... ... 
T Consensus       169 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~----~~~~-~~p-  236 (476)
T 2y94_A          169 G---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKIC----DGIF-YTP-  236 (476)
T ss_dssp             T---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHH----TTCC-CCC-
T ss_pred             c---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHh----cCCc-CCC-
Confidence            2   22334578999999999988765 6899999999999999999999864332   12222211    1111 000 


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                          ...    ...+.+||.+||+.||.+|||+.+++++.+...
T Consensus       237 ----~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          237 ----QYL----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             ----TTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             ----ccC----CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                011    135678999999999999999999999766543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-42  Score=323.95  Aligned_cols=256  Identities=26%  Similarity=0.346  Sum_probs=199.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcC--CCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +.+|++.+.||+|+||.||++.+.+++.|++|++..  ........+.+|+.+++.++  |+||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            456999999999999999999987799999999864  33455677889999999996  59999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      || +.+++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++ ++.+||+|||++..+..
T Consensus       135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 55789999996543   4889999999999999999999999   99999999999995 68999999999987543


Q ss_pred             CCCCCccccccccCCCCCcccccC-----------CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      ...........|++.|+|||++.+           ..++.++|||||||++|+|++|..||.....     .........
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~  281 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII  281 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence            322223345578999999998865           3688999999999999999999999854221     111111111


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .......+..     ..    ...+.+||.+||..||.+|||+.+++++.+..
T Consensus       282 ~~~~~~~~~~-----~~----~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          282 DPNHEIEFPD-----IP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             CTTSCCCCCC-----CS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CccccCCCCc-----cc----hHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence            1111111111     01    23567899999999999999999999987654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.4e-43  Score=323.11  Aligned_cols=254  Identities=23%  Similarity=0.268  Sum_probs=205.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..++|++++.||+|+||.||+|.++. ++.|++|++.+.   .......+..|..++..+ +||+|+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34799999999999999999999865 789999999753   223456678899999888 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||+++++|.+++....   .+++..++.++.||+.||.|||++|   |+||||||+||+++.+|.++|+|||++...
T Consensus        98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999986543   3999999999999999999999999   999999999999999999999999998753


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..  ........+|++.|+|||++.+..++.++|||||||++|+|++|..||...+.   ......+..   .. . .+.
T Consensus       172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~---~~-~-~~p  241 (353)
T 2i0e_A          172 IW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIME---HN-V-AYP  241 (353)
T ss_dssp             CC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---CC-C-CCC
T ss_pred             cc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHHHHHh---CC-C-CCC
Confidence            21  12223456789999999999999999999999999999999999999864322   122222221   11 1 111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~  315 (358)
                      .     .    ....+.++|.+||+.||.+||+     +.+++++.+..
T Consensus       242 ~-----~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~  281 (353)
T 2i0e_A          242 K-----S----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  281 (353)
T ss_dssp             T-----T----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred             C-----C----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence            1     1    1235678999999999999995     68998876643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.9e-43  Score=314.71  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=202.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      -++|++.+.||+|++|.||+|.+.. +..|++|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4789999999999999999998755 7799999986422   22346688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.... 
T Consensus        88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~-  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  160 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC-
Confidence            99999999999986543   3899999999999999999999999   9999999999999999999999999886532 


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                         ........+++.|+|||.+.+..++.++||||||+++|+|++|..||......   ........ ....    +.. 
T Consensus       161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-~~~~----~~~-  228 (279)
T 3fdn_A          161 ---SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISR-VEFT----FPD-  228 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHH-TCCC----CCT-
T ss_pred             ---cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHHHHHh-CCCC----CCC-
Confidence               22223456889999999999999999999999999999999999998643221   11111111 1001    111 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          .    ....+.++|.+||+.+|.+|||+.+++++.+..
T Consensus       229 ----~----~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          229 ----F----VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             ----T----SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred             ----c----CCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence                0    123566899999999999999999999987654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=324.72  Aligned_cols=267  Identities=21%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhh-HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++.+.||+|+||.||+|.+. +++.|++|.+....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            68999999999999999999986 58899999986533221 11344799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.+ +|.+++....  ..+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++......  
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--  153 (324)
T 3mtl_A           82 LDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--  153 (324)
T ss_dssp             CSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             ccc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--
Confidence            975 8888886543  34899999999999999999999999   999999999999999999999999998754221  


Q ss_pred             CCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......   ................ +....
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~-~~~~~  229 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEET-WPGIL  229 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTT-STTGG
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHh-chhhh
Confidence            122233467899999998876 578999999999999999999999986544322   2222222221111111 11000


Q ss_pred             CC------------CCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          276 QG------------SFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       276 ~~------------~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ..            ...     ......+.+||.+||+.||++|||+.+++++.+....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence            00            000     0112356789999999999999999999998876633

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-42  Score=312.13  Aligned_cols=262  Identities=23%  Similarity=0.335  Sum_probs=200.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHh--cCCCCccceeeEEEeC----Cee
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQG----EEK  110 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~--l~~~~iv~~~~~~~~~----~~~  110 (358)
                      ..++|++.+.||+|+||.||+|.+ +++.|++|++...   ....+..|.+++..  ++||||+++++++...    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            457999999999999999999988 7899999999653   23455567777766  7899999999986553    457


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH--------QDSRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH--------~~~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                      ++||||+++++|.+++...    .+++..++.++.|++.||.|||        +.+   ++||||||+||+++.++.++|
T Consensus        82 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            8999999999999999432    3899999999999999999999        888   999999999999999999999


Q ss_pred             eccccceecCCCCCC--CccccccccCCCCCcccccCC------CCCCcccchhHhHHHHHHHhC----------CCCCC
Q 018304          183 SDFGLARAFGGDETE--GNTKRVIGTYGYMAPEYASDG------QFSVKSDVFSFGILLLEIISG----------KKNRG  244 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g----------~~p~~  244 (358)
                      +|||++.........  .......+++.|+|||.+.+.      .++.++||||||+++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999999765332211  112234689999999998876      445799999999999999999          77765


Q ss_pred             CCCCCCCchhHHHHHHHh-hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          245 FYHSDNNLNLIGHAWKLW-NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..........  ...... ..........    ..........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       235 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPSFE--DMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCCHH--HHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcchh--hhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            4433322211  111111 1111111111    112234456788999999999999999999999998754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1e-42  Score=318.39  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=199.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CC----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~----~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .++|++.+.||+|+||.||+|.+.. ++    +|++|.+... .......+.+|+.+++.++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            4789999999999999999998643 44    4688877542 2345677889999999999999999999998754 78


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ++++|+.+++|.+++....  ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            8999999999999986543  34999999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .......    ......
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~----~~~~~~  240 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEK----GERLPQ  240 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHT----TCCCCC
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHHHc----CCCCCC
Confidence            44333333333456778999999999999999999999999999999 999986543322   1111111    111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .         ......+.+++.+||+.+|.+|||+.+++++|+.+..
T Consensus       241 ~---------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          241 P---------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             C---------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             C---------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1         1112357789999999999999999999999877643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.5e-43  Score=316.98  Aligned_cols=269  Identities=28%  Similarity=0.414  Sum_probs=212.7

Q ss_pred             eeHHHHHHhcCCCCcceeecccCCccEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccce
Q 018304           29 FELATIVSATNNFSINKKLGQGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKL  100 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~  100 (358)
                      ....+.....++|++.+.||+|+||.||+|.+      .+++.|++|.+... .......+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44556666779999999999999999999984      23678999999763 334556788999999999 79999999


Q ss_pred             eeEEEeCC-eeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCC
Q 018304          101 LGCCIQGE-EKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRD  166 (358)
Q Consensus       101 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~d  166 (358)
                      ++++...+ ..++||||+++++|.+++.....             ...+++..++.++.|++.||.|||+++   ++|+|
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987755 58999999999999999966432             123789999999999999999999999   99999


Q ss_pred             CCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCC
Q 018304          167 LKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGF  245 (358)
Q Consensus       167 i~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~  245 (358)
                      |+|+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999986543332223334557788999999998999999999999999999998 9999865


Q ss_pred             CCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          246 YHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .....  .......    .........     .    ....+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       254 ~~~~~--~~~~~~~----~~~~~~~~~-----~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDE--EFCRRLK----EGTRMRAPD-----Y----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSH--HHHHHHH----HTCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhH--HHHHHhc----cCccCCCCC-----C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            43321  1111111    111111111     1    123567899999999999999999999999765

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.7e-43  Score=314.71  Aligned_cols=264  Identities=25%  Similarity=0.367  Sum_probs=204.0

Q ss_pred             cCCCCcceeecccCCccEEEEEE-----cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Ce
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE  109 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~  109 (358)
                      .++|++.+.||+|+||.||+|.+     .+++.|++|.+... .......+.+|+.+++.++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            46699999999999999999983     34889999999753 233457788999999999999999999999876  66


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            899999999999999995543  23999999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCC--------CCCCchhHHHHHH
Q 018304          190 AFGGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYH--------SDNNLNLIGHAWK  260 (358)
Q Consensus       190 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~  260 (358)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++|..|+....        .............
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            76433211 12233457778999999998889999999999999999999998853321        0011111111122


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ............         .....+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       255 ~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          255 TLKEGKRLPCPP---------NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHTTCCCCCCT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhccCCCCCCC---------CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            222221111111         1123577899999999999999999999998753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-42  Score=317.89  Aligned_cols=262  Identities=27%  Similarity=0.406  Sum_probs=209.0

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI  105 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~--------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~  105 (358)
                      ...++|++.+.||+|+||.||+|.+.        ++..|++|++... .......+.+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34589999999999999999999863        3678999999753 344567788999999999 8999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcE
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV  172 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Ni  172 (358)
                      +.+..++||||+.+++|.+++.....             ...+++..++.++.||+.||.|||+++   ++|+||+|+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence            99999999999999999999966432             123889999999999999999999999   99999999999


Q ss_pred             EEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCC
Q 018304          173 LLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNN  251 (358)
Q Consensus       173 lv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~  251 (358)
                      +++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......  
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--  266 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  266 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence            999999999999999987643322222333456778999999988889999999999999999999 99997643221  


Q ss_pred             chhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                       .......    .........         .....+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       267 -~~~~~~~----~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          267 -ELFKLLK----EGHRMDKPA---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             -HHHHHHH----HTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHh----cCCCCCCCc---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             1111111    111111111         11235678999999999999999999999998773

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.8e-42  Score=310.57  Aligned_cols=263  Identities=19%  Similarity=0.264  Sum_probs=202.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeE-EEeCCeeEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC-CIQGEEKLLI  113 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-~~~~~~~~lv  113 (358)
                      ...++|++.+.||+|+||.||+|.+. +++.|++|++......  ..+..|+.+++.++|++++..+.. +...+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            34689999999999999999999974 5889999987543222  457789999999988776655544 4677788999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE---cCCCCeEEecccccee
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARA  190 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv---~~~~~i~L~Df~~~~~  190 (358)
                      |||+ +++|.+++....  ..+++..++.++.||+.||.|||+++   ++|+||+|+||++   +.++.++|+|||++..
T Consensus        84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 889999986433  23999999999999999999999999   9999999999999   7889999999999987


Q ss_pred             cCCCCCC-----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          191 FGGDETE-----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       191 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      .......     .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            6433221     12234568999999999999999999999999999999999999998765554444443332221111


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .........         ...+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~~~~~---------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          238 PIEVLCKGY---------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             CHHHHTTTS---------CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhhhhhccC---------CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            111111110         13577899999999999999999999998776

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.9e-42  Score=309.73  Aligned_cols=254  Identities=23%  Similarity=0.308  Sum_probs=207.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..++|++.+.||+|+||.||++.+.. ++.|++|++...   .......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            34789999999999999999999865 789999998653   34456778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus        93 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999999885533   3899999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...  .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......   ....    ....... .+. 
T Consensus       167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~-~~~-  235 (294)
T 2rku_A          167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYL----RIKKNEY-SIP-  235 (294)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHTTCC-CCC-
T ss_pred             cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhhccC-CCc-
Confidence            221  2223456889999999999888999999999999999999999998653321   1111    1111110 111 


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          ...    ...+.+++.+||+.||++|||+.+++++.+..
T Consensus       236 ----~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~  270 (294)
T 2rku_A          236 ----KHI----NPVAASLIQKMLQTDPTARPTINELLNDEFFT  270 (294)
T ss_dssp             ----TTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             ----ccc----CHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence                111    13566899999999999999999999876554

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=325.34  Aligned_cols=273  Identities=20%  Similarity=0.272  Sum_probs=213.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--eeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~l  112 (358)
                      ..++|++.+.||+|+||.||+|.+.. ++.|++|++.... ......+.+|+++++.++||||+++++++...+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            35789999999999999999999865 8999999997533 234567789999999999999999999998765  7799


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE----cCCCCeEEeccccc
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLA  188 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv----~~~~~i~L~Df~~~  188 (358)
                      ||||+.+++|.+++........+++..++.++.||+.||.|||+++   |+||||||+||++    +.++.++|+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999977655555999999999999999999999999   9999999999999    77778999999999


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccC--------CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC-chhHHHHH
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASD--------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN-LNLIGHAW  259 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~  259 (358)
                      ......   .......+++.|+|||++.+        ..++.++|||||||++|+|++|..||........ ...+....
T Consensus       164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            875322   22234568999999998764        4567899999999999999999999876544332 22222222


Q ss_pred             HHhhcCCCCccc-----------cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          260 KLWNEGMPSQLI-----------DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       260 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..........+.           ...............+.+++.+||+.||++|||+.++++.++.+
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            211111110000           00111233355566778899999999999999999999887665

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-42  Score=316.73  Aligned_cols=272  Identities=25%  Similarity=0.321  Sum_probs=200.9

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChh-----hHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-----GLKELKNEVILFSKLQHRNLVKLLGCCIQG  107 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  107 (358)
                      +....++|++.+.||+|+||.||+|.+.. |+.|++|.+......     ....+.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            44566899999999999999999999754 899999998652221     123577899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                      +..++||||+++ +|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||+
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             CceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccc
Confidence            999999999986 8888875433  34889999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      +......  ........+++.|+|||++.+. .++.++|||||||++|+|++|..||.....   ...+...........
T Consensus       159 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          159 AKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPT  233 (346)
T ss_dssp             GSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred             ceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCC
Confidence            9765322  1223345689999999988654 589999999999999999999998755332   222222222221111


Q ss_pred             CCccccCCc---------CCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          267 PSQLIDPCI---------QGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       267 ~~~~~~~~~---------~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .....+...         ......     .....+.+||.+||+.||++|||+.+++++.+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~  297 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  297 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence            111110000         000111     11246788999999999999999999999887653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6e-43  Score=320.47  Aligned_cols=269  Identities=23%  Similarity=0.319  Sum_probs=201.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .++|++.+.||+|++|.||+|.+.. ++.|++|.+...  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3789999999999999999999865 899999988543  3334566789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.++.....   .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999988988864433   3999999999999999999999999   999999999999999999999999999765322


Q ss_pred             CCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH--------HHh---
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW--------KLW---  262 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~---  262 (358)
                        ........+++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+....        ..+   
T Consensus       178 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 --GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             --ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence              1222344688999999988775 78999999999999999999999986544321111111000        000   


Q ss_pred             ---hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          263 ---NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       263 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                         ........................+.+||.+||+.||++|||+.+++++-+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f  310 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF  310 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence               0001111100000000001123467889999999999999999999987654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.1e-43  Score=320.21  Aligned_cols=271  Identities=23%  Similarity=0.272  Sum_probs=197.8

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .....++|++.+.||+|+||.||+|.+. +++.|++|++.....  .....+.+|+.+++.++||||+++++++.+.+..
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            3344579999999999999999999875 488999999965332  2345677899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc-----CCCCeEEecc
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-----QDMNPKISDF  185 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~-----~~~~i~L~Df  185 (358)
                      ++||||+++ +|.+++....   .+++..++.++.||+.||.|||+++   |+|+||||+||+++     .++.++|+||
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence            999999975 9999986543   3999999999999999999999999   99999999999995     4455999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      |++......  ........+++.|+|||++.+. .++.++|||||||++|+|++|..||.....   .............
T Consensus       182 g~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~  256 (329)
T 3gbz_A          182 GLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGL  256 (329)
T ss_dssp             THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCC
T ss_pred             CCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCC
Confidence            999765322  1222344678999999998774 589999999999999999999999865332   2222222222111


Q ss_pred             CCCCccc---------cCCcC-CCCCHH------HHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          265 GMPSQLI---------DPCIQ-GSFNLA------EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       265 ~~~~~~~---------~~~~~-~~~~~~------~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .......         ..... ......      ....+.+||.+||+.||++|||+.+++++.+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  324 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH  324 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence            1111000         00000 000111      1245678999999999999999999999877653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=321.33  Aligned_cols=248  Identities=22%  Similarity=0.272  Sum_probs=202.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  107 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|.+....        ......+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3479999999999999999999975 48899999987532        11234566799999999999999999999999


Q ss_pred             CeeEEEEEecCCC-CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          108 EEKLLIYEFMTNK-SLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       108 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      +..++||||+.++ +|.+++....   .+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999998766 9999985543   3999999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      ++......   .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.......            ...
T Consensus       176 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~~~  240 (335)
T 3dls_A          176 SAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------EAA  240 (335)
T ss_dssp             TCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------TTC
T ss_pred             cceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------hhc
Confidence            99875322   22334568999999999988776 789999999999999999999985422110            000


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .    ..   ...    ....+.++|.+||+.||++|||+.+++++.+...
T Consensus       241 ~----~~---~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          241 I----HP---PYL----VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             C----CC---SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             c----CC---Ccc----cCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence            0    00   000    1235678999999999999999999999977654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=315.97  Aligned_cols=268  Identities=21%  Similarity=0.294  Sum_probs=207.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCeeE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL  111 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~~~  111 (358)
                      ..++|++.+.||+|+||.||++.+ .+++.|++|.+..........+.+|+++++.++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            457899999999999999999997 4589999999977667777889999999999999999999999873    34778


Q ss_pred             EEEEecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          112 LIYEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      +||||+.+++|.+++.... ....+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999999986632 2345999999999999999999999999   99999999999999999999999998876


Q ss_pred             cCCCCCCC-------ccccccccCCCCCcccccCCC---CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH
Q 018304          191 FGGDETEG-------NTKRVIGTYGYMAPEYASDGQ---FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       191 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  260 (358)
                      ........       ......+++.|+|||++.+..   ++.++||||||+++|+|++|..||......... ...... 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~-  261 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQ-  261 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHH-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhh-
Confidence            42111000       011234688999999987554   688999999999999999999998542211111 111111 


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCCC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQP  321 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~~  321 (358)
                         .....  ..   ..    .....+.++|.+||+.||.+|||+.+++++|+.+....++
T Consensus       262 ---~~~~~--~~---~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          262 ---NQLSI--PQ---SP----RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             ---CC--C--CC---CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             ---ccCCC--Cc---cc----cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence               10000  00   00    1123577899999999999999999999999988654433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-42  Score=324.49  Aligned_cols=271  Identities=23%  Similarity=0.342  Sum_probs=197.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCC--ee
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EK  110 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~--~~  110 (358)
                      ..++|++++.||+|+||.||+|.+. +++.|++|.+..  ........+.+|+.+++.+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            3579999999999999999999975 489999999854  34455677889999999996 999999999997654  78


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++||||++ ++|.+++...    .+++..+..++.||+.||.|||+.|   |+||||||+||+++.++.++|+|||++..
T Consensus        87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999997 5898888542    3899999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCC-------------------CCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCC
Q 018304          191 FGGDE-------------------TEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN  250 (358)
Q Consensus       191 ~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~  250 (358)
                      +....                   .........+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-  237 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-  237 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence            53211                   0111223468999999999876 67899999999999999999999998654322 


Q ss_pred             CchhHHHHHHHhhcCCCCccc---------------------cCCcCCCCC------------HHHHHHHHHHHhhhcCC
Q 018304          251 NLNLIGHAWKLWNEGMPSQLI---------------------DPCIQGSFN------------LAEVIRCIHIGLLCVQQ  297 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~------------~~~~~~l~~li~~cl~~  297 (358)
                        ..+..+...........+.                     .......+.            ......+.+|+.+||+.
T Consensus       238 --~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          238 --NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             --HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             --HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence              2222222111111000000                     000000000            00123577899999999


Q ss_pred             CCCCCCChHHHHHHhccCCCC
Q 018304          298 HPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       298 ~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      ||++|||+.+++++.+.....
T Consensus       316 dP~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          316 NPNKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             SGGGSCCHHHHTTSTTTTTTC
T ss_pred             CcccCCCHHHHhCCHHHHHhc
Confidence            999999999999997765433

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.7e-42  Score=314.39  Aligned_cols=263  Identities=23%  Similarity=0.370  Sum_probs=199.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .++|++.+.||+|++|.||+|.+. +++.|++|.+..   ........+.+|+.+++.++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            368999999999999999999974 589999999874   3345567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          114 YEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      |||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999986532 2345899999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ...  .......++..|+|||.+.+..++.++||||||+++|+|++|..||......    .... ..............
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~~~~~~  260 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCDYPPLPS  260 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHH-HHHHHTTCSCCCCT
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHH-HHHhhcccCCCCcc
Confidence            221  1222346889999999999889999999999999999999999997543221    1111 11111111111111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                          ..    ....+.+++.+||..||.+|||+.++++.|+.+.+.
T Consensus       261 ----~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          261 ----DH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             ----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----cc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                11    123567899999999999999999999999887544

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6e-42  Score=308.52  Aligned_cols=262  Identities=19%  Similarity=0.268  Sum_probs=206.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeE-EEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC-CIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-~~~~~~~~lv~  114 (358)
                      ..++|++.+.||+|++|.||+|.+ .+++.|++|++......  ..+.+|+.+++.++|++++..+.. +......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            358999999999999999999997 45899999998653322  457899999999988776655544 46677889999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc---CCCCeEEeccccceec
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAF  191 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~---~~~~i~L~Df~~~~~~  191 (358)
                      ||+ +++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++   .++.++|+|||++...
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 889999986433  34999999999999999999999999   99999999999994   7889999999999876


Q ss_pred             CCCCCCC-----ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          192 GGDETEG-----NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       192 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      .......     ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            4332211     12345689999999999999999999999999999999999999987655444444333322211111


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...+...     +    ...+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       239 ~~~~~~~-----~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          239 IEVLCKG-----Y----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHHTTT-----S----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hHHHHhh-----C----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            1111110     1    13577899999999999999999999999876

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3e-42  Score=326.28  Aligned_cols=267  Identities=17%  Similarity=0.204  Sum_probs=209.8

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEe
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ  106 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  106 (358)
                      .+++....++|++.+.||+|+||.||+|.++. ++.|++|++.+..   ......+.+|..++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            44555566899999999999999999999865 7889999996521   1222337789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      .+..++||||+.+|+|.+++.+..  ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence            999999999999999999996532  33999999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      ++........ .......|++.|+|||++.     ...++.++|||||||++|+|++|..||.....   ......+...
T Consensus       221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~  296 (437)
T 4aw2_A          221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNH  296 (437)
T ss_dssp             TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTH
T ss_pred             hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhhc
Confidence            9976532221 1222357999999999886     45789999999999999999999999864332   2222222211


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCC--CCChHHHHHHhccC
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKD--RPSMPSVILMLGSE  315 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~ell~~l~~~  315 (358)
                      ......+.....         ....+.+||.+||+.+|++  ||++.+++++.+..
T Consensus       297 ~~~~~~p~~~~~---------~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          297 KERFQFPTQVTD---------VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             HHHCCCCSSCCC---------SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             cccccCCccccc---------CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence            111111111110         1235668999999998888  99999999987764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6e-42  Score=307.32  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=200.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .++|++.+.||+|+||.||++.+.. +..+++|.+.... ......+.+|+++++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            4689999999999999999999754 8899999986532 3345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE---cCCCCeEEeccccceec
Q 018304          116 FMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF  191 (358)
Q Consensus       116 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv---~~~~~i~L~Df~~~~~~  191 (358)
                      |+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||++   +.++.++|+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988654 22345999999999999999999999999   9999999999999   45678999999999764


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ...   .......+++.|+|||.+. ..++.++||||||+++|+|++|..||......   .......  ..........
T Consensus       178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~~~--~~~~~~~~~~  248 (285)
T 3is5_A          178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQKAT--YKEPNYAVEC  248 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH--HCCCCCCC--
T ss_pred             CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhhhc--cCCccccccc
Confidence            322   2233456889999999876 56899999999999999999999998643321   1111111  1111111000


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .     .    ....+.+++.+||+.||++|||+.+++++-+..
T Consensus       249 ~-----~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~  283 (285)
T 3is5_A          249 R-----P----LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK  283 (285)
T ss_dssp             C-----C----CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred             C-----c----CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence            0     0    123566899999999999999999999876643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=308.01  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=185.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .++|++.+.||+|++|.||+|.+. +++.|++|.+....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            368999999999999999999974 58999999996522   12346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999986532  34899999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..  .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........          .....   .
T Consensus       165 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------~~~~~---~  229 (278)
T 3cok_A          165 PH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----------VVLAD---Y  229 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSSC---C
T ss_pred             CC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH----------Hhhcc---c
Confidence            21  122245688999999999988899999999999999999999999865443221110          00000   0


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .....    ....+.++|.+||+.||++|||+.+++++.+..
T Consensus       230 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  267 (278)
T 3cok_A          230 EMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS  267 (278)
T ss_dssp             CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred             CCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhcCcccc
Confidence            01111    123567899999999999999999999876543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.1e-42  Score=327.71  Aligned_cols=251  Identities=27%  Similarity=0.392  Sum_probs=204.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-eeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-~~~lv~e  115 (358)
                      ..++|++.+.||+|+||.||+|.+ .++.|+||.++...  ....+.+|+.+++.++||||+++++++.... ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            347899999999999999999988 57899999997643  4567889999999999999999999987765 7899999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++..... ..+++..++.++.||+.||.|||+++   ++||||+|+||+++.++.+||+|||++...... 
T Consensus       268 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            9999999999976432 33789999999999999999999999   999999999999999999999999999864211 


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                          .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ........    ........ 
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~----~~~~~p~~-  410 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKG----YKMDAPDG-  410 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHHHTT----CCCCCCTT-
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC----CCCCCCCc-
Confidence                122356788999999999999999999999999999998 999986544332   22222211    11111111 


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                              ....+.++|.+||+.||++|||+.+|++.|+.+
T Consensus       411 --------~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          411 --------CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             --------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                    123567899999999999999999999998765

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.9e-42  Score=319.54  Aligned_cols=260  Identities=21%  Similarity=0.309  Sum_probs=205.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .++|++.+.||+|+||.||++.+. +++.|++|++... .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            468999999999999999999986 4889999998753 34456778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |+++++|.+++....   .+++..++.++.+++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++..... 
T Consensus       112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            999999999996543   389999999999999999999996 8   99999999999999999999999999865421 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHH------------------
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG------------------  256 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------------  256 (358)
                         .......+++.|+|||++.+..++.++||||||+++|+|++|..||.............                  
T Consensus       185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence               12234468899999999999999999999999999999999999986543211100000                  


Q ss_pred             -----------------HHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          257 -----------------HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       257 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                       ................        ......+.+||.+||+.||++|||+.+++++.+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  329 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS--------GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  329 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCT--------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCc--------ccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence                             0000000000000000        00123577899999999999999999999987654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-42  Score=308.57  Aligned_cols=255  Identities=25%  Similarity=0.420  Sum_probs=206.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .++|++.+.||+|++|.||++.+.+++.|++|.+..... ....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            478999999999999999999998888999999976432 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++++|.+++....  ..+++..++.++.|++.||.+||+++   ++|+||+|+||+++.++.++|+|||++....... .
T Consensus        86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  159 (267)
T ss_dssp             TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence            9999999996543  34899999999999999999999999   9999999999999999999999999987643211 1


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    ........     
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~i~----~~~~~~~~-----  227 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIS----TGFRLYKP-----  227 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----TTCCCCCC-----
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHHHh----cCCcCCCC-----
Confidence            11122345678999999988899999999999999999999 89997643221   1111111    11111100     


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..    ....+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       228 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          228 RL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cc----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            01    123567899999999999999999999999765

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.4e-43  Score=322.65  Aligned_cols=258  Identities=21%  Similarity=0.313  Sum_probs=203.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ...++|++.+.||+|+||.||+|.++. ++.|++|++.+...    ...+|++++..+ +||||+++++++.+.+..++|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            456789999999999999999999864 88999999976432    234688888888 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC----CCeEEeccccce
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLAR  189 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~----~~i~L~Df~~~~  189 (358)
                      |||+.+++|.+++....   .+++..++.++.||+.||.|||++|   |+||||||+||++..+    +.++|+|||++.
T Consensus        95 ~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           95 TELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             ECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999999986543   3999999999999999999999999   9999999999998543    349999999998


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ......  .......+++.|+|||++.+..++.++|||||||++|+|++|..||.................    .... 
T Consensus       169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~----~~~~-  241 (342)
T 2qr7_A          169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS----GKFS-  241 (342)
T ss_dssp             ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH----CCCC-
T ss_pred             cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc----CCcc-
Confidence            753221  223345689999999999887889999999999999999999999875433332222222221    1111 


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      +..     .........+.+||.+||..||++|||+.+++++.|..
T Consensus       242 ~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          242 LSG-----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             CCS-----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             cCc-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            000     00011123567899999999999999999999987654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-42  Score=316.59  Aligned_cols=271  Identities=25%  Similarity=0.341  Sum_probs=207.5

Q ss_pred             HHHHHHhcCCC-CcceeecccCCccEEEEEE-----cCCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeE
Q 018304           31 LATIVSATNNF-SINKKLGQGGFGPVYKGTL-----VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGC  103 (358)
Q Consensus        31 ~~~~~~~~~~y-~i~~~lg~g~~g~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~  103 (358)
                      +.+.....++| ++++.||+|+||.||++.+     .+++.|++|++.... ......+.+|+++++.++||||++++++
T Consensus        22 pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (318)
T 3lxp_A           22 PGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGC  101 (318)
T ss_dssp             --CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence            33444455677 9999999999999998864     247889999997633 3456778899999999999999999999


Q ss_pred             EEeC--CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeE
Q 018304          104 CIQG--EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK  181 (358)
Q Consensus       104 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~  181 (358)
                      +.+.  ...++||||+++++|.+++....    +++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~k  174 (318)
T 3lxp_A          102 CEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVK  174 (318)
T ss_dssp             EEETTTTEEEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EecCCCceEEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEE
Confidence            9884  57899999999999999985432    899999999999999999999999   99999999999999999999


Q ss_pred             EeccccceecCCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCC--------CCc
Q 018304          182 ISDFGLARAFGGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD--------NNL  252 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~--------~~~  252 (358)
                      |+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......        ...
T Consensus       175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~  254 (318)
T 3lxp_A          175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ  254 (318)
T ss_dssp             ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH
T ss_pred             ECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc
Confidence            9999999876432211 1222345677899999999888999999999999999999999997543211        000


Q ss_pred             hhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          253 NLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ....................         .....+.++|.+||+.||++|||+.++++.|+.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          255 MTVLRLTELLERGERLPRPD---------KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHHHHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHhcccCCCCCc---------cccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            00001111111111111111         112467789999999999999999999999987643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-42  Score=332.03  Aligned_cols=264  Identities=23%  Similarity=0.278  Sum_probs=199.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC------
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~------  107 (358)
                      ..++|++++.||+|+||.||+|.+.. ++.|++|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            35899999999999999999999754 889999999753  445567788999999999999999999999655      


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                      ...++||||+.+ ++.+.+..     .+++..++.++.||+.||.|||++|   |+||||||+||+++.++.+||+|||+
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence            356999999976 56665522     2889999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      +.....   ........+++.|+|||++.+..++.++|||||||++|+|++|..||...+..   .....+........+
T Consensus       211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          211 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCP  284 (464)
T ss_dssp             C--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCH
T ss_pred             eeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence            986532   22234467899999999999999999999999999999999999998654322   122222111110000


Q ss_pred             -----------------C--------ccc-cCCcCCCC--CHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          268 -----------------S--------QLI-DPCIQGSF--NLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       268 -----------------~--------~~~-~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                       .        ... +.......  .......+.+||.+||+.||++|||+.+++++.+..
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence                             0        000 00000000  011244678999999999999999999999988765

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-41  Score=329.42  Aligned_cols=259  Identities=25%  Similarity=0.329  Sum_probs=208.3

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||+|.++ +|+.|++|++.+..   ......+..|+.+++.++||||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            78999999999999999999985 48999999996522   233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          115 EFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||+++++|.+++.... ....+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.++|+|||++..+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999986643 2345999999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      ..  .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...  .....  ..+.. 
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~--i~~~~--~~~p~-  414 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR--VLEQA--VTYPD-  414 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH--HHHCC--CCCCT-
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH--Hhhcc--cCCCc-
Confidence            22  1223457999999999999999999999999999999999999998765432222222111  11111  11111 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh-----HHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM-----PSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~l~~~  315 (358)
                          .    ....+.++|.+||+.||++||++     .+|+.+.+..
T Consensus       415 ----~----~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~  453 (543)
T 3c4z_A          415 ----K----FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR  453 (543)
T ss_dssp             ----T----SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred             ----c----cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence                1    12356689999999999999965     7888776554

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.3e-42  Score=310.19  Aligned_cols=258  Identities=28%  Similarity=0.418  Sum_probs=209.7

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ...++|++.+.||+|++|.||+|.+.. +..|++|.+... ......+.+|+++++.++||||+++++++.+....++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            456889999999999999999999865 889999999763 345577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+++|.+++..... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        89 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999999966433 34899999999999999999999999   999999999999999999999999999765322


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      . ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   .........    ...... 
T Consensus       165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~~~~----~~~~~~-  235 (288)
T 3kfa_A          165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDY----RMERPE-  235 (288)
T ss_dssp             S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTC----CCCCCT-
T ss_pred             c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhccC----CCCCCC-
Confidence            1 122223446778999999998899999999999999999999 999976543321   222221111    111111 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          .    ....+.+++.+||..||.+|||+.++++.|+..
T Consensus       236 ----~----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          236 ----G----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             ----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----C----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                1    123577899999999999999999999988754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-42  Score=331.26  Aligned_cols=262  Identities=29%  Similarity=0.424  Sum_probs=210.0

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .+....++|++.+.||+|+||.||+|.+.++..|++|.+.... .....+.+|+.+++.++||||+++++++. .+..++
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            3445567899999999999999999999888999999997633 34678899999999999999999999986 567899


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+.+++|.+++..... ..+++..++.++.||+.||.|||+++   ++||||+|+||+++.++.+||+|||++....
T Consensus       260 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999999999965432 23889999999999999999999999   9999999999999999999999999998653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      .... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ...............+    
T Consensus       336 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~~----  407 (454)
T 1qcf_A          336 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRMPRP----  407 (454)
T ss_dssp             CHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCCCCC----
T ss_pred             CCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCC----
Confidence            2111 11112235678999999998899999999999999999999 9999864332   2222222221111111    


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .         .....+.++|.+||..||++|||+.+|++.|+.+..
T Consensus       408 ~---------~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          408 E---------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             T---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             C---------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            1         112357789999999999999999999999998743

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.2e-43  Score=333.18  Aligned_cols=253  Identities=21%  Similarity=0.270  Sum_probs=196.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .++|++.+.||+|+||.||+|.+.. |+.|++|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            4689999999999999999999754 899999999652   334455677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||+ .+   |+||||||+||+++.++.++|+|||++....
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999986543   38999999999999999999998 88   9999999999999999999999999987532


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .  .........|++.|+|||++.+..++.++|||||||++|+|++|..||......   .......   ....  .+..
T Consensus       301 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~---~~~~--~~p~  370 (446)
T 4ejn_A          301 K--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELIL---MEEI--RFPR  370 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HCCC--CCCT
T ss_pred             C--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHH---hCCC--CCCc
Confidence            1  122233467899999999999999999999999999999999999998543321   1111111   1111  1111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                           ..    ...+.+||.+||+.||.+||     |+.+++++.+..
T Consensus       371 -----~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          371 -----TL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             -----TS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             -----cC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence                 11    13567899999999999999     999999987665

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.2e-42  Score=314.13  Aligned_cols=267  Identities=25%  Similarity=0.418  Sum_probs=200.8

Q ss_pred             eHHHHHHhcCCCCcceeecccCCccEEEEEEcC----CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeE
Q 018304           30 ELATIVSATNNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGC  103 (358)
Q Consensus        30 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~  103 (358)
                      ..+++....++|++.+.||+|+||.||+|.+..    +..|++|.+...  .......+.+|+.+++.++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            344555667899999999999999999998643    447999998643  34556778899999999999999999999


Q ss_pred             EEeCC-----eeEEEEEecCCCCHHHHHhcc---ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc
Q 018304          104 CIQGE-----EKLLIYEFMTNKSLDSFIFDQ---ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD  175 (358)
Q Consensus       104 ~~~~~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~  175 (358)
                      +.+.+     ..++||||+++++|.+++...   .....+++..++.++.||+.||.|||+++   ++|+||+|+||+++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~  181 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR  181 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEEC
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc
Confidence            98765     349999999999999998542   22345999999999999999999999999   99999999999999


Q ss_pred             CCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchh
Q 018304          176 QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNL  254 (358)
Q Consensus       176 ~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~  254 (358)
                      .++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   ..
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~  258 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EM  258 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GH
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HH
Confidence            999999999999976543322222333456778999999999999999999999999999999 88887654332   22


Q ss_pred             HHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          255 IGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .....    .........         .....+.+++.+||..+|.+|||+.+|+++|+.+
T Consensus       259 ~~~~~----~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          259 YDYLL----HGHRLKQPE---------DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HHHHH----TTCCCCCBT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHH----cCCCCCCCc---------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            22111    111111111         1123577899999999999999999999999765

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.6e-43  Score=318.96  Aligned_cols=259  Identities=26%  Similarity=0.407  Sum_probs=198.7

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CC----EEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~----~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .++|++++.||+|+||.||+|.+.. ++    +|++|.+.. ........+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            4789999999999999999999744 44    357777754 23345678889999999999999999999998764 78


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      ++++++.+++|.+++....  ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            8999999999999986543  33899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   .......    ......
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~----~~~~~~  240 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEK----GERLPQ  240 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHT----TCCCCC
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc----CCCCCC
Confidence            43333223333446778999999999999999999999999999999 999986543322   2111111    111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      ..         .....+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       241 ~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          241 PP---------ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CT---------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             Cc---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            10         1122567899999999999999999999999887543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.7e-43  Score=337.09  Aligned_cols=256  Identities=26%  Similarity=0.302  Sum_probs=200.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ..++|++++.||+|+||.||+|.+. ++..|++|++.+..  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999986 48899999987532  23356788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC---CCeEEecccccee
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLARA  190 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~---~~i~L~Df~~~~~  190 (358)
                      |||+.+++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++..   +.++|+|||++..
T Consensus       115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999885543   3999999999999999999999999   9999999999999764   4599999999987


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ....   .......|++.|+|||++. ..++.++||||+||++|+|++|..||.....   ......+.... .......
T Consensus       189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~-~~~~~~~  260 (494)
T 3lij_A          189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGK-YTFDSPE  260 (494)
T ss_dssp             CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-CCCCSGG
T ss_pred             CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-CCCCchh
Confidence            5322   2233456899999999876 5689999999999999999999999865332   12222221110 0111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      +.         .....+.+||.+||+.+|.+|||+.+++++.|..
T Consensus       261 ~~---------~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  296 (494)
T 3lij_A          261 WK---------NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK  296 (494)
T ss_dssp             GT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             cc---------cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence            11         0123567899999999999999999999876543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.6e-42  Score=308.03  Aligned_cols=257  Identities=23%  Similarity=0.352  Sum_probs=195.0

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      ...++|++.+.||+|+||.||+|.+..    +..|++|.+... .......+.+|+..++.++||||+++++++ .++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCcc
Confidence            445799999999999999999998743    456999988653 344567788999999999999999999998 45678


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++||||+.+++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999999996543  23899999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    ......
T Consensus       166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i~----~~~~~~  237 (281)
T 1mp8_A          166 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE----NGERLP  237 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTCCCC
T ss_pred             cCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHHH----cCCCCC
Confidence            532211 11223345678999999988899999999999999999996 99998654332   2222221    111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...         .....+.+++.+||..||++|||+.++++.|+.+
T Consensus       238 ~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          238 MPP---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             CCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111         1123567899999999999999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-42  Score=336.55  Aligned_cols=274  Identities=24%  Similarity=0.320  Sum_probs=210.2

Q ss_pred             ccccCCCCcceeHHHHHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccCh-------------hhHHHHHH
Q 018304           19 IQNIDLELPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISE-------------QGLKELKN   84 (358)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~-------------~~~~~~~~   84 (358)
                      .+++.+++-.+-........++|++++.||+|+||.||+|.+.. ++.|++|++.....             .....+.+
T Consensus        16 ~~~~~~~~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (504)
T 3q5i_A           16 FQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN   95 (504)
T ss_dssp             SCCCCCCGGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHH
T ss_pred             ccceeechhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHH
Confidence            34444443333333333467899999999999999999999864 78999999865321             23567889


Q ss_pred             HHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 018304           85 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIH  164 (358)
Q Consensus        85 e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H  164 (358)
                      |+.+++.++||||+++++++.+....++||||+.+++|.+++....   .+++..++.++.||+.||.|||+++   |+|
T Consensus        96 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH  169 (504)
T 3q5i_A           96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVH  169 (504)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             HHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEe
Confidence            9999999999999999999999999999999999999999886543   3999999999999999999999999   999


Q ss_pred             CCCCCCcEEEcCCC---CeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCC
Q 018304          165 RDLKASNVLLDQDM---NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKK  241 (358)
Q Consensus       165 ~di~~~Nilv~~~~---~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  241 (358)
                      |||+|+||+++.++   .++|+|||++......   .......|++.|+|||++. ..++.++||||+||++|+|++|..
T Consensus       170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~  245 (504)
T 3q5i_A          170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP  245 (504)
T ss_dssp             SCCSGGGEEESSTTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCcHHHEEEecCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCC
Confidence            99999999998776   6999999999876322   2233456899999999887 468999999999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          242 NRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       242 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ||......   .....+..   .........   ..    .....+.+||.+||+.||.+|||+.+++++.|..
T Consensus       246 pf~~~~~~---~~~~~i~~---~~~~~~~~~---~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  306 (504)
T 3q5i_A          246 PFGGQNDQ---DIIKKVEK---GKYYFDFND---WK----NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK  306 (504)
T ss_dssp             SSCCSSHH---HHHHHHHH---CCCCCCHHH---HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CCCCCCHH---HHHHHHHc---CCCCCCccc---cC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence            98653321   12222111   111000000   00    0123577899999999999999999999987754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2e-42  Score=317.07  Aligned_cols=265  Identities=31%  Similarity=0.418  Sum_probs=210.1

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC-C-----CEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEE
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD-G-----QEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC  104 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~-----~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~  104 (358)
                      ++....++|++.+.||+|+||.||+|.+.. +     ..|++|.+... .......+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            445556899999999999999999998743 2     47999999753 334567788999999999 899999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhcccc-----------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEE
Q 018304          105 IQGEEKLLIYEFMTNKSLDSFIFDQER-----------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL  173 (358)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nil  173 (358)
                      .+.+..++||||+++++|.+++.....           ...+++..++.++.|++.||.|||+++   ++|+||+|+||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            999999999999999999999965431           234799999999999999999999999   999999999999


Q ss_pred             EcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCc
Q 018304          174 LDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNL  252 (358)
Q Consensus       174 v~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~  252 (358)
                      ++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......  
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  274 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--  274 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence            99999999999999986533322222233456778999999988899999999999999999998 888976543221  


Q ss_pred             hhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          253 NLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ........    ........     .    ....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       275 ~~~~~~~~----~~~~~~~~-----~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          275 KFYKLVKD----GYQMAQPA-----F----APKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHHHHHHH----TCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhc----CCCCCCCC-----C----CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            11111111    11111100     0    123567899999999999999999999998764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-43  Score=328.86  Aligned_cols=268  Identities=17%  Similarity=0.190  Sum_probs=209.7

Q ss_pred             eeHHHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEE
Q 018304           29 FELATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCC  104 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~  104 (358)
                      ...+++....++|++++.||+|+||.||++.++ +++.|++|++.+.   .......+.+|..++..++||||++++++|
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345566666789999999999999999999985 4899999999652   122334577899999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          105 IQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                      .+.+..++||||+++++|.+++.+..  ..+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.+||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence            99999999999999999999996543  23999999999999999999999999   99999999999999999999999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCccccc-------CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHH
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYAS-------DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGH  257 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~  257 (358)
                      ||++........ .......|++.|+|||++.       +..++.++|||||||++|+|++|..||.....   ......
T Consensus       206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~  281 (412)
T 2vd5_A          206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGK  281 (412)
T ss_dssp             CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH
T ss_pred             chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence            999987532211 1122457899999999886       35689999999999999999999999864332   122222


Q ss_pred             HHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCC---CChHHHHHHhccC
Q 018304          258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDR---PSMPSVILMLGSE  315 (358)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---pt~~ell~~l~~~  315 (358)
                      +.........+...     ..    ....+.+||.+||+ +|.+|   |++.+++++-+..
T Consensus       282 i~~~~~~~~~p~~~-----~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~  332 (412)
T 2vd5_A          282 IVHYKEHLSLPLVD-----EG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF  332 (412)
T ss_dssp             HHTHHHHCCCC---------C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred             HHhcccCcCCCccc-----cC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence            21110011111100     01    12356789999999 99998   6999999987653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=309.10  Aligned_cols=249  Identities=24%  Similarity=0.299  Sum_probs=193.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.++||+|+||.||+|.+. +++.|++|++...  ..........|+..+..+ +|+||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            68999999999999999999986 5899999988642  233334444555555555 8999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+ +++|.+++....  ..+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus       137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 568988886543  34999999999999999999999999   999999999999999999999999998775322


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                         .......|++.|+|||++.+ .++.++||||||+++|+|++|..|+....      .    ...+..........  
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~----~~~~~~~~~~~~~~--  274 (311)
T 3p1a_A          211 ---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------G----WQQLRQGYLPPEFT--  274 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------H----HHHHTTTCCCHHHH--
T ss_pred             ---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------H----HHHHhccCCCcccc--
Confidence               22234458999999998875 78999999999999999999976643211      0    11111111111000  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            ......+.++|.+||+.||++|||+.+++++.+..
T Consensus       275 ------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (311)
T 3p1a_A          275 ------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR  309 (311)
T ss_dssp             ------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred             ------cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence                  01124577899999999999999999999987654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.8e-42  Score=315.33  Aligned_cols=268  Identities=18%  Similarity=0.237  Sum_probs=200.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc----CCCEEEEEEecccChh-----------hHHHHHHHHHHHHhcCCCCcccee
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKISEQ-----------GLKELKNEVILFSKLQHRNLVKLL  101 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~iv~~~  101 (358)
                      ..++|++.+.||+|+||.||+|.+.    .+..+++|.+......           ....+.+|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            3579999999999999999999975    4678999988754321           112245678888999999999999


Q ss_pred             eEEEe----CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC
Q 018304          102 GCCIQ----GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD  177 (358)
Q Consensus       102 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~  177 (358)
                      +++.+    ....++||||+ +++|.+++....   .+++..++.++.||+.||.|||+++   ++||||+|+||+++.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence            99988    67899999999 889999986544   4999999999999999999999999   9999999999999887


Q ss_pred             C--CeEEeccccceecCCCCCC-----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCC
Q 018304          178 M--NPKISDFGLARAFGGDETE-----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN  250 (358)
Q Consensus       178 ~--~i~L~Df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~  250 (358)
                      +  .++|+|||++..+......     .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... 
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-  266 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-  266 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-
Confidence            7  9999999999875322111     1113446899999999999989999999999999999999999998542221 


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                       ...............+..+........    ....+.+++.+||..+|++|||+.+|++.|+....
T Consensus       267 -~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          267 -PVAVQTAKTNLLDELPQSVLKWAPSGS----SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             -HHHHHHHHHHHHHTTTHHHHHHSCTTS----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             -cHHHHHHHHhhcccccHHHHhhccccc----cHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence             112222222222222221111100001    12357789999999999999999999999998765

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-41  Score=308.33  Aligned_cols=261  Identities=18%  Similarity=0.257  Sum_probs=198.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .-++|++.+.||+|++|.||+|.+. +++.|++|++...   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3489999999999999999999975 4889999998753   23345778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999996543   3899999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC-ccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS-QLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  271 (358)
                      ... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||......    .   ........... ...
T Consensus       186 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~---~~~~~~~~~~~~~~~  257 (309)
T 2h34_A          186 DEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----V---MGAHINQAIPRPSTV  257 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----H---HHHHHHSCCCCGGGT
T ss_pred             ccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----H---HHHHhccCCCCcccc
Confidence            221 11222446888999999999889999999999999999999999998643221    1   11111111111 000


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-ChHHHHHHhccCCCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-SMPSVILMLGSETVLP  319 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ell~~l~~~~~~~  319 (358)
                      ..    .    ....+.++|.+||..||++|| |+.++++.|+......
T Consensus       258 ~~----~----~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          258 RP----G----IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ST----T----CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             CC----C----CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            00    0    112566799999999999999 9999999998775443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-42  Score=333.78  Aligned_cols=258  Identities=27%  Similarity=0.336  Sum_probs=204.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++...  .......+.+|+++++.++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999985 5899999998642  223457788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc---CCCCeEEecccccee
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARA  190 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~---~~~~i~L~Df~~~~~  190 (358)
                      |||+.+++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++   .++.++|+|||++..
T Consensus       100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999886543   3999999999999999999999999   99999999999995   456799999999876


Q ss_pred             cCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ....   .......|++.|+|||++.+ .++.++||||+||++|+|++|..||.....   ......+..   .......
T Consensus       174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~---~~~~~~~  243 (486)
T 3mwu_A          174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVET---GKYAFDL  243 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---TCCCSCS
T ss_pred             CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh---CCCCCCC
Confidence            5322   22234568999999999875 589999999999999999999999854322   122222211   1111100


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ..       .......+.++|.+||+.+|.+|||+.+++++.|....
T Consensus       244 ~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          244 PQ-------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             GG-------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             cc-------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            00       00112356789999999999999999999998776543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=311.80  Aligned_cols=261  Identities=21%  Similarity=0.289  Sum_probs=202.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCccceeeEEE--eCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~  109 (358)
                      ..++|++.+.||+|+||.||++.+. +++.|++|++....    ......+.+|+++++.++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3589999999999999999999975 48899999997532    234567889999999999999999999984  4458


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+.++ |.+++..... ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999875 7777755433 34999999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCC--CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQ--FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ...............+++.|+|||++.+..  ++.++||||||+++|+|++|..||.....   ........    ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~----~~~~  230 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFENIG----KGSY  230 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH----HCCC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHHh----cCCC
Confidence            764333333334456889999999987654  37799999999999999999999864321   11111111    1111


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                       .+.     ..    ....+.++|.+||..||.+|||+.+++++.+.....+
T Consensus       231 -~~~-----~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          231 -AIP-----GD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             -CCC-----SS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             -CCC-----Cc----cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence             111     11    1235668999999999999999999999877654443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.6e-42  Score=308.03  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=203.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEe---------
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ---------  106 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~---------  106 (358)
                      ...+|++.+.||+|++|.||+|.+. +++.|++|.+....    ..+.+|+++++.++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4578999999999999999999986 58999999997644    245689999999999999999998865         


Q ss_pred             -------CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC
Q 018304          107 -------GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN  179 (358)
Q Consensus       107 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~  179 (358)
                             ....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   3457999999999999999966432 34999999999999999999999999   999999999999999999


Q ss_pred             eEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH
Q 018304          180 PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      ++|+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+...         ....
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHH
Confidence            9999999998764322   223446889999999999889999999999999999999999874210         1111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCCC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQ  320 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~~  320 (358)
                      ..........        .+    ...+.++|.+||+.||.+|||+.+++++|+.....+.
T Consensus       229 ~~~~~~~~~~--------~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          229 TDLRDGIISD--------IF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHTTCCCT--------TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHhhcccccc--------cC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            1111221111        11    1246689999999999999999999999988765443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.4e-42  Score=303.43  Aligned_cols=254  Identities=22%  Similarity=0.347  Sum_probs=203.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv  113 (358)
                      .++|++.+.||+|++|.||+|.+ +++.|++|++...  .......+.+|+.+++.++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            37899999999999999999998 5889999998753  344566788999999999999999999999887  788999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ..++|+||+|+||+++.++.++|+||+++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            999999999999966433 24899999999999999999999864 359999999999999999999999998875421 


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCC---cccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSV---KSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                            .....+++.|+|||.+.+..++.   ++||||||+++|+|++|..||......   ..   ............+
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~---~~~~~~~~~~~~~  232 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM---EI---GMKVALEGLRPTI  232 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH---HH---HHHHHHSCCCCCC
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH---HH---HHHHHhcCCCCCC
Confidence                  12345788999999988765544   799999999999999999998643221   11   1111222222221


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ...         ....+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       233 ~~~---------~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          233 PPG---------ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            111         1235778999999999999999999999998754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.7e-42  Score=306.77  Aligned_cols=257  Identities=30%  Similarity=0.437  Sum_probs=205.9

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ...++|++.+.||+|++|.||+|.+.++..|++|.+.... .....+.+|+++++.++||||+++++++. .+..++|||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence            3457899999999999999999998778899999997533 34567889999999999999999999886 456899999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++..... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             CCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             cCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999999865432 23899999999999999999999999   9999999999999999999999999998764322


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      . .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    ........   
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~---  232 (279)
T 1qpc_A          164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLE----RGYRMVRP---  232 (279)
T ss_dssp             E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----TTCCCCCC---
T ss_pred             c-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHh----cccCCCCc---
Confidence            1 11223345678999999988889999999999999999999 89897543221   1221111    11111111   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                        ..    ....+.+++.+||..+|++|||+.++++.|+.+
T Consensus       233 --~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          233 --DN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             --TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --cc----ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence              11    123577899999999999999999999998776

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-42  Score=331.83  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=209.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..++|++.+.||+|+||.||+|.++. +..|++|.+.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            45678999999999999999999865 8899999997643 345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++..... ..+++..++.++.||+.||.|||+++   |+||||+|+||+++.++.+||+|||++.......
T Consensus       297 ~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999999999965433 34899999999999999999999999   9999999999999999999999999998653221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                       ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ........    ........  
T Consensus       373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~~~----~~~~~~~~--  442 (495)
T 1opk_A          373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEK----DYRMERPE--  442 (495)
T ss_dssp             -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHT----TCCCCCCT--
T ss_pred             -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----CCCCCCCC--
Confidence             111222345678999999998899999999999999999999 99997654322   22222221    11111111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                             .....+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       443 -------~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          443 -------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             -------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -------CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                   11235678999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.3e-42  Score=308.45  Aligned_cols=260  Identities=27%  Similarity=0.391  Sum_probs=201.0

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC----CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEE-eCCe
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGEE  109 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~~  109 (358)
                      ....+|++.+.||+|+||.||+|.+.+    ...+++|.+.. ........+.+|+.+++.++||||+++++++. .++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            344689999999999999999998643    23589998875 33455677889999999999999999999854 4568


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccc
Confidence            899999999999999996533  34899999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCC--CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          190 AFGGDET--EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       190 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      .......  ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .........    .
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~~~~----~  249 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQG----R  249 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHHHTT----C
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhcC----C
Confidence            6533221  112223446778999999998999999999999999999999 55555433322   222222111    1


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ......     ..    ...+.+++.+||..+|++|||+.++++.|+.+.
T Consensus       250 ~~~~~~-----~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          250 RLLQPE-----YC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             CCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCc-----cC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111000     01    135778999999999999999999999998763

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-42  Score=310.58  Aligned_cols=255  Identities=22%  Similarity=0.316  Sum_probs=201.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .++|++.+.||+|+||.||++.+. +++.|++|.+.....      .....+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999986 489999999865321      1357788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC----CeEEeccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG  186 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~----~i~L~Df~  186 (358)
                      ++||||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++    .++|+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999996533   3899999999999999999999999   99999999999998877    89999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      .+.......   ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......   ........ .....
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-~~~~~  230 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLTNISA-VNYDF  230 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT-TCCCC
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHHHhHh-cccCC
Confidence            998753221   223445889999999999889999999999999999999999998643221   11111110 00000


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ......         .....+.+++.+||..||++|||+.+++++.+.
T Consensus       231 ~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  269 (283)
T 3bhy_A          231 DEEYFS---------NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI  269 (283)
T ss_dssp             CHHHHT---------TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred             cchhcc---------cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence            000000         012356789999999999999999999986544

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-42  Score=306.46  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=205.6

Q ss_pred             hcCCCCcce-eecccCCccEEEEEEc---CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           37 ATNNFSINK-KLGQGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        37 ~~~~y~i~~-~lg~g~~g~v~~~~~~---~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..++|.+.+ .||+|+||.||+|.+.   ++..|++|.+... .......+.+|+++++.++||||+++++++ ..+..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            346788887 9999999999999853   4778999999763 345567788999999999999999999999 556789


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||+.+++|.+++....  ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999986432  34899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          192 GGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       192 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~----~~~~~~  233 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QGKRME  233 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHH----TTCCCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHh----cCCcCC
Confidence            432221 11222345788999999988889999999999999999998 99998654322   1211111    111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...         .....+.++|.+||..+|++|||+.+++++|+.+
T Consensus       234 ~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          234 CPP---------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             CCT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111         1123577899999999999999999999999876

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-42  Score=318.07  Aligned_cols=258  Identities=22%  Similarity=0.285  Sum_probs=204.1

Q ss_pred             CCCCcceeecccCCccEEEEEE----cCCCEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~  109 (358)
                      ++|++.+.||+|+||.||++.+    .+++.|++|++....    ......+.+|+++++.+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            6899999999999999999987    358899999986421    22334566799999999 79999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+++++|.+++....   .+++..++.++.||+.||.|||+++   |+|+||||+||+++.++.++|+|||++.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999996543   3899999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ...... ........|++.|+|||++.+  ..++.++|||||||++|+|++|..||...........+....  ....  
T Consensus       208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~--  282 (355)
T 1vzo_A          208 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSE--  282 (355)
T ss_dssp             ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCC--
T ss_pred             ecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccC--
Confidence            653211 112234568999999999885  357899999999999999999999987654433322221111  1111  


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccCC
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSET  316 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~~  316 (358)
                      ..+..     .    ....+.+||.+||..||.+||     |+.+++++.+...
T Consensus       283 ~~~~~-----~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          283 PPYPQ-----E----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             CCCCT-----T----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CCCCc-----c----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            11111     1    113466899999999999999     9999999887763

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4e-42  Score=327.92  Aligned_cols=262  Identities=27%  Similarity=0.406  Sum_probs=204.8

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +....++|++.+.||+|+||.||+|.+.++..|++|.+.... .....+.+|+.+++.++||||+++++++.+ +..++|
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            334557899999999999999999999878889999997633 334678899999999999999999999866 678999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+.+++|.+++..... ..+++..++.++.||+.||.|||+++   ++||||+|+||+++.++.+||+|||++.....
T Consensus       257 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             ehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            999999999999965332 34899999999999999999999999   99999999999999999999999999986532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .. ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .........    ........
T Consensus       333 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~----~~~~~~~~  404 (452)
T 1fmk_A          333 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVER----GYRMPCPP  404 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHT----TCCCCCCT
T ss_pred             Cc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CCCCCCCC
Confidence            21 111222345678999999988899999999999999999999 8999764332   122222221    11111111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                               .....+.++|.+||+.+|++|||+.+|++.|+.....
T Consensus       405 ---------~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          405 ---------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ---------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                     1123567899999999999999999999999987543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.2e-41  Score=301.78  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=201.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~  109 (358)
                      .+..|++.+.||+|+||.||+|.+.. +..|++|.+..  ........+.+|+.+++.++||||+++++++..    ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            34668999999999999999999754 78899998864  345566778899999999999999999999876    346


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc-CCCCeEEeccccc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLA  188 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~-~~~~i~L~Df~~~  188 (358)
                      .++||||+++++|.+++...   ..+++..++.++.|++.||.|||+.+ .+++|+||+|+||+++ .++.++|+|||++
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            89999999999999999654   33899999999999999999999975 3499999999999998 7899999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ....    ........+++.|+|||.+. ..++.++||||||+++|+|++|..||......  ..    ...........
T Consensus       180 ~~~~----~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~----~~~~~~~~~~~  248 (290)
T 1t4h_A          180 TLKR----ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQ----IYRRVTSGVKP  248 (290)
T ss_dssp             GGCC----TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HH----HHHHHTTTCCC
T ss_pred             cccc----ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HH----HHHHHhccCCc
Confidence            6532    22233456899999999876 45899999999999999999999998543221  11    11111111111


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      .......        ...+.++|.+||+.||.+|||+.+++++.+.
T Consensus       249 ~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~ell~h~~f  286 (290)
T 1t4h_A          249 ASFDKVA--------IPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             GGGGGCC--------CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             cccCCCC--------CHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence            1111111        1357789999999999999999999997664

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=318.07  Aligned_cols=261  Identities=25%  Similarity=0.283  Sum_probs=190.7

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEe------
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ------  106 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~------  106 (358)
                      .....+|++.+.||+|+||.||+|.+. +++.|++|.+..........+.+|+.+++.+. ||||+++++++..      
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            334568999999999999999999975 48999999997766677788899999999995 9999999999843      


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          107 --GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       107 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                        ....+++|||+. |+|.+++........+++..++.++.||+.||.|||+++ .+++|+||+|+||+++.++.++|+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence              345789999996 699998876555556999999999999999999999974 3499999999999999999999999


Q ss_pred             cccceecCCCCCCC----------ccccccccCCCCCcccc---cCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC
Q 018304          185 FGLARAFGGDETEG----------NTKRVIGTYGYMAPEYA---SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN  251 (358)
Q Consensus       185 f~~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~  251 (358)
                      ||++..........          ......+++.|+|||++   .+..++.++||||||+++|+|++|..||....... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            99998754322111          11134588899999988   56678999999999999999999999985432211 


Q ss_pred             chhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                        .   .........    ...     .    ...+.++|.+||+.||.+|||+.+++++|+.+.
T Consensus       261 --~---~~~~~~~~~----~~~-----~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          261 --I---VNGKYSIPP----HDT-----Q----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             ----------CCCCT----TCC-----S----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --h---hcCcccCCc----ccc-----c----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              0   000000000    000     0    113567999999999999999999999998874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=316.69  Aligned_cols=264  Identities=23%  Similarity=0.320  Sum_probs=199.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----  108 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.|++|.+..  ........+.+|+++++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            3589999999999999999999985 489999999854  33445667889999999999999999999997763     


Q ss_pred             -eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          109 -EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       109 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                       ..++||||+ +++|.+++..    ..+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence             459999999 7799999854    23899999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      +.....     ......++..|+|||++.+ ..++.++||||+||++|+|++|..||...+..   ..+..+..... ..
T Consensus       175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g-~~  245 (367)
T 1cm8_A          175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTG-TP  245 (367)
T ss_dssp             CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHC-CC
T ss_pred             cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC-CC
Confidence            987532     1234467899999998877 68999999999999999999999998654322   11111111110 00


Q ss_pred             CCccc-------------------cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          267 PSQLI-------------------DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       267 ~~~~~-------------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      +..+.                   ..... .........+.+|+.+||+.||.+|||+.+++++.+.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            00000                   00000 00011123577899999999999999999999987766443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.8e-42  Score=317.62  Aligned_cols=268  Identities=21%  Similarity=0.290  Sum_probs=203.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-------
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------  107 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-------  107 (358)
                      .++|++.+.||+|+||.||+|.+. +|+.|++|.+....  ......+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            378999999999999999999984 58999999886532  22345677899999999999999999999873       


Q ss_pred             -CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          108 -EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       108 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                       +..++||||+.+ +|.+.+....  ..+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             468999999976 7777665432  23999999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCC--CCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          187 LARAFGGDET--EGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       187 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      ++..+.....  ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||........   ........ 
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~-  245 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLC-  245 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH-
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHh-
Confidence            9987643221  122234567899999998876 4689999999999999999999999875433222   22221111 


Q ss_pred             cCCCCccccCC------------cCCCCCHHH-------HHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          264 EGMPSQLIDPC------------IQGSFNLAE-------VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       264 ~~~~~~~~~~~------------~~~~~~~~~-------~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...........            .........       ...+.+||.+||+.||++|||+.+++++-+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence            11111111110            000111111       13477899999999999999999999987764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-41  Score=323.78  Aligned_cols=272  Identities=21%  Similarity=0.298  Sum_probs=189.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----Ce
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE  109 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~  109 (358)
                      .++|++.+.||+|+||.||+|.+. +++.|++|.+..  ........+.+|+.+|+.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999975 489999999865  3344567788999999999999999999998543     57


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+. ++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            899999985 6898888543   34999999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCC-------------------------CccccccccCCCCCcccc-cCCCCCCcccchhHhHHHHHHHh-----
Q 018304          190 AFGGDETE-------------------------GNTKRVIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIIS-----  238 (358)
Q Consensus       190 ~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~-----  238 (358)
                      ........                         .......||+.|+|||++ .+..++.++|||||||++|+|++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            75322111                         112334679999999976 55679999999999999999999     


Q ss_pred             ------CCCCCCCCCCCC-----------------CchhHHHHHHHhhcCCCCccccC------------C---cC---C
Q 018304          239 ------GKKNRGFYHSDN-----------------NLNLIGHAWKLWNEGMPSQLIDP------------C---IQ---G  277 (358)
Q Consensus       239 ------g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~------------~---~~---~  277 (358)
                            |..+|.......                 ....+..+....... ....+..            .   ..   .
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTP-SEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCC-CHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCC-CHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                  444443322100                 001111111111000 0000000            0   00   0


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .........+.+||.+||..||++|||+.+++++-+....
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            0001113457789999999999999999999999887654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-41  Score=306.47  Aligned_cols=256  Identities=25%  Similarity=0.356  Sum_probs=200.3

Q ss_pred             CCCcceeecccCCccEEEEEEcC-C---CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee-EEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLI  113 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~-~---~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~-~lv  113 (358)
                      .|++.+.||+|+||.||+|.+.+ +   ..+++|.+... .......+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            56677999999999999998643 2   26999998753 344567788999999999999999999999877655 999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+.+++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus       102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999999996532  34899999999999999999999999   99999999999999999999999999975532


Q ss_pred             CC--CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          194 DE--TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       194 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..  .........++..|+|||.+.+..++.++||||||+++|+|++|..|+...  ..............    .....
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~--~~~~~~~~~~~~~~----~~~~~  250 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH--IDPFDLTHFLAQGR----RLPQP  250 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--SCGGGHHHHHHTTC----CCCCC
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc--CCHHHHHHHhhcCC----CCCCC
Confidence            21  112223345778999999999999999999999999999999966553221  12222222222111    11111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .     .    ....+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       251 ~-----~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          251 E-----Y----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             T-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             c-----c----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0     0    113577899999999999999999999998876

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1e-41  Score=308.01  Aligned_cols=258  Identities=25%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..++|++++.||+|++|.||+|.+.. ++.|++|.+..........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            45889999999999999999999864 88999999987666677888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus        97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  169 (302)
T 2j7t_A           97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--  169 (302)
T ss_dssp             CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred             eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence            999999999886533  23999999999999999999999999   99999999999999999999999998753210  


Q ss_pred             CCCccccccccCCCCCcccc-----cCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          196 TEGNTKRVIGTYGYMAPEYA-----SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      .........+++.|+|||.+     .+..++.++||||||+++|+|++|..||......   ...   ............
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~~~~~~~~  243 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVL---LKIAKSDPPTLL  243 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHHSCCCCCS
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHH---HHHhccCCcccC
Confidence            01112234578899999987     4667899999999999999999999997653321   111   111111111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..        ......+.++|.+||+.||++|||+.+++++.+..
T Consensus       244 ~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  280 (302)
T 2j7t_A          244 TP--------SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS  280 (302)
T ss_dssp             SG--------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred             Cc--------cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence            11        01123567899999999999999999999876544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.9e-42  Score=308.17  Aligned_cols=251  Identities=22%  Similarity=0.282  Sum_probs=204.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      .++|++.+.||+|++|.||+|.+.. ++.|++|.+....   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            3789999999999999999999864 7789999986422   22346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999986543   3899999999999999999999999   99999999999999999999999999876432


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                          .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......   ......   . ... ..+   
T Consensus       167 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~---~-~~~-~~~---  231 (284)
T 2vgo_A          167 ----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---ETHRRI---V-NVD-LKF---  231 (284)
T ss_dssp             ----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH---H-TTC-CCC---
T ss_pred             ----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---HHHHHH---h-ccc-cCC---
Confidence                1223456889999999999989999999999999999999999998643321   111111   1 111 011   


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                        ...    ....+.++|.+||+.||.+|||+.+++++.+..
T Consensus       232 --~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          232 --PPF----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             --CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             --CCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence              011    123567899999999999999999999876544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.8e-42  Score=305.28  Aligned_cols=264  Identities=25%  Similarity=0.315  Sum_probs=206.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKL  111 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~  111 (358)
                      ..++|++.+.||+|++|.||++.+. +++.|++|.+...  .......+.+|+.+++.++||||+++++++.+  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            3578999999999999999999986 4899999998642  34556778899999999999999999998854  56889


Q ss_pred             EEEEecCCCCHHHHHhccc-cccCCCHHHHHHHHHHHHHHHHHHhcCC--CCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          112 LIYEFMTNKSLDSFIFDQE-RCKILDWSKRFHIICGTARGVMYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~i~~al~~LH~~~--~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      +||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+++|+||+|+||+++.++.++|+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999996643 2344899999999999999999999976  234999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      .......  .......++..|+|||.+.+..++.++||||||+++|+|++|..||.....   ........    .....
T Consensus       164 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~----~~~~~  234 (279)
T 2w5a_A          164 RILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIR----EGKFR  234 (279)
T ss_dssp             HHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HTCCC
T ss_pred             eeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHh----hcccc
Confidence            7653211  112234688999999999988999999999999999999999999865432   11111111    12111


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      .+..     .    ....+.++|.+||+.+|++|||+.+|+++++.....
T Consensus       235 ~~~~-----~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          235 RIPY-----R----YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CCCT-----T----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             cCCc-----c----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            1111     1    123577899999999999999999999988765443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2e-41  Score=306.44  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=206.8

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .++|++.+.||+|++|.||+|.+. +++.|++|.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            467999999999999999999875 48899999986532 3456788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++++|.+++..    ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999854    34899999999999999999999999   9999999999999999999999999998753221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....   ........    ......+.    
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~~~~~~~----  240 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIP----KNNPPTLE----  240 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HSCCCCCC----
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhh----cCCCCCCc----
Confidence              122345688899999999988999999999999999999999999764322   11111111    11111111    


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ..+    ...+.+++.+||+.+|.+|||+.+++++.+..
T Consensus       241 -~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          241 -GNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             -SSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             -ccc----CHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence             111    13567899999999999999999999876643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.5e-42  Score=317.76  Aligned_cols=261  Identities=19%  Similarity=0.300  Sum_probs=206.3

Q ss_pred             HHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--------hhhHHHHHHHHHHHHhc-CCCCcccee
Q 018304           32 ATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKL-QHRNLVKLL  101 (358)
Q Consensus        32 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l-~~~~iv~~~  101 (358)
                      .......++|++.+.||+|++|.||+|.+. +|+.|+||++....        ......+.+|+.+++.+ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334455678999999999999999999985 59999999986432        12245677899999999 799999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeE
Q 018304          102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK  181 (358)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~  181 (358)
                      +++......++||||+++++|.+++....   .+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999986533   3999999999999999999999999   99999999999999999999


Q ss_pred             EeccccceecCCCCCCCccccccccCCCCCcccccC------CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhH
Q 018304          182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI  255 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~  255 (358)
                      |+|||++..+...   .......|++.|+|||++.+      ..++.++||||||+++|+|++|..||.....   ....
T Consensus       241 l~DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~  314 (365)
T 2y7j_A          241 LSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILML  314 (365)
T ss_dssp             ECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH
T ss_pred             EEecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHH
Confidence            9999999876422   22334568999999998853      3578899999999999999999999854321   1111


Q ss_pred             HHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          256 GHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      .....   ........  .. .    .....+.++|.+||+.||++|||+.+++++.+.
T Consensus       315 ~~i~~---~~~~~~~~--~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f  363 (365)
T 2y7j_A          315 RMIME---GQYQFSSP--EW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQHPFF  363 (365)
T ss_dssp             HHHHH---TCCCCCHH--HH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHHHh---CCCCCCCc--cc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            11111   11000000  00 0    011356789999999999999999999998764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-42  Score=334.58  Aligned_cols=256  Identities=28%  Similarity=0.329  Sum_probs=206.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++...   .......+.+|+.+++.++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4568999999999999999999986 5899999998642   23456778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE---cCCCCeEEeccccce
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLAR  189 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv---~~~~~i~L~Df~~~~  189 (358)
                      ||||+.+++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||++   +.++.++|+|||++.
T Consensus       104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999986543   3999999999999999999999999   9999999999999   467899999999997


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .....   .......|++.|+|||++.+ .++.++|||||||++|+|++|..||.....   ......+..   ......
T Consensus       178 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~---~~~~~~  247 (484)
T 3nyv_A          178 HFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKVEK---GKYTFE  247 (484)
T ss_dssp             HBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---CCCCCC
T ss_pred             Ecccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHc---CCCCCC
Confidence            65322   23344578999999998875 689999999999999999999999865332   122222211   111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...       .......+.+||.+||+.+|.+|||+.+++++.|..
T Consensus       248 ~~~-------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~  286 (484)
T 3nyv_A          248 LPQ-------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ  286 (484)
T ss_dssp             SGG-------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             Ccc-------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence            000       001123567899999999999999999999987754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=303.48  Aligned_cols=258  Identities=24%  Similarity=0.347  Sum_probs=201.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      ++|.....||+|+||.||+|.+. +++.|++|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34555569999999999999975 48899999997766666678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEeccccceecCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df~~~~~~~~~~~  196 (358)
                      ++++|.+++........+++..++.++.|++.||.|||+++   ++|+||+|+||+++. ++.++|+|||++....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999976544445789999999999999999999999   999999999999987 8999999999998753221 


Q ss_pred             CCccccccccCCCCCcccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                       .......+++.|+|||.+.+.  .++.++||||||+++|+|++|..||.......  ...   ...........+..  
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~---~~~~~~~~~~~~~~--  249 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAM---FKVGMFKVHPEIPE--  249 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHH---HHHHHHCCCCCCCT--
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHH---Hhhccccccccccc--
Confidence             122344688999999988764  37899999999999999999999985432211  111   11000111111111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         .    ....+.++|.+||+.||++|||+.+++++-+..
T Consensus       250 ---~----~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~  283 (295)
T 2clq_A          250 ---S----MSAEAKAFILKCFEPDPDKRACANDLLVDEFLK  283 (295)
T ss_dssp             ---T----SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred             ---c----CCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence               1    123567899999999999999999999876655

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.4e-42  Score=312.00  Aligned_cols=261  Identities=29%  Similarity=0.438  Sum_probs=203.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEE------cCCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~------~~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ..++|++.+.||+|+||.||+|.+      .++..|++|.+... .......+.+|+.+++.++||||+++++++.+...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            458999999999999999999983      23678999999653 34456678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhcccc----ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CCCeEE
Q 018304          110 KLLIYEFMTNKSLDSFIFDQER----CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKI  182 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~~i~L  182 (358)
                      .++||||+++++|.+++.....    ...+++..++.++.|++.||.|||+++   ++|+||+|+||+++.   +..++|
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999976432    134889999999999999999999999   999999999999984   446999


Q ss_pred             eccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHH
Q 018304          183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....   ........  
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~--  259 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVT--  259 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH--
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHHh--
Confidence            99999875533322223334557889999999988899999999999999999998 8888754322   11111111  


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                        .........     .    ....+.++|.+||+.||.+|||+.+++++|+...
T Consensus       260 --~~~~~~~~~-----~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          260 --SGGRMDPPK-----N----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             --TTCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --cCCCCCCCC-----C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence              111111111     1    1235678999999999999999999999998763

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-42  Score=323.27  Aligned_cols=252  Identities=21%  Similarity=0.246  Sum_probs=193.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHH-HHhcCCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~-l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|++++.||+|+||.||+|.++. ++.|++|++.+..   ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4789999999999999999999865 8899999996532   2233455566665 466799999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+.+++|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+||+++.+|.++|+|||++....
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999986543   3899999999999999999999999   9999999999999999999999999987532


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ..  .......+|++.|+|||++.+..++.++|||||||++|+|++|..||...+.   ......+..   ..  ..+. 
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~---~~--~~~~-  259 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILN---KP--LQLK-  259 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHHHHH---SC--CCCC-
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHh---cc--cCCC-
Confidence            11  2233456799999999999999999999999999999999999999854322   112221111   11  1111 


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh----HHHHHHhcc
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM----PSVILMLGS  314 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~----~ell~~l~~  314 (358)
                          ...    ...+.++|.+||+.||.+||++    .+++++.+.
T Consensus       260 ----~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f  297 (373)
T 2r5t_A          260 ----PNI----TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF  297 (373)
T ss_dssp             ----SSS----CHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred             ----CCC----CHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence                111    2356689999999999999997    466665543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-41  Score=312.42  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=201.8

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||+|.+. +++.|++|.+...   .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            46999999999999999999974 5889999998642   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+. |+|.+++....  ..+++..++.++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||++..... 
T Consensus       134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence            9997 57888775432  34999999999999999999999999   99999999999999999999999999876421 


Q ss_pred             CCCCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                           .....+++.|+|||++.   +..++.++||||||+++|+|++|..||.....   ....   ........ ....
T Consensus       207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~---~~~~~~~~-~~~~  274 (348)
T 1u5q_A          207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSAL---YHIAQNES-PALQ  274 (348)
T ss_dssp             -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---HHHHHSCC-CCCC
T ss_pred             -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHH---HHHHhcCC-CCCC
Confidence                 22346899999999874   56789999999999999999999999754321   1111   11111111 1111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .    ...    ...+.++|.+||+.+|++|||+.+++++.+....
T Consensus       275 ~----~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          275 S----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             C----CCC----CHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            1    111    2346689999999999999999999998776543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-41  Score=321.85  Aligned_cols=274  Identities=19%  Similarity=0.223  Sum_probs=204.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhc------CCCCccceeeEEEeCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL------QHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l------~~~~iv~~~~~~~~~~~  109 (358)
                      ...+|++.+.||+|+||.||+|.+.. ++.||+|++... ......+.+|+.+++.+      +|+||+++++++...+.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            34689999999999999999998755 889999999753 34456677788888877      46799999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC--eEEecccc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGL  187 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~--i~L~Df~~  187 (358)
                      .++||||+. ++|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.  ++|+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999996 589998866443 23899999999999999999999999   999999999999999887  99999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC--
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG--  265 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  265 (358)
                      +.....     ......+++.|+|||++.+..++.++|||||||++|+|++|..||.......   .+..........  
T Consensus       249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~---~l~~i~~~~~~p~~  320 (429)
T 3kvw_A          249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD---QLACMIELLGMPSQ  320 (429)
T ss_dssp             CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred             ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence            976422     2224568899999999999999999999999999999999999986543322   221111111000  


Q ss_pred             ----------------CCCccc------cC---------------CcCCCCCHHH------HHHHHHHHhhhcCCCCCCC
Q 018304          266 ----------------MPSQLI------DP---------------CIQGSFNLAE------VIRCIHIGLLCVQQHPKDR  302 (358)
Q Consensus       266 ----------------~~~~~~------~~---------------~~~~~~~~~~------~~~l~~li~~cl~~~P~~R  302 (358)
                                      ..+...      +.               ..........      ...+.+||.+||+.||++|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R  400 (429)
T 3kvw_A          321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR  400 (429)
T ss_dssp             HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence                            000000      00               0000011111      2457789999999999999


Q ss_pred             CChHHHHHHhccCCCCCCCCCC
Q 018304          303 PSMPSVILMLGSETVLPQPKQP  324 (358)
Q Consensus       303 pt~~ell~~l~~~~~~~~~~~~  324 (358)
                      ||+.+++++.|.....+.++..
T Consensus       401 pta~e~L~Hpw~~~~~~~~~~~  422 (429)
T 3kvw_A          401 MTPGQALRHPWLRRRLPKPPTG  422 (429)
T ss_dssp             CCHHHHHTSTTTC---------
T ss_pred             CCHHHHhCChhhccCCCCCCcc
Confidence            9999999998887666555443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.3e-42  Score=315.42  Aligned_cols=257  Identities=22%  Similarity=0.297  Sum_probs=198.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  107 (358)
                      ..++|++.+.||+|+||.||+|.+.. ++.|++|.+....        ......+.+|+++++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            45789999999999999999999754 7899999986522        12234577899999999999999999998765


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC---eEEec
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISD  184 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~---i~L~D  184 (358)
                      + .++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.   ++|+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 89999999999999988543   34999999999999999999999999   999999999999987654   99999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL  261 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  261 (358)
                      ||++......   .......+++.|+|||++.   +..++.++||||||+++|+|++|..||........  ........
T Consensus       161 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~  235 (322)
T 2ycf_A          161 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITSG  235 (322)
T ss_dssp             CTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHHT
T ss_pred             Cccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHhC
Confidence            9999875321   1223456899999999863   46789999999999999999999999865443322  11111110


Q ss_pred             hhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          262 WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ..........         .....+.++|.+||..||++|||+.+++++-+..
T Consensus       236 -~~~~~~~~~~---------~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~  279 (322)
T 2ycf_A          236 -KYNFIPEVWA---------EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  279 (322)
T ss_dssp             -CCCCCHHHHT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred             -ccccCchhhh---------hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence             0000000000         0123577899999999999999999999876543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.1e-41  Score=320.07  Aligned_cols=201  Identities=24%  Similarity=0.427  Sum_probs=168.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----C
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~  108 (358)
                      ..++|++.+.||+|+||.||+|.+.. ++.|++|++..  ........+.+|+.+++.++|+||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            35899999999999999999999755 88999999975  3344567788999999999999999999999776     5


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..++||||+. ++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            7899999996 5999998543   34999999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCCC--------------------CccccccccCCCCCcccc-cCCCCCCcccchhHhHHHHHHHhCCCCCC
Q 018304          189 RAFGGDETE--------------------GNTKRVIGTYGYMAPEYA-SDGQFSVKSDVFSFGILLLEIISGKKNRG  244 (358)
Q Consensus       189 ~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~p~~  244 (358)
                      .........                    .......+++.|+|||++ .+..++.++|||||||++|+|++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            876432211                    112455789999999986 55679999999999999999998665544

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-41  Score=308.45  Aligned_cols=267  Identities=22%  Similarity=0.332  Sum_probs=200.3

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc--CCCCccceeeEEEeC---
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL--QHRNLVKLLGCCIQG---  107 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l--~~~~iv~~~~~~~~~---  107 (358)
                      .-....++|++.+.||+|+||.||+|.+ .++.|++|++....   ......|.+++..+  +||||+++++++.+.   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3344557999999999999999999988 58999999986432   23444566666555  899999999999887   


Q ss_pred             -CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC--------CCCCcccCCCCCCcEEEcCCC
Q 018304          108 -EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD--------SRLRIIHRDLKASNVLLDQDM  178 (358)
Q Consensus       108 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~--------~~~~i~H~di~~~Nilv~~~~  178 (358)
                       ...++||||+++++|.+++...    .+++..++.++.|++.||.|||++        +   ++|+||||+||+++.++
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred             CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence             6889999999999999999543    389999999999999999999998        8   99999999999999999


Q ss_pred             CeEEeccccceecCCCCCCC--ccccccccCCCCCcccccCCCCCCc------ccchhHhHHHHHHHhC----------C
Q 018304          179 NPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYASDGQFSVK------SDVFSFGILLLEIISG----------K  240 (358)
Q Consensus       179 ~i~L~Df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~il~~l~~g----------~  240 (358)
                      .++|+|||++..........  ......|++.|+|||++.+..++.+      +|||||||++|+|++|          .
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            99999999997653322111  1123468999999999987766655      9999999999999999          5


Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcC-CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          241 KNRGFYHSDNNLNLIGHAWKLWNEG-MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       241 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .||...........  ......... ....+..    ..........+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus       260 ~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          260 LPYHDLVPSDPSYE--DMREIVCIKKLRPSFPN----RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CTTTTTSCSSCCHH--HHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccHhhhcCCCCchh--hhHHHHhhhccCccccc----cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            55544332222111  111111111 1111110    0111244566888999999999999999999999998763

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.4e-42  Score=309.01  Aligned_cols=261  Identities=27%  Similarity=0.383  Sum_probs=203.2

Q ss_pred             HHHHHhcCCCCcce-eecccCCccEEEEEEc---CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEE
Q 018304           32 ATIVSATNNFSINK-KLGQGGFGPVYKGTLV---DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCI  105 (358)
Q Consensus        32 ~~~~~~~~~y~i~~-~lg~g~~g~v~~~~~~---~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~  105 (358)
                      +++....++|++.+ .||+|+||.||+|.+.   .++.|++|++....  ......+.+|+++++.++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34444567899998 9999999999999642   36789999997532  23356788999999999999999999999 


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecc
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF  185 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df  185 (358)
                      ..+..++||||+++++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence            5678899999999999999996543   3899999999999999999999999   999999999999999999999999


Q ss_pred             ccceecCCCCCCC-ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          186 GLARAFGGDETEG-NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       186 ~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      |++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .....    ..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~  234 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----LE  234 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HH
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HH
Confidence            9998764322211 1122335678999999988889999999999999999999 99997653321   11111    11


Q ss_pred             cCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          264 EGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .........         .....+.++|.+||+.||.+|||+.++++.|+.+
T Consensus       235 ~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          235 KGERMGCPA---------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             TTCCCCCCT---------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111111         1123577899999999999999999999998765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=312.03  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=199.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .++|++.+.||+|+||.||+|.+..     +..|++|.+... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4788999999999999999998643     235999998753 3444567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus       123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            9999999999999986532  34899999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCCCC-ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          192 GGDETEG-NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       192 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ........    ......
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~----~~~~~~  270 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAIN----DGFRLP  270 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH----TTCCCC
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----CCCcCC
Confidence            3322111 1112335678999999998899999999999999999998 9999754322   11221111    111111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ...         .....+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       271 ~~~---------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          271 TPM---------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             CCT---------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             Ccc---------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            110         11235678999999999999999999999998764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-41  Score=324.76  Aligned_cols=262  Identities=20%  Similarity=0.286  Sum_probs=207.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCC-CCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|+||++......  ..+..|+++++.++| +++..+..++...+..++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            3589999999999999999999974 4899999988653322  357789999999976 56667777777888999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE---cCCCCeEEeccccceec
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLARAF  191 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv---~~~~~i~L~Df~~~~~~  191 (358)
                      ||+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||||   +.++.++|+|||++..+
T Consensus        83 e~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            999 889999996433  23999999999999999999999999   9999999999999   58899999999999876


Q ss_pred             CCCCCC-----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          192 GGDETE-----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       192 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      ......     .......|+..|+|||.+.+..++.++|||||||++|+|++|..||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            433221     122255689999999999999999999999999999999999999977655444333333322221111


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...+....         ...+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       237 ~~~l~~~~---------p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          237 IEALCRGY---------PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHHHTTS---------CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHhcCC---------cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11111111         13577899999999999999999999988665

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.1e-41  Score=303.42  Aligned_cols=251  Identities=21%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..++|++.+.||+|++|.||+|.+. +++.|++|.+...  .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3478999999999999999999986 5899999998752  233456778899999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcccc-ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC--------------
Q 018304          113 IYEFMTNKSLDSFIFDQER-CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD--------------  177 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~--------------  177 (358)
                      ||||+++++|.+++..... ...+++..++.++.||+.||.|||+++   ++|+||+|+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999966432 245899999999999999999999999   9999999999999844              


Q ss_pred             -----CCeEEeccccceecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC
Q 018304          178 -----MNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN  251 (358)
Q Consensus       178 -----~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~  251 (358)
                           ..++|+|||.+.......      ...+++.|+|||.+.+. .++.++||||||+++|+|++|..++...     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----  234 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----  234 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence                 479999999998753221      23488999999998765 5668999999999999999998764321     


Q ss_pred             chhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ....    .........+...     .    ...+.++|.+||+.||++|||+.+++++.+..
T Consensus       235 -~~~~----~~~~~~~~~~~~~-----~----~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          235 -DQWH----EIRQGRLPRIPQV-----L----SQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             -HHHH----HHHTTCCCCCSSC-----C----CHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             -hHHH----HHHcCCCCCCCcc-----c----CHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence             1111    1112222221111     1    23567899999999999999999999987654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4e-42  Score=318.77  Aligned_cols=278  Identities=19%  Similarity=0.255  Sum_probs=205.1

Q ss_pred             eeHHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEeccc-----------ChhhHHHHHHHHHHHHhcCCCCc
Q 018304           29 FELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI-----------SEQGLKELKNEVILFSKLQHRNL   97 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i   97 (358)
                      ..++++....++|++.+.||+|+||.||+|.+.++..|++|.+...           .......+.+|+.+++.++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3467888899999999999999999999999888999999998542           12234778899999999999999


Q ss_pred             cceeeEEEeC-----CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcE
Q 018304           98 VKLLGCCIQG-----EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV  172 (358)
Q Consensus        98 v~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Ni  172 (358)
                      +++++++...     ...++||||+. ++|.+++....  ..+++..++.++.||+.||.|||+++   ++|+||+|+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            9999998553     36799999997 58888775432  34999999999999999999999999   99999999999


Q ss_pred             EEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCC
Q 018304          173 LLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN  251 (358)
Q Consensus       173 lv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~  251 (358)
                      +++.++.++|+|||++.....   ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||......  
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--  240 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--  240 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred             EEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--
Confidence            999999999999999975321   222334567889999998876 67899999999999999999999998654322  


Q ss_pred             chhHHHHHHHhhcCCCC---------------ccccCCcCC---CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          252 LNLIGHAWKLWNEGMPS---------------QLIDPCIQG---SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                       ................               .........   .........+.+||.+||+.||++|||+.+++++.+
T Consensus       241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          241 -NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             -HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             -HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence             1111111111100000               000000000   000011235778999999999999999999999887


Q ss_pred             cCCCC
Q 018304          314 SETVL  318 (358)
Q Consensus       314 ~~~~~  318 (358)
                      .....
T Consensus       320 f~~~~  324 (362)
T 3pg1_A          320 FESLF  324 (362)
T ss_dssp             GTTTC
T ss_pred             hhhcc
Confidence            76543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-41  Score=303.42  Aligned_cols=256  Identities=24%  Similarity=0.359  Sum_probs=201.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ..++|++.+.||+|++|.||+|.+..    +..|++|.+... .......+.+|+.+++.++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            45789999999999999999998643    235999998763 34456778899999999999999999999865 4568


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||+.+++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus        89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            9999999999999996543  33899999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   ........    .....
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~~----~~~~~  235 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEKG----DRLPK  235 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHHT----CCCCC
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhcC----CCCCC
Confidence            32211 11223346778999999988899999999999999999998 999986443322   22222111    11111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..     .    ....+.+++.+||..+|++|||+.+++++|+.+
T Consensus       236 ~~-----~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          236 PD-----L----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             CT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----C----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            11     1    123567899999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.5e-42  Score=316.96  Aligned_cols=267  Identities=17%  Similarity=0.214  Sum_probs=199.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecccChhhHH-----------HHHHHHHHHHhcCCCCccc
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKISEQGLK-----------ELKNEVILFSKLQHRNLVK   99 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~~~~~~~-----------~~~~e~~~l~~l~~~~iv~   99 (358)
                      ..++|++.+.||+|+||.||+|.+..      ++.|++|++.........           ....|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45799999999999999999998754      478999998764322111           1223455566778999999


Q ss_pred             eeeEEEeC----CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc
Q 018304          100 LLGCCIQG----EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD  175 (358)
Q Consensus       100 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~  175 (358)
                      +++++...    ...++||||+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||+++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998775    4589999999 889999986532  34999999999999999999999999   99999999999999


Q ss_pred             --CCCCeEEeccccceecCCCCCC-----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCC
Q 018304          176 --QDMNPKISDFGLARAFGGDETE-----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHS  248 (358)
Q Consensus       176 --~~~~i~L~Df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~  248 (358)
                        .++.++|+|||++..+......     .......|++.|+|||.+.+..++.++|||||||++|+|++|..||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999875322111     111234589999999999999999999999999999999999999875332


Q ss_pred             CCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          249 DNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..  .........+.. ....+.+.++.....   ...+.+++.+||..+|.+||++.+|++.|+.+
T Consensus       267 ~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DP--KYVRDSKIRYRE-NIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CH--HHHHHHHHHHHH-CHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CH--HHHHHHHHHhhh-hHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            21  111111111111 111222211111111   13566799999999999999999999998766

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.8e-41  Score=320.33  Aligned_cols=258  Identities=22%  Similarity=0.298  Sum_probs=194.4

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCccceeeEEEe
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ  106 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~  106 (358)
                      ...++|++.+.||+|+||.||+|.+.. ++.|++|++....        ......+.+|+.+++.++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            456899999999999999999999755 8899999986521        1122347789999999999999999999854


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC---CeEEe
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS  183 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~---~i~L~  183 (358)
                       +..++||||+++++|.+++...   ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++   .++|+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence             5689999999999999988543   34999999999999999999999999   99999999999997544   59999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCcccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  260 (358)
                      |||++.....   ........|++.|+|||++.+   ..++.++||||||+++|+|++|..||........  .......
T Consensus       285 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~~  359 (419)
T 3i6u_A          285 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS  359 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHHT
T ss_pred             ecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHhc
Confidence            9999986532   222334578999999998853   5778899999999999999999999865433222  1111111


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      . ..........         .....+.++|.+||+.||++|||+.+++++.|..
T Consensus       360 ~-~~~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  404 (419)
T 3i6u_A          360 G-KYNFIPEVWA---------EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  404 (419)
T ss_dssp             T-CCCCCHHHHT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             C-CCCCCchhhc---------ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence            0 0000000000         0123577899999999999999999999987754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.6e-42  Score=306.99  Aligned_cols=254  Identities=23%  Similarity=0.358  Sum_probs=198.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..++|++.+.||+|++|.||+|.+. +++.|++|.+....   ......+.+|+..++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3479999999999999999999986 58999999986522   2335678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+.+++|.+++....   .+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence            999999999999996543   3899999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..   .......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||......   .......    .... .+ 
T Consensus       163 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~----~~~~-~~-  230 (276)
T 2h6d_A          163 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIR----GGVF-YI-  230 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCCC-CC-
T ss_pred             CC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhh----cCcc-cC-
Confidence            22   12234468899999999987765 68999999999999999999998543211   1111111    1110 00 


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                          ....    ...+.++|.+||+.||++|||+.+++++.+...
T Consensus       231 ----~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          231 ----PEYL----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             ----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ----chhc----CHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence                0111    135668999999999999999999999866543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=311.47  Aligned_cols=264  Identities=27%  Similarity=0.422  Sum_probs=200.7

Q ss_pred             eeHHHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEe
Q 018304           29 FELATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ  106 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~  106 (358)
                      ++..++....++|++.+.||+|++|.||+|.+. +++.|++|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            344455556789999999999999999999985 58999999986533 3346788999999999 79999999999987


Q ss_pred             ------CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCe
Q 018304          107 ------GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP  180 (358)
Q Consensus       107 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i  180 (358)
                            .+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                  4678999999999999999976432 34899999999999999999999999   9999999999999999999


Q ss_pred             EEeccccceecCCCCCCCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhH
Q 018304          181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI  255 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~  255 (358)
                      +|+|||++......  ........+++.|+|||++.     +..++.++||||||+++|+|++|..||......   ...
T Consensus       169 kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~  243 (326)
T 2x7f_A          169 KLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RAL  243 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH
T ss_pred             EEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH
Confidence            99999998765321  11223446889999999886     567899999999999999999999997543221   111


Q ss_pred             HHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          256 GHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                         ....... .......    .+    ...+.++|.+||..||.+|||+.+++++.+.
T Consensus       244 ---~~~~~~~-~~~~~~~----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~  290 (326)
T 2x7f_A          244 ---FLIPRNP-APRLKSK----KW----SKKFQSFIESCLVKNHSQRPATEQLMKHPFI  290 (326)
T ss_dssp             ---HHHHHSC-CCCCSCS----CS----CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred             ---HHhhcCc-cccCCcc----cc----CHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence               1111111 1111111    11    2356789999999999999999999986554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-41  Score=306.52  Aligned_cols=260  Identities=20%  Similarity=0.270  Sum_probs=204.9

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---------hhhHHHHHHHHHHHHhcC-CCCccceee
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLG  102 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---------~~~~~~~~~e~~~l~~l~-~~~iv~~~~  102 (358)
                      .....++|++.+.||+|++|.||+|.+.. ++.|++|++....         ......+.+|+++++.+. ||||+++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (298)
T 1phk_A           12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   91 (298)
T ss_dssp             ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            34566899999999999999999999854 8899999986532         223456778999999995 999999999


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                      ++.+....++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           92 TYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence            999999999999999999999999653   33899999999999999999999999   999999999999999999999


Q ss_pred             eccccceecCCCCCCCccccccccCCCCCccccc------CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHH
Q 018304          183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS------DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG  256 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~  256 (358)
                      +|||++......   .......+++.|+|||++.      ...++.++||||||+++|+|++|..||.....   .....
T Consensus       166 ~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~  239 (298)
T 1phk_A          166 TDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR  239 (298)
T ss_dssp             CCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH
T ss_pred             ecccchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHH
Confidence            999999875322   2223456888999999874      45688999999999999999999999754321   11111


Q ss_pred             HHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          257 HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ....   ....  .....     .......+.+++.+||+.||++|||+.+++++-+..
T Consensus       240 ~~~~---~~~~--~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (298)
T 1phk_A          240 MIMS---GNYQ--FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  288 (298)
T ss_dssp             HHHH---TCCC--CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHhc---CCcc--cCccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence            1111   1100  00000     011123577899999999999999999999876654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=312.53  Aligned_cols=265  Identities=26%  Similarity=0.413  Sum_probs=206.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-----cCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--e
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--E  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~  109 (358)
                      ..++|++++.||+|++|.||++.+     .+++.|++|.+..........+.+|+++++.++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            357899999999999999999983     358899999998776677788999999999999999999999886654  7


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            899999999999999996543  23899999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCC--------CCCchh-HHHHH
Q 018304          190 AFGGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHS--------DNNLNL-IGHAW  259 (358)
Q Consensus       190 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~--------~~~~~~-~~~~~  259 (358)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++|..||.....        ...... .....
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            76432211 111223456779999999888899999999999999999999988653210        000000 01111


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .............         .....+.++|.+||+.||++|||+.+|++.|+.+
T Consensus       274 ~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          274 ELLKNNGRLPRPD---------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHTTCCCCCCT---------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCC---------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111111111111         1123577899999999999999999999998765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.1e-41  Score=303.85  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=201.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ..++|++.+.||+|++|.||+|.+.. |+.|++|.+....  ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            45789999999999999999999864 8999999997532  34678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+++|.+++....  ..+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus       105 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999999985322  34899999999999999999999999   9999999999999999999999999997753221


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......   ...   .. ........+..   
T Consensus       180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~-~~~~~~~~~~~---  247 (314)
T 3com_A          180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAI---FM-IPTNPPPTFRK---  247 (314)
T ss_dssp             --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HH-HHHSCCCCCSS---
T ss_pred             --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHH---HH-HhcCCCcccCC---
Confidence              1223446888999999999889999999999999999999999998643221   111   11 11111111110   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                          .......+.++|.+||..||.+|||+.+++++.+..
T Consensus       248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence                000123567899999999999999999999876554

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.5e-41  Score=316.81  Aligned_cols=265  Identities=20%  Similarity=0.257  Sum_probs=204.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcC--------CCCccceeeEEE---
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ--------HRNLVKLLGCCI---  105 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--------~~~iv~~~~~~~---  105 (358)
                      .++|++.+.||+|+||.||+|.+.. ++.|++|++.. .......+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            5899999999999999999998754 88999999975 3445567889999999985        778999999987   


Q ss_pred             -eCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEcCCC-----
Q 018304          106 -QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDM-----  178 (358)
Q Consensus       106 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~~~~-----  178 (358)
                       +....++||||+ ++++.+++..... ..+++..++.++.||+.||.|||++ +   |+||||||+||+++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             456889999999 5566666654322 3499999999999999999999998 8   99999999999998775     


Q ss_pred             --------------------------------------------CeEEeccccceecCCCCCCCccccccccCCCCCccc
Q 018304          179 --------------------------------------------NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY  214 (358)
Q Consensus       179 --------------------------------------------~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  214 (358)
                                                                  .++|+|||++......     .....+++.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999875321     233468899999999


Q ss_pred             ccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchh---HHHHHHHhhcCCCCc----------cccC--------
Q 018304          215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNL---IGHAWKLWNEGMPSQ----------LIDP--------  273 (358)
Q Consensus       215 ~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~----------~~~~--------  273 (358)
                      +.+..++.++|||||||++|+|++|..||...........   +....... ...+..          +...        
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL-GKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH-CSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc-CCCChHHhhcccccccccCCcccccccc
Confidence            9999999999999999999999999999976554432211   11111111 110000          0000        


Q ss_pred             -C----------cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          274 -C----------IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       274 -~----------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                       .          ............+.+||.+||+.||++|||+.+++++-+.
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  395 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL  395 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence             0          0012234556678899999999999999999999988653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.3e-42  Score=312.14  Aligned_cols=272  Identities=23%  Similarity=0.362  Sum_probs=189.1

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .....++|++.+.||+|++|.||+|.+. +++.|++|.+.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            3445689999999999999999999864 58899999886532 334566778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccc-----cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          112 LIYEFMTNKSLDSFIFDQE-----RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      +||||+++++|.+++....     ....+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence            9999999999999986421     2344899999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCC---CCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh
Q 018304          187 LARAFGGDET---EGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW  262 (358)
Q Consensus       187 ~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (358)
                      ++........   ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......   .......  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~--  241 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQ--  241 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHT--
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhc--
Confidence            9876532211   111233468899999998865 568999999999999999999999986543321   1111111  


Q ss_pred             hcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                        ......................+.++|.+||+.||.+|||+.+++++.+..
T Consensus       242 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  292 (303)
T 2vwi_A          242 --NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ  292 (303)
T ss_dssp             --SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred             --cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence              111111110000000011123567899999999999999999999976654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.2e-42  Score=304.83  Aligned_cols=250  Identities=27%  Similarity=0.403  Sum_probs=196.7

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-CeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv~e~  116 (358)
                      .++|++.+.||+|++|.||++.+ .++.|++|.+....  ..+.+.+|+.+++.++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            47899999999999999999987 68899999997543  456788999999999999999999987554 478999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++++|.+++..... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        97 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            999999999965432 23889999999999999999999999   999999999999999999999999998754221  


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    .........   
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~~~~~~---  237 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KGYKMDAPD---  237 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHT----TTCCCCCCT---
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cCCCCCCcc---
Confidence               223356788999999988899999999999999999998 99998654322   1211111    111111111   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                        .    ....+.++|.+||+.||++|||+.++++.|+.+
T Consensus       238 --~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          238 --G----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             --T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --c----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence              1    123577899999999999999999999998765

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8e-42  Score=310.50  Aligned_cols=269  Identities=25%  Similarity=0.329  Sum_probs=203.1

Q ss_pred             CcceeHHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcC--CCCcccee
Q 018304           26 LPLFELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLL  101 (358)
Q Consensus        26 ~~~~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~--~~~iv~~~  101 (358)
                      ...+..+++...+++|++.+.||+|+||.||++.+.+++.|++|.+..  ........+.+|+.+++.++  |+||++++
T Consensus        15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~   94 (313)
T 3cek_A           15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY   94 (313)
T ss_dssp             -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred             CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence            334445556666789999999999999999999988899999999864  33455678889999999996  59999999


Q ss_pred             eEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeE
Q 018304          102 GCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK  181 (358)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~  181 (358)
                      +++.+.+..++||| +.+++|.+++....   .+++..++.++.|++.||.|||+++   ++|+||+|+||+++ ++.++
T Consensus        95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~k  166 (313)
T 3cek_A           95 DYEITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLK  166 (313)
T ss_dssp             EEEECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEE
T ss_pred             EEeecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEE
Confidence            99999999999999 55779999996543   4899999999999999999999999   99999999999996 58999


Q ss_pred             EeccccceecCCCCCCCccccccccCCCCCcccccC-----------CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCC
Q 018304          182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD-----------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN  250 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~  250 (358)
                      |+|||++................+++.|+|||.+.+           ..++.++||||||+++|+|++|..||.....  
T Consensus       167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--  244 (313)
T 3cek_A          167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--  244 (313)
T ss_dssp             ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--
T ss_pred             EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--
Confidence            999999986543332222334568999999999865           4678899999999999999999999854321  


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                         ................+..     ..    ...+.++|.+||+.||.+|||+.+++++.+...
T Consensus       245 ---~~~~~~~~~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          245 ---QISKLHAIIDPNHEIEFPD-----IP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             ---HHHHHHHHHCTTSCCCCCC-----CS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             ---HHHHHHHHHhcccccCCcc-----cc----hHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence               1111111111111111111     11    235678999999999999999999999877653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1e-41  Score=316.46  Aligned_cols=264  Identities=23%  Similarity=0.317  Sum_probs=188.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC------
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~------  107 (358)
                      ..++|++++.||+|+||.||+|.+. +|+.|++|.+..  ........+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3589999999999999999999975 488999999865  2344567788999999999999999999998654      


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                      ...++++|++ +++|.+++..    ..+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            5679999999 6799888854    33999999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      +.....     ......++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..   ..+..+....... 
T Consensus       179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p-  249 (367)
T 2fst_X          179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTP-  249 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSC-
T ss_pred             cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC-
Confidence            976421     2234568899999999877 67899999999999999999999998654332   2222222111110 


Q ss_pred             CCccccCC------------c-CCCCCHH-----HHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          267 PSQLIDPC------------I-QGSFNLA-----EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       267 ~~~~~~~~------------~-~~~~~~~-----~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ....+...            . .......     ....+.+||.+||+.||++|||+.+++++.+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            00000000            0 0001111     12356789999999999999999999998876643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-41  Score=319.42  Aligned_cols=267  Identities=19%  Similarity=0.234  Sum_probs=198.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe------e
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE------K  110 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~------~  110 (358)
                      ...+|++.+.||+|+||.||+|.+..+..+++|.+.....    ...+|+++++.++||||+++++++.....      .
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            4568999999999999999999987777799998854322    22369999999999999999999965443      7


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc-CCCCeEEeccccce
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLAR  189 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~-~~~~i~L~Df~~~~  189 (358)
                      ++||||+.++.+............+++..++.++.||+.||.|||+++   |+||||||+||+++ .++.+||+|||++.
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            899999987544443332333445999999999999999999999999   99999999999999 78999999999998


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc----
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE----  264 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  264 (358)
                      ......   ......+++.|+|||++.+. .++.++||||+||++|+|++|..||......   ..+.........    
T Consensus       191 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          191 ILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             ECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHH
T ss_pred             cccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHH
Confidence            753222   22244678899999988765 5899999999999999999999998654322   112111111100    


Q ss_pred             -----------CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          265 -----------GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       265 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                                 ...+..................+.+||.+||+.||.+|||+.+++++.+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE  327 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence                       0000000000000000112246778999999999999999999999876653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-42  Score=322.67  Aligned_cols=245  Identities=16%  Similarity=0.178  Sum_probs=189.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc---cChhhHHHHHHHHH---HHHhcCCCCcccee-------eE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVI---LFSKLQHRNLVKLL-------GC  103 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~---~~~~~~~~~~~e~~---~l~~l~~~~iv~~~-------~~  103 (358)
                      .++|++.+.||+|+||.||+|.+. +|+.|++|++..   ........+.+|+.   .++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467999999999999999999964 599999999863   33445677889995   45555799999988       66


Q ss_pred             EEeCCe-----------------eEEEEEecCCCCHHHHHhccccc----cCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 018304          104 CIQGEE-----------------KLLIYEFMTNKSLDSFIFDQERC----KILDWSKRFHIICGTARGVMYLHQDSRLRI  162 (358)
Q Consensus       104 ~~~~~~-----------------~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~i~~al~~LH~~~~~~i  162 (358)
                      +.+.+.                 .+++|||+ +|+|.+++......    ..+++..++.++.||+.||.|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            665532                 78999999 57999999664321    11334888899999999999999999   9


Q ss_pred             ccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCC-----------CCCCcccchhHhH
Q 018304          163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-----------QFSVKSDVFSFGI  231 (358)
Q Consensus       163 ~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~  231 (358)
                      +||||||+||+++.++.+||+|||++....     .......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            999999999999999999999999998632     12234456 999999999877           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          232 LLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       232 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                      ++|+|++|..||...........+               ....  ...    ...+.++|.+||+.||++|||+.+++++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~---------------~~~~--~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWI---------------FRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGG---------------GSSC--CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHHCCCCCcccccccchhhh---------------hhhc--cCC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            999999999998654432221111               0000  011    1356789999999999999999999986


Q ss_pred             hc
Q 018304          312 LG  313 (358)
Q Consensus       312 l~  313 (358)
                      .+
T Consensus       361 p~  362 (377)
T 3byv_A          361 PE  362 (377)
T ss_dssp             HH
T ss_pred             hH
Confidence            54

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.2e-41  Score=306.28  Aligned_cols=262  Identities=17%  Similarity=0.280  Sum_probs=202.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEe--CCeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ--GEEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~--~~~~~lv  113 (358)
                      .++|++.+.||+|+||.||+|.+. +++.|++|++....   ...+.+|+.+++.++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            378999999999999999999874 58999999997533   367889999999996 9999999999988  5678999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEeccccceecC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFG  192 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df~~~~~~~  192 (358)
                      |||+.+++|.+++.      .+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++ .++|+|||++....
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999873      2889999999999999999999999   99999999999999776 89999999998753


Q ss_pred             CCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHh---------
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW---------  262 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------  262 (358)
                      ...   ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......  ...+.......         
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHH
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHH
Confidence            222   2234467889999999877 67899999999999999999999997432221  11111111000         


Q ss_pred             h--------------cCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          263 N--------------EGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       263 ~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .              .......+...............+.+||.+||+.||++|||+.+++++.+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  325 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  325 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence            0              00000111111111111112346778999999999999999999999877654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.8e-41  Score=309.60  Aligned_cols=264  Identities=21%  Similarity=0.280  Sum_probs=205.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEE-c-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC------CccceeeEEEeCC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTL-V-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR------NLVKLLGCCIQGE  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~-~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~------~iv~~~~~~~~~~  108 (358)
                      ..++|++.+.||+|+||.||+|.+ . +++.|++|++... ......+.+|+.+++.++|+      +++++++++.+.+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            357999999999999999999987 3 4789999999753 44556788899999988755      4999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC------------
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ------------  176 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~------------  176 (358)
                      ..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            999999999 7899999865443 24889999999999999999999999   999999999999987            


Q ss_pred             -------CCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCC
Q 018304          177 -------DMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD  249 (358)
Q Consensus       177 -------~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~  249 (358)
                             ++.++|+|||++.....     ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                   67899999999986422     223456889999999999989999999999999999999999998754432


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCC-------------------------------cCCCCCHHHHHHHHHHHhhhcCCC
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPC-------------------------------IQGSFNLAEVIRCIHIGLLCVQQH  298 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~  298 (358)
                      .....+....    ...+.......                               ............+.+||.+||+.|
T Consensus       241 ~~~~~~~~~~----~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          241 EHLAMMERIL----GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             HHHHHHHHHH----CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHh----CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            2111111111    11111000000                               000112233456889999999999


Q ss_pred             CCCCCChHHHHHHhccC
Q 018304          299 PKDRPSMPSVILMLGSE  315 (358)
Q Consensus       299 P~~Rpt~~ell~~l~~~  315 (358)
                      |.+|||+.+++++-+..
T Consensus       317 P~~Rpt~~ell~hp~f~  333 (339)
T 1z57_A          317 PAKRITLREALKHPFFD  333 (339)
T ss_dssp             TTTSCCHHHHTTSGGGG
T ss_pred             cccccCHHHHhcCHHHH
Confidence            99999999999876543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-41  Score=311.25  Aligned_cols=257  Identities=27%  Similarity=0.424  Sum_probs=201.1

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCE--EEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQE--IAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~--v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|++.+.||+|+||.||+|.+.. +..  +++|.+... .......+.+|+++++.+ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            688999999999999999998754 554  488988652 233456688999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhccc-------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCe
Q 018304          114 YEFMTNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP  180 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i  180 (358)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996543             2235999999999999999999999999   9999999999999999999


Q ss_pred             EEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHH
Q 018304          181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~  259 (358)
                      +|+|||++....   .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   ....   
T Consensus       182 kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~---  252 (327)
T 1fvr_A          182 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE---  252 (327)
T ss_dssp             EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---
T ss_pred             EEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHH---
Confidence            999999987431   1112223456788999999988889999999999999999998 99998543321   1111   


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                       ...........     ..    ....+.++|.+||..+|.+|||+.++++.|+.+..
T Consensus       253 -~~~~~~~~~~~-----~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          253 -KLPQGYRLEKP-----LN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             -HGGGTCCCCCC-----TT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HhhcCCCCCCC-----CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             11111111111     11    12357789999999999999999999999987633

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.4e-41  Score=310.89  Aligned_cols=267  Identities=21%  Similarity=0.295  Sum_probs=206.0

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHh--cCCCCccceeeEEEeCC--
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE--  108 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~--l~~~~iv~~~~~~~~~~--  108 (358)
                      --....++|++.+.||+|+||.||+|.+ +++.|++|.+...   ....+..|++++..  ++||||+++++++....  
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            3445678999999999999999999988 6899999999653   33566788888887  68999999999998876  


Q ss_pred             --eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCcccCCCCCCcEEEcCCC
Q 018304          109 --EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH--------QDSRLRIIHRDLKASNVLLDQDM  178 (358)
Q Consensus       109 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH--------~~~~~~i~H~di~~~Nilv~~~~  178 (358)
                        ..++||||+++++|.+++.+.    .+++..++.++.|++.||.|||        +.+   ++|+||+|+||+++.++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred             cceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence              789999999999999999543    3899999999999999999999        788   99999999999999999


Q ss_pred             CeEEeccccceecCCCCCCC--ccccccccCCCCCcccccCCC------CCCcccchhHhHHHHHHHhC----------C
Q 018304          179 NPKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYASDGQ------FSVKSDVFSFGILLLEIISG----------K  240 (358)
Q Consensus       179 ~i~L~Df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~~l~~g----------~  240 (358)
                      .++|+|||++..........  ......+++.|+|||++.+..      ++.++||||||+++|+|++|          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            99999999997753322111  123446889999999987652      33689999999999999999          6


Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhc-CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          241 KNRGFYHSDNNLNLIGHAWKLWNE-GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       241 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .||..........  ......... .....+..    ..........+.+++.+||+.||++|||+.+|+++|+.+.
T Consensus       265 ~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          265 LPYYDLVPSDPSV--EEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CTTTTTSCSSCCH--HHHHHHHTTSCCCCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCccccCcCcccH--HHHHHHHHHHHhCCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            6765433322111  111111111 11111111    1112344567888999999999999999999999998763

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=311.89  Aligned_cols=265  Identities=25%  Similarity=0.361  Sum_probs=194.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHH--HHhcCCCCccceeeEEEe-----CCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVIL--FSKLQHRNLVKLLGCCIQ-----GEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~--l~~l~~~~iv~~~~~~~~-----~~~  109 (358)
                      ..++|++.+.||+|+||.||+|.+ +++.|++|++.....   ..+..|.++  +..++|+||+++++.+..     ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            348999999999999999999977 789999999965332   333344444  445799999999976543     235


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC---------CCCCcccCCCCCCcEEEcCCCCe
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD---------SRLRIIHRDLKASNVLLDQDMNP  180 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---------~~~~i~H~di~~~Nilv~~~~~i  180 (358)
                      .++||||+++++|.+++....    .++..++.++.||+.||.|||+.         +   |+||||||+||+++.++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence            689999999999999995433    58899999999999999999999         8   9999999999999999999


Q ss_pred             EEeccccceecCCCCC------CCccccccccCCCCCcccccC-------CCCCCcccchhHhHHHHHHHhCCCCCCCCC
Q 018304          181 KISDFGLARAFGGDET------EGNTKRVIGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIISGKKNRGFYH  247 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~g~~p~~~~~  247 (358)
                      +|+|||++..+.....      ........|++.|+|||++.+       ..++.++|||||||++|+|++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            9999999987643211      111223468999999999876       345678999999999999999977754332


Q ss_pred             CCCCchh-HH----------HHHH-HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          248 SDNNLNL-IG----------HAWK-LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       248 ~~~~~~~-~~----------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ....... ..          .... .........+.....   ........+.++|.+||+.||++|||+.++++.|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK---ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC---CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc---cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            2211111 00          0000 011111111111111   1223445688899999999999999999999998876

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=313.02  Aligned_cols=262  Identities=15%  Similarity=0.232  Sum_probs=203.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC---------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccc---------
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK---------   99 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~---------   99 (358)
                      +++|++.+.||+|+||.||+|.+..         ++.|++|.+...     ..+.+|+++++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            5899999999999999999999764         789999998653     35678999999999998887         


Q ss_pred             ------eeeEEEe-CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcE
Q 018304          100 ------LLGCCIQ-GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV  172 (358)
Q Consensus       100 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Ni  172 (358)
                            +++++.. +...++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++   ++|+||+|+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6677766 67889999999 8999999976422 34999999999999999999999999   99999999999


Q ss_pred             EEcCCC--CeEEeccccceecCCCCCC-----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCC
Q 018304          173 LLDQDM--NPKISDFGLARAFGGDETE-----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF  245 (358)
Q Consensus       173 lv~~~~--~i~L~Df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~  245 (358)
                      +++.++  .++|+|||++..+......     .......+++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999988  8999999999765322111     111234689999999999998999999999999999999999999876


Q ss_pred             CCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          246 YHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .....  ..+......+... ...+........   .....+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       271 ~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          271 CLPNT--EDIMKQKQKFVDK-PGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GTTCH--HHHHHHHHHHHHS-CCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CCcCH--HHHHHHHHhccCC-hhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            44221  1222222222121 122222111100   0113567899999999999999999999999876

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-40  Score=308.84  Aligned_cols=270  Identities=20%  Similarity=0.294  Sum_probs=206.0

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----C
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E  108 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~  108 (358)
                      ..+++|++.+.||+|+||.||+|.+. +++.|++|.+... .......+.+|+++++.++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            44679999999999999999999975 4889999999753 344457788999999999999999999999765     3


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..++||||+.+ +|.+++...    .+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus       104 ~~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          104 DVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             CEEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence            68999999975 899888542    3999999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCCC-CccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          189 RAFGGDETE-GNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       189 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      ......... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........   ............
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~  252 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPS  252 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCC
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence            875322111 11234578999999997654 5689999999999999999999999865443322   222211111100


Q ss_pred             CCccccC-------------CcCCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          267 PSQLIDP-------------CIQGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       267 ~~~~~~~-------------~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                       ......             ........     .....+.+||.+||+.||++|||+.+++++.+....
T Consensus       253 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          253 -QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             -HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             -HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence             000000             00000000     112357789999999999999999999998887654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=316.08  Aligned_cols=273  Identities=19%  Similarity=0.299  Sum_probs=190.3

Q ss_pred             hcCCCCcc-eeecccCCccEEEEEEc---CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCee
Q 018304           37 ATNNFSIN-KKLGQGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK  110 (358)
Q Consensus        37 ~~~~y~i~-~~lg~g~~g~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~  110 (358)
                      ..+.|++. ++||+|+||.||+|.++   +++.|++|.+.....  ...+.+|+.+++.++||||+++++++..  ....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            34557774 48999999999999965   478999999975432  2467789999999999999999999965  6688


Q ss_pred             EEEEEecCCCCHHHHHhcccc------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE----cCCCCe
Q 018304          111 LLIYEFMTNKSLDSFIFDQER------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL----DQDMNP  180 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv----~~~~~i  180 (358)
                      ++||||+.+ +|.+++.....      ...+++..++.++.||+.||.|||+++   |+||||||+||++    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence            999999975 88877753321      123899999999999999999999999   9999999999999    677899


Q ss_pred             EEeccccceecCCCCC-CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCC------Cc
Q 018304          181 KISDFGLARAFGGDET-EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDN------NL  252 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~------~~  252 (358)
                      +|+|||++........ ........+++.|+|||++.+. .++.++|||||||++|+|++|..||.......      ..
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            9999999986532211 1223345789999999998874 58999999999999999999999986543321      11


Q ss_pred             hhHHHHHHHhhcCCCCccccCCcC----------------CCCCHH---------HHHHHHHHHhhhcCCCCCCCCChHH
Q 018304          253 NLIGHAWKLWNEGMPSQLIDPCIQ----------------GSFNLA---------EVIRCIHIGLLCVQQHPKDRPSMPS  307 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~---------~~~~l~~li~~cl~~~P~~Rpt~~e  307 (358)
                      ..+..+........... +.....                ......         ....+.+||.+||+.||.+|||+.+
T Consensus       252 ~~l~~i~~~~g~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKD-WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHCCCCTTT-CGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHhhCCCChhh-cchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            22222222221111111 000000                000000         0235678999999999999999999


Q ss_pred             HHHHhccCC
Q 018304          308 VILMLGSET  316 (358)
Q Consensus       308 ll~~l~~~~  316 (358)
                      ++++-|...
T Consensus       331 ~L~hp~f~~  339 (405)
T 3rgf_A          331 AMQDPYFLE  339 (405)
T ss_dssp             HHTSGGGTS
T ss_pred             HhcChhhcc
Confidence            999988764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-41  Score=315.50  Aligned_cols=257  Identities=28%  Similarity=0.417  Sum_probs=192.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcC--C--CEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEE-eCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD--G--QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~--~--~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~~~~l  112 (358)
                      .+|++.+.||+|+||.||+|.+.+  +  ..|++|.+... .......+.+|+.+++.++||||+++++++. .++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            357788999999999999998632  2  36899988653 3345678889999999999999999999865 4567899


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++....  ..+++..++.++.||+.||.|||+++   ++||||+|+||+++.++.+||+|||++..+.
T Consensus       169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999996533  33889999999999999999999999   9999999999999999999999999997653


Q ss_pred             CCCCC--CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          193 GDETE--GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       193 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .....  .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......   .......    .....
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~~----~~~~~  316 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQ----GRRLL  316 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHHT----TCCCC
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHHc----CCCCC
Confidence            22211  11223346678999999999999999999999999999999 677765443322   2222211    11110


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ..     ..    ....+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       317 ~p-----~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          317 QP-----EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             CC-----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-----CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            00     01    1135678999999999999999999999998764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-41  Score=330.61  Aligned_cols=261  Identities=27%  Similarity=0.410  Sum_probs=207.8

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +....++|++.+.||+|+||.||+|.+.++..|+||++.... .....+.+|+++|+.++|+||+++++++.+ +..++|
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            334557899999999999999999999878889999997633 334678899999999999999999999866 678999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+.+++|.+++..... ..+++..++.++.||+.||.|||+++   |+||||+|+|||++.++.+||+|||++.....
T Consensus       340 ~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            999999999999965322 33899999999999999999999999   99999999999999999999999999976432


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .. ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ......+..    ........
T Consensus       416 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~----~~~~~~~~  487 (535)
T 2h8h_A          416 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVER----GYRMPCPP  487 (535)
T ss_dssp             HH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHT----TCCCCCCT
T ss_pred             Cc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CCCCCCCC
Confidence            11 111112335678999999988899999999999999999999 8999764322   122222221    11111111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                               .....+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       488 ---------~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          488 ---------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ---------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                     112356789999999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.5e-41  Score=301.91  Aligned_cols=257  Identities=25%  Similarity=0.350  Sum_probs=189.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|.+....  ......+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            4578999999999999999999974 58899999997532  22233344555567778999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          114 YEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      |||+++ +|.+++... .....+++..++.++.|++.||.|||++ +   ++|+||+|+||+++.++.++|+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999975 888877542 2334599999999999999999999998 9   999999999999999999999999998765


Q ss_pred             CCCCCCCccccccccCCCCCcccc----cCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYA----SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ...   .......+++.|+|||.+    .+..++.++||||||+++|+|++|..||......  ....   .........
T Consensus       161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~---~~~~~~~~~  232 (290)
T 3fme_A          161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQL---KQVVEEPSP  232 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHH---HHHHHSCCC
T ss_pred             ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHH---HHHhccCCC
Confidence            322   222234688999999986    5567899999999999999999999998643221  1111   111112111


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      . ....    .    ....+.+++.+||+.||++|||+.+++++.+.
T Consensus       233 ~-~~~~----~----~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f  270 (290)
T 3fme_A          233 Q-LPAD----K----FSAEFVDFTSQCLKKNSKERPTYPELMQHPFF  270 (290)
T ss_dssp             C-CCTT----T----SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             C-cccc----c----CCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence            1 1111    1    12356789999999999999999999987654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.2e-41  Score=333.15  Aligned_cols=253  Identities=24%  Similarity=0.275  Sum_probs=206.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|++++.||+|+||.||+|.++. ++.||+|++.+.   .......+..|..++..+ +|++|+++++++.+.+.+++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            4689999999999999999999765 888999999752   233456677899999888 79999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.++|+|||++....
T Consensus       420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999996543   3999999999999999999999999   9999999999999999999999999998642


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      ..  ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+.   ......+.    ... ..+..
T Consensus       494 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~~i~----~~~-~~~p~  563 (674)
T 3pfq_A          494 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM----EHN-VAYPK  563 (674)
T ss_dssp             CT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----SSC-CCCCT
T ss_pred             cC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHHHHH----hCC-CCCCc
Confidence            21  2233456799999999999999999999999999999999999999865322   12222221    111 11111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCCh-----HHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM-----PSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~ell~~l~~~  315 (358)
                           .    ...++.+||.+||+.||++||++     .+|+++.+..
T Consensus       564 -----~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~  602 (674)
T 3pfq_A          564 -----S----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  602 (674)
T ss_dssp             -----T----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred             -----c----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence                 1    12356789999999999999998     8898876543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=305.60  Aligned_cols=270  Identities=21%  Similarity=0.279  Sum_probs=198.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEE----------
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI----------  105 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~----------  105 (358)
                      ..++|++.+.||+|++|.||+|.+.. ++.|++|.+..........+.+|+++++.++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            35899999999999999999999865 8999999998777777788899999999999999999999873          


Q ss_pred             ----eCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc-CCCCe
Q 018304          106 ----QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNP  180 (358)
Q Consensus       106 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~-~~~~i  180 (358)
                          +....++||||+. ++|.+++..    ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++ .++.+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence                3467899999997 599998843    33899999999999999999999999   99999999999997 56799


Q ss_pred             EEeccccceecCCCCC-CCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH
Q 018304          181 KISDFGLARAFGGDET-EGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA  258 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  258 (358)
                      +|+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||......   ......
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~  237 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLI  237 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence            9999999986532211 112234457889999998765 67899999999999999999999998654321   111111


Q ss_pred             HHHhhcC----------CCCccc-cCCcCCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          259 WKLWNEG----------MPSQLI-DPCIQGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       259 ~~~~~~~----------~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      .......          ...... ..........     .....+.++|.+||+.||++|||+.+++++.+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            1110000          000000 0000000000     112457789999999999999999999998766543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.2e-41  Score=309.70  Aligned_cols=263  Identities=20%  Similarity=0.235  Sum_probs=178.3

Q ss_pred             HhcCCCCcce-eecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCe
Q 018304           36 SATNNFSINK-KLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEE  109 (358)
Q Consensus        36 ~~~~~y~i~~-~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~  109 (358)
                      ...++|++.+ .||+|+||.||+|.+. +++.|++|++....    ....+....++.+.||||+++++++..    ...
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            3457899966 6999999999999986 48999999996532    122233344566799999999999976    445


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CCCeEEeccc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG  186 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~~i~L~Df~  186 (358)
                      .++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.   ++.++|+|||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence            8999999999999999976443 34999999999999999999999999   999999999999986   4559999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      ++.....    .......+++.|+|||++.+..++.++||||||+++|+|++|..||.......................
T Consensus       177 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (336)
T 3fhr_A          177 FAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF  252 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred             cceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence            9986532    222345678999999999888899999999999999999999999865443221111100000000000


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCCC
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLP  319 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~~  319 (358)
                      +...         .......+.+||.+||+.||++|||+.+++++.+......
T Consensus       253 ~~~~---------~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          253 PNPE---------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             CTTT---------STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             Cchh---------hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence            0000         0011235678999999999999999999999877655443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=311.32  Aligned_cols=256  Identities=15%  Similarity=0.127  Sum_probs=202.6

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEE------EcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCccceeeE
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGC  103 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~------~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~  103 (358)
                      ++....++|++.+.||+|+||.||+|.      ...++.|++|++.....   ..+..|+++++.++   |+||++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            344456889999999999999999994      34588999999976443   45667777777776   8999999999


Q ss_pred             EEeCCeeEEEEEecCCCCHHHHHhccc--cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-----
Q 018304          104 CIQGEEKLLIYEFMTNKSLDSFIFDQE--RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-----  176 (358)
Q Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-----  176 (358)
                      +...+..++||||+++++|.+++....  ....+++..++.++.||+.||.|||+++   |+||||||+||+++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence            999999999999999999999996532  2345999999999999999999999999   999999999999988     


Q ss_pred             ------CCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCC
Q 018304          177 ------DMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN  250 (358)
Q Consensus       177 ------~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~  250 (358)
                            ++.++|+|||++..+.............|++.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999976532222333345678999999999999999999999999999999999999975432211


Q ss_pred             CchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCC-CChHHHHHHhccC
Q 018304          251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDR-PSMPSVILMLGSE  315 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-pt~~ell~~l~~~  315 (358)
                      .                  ...........   ...+.+++..||..+|.+| |++.++.+.|+..
T Consensus       293 ~------------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 C------------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             E------------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             e------------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            0                  00111111111   3345578889999999999 6777777766554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-40  Score=309.52  Aligned_cols=264  Identities=23%  Similarity=0.273  Sum_probs=196.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----  108 (358)
                      ..++|++++.||+|+||.||+|.+. +++.|++|.+..  ........+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            3489999999999999999999975 488999999865  33455667889999999999999999999997665     


Q ss_pred             -eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          109 -EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       109 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                       ..++||||+.+ +|.+++.     ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence             67999999975 7877773     22889999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc---
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE---  264 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  264 (358)
                      +......   .......+++.|+|||++.+..++.++|||||||++|+|++|..||...+..   ............   
T Consensus       174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCP  247 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCH
T ss_pred             ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence            9764321   1223456889999999999999999999999999999999999998654321   111111110000   


Q ss_pred             ---------------CCCC-------ccccCC-cCCC--CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          265 ---------------GMPS-------QLIDPC-IQGS--FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       265 ---------------~~~~-------~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                                     ..+.       ...... ....  ........+.+||.+||+.||++|||+.+++++.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                           0000       000000 0000  0112245678999999999999999999999987764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.6e-41  Score=308.80  Aligned_cols=267  Identities=24%  Similarity=0.316  Sum_probs=205.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhh-----------------HHHHHHHHHHHHhcCCCCccc
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQG-----------------LKELKNEVILFSKLQHRNLVK   99 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~-----------------~~~~~~e~~~l~~l~~~~iv~   99 (358)
                      ..++|++.+.||+|++|.||+|.+ +++.|++|.+.......                 ...+.+|+.+++.++||||++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            357999999999999999999999 99999999986522111                 177889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCCHHHH------HhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcE
Q 018304          100 LLGCCIQGEEKLLIYEFMTNKSLDSF------IFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNV  172 (358)
Q Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Ni  172 (358)
                      +++++.+.+..++||||+++++|.++      +... ....+++..++.++.|++.||.|||+ .+   ++|+||+|+||
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni  183 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI  183 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence            99999999999999999999999998      4332 13459999999999999999999999 88   99999999999


Q ss_pred             EEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCC-CCCC-cccchhHhHHHHHHHhCCCCCCCCCCCC
Q 018304          173 LLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSV-KSDVFSFGILLLEIISGKKNRGFYHSDN  250 (358)
Q Consensus       173 lv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~il~~l~~g~~p~~~~~~~~  250 (358)
                      +++.++.++|+|||.+......    ......++..|+|||.+.+. .++. ++||||||+++|+|++|..||...... 
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-  258 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-  258 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred             EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence            9999999999999999875322    23345688999999999877 6666 999999999999999999998654331 


Q ss_pred             CchhHHHHHHHhhcCCCCc---cccCCcC---CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          251 NLNLIGHAWKLWNEGMPSQ---LIDPCIQ---GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       ........... ...+..   .......   ..........+.++|.+||+.||.+|||+.+++++.+..
T Consensus       259 -~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          259 -VELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             -HHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             -HHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence             11211111100 000000   0000000   000011224677899999999999999999999976654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.1e-41  Score=311.61  Aligned_cols=276  Identities=19%  Similarity=0.214  Sum_probs=194.2

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ..+....-++|++.+.||+|+||.||+|.+. +++.|++|.+.... .......++++.+..++||||+++++++.....
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            3456666799999999999999999999985 48999999886532 233456678888889999999999999976443


Q ss_pred             -------eEEEEEecCCCCHHHHHhc-cccccCCCHHHHHHHHHHHHHHHHHHh--cCCCCCcccCCCCCCcEEEcC-CC
Q 018304          110 -------KLLIYEFMTNKSLDSFIFD-QERCKILDWSKRFHIICGTARGVMYLH--QDSRLRIIHRDLKASNVLLDQ-DM  178 (358)
Q Consensus       110 -------~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~~~~i~H~di~~~Nilv~~-~~  178 (358)
                             .++||||+.+ +|.+.+.. ......+++..++.++.|++.||.|||  +.+   |+|+||||+||+++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence                   7899999987 55444432 234445899999999999999999999  888   999999999999996 89


Q ss_pred             CeEEeccccceecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHH
Q 018304          179 NPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGH  257 (358)
Q Consensus       179 ~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~  257 (358)
                      .++|+|||++.......   ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.......   ....
T Consensus       170 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~  243 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHE  243 (360)
T ss_dssp             EEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             cEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHH
Confidence            99999999998653222   22344678999999988665 48999999999999999999999986543321   2222


Q ss_pred             HHHHhhcC-----------C-CCccccCCc------CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          258 AWKLWNEG-----------M-PSQLIDPCI------QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       258 ~~~~~~~~-----------~-~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ........           . .........      ...........+.+||.+||+.||.+|||+.+++++.+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence            21111000           0 000000000      000111124567889999999999999999999998877643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.6e-41  Score=302.41  Aligned_cols=257  Identities=26%  Similarity=0.332  Sum_probs=203.2

Q ss_pred             HHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           34 IVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        34 ~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .....++|++.+.||+|++|.||+|.+. +++.|++|++...  .......+.+|+++++.++||||+++++++.+.+..
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            3455689999999999999999999986 5899999998642  233467788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC---CCeEEecccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGL  187 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~---~~i~L~Df~~  187 (358)
                      ++||||+.+++|.+++....   .+++..++.++.||+.||.+||+++   ++|+||+|+||+++.+   +.++|+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            99999999999999886543   3899999999999999999999999   9999999999999754   4699999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      +.......   ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.....   .........   ....
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~---~~~~  240 (287)
T 2wei_A          171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVET---GKYA  240 (287)
T ss_dssp             GGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---CCCC
T ss_pred             ceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHc---CCCC
Confidence            87653221   2223457889999998875 489999999999999999999999764322   111111111   1111


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .....   ...    ....+.++|.+||..+|++|||+.+++++.+
T Consensus       241 ~~~~~---~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  279 (287)
T 2wei_A          241 FDLPQ---WRT----ISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (287)
T ss_dssp             CCSGG---GTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             CCchh---hhh----cCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence            11000   001    1235678999999999999999999998654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-41  Score=315.12  Aligned_cols=267  Identities=21%  Similarity=0.237  Sum_probs=197.4

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC------
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------  107 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~------  107 (358)
                      ....++|++.+.||+|+||.||+|.+. +|+.||+|.+.....    ...+|+++++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            456789999999999999999999974 589999999865332    223799999999999999999998543      


Q ss_pred             --------------------------------CeeEEEEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHH
Q 018304          108 --------------------------------EEKLLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYL  154 (358)
Q Consensus       108 --------------------------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~L  154 (358)
                                                      ...++||||+++ +|.+.+... .....+++..++.++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            347899999985 877777542 2334599999999999999999999


Q ss_pred             hcCCCCCcccCCCCCCcEEEc-CCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHH
Q 018304          155 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGIL  232 (358)
Q Consensus       155 H~~~~~~i~H~di~~~Nilv~-~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~i  232 (358)
                      |+.|   |+||||||+||+++ .++.++|+|||++..+....   ......++..|+|||.+.+. .++.++||||+||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   99999999999998 68899999999998753222   22344678899999988765 58999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC---------------CCCccccCCcCCCCCHHHHHHHHHHHhhhcCC
Q 018304          233 LLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG---------------MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQ  297 (358)
Q Consensus       233 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  297 (358)
                      +|+|++|..||......   ..+..........               ..+..................+.+||.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            99999999998654322   2222221111110               00000000000000111223577899999999


Q ss_pred             CCCCCCChHHHHHHhccC
Q 018304          298 HPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       298 ~P~~Rpt~~ell~~l~~~  315 (358)
                      ||++|||+.+++++-+..
T Consensus       309 dP~~R~t~~e~l~hp~f~  326 (383)
T 3eb0_A          309 EPDLRINPYEAMAHPFFD  326 (383)
T ss_dssp             SGGGSCCHHHHHTSGGGH
T ss_pred             ChhhCCCHHHHhcCHHHH
Confidence            999999999999876654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2e-41  Score=315.17  Aligned_cols=256  Identities=10%  Similarity=0.044  Sum_probs=182.4

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhc--CCCCcccee-------eEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKL--QHRNLVKLL-------GCCI  105 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l--~~~~iv~~~-------~~~~  105 (358)
                      .+|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45999999999999999999975 58899999997633   34456677785545444  699988755       4444


Q ss_pred             eC-----------------CeeEEEEEecCCCCHHHHHhccccccCCCHHHH------HHHHHHHHHHHHHHhcCCCCCc
Q 018304          106 QG-----------------EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKR------FHIICGTARGVMYLHQDSRLRI  162 (358)
Q Consensus       106 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~~~~~i~~al~~LH~~~~~~i  162 (358)
                      ..                 ...++||||++ ++|.+++.....  .+....+      +.++.||+.||.|||+++   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            33                 33799999998 799999976432  2555555      778899999999999999   9


Q ss_pred             ccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCC
Q 018304          163 IHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGK  240 (358)
Q Consensus       163 ~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~  240 (358)
                      +||||||+||+++.++.+||+|||++.....     ......+++.|+|||++.+  ..++.++|||||||++|+|++|.
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999986521     1113456699999999987  67999999999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          241 KNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       241 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      .||...........        ........................+.+||.+||+.||++|||+.+++++.+
T Consensus       291 ~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  355 (371)
T 3q60_A          291 LPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE  355 (371)
T ss_dssp             CSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred             CCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence            99876543211100        000000000000000000112346778999999999999999999998654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-40  Score=308.04  Aligned_cols=269  Identities=21%  Similarity=0.287  Sum_probs=204.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCCccceeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCI  105 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~iv~~~~~~~  105 (358)
                      .++|++.+.||+|+||.||+|.+. +++.|++|++.. .......+.+|+.+++.+.           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            479999999999999999999974 588999999975 3344566788999988886           789999999998


Q ss_pred             eCC----eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEc-----
Q 018304          106 QGE----EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLD-----  175 (358)
Q Consensus       106 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~-----  175 (358)
                      ..+    ..+++||++ +++|.+++...... .+++..++.++.||+.||.|||++ +   |+|+||||+||+++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 88999998764432 389999999999999999999998 9   99999999999994     


Q ss_pred             -CCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCc--
Q 018304          176 -QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL--  252 (358)
Q Consensus       176 -~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~--  252 (358)
                       ..+.++|+|||++.....     ......+++.|+|||++.+..++.++||||||+++|+|++|..||.........  
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             344799999999987532     122346889999999999999999999999999999999999998765432211  


Q ss_pred             -hhHHHHHHHhhcCCCCc----------------cccCCc-------------CCCCCHHHHHHHHHHHhhhcCCCCCCC
Q 018304          253 -NLIGHAWKLWNEGMPSQ----------------LIDPCI-------------QGSFNLAEVIRCIHIGLLCVQQHPKDR  302 (358)
Q Consensus       253 -~~~~~~~~~~~~~~~~~----------------~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~~P~~R  302 (358)
                       ..+....... ...+..                ......             ...........+.+||.+||+.||++|
T Consensus       247 ~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          247 DDHIAQIIELL-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHH-CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             HHHHHHHHHhc-CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence             1111111111 110000                000000             012234556678899999999999999


Q ss_pred             CChHHHHHHhccCCCC
Q 018304          303 PSMPSVILMLGSETVL  318 (358)
Q Consensus       303 pt~~ell~~l~~~~~~  318 (358)
                      ||+.+++++.+.....
T Consensus       326 pt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          326 ADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             BCHHHHHTCGGGTTCT
T ss_pred             CCHHHHhhChhhhccc
Confidence            9999999988776543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.2e-41  Score=301.15  Aligned_cols=260  Identities=25%  Similarity=0.356  Sum_probs=195.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC--CC--EEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD--GQ--EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~--~~--~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~  109 (358)
                      ..++|++.+.||+|++|.||+|.+..  ++  .|++|.+...   .......+.+|+++++.++||||+++++++.+.. 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            34789999999999999999998532  33  6899988653   2345677889999999999999999999997765 


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+.+++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence            889999999999999986543  33899999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          190 AFGGDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       190 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......   ......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~---~~~~~~  243 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---DKEGER  243 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTSCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHH---HccCCC
Confidence            76432211 11223346678999999988888999999999999999999 99998643321   111111   111111


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ....     .    .....+.+++.+||..+|.+|||+.++++.|+....
T Consensus       244 ~~~~-----~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          244 LPRP-----E----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCCC-----T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCC-----c----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            1111     1    112357789999999999999999999999987654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.9e-40  Score=306.51  Aligned_cols=266  Identities=20%  Similarity=0.259  Sum_probs=204.6

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcC-CC-----CccceeeEEEeC
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR-----NLVKLLGCCIQG  107 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~iv~~~~~~~~~  107 (358)
                      ....++|++.+.||+|+||.||+|.+.. ++.|++|++.. .......+..|+.+++.++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            3446899999999999999999999754 78999999975 3444566778888888884 54     499999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc--CCCCCcccCCCCCCcEEEc--CCCCeEEe
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ--DSRLRIIHRDLKASNVLLD--QDMNPKIS  183 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~~~~i~H~di~~~Nilv~--~~~~i~L~  183 (358)
                      +..++||||+.+ +|.+++..... ..+++..++.++.|++.||.|||+  .+   |+||||||+||+++  .++.++|+
T Consensus       129 ~~~~lv~e~~~~-~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          129 NHLCLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             TEEEEEEECCCC-BHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred             CceEEEEecCCC-CHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999964 99999866432 338999999999999999999995  56   99999999999995  46789999


Q ss_pred             ccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          184 DFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       184 Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      |||++......     .....+++.|+|||++.+..++.++|||||||++|+|++|..||......   ..+........
T Consensus       204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---~~~~~i~~~~~  275 (382)
T 2vx3_A          204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV---DQMNKIVEVLG  275 (382)
T ss_dssp             CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHC
T ss_pred             eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhC
Confidence            99999875322     23456888999999999999999999999999999999999998754322   22222211110


Q ss_pred             cCCCCcc----------ccCC-----------------------------------------cCCCCCHHHHHHHHHHHh
Q 018304          264 EGMPSQL----------IDPC-----------------------------------------IQGSFNLAEVIRCIHIGL  292 (358)
Q Consensus       264 ~~~~~~~----------~~~~-----------------------------------------~~~~~~~~~~~~l~~li~  292 (358)
                      .. +...          ....                                         -.......+...+.+||.
T Consensus       276 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  354 (382)
T 2vx3_A          276 IP-PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL  354 (382)
T ss_dssp             SC-CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred             CC-CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence            00 0000          0000                                         000112234457889999


Q ss_pred             hhcCCCCCCCCChHHHHHHhccC
Q 018304          293 LCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       293 ~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      +||+.||++|||+.+++++-+..
T Consensus       355 ~mL~~dP~~Rpta~e~L~hp~f~  377 (382)
T 2vx3_A          355 RMLDYDPKTRIQPYYALQHSFFK  377 (382)
T ss_dssp             HHTCSCTTTSCCHHHHTTSGGGC
T ss_pred             HhcCCChhhCCCHHHHhcCcccc
Confidence            99999999999999999987754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.2e-40  Score=298.85  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=194.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEe---------
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ---------  106 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~---------  106 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|.+.. .......+.+|+.+++.++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3578999999999999999999975 589999999965 34556778899999999999999999998865         


Q ss_pred             ----CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          107 ----GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       107 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                          ....++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                356799999999999999996533  23788999999999999999999999   999999999999999999999


Q ss_pred             eccccceecCCCCC------------CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCC
Q 018304          183 SDFGLARAFGGDET------------EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSD  249 (358)
Q Consensus       183 ~Df~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~  249 (358)
                      +|||++........            ........+++.|+|||.+.+. .++.++||||||+++|+|++   ||....  
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--  232 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--  232 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence            99999876532110            1122344688999999998764 78999999999999999998   432110  


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         ... .......... ..+.     ..........+.++|.+||+.||.+|||+.+++++.+..
T Consensus       233 ---~~~-~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          233 ---ERV-NILKKLRSVS-IEFP-----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             ---HHH-HHHHHHHSTT-CCCC-----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             ---hHH-HHHHhccccc-cccC-----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence               111 1111111110 0111     111112223567899999999999999999999987664

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-40  Score=301.85  Aligned_cols=269  Identities=22%  Similarity=0.315  Sum_probs=200.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc--CCCEEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCccceeeEEE----
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCI----  105 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~--~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~----  105 (358)
                      ..++|++.+.||+|+||.||+|.+.  +++.|++|++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4589999999999999999999983  47889999886422  11123455677766666   8999999999987    


Q ss_pred             -eCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEec
Q 018304          106 -QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD  184 (358)
Q Consensus       106 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~D  184 (358)
                       .....++||||+. ++|.+++..... ..+++..++.++.|++.||.|||++|   ++|+||+|+||+++.++.++|+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999997 599999866443 23899999999999999999999999   99999999999999999999999


Q ss_pred             cccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          185 FGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       185 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      ||++.....   ........++..|+|||.+.+..++.++||||||+++|+|++|..||......   ............
T Consensus       164 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~  237 (326)
T 1blx_A          164 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL  237 (326)
T ss_dssp             CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred             CcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCC
Confidence            999876421   11223456889999999999889999999999999999999999998654322   222222221111


Q ss_pred             CCCCccccC------Cc-------CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          265 GMPSQLIDP------CI-------QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       265 ~~~~~~~~~------~~-------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .....+...      ..       ...........+.+||.+||..||++|||+.+++++-+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  302 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  302 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence            100000000      00       00000111235678999999999999999999998766543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-40  Score=306.04  Aligned_cols=271  Identities=21%  Similarity=0.274  Sum_probs=203.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----Ce
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~  109 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.|++|.+... .......+.+|+.+++.++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4589999999999999999999985 4889999999653 334456778999999999999999999987654     67


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .++||||+. ++|.+++..    ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999997 589998854    23999999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCCC--------ccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH
Q 018304          190 AFGGDETEG--------NTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       190 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  260 (358)
                      .........        ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......   .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHH
Confidence            764222111        1122467889999998754 678999999999999999999999986543221   1111111


Q ss_pred             HhhcCCCCccccC------------CcC-CCCC-----HHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          261 LWNEGMPSQLIDP------------CIQ-GSFN-----LAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       261 ~~~~~~~~~~~~~------------~~~-~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      .............            ... ....     ......+.++|.+||+.||++|||+.+++++.+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            1111000000000            000 0000     01123567899999999999999999999988776443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=326.61  Aligned_cols=255  Identities=26%  Similarity=0.401  Sum_probs=198.7

Q ss_pred             CCCCcce-eecccCCccEEEEEEc---CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINK-KLGQGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~-~lg~g~~g~v~~~~~~---~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +++.+.+ .||+|+||.||+|.+.   ++..|+||+++.. .......+.+|+++++.++||||+++++++.. +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444555 7999999999999864   3567999999763 23456788999999999999999999999976 568999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+.+++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++..+..
T Consensus       414 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            99999999999986532  34999999999999999999999999   99999999999999999999999999976532


Q ss_pred             CCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          194 DETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       194 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      .... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......   .....+.    ........
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~----~~~~~~~p  561 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QGKRMECP  561 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHH----TTCCCCCC
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cCCCCCCC
Confidence            2211 11112235678999999998999999999999999999998 99998654332   2222222    11111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .         .....+.++|.+||..+|++|||+.+|++.|+..
T Consensus       562 ~---------~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          562 P---------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             T---------TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             C---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1         1123577899999999999999999999998775

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.2e-39  Score=303.13  Aligned_cols=262  Identities=21%  Similarity=0.301  Sum_probs=200.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee---
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK---  110 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~---  110 (358)
                      ..++|.+.+.||+|+||.||+|.+.. |+.|++|.+...  .......+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            46899999999999999999999754 889999999752  344467788999999999999999999999877655   


Q ss_pred             ---EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          111 ---LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       111 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                         ++||||+. ++|.+++.     ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999997 58887762     22899999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      +.....     ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......   ........... ..
T Consensus       191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~-~~  261 (371)
T 4exu_A          191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTG-VP  261 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC-CC
T ss_pred             cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC-CC
Confidence            976422     2234467899999998877 68899999999999999999999998654321   11111111110 00


Q ss_pred             CCccccCC------------c-CCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          267 PSQLIDPC------------I-QGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       267 ~~~~~~~~------------~-~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ........            . ......     .....+.+||.+||+.||++|||+.+++++.+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  329 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  329 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence            00000000            0 000000     11246778999999999999999999999887653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.4e-41  Score=317.83  Aligned_cols=264  Identities=22%  Similarity=0.264  Sum_probs=195.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC------Cee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~------~~~  110 (358)
                      ..+|++.+.||+|+||.||+|.+.. ++.|+||.+.....    ...+|+++++.++|+||++++++|...      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            3479999999999999999999864 89999999865322    234799999999999999999988542      136


Q ss_pred             EEEEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-CCeEEeccccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLA  188 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-~~i~L~Df~~~  188 (358)
                      ++||||+.+ ++.+++... .....+++..++.++.||+.||.|||+++   |+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999976 666665432 22345999999999999999999999999   9999999999999965 56899999999


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc---
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE---  264 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  264 (358)
                      ..+....   ......+++.|+|||++.+. .++.++|||||||++|+|++|..||......   ..+.........   
T Consensus       205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTR  278 (420)
T ss_dssp             EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCH
T ss_pred             hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence            8753222   22345688999999988765 7899999999999999999999998654322   222222111100   


Q ss_pred             -------CCCCccccCCcCCC-----CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          265 -------GMPSQLIDPCIQGS-----FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       265 -------~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                             .....+.-+.....     +.......+.+||.+||+.||.+|||+.+++++.+..
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~  341 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  341 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence                   00000000000000     0011124677899999999999999999999877654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.4e-40  Score=305.43  Aligned_cols=265  Identities=18%  Similarity=0.271  Sum_probs=203.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-C-CEEEEEEecccChhhHHHHHHHHHHHHhcCCCC------ccceeeEEEeCC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-G-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGE  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~-~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~------iv~~~~~~~~~~  108 (358)
                      ..++|++.+.||+|+||.||+|.+.. + ..|++|++... ......+.+|+.+++.++|++      ++.+++++...+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            35899999999999999999999754 4 68999999753 344567788999999987654      899999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEE--------------
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLL--------------  174 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv--------------  174 (358)
                      ..++||||+ ++++.+++..... ..+++..++.++.||+.||.|||+++   |+|+||||+||++              
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            999999999 5577777654332 34899999999999999999999999   9999999999999              


Q ss_pred             -----cCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCC
Q 018304          175 -----DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSD  249 (358)
Q Consensus       175 -----~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~  249 (358)
                           +.++.++|+|||++.....     ......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 5678999999999986422     223456889999999999999999999999999999999999998754432


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCC-------------------------------cCCCCCHHHHHHHHHHHhhhcCCC
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPC-------------------------------IQGSFNLAEVIRCIHIGLLCVQQH  298 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~  298 (358)
                      .....+....    ...+.......                               ............+.+||.+||+.|
T Consensus       246 ~~~~~~~~~~----~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          246 EHLVMMEKIL----GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             HHHHHHHHHH----CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHc----CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            2111111111    11111000000                               000111233456789999999999


Q ss_pred             CCCCCChHHHHHHhccCC
Q 018304          299 PKDRPSMPSVILMLGSET  316 (358)
Q Consensus       299 P~~Rpt~~ell~~l~~~~  316 (358)
                      |++|||+.+++++-+...
T Consensus       322 P~~Rpt~~e~l~hp~f~~  339 (355)
T 2eu9_A          322 PAQRITLAEALLHPFFAG  339 (355)
T ss_dssp             TTTSCCHHHHTTSGGGGG
T ss_pred             hhhCcCHHHHhcChhhcC
Confidence            999999999998876653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=306.01  Aligned_cols=261  Identities=22%  Similarity=0.288  Sum_probs=198.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-----
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-----  109 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-----  109 (358)
                      .++|.+.+.||+|+||.||+|.+. +|+.|++|.+...  .......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            578999999999999999999975 4899999999652  34445678899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          110 -KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       110 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                       .++||||+. ++|.+++.     ..+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 48877762     12899999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC--
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG--  265 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--  265 (358)
                      .....     ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......   ..+..........  
T Consensus       174 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          174 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGT  245 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCH
T ss_pred             cCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence            75421     1223467899999998877 67899999999999999999999998654322   1111111110000  


Q ss_pred             ----------------CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          266 ----------------MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       266 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                                      .......... ..........+.++|.+||+.||++|||+.+++++-+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  311 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  311 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                            0000000000 0001112346778999999999999999999999877653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.6e-40  Score=324.69  Aligned_cols=248  Identities=29%  Similarity=0.391  Sum_probs=194.3

Q ss_pred             eeecccCCccEEEEEEc---CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLV---DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~---~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      +.||+|+||.||+|.+.   .++.|+||+++...  ......+.+|+++++.++||||+++++++.. +..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   36789999997532  3346788999999999999999999999864 568899999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC-C
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-G  198 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~-~  198 (358)
                      ++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++..+...... .
T Consensus       454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            9999999543   33899999999999999999999999   999999999999999999999999999875432211 1


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......   .......    ..........    
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~----~~~~~~~p~~----  596 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLE----KGERMGCPAG----  596 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----TTCCCCCCTT----
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCCCCCCCCC----
Confidence            1222345678999999999999999999999999999998 99998654322   1222222    1111111111    


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                           ....+.++|.+||+.||++|||+.+|++.|+..
T Consensus       597 -----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          597 -----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             -----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 124577899999999999999999999998753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=300.50  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=191.1

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh------hhHHHHHHHHHHHHhc----CCCCccc
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKL----QHRNLVK   99 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l----~~~~iv~   99 (358)
                      .++.....++|++.+.||+|+||.||+|.+. +++.|++|++.....      .....+.+|+.++..+    +|+||++
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            4556667899999999999999999999874 488999999965332      1223345789999888    8999999


Q ss_pred             eeeEEEeCCeeEEEEEe-cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc-CC
Q 018304          100 LLGCCIQGEEKLLIYEF-MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QD  177 (358)
Q Consensus       100 ~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~-~~  177 (358)
                      +++++.+.+..++|+|+ +.+++|.+++....   .+++..++.++.||+.||.|||+++   ++|+||+|+||+++ .+
T Consensus       103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          103 LLDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR  176 (312)
T ss_dssp             EEEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred             EEEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence            99999999999999999 78899999996533   3899999999999999999999999   99999999999999 88


Q ss_pred             CCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCC-CcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHH
Q 018304          178 MNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFS-VKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG  256 (358)
Q Consensus       178 ~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~  256 (358)
                      +.++|+|||++......    ......++..|+|||++.+..+. .++||||||+++|+|++|..||....         
T Consensus       177 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------  243 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------  243 (312)
T ss_dssp             TEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred             CeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------
Confidence            99999999999875322    22345588999999988776654 58999999999999999999975321         


Q ss_pred             HHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          257 HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ....   ..  ..+.     ..    ....+.++|.+||+.+|++|||+.+++++.+..
T Consensus       244 ~~~~---~~--~~~~-----~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          244 EILE---AE--LHFP-----AH----VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             HHHH---TC--CCCC-----TT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             HHhh---hc--cCCc-----cc----CCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            0000   00  0000     11    123567899999999999999999999987655

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.2e-40  Score=300.95  Aligned_cols=261  Identities=26%  Similarity=0.341  Sum_probs=180.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHH-HHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|.+.... ......+..|+. +++.++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            3489999999999999999999985 48899999997532 333444555555 66777999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcc--ccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          114 YEFMTNKSLDSFIFDQ--ERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      |||+.+ +|.+++...  .....+++..++.++.|++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++..
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999975 888877532  1234589999999999999999999998 9   99999999999999999999999999876


Q ss_pred             cCCCCCCCccccccccCCCCCcccc----cCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          191 FGGDETEGNTKRVIGTYGYMAPEYA----SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      ....   .......+++.|+|||++    .+..++.++||||||+++|+|++|..||........  .   ... .....
T Consensus       176 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~-~~~~~  246 (327)
T 3aln_A          176 LVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--Q---LTQ-VVKGD  246 (327)
T ss_dssp             ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSC
T ss_pred             cccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--H---HHH-HhcCC
Confidence            5322   122233688999999998    456789999999999999999999999865332100  0   000 00111


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...+..     .........+.+++.+||..||.+|||+.+++++.+..
T Consensus       247 ~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          247 PPQLSN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             CCCCCC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             CCCCCC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            111111     00011123577899999999999999999999865543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=303.47  Aligned_cols=265  Identities=27%  Similarity=0.406  Sum_probs=200.3

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE  108 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  108 (358)
                      .++.....++|++.+.||+|++|.||+|.+.+  .+++|.+....  ......+.+|+.+++.++|+||+++++++.+.+
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            44555556899999999999999999998743  48999886422  223345678999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++ ++.++|+|||++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             ceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence            9999999999999999986533  34899999999999999999999999   99999999999997 689999999997


Q ss_pred             eecCCCC---CCCccccccccCCCCCcccccC---------CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHH
Q 018304          189 RAFGGDE---TEGNTKRVIGTYGYMAPEYASD---------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG  256 (358)
Q Consensus       189 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~  256 (358)
                      .......   .........+++.|+|||.+.+         ..++.++||||||+++|+|++|..||......   ....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~  253 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIW  253 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence            6542111   1122223457889999998864         35788999999999999999999998643321   1111


Q ss_pred             HHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          257 HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      ..    .............        ...+.+++.+||..+|++|||+.++++.|+.+...
T Consensus       254 ~~----~~~~~~~~~~~~~--------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          254 QM----GTGMKPNLSQIGM--------GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HH----HTTCCCCCCCSSC--------CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             Hh----ccCCCCCCCcCCC--------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            11    1111111111101        12466899999999999999999999999998654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-40  Score=303.61  Aligned_cols=254  Identities=24%  Similarity=0.352  Sum_probs=200.9

Q ss_pred             HHHHHHhcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChh------hHHHHHHHHHHHHhcC--CCCcccee
Q 018304           31 LATIVSATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQ--HRNLVKLL  101 (358)
Q Consensus        31 ~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~--~~~iv~~~  101 (358)
                      .++.....++|++.+.||+|+||.||+|.+. +++.|++|.+......      ....+.+|+.+++.++  |+||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            4455667789999999999999999999875 4889999998653211      1234567999999996  59999999


Q ss_pred             eEEEeCCeeEEEEEecCC-CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc-CCCC
Q 018304          102 GCCIQGEEKLLIYEFMTN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMN  179 (358)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~-~~~~  179 (358)
                      +++.+.+..++|+|++.+ ++|.+++....   .+++..++.++.||+.||.|||+.+   ++|+||+|+||+++ +++.
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTE
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCC
Confidence            999999999999999976 89999986533   4899999999999999999999999   99999999999999 7899


Q ss_pred             eEEeccccceecCCCCCCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHH
Q 018304          180 PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA  258 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  258 (358)
                      ++|+|||++......    ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.....         .
T Consensus       189 ~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~  255 (320)
T 3a99_A          189 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------I  255 (320)
T ss_dssp             EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H
T ss_pred             EEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------h
Confidence            999999999875322    2234468899999998877665 6789999999999999999999754210         0


Q ss_pred             HHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          259 WKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                         ......  +     ....    ...+.++|.+||..||++|||+.+++++.+....
T Consensus       256 ---~~~~~~--~-----~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          256 ---IRGQVF--F-----RQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             ---HHCCCC--C-----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             ---hccccc--c-----cccC----CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence               011100  0     0111    2356789999999999999999999998766543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.8e-39  Score=308.01  Aligned_cols=258  Identities=23%  Similarity=0.279  Sum_probs=190.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .+.|.+.+.||+|+||+||.+...+|+.||||++...   ....+.+|+.+++.+ +||||+++++++.+.+..++||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            3566777899999999998776667999999998653   235667899999887 899999999999999999999999


Q ss_pred             cCCCCHHHHHhcccccc----CCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC-------------CC
Q 018304          117 MTNKSLDSFIFDQERCK----ILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD-------------MN  179 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~-------------~~  179 (358)
                      +. ++|.+++.......    ...+..++.++.||+.||.|||+++   |+||||||+||+++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 59999996543211    1133456789999999999999999   9999999999999754             47


Q ss_pred             eEEeccccceecCCCCCCC--ccccccccCCCCCcccccC-------CCCCCcccchhHhHHHHHHHh-CCCCCCCCCCC
Q 018304          180 PKISDFGLARAFGGDETEG--NTKRVIGTYGYMAPEYASD-------GQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD  249 (358)
Q Consensus       180 i~L~Df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~  249 (358)
                      ++|+|||++..........  ......|++.|+|||++.+       ..++.++|||||||++|+|++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998764332211  1234568999999999865       578999999999999999999 99998543221


Q ss_pred             CCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          250 NNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                          . .....   ......    .............+.++|.+||+.||.+|||+.+++++.+.
T Consensus       247 ----~-~~i~~---~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          247 ----E-SNIIR---GIFSLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             ----H-HHHHH---TCCCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             ----H-HHHhc---CCCCcc----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence                1 11111   111000    01111233445678899999999999999999999987654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=296.09  Aligned_cols=255  Identities=22%  Similarity=0.345  Sum_probs=181.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      -++|++.+.||+|+||.||+|.+. +++.|++|.+....  ......+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            478999999999999999999985 58999999996532  222333445556777889999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      ||+ ++.+..+....  ...+++..++.++.|++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++.....
T Consensus       104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 55666555432  23489999999999999999999995 8   99999999999999999999999999876532


Q ss_pred             CCCCCccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      .   .......+++.|+|||++.     +..++.++||||||+++|+|++|..||.....  ..........   . ...
T Consensus       178 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~---~-~~~  248 (318)
T 2dyl_A          178 D---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQ---E-EPP  248 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHH---S-CCC
T ss_pred             C---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhc---c-CCC
Confidence            2   1223446889999999984     45788999999999999999999999864322  1122222211   1 111


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      .+...   ..    ....+.++|.+||..||.+|||+.+++++.+.
T Consensus       249 ~~~~~---~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (318)
T 2dyl_A          249 LLPGH---MG----FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI  287 (318)
T ss_dssp             CCCSS---SC----CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred             CCCcc---CC----CCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence            11110   00    12356789999999999999999999986543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-39  Score=322.46  Aligned_cols=260  Identities=23%  Similarity=0.345  Sum_probs=202.6

Q ss_pred             HHHHhcCCCCcceeecccCCccEEEEEEcC----CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 018304           33 TIVSATNNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG  107 (358)
Q Consensus        33 ~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~  107 (358)
                      +.....++|++.+.||+|+||.||+|.+..    +..|++|.+... .......+.+|+.+++.++||||+++++++. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            334455789999999999999999998743    457999988653 3445577889999999999999999999984 4


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                      +..++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||+
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence            67899999999999999996533  23899999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      +........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   ........    ..
T Consensus       538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~~----~~  609 (656)
T 2j0j_A          538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIEN----GE  609 (656)
T ss_dssp             CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHH----TC
T ss_pred             CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHc----CC
Confidence            986532221 11223345678999999988899999999999999999997 99997643321   22222221    11


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ......     .    ....+.++|.+||..||++|||+.+|++.|+.+
T Consensus       610 ~~~~~~-----~----~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          610 RLPMPP-----N----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             CCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCc-----c----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111111     1    123567899999999999999999999998764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.9e-39  Score=317.96  Aligned_cols=266  Identities=22%  Similarity=0.299  Sum_probs=198.0

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe------CCee
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GEEK  110 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~------~~~~  110 (358)
                      ++|++.+.||+|+||.||+|.+. +|+.|++|++... .......+.+|+++++.++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            79999999999999999999874 4899999998653 44556778899999999999999999998765      6678


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCC---eEEecccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGL  187 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~---i~L~Df~~  187 (358)
                      ++||||+++++|.+++........+++..++.++.+++.||.|||+.|   ++|+||+|+||+++.++.   ++|+|||.
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999977655556999999999999999999999999   999999999999997765   89999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCch--hHHHH-HHHhhc
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLN--LIGHA-WKLWNE  264 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~--~~~~~-~~~~~~  264 (358)
                      +......   .......+++.|+|||.+.+..++.++||||||+++|+|++|..||..........  ..... ......
T Consensus       171 a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          171 AKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             ccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            9875322   22234568999999999999999999999999999999999999986431110000  00000 000000


Q ss_pred             CCCC---ccccC-CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHH
Q 018304          265 GMPS---QLIDP-CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL  310 (358)
Q Consensus       265 ~~~~---~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  310 (358)
                      ....   .+... .............+.++|.+||..||++|||+.++++
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~  297 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN  297 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence            0000   00000 0011222334567788999999999999999987543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-39  Score=304.04  Aligned_cols=255  Identities=22%  Similarity=0.288  Sum_probs=189.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ...+|++.+.||+|+||.||.....+++.||||++.....   ..+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            3457999999999999997665566899999999865322   2345799999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-----CCCeEEecccccee
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLARA  190 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-----~~~i~L~Df~~~~~  190 (358)
                      |+. ++|.+++.....  ...+..++.++.||+.||.|||+++   |+||||||+||+++.     ...++|+|||++..
T Consensus        99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            996 599999865432  2455567799999999999999999   999999999999953     23588999999987


Q ss_pred             cCCCCC-CCccccccccCCCCCccccc---CCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          191 FGGDET-EGNTKRVIGTYGYMAPEYAS---DGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       191 ~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      ...... ........|++.|+|||++.   ...++.++|||||||++|+|++ |..||......    ....    ....
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~~----~~~~  244 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QANI----LLGA  244 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHHH----HTTC
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHHH----Hhcc
Confidence            532211 12233456899999999987   3567889999999999999999 89887532211    1111    1111


Q ss_pred             CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          266 MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      .......      ........+.+||.+||+.||.+|||+.+++++.+.
T Consensus       245 ~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f  287 (432)
T 3p23_A          245 CSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF  287 (432)
T ss_dssp             CCCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred             CCccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence            1111110      011233446789999999999999999999987654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-38  Score=287.20  Aligned_cols=235  Identities=19%  Similarity=0.236  Sum_probs=181.9

Q ss_pred             cCCCCcc-eeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHH-HhcCCCCccceeeEEEe----CCee
Q 018304           38 TNNFSIN-KKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEEK  110 (358)
Q Consensus        38 ~~~y~i~-~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l-~~l~~~~iv~~~~~~~~----~~~~  110 (358)
                      .++|.+. +.||+|+||.||++.+. +++.|++|++...     ....+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3678887 78999999999999974 4889999999642     3456788887 55589999999999987    6688


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CCCeEEecccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL  187 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~~i~L~Df~~  187 (358)
                      ++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.   ++.++|+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            999999999999999976433 34999999999999999999999999   999999999999997   78899999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      +....                        +..++.++|||||||++|+|++|..||.........           ....
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~  211 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK  211 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHH
Confidence            87531                        234678999999999999999999998653322100           0000


Q ss_pred             CccccCCcCCCCCH----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          268 SQLIDPCIQGSFNL----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       268 ~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                      ..+....  .....    .....+.++|.+||+.||.+|||+.+++++.+.....
T Consensus       212 ~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          212 TRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             CSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            0000000  00111    1124577899999999999999999999987665443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.8e-38  Score=281.50  Aligned_cols=233  Identities=12%  Similarity=0.070  Sum_probs=183.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      ..++|++.+.||+|+||.||+|.+.. ++.|++|++....   ......+.+|+..+..++||||+++++++.+.+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            45789999999999999999999865 8999999997532   3445778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++++|.+++..    + .....+..++.|++.||.|||++|   |+|+||||+||+++.+|.++|++++      
T Consensus       109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999999843    1 455678899999999999999999   9999999999999999999997433      


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                                      |++       .++.++|||||||++|+|++|..||..............   ..... ... ..
T Consensus       175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~---~~~~~-~~~-~~  226 (286)
T 3uqc_A          175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER---DTAGQ-PIE-PA  226 (286)
T ss_dssp             ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB---CTTSC-BCC-HH
T ss_pred             ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH---HhccC-CCC-hh
Confidence                            333       368899999999999999999999876544321110000   00000 000 00


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                       ..    .......+.++|.+||+.||++| |+.++++.|.....
T Consensus       227 -~~----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          227 -DI----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             -HH----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             -hc----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence             00    00112356789999999999999 99999999988643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-37  Score=311.72  Aligned_cols=237  Identities=18%  Similarity=0.303  Sum_probs=189.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc--CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe----
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV--DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----  109 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~--~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~----  109 (358)
                      ..++|++.+.||+|+||.||++.+.  +++.|++|.+... .......+..|+.++..++||||+++++++.+.+.    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3489999999999999999999985  5889999998653 34455678899999999999999999999988765    


Q ss_pred             -eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          110 -KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       110 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                       .++||||+++++|.+++..     .+++..++.++.||+.||.|||+++   |+||||||+||+++.+ .+||+|||++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence             6999999999999987633     3999999999999999999999999   9999999999999875 9999999999


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ......      ....|++.|+|||++.+.. +.++||||||+++|+|++|..||.......               .. 
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------~~-  285 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------LP-  285 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------CC-
T ss_pred             hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------cc-
Confidence            875322      3456899999999887654 889999999999999999988864321110               00 


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHH-HHHHh
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPS-VILML  312 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e-ll~~l  312 (358)
                             ...........+.++|.+||+.||++||+..+ +.+.+
T Consensus       286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL  323 (681)
T ss_dssp             -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence                   00111122346778999999999999996544 44444

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-37  Score=293.14  Aligned_cols=242  Identities=17%  Similarity=0.176  Sum_probs=177.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCC-CCc---------ccee---
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQH-RNL---------VKLL---  101 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~-~~i---------v~~~---  101 (358)
                      .+|...+.||+|+||.||+|.+. +|+.||||++....   ....+.+.+|+.+++.+.| .|.         +...   
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34778899999999999999975 48999999987322   2335778899999999876 221         1111   


Q ss_pred             ---------eEEEe-----CCeeEEEEEecCCCCHHHHHhcc----ccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 018304          102 ---------GCCIQ-----GEEKLLIYEFMTNKSLDSFIFDQ----ERCKILDWSKRFHIICGTARGVMYLHQDSRLRII  163 (358)
Q Consensus       102 ---------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~  163 (358)
                               .++..     ....+++|+++ +++|.+++...    .....+++..++.++.||+.||.|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                     11111     12456777766 56999888422    12234778899999999999999999999   99


Q ss_pred             cCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccc----------cCCCCCCcccchhHhHHH
Q 018304          164 HRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA----------SDGQFSVKSDVFSFGILL  233 (358)
Q Consensus       164 H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~il  233 (358)
                      ||||||+|||++.++.+||+|||++......     .....| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998764221     334456 999999998          555688899999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHH
Q 018304          234 LEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM  311 (358)
Q Consensus       234 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~  311 (358)
                      |+|++|..||...........               ......  ..    ...+.+||.+||+.||++|||+.+++++
T Consensus       308 ~elltg~~Pf~~~~~~~~~~~---------------~~~~~~--~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSEW---------------IFRSCK--NI----PQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSGG---------------GGSSCC--CC----CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHCCCCCCCcchhhhHHH---------------HHhhcc--cC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999999999865433221111               111000  11    1457789999999999999998777654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.3e-37  Score=282.95  Aligned_cols=247  Identities=15%  Similarity=0.099  Sum_probs=183.9

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcC---------CCCccc
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---------HRNLVK   99 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~---------~~~iv~   99 (358)
                      ..++|++.+.||+|+||.||+|.+ +|+.||+|++....        ......+.+|+.+++.++         |+||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            347899999999999999999998 78999999997532        233467888999998886         666666


Q ss_pred             eeeE-----------------EEe-------------CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHH
Q 018304          100 LLGC-----------------CIQ-------------GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR  149 (358)
Q Consensus       100 ~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~  149 (358)
                      +.++                 |.+             .+..++||||+++|++.+.+.+    +.+++..++.++.||+.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence            5554                 333             6789999999999876666533    33899999999999999


Q ss_pred             HHHHHh-cCCCCCcccCCCCCCcEEEcCCC--------------------CeEEeccccceecCCCCCCCccccccccCC
Q 018304          150 GVMYLH-QDSRLRIIHRDLKASNVLLDQDM--------------------NPKISDFGLARAFGGDETEGNTKRVIGTYG  208 (358)
Q Consensus       150 al~~LH-~~~~~~i~H~di~~~Nilv~~~~--------------------~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~  208 (358)
                      ||.||| +++   |+||||||+|||++.++                    .+||+|||++.....       ....|++.
T Consensus       173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCC
T ss_pred             HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeec
Confidence            999999 899   99999999999999887                    899999999987532       13468999


Q ss_pred             CCCcccccCCCCCCcccchhHhHH-HHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHH
Q 018304          209 YMAPEYASDGQFSVKSDVFSFGIL-LLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRC  287 (358)
Q Consensus       209 y~aPE~~~~~~~~~~~DiwslG~i-l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  287 (358)
                      |+|||++.+.. +.++||||+|++ .++++.|..||...      ................   ...............+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTF---KTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCC---SSCCCSHHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhcc---CcccchhhhhhcCHHH
Confidence            99999998766 889999998777 77788888885310      0000011111100000   0000111122345678


Q ss_pred             HHHHhhhcCCCCCCCCChHHHH-HHhc
Q 018304          288 IHIGLLCVQQHPKDRPSMPSVI-LMLG  313 (358)
Q Consensus       288 ~~li~~cl~~~P~~Rpt~~ell-~~l~  313 (358)
                      .+||.+||+.|     |+.+++ ++-+
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~Hp~  334 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQHSL  334 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred             HHHHHHHhccC-----CHHHHHhcCCC
Confidence            89999999976     999999 7755

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=4e-30  Score=250.81  Aligned_cols=184  Identities=16%  Similarity=0.150  Sum_probs=127.6

Q ss_pred             ecccCCccEEEEEE-cCCCEEEEEEeccc----------ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 018304           47 LGQGGFGPVYKGTL-VDGQEIAVKRLSKI----------SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        47 lg~g~~g~v~~~~~-~~~~~v~vK~~~~~----------~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .+.|+.|....+.. .-|+.|++|.+.+.          .......+.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            34444444443332 23788999998642          123345688999999999 7999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||++|++|.+++....   +++..   +++.||+.||.|+|++|   |+||||||+|||++.+|++||+|||+++.....
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999996543   36654   47899999999999999   999999999999999999999999999865322


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKN  242 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  242 (358)
                        .......+||+.|+|||++.+ .+..++|+|++|++++.+.++..+
T Consensus       393 --~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 --CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             --CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence              223445679999999999875 467789999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.4e-26  Score=224.52  Aligned_cols=187  Identities=18%  Similarity=0.203  Sum_probs=143.0

Q ss_pred             CCCcceeecccCCccEEEEEEcCCCEEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      .+...+.||+|+||.||++.. .+..+++|......        ....+.+.+|++++++++||||+++..++...+..+
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             -----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred             cCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence            334567999999999999954 67888888764311        112345789999999999999996666666778889


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||+++++|.+++..           +..++.|++.||.|||+++   |+||||||+||+++.  .+||+|||++...
T Consensus       416 lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            99999999999999844           5689999999999999999   999999999999998  9999999999876


Q ss_pred             CCCCCCC-----ccccccccCCCCCcccccC--CCCCCcccchhHhHHHHHHHhCCCCC
Q 018304          192 GGDETEG-----NTKRVIGTYGYMAPEYASD--GQFSVKSDVFSFGILLLEIISGKKNR  243 (358)
Q Consensus       192 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~  243 (358)
                      .......     ......||+.|+|||++..  ..|+..+|+|+..+-..+-..++.+|
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            3221111     1235578999999999876  56788899999988888888777664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.9e-23  Score=186.37  Aligned_cols=154  Identities=20%  Similarity=0.162  Sum_probs=123.2

Q ss_pred             eHHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccCh------------------hhHHHHHHHHHHHHh
Q 018304           30 ELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISE------------------QGLKELKNEVILFSK   91 (358)
Q Consensus        30 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~------------------~~~~~~~~e~~~l~~   91 (358)
                      .+.+....+..|.+.+.||+|++|.||+|.+.+|+.|++|.+.....                  .....+.+|+.+++.
T Consensus        81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            34556666777888899999999999999996699999999964221                  134567899999999


Q ss_pred             cCCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCc
Q 018304           92 LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASN  171 (358)
Q Consensus        92 l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~N  171 (358)
                      ++  | +++.+++.. +..++||||+++++|.+ +.       .  .....++.|++.||.+||+.|   ++||||||+|
T Consensus       161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N  223 (282)
T 1zar_A          161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN  223 (282)
T ss_dssp             TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred             cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence            98  4 666665544 56699999999999988 41       1  224479999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCccccc
Q 018304          172 VLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS  216 (358)
Q Consensus       172 ilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  216 (358)
                      |+++ ++.++|+|||++...               ..+.|||.+.
T Consensus       224 ILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVEV---------------GEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence            9999 999999999998753               3467888763

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=2.4e-19  Score=157.75  Aligned_cols=148  Identities=16%  Similarity=0.166  Sum_probs=113.5

Q ss_pred             eeHHHHHHhcCCCCcceeecccCCccEEEEEE-cCCCE--EEEEEecccChh------------------------hHHH
Q 018304           29 FELATIVSATNNFSINKKLGQGGFGPVYKGTL-VDGQE--IAVKRLSKISEQ------------------------GLKE   81 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~-~~~~~--v~vK~~~~~~~~------------------------~~~~   81 (358)
                      +.+......+.-|++.+.||+|++|.||+|.+ .+|+.  ||+|++......                        ....
T Consensus        37 ~~l~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  116 (258)
T 1zth_A           37 KTLYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIW  116 (258)
T ss_dssp             HHHHHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHH
T ss_pred             HHHHHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHH
Confidence            33445555556688999999999999999998 67888  999987542111                        1235


Q ss_pred             HHHHHHHHHhcCCCCc--cceeeEEEeCCeeEEEEEecCC-C----CHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH
Q 018304           82 LKNEVILFSKLQHRNL--VKLLGCCIQGEEKLLIYEFMTN-K----SLDSFIFDQERCKILDWSKRFHIICGTARGVMYL  154 (358)
Q Consensus        82 ~~~e~~~l~~l~~~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~L  154 (358)
                      +.+|+..+..+.|+++  +.+++.    +..++||||+.+ |    +|.++...      .++..+..++.|++.+|.+|
T Consensus       117 ~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~l  186 (258)
T 1zth_A          117 TEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRL  186 (258)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHH
Confidence            7789999999987754  444432    367899999942 3    67666422      23456788999999999999


Q ss_pred             h-cCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          155 H-QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       155 H-~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      | +.|   ++||||+|.|||++.  .++|+|||++...
T Consensus       187 H~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          187 YQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9 999   999999999999988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=8.2e-17  Score=147.74  Aligned_cols=146  Identities=12%  Similarity=0.186  Sum_probs=107.7

Q ss_pred             eHHHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccC-----------------h-h----hHHHHHHHHH
Q 018304           30 ELATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS-----------------E-Q----GLKELKNEVI   87 (358)
Q Consensus        30 ~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~-----------------~-~----~~~~~~~e~~   87 (358)
                      ++.....-+.=|++.+.||.|++|.||+|.+.+|+.||||+++...                 . .    ..-....|..
T Consensus        86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            4566666666799999999999999999999889999999874210                 0 0    0111235677


Q ss_pred             HHHhcCCCCcc--ceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccC
Q 018304           88 LFSKLQHRNLV--KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHR  165 (358)
Q Consensus        88 ~l~~l~~~~iv--~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~  165 (358)
                      .|.++.+.++.  ..++.    ...++||||++|++|.++.         .......++.|++.+|.+||+.|   |+||
T Consensus       166 nL~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHr  229 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHG  229 (397)
T ss_dssp             HHHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred             HHHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCC
Confidence            77777544432  23322    2347999999998876543         11234568899999999999999   9999


Q ss_pred             CCCCCcEEEcCCCC----------eEEeccccceec
Q 018304          166 DLKASNVLLDQDMN----------PKISDFGLARAF  191 (358)
Q Consensus       166 di~~~Nilv~~~~~----------i~L~Df~~~~~~  191 (358)
                      ||||.|||++.+|.          +.++||+.+...
T Consensus       230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99999999987763          899999988654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=8.6e-13  Score=115.92  Aligned_cols=144  Identities=16%  Similarity=0.069  Sum_probs=112.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      -..|++...++.|+.+.||++.. ++..+++|............+..|+..++.+. +..++++++++.+.+..++|||+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            36799999999999999999975 47899999986422122345788999999984 67788999999988899999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS--------------------------------------  158 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--------------------------------------  158 (358)
                      ++|.+|.+.+.        +......++.++++++..||+..                                      
T Consensus        92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999887631        12223467888999999999811                                      


Q ss_pred             ------------------CCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          159 ------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       159 ------------------~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                                        ...++|+|+++.||++++++.+.|.||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                              02389999999999997655566999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=1.1e-10  Score=101.93  Aligned_cols=138  Identities=16%  Similarity=0.118  Sum_probs=99.6

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--ccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ..|.+....+.|..+.||++...+|..+++|.....   ....+..|+..++.+.+.+  +++++.+...++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            456655444566679999997766788999987653   2245678999998885433  56788888887788999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS--------------------------------------  158 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--------------------------------------  158 (358)
                      ++|.++.  ..   .   .+   ...++.+++..+..||+..                                      
T Consensus        97 i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9998874  21   1   11   1245666777777777643                                      


Q ss_pred             -----------------CCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          159 -----------------RLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       159 -----------------~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                                       ...++|+|++|.||++++++.+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             11299999999999998765566999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.11  E-value=4.9e-10  Score=102.93  Aligned_cols=145  Identities=17%  Similarity=0.208  Sum_probs=107.0

Q ss_pred             CCCcceeecccCCccEEEEEEcCCCEEEEEEec--ccC-hhhHHHHHHHHHHHHhcC--CCCccceeeEEEeC---CeeE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLS--KIS-EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQG---EEKL  111 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~--~~~-~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~---~~~~  111 (358)
                      ...-++.|+.|.++.||++.. ++..+++|+..  ... ......+..|+.+++.+.  +..+++++.++.+.   +..+
T Consensus        39 ~~~~~~~l~~G~sn~~y~v~~-~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           39 GPLSVEQFKGGQSNPTFKLVT-PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             CCCEEEECCC-CCSCEEEEEC-SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             CCceEEEcCCcccceEEEEEE-CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            344567899999999999876 45788888775  211 122356778999999996  34578888888766   3479


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS---------------------------------  158 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---------------------------------  158 (358)
                      +||||++|..+.+..     ...++......++.+++.+|..||+..                                 
T Consensus       118 ~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            999999997774421     122677888889999999999999731                                 


Q ss_pred             ----------------------CCCcccCCCCCCcEEEcCCCC--eEEecccccee
Q 018304          159 ----------------------RLRIIHRDLKASNVLLDQDMN--PKISDFGLARA  190 (358)
Q Consensus       159 ----------------------~~~i~H~di~~~Nilv~~~~~--i~L~Df~~~~~  190 (358)
                                            ...++|||+++.||+++.++.  +.|.||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  135999999999999997753  68999998865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.84  E-value=4.4e-09  Score=94.26  Aligned_cols=182  Identities=19%  Similarity=0.205  Sum_probs=118.4

Q ss_pred             ceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCC--ccceeeEEEeCC---eeEEEEEec
Q 018304           44 NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRN--LVKLLGCCIQGE---EKLLIYEFM  117 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~--iv~~~~~~~~~~---~~~lv~e~~  117 (358)
                      ++.++.|....||++.    ..+++|....  ......+..|+..++.+ .+..  +++++......+   ..++||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    5688897653  24456788999999888 4433  445554433333   347899999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS---------------------------------------  158 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---------------------------------------  158 (358)
                      +|.++.+...     ..++......++.+++..+..||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988765321     12666777777888888888887621                                       


Q ss_pred             ----------------CCCcccCCCCCCcEEEcC--CCCeEEeccccceecCCCCCCCccccccccCCC---CCcccccC
Q 018304          159 ----------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGDETEGNTKRVIGTYGY---MAPEYASD  217 (358)
Q Consensus       159 ----------------~~~i~H~di~~~Nilv~~--~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y---~aPE~~~~  217 (358)
                                      ...++|+|+++.||+++.  .+.+.+.||+.+..-...   .   ........   ..|+....
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~---Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---N---DFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---H---HHHTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---H---HHHHHHhhccccCHHHHHH
Confidence                            124899999999999997  455789999988653110   0   00000111   22222110


Q ss_pred             -----CCC---------CCcccchhHhHHHHHHHhCCCC
Q 018304          218 -----GQF---------SVKSDVFSFGILLLEIISGKKN  242 (358)
Q Consensus       218 -----~~~---------~~~~DiwslG~il~~l~~g~~p  242 (358)
                           +..         ..-.+.|++|.++|.+.+|..+
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence                 000         1125889999999999999866

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=9.3e-07  Score=77.44  Aligned_cols=135  Identities=15%  Similarity=0.109  Sum_probs=98.6

Q ss_pred             eecccCCc-cEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           46 KLGQGGFG-PVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        46 ~lg~g~~g-~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      .+..|..+ .||+..... +..+++|+-..   .....+..|+..|+.+. +-.+.+++.++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            44556655 589887644 67899997643   34566788999999884 44578889999999999999999999888


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCC-------------------------------------------
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR-------------------------------------------  159 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~-------------------------------------------  159 (358)
                      .+.....       ......++.+++..|..||....                                           
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            7765221       12233566677777777776420                                           


Q ss_pred             ------------CCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          160 ------------LRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       160 ------------~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                                  ..++|+|+++.||+++.++.+-|.||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        1279999999999998776677999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.46  E-value=2.8e-06  Score=75.99  Aligned_cols=136  Identities=20%  Similarity=0.153  Sum_probs=91.4

Q ss_pred             ceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC---CccceeeEEE-eCCeeEEEEEecCC
Q 018304           44 NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCI-QGEEKLLIYEFMTN  119 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~---~iv~~~~~~~-~~~~~~lv~e~~~~  119 (358)
                      ++.++.|....||+.    +..+++|+-..  ......+..|+.+|+.+.+.   .+.+++.+.. ..+..+++|++++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            467888888899987    57788887532  34456788999999999642   3667776664 34467899999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS-----------------------------------------  158 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-----------------------------------------  158 (358)
                      .++.+...  .   .++......++.++...|..||+..                                         
T Consensus        98 ~~l~~~~~--~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM--A---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH--T---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh--h---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            88765321  0   1233333344444444444444321                                         


Q ss_pred             ----------------CCCcccCCCCCCcEEEcC---CCCe-EEecccccee
Q 018304          159 ----------------RLRIIHRDLKASNVLLDQ---DMNP-KISDFGLARA  190 (358)
Q Consensus       159 ----------------~~~i~H~di~~~Nilv~~---~~~i-~L~Df~~~~~  190 (358)
                                      ...++|+|+++.||+++.   ++.+ .|.||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            123799999999999987   4665 7999998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.22  E-value=2.6e-06  Score=77.79  Aligned_cols=81  Identities=6%  Similarity=0.003  Sum_probs=55.2

Q ss_pred             cceee-cccCCccEEEEEEc-------CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcC-C--CCccceeeEEEeC-
Q 018304           43 INKKL-GQGGFGPVYKGTLV-------DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQ-H--RNLVKLLGCCIQG-  107 (358)
Q Consensus        43 i~~~l-g~g~~g~v~~~~~~-------~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~-~--~~iv~~~~~~~~~-  107 (358)
                      ..+.| +.|....+|+....       ++..+++|......   ......+..|+..++.+. +  -.+.+++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            34677 88888999988753       26788998765422   001245677888888884 3  3577788776554 


Q ss_pred             --CeeEEEEEecCCCCHH
Q 018304          108 --EEKLLIYEFMTNKSLD  123 (358)
Q Consensus       108 --~~~~lv~e~~~~~~L~  123 (358)
                        ...++|||+++|..+.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3568999999886654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.16  E-value=2.3e-05  Score=70.77  Aligned_cols=141  Identities=16%  Similarity=0.183  Sum_probs=77.8

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC--CCCccceee------EEEeCCeeEEEEEe
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--HRNLVKLLG------CCIQGEEKLLIYEF  116 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~------~~~~~~~~~lv~e~  116 (358)
                      +.|+.|..+.||++...+ ..+++|+.... .   ..+..|+..++.+.  .-.+++++.      +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETT-EEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCC-CCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            456667788999987744 45899988752 2   23334555555553  113344443      22346678999999


Q ss_pred             cCCCCHH-----------HHH---hcc-cccc-C---------CCHHH-------------------------------H
Q 018304          117 MTNKSLD-----------SFI---FDQ-ERCK-I---------LDWSK-------------------------------R  140 (358)
Q Consensus       117 ~~~~~L~-----------~~l---~~~-~~~~-~---------~~~~~-------------------------------~  140 (358)
                      ++|..+.           ..+   +.. .... +         ..+..                               +
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9985442           111   111 0000 0         01110                               0


Q ss_pred             HHHHHHHHHHHHHHhc--------C--CCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          141 FHIICGTARGVMYLHQ--------D--SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       141 ~~~~~~i~~al~~LH~--------~--~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ..+...+..++.+|+.        .  ....++|||+++.||+++.++.+.|.||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1111123345556652        0  123499999999999998888999999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.08  E-value=1.5e-05  Score=73.89  Aligned_cols=76  Identities=11%  Similarity=0.159  Sum_probs=50.0

Q ss_pred             cceeecccCCccEEEEEEc-CCCEEEEEEecccCh-------hhHHHHHHHHHHHHhcC-C-C-CccceeeEEEeCCeeE
Q 018304           43 INKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQ-H-R-NLVKLLGCCIQGEEKL  111 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~-------~~~~~~~~e~~~l~~l~-~-~-~iv~~~~~~~~~~~~~  111 (358)
                      -.+.||.|..+.||++... +++.+++|.......       .....+..|++.++.+. . + .+++++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3568999999999999754 468899997643211       12345567888888873 2 3 34456543  455678


Q ss_pred             EEEEecCCC
Q 018304          112 LIYEFMTNK  120 (358)
Q Consensus       112 lv~e~~~~~  120 (358)
                      +|||++.+.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.85  E-value=0.00015  Score=63.90  Aligned_cols=81  Identities=16%  Similarity=0.199  Sum_probs=59.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCC---CCccceeeEEEeCCeeEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~---~~iv~~~~~~~~~~~~~lv  113 (358)
                      .+.+..-++.+|.|..+.||+....+|+.|++|+-..........+..|+..|+.+..   -.+++++.+.    ..++|
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            3456777889999999999999988899999998765433334567789999998842   2355555542    34789


Q ss_pred             EEecCCCC
Q 018304          114 YEFMTNKS  121 (358)
Q Consensus       114 ~e~~~~~~  121 (358)
                      ||+++++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.85  E-value=0.00023  Score=63.58  Aligned_cols=77  Identities=16%  Similarity=0.107  Sum_probs=60.9

Q ss_pred             CcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEEEEEecC
Q 018304           42 SINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMT  118 (358)
Q Consensus        42 ~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---~~~iv~~~~~~~~~~~~~lv~e~~~  118 (358)
                      .-.+.|+.|....+|+... ++..+++|+....   ....+..|+..|+.+.   ...+++++.+....+..++|||+++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3356789999999999876 6778999987542   3567788999998883   3568889988887888999999999


Q ss_pred             CCCH
Q 018304          119 NKSL  122 (358)
Q Consensus       119 ~~~L  122 (358)
                      +..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.70  E-value=0.00023  Score=66.39  Aligned_cols=74  Identities=11%  Similarity=0.133  Sum_probs=45.5

Q ss_pred             cceeecccCCccEEEEEEcCCCEEEEEEeccc----Chh-----hHHHHHHHHHHHHh-cCCCCccceeeEEEeCCeeEE
Q 018304           43 INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKI----SEQ-----GLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~----~~~-----~~~~~~~e~~~l~~-l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      -++.||.|..+.||++.. ++..+++|.....    ...     ....+..|+..+.. .....+++++.+.  ....++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            457889999999999964 5778999943210    111     22233333333222 1234566777665  567899


Q ss_pred             EEEec-CC
Q 018304          113 IYEFM-TN  119 (358)
Q Consensus       113 v~e~~-~~  119 (358)
                      |||++ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.46  E-value=0.00043  Score=63.47  Aligned_cols=142  Identities=15%  Similarity=0.185  Sum_probs=82.6

Q ss_pred             ceeecccCCccEEEEEEc--------CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEE
Q 018304           44 NKKLGQGGFGPVYKGTLV--------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~--------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++.|..|....+|++...        +++.+++|+... .........+|+.+++.+. +.--.++++.+.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            467888989999998763        247899998633 2223455668999998884 3333567766543    3999


Q ss_pred             EecCCCCHHHH--------------Hhc---c--ccccCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 018304          115 EFMTNKSLDSF--------------IFD---Q--ERCKILD--WSKRFHIICGTAR-------------------GVMY-  153 (358)
Q Consensus       115 e~~~~~~L~~~--------------l~~---~--~~~~~~~--~~~~~~~~~~i~~-------------------al~~-  153 (358)
                      ||++|.++..-              +.+   .  ...+...  ...+.+|+.++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99987554311              110   0  0011122  2445555544322                   1222 


Q ss_pred             ---HhcCC-CCCcccCCCCCCcEEEcCC----CCeEEecccccee
Q 018304          154 ---LHQDS-RLRIIHRDLKASNVLLDQD----MNPKISDFGLARA  190 (358)
Q Consensus       154 ---LH~~~-~~~i~H~di~~~Nilv~~~----~~i~L~Df~~~~~  190 (358)
                         |...+ ...++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               22221 2359999999999999876    7899999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.46  E-value=0.00058  Score=60.53  Aligned_cols=72  Identities=10%  Similarity=0.131  Sum_probs=46.0

Q ss_pred             cceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEEec-CCC
Q 018304           43 INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFM-TNK  120 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~lv~e~~-~~~  120 (358)
                      -++.|+.|....+|++     ..+++|+........ -....|+..++.+...++ .+++.+  +.+.-++++||+ ++.
T Consensus        22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             SCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             ceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            3788999999999998     678888876432211 122467777777743222 456544  344567899999 664


Q ss_pred             CH
Q 018304          121 SL  122 (358)
Q Consensus       121 ~L  122 (358)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.45  E-value=0.0014  Score=54.51  Aligned_cols=103  Identities=12%  Similarity=0.077  Sum_probs=67.9

Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCCCc
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGN  199 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~  199 (358)
                      -+|.+++....  .+++++.+|.++.|.+.+|.-+-....  -...=+.|..|++..+|.|.+.+ ..+.          
T Consensus        33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence            47899886544  459999999999999999887632110  12334567899999999998874 1110          


Q ss_pred             cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCC
Q 018304          200 TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKN  242 (358)
Q Consensus       200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  242 (358)
                          .....+.|||... ...+.+.-|||||+++|.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                0123466888653 3446788899999999998885544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.37  E-value=0.0032  Score=56.27  Aligned_cols=75  Identities=11%  Similarity=0.017  Sum_probs=48.1

Q ss_pred             eeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--CccceeeE-----EEeCCeeEEEEEec
Q 018304           45 KKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGC-----CIQGEEKLLIYEFM  117 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~~~-----~~~~~~~~lv~e~~  117 (358)
                      ..|+ |....||++...+|+.+++|...... .....+..|...++.+...  .+++++..     ....+..+++|+++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4577 88889998876567789999885321 1234566788877777421  23444432     22345667899999


Q ss_pred             CCCC
Q 018304          118 TNKS  121 (358)
Q Consensus       118 ~~~~  121 (358)
                      +|..
T Consensus       110 ~G~~  113 (328)
T 1zyl_A          110 GGRQ  113 (328)
T ss_dssp             CCEE
T ss_pred             CCCC
Confidence            8743

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.33  E-value=0.0018  Score=58.17  Aligned_cols=142  Identities=15%  Similarity=0.076  Sum_probs=72.5

Q ss_pred             ceeecccCCcc-EEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-C-CCccceeeEEEeCCeeEEEEEecCCC
Q 018304           44 NKKLGQGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H-RNLVKLLGCCIQGEEKLLIYEFMTNK  120 (358)
Q Consensus        44 ~~~lg~g~~g~-v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~-~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (358)
                      ++.|+.|+... +|+....++..+++|.......   ..+..|+.+++.+. + -.+++++.+.  ...-+++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCc
Confidence            34566666554 6676553477888886543211   22345666666663 2 2355666653  23337899999776


Q ss_pred             CHHHHHhccc-----------------------cccCCCHHHHH-------HHH-------------HHHHHHHHHHh--
Q 018304          121 SLDSFIFDQE-----------------------RCKILDWSKRF-------HII-------------CGTARGVMYLH--  155 (358)
Q Consensus       121 ~L~~~l~~~~-----------------------~~~~~~~~~~~-------~~~-------------~~i~~al~~LH--  155 (358)
                      .+.+++....                       ....++.....       .+.             ..+...+..+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6654432110                       00112221110       000             01111222221  


Q ss_pred             -cCCCCCcccCCCCCCcEEEcCC----CCeEEecccccee
Q 018304          156 -QDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLARA  190 (358)
Q Consensus       156 -~~~~~~i~H~di~~~Nilv~~~----~~i~L~Df~~~~~  190 (358)
                       ......++|||+++.||+++.+    +.+.+.||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1112349999999999999874    6799999998875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.27  E-value=0.0092  Score=53.06  Aligned_cols=159  Identities=14%  Similarity=0.075  Sum_probs=84.2

Q ss_pred             eeHHHHHHhcCCCCc-----ceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCC--Ccccee
Q 018304           29 FELATIVSATNNFSI-----NKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLL  101 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i-----~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~--~iv~~~  101 (358)
                      ++.+++...-.+|.+     ++.|+.|....+|++...++ .+++|.....  .....+..|+..++.+...  .+++++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344555555555665     34567788889999876444 7889988652  1123455677777766321  133333


Q ss_pred             eE------EEeCCeeEEEEEecCCCCHHH-----------H---Hhcc-cccc-C----CCHHHHHHH------------
Q 018304          102 GC------CIQGEEKLLIYEFMTNKSLDS-----------F---IFDQ-ERCK-I----LDWSKRFHI------------  143 (358)
Q Consensus       102 ~~------~~~~~~~~lv~e~~~~~~L~~-----------~---l~~~-~~~~-~----~~~~~~~~~------------  143 (358)
                      ..      ....+..++++++++|..+..           .   ++.. .... .    .........            
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      223456789999998754311           0   1110 0000 0    010000000            


Q ss_pred             ---HHHHHHHHHHHhcC----CCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          144 ---ICGTARGVMYLHQD----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       144 ---~~~i~~al~~LH~~----~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                         ...+...+..+...    ....++|+|+++.||+++.++.+.+.||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               00133344444421    123499999999999998765567999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.26  E-value=0.00078  Score=62.98  Aligned_cols=73  Identities=16%  Similarity=0.227  Sum_probs=49.0

Q ss_pred             cceeecccCCccEEEEEEcC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEE
Q 018304           43 INKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLI  113 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~lv  113 (358)
                      -++.|+.|....+|++...+        +..+++|+.....  ....+..|+.+++.+...++ +++++.+.+    .+|
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            35678889899999998642        5789999884421  11344578888888853333 566665532    389


Q ss_pred             EEecCCCC
Q 018304          114 YEFMTNKS  121 (358)
Q Consensus       114 ~e~~~~~~  121 (358)
                      ++|++|.+
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            99998633

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.21  E-value=0.0019  Score=60.81  Aligned_cols=74  Identities=15%  Similarity=0.103  Sum_probs=47.2

Q ss_pred             ceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEEecCCCC
Q 018304           44 NKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMTNKS  121 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~lv~e~~~~~~  121 (358)
                      ++.|+.|....+|++...+ +..+++|+......... ....|+.+++.+...++ +++++.+.  +  ..|+||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4578888889999998744 47899997743221111 12478889998865444 56776662  2  35999998744


Q ss_pred             H
Q 018304          122 L  122 (358)
Q Consensus       122 L  122 (358)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.89  E-value=0.0024  Score=58.29  Aligned_cols=73  Identities=14%  Similarity=0.157  Sum_probs=43.9

Q ss_pred             ceeecccCCccEEEEEEcC---------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEE
Q 018304           44 NKKLGQGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~lv  113 (358)
                      ++.|+.|....+|++...+         +..+++|+...... .......|...++.+...+ .++++..+  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            4577888888999987643         26888887754222 1112356888888874333 44666544  2  3689


Q ss_pred             EEecCCCC
Q 018304          114 YEFMTNKS  121 (358)
Q Consensus       114 ~e~~~~~~  121 (358)
                      |+|++|..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998744

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.75  E-value=0.012  Score=52.90  Aligned_cols=30  Identities=27%  Similarity=0.360  Sum_probs=27.0

Q ss_pred             CcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          161 RIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       161 ~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      .++|+|+.+.||+++.++.+.+.||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            499999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.67  E-value=0.055  Score=50.19  Aligned_cols=74  Identities=18%  Similarity=0.172  Sum_probs=48.4

Q ss_pred             ceeecccCCccEEEEEEcC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEE
Q 018304           44 NKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++.|..|....+|++...+        +..+++|+....... .-...+|..+++.+. +.-.+++++.+  .  -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            4577888889999998643        578999986543221 112347888888874 33245566533  2  37899


Q ss_pred             EecCCCCH
Q 018304          115 EFMTNKSL  122 (358)
Q Consensus       115 e~~~~~~L  122 (358)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998553

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.27  E-value=0.086  Score=48.50  Aligned_cols=29  Identities=24%  Similarity=0.410  Sum_probs=24.9

Q ss_pred             cccCCCCCCcEEE------cCCCCeEEecccccee
Q 018304          162 IIHRDLKASNVLL------DQDMNPKISDFGLARA  190 (358)
Q Consensus       162 i~H~di~~~Nilv------~~~~~i~L~Df~~~~~  190 (358)
                      ++|+|+.+.||++      +.++.+.+.||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3457799999998765

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.72  E-value=0.81  Score=37.98  Aligned_cols=114  Identities=8%  Similarity=0.107  Sum_probs=76.4

Q ss_pred             CCCCccceeeEEEeCCeeEEEEEecCC-CCHHHHHhccccccCCCHHHHHHHHHHHHHHHH-HHhcCCCCCcccCCCCCC
Q 018304           93 QHRNLVKLLGCCIQGEEKLLIYEFMTN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVM-YLHQDSRLRIIHRDLKAS  170 (358)
Q Consensus        93 ~~~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~-~LH~~~~~~i~H~di~~~  170 (358)
                      .||++  -..+-.+++.+.+.++.-.+ .++..+       ..++...+++++.+|+.... +++.     -+|--++|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            57887  44445677787777776533 344433       12888999999999988777 5544     688899999


Q ss_pred             cEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCC
Q 018304          171 NVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRG  244 (358)
Q Consensus       171 Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  244 (358)
                      |++++.++.+++.=.|+-..                   ++|.-     .+...=.-++=|++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999987665332                   23321     1111122347778888888876653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.96  E-value=0.53  Score=38.94  Aligned_cols=117  Identities=10%  Similarity=0.072  Sum_probs=77.9

Q ss_pred             CCCCccceeeEEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcE
Q 018304           93 QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV  172 (358)
Q Consensus        93 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Ni  172 (358)
                      .+|+++.. .+-++++.+.+.++.-.  ....|-    .-+..+....++++.+|+....+++.     -+|--++|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            57888866 45666676666665443  222221    12238899999999999988855554     58889999999


Q ss_pred             EEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCC
Q 018304          173 LLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGF  245 (358)
Q Consensus       173 lv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~  245 (358)
                      +++.++.+++.=.|+-..                   ++|.     .++...=.-.+=|++..+++++..|+.
T Consensus       111 ~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             EECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999986665322                   2221     112222233577888899998877643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	358
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-75
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-70
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-69
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-68
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-65
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-64
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-64
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-64
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-63
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-63
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-62
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-61
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-61
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-60
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-59
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-57
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-56
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-55
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-47
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-46
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-44
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-41
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-25

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 6e-75
 Identities = 70/277 (25%), Positives = 131/277 (47%), Gaps = 20/277 (7%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
              ++ +++G G FG VYKG       + +  ++  + Q L+  KNEV +  K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
             +G     +   ++ ++    SL   +   E     +  K   I   TA+G+ YLH  S
Sbjct: 68  LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA--- 215
              IIHRDLK++N+ L +D+  KI DFGLA            +++ G+  +MAPE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
               +S +SDV++FGI+L E+++G+    + + +N   +I    + +     S++   C 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
           +             +   C+++   +RP  P ++  +
Sbjct: 240 K---------AMKRLMAECLKKKRDERPLFPQILASI 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 1e-70
 Identities = 78/274 (28%), Positives = 126/274 (45%), Gaps = 22/274 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
               + ++LG G FG V+ G      ++AVK L +           E  L  +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L     Q E   +I E+M N SL  F+      K L  +K   +    A G+ ++ + +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
               IHRDL+A+N+L+   ++ KI+DFGLAR    +E             + APE  + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS 278
            F++KSDV+SFGILL EI++  +    Y    N  +I +  + +    P    +      
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRMVRPDNCPE------ 237

Query: 279 FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                      +  LC ++ P+DRP+   +  +L
Sbjct: 238 -------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 3e-69
 Identities = 64/275 (23%), Positives = 121/275 (44%), Gaps = 24/275 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           +  +  +++G G FG V+ G  ++  ++A+K + +      ++   E  +  KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C++     L++EFM +  L    + + +  +        +      G   +    
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLE 118

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
              +IHRDL A N L+ ++   K+SDFG+ R    D+   ++        + +PE  S  
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 219 QFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
           ++S KSDV+SFG+L+ E+ S GK       +   +  I   ++L+   + S         
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST-------- 229

Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                       I   C ++ P+DRP+   ++  L
Sbjct: 230 --------HVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 2e-68
 Identities = 76/288 (26%), Positives = 131/288 (45%), Gaps = 23/288 (7%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            +  +  KLGQG FG V+ GT      +A+K L        +    E  +  KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L     + E   ++ E+M+  SL  F+   E  K L   +   +    A G+ Y+ +  
Sbjct: 76  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
            +  +HRDL+A+N+L+ +++  K++DFGLAR    +E             + APE A  G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189

Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS 278
           +F++KSDV+SFGILL E+ +  +    Y    N  ++    + +    P +  +      
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPE------ 241

Query: 279 FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK-QPG 325
                      +   C ++ P++RP+   +   L       +P+ QPG
Sbjct: 242 -------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 2e-66
 Identities = 62/292 (21%), Positives = 119/292 (40%), Gaps = 28/292 (9%)

Query: 43  INKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 102
           + + +G+G FG V++G    G+E+AVK  S   E+     + E+     L+H N++  + 
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64

Query: 103 CCIQGEEKL----LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD- 157
              +         L+ ++  + SL  ++        +       +   TA G+ +LH + 
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 158 ----SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF--GGDETEGNTKRVIGTYGYMA 211
                +  I HRDLK+ N+L+ ++    I+D GLA       D  +      +GT  YMA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 212 PEYASD------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN----NLNLIGHAWKL 261
           PE   D       +   ++D+++ G++  EI       G +        +L     + + 
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 262 WNEGMPSQLIDPCIQGSFNLAEVIRCIH-IGLLCVQQHPKDRPSMPSVILML 312
             + +  Q + P I   +   E +R +  I   C   +   R +   +   L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-65
 Identities = 64/274 (23%), Positives = 107/274 (39%), Gaps = 22/274 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + +  K+LG G FG V  G      ++A+K + +       E   E  +   L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +L G C +     +I E+M N  L +++ +          +   +       + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
             + +HRDL A N L++     K+SDFGL+R    DE   +         +  PE     
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176

Query: 219 QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGS 278
           +FS KSD+++FG+L+ EI S  K    Y    N     H  +      P    +      
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKM--PYERFTNSETAEHIAQGLRLYRPHLASE------ 228

Query: 279 FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                  +   I   C  +   +RP+   ++  +
Sbjct: 229 -------KVYTIMYSCWHEKADERPTFKILLSNI 255

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  207 bits (526), Expect = 3e-65
 Identities = 71/302 (23%), Positives = 124/302 (41%), Gaps = 46/302 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGTL------VDGQEIAVKRLSK-ISEQGLKELKNEVILFSK 91
           NN    + +G+G FG V++              +AVK L +  S     + + E  L ++
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI----------------- 134
             + N+VKLLG C  G+   L++E+M    L+ F+       +                 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 135 ----LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
               L  +++  I    A G+ YL +    + +HRDL   N L+ ++M  KI+DFGL+R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
               +             +M PE     +++ +SDV+++G++L EI S       Y+   
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA 247

Query: 251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
           +  +I        +G      + C              ++  LC  + P DRPS  S+  
Sbjct: 248 HEEVI----YYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 311 ML 312
           +L
Sbjct: 295 IL 296

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 1e-64
 Identities = 70/275 (25%), Positives = 112/275 (40%), Gaps = 28/275 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
               + + +G+G FG V  G    G ++AVK +    +   +    E  + ++L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63

Query: 99  KLLGCCIQGEEKL-LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           +LLG  ++ +  L ++ E+M   SL  ++  + R  +L               + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
                +HRDL A NVL+ +D   K+SDFGL +     +             + APE   +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE 174

Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
            +FS KSDV+SFGILL EI S  +    Y      +++        +G      D C   
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVV----PRVEKGYKMDAPDGCPP- 227

Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                       +   C       RPS   +   L
Sbjct: 228 --------AVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (520), Expect = 1e-64
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 22/275 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            + ++  KLG G +G VY+G        +AVK L +     ++E   E  +  +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V+LLG C +     +I EFMT  +L  ++ +  R + +      ++    +  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE-- 132

Query: 158 SRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASD 217
            +   IHRDL A N L+ ++   K++DFGL+R   GD    +         + APE  + 
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190

Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
            +FS+KSDV++FG+LL EI +   +   Y   +   +    ++L  +    +  + C + 
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQV----YELLEKDYRMERPEGCPE- 243

Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                   +   +   C Q +P DRPS   +    
Sbjct: 244 --------KVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (520), Expect = 2e-64
 Identities = 72/301 (23%), Positives = 126/301 (41%), Gaps = 37/301 (12%)

Query: 29  FELATIVSATNNFS---------INKKLGQGGFGPVYKGTLV----DGQEIAVKRLSK-I 74
           F       A   F+         I + +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 75  SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI 134
           +E+  ++  +E  +  +  H N++ L G   +    ++I EFM N SLD   F ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD--SFLRQNDGQ 124

Query: 135 LDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD 194
               +   ++ G A G+ YL     +  +HRDL A N+L++ ++  K+SDFGL+R    D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 195 ETEGNTKRVIG---TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN 251
            ++      +G      + APE     +F+  SDV+S+GI++ E++S  +    Y    N
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTN 239

Query: 252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILM 311
            ++I               I+   +    +        + L C Q+    RP    ++  
Sbjct: 240 QDVI-------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 312 L 312
           L
Sbjct: 287 L 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 2e-64
 Identities = 74/305 (24%), Positives = 136/305 (44%), Gaps = 31/305 (10%)

Query: 18  QIQNIDLELPLFELATIVSATNNFSIN--KKLGQGGFGPVYKGTLVD----GQEIAVKRL 71
            +  ++ EL +  +  +V   ++  ++  + +G+G FG VY GTL+D        AVK L
Sbjct: 5   DLSALNPEL-VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63

Query: 72  SKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMTNKSLDSFIFDQ 129
           ++I++ G + +   E I+     H N++ LLG C++ E   L++  +M +  L +FI ++
Sbjct: 64  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123

Query: 130 ERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR 189
                +     F +          +   +  + +HRDL A N +LD+    K++DFGLAR
Sbjct: 124 THNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 190 AFGGDETEGNTKR--VIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYH 247
                E +    +        +MA E     +F+ KSDV+SFG+LL E+++       Y 
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYP 236

Query: 248 SDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPS 307
             N  ++  +  +      P    DP  +             + L C     + RPS   
Sbjct: 237 DVNTFDITVYLLQGRRLLQPEYCPDPLYE-------------VMLKCWHPKAEMRPSFSE 283

Query: 308 VILML 312
           ++  +
Sbjct: 284 LVSRI 288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 6e-64
 Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 11/206 (5%)

Query: 37  ATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGL-KELKNEVILFSKLQH 94
             ++F    +LG G  G V+K +    G  +A K +    +  +  ++  E+ +  +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             +V   G      E  +  E M   SLD  +    R   +       +     +G+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
               + +I+HRD+K SN+L++     K+ DFG++        +      +GT  YM+PE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGK 240
                +SV+SD++S G+ L+E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 7e-63
 Identities = 78/305 (25%), Positives = 118/305 (38%), Gaps = 45/305 (14%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKISEQG-LKELKNEVILFSK 91
            N    K LG G FG V   T           ++AVK L + ++    + L +E+ + ++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQ--------------------E 130
           L  H N+V LLG C       LI+E+     L +++  +                    E
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 131 RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA 190
              +L +          A+G+ +L        +HRDL A NVL+      KI DFGLAR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 191 FGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDN 250
              D              +MAPE   +G +++KSDV+S+GILL EI S      +     
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272

Query: 251 NLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
           + N     +KL   G          +             I   C     + RPS P++  
Sbjct: 273 DANF----YKLIQNGFKMDQPFYATE---------EIYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 311 MLGSE 315
            LG +
Sbjct: 320 FLGCQ 324

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 7e-63
 Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 27/282 (9%)

Query: 37  ATNNFSI-NKKLGQGGFGPVYKGTLV---DGQEIAVKRLSKISEQG-LKELKNEVILFSK 91
             +N  I + +LG G FG V +G         ++A+K L + +E+   +E+  E  +  +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           L +  +V+L+G C Q E  +L+ E      L  F+  +     +  S    ++   + G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI-GTYGYM 210
            YL +      +HRDL A NVLL      KISDFGL++A G D++    +        + 
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           APE  +  +FS +SDV+S+G+ + E +S  +    Y       ++        +G   + 
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVM----AFIEQGKRMEC 233

Query: 271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
              C               +   C     +DRP   +V   +
Sbjct: 234 PPECPP---------ELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 7e-63
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 26/282 (9%)

Query: 36  SATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL 92
           S   ++ +   +G G +G   K     DG+ +  K L    ++E   + L +EV L  +L
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 93  QHRNLVKLLGCCIQGEEKLL--IYEFMTNKSLDSFIFDQERCK-ILDWSKRFHIICGTAR 149
           +H N+V+     I      L  + E+     L S I    + +  LD      ++     
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 150 GVMYLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTY 207
            +   H+  D    ++HRDLK +NV LD   N K+ DFGLAR    D +    K  +GT 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTP 178

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
            YM+PE  +   ++ KSD++S G LL E+ +       + + +   L         EG  
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELA----GKIREGKF 231

Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
            ++       S  L E+I         +      RPS+  ++
Sbjct: 232 RRIPYRY---SDELNEIITR------MLNLKDYHRPSVEEIL 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-62
 Identities = 73/298 (24%), Positives = 133/298 (44%), Gaps = 29/298 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 92
           +  +  K +G G FG VYKG L          +A+K L    +E+   +   E  +  + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 93  QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
            H N+++L G   + +  ++I E+M N +LD F   +E+       +   ++ G A G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGYMA 211
           YL     +  +HRDL A N+L++ ++  K+SDFGL+R    D     T         + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI 271
           PE  S  +F+  SDV+SFGI++ E+++  +   +  S++ +                + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAI 226

Query: 272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLAD 329
           +   +    +        + + C QQ    RP    ++ +L  + ++  P     LAD
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL--DKLIRAPDSLKTLAD 282

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-62
 Identities = 65/277 (23%), Positives = 120/277 (43%), Gaps = 31/277 (11%)

Query: 41  FSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 97
              + ++G+G F  VYKG   +   E+A   L    +++   +  K E  +   LQH N+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 98  VKLLGCCIQGEEK----LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           V+         +     +L+ E MT+ +L +++    R K++             +G+ +
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127

Query: 154 LHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAP 212
           LH  +   IIHRDLK  N+ +     + KI D GLA            K VIGT  +MAP
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182

Query: 213 EYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 272
           E   + ++    DV++FG+ +LE+ + +    +    N   +    ++    G+     D
Sbjct: 183 EMY-EEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQI----YRRVTSGVKPASFD 235

Query: 273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
                   + E+I        C++Q+  +R S+  ++
Sbjct: 236 KVA--IPEVKEIIEG------CIRQNKDERYSIKDLL 264

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 3e-62
 Identities = 71/275 (25%), Positives = 113/275 (41%), Gaps = 28/275 (10%)

Query: 44  NKKLGQGGFGPVYKGTLVD---GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 98
           +K+LG G FG V KG        + +AVK L           EL  E  +  +L +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
           +++G C + E  +L+ E      L+ ++        +       ++   + G+ YL +  
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTK-RVIGTYGYMAPEYASD 217
               +HRDL A NVLL      KISDFGL++A   DE     +        + APE  + 
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 218 GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
            +FS KSDV+SFG+L+ E  S  +    Y       +      +  +G        C + 
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVT----AMLEKGERMGCPAGCPR- 237

Query: 278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
                       +  LC     ++RP   +V L L
Sbjct: 238 --------EMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-62
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 23/273 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRN 96
            ++ + + LG+G +G V      V  + +AVK +    +    + +K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VK  G   +G  + L  E+ +   L   I        +              GV+YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
              + I HRD+K  N+LLD+  N KISDFGLA  F  +  E    ++ GT  Y+APE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 217 DGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
             +F +   DV+S GI+L  +++G+    +    ++        +      P + ID   
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKIDS-- 234

Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV 308
                   ++         + ++P  R ++P +
Sbjct: 235 ----APLALLHK------ILVENPSARITIPDI 257

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 8e-62
 Identities = 76/297 (25%), Positives = 112/297 (37%), Gaps = 40/297 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSKISEQG-LKELKNEVILFSK 91
           N  S  K LG G FG V + T            +AVK L   +     + L +E+ + S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 92  L-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI---------------L 135
           L  H N+V LLG C  G   L+I E+     L +F+  +    I               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 136 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
           D           A+G+ +L        IHRDL A N+LL      KI DFGLAR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI 255
                        +MAPE   +  ++ +SDV+S+GI L E+ S   +       ++    
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255

Query: 256 GHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
              +K+  EG      +                 I   C    P  RP+   ++ ++
Sbjct: 256 -KFYKMIKEGFRMLSPEHAPA---------EMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-61
 Identities = 76/326 (23%), Positives = 126/326 (38%), Gaps = 46/326 (14%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 93
           N+      +G+G FG V K  +       + A+KR+ +  S+   ++   E+ +  KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFI-------------FDQERCKILDWSKR 140
           H N++ LLG C       L  E+  + +L  F+                     L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 141 FHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT 200
            H     ARG+ YL Q    + IHRDL A N+L+ ++   KI+DFGL+R     E     
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183

Query: 201 KRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK 260
                   +MA E  +   ++  SDV+S+G+LL EI+S       Y       L     +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ 241

Query: 261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQ 320
            +    P    D                 +   C ++ P +RPS   +++ L    +L +
Sbjct: 242 GYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSL--NRMLEE 286

Query: 321 PKQPGYLADRNSTRLDSSSSRPESSS 346
            K        N+T  +  +      S
Sbjct: 287 RKTY-----VNTTLYEKFTYAGIDCS 307

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-61
 Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 27/277 (9%)

Query: 35  VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ 93
           ++  + + I  +LG G FG VYK    +     A K +   SE+ L++   E+ + +   
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H N+VKLL          ++ EF    ++D+ + + ER   L  S+   +   T   + Y
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 125

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           LH     +IIHRDLKA N+L   D + K++DFG++          ++   IGT  +MAPE
Sbjct: 126 LHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPE 180

Query: 214 YA-----SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
                   D  +  K+DV+S GI L+E+   +     +H  N + ++    K+     P+
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL---LKIAKSEPPT 234

Query: 269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
                    S N  + ++       C++++   R + 
Sbjct: 235 LAQPSRW--SSNFKDFLKK------CLEKNVDARWTT 263

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 4e-61
 Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 33/302 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSK 91
              +++++LGQG FG VY+G             +A+K +++  S +   E  NE  +  +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIF-------DQERCKILDWSKRFHII 144
               ++V+LLG   QG+  L+I E MT   L S++        +         SK   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 145 CGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVI 204
              A G+ YL+ +   + +HRDL A N ++ +D   KI DFG+ R     +      + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 205 GTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE 264
               +M+PE   DG F+  SDV+SFG++L EI +  +    Y   +N  +     +   E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQV----LRFVME 250

Query: 265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQP 324
           G      D C               +  +C Q +PK RPS   +I  +  E + P  ++ 
Sbjct: 251 GGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSI-KEEMEPGFREV 300

Query: 325 GY 326
            +
Sbjct: 301 SF 302

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-60
 Identities = 65/282 (23%), Positives = 133/282 (47%), Gaps = 27/282 (9%)

Query: 28  LFELATIVSA---TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK 83
           L +L +IVS       ++  +K+GQG  G VY    +  GQE+A+++++   +   + + 
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 84  NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHI 143
           NE+++  + ++ N+V  L   + G+E  ++ E++   SL   + +       D  +   +
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAV 121

Query: 144 ICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRV 203
                + + +LH     ++IHRD+K+ N+LL  D + K++DFG       +++      +
Sbjct: 122 CRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 176

Query: 204 IGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN 263
           +GT  +MAPE  +   +  K D++S GI+ +E+I G+     Y ++N L  +   + +  
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL---YLIAT 230

Query: 264 EGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
            G P       +  S    + +        C+    + R S 
Sbjct: 231 NGTPELQNPEKL--SAIFRDFLNR------CLDMDVEKRGSA 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (495), Expect = 2e-60
 Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 34/272 (12%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 96
           FS  +++G G FG VY    + + + +A+K++S     S +  +++  EV    KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
            ++  GC ++     L+ E+    + D     +   K L   +   +  G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS 133

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA- 215
                +IHRD+KA N+LL +    K+ DFG A               +GT  +MAPE   
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184

Query: 216 --SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
              +GQ+  K DV+S GI  +E+      +    + N ++ +   + +     P+     
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAER---KPPLFNMNAMSAL---YHIAQNESPALQSGH 238

Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
               S      +        C+Q+ P+DRP+ 
Sbjct: 239 W---SEYFRNFVDS------CLQKIPQDRPTS 261

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 4e-60
 Identities = 73/322 (22%), Positives = 127/322 (39%), Gaps = 31/322 (9%)

Query: 41  FSINKKLGQGGFGPVYKGTLVDGQE-----IAVKRLSKI-SEQGLKELKNEVILFSKLQH 94
           F   K LG G FG VYKG  +   E     +A+K L +  S +  KE+ +E  + + + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            ++ +LLG C+      LI + M    L  ++ + +           +     A+G+ YL
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                 R++HRDL A NVL+    + KI+DFGLA+  G +E E + +       +MA E 
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC 274
                ++ +SDV+S+G+ + E+++       Y       +     K      P       
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKGERLPQPPICTI-- 240

Query: 275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYLADRNSTR 334
                          I + C       RP    +I+        PQ     YL  +   R
Sbjct: 241 -----------DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR----YLVIQGDER 285

Query: 335 LDSSSSRPESSSTNTITISELE 356
           +   S    +     +   +++
Sbjct: 286 MHLPSPTDSNFYRALMDEEDMD 307

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 2e-59
 Identities = 72/282 (25%), Positives = 114/282 (40%), Gaps = 28/282 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 91
            +  + +KLG G FG V +G           +AVK L        + + +   EV     
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           L HRNL++L G  +    K+ + E     SL   +   +   +L    R+ +    A G+
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV--AEGM 124

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTKRVIGTYGYM 210
            YL      R IHRDL A N+LL      KI DFGL RA   ++      +     + + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 211 APEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           APE      FS  SD + FG+ L E+ +  +    +   N   ++    K+  EG     
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL---HKIDKEGERLPR 236

Query: 271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
            + C Q            ++ + C    P+DRP+  ++   L
Sbjct: 237 PEDCPQ---------DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-59
 Identities = 62/277 (22%), Positives = 104/277 (37%), Gaps = 35/277 (12%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F I + LG+G FG VY          +A+K L K          +L+ EV + S L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
            N+++L G         LI E+    ++   +   ++    D  +    I   A  + Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H     R+IHRD+K  N+LL      KI+DFG +              + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC 274
                   K D++S G+L  E + GK                     +      +     
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK-------------------PPFEANTYQETYKRI 216

Query: 275 IQGSFNLAEVI--RCIHIGLLCVQQHPKDRPSMPSVI 309
            +  F   + +      +    ++ +P  RP +  V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 1e-57
 Identities = 72/298 (24%), Positives = 111/298 (37%), Gaps = 39/298 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKE--LKNEVILFS 90
           +   + K LG+G FG V +            + +AVK L + +        +    IL  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 91  KLQHRNLVKLLGCCIQGEEKLLI-YEFMTNKSLDSFIFDQERC-------------KILD 136
              H N+V LLG C +    L++  EF    +L +++  +                  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 137 WSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET 196
                      A+G+ +L      + IHRDL A N+LL +    KI DFGLAR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG 256
                       +MAPE   D  ++++SDV+SFG+LL EI S             + +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244

Query: 257 HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS 314
              +   EG   +  D                   L C    P  RP+   ++  LG+
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 77/297 (25%), Positives = 121/297 (40%), Gaps = 41/297 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV--------DGQEIAVKRLSK-ISEQGLKELKNEVILF 89
           +   + K LG+G FG V     +           ++AVK L    +E+ L +L +E+ + 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 90  SKL-QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKI-------------L 135
             + +H+N++ LLG C Q     +I E+ +  +L  ++  +    +             L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 136 DWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE 195
                       ARG+ YL      + IHRDL A NVL+ +D   KI+DFGLAR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI 255
               T        +MAPE   D  ++ +SDV+SFG+LL EI +   +   Y       L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL- 246

Query: 256 GHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
              +KL  EG        C               +   C    P  RP+   ++  L
Sbjct: 247 ---FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 4e-56
 Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 29/289 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 93
               + + +G+G FG V++G  +        +A+K     +   ++E    E +   +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H ++VKL+G   +     +I E  T   L SF+    R   LD +         +  + Y
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAY 123

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           L      R +HRD+ A NVL+  +   K+ DFGL+R +  D T     +      +MAPE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 179

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
             +  +F+  SDV+ FG+ + EI+        +    N ++IG         MP      
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPK 322
                  L  ++        C    P  RP    +   L   T+L + K
Sbjct: 235 ----PPTLYSLMTK------CWAYDPSRRPRFTELKAQL--STILEEEK 271

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  181 bits (460), Expect = 8e-55
 Identities = 63/324 (19%), Positives = 120/324 (37%), Gaps = 32/324 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
           +++ I+++LG G FG V++ T    G   A K +    E   + ++ E+   S L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           V L        E ++IYEFM+   L   + D+     +   +    +    +G+ ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141

Query: 158 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
                +H DLK  N++     +   K+ DFGL       ++    K   GT  + APE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
                   +D++S G+L   ++SG      +  +N+   +    K  +  M         
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETL-RNVKSCDWNMDDSAFSGI- 252

Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSV--------ILMLGSETVLPQPKQPGYL 327
             S +  + IR        +   P  R ++               G ++ +P  +     
Sbjct: 253 --SEDGKDFIRK------LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304

Query: 328 ADRNSTRLDSSSSRPESSSTNTIT 351
               +         P     +  +
Sbjct: 305 DSIKTKYDAWPEPLPPLGRISNYS 328

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-54
 Identities = 60/272 (22%), Positives = 105/272 (38%), Gaps = 31/272 (11%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHR 95
           +F   K LG+G F  V     L   +E A+K L K   I E  +  +  E  + S+L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
             VKL       E+      +  N  L  +I    +    D +            + YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
                 IIHRDLK  N+LL++DM+ +I+DFG A+    +  +      +GT  Y++PE  
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           ++      SD+++ G ++ ++++G                      +  G    +    I
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKII 223

Query: 276 QGSFNLAEVI--RCIHIGLLCVQQHPKDRPSM 305
           +  ++  E    +   +    +      R   
Sbjct: 224 KLEYDFPEKFFPKARDLVEKLLVLDATKRLGC 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  171 bits (435), Expect = 5e-51
 Identities = 57/270 (21%), Positives = 107/270 (39%), Gaps = 24/270 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
           + + I ++LG G FG V++      G+    K ++         +KNE+ + ++L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           + L        E +LI EF++   L   I        +  ++  + +     G+ ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 158 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
               I+H D+K  N++ +       KI DFGLA     DE     K    T  + APE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
                   +D+++ G+L   ++SG            L  +      ++E   S +     
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----- 255

Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
             S    + I+        +Q+ P+ R ++
Sbjct: 256 --SPEAKDFIKN------LLQKEPRKRLTV 277

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  166 bits (422), Expect = 5e-50
 Identities = 57/282 (20%), Positives = 117/282 (41%), Gaps = 28/282 (9%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 93
           ++ + + + LG GG   V+    L   +++AVK L              + E    + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 94  HRNLVKLLGCCI----QGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           H  +V +          G    ++ E++   +L   +        +   +   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQ 122

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEG-NTKRVIGTYG 208
            + + H   +  IIHRD+K +N+++      K+ DFG+ARA          T  VIGT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
           Y++PE A       +SDV+S G +L E+++G+     +  D+ +++      +  + +P 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVA--YQHVREDPIPP 234

Query: 269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
                 +  S +L  V+         + ++P++R    + + 
Sbjct: 235 SARHEGL--SADLDAVVLK------ALAKNPENRYQTAAEMR 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 6e-49
 Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 30/277 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEV-ILFSKLQ 93
            +F ++K LG+G FG V+        Q  A+K L K   + +  ++    E  +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 94  HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMY 153
           H  L  +       E    + E++    L   I   + C   D S+          G+ +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQF 118

Query: 154 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           LH      I++RDLK  N+LLD+D + KI+DFG+ +     + + NT    GT  Y+APE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
                +++   D +SFG+LL E++ G+     +H  +   L  H+ ++ N   P  L   
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELF-HSIRMDNPFYPRWL--- 226

Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL 310
                    +++           + P+ R  +   I 
Sbjct: 227 ----EKEAKDLLVK------LFVREPEKRLGVRGDIR 253

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  164 bits (417), Expect = 7e-49
 Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 24/270 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
            +F I + LG G FG V+      +G+  A+K L K   +  + ++   +E ++ S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             ++++ G     ++  +I +++    L S +   +R            +C      + L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
                  II+RDLK  N+LLD++ + KI+DFG A+             + GT  Y+APE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNN--LNLIGHAWKLWNEGMPSQ--- 269
            S   ++   D +SFGIL+ E+++G     FY S+       I +A   +          
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNEDVKD 230

Query: 270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHP 299
           L+   I    +L++ +  +  G   V+ HP
Sbjct: 231 LLSRLIT--RDLSQRLGNLQNGTEDVKNHP 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 4e-48
 Identities = 60/323 (18%), Positives = 117/323 (36%), Gaps = 33/323 (10%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
            + I + LG+G FG V++       +    K + K+       +K E+ + +  +HRN++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            L       EE ++I+EF++   +   I        L+  +    +      + +LH   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS-- 120

Query: 159 RLRIIHRDLKASNVLLDQDMNP--KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYAS 216
              I H D++  N++     +   KI +FG AR     +   N + +     Y APE   
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176

Query: 217 DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ 276
               S  +D++S G L+  ++SG        +   +  I +A   ++E    ++      
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI------ 230

Query: 277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI--------LMLGSETVLPQPKQPGYLA 328
            S    + +         + +  K R +    +        +   S  V+   K   Y  
Sbjct: 231 -SIEAMDFVDR------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYH 283

Query: 329 DRNSTRLDSSSSRPESSSTNTIT 351
                 L+   S    S    I 
Sbjct: 284 TLIKKDLNMVVSAARISCGGAIR 306

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  164 bits (415), Expect = 4e-48
 Identities = 66/277 (23%), Positives = 109/277 (39%), Gaps = 32/277 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVI---LFSK 91
           N+FS+++ +G+GGFG VY     D G+  A+K L K     +QG     NE I   L S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
                +V +       ++   I + M    L   +           +           G+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
            ++H      +++RDLK +N+LLD+  + +ISD GLA  F     +      +GT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173

Query: 212 PEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL 270
           PE    G  +   +D FS G +L +++ G       H   + + I          +P   
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDSF 232

Query: 271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPS 307
                  S  L  ++         +Q+    R     
Sbjct: 233 -------SPELRSLLEG------LLQRDVNRRLGCLG 256

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 61/296 (20%), Positives = 119/296 (40%), Gaps = 31/296 (10%)

Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFS 90
            +      ++    +G+G +G V      V+   +A+K++S    Q   +    E+ +  
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 91  KLQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARG 150
           + +H N++ +         + +   ++    + + ++   + + L      + +    RG
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 151 VMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNT-KRVIGTYGY 209
           + Y+H      ++HRDLK SN+LL+   + KI DFGLAR    D          + T  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 210 MAPEYASDGQFSVKS-DVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS 268
            APE   + +   KS D++S G +L E++S +     +   + L+ + H   +   G PS
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYLDQLNHILGI--LGSPS 233

Query: 269 QLIDPCIQGSFNLAEVIRCIH-----------------IGLL--CVQQHPKDRPSM 305
           Q    CI        ++   H                 + LL   +  +P  R  +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 51/283 (18%), Positives = 94/283 (33%), Gaps = 25/283 (8%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
           N + + +K+G G FG +Y GT +  G+E+A+K     ++    +L  E  ++  +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           +  +  C    +  ++   +   SL+       R           +       + Y+H  
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120

Query: 158 SRLRIIHRDLKASNVL---LDQDMNPKISDFGLARAFGGDETEGN-----TKRVIGTYGY 209
                IHRD+K  N L     +     I DFGLA+ +    T  +      K + GT  Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 210 MAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ 269
            +       + S + D+ S G +L+    G        +           +         
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
           L           A  +        C      D+P    +  + 
Sbjct: 240 LCKGY---PSEFATYLNF------CRSLRFDDKPDYSYLRQLF 273

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  157 bits (397), Expect = 4e-46
 Identities = 41/285 (14%), Positives = 104/285 (36%), Gaps = 27/285 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 97
            ++ + +++G+G FG +++GT L++ Q++A+K   + S+    +L++E   +  L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 98  VKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQD 157
           +  +    Q     ++   +   SL+  +      +                 V  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 158 SRLRIIHRDLKASNVLLDQDMNP-----KISDFGLARAFGGDETEGN-----TKRVIGTY 207
               +++RD+K  N L+ +  +       + DFG+ + +    T+ +      K + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
            YM+       + S + D+ + G + +  + G        +  N        ++  +   
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---ERIGEKKQS 234

Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILML 312
           + L + C        + +                 P    +  + 
Sbjct: 235 TPLRELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLF 273

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (398), Expect = 4e-46
 Identities = 56/270 (20%), Positives = 100/270 (37%), Gaps = 21/270 (7%)

Query: 38  TNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKLQHR 95
            + +     LG G F  V         + +A+K ++K + +G    ++NE+ +  K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N+V L      G    LI + ++   L   I                +I      V YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
               +    +        LD+D    ISDFGL++               GT GY+APE  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
           +   +S   D +S G++   ++ G      ++ +N+  L             S   D   
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLF-EQILKAEYEFDSPYWDDI- 236

Query: 276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
             S +  + IR        +++ P+ R + 
Sbjct: 237 --SDSAKDFIRH------LMEKDPEKRFTC 258

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (393), Expect = 9e-46
 Identities = 56/283 (19%), Positives = 109/283 (38%), Gaps = 39/283 (13%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---------ISEQGLKELKNEVILF 89
           N+   + LG+G    V +       +E AVK +             ++  +    EV + 
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 90  SKLQ-HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA 148
            K+  H N+++L           L+++ M    L  ++        L   +   I+    
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
             +  LH   +L I+HRDLK  N+LLD DMN K++DFG +      E     + V GT  
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174

Query: 209 YMAPEYASDGQ------FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW 262
           Y+APE            +  + D++S G+++  +++G      +     + ++    ++ 
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLML----RMI 227

Query: 263 NEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
             G            S  + +++         +   P+ R + 
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLVSR------FLVVQPQKRYTA 264

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 2e-44
 Identities = 66/287 (22%), Positives = 121/287 (42%), Gaps = 33/287 (11%)

Query: 40  NFSINKKLGQGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
           NF   +K+G+G +G VYK    + G+ +A+K  RL   +E        E+ L  +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKLL       +  L++EF+          D      +        +    +G+ + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YA 215
               R++HRDLK  N+L++ +   K++DFGLARAFG           + T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI 275
               +S   D++S G +  E+++ +     +  D+ ++ +   ++    G P +++ P +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFR--TLGTPDEVVWPGV 230

Query: 276 Q------------GSFNLAEVIRCIHIGLL-----CVQQHPKDRPSM 305
                           + ++V+  +           +   P  R S 
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-44
 Identities = 58/292 (19%), Positives = 112/292 (38%), Gaps = 32/292 (10%)

Query: 37  ATNNFSINKKLGQGGFGPVYKGTLV--DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL 92
           A   +    ++G+G +G V+K   +   G+ +A+KR+      E        EV +   L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 93  ---QHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDS---FIFDQERCKILDWSKRFHIICG 146
              +H N+V+L   C            +  + +D       D+     +       ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGT 206
             RG+ +LH     R++HRDLK  N+L+      K++DFGLAR +     +     V+ T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178

Query: 207 YGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL----- 261
             Y APE      ++   D++S G +  E+   K     +   ++++ +G    +     
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235

Query: 262 ---WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLL-----CVQQHPKDRPSM 305
              W   +         + +  + + +  I          C+  +P  R S 
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  151 bits (381), Expect = 5e-44
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 29/285 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 96
             +   +K+G+G +G VYK     G+  A+K  RL K  E        E+ +  +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 97  LVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +VKL       +  +L++E +           +     L+       +     G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD 118

Query: 157 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE-YA 215
               R++HRDLK  N+L++++   KI+DFGLARAFG    +      I T  Y AP+   
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLW----NEGMPSQLI 271
              ++S   D++S G +  E+++G      +   +  + +   +++     ++  P+   
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 272 DPCIQGSFNLAEVIR-----------CIHIGLLCVQQHPKDRPSM 305
            P    +F + E +             I +    ++  P  R + 
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-43
 Identities = 67/315 (21%), Positives = 122/315 (38%), Gaps = 46/315 (14%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVILFSK 91
           + +   ++LG G F  V K      G + A K + K            ++++ EV +  +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
           +QH N++ L        + +LI E +    L  F+ ++E    L   +    +     GV
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 126

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLARAFGGDETEGNTKRVIGTY 207
            YLH    L+I H DLK  N++L     P    KI DFGLA            K + GT 
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 208 GYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
            ++APE  +     +++D++S G++   ++SG            L  +      + +   
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240

Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVLPQPKQPGYL 327
           S         S    + IR        + + PK R ++         +  L  P    ++
Sbjct: 241 SNT-------SALAKDFIRR------LLVKDPKKRMTI---------QDSLQHP----WI 274

Query: 328 ADRNSTRLDSSSSRP 342
             +++ +  SS+   
Sbjct: 275 KPKDTQQALSSAWSH 289

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 9e-43
 Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 32/282 (11%)

Query: 45  KKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-----LKNEVILFSKLQHRNLV 98
             LG+G F  VYK       Q +A+K++        K+        E+ L  +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 99  KLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS 158
            LL          L+++FM           ++   +L  S     +  T +G+ YLHQ  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 159 RLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDG 218
              I+HRDLK +N+LLD++   K++DFGLA++FG           + T  Y APE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175

Query: 219 Q-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG 277
           + + V  D+++ G +L E++       F   D++L+ +   ++        Q  D C   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLR---VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 278 SFNLAEVIRCIHIGLL--------------CVQQHPKDRPSM 305
            +   +    I +  +                  +P  R + 
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-41
 Identities = 62/282 (21%), Positives = 104/282 (36%), Gaps = 43/282 (15%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN------EVILFSK 91
           + + +   LG GGFG VY G  + D   +A+K + K       EL N      EV+L  K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 92  LQ--HRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
           +      +++LL    + +  +LI E             +     L              
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
            V + H      ++HRD+K  N+L+D +    K+ DFG          +       GT  
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174

Query: 209 YMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           Y  PE+    ++    + V+S GILL +++ G     F H +     I      + + + 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEE----IIRGQVFFRQRVS 228

Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVI 309
           S+              +IR       C+   P DRP+   + 
Sbjct: 229 SECQH-----------LIRW------CLALRPSDRPTFEEIQ 253

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-41
 Identities = 55/285 (19%), Positives = 114/285 (40%), Gaps = 27/285 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 95
             +   +K+G+G +G V+K       + +A+KR+      E        E+ L  +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N+V+L       ++  L++EF        F          D       +    +G+ + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
                 ++HRDLK  N+L++++   K+++FGLARAFG       +  V+  +        
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLF 174

Query: 216 SDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN----------EG 265
               +S   D++S G +  E+ +    R  +  ++  + +   ++L              
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAG--RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 266 MPSQLIDPCIQGSFNLAEVIRCIHIGLL-----CVQQHPKDRPSM 305
           +P     P    + +L  V+  ++          ++ +P  R S 
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 6e-41
 Identities = 59/289 (20%), Positives = 106/289 (36%), Gaps = 35/289 (12%)

Query: 40  NFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 98
           +++  K +G G FG VY+  L D G+ +A+K++ +           E+ +  KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76

Query: 99  KLLGCCIQGEEK------LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVM 152
           +L        EK       L+ +++               + L        +    R + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 153 YLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
           Y+H      I HRD+K  N+LLD D    K+ DFG A+     E   N   +   Y    
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAP 191

Query: 212 PEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL---------- 261
                   ++   DV+S G +L E++ G+     +  D+ ++ +    K+          
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 262 -----WNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
                + E    Q+        F        I +    ++  P  R + 
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 7e-41
 Identities = 56/271 (20%), Positives = 101/271 (37%), Gaps = 29/271 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           N+F   K LG+G FG V        G+  A+K L K   I++  +     E  +    +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             L  L       +    + E+     L   +    R ++    +           + YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H      +++RD+K  N++LD+D + KI+DFGL +    D      K   GT  Y+APE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC 274
             D  +    D +  G+++ E++ G+        +    LI      +   +  +     
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS-- 234

Query: 275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
                    ++         +++ PK R   
Sbjct: 235 ---------LLAG------LLKKDPKQRLGG 250

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 1e-40
 Identities = 54/299 (18%), Positives = 112/299 (37%), Gaps = 41/299 (13%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 95
           + +    K+GQG FG V+K      GQ++A+K++      E        E+ +   L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 96  NLVKLLGCCIQGEEK--------LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGT 147
           N+V L+  C               L+++F  +           +  + +  +   ++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-- 127

Query: 148 ARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKR--VIG 205
                 L+   R +I+HRD+KA+NVL+ +D   K++DFGLARAF   +     +    + 
Sbjct: 128 ----NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 206 TYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIG-------- 256
           T  Y  PE     + +    D++  G ++ E+ +          +   + +         
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQHQLALISQLCGS 240

Query: 257 ---HAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIH-----IGLL--CVQQHPKDRPSM 305
                W   +     + ++        + + ++        + L+   +   P  R   
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 51/272 (18%), Positives = 103/272 (37%), Gaps = 30/272 (11%)

Query: 43  INKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNLVKL 100
            ++ LG G  G V +       ++ A+K L         + + EV + +   Q  ++V++
Sbjct: 16  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 70

Query: 101 LGCCIQGEEK----LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ 156
           +             L++ E +    L S I D+   +     +   I+      + YLH 
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS 129

Query: 157 DSRLRIIHRDLKASNVLLDQDMNP---KISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
              + I HRD+K  N+L          K++DFG A+      +         T  Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP 273
                ++    D++S G+++  ++ G      ++S++ L +          G        
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
             + S  +  +IR        ++  P  R ++
Sbjct: 241 WSEVSEEVKMLIRN------LLKTEPTQRMTI 266

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (350), Expect = 9e-39
 Identities = 57/268 (21%), Positives = 98/268 (36%), Gaps = 20/268 (7%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 94
           + F   K LG G FG V        G   A+K L K   +  + ++   NE  +   +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 95  RNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
             LVKL           ++ E++    + S +    R                     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEY 214
           H    L +I+RDLK  N+L+DQ    +++DFG A+   G         + GT   +APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209

Query: 215 ASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ---LI 271
                ++   D ++ G+L+ E+ +G               I      +     S    L+
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 272 DPCIQGSFNLAEVIRCIHIGLLCVQQHP 299
              +Q   +L +    +  G+  ++ H 
Sbjct: 270 RNLLQ--VDLTKRFGNLKNGVNDIKNHK 295

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 9e-37
 Identities = 60/288 (20%), Positives = 117/288 (40%), Gaps = 31/288 (10%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 95
             +   + +G G +G V        G ++A+K+L +   SE   K    E+ L   ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 96  NLVKLLGCCIQGEEKLLIYEF-MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           N++ LL      E      +F +    + + +    + + L   +   ++    +G+ Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 155 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE- 213
           H      IIHRDLK  N+ +++D   KI DFGLAR     + +      + T  Y APE 
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189

Query: 214 YASDGQFSVKSDVFSFGILLLEIISGK----------------KNRGFYHSDNNLNLIGH 257
             +  +++   D++S G ++ E+I+GK                K  G   ++    L   
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 258 AWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
             K + +G+P            N + +   +++    +    + R + 
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPL--AVNLLEKMLVLDAEQRVTA 295

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 4e-35
 Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 31/278 (11%)

Query: 39  NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFS 90
            NF + K LG G +G V+    +     G+  A+K L K +     +  +  + E  +  
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 91  KLQHR-NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTAR 149
            ++    LV L        +  LI +++    L + +  +ER    +       I     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV---- 139

Query: 150 GVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGY 209
             + L    +L II+RD+K  N+LLD + +  ++DFGL++ F  DETE       GT  Y
Sbjct: 140 --LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 210 MAPEYASDGQ--FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP 267
           MAP+    G        D +S G+L+ E+++G          N+   I           P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256

Query: 268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSM 305
            ++       S    ++I+        + + PK R   
Sbjct: 257 QEM-------SALAKDLIQR------LLMKDPKKRLGC 281

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (319), Expect = 1e-34
 Identities = 48/240 (20%), Positives = 104/240 (43%), Gaps = 23/240 (9%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN 96
           +++ + +KLG+G +  V++   + + +++ VK L  + +   K++K E+ +   L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91

Query: 97  LVKLLGCCIQGEEKL--LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYL 154
           ++ L         +   L++E + N             + L        +    + + Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 155 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPE 213
           H    + I+HRD+K  NV++D +    ++ D+GLA  +   +        + +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199

Query: 214 YASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID 272
              D Q +    D++S G +L  +I  K+   F+H  +N + +    K+         ID
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYID 257

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 4e-33
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 9/205 (4%)

Query: 39  NNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 95
             +   K +G G  G V      V  + +A+K+LS+   ++   K    E++L   + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 96  NLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLH 155
           N++ LL      +      +      L      Q     LD  +  +++     G+ +LH
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 156 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYA 215
                 IIHRDLK SN+++  D   KI DFGLAR  G           + T  Y APE  
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVI 190

Query: 216 SDGQFSVKSDVFSFGILLLEIISGK 240
               +    D++S G ++ E++  K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 25/291 (8%)

Query: 33  TIVSATNNFSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILF 89
           TI      +     +G G +G V        G  +AVK+LS+   S    K    E+ L 
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71

Query: 90  SKLQHRNLVKLLGCCIQGEE-KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTA 148
             ++H N++ LL         +     ++    + + + +  +C+ L       +I    
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131

Query: 149 RGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYG 208
           RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    +     T  V   + 
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWY 184

Query: 209 YMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHA---------W 259
                  +   ++   D++S G ++ E+++G+         + L LI             
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIH---IGLL--CVQQHPKDRPSM 305
           K+ +E   + +         N A V    +   + LL   +      R + 
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (288), Expect = 6e-30
 Identities = 42/215 (19%), Positives = 82/215 (38%), Gaps = 18/215 (8%)

Query: 41  FSINKKLGQGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 99
           + + +KLG G F  V+    +V+   +A+K +    +   +  ++E+ L  ++   +  K
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 100 LLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERC-------------KILDWSKRFHIICG 146
                     KLL +      +    +   E               + +       I   
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 147 TARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLARAFGGDETEGNTKRVIG 205
              G+ Y+H+  R  IIH D+K  NVL++  D    +    +A        + +    I 
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 206 TYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK 240
           T  Y +PE      +   +D++S   L+ E+I+G 
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 97.5 bits (242), Expect = 8e-25
 Identities = 35/204 (17%), Positives = 71/204 (34%), Gaps = 25/204 (12%)

Query: 42  SINKKLGQGGFGPVYKGTLVDGQEIAVK--RLSKIS--------EQGLKELKNEVILFSK 91
           +I K +G+G    V+        E  VK  ++   S        + G        I  ++
Sbjct: 3   AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 92  LQHRNLVKLLGCCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGV 151
            + R L KL G  +       +Y +  N ++   + D +    +       ++      V
Sbjct: 63  NEFRALQKLQGLAVPK-----VYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEV 116

Query: 152 MYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMA 211
              +      I+H DL   NVL+  +    I DF  +   G +      +R +     + 
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV---RNII 169

Query: 212 PEYASDGQFSVKSDVFSFGILLLE 235
             ++    +  + D+ S    +L+
Sbjct: 170 TYFSRT--YRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	358
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.92
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.09
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.9
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.07
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.03
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.86

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-54  Score=377.88  Aligned_cols=261  Identities=25%  Similarity=0.310  Sum_probs=207.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .++|++++.||+|+||.||+|.++ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            468999999999999999999985 48999999986533 2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+++|+|.+++...   ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++..+....
T Consensus        84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999998543   34999999999999999999999999   9999999999999999999999999998764333


Q ss_pred             CCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      .........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.......  .......   ..........  
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~---~~~~~~~~~~--  230 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWK---EKKTYLNPWK--  230 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHH---TTCTTSTTGG--
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHh---cCCCCCCccc--
Confidence            3333445679999999999988776 578999999999999999999986543321  1111111   0111110000  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCCC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETVL  318 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~~  318 (358)
                             .....+.+||.+||+.||++|||+.+++++-|.....
T Consensus       231 -------~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         231 -------KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             -------GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -------cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence                   0123566899999999999999999999987765433

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-53  Score=375.61  Aligned_cols=254  Identities=23%  Similarity=0.387  Sum_probs=210.4

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      ++|++++.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            58999999999999999999974 49999999997655556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++|+|.+++...    .+++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||++..+...  .
T Consensus       100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~  170 (293)
T d1yhwa1         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q  170 (293)
T ss_dssp             TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred             CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--c
Confidence            999999987542    3999999999999999999999999   999999999999999999999999999876322  2


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC-CccccCCcC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP-SQLIDPCIQ  276 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  276 (358)
                      .......||+.|+|||++.+..++.++||||+||++|+|++|..||.....   ...+.....   ...+ .....    
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~---~~~~~~~~~~----  240 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIAT---NGTPELQNPE----  240 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHH---HCSCCCSSGG----
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHh---CCCCCCCCcc----
Confidence            233455799999999999999999999999999999999999999854322   122211111   1111 11111    


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                           .....+.+||.+||+.||++|||+.|++++-+...
T Consensus       241 -----~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         241 -----KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             -----GSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -----cCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                 11235678999999999999999999999876643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=372.10  Aligned_cols=248  Identities=25%  Similarity=0.320  Sum_probs=205.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++.+.||+|+||.||+|.++. ++.||+|++.+.   .......+.+|+++++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            579999999999999999999854 889999998642   2234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++|+|.+++....   .+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++..... 
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-
Confidence            9999999999996543   3999999999999999999999999   99999999999999999999999999976432 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ........    ... ..+.+  
T Consensus       159 ---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~----~~~-~~~p~--  225 (263)
T d2j4za1         159 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRIS----RVE-FTFPD--  225 (263)
T ss_dssp             ---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH----TTC-CCCCT--
T ss_pred             ---CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHHHHHH----cCC-CCCCc--
Confidence               223456799999999999999999999999999999999999999864321   12222111    111 11111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                         .    ....+.+||.+||+.||++|||+.+++++-|
T Consensus       226 ---~----~s~~~~~li~~~L~~dp~~R~t~~eil~hp~  257 (263)
T d2j4za1         226 ---F----VTEGARDLISRLLKHNPSQRPMLREVLEHPW  257 (263)
T ss_dssp             ---T----SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred             ---c----CCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence               1    1235678999999999999999999998654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=373.44  Aligned_cols=256  Identities=27%  Similarity=0.352  Sum_probs=208.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      +.|++++.||+|+||.||+|.+. +++.||+|++........+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56999999999999999999985 48899999998766667778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++|+|.+++.+..  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....  ..
T Consensus        92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~  164 (288)
T d2jfla1          92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TI  164 (288)
T ss_dssp             TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--HH
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--Cc
Confidence            9999999875533  34999999999999999999999999   99999999999999999999999999876421  11


Q ss_pred             CccccccccCCCCCccccc-----CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          198 GNTKRVIGTYGYMAPEYAS-----DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                      .......||+.|+|||++.     +..|+.++|||||||++|+|++|..||......   ........   .. ...+..
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~---~~-~~~~~~  237 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAK---SE-PPTLAQ  237 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHH---SC-CCCCSS
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHc---CC-CCCCCc
Confidence            1223456899999999874     456889999999999999999999998654322   22222221   11 111110


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                             .......+.+||.+||+.||++|||+.|++++-+..
T Consensus       238 -------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~  273 (288)
T d2jfla1         238 -------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT  273 (288)
T ss_dssp             -------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred             -------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                   011123577899999999999999999999976543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=372.31  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=201.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||+|.+. +|+.||||++.+.   .......+.+|+++++.++||||++++++|.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999985 4899999998642   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++|+|.+++....   .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++..+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999986543   3999999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++|..||...+   .......+..   ..  ..+..  
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~---~~--~~~p~--  231 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQKIIK---LE--YDFPE--  231 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHT---TC--CCCCT--
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHHHHHc---CC--CCCCc--
Confidence            33333445679999999999999999999999999999999999999986432   1222222211   11  11111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHH
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVIL  310 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~  310 (358)
                         ..    ...+.+||.+||+.||++|||+.|++.
T Consensus       232 ---~~----s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         232 ---KF----FPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---TC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---cC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               11    235678999999999999999998643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=367.62  Aligned_cols=260  Identities=28%  Similarity=0.439  Sum_probs=201.1

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++.+.||+|+||.||+|+++  ..||||+++.  ......+.+.+|+.++++++||||+++++++. .+..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence            3578999999999999999999763  3699999864  34556678899999999999999999999864 45789999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        83 Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            9999999999986543  23999999999999999999999999   999999999999999999999999999876433


Q ss_pred             CCCCccccccccCCCCCcccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..........||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.......  ...................
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p~~~~~~  235 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSKVR  235 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCCCGGGSC
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCCcchhcc
Confidence            33334445678999999999864   358999999999999999999999986433211  1111122111111111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..         ....+.+||.+||+.||++|||+.+|++.|+.+
T Consensus       236 ~~---------~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         236 SN---------CPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             TT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cc---------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11         123577899999999999999999999999865

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=364.18  Aligned_cols=255  Identities=25%  Similarity=0.420  Sum_probs=198.7

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .++|++++.||+|+||.||+|.+.+++.||||.+.... ...+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            37899999999999999999999888899999997633 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++........ 
T Consensus        83 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  156 (263)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence            9999999986543  34889999999999999999999999   99999999999999999999999999986532221 


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCC-CCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK-KNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .......|++.|+|||++.+..++.++|||||||++|+|+++. .||...   ........+........+    .    
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~~~p----~----  225 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRLYKP----R----  225 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCCCCCC----T----
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCCCCCc----c----
Confidence            1222356889999999999999999999999999999999954 444322   222222222222111111    1    


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       .    ....+.+||.+||+.||++|||+.+|+++|+.+
T Consensus       226 -~----~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         226 -L----ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             -T----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -c----cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             0    113567899999999999999999999999764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=378.74  Aligned_cols=259  Identities=21%  Similarity=0.309  Sum_probs=205.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .++|++++.||+|+||+||+|.+. +|+.||+|++... .......+.+|+.+|+.++||||++++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            478999999999999999999975 4889999998653 33445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      |+++|+|.+++.+..   .+++..++.++.|++.||.|||+ ++   |+||||||+|||++.+|.+||+|||++..+.  
T Consensus        85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~--  156 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--  156 (322)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH--
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC--
Confidence            999999999996543   39999999999999999999997 48   9999999999999999999999999998652  


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH--------------
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK--------------  260 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------  260 (358)
                        ........||+.|+|||++.+..|+.++||||+||++|+|++|+.||...+.............              
T Consensus       157 --~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         157 --DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             --HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             --CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence              1223356799999999999999999999999999999999999999865432211000000000              


Q ss_pred             ---------------------HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          261 ---------------------LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       261 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                                           ......++.+..        .....++.+||.+||+.||++|||+.|++++-+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~  301 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--------GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI  301 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCB--------TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCcc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence                                 000000000000        0012357789999999999999999999987543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=365.94  Aligned_cols=258  Identities=26%  Similarity=0.345  Sum_probs=196.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l  112 (358)
                      .++|++++.||+|+||.||+|.++ +|+.||+|.+...  ++...+.+.+|++++++++||||+++++++.+  ++.+++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            368999999999999999999975 4899999998653  44556778899999999999999999999865  456899


Q ss_pred             EEEecCCCCHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHhcCC--CCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          113 IYEFMTNKSLDSFIFDQ-ERCKILDWSKRFHIICGTARGVMYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~i~~al~~LH~~~--~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      ||||+++|+|.+++.+. .....+++..++.++.||+.||.|||+++  .++|+||||||+|||++.++.+||+|||++.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998654 23345999999999999999999999864  2349999999999999999999999999998


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      .+...  ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.   ......+.    ......
T Consensus       163 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i~----~~~~~~  233 (269)
T d2java1         163 ILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIR----EGKFRR  233 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH----HTCCCC
T ss_pred             ecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHHHH----cCCCCC
Confidence            75322  1223356789999999999999999999999999999999999999864322   22222222    222222


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      +..     .+    ...+.+||.+||+.||++|||+.|++++.+
T Consensus       234 ~~~-----~~----s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         234 IPY-----RY----SDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             CCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             CCc-----cc----CHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence            111     11    235778999999999999999999998743

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-51  Score=376.24  Aligned_cols=256  Identities=22%  Similarity=0.300  Sum_probs=211.1

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      ++|++++.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.+|+.++||||+++++++.+++..++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            58999999999999999999975 48999999998877777788899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC--CCCeEEeccccceecCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~--~~~i~L~Df~~~~~~~~~~  195 (358)
                      ++|+|.+++.+..  ..+++..++.++.||+.||.|||++|   |+||||||+|||++.  ++.+||+|||++..+..  
T Consensus       106 ~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--  178 (350)
T d1koaa2         106 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--  178 (350)
T ss_dssp             CSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred             CCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc--
Confidence            9999999985433  33999999999999999999999999   999999999999964  57899999999987632  


Q ss_pred             CCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.   ...+..+.... .........   
T Consensus       179 -~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~-~~~~~~~~~---  250 (350)
T d1koaa2         179 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCD-WNMDDSAFS---  250 (350)
T ss_dssp             -TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-CCSCCGGGG---
T ss_pred             -ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-CCCCccccc---
Confidence             2233456789999999999999999999999999999999999999864322   22222222110 011111111   


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            .....+.+||.+||+.||++|||+.+++++-+..
T Consensus       251 ------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~  284 (350)
T d1koaa2         251 ------GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  284 (350)
T ss_dssp             ------GCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred             ------CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                  1123567899999999999999999999986544

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.1e-52  Score=378.64  Aligned_cols=257  Identities=20%  Similarity=0.274  Sum_probs=210.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      -++|++++.||+|+||.||+|.+. +|+.||+|++..........+.+|+.+|+.++||||++++++|.+++..++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999975 5999999999876666667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc--CCCCeEEeccccceecCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~--~~~~i~L~Df~~~~~~~~~  194 (358)
                      |++|+|.+++....  ..+++..++.++.||+.||.|||++|   |+||||||+|||++  .++.+||+|||++..+.. 
T Consensus       108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-  181 (352)
T d1koba_         108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-  181 (352)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred             CCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC-
Confidence            99999998875433  23999999999999999999999999   99999999999997  678999999999987632 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                        ........+++.|+|||++.+..++.++|||||||++|+|++|..||.....   ...+..+.... ...+.....  
T Consensus       182 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~-~~~~~~~~~--  253 (352)
T d1koba_         182 --DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCD-WEFDEDAFS--  253 (352)
T ss_dssp             --TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCC-CCCCSSTTT--
T ss_pred             --CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-CCCCccccc--
Confidence              2233456789999999999999999999999999999999999999864332   12222222110 011111111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                             .....+.+||.+||+.||.+|||+.+++++-|..
T Consensus       254 -------~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~  287 (352)
T d1koba_         254 -------SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  287 (352)
T ss_dssp             -------TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             -------CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence                   1123567899999999999999999999986543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-52  Score=372.88  Aligned_cols=257  Identities=23%  Similarity=0.288  Sum_probs=192.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ..++|++.+.||+|+||.||+|.++ +|+.||+|++.+.. ......+.+|+.+|+.++||||+++++++.+++..++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4577999999999999999999985 48999999997533 223456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc---CCCCeEEeccccceec
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLARAF  191 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~---~~~~i~L~Df~~~~~~  191 (358)
                      ||++||+|.+++...   +.+++..++.++.||+.||.|||+++   |+||||||+||++.   .++.+||+|||++...
T Consensus        87 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999999653   34999999999999999999999999   99999999999995   5789999999999865


Q ss_pred             CCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ..   ........||+.|+|||++.+..++.++|||||||++|+|++|..||.....   .........   ....  ..
T Consensus       161 ~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~---~~~~--~~  229 (307)
T d1a06a_         161 DP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQILK---AEYE--FD  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHT---TCCC--CC
T ss_pred             cC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHhc---cCCC--CC
Confidence            32   2223356799999999999999999999999999999999999999864322   112111111   1111  00


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .+ ....    ....+.+||.+||+.||++|||+.|++++.+..
T Consensus       230 ~~-~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  268 (307)
T d1a06a_         230 SP-YWDD----ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA  268 (307)
T ss_dssp             TT-TTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred             Cc-cccC----CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence            00 0001    123567899999999999999999999986543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=358.02  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=200.1

Q ss_pred             cCCC-CcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCe
Q 018304           38 TNNF-SINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEE  109 (358)
Q Consensus        38 ~~~y-~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~  109 (358)
                      .++| ++.+.||+|+||.||+|.+.. ++.|++|.+..  ........+.+|+++|++++||||+++++++.+    ...
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            3455 678899999999999999854 88999999864  245556778899999999999999999999876    346


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEc-CCCCeEEeccccc
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLA  188 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~-~~~~i~L~Df~~~  188 (358)
                      .++||||+++|+|.+++.+..   .+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||++
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            799999999999999996543   3999999999999999999999975 3499999999999997 5789999999999


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ....    ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||......  ....    ........+
T Consensus       163 ~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~----~~i~~~~~~  231 (270)
T d1t4ha_         163 TLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIY----RRVTSGVKP  231 (270)
T ss_dssp             GGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHH----HHHTTTCCC
T ss_pred             eecc----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHH----HHHHcCCCC
Confidence            7532    223345679999999998875 6999999999999999999999998543211  1111    111122111


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ...+..        ....+.+||.+||+.||++|||+.|++++-+
T Consensus       232 ~~~~~~--------~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~  268 (270)
T d1t4ha_         232 ASFDKV--------AIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  268 (270)
T ss_dssp             GGGGGC--------CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             cccCcc--------CCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence            111111        1124668999999999999999999998765

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-51  Score=357.31  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=209.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .++|++.+.||+|+||.||+|++++++.||||.+++.. .....+.+|+.++.+++||||+++++++.+++..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            37899999999999999999999888899999997643 34467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      .+|+|.+++.....  .+++..+++++.||++||.|||+++   |+||||+|+||+++.++.+||+|||++..+..... 
T Consensus        82 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-  155 (258)
T d1k2pa_          82 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  155 (258)
T ss_dssp             TTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred             CCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence            99999999755433  3889999999999999999999999   99999999999999999999999999986543322 


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQ  276 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (358)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......   .....+..    ........    
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~i~~----~~~~~~p~----  224 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQ----GLRLYRPH----  224 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHT----TCCCCCCT----
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHHHHh----CCCCCCcc----
Confidence            22234568889999999999999999999999999999998 89898654422   22222221    11111111    


Q ss_pred             CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          277 GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       277 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                       .    ....+.+||.+||+.||++|||+.+|+++|.+
T Consensus       225 -~----~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         225 -L----ASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -T----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -c----ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             1    11356789999999999999999999999865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-52  Score=369.28  Aligned_cols=260  Identities=27%  Similarity=0.394  Sum_probs=208.9

Q ss_pred             HHhcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           35 VSATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        35 ~~~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      +...++|++.+.||+|+||.||+|.++. ++.||||.++... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            3445789999999999999999999865 8899999997643 3456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++|+|.+++..... ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             eecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence            999999999999865433 34899999999999999999999999   99999999999999999999999999986532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .. ........+++.|+|||.+.+..++.++|||||||++|+|++|..||....  .........    .........+.
T Consensus       168 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i----~~~~~~~~~~~  240 (287)
T d1opja_         168 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELL----EKDYRMERPEG  240 (287)
T ss_dssp             SS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHH----HTTCCCCCCTT
T ss_pred             CC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHH----hcCCCCCCCcc
Confidence            21 112223457889999999999999999999999999999999777643211  111111111    12221111111


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                               ....+.+||.+||+.||++|||+.+|++.|+.+
T Consensus       241 ---------~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         241 ---------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             ---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ---------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                     123577899999999999999999999988765

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=362.59  Aligned_cols=255  Identities=31%  Similarity=0.441  Sum_probs=204.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .++|++.+.||+|+||.||+|.+++++.||||.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            47899999999999999999999888899999997633 345678999999999999999999998754 5679999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++|+|.+++...... .+++..++.++.||++||.|||+++   |+||||||+||++++++.+||+|||++..+..... 
T Consensus        90 ~~g~L~~~~~~~~~~-~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          90 ENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TTCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            999999987654432 3899999999999999999999999   99999999999999999999999999987643221 


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .......+++.|+|||++.+..++.++|||||||++|+|++|..|+...  .........+.    ........+.    
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~----~~~~~~~p~~----  234 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLE----RGYRMVRPDN----  234 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHH----TTCCCCCCTT----
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHHH----hcCCCCCccc----
Confidence            1223446888999999999889999999999999999999966553221  12222222222    1111111111    


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                       .    ...+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       235 -~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         235 -C----PEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             -C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -C----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence             1    1356789999999999999999999998875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=364.76  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=206.3

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .++|++.+.||+|+||+||+|.++ +|+.||+|++.+..      ....+.+.+|+.+|+.++||||++++++|.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            478999999999999999999985 48999999986421      22357788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC----CeEEeccc
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG  186 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~----~i~L~Df~  186 (358)
                      ++|||||++|+|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999996543   4999999999999999999999999   99999999999998776    49999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM  266 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (358)
                      ++......   .......+++.|+|||++.+..++.++||||+||++|+|++|..||......   .....+... ....
T Consensus       163 ~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~-~~~~  235 (293)
T d1jksa_         163 LAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAV-NYEF  235 (293)
T ss_dssp             TCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTT-CCCC
T ss_pred             hhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHHHHHhc-CCCC
Confidence            99876322   2233456889999999999999999999999999999999999998643221   111111110 0000


Q ss_pred             CCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          267 PSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                      ......         .....+.+||.+||+.||++|||+.+++++-+.
T Consensus       236 ~~~~~~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  274 (293)
T d1jksa_         236 EDEYFS---------NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  274 (293)
T ss_dssp             CHHHHT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             CchhcC---------CCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            000100         012356789999999999999999999997654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-50  Score=361.54  Aligned_cols=249  Identities=28%  Similarity=0.426  Sum_probs=201.9

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      .|++++.||+|+||.||+|.+. +|+.||||.+....   ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            5999999999999999999975 48899999986532   3445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      ||.+|+|..++...   +.+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++....   
T Consensus        96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~---  166 (309)
T d1u5ra_          96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA---  166 (309)
T ss_dssp             CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS---
T ss_pred             ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC---
Confidence            99999887766433   34999999999999999999999999   9999999999999999999999999997642   


Q ss_pred             CCCccccccccCCCCCcccccC---CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASD---GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID  272 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (358)
                         ......||+.|+|||++.+   ..|+.++|||||||++|+|++|..||.....   ...+....   ....+ ....
T Consensus       167 ---~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~~i~---~~~~~-~~~~  236 (309)
T d1u5ra_         167 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIA---QNESP-ALQS  236 (309)
T ss_dssp             ---SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH---HSCCC-CCSC
T ss_pred             ---CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH---hCCCC-CCCC
Confidence               1234569999999999864   4689999999999999999999999854321   12222111   12111 1111


Q ss_pred             CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          273 PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       273 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .    ..    ...+.+||.+||+.||++|||+.+++++-+-.
T Consensus       237 ~----~~----s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         237 G----HW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             T----TS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             C----CC----CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence            1    11    23567899999999999999999999875543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-50  Score=361.83  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=196.3

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CC---EEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQ---EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~---~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|++.+.||+|+||.||+|.++. ++   .|+||.+.. ......+.+.+|+++|++++||||+++++++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            678999999999999999998753 32   588888865 3445567789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++|+|.+++....  +.+++..++.++.||+.||.|||+++   ++||||||+|||++.++.+||+|||++..+..
T Consensus       106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999886533  34899999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCCCCc---cccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCc
Q 018304          194 DETEGN---TKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQ  269 (358)
Q Consensus       194 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (358)
                      ......   .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.....   ......+...    ....
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~----~~~~  253 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQD----YRLP  253 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTT----CCCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcC----CCCC
Confidence            222211   112346889999999999999999999999999999998 8999764332   2222222211    1111


Q ss_pred             cccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          270 LIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       270 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ...         .....+.+||.+||+.||++|||+.+|++.|+.+
T Consensus       254 ~~~---------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         254 PPM---------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             CCT---------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCc---------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111         1123567899999999999999999999998765

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=366.51  Aligned_cols=259  Identities=30%  Similarity=0.439  Sum_probs=204.8

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-C-----CEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-G-----QEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~-----~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~  108 (358)
                      ..++|++.+.||+|+||+||+|.+.. +     ..|++|.+... .......+.+|+.++.++ +||||+++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34789999999999999999998644 2     26899988652 334456788999999998 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhcccc--------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQER--------------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLK  168 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~  168 (358)
                      ..++||||+++|+|.+++.....                    ...+++..++.++.||+.||.|||+++   |+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence            99999999999999999965432                    234899999999999999999999999   9999999


Q ss_pred             CCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCC
Q 018304          169 ASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYH  247 (358)
Q Consensus       169 ~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~  247 (358)
                      |+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986543333223334567899999999999999999999999999999997 899986544


Q ss_pred             CCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhc
Q 018304          248 SDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLG  313 (358)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~  313 (358)
                      ...  .......    ..........         ....+.+||.+||+.||++|||+.+|+++|.
T Consensus       272 ~~~--~~~~~~~----~~~~~~~p~~---------~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VDA--NFYKLIQ----NGFKMDQPFY---------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CSH--HHHHHHH----TTCCCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH--HHHHHHh----cCCCCCCCCc---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            321  1111111    1111111111         1235778999999999999999999999985

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=364.17  Aligned_cols=252  Identities=22%  Similarity=0.262  Sum_probs=208.3

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||+|+++ +|+.||+|++.+.   .......+.+|+.+|+.++||||++++++|.+.+.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999975 4999999999752   2335677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+++|+|.+++.....   +++..++.++.||+.||+|||++|   |+||||||+||+++.+|.+||+|||++......
T Consensus        85 ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999865443   899999999999999999999999   999999999999999999999999999864321


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                        .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.   .........   ..  ..+..  
T Consensus       159 --~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i~~---~~--~~~p~--  226 (337)
T d1o6la_         159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILM---EE--IRFPR--  226 (337)
T ss_dssp             --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---CC--CCCCT--
T ss_pred             --CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHHHHhc---CC--CCCCc--
Confidence              2233456799999999999999999999999999999999999999865432   122222211   11  11111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~  315 (358)
                         ..    ...+.+||.+||+.||.+||+     +.+++++-+..
T Consensus       227 ---~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~  265 (337)
T d1o6la_         227 ---TL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             ---TS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             ---cC----CHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence               11    135678999999999999994     89999886653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=354.67  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=204.3

Q ss_pred             cCCCCccee-ecccCCccEEEEEEcC---CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKK-LGQGGFGPVYKGTLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~-lg~g~~g~v~~~~~~~---~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|.+.+. ||+|+||.||+|.++.   +..||||.++.. .......+.+|+++|++++||||+++++++.+ +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            356778884 9999999999997642   457999999753 34556788999999999999999999999865 56899


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+++|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++..+.
T Consensus        86 vmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            999999999999875433  34999999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCC-CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          193 GDETE-GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       193 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ..... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......   .....+.    .+.....
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~----~~~~~~~  233 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QGKRMEC  233 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHH----TTCCCCC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCCCCCC
Confidence            33221 22223457889999999998999999999999999999998 89998654322   2222222    2222222


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ....         ...+.+||.+||..+|++|||+.+|++.|+..
T Consensus       234 p~~~---------~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         234 PPEC---------PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CTTC---------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcC---------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1111         13567899999999999999999999888654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-48  Score=357.74  Aligned_cols=249  Identities=20%  Similarity=0.215  Sum_probs=206.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||+|.++ +|+.||||++.+.   .......+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            58999999999999999999985 4999999998642   2234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.+|+|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++..+.. 
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence            9999999999986544   3999999999999999999999999   99999999999999999999999999987632 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|..||....   .......+..   ...  ....  
T Consensus       194 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~---~~~--~~p~--  259 (350)
T d1rdqe_         194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVS---GKV--RFPS--  259 (350)
T ss_dssp             ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH---CCC--CCCT--
T ss_pred             ----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHHHHhc---CCC--CCCc--
Confidence                2234679999999999999999999999999999999999999986432   2222222221   111  1111  


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                         .    ...++.++|.+||+.||.+|+     |+.+|+++-+..
T Consensus       260 ---~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~  298 (350)
T d1rdqe_         260 ---H----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             ---T----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             ---c----CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence               1    123567899999999999994     999999876653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=353.52  Aligned_cols=257  Identities=27%  Similarity=0.410  Sum_probs=201.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEec
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM  117 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~  117 (358)
                      .++|++.+.||+|+||.||+|.+++++.||||++.... ...+.+.+|+.++++++|+||+++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46899999999999999999999888889999997533 344678999999999999999999999854 5688999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++|+|..++..... +.+++..++.++.||+.||.|||+++   |+||||||+||+|+.++.+||+|||++..+.... .
T Consensus        94 ~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~  168 (285)
T d1fmka3          94 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  168 (285)
T ss_dssp             TTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-c
Confidence            99999998865432 23999999999999999999999999   9999999999999999999999999998653222 1


Q ss_pred             CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          198 GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+.....  .......+..    .........    
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~~----~~~~~~~~~----  238 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVER----GYRMPCPPE----  238 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT----TCCCCCCTT----
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHh----cCCCCCCcc----
Confidence            222345688999999999999999999999999999999997766433222  1222222221    111111111    


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                           ....+.++|.+||+.||++|||+.+|++.|+...
T Consensus       239 -----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         239 -----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             -----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             -----cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                 1235778999999999999999999999988754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=352.03  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=198.5

Q ss_pred             CCCCcceeecccCCccEEEEEEcCC-----CEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDG-----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~-----~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      +.|++.+.||+|+||.||+|.++.+     ..||||.+.. ........+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5789999999999999999987542     3699999865 334445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+.++++.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++..+.
T Consensus        87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999998875443  34999999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCCC-ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEG-NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ...... ......|++.|+|||.+.+..++.++|||||||++|+|++|..|+....  ........+.    .+......
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~----~~~~~~~~  235 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAIN----DGFRLPTP  235 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHH----TTCCCCCC
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHh----ccCCCCCc
Confidence            322211 2223457889999999999999999999999999999999766643221  1222222222    22111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ..         ....+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus       236 ~~---------~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         236 MD---------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             TT---------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             hh---------hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence            11         1235778999999999999999999999987653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.9e-50  Score=360.92  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=205.6

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~  114 (358)
                      ++|++++.||+|+||.||+|+++ +|+.||||++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999985 4899999999642   2334577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCC
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGD  194 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~  194 (358)
                      ||+.|++|..++.....   +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||++..... 
T Consensus        84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc-
Confidence            99999999998855443   889999999999999999999999   99999999999999999999999999987532 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.   ......+..   ...  .+.   
T Consensus       157 ----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~---~~~--~~p---  221 (316)
T d1fota_         157 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKILN---AEL--RFP---  221 (316)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH---CCC--CCC---
T ss_pred             ----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HHHHHHHHc---CCC--CCC---
Confidence                23356799999999999999999999999999999999999999864322   222222211   111  111   


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhcc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGS  314 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~  314 (358)
                        ...    ..++.+++.+||..||.+|+     |+.+++++.+.
T Consensus       222 --~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f  260 (316)
T d1fota_         222 --PFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  260 (316)
T ss_dssp             --TTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             --CCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence              111    13567899999999999996     99999987654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-50  Score=361.55  Aligned_cols=255  Identities=19%  Similarity=0.250  Sum_probs=206.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      -++|++.+.||+|+||.||+|.++ +++.||+|.++.... ....+.+|+++|+.++||||++++++|++++.+|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            478999999999999999999986 488999999976543 345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCC--CCeEEeccccceecCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLARAFGGD  194 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~--~~i~L~Df~~~~~~~~~  194 (358)
                      |+|++|.+++....  ..+++..++.++.||+.||.|||++|   |+||||||+||+++.+  ..++|+|||++..... 
T Consensus        83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-  156 (321)
T d1tkia_          83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-  156 (321)
T ss_dssp             CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred             CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence            99999999996533  23999999999999999999999999   9999999999999854  5799999999987532 


Q ss_pred             CCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC
Q 018304          195 ETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC  274 (358)
Q Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (358)
                        ........+++.|+|||.+.+..++.++||||+||++|+|++|..||.....   ......+... ....+...... 
T Consensus       157 --~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i~~~-~~~~~~~~~~~-  229 (321)
T d1tkia_         157 --GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNA-EYTFDEEAFKE-  229 (321)
T ss_dssp             --TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHT-CCCCCHHHHTT-
T ss_pred             --CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-CCCCChhhccC-
Confidence              2233456789999999999999999999999999999999999999865332   1222222111 00001100000 


Q ss_pred             cCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          275 IQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       275 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                              ...++.+||.+||..||++|||+.|++++-|.
T Consensus       230 --------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         230 --------ISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             --------SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             --------CCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence                    12356789999999999999999999997543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=350.96  Aligned_cols=247  Identities=29%  Similarity=0.389  Sum_probs=194.9

Q ss_pred             eeecccCCccEEEEEEcC---CCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEecCC
Q 018304           45 KKLGQGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        45 ~~lg~g~~g~v~~~~~~~---~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~  119 (358)
                      ++||+|+||.||+|.+..   ++.||||+++..  +....+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998643   467999998652  23345678899999999999999999999865 467899999999


Q ss_pred             CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC-C
Q 018304          120 KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE-G  198 (358)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~-~  198 (358)
                      |+|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++.++.++|+|||++..+...... .
T Consensus        92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999986543   3999999999999999999999999   999999999999999999999999999876433222 2


Q ss_pred             ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCcCC
Q 018304          199 NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQG  277 (358)
Q Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (358)
                      ......|++.|+|||.+.+..++.++|||||||++|+|++ |..||.....   ......+.    .+........    
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~----~~~~~~~p~~----  234 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE----KGERMGCPAG----  234 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH----TTCCCCCCTT----
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHH----cCCCCCCCcc----
Confidence            2233468889999999999999999999999999999997 8999865332   12222222    2221111111    


Q ss_pred             CCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          278 SFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       278 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                           ....+.+||.+||+.||++|||+.+|++.|+.
T Consensus       235 -----~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         235 -----CPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             -----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                 12356789999999999999999999887764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.6e-49  Score=350.60  Aligned_cols=256  Identities=21%  Similarity=0.268  Sum_probs=205.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC---------hhhHHHHHHHHHHHHhcC-CCCccceeeEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ  106 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~---------~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~  106 (358)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+..         ....+.+.+|+.+++.++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            479999999999999999999975 58899999986532         122345778999999996 9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      ++..++||||+++|+|.+++....   .+++..++.++.||+.||.|||++|   |+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            999999999999999999996533   4999999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCCCccccccccCCCCCcccccC------CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHH
Q 018304          187 LARAFGGDETEGNTKRVIGTYGYMAPEYASD------GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  260 (358)
                      ++..+...   .......|++.|.|||.+.+      ..++.++||||+||++|+|++|..||...+.   .........
T Consensus       156 ~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~~i~~  229 (277)
T d1phka_         156 FSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIMS  229 (277)
T ss_dssp             TCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH
T ss_pred             heeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHHHHHh
Confidence            99876432   22334578999999998853      3568899999999999999999999865332   122222221


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         .....  ...     ........+.+|+.+||+.||++|||+.+++++-|..
T Consensus       230 ---~~~~~--~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~  274 (277)
T d1phka_         230 ---GNYQF--GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  274 (277)
T ss_dssp             ---TCCCC--CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             ---CCCCC--CCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence               11110  000     0011123677899999999999999999999886543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-48  Score=359.04  Aligned_cols=253  Identities=25%  Similarity=0.313  Sum_probs=201.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEecccC---hhhHHHHH---HHHHHHHhcCCCCccceeeEEEeCCeeE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELK---NEVILFSKLQHRNLVKLLGCCIQGEEKL  111 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~~---~~~~~~~~---~e~~~l~~l~~~~iv~~~~~~~~~~~~~  111 (358)
                      ++|++++.||+|+||.||+|++.. |+.||+|++.+..   ......+.   .++.+++.++||||++++++|.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            689999999999999999999864 8999999986421   11222333   3466777778999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceec
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAF  191 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~  191 (358)
                      +||||+++|+|.+++.+..   .+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++..+
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999996543   3899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcc
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQL  270 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (358)
                      ...    ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............   ..  ......+
T Consensus       158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~--~~~~~~~  228 (364)
T d1omwa3         158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MT--LTMAVEL  228 (364)
T ss_dssp             SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---HS--SSCCCCC
T ss_pred             CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc--ccCCCCC
Confidence            432    2334579999999999864 578999999999999999999999987654433221111   11  1111111


Q ss_pred             ccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----hHHHHHHhccC
Q 018304          271 IDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPS-----MPSVILMLGSE  315 (358)
Q Consensus       271 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~ell~~l~~~  315 (358)
                      ..     ..    ...+.+||.+||+.||++|||     +.+++++-+..
T Consensus       229 ~~-----~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~  269 (364)
T d1omwa3         229 PD-----SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  269 (364)
T ss_dssp             CS-----SS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred             CC-----CC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence            11     11    135678999999999999999     79999876654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.3e-49  Score=349.59  Aligned_cols=258  Identities=21%  Similarity=0.326  Sum_probs=199.6

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----  108 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|+++..   +......+.+|+++++.++||||+++++++...+    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            3578999999999999999999975 5899999999652   3444567889999999999999999999998754    


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..|+||||+++++|.+++....   .+++..++.++.||+.||.|||++|   |+||||||+||+++.++..+++|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence            3789999999999999885543   3999999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCC-CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          189 RAFGGDET-EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       189 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ........ ........|++.|+|||++.+..++.++|||||||++|+|++|..||.....   ...   ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~---~~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSV---AYQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHHHCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---HHH---HHHHHhcCCC
Confidence            76532222 2233345789999999999999999999999999999999999999864322   111   1122222211


Q ss_pred             -CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-ChHHHHHHhcc
Q 018304          268 -SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-SMPSVILMLGS  314 (358)
Q Consensus       268 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~ell~~l~~  314 (358)
                       ......    .    ....+.++|.+||+.||++|| |+.++++.|..
T Consensus       233 ~~~~~~~----~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         233 PPSARHE----G----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CGGGTSS----S----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCchhcc----C----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence             111111    1    113567899999999999999 89999887654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-49  Score=358.69  Aligned_cols=256  Identities=18%  Similarity=0.198  Sum_probs=199.2

Q ss_pred             CCCCcce-eecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCccceeeEEEe----CCeeE
Q 018304           39 NNFSINK-KLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ----GEEKL  111 (358)
Q Consensus        39 ~~y~i~~-~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~----~~~~~  111 (358)
                      ++|++++ .||+|+||+||+|.+. +++.||||+++..     ..+.+|++++.++ +||||++++++|++    +..+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            6899886 5999999999999974 4899999999642     3566899886655 89999999999976    35789


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CCCeEEeccccc
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLA  188 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~~i~L~Df~~~  188 (358)
                      +|||||+||+|.+++.+... ..+++..++.++.||+.||.|||++|   |+||||||+||+++.   .+.+||+|||++
T Consensus        86 ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            99999999999999965432 34999999999999999999999999   999999999999985   467999999999


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ......   .......|++.|+|||++.+..|+.++|||||||++|+|++|..||...........+   ..    ....
T Consensus       162 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~----~i~~  231 (335)
T d2ozaa1         162 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT----RIRM  231 (335)
T ss_dssp             EECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCS
T ss_pred             eeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HH----HHhc
Confidence            876432   2234567999999999999999999999999999999999999998654332211111   00    0000


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .  ..............++.+||.+||+.||++|||+.+++++-|..
T Consensus       232 ~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         232 G--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             C--SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             C--CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence            0  00001111112234678899999999999999999999975543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-49  Score=352.76  Aligned_cols=260  Identities=27%  Similarity=0.420  Sum_probs=207.4

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC------CCEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .++|++++.||+|+||.||+|++++      ++.||||++... .......+.+|+++++.++||||+++++++.+.+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            4789999999999999999998642      468999999753 334456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhccc---------------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCC
Q 018304          111 LLIYEFMTNKSLDSFIFDQE---------------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKA  169 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~  169 (358)
                      +++|||+.+|+|.+++....                     ....+++..++.++.|++.||+|||+++   ++||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence            99999999999999985432                     1224889999999999999999999999   99999999


Q ss_pred             CcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCC-CCCCCCCC
Q 018304          170 SNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK-KNRGFYHS  248 (358)
Q Consensus       170 ~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~-~p~~~~~~  248 (358)
                      +||+++.++.+||+|||++..+.............+++.|+|||.+.+..++.++|||||||++|+|++|. .||.....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999997653333233333456788999999999999999999999999999999986 45544322


Q ss_pred             CCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          249 DNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                         ......+    ............         ..++.+||.+||+.+|++|||+.+|+++|+++.
T Consensus       249 ---~e~~~~v----~~~~~~~~p~~~---------~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         249 ---EEVIYYV----RDGNILACPENC---------PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             ---HHHHHHH----HTTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---HHHHHHH----HcCCCCCCCccc---------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence               2222222    222222222111         135778999999999999999999999998763

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-49  Score=352.35  Aligned_cols=262  Identities=24%  Similarity=0.280  Sum_probs=197.7

Q ss_pred             cceeecccCCccEEEEEEc-CCCEEEEEEecccChh-----hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           43 INKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-----GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        43 i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      .+++||+|+||+||+|.++ +|+.||||++......     ....+.+|+++++.++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4689999999999999975 4899999998653221     124578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.++++..+...   ...+++..+..++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++......  
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--  153 (299)
T d1ua2a_          82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--  153 (299)
T ss_dssp             CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred             hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC--
Confidence            988777666532   234999999999999999999999999   999999999999999999999999999765322  


Q ss_pred             CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCC-
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPC-  274 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  274 (358)
                      ........+|+.|+|||++.+. .++.++||||+||++|+|++|..||.....   .+.+..+.............+.. 
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhc
Confidence            2223345689999999988654 679999999999999999999999864332   22333322222111111100000 


Q ss_pred             --------cCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          275 --------IQGSFNLA-----EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       275 --------~~~~~~~~-----~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                              ........     ...++.+||.+||+.||++|||+.|++++-+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence                    00011111     124678899999999999999999999986643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=346.92  Aligned_cols=250  Identities=28%  Similarity=0.418  Sum_probs=197.0

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEe-CCeeEEEEEe
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEF  116 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv~e~  116 (358)
                      .++|++.+.||+|+||.||+|.+ .|..||||.++..  ...+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            36789999999999999999998 6789999999763  344678899999999999999999998855 4578999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +++|+|.+++..... ..+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....   
T Consensus        83 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---  155 (262)
T ss_dssp             CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC---
Confidence            999999999965432 23899999999999999999999999   99999999999999999999999999976422   


Q ss_pred             CCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          197 EGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                        ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .....+.    ......+.... 
T Consensus       156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~----~~~~~~~~~~~-  225 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KGYKMDAPDGC-  225 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHT----TTCCCCCCTTC-
T ss_pred             --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cCCCCCCCccC-
Confidence              2234457889999999998999999999999999999998 67776543322   2222222    11122221111 


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                              ...+.+||.+||+.||++|||+.+|+++|+.+
T Consensus       226 --------~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         226 --------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             --------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                    13567899999999999999999999999765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=350.39  Aligned_cols=269  Identities=27%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             eeHHHHHHhcCCCCcceeecccCCccEEEEEEcC------CCEEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCCccce
Q 018304           29 FELATIVSATNNFSINKKLGQGGFGPVYKGTLVD------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKL  100 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~------~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l-~~~~iv~~  100 (358)
                      ++..+++...++|++.+.||+|+||.||+|.+..      ++.||+|.+.. ........+..|...+.++ +|+||+.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            4555665556899999999999999999998633      35799999865 3344556677888888777 68999999


Q ss_pred             eeEEEeC-CeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCC
Q 018304          101 LGCCIQG-EEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRD  166 (358)
Q Consensus       101 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~d  166 (358)
                      ++++... ...++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++   |+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence            9987654 468999999999999999965432             234889999999999999999999999   99999


Q ss_pred             CCCCcEEEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCC-CCCCC
Q 018304          167 LKASNVLLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK-KNRGF  245 (358)
Q Consensus       167 i~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~-~p~~~  245 (358)
                      |||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|+|++|. .||..
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998764444443444567899999999999999999999999999999999865 56654


Q ss_pred             CCCCCCchhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          246 YHSDNNLNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ....  ........    .+......+..         ..++.++|.+||+.||++|||+.+|+++|+.+
T Consensus       240 ~~~~--~~~~~~~~----~~~~~~~~~~~---------~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         240 VKID--EEFCRRLK----EGTRMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CCCS--HHHHHHHH----HTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHH--HHHHHHHh----cCCCCCCCccC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            3322  11212222    22222222111         13577899999999999999999999999754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=357.27  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=202.0

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CCEEEEEEeccc---ChhhHHHHHHHHHHHH-hcCCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|++++.||+|+||+||+|.++. |+.||||++.+.   .......+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            689999999999999999999854 899999999652   2233455666666655 68999999999999999999999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGG  193 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~  193 (358)
                      |||+++|+|.+++.....   +++..++.++.||+.||.|||+++   ++||||||+|||++.++.+||+|||++.....
T Consensus        82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999965443   899999999999999999999999   99999999999999999999999999986532


Q ss_pred             CCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccC
Q 018304          194 DETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDP  273 (358)
Q Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (358)
                      .  ........||+.|+|||++.+..++.++||||+||++|+|++|..||...+.   ......+..    ..+ .+.. 
T Consensus       156 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~----~~~-~~p~-  224 (320)
T d1xjda_         156 G--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRM----DNP-FYPR-  224 (320)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----CCC-CCCT-
T ss_pred             c--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHc----CCC-CCCc-
Confidence            2  2233446799999999999999999999999999999999999999864322   122222211    111 1111 


Q ss_pred             CcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChH-HHHHHhc
Q 018304          274 CIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP-SVILMLG  313 (358)
Q Consensus       274 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-ell~~l~  313 (358)
                          ..    ...+.+||.+||+.||++|||+. +|+++-+
T Consensus       225 ----~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf  257 (320)
T d1xjda_         225 ----WL----EKEAKDLLVKLFVREPEKRLGVRGDIRQHPL  257 (320)
T ss_dssp             ----TS----CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             ----cC----CHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence                11    23567899999999999999996 7877544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=348.24  Aligned_cols=267  Identities=22%  Similarity=0.305  Sum_probs=201.3

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++++.||+|+||+||+|.+. +|+.||+|++....  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999984 48999999996532  2335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      |+.+ .+.+++.... ...+++..++.++.||+.||.|||++|   |+||||||+||+++.++.+||+|||.+...... 
T Consensus        82 ~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-  155 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-  155 (298)
T ss_dssp             CCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-
T ss_pred             ecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC-
Confidence            9976 4444443322 233999999999999999999999999   999999999999999999999999999875322 


Q ss_pred             CCCccccccccCCCCCcccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCC---CCccc
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGM---PSQLI  271 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  271 (358)
                       ........|++.|+|||.+.... ++.++||||+||++|+|++|+.||...+.   ...............   .....
T Consensus       156 -~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 -VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             -SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             -cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhccccc
Confidence             22333457899999999877665 57899999999999999999999864322   222222221111100   00000


Q ss_pred             ------cCC-cCCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 ------DPC-IQGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ------~~~-~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                            ... .......     .....+.+|+.+||+.||++|||+.|++++-+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~  287 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhc
Confidence                  000 0000011     1124577899999999999999999999986654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-48  Score=350.21  Aligned_cols=255  Identities=26%  Similarity=0.409  Sum_probs=199.4

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CC----EEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~----~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .+|++++.||+|+||.||+|.+.. |+    +|++|.+.. ......+.+.+|+.++++++||||+++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            579999999999999999998743 43    688898865 3334567889999999999999999999999865 5677


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      +++++.+++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++..+.
T Consensus        88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            889999999999876543  34999999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ............|++.|+|||.+.+..++.++|||||||++|+|++ |..||......   ............    ...
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~~~~~~----~~p  235 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGERL----PQP  235 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHHHTCCC----CCC
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCC----CCC
Confidence            4333333334568899999999999999999999999999999998 78887654332   222222221111    111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      .         .....+.+|+.+||+.||++|||+.+|+++|+.+
T Consensus       236 ~---------~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         236 P---------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             T---------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             c---------ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            1         1123567899999999999999999999988765

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=344.02  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=195.2

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC----CCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~----~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l  112 (358)
                      .++|++.+.||+|+||.||+|.+..    +..|++|.+.. ........+.+|++++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4789999999999999999998643    34688998865 34445677889999999999999999999985 467899


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecC
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFG  192 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~  192 (358)
                      ||||+.+|+|.+++....  ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++..+.
T Consensus        85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999999875433  34899999999999999999999999   9999999999999999999999999998653


Q ss_pred             CCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI  271 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (358)
                      ... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||......   .....+..    .....+.
T Consensus       160 ~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~~----~~~~~~~  231 (273)
T d1mp8a_         160 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIEN----GERLPMP  231 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHT----TCCCCCC
T ss_pred             CCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHHHc----CCCCCCC
Confidence            222 122234567889999999999999999999999999999998 88887654332   23222222    2111111


Q ss_pred             cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          272 DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       272 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..         ....+.+||.+||..||++|||+.+|++.|+.+
T Consensus       232 ~~---------~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         232 PN---------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             TT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11         123577899999999999999999999988653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=344.34  Aligned_cols=257  Identities=26%  Similarity=0.389  Sum_probs=195.5

Q ss_pred             cCCCCcceeecccCCccEEEEEEcC--C--CEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVD--G--QEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~--~--~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~  110 (358)
                      .++|++.+.||+|+||.||+|.+..  +  ..||||.+.+.   .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            3679999999999999999998533  2  36899988652   33445778999999999999999999999965 467


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ++||||++++++.+++....  +.+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            89999999999999876543  33999999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCC-ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          191 FGGDETEG-NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       191 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      +....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..   ....   .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~---~i~~~~~~~  234 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILH---KIDKEGERL  234 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHTSCCCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHH---HHHhCCCCC
Confidence            64433222 2223456778999999999999999999999999999998 89997643222   1222   222222221


Q ss_pred             ccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          269 QLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ......         ...+.+||.+||..||++|||+.+|++.|.+.
T Consensus       235 ~~~~~~---------~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 PRPEDC---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccc---------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111111         13567899999999999999999999998764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=344.63  Aligned_cols=261  Identities=29%  Similarity=0.409  Sum_probs=206.9

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEcC--------CCEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCccceeeEEE
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCI  105 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~~--------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~  105 (358)
                      ...++|++.+.||+|+||.||+|.+..        +..||||.++... ......+.+|+..+.++ +||||+++++++.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            345799999999999999999998533        2369999987633 34567788899999888 7999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHHhcccc-------------ccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcE
Q 018304          106 QGEEKLLIYEFMTNKSLDSFIFDQER-------------CKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNV  172 (358)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Ni  172 (358)
                      +++..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++   ++||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence            99999999999999999999965431             245899999999999999999999999   99999999999


Q ss_pred             EEcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHh-CCCCCCCCCCCCC
Q 018304          173 LLDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNN  251 (358)
Q Consensus       173 lv~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~  251 (358)
                      |++.++.+||+|||++................+++.|+|||.+.++.|+.++||||||+++|+|++ |..||......  
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--  244 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  244 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence            999999999999999987755444444555678899999999999999999999999999999998 67776543321  


Q ss_pred             chhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          252 LNLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                       .    ....+..+........         ...++.+||.+||+.||++|||+.+|++.|+.+
T Consensus       245 -~----~~~~i~~~~~~~~p~~---------~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         245 -E----LFKLLKEGHRMDKPSN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             -H----HHHHHHTTCCCCCCSS---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -H----HHHHHHcCCCCCCCcc---------chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             1    2222222222222211         123577899999999999999999999999765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.3e-48  Score=344.77  Aligned_cols=265  Identities=22%  Similarity=0.304  Sum_probs=201.9

Q ss_pred             CCCCcceeecccCCccEEEEEEcCCCEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF  116 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~  116 (358)
                      ++|++++.||+|+||+||+|.+++|+.||||++....  ......+.+|+.+|+.++||||+++++.+.+.+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999889999999996532  33357788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCC
Q 018304          117 MTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDET  196 (358)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~  196 (358)
                      +.++.+..+....   +.+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||.+......  
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--  153 (286)
T d1ob3a_          82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--  153 (286)
T ss_dssp             CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC--
Confidence            9887666665333   34999999999999999999999999   999999999999999999999999999875322  


Q ss_pred             CCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCcccc---
Q 018304          197 EGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLID---  272 (358)
Q Consensus       197 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  272 (358)
                      ........+++.|.|||.+.+. .++.++||||+||++|+|++|+.||.....   .....................   
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchhh
Confidence            1222344688899999988754 568999999999999999999999864332   222222221111110000000   


Q ss_pred             ------------CCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhcc
Q 018304          273 ------------PCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGS  314 (358)
Q Consensus       273 ------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~  314 (358)
                                  ..............+.+||.+||+.||++|||+.|++++-+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f  284 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence                        000000001112357789999999999999999999987654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-48  Score=347.07  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=200.7

Q ss_pred             CCCCcceeecccCCccEEEEEEcC-CC--EEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLVD-GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI  113 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~~-~~--~v~vK~~~~-~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv  113 (358)
                      ++|++.+.||+|+||.||+|.+++ |.  .|+||.+.. ........+.+|+++|.++ +||||+++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            688999999999999999998754 43  577888754 2334556788999999998 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhccc-------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCe
Q 018304          114 YEFMTNKSLDSFIFDQE-------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNP  180 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i  180 (358)
                      |||+++|+|.+++....             ....+++..+++++.||+.||.|||+++   ++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            99999999999986542             2345999999999999999999999999   9999999999999999999


Q ss_pred             EEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCC-CCCCCCCCCCchhHHHHH
Q 018304          181 KISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKK-NRGFYHSDNNLNLIGHAW  259 (358)
Q Consensus       181 ~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~-p~~~~~~~~~~~~~~~~~  259 (358)
                      ||+|||++....   .........++..|+|||.+.+..++.++|||||||++|+|++|.. ||...+   .......+.
T Consensus       167 kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~i~  240 (309)
T d1fvra_         167 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLP  240 (309)
T ss_dssp             EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHGG
T ss_pred             EEcccccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHHHHH
Confidence            999999997542   2222234468899999999999999999999999999999999765 554322   222222222


Q ss_pred             HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          260 KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      .    .........         ....+.+||.+||+.||++|||+.+|+++|+.+.
T Consensus       241 ~----~~~~~~~~~---------~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         241 Q----GYRLEKPLN---------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             G----TCCCCCCTT---------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             h----cCCCCCCcc---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2    111111111         1235778999999999999999999999987763

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-47  Score=342.90  Aligned_cols=261  Identities=29%  Similarity=0.402  Sum_probs=208.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEecc-cChhhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~  108 (358)
                      ..++|++.+.||+|+||.||+|++.      .++.||||+++. ........+.+|+.++..+ +||||+++++++.+.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3479999999999999999999852      356899999975 3344566788999999999 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccc---------------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEE
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQE---------------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVL  173 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nil  173 (358)
                      ..++||||+++|+|.+++....               ....+++..+..++.||+.||.|||+++   ++||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence            9999999999999999986543               2234899999999999999999999999   999999999999


Q ss_pred             EcCCCCeEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhC-CCCCCCCCCCCCc
Q 018304          174 LDQDMNPKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISG-KKNRGFYHSDNNL  252 (358)
Q Consensus       174 v~~~~~i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~p~~~~~~~~~~  252 (358)
                      ++.++.++++|||.+................+++.|+|||.+.+..++.++|||||||++|+|+++ .+||......   
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---  254 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---  254 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence            999999999999999876544333334456789999999999999999999999999999999984 5544333222   


Q ss_pred             hhHHHHHHHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          253 NLIGHAWKLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..+....   ..+........         ....+.+||.+||+.||++|||+.+|+++|+..
T Consensus       255 ~~~~~~i---~~~~~~~~~~~---------~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         255 SKFYKMI---KEGFRMLSPEH---------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHHHHH---HHTCCCCCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHH---hcCCCCCCccc---------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            2222111   11111111111         123577899999999999999999999998753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=338.55  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=199.5

Q ss_pred             ceeecccCCccEEEEEEcCC----CEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC-CeeEEEEEec
Q 018304           44 NKKLGQGGFGPVYKGTLVDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM  117 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~~----~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv~e~~  117 (358)
                      .++||+|+||+||+|.+.++    ..|+||.++. .+......+.+|++++.+++||||+++++++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999987442    2589999975 4556678899999999999999999999998764 5889999999


Q ss_pred             CCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCCCC
Q 018304          118 TNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDETE  197 (358)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~~~  197 (358)
                      ++++|.+++....  ...++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++..+......
T Consensus       112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999986543  23778889999999999999999999   999999999999999999999999999876433222


Q ss_pred             C--ccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccccCCc
Q 018304          198 G--NTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLIDPCI  275 (358)
Q Consensus       198 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (358)
                      .  ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....  .......+...    ........  
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g----~~~~~p~~--  258 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQG----RRLLQPEY--  258 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTT----CCCCCCTT--
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcC----CCCCCccc--
Confidence            1  22234578899999999999999999999999999999998888654322  22222222221    11111111  


Q ss_pred             CCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          276 QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       276 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                             ....+.+||.+||+.||++|||+.||+++|+.+.
T Consensus       259 -------~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         259 -------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                   1135678999999999999999999999998773

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=343.41  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=197.5

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccCh------hhHHHHHHHHHHHHhcC--CCCccceeeEEEeC
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCIQG  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~  107 (358)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+.+...      .....+.+|+.++++++  ||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            3579999999999999999999975 489999999864211      11233568999999986  89999999999999


Q ss_pred             CeeEEEEEecCC-CCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-CCCeEEecc
Q 018304          108 EEKLLIYEFMTN-KSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDF  185 (358)
Q Consensus       108 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-~~~i~L~Df  185 (358)
                      +..++||||+.+ +++.+++....   .+++..++.++.||+.||.|||+++   |+||||||+||+++. ++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CeEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence            999999999976 57777775433   3999999999999999999999999   999999999999985 579999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCC-CCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQF-SVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      |++.....    .......||+.|+|||++.+..+ +.++||||+||++|+|++|..||....         ...   ..
T Consensus       156 G~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~---~~  219 (273)
T d1xwsa_         156 GSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EII---RG  219 (273)
T ss_dssp             TTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHH---HC
T ss_pred             ccceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHh---hc
Confidence            99986532    22335579999999999887765 567999999999999999999986421         011   11


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..  .+     ....    ..++.+||.+||+.||++|||+.|++++-+..
T Consensus       220 ~~--~~-----~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  259 (273)
T d1xwsa_         220 QV--FF-----RQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  259 (273)
T ss_dssp             CC--CC-----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             cc--CC-----CCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence            10  00     1111    23577899999999999999999999986654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=340.63  Aligned_cols=261  Identities=29%  Similarity=0.448  Sum_probs=209.6

Q ss_pred             HhcCCCCcceeecccCCccEEEEEEc------CCCEEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 018304           36 SATNNFSINKKLGQGGFGPVYKGTLV------DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE  108 (358)
Q Consensus        36 ~~~~~y~i~~~lg~g~~g~v~~~~~~------~~~~v~vK~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~  108 (358)
                      ...++|++.+.||+|+||.||+|.++      ++..||||+++. ........+.+|++++++++||||+++++++..++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            33478999999999999999999863      257899999975 33445566889999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhccc-------cccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeE
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQE-------RCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPK  181 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~  181 (358)
                      ..++||||+.+|+|.+++....       ....+++..+.+++.+++.||.|||+++   |+||||||+|||++.++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence            9999999999999999985532       2234788999999999999999999999   99999999999999999999


Q ss_pred             EeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCC-CCCCCCCCCCCchhHHHHHH
Q 018304          182 ISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGK-KNRGFYHSDNNLNLIGHAWK  260 (358)
Q Consensus       182 L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~  260 (358)
                      |+|||++..+.............+++.|+|||.+.+..++.++||||||+++|+|++|. .||.....   ......+. 
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~~~~i~-  249 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVM-  249 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHHH-
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH-
Confidence            99999998664333333344456889999999999999999999999999999999985 56543221   12222222 


Q ss_pred             HhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          261 LWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                         ........+..         ...+.++|.+||+.+|++|||+.+|+++|+..
T Consensus       250 ---~~~~~~~p~~~---------~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         250 ---EGGLLDKPDNC---------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             ---TTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ---hCCCCCCcccc---------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence               11111111111         13577899999999999999999999999876

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=343.45  Aligned_cols=267  Identities=21%  Similarity=0.285  Sum_probs=197.6

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-C-CCEEEEEEeccc--ChhhHHHHHHHHHHHHhc---CCCCccceeeEEEe----
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-D-GQEIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ----  106 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~-~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l---~~~~iv~~~~~~~~----  106 (358)
                      .++|++++.||+|+||+||+|.+. + ++.||||++...  .......+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            479999999999999999999974 4 567899998642  222223455677777665   79999999999864    


Q ss_pred             -CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecc
Q 018304          107 -GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF  185 (358)
Q Consensus       107 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df  185 (358)
                       ....+++|||+.++.+.......  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.++|+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             24679999999887665444332  234899999999999999999999999   999999999999999999999999


Q ss_pred             ccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcC
Q 018304          186 GLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEG  265 (358)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  265 (358)
                      |++....   .........||+.|+|||++.+..|+.++||||+||++|+|++|..||.....   ...+..........
T Consensus       161 g~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~  234 (305)
T d1blxa_         161 GLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred             hhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCC
Confidence            9987542   22333456799999999999999999999999999999999999999865432   22222222211111


Q ss_pred             CCCcccc----------CCcC---CCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          266 MPSQLID----------PCIQ---GSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       266 ~~~~~~~----------~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ....+..          ....   ..........+.+||.+||+.||++|||+.|++++.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~  297 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  297 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence            0000000          0000   000011123567899999999999999999999986643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=339.45  Aligned_cols=269  Identities=20%  Similarity=0.266  Sum_probs=200.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEe--------
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------  106 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--------  106 (358)
                      .++|++++.||+|+||+||+|++. +|+.||||++...  .......+.+|+++|+.++|+||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            389999999999999999999985 5899999998542  33445678899999999999999999998855        


Q ss_pred             CCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          107 GEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      .+..+++|||+.++.+..+..   ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.++|+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            346799999998766655442   2234899999999999999999999999   9999999999999999999999999


Q ss_pred             cceecCCCCCC--CccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhh
Q 018304          187 LARAFGGDETE--GNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN  263 (358)
Q Consensus       187 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (358)
                      ++.........  .......+|+.|+|||++.+. .++.++||||+||++|+|++|..||.....   ........... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~-  238 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLC-  238 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHH-
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhc-
Confidence            99776432221  222234689999999988765 689999999999999999999999864332   22222222221 


Q ss_pred             cCCCCccccC------------CcCCCCCHHH-------HHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          264 EGMPSQLIDP------------CIQGSFNLAE-------VIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       264 ~~~~~~~~~~------------~~~~~~~~~~-------~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                      ..........            ..........       ...+.+||.+||+.||++|||+.|++++-+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            1111111111            0011111111       235678999999999999999999999988653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=336.23  Aligned_cols=266  Identities=21%  Similarity=0.297  Sum_probs=196.7

Q ss_pred             cCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHH--HHHHHHhcCCCCccceeeEEEeCC----eeE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN--EVILFSKLQHRNLVKLLGCCIQGE----EKL  111 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~--e~~~l~~l~~~~iv~~~~~~~~~~----~~~  111 (358)
                      ..+|.+.+.||+|+||.||+|++ +|+.||||++.....   .....  |+..+..++||||+++++++.+.+    ..+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            35788899999999999999987 789999999965322   33333  444555679999999999998654    578


Q ss_pred             EEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCcccCCCCCCcEEEcCCCCeEEeccc
Q 018304          112 LIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISDFG  186 (358)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-----~~~i~H~di~~~Nilv~~~~~i~L~Df~  186 (358)
                      +||||+++|+|.+++.+.    .+++..++.++.+++.||.|||+..     .++|+||||||+||||+.++.+||+|||
T Consensus        78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            999999999999999653    3889999999999999999999741     1239999999999999999999999999


Q ss_pred             cceecCCCCCC--CccccccccCCCCCcccccCCC------CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCc------
Q 018304          187 LARAFGGDETE--GNTKRVIGTYGYMAPEYASDGQ------FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNL------  252 (358)
Q Consensus       187 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~------  252 (358)
                      ++.........  .......|++.|+|||.+.+..      ++.++|||||||++|+|++|..||.........      
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            99876432221  1233457899999999887543      567899999999999999999887543322111      


Q ss_pred             --hhHHHHHHHhhcCCC-CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          253 --NLIGHAWKLWNEGMP-SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       253 --~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                        ............... +.+..    ..........+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCG----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCc----ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence              011111111111111 11111    111223445678899999999999999999999998765

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-46  Score=339.71  Aligned_cols=262  Identities=23%  Similarity=0.315  Sum_probs=197.0

Q ss_pred             hcCCCCcceeecccCCccEEEEEEcC-CCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----  108 (358)
                      ..++|++++.||+|+||+||+|.+.. |+.||||++.+  ........+.+|+++|+.++||||++++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            35899999999999999999999754 99999999975  34455677889999999999999999999997654     


Q ss_pred             -eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          109 -EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       109 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                       ..++||||+ +.+|..++..    ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.++++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence             469999999 5578777643    23999999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHH-------
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAW-------  259 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------  259 (358)
                      +.....     ......+++.|+|||.+.+. .++.++||||+||++|+|++|..||...+............       
T Consensus       168 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         168 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            987532     22345688999999988764 56899999999999999999999986543221111111100       


Q ss_pred             -------------HHhhcCCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          260 -------------KLWNEGMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       260 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                                   ..... .....+....     ......+.+||.+||+.||++|||+.|++++-+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPE-LEKKDFASIL-----TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCC-CCCCCGGGTC-----TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HhhhcchhhhhhhccCCc-ccccchHHhc-----cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                         00000 0000000000     0112356789999999999999999999998765543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=341.06  Aligned_cols=263  Identities=22%  Similarity=0.238  Sum_probs=195.8

Q ss_pred             CCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCCccceeeEEEeC------CeeEE
Q 018304           40 NFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEKLL  112 (358)
Q Consensus        40 ~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~------~~~~l  112 (358)
                      +|+.+++||+|+||+||+|++. +|+.||||++.....    ...+|+++|++++|+||++++++|...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            7899999999999999999985 489999999976332    234799999999999999999998643      25789


Q ss_pred             EEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEeccccceec
Q 018304          113 IYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAF  191 (358)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df~~~~~~  191 (358)
                      ||||++++.+..+.........+++..++.++.||+.||+|||++|   |+||||||+|||++.++ .+||+|||++..+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987544444333333445999999999999999999999999   99999999999999775 8999999999876


Q ss_pred             CCCCCCCccccccccCCCCCcccccC-CCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH---------
Q 018304          192 GGDETEGNTKRVIGTYGYMAPEYASD-GQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL---------  261 (358)
Q Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  261 (358)
                      ...   .......|++.|+|||.+.+ ..++.++||||+||++|+|++|..||......   ..+......         
T Consensus       174 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         174 VRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCHHHH
T ss_pred             cCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH---HHHHHHHHHhCCChHHhh
Confidence            332   22334578999999998765 57899999999999999999999998654322   121111111         


Q ss_pred             --hhcC----CCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          262 --WNEG----MPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       262 --~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                        ....    ....................++.+||.+||+.||++|||+.|++++-+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  307 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  307 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence              0000    00000000000011111234577899999999999999999999876543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=328.88  Aligned_cols=268  Identities=20%  Similarity=0.250  Sum_probs=206.9

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEE
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e  115 (358)
                      ++|++++.||+|+||+||+|++. +++.||||+++.  ........+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999985 488999999854  334456788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccceecCCCC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARAFGGDE  195 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~~~~~~  195 (358)
                      ++.++++..++...   +.+++..++.++.|++.||+|||+++   |+||||||+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99998888877543   33899999999999999999999999   9999999999999999999999999998764322


Q ss_pred             CCCccccccccCCCCCcccccCCC-CCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCCccc---
Q 018304          196 TEGNTKRVIGTYGYMAPEYASDGQ-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPSQLI---  271 (358)
Q Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  271 (358)
                        .......++..|.|||.+.+.. ++.++||||+||++|+|++|..||..  ........................   
T Consensus       156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             --ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence              1222334677899999887664 68999999999999999999999632  222222222222222111110000   


Q ss_pred             ------------cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          272 ------------DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       272 ------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                                  ...............+.+|+.+||+.||++|||+.|++++-|...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence                        000000111112245678999999999999999999999877643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-46  Score=339.09  Aligned_cols=269  Identities=20%  Similarity=0.287  Sum_probs=198.4

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----ee
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EK  110 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~----~~  110 (358)
                      .+++|++++.||+|+||+||+|.+. +|+.||||++.+.. ......+.+|+++|+.++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            4578999999999999999999974 59999999997533 445667889999999999999999999987653    23


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      +++++++.+++|.+++...    .+++..++.++.||+.||.|||++|   |+||||||+|||+++++.+||+|||++..
T Consensus        86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            4555667789999998543    3999999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCC-CCccccccccCCCCCccccc-CCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCCC
Q 018304          191 FGGDET-EGNTKRVIGTYGYMAPEYAS-DGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMPS  268 (358)
Q Consensus       191 ~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (358)
                      ...... ........+++.|+|||++. +..++.++||||+||++|+|++|..||.......   ...............
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQE  235 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChh
Confidence            533222 12233456889999999875 4567899999999999999999999986543211   111111110000000


Q ss_pred             cc------------ccCCcCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          269 QL------------IDPCIQGSFNLA-----EVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       269 ~~------------~~~~~~~~~~~~-----~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..            ............     ...++.+|+.+||+.||++|||+.+++++-+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~  299 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  299 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence            00            000000000110     113567899999999999999999999986543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=332.31  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=205.1

Q ss_pred             CCCCcceeecccCCccEEEEEEc----CCCEEEEEEeccc----ChhhHHHHHHHHHHHHhcCC-CCccceeeEEEeCCe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEE  109 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~----~~~~v~vK~~~~~----~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~  109 (358)
                      ++|++++.||+|+||+||+|++.    +|+.||+|.+.+.    .......+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999852    3789999998642    22334567789999999966 899999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccce
Q 018304          110 KLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLAR  189 (358)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~  189 (358)
                      .+++|||+.+++|.+++.....   +++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999865543   889999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCCCCccccccccCCCCCcccccCC--CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          190 AFGGDETEGNTKRVIGTYGYMAPEYASDG--QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      .+... .........+++.|++||.+.+.  .++.++|||||||++|+|++|..||...........+...........+
T Consensus       178 ~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~  256 (322)
T d1vzoa_         178 EFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP  256 (322)
T ss_dssp             ECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred             hhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence            65322 22223356789999999988754  4688999999999999999999998766555444333322221111111


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----ChHHHHHHhccC
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRP-----SMPSVILMLGSE  315 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~ell~~l~~~  315 (358)
                      .             .....+.+||.+||.+||++||     |+.|++++.+..
T Consensus       257 ~-------------~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~  296 (322)
T d1vzoa_         257 Q-------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  296 (322)
T ss_dssp             T-------------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             c-------------cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence            1             1123577899999999999999     589999876643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.1e-45  Score=324.47  Aligned_cols=262  Identities=16%  Similarity=0.216  Sum_probs=207.2

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCC-CCccceeeEEEeCCeeEEEE
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv~  114 (358)
                      .+++|++.+.||+|+||.||+|++. +|+.||+|++.....  ...+.+|++.++.+.| +|++.+++++..+...++||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            4689999999999999999999975 488999998865332  2456789999999965 89999999999999999999


Q ss_pred             EecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC-----CCCeEEeccccce
Q 018304          115 EFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLAR  189 (358)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~-----~~~i~L~Df~~~~  189 (358)
                      ||+ +++|.+++....  ..++...+..++.|++.||+|||++|   |+||||||+||+++.     ++.++|+|||++.
T Consensus        81 e~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            999 679999885543  23999999999999999999999999   999999999999964     5789999999998


Q ss_pred             ecCCCCCC-----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhc
Q 018304          190 AFGGDETE-----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNE  264 (358)
Q Consensus       190 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  264 (358)
                      .+......     .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            76433221     1223456999999999999999999999999999999999999999766555444333332222111


Q ss_pred             CCCCccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          265 GMPSQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ....++....         ...+.+++..|+..+|++||++..+.+.|++.
T Consensus       235 ~~~~~l~~~~---------p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         235 TPLRELCAGF---------PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             SCHHHHTTTS---------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CChHHhcCCC---------CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            1111111111         13567789999999999999998888776654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-45  Score=327.09  Aligned_cols=261  Identities=20%  Similarity=0.275  Sum_probs=197.1

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE  115 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~lv~e  115 (358)
                      +++|++.+.||+|+||.||+|.+. +|+.||||++......  ..+..|+++++.++|++ |+.+..++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            578999999999999999999975 4889999988653322  45678999999997665 5556667778889999999


Q ss_pred             ecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcC---CCCeEEeccccceecC
Q 018304          116 FMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLARAFG  192 (358)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~---~~~i~L~Df~~~~~~~  192 (358)
                      |+. +++.+.+....  ..+++..++.++.|++.||+|||+++   |+||||||+||+++.   +..++|+|||++..+.
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            995 46666654333  33999999999999999999999999   999999999999864   4579999999998864


Q ss_pred             CCCCC-----CccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          193 GDETE-----GNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       193 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|+|++|..||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            33221     1223457999999999999999999999999999999999999999776655444333222221111111


Q ss_pred             CccccCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccC
Q 018304          268 SQLIDPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSE  315 (358)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~  315 (358)
                      ..+....         ...+.++|.+||+.+|++||++.++.+.|+..
T Consensus       238 ~~~~~~~---------p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         238 EVLCKGY---------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHTTTS---------CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             hHhccCC---------CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1111111         13567899999999999999999887776644

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.1e-45  Score=329.99  Aligned_cols=262  Identities=18%  Similarity=0.288  Sum_probs=199.9

Q ss_pred             cCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeC--CeeEEE
Q 018304           38 TNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLI  113 (358)
Q Consensus        38 ~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~--~~~~lv  113 (358)
                      .++|++++.||+|+||+||+|++. +|+.||+|+++...   .+.+.+|+++|+.++ ||||++++++|...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            368999999999999999999985 48999999997543   356789999999995 99999999999854  468999


Q ss_pred             EEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCC-CeEEeccccceecC
Q 018304          114 YEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLARAFG  192 (358)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~-~i~L~Df~~~~~~~  192 (358)
                      |||+.+++|..+.      +.+++..++.++.||+.||.|||++|   |+||||||+|||++.++ .++|+|||++..+.
T Consensus       111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            9999999987653      23999999999999999999999999   99999999999998665 59999999998763


Q ss_pred             CCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHH----------
Q 018304          193 GDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKL----------  261 (358)
Q Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------  261 (358)
                      ..   .......+++.|+|||.+.+. .++.++||||+||++|+|++|..||.......  .........          
T Consensus       182 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         182 PG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             TT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHH
T ss_pred             CC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhh
Confidence            22   223345688999999987765 57999999999999999999999976543321  111111000          


Q ss_pred             --hhcCCCCccc-----------cCCcCCCCCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          262 --WNEGMPSQLI-----------DPCIQGSFNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       262 --~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                        ........+.           ..............++.+||.+||+.||++|||++|++++-+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence              0000000000           000111111112245778999999999999999999999877653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-45  Score=334.06  Aligned_cols=265  Identities=23%  Similarity=0.269  Sum_probs=194.7

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCccceeeEEEe------C
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------G  107 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~------~  107 (358)
                      +-++|+++++||+|+||+||+|.+. +|+.||||++.+  .+......+.+|+.++++++||||++++++|..      .
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            3478999999999999999999986 499999999965  334455678899999999999999999999964      3


Q ss_pred             CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEecccc
Q 018304          108 EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL  187 (358)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~  187 (358)
                      ...|+||||+.++.+..+.      ..+++..++.++.||+.||.|||+.|   |+||||||+||+++.++.++++|||+
T Consensus        95 ~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             ceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence            6889999999775554432      23899999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhh----
Q 018304          188 ARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWN----  263 (358)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  263 (358)
                      +.....   ........+|+.|+|||.+.+..++.++||||+||++++|++|..||...+..   ...........    
T Consensus       166 ~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~---~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         166 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCP  239 (355)
T ss_dssp             ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCH
T ss_pred             hhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH---HHHHHHHHhccCCCH
Confidence            876532   22334556899999999999999999999999999999999999998643321   11111111000    


Q ss_pred             --------------cCCCCc-------cc-cCCcCCC--CCHHHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCC
Q 018304          264 --------------EGMPSQ-------LI-DPCIQGS--FNLAEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSET  316 (358)
Q Consensus       264 --------------~~~~~~-------~~-~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~  316 (358)
                                    ......       .. .......  ........+.+||.+||..||++|||++|++++-|...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                          000000       00 0000000  11223456889999999999999999999999877653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=329.78  Aligned_cols=265  Identities=22%  Similarity=0.305  Sum_probs=198.3

Q ss_pred             hcCCCCcceeecccCCccEEEEEEc-CCCEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----
Q 018304           37 ATNNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----  108 (358)
Q Consensus        37 ~~~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----  108 (358)
                      +.++|++++.||+|+||+||+|.+. +|+.||||++.+.  .......+.+|+++|+.++||||+++++++....     
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            4679999999999999999999975 5999999999753  3445567889999999999999999999986432     


Q ss_pred             eeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEEeccccc
Q 018304          109 EKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLA  188 (358)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L~Df~~~  188 (358)
                      ..+++++++.+++|.+++...    .+++..++.++.||+.||.|||++|   |+||||||+||+++.++.++++|||.+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence            346667778899999998432    3999999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCCCCccccccccCCCCCcccccCC-CCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhHHHHHHHhhcCCC
Q 018304          189 RAFGGDETEGNTKRVIGTYGYMAPEYASDG-QFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLIGHAWKLWNEGMP  267 (358)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (358)
                      ...     ........|+..|+|||.+.+. .++.++||||+||++|+|++|..||...+..   .....+..... ...
T Consensus       169 ~~~-----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~-~~~  239 (348)
T d2gfsa1         169 RHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVG-TPG  239 (348)
T ss_dssp             -CC-----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC-CCC
T ss_pred             ccc-----CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC-CCC
Confidence            753     2223345688899999987665 5689999999999999999999998654322   11111111110 000


Q ss_pred             CccccC------------Cc-CCCCCH-----HHHHHHHHHHhhhcCCCCCCCCChHHHHHHhccCCC
Q 018304          268 SQLIDP------------CI-QGSFNL-----AEVIRCIHIGLLCVQQHPKDRPSMPSVILMLGSETV  317 (358)
Q Consensus       268 ~~~~~~------------~~-~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~ell~~l~~~~~  317 (358)
                      ......            .. ......     .....+.+||.+||+.||++|||+.|++++-+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            000000            00 000011     112356789999999999999999999998776543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.2e-39  Score=297.13  Aligned_cols=268  Identities=19%  Similarity=0.192  Sum_probs=194.1

Q ss_pred             CCCCcceeecccCCccEEEEEEc-CCCEEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCCccceeeEEEe
Q 018304           39 NNFSINKKLGQGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCIQ  106 (358)
Q Consensus        39 ~~y~i~~~lg~g~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~iv~~~~~~~~  106 (358)
                      +||++++.||+|+||+||+|++. +|+.||||++++. ....+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            57999999999999999999985 5899999999763 333466778998888875           4789999988865


Q ss_pred             C--CeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCcEEEcCCCC----
Q 018304          107 G--EEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQ-DSRLRIIHRDLKASNVLLDQDMN----  179 (358)
Q Consensus       107 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~~~~i~H~di~~~Nilv~~~~~----  179 (358)
                      .  ...++++.++..+..............+++..++.++.||+.||.|||+ .|   |+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            3  4566777776655444433333444559999999999999999999998 88   999999999999986653    


Q ss_pred             --eEEeccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHHHHHHHhCCCCCCCCCCCCCchhH--
Q 018304          180 --PKISDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGILLLEIISGKKNRGFYHSDNNLNLI--  255 (358)
Q Consensus       180 --i~L~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~--  255 (358)
                        ++++|||.+.....     ......+++.|+|||++.+..++.++||||+||++++|++|+.||............  
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              99999999876422     223456899999999999999999999999999999999999998765432211111  


Q ss_pred             -HHHHHHhhc------------------CCCCccccCCc----------CCCCCHHHHHHHHHHHhhhcCCCCCCCCChH
Q 018304          256 -GHAWKLWNE------------------GMPSQLIDPCI----------QGSFNLAEVIRCIHIGLLCVQQHPKDRPSMP  306 (358)
Q Consensus       256 -~~~~~~~~~------------------~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  306 (358)
                       .........                  ...........          ...........+.+||.+||+.||.+|||+.
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence             111110000                  00000000000          1112344556788999999999999999999


Q ss_pred             HHHHHhccC
Q 018304          307 SVILMLGSE  315 (358)
Q Consensus       307 ell~~l~~~  315 (358)
                      |+|++-+..
T Consensus       324 e~L~Hp~f~  332 (362)
T d1q8ya_         324 GLVNHPWLK  332 (362)
T ss_dssp             HHHTCGGGT
T ss_pred             HHhcCcccC
Confidence            999987655

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=2.4e-23  Score=173.05  Aligned_cols=169  Identities=20%  Similarity=0.166  Sum_probs=119.9

Q ss_pred             CCcceeecccCCccEEEEEEcCCCEEEEEEecccC------------------hhhHHHHHHHHHHHHhcCCCCccceee
Q 018304           41 FSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKIS------------------EQGLKELKNEVILFSKLQHRNLVKLLG  102 (358)
Q Consensus        41 y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~------------------~~~~~~~~~e~~~l~~l~~~~iv~~~~  102 (358)
                      +.+.++||+|+||.||+|.+.+|+.||||++....                  .........|...+..+.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45688999999999999998889999999864211                  111223446888899999999988876


Q ss_pred             EEEeCCeeEEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCcEEEcCCCCeEE
Q 018304          103 CCIQGEEKLLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSRLRIIHRDLKASNVLLDQDMNPKI  182 (358)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~~~i~H~di~~~Nilv~~~~~i~L  182 (358)
                      +.    ..+++|||+++..+.+          ++......++.|++.++.+||++|   ++||||||+|||++++ .++|
T Consensus        82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence            53    3479999998755432          445556789999999999999999   9999999999999865 5899


Q ss_pred             eccccceecCCCCCCCccccccccCCCCCcccccCCCCCCcccchhHhHH
Q 018304          183 SDFGLARAFGGDETEGNTKRVIGTYGYMAPEYASDGQFSVKSDVFSFGIL  232 (358)
Q Consensus       183 ~Df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i  232 (358)
                      +|||.+.....+............    -.+. ....|+.++|+||+.--
T Consensus       144 iDFG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         144 IDFPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCCTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHHHHHHHH----HHHH-HcCCCCCcccHHHHHHH
Confidence            999998765322111000000000    0011 13567889999996543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.92  E-value=5.9e-09  Score=89.06  Aligned_cols=150  Identities=15%  Similarity=0.060  Sum_probs=108.7

Q ss_pred             HHHHHhcCCCCcceeecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCee
Q 018304           32 ATIVSATNNFSINKKLGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK  110 (358)
Q Consensus        32 ~~~~~~~~~y~i~~~lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~  110 (358)
                      +++...-..|++++..+.+..+.||+... +++.+++|+...........+..|...+..+. +-.+.+++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            36677778999888866666678998854 67788899887654444556778888888874 44467888888888899


Q ss_pred             EEEEEecCCCCHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCCC-------------------------------
Q 018304          111 LLIYEFMTNKSLDSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDSR-------------------------------  159 (358)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~~-------------------------------  159 (358)
                      ++||++++|.++.+....        ......++.++++.+..||+...                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            999999999887665421        11223345566666666765420                               


Q ss_pred             -------------------------CCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          160 -------------------------LRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       160 -------------------------~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                                               ..++|+|+.|.||++++++.+-|.||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                     1279999999999998766667999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.09  E-value=1.3e-05  Score=67.21  Aligned_cols=131  Identities=18%  Similarity=0.118  Sum_probs=86.0

Q ss_pred             eecccCC-ccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcC--CCCccceeeEEEeCCeeEEEEEecCCCCH
Q 018304           46 KLGQGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMTNKSL  122 (358)
Q Consensus        46 ~lg~g~~-g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (358)
                      .+..|.. +.||+....++..+++|.......   ..+..|+..++.+.  .-.+.+++.+..+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444554 578999876788889997754322   34667888887774  23467788888888889999999988655


Q ss_pred             HHHHhccccccCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 018304          123 DSFIFDQERCKILDWSKRFHIICGTARGVMYLHQDS--------------------------------------------  158 (358)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--------------------------------------------  158 (358)
                      .+..        ....   ..+.++...+..||+..                                            
T Consensus        94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            3311        1111   11223333444444321                                            


Q ss_pred             -----------CCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          159 -----------RLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       159 -----------~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                                 ...++|+|+.|.||+++.++.+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                       11279999999999998876677999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.90  E-value=3.7e-05  Score=68.91  Aligned_cols=76  Identities=11%  Similarity=0.174  Sum_probs=49.4

Q ss_pred             ceeecccCCccEEEEEEcC-CCEEEEEEecc----c---ChhhHHHHHHHHHHHHhc-CC-C-CccceeeEEEeCCeeEE
Q 018304           44 NKKLGQGGFGPVYKGTLVD-GQEIAVKRLSK----I---SEQGLKELKNEVILFSKL-QH-R-NLVKLLGCCIQGEEKLL  112 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~-~~~v~vK~~~~----~---~~~~~~~~~~e~~~l~~l-~~-~-~iv~~~~~~~~~~~~~l  112 (358)
                      .+.||.|....||++...+ ++.+++|.-..    .   -.....+...|++.|+.+ .+ | .+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4578999999999998644 67899996532    1   111234455688888776 33 2 45566543  5667789


Q ss_pred             EEEecCCCC
Q 018304          113 IYEFMTNKS  121 (358)
Q Consensus       113 v~e~~~~~~  121 (358)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.07  E-value=0.0021  Score=55.10  Aligned_cols=159  Identities=12%  Similarity=0.010  Sum_probs=82.0

Q ss_pred             eeHHHHHHhcCCCCccee-----ecccCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cccee
Q 018304           29 FELATIVSATNNFSINKK-----LGQGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLL  101 (358)
Q Consensus        29 ~~~~~~~~~~~~y~i~~~-----lg~g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~  101 (358)
                      ++.+++...-.+|-+.+.     |..|-.-+.|+....+ ..+++|+.....  ....+..|++.+..+...+  ++...
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-CcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            455677777788877543     3456667789988744 458999886421  1234445666666663211  11111


Q ss_pred             e------EEEeCCeeEEEEEecCCCCHHH-----------HH---hccc------------------------cccCCCH
Q 018304          102 G------CCIQGEEKLLIYEFMTNKSLDS-----------FI---FDQE------------------------RCKILDW  137 (358)
Q Consensus       102 ~------~~~~~~~~~lv~e~~~~~~L~~-----------~l---~~~~------------------------~~~~~~~  137 (358)
                      .      +.........++.++.+.....           .+   ....                        .......
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      1222445566676665422210           00   0000                        0000111


Q ss_pred             HHHHHHHHHHHHHHHHHhcCC-CCCcccCCCCCCcEEEcCCCCeEEecccccee
Q 018304          138 SKRFHIICGTARGVMYLHQDS-RLRIIHRDLKASNVLLDQDMNPKISDFGLARA  190 (358)
Q Consensus       138 ~~~~~~~~~i~~al~~LH~~~-~~~i~H~di~~~Nilv~~~~~i~L~Df~~~~~  190 (358)
                      ......+..+...+...+..+ ..+++|+|+.++||+++++...-+.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            112222222333333332221 22499999999999999887778999998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.03  E-value=0.001  Score=59.27  Aligned_cols=73  Identities=18%  Similarity=0.246  Sum_probs=49.3

Q ss_pred             ceeecccCCccEEEEEEcC--------CCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEEE
Q 018304           44 NKKLGQGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIY  114 (358)
Q Consensus        44 ~~~lg~g~~g~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~lv~  114 (358)
                      ++.|+.|..-.+|++...+        .+.|++++... .. ..-...+|..+++.+...+ .+++++++.    -.+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            4678889999999997643        35677777653 22 2334567899998885334 457777763    26889


Q ss_pred             EecCCCCH
Q 018304          115 EFMTNKSL  122 (358)
Q Consensus       115 e~~~~~~L  122 (358)
                      +|++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.86  E-value=0.006  Score=52.44  Aligned_cols=69  Identities=10%  Similarity=0.000  Sum_probs=46.0

Q ss_pred             cCCccEEEEEEcCCCEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--cccee-----eEEEeCCeeEEEEEecCC
Q 018304           50 GGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLL-----GCCIQGEEKLLIYEFMTN  119 (358)
Q Consensus        50 g~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~~~--iv~~~-----~~~~~~~~~~lv~e~~~~  119 (358)
                      +..-.||++...+|..|++|+... ......++..|...+..|....  ++...     ..+......+.+++++.|
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cccceeEEEEcCCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            445689999888899999998754 2334466778888888874221  11111     223455677889999876